<SEC-DOCUMENT>0000856982-23-000011.txt : 20230224
<SEC-HEADER>0000856982-23-000011.hdr.sgml : 20230224
<ACCEPTANCE-DATETIME>20230224164531
ACCESSION NUMBER:		0000856982-23-000011
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		132
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230224
DATE AS OF CHANGE:		20230224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18592
		FILM NUMBER:		23668136

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mmsi-20221231x10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.2.0.4 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 2/24/2023 8:59:24 PM -->
      <!-- iXBRL Library version: 1.0.8405.27969 -->
      <!-- iXBRL Service Job ID: ee758cdf-6780-484d-9410-c9747811f263 -->

  <html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:mmsi="http://www.merit.com/20221231" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" xs:nil="true" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" name="us-gaap:CommitmentsAndContingencies" id="Hidden_jZK6Ff6E6E29e0MCB7PA_w"></ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" xs:nil="true" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" name="us-gaap:CommitmentsAndContingencies" id="Hidden_Q5mMTZ3-9Ei4SLdnz3sSZA"></ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_a6q6MSDqW02kPa4lJGG3MQ" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_-F6JAansME-6ivQLmCJpgQ">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_ojRaZ6fkA069121R4Kpt7A">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityCentralIndexKey" id="Tc_zeVN8Ij9d0uMa9UYvBsSEw_2_1">0000856982</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:DocumentFiscalPeriodFocus" id="Tc_dQfE1MA3vUmOHWgK1H53og_3_1">FY</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:AmendmentFlag" id="Tc_ftZzsjtvp0Sz2HdeH0pGEA_4_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="Hidden_frXeFarGiUC9Xa6_8PBv_w">http://www.merit.com/20221231#BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_RRFbuM6IW0WMiChfS3Tzdg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_UWAof0yarU6NTEHaMNw7SA">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_pJvOPl2RREyfdTsXzdBBYg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityRegistrantName" id="Hidden_POn8fFDjMkenU0zOUvoI0g">MERIT MEDICAL SYSTEMS INC</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" name="us-gaap:CommonStockSharesIssued" id="Hidden_ExF1dirmUkOPTq79RIy2qw">56570000</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" id="Hidden_p8UrIZ0jDUysfw2uR9n5Qw">57306000</ix:nonFraction><ix:nonNumeric contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" name="us-gaap:RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" id="Hidden_3TY6OSQeDUqQF8jraSti9w">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg" name="us-gaap:RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" id="Hidden_wEJKBHaF4ku_LLZF6o-vSQ">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentOneMember_p32be_SWykGz2teKntXcOw" name="mmsi:ContingentConsiderationPaymentPeriod" id="Hidden_omYxHiM9FUeLz86EaJiDGg">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_Yg3eGli2zEW7bA8OSCslYA" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_C8dJmPtioUimQru8e7qEng">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_VqI937vS7Uyy85OFwQu_0A">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_jrl_1y8mUE2lw5OKuH_56w">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_ccOqommAIUOJx6oYxeTW7g" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_ys3ojRh7S0GRuIZh-sLDXg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_LauraneMedicalS.A.S.Member_1wpeXbI0cEecSrjzJb-LeQ" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_gcPAqbzfw0OI2MXDaQHSdA">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_GZdF6FbMRk6IMRPpvp4agg" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_H5Y08u8ZsUaN3kikLiRRBA">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_OtherIntangibleAssetsAcquiredMember_kqfrwoAXJEelfiTvRFAw3A" name="us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_Xf0THVuuXkWITmOMBoHiHQ">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_w_w-NqxInkmFUqMf_XcMMQ" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_EbHCmjYljUGB_8dKno-fsQ">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_zAFzt7xtHEazGu7si-1YKg" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Hidden_hlnL4vN8SUG8ae4Eqn09kg">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_iyd5XGEpw0C-bvBjxzoeAw" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Hidden_xGgJ2uRJGkuzkcphmVUYXA">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember__4rStAvy_02iitxQUT2v7w" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Hidden_z1_aUA5vikuLxGHYLl_gBQ">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_NDXPu66jak-ZMyYsakdLbQ" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Hidden_d8w-m4ewDEurtEdt4iLbkQ">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cPPJwMeQPUeIYf6LbWUGag" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Hidden_t8cBNSblNE-IWNGe1sg12Q">P2Y</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Hidden_eEnAFWZ5UEGI9LcVSBtx5g">0</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="Hidden_TpnXjRgdGkC2N239gRk-Nw">http://www.merit.com/20221231#BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_PXZ4MOWrBUiFixPo1YrNdQ">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_srt_CounterpartyNameAxis_mmsi_NinePointMedicalInc.Member_DqLbR1-f_USM3HqTH1_MPQ" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="Hidden_5ha5obNG7EukzOsmSgU-lg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="mmsi-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_eIOjLCC_ckKJd7j-tagx0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Tcw0rwvwnUCNggwvx-hToA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vuB28aRB70m7DQkE04axrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_ymPQ_EUUskWNwXusRc-oFg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vb9_o2qO3UyDJVFE_VYJKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_j64W9w2JFkaNZCAs8PllJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_DS1rt81n2UuuEQSAYL8cwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_XT-DImLBW0CLqTtA5KznqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_fERnc1ZCQkW-tUKySpgZRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_B7su2MaR6Ue9mzoD3SVZSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Ksk8oPM3pkWXnmJp3aVfjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dwnvij5qh0aeUakBIbwM3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_85rQK-4M5ECcEsi9kKnxVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gSVl3EPpKEKYTN8MPw6Tkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bQN0IS6wDU6ClnshU71aSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_KA5J2PovC0-VQ20gGn884Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0dOxMvz3KkeA-_6PU6WRIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_4hpPQW9-gkirQ7OHsm1waA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_689J25SRoUeFQ-mb_xQzMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_aN4IaMh0wkmaWTjP49uYEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_NNFXt7P21UW4Paq_45LQzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGIvY-Wghke_ETbCqrVrlA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_Xv_jjMZ61Uuj4krxMBlGGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3aRiaMEyxkWBqtSJEkrr9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_m354GPzJSkesgFQaFE_wMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gK8hNbA-mU2xGdCtF3REPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_0Wxh9uRER0u6z2OziPvL-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_G-kv3r9YKUyaVq6iMWD8VQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2ZYBTZI1iUGbF66gUMJ3jA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_N2nptxswq06E37WY0fAdLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_DsDJDza1hEOKOCEENBEccw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_AIeZ1LxyUU-U04p2bkns4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_7hQKDlFBGE-A_JKU8z88Kg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_WBFuNp9-sEOaCJ0Ax7YM3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_3fb8WLlr80-4_6v213qfgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_GxO2voBvw0KcdDmVJ8OK8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_a0RjGlBUeUa4iriFWOGd0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yq6tnYStUk6a7MAFzkSQcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_4i2h-0r8ekOAQM9CYwMASw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_i-4hy_JVkUqCTXWyIeMrmQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_30JNZGvr7EC6MKrc7WWXwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_fxzT2CfP7UGLlti0xqKeog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_4HZjeHhca0CJ9R9TG0L3fA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:TargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_b4qnuJ-OWEiHrjQRnWlLXw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumUnitsGrantedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_gLbiasFwxkmKONzOlnKAwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumPotentialSharesGrantedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_94jGRzIuckyUf5V563Shhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:TargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_RYZsnkxzTkaTfXLFz_Zj2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumUnitsGrantedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s46DzGkVO0Sh6osOFwanZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumPotentialSharesGrantedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_kGEvFzHWaUq1-E8uQ61arA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:TargetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_OSPO592R7EqioAf9pi9vfA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumUnitsGrantedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_U_TUWGHmYk20d863KAh-8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumPotentialSharesGrantedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_zAFzt7xtHEazGu7si-1YKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_R06ETi2TMkqS-odoJkwA1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember__4rStAvy_02iitxQUT2v7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_n09B1uG-xESAohYo-rybSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_iyd5XGEpw0C-bvBjxzoeAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cPPJwMeQPUeIYf6LbWUGag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_WIq3iXtF5EuvyViG_OJs8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_NDXPu66jak-ZMyYsakdLbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_OvQHRNSqw06QppxX6EnjNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_bbrBKCNcLUOQmTf4LjLfbA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W7ZIFyCygUuKNAAvOSvoSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Nn7nL1keE0GsDMUUEXCHfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XDLejGk_vku62keNdhz1pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_W4Nbl4v2vEWmCyXaR8_MbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_JN31JqK8TUSZFC4jUhNaUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_GzZqc0UGTEKLB-X3K1JMdg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_PGWSswwuFk6OV2hMBsWqtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_5mDvHL5jDk-TEtW54Ne1dw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_fMTs59rneUqo5v_BpAVSDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o4zAyiweSU6Li2EVnzgs_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_va_cfvyIrkys5qSCajkJtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dh9NAeeWGEOTyKx9dRNgQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_80TSk5DGpEiuyohE3PdYuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_EZu2oq9JWkySFQgXZx80hQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pL5Mknj4JEmgIcuiUR69sg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_gXuoUnaox02wGzKWXWNqtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_1Z_4de4ygUqLS5DxUcunbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qOiOMhYAGEOB7wKJJI87ZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_-UggGEQK5U2pkGO6tH6iag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_dSg8kh6DlkyLKSVn2mRmPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_q-ArAJXhsESzPPSHFsKcWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_CN_qZO_CIcm8EKmg0YTRChTXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_67-Tqlponk6UZvQATQw19w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vqVnEcbqgk2jvODZ8WKvRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_lluU2dZDfkKiBp-RaJI-hQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vZc6fJE-3EKIbRcC9xqtKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_rbVoGsHPjU-z7VMqPG5eTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_TuXIR_4O_0SCoIN9zotxUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_6oiLFHWLjEaJLXpc4zEA1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_aoV-srO-v0C_CmlJQCQsxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_cOSP19REXkC1_oAwXrzLgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_g8ILwIqCCkGF8WrNEHY3EA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_b4I5jqtYA0uVHc7AxRDbqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_Hz0JZzm31kalsEp3ZcM9cA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_129nQ-x5H0i8Qfcm3bT7Ew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_NKU1bXBovEOvuplur33cjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_49WaWthqHUyKFHaIaWPRbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_UdQi9w9_x0afDHEY0-2BYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hYBaR7_UwkCAZ6qoxFrGIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_2Zks2ScobUOdPYr6gUlL_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_lPoQtyNyi0OGB2OF5XQXnw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_CN_P4z8MxOErEe5ei5ipgHNOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hLXkkEVnQ0euQQ6ojlb_1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XRuhIx6aiEeybATIhaSCew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_RROgTsYenkCF6Vl9lsgjUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_m-3FCbMdj0GAx8FAxAcY0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_ezMW-IvdrEydHhCgww1eQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_-HWMY93UmE2VbbgFMJMnIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pPXbTXxRSEOTXXv96LRH3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o6wsE8xC70etjMC36EOexw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_nB-ZtSzHwEaoYetvplSrzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_SZX6ag4YY02YUh000gdDGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_9SbQy8Y_7E6dXc-zGjv5Ng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_rIqmoSek306nJEUyZctJvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vOi-T_pyI0GCZHYU5lqDhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_oykmNEiVm0ie0Ya6Hql15Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_2faHD7Y0VE2-7TwAJ3e-Vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dQ1w9qgJwkKMRf4Eg6YHWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_bAPCtJ49gEqQWOqwDxwUJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_mCRjJpSbEE2JseTs6klpUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_UKcyzBm0EE25HgNKqiye4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_CN_DoIlPAu9x0ysbFQn9Of8Yw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_YvMztLBIikevootYF9Q_Vw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_r2Dw8i5qFkieuyppXBpYLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_YTeZcpsajkOtbBGdZAUyYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_s1acsZS6iEKC098oWQyTug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_5XhIeqfIC0aQ7HSWBJyoYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_c5bBLUi-vkiFEa6Kh9D6GQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_4_A4JH-cIkyKmiFBjtHFug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_bHmUCFOtj06ZlP-Hj9nRQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember_zjDdU-1CK0yQn-YgCOPErQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_eeu5akz68Uus_Sjj54jzQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mmsi:NonUSExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_US_snTmzJ5T0E656AhhDMpMQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_IE_GfG6bD0w406OQ3evGEIt8A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_VeCyfvZPU0KduGRAlFl2sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mmsi:NonUSExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_US_GwhTWC6jokaibH93vL9asg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_IE_VUWTuDtMwkqMhwjAVcktqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember__hoYCGHvzUiBpV80UeFJuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mmsi:NonUSExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_US_8HeXqvsEIk-auaw5myy4uA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_IE_eGJe27sczEalkw_qMPNw1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_SNuT8N5JSkC1oU513hKP5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-04</xbrli:startDate><xbrli:endDate>2022-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_4_30_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_kSDG572XaUOLA_xcDYEc0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_9_1_2021_To_9_30_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_2Xu6PUGyB0KxT8eU3R1ceA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_12_31_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_nvOWf0YPFkKnDI6lHS5MgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_3u3FWHkJQ0qDFakJiBI-Qg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:CiannaMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_sxaYw4aSrkameQjBWdLV-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:CiannaMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_LitigationCaseAxis_mmsi_MeritShareholderDerivativeSuitMember_ewzR_Ik4L0K4K-iU6Qne5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mmsi:MeritShareholderDerivativeSuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_YtPykTJnRkKC0CuJpKTvOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_J_jEZHS6W0CE4zFDg0hOEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9e9qLIpZ9kKq6G-HazuXuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_651_ONWx0E-kOfcPokz1LQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_DSBEv7Elwk6u3sZ3evR8Mg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9f2ZOgRsCESUeU-GyCvi5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_z9Y6hxatL0aNPYGB24x1vQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_EjcLYIKKkkCUoWHgDM1Mxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Mb6B1L4bMUW6eZXS3Daluw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_zc2ERyYBRUKEX1L10n6VZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_Ywl3JgUM702U95RFgQlRaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_GVmvdOejHUemtyQusSrLBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_vnyL3I4nU0O1maZQbdeu6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_cNz_-CadmU-KLZHsUgTE7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_bN8XBH6sl0Oi6_jiK3FrEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_smMsnEfusEi6-EuzPWs_CQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_e0_SslW0xEmjVG9Y4QH58Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QnNOgXob5EeqCbUSSdW6NQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_T8JXswSBYku-qE6hvnoCVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_LgZE-P7vHUGygqnbkaU4QA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_QnCxU02fNUm64FC2KL9WNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_Yg3eGli2zEW7bA8OSCslYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:STDPharmaceuticalProductsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_ccOqommAIUOJx6oYxeTW7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:STDPharmaceuticalProductsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_OtherIntangibleAssetsAcquiredMember_kqfrwoAXJEelfiTvRFAw3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:OtherIntangibleAssetsAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_GZdF6FbMRk6IMRPpvp4agg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mmsi:LicenseAgreementArravascLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_LauraneMedicalS.A.S.Member_1wpeXbI0cEecSrjzJb-LeQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:LauraneMedicalS.A.S.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mmsi:LicenseAgreementArravascLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_CounterpartyNameAxis_mmsi_NinePointMedicalInc.Member_DqLbR1-f_USM3HqTH1_MPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:NinePointMedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_MDSV0pNPBkaFq-morkVg5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-04</xbrli:startDate><xbrli:endDate>2022-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_Q-sH4tc8t0y8Us3FOrczrg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_M_cqHBv4VEmQzw8E4TMvlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_ivrHt2y9VEu_1nKzuAKxTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_ounleXUwDkGNqZctsTtL_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:SelioMedicalLimitedSelioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_FjbGmVYKb0ij4cN6X0KS1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:SelioMedicalLimitedSelioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_4qQbrD0xJ02K_LJUhv6gQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_-dsubK6ei02Er5tXNOop6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_mmsi_BluegrassVascularTechnologiesIncMember_SYBvPqScc0WI8eIanV1mkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mmsi:BluegrassVascularTechnologiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_bvBD3HDjRUa2xKKy5B1nrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_WFeSl2nEiUeMnJom75DnaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_DUaZCPw_8kabeorUeHmx0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FusionMedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_XableCathMember_olpSi2DLokilw5cmv-tukQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:XableCathMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_rCYZXv1CfE2ubKNZDLYiJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FusionMedicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_BluegrassVascularTechnologiesIncMember_F_LmcolU_0qcGjS4sv6hNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:BluegrassVascularTechnologiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_ATNZbLCh8keW60__JyknWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_8_8yxPQPFUu5XLbijWH-yA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_H7J11ScbqEi4fWoBfmyKZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_qFOq_wW62kSSMs1OwxY3-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_RnYw5KwjtEiUa6kDr0cJuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_QrfXxo7G-0CQLXG-eerz5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_a6q6MSDqW02kPa4lJGG3MQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_w_w-NqxInkmFUqMf_XcMMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_0hUma_OATUuPqA-Tunbzmw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLiborSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_mTy83y8sAEyrrLjPi86-Aw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLiborSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V96Xu0PnRkq7CZcqhwZ9wg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_7Bk5S5y3pUqsM1mFsZA5qw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V3-frjJY_UmM_jR_g6jVHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_BBWY2l8nB0G5rPJksNt47A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_6HKnbEJ3LkOuSxP6-rmASg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_ubGIOi0F8UCMr2ybX-8S_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_jOoxPiQ8oEKYkVGlwyYgBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_sDnLdoNkA0G_KKlMx5qh6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_vMDqDRimQUGVsJqDaXM38A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_IUTMOoGSYUSlf5FDP00RrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_uNomnuKXAECdAPu7QMed0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OD_1uS3fckadl_NP9-khyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_L0K7XndHi0OEyV8MrOqpmA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_d3jAs283gEicHG2ZvBV4CQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_EqJKyjSWGE2cWtmKmguTYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_fGTXof4L9kC2AsOYsnC7lA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JDBrXX4eGkm0WfKXgEw4_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JOxaSybhBEmm93r7VwCklA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_IouJ1SF8gkaMhJelEUky_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_4HjX7W_AtkazUBHgOvHHrw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_KKxUChovJUKc65GGLrR6Tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_mnlw2YbJNke1XUMLVydA-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_nxzNJ9zo90yLi_8Qv5ROqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_9Ang2hn4Y0KLAWIwdCgBog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_cNga-H3nA0mvS1ecmQSc8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_BT1_boCV1EyK74esn0nh_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_v_3MlJjEwkOhh_n4KP2NWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_qVc5qszmDkqekOg1yJuHmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_jemfLXarqUS_VyGv8WDThA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e1glezOlAEmHZyfzYLhmhA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_iWQuWEDGp0W1mLQsaz5M_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e03sqdjmAUSi1TluISkF4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_hsK8EQLFzEaatbWI6fI09A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wFq40ECBeEqsCzPUL8162A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wS-nk3dwt0SoycQ0IxdNoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_8hQxF1RJzU--ikXVveEKCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_XG-RKCkLlk22Ae6PugLZbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_E2OX24rrYEG3vsZbSdeyig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_9kdasnow90OyrWKURUS9Eg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_DfuOLsD7TkeHPFVz0G_RxA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_sNZB_NpM8EKYkfbbamr2_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mmsi:MilestonePaymentProbabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_NTaqduRlGUyMLasvGWVtVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_xbdo5FZuEUGtMQe0eFs_lQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_qnG1d3UiJEG-s9zu8DRZxQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_CDuUTCWXo02V70P4F5nz2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_5Yv24v4EpUO9_ajmgjSijg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_SkTzv3hCxUmDhTZzadO0Pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_3l2pT_uLsEe6KfiO2ucLyg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_yo_aT89odUGvgS5r4beT1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mmsi:MilestonePaymentProbabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__v2v-UROZ0yrwpSXvqOD4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_WLKoC-9vCUuynE48y7ekMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member__0z7AfckH0-izPRxsHj-CA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_ShfGhn6sDEqCKCrlJf3LYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_jvGr01_VCUqWKwQSHCGhuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_UyL0y39Dlki1ZpAdwy5TMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_FDcVr11fvEi_blj5LZlxhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_kDxdTejFnEar4hcZNMbfOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_tITBjrk_HkGRwTnHLPq2Og"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_DL7l9lCsn0yCicMiO9Paag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_lmH4hrr3Yk2ZNTHoyQXrRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_mhPvROMdBUy9ISn8bUcQsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_kZ1T208TZkm_Zha3uivU5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_jPM7z4e9ckWasY0kB4A02w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_K77TjlnLw02weRu3pGVeuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Cw05VY0_I0-Am1JQU64fgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_iDtT3Y7T4ES-G4M9NJ5iwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Imq-yl3UN0SxC6ocv52NnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_IvGlF5Zb_0aI82EUdrzxpw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_ZZfj3R7V5Eaf4KlhxZX0NA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_MSYHJr3mNU2lIv5avLZ04Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Pn_ji6z-9EujtMdTc7Xe2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N0bSnffBZEK-_wgFvh8Ohg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Kq8CJRyvgEqTiCMrffL5Dg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_T7UpOFHUfUKuQYJJK2urrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_QL5MDDksJk6BV7x5RToVoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W2-lwaQajUmjU-r2zs34Yg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BOpfzPG26ECbr8ZPTKepRw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8PfvIfnmqUCeZXIMgXoYkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62E2hM7g4EGHRbMuBjMCIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_wNH7WZpHE0KRoLTZeAliog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N8U8BNsA1kKxcg9Cty-FoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_z8YzjacK6k6Eh7TEMhdvDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_4h-sVt6F-068ZNWfSqnEFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_yy2rfbwVDkuhigmz2rclqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_NHhcrvVH_U2r85qDDyQQ3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_oIKpm7mrOkCqi-F2r9hloA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-06</xbrli:startDate><xbrli:endDate>2020-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_73syZyrdCEaiuRTfMsiD0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_qRyUmYl8O0y6oUbd1lTTIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_63ieaO-AO0SYaBWn-TK6JQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_2cbkT8Rpj0C4W9Vnfbtf7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_MZN3RxPRPkq5v4w2teFQGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_6xqiAKy5wky58rfPLPedWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_ps-20gTg802P7I1jBP-j0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_CR57zo9ehUqUx1y_296vpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_eA79SptKRUq01tLxfpAtTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Q9sli6HR8kmLtGS6z2LKLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_w8-ho-GtDECtGQ1su5JiUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_HTBgdVUkNka5_SS_wCZMfA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_WBGzb7-2s0OMpcaC1kZThA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_TTFS404ILUWejinxzomjcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_OtYJx8DRZUWhCfnnj12CUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Xa71dYPKVEyT6sWRUfs7wg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_mVSC0isQAkKGdsXQLJIZuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2020_To_6_30_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_r8j-LAr880aFYWGRQw_EMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_umbZmmf59kKHmVjonTjMXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_YBlNOyPkLU23Z6ZjVlbEKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentTwoMember_ezEJWgK2Dki4vj-ItKKXBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:ContingentConsiderationPaymentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentOneMember_p32be_SWykGz2teKntXcOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:ContingentConsiderationPaymentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_HwhbRLWUDECOhM6E1bMPeg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mmsi:RevenueAndCostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_9jqh0ZIn_keRlp7QGXHQFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_Ra4A3LDTXUq1U3wrhOYTzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_-o3_7GcrH0SXneGGIP-6AA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_wkB4WLQ3Z0eP8rqn-djVrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-06</xbrli:startDate><xbrli:endDate>2020-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_4_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_nXJmF9kinUC64uCJFUF8Uw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_4_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_gvKcRF6bkEqNTgBLgoiS5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_-2X5MrVXTE-f1Bx7exs50Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2022_B0at-ZgNSUal6WBDs0yTtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_22_2023_L_MER9-GsU2ij8SaU2daZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg"><xbrli:measure>mmsi:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ"><xbrli:measure>mmsi:DerivativeInstrument</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg"><xbrli:measure>mmsi:segment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:21.01pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_4da93f8e_efb5_4891_802e_8203cb6caeb6"></a><a id="_Hlk126938874"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">UNITED STATES</b><span style="font-size:12pt;"> </span><b style="font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Washington, D.C.&#160;20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:4pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:DocumentType" id="Narr_ltB52QqM1Um0ZvQBbrSy4Q"><b style="font-weight:bold;">10-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:7.2pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:DocumentAnnualReport" id="Narr_APBXb6jPxUKsp8pnl1DP4A"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">Annual report pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt 0pt 0pt 2.9pt;"><span style="font-size:9pt;">For the fiscal&#160;year ended </span><ix:nonNumeric format="ixt:datemonthdayyearen" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:DocumentPeriodEndDate" id="Narr_v2Ie5_ggEkCZ3Ai13vaT-Q"><ix:nonNumeric format="ixt:datemonthdayen" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:CurrentFiscalYearEndDate" id="Narr_VSl2nKyTQkO71ZciqKAk-g"><span style="font-size:9pt;">December&#160;31</span></ix:nonNumeric><span style="font-size:9pt;">,&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:DocumentFiscalYearFocus" id="Narr_yMNiiz3-sEC5gsi90CUvww"><span style="font-size:9pt;">2022</span></ix:nonNumeric></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:36pt;margin:0pt 0pt 0pt 2.9pt;"><b style="font-weight:bold;">or</b></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:7.2pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:DocumentTransitionReport" id="Narr_h1ryGjXd4kKt2UUBOyFzSA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">Transition report pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:36pt;margin:0pt 0pt 0pt 3pt;">For the transition period from&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;to&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>&#160;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:6pt 0pt 0pt 2.9pt;"><b style="font-size:9pt;font-weight:bold;white-space:pre-wrap;">Commission File Number   </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityFileNumber" id="Narr_wfZxCj4cgUyAEJxS4vts3g"><b style="font-size:9pt;font-weight:bold;">0-18592</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:4pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:36pt;margin:0pt 0pt 2pt 0pt;"><img src="mmsi-20221231x10k001.jpg" alt="Graphic" style="display:inline-block;height:20.46pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:119.48pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_POn8fFDjMkenU0zOUvoI0g;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC.</b></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;text-indent:36pt;margin:0pt;">(Exact name of registrant as specified in its charter)</p><a id="_74484d09_8b54_4f56_8dd4_c5822e487f24"></a><a id="Tc_ZdIuq-t2kUmK40KuxS3UUw_1_0"></a><a id="Tc_tGBZPAEaLkGqz_78BcsjJA_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;background:#ffffff;"><tr style="height:1pt;"><td style="vertical-align:top;width:47.74%;margin:0pt;padding:0pt 3pt 0pt 3pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityIncorporationStateCountryCode" id="Tc_y-yhUIgOR0KMOw6ylu9dIw_0_0"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:top;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt 0pt 0pt 3pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:36pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:42.36%;margin:0pt;padding:0pt 3pt 0pt 3pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityTaxIdentificationNumber" id="Tc_PRmJ0GyGYUO4cVa-3pHidA_0_2"><b style="font-size:9pt;font-weight:bold;">87-0447695</b></ix:nonNumeric></p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:47.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">(State or other jurisdiction of incorporation or organization)</p></td><td style="vertical-align:top;white-space:nowrap;width:9.89%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.36%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:36pt;margin:0pt;">(IRS Employer Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:9pt;">&#160;</span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityAddressAddressLine1" id="Narr_whzlD0vO_kCi_trIqTDeEA"><b style="font-size:9pt;font-weight:bold;">1600 West Merit Parkway</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityAddressCityOrTown" id="Narr_MPqdKQCQFUumJfvdcSw0Tw"><b style="font-size:9pt;font-weight:bold;">South Jordan</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityAddressStateOrProvince" id="Narr_PcylK2Jgo0Go1bt7uVzyXw"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityAddressPostalZipCode" id="Narr_s44rlI8ZckGRch7qQwS8Dg"><b style="font-size:9pt;font-weight:bold;">84095</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;">(Address of principal executive offices, including zip code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:8pt;">Registrant&#8217;s telephone number, including area code:&#160;</span><b style="font-size:8pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:CityAreaCode" id="Narr_XY65n8I-2kW_IhYCwkpF5g"><b style="font-size:8pt;font-weight:bold;">801</b></ix:nonNumeric><b style="font-size:8pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:LocalPhoneNumber" id="Narr_SGQsIA_-4kuzcmnyT8KUWQ"><b style="font-size:8pt;font-weight:bold;">253-1600</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;background:#ffffff;">Securities registered pursuant to Section 12(b) of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_1f0e04b9_bbb8_4914_a511_24501eafbe19"></a><a id="Tc_8KxXycCgyEutLSkbDwGxcg_0_0"></a><a id="Tc_SVNNpN_970Wcyi4J9G6tGg_0_1"></a><a id="Tc_xMsu1ylIzUGmgl-vVFDP4A_0_2"></a><a id="Tc_v9rDhlco-kaxvUQfoweqng_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:31.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Trading Symbol</b></p></td><td style="vertical-align:bottom;width:36.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;">Name of exchange on which registered</b></p></td></tr><tr><td style="vertical-align:middle;width:31.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:Security12bTitle" id="Tc_mbwhihsbzkmI8wMDxz-3eg_1_0"><span style="font-size:8pt;">Common Stock, no par value</span></ix:nonNumeric></p></td><td style="vertical-align:middle;width:31.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:TradingSymbol" id="Tc_c_7vdpZam0eB9GBgoAgLUg_1_1"><span style="font-size:8pt;">MMSI</span></ix:nonNumeric></p></td><td style="vertical-align:middle;width:36.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:SecurityExchangeName" id="Narr_UIyCKukdzUaJT-5-HzLuVw"><span style="font-size:8pt;">NASDAQ</span></ix:nonNumeric><span style="font-size:8pt;"> Global Select Market</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:4pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;background:#ffffff;">Securities registered pursuant to Section 12(g) of the Act: None</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:8pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act. </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityWellKnownSeasonedIssuer" id="Narr_pPkalVO0TkWbK2x_23TjDw"><span style="font-size:8pt;">Yes</span></ix:nonNumeric><span style="font-size:8pt;">&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span><span style="font-size:8pt;"> No&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:8pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d)&#160;of the Act. Yes&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span><span style="font-size:8pt;"> </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityVoluntaryFilers" id="Narr_YojeUEbHzEuKRcL3PzgXLg"><span style="font-size:8pt;">No</span></ix:nonNumeric><span style="font-size:8pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:8pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityCurrentReportingStatus" id="Narr_Y5j8wTvvq0mXQabibwaw1Q"><span style="font-size:8pt;">Yes</span></ix:nonNumeric><span style="font-size:8pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span><span style="font-size:8pt;">&#160; No </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:8pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityInteractiveDataCurrent" id="Narr_puJEPQ3Skke8_4eNymw0ng"><span style="font-size:8pt;">Yes</span></ix:nonNumeric><span style="font-size:8pt;"> </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span><span style="font-size:8pt;">&#160; No </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:36pt;margin:0pt 0pt 3pt 0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &quot;emerging growth company&quot; in Rule&#160;12b-2 of the Exchange Act.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:entityfilercategoryen" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityFilerCategory" id="Narr_M7HysM7ZlkGjhxwyA3keFw"><span style="font-size:8pt;">Large Accelerated Filer</span></ix:nonNumeric><span style="font-size:8pt;">&#160;</span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></p></td><td style="vertical-align:top;width:15.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;">Accelerated Filer&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:17.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt;">Non-Accelerated Filer&#160; <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:20.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:8pt;">Smaller Reporting&#160;Company&#160;</span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntitySmallBusiness" id="Narr_7JhUistK1UyRx6wV5v7hDw"><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:28.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:36pt;margin:0pt;"><span style="font-size:8pt;">Emerging&#160;Growth&#160;Company&#160;</span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityEmergingGrowthCompany" id="Narr_QQN1_g6geUySCzxa6WqJPg"><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:36pt;margin:6pt 0pt 6pt 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:8pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span><span style="font-family:'Segoe UI Symbol';font-size:8pt;"> </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:IcfrAuditorAttestationFlag" id="Narr_eAShb5VNq0eVYpfuJqaSyQ"><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span></ix:nonNumeric><span style="font-size:8pt;">&#160;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:8pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:EntityShellCompany" id="Narr_TkrDoxSoj0GStp4qlrWuPg"><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9744;</span></ix:nonNumeric><span style="font-size:8pt;">&#160; No </span><span style="font-family:'Segoe UI Symbol';font-size:8pt;">&#9746;</span><span style="font-size:8pt;">&#160;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-indent:36pt;margin:0pt 0pt 5pt 0pt;">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant on June&#160;30, 2022, based upon the closing price of the common stock as reported by the NASDAQ Global Select Market on such date, was approximately $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" format="ixt:numdotdecimal" scale="9" contextRef="As_Of_6_30_2022_B0at-ZgNSUal6WBDs0yTtQ" decimals="-8" name="dei:EntityPublicFloat" id="Narr_m9YeDKAblk-Na6s34MPXjg">3.0</ix:nonFraction> billion.&#160;As of February&#160;22, 2023, the registrant had <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" format="ixt:numdotdecimal" scale="0" contextRef="As_Of_2_22_2023_L_MER9-GsU2ij8SaU2daZQ" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" id="Narr_vrPCJwp2WEGEDIsleXMufA">57,318,032</ix:nonFraction> shares of common stock outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:36pt;margin:0pt 0pt 5pt 0pt;"><b style="font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 5pt 0pt;">Portions of the following document are incorporated by reference in Part&#160;III of this Report: the registrant&#8217;s definitive proxy statement relating to its 2023 Annual Meeting of Shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_c34a4d1d_6991_45b2_8644_b3a529ae2040"></a><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">TABLE OF CONTENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PARTI_956676"><span style="font-style:normal;font-weight:normal;">PART&#160;I</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1Business_808372"><span style="font-style:normal;font-weight:normal;">Item&#160;1.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1Business_808372"><span style="font-style:normal;font-weight:normal;">Business</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1ARiskFactors_780049"><span style="font-style:normal;font-weight:normal;">Item&#160;1A.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1ARiskFactors_780049"><span style="font-style:normal;font-weight:normal;">Risk Factors</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">22</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1BUnresolvedStaffComments_383037"><span style="font-style:normal;font-weight:normal;">Item&#160;1B.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item1BUnresolvedStaffComments_383037"><span style="font-style:normal;font-weight:normal;">Unresolved Staff Comments</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">36</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item2Properties_908317"><span style="font-style:normal;font-weight:normal;">Item&#160;2.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item2Properties_908317"><span style="font-style:normal;font-weight:normal;">Properties</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">36</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item3LegalProceedings_389974"><span style="font-style:normal;font-weight:normal;">Item&#160;3.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item3LegalProceedings_389974"><span style="font-style:normal;font-weight:normal;">Legal Proceedings</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">37</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item4MineSafetyDisclosures_769449"><span style="font-style:normal;font-weight:normal;">Item&#160;4.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item4MineSafetyDisclosures_769449"><span style="font-style:normal;font-weight:normal;">Mine Safety Disclosures</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">37</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PARTII_16262"><span style="font-style:normal;font-weight:normal;">PART&#160;II</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item5MarketforRegistrantsCommonEquityRel"><span style="font-style:normal;font-weight:normal;">Item&#160;5.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item5MarketforRegistrantsCommonEquityRel"><span style="font-style:normal;font-weight:normal;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">38</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item6SelectedFinancialDatainthousandsexc"><span style="font-style:normal;font-weight:normal;">Item&#160;6.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item6SelectedFinancialDatainthousandsexc"><span style="font-style:normal;font-weight:normal;">Reserved</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">39</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item7ManagementsDiscussionandAnalysisofF"><span style="font-style:normal;font-weight:normal;">Item&#160;7.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item7ManagementsDiscussionandAnalysisofF"><span style="font-style:normal;font-weight:normal;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">39</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item7AQuantitativeandQualitativeDisclosu"><span style="font-style:normal;font-weight:normal;">Item&#160;7A.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item7AQuantitativeandQualitativeDisclosu"><span style="font-style:normal;font-weight:normal;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">49</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item8FinancialStatementsandSupplementary"><span style="font-style:normal;font-weight:normal;">Item&#160;8.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item8FinancialStatementsandSupplementary"><span style="font-style:normal;font-weight:normal;">Financial Statements and Supplementary Data</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">51</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9ChangesinandDisagreementswithAccoun"><span style="font-style:normal;font-weight:normal;">Item&#160;9.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9ChangesinandDisagreementswithAccoun"><span style="font-style:normal;font-weight:normal;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">90</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9AControlsandProcedures_867997"><span style="font-style:normal;font-weight:normal;">Item&#160;9A.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9AControlsandProcedures_867997"><span style="font-style:normal;font-weight:normal;">Controls and Procedures</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">90</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9BOtherInformation_688057"><span style="font-style:normal;font-weight:normal;">Item&#160;9B.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item9BOtherInformation_688057"><span style="font-style:normal;font-weight:normal;">Other Information</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PARTIII_31510"><span style="font-style:normal;font-weight:normal;">PART&#160;III</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Item&#160;10.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Directors, Executive Officers and Corporate Governance</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Item&#160;11.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Executive Compensation</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Item&#160;12.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Item&#160;13.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Certain Relationships and Related Transactions and Director Independence</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Item&#160;14.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Items10111213and14_536293"><span style="font-style:normal;font-weight:normal;">Principal Accountant Fees and Services</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#PARTIV_707140"><span style="font-style:normal;font-weight:normal;">PART&#160;IV</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item15ExhibitsandFinancialStatementSched"><span style="font-style:normal;font-weight:normal;">Item&#160;15.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item15ExhibitsandFinancialStatementSched"><span style="font-style:normal;font-weight:normal;">Exhibits and Financial Statement Schedules</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">93</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16Form10KSummary_508739"><span style="font-style:normal;font-weight:normal;">Item&#160;16.</span></a></p></td><td style="vertical-align:top;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#Item16Form10KSummary_508739"><span style="font-style:normal;font-weight:normal;">Form&#160;10-K Summary</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">98</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:85.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:93.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a href="#SIGNATURES_119406"><span style="font-style:normal;font-weight:normal;">SIGNATURES</span></a></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">99</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_77013c22_ec77_4e91_b21c_8fdb7d8826cf"></a><a id="PARTI_956676"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;I</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Unless otherwise indicated in this report, &#8220;Merit,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar terms refer to Merit Medical Systems,&#160;Inc. and our consolidated subsidiaries.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">This report includes &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements in this report, other than statements of historical fact, are &#8220;forward-looking statements&#8221; for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of our management for future operations, any statements concerning proposed new products or services, any statements regarding the integration, development or commercialization of the business or any assets acquired from other parties, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;forecasts,&#8221; &#8220;continue,&#8221; or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results will likely differ, and could differ materially, from those projected or assumed in the forward-looking statements. Investors are cautioned not to unduly rely on any such forward-looking statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Our actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. If we do update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties. Please see Item&#160;1A &#8220;Risk Factors&#8221; for a discussion of these risks and uncertainties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">DISCLOSURE REGARDING TRADEMARKS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">This report includes trademarks, tradenames and service marks that are our property or the property of other third parties.&#160;Solely for convenience, such trademarks and tradenames sometimes appear without any &#8220;&#8482;&#8221; or &#8220;&#174;&#8221; symbol. However, failure to include such symbols is not intended to suggest, in any way, that we will not assert our rights or the rights of any applicable licensor, to these trademarks and tradenames.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_f0dc9de9_2f1b_4461_bc32_e9c219d8b96e"></a><a id="_Hlk127798002"></a><a id="Item1Business_808372"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;1.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Our Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Merit Medical Systems,&#160;Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. We strive to be the most customer-focused company in healthcare. Each day we are determined to make a difference by understanding our customers&#8217; needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world. We believe that long-term value is created for our customers, employees, shareholders, and communities when we focus outward and are determined to deliver an exceptional customer experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Merit Medical Systems,&#160;Inc. was founded in 1987 by Fred P. Lampropoulos, Kent W. Stanger, Darla Gill and William Padilla. Initially we focused our operations on injection and insert molding of plastics. Our first product was a specialized control syringe used to inject contrast solution into a patient&#8217;s arteries for a diagnostic cardiac procedure called an </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">angiogram. Since that time, our products and product lines have expanded substantially, both through internal research and development projects and through strategic acquisitions.</p><a id="_Hlk31717340"></a><a id="_Hlk63982348"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Business Strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our business strategy focuses on five target areas as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">enhancing global growth and profitability through research and development, sales model optimization, cost discipline and operational focus;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">optimizing our operational capability through lean processes, cost effective environments and asset utilization;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">targeting high-growth, high-return opportunities by understanding, innovating and delivering in our core divisions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">maintaining a highly disciplined, customer-focused enterprise guided by strong core values to globally address unmet or underserved healthcare needs; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">creating sustainability of our business for our employees, shareholders and community.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:0pt;margin:0pt;">We conduct our operations through a number of domestic and foreign subsidiaries and representative offices. Our principal offices are located at 1600 West Merit Parkway, South Jordan, Utah, 84095, and our telephone number is (801) 253-1600. We maintain an internet website at www.merit.com.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">During the last three years, COVID-19 has had an unsteady but significant impact on our business, suppliers, customers, employees, families and communities. Measures designed to contain the virus, including travel bans and restrictions, border closures, quarantines, shelter-in-place orders, business limitations and shutdowns continued during portions of the year ended December 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">In efforts to contain the spread of the virus, many of our hospital customers prioritized their efforts on their COVID-19 response, diverting their focus and resources away from their normal operations and restricting access to their sites. In 2022, these restrictions were generally reduced, and we were able to achieve the highest annual revenue in the history of the Company. However, lingering effects continue, including unpredictable freight and other logistical expenses and obstacles, and the responses of government authorities and our customers vary from region to region. Please refer to the discussion of the risks and uncertainties associated with COVID-19 under the heading &#8220;<i style="font-style:italic;">The</i> <i style="font-style:italic;">COVID-19 pandemic and related ongoing implications have negatively impacted our business and operations around the world and may&#160;continue to&#160;materially and adversely impact our business, operations and financial results</i>.&#8221; set forth below in Item 1A &#8220;Risk Factors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Products</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We design, develop, market and manufacture, through our own operations and contract manufacturers, medical products that offer a high level of quality, value and safety to our customers, as well as the patients they serve. Our products are used in the following clinical areas: radiology; diagnostic and interventional cardiology; interventional radiology; neurointerventional radiology; vascular, general and thoracic surgery; electrophysiology; cardiac rhythm management; interventional pulmonology; interventional nephrology; orthopedic spine surgery; interventional oncology; pain management; breast cancer surgery, outpatient access centers; intensive care; computed tomography; ultrasound; and interventional gastroenterology. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The success of our products is enhanced by the extensive experience of our management team in the healthcare industry, our experienced direct sales force and distributors, our ability to provide custom procedural solutions such as kits, trays </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">and procedural packs at the request of our customers, and our dedication to offering facility-unique solutions in the markets we serve worldwide.</p><a id="_Hlk63975682"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We conduct our business through two operating segments: cardiovascular (which includes peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (&#8220;OEM&#8221;)) and endoscopy. For information relating to our operating segments and product categories, see Note&#160;13 to our consolidated financial statements set forth in Item&#160;8 of this report and Management&#8217;s Discussion and Analysis set forth in Item 7 of this report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following sections describe our principal product offerings by reporting segment and product category. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Cardiovascular </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We offer a broad line of medical devices used to gain and maintain vascular access. These products include our&#160;micropuncture kits, angiographic needles, our family of Prelude&#174; Introducer Sheaths and a wide range of guide wires and safety products. Our cardiovascular segment includes the following product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Peripheral Intervention</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our peripheral intervention products support the minimally invasive diagnosis and treatment of diseases in peripheral vessels and organs throughout the body, excluding the heart. Products in our peripheral intervention product category are organized into the following product groups: peripheral intervention, spine, and oncology. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_DV_C62"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Merit Vascular </i>&#8211;<i style="font-style:italic;"> Peripheral</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our peripheral intervention products include product offerings in the following product portfolios: access (peripheral), angiography, drainage, delivery systems, embolotherapy, and intervention (peripheral). The principal product offerings in our access (peripheral) portfolio include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">HeRO&#174; (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous vascular access system, which is intended for use in maintaining long-term vascular access for chronic hemodialysis patients; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">CentrosFLO&#174; Long-Term Hemodialysis Catheter and ProGuide&#174; Chronic Dialysis Catheter; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Broad offering of peritoneal dialysis catheters, accessories and implantation kits for home dialysis therapy; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Merit Wrapsody &#8482; Endoprosthesis, a cell-impermeable endoprosthesis which is designed to maintain long-term vessel patency in patients with obstructions in the dialysis outflow circuit (this device is not currently available for use in the United States). </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The products in our angiography portfolio are used to identify blockages and other disease states in the blood vessel. The principal product offerings in our angiography portfolio include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Extensive line of Merit Laureate&#174; Hydrophilic Guide Wires, a smooth-surface guide wire designed to minimize friction and promote rapid catheter exchanges; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our newest offering of Merit SplashWire&#174; hydrophilic Steerable Guide Wires, combining optimum lubricity, exceptional torque response and enhanced visibility;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Performa&#174; and Impress&#174; Diagnostic Catheters, a catheter offering designed for traversing difficult to access peripheral blood vessels; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Performa Vessel Sizing Catheters for vessel measurement.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We offer a broad line of drainage products. The principal product offerings in our drainage portfolio include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Aspira&#174; Pleural Effusion Drainage and Aspira&#174; Peritoneal Drainage Systems, a compassionate treatment option for end-stage cancer, allowing patients to spend more time at home by reducing the need for frequent hospital visits to treat their drainage needs;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Family of ReSolve&#174; Drainage Catheters, including our ReSolve ConvertX&#174; Stent System and ReSolve Mini&#8482; Locking Drainage Catheter, and our related tubing sets and drainage bag; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">One-Step&#174; and Valved One-Step&#174; Drainage Catheters, sold individually and in kits, for quickly removing unwanted fluid accumulation; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revolution&#8482; Catheter Securement Device and StayFIX&#174; Fixation Device, used to stop migration, movement and accidental removal of percutaneous catheters. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="font-style:italic;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The principal product offerings in our delivery systems portfolio include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></span><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">SwiftNINJA&#174; Steerable Microcatheter, an advanced microcatheter with a 180-degree articulating tip, sold through our exclusive worldwide distribution agreement (excluding Japan) with SB-Kawasumi Laboratories, Inc.; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Merit Maestro&#174; and Merit Pursue&#8482; Microcatheters, small microcatheters designed for pushability and trackability through small and tortuous vessels; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">True Form&#8482; Reshapable Guide Wire, designed to be reshaped multiple times, reducing the need for multiple guide wires.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our embolotherapy products treat disease by blocking or slowing the flow of blood into the arteries or delivering chemotherapy drugs in the treatment of primary and metastatic liver cancer. The principal product offerings in our embolotherapy portfolio include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Embosphere&#174; Microspheres, a highly studied, round embolic for consistent and predictable results; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">HepaSphere&#174; Microspheres, soft embolics with a consistent cross-sectional diameter for predictable, flow-directed targeting.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The products in our intervention (peripheral) portfolio are chiefly used to remove blood clots, retrieve foreign bodies in blood vessels and assist with placing balloons and stents to treat arterial disease. The principal product offerings in our intervention (peripheral) portfolio include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ClariVein&#174; Specialty Infusion Catheter which is designed for controlled 360-degree dispersion of physician specified agents to the peripheral vasculature; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Dynamis AV&#8482; PTA Dilatation Catheter, a line of balloon catheters that facilitates the opening of blockages located in the arteriovenous system of dialysis patients;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Q50X&#8482;, Q50&#174; and Q50&#174; Plus Stent Graft Balloon Catheters, a line of catheters that treat abdominal and thoracic endovascular aortic repair procedures and reinterventions; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Fountain&#174; Infusion System and Mistique&#174; Infusion Catheters, a line of catheters that treat arterial and hemodialysis graft occlusions and deep vein thrombosis; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">EN Snare&#174; and One Snare&#174; Endovascular Snare Systems, a complete line of snares designed to manipulate, capture and retrieve foreign material in the body.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="font-style:italic;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Merit Spine</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our spine products are used in the treatment of vertebral compression fractures and metastatic spinal tumors and in musculoskeletal biopsy procedures. Our spine product line includes the following product portfolios: vertebral augmentation, radiofrequency ablation, and bone biopsy systems. Our primary product offerings in the vertebral augmentation and radiofrequency ablation portfolios include our: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">STAR&#8482; Tumor Ablation System, designed to provide palliative treatment of painful metastatic spinal tumors in cancer patients by targeted radiofrequency ablation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Arcadia&#174; Steerable and straight balloons, designed to achieve controlled, precise, targeted cavity creation in vertebral augmentation procedures; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">StabiliT&#174; MX Vertebral Augmentation System, which uses our inflation devices to deliver bone cement.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The bone biopsy systems portfolio contains a full offering of manual bone biopsy products, including our Madison&#8482;, Huntington&#8482;, Kensington&#8482;, Preston&#8482; and Westbrook&#8482; biopsy products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Merit Oncology </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our oncology products are dedicated to the accurate diagnosis and localization of breast and soft tissue tumors and the innovative treatment of early-stage breast cancer. We also offer an extensive line of soft tissue biopsy products and accessories. Our primary product offerings in our oncology portfolio include our:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">SCOUT&#174; Radar Localization System, a nonradioactive, wire-free tumor localization system that facilitates successful surgical removal of marked lesions and lymph nodes, improving workflow and the patient experience; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">CorVocet&#174; Biopsy System, one of our innovative soft tissue core needle biopsy and accessory products, designed to cut a full core of tissue and provide large specimens for pathological examination;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Achieve&#174;, Temno&#174; and Tru-Cut&#174; Soft Tissue Biopsy Devices; and </span></td></tr></table><a id="_Hlk32926655"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">SAVI&#174; Brachytherapy, a precise, targeted approach to accelerated partial breast irradiation with lower toxicities and reduced treatment duration.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cardiac Intervention</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We manufacture and sell a variety of products designed to treat various heart conditions. Products in our cardiac intervention product category are organized into the following product portfolios: access (cardiac), angiography, electrophysiology and CRM, fluid management, hemodynamic monitoring, hemostasis, and intervention (cardiac). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Merit Vascular </i>&#8211;<i style="font-style:italic;"> Cardiac</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The principal product offerings in our access portfolio (cardiac) include our family of Prelude Introducer Sheaths, for both radial and femoral access, featuring our Prelude IDeal&#8482; Hydrophilic Sheath Introducer, an ultra-thin wall introducer sheath that provides more room for the insertion of catheters and other devices in the radial artery.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The principal product offerings in our angiography portfolio include our InQwire&#174; Guide Wires and Performa Diagnostic and Ultimate&#8482; catheters for femoral and radial procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Electrophysiology is the study of diagnosing and treating abnormal electrical activities of the heart. Cardiac rhythm management (&#8220;CRM&#8221;) is the field of cardiac disease therapy that relates to the diagnosis and treatment of cardiac arrhythmias or the improper beating of the heart. The principal product offerings in our electrophysiology and CRM portfolio include our: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Worley&#8482; Advanced LV Delivery System, used to aid in the insertion and implantation of left ventricular pacing leads; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">HeartSpan&#174; Transseptal Needle, for left-heart access procedures; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">HeartSpan&#174; Steerable and Fixed Curve Sheath Introducer, featuring a neutral position indicator and tactile click to help physicians identify curve orientation with an expanded product line that includes fixed curve shapes. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The product offerings in our fluid management portfolio include manifolds, control syringes and tubing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The principal product offerings in our hemostasis portfolio include our Prelude SYNC EVO&#8482; and PreludeSYNC Distal&#8482; Radial Compression devices, designed to reduce and stop blood flow after radial access procedures, and the SafeGuard&#174; Pressure Assisted Device which provides hemostasis after femoral procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The principal product offerings in our intervention (cardiac) portfolio include a full line of inflation devices and hemostasis valves, including the BasixCompak&#8482;, basixTOUCH&#8482;, Blue Diamond&#8482; and DiamondTouch&#8482; inflation devices and the PhD&#8482; Hemostasis Valve, the latest addition to our hemostasis valve portfolio.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Custom Procedural Solutions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our custom procedural solutions product category is comprised of standard and custom kit and pack solutions that include items needed for peripheral procedures, safety and waste management products, and hemostasis accessories. Our kit and pack solutions can optimize efficiency and reduce cost and waste. The principal product offerings in this product category include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Critical care products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Dual Cap&#174; Disinfection Protection System and Medallion &#174; syringes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Manifold Kits; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Trays and Packs.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">OEM</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We provide coating services for medical tubes and wires under OEM brands in addition to many of the products identified above. We offer coated tubes and wires to customers on a spool or as further manufactured components including guide wire components, coated mandrels/stylets and coated needles. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We also manufacture and sell sensor components for microelectromechanical systems. These components consist of piezoresistive pressure sensors in various forms, including bare silicon die, die mounted on ceramic substrates, and fully calibrated components for numerous applications both inside and outside the healthcare industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk64638020"></a><a id="_Hlk63981757"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Endoscopy</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The products in our endoscopy operating segment, Merit Medical <span style="color:#212529;background:#ffffff;">Endotek</span>&#8482;&#174;<span style="color:#212529;background:#ffffff;">,</span> are organized in two product portfolios: gastroenterology and pulmonary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our gastroenterology products include a complete range of innovative, gastrointestinal solutions. Our primary product offerings in our gastroenterology portfolio include our:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Alimaxx-ES&#8482; and EndoMAXX&#174; Fully Covered Esophageal Stents, for maintaining esophageal luminal patency in certain esophageal strictures; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">BIG60&#174; Inflation Device, a 60-mL syringe and gauge designed to inflate and deflate non-vascular balloon dilators while monitoring and displaying inflation pressures up to 12 atmospheres; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Elation&#174; Fixed Wire, Wire Guided and new 5-stage Balloon Dilators, intended for use in the alimentary tract.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our pulmonary products consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems and dilation balloons to endoscopically dilate strictures. Our primary product offerings in our pulmonary portfolio include our:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">AERO&#174;, AEROmini&#174; and AERO DV&#174; Fully Covered Tracheobronchial Stents, for the treatment of tracheobronchial strictures produced by malignant neoplasms; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Elation&#174; Pulmonary&#8482; Balloon Dilator, for the dilation of strictures of the trachea and bronchi.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We also offer a variety of kits and accessories for endoscopy and bronchoscopy procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Marketing and Sales</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Target Market/Industry.</b> Our principal target markets are peripheral intervention, cardiac intervention, interventional oncology, critical care and endoscopy. Within these markets our products are used in the following clinical areas: diagnostic and interventional cardiology; interventional radiology; neurointerventional radiology; vascular, general and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">thoracic surgery; electrophysiology; cardiac rhythm management; interventional pulmonology; interventional nephrology; orthopedic spine surgery; interventional oncology; pain management; breast cancer surgery; outpatient access centers; intensive care; computed tomography; ultrasound; and interventional gastroenterology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">According to statistics published by the National Center for Health Statistics, cardiovascular disease continues to be a leading cause of death and a significant health problem in the U.S.<b style="font-weight:bold;">&#160;</b>Treatment options range from dietary changes to surgery, depending on the nature of the specific disease or disorder.&#160;Endovascular techniques, including angioplasty, stenting and endoluminal stent grafts, continue to represent important therapeutic options for the treatment of vascular disease. Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among women. We derive a large&#160;percentage of our revenues from sales of products used during percutaneous diagnostic and interventional procedures such as angiography, angioplasty and stent placement, and we intend to pursue additional sales growth by building on our existing market position in both core technology and accessory products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Marketing Strategy.</b>&#160;Traditionally, as part of our product sales and marketing efforts, we attend major medical conventions throughout the world pertaining to our target markets and invest in market development including physician training, peer-to-peer education, and patient outreach.&#160;Due to the various restrictions imposed in response to COVID-19, during 2020 and 2021 most medical conventions in which we participated were virtual meetings; however, many of the groups hosting those conventions resumed in-person meetings during 2022. Additionally, we are building out digital and direct-to-customer programs to increase awareness of our products, and we work closely with major healthcare facilities and physicians involving our primary target markets in the areas of training, therapy awareness programs, clinical studies and ongoing product research and development. In general, our target markets are characterized by rapid change resulting from technological advances and scientific discoveries. We plan to continue to develop and launch innovative products to support clinical trends and to address the increasing demands of these markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Product Development Strategy.</b> Our product development is focused on identifying and introducing a regular flow of profitable products that meet customer needs.&#160;To stay abreast of customer needs, we work closely with health care professionals working in the fields of medicine in which we offer or develop products.&#160;Suggestions for new products and product improvements may also come from engineers, marketing and sales personnel, physicians and technicians who perform clinical procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">When we believe that a product suggestion demonstrates a sustainable competitive advantage, meets customer needs, fits strategically and technologically with our business and has a good potential financial return, we generally assemble a &#8220;project team&#8221; comprised of individuals from our sales, marketing, engineering, manufacturing, legal and quality assurance departments. This team works to identify the customer requirements, develop the design, compile necessary documentation and testing, and prepare the product for market introduction. We believe that one of our competitive strengths is our capacity to rapidly conceive, design, develop and introduce new products that meet customer needs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">U.S. and International Sales.</b>&#160;Sales of our products in the U.S. accounted for 57% of our net sales for each of the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. In the U.S., we have dedicated, direct sales organizations primarily focused on selling to end-user physicians, hospitals and alternate site facilities (e.g., office-based labs), major buying groups and integrated healthcare networks.</p><a id="_Hlk64622019"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Internationally, we employ sales representatives and contract with independent dealer organizations and custom procedure tray manufacturers to distribute our products worldwide, including territories in Europe, the Middle East, Africa, Asia, Oceania, Central and South America, Mexico and Canada. In 2022, our international sales grew 7.4% over our 2021 international sales and accounted for 43% of our net sales. Our largest non-U.S. market is China, which represented 13% of our net sales in 2022 and reported net sales of $149.3 million, $138.2 million, and $113.2 million for the years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. We maintain a distribution center and administrative office in Beijing. We sell our products through more than 500 distributors in mainland China, who are responsible for reselling our products, primarily to hospitals. We use the &#8220;modified direct&#8221; sales approach in China, employing sales personnel throughout China who work with our distributors to promote the clinical advantages of our products to clinicians and other decision makers at hospitals.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk64638705"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Beginning in 2020, we experienced a significant disruption of our business throughout the world as a result of COVID-19, and t<span style="background:#ffffff;">his disruption continued through 2021 and 2022. We are unable to calculate the full impact of COVID-19 on our business, and we are unable to predict whether we will continue to be affected by it, but we experienced a material adverse impact on our global operations and financial condition during 2020. In 2021, we saw growth in global sales compared to 2020 as the demand for our products increased when many of the medical procedures delayed from 2020 were performed and the restrictions put in place in response to the pandemic were generally reduced. That trend continued during 2022, and we were able to achieve the highest annual revenue in the history of the Company. For further discussion of the risks and uncertainties associated with COVID-19, please</span> refer to disclosure under the heading &#8220;<i style="font-style:italic;">The</i> <i style="font-style:italic;background:#ffffff;">COVID-19&#160;pandemic and related ongoing implications have negatively impacted our business and operations around the world and may&#160;continue to&#160;materially and adversely impact our business, operations and financial results</i>.&#8221; set forth in Item 1A &#8220;Risk Factors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In Europe, the Middle East and Africa (&#8220;EMEA), we have both direct and modified direct sales operations. Such sales operations are active throughout the region, including the largest markets in Western, Southern, Central and Eastern Europe and the emerging markets within EMEA.</p><a id="_Hlk64638856"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our direct sales personnel are principally engaged in each of our divisions. Marketing teams responsible for each division operate clinical education programs, often directed by leading subject matter personnel, who provide technical instruction on techniques and therapies to physicians, nurses and technologists. We are currently conducting education programs specific to radial access, spinal intervention, surgical grafts, wire-free tumor localization, electrophysiology, endoscopy, dialysis and embolism.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We require our international dealers to store products and sell directly to customers within defined sales territories. Each of our products must be approved for sale under the laws of the country in which it is sold. International dealers are responsible for compliance with applicable anti-corruption laws, such as the U.S. Foreign Corrupt Practices Act, as well as all applicable laws and regulations in their respective countries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We consider training to be a critical factor in the success of our sales force. Members of our sales force are trained by our clinical marketers, our staff professionals, consulting physicians, and senior field trainers in their respective territories.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">OEM Sales.</b>&#160;Our global OEM Division sells components and finished devices, including molded components, sub-assembled goods, custom kits and bulk non-sterile goods, to medical device manufacturers. These products may be combined with other components and products from other companies and sold under a Merit or customer label. Products sold by our OEM Division can be customized and enhanced to customer specifications, including packaging, labeling and a variety of physical modifications. Our OEM Division serves customers with a staff of regional sales representatives based in the U.S., Europe and Asia, and a dedicated OEM Engineering and Customer Service Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We provide products to hospitals and alternate site-based physicians, technicians and nurses. Hospitals and acute care facilities in the U.S. purchase our products through our direct sales force, distributors, OEM partners, or custom procedure tray manufacturers who assemble and combine our products in custom kits and packs.&#160;Outside the U.S., hospitals and acute care facilities generally purchase our products through our direct sales force, or, in the absence of a sales force, through independent distributors or OEM partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Research and Development</p><a id="_Hlk64638981"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our research and development operations have been central to our historical growth, and we believe they will be critical to our continued growth. In recent years, our commitment to innovation led to the introduction of several new products, improvements to our existing products and expansion of our product lines, as well as enhancements and new equipment in our research and development facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We continue to develop new products and make improvements to our existing products utilizing many different sources. In 2022,<span style="font-family:'acumin-pro-semi-condensed';font-size:13.5pt;background:#ffffff;"> </span>our Chief Executive Officer and our Executive Vice President of Global Research&#160;&amp; Development worked closely </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">with our sales and marketing teams to incorporate feedback from physicians and clinicians in the field, which contributed to innovative new products and improvements to our existing products.</p><a id="_Hlk127518377"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In 2022, we completed projects that resulted in the newest additions to our product lineup: Prelude Roadster<span style="background:#ffffff;">&#174;</span>, Sync EZ&#8482;, Safeguard Focus Cool&#8482;, and Scout BX&#8482;.</p><a id="_Hlk127803308"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Currently, we have research and development facilities in California, Texas, Utah, Ireland, France, and Singapore.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Manufacturing</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We manufacture many of our products using our proprietary technology and our expertise in plastic injection and insert molding.&#160;We generally contract with third parties for the tooling of our molds, but we design and own most of our molds.&#160;We have also received various International Standards Organization (&#8220;ISO&#8221;) certifications for many of our facilities; for further details, please refer to Item 1. &#8220;Business - Sustainability&#8221; below. Merit Sensor Systems,&#160;Inc. (&#8220;Merit Sensors&#8221;) develops and markets silicon pressure sensors to a range of enterprises and presently supplies the sensors we use in our digital inflation devices and blood pressure sensors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Given the specialization of our manufacturing personnel and processes in our Utah and Ireland facilities, we possess the capability to strategically shift the manufacture of more technologically advanced products to those facilities and use the manufacturing capacity of our other facilities for more commoditized products.&#160;The actual determination of manufacturing location will be based upon&#160;multiple factors, including technological capabilities, market demand, acquisition and integration activities and economic and competitive conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We currently produce and package all of our embolic products. Manufacturing of our embolic products includes the synthesis and processing of raw materials and third-party manufactured compounds.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk127803330"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We have packaging and manufacturing facilities located in Texas, Virginia, Utah, Mexico, Brazil, Ireland, France, The Netherlands, and Singapore. See Item&#160;2. &#8220;Properties.&#8221;</p><a id="_Hlk127803343"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (&#8220;UK&#8221;), South Africa, South Korea, India, New Zealand, Japan, China and Australia.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Competition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The medical products industry is highly competitive. Many of our competitors are much larger than us and have access to greater resources. We also compete with smaller companies that sell single or limited numbers of products in specific product lines or geographies. We compete globally in several market areas, including radiology; diagnostic and interventional cardiology; interventional radiology; neurointerventional radiology; vascular, general and thoracic surgery; electrophysiology; cardiac rhythm management; interventional pulmonology; interventional nephrology; orthopedic spine surgery; interventional oncology; pain management; outpatient access centers; intensive care; computed tomography; ultrasound; and interventional gastroenterology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The principal competitive factors in the markets in which our products are sold are quality, price, product features, customer service, breadth of line, and customer relationships. We believe our products are attractive to customers due to their innovative design, the quality of materials and workmanship, clinical performance, and our strong focus on customer needs, and our prompt attention to customer requests. Some of our primary competitive strengths are our relative stability in the marketplace; comprehensive, broad line of ancillary products; manufacturing integration to secure our supply chain; and strong cadence of new products and product line extensions that enhance our portfolio.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our primary competitors in our peripheral intervention market are Teleflex Incorporated (&#8220;Teleflex&#8221;), Cook Medical Incorporated (&#8220;Cook Medical&#8221;), Medtronic plc (&#8220;Medtronic&#8221;), Boston Scientific Corporation (&#8220;Boston Scientific&#8221;), and Becton, Dickinson and Company (&#8220;BD&#8221;). Our primary competitors in our cardiac intervention market are BD, Teleflex, Medtronic, Abbott Laboratories, Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical, and Boston Scientific. Our primary competitors in our spine market are Medtronic, Stryker Corporation, and Johnson &amp; Johnson. Our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">primary competitors in our oncology market are BD, Hologic, Inc., Argon Medical Devices, Inc. and Cook Medical. Our primary competitors in our endoscopy market are Getinge AB, Boston Scientific, Cook Medical, and Olympus Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Based on available industry data, with respect to the number of procedures performed, we believe we are a leading provider of digital inflation technology in the world.&#160;In addition, we believe we are one of the market leaders in the U.S. for analog inflation devices.&#160;We believe we are a market leader in the U.S. for control syringes, radar localization, waste-disposal systems, embolic beads, tubing and manifolds. Although we believe our recent and planned additions to these product lines will help us compete even more effectively in both the U.S. and international markets, we cannot give any assurance that we will be able to maintain our existing competitive advantages or compete successfully in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Sources and Availability of Raw Materials</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Raw materials essential to our business are generally purchased worldwide and are normally available in quantities adequate to meet the needs of our business. Where there are exceptions, the temporary unavailability of those raw materials has not historically had a material adverse effect on our financial results; however, fluctuations and uncertainties in supply chain, transportation logistics, and freight expenses that we have experienced during the past several years have challenged our operating capabilities and could result in disruptions in our operations and materially impact our financial results. For further discussion of the risks and uncertainties associated with recent disruptions in supply chain and logistics, please refer to disclosure under the heading &#8220;<i style="font-style:italic;">Termination or interruption of our supply relationships and increases in labor costs and the prices of our component parts, finished products, third-party services and raw materials, particularly petroleum-based products, is negatively impacting our business and could have a further adverse effect on our business, operations or financial condition.</i>&#8221; set forth in Item 1A &#8220;Risk Factors.&#8221; &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Proprietary Rights and Litigation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We rely on a combination of patents, trade secrets, trademarks, copyrights and confidentiality agreements to protect our intellectual property. We have a number of U.S. and foreign-issued patents and pending patent applications, including rights to patents and patent applications acquired through strategic transactions, which relate to various aspects of our products and technology. The duration of our patents is determined by the laws of the country of issuance and, for the U.S., is typically 20 years from the date of filing of the patent application.&#160;As of December&#160;31,&#160;2022, we owned approximately 1,600 U.S. and international patents and patent applications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Additionally, we hold exclusive and non-exclusive licenses to a variety of third-party technologies covered by patents and patent applications. In the aggregate, our intellectual property assets are critical to our business, but no single patent, trademark or other intellectual property asset is of material importance to our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Merit&#174; name and logo are trademarks in the U.S. and other countries.&#160;In addition to the Merit name and logo, we have used, registered or applied for registration of other specific trademarks and service marks to help distinguish our products, technologies and services from those of our competitors in the U.S. and foreign countries.&#160;See Item 1. &#8220;Business - Products&#8221; above.&#160;The duration of our trademark registrations varies from country to country; in the U.S. we can generally maintain our trademark rights and renew any trademark registrations for as long as the trademarks are in use.&#160;As of December&#160;31,&#160;2022, we owned approximately 650 U.S. and foreign trademark registrations and trademark applications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">There is substantial litigation regarding patents and other intellectual property rights in the medical device industry. At any given time, we may be involved as either a plaintiff or a defendant, as well as a counter-claimant or counter-defendant, in patent, trademark, and other intellectual property infringement actions. If a court rules against us in any intellectual property litigation we could be subject to significant liabilities, be forced to seek licenses from third parties, or be prevented from marketing certain products. In addition, intellectual property litigation is costly and may consume significant time of employees and management.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Regulation </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Corporate Integrity Agreement</b>. In October 2020, we entered into a Corporate Integrity Agreement (&#8220;CIA&#8221;) with the Office of Inspector General (&#8220;OIG&#8221;), a five-year agreement that was a condition of our settlement with the United States Department of Justice (&#8220;DOJ&#8221;). The CIA subjects us to certain compliance, monitoring, reporting, certification, oversight and training obligations. The CIA requires, among other matters, that we (i) maintain a compliance officer, a compliance committee, board review and oversight of certain federal healthcare compliance matters and compliance and disclosure programs; (ii) establish compliance policies and procedures to meet the requirements of all federal health care programs and the <span style="font-family:'TimesNewRoman';">U.S. Food and Drug Administration (&#8220;FDA&#8221;)</span>; (iii) provide management certifications and compliance training and education; (iv) engage an independent review organization to conduct a thorough review of our systems, policies, processes and procedures related to promotional materials, product evaluations, consulting agreements, trainings provided to healthcare professionals, sponsorships, grants and charitable contributions; (v) implement a risk assessment and internal review process; (vi) establish a disclosure program for whistleblowers; (vii) increase oversight of the interactions between our sales personnel and healthcare providers; and (viii) report or disclose certain events and physician payments. We recently completed our second reporting period under the CIA and continue to implement compliance program enhancements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our failure to comply with our obligations under the CIA could result in monetary penalties and our exclusion from participation in federal health care programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The foregoing description of the CIA is qualified in its entirety by the full terms of the&#160;CIA, which is attached as&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit 10.44</span> hereto and incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Regulatory Approvals</b>. Our products and operations are global and are subject <span style="font-family:'TimesNewRoman';">to regulations by the FDA and various other federal and state agencies, as well as by foreign governmental agencies. These agencies enforce laws and regulations that control the design, development, testing, clinical trials, manufacturing, labeling, storage, advertising, marketing, distribution, and post-market surveillance of our medical products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-family:'TimesNewRoman';visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'TimesNewRoman';">The time required to obtain approval by the FDA and other foreign governmental agencies can be lengthy and the requirements may differ. In particular, </span>in May 2017, the EU adopted Regulation (EU) 2017/745 (&#8220;MDR&#8221;), which replaced Council Directive 93/92/EEC (&#8220;MDD&#8221;) as of May 26, 2021. Under transitional provisions, medical devices with notified body certificates issued under MDD prior to May 26, 2021 may continue to be placed on the market for the remaining validity of the certificate or until May 26, 2024, whichever is first. After the expiry of any applicable transitional period, only devices that have been CE marked under MDR may be placed on the market in the EU. On January 6, 2023, the EU Commission proposed a draft amendment to the MDR which would extend the transitional period, thus allowing for additional time to transition to the new requirements of the MDR. At time of publication, the amendment had not been through the entire legislative process, leaving some uncertainty as to whether or not it would be approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We are preparing to comply with these new regulations under the MDR before the transitional period expires. However, there will be products that we will instead choose to discontinue or postpone introduction in the EU. This decision will depend on a number of factors, including changing business strategies, timing and cost of obtaining MDR certification, availability of necessary data and the capacity of notified bodies. MDR includes increasingly stringent requirements in multiple areas, such as pre-market clinical evidence, review of high-risk devices, labeling and post-market surveillance. Under MDR, pre-market clinical data will now be required to obtain CE Mark approval for high-risk, new and modified medical devices. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'TimesNewRoman';">U.S. and global counter-part regulatory approval processes for medical</span> devices are expensive, uncertain and lengthy. There can be no assurance that we will be able to obtain necessary regulatory approvals for any product on a timely basis or at all. Delays in receiving of or failure to receive such approvals, the loss of previously received approvals, or the failure to comply with existing or future regulatory requirements could have a material adverse effect on our business, financial condition or results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In May 2020, we received the CE mark<span style="background:#ffffff;"> for the Merit Wrapsody Cell-Impermeable &#160;Endoprosthesis, and we are pursuing regulatory approval in the U.S. and elsewhere. We are conducting a large, multinational pivotal human clinical trial of the Wrapsody Endoprosthesis, which is required for us to obtain approval from the FDA and some international regulatory agencies.</span> Human clinical trials of a medical device are often required for regulatory clearance or approval for devices and are expensive, time-consuming and uncertain. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Quality System Requirements. </b>The Federal Food, Drug and Cosmetic Act (&#8220;FDCA&#8221;) and its counterpart non-U.S. laws require us to comply with quality system regulations (&#8220;QSR&#8221;) pertaining to all aspects of our product design and manufacturing processes, including requirements for packaging, labeling, record keeping, personnel training, supplier controls, design controls, complaint handling, corrective and preventive actions and internal quality system auditing. The FDA and foreign regulators enforce these requirements through periodic inspections of medical device manufacturers. These requirements are complex, technical and require substantial resources to remain compliant. Our failure or the failure of our suppliers to maintain compliance with these requirements could result in the shutdown of our manufacturing operations or the recall of our products, or could restrict our ability to obtain new product approvals or certificates from the FDA that are necessary for export of our products to foreign countries. Any of these results could have a material adverse effect on our business. If one of our suppliers fails to maintain compliance with our quality requirements, we may have to qualify a new supplier and could experience manufacturing delays as a result. We also could be subject to injunctions, product seizures, or civil or criminal penalties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Labeling and Promotion</b><span style="font-style:italic;font-weight:bold;">. </span>Our labeling and promotional activities are also subject to scrutiny by the FDA and foreign regulators. Labeling includes not only the label on a device, but also includes any descriptive or informational literature that accompanies or is used to promote the device. Among other things, labeling violates the law if it is false or misleading in any respect or it fails to contain adequate directions for use. Moreover, product claims that are outside the approved or cleared labeling violate the FDCA and other applicable laws. If the FDA determines that our promotional materials constitute promotion of an uncleared or unapproved use, or otherwise violate the FDCA, it could request that we modify our promotional materials or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a notice of violation, a warning letter, injunction, seizure, civil fines or criminal penalties. Allegations of off-label promotion can also result in enforcement action by federal, state, or foreign enforcement authorities and trigger significant civil or criminal penalties, including exclusion from the Medicare and Medicaid programs and liability under the False Claims Act, discussed further below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our product promotion is also subject to regulation by the Federal Trade Commission (the &#8220;FTC&#8221;), which has primary oversight of the advertising of unrestricted devices, including FDA-cleared devices. The Federal Trade Commission Act prohibits unfair methods of competition and unfair or deceptive acts or practices in or affecting commerce, as well as unfair or deceptive practices such as the dissemination of any false or misleading advertisement pertaining to medical devices. FTC enforcement can result in orders requiring, among other things, limits on advertising, corrective advertising, consumer redress, rescission of contracts and such other relief as the FTC may deem necessary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In addition, under the federal Lanham Act and similar state laws, competitors and others can initiate litigation relating to advertising claims.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Import Requirements.</b> To import a medical device into the U.S., the importer must file an entry notice and bond with the U.S. Bureau of Customs and Border Protection (&#8220;CBP&#8221;). All devices are subject to FDA examination before release from the CBP. Any article that appears to be in violation of the FDCA may be refused admission and a notice of detention and hearing may be issued. If the FDA ultimately refuses admission, the CBP may issue a notice for redelivery and assess liquidated damages for up to three times the value of the lot. Additionally, the laws of the U.S. require imported articles to have their labels accurately marked with the appropriate country of origin, the violation of which may result in confiscation, fines and penalties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Export Requirements.</b> Products for export are subject to foreign countries&#8217; import requirements and the exporting requirements of the exporting countries&#8217; regulating bodies, as applicable. International sales of medical devices manufactured in the U.S. that are not approved or cleared by the FDA for use in the U.S., or are banned or deviate from lawful performance standards, are subject to FDA export requirements and we may not be able to export such products.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Foreign countries often require, among other things, an FDA certificate for products for export, also called a Certificate to Foreign Government. To obtain this certificate from the FDA, the device manufacturer must apply to the FDA. The FDA certifies that the product has been granted clearance or approval in the U.S. and that the manufacturing facilities were in compliance with the QSR at the time of the last FDA inspection.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Additionally, the export of our products is subject to restrictions due to trade and economic sanctions imposed by the U.S., the EU and other governments and organizations. The U.S. Departments of Justice, Commerce, State and Treasury and other federal agencies and authorities have a broad range of civil and criminal penalties they may seek to impose against corporations and individuals for violations of economic sanctions laws, export control laws, and other federal statutes and regulations, including those established by the Office of Foreign Assets Control (&#8220;OFAC&#8221;). Under these laws and regulations, as well as other export control laws, customs laws, sanctions laws and other laws governing our operations, various government agencies may require export licenses and may seek to impose modifications to business practices, including cessation of business activities in sanctioned countries or with sanctioned persons or entities. With the U.S. and other countries exploring export sanctions in response to military exercises and escalating tensions in certain parts of the world, any such export restrictions may affect the company&#8217;s business in certain regions of the world.</p><a id="_Hlk64640030"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt -0.7pt 12pt 0pt;"><b style="font-weight:bold;">Additional Post-Market Requirements.</b> As a medical<span style="letter-spacing:-0.7pt;"> </span>device<span style="letter-spacing:-0.7pt;"> </span>manufacturer, we are<span style="letter-spacing:-0.7pt;"> </span>subject<span style="letter-spacing:-0.7pt;"> </span>to<span style="letter-spacing:-0.65pt;"> </span>other<span style="letter-spacing:-0.6pt;"> </span>post-market requirements in multiple jurisdictions, including (i) product listing, (ii) establishment registration, (iii) Unique Device Identification<span style="letter-spacing:-0.7pt;"> </span>(&#8220;UDI&#8221;), and (iv)<span style="letter-spacing:-0.65pt;"> </span>reports<span style="letter-spacing:-0.6pt;"> </span>of<span style="letter-spacing:-0.6pt;"> </span>corrections<span style="letter-spacing:-0.55pt;"> </span>and<span style="letter-spacing:-0.6pt;"> </span>removals.<span style="letter-spacing:-0.5pt;"> </span>We are also subject to regulations that require manufacturers to report to the FDA, or an equivalent foreign regulatory<span style="letter-spacing:-0.55pt;"> </span>body,<span style="letter-spacing:-0.5pt;"> </span>any<span style="letter-spacing:-0.5pt;"> </span>incident<span style="letter-spacing:-0.35pt;"> </span>in<span style="letter-spacing:-0.3pt;"> </span>which<span style="letter-spacing:-0.35pt;"> </span>their<span style="letter-spacing:-0.3pt;"> </span>device<span style="letter-spacing:-0.4pt;"> </span>may<span style="letter-spacing:-0.5pt;"> </span>have<span style="letter-spacing:-0.35pt;"> </span>caused<span style="letter-spacing:-0.35pt;"> </span>or<span style="letter-spacing:-0.35pt;"> </span>contributed<span style="letter-spacing:-0.25pt;"> </span>to<span style="letter-spacing:-0.35pt;"> </span>a<span style="letter-spacing:-0.4pt;"> </span>death<span style="letter-spacing:-0.35pt;"> </span>or<span style="letter-spacing:-0.3pt;"> </span>serious<span style="letter-spacing:-0.3pt;"> </span>injury,<span style="letter-spacing:-0.25pt;"> </span>or<span style="letter-spacing:-0.3pt;"> </span>has malfunctioned<span style="letter-spacing:-0.5pt;"> </span>in<span style="letter-spacing:-0.5pt;"> </span>a<span style="letter-spacing:-0.45pt;"> </span>way<span style="letter-spacing:-0.75pt;"> </span>that<span style="letter-spacing:-0.5pt;"> </span>would<span style="letter-spacing:-0.6pt;"> </span>likely<span style="letter-spacing:-0.75pt;"> </span>cause<span style="letter-spacing:-0.6pt;"> </span>or<span style="letter-spacing:-0.55pt;"> </span>contribute<span style="letter-spacing:-0.55pt;"> </span>to<span style="letter-spacing:-0.6pt;"> </span>a<span style="letter-spacing:-0.45pt;"> </span>death<span style="letter-spacing:-0.6pt;"> </span>or<span style="letter-spacing:-0.55pt;"> </span>serious<span style="letter-spacing:-0.4pt;"> </span>injury<span style="letter-spacing:-0.75pt;"> </span>if<span style="letter-spacing:-0.45pt;"> </span>the<span style="letter-spacing:-0.6pt;"> </span>malfunction<span style="letter-spacing:-0.5pt;"> </span>of<span style="letter-spacing:-0.5pt;"> </span>the<span style="letter-spacing:-0.45pt;"> </span>device or a similar device were to recur. Our obligation to report a complaint is triggered on the date on which we become aware of an adverse event and the nature of the event. The FDA also regularly inspects companies to determine compliance with the QSRs and other post-market requirements. Please refer to our discussion of the risks and uncertainties associated with these post-market requirements under the heading &#8220;<i style="font-style:italic;">Our products may cause or contribute to adverse medical events that we are required to report to the FDA or other governmental authorities, and if we fail to do so, we may be subject to sanctions that may materially harm our business.</i>&#8221; set forth in Item 1A &#8220;Risk Factors.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reimbursement.</b> Our products are generally used in medical procedures that are covered and reimbursed by governmental payers, such as Medicare, and/or private health plans. In general, these third-party payers cover a medical device and/or related procedure in which the device is used only when the payer determines that healthcare outcomes are supported by medical evidence and the device and procedure is medically necessary for the diagnosis or treatment of the patient&#8217;s illness or injury. Even if a device has received clearance or approval for marketing by the FDA or, for uses outside of the U.S., a similar foreign regulatory agency, there is no certainty that third-party payers will cover and reimburse for the cost of the device and/or related procedures involving the use of the device. Because of increasing cost-containment pressures, some private payers in the U.S. and government payers in foreign countries may also condition payment on the cost-effectiveness of the device and/or procedure. Even if coverage is available, third-party payers may place restrictions on the circumstances in which they provide coverage or may offer reimbursement that is not sufficient to cover the cost of our products. If healthcare providers such as hospitals and physicians cannot obtain adequate coverage and reimbursement for our products or the procedures in which they are used, this may affect demand for our products and our business, financial condition, results of operations, or cash flows could suffer a material adverse impact.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt -0.7pt 12pt 0pt;"><b style="font-weight:bold;">Anti-Corruption Laws.</b> Our international operations are subject to the Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;), the U.K. Bribery Act and other foreign anti-corruption laws. The FCPA prohibits offering, paying, or promising to pay anything of value to foreign officials for the purpose of obtaining or maintaining an improper business advantage. The FCPA also requires that we maintain fair and accurate books and records and devise and maintain an adequate system of internal accounting controls. In certain countries, the individuals and entities that we regularly interact with may meet the definition of a foreign government official for purposes of the FCPA. As part of our compliance program, we train our U.S. and international employees, and we also train and monitor foreign third parties with whom we contract (e.g., distributors), to comply with the FCPA and other anti-corruption laws. Failing to comply with the FCPA or any other anti-corruption law could result in fines, penalties or other adverse consequences. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt -0.7pt 12pt 0pt;">As we expand our international operations, we continue to increase the scope of our compliance programs to match the risks relating to the potential for violations of the FCPA and other anti-corruption laws. Our compliance program includes (i) policies addressing not only the FCPA, but also the provisions of a variety of anti-corruption laws in multiple foreign jurisdictions, (ii) provisions relating to books and records that apply to us as a public company, and (iii) effective training for our personnel and relevant third parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt -0.7pt 12pt 0pt;"><b style="font-weight:bold;">Transparency Laws. </b>The U.S. Physician Payment Sunshine Act, and similar state laws, include annual reporting and disclosure requirements for device manufacturers aimed at increasing the transparency of the interactions between device manufacturers and healthcare providers. Reports submitted under these requirements are placed in a public database. Several other jurisdictions outside the U.S. have also adopted or begun adopting similar transparency laws. In addition to the burden of establishing processes for compliance, if we fail to provide these reports, or if the reports we provide are not accurate, we could be subject to significant penalties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt -0.7pt 12pt 0pt;"><b style="font-weight:bold;">Anti-Kickback Statutes.</b> The federal Anti-Kickback Statute prohibits persons and entities from, among other things, knowingly and willfully offering or paying remuneration, directly or indirectly, to induce the purchase, order, lease, or recommendation of a good or service for which payment may be made in whole or part under a federal healthcare program such as Medicare or Medicaid, unless the arrangement fits within one of several statutory exemptions or regulatory &#8220;safe harbors.&#8221; The definition of remuneration has been broadly interpreted to include anything of value, including, for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash and waivers of payments. Violations can result in significant penalties, imprisonment and exclusion from Medicare, Medicaid and other federal healthcare programs. Exclusion of a manufacturer would preclude any federal healthcare program from paying for the manufacturer&#8217;s products. Under the Affordable Care Act, a violation of the Anti-Kickback Statute is deemed to be a violation of the False Claims Act, which is discussed in more detail below. A party&#8217;s failure to fully satisfy the obligations of a regulatory &#8220;safe harbor&#8221; provision may result in increased scrutiny by government enforcement<span style="letter-spacing:-0.15pt;"> </span>authorities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In addition to the federal Anti-Kickback Statute, many states have their own anti-kickback laws. Often, these laws closely follow the language of the federal law, although they do not always have the same exceptions or safe harbors. In some states, these anti-kickback laws apply with respect to all payers, including commercial health insurance companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Government officials continue their vigorous enforcement efforts on the sales and marketing activities of pharmaceutical, medical device and other healthcare companies, including the pursuit of cases against individuals or entities that allegedly offered unlawful inducements to potential or existing customers to procure their business. Settlements of these government cases have involved significant fines and penalties and, in some instances, criminal proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">False Claims Laws. </b>The False Claims Acts prohibit any person from knowingly presenting, or causing to be presented, a false claim for payment to the federal government or knowingly making, or causing to be made, a false statement to get a claim paid. The Civil False Claims Act can be violated without actual knowledge and only requires reckless disregard or deliberate ignorance, while the Criminal False Claims Act requires a higher knowledge standard of actual knowledge and intent to violate. Manufacturers can be held liable under the False Claims Acts, even if they do not submit claims to the government, if they are found to have caused the submission of false claims (e.g., by third parties such as healthcare providers). The Civil False Claims Act also includes whistleblower provisions that allow private citizens to bring suit against an entity or individual on behalf of the U.S. and to recover a portion of any monetary recovery. Many of the recent, highly publicized settlements in the healthcare industry relating to sales and marketing practices have been cases brought under the Civil False Claims Act. Most states also have adopted statutes or regulations similar to the federal laws, which apply to items and services reimbursed under Medicaid and other state programs. Sanctions under the federal False Claims Acts and similar state laws may include civil monetary penalties, treble damages, criminal fines and/or imprisonment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Labor Standards Laws.</b> We are also subject to corporate social responsibility (&#8220;CSR&#8221;) laws and regulations which require us to monitor the labor standards in our supply chain, including the California Transparency in Supply Chains Act, the UK Modern Slavery Act, and U.S. Federal Acquisition Regulations regarding Combating Trafficking in Persons. These CSR laws and regulations may impose additional processes and supplier management systems and have led certain key customers to impose additional requirements on medical device companies, including audits, as a prerequisite to selling products to such customers, which could result in increased costs for our products, the termination or suspension of certain suppliers, and reductions in our margins and profitability.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Privacy and Security.</b> Due to Merit&#8217;s global presence, we are impacted by the privacy and data security requirements at the international, federal, state and regional level, as well as on an industry specific basis. More privacy and data security laws and regulations are being adopted and enforced, with increasingly significant fines and financial penalties for violations in the jurisdictions in which we conduct our operations. &#160;Compliance with these evolving and complex data privacy and cybersecurity laws and regulations has resulted in, and will likely continue to result in new compliance challenges and increased costs. Our business relies on the secure electronic transmission, storage and hosting of personal and sensitive personal information, including protected health information, financial information, intellectual property and other sensitive information related to our customers and workforce.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Internationally, Merit is impacted by a number of stringent privacy regimes, such as the General Data Protection Regulation (&#8220;GDPR&#8221;) in the EU and the Personal Information Protection Law (&#8220;PIPL&#8221;) in China, &#160;GDPR applies uniformly across the EU and includes, among other things, a requirement for prompt notice of data breaches to the owner of the personal data and to supervisory authorities in certain circumstances, and the imposition of significant fines for non-compliance. GDPR also requires companies based outside of the EU but processing personal data of individuals residing in the EU to comply with EU privacy and data protection rules. Non-compliance could result in the imposition of significant fines, penalties, and/or orders to stop non-compliant activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">GDPR provides for a harmonization of the data protection regulations throughout the EU. It imposes a strict data protection compliance regime with severe penalties and includes rights such as the &#8220;portability&#8221; of personal data and the right of erasure of personal data for the data subject. Although GDPR applies across the EU without a need for local implementing legislation, it contains a number of opener clauses enabling the EU member states to provide for additional legislation. In addition, local data protection authorities still have the ability to interpret GDPR, which has the potential to create inconsistencies on a country-by-country basis. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As a consequence of Brexit, GDPR no longer directly applies in the United Kingdom. However, the UK has adopted its own UK General Data Protection Regulation (&#8220;UKGDPR&#8221;). &#160;This regulation came into effect on January 1, 2021 and is generally similar to GDPR, while at the same time accommodating applicable laws in the UK. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">The People&#8217;s Republic of China has introduced a comprehensive personal information protection regime by establishing a unified, cross-sector legislation, as the EU does with GDPR. This legislation, called PIPL, went into effect on November 1, 2021, and has many aspects that are similar to GDPR. The PIPL sets rules for personal information processing activities such as collection, use, sharing, transfer, and disclosure of personal information in China. It also applies to personal information processing activities outside of China if relevant business operators (a) aim at providing products or services to individuals in China; or (b) engage in analyzing and evaluating the behavior of individuals in China. Among other provisions, the PIPL requires companies identified as personal information processors (which can be viewed as equivalent to data controllers under GDPR) to obtain informed consents from the data subjects for the processing activities of their personal information, and separate consents under certain circumstances such as cross-border transfer of personal information. The PIPL also requires storage of personal information locally in China if the company is certified as a critical information infrastructure operator or processing personal information exceeding a certain volume threshold. Further, the PIPL grants statutory rights to data subjects, such as the right to information, the right to withdraw consents, the right of data portability, and the right to refuse automated decision-making. In addition, the PIPL also imposes a number of new administrative requirements on the personal information processors, including, among others, designating a data protection officer if certain conditions are met, signing data processing agreements with entrusted processors (which can be viewed as equivalent to data processors under GDPR), preparing data breach notices, conducting a personal information impact assessment as required, and obtaining regulatory approval for certain cross-border data transfer activities. Violations of the PIPL may incur severe penalties, revocation of the company&#8217;s license to do business in China, and personal liabilities for company executives. As the PIPL is new and relevant implementation rules are to be finalized and released, we are in the process of implementing changes to our business practices to comply with the PIPL while monitoring further developments in the law.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In the U.S., the collection, maintenance, protection, use, transmission, disclosure and disposal of certain personal information and the security of medical devices are regulated at the U.S. federal and state, international and industry levels. U.S. federal and state laws protect the confidentiality of certain patient health information, including patient medical records (&#8220;PHI&#8221;), and restrict the use and disclosure of patient health information by healthcare providers. &#8220;Privacy&#8221; and </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#8220;Security&#8221; Rules under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended, and the Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;), govern the use, disclosure, and security of protected health information by &#160;&#8220;Covered Entities&#8221; (which are healthcare providers, &#160;health plans and healthcare clearinghouses), and by their &#8220;Business Associates&#8221; (which is anyone that performs a service on behalf of a Covered Entity involving the use or disclosure of PHI and is not a member of the Covered Entity&#8217;s workforce). Regulations under these laws establish standards, including standards regarding the privacy and security of PHI and breach notification requirements. The U.S. Department of Health and Human Services (through the Office of Civil Rights) has direct enforcement authority against Covered Entities and Business Associates with respect to both the Security and Privacy Rules, including both civil and criminal liability. Although Merit is a healthcare provider, Merit is not a Business Associate under the &#160;HIPAA/HITECH Act. Our risk is therefore significantly reduced because we do not create, receive, maintain, have access to, use, disclose or transmit PHI. &#160;Many state laws also regulate the use and protection of PHI by healthcare providers and may require notification in the event of a breach of such information. &#160;Merit may be subject to these laws in certain instances.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">With the advent of digital technology, artificial intelligence, social media, and the speed at which information moves, the protection and security of data has become an increasingly important public, media and legislative concern. As a result, and in addition to the U.S. federal regulation of PHI, a number of states have also adopted laws and regulations that may affect our privacy and data security practices for other kinds of personally identifiable information, such as state laws that govern the use, disclosure and protection of personal information and sensitive personal information (such as social security numbers). State consumer protection laws may also establish privacy and security standard for the storage, use and management of personally identifiable information, including information related to consumers or employees (which include job applicants, employees, owners, officers, directors, and medical staff members of Merit).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December 31 2022, five U.S. states had enacted comprehensive data privacy laws. In general, these state laws (California, Colorado, Connecticut, Utah and Virginia) give residents the right to obtain their personal information from companies, request to have their personal information deleted, and opt out of having that information sold to third parties. The state laws also compel companies to post clear privacy policies that detail the types of personal information they collect about consumers, with whom they share this data, and how consumers can control their personal data. We post on our websites our privacy notices, policies and practices regarding the collection, use and disclosure of user data, as well as providing our privacy policies to our employees (including job applicants) by linking to the Merit privacy policy (posted on the Merit website) from our Employee Handbook and our job application board. Any failure, or perceived failure, by us to comply with our posted privacy notices or policies or with any applicable regulatory requirements or orders, or privacy, data protection, information security or consumer protection-related privacy laws and regulations in one or more jurisdictions could result in proceedings or actions against us by governmental entities or others, including class action privacy litigation in certain jurisdictions, subject us to significant fines, penalties, judgments and negative publicity, require us to change our business practices, increase the costs and complexity of compliance, and adversely affect our business. California&#8217;s Consumer Protection Act (&#8220;CCPA&#8221;) went into effect on January 1, 2020, giving consumers the right to (i) prevent businesses from sharing their personal information, (ii) correct inaccurate personal information, and (iii) restrict companies from utilizing sensitive data and personal information. The California Privacy Rights Act (&#8220;CPRA&#8221;), which went into effect on January 1, 2023, amended the CCPA to include job applicants, employees, owners, officers, directors, and medical staff members of a business (collectively &#8220;employees&#8221;), give consumers even more control over their data, and increase the maximum penalties for violations against consumers who are less than 16 years old. The CPRA also prevents companies from keeping personal data longer than necessary. The addition of employees to the protections afforded by the CCPA can cause business concerns because we also have legal requirements to retain certain employee data, such as confidential disciplinary files, as well as legal document retention requirements. Virginia&#8217;s Consumer Data Protection Act, which also went into effect on January 1, 2023, sets forth regulations regarding how we can control and process data, giving consumers the right to access, delete, and correct their data, as well as opt-out of personal data processing for advertising purposes. &#160;The Colorado Privacy Act and the Connecticut Personal Data Privacy and Online Monitoring law, both of which establish standards for how companies control and process consumer personal data, are both scheduled to take effect July 1, 2023. The Utah Consumer Privacy Act, which is scheduled to take effect on December 31, 2023, gives consumers the right to know what type of data businesses collect about them, how their data is being used and whether or not businesses intend to sell their data to third parties. All five of these state laws let consumers access and delete their personal data that the business has collected on them and opt out of data collection.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Because privacy and data security laws and regulations continue to expand, differ from jurisdiction to jurisdiction, and are subject to evolving (and at times inconsistent) governmental interpretation, compliance with these laws and regulations may require significant additional cost expenditures or changes in products or business that increase competition or reduce revenue. Noncompliance with such laws or regulations could result in the imposition of fines, penalties, or orders to stop noncompliant activities, as well as harm to reputation, or other consequences. If our customers were to reduce their use of our products and services as a result of these concerns, our business could be materially harmed. As noted above, we are also subject to the possibility of security and privacy breaches, which themselves may result in a violation of these privacy laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CARES Act. </b>On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was signed into law. The $2.2 trillion economic stimulus bill contains numerous tax law changes. The CARES Act esta<span style="background:#ffffff;">blished a program with provisions to allow U.S. companies to defer the employer&#8217;s portion of social security taxes between March 27, 2020 and December 31, 2020 and pay such taxes in two installments in 2021 and 2022. </span>As permitted by the CARES Act we deferred payment of the employer&#8217;s portion of social security payroll tax payments and made a payment equal to one half of the deferred amount during each of the years ended December 31, 2021 and 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Seasonality</p><a id="_Hlk30519364"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our worldwide sales have not historically reflected a significant degree of seasonality; however, customer purchases have historically been lower during the third quarter of the&#160;year, as compared to other quarters. This reflects, among other factors, lower demand during summer&#160;months in countries in the northern hemisphere.</p><a id="_Hlk63985699"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Sustainability</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the oversight of our Board of Directors and management team, we continue to make sustainability a key focus of our business. We have a cross-functional Corporate Sustainability Council that is driving long-term Environment, Social and Governance (&#8220;ESG&#8221;) goals across our enterprise. These efforts have included proactive actions to address both risks and opportunities related to our sustainability program, as we strive for continued growth and profitability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The majority of our products are disposable medical devices and are generally disposed of after a single use due primarily to the risks of exposing patients to bloodborne pathogens capable of transmitting disease or other potentially infectious materials. Additionally, repeated sterilization to address such risks is not possible because it may adversely affect the quality of the materials used in many of our products and result in the failure of our product to function properly if used in multiple medical procedures. Consequently, many of our used products will likely end up in a medical waste disposal facility at the end of their usefulness. We continually look for opportunities to deliver <span style="background:#ffffff;">sustainable, long-term growth of our business. Our sustainability practices are an integral component of our business strategy. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="background:#ffffff;">We have identified our sustainability opportunities, and</span> have developed areas of focus where we are positioned to make a positive impact. These include programs designed to reduce waste, improve efficiencies, reduce greenhouse gas emissions, and protect the environment. Our sustainability values in action include:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">achievement of ISO 14001 certification at all of our largest manufacturing facilities (seven in scope) with the goal of continual improvement of our environmental management system (ISO 14001 is the international standard that specifies requirements for an effective environmental management system);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">achievement of ISO 45001 certification at all of our largest manufacturing facilities (seven in scope) with the goal of continual improvement to our occupational health and safety management system (ISO 45001 is the international standard that specifies requirements for an effective safety management system);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">achievement of ISO 50001 certification at five of our largest manufacturing facilities (seven in scope), and our goal is to achieve ISO 50001 certification at all our in scope manufacturing facilities by the end of 2024 (ISO 50001 is the international standard that specifies requirements for an effective energy management system); </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishment and support of employee gardens that promote pollination and provide farm-to-table nutrition for our employees at our headquarters in South Jordan, Utah;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">transition to re-usable pallets and methods to move products in reusable bulk containers, reducing intra-company shipping materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reduction in water consumption at our water-stressed location in South Jordan, Utah by investing in campus-wide xeriscaping and water recirculation systems within our most water intensive operations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reduction in packaging materials by implementing product family packaging reviews to consolidate shipments by better understanding our customers&#8217; purchasing practices&#8212;these reviews often allow us to increase quantities per box, eliminate the usage of intermediate packaging, reducing film thickness and use original product packaging where possible;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">transition from paper work orders to electronic work orders through our internally designed eWorq program&#8212;at full completion, this project will save millions of pieces of paper and thousands of plastic sleeves annually&#8212;currently we are working to implement this program at our largest manufacturing facilities in South Jordan, Utah and Tijuana, Mexico, with plans to continue the roll-out to other sites thereafter;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recycling programs where our employees recycle materials, including food waste, paper, plastic, cardboard, food waste and beverage containers, scrap metal, and pallets, and re-use of our plastic scrap waste leftover from the manufacturing process of our molded parts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">placement of free car charging stations for employees who have transitioned to electric vehicles; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">installation of efficient heating and cooling systems that operate on variable efficiency drives, increasing our energy efficiency at our headquarters in South Jordan, Utah and our transition to Light Emitting Diode (&#8220;LED&#8221;) lighting in our manufacturing facilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">operation of an environmental tracking system at our world-wide facilities to facilitate monthly reporting and accountability for energy, water, waste, recycling, and scope 1 and 2 greenhouse gas emissions metrics&#8212;this system supports our 2030 operational sustainability goals; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#8226;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">engaged in a comprehensive materiality assessment to better align ESG expectations from our internal and external stakeholders.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:9pt;text-indent:-9pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">To learn more about our sustainability programs and accomplishments, you may visit www.merit.com/about/corporate-sustainability/; however, the information on this website is not, and will not be deemed, a part of this report or incorporated into any other filings we make with the SEC.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Human Capital Management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of December&#160;31,&#160;2022, we had 6,846 employees located in approximately 40 different countries in a variety of different roles. In the highly competitive medical device industry, we consider attracting, developing, and retaining talented people in technical, operational, marketing, sales, research, management, and other positions to be critical to our overall long-term growth strategy. Our ability to recruit and retain such talent depends on several factors, including compensation and benefits, talent development, career opportunities, and work environment. We invest in our people and cultivate a company culture committed to supporting a diverse and inclusive workforce.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Diversity and Inclusion.</b> Our goal is to create a diverse and inclusive global culture that reflects the diversity of the customers we serve and encourages an environment where employees feel welcomed, respected, and valued. With this goal in mind, our Chief Human Resources Officer has been charged with working with our leadership team to strengthen and enhance our diversity and inclusion efforts company wide.&#160;We are committed to providing equal opportunity in all aspects of employment. In the U.S., we are an equal opportunity/affirmative action employer committed to making employment decisions without regard to race, religion, ethnicity or national origin, gender, sexual orientation, gender identity or expression, age, disability, protected veteran status or any other characteristics protected by law.&#160;Over 50% of our U.S. employee population identifies as non-white. To further promote a culture of inclusion, during 2021 we started the Women&#8217;s Leadership Initiative (&#8220;WLI&#8221;), our first ever affinity group led by women and open to all Merit employees. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The WLI contributes to our long-term strategies by promoting a culture of diversity, equity and inclusion through (i) sponsoring professional development activities focused on overcoming barriers and restraints to the advancement of women&#8217;s careers, (ii) facilitating external interactions with organizations and thought leaders, and (iii) providing resources focused on improving diversity, equity, and inclusion. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Employee Engagement.</b> The engagement of our workforce is critical to delivering on our competitive strategy, and we place high importance on informed and engaged employees. We communicate frequently with our employees through a variety of communication methods, including video and written communications, town hall meetings, and our company intranet, and we acknowledge individual contributions to Merit by celebrating milestones of service in five-year increments. Since 2021 we have substantially strengthened our employee communications capabilities through the addition of dedicated internal resources and programs aimed at doing even more to communicate with and engage our workforce. In partnership with the Gallup organization, in 2022 we launched our first ever global employee engagement survey. This survey provided us with many insights into the engagement of our employees from which we have been able to develop action plans at the team and company level in order to further strengthen employee engagement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Compensation and Benefits.</b> Because our mission is to create innovative medical devices that improve lives, we aim to hire and develop employees who want to build something special through hard work, team effort, and commitment. That is why we provide all our employees with competitive benefit packages and strive to provide the most cost-effective medical benefits and wellness programs. As a result of our focus on competitive health and wellness benefits, we have achieved our eighth consecutive year of zero health care plan cost increases for our U.S. employees who participate in our group healthcare plans. Our benefits include competitive pay, annual incentive awards and bonus opportunities, healthcare and retirement benefits, an Employee Stock Purchase Plan, paid time off and sick leave, paid parental leave, flexible work schedules, remote working opportunities, and a wellness program. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Talent Development. </b>In 2021, we hired our first ever Director of Global Talent Management who continues to be focused on building and strengthening global programs around strategic talent management, employee performance, development and engagement.&#160;To improve employee performance, we have begun building out a global performance management program which will be officially launched in 2023 alongside our new human resources information system.&#160;Employee development programs are also being executed at different regional and local levels with a focus on management and leadership development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Community. </b>Our employees are actively involved in their communities and supporting causes. At our headquarters, we provide an onsite garden where employees take part in growing and distributing produce to employees and to the local community. Employees also actively support causes by raising awareness and funds for non-profit organizations. Areas that our employees have supported in recent years include Breast Cancer Awareness Month, Heart Health Month, children&#8217;s charities and supporting those in need. In 2022, we continued our support of humanitarian missions through Merit product donations in Haiti, Kenya, Honduras, Nicaragua, and Tanzania. Merit also conducts and/or participates in medical education conferences around the globe.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Wellness. </b>Wellness is at the foundation of creating a positive employee experience. At our company headquarters in Utah, we have an onsite medical clinic available for our employees and their families where we provide preventative and general medical care. In addition, we have a Chief Wellness Officer dedicated to designing programs and initiatives that support the physical, emotional, and mental health of our employees. We have a monthly wellness committee meeting and create a &#8220;Get Healthy&#8221; wellness program available to all sites across the globe. Programs include providing health information from medical and nutrition experts, newsletters with wellness and dietary tips, and activities promoting health and wellbeing such as walking groups and fitness challenges. Some programs include suicide prevention awareness, on-site diabetes screenings, mental health awareness, lifestyle modification to prevent diseases, tobacco cessation, breast cancer awareness, and our Smart Choice meal program designed by our onsite nutritionist and chef to provide free heart healthy meals to employees in our Utah headquarters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">COVID-19 Response; Health and Safety. </b>During the COVID-19 pandemic, the majority of our manufacturing employees continued to work from our facilities, where we adopted health screening, implemented social distancing and personal protective equipment requirements, enhanced food service, cleaning and sanitation procedures, and modified workspaces to reduce the potential for disease transmission, and implemented a COVID-19 vaccine mandate for our U.S. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">employees. During 2022 most employees who do not require access to our facility to perform their work continued to work remotely, without a significant impact to productivity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Information Security</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We maintain strong cybersecurity systems to guard against unauthorized access, malicious software, corruption of data, disruption of our networks and systems and unauthorized release of confidential information. We employ an experienced and dedicated information security team, follow industry best practices, and work with our employees globally to create awareness and mitigate cyber risk. On an ongoing basis, we assess risks and implement procedures and practices designed to improve the security, confidentiality, integrity and availability of our systems. We voluntarily engage third-party security auditors to test our systems and controls at least annually against the most widely recognized security standards and regulations. We have developed and continue to implement a continuing cyber awareness training program which is designed to increase awareness of cybersecurity threats throughout our company and reduce the risk of human error. We conduct periodic phishing testing on all our employees with e-mail access and emphasize information security in training events and programs we host throughout the year<span style="background:#ffffff;">. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">We have established controls and procedures to escalate enterprise-level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Our Board of Directors is responsible for enterprise risk management, including our approach to managing cybersecurity risk, and has delegated oversight responsibility of information security risks to its Audit Committee. The Audit Committee regularly reviews information security risks and receives reports from our Chief Technology Officer and other members of the Company&#8217;s management regarding those risks. Under our framework, cybersecurity issues are analyzed by subject matter experts for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company&#8217;s financial results, operations, and/or reputation are immediately reported by management to our Board of Directors or its Audit Committee, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made as appropriate. We maintain cyber insurance coverage that may, subject to policy terms, conditions and limitations, cover certain aspects of cybersecurity risks; however, such insurance coverage may be unavailable or insufficient to cover all losses or all types of claims that may arise in the continually evolving area of cyber risk. During the last three years, we have not experienced a material security breach and, as a result, we have not incurred any material expenses from such a breach. Furthermore, during such time, we have not been penalized or paid any amount under any information security breach settlement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Recent Developments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt;">Available Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:9pt 0pt 0pt 0pt;">We file annual, quarterly and current reports and other information with the SEC. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of the SEC&#8217;s internet website is www.sec.gov.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our internet address is www.merit.com. On our Investor Relations website, www.merit.com/investors, we make available, free of charge, a variety of information for investors. Our goal is to maintain the Investor Relations website as a portal through which investors can easily find or navigate to pertinent information about us, including: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:30.6pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.35pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after we electronically file that material with or furnish it to the SEC. </p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:30.6pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18.35pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Press releases on our quarterly earnings and other pertinent information, including product launches, corporate initiatives, and participation in upcoming investor conferences.</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="width:30.95pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">&#8226;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;text-align:justify;">Corporate governance information including our corporate governance guidelines, committee charters, and codes of business conduct and ethics.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 0pt 30.95pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Additionally, we provide electronic and paper copies of such filings free of charge upon request.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18.35pt;text-align:justify;text-indent:-18.35pt;margin:0pt 0pt 0pt 30.6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The information on www.merit.com is not, and will not be deemed, a part of this report or incorporated into any other filings we make with the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18.35pt;text-align:justify;text-indent:-18.35pt;margin:0pt 0pt 0pt 30.6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial Information About Foreign and Domestic Sales</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-style:normal;font-weight:normal;">For financial information relating to our foreign and domestic sales see Note&#160;2 and Note&#160;13 to our consolidated financial statements set forth in Item&#160;8 of this report.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_6d8a59de_8b16_4d11_a39d_69c1930809ff"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Item1ARiskFactors_780049"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;1A.</b></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Risk Factors.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our business, operations and financial condition are subject to certain risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, our actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected. Among the key factors that may have a direct bearing on our business, operations or financial condition are the factors identified below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Business, Economic, Industry and Operational Risks</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Termination or interruption of our supply relationships and increases in labor costs and the prices of our component parts, finished products, third-party services and raw materials, particularly petroleum-based products, is negatively impacting our business and could have a further adverse effect on our business, operations or financial condition<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We rely on raw materials, component parts, finished products and third-party services in connection with our business. For example, substantially all of our products are sterilized by only a few different entities. If any of these sterilizers goes out of business or fails to comply with quality or regulatory requirements, we may be unable to find a suitable supplier to replace them. This could significantly delay or stop production and cause sales of such products to materially decline. Additionally, many of our products have components that are manufactured using resins, plastics and other petroleum-based materials which are available from a limited number of suppliers. We are experiencing a growing trend among suppliers of polymer resins to refuse to supply resin to the medical device manufacturers or to require such manufacturers to assume additional risks due to the potential for product liability claims. Additionally, there is no assurance that crude oil supplies will be uninterrupted or that petroleum-based manufacturing materials will be available for purchase in the future.&#160;The military conflict between Russia and Ukraine may increase the likelihood of supply interruptions and further hinder our ability to find the materials we need to make our products. Supply disruptions are making it harder for us to find favorable pricing and reliable sources for the materials we need, putting upward pressure on our costs and increasing the risk that we may be unable to acquire the materials and services we need to continue to manufacture certain products.</p><a id="_DV_M284"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The availability and price of these materials, parts, products and services are affected by a variety of factors beyond our control, including the willingness of suppliers to sell into the medical device industry, changes in supply and demand, general economic conditions, labor costs, fuel-related transportation costs, liability concerns, climate change (including new and existing laws and regulations to address climate change), competition, import duties, tariffs, currency exchange rates and political uncertainty around the world. During 2022, we experienced significantly elevated commodity and supply chain costs, including the costs of labor, raw materials, energy, fuel, packaging materials and other inputs necessary for the production and distribution of our products, and we expect elevated levels of inflation to continue in 2023. Our suppliers often pass some of their cost increases on to us, and if such increased costs are sustained or increase further, our suppliers may pass further cost increases on to us. In addition to the effect on resin prices, transportation costs have generally increased and may further increase if crude oil prices increase. Our transportation and service providers are typically able to pass any significant increases in oil prices on to us. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our ability to recover such increased costs may depend upon our ability to raise prices on our products. Due to the highly competitive nature of the healthcare industry and the cost-containment efforts of our customers and third-party payers, we may be unable to pass along cost increases through higher prices. If we are unable to fully recover these costs through price increases or offset these increases through cost reductions, or we experience terminations or interruption of our relationships with our suppliers, we could experience lower margins and profitability, and our results of operations, financial condition and cash flows could be materially harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Changes in general economic conditions, geopolitical conditions, domestic and foreign trade policies, monetary policies and other factors beyond our control may adversely impact our business and operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our operations and performance depend significantly on global, regional and U.S. economic and geopolitical conditions. The global macroeconomic environment continues to be challenging due to the effects of the COVID-19 pandemic and government responses, increases in inflation globally, instability in the global credit markets, the impact of uncertainty regarding global central bank monetary policy, the instability in the geopolitical environment in many parts of the world (including as a result of the on-going Russia and Ukraine war and China-Taiwan relations), the current economic challenges in China, and other disruptions. Periods of intense diplomatic or armed conflict, such as the ongoing conflict in </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_DV_M291"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Ukraine, may result in (i) new and rapidly evolving sanctions and trade restrictions, which may impair trade with sanctioned individuals and countries, and (ii) negative impacts to regional trade ecosystems among our customers, partners, and us. Non-compliance with sanctions as well as general ecosystem disruptions could result in reputational harm, operational delays, monetary fines, loss of revenues, increased costs, loss of export privileges, or criminal sanctions. Furthermore, U.S. trade policy could trigger retaliatory actions by other countries, including China, resulting in a &#8220;trade war.&#8221; A trade war could result in increased costs for raw materials we use in our manufacturing and could result in foreign governments imposing tariffs on products that we export outside the U.S. or otherwise limiting our ability to sell our products abroad. These increased costs would have a negative effect on our financial condition and profitability. Furthermore, if the conflict between Russia and Ukraine continues for a long period of time, or if other countries, including the U.S., become further involved in the conflict, we could face significant adverse effects to our business and financial condition.</p><a id="_DV_C21"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The occurrence of regional epidemics or a global pandemic, such as COVID-19, may adversely affect our operations, financial condition, and results of operations. The COVID-19 pandemic and governmental responses have had widespread, rapidly evolving, and unpredictable impacts on global society, economies, financial markets, and business practices. The extent to which global pandemics impact our business going forward will depend on factors such as the duration and scope of the pandemic; governmental, business, and individuals&#8217; actions in response to the pandemic; and the impact on economic activity, including the possibility of recession or financial market instability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The above factors, including a number of other economic and geopolitical factors both in the U.S. and abroad, could ultimately have material adverse effects on our business, financial condition, results of operations or cash flows, including the following:</p><a id="_DV_C23"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">effects of significant changes in economic, monetary and fiscal policies in the U.S. and abroad including currency fluctuations, inflationary pressures and significant income tax changes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">global increases in inflation</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a global or regional economic slowdown in any of our market segments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in government policies and regulations affecting the Company or its significant customers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">industrial policies in various countries that favor domestic industries over multinationals or that restrict foreign companies altogether;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">new or stricter trade policies and tariffs enacted by countries, such as China, in response to changes in U.S. trade policies and tariffs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">postponement of spending, in response to tighter credit, financial market volatility and other factors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">rapid material escalation of the cost of regulatory compliance and litigation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulties protecting intellectual property;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">longer payment cycles;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">credit risks and other challenges in collecting accounts receivable; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the impact of each of the foregoing on outsourcing and procurement arrangements.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-family:'TimesNewRoman';font-style:italic;font-weight:bold;">Any damage or interruption to our operations, facilities, infrastructure, manufacturing processes or information technology systems, or those of our suppliers, including as a result of our facility consolidation initiatives, could result in lost revenues and our business could be seriously harmed.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-family:'TimesNewRoman';">Damage or interruption to our facilities or systems relating to manufacturing, distribution, research and development, or information technology because of fire, extreme weather conditions, natural disaster, power loss, communications failure, geopolitical disruption, labor strikes, riots, cyber-attack, health epidemics and pandemics, unauthorized entry or other events could significantly disrupt our operations, the operations of suppliers and critical infrastructure. These events may also delay or prevent product manufacturing and shipment during the time required to repair, rebuild or replace the damaged facilities or systems. We have recently closed or reduced the operations of certain facilities and moved operations and resources to other facilities, and we are in the process of other facility consolidation initiatives. The resulting concentration of resources and the potential disruption and logistical challenges resulting from those initiatives may further exacerbate the adverse effects of these events or make it more difficult for us to respond to the effects of these events. &#160;Those initiatives may also divert the attention of our management team or other personnel, result in unanticipated expense and disrupt our operations. Climate change may increase both the frequency and severity of natural disasters and, </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'TimesNewRoman';">consequently, risks to our operations and growth. Although we maintain property damage and business interruption i</span><span style="font-family:'TimesNewRoman';">nsurance coverage on our </span>facilities<span style="font-family:'TimesNewRoman';">, our insurance might not cover all losses under such circumstances, and we may not be able to renew or obtain such insurance in the future on acceptable terms with adequate coverage or at reasonable costs.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Consolidation in the healthcare industry, group purchasing organizations and public procurement policies have lead to demands for price concessions, which reduces our revenues and may harm our ability to sell our products at prices necessary to support our current business strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Healthcare costs have risen significantly over the past decade, which has resulted in or led to numerous cost reform initiatives by legislators, regulators and third-party payers. Cost reform has triggered a consolidation trend in the healthcare industry to aggregate purchasing power, which has created more requests for pricing concessions and is expected to continue in the future. Additionally, many of our customers belong to group purchasing organizations or integrated delivery networks that use their market power to consolidate purchasing decisions for these hospitals and healthcare service providers. These customers are often able to obtain lower prices and more favorable terms because of the potential sales volume they represent, which has lead to lower revenues and required us to take on additional liability. We expect that market demand, government regulation, third-party coverage and reimbursement policies and societal pressures will continue to change the healthcare industry worldwide, resulting in further business consolidations and alliances among our customers, which may exert further downward pressure on the prices of our products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We may be unable to compete in our markets, particularly if there is a significant change in relevant practices or technology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The markets in which our products compete are highly competitive. We face competition from many companies which are larger, better established, have greater financial, technical and other resources and possess a greater market presence than we do. Such resources and market presence may enable our competitors to more effectively market competing products or to market competing products at reduced prices in order to gain market share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">In addition, our ability to compete successfully is dependent, in part, upon our response to changes in technology and upon our efforts to develop and market new products which achieve significant market acceptance. Competing companies with substantially greater resources than us are actively engaged in research and development of new methods, treatments, drugs, and procedures to treat or prevent cardiovascular disease that could limit the market for our products and eventually make some of our products obsolete. A reduction in the demand for a significant number of our products, or a few key products, could have a material adverse effect on our business, operations or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">COVID-19 Risks</b></p><a id="_Hlk33710708"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;background:#ffffff;">The COVID-19&#160;pandemic and related ongoing implications have negatively impacted our business and operations around the world and may&#160;continue to&#160;materially and adversely impact our business, operations and financial results</span><span style="font-style:italic;font-weight:bold;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">The COVID-19 pandemic and the resulting containment measures created significant disruption and uncertainty in the global economy and negatively impacted our business, results of operations and financial condition during 2020, 2021 and 2022. Although the impact of COVID-19 and the resulting containment measures decreased during 2022, they have the potential to continue to negatively impact our business, results of operations and financial condition in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Numerous national, international, state and local jurisdictions imposed a variety of government orders and restrictions for their residents to control the spread of COVID-19. In 2020, such orders and restrictions caused significant alterations of our operations, work stoppages, slowdowns and delays, travel restrictions and event cancellations, among other effects, thereby significantly and negatively impacting our financial condition. In 2021 and 2022, these conditions continued at varying levels. Other disruptions that we experienced include (i) restrictions on our personnel and personnel of business partners to travel and access customers for training and case support&#894; (ii) supply chain delays and disruptions, logistical challenges and increased freight, transportation and other expenses; (iii) delays in regulatory approvals by governmental and regulatory bodies; (iv) reductions in spending by our customers; (v) diversion of or limitations on employee resources that would otherwise be focused on the operations of our business, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people&#894; (vi) fluctuations in the availability of employees and potential employees&#894; (vii) additional government requirements or other incremental mitigation efforts that </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">may further impact our or our suppliers&#39; capacity to manufacture our products; (viii) disruption of our research and development activities; and (ix) delays in ongoing studies and pre-clinical trials. Although some of these disruptions diminished in 2021 and the impact lessened further during 2022, they may again return or further intensify their effect on our operations, whether as a direct result of COVID-19 or other factors exacerbated by the effects of COVID-19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">In addition, elective procedures that use our products significantly decreased in number during much of 2020 as health care organizations around the world prioritized the treatment of patients with COVID-19 and reduced spending in other areas. For example, in the United States, governmental authorities recommended, and in certain cases required, that elective, deferrable, specialty and other procedures and appointments (many of which use our products), be suspended or canceled to avoid non-essential patient exposure to medical environments and potential infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of COVID-19 patients. In 2021, these procedures resumed in many locations, and overall, we saw significant improvement in our business during 2021. We saw further improvement in the availability of elective procedures during 2022. It is possible, however, that a resurgence of COVID-19, or increased spread of its variants, could again cause a rise in severe infections and force authorities and customers to impose restrictions that would negatively impact our operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 10pt 0pt;">All of these factors have also caused or contributed to disruptions and delays in our logistics and supply chain, and we may continue to experience these disruptions and delays. The full extent to which COVID-19 and resulting containment measures impact our business, operations and financial results will depend on future developments that are uncertain and cannot be predicted, including new information that may emerge concerning the severity and spread of the virus and its variants. To the extent COVID-19 (including existing variants and any new variants) and resulting containment measures continue to adversely affect our business, operations and financial results, they may also have the effect of heightening other risks described herein, such as those relating to general economic conditions, demand for our products, relationships with suppliers and sales efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Strategic, Business Development and Employee Attraction and Retention Risks</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We may be unable to successfully manage growth and maintain operational efficiencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Successful implementation and execution of our business strategy will require that we effectively manage our growth. As the Company grows, we are often faced with decisions to (i) expand certain product lines and discontinue others, (ii) open or expand new facilities and close others, (iii) allocate resources between new and established markets, or (iv) allocate resources between the expansion of organic business and the acquisition of new product lines. The outcome of each of these decisions is uncertain, and even with the exercise of excellent business judgment, results may not align with expectations because of the many factors listed in this section. In addition, our management will need to continue to implement changes in certain aspects of our business, improve our information systems, infrastructure and operations to respond to increased demand, attract and retain qualified personnel, and develop, train, and manage an increasing number of employees. We may not have the resources available to implement certain necessary changes, and as a result, growth may be delayed or we may not be able to take advantage of certain business opportunities. Growth has placed, and will likely continue to place, an increasing strain on our management, sales and other personnel, and on our financial, product design, marketing, distribution, technology and other resources. Any failure to manage growth effectively could have a material adverse effect on our business, operations or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Substantial costs are incurred when identifying, evaluating, negotiating and closing acquisitions, and failure to integrate acquired businesses may adversely impact our business and financial results. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We have completed a series of significant acquisitions and, continue to evaluate other potential acquisitions and strategic transactions, certain of which may also be significant. We have incurred, and will likely continue to incur, significant expenses in connection with evaluating, negotiating and consummating various acquisition and other strategic transactions. As we grow through acquisitions, we face the additional challenges of integrating the operations, culture, information management systems and other characteristics of the acquired entity with our own, including sales models related to capital equipment. Our efforts to integrate acquisitions may be hampered by delays, the loss of certain employees, suppliers or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">customers, proceedings resulting from employment terminations, culture clashes, unbudgeted costs, and other issues, which may occur at levels that are more severe or prolonged than anticipated. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Additionally, past and future acquisitions may increase the risks of competition we face by, among other things, extending our operations into industry segments and product lines where we have few existing customers or qualified sales personnel and limited expertise. Further, as a result of certain acquisitions, we are selling capital equipment, in addition to our historical sales of disposable medical devices. The sale of capital equipment may create additional risks and potential liability, which may negatively affect our business, operations or financial condition. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">In addition, we may not realize competitive advantages, synergies or other benefits anticipated in connection with any such acquisition or other transaction. If we do not adequately identify and value targets for, or manage issues related to, acquisitions and strategic transactions, such transactions may not produce the anticipated benefits and have an adverse effect on our business, operations or financial condition. We have incurred expenses in connection with the disposition of businesses and assets which we acquired but determined that they did not produce the benefits contemplated at the time of acquisition. We may incur similar expenses in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We will be required to expend significant resources for research, development, testing and regulatory approval or clearance of our products under development, and these products may not be developed successfully or approved for commercial use<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Most of our products under development will require significant additional research, development, engineering and, in some cases, preclinical and clinical testing, as well as regulatory approval or clearance and a commitment of significant additional resources prior to their commercialization. It is possible that our products may not:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be developed successfully;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be proven safe or effective in clinical trials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">offer therapeutic or other improvements over current treatments and products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">meet applicable regulatory standards or receive regulatory approvals or clearances;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be capable of production in commercial quantities at acceptable costs and in compliance with regulatory requirements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be successfully marketed; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be covered by private or public insurers.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We may be unable to accurately forecast customer demand for our products and manage our inventory.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">To ensure adequate supply, we must forecast our inventory needs and place orders with our suppliers based on estimates of future demand for particular products. Our ability to accurately forecast demand for our products could be negatively affected by many factors, including our failure to accurately manage our expansion strategy and customer acceptance of new products, product introductions by our competitors, an increase or decrease in customer demand for our products or for products of our competitors, unanticipated changes in general market conditions or regulatory matters and weakening of economic conditions, effects of COVID-19 or decreased consumer confidence in future economic conditions. Inventory levels in excess of customer demand may result in inventory write-downs or write-offs, which would impact our gross margin. Conversely, if we underestimate customer demand for our products, our manufacturing facilities may not be able to deliver products to meet our order requirements, which could damage our reputation and customer relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our forecasts of customer demand and related decisions that we make about production levels may take into account potential opportunities created by regulatory issues, supply disruptions or other challenges experienced by our competitors. We generally do not know the extent and cannot predict the duration of these challenges experienced by our competitors. As a result, our estimates about related increased demand for our products are inherently uncertain and subject to change. If our estimates incorrectly forecast the extent or duration of this increased demand, or the product types to which it relates, our revenues, margins and earnings could be adversely affected.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We lack direct sales and marketing capabilities in many countries and are dependent on our distributors for the commercialization of our products in these countries. If we are unable to maintain or establish sales capabilities on our own or through third parties, we may not be able to commercialize any of our products in those countries<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We have no or limited direct sales or marketing capabilities in some of the regions and countries in which our products are sold, including, among others, China, Japan, Russia and India. We have entered into distribution agreements with third parties to market and sell our products in those countries in which we do not have a direct sales force and in those countries in which we utilize a &#8220;modified direct&#8221; sales approach. If we are unable to maintain or enter into such distribution arrangements on acceptable terms, or at all, we may not be able to successfully commercialize our products in certain countries. Moreover, to the extent that we enter into distribution arrangements with other companies, our revenues, if any, will depend on the terms of any such arrangements and the efforts of others. These efforts may turn out not to be sufficient and our third-party distributors may not effectively sell our products. In addition, although our contract terms require our distributors to comply with all applicable laws regarding the sale of our products, including anti-competition, anti-corruption, anti-money laundering and sanctions laws, we may not be able to ensure proper compliance. If our distributors fail to effectively market and sell our products in full compliance with applicable laws, our results of operations and business could be impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We are dependent upon key personnel<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our success is dependent on key management personnel, including Fred P. Lampropoulos, our Chairman of the Board, President and Chief Executive Officer. Mr.&#160;Lampropoulos is not subject to any agreement prohibiting his departure, and we do not maintain key man life insurance on his life. The loss of Mr.&#160;Lampropoulos, or of certain other key management personnel, could have a materially adverse effect on our business and operations. Our success also depends on, among other factors, the successful recruitment and retention of key operating, manufacturing, sales and other personnel.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Regulatory, Litigation, Tax and Legal Compliance Risks</b></p><a id="_Hlk63953106"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Regulations and trade policies implemented by foreign governments to reduce the costs of healthcare or promote business in their countries have caused, and are likely to continue to cause our sales to decline in such countries. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">These regulations and policies result in increased costs, lower margins and lower sales than we would otherwise expect, which have a material adverse effect on our business, financial condition, results of operations, or cash flows. Our customers and suppliers may also be affected by these events, so even if we are not directly impacted, we may still experience lower demand for our products and increases in our manufacturing costs because of the effects these events may have on our customers and suppliers. For example, China has implemented a volume-based procurement process designed to decrease prices for medical devices and other products. This process has had a negative impact on our revenues in China and we expect it will continue to cause a decrease in the revenue we are able to generate in China. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">The FDA regulatory clearance process is expensive, time-consuming and uncertain, and the failure to obtain and maintain required regulatory clearances and approvals could prevent us from commercializing our products<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Before we can introduce a new device or a new use of or a claim for a cleared device in the U.S., we must generally obtain clearance from the FDA, unless an exemption from premarket review or an alternative procedure, such as a <i style="font-style:italic;">de novo</i> risk-based classification or a humanitarian device exemption, applies. The FDA clearance and approval processes for medical devices are expensive, uncertain and time-consuming. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We may make changes to our cleared products without seeking additional clearances or approvals if we determine such clearances or approvals are not necessary and document the basis for that conclusion. However, the FDA may disagree with our determination or may require additional information, including clinical data, to be submitted before a determination is made, in which case we may be required to delay the introduction and marketing of our modified products, redesign our products, conduct clinical trials to support any modifications and pay significant regulatory fines or penalties. In addition, the FDA may not approve or clear our products for the indications that are necessary or desirable for successful commercialization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In particular, w<span style="background:#ffffff;">e are currently conducting a large, multinational pivotal human clinical trial of the Wrapsody Endoprosthesis. A successful outcome of this trial is required to obtain approval from the FDA and some international </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="background:#ffffff;">regulatory agencies.</span> However, there is no assurance that we will be able to obtain the necessary regulatory clearances or approvals for the Wrapsody Endoprosthesis or any other products on a timely basis or at all. Further, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance of our products under development or impact our ability to modify our currently cleared products on a timely basis. Delays in receipt of, or failure to obtain, regulatory clearances for any product enhancements or new products we develop would result in delayed or no realization of revenue from such product enhancements or new products and in substantial additional costs, which could decrease our profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">In addition, we are required to continue to comply with applicable FDA and other regulatory requirements once we have obtained clearance or approval for a product. We cannot provide assurance that we will successfully maintain the clearances or approvals we have received or may receive in the future. The loss of previously received clearances or approvals, or the failure to comply with existing or future regulatory requirements, could also have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our products are generally subject to regulatory requirements in foreign countries in which we sell them. We have experienced delays and expended significant resources in obtaining those approvals and clearances and we will likely continue to experience delays and uncertainty, and incur significant expenses, in obtaining those approvals or clearances<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">In order to sell our products in foreign countries, generally we must obtain regulatory approvals and comply with the regulations of those countries. These regulations, including the requirements for approvals or clearances and the time required for regulatory review, vary from country-to-country. See our related discussion under Item 1. &#8220;Business &#8211; Regulation - Regulatory Approvals.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In general, we intend to obtain MDR approvals for our principal products sold in the EU ahead of expiry dates; however for multiple reasons, including but not limited to changing business strategies, limited labor pool and contract resources, administrative delays, increased costs of obtaining MDR certification, availability of necessary data and notified body capacity, there will be some products that will not be fully compliant at the time of expiry. The additional time and resources required to obtain MDR certification has been a significant factor in, and will likely continue to influence, our decisions to discontinue sales and distribution of certain products in the EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Complying with and obtaining regulatory approval in foreign countries, including our efforts to comply with the requirements of the MDR, have caused and will likely continue to cause us to experience more uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, which could have a material adverse impact our net sales, market share and operating profits from our international operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">The medical device industry is subject to extensive scrutiny and regulation by governmental authorities and we are currently operating under a Corporate Integrity Agreement. If governmental authorities determine that we have violated laws, regulations or our Corporate Integrity Agreement, our company or our employees may be subject to various penalties, including civil or criminal penalties<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our products and business activities are subject to rigorous regulation by the FDA and other federal, state and foreign governmental authorities.&#160;These authorities and domestic and foreign legislators continue to scrutinize the medical device industry.&#160;In recent&#160;years, the U.S. Congress, DOJ, OIG, SEC and the Department of Defense, as well as foreign counterparts, have issued subpoenas and other requests for information to medical device manufacturers, primarily related to financial arrangements with healthcare providers, regulatory compliance and product promotional practices. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">In October 2020, we entered into a Settlement Agreement with the DOJ to resolve their investigation into our past marketing transactions and practices. Under the Settlement Agreement and related agreements, we paid $18.7 million (which includes interest and certain fees) in exchange for a release from liability for the alleged conduct. The settlement was also conditioned upon our entering into the CIA. Please refer to the discussion in Item 1. &#8220;Business - Regulation - Corporate Integrity Agreement.&#8221; Even if we fully comply with the CIA, we have incurred, and anticipate that we will continue to incur, substantial costs in connection with the settlement and compliance with the CIA. It is unclear what impact the settlement has had and may have on our reputation. This matter has consumed a significant amount of our resources and management&#8217;s attention. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We anticipate that government authorities will continue to scrutinize our industry closely, and that additional regulation by government authorities may increase compliance costs, exposure to litigation and other adverse effects on our operations. If we fail to comply with applicable regulatory requirements, including the terms of the CIA, we may be subjected to a wide variety of sanctions and enforcement actions, including warning letters that require corrective action, injunctions, product seizures or recalls, suspension of product manufacturing, revocation of approvals, import or export prohibitions, exclusion from participation in government healthcare programs, civil fines and/or criminal penalties, which in turn may have a negative impact on our business, results of operations, financial condition and ability to obtain financing on reasonable terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We are subject to laws targeting fraud and abuse in the healthcare industry, the violation of which could adversely affect our business or financial results<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our operations are subject to various state and federal laws targeting fraud and abuse in the healthcare industry, including the federal Anti-Kickback Statute and other anti-kickback laws, which prohibit any person from knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, to induce or reward either the referral of an individual, or the furnishing or arranging for an item or service, for which payment may be made under federal healthcare programs, such as the Medicare and Medicaid programs. Violations of these fraud and abuse-related laws are punishable by criminal or civil sanctions, including substantial fines, imprisonment and exclusion from participation in healthcare programs such as Medicare and Medicaid, any of which could harm our business or negatively impact our financial results. Allegations of such violations could lead to expensive and time-consuming investigations by government authorities and result in conviction of these violations or settlement costs and additional restrictions, like the CIA discussed above under Item 1. &#8220;Business - Regulation - Corporate Integrity Agreement.&#8221; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Furthermore, our contracts with government-sponsored healthcare entities are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Our international operations make us subject to the U.S. Foreign Corrupt Practices Act and similar anti-bribery laws in non-U.S. jurisdictions, and our failure, or the failure of our distributors and agents, to comply with these laws could subject us to civil and criminal penalties and adversely affect our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We currently conduct our business in various foreign countries, and we expect to continue to expand our foreign operations. As a result, we are subject to the FCPA, the U.K. Bribery Act, and similar anti-corruption laws in non-U.S. jurisdictions. These laws generally prohibit companies and their intermediaries from illegally offering things of value to any individual for the purpose of obtaining or retaining business. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Compliance with the FCPA and other anti-bribery laws presents challenges to our operations. Our policies mandate compliance with the FCPA and all other applicable anti-bribery laws. Further, we expect our employees, distributors, agents and others who work for us or on our behalf to comply with these anti-bribery laws. Despite our training and compliance programs, our internal control policies and procedures may not always protect us from reckless or criminal acts committed by our employees, distributors or agents. If our employees, distributors or agents violate the provisions of the FCPA or other anti-bribery laws, or even if there are allegations of such violations, we could be subject to investigations or civil and criminal penalties or other sanctions, which could have a material, adverse effect on our reputation, business, results of operations, financial condition or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Limits on reimbursement imposed by governmental and other programs may adversely affect our business and results of operation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We sell our products to hospitals and other healthcare providers around the world that typically receive reimbursement for the services provided to patients, which incorporate the use of our products, from third-party payers such as government programs (e.g., Medicare and Medicaid in the U.S.) and private insurance programs.&#160;The ability of our customers to obtain adequate reimbursement for the health care procedures that use our products, such that the cost of our products is covered, is critical to our business.&#160;Limits on reimbursement imposed by such third-party payers may adversely affect our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">customers, such as hospitals, physicians and other healthcare providers, to purchase our products, which could adversely affect our business and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Third-party payers, whether foreign or domestic, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In general, a third-party payer covers a medical procedure only when the plan administrator is satisfied that the product or procedure is reasonable and necessary to the patient&#8217;s treatment; however, for certain payers (such as foreign governments and some commercial insurers) the cost-effectiveness of the treatment may also be a condition. In addition, in the U.S., no uniform policy of coverage and reimbursement for procedures using our products exists among third-party payers. Therefore, coverage and reimbursement for procedures using our products can differ significantly from payer to payer and, in some cases, jurisdiction to jurisdiction. In addition, payers continually review new and existing technologies for possible coverage and can, without notice, deny, change or reverse coverage decisions or alter prior authorization requirements for new or existing products and procedures. We cannot provide assurance that we will be successful in any efforts we may potentially undertake to reverse such non-coverage or unfavorable coverage decisions. If we are not successful in reversing non-coverage or unfavorable coverage policies, or if third-party payers that currently cover or reimburse certain procedures involving the use of our products reverse, change or limit their coverage of such procedures in the future, or if other third-party payers issue similar policies or adopt similar practices, our business could be adversely impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Further, we believe that future coverage and reimbursement may be subject to increased restrictions, such as additional prior authorization requirements, both in the U.S. and in international markets. Third-party coverage and reimbursement for procedures using our products or any of our products in development for which we may receive regulatory approval may not be available or adequate in either the U.S. or international markets, which could have an adverse impact on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our business is subject to complex and evolving U.S., state and international laws and regulations regarding privacy and data protection. Many of these laws and regulations are subject to change and uncertain interpretation and could result in claims, changes to our business practices, penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The U.S. and many other countries in which we conduct our operations have adopted laws and regulations protecting certain data, including medical and personal data (including HIPAA, the HITECH Act and the rules issued thereunder), and requiring data holders and controllers to implement administrative, logical and technical controls and procedures in order to protect the privacy of such data. Individual states have also begun to enact data privacy laws giving consumers the right to demand certain information and actions from companies who collect personal information. Internationally, some countries have also passed laws and regulations that require individually identifiable data on their citizens to be maintained on local servers and that may restrict transfer or processing of that data. In addition, regulatory authorities around the world are considering additional proposals concerning data protection. These laws and regulations have been, and may continue to be, inconsistent with each other, requiring different approaches in different jurisdictions. In addition, the interpretation and application of medical and personal data protection laws and regulations in the U.S., Europe, China and elsewhere are often uncertain and in flux. Further, we have incurred, and will likely continue to incur, significant expense in connection with our efforts to comply with those applicable laws and regulations. It is possible that these laws and regulations may be interpreted and applied in a manner that is inconsistent with our data practices, resulting in fines or orders requiring that we change our data practices, which could in turn (i) cause us to incur substantial costs or (ii) have an adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Legal developments in foreign countries have created uncertainty regarding certain transfers of personal data from certain countries to the U.S. or other foreign countries. For example, GDPR applies to the processing of personal data related to: (i) the activities of an establishment in the EU or (ii) the processing of personal data of data subjects who are in the EU where this is related to products and services that we offer to EU users. GDPR includes compliance obligations, which could cause us to change our business practices, and significantly increases financial penalties for noncompliance. In addition, the PIPL, similar to GDPR, applies to personal information processing activities outside of China if companies provide products or services to individuals in China or analyze and evaluate the behavior of individuals in China. If we fail to comply with the requirements of the PIPL, we could incur severe penalties. If we incur any of these penalties in the EU or China for violations of GDPR or the PIPL, our business and operations in those areas could be adversely affected and have a material adverse effect on our financial results. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our failure to comply with applicable environmental, health and safety laws and regulations could affect our business, operations or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We manufacture and assemble certain products that require the use of hazardous materials that are subject to various national, federal, state and local laws and regulations governing the protection of the environment, health and safety. <span style="font-family:'TimesNewRoman';background:#ffffff;">Moreover, </span>climate<span style="font-family:'TimesNewRoman';background:#ffffff;"> </span>change<span style="font-family:'TimesNewRoman';background:#ffffff;"> and sustainability efforts and potential </span>climate<span style="font-family:'TimesNewRoman';background:#ffffff;"> </span>change<span style="font-family:'TimesNewRoman';background:#ffffff;"> regulations could lead to business interruption, significantly increased costs and other adverse consequences to our business. </span>While the cost of compliance with such laws and regulations has not had a material adverse effect on our results of operations historically, compliance with future regulations may require additional capital investments or other expenses. Additionally, because we use a limited amount of hazardous and other regulated materials in our manufacturing processes, we are subject to certain risks of future liabilities, lawsuits and claims resulting from any substances we manufacture, dispose of or release. Certain environmental laws and regulations may impose &#8220;strict liability&#8221; for the conduct of, or conditions caused by, others, or for acts that were in non-compliance with all applicable laws at the time the acts were performed, rendering us liable without regard to our negligence or fault. Because of these laws, any accidental release may have an adverse effect on our business, operations or financial condition. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our operations are also subject to various laws and regulations relating to occupational health and safety. We maintain safety, training and maintenance programs as part of our ongoing efforts to ensure compliance with applicable laws and regulations. Compliance with applicable health and safety laws and regulations has required and continues to require significant expenditures. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We are also subject to corporate social responsibility, or CSR, laws and regulations which require us to monitor the labor standards in our supply chain, including the California Transparency in Supply Chains Act, the UK Modern Slavery Act, and U.S. Federal Acquisition Regulations regarding Combating Trafficking in Persons. These CSR labor laws and regulations may impose additional processes and supplier management systems and have led certain key customers to impose additional requirements on medical device companies, including audits, as a prerequisite to selling products to such customers, which could result in increased costs for our products, the termination or suspension of certain suppliers, and reductions in our margins and profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Use of our products in unapproved circumstances could expose us to liabilities<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The marketing clearances and approvals from the FDA and other regulators of certain of our products are, or are expected to be, limited to specific uses.&#160;We are prohibited from marketing or promoting any uncleared or unapproved use of our product.&#160;However, physicians may use these products in ways or circumstances other than those strictly within the scope of the regulatory approval or clearance. The use of our products for unauthorized purposes could arise from our sales personnel or distributors violating our policies by providing information or recommendations about such unauthorized uses.&#160;Consequently, claims may be asserted by the FDA or other enforcement agencies that we are not in compliance with applicable laws or regulations or have improperly promoted our products for uncleared or unapproved uses.&#160;The FDA or such other agencies could require a recall of products or allege that our promotional activities misbrand or adulterate our products or violate other legal requirements, which could result in investigations, prosecutions, fines or other civil or criminal actions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our products may be subject to product liability claims and warranty claims<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our products are used in connection with invasive procedures and in other medical contexts that entail an inherent risk of product liability claims. If medical personnel or their patients suffer injury or death in connection with the use of our products, whether as a result of a failure of our products to function as designed, an inappropriate design, inadequate disclosure of product-related risks or information, improper use, or for any other reason, we could be subject to lawsuits seeking significant compensatory and punitive damages. Product liability claims may be brought by individuals or by groups seeking to represent a class. We have previously faced, and currently face, claims by patients claiming injuries from our products. To date, these claims have not resulted in material harm to our operations or financial condition. The outcome of this type of personal injury litigation is difficult to assess or quantify. We maintain product liability insurance; however, there is no assurance that this coverage will be sufficient to satisfy any claim made against us. Moreover, any product liability claim brought against us could result in significant costs, divert our management&#8217;s attention from other business matters or operations, increase our product liability insurance rates, or prevent us from securing insurance </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">coverage in the future. As a result, any lawsuit seeking significant monetary damages may have a material adverse effect on our business, operations or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We generally offer a limited warranty for the return of product due to defects in quality and workmanship. We attempt to estimate our potential liability for future product returns and establish reserves on our financial statements in amounts that we believe will be sufficient to address our warranty obligations; however, our actual liability for product returns may significantly exceed the amount of our reserves. If we underestimate our potential liability for future product returns, or if unanticipated events result in returns that exceed our historical experience, our financial condition and operating results could be materially harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">In addition, the occurrence of such an event or claim could result in a recall of products from the market or a safety alert relating to such products. Such a recall could result in significant costs, reduce our revenue, divert management&#8217;s attention from our business, and harm our reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our products may cause or contribute to adverse medical events that we are required to report to the FDA or other governmental authorities, and if we fail to do so, we may be subject to sanctions that may materially harm our business<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our products are subject to medical device reporting regulations, which require us to report to the FDA information that reasonably suggests one of our products may have caused or contributed to a death or serious injury, or one of our products malfunctioned and, if the malfunction were to recur, this device or a similar device that we market would be likely to cause or contribute to a death or serious injury. Our obligation to report under the medical device reporting regulations is triggered on the date on which we become aware of information that reasonably suggests a reportable adverse event occurred. We may fail to report adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or if the product characteristic that caused the adverse event is removed in time from our products. Inspections by the FDA or other regulators may reveal violations or instances of noncompliance under the QSRs and other post-market requirements. If we fail to comply with our medical device reporting obligations or commit a violation of these requirements, the FDA could issue warning letters or untitled letters, take administrative actions, commence criminal prosecution, impose civil monetary penalties, demand or initiate a product recall, seize our products, or delay the clearance of our future products. Other regulatory authorities could take similar actions within their<span style="letter-spacing:-0.6pt;"> </span>jurisdictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our employees, independent contractors, consultants, manufacturers and distributors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We are exposed to the risk that our employees, independent contractors, consultants, manufacturers and distributors may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless or negligent conduct, or unauthorized activities that violate the healthcare laws and regulations of the FDA and other federal, state and international authorities, manufacturing standards, and laws that require the true, complete and accurate reporting of financial information or data. We have adopted a code of business conduct and ethics, and a global anti-corruption policy, but it is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties.</p><a id="_Hlk33721102"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">We may be a party to litigation in the course of our business or otherwise, which could affect our financial condition and results of operations</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We are routinely a party to or otherwise involved in legal proceedings, claims or other legal matters, arising in the course of our business. Legal proceedings can be complex and take many months, or even years, to reach resolution, with the final outcome depending on a number of variables, some of which are not within our control. Litigation is subject to significant uncertainty and may be expensive, time-consuming, and disruptive to our operations. Although it is our intention to vigorously defend ourselves in such legal proceedings, their ultimate resolution and potential financial and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">other impacts on us are uncertain. If a legal proceeding is resolved against us, it could result in significant compensatory damages or injunctive relief that could materially adversely affect our financial condition, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intellectual Property</b></p><a id="_Hlk34038367"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We may not be able to effectively protect our intellectual property, which could harm our business and financial condition<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Our ability to remain competitive is dependent, in part, upon our ability to protect our intellectual property rights and prevent other companies from infringing our intellectual property rights to produce competing products. We seek to protect our intellectual property rights through a combination of confidentiality and license agreements, maintaining certain trade secrets, and through registrations under patent, trademark, and copyright laws. However, these measures afford only limited protection and may be challenged, invalidated, or circumvented by third parties. Additionally, these measures may not prevent competitors from duplicating our products or gaining access to our proprietary information and technology. Third parties may copy all or portions of our products or otherwise use our intellectual property without authorization, and we may not be able to prevent the unauthorized disclosure or use of our intellectual property by consultants, vendors, former employees and current employees. Despite our efforts to restrict such unauthorized disclosure or use through nondisclosure agreements and other contractual restrictions, we may not be able to enforce these contractual provisions or we may incur substantial costs enforcing our legal rights. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Third parties may also develop similar or superior technology independently or by designing around our patents. In addition, the laws of some foreign countries do not offer the same level of protection for our intellectual property as the laws of the U.S. Further, no assurances can be given that any patent application we have filed or will file will result in a patent being issued, or that any existing or future patents will afford adequate or meaningful protection against competitors or against similar technologies. All of our patents and copyrights will eventually expire and some of our patents, including patents protecting significant elements of our technology, will expire within the next several&#160;years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 10pt 0pt;">Filing, prosecuting and defending our intellectual property in countries throughout the world may be impractical and prohibitively expensive. Litigation may be necessary in the future to enforce our intellectual property rights, protect our trade secrets or to determine the validity and scope of proprietary rights claimed by others. Any such lawsuits that we might initiate could be expensive, take significant time and divert management&#8217;s attention from our business. Litigation also puts our patents at risk of being invalidated or interpreted narrowly. Additionally, we may provoke third parties to assert claims against us. Moreover, the legal systems of certain countries, particularly certain developing countries, do not favor the aggressive enforcement of patents and other intellectual property protections, which makes it difficult to stop infringement. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially valuable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Third parties claiming that we infringe their intellectual property rights could cause us to incur significant legal or licensing expenses and prevent us from selling our products<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our commercial success will depend in part on not infringing or violating the intellectual property rights of others. From time to time, third parties may claim that we have infringed their intellectual property rights, including claims regarding patents, copyrights, trademarks, trade secrets, and confidential information. We may not be aware of whether our products do or will infringe existing or future patents or the intellectual property rights of others. Because of constant technological change in the medical device industry in which we compete, the extensive patent coverage of existing technologies, and the rapid rate of issuance of new patents, it is possible that the number of these claims may grow. In addition, former employers of our former, current, or future employees may assert claims that such employees have improperly disclosed to us the confidential or proprietary information of such former employers. Any such claim, with or without merit, could result in costly litigation, distract management from day-to-day operations and harm our brand or reputation, which in turn could harm our business or results of operations. If we are not successful in defending such claims, we could be required to (i) stop selling our products, (ii) redesign our products, (iii) discontinue the use of related trademarks, technologies or designs, (iv) pay damages or indemnification obligations, or (v) enter into royalty or licensing arrangements. Royalty or licensing arrangements that we may seek in such circumstances may not be available to us on commercially reasonable terms or at all and we may not be able to redesign applicable products in a way to avoid infringing the intellectual property </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">rights of others. We have made and expect to continue making significant expenditures to investigate, defend and settle claims related to the use of technology and intellectual property rights as part of our strategy to manage this risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Information Technology and Cybersecurity Risks</b></p><a id="_Hlk63988925"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We rely on the proper function, availability and security of information technology systems to operate our business, and a material disruption of critical information systems or a material breach in the security of our systems may adversely affect our business and customer relationships<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We rely on information technology systems (including technology from third-party providers) to process, transmit, and store electronic information in our day-to-day operations, including sensitive personal information and proprietary or confidential information. We also rely on our technology infrastructure, among other functions, to interact with customers and suppliers, fulfill orders and bill, collect and make payments, ship products, provide support to customers, fulfill contractual obligations and otherwise conduct business. Our internal information technology systems, as well as those systems maintained by third-party providers, may be subjected to computer viruses or other malicious code, unauthorized access attempts, and cyber-attacks, any of which could result in data leaks or otherwise compromise our confidential or proprietary information and disrupt our operations. Cyber-attacks are becoming more sophisticated and frequent, and there can be no assurance that our protective measures have prevented or will prevent security breaches, any of which could have a significant impact on our business, reputation and financial condition, particularly attacks that result in our intellectual property and other confidential information being accessed or stolen.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We rely on third-party vendors to supply and support certain aspects of our information technology systems. These third-party systems could also become vulnerable to cyber-attacks, malicious intrusions, breakdowns, interference or other significant disruptions, and may contain defects in design or manufacture or other problems that could result in system disruption or compromise the information security of our own systems. In addition, we continue to grow in part through business and product acquisitions and, as a result, may face risks associated with defects and vulnerabilities in the systems operated by the other parties to those transactions, or difficulties or other breakdowns or disruptions in connection with the integration of the acquired businesses and products into our information technology systems.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Cyber-attacks could also result in unauthorized access to our systems and products, including personal information of individuals, which could trigger notification requirements, encourage actions by regulatory bodies, result in adverse publicity, prompt us to offer credit support products or services to affected individuals and lead to class action or other civil litigation. If we fail to monitor, maintain or protect our information technology systems and data integrity effectively or fail to anticipate, plan for or manage significant disruptions to these systems, we could (i) lose customers, (ii) be subject to fraud, (iii) breach our agreements with or duties toward customers, physicians, other health care professionals and employees, (iv) be subject to regulatory sanctions or penalties, (v) incur expenses or lose revenues, (vi) sustain damage to our reputation, or (vii) suffer other adverse consequences.&#160;Unauthorized tampering, adulteration or interference with our products may also create issues with product functionality that could result in a loss of data, risk to patient safety, and product recalls or field actions. Any of these events could have a material adverse effect on our business, operations or financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Market, Liquidity and Credit Risks</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">The agreements and instruments governing our debt contain restrictions and limitations that could significantly affect our ability to operate our business, as well as significantly affect our liquidity<b style="font-style:normal;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On July 31, 2019 we entered into a Third Amended and Restated Credit Agreement (&#8220;Third Amended Credit Agreement&#8221;), with Wells Fargo Bank, National Association, as administrative agent and a lender, and Wells Fargo Securities, LLC, BOFA Securities, Inc., HSBC Bank USA, National Association, and U.S. Bank National Association as joint lead arrangers and joint bookrunners, and Bank of America, N.A., HSBC Bank USA, National Association and U.S. Bank National Association as co-syndication agents. In addition, Bank of America, N.A., HSBC Bank USA, National Association, U.S. Bank, National Association, BMO Harris Bank, N.A., and MUFG Union Bank, Ltd. are parties to the Third Amended Credit Agreement as lenders. The Third Amended Credit Agreement amends and restates in its entirety our previously outstanding Second Amended and Restated Credit Agreement and all amendments thereto (the &#8220;Second Amended Credit Agreement&#8221;). The Third Amended Credit Agreement contains a number of significant covenants that </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">could adversely affect our ability to operate our business, our liquidity or our results of operations. These covenants restrict, among other things, our incurrence of indebtedness, creation of liens or pledges on our assets, mergers or similar combinations or liquidations, asset dispositions, repurchases or redemptions of equity interests or debt, issuances of equity, payment of dividends and certain distributions and entry into related party transactions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We have pledged substantially all of our assets as collateral for the Third Amended Credit Agreement. Our breach of any covenant in the Third Amended Credit Agreement, not otherwise cured, waived or amended, could result in a default under that agreement and could trigger acceleration of the underlying obligations. Any default under the Third Amended Credit Agreement could adversely affect our ability to service our debt and to fund our planned capital expenditures and ongoing operations. The administrative agent, joint lead arrangers, joint bookrunners and lenders under the Third Amended Credit Agreement have available to them the remedies typically available to lenders and secured parties, including the ability to foreclose on the collateral we have pledged. It could lead to an acceleration of indebtedness and foreclosure on our assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">As currently amended, the Third Amended Credit Agreement provides for potential borrowings of up to $750 million. Such increased borrowing limits may make it more difficult for us to comply with leverage ratios and other restrictive covenants in the Third Amended Credit Agreement. We may also have less cash available for operations and investments in our business, as we will be required to use additional cash to satisfy the minimum payment obligations associated with this increased indebtedness.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We depend on generating sufficient cash flow to fund our debt obligations, capital expenditures, and ongoing operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We are dependent on our cash on hand and free cash flow to fund our debt obligations, capital expenditures and ongoing operations.&#160;Our ability to service our debt and to fund our planned capital expenditures and ongoing operations will depend on our ability to continue to generate cash flow.&#160;If we are unable to generate sufficient cash flow or we are unable to access additional liquidity sources, we may not be able to service or repay our debt, operate our business, respond to competitive challenges, or fund our other liquidity and capital needs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">The market price of our common stock has been and may continue to be volatile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The market price of our common stock has at times, been, and may in the future be, volatile for various reasons, including those discussed in these risk factors. Other events that could cause volatility in our stock include, without limitation, variances in our financial results; analysts&#8217; and other projections or recommendations regarding our common stock specifically or medical technology stocks generally; any restatement of our financial statements or any investigation of us by the SEC, DOJ, OIG, FDA, or another regulatory authority; actions taken by activist investors or other shareholders, significant litigation or a decline, or rise, of stock prices in capital markets generally.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Fluctuations in foreign currency exchange rates may negatively impact our financial results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">As our operations have grown outside the U.S., we have also become increasingly subject to market risk relating to foreign currency.&#160;Those fluctuations could have a negative impact on our margins and financial results.&#160;During 2022, 2021 and 2020, the exchange rate between all applicable foreign currencies and the U.S. Dollar resulted in a decrease in net sales of $23.8 million, an increase in net sales of $10.3 million, and a decrease in net sales of $1.3 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">For the&#160;year ended December&#160;31,&#160;2022, $394.1 million, or&#160;34.2%, of our net sales were denominated in foreign currencies, with our CNY- and Euro-denominated sales representing our largest currency risks to net sales.&#160;If the rate of exchange between foreign currencies declines against the U.S. Dollar, we may not be able to increase the prices we charge our customers for products whose prices are denominated in those respective foreign currencies. Furthermore, we may be unable or elect not to enter into hedging transactions which could mitigate the effect of declining exchange rates.&#160;As a result, if the rate of exchange between foreign currencies declines against the U.S. Dollar, our financial results may be negatively impacted. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">We are subject to changes in tax laws, fluctuations in tax rates, the adoption of new tax legislation or exposure to additional tax liabilities, which may adversely affect our effective tax rate, business, financial condition, or results of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-style:normal;font-weight:normal;">We are subject to taxation in numerous countries, states and other jurisdictions. Our effective tax rate is derived from a combination of applicable tax rates in the various countries, states and other jurisdictions in which we operate. In preparing our financial statements, we estimate the amount of tax that will become payable in each of these jurisdictions. Our effective tax rate may, however, differ from the estimated amount due to numerous factors, including a change in the mix of our profitability from country to country and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations, which could have an adverse effect on our business, financial condition or results of operation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In many countries, including the United States, we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned by our U.S.&#160;or local entities and are taxed accordingly. Although we believe we are in substantial compliance with applicable regulations and restrictions, we are subject to the risk that governmental authorities could assert that we owe additional taxes. In the event that audits, assessments, or other determinations by governmental authorities are concluded adversely to us, they could have an adverse effect on our business, financial condition or results of operation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><a id="_a23a8f42_96a7_4e8e_8cba_450ba6d09807"></a><a id="Item1BUnresolvedStaffComments_383037"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:43.2pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;1B.&#160;</b></span><span style="display:inline-block;width:28.8pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Unresolved Staff Comments.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_1760102b_0e90_465d_9c59_2613b2e917f7"></a><a id="_Hlk127803617"></a><a id="Item2Properties_908317"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;2.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">P</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">r</b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">operties.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our world headquarters is located in South Jordan, Utah, with our principal office for European operations located in Galway, Ireland and our principal office for Asian distribution located in Beijing, China. We also support our European operations from a distribution and customer service facility located in Maastricht, The Netherlands. In addition, we lease commercial space in India, Hong Kong, Italy, Dubai, Australia, Canada, Brazil, Malaysia, South Korea, Japan, South Africa, Singapore, Great Britain, Vietnam, Taiwan, New Zealand, Indonesia, and France, as well as in California and Texas. Our principal manufacturing and packaging facilities are located in Utah, Virginia, Texas, Ireland, Brazil, France, Singapore, Mexico, and The Netherlands. Our research and development activities are conducted principally at facilities located in Utah, California, Texas, Ireland, France, and Singapore.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our total manufacturing, commercial, distribution, and research space is approximately 1.9 million square feet, of which approximately 1.0 million square feet is owned, and 0.9 million square feet is leased. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following is a summary of the approximate square footage of our key facilities as of December&#160;31,&#160;2022:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Location</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Main Purpose</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Area (sq. ft.)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Utah</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">HQ, Manufacturing, Distribution, Research</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 724,170</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Mexico</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Manufacturing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 196,690</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Virginia</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Manufacturing, Distribution</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 187,659</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ireland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Manufacturing, Research</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 139,680</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">The Netherlands</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Manufacturing, Distribution</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 136,501</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Texas</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Manufacturing, Research</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 94,000</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Singapore</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Manufacturing, Research</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 68,000</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:27.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">China</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Distribution</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50,290</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Operations associated with our cardiovascular segment utilize all of our facilities, while operations associated with our endoscopy segment are conducted primarily from our facilities located in Utah and Texas.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We believe our existing and proposed facilities will generally be adequate for our present and future anticipated levels of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_857b5e1b_6ff4_476f_9644_ebdc86452089"></a><a id="Item3LegalProceedings_389974"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;3.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legal Proceedings.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">See Note 10 &#8220;Commitments and Contingencies&#8221; to our consolidated financial statements set forth in Item 8 of this report and incorporated herein by reference. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_41201af9_b9dc_4537_b13e_edf592f3d6bd"></a><a id="Item4MineSafetyDisclosures_769449"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;4.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mine Safety Disclosures.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The disclosure required by this item is not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:279.5pt;"><a id="_535c2d0f_fa2c_41e6_a755_b845f8ba5055"></a><a id="_Hlk128043673"></a><a id="PARTII_16262"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;II</p><a id="Item5MarketforRegistrantsCommonEquityRel"></a><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:72pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">Item&#160;5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Market Price for the Common Stock</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our common stock is traded on the NASDAQ Global Select Market under the symbol &#8220;MMSI.&#8221; As of February&#160;22, 2023, the number of shares of our common stock outstanding was 57,318,032 held by approximately 96 shareholders of record, not including shareholders whose shares are held in securities position listings. We did not repurchase any shares during the years ended December&#160;31,&#160;2022, 2021 and 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Performance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following graph compares the performance of our common stock with the performance of the NASDAQ US Benchmark TR Index and NASDAQ Stocks (SIC 3840-3849 U.S. Companies&#160;- Surgical, Medical and Dental Instruments and Supplies) f<span style="background:#ffffff;">or a five-year period by measuring the changes in common stock prices from December&#160;31, 2017 to December&#160;31, 2022. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><img src="mmsi-20221231x10k002.jpg" alt="Graphic" style="display:inline-block;height:279.5pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:485.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">12/2017</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">12/2018</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">12/2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">12/2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">12/2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">12/2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Merit Medical Systems, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 100.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 129.19</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 72.27</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 128.50</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 144.21</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 163.45</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">NASDAQ US Benchmark (TR)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 100.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 94.56</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 124.03</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 150.41</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 189.36</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 152.00</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">NASDAQ Stocks (SIC 3840-3849 U.S. Companies)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 100.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 112.98</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 138.90</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 202.84</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 228.47</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 165.59</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">The stock performance graph assumes for comparison that the value of our common stock and of each index was $100 on December&#160;31, 2017 and that all dividends were reinvested.&#160;Past performance is not necessarily an indicator of future results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 2pt 0pt;">NOTE:&#160;&#160;&#160;&#160;&#160;&#160;Performance graph data is complete through last fiscal&#160;year. Corporate Performance Graph with peer group uses peer group only performance (excludes only Merit). Peer group indices use beginning of period market capitalization weighting.<span style="font-size:10pt;"> </span>Prepared by Zacks Investment Research, Inc. Used with permission. All rights reserved. Copyright 1980-2023. Used with permission. All rights reserved. Index Data: Copyright NASDAQ OMX, Inc. Used with permission. All rights reserved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 2pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><a id="_a1d5a4dd_80c4_4357_bce6_db53250f1f3c"></a><a id="Item6SelectedFinancialDatainthousandsexc"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;6.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reserved.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_27b49b5c_5c48_41d4_9c79_fbc3d81fb908"></a><a id="Item7ManagementsDiscussionandAnalysisofF"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;7.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Consolidated Financial Statements and related Notes&#160;thereto set forth in Item&#160;8 of this report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within those two operating segments, we offer products focused in five core product categories: <span style="color:#212529;background:#ffffff;">peripheral intervention, cardiac intervention, custom procedural solutions, OEM and endoscopy.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31,&#160;2022, we reported sales of $1.151 billion, up $76.2 million or 7.1%, compared to 2021 sales of $1.075 billion. <span style="background:#ffffff;">Our revenue results for the year ended December 31, 2022 were driven primarily by stronger-than-anticipated demand in the U.S. and more favorable than anticipated international sales trends, particularly in the EMEA and &#8220;Rest of World&#8221; (&#8220;ROW&#8221;) regions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Gross profit as a&#160;percentage of sales was 45.1%&#160;for the&#160;year ended December&#160;31,&#160;2022 as compared to 45.2% for the&#160;year ended December&#160;31,&#160;2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Net income for the&#160;year ended December&#160;31,&#160;2022 was $74.5 million, or $1.29 per share, as compared to $48.5 million, or $0.84 per share, for the&#160;year ended December&#160;31,&#160;2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">During 2022 we received &#8220;Breakthrough Device Designation&#8221; for Embosphere Microspheres for use in genicular artery embolization for symptomatic knee osteoarthritis. We also received FDA clearance for the SCOUT Bx Delivery System, the first wire-free breast localization solution that can be deployed at the time of stereotactic or MRI-guided biopsy representing a notable addition to the Merit Oncology portfolio. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="background:#ffffff;">We have launched eight new products during 2022 including the basixALPHA inflation device, </span>PreludeSYNC EZ&#8482; Radial Compression Device, <span style="background:#ffffff;">TEMNO Elite&#8482; Soft Tissue Biopsy System, Prelude Roadster&#8482; Guide Sheath, SafeGuard Focus Cool&#8482; Compression Device, SCOUT&#174; Mini Reflector, ReSolve</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup>&#160;Thoracostomy Tray and the commercial release of the smallest and shortest configuration in the Elation&#160;Pulmonary Balloon Dilator portfolio.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#293849;font-family:'Montserrat';visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On November 10, 2020, we introduced a corporate transformation initiative known as &#8220;Foundations for Growth&#8221; with multi-year financial targets for growth and improved profitability for the three-year period ending December 31, 2023.<span style="background:#ffffff;"> As part of this initiative, we continue to review the need to consolidate facilities, strategically reduce operating expenses and incentivize our sales force to focus on products that will improve our financial performance.</span> <span style="background:#ffffff;">Our dedication to the Foundations for Growth program has helped offset inflationary cost pressures in certain raw materials, shipping, and freight expenses.</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Results of Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth certain operational data as a&#160;percentage of sales for the&#160;years indicated:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 45.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 41.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 29.8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 31.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3.8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (0.8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Acquired in-process research and development expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 0.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (loss) from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (0.2)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (loss) before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1.4)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1.0)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Sales</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Listed below are the sales by product category within each operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands, other than&#160;percentage changes):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">%&#160;Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">%&#160;Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">%&#160;Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Cardiovascular</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Peripheral Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 439,810</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 18.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 405,116</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2.7)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 341,568</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cardiac Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 343,186</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 14.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 320,641</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (8.2)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 279,671</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Custom Procedural Solutions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1.9)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 190,194</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (4.6)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 193,942</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 8.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 203,196</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">OEM</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 17.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 145,034</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 12.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 123,528</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (6.9)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 109,767</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,118,224</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,043,227</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (2.8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 934,202</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Endoscopy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Endoscopy Devices</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 32,757</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 31,524</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (12.4)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 29,673</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,150,981</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 11.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,074,751</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (3.1)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 963,875</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cardiovascular Sales.</i> Our cardiovascular sales for the&#160;year ended December&#160;31,&#160;2022 were $1.118 billion, up 7.2%, when compared to the year ended December 31, 2021 of $1.043 billion. Sales for the&#160;year ended December&#160;31,&#160;2022 were favorably affected by increased sales of: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Peripheral intervention products, which increased by $34.7 million, or 8.6%, from the corresponding period of 2021. This increase was driven primarily by sales of our access, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">embolotherapy, and</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">radar localization products.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cardiac intervention products, which increased by $22.5 million, or 7.0%, from the corresponding period of 2021. This increase was driven primarily by sales of our intervention, cardiac rhythm management/electrophysiology (&#8220;CRM/EP&#8221;), and angiography products, partially offset by a decrease in sales of our fluid management products.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OEM products, which increased by $21.5 million, or 17.4% from the corresponding period of 2021. This increase was driven primarily by sales of our access, angiography, fluid management, intervention, coating products and kits, partially offset by a decrease in sales of our CRM/EP products.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The foregoing increase in sales for the&#160;year ended December&#160;31,&#160;2022 was partially offset by decreased sales of:</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Custom procedural solutions products, which decreased by $(3.7) million, or (1.9)% from the corresponding period of 2021. This decrease was driven primarily by decreased sales of our critical care products</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">, offset partially by increased sales of trays. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our cardiovascular sales for the&#160;year ended December&#160;31,&#160;2021 were $1.043 billion, up 11.7%, when compared to the year ended December 31, 2020 of $934.2 million. Sales for the year ended December 31, 2021 were favorably affected by increased sales of:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Peripheral intervention products, which increased by $63.5 million, or 18.6%, from the corresponding period of 2020. This increase was driven primarily by sales of our </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">radar localization, embolotherapy, drainage, biopsy, angiography, access and intervention products</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cardiac intervention products, which increased by $41.0 million, or 14.6%, from the corresponding period of 2020. This increase was driven primarily by sales of our intervention, fluid management </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">(including our Medallion Syringes, which saw increased demand due to COVID-19 vaccination efforts)</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and angiography products.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">OEM products, which increased by $13.8 million, or 12.5% from the corresponding period of 2020. This increase was driven primarily by sales of our CRM/EP, angiography products and kits.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The foregoing increase in sales for the&#160;year ended December&#160;31,&#160;2021 was partially offset by decreased sales of:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Custom procedural solutions products, which decreased by $(9.3) million, or (4.6)% from the corresponding period of 2020. This decrease was driven primarily by decreased sales of our critical care products (including a $(15.9) million decrease in </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Cultura&#174;&#160;nasopharyngeal swab and test kit sales) and trays, offset partially by sales of kits</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Endoscopy Sales.</i> Our endoscopy sales for the&#160;year ended December&#160;31,&#160;2022 were $32.8 million, up 3.9%, when compared to sales for the year ended December 31, 2021 of $31.5 million. Sales for the year ended December&#160;31,&#160;2022 were favorably affected by increased sales of <span style="background:#ffffff;">our Elation Balloon Dilator and other stents, partially offset by a decrease in sales of our EndoMAXX fully covered esophageal stent. </span>Our endoscopy sales for the&#160;year ended December&#160;31,&#160;2021 were $31.5 million, up 6.2%, when compared to sales for the corresponding period in 2020 of $29.7 million. Sales for the year ended December&#160;31,&#160;2021 were favorably affected by increased sales of <span style="background:#ffffff;">our Elation Balloon Dilator and our EndoMAXX fully covered esophageal stent</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Geographic Sales</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Sales trends for the years ended December 31, 2022, 2021, and 2020 were influenced by the incidence and timing of COVID-19 infections and the associated governmental and patient responses, which varied between countries and regions in both the current and prior-year periods. Listed below are sales by geography for the years ended December&#160;31,&#160;2022, 2021, and 2020 (in thousands, other than&#160;percentage changes):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">%&#160;Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">%&#160;Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">%&#160;Change</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">United States</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6.8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 650,559</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 608,878</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4.5)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 550,061</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">International</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 500,422</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 465,873</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.3)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 413,814</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,150,981</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,074,751</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.1)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 963,875</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">United States Sales:</i><i style="font-style:italic;"> </i>U.S. sales for the year ended December&#160;31,&#160;2022 were $650.6 million, or 56.5% of net sales, up 6.8% when compared to 2021. The increase in our domestic sales in 2022 was driven primarily by our U.S. direct, sensors and OEM businesses. U.S. sales for the year ended December 31, 2021 were $608.9 million, or 56.7% of net sales, up 10.7% when compared to 2020. The increase in our domestic sales in 2021 was driven primarily by our U.S. direct and OEM businesses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">International Sales</i>. International sales for the&#160;year ended December&#160;31,&#160;2022 were $500.4 million, or 43.5% of net sales, up 7.4% when compared to 2021. The increase in our international sales during 2022 was primarily a result of higher sales </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">in APAC, which increased $13.3 million or 5.9%, higher sales in EMEA, which increased $11.4 million or 5.5%, and higher rest of world sales which increased $9.9 million or 30.8%, compared to the corresponding period of 2021. International sales for the&#160;year ended December&#160;31,&#160;2021 were $465.9 million, or 43.3% of net sales, up 12.6% when compared to 2020. The increase in our international sales during 2021 was primarily a result of higher sales in APAC, which increased 12.8% or $25.9 million, higher sales in EMEA, which increased 11.8% or $21.7 million, and higher rest of world sales which increased 16.2% or $4.5 million, compared to the corresponding period of 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our international sales are subject to foreign currency exchange rate fluctuations between the natural currency of a foreign country and the U.S. Dollar.&#160;Foreign currency exchange rate fluctuations, calculated by using the applicable average foreign exchange rates for the prior year decreased sales (2.2)% for the&#160;year ended December&#160;31,&#160;2022 compared to 2021 and increased sales 1.1% for the&#160;year ended December&#160;31,&#160;2021 compared to 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Gross Profit</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our gross profit as a&#160;percentage of sales was 45.1%, 45.2%, and 41.6% for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. The decrease in gross profit as a&#160;percentage of sales for 2022, as compared to 2021, <span style="background:#ffffff;">was primarily due to less favorable manufacturing variances and higher freight costs as a percentage of sales, partially offset by more favorable changes in standard cost and product mix, decreased intangible amortization expense as a percentage of sales, and lower obsolescence expense, among other factors.</span> The increase in gross profit as a percentage of sales for 2021, as compared to 2020, <span style="background:#ffffff;">was primarily due to decreased amortization expense associated with acquisitions ($42.5 million in 2021 compared to $50.7 million in 2020), changes in product mix, improvements in manufacturing variances, and decreased obsolescence expense as a percentage of sales, partially offset by higher shipping and freight costs, among other factors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Operating Expenses</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Selling, General and Administrative Expenses</i>. Our selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses increased $6.8 million, or 2.0%, for the&#160;year ended December&#160;31,&#160;2022 compared to 2021 and increased $38.0 million, or 12.8%, for the&#160;year ended December&#160;31,&#160;2021 compared to 2020. SG&amp;A expenses as a&#160;percentage of sales were 29.8%, 31.2% and 30.9% for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The increase in SG&amp;A expenses for the&#160;year ended December&#160;31,&#160;2022 compared to the&#160;year ended December&#160;31,&#160;2021 was primarily related to an increase in labor-related costs, including a $6.6 million increase for severance associated with restructuring and site closures, and higher travel related expenses as restrictions from the pandemic continued to decline; partially offset by a decrease of <span style="background:#ffffff;">approximately $6 million for contract termination costs incurred in 2021 to renegotiate certain terms </span>of our September 1, 2017 share purchase agreement with IntelliMedical Technologies Pty. Ltd. (&#8220;IntelliMedical&#8221;). In addition, f<span style="color:#212529;">or the year ended December 31, 2022, we recorded $1.0 million of expense in connection with the negotiated settlement of a shareholder derivative lawsuit filed in the United States District Court for the District of Utah against Merit, our Chief Executive Officer, our Chief Financial Officer and certain of our directors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The increase in SG&amp;A expenses for the&#160;year ended December&#160;31,&#160;2021 compared to the&#160;year ended December&#160;31,&#160;2020 was primarily related to labor-related costs, which increased due primarily to higher commissions and bonus expense in the current-year period, in contrast to temporary salary cuts and furloughs in 2020. During the year ended December 31, 2021, w<span style="background:#ffffff;">e incurred approximately $6 million of contract termination costs in SG&amp;A to renegotiate certain terms </span>of our September 1, 2017 share purchase agreement with IntelliMedical<span style="background:#ffffff;"> and $18.6 million of corporate transformation and restructuring costs, including consulting charges, in connection with our Foundations for Growth program</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Research and Development Expenses</i>. Our research and development (&#8220;R&amp;D&#8221;) expenses as a&#160;percentage of sales were 6.6%, 6.6% and 6.0% for the years ended December 31 2022, 2021, and 2020, respectively. R&amp;D expenses increased by $4.3 million or 6.0% to $75.5 million for the&#160;year ended December&#160;31,&#160;2022, compared to $71.2 million in 2021. The increase in R&amp;D expenses for the&#160;year ended December&#160;31,&#160;2022 compared to the&#160;year ended December&#160;31,&#160;2021 was primarily related to labor-related costs consistent with an increase in headcount. We also incurred increased outside service and consulting costs due to higher costs from clinical trials and the implementation of the MDR in the European Union.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">R&amp;D expenses increased by $13.7 million or 23.8% to $71.2 million for the year ended December 31, 2021, compared to $57.5 million for the year ended December 31, 2020. The increase in R&amp;D expenses for the year ended December 31, 2021 compared to the&#160;year ended December&#160;31,&#160;2020 was primarily related to labor-related costs, which increased due to higher bonus expense in the current-year period, in contrast to temporary salary cuts and furloughs in the prior year. We also incurred increased clinical expenses for certain R&amp;D projects <span style="background:#ffffff;">(including our Wrapsody AV Access Efficacy Study) and higher expenses related to implementation of the MDR in the European Union</span>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legal Settlement</i>.<span style="color:#212529;"> </span>For the year ended December 31, 2021, we recorded approximately $10 million of net expense in connection with an agreement in principle to settle the securities class action lawsuit in December 2019 against Merit, our Chief Executive Officer and our Chief Financial Officer in the United States District Court for the Central District of California (the &#8220;Class Action Litigation&#8221;). This expense includes $18.25 million of settlement related costs, net of $8.2 million of insurance proceeds<span style="color:#212529;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">For the year ended December 31, 2020, w</span><span style="color:#212529;background:#ffffff;">e recorded $18.7 million of expense in connection with a settlement agreement with the United States Department of Justice (&#8220;</span><span style="background:#ffffff;">DOJ&#8221;)</span><span style="color:#212529;background:#ffffff;">&#160;to resolve the DOJ&#8217;s investigation of certain marketing and promotional practices.</span></p><a id="_Hlk31372270"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Impairment Charges</i>. For the year ended December 31, 2022, we recorded impairment charges of $2.2 million. These impairments included $1.7 million of intangible assets for our divestiture of STD Pharmaceutical Products Limited (&#8220;STD Pharmaceutical&#8221;) business acquired in our August 2019 acquisition of Fibrovein Holdings and $0.5 million impairment of our equity investment in XableCath, Inc. as this business ceased operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2021 we recorded impairment charges of $4.3 million. These impairments included $1.6 million of intangible asset and $1.3 million of property and equipment due to the planned discontinuance of the Advocate&#8482; Peripheral Angioplasty Balloon product line, sold under our license agreements with ArraVasc Limited (&#8220;ArraVasc&#8221;) and $1.4 million of impairments of certain right-of-use (&#8220;ROU&#8221;) operating lease assets due to site consolidation decisions and changes in our projected cash flows for the underlying lease assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2020 we recorded impairment charges of $36.5 million, which included $1.8 million related to certain ROU operating lease assets and property and equipment, $6.0 million related to equity investments and purchase options, and $28.7 million related to certain acquired intangible assets, which included<span style="background:#ffffff;"> a partial impairment charge of $8.2 million of intangible assets from our acquisition of STD Pharmaceutical,</span> a partial impairment charge of $8.0 million<span style="background:#ffffff;"> of intangible assets from our acquisition of certain assets from Laurane Medical S.A.S, a partial impairment charge of $4.8 million related to our license agreements with ArraVasc, and other intangible asset impairments charges of $7.7 million related to intangible assets from our acquisition of certain assets from DirectACCESS Medical, LLC, in-process technology intangible assets of Sontina Medical LLC acquired in connection with our acquisition of certain divested assets from BD, and a customer list intangible asset&#160;from&#160;our acquisition of ITL Healthcare Pty Ltd (&#8220;ITL&#8221;).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Contingent Consideration Expense (Benefit)</i>. For the years ended December 31, 2022, 2021 and 2020, we recorded $4.6 million, $3.2 million and $(8.0) million, respectively, of net contingent consideration expense (benefit) from changes in the estimated fair value of our contingent consideration obligations stemming from our previously disclosed business acquisitions. The expense (benefit) in each fiscal year relates to changes in the probability and timing of achieving certain revenue and operational milestones, as well as expense for the passage of time. </p><a id="_Hlk127355244"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acquired In-process Research and Development</i>. During the&#160;year ended December 31, 2022, we incurred in-process research and development charges of $6.7 million p<span style="background:#ffffff;">rimarily associated with our acquisition of Restore Endosystems, LLC (&#8220;Restore Endosystems&#8221;). </span>We did not incur in-process research and development charges during the year ended December 31, 2021. We incurred $0.3 million for in-process research and development associated with various asset acquisitions during the year ended December 31, 2020.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Operating Income (Loss)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our operating profit by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was as follows (in&#160;thousands): </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating Income (Loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 80,946</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 53,415</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (7,042)</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 6,617</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,501</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 5,480</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total operating income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 87,563</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 60,916</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="white-space:pre-wrap;"> (1,562)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cardiovascular Operating Income (Loss).</i> Our cardiovascular operating income for the&#160;year ended December&#160;31,&#160;2022 was $80.9 million, compared to cardiovascular operating income of $53.4 million for the&#160;year ended December&#160;31,&#160;2021. This increase in cardiovascular operating income was primarily related to higher sales, decreased legal settlement costs, including $10 million in 2021 in connection with an agreement in principle to settle a securities class action lawsuit, and decreased impairment charges within our cardiovascular operating segment ($2.2 million in 2022 compared to $4.3 million in 2021), partially offset by increased labor-related and travel costs, and increased contingent consideration expense ($4.6 million in 2022, compared to $3.2 million in 2021).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our cardiovascular operating income for the&#160;year ended December&#160;31,&#160;2021 was $53.4 million, compared to cardiovascular operating loss of $(7.0) million for the&#160;year ended December&#160;31,&#160;2020. This increase in cardiovascular operating income was primarily related to higher sales and increased gross margin percentage, decreased legal settlement costs ($10 million in 2021, compared to $18.7 million in 2020) and decreased impairment charges within our cardiovascular operating segment ($4.3 million in 2021 compared to $36.5 million in 2020), partially offset by increased labor-related costs, approximately $6 million of contract termination costs to renegotiate certain terms of our share purchase agreement with IntelliMedical, increased corporate transformation costs, including consulting charges, in connection with our Foundations for Growth program and increased contingent consideration ($3.2 million of expense in 2021, compared to a benefit of $(8.0) million in 2020).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Endoscopy Operating Income.</i> Our endoscopy operating income for the&#160;year ended December&#160;31,&#160;2022 was $6.6 million, compared to operating income of $7.5 million for the&#160;year ended December&#160;31,&#160;2021. This decrease in endoscopy operating income relative to 2021 was primarily due to decreased gross margin percentage as a result of changes in product mix and higher shipping costs and higher labor-related costs, partially offset by higher sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our endoscopy operating income for the&#160;year ended December&#160;31,&#160;2021 was $7.5 million, compared to operating income of $5.5 million for the year ended December 31, 2020. This increase in endoscopy operating income relative to 2020 was primarily due to higher sales and increased gross margin percentage, partially offset by increased labor-related costs.</p><a id="_Hlk31019118"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Income (Expense)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our other expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $4.9 million, $7.0 million, and $11.7 million, respectively. The decrease in other expense for 2022 compared to 2021 was principally the result of an increase in other income associated with realized and unrealized foreign currency gain (loss), partially offset by an increase in interest expense associated with rising interest rates and an increase in other expense related to the divestiture of the STD Pharmaceutical business. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The decrease in other expense for 2021 compared to 2020 was principally the result of decreased interest expense due to lower average debt balances and a lower average interest rate during 2021 partially offset by <span style="background:#ffffff;">a gain of $0.5 million on the sale of the assets associated with our Hypotube&#8482; product line in 2020</span>. </p><a id="_Hlk125639784"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Effective Tax Rate</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our provision for income taxes for the years ended December&#160;31,&#160;2022, 2021 and 2020 was a tax expense (benefit) of $8.1 million, $5.5 million and $(3.4) million, respectively, which resulted in an effective income tax rate of 9.8%, 10.1%, and 25.6%, respectively. The decrease in the effective income tax rate for 2022 compared to 2021 was primarily the result of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">a benefit from the change in foreign withholding taxes on unremitted foreign earnings due to the restructuring of our foreign entities, more foreign tax credits being utilized, as well as additional benefit from the foreign-derived intangible income (FDII) deduction. The decrease in the effective income tax rate for 2021 compared to 2020 was primarily the result of a change in the jurisdictional mix of earnings, additional benefit from stock-based compensation awards, as well as more foreign tax credits being utilized. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Net Income (Loss)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our net income (loss) for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $74.5 million, $48.5 million, and $(9.8) million, respectively. The increase in net income for 2022, when compared to 2021, was primarily related to higher sales, decreased legal settlement costs primarily due to the $10.0 million settlement in 2021 in connection with an agreement in principle to settle a securities class action lawsuit, and decreased impairment charges ($2.2 million in 2022 compared to $4.3 million in 2021); partially offset by higher SG&amp;A expenses due to higher labor-related and travel costs<span style="background:#ffffff;">, as well as increased contingent consideration expense of $4.6 million in 2022 compared to $3.2 million in 2021. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The increase in net income for 2021, when compared to 2020, was primarily related to higher sales and increased gross margin percentage, as we observed an operating environment with fewer COVID-19 related restrictions throughout the year. Legal settlement costs decreased to $10 million in 2021, compared to $18.7 million in 2020, and impairment charges decreased to $4.3 million in 2021 compared to $36.5 million in 2020. This was partially offset by higher SG&amp;A expenses due to higher labor-related costs, <span style="background:#ffffff;">$6 million of contract termination costs to renegotiate certain terms of an acquisition agreement, </span>increased corporate transformation costs, including consulting charges, in connection with our Foundations for Growth program<span style="background:#ffffff;">, as well as contingent consideration expense of $3.2 million in 2021 compared to a benefit of $(8.0) million in 2020</span>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity and Capital Resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Capital Commitments and Contractual Obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our most significant contractual obligations as of December 31, 2022 included long-term debt of $198.2 million, of which $11.3 million is recorded in current liabilities, interest payments on this debt, operating lease liabilities of $70.7 million, of which $11.0 million is recorded in current liabilities, and contingent consideration liabilities of $18.1 million, of which $15.8 million is recorded in current liabilities. Additional information about these obligations is contained in Notes 8, 15 and 17 to our consolidated financial statements set forth in Item 8 of this report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash Flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31, 2022 and 2021, we had cash, cash equivalents and restricted cash of $60.6 million and $67.8 million respectively, of which $49.6 million and $55.7 million, respectively, were held by foreign subsidiaries. We do not consider our foreign earnings to be permanently reinvested. As of December 31, 2022 and 2021, approximately $2.1 million and $1.9 million respectively, of our cash and cash equivalents represents restricted cash for the payment of certain import and other taxes for our subsidiary in China. Cash held by our subsidiary in China is subject to local laws and regulations that require government approval for the transfer of such funds to entities located outside of China. As of December&#160;31, 2022 and 2021, we had cash and cash equivalents, including restricted cash, of $26.1 million and $28.5 million, respectively, held by our subsidiary in China.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cash flows provided by operating activities.</i> We generated cash from operating activities of $114.3 million, $147.2 million and $165.3 million during the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. Net cash provided by operating activities decreased $32.9 million for the year ended December&#160;31,&#160;2022 compared to the year ended December&#160;31,&#160;2021. Significant changes in operating assets and liabilities affecting cash flows during these years included:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Net income was $74.5 million and $48.5 million for the years ended December 31, 2022 and 2021, respectively. This improvement in net income was partially offset by an increase in the non-cash adjustment for deferred income taxes within the statement of cash flows of $(14.9) million and $(4.6) million for the years ended December 31, 2022 and 2021, respectively.</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">45</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash (used for) accounts receivable was $(15.1) million and $(8.6) million for the years ended December 31, 2022 and 2021, respectively, due primarily to increases in sales volume,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash provided by (used for) other receivables was $4.2 million and $(10.4) million for the years ended December 31, 2022 and 2021, respectively, due primarily to the collection of approximately $8.2 million of insurance proceeds in connection with the consolidated securities class action lawsuit we settled in April 2022,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash (used for) inventories was $(47.9) million and $(25.2) million for the years ended December 31, 2022 and 2021, respectively, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">due primarily to efforts to normalize inventory levels as well as build bridge inventory for production line transfers and increases in safety stock due to vendor supply delays, and</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash provided by (used for) accrued expenses was $(16.4) million and $36.5 million for the years ended December 31, 2022 and 2021, respectively, primarily related to payment of a legal settlement accrual of $18.25 million in 2022 associated with the agreement in principle to settle the Class Action Litigation and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">increased labor-related cost accruals associated with higher commissions and bonus expense in the prior-year period,&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">among other items.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Net cash provided by operating activities decreased $18.0 million for the year ended December 31, 2021 compared to the year ended December 31, 2020. Significant changes in operating assets and liabilities affecting cash flows during these years included:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk31301725"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Net income (loss) was $48.5 million and $(9.8) million for the years ended December 31, 2021 and 2020, respectively. This improvement in net income was offset by a decrease in the non-cash adjustment for the write-off of certain intangible and other long-term assets within the statement of cash flows of $4.4 million and $36.6 million for the years ended December 31, 2021 and 2020, respectively.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash provided by (used for) accounts receivable was $(8.6) million and $10.4 million for the years ended December 31, 2022 and 2021, respectively, due primarily to increases in sales volume,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash provided by (used for) other receivables was $(10.4) million and $1.7 million for the years ended December 31, 2021 and 2020, respectively, due primarily to an increase in an insurance receivable associated with the agreement in principle to settle the Class Action Litigation,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash provided by (used for) inventories was $(25.2) million and $29.4 million for the years ended December 31, 2021 and 2020, respectively, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">due primarily to efforts to manage inventory levels to support the growth in sales and reduced production in the prior-year period during the economic downturn related to the COVID-19 pandemic, and</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 74.15pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:56.15pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Cash provided by accrued expenses was $36.5 million and $4.6 million for the years ended December 31, 2021 and 2020, respectively, related to increased labor-related cost accruals associated with higher commissions and bonus expense in the current-year period and a legal settlement accrual of $18.25 million in 2021 associated with the agreement in principle to settle the Class Action Litigation, among other items.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cash flows used in investing activities.</i> We used cash in investing activities of $57.4 million, $37.2 million, and $58.7 million for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. We invested in capital expenditures for property and equipment of $45.0 million, $27.9 million, and $46.0 million for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. Capital expenditures in each period were primarily related to investment in property and equipment to support development and production of our products. Historically, we have incurred significant expenses in connection with facility construction, production automation, product development and the introduction of new products. We anticipate that we will spend approximately $55 to $60 million in 2023 for property and equipment.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">46</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Cash outflows invested in acquisitions for the year ended December&#160;31,&#160;2022 were $8.3 million and were primarily related to our $3.0 million upfront payment in our purchase of Restore Endosystems, our $2.5 million payment in our purchase of BioTrace Medical, Inc., and our additional equity investment in <span style="background:#ffffff;">FluidX Medical Technology, Inc. (&#8220;Fluidx&#8221;)</span> of $1.4 million. Cash outflows invested in acquisitions for the year ended December 31, 2021 were $7.2 million and were primarily related to $4.1 for <span style="background:#ffffff;">the settlement of deferred payments and the working capital adjustment associated with our acquisition of KA Medical, LLC (&#8220;KA Medical&#8221;) completed in November 2020 and $2.7 million for an equity investment in FluidX</span>. <span style="background:#ffffff;">Cash outflows invested in acquisitions for the year ended December 31, 2020 were $11.0 million and were primarily related to our acquisition of KA Medical. </span>For further discussion, refer to Note 3 to our consolidated financial statements set forth in Item&#160;8 of this report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cash flows used in financing activities.</i> Cash used in financing activities for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $60.3 million, $98.4 million, and $95.7 million, respectively. In 2022 we decreased our net borrowings under our Third Amended Credit Agreement by $44.9 million and paid contingent consideration of $32.9 million, which is classified as a financing activity, principally related to our acquisitions of Cianna Medical Inc. (&#8220;Cianna Medical&#8221;) and Vascular Insights LLC (&#8220;Vascular Insights&#8221;). In 2021 we decreased our net borrowings under our Third Amended Credit Agreement by $108.5 million and paid contingent consideration of $10.7 million, which is classified as a financing activity, principally related to our acquisition of Vascular Insights. In 2020 we decreased our net borrowings by $88.4 million and paid contingent consideration of $13.1 million, which is classified as a financing activity, principally related to our acquisition of Cianna Medical.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, we had outstanding borrowings of $198.2 million and issued letter of credit guarantees of $3.2 million under the Third Amended Credit Agreement, with additional available borrowings of approximately $523 million, based on the leverage ratio required pursuant to the Third Amended Credit Agreement. Our interest rate as of December 31, 2022 was a fixed rate of 2.71% on $75 million as a result of an interest rate swap and a variable floating rate of 5.38% on $123.2 million. Our interest rate as of December 31, 2021 was a fixed rate of 2.71% on $75 million as a result of an interest rate swap and a variable floating rate of 1.10% on $168.1 million. The foregoing fixed rates are exclusive of potential future changes in the applicable margin. See Note 8 and Note 9 to our consolidated financial statements set forth in Item 8 of this report for additional details regarding the Third Amended Credit Agreement, our long-term debt and our interest rate swaps.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We currently believe that our existing cash balances, anticipated future cash flows from operations and borrowings under the Third Amended Credit Agreement will be adequate to fund our current and currently planned future operations for the next twelve months and the foreseeable future. In the event we pursue and complete significant transactions or acquisitions in the future, additional funds will likely be required to meet our strategic needs, which may require us to raise additional funds in the debt or equity markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Critical Accounting Policies and Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our significant accounting policies are summarized in Note&#160;1 to our consolidated financial statements set forth in Item&#160;8 of this report. While these significant accounting policies affect the reporting of our financial condition and results of operations, the SEC has requested that all registrants address their most critical accounting policies. The SEC has indicated that a &#8220;critical accounting policy&#8221; is one which is both important to the representation of the registrant&#8217;s financial condition and results and requires management&#8217;s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. We base our estimates on past experience and on various other assumptions our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results will differ and may differ materially from these estimates under different assumptions or conditions. Additionally, changes in accounting estimates could occur in the future from period to period. The following paragraphs identify our most critical accounting policies: </p><a id="_Hlk126675958"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Inventory Obsolescence.</i><i style="font-style:italic;"> </i>Our management reviews inventory quantities on hand and records provisions for estimated excess, slow moving and obsolete inventory. Based on this review, we provide adjustments for any slow-moving finished good products or raw materials that we believe will expire prior to being sold or used to produce a finished good and any </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">47</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">products that are unmarketable. This review of inventory quantities for unmarketable and/or slow moving products is based on forecasted product demand derived from our historical experience of product sales and production raw material usage. If market conditions become less favorable than those projected by our management, additional inventory write-downs may be required. During the years ended December 31, 2022, 2021 and 2020, we recorded obsolescence expense of approximately $9.8 million, $10.9 million, and $14.1 million, respectively, and wrote off approximately $10.2 million, $11.6 million, and $8.9 million, respectively. Based on this historical trend, we believe that our inventory balances as of December 31, 2022 have been accurately adjusted for any unmarketable and/or slow moving products that may expire prior to being sold.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Valuation of Goodwill and Intangible Assets.</i><b style="font-weight:bold;"> </b>We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We base the fair value of identifiable intangible assets acquired in a business combination on valuations that use information and assumptions that a market participant would use, including assumptions for estimated revenue projections, growth rates, cash flows, discount rates, useful life, and other relevant assumptions. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We test our goodwill balances for impairment annually as of July 1, or whenever impairment indicators arise. When impairment indicators are identified, we may elect to perform an optional qualitative assessment to determine whether it is more likely than not that the fair value of our reporting units has fallen below their carrying value. During our annual impairment test performed as of July 1, we utilized four reporting units in evaluating goodwill for impairment using a quantitative assessment, which uses a combination of a guideline public company market-based approach and a discounted cash flow income-based approach. The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value. This analysis requires significant judgment, including estimation of the amount, timing and duration of future cash flows, which is based on internal forecasts, and a determination of a discount rate based on our weighted average cost of capital. During our annual test of goodwill balances in 2022, which was completed during the third quarter of 2022, we determined that the fair value of each reporting unit with goodwill exceeded the carrying amount by a significant amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">We evaluate long-lived assets, including amortizing intangible assets, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform the impairment analysis at the asset group for which the lowest level of identifiable cash flows is largely independent of the cash flows of other assets and liabilities.&#160;We first compare </span>undiscounted cash flows to the carrying amount of the asset group to determine if impairment exists, and then <span style="background:#ffffff;">determine the fair value of our amortizing assets based on estimated future cash flows discounted back to their present value using a discount rate that reflects the risk profiles of the underlying activities. </span>This analysis requires similar significant judgments as those discussed above regarding goodwill. In-process technology intangible assets, which are not subject to amortization until projects reach commercialization, are assessed for impairment at least annually and more frequently if events occur that would indicate a potential reduction in the fair value of the assets below their carrying value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">During the years ended December&#160;31,&#160;2022, 2021 and 2020, we identified indicators of impairment associated with certain acquired intangible assets within the asset groups based on our qualitative assessment.&#160;During the years ended December 31, 2022, 2021 and 2020 we recorded total impairment charges associated with intangible assets in our cardiovascular segment of $1.7 million, $1.6 million, and $28.7 million, respectively. These expenses are reflected within impairment charges in our consolidated statements of income (loss).&#160;The primary factors driving impairment of certain intangible assets were planned closure and restructuring activities and uncertainty about future product development and commercialization associated with certain acquired technologies, due in part to the economic impacts of the COVID-19 pandemic. </span>See Note&#160;5 to our consolidated financial statements set forth in Item&#160;8 of this report<span style="background:#ffffff;"> for additional details regarding impairments of intangible assets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Contingent Consideration.</i><b style="font-weight:bold;"> </b><span style="color:#212529;background:#ffffff;">Contingent consideration is an obligation by the buyer to transfer additional assets or equity interests to the former owner upon reaching certain performance targets. Certain of our business combinations involve the potential for the payment of future contingent consideration, generally based on a&#160;percentage of future product sales or upon attaining specified future revenue or other relevant milestones. In connection with a business combination, any contingent consideration is recorded at fair value on the acquisition date based upon the consideration expected to be </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">48</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="color:#212529;background:#ffffff;">transferred in the future. We base the fair value of contingent consideration obligations acquired in a business combination on valuations that use information and assumptions that a market participant would use, including assumptions for estimated revenue growth rates, discount rates, probabilities of achieving regulatory approval, performance, or revenue-based milestones and other relevant factors. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="color:#212529;background:#ffffff;">We re-measure the estimated liability each quarter and record changes in the estimated fair value through operating expense in our consolidated statements of income (loss). Significant increases or decreases in our estimates could result in changes to the estimated fair value of our contingent consideration liability, as well as the result of changes in the timing and amount of revenue estimates and changes in the discount rate or periods. Our revenue milestone contingent liability associated with the November 2018 acquisition of Cianna Medical includes a sales growth multiplier, and our revenue milestones for the acquisition of Brightwater Medical, Inc. includes payment thresholds. These and other similar contract features of our contingent consideration liabilities create sensitivity regarding the occurrence, timing, and amount of future payments. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">For the years ended December&#160;31,&#160;2022, 2021 and 2020, we recognized contingent consideration expense (benefit) of $4.6&#160;million, $3.2 million and <span style="color:#212529;background:#ffffff;">$(8.0) million, respectively, from changes in the estimated fair value of our contingent consideration obligations stemming from our previously disclosed business acquisitions. Changes in the fair value of our contingent consideration liabilities were&#160;primarily attributable to changes in anticipated sales growth in the acquired products and the anticipated timing of milestone payments. See Note&#160;15 to our consolidated financial statements set forth in Item&#160;8 of this report for additional details regarding our contingent liabilities.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:36pt;text-indent:-36pt;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_a4df70cd_2f4a_4b34_ba42_5a2ceddfe3c9"></a><a id="Item7AQuantitativeandQualitativeDisclosu"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;7A.</b></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Quantitative and Qualitative Disclosures About Market Risk.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Currency Exchange Rate Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our consolidated financial statements are denominated in, and our principal currency is, the U.S. Dollar. For the&#160;year ended December&#160;31,&#160;2022, a portion of our net sales ($394.1 million, representing 34.2% of our aggregate net sales), was attributable to sales that were denominated in foreign currencies. All other international sales were denominated in U.S. Dollars. Our principal market risk relates to changes in the value of the Chinese Yuan Renminbi (CNY) and Euro (EUR) relative to the U.S. Dollar (USD), with limited market risk relating to various other currencies. In general, a strengthening of the U.S. Dollar against CNY has a negative effect on our operating income. Our Euro-denominated expenses associated with our European operations (manufacturing sites, a distribution facility and sales representatives) provide a natural hedge for Euro-denominated revenues. Accordingly, a strengthening of the U.S. Dollar against the Euro will generally have a positive effect on our operating income. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We forecast our net exposure related to sales and expenses denominated in foreign currencies. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts, which qualified as cash flow hedges, with aggregate notional amounts of $87.8 million and $123.0 million, respectively. We also forecast our net exposure in various receivables and payables to fluctuations in the value of various currencies, and we enter into foreign currency forward contracts to mitigate that exposure. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts, which were not designated as hedging instruments, related to those balance sheet accounts with aggregate notional amounts of $92.4 million and $86.0 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">A sensitivity analysis of changes in the fair value of all currency exchange rate derivative contracts at December 31, 2022 and 2021 indicates that, if the U.S. Dollar strengthened or weakened by 10% against all currencies, it would have the following impact on the fair value of these contracts (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">10%&#160;Strengthening</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,660</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,470</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">10%&#160;Weakening</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4,660)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3,470)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Gains or losses on the fair value of derivative contracts would generally be offset by gains and losses on the underlying hedged transaction or net exposure. These offsetting gains and losses are not reflected above. See Note&#160;9 to our consolidated financial statements set forth in Item&#160;8 of this report for additional discussion of our foreign currency forward contracts.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">49</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Interest Rate Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">As discussed in Note&#160;8 to our consolidated financial statements set forth in Item&#160;8 of this report, as of December&#160;31,&#160;2022, we had outstanding borrowings of $198.2 million under the Third Amended Credit Agreement.&#160;Accordingly, our earnings and after-tax cash flow are affected by changes in interest rates. On December&#160;23, 2019, we entered into a pay-fixed, receive-variable interest rate swap with Wells Fargo Bank, with a notional amount of $75 million, to fix the one-month LIBOR rate at 1.71% for the period from July 6, 2021 to July 31, 2024. This interest rate swap is intended to reduce our exposure to interest rate fluctuations and was not entered into for speculative purposes. Excluding the amount that is subject to a fixed rate under the interest rate swap and assuming the current level of borrowings remained the same, it is estimated that our interest expense and income before income taxes would change by approximately $1.2 million annually for each one&#160;percentage point change in the average interest rate under these borrowings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Certain of the interest rates applicable to our Third Amended Credit Agreement and to hedging instruments we have purchased to offset interest rate risk under our Third Amended Credit Agreement, are LIBOR-based. We anticipate replacement rates will be identified, as provided for in our Third Amended Credit Agreement, as LIBOR-based rates become unavailable. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">50</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_60455d84_3f5c_4f2d_9fda_96f33a110526"></a><a id="Item8FinancialStatementsandSupplementary"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;8.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Statements and Supplementary Data.</b></p><a id="_REPORT_OF_INDEPENDENT_1"></a><a id="REGISTEREDPUBLICACCOUNTINGFIRM_44170"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">To the stockholders and the Board of Directors of Merit Medical Systems, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Opinion on the Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We have audited the accompanying consolidated balance sheets of Merit Medical Systems, Inc. and subsidiaries (the &quot;Company&quot;) as of December 31, 2022 and 2021, the related consolidated statements of income (loss), comprehensive income (loss), stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the &quot;financial statements&quot;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#39;s internal control over financial reporting as of December 31, 2022, based on criteria established in <i style="font-style:italic;">Internal Control &#8212; Integrated Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 24, 2023, expressed an unqualified opinion on the Company&#39;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Basis for Opinion</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">These financial statements are the responsibility of the Company&#39;s management. Our responsibility is to express an opinion on the Company&#39;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Critical Audit Matter</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">51</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk127007167"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Inventories - </span><span style="font-style:italic;font-weight:bold;">Provision for estimated excess, slow moving and obsolete </span><span style="font-style:italic;font-weight:bold;">inventories &#8211; Refer to Note 1 to the financial statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Critical Audit Matter Description </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="white-space:pre-wrap;">Inventories are valued at the lower of cost, at approximate costs determined on a first-in, first-out method, or net realizable value. The Company reviews inventories on hand and records provisions based on estimated excess, slow moving and obsolete inventories. The inventories valuation reviews include an assessment of future product demand based on historical sales and raw material usage and product expiration. As of December 31, 2022, the Company&#8217;s inventories were $266.0 million.  During the year ended December 31, 2022, the Company recorded obsolescence expense of approximately $9.8 million.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 12pt 0pt;">We identified the provision for estimated excess, slow moving and obsolete inventories as a critical audit matter because of management&#8217;s significant judgment and estimates in determining the provision for estimated excess, slow moving and obsolete inventories primarily around future product demand based on historical sales. This required a high degree of auditor judgment and an increased extent of effort<span style="font-family:'Calibri Light';font-size:11pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">How the Critical Audit Matter Was Addressed in the Audit</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Our audit procedures related to management&#8217;s estimates of the valuation of excess and obsolete inventories included the following, among others:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We tested the effectiveness of controls over the provision for estimated excess, slow moving and obsolete inventories. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We evaluated management&#8217;s ability to accurately estimate the provision for estimated excess, slow moving and obsolete inventories by comparing actual write-downs of inventories to management&#8217;s historical estimates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We evaluated the reasonableness of the Company&#39;s provision for estimated excess, slow moving and obsolete inventories, considering future product demand based on historical sales and raw material usage and product expiration and the underlying assumptions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We tested the accuracy and completeness of the underlying data used in the Company&#8217;s calculations of the valuation of excess and obsolete inventories, including historical usage, quantities on hand, expiration dates, and pricing.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We assessed the reasonableness of the assumptions used in the calculations of the provision for estimated excess, slow moving and obsolete inventories by developing an independent expectation and comparing our independent expectation to the results of the Company&#8217;s calculations.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We tested the mathematical accuracy of the Company&#8217;s calculations of excess, slow moving and obsolete inventories.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_cf13bfaf_38e6_41a9_a895_ee9f66ef5d3a"></a><a id="Tc_95bGiPKWI0evQYUjv2sYBw_0_0"></a><a id="Tc_SzopdETVmkW2gFgIwvBtxA_3_0"></a><a id="Tc_2QNRH1TU0UegeAPZGA-sGw_4_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:55.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 3pt;">/s/ <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:AuditorName" id="Narr_DKPpif7EFka5LylY4MJIBw">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 3pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:AuditorLocation" id="Tc_cgTBfJhI2EK7vq7g47asng_2_0">Salt Lake City, Utah</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 3pt;">February 24, 2023</p></td><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 3pt;">We have served as the Company&#8217;s auditor since 1988.</p></td><td style="vertical-align:bottom;width:44.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">52</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_2241354f_0465_43a9_ac7a_f3c7c0ae5c09"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</b></p><a id="CONSOLIDATEDBALANCESHEETS_917441"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED BALANCE SHEETS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(In thousands)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_ffb5583c_9c1e_435d_8db4_755603b1049a"></a><a id="Tc_cCzU-rzhg06eFy4HZWyYTQ_1_2"></a><a id="Tc_sJv-evpawU-xBPF-UfURaQ_1_5"></a><a id="Tc_iE8b1xTl_kGt4OUjlqgaMw_2_0"></a><a id="Tc_AzONfz0tZEep87YsfvieCQ_2_2"></a><a id="Tc_Q8GLYgTvrkyu4q_fb3dsEw_2_5"></a><a id="Tc_Pt9wYxyAtUWQ-YcD61Kl2Q_4_0"></a><a id="Tc_6iMaVl1YeE6y1JCMpu3How_5_0"></a><a id="Tc_GvM3bmWlwE2_C-TBHrvfEA_5_2"></a><a id="Tc_iUPGBKHOuUqNvBAFZ1NtOA_5_5"></a><a id="Tc_3illPB76NkiTmROykdo84Q_6_0"></a><a id="Tc_OpkBZXhF8UieVnNED_83NQ_7_0"></a><a id="Tc_vZ6axPJIuUymkl8tb9kieg_8_0"></a><a id="Tc_8h897V66H0qMAWCUtuL_AA_9_0"></a><a id="Tc_81-KV0MyQUK1B6xgix9FYw_10_0"></a><a id="Tc_aknhlnFiFEG8GQWm6ptuGQ_11_0"></a><a id="Tc_9KPR2XYsG06fN1JNaemUNQ_12_0"></a><a id="Tc_26O6rA4D90WpZcXR04h0sA_14_0"></a><a id="Tc_E-ixQBFhpkO8F496kwbP4g_15_0"></a><a id="Tc_Ts08HBQVIkqkwFrs354BVw_16_0"></a><a id="Tc_xUx6xsO5f0ObwdpPqG5d2Q_17_0"></a><a id="Tc_DPCpU27jykSL0WPfTD0xmQ_18_0"></a><a id="Tc_oQPgXU85ukm8fHrzGt5Uaw_19_0"></a><a id="Tc_DaTdfiYBWEu3JSN1cAQFow_20_0"></a><a id="Tc_gypmK8aTU0GcjVDMoNPqdw_21_0"></a><a id="Tc_yBEM5OPKAkO5eBNdeEybdA_22_0"></a><a id="Tc_5ypvGP7NwkSzYVonDoi-LQ_23_0"></a><a id="Tc_HSsWl4ZpAEKCmU-df9DljA_25_0"></a><a id="Tc_xyRDZxm6jUaG8i4UJDVxow_26_0"></a><a id="Tc_Iqwp_Xl3QU672o7ZtneXBg_27_0"></a><a id="Tc_EE7Gh2rcIkS7EDC2vZt0gw_28_0"></a><a id="Tc_LQy-eEy-KUGhBHWZlh1NxQ_29_0"></a><a id="Tc_rk8dXs8uLUCweLDJwGQ4og_30_0"></a><a id="Tc_Yjmw9MlX0EefKItk5iHDJA_31_0"></a><a id="Tc_zv1tmRaYn06wigXlwqdt0Q_32_0"></a><a id="Tc_3rvRWWK5uUeAZqxH1xj_0Q_33_0"></a><a id="Tc_of_m9cF1Mky3oTI7j8NTMg_35_0"></a><a id="Tc_sZaGGgtXOEaIEHfTatsKRw_35_2"></a><a id="Tc_sS9JztKst0658MOfk6rOAA_35_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_jTT5Wo9mu0aokoJ02YtCfQ_5_3">58,408</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_YbyaXmc1E0CWqxt3aRsySA_5_6">67,750</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Trade receivables &#8212; net of allowance for credit losses &#8212; 2022 &#8212; $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="Narr_KG5IWsyp00KbioJQxOEZvQ">8,423</ix:nonFraction> and 2021 &#8212; $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="Narr_bL7N3gNy_EWN5427qWCgfg">6,767</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Tc_UM6FsSiR9E677f2WEZ0FqQ_6_3">164,677</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="Tc_JZyVs8kkl02_3O0T-9fz1w_6_6">152,301</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NontradeReceivablesCurrent" scale="3" id="Tc_v2wGX7WBUUqi5phloyBAnA_7_3">12,992</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NontradeReceivablesCurrent" scale="3" id="Tc_NMx31AOrf0mL0ktr4KSyuA_7_6">17,763</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="Tc_JGYjCTfIFkuHU0l7JjRglA_8_3">265,991</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="Tc_4gGTmtqSb0Ky8GSopWxewA_8_6">221,922</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="Tc_3s0X5Zse8kmrzge3zBYckw_9_3">22,324</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="Tc_mPYnwoQrw0aVnnhQvQ8Xtw_9_6">16,149</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Prepaid income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="Tc_nTfaDENs20y63VvEQQtl8A_10_3">3,913</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="Tc_HEaJoEjr80aC1T58rdlv7g_10_6">3,550</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income tax refund receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="Tc_gm5iDZlan0CoLK58Kg7ykQ_11_3">779</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="Tc__v9YVVEgg0KrHw0VKAdyDQ_11_6">2,777</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="Tc_kGfYQ7mwRkGtZXIeRdjERg_12_3">529,084</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="Tc_w1BPDjuaC0WZQmQns43oMg_12_6">482,212</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property and equipment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Land and land improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Land" scale="3" id="Tc_kge-qe-BCkK6GOe3NqCwRA_15_3">25,940</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Land" scale="3" id="Tc_ulTNQcleW0aySj9s95mTCQ_15_6">25,287</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="3" id="Tc_tJCK1a4do0W8uhJpoSZHgw_16_3">189,148</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="3" id="Tc_8KxzU7DHCUG8h5BTBStCwg_16_6">190,044</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Manufacturing equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MachineryAndEquipmentGross" scale="3" id="Tc_HDQDuejSZ0qAIq81UOLKnw_17_3">299,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MachineryAndEquipmentGross" scale="3" id="Tc_nUCp8JQJV06k62qi7qmWmA_17_6">277,976</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Furniture and fixtures</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FurnitureAndFixturesGross" scale="3" id="Tc_VxIbM2iRFkeaOZ1IsVyAlQ_18_3">61,128</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FurnitureAndFixturesGross" scale="3" id="Tc_Klxz_rlpJUKOEZAT1cbZoA_18_6">61,446</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseholdImprovementsGross" scale="3" id="Tc_dZuQoSmIb0-3oXYAld1ekw_19_3">49,673</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseholdImprovementsGross" scale="3" id="Tc_ekCjluBXnkGz1Twc8AMG0w_19_6">46,341</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Construction-in-progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="3" id="Tc_tE_HZZUPw02qqLS5Hk_FQQ_20_3">61,269</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="3" id="Tc_FrFgBcp5EUK1PknAKiLFNw_20_6">51,182</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="Tc_RvBbZesXu0WKPI94FdmrLA_21_3">686,247</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="Tc_fZ59AiMFtEqAYFaqBZbl1g_21_6">652,276</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Less accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="Tc_2heARNmNmUumAi06blY0tg_22_3">303,271</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="Tc_pSqyXcLo9UOX6tSXurfiow_22_6">280,618</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Property and equipment &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_KyviPuWB2EqQAp4X9LyjMg_23_3">382,976</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_webbUFgKL0-cVct9HT-gzg_23_6">371,658</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Intangible assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Developed technology &#8212; net of accumulated amortization &#8212; 2022 &#8212; $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_M_cqHBv4VEmQzw8E4TMvlQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Narr_jAgH3HdXNUigqf4IHpcMqQ">274,570</ix:nonFraction> and 2021 &#8212; $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_ivrHt2y9VEu_1nKzuAKxTw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Narr_lANE1gCUV0CuTFyk7O0cNA">234,016</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_M_cqHBv4VEmQzw8E4TMvlQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_OdedzssmGE2RbavUtQAFDw_27_3">237,522</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_ivrHt2y9VEu_1nKzuAKxTw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_BAGDlYsnSki_QVpgpHzCQw_27_6">276,833</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Other &#8212; net of accumulated amortization &#8212; 2022 &#8212; $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Narr__eXyE55LIUSmuYicenWVyA">69,780</ix:nonFraction> and 2021 &#8212; $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Narr_keCaFPMGT0a-riOJH9ycgw">65,053</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_suzSzTmJ1kGoLZxS5LpFgw_28_3">38,350</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_RyV65ond606xOHCFc6SrEw_28_6">42,436</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_iTmr11orCEWn3ZlqSlMZbg_29_3">359,821</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_5QKfiTl-rkGIIZ9qs50UDA_29_6">361,741</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="Tc_CqPAhu8u7U6_mvPfqpEKMg_30_3">6,599</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="Tc_CsRBTChXdkOcf6wONo2Vsw_30_6">6,080</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Right-of-use operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Tc_Xbvsozxoz0qeBtmGllr4aQ_31_3">65,262</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Tc_R019c1kwNkmXskxIwCWEaQ_31_6">65,913</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="Tc_vKXwrYPEkUa1AGtrey53uA_32_3">44,352</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="Tc_ug_fDNOUCEGM5iFLoC8dyQ_32_6">41,421</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" scale="3" id="Tc_NqZp56Ef5ke4Og2W0BdyDQ_33_3">751,906</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" scale="3" id="Tc_05CTI6DHP0mYyroj4IcuAA_33_6">794,424</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_d_Yn6WIW1UabnkApbX2qSQ_35_3">1,663,966</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_NjhFn_vhl0-LRDTKnpTDAg_35_6">1,648,294</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:bottom;width:58.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">See notes to consolidated financial statements.</p></td><td style="vertical-align:bottom;width:41.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(continued)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">53</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED BALANCE SHEETS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(In thousands)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_701c0859_59b7_4246_b591_aceab1c9f434"></a><a id="Tc_0SbfcS-ldk-7lk_sYVOFxA_1_2"></a><a id="Tc_qwZEh91QCkaAkXOpFQv4dw_1_5"></a><a id="Tc_zNzMyhSwPEukJQZVo1Fn3w_2_0"></a><a id="Tc_rB4iR76dp0SmoOCz87bFgA_2_2"></a><a id="Tc_5FFg57jjakSbQB-KuP2weQ_2_5"></a><a id="Tc_6704hnkquUCoBQJ3z_O7XQ_4_0"></a><a id="Tc_C2KXTipPKkCstQ-rBDvmvQ_5_0"></a><a id="Tc_vKu6YzJVIkO-AH7Ng_k-Ag_5_2"></a><a id="Tc_AIxcx6WojUy1KRg2dnpkwQ_5_5"></a><a id="Tc_c2NvxcY_LEmFzVe_QyrmRQ_6_0"></a><a id="Tc_sQzq74ztwE2mEnZKUJCW6A_7_0"></a><a id="Tc_6UNPggLJUEuB6JJnzLw_PA_8_0"></a><a id="Tc_heRKKDQHdEGyv2jF73UHEg_9_0"></a><a id="Tc_17Ru5vt0qEWBJtgMy7v90w_10_0"></a><a id="Tc_ao400HG5OEKsOcJxDvSv3Q_12_0"></a><a id="Tc_Upa5rMP1VkGvNp5jS6NAnA_13_0"></a><a id="Tc_k_5SaOqhhUeaMNz5kXydSg_14_0"></a><a id="Tc_F6FDiHs7kUKHuoUrCOHB7A_15_0"></a><a id="Tc_1kWAxfMuA0WaaFOpsnpdBA_16_0"></a><a id="Tc_4Gb3Glztlk658MNbRrhkGQ_17_0"></a><a id="Tc_sXx6BFLwBEiiIh0zToYqWw_18_0"></a><a id="Tc_T-6OLYjPnUm2kgFMErR1tw_19_0"></a><a id="Tc_lyiNtedr9UitfDiiBKqXfw_20_0"></a><a id="Tc_nHBEKtvomEm--SfNun1Beg_22_0"></a><a id="Tc_95Ovl1ddv02P5ojJ964e-Q_24_0"></a><a id="Tc_69plux-dz0yCcEX9UE9J_Q_25_0"></a><a id="Tc_BNakL247wkyqxVokVXd0XA_26_0"></a><a id="Tc_LvwTHQG3OESGfER0sSHepw_27_0"></a><a id="Tc_K5Ti6TYvZE-Rj8fpRDfqwg_28_0"></a><a id="Tc_s82UBzbaLE2PU0Qr8OTUuA_29_0"></a><a id="Tc_vhZnHfgCokailAXWJmq_4w_31_0"></a><a id="Tc_zYPsgsYE2EWu20o9jTfqhQ_31_2"></a><a id="Tc_lfBtYMDyEESAGTfbPAtgvg_31_5"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" id="Tc_eI6Yt6YXokeJ0dlnQZwCCA_5_3">68,504</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" id="Tc_1Mq61tDkdEqShJUv2i47mA_5_6">55,624</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_1-J51LmCHkmD38bVTey7_w_6_3">123,189</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc__-NM-Wd17E63othx4V8FXA_6_6">159,014</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current portion of long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="Tc_m6xqvbN9RkywqoPrp5OrMw_7_3">11,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="Tc_aH-b0E6Puky5T407gWYQjQ_7_6">8,438</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Short-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="Tc_hog9UqcNqU2K90SP5WnbFA_8_3">11,005</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="Tc_hESGnyOvmkyJ-BvBSoru-w_8_6">10,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="Tc_NWfjdeF9akW-bASw7dO5Sg_9_3">6,697</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="Tc_9qEijmhshUmIwF-_0qvVTw_9_6">2,536</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="Tc_MVVMmlDkLke1tqkqzrXECA_10_3">220,645</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="Tc_Bg242Cx4HE6oNuAwCmld_g_10_6">236,280</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="Tc_JnYtgVyde0Sfd_yeZdbjwA_12_3">186,759</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="Tc_9cpfV9_XaE6WbIiQYiwOkw_12_6">234,397</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="Tc_ebkuE2AIDE2roPCr53h4ww_13_3">18,462</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="Tc_wmOq53S-UkiZe0z9CR7HKA_13_6">31,503</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term income taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="3" id="Tc_JXSVMMG9VUee-1jabecWcQ_14_3">347</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="3" id="Tc_QwXZ4siIE0uvyhl_dZ639Q_14_6">347</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Liabilities related to unrecognized tax benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="Tc_ZWB_z76U3Eq9LadKGvHxqg_15_3">1,912</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="Tc_mgOF5PHVH0KilT-nKxYS9g_15_6">932</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred compensation payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="Tc_8FpXxiK4J0KXOPgaUgqvcw_16_3">15,264</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="Tc_fFG7KzSUmkSHYH1hgrL9jQ_16_6">18,111</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="Tc_vu5t3MGQ-EGqMFiP25A4uA_17_3">1,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="Tc_uucDyVjSak2ekRJnmaJdzQ_17_6">1,815</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="Tc_oH8kLyr48kagBklGEigsdQ_18_3">59,736</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="Tc_UvczEFWNDEmJg0-BiKhAZQ_18_6">61,526</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="Tc_jrpqAzaY2kq_lVRtGBuG_A_19_3">14,736</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="Tc_jli6Q8ma0Ey2QcPWzEo5-w_19_6">23,584</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="Tc_I_IbDjQk8U2zJ6AjXOZm5Q_20_3">519,569</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="Tc_RDae6OG4O0aAe2Esp8TTaQ_20_6">608,495</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Commitments and contingencies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stockholders&#39; equity:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Preferred stock &#8212; <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="Narr_uufwkqpvhUWkqyxDTtC-oQ"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="Narr_cSLD-tvE0Uuqidu8pODwLw">5,000</ix:nonFraction></ix:nonFraction> shares authorized as of December&#160;31,&#160;2022 and December&#160;31,&#160;2021; <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="Narr_xDd-e30PEk2gC6J2QQkhDg"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="Narr_TpHUzaExNUKCwB6BLNlYvg">no</ix:nonFraction></ix:nonFraction> shares issued</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="Tc_vIWXQSe4qE-cxZwoGWqpNw_25_3">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="Tc_z4HsySwZAUSXxlRwAuHOyA_25_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Common stock, <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_5kjQc0J-c0uGuosYIIWjLA"><ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="Narr_untn8JEAT0a5NUAbxYVj0Q">no</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="Narr_uc4X4npzz0enk6jNMplG8g"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="Narr_JUbAw3p9QkO68q1mvojuDQ">100,000</ix:nonFraction></ix:nonFraction> shares authorized; <span style="-sec-ix-hidden:Hidden_ExF1dirmUkOPTq79RIy2qw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and <span style="-sec-ix-hidden:Hidden_p8UrIZ0jDUysfw2uR9n5Qw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span> as of December&#160;31,&#160;2022 - <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="Narr_IMXwK_gU0U6sCDKOBZtYbQ">57,306</ix:nonFraction> and December&#160;31,&#160;2021 - <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="Narr_Qqsbt7KnWUGPKPlZeKoeiw">56,570</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="Tc_C_WyWwLLRUWhocjYes7TuQ_26_3">675,174</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="Tc_IRIXaAwlmUmu3fwiWm3Vjw_26_6">641,533</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="Tc_wXUmioLw_U6Zmh6R3Rt7yQ_27_3">480,773</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="Tc_ObpgLA97BU2v-fdpsRQuQw_27_6">406,257</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Accumulated other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_5SfvPjY3qkK6YKDy4gP1Bw_28_3">11,550</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_HPBGGGzjFkG-X7CRtZwxTg_28_6">7,991</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total stockholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_khLkvvaiTUSLSW6vI6bbVg_29_3">1,144,397</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc__3JKjofwtUaBq7oPIU00iA_29_6">1,039,799</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total liabilities and stockholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="Tc_I_k5GMzoBESzkLvW5GplVQ_31_3">1,663,966</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="Tc_w3EP7tveX0iFC3z8Boe4zA_31_6">1,648,294</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:41.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">See notes to consolidated financial statements.</p></td><td style="vertical-align:bottom;width:41.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(concluded)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">54</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9e85dceb_0388_4576_9138_d7eb1ed2ff63"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</b></p><a id="CONSOLIDATEDSTATEMENTSOFINCOME_61101"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF INCOME</b><b style="font-weight:bold;"> (LOSS)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(In thousands, except per share amounts)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_f11dda29_0a15_4e89_9787_f0428c6cb7b0"></a><a id="Tc_ZT5V_bwUuU24DaPyIqHLGw_3_2"></a><a id="Tc_ta_5PhBmh0iP2Sr76rPvUg_3_5"></a><a id="Tc_HDkHSH_7GUu3AooqcV8AvQ_3_8"></a><a id="Tc_oOsZdV-FVUeVNygmBBoaEA_4_0"></a><a id="Tc__vFmgyH0nU6ZjILOIwZBQw_4_2"></a><a id="Tc_UP4yJeoCDkmivit7Ds_UmQ_4_5"></a><a id="Tc_FfdN4AaffEWjltVmNUa3xw_4_8"></a><a id="Tc_t-MjQCOEBkS1-hJWGQNIHw_5_0"></a><a id="Tc_1A3h73UVEEyXOZwrDo-R_Q_6_0"></a><a id="Tc_uTRnFcKpPEmabTgqTHrfQw_8_0"></a><a id="Tc_SwOMHtWPH0W9au0dORxV2w_9_0"></a><a id="Tc_I1hKKInHe0ipw2G9y9xJlg_10_0"></a><a id="Tc_UEKOPFksKkmgPkaFtqC63Q_11_0"></a><a id="Tc_gKaOJas_FU28BNQOJwGWjg_11_3"></a><a id="Tc_pRt5QHHDXEmEerLonfNVkQ_12_0"></a><a id="Tc_hmYtblZ19kuvip-mqFxyBw_13_0"></a><a id="Tc_DTeRDmPh8Uyyu7OQvg7clw_14_0"></a><a id="Tc_cGra4ECq9E2jb0RlKvopPg_14_6"></a><a id="Tc_jE90ktVZikCLeMhQNm-sig_15_0"></a><a id="Tc_EHvb5Mc2NEiq0_j3SjJOkQ_17_0"></a><a id="Tc_KvJEOcitbE2k50ZvRtY4rg_19_0"></a><a id="Tc_j017KGy6vE6AGjLEqxWeBQ_20_0"></a><a id="Tc_beZFWpzAKUyulqw54iW6ew_21_0"></a><a id="Tc_9nuhD6f_EUudtGs7SNeu8Q_22_0"></a><a id="Tc_rnMW_XMYtUesGja1_ArMKA_23_0"></a><a id="Tc_w8FOt9LXqEun7P3Y0jOe2Q_25_0"></a><a id="Tc_r-uhNbBgHkKjVBMNLQR3pg_27_0"></a><a id="Tc_AN_jkSHje0efFWXnV9dzyA_29_0"></a><a id="Tc_y_wwh2EPzkWVdpu8akKAxA_29_2"></a><a id="Tc_BCe3TCDflUaRPHh35TeSHg_29_5"></a><a id="Tc_eX_QfMhNT0SQ1wfWUcO4AA_29_8"></a><a id="Tc_Hul00Aq1BUCl1Jsgz6_DOA_31_0"></a><a id="Tc_bi_xEkc8CUy-GJA3WIqmtA_32_0"></a><a id="Tc_nNL-eCMkskKOc4fRwliTUg_32_2"></a><a id="Tc_mZle8ws_IUunn3_zPJ9L4g_32_5"></a><a id="Tc_jm_NUc-wpkStn1RzeR61BA_32_8"></a><a id="Tc_dQEW3BmkKUWdOUCEvE3eZg_33_0"></a><a id="Tc_YGS2vUE-J0yQNejpTppDSg_33_2"></a><a id="Tc_ZSAwc1BqIkKOaOXuunx6sQ_33_5"></a><a id="Tc_av6p_0T1IUyONJfRjML6Aw_33_8"></a><a id="Tc_LQAvebuhVU63wpf26l4TQw_35_0"></a><a id="Tc_sxaj4Y2BzkmvLO_3-Br5uQ_36_0"></a><a id="Tc_sK0a-qKCxEeVtIdsWpgYPw_37_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_FZvdbXZHuUqP6l0kb9ePog_4_3">1,150,981</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_M2Rh_HN56kWC3s8AIOj0AQ_4_6">1,074,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_2jJQ3dZHfEi766GFxeu_4w_4_9">963,875</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_BiahxntyeUCvk54r_NJyHg_5_3">631,882</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_xm1B1UKPbUOUT7FdPgJpEw_5_6">589,418</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_Scp1YrrfOUyrCneU1edkbw_5_9">562,698</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="Tc_HTzKuuPPAEWR_9i_lmbCTw_6_3">519,099</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="Tc_JnXD3krIg06si-InpwJJQw_6_6">485,333</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="Tc_CnnakW_k8kibQ4hJrj_DjA_6_9">401,177</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating expenses:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="Tc_TQDbJlmO30GA3KOHowRDNQ_9_3">342,525</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="Tc_MoU9ciSpJ0m8vvRz6WXNJw_9_6">335,690</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="Tc_tZnW6Y5Dp0GWsWHtOyrrSQ_9_9">297,724</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="Tc_I3gbnmcrvUSaqGub3OXw7Q_10_3">75,510</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="Tc_fEE9YOxuy0mK4wVl0UVP4g_10_6">71,247</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="Tc_3QQRaPYsH06ddTC9fWxxjg_10_9">57,537</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="Tc_yCaczoWaMk-CmZD87ISUiw_11_6">10,036</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="Tc_rqxwEn7Fy0CkLtF2HkF6dQ_11_9">18,684</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Impairment charges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="Tc_83sB3DBV40uwaXk4KayNIg_12_3">2,219</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="Tc_Sz3W0dAByECwonK1Ksfu_g_12_6">4,283</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="Tc_3WmaHzuBFk2BgWfKJ9WCHQ_12_9">36,504</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Contingent consideration expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" sign="-" scale="3" id="Tc_G8r5ZocvmU2tYfywJad8LQ_13_3">4,611</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" sign="-" scale="3" id="Tc_N99DBDH-JkedPtxyp9CMLg_13_6">3,161</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" scale="3" id="Tc_5klC-jvg9kaNcfeaiqnEUA_13_9">7,960</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Acquired in-process research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="3" id="Tc_UUxI1k1DIUGEBALZQUdLtA_14_3">6,671</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="3" id="Tc_mEru_xsTwkqMhIZvh6md-g_14_9">250</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="Tc_D3bQ0mdAF0qRjQIxo2ZZlg_15_3">431,536</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="Tc_TkRezI-xrESXorXFC-Ummg_15_6">424,417</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="Tc_DSvN8EZIu0Kt-L2v7BshSg_15_9">402,739</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (loss) from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc__XXHLZMwWUeIdmKz2xWpKQ_17_3">87,563</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_-vghc-0dX0S7bTI1ukhT_A_17_6">60,916</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="3" id="Tc_3xj2SnfrzUyUnFqZHpx8eQ_17_9">1,562</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other income (expense):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="3" id="Tc_K-Ojl_Jo50KtkKI1gtQHaQ_20_3">439</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="3" id="Tc_RJUswgAn7EOf88Eb3p5CDg_20_6">769</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="3" id="Tc_aaWFmWlmxEO_b7T1bkkvPg_20_9">604</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="Tc_72RTZhaGT02p3bSkAk70fg_21_3">6,339</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="Tc_CTJLuhTD4UGHBIeH7U6qHQ_21_6">5,261</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="Tc_8vu63HS7OkCKECvswwPKSQ_21_9">9,994</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other income (expense) &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="Tc_39_YmBycv0qkDC84wVRRLw_22_3">966</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" sign="-" scale="3" id="Tc_miFyDMwjUkaNdzvPymBUOw_22_6">2,507</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" sign="-" scale="3" id="Tc_S6wyhpxz8UeTSnQcYUWyUA_22_9">2,279</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total other expense &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="3" id="Tc_ZFCBK3WPLE-Uav-DsPKlIQ_23_3">4,934</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="3" id="Tc_NjCfz1tgg0mIS8I5qUbN5g_23_6">6,999</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="3" id="Tc_blaPruGRtE2JypZEoh1c3A_23_9">11,669</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income (loss) before income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_4qPR4H2fL0Kgl9EMThJkzg_25_3">82,629</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_CzYwS70h2E6p1f53gNz1jw_25_6">53,917</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" sign="-" scale="3" id="Tc_BdN-B5dxMEmQXS0hIBje_Q_25_9">13,231</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_frnWLcnMEkmZkYPktwFv3Q_27_3">8,113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_mLGehLkCCUmG0RKq071xlQ_27_6">5,463</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_dBQOsD9r50SYzLmzB0unCQ_27_9">3,388</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_Wpkx9GxQmk2NEos4ObeINg_29_3">74,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_6UP8pTWYb06mFxu_FVFCFg_29_6">48,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_IJlVJlDklUuzg0B1LV04ng_29_9">9,843</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Earnings (loss) per common share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Basic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_WSrC1q883Euw9EyuPhbX_Q_32_3">1.31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_NVcx_AeNUUyZT3Jv4jCy4w_32_6">0.86</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_SqUDLopadkqRgei1V4n7nw_32_9">0.18</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_U0Pe8C5Z5kGH6vqd9mpQ8A_33_3">1.29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_MG7CQ_3rMUWn1PGvlsS1XQ_33_6">0.84</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" sign="-" scale="0" id="Tc_YiDqHLRJoUCYLa5Mv0fxvQ_33_9">0.18</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Basic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_A60ulvhEnkKbFPqJXIEkAg_36_3">56,806</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_8F_Gzy2XhE65UOqUiODjDg_36_6">56,145</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_nEd9kvwjG0W1ipELQWr3Zw_36_9">55,434</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_WWOISGrY50Sb06_vjT9Hcw_37_3">57,671</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_ViH2rahetk2P5TiARqzoGw_37_6">57,359</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_K-jLFtPiBE-aL3DJIw54jw_37_9">55,434</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">See notes to consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">55</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ba155b85_acb3_4ed0_920d_e12d13e970a6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</p><a id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">(In thousands)</p><a id="_22e5bbd4_a1ae_496a_9833_f20cc1be72b9"></a><a id="Tc_TUZj50OeLUWoytLnclxAjA_1_2"></a><a id="Tc_2tsYaseV20-CiP4Yle1DRw_1_5"></a><a id="Tc_lGjXfpCcb0i-HcuNlGagvg_1_8"></a><a id="Tc_pPQ6tJ_g20GsN2LN6T65TQ_2_0"></a><a id="Tc_LxnWZ0Dq7kWjl8emgOf8jQ_2_2"></a><a id="Tc_Swpdn-zcH0-xaKO6XaCBzQ_2_5"></a><a id="Tc_oqAZfAQVXEiHGYbwKsHaqQ_2_8"></a><a id="Tc_GQelC6frjkOAybiNl6M5Xg_3_0"></a><a id="Tc_uSHsqmzwwkmR2UAunA2yNA_4_0"></a><a id="Tc_4054FFzk1kyk7qwmtscPCg_5_0"></a><a id="Tc_j5v37nOIN0mUZ4gqRXwhEA_6_0"></a><a id="Tc_TpykxFlJnUKjpdYw4SyzKg_7_0"></a><a id="Tc_GwHIUdGitUac2gjd7Ji-Ww_8_0"></a><a id="Tc_ICPyuSB38UeKZi92C1geyg_9_0"></a><a id="Tc_ha-GogfgwkGbtZ9muMfJ4Q_9_2"></a><a id="Tc_XlZnqVyUO0K7uyw7KjbRRQ_9_5"></a><a id="Tc__FIUb_ry8kq6biQvi-BGmg_9_8"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_N1Pb9CGzEEGeGL_XFdQ3hQ_2_3">74,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_6Lp2-t8O4kea7zR2_B6L2w_2_6">48,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_ixXqY3RBPUGXVmviRi_IXg_2_9">9,843</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other comprehensive income (loss):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash flow hedges</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="Tc_Jb-aiDoAgk6tole7yaa2dw_4_3">9,007</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="Tc_-cehm6SfdkKIWOwDtOZ2OQ_4_6">5,965</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" sign="-" scale="3" id="Tc_m_y3NCzeukKZeOlqDr9PMQ_4_9">9,523</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Income tax benefit (expense)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="Tc_hCx0B304PkSp2xmtqWkEFQ_5_3">2,177</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="Tc_Z7uwmI_vgkmiO_1jsNvCvg_5_6">1,489</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" sign="-" scale="3" id="Tc_qsEmkQRQAEmkf97TUVCHdw_5_9">2,365</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign currency translation adjustment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" sign="-" scale="3" id="Tc_b9UUnGXrC0qqMF6njQtIQQ_6_3">10,491</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" sign="-" scale="3" id="Tc_94Ug_59-bkOa-JB_FkoPHg_6_6">7,704</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="3" id="Tc_BU_u2PwDyke5OhtpSFvxDg_6_9">7,786</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Income tax benefit (expense)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" sign="-" scale="3" id="Tc_urKWVbKXikyGEZ6CzY76Xg_7_3">102</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" sign="-" scale="3" id="Tc_ia3FMMzwOE2zG73ED4LwOw_7_6">689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="3" id="Tc_pZIh0oQ7mkyiVICWSFaHVA_7_9">786</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_f_Oxv1lNwkSo_8q9gWDMDA_8_3">3,559</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_gpK3esns3UW9jncAIspYIg_8_6">2,539</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_CpGuuWtAXEW_EvLDJeA_fw_8_9">158</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="Tc_9EaOgnLdYk-kkQnlr2FIqQ_9_3">70,957</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="Tc_v-KEwO6_OE25-HzDgu3XWg_9_6">45,915</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="3" id="Tc_MPWuElGl2kCvYRxR3KSGZQ_9_9">10,001</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">See notes to consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">56</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_652aa10a_348a_46ea_abd3_71a1ff7267b3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</b></p><a id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUI"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(In thousands)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_494ed95e_5e35_4099_90b4_cbd6c0dca183"></a><a id="Tc_dgeSQAK6_0GWRlemincZ2w_1_2"></a><a id="Tc_5WQR6LnfyEajmJvHxrckFg_1_7"></a><a id="Tc_cFQLcIDy-ECH1RFwZsmsKA_1_10"></a><a id="Tc_-6fT4UzXpkuqqESZoXxJHQ_2_2"></a><a id="Tc_WPZ2hoRooE-_X17nLyPiCQ_2_4"></a><a id="Tc_Qq_1ipVY_0C5zxk4X8ke4g_2_7"></a><a id="Tc__rAHix2CVkSw4TnT9u5OnA_2_10"></a><a id="Tc_3bmjPqYx_06k6thsyyV00Q_2_13"></a><a id="Tc_6JAyPfYPKU-fuNynL9JBoA_3_0"></a><a id="Tc_iXrcQYU6hEimYihmkvaHHA_3_4"></a><a id="Tc_m_3vNpqN8kaWAnlxLV-URw_3_7"></a><a id="Tc_EfxDvO0Sp021E5ma-TG2Yg_3_10"></a><a id="Tc_9IeyFqByYkeywo3OlzjZiA_3_13"></a><a id="Tc_RMP9Q7DBOkaviFUSRKUCCw_4_0"></a><a id="Tc_6qmGFOwju060jQaPb61eBg_5_0"></a><a id="Tc_mFBqcjq_yke-mh-uSZfnPA_6_0"></a><a id="Tc_PbbbwPxjSEOGLRCblt8k5Q_7_0"></a><a id="Tc_N2kTMrblkkKOnNAGRC9UmA_8_0"></a><a id="Tc_qi9p7OzuBkyULEbtt2tMWA_9_0"></a><a id="Tc_su6arYgvIUyOF6Ikc0qiEw_10_0"></a><a id="Tc_BVz3AvOmfkKzTMWn-0g5xA_11_0"></a><a id="Tc_N9SZ0Hps3k6sgv0gr4kBqg_12_0"></a><a id="Tc_FzS9FLKx4k6UVVvleLwtxg_13_0"></a><a id="Tc_C-PDf8sD2kaMf6c4gwRo-A_14_0"></a><a id="Tc_wcmedUO2FEWcmgfKnnDFrA_15_0"></a><a id="Tc_-igjO8hkm0eaSbLxcbmvZA_16_0"></a><a id="Tc_C1rd9NonLEOovyGhokmT4g_17_0"></a><a id="Tc_yiHtFpaZBU2Pwu_PlUyVVA_18_0"></a><a id="Tc_SW7uOp9vG0yX0SNmyOEJRg_18_5"></a><a id="Tc_QxlTjUztrE23ThnC0U4Rmw_18_14"></a><a id="Tc_dTI4y8cM0kWUUKZIZU7VJA_19_0"></a><a id="Tc_Ey8u_DTfIE-Js6tRBJ7G4Q_20_0"></a><a id="Tc_55fkl3tRtUaIDtbzfbRnwA_21_0"></a><a id="Tc_22knw8LUYk-Xc3yxA31T7Q_22_0"></a><a id="Tc_RbxzEk9SDU-t1BrT9JIfNw_23_0"></a><a id="Tc_rnwKI8-uSU6Vlw6Tv9zsWw_24_0"></a><a id="Tc_osOVGcVDTkO104HU9X5D2A_25_0"></a><a id="Tc_zKOCZdoLEEexjS6jvmGXfw_26_0"></a><a id="Tc_dMK-b6troUa2sQbu4kD13w_27_0"></a><a id="Tc_xHhuR1RHZEGIURheEdKafw_27_5"></a><a id="Tc_n7hP1oEty0aoQ4O_mBmVeA_27_14"></a><a id="Tc_82UKQ88C206gUk6KIh7GhQ_28_0"></a><a id="Tc_-bPKOCBxyUyE6HFPFlt5JQ_29_0"></a><a id="Tc_LD7jWIHpHUOTct1kqTsFDA_30_0"></a><a id="Tc_-ffumro8vkuh4Wk5c7g6Mw_30_4"></a><a id="Tc_2XPn2LmzPUaYP6vZAy7TmQ_30_7"></a><a id="Tc_93SiIx0wK0e_jRtXfbVvvg_30_10"></a><a id="Tc_ahHYWJxA_U6TTbhx6MCKjA_30_13"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:17.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Common&#160;Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated&#160;Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Comprehensive Income (Loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">BALANCE &#8212; January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e03sqdjmAUSi1TluISkF4w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="Tc_vNHkK7HwW061U8a4LV7M0Q_3_2">55,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e03sqdjmAUSi1TluISkF4w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_pFPKv3BoOky_VdOto2cP2Q_3_5">587,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_G-kv3r9YKUyaVq6iMWD8VQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_D-D6UNWs_Uup7ZCB2iTO6g_3_8">368,221</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_N2nptxswq06E37WY0fAdLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_fy-n7ciTlEOlqTfPW4VntA_3_11">5,294</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_UylojrW3ZkerU7tjWM92pA_3_14">949,944</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QnNOgXob5EeqCbUSSdW6NQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_qyzDAsLN6EiWvhRBNYumDA_4_8">9,843</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_dkYlehu9dkO_8RSzREqUqw_4_14">9,843</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cumulative effect adjustment upon adoption of ASU 2016-13, <i style="font-style:italic;">Credit Losses</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gK8hNbA-mU2xGdCtF3REPw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_vj9wX0DDtkugfT492Qy7WA_5_8">575</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_0Wxh9uRER0u6z2OziPvL-g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_qisdpHKvEkCl1024OXBI8g_5_14">575</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_iuS578-mekKkip4_rtcKYA_6_11">158</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_8dAhohrgJ0uxJR9z5eOYIQ_6_14">158</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_zSX_yid3u0SsiB6aSV5mpw_7_5">13,433</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_IMUPRlFLmkmpzKU6pRJwcA_7_14">13,433</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_hMwA5pGVDkSozuo2KaXLPg_8_2">442</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_rnl7enQ4fU6Fg1BH3FQt5Q_8_5">6,948</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_udQsimzY7k-s52CrE0cKRA_8_14">6,948</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Issuance of common stock under Employee Stock Purchase Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="Tc_AgAMnAyQz0uiq8_OXlAZfQ_9_2">30</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="Tc_hqUQGc_acUy4OQon0Qooog_9_5">1,159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="Tc_7LrvZYn1dkmvDSDyaKNxVA_9_14">1,159</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares surrendered in exchange for payment of payroll tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_A_qnxQTGq0yc3mE24SqK3A_10_2">23</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_MWkUA_CAMk-AquJADLrY2A_10_5">866</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_ZlnlgphBIUaWunO5gi4ZDg_10_14">866</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares surrendered in exchange for exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_jEqJu0FpD0CF_yHJD7VTQg_11_2">39</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_XVpP3jzJ20agklcTV2zFww_11_5">1,467</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_7fy6PIJcZUabB-vXIi5MNQ_11_14">1,467</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">BALANCE &#8212; December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_iWQuWEDGp0W1mLQsaz5M_g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="Tc_0-FmeCeI20C-fcOTrv9ZHg_12_2">55,623</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_iWQuWEDGp0W1mLQsaz5M_g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_lnkQy3KOd028RA1SOcJdgA_12_5">606,224</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGIvY-Wghke_ETbCqrVrlA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_PaUCMl54TEqydN4pzfaTgA_12_8">357,803</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3aRiaMEyxkWBqtSJEkrr9g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_dbRlCMtkpEet8ZChqyM6Vg_12_11">5,452</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_c9gulu64a0azS_GANUwenw_12_14">958,575</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_e0_SslW0xEmjVG9Y4QH58Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_Yrgd5jkbNEqtkyvDHbcgeg_13_8">48,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_2nnboQ9xM0KaPdu-ST-X4w_13_14">48,454</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_2XAOzBu4eEmmTUaRgA-j8w_14_11">2,539</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_OcyMMjSAuk-366kCeOLsug_14_14">2,539</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_2sUwdqjaQUa7U3k1cQ1RxQ_15_5">14,579</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_uPqBAzxOnkK6a5jwb0h7wA_15_14">14,579</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_2jBsS5verUmwBat9Vbmszw_16_2">883</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_X7BXxb7pbECfsxfRfFQeqw_16_5">20,374</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_Ful7iBJhD0O56PNFaItdhQ_16_14">20,374</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Issuance of common stock under Employee Stock Purchase Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="Tc_c3sObtSguEmWNIQxPrWeAA_17_2">18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="Tc_RH8h0F5BLUiXhgFPqEepLg_17_5">1,112</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="Tc_6TwjWi1CbECEoyCrVNgbcw_17_14">1,112</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares issued from time-vested restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="Tc_Zyfp7YSCuECBzZVrZ--smQ_18_2">59</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares surrendered in exchange for payment of payroll tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_qEdkJ8qYTEWjFWnNb4uaWw_19_2">10</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_Op6Ikt6y0EaxXlIHVN67NA_19_5">576</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_xWoJO-Glb0W4awsK3izDrg_19_14">576</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares surrendered in exchange for exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_npa0lIkFqUiVpAor6dFm-A_20_2">3</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_h4Many8CIUmhpkPwtTKdEQ_20_5">180</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_V-W8_1bXqEmJ_7_yvYo2eA_20_14">180</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">BALANCE &#8212; December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e1glezOlAEmHZyfzYLhmhA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="Tc_WJh-91popE2rwVeEteyftw_21_2">56,570</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e1glezOlAEmHZyfzYLhmhA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_OlEIwlmhskWEsHLYcZnarQ_21_5">641,533</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_4hpPQW9-gkirQ7OHsm1waA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_wEh_7OyUe0WwbkMY6OI0sA_21_8">406,257</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_aN4IaMh0wkmaWTjP49uYEQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_gsHQ5QbO7EqEzln2P_9WVw_21_11">7,991</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_Sf5u0Gai8EaplEIUqPFEeQ_21_14">1,039,799</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Net income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_smMsnEfusEi6-EuzPWs_CQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_PW1RXP6UFUmKm5Wy0TuznQ_22_8">74,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_kHTodCTbQkuVsk-GNuMmyQ_22_14">74,516</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_dJu5OjPbw0OyCJMVQo9WWA_23_11">3,559</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" sign="-" scale="3" id="Tc_pfne92Rsz0-iGsXs72wXVQ_23_14">3,559</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc_7Tb0kF4BwEiEaIWZ3aQeSw_24_5">16,045</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="Tc___CMTeUPJ0e9ZgYC3swC7A_24_14">16,045</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_9w3-TU5G0U2Lki3paV_LMg_25_2">703</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_aHf05jGdt0eKv9H0vQ228A_25_5">20,092</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_Xb4SptV-C06tiuy85ZC1ig_25_14">20,092</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Issuance of common stock under Employee Stock Purchase Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="Tc_4OMvYcd1SUuTwCs3BPF2lQ_26_2">19</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="Tc_8zlEpp5F2EG8SUi61_Ojkw_26_5">1,118</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="Tc_4qIVzhxPn0uV3MvXcuXKYQ_26_14">1,118</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares issued from time-vested restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="Tc_rAJi-dgeEUW69k0tEB3Wwg_27_2">70</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares surrendered in exchange for payment of payroll tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_cnS4WmNln06UnpH7aomhug_28_2">38</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_lZvyh3W8tEqCdbJTiigu8A_28_5">2,474</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" scale="3" id="Tc_Qd9JGaaVWUOr5e3uuNyxwg_28_14">2,474</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shares surrendered in exchange for exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_7-ZIlLUP10m61k6TXefrsQ_29_2">18</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_0hD8Dk1hIk6KF9aMmHk6Fw_29_5">1,140</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_tN2mee0kyUuWnk_csHHNuQ_29_14">1,140</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">BALANCE &#8212; December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_jemfLXarqUS_VyGv8WDThA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="Tc_axei0-OOnEWwFtgdH2_RBQ_30_2">57,306</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_jemfLXarqUS_VyGv8WDThA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_lIE5HWFxaUitFYqkE2N1Yg_30_5">675,174</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gSVl3EPpKEKYTN8MPw6Tkg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_GdUy2ykPcUqrZtN2rAvBPw_30_8">480,773</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_KA5J2PovC0-VQ20gGn884Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_aeeVWlDNUkK51UDVcPCc7g_30_11">11,550</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_GutcmxRru0uQu2B1YJM5Yw_30_14">1,144,397</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 2pt 0pt;">See notes to consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">57</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_04979174_9850_4f1b_8bfe_89e0fdc206a8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</b></p><a id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS_863485"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(In thousands)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_4a182779_2918_4066_ae3e_c090cc1bc6c0"></a><a id="Tc_cSw4Y9zq6ke7-9Ny7FdnOQ_1_2"></a><a id="Tc_NZT8IIDfgkCMuYwCHJoqXA_1_5"></a><a id="Tc_SmC14LjAzUShfjyu4A1uBA_1_8"></a><a id="Tc_V-dMI0fzWEK1yvnmHBoB4Q_2_0"></a><a id="Tc_EXoljVhrQkqllYuVYhnUnw_3_0"></a><a id="Tc_vYDK8vDjh0uZ7MJ91NteKg_3_2"></a><a id="Tc_p4K1MIXeu0Sb9DjKL6BAmw_3_5"></a><a id="Tc_NjCLP8dn70mTn62-UDpUKg_3_8"></a><a id="Tc_6nKhWKn8pEKVd_3XqxCNLQ_4_0"></a><a id="Tc_Ts1taj4wqk23dQJ0tl7QWw_5_0"></a><a id="Tc_S6-S4vbSJ0iQ_4CWlAx3-g_6_0"></a><a id="Tc_6fbovHoe5ECXIJDC9ItcNQ_6_6"></a><a id="Tc_1UXIbmO3nkasV42ZlLdhoQ_7_0"></a><a id="Tc_pMS_ZMTLdEq1-FIkRFErhQ_8_0"></a><a id="Tc_Ejr4G6UcjE2GWFI06D1zWA_9_0"></a><a id="Tc_L6ip5vvjLEaWaji0DHDm2w_9_6"></a><a id="Tc_LaeHRE3k2USO8u6_pl9zSw_10_0"></a><a id="Tc_hn1JlFtSuke7TjKEekKENw_11_0"></a><a id="Tc_BR0neZ6uGEiFPcGkFhcjmA_12_0"></a><a id="Tc_jL-wPF_6Q0y-h10ejDS5iQ_13_0"></a><a id="Tc_8RKDe1KH4k2EgYew6J5sNA_14_0"></a><a id="Tc_VEzQrJyRP063sq56KT_YvA_15_0"></a><a id="Tc_N-R85Ce1_U2cSc4595n3wA_16_0"></a><a id="Tc_OUxeVhQheEyfXs9nOSrCwg_17_0"></a><a id="Tc_KwOEvPJsN0yYRje9jRuAtQ_18_0"></a><a id="Tc_sGyulCn4fEefGg9esQ0bXA_19_0"></a><a id="Tc_7ZRlDTOX60GXtGMXpdHTFg_20_0"></a><a id="Tc_ReXLK7AeYUCgl7NpdGi4XQ_21_0"></a><a id="Tc_2j06of4cu0-vfwTu1MRWGw_22_0"></a><a id="Tc_nzvWxas3kk2nBhQvqkeUWQ_23_0"></a><a id="Tc_piTtnwU9-EmkbI9qlr_lOw_24_0"></a><a id="Tc_Uz7PQCZcTUeThdItNdBwUg_25_0"></a><a id="Tc_Wic5VNqZRUOe34ttu1Mx8w_26_0"></a><a id="Tc_9zNtDgW3DkecmboHZtLZLw_27_0"></a><a id="Tc_G5fZhMX4WUef_Ba7ccQLTw_28_0"></a><a id="Tc_gSDc91EtvUCH4y_9_IsGAA_29_0"></a><a id="Tc_eDr4zvGEdUyKGQlHM3dOXQ_30_0"></a><a id="Tc_-jEO1xclOkyE42y8M8eGxA_31_0"></a><a id="Tc_rZ0ArmNubUKVX6eSD0qB7w_32_0"></a><a id="Tc_uOBNkPs4oEGoXZRujnXsXg_34_0"></a><a id="Tc_JFU5ba-2Ck6qXA_hMOaXXQ_35_0"></a><a id="Tc_SfrYJ9uWJ06UD5riNA9IfA_36_0"></a><a id="Tc_zGJNWkCNy0Sf-cTDs9WQGw_37_0"></a><a id="Tc_MjKX7unUBkGNcyC2gJ1GnA_38_0"></a><a id="Tc_phySVRyimEeZT20Tv2aNGQ_39_0"></a><a id="Tc_Qxx3iQTK8EG-Tiv7r36tDQ_39_6"></a><a id="Tc__BQd8Qw1u0qdiWXy7k2WaA_40_0"></a><a id="Tc_C5o1MteIRkWwhntpdmFyQA_40_3"></a><a id="Tc_KFlN3_irQkSz2je8EOHBvw_41_0"></a><a id="Tc_91xT-SpycE--KiU3W7SnGw_41_3"></a><a id="Tc_p6T31002KkWGza9dltyILA_41_9"></a><a id="Tc_n_4CiSSwiU-KzqisQclV7g_42_0"></a><a id="Tc_SCX2725fvE-eknI0h5yGsA_43_0"></a><a id="Tc_8_zT9zw9SkyRuA7KliI_xg_43_2"></a><a id="Tc_wlp5oc8MiUC8StUCVR3vYg_43_5"></a><a id="Tc_40P3KXf0XEGO2u0lP2bIvw_43_8"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">CASH FLOWS FROM OPERATING ACTIVITIES:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_R4UHMkl5PUOOrxMLfbkvxg_3_3">74,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_RGg3WRVOiU-dpFZ0KKIXmQ_3_6">48,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_5J13lb5pykK1600nEHXYtg_3_9">9,843</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_JLT0ZipBHUKEF70f6oNC8A_5_3">81,804</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_ejjoHShP0Umz5vg7412SVA_5_6">84,066</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_6JNyMNxOP02o_IRS6MBTXA_5_9">94,070</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Loss (gain) on disposition of business</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" sign="-" scale="3" id="Tc_wVv-095c_0e0piUrkjRkqA_6_3">1,417</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="Tc_pVA7W69WBUGBnnwuqNuvGQ_6_9">517</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Loss on sale or abandonment of property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" sign="-" scale="3" id="Tc_g3BhD185gUSvpBgKZTSiJA_7_3">380</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" sign="-" scale="3" id="Tc_wS17lgwgskmLtdnms13ttw_7_6">1,303</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" sign="-" scale="3" id="Tc_JTwjw11i-0u2LwfHim_VnA_7_9">2,159</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Write-off of certain intangible assets and other long-term assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="Tc_urlGgg5QkkiZC1vqGrLFCg_8_3">2,281</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="Tc_sa3fpkox5k6DeMhNkDotqg_8_6">4,412</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="Tc_xShyTKL_DkW7hWNiX05h9A_8_9">36,609</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Acquired in-process research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="3" id="Tc_mdZQK5Z7k0aR_dy9TsgivQ_9_3">6,671</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="3" id="Tc_n7rv4l1atk2GB-kdU_146Q_9_9">250</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Amortization of right-of-use operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="Tc_4opHVMn5xkOFga0uS5gvcg_10_3">10,394</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="Tc_Q5CQ9hAaZ0e_Cu7aL4HM1Q_10_6">11,718</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="Tc_r00kNT5Cv0COPSoIFx0wmw_10_9">12,746</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Adjustments related to contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="Tc_lyD7-6p7vE2Ga78vCtGXAA_11_3">4,611</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="Tc_FeTJ4PwLuEaji4kSAIS4hQ_11_6">3,161</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" sign="-" scale="3" id="Tc_02Q_TI04RUaueYgyK5TJ9w_11_9">7,960</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Amortization of deferred credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="Tc_ni0Ub9JMTEm5ILXZ49nw0A_12_3">107</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="Tc_BM3a_RvNWki39OSdMoUpuA_12_6">108</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="Tc_cfqAsE7jR06JQOYaruralA_12_9">130</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Amortization of long-term debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="Tc_jMnXKqEZ60uU7s1g0zMcPQ_13_3">604</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="Tc_l0-cDawcQ02XSL1s_ovrZg_13_6">604</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="Tc_SahanZ8ya0yirQZM3eknBg_13_9">604</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Deferred income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_9qAaT9ZAy0KEFZqgweBtGA_14_3">14,924</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_M0ejBN6d9UCt91JkgIfaqw_14_6">4,631</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_95PuESD3N0OmQoeofrE7fg_14_9">11,295</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="Tc_4fCpY5n4QUCUz4_qpRPIFA_15_3">18,042</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="Tc_fNeLlTDqCE6lsILlTc3ziA_15_6">16,090</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="Tc_RzZvWotfkEiPRBUNhzxjuA_15_9">14,339</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Changes in operating assets and liabilities, net of acquisitions and divestitures:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="Tc_z0_SZ_W_1Um1ER5wVMF8OA_17_3">15,116</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="Tc_ukJpH-ToqEiG4FjUwpQHsg_17_6">8,618</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" sign="-" scale="3" id="Tc_PJ5ddURe00u8SInigDD8Mg_17_9">10,425</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" sign="-" scale="3" id="Tc_rfFbLBjgtECAoVnLNATDsg_18_3">4,154</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="Tc_6X52VFvAXUyptLwV8zskRw_18_6">10,418</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" sign="-" scale="3" id="Tc_qaZbW7wBFUmQlaswlAgrig_18_9">1,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="Tc_o78Ca6SLeUWNk-Jv4qFHWg_19_3">47,929</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="Tc_nqou5RJv-EmoNZdWLlf9yA_19_6">25,183</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" sign="-" scale="3" id="Tc_vARBtHbpGEiq_jOR_xM--g_19_9">29,429</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="Tc_hwT5u2zloUiT0nmEp9tAZQ_20_3">1,798</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="Tc_lo9kVrcb10SXPglqrWDOMQ_20_6">3,555</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="Tc_TYyjIb-ID02Yl0UDy-l9EA_20_9">446</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Prepaid income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="Tc_fKGLqFTiDUyZEyxgSyKYlQ_21_3">379</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" sign="-" scale="3" id="Tc_UO9330NbV0G7PhnnXpFrRQ_21_6">125</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="Tc_Rb1prcRaiEK-imQZCiFq8A_21_9">162</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Income tax refund receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" sign="-" scale="3" id="Tc_9-de5bbwKUWmxyvyZlmvwg_22_3">1,952</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" sign="-" scale="3" id="Tc_M4aLAoT7eUy6EJAYQdiesA_22_6">739</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="Tc_tzeOwVgKV0edmTiw8Dtb6Q_22_9">339</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" sign="-" scale="3" id="Tc_Wwi0Shg8V0KFanCjlP6lng_23_3">657</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="Tc_bQ201Ac91kSmIj28NFdA1w_23_6">1,670</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="Tc_Fg_8pHQOeEWp2tuoffSHVw_23_9">3,511</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="Tc_21asuyRuUUqu4_QuTAcgvw_24_3">12,661</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="Tc_wTLy9qYom0KSdVrzpvFCDw_24_6">6,050</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="Tc_duKnBcX1JU2CqN1HBQHSTg_24_9">333</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" sign="-" scale="3" id="Tc_ws6_jEej5E6F86ucFFpG5g_25_3">16,379</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="Tc_I7xqhlZs8UKCUyTbdLYTmw_25_6">36,462</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="Tc_S9kv6joIpUuPs2HOAsWB3w_25_9">4,603</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Income taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="Tc_lSHQgUiOLkGSvm95eSxoVA_26_3">4,521</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" sign="-" scale="3" id="Tc__fiVGpqWr0mcxLuGG4ih-A_26_6">119</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" sign="-" scale="3" id="Tc_ROr-yZtoRkuzpIt6Kvi5eg_26_9">86</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Liabilities related to unrecognized tax benefits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions" sign="-" scale="3" id="Tc_86_z-kvvLUuWy8ka7d8dcw_27_3">45</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions" scale="3" id="Tc_ZvxP5qK77k6kGWW-VFF7wA_27_6">314</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions" sign="-" scale="3" id="Tc_kpWFXo8gJECmiJTfqvJjDw_27_9">576</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Deferred compensation payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredCompensation" sign="-" scale="3" id="Tc_LYBJFL4QBUCq6w-eLaZ9KA_28_3">2,848</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="Tc_B7RQw1XLsEyuKqkapAoNkA_28_6">1,303</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="Tc_W0H0gznkUkWA9M2RaFDyvg_28_9">1,953</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" sign="-" scale="3" id="Tc_8BrCRkB7y0S7Dqqm9uEP0Q_29_3">11,127</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" sign="-" scale="3" id="Tc_6l-3sJGXmk6sWyyf1kmIyA_29_6">12,410</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" sign="-" scale="3" id="Tc_AUkGJDl1g0C8mBs0x-4MBg_29_9">12,659</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="Tc_MYWezI7tw0K-4GdHb-CWgA_30_3">278</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" sign="-" scale="3" id="Tc_KA9ysdU8HEuY34MHLqjq6Q_30_6">858</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="Tc_kU_OtQe0iU2mGy60PIAJCw_30_9">3,606</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Total adjustments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_ROPXztxEBkOb7tYNuSaBtQ_31_3">39,775</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_o6oIuw8S_U6cWY78eihU3Q_31_6">98,777</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_L45MZ4QeTUORjzYeS5EE6w_31_9">175,113</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net cash, cash equivalents, and restricted cash provided by operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_X593VyLeG0CuG6JNu0jbQA_32_3">114,291</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_Qhlk5yzaKUem9ydWsztzrw_32_6">147,231</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="Tc_N6l71Az7PE6_6QXmjq0ViA_32_9">165,270</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">CASH FLOWS FROM INVESTING ACTIVITIES:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Capital expenditures for:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_Slmpfet0-0CI8Zr0Ce9t1Q_36_3">45,029</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_ZbknVG-iLUykRmrr8Ron-A_36_6">27,939</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_gXUaAXiGUU2XftSd3boDaQ_36_9">45,988</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="Tc_5DyAc3Eae0alF6ujywF6KQ_37_3">3,175</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="Tc_YLOMVYQzyU-FgzLQfmQJJg_37_6">2,834</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="Tc_1UMfBkPHAE67I_645rqsLg_37_9">3,288</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds from the sale of property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="Tc_Hs0ZBisuQE-Y2LSw-q3vUA_38_3">65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="Tc_dnTzEzjGJkij1xD8OkgmNw_38_6">1,037</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="Tc_nQlwK12hNUi8lzfIiEvrRA_38_9">42</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds (payments) from disposition of business</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" sign="-" scale="3" id="Tc_Up3blAHGM0-yH6WHmlNf_w_39_3">971</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="3" id="Tc_sSQ0gv5PSkCDBFX7v49vIA_39_9">1,285</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cash received for settlement of note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="3" id="Tc_R5WGSSG3bkSYon_Kfp3HvQ_40_6">2,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="3" id="Tc_DtuIOrr2DUCPTivUMk74zw_40_9">250</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issuance of note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="Tc_JZ6AsWs3g06CPNFndkKdcg_41_6">2,254</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cash paid in acquisitions, net of cash acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="Tc_CkF5y5hHDEOEKNSQnxk7Gw_42_3">8,287</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="Tc_WCipkP_1xkyOOISHg_VxMw_42_6">7,171</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="Tc_qgJZ02J8CU6EnVbt4oEJGQ_42_9">10,953</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net cash, cash equivalents, and restricted cash used in investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="3" id="Tc_jdTjx5H3TESltphzYh14CA_43_3">57,397</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="3" id="Tc_WVht8mi_A0qCYrEpD07ENg_43_6">37,161</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="3" id="Tc_qIOxqu1Fa0CXjs2upJce9w_43_9">58,652</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-size:6pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">See notes to consolidated financial statements.</p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(continued)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">58</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(In thousands)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_c3f9fb24_575e_4d07_9d35_29f48ae3b4e3"></a><a id="Tc_s8S3uuGxjEm7NHd2hjewhQ_1_2"></a><a id="Tc_xaDDPQ9ds0qpG9cKshr5cA_1_5"></a><a id="Tc_fxGH8yg4f06MVL6oIpjO7g_1_8"></a><a id="Tc_GrYgzh5tdU2CQWY80YsRBQ_2_0"></a><a id="Tc_2Rb5dlcjRECz129WBCN0SA_3_0"></a><a id="Tc_IU23V6kPqEudXS3ZVr_U6w_3_2"></a><a id="Tc_Zyg4TbVIrkKR7kLfes17Hg_3_5"></a><a id="Tc_SAehnZA-a0WWnwYyUxTyPQ_3_8"></a><a id="Tc_uTpa8S4TtESb1jYCEnGx6g_4_0"></a><a id="Tc_Zu0jiZ1em0Wa2JWgyB0dtQ_5_0"></a><a id="Tc_-_uf6gbNRU2KNJIErBLelA_6_0"></a><a id="Tc__qSY2LyJ9kux1_PnAmh1jw_7_0"></a><a id="Tc_-6xsj6T_X0yMALbbPfFg4A_8_0"></a><a id="Tc_x3jmuPHnwk6lcG-05MZmsQ_9_0"></a><a id="Tc_wuiOQXhxmUa6mFZ-hh_SiA_10_0"></a><a id="Tc_HvtIUA1sYEuiCMFkiNg57A_12_0"></a><a id="Tc_Qbhspsz_gUiEfyl0lz3GRQ_13_0"></a><a id="Tc_xSKsNeIE9kes6YAHWT2zOA_14_0"></a><a id="Tc_gEUd2hJZqk-V9S4MMl3dsA_14_2"></a><a id="Tc_BNjLZFcpCUK_mprZ_p_lGg_14_5"></a><a id="Tc_55Fzp7Ubak2Yu8Fs92o2hg_14_8"></a><a id="Tc_XimH9KmyOkSh1E1KNujWjQ_16_0"></a><a id="Tc_BBakVupKPUmrCIcxTvK9lw_17_0"></a><a id="Tc_nB_FLwFbt0qv_YQqYOfiHw_18_6"></a><a id="Tc_ImXGJbCDtUCtpIA2iDbtkw_18_9"></a><a id="Tc_-AZl_5yTWE6gT5cPnKPt7w_19_0"></a><a id="Tc_eIDncmhCVU2cxFvte_Ssuw_19_2"></a><a id="Tc_Ga5__L8TQEqjCiJ0wrSh9Q_19_5"></a><a id="Tc_hVKJ8sG8TUm-JJcgeF0iHA_19_8"></a><a id="Tc_ygyWbSWEg0Gjm4YLcBJFEw_21_0"></a><a id="Tc_WEx73Rwb1USy5eEyOUw-Zw_22_0"></a><a id="Tc_SaroOY9ANk-d5rrwFEc4PQ_23_0"></a><a id="Tc_Ytb30PpXSUOewWAC93i0Vg_23_2"></a><a id="Tc_zfPOgWCJgUuXJrC0rivYHQ_23_5"></a><a id="Tc_caq8oJoOjE2SkDD_QnjxDA_23_8"></a><a id="Tc_a0vZlH2OV0SDJ2gIbVve8A_24_0"></a><a id="Tc_u5vEjSqmmEeBzlOCbchVxQ_26_0"></a><a id="Tc_6pJCgagLokqsRvyzhT25tQ_27_0"></a><a id="Tc_17QDesRbiEahi650ZWDoqg_27_2"></a><a id="Tc_Tof5kaxXR02eA49Iz_4lXw_27_5"></a><a id="Tc_z_v49f5piEWeldnAmGOP4g_27_8"></a><a id="Tc_HYCb2I2Qd0ifTdqf7u-ZIA_28_0"></a><a id="Tc_OmtZXFiCg02VfC4ceWvnWA_28_3"></a><a id="Tc_RIAeKwcOl061WSrTBuTS9g_28_6"></a><a id="Tc_RGNBKZr4TE6nhteUm7ueUQ_29_0"></a><a id="Tc_2MtCCYrSQkiIfyAEp4APsQ_29_3"></a><a id="Tc_jYiMB4spg06C1pQ9hMapiA_29_6"></a><a id="Tc_TDOGsYxrTUiyggfdV9FkPw_30_0"></a><a id="Tc__znLiLawO0iRaUAMkGZM6Q_30_6"></a><a id="Tc_6GPJlas710aJiE5jU7AsyA_31_0"></a><a id="Tc_9Z_YInYL_0eLN0VXQjzeLQ_32_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CASH FLOWS FROM FINANCING ACTIVITIES:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from issuance of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="Tc_r2ZUgstTA0-nqB-WejPZMw_3_3">20,070</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="Tc_ASL6oRD-qUWzId8toHGOtg_3_6">21,306</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="Tc_ZFHE06Z8t0ujEs9zAJwbrg_3_9">6,635</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from issuance of long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="Tc_nWU1gjS1LEOD_ypsWSnw2w_4_3">215,205</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="Tc_wp9iNuNoVU2Ury0_7pTAEQ_4_6">98,421</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="Tc_aRRYCF9mmUWe7zr4HSlZDw_4_9">68,625</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Payments on long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="Tc_tb9Vrddi50W4NGFIDJ3e8g_5_3">260,143</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="Tc_yVg__szaikicmyLGG5RL8Q_5_6">206,921</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="Tc_pqexBZzq8k2A4zausm_r2Q_5_9">157,000</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Contingent payments related to acquisitions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="Tc_Nf1Oh3AY902H39VgG8Ockw_6_3">32,918</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="Tc_mra1HgpE806mNZxJOZnV4A_6_6">10,665</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="Tc_xkJnFegcDEOmIdMkH9KZPA_6_9">13,100</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Payment of taxes related to an exchange of common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" scale="3" id="Tc_iiR2XepMxEWchq1Xpws84Q_7_3">2,474</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" scale="3" id="Tc_0pbnSfffvkyPCvq32jabeA_7_6">576</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" scale="3" id="Tc_zHFH1mjoAkm8vj8k7IfCvw_7_9">866</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net cash, cash equivalents, and restricted cash used in financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" sign="-" scale="3" id="Tc_v6Q-Ye_u6USSaIotPs4X6A_8_3">60,260</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" sign="-" scale="3" id="Tc_XHK018TmPkedsCxTMjQuqQ_8_6">98,435</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" sign="-" scale="3" id="Tc_x1HyO4f8s0uPUPCH-DfY7g_8_9">95,706</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of exchange rates on cash, cash equivalents, and restricted cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" sign="-" scale="3" id="Tc_gfHmPypWC0aiM2i85im5Vw_9_3">3,826</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" sign="-" scale="3" id="Tc_DGhknU4y_ESXbx0DzfvkyQ_9_6">801</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="Tc_yzhlLgflsEuR4CQETiiU9A_9_9">1,684</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net increase (decrease) in cash, cash equivalents and restricted cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" sign="-" scale="3" id="Tc_ZCvKzHuuFEaz0sOVdLb5Jg_10_3">7,192</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="Tc_miCwUS8VDU2agIRsgZb5UQ_10_6">10,834</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="Tc_TeK7ds3pjk2cnVmtuJhuxg_10_9">12,596</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CASH, CASH EQUIVALENTS AND RESTRICTED CASH:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Beginning of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc__hjPQLZZ20aknkarpOTtRA_13_3">67,750</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_xaw3k8CJI06nRXslEiEwVg_13_6">56,916</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_V5PGPfXQoUuYg-GRdimjCw_13_9">44,320</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">End of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_XYKXKw1S_0mwsBXnrGGNFg_14_3">60,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_kgB5SZizCE28vOWncFLkWQ_14_6">67,750</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_ADeQ-_AysUmlUo184-gb0w_14_9">56,916</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEETS:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_gfoyJbQ0L0iTpqoQ9t-uSA_17_3">58,408</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_JhyHDOi45EyAcHFlMn2SIg_17_6">67,750</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_jfkoBvHbbUebvP8iGJjw_g_17_9">56,916</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="-sec-ix-hidden:Hidden_3TY6OSQeDUqQF8jraSti9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Restricted cash reported in prepaid expenses and other current assets</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="Tc_koGD3Lbc5EC5BG9UeVnadg_18_3">2,150</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total cash, cash equivalents and restricted cash </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_M-ZZNkQdkE6h6SXL-pQeAQ_19_3">60,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_CaRBYbsGQ0O9Pv5cyQ2aIQ_19_6">67,750</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="Tc_ci-vVgYxe0aVfHVL53zEqA_19_9">56,916</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash paid during the period for:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest (net of capitalized interest of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidCapitalized" scale="3" id="Narr_DwTKzUHbv0S1J1WV7GQnMg">858</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidCapitalized" scale="3" id="Narr_1ZCOig7Jl06Q22LwDM81YA">480</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidCapitalized" scale="3" id="Narr_PAOA8biz4k-na4WI82GORw">813</ix:nonFraction>, respectively)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="Tc_Yv5htOC8wUSdLexCVTDXDg_23_3">6,258</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="Tc_j45EZyj4xUuS2hx87gyH2g_23_6">5,261</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="Tc_mQizF46hdkGueLfz6cvkyQ_23_9">10,077</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="Tc_VQSkqlZ0pEG9NTTgZlK7Lw_24_3">17,092</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="Tc_4afZ5ZFYTUKqvawPPqgkww_24_6">8,828</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="Tc_qU_Qzb0nYE6q9NRpMK-mng_24_9">8,918</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Property and equipment purchases in accounts payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="Tc_oBrr6FMhL0-sgxFSKWw2og_27_3">3,702</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="Tc_951R3gne0k20YhxlR1MYPg_27_6">2,558</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="Tc_BTxPTRzwBkqb94BqW9qFLA_27_9">2,180</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current note receivable converted to equity investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" scale="3" id="Tc_qna9rdHm_0aXUHMW5GMWcw_28_9">899</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Proceeds from sale of business in other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" scale="3" id="Tc_NtcBVLhFzk6MmncXQHIAfw_29_9">321</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Acquisition purchases in accrued expenses and other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses" scale="3" id="Tc_TGhgb1b_JU2aamOq7XkrQQ_30_3">3,526</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses" scale="3" id="Tc_V7voei2QX0aTbArIlzxoJQ_30_9">4,358</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Merit common stock surrendered (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised" scale="3" id="Narr_5r5rzM5_fE-0W3NUZoKWTw">18</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised" scale="3" id="Narr_iPUwh6U3GkqBOrIdhcuc-w">3</ix:nonFraction>, and <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised" scale="3" id="Narr_tqepRbi6_ke4Iex_b33LKg">39</ix:nonFraction> shares, respectively) in exchange for exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_HLsV_svZd0--bfBC-Yhm4w_31_3">1,140</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_9YfK2FBZCEuCIyamsI83lw_31_6">180</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised" scale="3" id="Tc_P75CLuLvZUutbooAIJVV8g_31_9">1,467</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Right-of-use operating lease assets obtained in exchange for operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="Tc_IkNL9pzCqUuPcgOBmoVLrg_32_3">11,130</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="Tc_h95XqXocoEm2LJjk9YhZVw_32_6">1,524</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="Tc_w8BNJBFzTUuTgd1P-z2FWA_32_9">10,938</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">See notes to consolidated financial statements.</p></td><td style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">(concluded)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">59</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS_7"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="Tb_5jD4bbOy-UiONCdRKNNt3Q" continuedAt="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Organization</b>.&#160;Merit Medical Systems,&#160;Inc. (&#8220;Merit,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;) designs, develops, manufactures and markets single-use medical products for interventional and diagnostic procedures.&#160;For financial reporting purposes, we report our operations in <ix:nonFraction unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="Narr_Jkg26a-uVUq-yhR433r-ng">two</ix:nonFraction> operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology medical device products which assist in diagnosing and treating coronary artery disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within those <ix:nonFraction unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="Narr_rZrKUsV8g06llDvzjRODOQ">two</ix:nonFraction> operating segments, we offer products focused in <ix:nonFraction unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="INF" format="ixt-sec:numwordsen" name="mmsi:NumberOfProductCategories" scale="0" id="Narr_ciDVumrR902dNgb2uAI6eQ">five</ix:nonFraction> product categories: <span style="color:#212529;background:#ffffff;">peripheral intervention, cardiac intervention, custom procedural solutions,</span> original equipment manufacturer (&#8220;<span style="color:#212529;background:#ffffff;">OEM&#8221;)</span> and endoscopy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We manufacture our products in plants located in the U.S., Mexico, The Netherlands,&#160;Ireland, France, Brazil and Singapore. We export sales to dealers and have direct or modified direct sales forces in the U.S., Canada, Western Europe, Australia, Brazil, Japan, China, Malaysia, South Korea, UAE, India, New Zealand and South Africa (see Note&#160;13).&#160;Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.&#160;The following is a summary of the more significant of such policies.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:UseOfEstimates" id="Tb_-HkjOEfWikGwXArI_357OA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates in Preparing Financial Statements</b>.&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&quot;U.S. GAAP&quot;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ConsolidationPolicyTextBlock" id="Tb_J5xV1EFotUSFXtN7akIA1Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b>.&#160;The consolidated financial statements include our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated. Amounts presented in this report are rounded, while percentages and earnings per share amounts presented are calculated from the underlying amounts. </p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Tb_7WX--GWk6UCZQ_xCB-0PBw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b>. We consider interest-bearing deposits with an original maturity date of three&#160;months or less to be cash equivalents. As of <span style="-sec-ix-hidden:Hidden_wEJKBHaF4ku_LLZF6o-vSQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2021</span></span>, approximately $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="Narr_G-wg3zM74kG7y3BpcoWI5g">1.9</ix:nonFraction> million, respectively, of our cash and cash equivalents represents restricted cash for the payment of certain import and other taxes for our subsidiary in China.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ReceivablesPolicyTextBlock" id="Tb_V-Wse2vZvEK7ki4uzUTmDA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Receivables</b>.<b style="font-weight:bold;">&#160;</b>Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. An allowance for credit losses on trade receivables is recorded based on our expectation of credit losses and is based upon our historical bad debt experience, current economic conditions, expectations of future economic conditions and management&#8217;s evaluation of our ability to collect individual outstanding balances. Once collection efforts have been exhausted and a receivable is deemed to be uncollectible, such balance is charged against the allowance for credit losses.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:InventoryPolicyTextBlock" id="Tb_2a84z0xoH02oW-DVI4bInw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Inventories</b>. We value our inventories at the lower of cost, at approximate costs determined on a first-in, first-out method, or net realizable value.&#160;Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160;Inventory costs include material, labor and manufacturing overhead.&#160;We review inventories on hand and record provisions based on estimated excess, slow moving and obsolete inventory, as well as inventories with a carrying value in excess of net realizable value.&#160;The regular and systematic review of the valuation of inventories includes an assessment of future product demand based on historical sales and raw material usage and product expiration.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="Tb_DneT-g_Vg0eLiXRNC1acvQ" continuedAt="Tb_DneT-g_Vg0eLiXRNC1acvQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Goodwill and Intangible Assets</b>.<b style="font-weight:bold;">&#160;</b>We test goodwill balances for impairment on an annual basis as of July&#160;1 or whenever impairment indicators arise.&#160;When impairment indicators are identified, we may elect to perform an optional qualitative assessment to determine whether it is more likely than not that the fair value of our reporting units has fallen below their carrying value. During our annual impairment test, we utilize <ix:nonFraction unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="Narr_5vNPZ4wUSUyMe95FbRB2uA">four</ix:nonFraction> reporting units in evaluating goodwill for impairment </p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">60</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_FoFBqYDJXE-fMY2b_IgmrA_1_0"></a><a id="Tc_mjG2XMMXzkeA0PApJ49mVA_2_0"></a><a id="Tc_9srn4Iokkkuej7DFP9cX-g_2_2"></a><a id="Tc_tPM70L2QZUGlWdsxkcJK1A_3_0"></a><a id="Tc_etXn2WxEL0az_cNFaFaglw_3_2"></a><a id="Tc_x11j15aWFUuBFgeXjdaBqw_4_0"></a><a id="Tc_2nQTUgb9zkCqRoBTxdzA0w_4_2"></a><a id="Tc_xZNmx2vLIUmCA98ekO5YKQ_5_0"></a><a id="Tc_MOEDA0apzEKVgzR0FLBHIw_5_2"></a><ix:continuation id="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont1" continuedAt="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont2"><ix:continuation id="Tb_DneT-g_Vg0eLiXRNC1acvQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">using a quantitative assessment, which uses a combination of a guideline public company market-based approach and a discounted cash flow income-based approach. The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Finite-lived intangible assets including developed technology, customer lists, distribution agreements, license agreements, trademarks and patents are subject to amortization. Intangible assets are amortized over their estimated useful life on a straight-line basis, except for customer lists, which are generally amortized on an accelerated basis. Estimated useful lives are determined considering the period the assets are expected to contribute to future cash flows. We evaluate long-lived assets, including amortizing intangible assets, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform the impairment analysis at the asset group for which the lowest level of identifiable cash flows are largely independent of the cash flows of other assets and liabilities. We compare the carrying value of the asset group to the undiscounted cash flows expected to result from the asset group and determine whether the carrying amount is recoverable. We determine the fair value of each asset group based on estimated future cash flows discounted back to their present value using a discount rate that reflects the risk profiles of the underlying activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In-process technology intangible assets, which are not subject to amortization until projects reach commercialization, are assessed for impairment at least annually and more frequently if events occur that would indicate a potential reduction in the fair value of the assets below their carrying value. An impairment charge would be recognized to the extent the carrying amount of the in-process technology exceeded its fair value.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="Tb_zjeF_pCyL0mrgYCfH3NpXQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Long-Lived Assets</b>.&#160;We periodically review the carrying amount of our depreciable long-lived assets for impairment.&#160;An asset is considered impaired when undiscounted estimated future cash flows are less than the carrying amount of the asset.&#160;In the event the carrying amount of such asset is not considered recoverable, the asset is adjusted to its fair value.&#160;Fair value is generally determined based on discounted future cash flow.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="Tb_rLKOhMhFj02yeGcziig4iw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Property and Equipment</b>.&#160;Property and equipment is stated at the historical cost of construction or purchase. Construction costs include interest costs capitalized during construction.&#160;Maintenance and repairs of property and equipment are charged to operations as incurred.&#160;Leasehold improvements are amortized over the lesser of the base term of the lease or estimated life of the leasehold improvements.&#160;Construction-in-process consists of new buildings and various production equipment being constructed internally and externally.&#160;Assets in construction-in-process will commence depreciating once the asset has been placed in service.&#160;<ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="Group_bVWzP05CbE-fxt--meR8Hg" continuedAt="Group_bVWzP05CbE-fxt--meR8Hg_2" escape="true">Depreciation is computed using the straight-line method over estimated useful lives as follows:</ix:nonNumeric></p><ix:continuation id="Group_bVWzP05CbE-fxt--meR8Hg_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember_zjDdU-1CK0yQn-YgCOPErQ" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Tc_PkYU-EXnT0muXaNJDYLY5A_1_2">40 years</ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manufacturing equipment</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_s1acsZS6iEKC098oWQyTug" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_8E2IvHG5E0OhQBoDRQp7Sw">4</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_bHmUCFOtj06ZlP-Hj9nRQQ" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_oKovrGwt3EueuiYI9kUrTw">20 years</ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Furniture and fixtures</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_YTeZcpsajkOtbBGdZAUyYg" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_sYC0SpNEYEeQ8OOUD-F6GQ">3</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_4_A4JH-cIkyKmiFBjtHFug" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_zDiGl_8BvkaEgJpF4gBXqQ">20 years</ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land improvements</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_r2Dw8i5qFkieuyppXBpYLA" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_7Lh1J8y2o0iWSIOCSIK28g">10</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_c5bBLUi-vkiFEa6Kh9D6GQ" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_ZmVdg6-7vUioo2PtHKiu9A">20 years</ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_YvMztLBIikevootYF9Q_Vw" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_y97TnOjN5kqcd-iydbiZCg">4</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_5XhIeqfIC0aQ7HSWBJyoYA" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Narr_qMTO3EXF2EKgSVWrPHGsLQ">25 years</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Depreciation expense related to property and equipment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="Narr_a60GH25IzU-8XL6dF5Szgw">33.4</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="Narr_F8vMuR2qV02ihVOZ7wUp_w">34.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="Narr_Aatt7sO_70-TrpgavRXLoA">35.4</ix:nonFraction> million, respectively.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:DeferredCompensationPolicyTextBlockPolicyTextBlock" id="Tb_G67VY3QI3UmT8teA_LcKjQ" continuedAt="Tb_G67VY3QI3UmT8teA_LcKjQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Deferred Compensation</b>.&#160;We have a deferred compensation plan that permits certain management employees to defer a portion of their salary until the future.&#160;We established a Rabbi trust to finance obligations under the plan with corporate-owned variable life insurance contracts.&#160;The cash surrender value totaled $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="Narr_ffleO8pcA0eCvgkKDW-AtQ">15.8</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="Narr_LLebnAixWUmIsQCTLzMjTQ">19.1</ix:nonFraction> million at December&#160;31,&#160;2022 and 2021, respectively, which is included in other assets in our consolidated balance sheets.&#160;We have recorded a deferred compensation payable of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="Narr_Ea96FG3z2E-mS03PnhIaoQ">15.3</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="Narr_cIoYenszHUGm3PKtUMOIKw">18.1</ix:nonFraction> million at December&#160;31,&#160;2022 and 2021, respectively, to reflect the liability to our employees under this plan.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">61</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_Ek8kKLOmZE-axC8SoR9uyg_1_2"></a><a id="Tc_EKHBcIYKwECcMW89pGk7lw_1_5"></a><a id="Tc_mKpZ0hWvSkikLV7G6d_NhQ_2_0"></a><a id="Tc_RE6_PXq8jEGNcNPiFEpXIQ_2_2"></a><a id="Tc_20BSlzj2dUCkcnEAVzJq4w_2_5"></a><a id="Tc_tEXabc0_0UuRLq5p492MYQ_3_0"></a><a id="Tc_kPJu1TugxEuj_RoLPHf5vg_4_0"></a><a id="Tc_0g0D7pyzzkqAjo9jEExykA_5_0"></a><a id="Tc_XxE2G8E8hEyvKf6LAKmNnA_6_0"></a><a id="Tc_Hhc9FyNKI0iyPna-4xvA2g_6_2"></a><a id="Tc_1IHqAFPbUk-SfZX2FUZcZA_6_5"></a><a id="Tc_bxmpxjnP8EisTRryp8UBIQ_1_2"></a><a id="Tc_VvRDhRWdaUOFgcBUe5rE_Q_1_5"></a><a id="Tc_mDkNZQr20k2AZ8PkciFXAA_2_0"></a><a id="Tc_DFmoZPqzDECT6JFIaA_qsw_2_2"></a><a id="Tc_O5aSgix5MUWxWWN979LhFA_2_5"></a><a id="Tc_dpb_B1Bho0CHjlL2BLdrkQ_3_0"></a><a id="Tc_wyksdVlLW0q72tWDPFUN1A_4_0"></a><a id="Tc_N3FiCIt9dUqReBZv1ZJ2gA_4_2"></a><a id="Tc_7WwyT19JDk2SFRRSH0_1NQ_4_5"></a><ix:continuation id="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont2" continuedAt="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont3"><ix:continuation id="Tb_G67VY3QI3UmT8teA_LcKjQ_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:OtherAssetsPolicyTextBlockPolicyTextBlock" id="Tb_PZ1iBMdfr0yeuUCCKNGTSw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Assets</b>.<b style="font-weight:bold;">&#160;</b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="Group_gsMw028Kd0qo5CfnzvDHJQ" continuedAt="Group_gsMw028Kd0qo5CfnzvDHJQ_2" escape="true">Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):</ix:nonNumeric></p><ix:continuation id="Group_gsMw028Kd0qo5CfnzvDHJQ_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in privately held companies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="Tc_tcd5atVH10--efJhEgtmAA_2_3">15,576</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="Tc_UzCJ61UIyEy1AUduwm1CkQ_2_6">14,711</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred compensation plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationPlanAssets" scale="3" id="Tc_lQph9SnuBkqG6_Zn_bctxQ_3_3">15,767</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationPlanAssets" scale="3" id="Tc_lUSHdaEYRE2noVxv8Wp-Qg_3_6">19,126</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term notes receivable, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" scale="3" id="Tc_t4I3ixkKPkCWCXfi_hIdZA_4_3">2,397</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" scale="3" id="Tc_DPnEiPVwGkavlT6hMmcMMQ_4_6">2,345</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="Tc_7QsmYkAih0Kggfewk9pCUw_5_3">10,612</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="Tc_0DZLss3ViEmnK2oZyovihQ_5_6">5,239</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="Tc_9vPoCwLQZEecBldbJzojhA_6_3">44,352</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="Tc_I658gWEAq0u-I9seHFw7HA_6_6">41,421</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Our share of earnings associated with equity method investments is reported within other income (expense) in our consolidated statements of income (loss). Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="Tb_k--irQcjbkaKp9D4gSJazg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Long-term Obligations. </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="Group_DUlWstePNkSHq4IEmKGTtg" continuedAt="Group_DUlWstePNkSHq4IEmKGTtg_2" escape="true">Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):</ix:nonNumeric></p><ix:continuation id="Group_DUlWstePNkSHq4IEmKGTtg_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_6SvKyC8Vu0q3RhUDyheuBQ_2_3">2,260</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_xhvdaw-QO0qxH88txVr3VA_2_6">13,500</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLongTermDebt" scale="3" id="Tc_WLsWXG5zeUiv69EFAWIQvw_3_3">12,476</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLongTermDebt" scale="3" id="Tc_1RW-M5Bjm0K9Q-QiVXr8Aw_3_6">10,084</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="Tc_JXBLWE7DS0mcspSMic-g9A_4_3">14,736</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="Tc_heMQkGo-eU2JUiejGIy7cg_4_6">23,584</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In connection with a business combination, any contingent consideration is recorded at fair value on the acquisition date based upon the consideration expected to be transferred in the future. We re-measure the estimated liability each quarter based upon changes in revenue estimates, changes in the probability of achieving relevant milestones and changes in the discount rate or expected period of payment. Changes in the estimated fair value are recorded through operating expense in our consolidated statements of income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="Tb_nFR3Mtmzokywxdngxa4s7w" continuedAt="Tb_nFR3Mtmzokywxdngxa4s7w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Revenue Recognition</b>.<b style="font-weight:bold;">&#160;</b>We sell our medical products through a direct sales force in the U.S. and&#160;through OEM relationships, custom procedure tray manufacturers and a combination of direct sales force and independent&#160;distributors in international markets.&#160;Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods.&#160;This core principle is achieved through the following steps:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Identify the contract with the customer</i>. A contract with a customer exists when (i)&#160;we enter into an enforceable contract with a customer that defines each party&#8217;s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii)&#160;the contract has commercial substance and (iii)&#160;we determine that collection of substantially all consideration for services that are transferred is probable based on the customer&#8217;s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred if the amortization period would have been one&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Identify the performance obligations in the contract</i>. Generally, our contracts with customers do not include multiple performance obligations to be completed over a period of time. Our performance obligations generally relate to delivering single-use medical products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds. We do not have significant returns. We do not typically offer extended warranty or service plans, except in limited cases which are not material. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Determine the transaction price</i>. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. Our contracts do not typically contain a financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and </p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">62</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont3" continuedAt="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont4"><ix:continuation id="Tb_nFR3Mtmzokywxdngxa4s7w_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Allocate the transaction price to performance obligations in the contract</i>. We typically do not have multiple performance obligations in our contracts with customers. As such, we generally recognize revenue upon transfer of the product to the customer&#8217;s control at contractually stated pricing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Recognize revenue when or as we satisfy a performance obligation.&#160;</i>We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue. Contract assets are recognized for the future right to invoice customers, and contract liabilities are recognized for unearned revenue if payment is received prior to our fulfillment of performance obligations. We do not have material contract assets or contract liabilities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Reserves are recorded as a reduction in net sales and are not considered material to our consolidated statements of income (loss) for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020.&#160;In addition, we invoice our customers for taxes assessed by governmental authorities, such as sales tax and value-added taxes.&#160;We present these taxes on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Shipping and Handling</b>.&#160;When billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cost of Sales</b>.&#160;We include product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, product royalty expense, developed technology amortization expense, production-related depreciation expense and product license agreement expense in cost of sales.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="Tb_vBbYWLZMA0qi92YHjJ6gqA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Research and Development</b>.&#160;Research and development costs, including new product development, clinical trials, and regulatory compliance, are expensed as incurred.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:IncomeTaxPolicyTextBlock" id="Tb_r5aVYQ6xkk69tprQBrUC6A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes</b>.&#160;Under our accounting policies, we initially recognize a tax position in our financial statements when it becomes more likely than not that the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax positions that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authorities assuming full knowledge of the position and all relevant facts. Although we believe our provisions for unrecognized tax positions are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our income tax provisions and accruals. Such differences could have a material impact on our income tax provisions and operating results in the periods&#160;in which we make such determination.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:EarningsPerSharePolicyTextBlock" id="Tb_PMcg10o0A0mM-YVhKIWvWg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Earnings per Common Share</b>.&#160;Net income (loss) per common share is computed by both the basic method, which uses the weighted average number of our common shares outstanding, and the diluted method, which includes the dilutive common shares from stock options and restricted stock units as calculated using the treasury stock method. Performance stock units are considered contingently issuable awards and are excluded from the weighted average basic share calculation. These awards are included in the weighted average dilutive share calculation, to the extent they are dilutive, based on the number of shares, if any, that would be issuable as of the end of the reporting period assuming the end of the reporting period is also the end of the performance period.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Tb_gLO5n6DWfUemJ-7Os1RiVQ" continuedAt="Tb_gLO5n6DWfUemJ-7Os1RiVQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements</b>.<b style="font-weight:bold;">&#160;</b>The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Financial assets are marked to bid prices and financial liabilities are marked to offer prices.&#160;Fair value measurements do not include transaction costs.&#160;A fair value hierarchy is used to prioritize the quality and reliability of the information </p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">63</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont4" continuedAt="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont5"><ix:continuation id="Tb_gLO5n6DWfUemJ-7Os1RiVQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">used to determine fair values.&#160;Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.&#160;The fair value hierarchy is defined in the following three categories:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Level 1: Quoted market prices in active markets for identical assets or liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Level 2: Observable market-based inputs or inputs that are corroborated by market data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Level 3: Unobservable inputs that are not corroborated by market data.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Tb_HcuwySpH70yUkupANk5UyQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation</b>.<b style="font-weight:bold;">&#160;</b>We recognize the fair value compensation cost relating to stock-based payment transactions in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718, <i style="font-style:italic;">Compensation&#160;&#8212; Stock Compensation</i>.&#160;Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#8217;s requisite service period, which is generally the vesting period.&#160;The fair value of our stock options is estimated using a Black-Scholes option valuation model.&#160;The fair value of our performance stock units linked to total shareholder return is estimated using Monte-Carlo simulations. Compensation expense is adjusted each period based on the grant-date fair value and the number of shares that are probable of being awarded based on the performance conditions of the awards. Restricted stock units are valued based on the closing stock price on the date of grant. Cash-settled share-based awards, or liability awards, are remeasured at fair value each reporting period until the awards are settled. Total stock-based compensation expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Narr_vHx90eOFyUSHMKzJGxmhBg">18.0</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Narr_eFHFoAzVTkSM3JNAxkYfbQ">16.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Narr_arQlSUvQ1k6GidmnZx4Osw">14.3</ix:nonFraction> million, respectively (see Note 12).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:ConcentrationOfCreditRiskPolicyTextBlock" id="Tb_eAPgoSUQbUC0Df5p01R4mg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b>.&#160;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&#160;We provide credit, in the normal course of business, primarily to hospitals and independent third-party custom procedure tray manufacturers and distributors.&#160;We perform ongoing credit evaluations of our customers and maintain allowances for potential credit losses. Due to the diversified nature and number of our customers, concentrations of credit risk with respect to accounts receivable are limited.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="Tb_-9g_3-F-ak21oKS3sLNDgg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Foreign Currency</b>.&#160;The financial statements of our foreign subsidiaries are measured using local currencies as the functional currency, with the exception of our manufacturing subsidiaries in Ireland and Mexico, which each use the U.S. Dollar as its functional currency.&#160;Assets and liabilities are translated into U.S. Dollars at&#160;year-end rates of exchange and results of operations are translated at average rates for the&#160;year.&#160;Gains and losses resulting from these translations are included in accumulated other comprehensive income (loss) as a separate component of stockholders&#8217; equity.&#160;Transactional exchange gains or losses are included in other income (expense) in determining net income (loss) for the period.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:DerivativesPolicyTextBlock" id="Tb_NGFpM0gFgUiKUXOWyci1vw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivatives</b>.<b style="font-weight:bold;">&#160;</b>We use forward contracts to mitigate our exposure to volatility in foreign exchange rates, and we use interest rate swaps to hedge changes in the benchmark interest rate related to our Third Amended Credit Agreement described in Note&#160;8.&#160;All derivatives are recognized in the consolidated balance sheets at fair value.&#160;Classification of each hedging instrument is based upon whether the maturity of the instrument is less than or greater than 12&#160;months.&#160;We do not purchase or hold derivative financial instruments for speculative or trading purposes (see Note&#160;9).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Tb_g1O2ijbPoUSraWSOz3OcTg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">New Financial Accounting Standards. In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2020-04, <i style="font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i>, which provides temporary optional expedients and exceptions in accounting for modifications of contracts that reference the London interbank offered rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued as a result of reference rate reform. In January 2021, the FASB issued ASU 2021-01, <i style="font-style:italic;">Reference Rate Reform (Topic 848): Scope</i>, which amends the scope of ASU 2020-04. In December 2022, the FASB issued ASU 2022-06, <i style="font-style:italic;">Deferral of the Sunset Date of Topic 848</i>, which defers the sunset date of the guidance in ASC 848 to December 31, 2024. ASU 2020-04 and ASU 2021-01 were effective as of March 12, 2020; ASU 2022-06 was effective upon its issuance in December 2022. The provisions of these updates may be applied prospectively to transactions through December 31, 2024, when reference rate reform activity is expected to be completed. As of December 31, 2022, we had not modified any contracts as a result of reference rate reform. We are currently assessing the anticipated impact of these standards on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We currently believe that all other issued and not yet effective accounting standards are not materially relevant to our financial statements.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">64</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_5jD4bbOy-UiONCdRKNNt3Q_cont5"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_9e7b0b08_5f71_49bf_b7fc_10a7b1358a07"></a><a id="Tc_rSBpBDzLLEOa0jRKZ9oqHg_1_2"></a><a id="Tc_jac1GSHRQ0KTRv5a93A3wg_1_11"></a><a id="Tc_PHFWEKYHMUa6IhybafJJCg_1_20"></a><a id="Tc_5CJveJFeQkOa95mF1X8R9Q_2_2"></a><a id="Tc_nO65qPQ3f02kY2lWd36HfQ_2_11"></a><a id="Tc_pTqteEiSg0ug89aufRXUnQ_2_20"></a><a id="Tc_1fZHna0Hc0SJmvGujzRQDg_3_2"></a><a id="Tc__Qy773Y6yk6cautNdl8A6A_3_5"></a><a id="Tc_9TFO6_XDNE6WriS4gb6V0g_3_8"></a><a id="Tc_UkGOxsCul0C9v0XwmggU-g_3_11"></a><a id="Tc_g7NZhtMuQ0SAHRQ5EhF5uQ_3_14"></a><a id="Tc_EQtz3jG7h0agppql_xK_HA_3_17"></a><a id="Tc_JTsY_E8-t0aLRkdParrCww_3_20"></a><a id="Tc_VHjUkTFpTEaxk7b1nIcWjw_3_23"></a><a id="Tc_-TFlKtAUS0GADkSTkzt0Fw_3_26"></a><a id="Tc_hl2VULJvsk-CqmXCiELR2A_4_0"></a><a id="Tc_k4FbMtUO5Em_5IOF-2WJoA_5_0"></a><a id="Tc_LvyMcgfkXk-WgE7rPRSlAg_5_2"></a><a id="Tc_bDHd9W-AtE2QN4CRFgwtIQ_5_5"></a><a id="Tc_FfQQGvfOxkmG79cP6BJPDA_5_8"></a><a id="Tc_Tu_WkH-OnUCExp0Che46Rg_5_11"></a><a id="Tc_bWgectp8cESJ7SMXddxgRw_5_14"></a><a id="Tc_LD34R3fySkCDO149h5tUxw_5_17"></a><a id="Tc_4a_cupcqv025K63w7rLJXQ_5_20"></a><a id="Tc_Ob89WmChwEiX1NTqwXOAhA_5_23"></a><a id="Tc_SpJjaCONNUOL6j-b7XJwiQ_5_26"></a><a id="Tc_swe2zDBsbEmL4zmMJEgD5g_6_0"></a><a id="Tc_tZTQ-Lb-wEaj_z8N7V7gwg_7_0"></a><a id="Tc_ml-_94p4BEG80GW6nkmvlg_8_0"></a><a id="Tc_njn1aUR3YEuXx-cHQuHA9w_9_0"></a><a id="Tc_6e35WAcbAEOHjQSkVnN22A_11_0"></a><a id="Tc_oqc_R5bDTUqzf5sf4b5BfA_12_0"></a><a id="Tc_qzFZvVsExE-clDvbp4EFyA_14_0"></a><a id="Tc_9bPDOZiFG02kQFi8iPx6_w_14_2"></a><a id="Tc_4wu7RuargkClo0QmNxm-LQ_14_5"></a><a id="Tc_yPwBBwlxL0GuqlhpummRMQ_14_8"></a><a id="Tc_EFWWGoFv2Ua-W1ZBeCp-ng_14_11"></a><a id="Tc_vgUkID6wrUeAq3WZFaJIjQ_14_14"></a><a id="Tc_bH4FFs-DcEym73D1tdltxQ_14_17"></a><a id="Tc_g12i1yI1Y0KTyUDFl6BcVA_14_20"></a><a id="Tc_VyJ3XvGRQki7dkDNb2FXvA_14_23"></a><a id="Tc_FI2BKKyIX0-lJg5Duch7iw_14_26"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="Tb_Jc_Nr_-jU0WgAZTGiitvcQ" continuedAt="Tb_Jc_Nr_-jU0WgAZTGiitvcQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span>REVENUES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="color:#212529;font-weight:bold;background:#ffffff;">Disaggregation of Revenue.</b><span style="color:#212529;background:#ffffff;"> Our revenue is disaggregated based on reporting segment, product category and geographical region. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#212529;background:#ffffff;">We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in&#160;</span><span style="color:#212529;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="Narr_cJxGVKgw0kGOFjZB18-n4A">two</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">&#160;operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of&#160;</span><span style="color:#212529;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="INF" format="ixt-sec:numwordsen" name="mmsi:NumberOfProductCategories" scale="0" id="Narr_tJXgb_tuxUWjor2kpjzTUA">four</ix:nonFraction></span><span style="color:#212529;background:#ffffff;">&#160;product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="Tb_2sFaCj-1t0eF0bTYMpqgtw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following table presents sales by operating segment disaggregated based on product category and geographic region for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands).</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cardiovascular</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Peripheral Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_W4Nbl4v2vEWmCyXaR8_MbQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_pk7UvnWaUkq4eGRI6PJYEA_5_3">263,602</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XDLejGk_vku62keNdhz1pg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_STZdPEtxB0W8q679-7MQGg_5_6">176,208</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_EZu2oq9JWkySFQgXZx80hQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_V5GWiAwnLEiUoJAyocRGgg_5_9">439,810</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vqVnEcbqgk2jvODZ8WKvRQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_NEyj28zfUkaL36ga_w1uGg_5_12">244,459</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_67-Tqlponk6UZvQATQw19w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_kPnuKoUXU0WsRJRdGVDbTA_5_15">160,657</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_Hz0JZzm31kalsEp3ZcM9cA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_MZQIMeJoG0qRNFtZaNvSpg_5_18">405,116</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XRuhIx6aiEeybATIhaSCew" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_662v6U--_02M8xZDbUI_-g_5_21">211,999</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hLXkkEVnQ0euQQ6ojlb_1g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_nyqfKxuvNES00jeTRsLhpw_5_24">129,569</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_rIqmoSek306nJEUyZctJvw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_A65lj4VpZ0S-QIfa-5ynnw_5_27">341,568</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiac Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dh9NAeeWGEOTyKx9dRNgQQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_w1zLuQwFv0CseLLfHOozFQ_6_3">128,711</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_va_cfvyIrkys5qSCajkJtQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_JEqwfPQ2IUKqKqpaOkF8_w_6_6">214,475</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qOiOMhYAGEOB7wKJJI87ZQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_qX2K0QWhnEyY_qf9SZvFyw_6_9">343,186</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_g8ILwIqCCkGF8WrNEHY3EA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_VlPwemcQRUOvItcZV5-zuw_6_12">122,452</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_cOSP19REXkC1_oAwXrzLgw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_ZsLe1LkegUOPQHgF67clTg_6_15">198,189</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_UdQi9w9_x0afDHEY0-2BYw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_0oIUEmI2VUi1ivEWWCw3Vg_6_18">320,641</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_SZX6ag4YY02YUh000gdDGQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_3jmfOCmv5kG0mORgyWaVLA_6_21">108,109</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_nB-ZtSzHwEaoYetvplSrzw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_JNVVXGPUA0yEzZrGLVDuOw_6_24">171,562</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dQ1w9qgJwkKMRf4Eg6YHWw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_aJ_f1H6PmE-wu6RvGz_6Gg_6_27">279,671</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Custom Procedural Solutions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o4zAyiweSU6Li2EVnzgs_A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_pCSP67KLgEKwwAmYzCkspA_7_3">108,778</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_fMTs59rneUqo5v_BpAVSDw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_LCJSyEYexk6_DANiLhmQ9g_7_6">81,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_1Z_4de4ygUqLS5DxUcunbQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_wvFEMMHtsEW7xI6qHvFCog_7_9">190,194</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_aoV-srO-v0C_CmlJQCQsxw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_I-g_y6dAKEab1f_dU44mGA_7_12">108,068</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_6oiLFHWLjEaJLXpc4zEA1A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_MenCyNPhuEWCfD-5d3w8jw_7_15">85,874</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_49WaWthqHUyKFHaIaWPRbw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_T9Zx9OQvCUyRy_oGceRjFA_7_18">193,942</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o6wsE8xC70etjMC36EOexw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_Em9HVv_P_06KCEx_3z1sSg_7_21">110,269</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pPXbTXxRSEOTXXv96LRH3g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_ZrSmwCHo_EC9DFPsgpFG9g_7_24">92,927</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_2faHD7Y0VE2-7TwAJ3e-Vg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_fUSKfr04OEid1Xb1yMOCgA_7_27">203,196</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">OEM</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_GzZqc0UGTEKLB-X3K1JMdg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_is6QwpLm90OGwCt0eJj9UQ_8_3">118,869</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_JN31JqK8TUSZFC4jUhNaUw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_NLvpp0kx70O1uZevB03iEw_8_6">26,165</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pL5Mknj4JEmgIcuiUR69sg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_IWJHDrHAK02wTT7CcJJ94Q_8_9">145,034</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vZc6fJE-3EKIbRcC9xqtKg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_q4x9_hBVJ0aqZEMxce1rNw_8_12">104,436</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_lluU2dZDfkKiBp-RaJI-hQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_vgAHQJNBzkaZrodffV4iIQ_8_15">19,092</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_129nQ-x5H0i8Qfcm3bT7Ew" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_k-Ioqq34D0CW2F7VfGNx5g_8_18">123,528</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_m-3FCbMdj0GAx8FAxAcY0g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_byogR4u6bEeuRxRjLzXwYg_8_21">91,826</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_RROgTsYenkCF6Vl9lsgjUQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_VYiPHuvjqkCzWDKFm9S97g_8_24">17,941</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vOi-T_pyI0GCZHYU5lqDhg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_mgjfcGuFQEKOblCJTZUNbQ_8_27">109,767</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_-UggGEQK5U2pkGO6tH6iag" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_zl1iqTtDQEKy5oFWGacEXw_9_3">619,960</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_80TSk5DGpEiuyohE3PdYuw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_NhojXB30wEa-ugVlSjmjwQ_9_6">498,264</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_8y4Hm0sgnEGAXlmlo4a0yg_9_9">1,118,224</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hYBaR7_UwkCAZ6qoxFrGIA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_jJoEF3OefEe5Y90Q6LFp5Q_9_12">579,415</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_b4I5jqtYA0uVHc7AxRDbqQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_CtIfdm1e7kCRiSXRXGdWsA_9_15">463,812</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_nx280WDxXkGurXYrzw3ztA_9_18">1,043,227</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_bAPCtJ49gEqQWOqwDxwUJA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_D5JwNqapzEyB6lvACiAd8Q_9_21">522,203</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_9SbQy8Y_7E6dXc-zGjv5Ng" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_6btPRIUsfUadPBbOjMov3w_9_24">411,999</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_0F1-6pBZx0mwPzH6OVl2rw_9_27">934,202</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Endoscopy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy Devices</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_5mDvHL5jDk-TEtW54Ne1dw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_z6uA0XrvXEazK_EVLMmbrw_12_3">30,599</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_PGWSswwuFk6OV2hMBsWqtQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_OFIMuvBCZEy3kiPRfYW96g_12_6">2,158</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_gXuoUnaox02wGzKWXWNqtQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_RuqPY8EqEUaw3EiukJYEJQ_12_9">32,757</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_TuXIR_4O_0SCoIN9zotxUg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_uEoiIURrbkeaVY4-J32hwQ_12_12">29,463</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_rbVoGsHPjU-z7VMqPG5eTw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_7AfH6BsLVU-2e9UUf8TqNg_12_15">2,061</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_NKU1bXBovEOvuplur33cjg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_FA4OoJrnF0ycdVYcRYiDuw_12_18">31,524</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_-HWMY93UmE2VbbgFMJMnIA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_9JjCiFq7okSl58_wx28fKw_12_21">27,858</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_ezMW-IvdrEydHhCgww1eQg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_nbl1cYm0IkCH3EiOIYKueQ_12_24">1,815</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_oykmNEiVm0ie0Ya6Hql15Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_dMS29-o7HU2_kRZXMyUadw_12_27">29,673</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_q-ArAJXhsESzPPSHFsKcWQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_mT4A1y6fA0-FYsBRdmLkmA_14_3">650,559</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_dSg8kh6DlkyLKSVn2mRmPQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_jTNLq9m0ck2m6SMav2copQ_14_6">500,422</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_FKmwpeRzOEqOQFbRd18pAA_14_9">1,150,981</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_lPoQtyNyi0OGB2OF5XQXnw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_rZZ-X1aB7EqJ_De9taATxQ_14_12">608,878</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_2Zks2ScobUOdPYr6gUlL_A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_aSD_SwV_T0CnDzFWhkFu8w_14_15">465,873</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_BO62jgBx-Ei-OQlHZnrH7Q_14_18">1,074,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_UKcyzBm0EE25HgNKqiye4g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_g5Eb8alzgUakVjCDIinvMg_14_21">550,061</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_mCRjJpSbEE2JseTs6klpUw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_4i-br6_q30KxZ4wK-PTFVQ_14_24">413,814</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_N4InPPMPoUmkyA1u4xBBLg_14_27">963,875</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><i style="font-style:italic;"> </i><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">65</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_Jc_Nr_-jU0WgAZTGiitvcQ_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="Tb_1GOOT9V20U6mvXpiWCzELQ" continuedAt="Tb_1GOOT9V20U6mvXpiWCzELQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span>ACQUISITIONS AND OTHER STRATEGIC TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2022 Acquisitions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">On October 3, 2022, we entered into an asset purchase agreement with BioTrace Medical, Inc.,<span style="background:#ffffff;"> developer of the Tempo&#174; Temporary Pacing Lead device,</span> for a purchase price of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_SNuT8N5JSkC1oU513hKP5A" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="Narr_GuN6kta98UihFTM1yypjPg">2.5</ix:nonFraction> million.<span style="background:#ffffff;"> W</span>e are also required to pay a total of <ix:nonFraction unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg" contextRef="As_Of_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_-2X5MrVXTE-f1Bx7exs50Q" decimals="INF" format="ixt-sec:numwordsen" name="mmsi:AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" scale="0" id="Narr_noGZDDiAU02ZVG0T8ARpHA">six</ix:nonFraction> annual royalty payments between <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_10_4_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_nXJmF9kinUC64uCJFUF8Uw" decimals="2" format="ixt:numdotdecimal" name="mmsi:AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" scale="-2" id="Narr_h4hgYHpIZkK3vgSvL5uU8g">5</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_10_4_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_gvKcRF6bkEqNTgBLgoiS5g" decimals="2" format="ixt:numdotdecimal" name="mmsi:AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" scale="-2" id="Narr_0BjsA_2stkKhysi1b5c3Dg">10</ix:nonFraction>% of net sales, dependent on net sales goal achievement, u<span style="background:#ffffff;">pon achievement of the first device sold in the United States</span>. We accounted for this transaction as an asset purchase. We recorded the amount paid upon closing as a developed technology intangible asset, which we are amortizing over <ix:nonNumeric contextRef="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_MDSV0pNPBkaFq-morkVg5g" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Narr_OmyzHAeDE0uP-eVdlT3crQ">10 years</ix:nonNumeric>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">On April 30, 2022, we acquired the Restore Endosystems Bifurcated Stent System pursuant to the terms of a unit purchase agreement we executed with all of the members of Restore Endosystems. Subject to the terms and conditions of the unit purchase agreement, we paid $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_K77TjlnLw02weRu3pGVeuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="Narr_TWJlT75Yb0KF6uOxHSQVow">3</ix:nonFraction> million in cash at closing. We also accrued $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_K77TjlnLw02weRu3pGVeuw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" scale="6" id="Narr_mh9biEXdZEKuKEsqnQ4dVw">3.5</ix:nonFraction> million of other long-term obligations, which represents the fair value of <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentTwoMember_ezEJWgK2Dki4vj-ItKKXBA" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" scale="6" id="Narr_noHOY_SugUig_RC7i_ZvHQ">two</ix:nonFraction> separate $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentOneMember_p32be_SWykGz2teKntXcOw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" scale="6" id="Narr_4fmUhK3jVkylZe8C7nGKIw">2</ix:nonFraction> million payments which are payable no later than <span style="-sec-ix-hidden:Hidden_omYxHiM9FUeLz86EaJiDGg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span> and <ix:nonNumeric contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentTwoMember_ezEJWgK2Dki4vj-ItKKXBA" format="ixt-sec:durwordsen" name="mmsi:ContingentConsiderationPaymentPeriod" id="Narr_Vz2FVtGh9EyK16gXL_-0wA">four years</ix:nonNumeric> following the closing of the acquisition, respectively, or earlier upon the achievement of specified milestones. We will impute interest on these liabilities with the passage of time. We have accounted for this transaction as an asset purchase and recorded $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_Q-sH4tc8t0y8Us3FOrczrg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="Narr_S3ewgPSnRkabeemsixQfgw">6.5</ix:nonFraction> million of acquired in-process research and development expense because the technological feasibility of the underlying research and development project has not yet been reached and such technology has no identified future alternative use as of the date of acquisition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During April 2022, we paid $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_4_1_2022_To_4_30_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_kSDG572XaUOLA_xcDYEc0Q" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="Narr_Vp8F-53iq0G4bgjzbcn7gw">1.4</ix:nonFraction> million to acquire shares of series A preferred stock of Fluidx Medical Technology, Inc.(&quot;Fluidx&quot;), owner of certain technology proposed to be used in the development of embolic and adhesive agents for use in arterial, venous, vascular graft and cardiovascular applications inside and outside the heart and related appendages. We had previously purchased, and continue to hold, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_bvBD3HDjRUa2xKKy5B1nrA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="Narr_9gtU36L_jUSFX2H7tYHPNQ">4.7</ix:nonFraction> million of participating preferred shares of Fluidx. Our investments have been recorded as equity investments accounted for at cost and reflected within other assets in the accompanying consolidated balance sheets because we are not able to exercise significant influence over the operations of Fluidx. Our total current investment in Fluidx represents an ownership of approximately <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_bvBD3HDjRUa2xKKy5B1nrA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_OwqIbvPlmUWRhl5ir1Dg8Q">17</ix:nonFraction>% of its outstanding capital stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2021 Acquisitions </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-weight:normal;">During September 2021, we paid </span><span style="font-weight:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_9_1_2021_To_9_30_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_2Xu6PUGyB0KxT8eU3R1ceA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="Narr_jdAbpISAx0-caLwcwEFK4Q">2.7</ix:nonFraction></span><span style="font-weight:normal;"> million to acquire series A preferred shares of Fluidx. We had previously purchased </span><span style="font-weight:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2019_To_12_31_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_nvOWf0YPFkKnDI6lHS5MgA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="Narr_Lxu5H1RpjkKcjuEKNSoQYg">2</ix:nonFraction></span><span style="font-weight:normal;"> million of participating preferred shares during 2019. Our investment has been recorded as an equity investment accounted for at cost and reflected within other assets in the accompanying consolidated balance sheets because we are not able to exercise significant influence over the operations of Fluidx. Our total current investment in Fluidx represents an ownership of </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_WFeSl2nEiUeMnJom75DnaA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_QsVsNkzsHEyniS65X9CucQ">15.0</ix:nonFraction>%</span><span style="font-weight:normal;"> of the outstanding stock. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2020 Acquisitions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On November 6, 2020, we entered into a unit purchase agreement to acquire KA Medical, LLC (&#8220;KA Medical&#8221;). Subject to the terms and conditions of the unit purchase agreement, we paid $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="Narr_AgPk8eudak2kU_ZGN4ISrQ">14.6</ix:nonFraction> million in cash, net of cash acquired, including adjustments for working capital and deferred payments of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw" decimals="-6" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationConsiderationTransferredNotePayable" scale="6" id="Narr_6xAnbXDRakKLZfgeSBlVXw">4</ix:nonFraction> million. KA Medical developed the Micro Plug Set, a self-expanding nitinol vascular occlusion device, which is FDA-cleared and CE marked. We accounted for this acquisition as a business combination. The sales and results of operations related to the acquisition have been included in our cardiovascular segment since the acquisition date and were not material for the years ended December 31, 2022, 2021 and 2020. <span style="background:#ffffff;">Acquisition-related costs associated with the KA Medical acquisition, which were included in selling, general and </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">66</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_5cd28d8e_7997_4042_998e_dc064751a476"></a><a id="Tc_rgYp4QplWUKXcgmynbdZhA_1_0"></a><a id="Tc_ArvMSIdPzUGuf6NodK8Kjg_2_0"></a><a id="Tc_Ul8yGNtAE0agCtcCvaRlZg_2_2"></a><a id="Tc_bWJ8SM6BskmroeG7Z_KP3A_3_0"></a><a id="Tc_qq8guoBZSkqQyqAYQBIdBg_4_0"></a><a id="Tc_4qLeyox0n06li76-WSOO5w_5_0"></a><a id="Tc_fWWTmbM5ckKkT2NZKpSTZg_6_0"></a><a id="Tc_d1VfrNyY2UiKV8wj0MTUqw_7_0"></a><a id="Tc_LWNDwPIe2UK_hTsKgyZjXw_8_0"></a><a id="Tc_o2GgKMv5tUW7GM3r3cggTg_9_0"></a><a id="Tc_h_K86VPKXUeQ0vfZ0kg7uw_10_0"></a><a id="Tc_jwbAwzWBOkyZwp2GiuC4Jw_12_0"></a><a id="Tc_wSrHiQiir0q4l1ce6O6uWQ_13_0"></a><a id="Tc_abnYIZpkRECmbJMxo8r91w_14_0"></a><a id="Tc_D2q_jjRkLUeoF-RaEEoGrA_15_0"></a><a id="Tc_VfqccuH7_EKvbvPEO0MUlQ_17_0"></a><a id="Tc_Rt3hDfCVY02Goy0sypPzgw_17_2"></a><ix:continuation id="Tb_1GOOT9V20U6mvXpiWCzELQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><span style="background:#ffffff;">administrative expenses, were not material. </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_OvQHRNSqw06QppxX6EnjNA" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="Group_pAXQ1k8-iEmKR4VKhUzuxw" continuedAt="Group_pAXQ1k8-iEmKR4VKhUzuxw_2" escape="true"><span style="background:#ffffff;">During the fourth quarter of 2021, certain immaterial measurement period adjustments were recorded to our purchase price allocation. </span>The purchase price was allocated as follows (in thousands):</ix:nonNumeric></p><ix:continuation id="Group_pAXQ1k8-iEmKR4VKhUzuxw_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:92.71%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets Acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" scale="3" id="Tc_zbJhaE7ZQ06nKZbH37b8sA_2_3">24</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" scale="3" id="Tc_QLpUYvMuGk-nZnTdk0OUCw_3_3">13</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="Tc_184B5PuPdEeGTi7Q1QAcBg_4_3">211</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="Tc_-vbKkaLreEWpOnk-J8Gd0g_5_3">298</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other long-term assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="Tc_8bqDW567vUKTd1UfqJjBlQ_6_3">10</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Developed technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_hsK8EQLFzEaatbWI6fI09A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="Tc_QXnIqhOktk-rby6gKKF62w_8_3">6,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_C9SH1Rb8_0mmfimJvX8Mxg_9_3">8,570</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" scale="3" id="Tc_v0ZOzsPCPkOb_Qn1q_8HRA_10_3">15,126</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Liabilities Assumed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="Tc_b6q5U9gRoUqpYNaZurOH3Q_13_3">31</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" scale="3" id="Tc_KmIV-Xs3Y0OSU5PiaZfVmQ_14_3">507</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total liabilities assumed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="Tc_FFhVFAmWIE2DS5lBVzzkeA_15_3">538</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total net assets acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="Tc_76DPlFpWiE6HfRR1m9Cevg_17_3">14,588</ix:nonFraction></b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We are amortizing the developed technology intangible asset acquired from KA Medical over <ix:nonNumeric contextRef="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_oIKpm7mrOkCqi-F2r9hloA" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="Narr_NtEv9Bz8S06T6y00ytnG-Q">17 years</ix:nonNumeric>. The goodwill consists largely of the synergies expected from combining operations and is expected to be deductible for income tax purposes. We do not deem the pro forma effects to our consolidated results of operations of the KA Medical acquisition to be material.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_8fb4b954_ea7e_41d5_88ec_e186c3510e74"></a><a id="Tc_s92SYl8sfE6VqUzrewIuIQ_1_2"></a><a id="Tc_z5SmdpmhMEG7LTBNPKeMHg_1_5"></a><a id="Tc_YsgS8I2IoESY3IfW6TV7-g_2_0"></a><a id="Tc_Vef-AAVnhkWcI545GvS1Pg_2_2"></a><a id="Tc_P0w7Sx1c80O9DC1E79Vf7Q_2_5"></a><a id="Tc_CHrmr8nAXUeUy3p6uTdw_Q_3_0"></a><a id="Tc_JlV7rmyWpEy02gY4WMIOMA_4_0"></a><a id="Tc_9CCkFKjsf0eun4Nz6BlDaA_5_0"></a><a id="Tc_2tLSwu65IkSJEXYALbGqNw_5_2"></a><a id="Tc_EDQ5wiryGUaPcQ-JLXRpoQ_5_5"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:InventoryDisclosureTextBlock" id="Tb_f7UrCzRQR0-Q4Z3NDMxXSw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span>INVENTORIES</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="Tb_qwBgxZeoZ0iWA3AQXKlZmg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Inventories at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finished goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="Tc_NvzmD7BH4Uad6EvD0LLuHw_2_3">147,051</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="Tc_r5-lYX2R80GmURNNQdZIQg_2_6">132,403</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Work-in-process</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="Tc_oLyVmyq0I02Qfp6irmO1sg_3_3">29,534</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="Tc_nsMefU1m5EWhNnPB7xN2jw_3_6">22,160</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Raw materials</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="Tc_8cYnapMmOkqZ2QHAkyRrBw_4_3">89,406</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="Tc_QdW2WxZxD0CPvg39urQL9g_4_6">67,359</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="Tc_fZws5wYpYEipWqt5ePBzRw_5_3">265,991</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="Tc_egx4NobdKkWto99ABiTIVw_5_6">221,922</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_4340e08d_0d05_41af_95aa_34ad392bbd2c"></a><a id="Tc_HoMq0shT1UCELXzSYFB-hg_1_2"></a><a id="Tc_Pr1vE3m0kkKehdmEcoq0Mw_1_5"></a><a id="Tc_zg1K7Miy2EmihlPl0tWrAA_2_0"></a><a id="Tc_VXB2tUm6I02lEy5TKrhG2A_2_2"></a><a id="Tc_Ne_ujQwQR0erzxdqyvesfg_2_5"></a><a id="Tc_XrrUph8F_EyXVM1XarHm7g_3_0"></a><a id="Tc_7fCY1WgmcU-u3VY3z6PdbQ_4_0"></a><a id="Tc_eMnmUTYbqUOB_QRqQUWzAQ_4_3"></a><a id="Tc_Hc6W4oZGxUOCxW4R3AUElA_5_0"></a><a id="Tc_sgkBwbIEIUqtV3oPa31ZSQ_5_2"></a><a id="Tc_gTjdKTv63kO9Q34iHzd6Iw_5_5"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="Tb_8Hrn1JPULUqm5yJKxFwmqw" continuedAt="Tb_8Hrn1JPULUqm5yJKxFwmqw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span>GOODWILL AND INTANGIBLE ASSETS</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfGoodwillTextBlock" id="Tb_DRVBgVwtoEepjc_d5g6j9A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The changes in the carrying amount of goodwill for the&#160;years ended December&#160;31,&#160;2022 and 2021, are as follows (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill balance at January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_Hj9h6KkCr0m0CCY97KA_sQ_2_3">361,741</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_aXNGHgBA8UCFtPRXEWESqA_2_6">363,533</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of foreign exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="Tc_5wa2Sd0E4E2tz4B3mnn8_A_3_3">1,920</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="Tc_7opA6UJTJU6JOWwkyMmdXQ_3_6">2,078</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions and adjustments as the result of acquisitions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:GoodwillPurchaseAccountingAdjustmentsAndAdditions" scale="3" id="Tc_FgjDJqJ3-kmJ37ZpohCY4A_4_6">286</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill balance at December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_mnJzOKQBZ0mrZI1hMyjrFg_5_3">359,821</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="Tc_yTTgF74ZnkCT6WzgjDQecw_5_6">361,741</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total accumulated goodwill impairment losses aggregated to $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="Narr_pxZ0_lw5sUee6t489bdtHg"><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="Narr_ZrSRhlhuI0ii-l0X1hlaGA">8.3</ix:nonFraction></ix:nonFraction> million as of December&#160;31,&#160;2022 and 2021. We did <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="Narr_frlmbo_VCE-U1cT6CScNMA"><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="Narr_Au8RTFP-Qk205T9LpVYkww"><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="Narr_dl6FnW-1k0admSTCpNCjQQ">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t have any goodwill impairments for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020. The total goodwill balance as of December&#160;31,&#160;2022 and 2021 is related to our cardiovascular segment.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">67</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_294492d6_bd1e_4dcd_8283_f4c99bcfef5e"></a><a id="Tc_u4EwcNHYtE22osiXITlFUQ_1_2"></a><a id="Tc_4N1XXRBWZUq_68eXXg-x2A_2_2"></a><a id="Tc_4nfgEebCsUeA14RDfJ3BUQ_2_5"></a><a id="Tc_PCaoCt0kxEmiwu901AtfPQ_2_8"></a><a id="Tc_3xbapsJti0SHIT4Nw2Vw0g_3_2"></a><a id="Tc_fy4KOlte9kOuSFzCOxZ4QQ_3_5"></a><a id="Tc_BYsGCbZRwUarkU2PqYLEVQ_3_8"></a><a id="Tc_6lXYyqM11k6WnArS7dPo6g_4_0"></a><a id="Tc_cjnHQhAbTkix4xV6fi-6fA_4_2"></a><a id="Tc_Bku2ftpB-UKTcRkKlUlPcw_4_5"></a><a id="Tc_4KWXgxtFFEqBaYCJ0i4m7w_4_8"></a><a id="Tc_jxo-Epv8Lkez7RHAAkbMXg_5_0"></a><a id="Tc_slxaCvSsvki9Vc6Jzn7hfA_6_0"></a><a id="Tc_Kpysk-xkUUu6wR9-79TlYw_7_0"></a><a id="Tc_E7Xu5XfVP0yAmckZp_I0Kg_8_0"></a><a id="Tc_BrG6UFe2VkKa-wTBXn4uDA_9_0"></a><a id="Tc_G6nPC77JzUmyaWl3H9chxA_9_2"></a><a id="Tc_uiPHs8K1oE6TXqMvE-GIkw_9_5"></a><a id="Tc_aX6ApwpC2kif7B8dDSK00g_9_8"></a><a id="_25697033_3bb5_4dbe_9def_fed10083a619"></a><a id="Tc_aLoXKJFqDEqAnSLuwwfEKQ_1_2"></a><a id="Tc_fHJaWPEiMUOE1Age_r8FDQ_2_2"></a><a id="Tc_SH0HJJ4ot0K_S-9-3pCfMw_2_5"></a><a id="Tc_Q9VZfHPz006ap1Sf1fE1Og_2_8"></a><a id="Tc_SqX1nYz8gEOuOYUZTaJlvQ_3_2"></a><a id="Tc_z32p9sBsBkqAp9D-l2TlNQ_3_5"></a><a id="Tc_3Zu89rUWU0iTCvXUNvhjIg_3_8"></a><a id="Tc_qCOu8DhrZkiiXuWeZAeVJQ_4_0"></a><a id="Tc__9kG8IdCgEexplAiWWX2rg_4_2"></a><a id="Tc_VfuljuiQxkmQ_0k67ZhXlQ_4_5"></a><a id="Tc_94YMddeMEEqw44qEZI3BHQ_4_8"></a><a id="Tc_3fbgC-YzEkqB0u0GZBSD9A_5_0"></a><a id="Tc_zCX1OA0mRUeNiYj1eaYu-g_6_0"></a><a id="Tc_qZ7xjMktDkCRkLa04iVeQw_7_0"></a><a id="Tc_SjJ7Ggw7Y0SOvR5sI-JXxw_8_0"></a><a id="Tc_afM8FWG3z0ad6LYHGY8HvA_9_0"></a><a id="Tc_6o-0orgeqk6BTy50BR37Jw_9_2"></a><a id="Tc_A5vs8-0RJEmrLLiOBwbh-A_9_5"></a><a id="Tc_v_fnRI6pdUGnqiJLa4Lvgg_9_8"></a><a id="_fc74419b_19a1_4325_8ce7_8403874ff240"></a><a id="Tc_nQghCuBc7EODKLh0VyltBQ_1_0"></a><a id="Tc_q4lVO6u4uEyT3ovH_O3Jrg_1_2"></a><a id="Tc_bEqlY9IE9U2F4EIMcCpS6w_2_0"></a><a id="Tc_-MGf5zx8ik-uLtRY6EUhvw_2_2"></a><a id="Tc_F5T2qFvAL0yMrKrnf_7vVQ_3_0"></a><a id="Tc_3yC6RTk5j06-kQ3tik6daw_4_0"></a><a id="Tc_pI4Z6RdCC0ypghlEFcP3-g_5_0"></a><a id="Tc_tbGd46AoekCzd8ibEmVV6w_6_0"></a><ix:continuation id="Tb_8Hrn1JPULUqm5yJKxFwmqw_cont1" continuedAt="Tb_8Hrn1JPULUqm5yJKxFwmqw_cont2"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="Tb_ZREdzo_pGUOylSt8DzLhDQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Other intangible assets at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross&#160;Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_hZ7xsBk4VkCFW8qABlrN4Q_4_3">29,445</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_RxDU9X50I0GsFFG09fW-tA_4_6">10,203</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_5VCTqgqObk-mEeuckK0Eaw_4_9">19,242</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Distribution agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_MS2gF6dNIEeddao2swudJg_5_3">3,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_GzE9cNT0I0OnyYUmXKClDg_5_6">2,715</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_N5zUfETsWUGxoMd-97rZYg_5_9">535</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_8RtE9qRyb0Sm1uBvQMQ0lw_6_3">11,109</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_aR_dhzUFYk-0vOdwHXNWYQ_6_6">7,250</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_0duFq31MlEOz2rmwSVqAdQ_6_9">3,859</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_8O1NF3eC20G0u5TPJTSvnw_7_3">30,221</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_Kj3I4APIGUmC792rOKoAtg_7_6">17,863</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_86ZfKc2HT0y5wfanphGrXg_7_9">12,358</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_z_oTR1djQUKt_Ing237DcQ_8_3">34,105</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_kinCVc0zjE2j4ZRwkO8sPg_8_6">31,749</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_xhL07lEfKUmHKJuetyDfWQ_8_9">2,356</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_dV8XhckSjk6nAh8Q1mR1Jw_9_3">108,130</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_cF9s0-TxFkO5d6Eg_wbeYg_9_6">69,780</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_0NlQz7igRkaJw1H_bsQUDQ_9_9">38,350</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross&#160;Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_Xk2u2wLl9EWBrzZzuXJ5fQ_4_3">26,349</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_duPugOZHWEqbQK3PemmEHg_4_6">8,315</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_0IlM7KN_fEGZPkyP0YBnIg_4_9">18,034</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Distribution agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_9yCKCug48UWaONYpBzLhQQ_5_3">3,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_bI3PNLLtu0W-VvF0O-m4nA_5_6">2,519</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_pg5E41R3Tky-kby8IvUdAA_5_9">731</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_IMMgx_njikW6PcsaHTscnw_6_3">12,663</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_Ykehq7tK9kaGlmpqVUIU4A_6_6">7,768</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_wwUg5jWCQ0KIRC5I3rBvDA_6_9">4,895</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_37eJ12H2hE6jUhNGeshVQg_7_3">30,242</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_0jGu9F0RwU66-xeB2AfcIA_7_6">15,256</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_KJrbBAen6UaWRrX7rpywJw_7_9">14,986</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_bKDuCiCEZkGseRgoNhpJHw_8_3">34,985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_FdWVASwwS0-oXgYMstxVzg_8_6">31,195</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_XZXiavwgREmqYTbZ_41OeA_8_9">3,790</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="Tc_kI4JB3bcTUyXvQ5ZGKvOBQ_9_3">107,489</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="Tc_2YGJMg_auUi1vGotNwRRYg_9_6">65,053</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="Tc_3DKvj08YckORes7rlDka3w_9_9">42,436</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Aggregate amortization expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="Narr_lDwtVN4ZXESy84r0mRwIVg">48.4</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="Narr_bO9UReIiBEaIfqRKf_CSjA">49.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="Narr_qj5nTU2Xh0mFh2JKZgdlKQ">58.6</ix:nonFraction> million, respectively.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="Tb_iuW-7iIiwEmwSuO7BLv0PQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Estimated amortization expense for the developed technology and other intangible assets for the next five&#160;years consists of the following as of December&#160;31,&#160;2022 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.45%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:28.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Amortization Expense</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="Tc_VMxTniLuKk-Dtg8ez3xlVQ_2_3">47,496</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="Tc_3ikcCUN8lUicmEuCdBxaig_3_3">44,434</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="Tc_V4BU6RI0fkyl1Vbazpxwow_4_3">42,610</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="Tc_dwzB4ieCXkiZPAJa3MTN5A_5_3">32,040</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="Tc_oOCJ74B-dUKPheSLSkv0aA_6_3">28,966</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the years ended December&#160;31,&#160;2022, 2021 and 2020, we identified indicators of impairment associated with certain acquired intangible assets based on our qualitative assessment that carrying amounts may not be recoverable, which required us to then complete a quantitative impairment assessment. The primary indicators of impairment <span style="background:#ffffff;">were planned closure and restructuring activities and uncertainty about future product development and commercialization associated with certain acquired technologies, due in part to the economic impacts of the COVID-19 pandemic in 2021 and 2020.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the year ended <span style="-sec-ix-hidden:Hidden_C8dJmPtioUimQru8e7qEng;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2022</span></span>, we recorded total impairment charges related to our intangible assets of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_Yg3eGli2zEW7bA8OSCslYA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_t2UxUY3ii02bv-wEe6qlJg">1.7</ix:nonFraction> million for our divestiture on April 30, 2022 of the STD Pharmaceutical Products Limited (&#8220;STD Pharmaceutical&#8221;) business acquired in our August 2019 acquisition of Fibrovein Holdings Limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the year ended <span style="-sec-ix-hidden:Hidden_VqI937vS7Uyy85OFwQu_0A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2021</span></span>, we recorded total impairment charges related to our intangible assets of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_o1YqQ2tJrkqLSNJ4OlzAkw">1.6</ix:nonFraction> million for the remaining carrying value of ArraVasc license agreements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">During the year ended <span style="-sec-ix-hidden:Hidden_jrl_1y8mUE2lw5OKuH_56w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2020</span></span>, we recorded total impairment charges related to our intangible assets of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_3NOUndhvvkuYZh9EXNFHpQ">28.7</ix:nonFraction> million which included <span style="background:#ffffff;">a partial impairment charge of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_ccOqommAIUOJx6oYxeTW7g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_Ge79CGGwE0mNFFzdgSmpaQ">8.2</ix:nonFraction></span><span style="background:#ffffff;"> million of intangible assets from our acquisition of </span><span style="-sec-ix-hidden:Hidden_ys3ojRh7S0GRuIZh-sLDXg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">STD Pharmaceutical</span></span><span style="background:#ffffff;">, </span>a partial impairment charge of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_LauraneMedicalS.A.S.Member_1wpeXbI0cEecSrjzJb-LeQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_IV_m_eYL60mzyjaxB499oQ">8.0</ix:nonFraction> million<span style="background:#ffffff;"> of intangible assets from our acquisition of certain assets from </span><span style="-sec-ix-hidden:Hidden_gcPAqbzfw0OI2MXDaQHSdA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Laurane Medical S.A.S</span></span><span style="background:#ffffff;">, a partial impairment charge of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_GZdF6FbMRk6IMRPpvp4agg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_zdg7adgVHE2cuKj4nCm1Tg">4.8</ix:nonFraction></span><span style="background:#ffffff;"> million related to our license agreements with </span><span style="-sec-ix-hidden:Hidden_H5Y08u8ZsUaN3kikLiRRBA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ArraVasc Limited</span></span><span style="background:#ffffff;">, and </span><span style="-sec-ix-hidden:Hidden_Xf0THVuuXkWITmOMBoHiHQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">other intangible asset</span></span><span style="background:#ffffff;"> impairments charges of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_OtherIntangibleAssetsAcquiredMember_kqfrwoAXJEelfiTvRFAw3A" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_qq2gGSZj-EiE3KpLg0K5zQ">7.7</ix:nonFraction></span><span style="background:#ffffff;"> million related to intangible assets from our acquisition of certain assets from DirectACCESS Medical, LLC, in-process technology intangible assets of Sontina Medical LLC </span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">68</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_8Hrn1JPULUqm5yJKxFwmqw_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">acquired in connection with our acquisition of certain divested assets from Becton, Dickinson and Company, and a customer list intangible asset&#160;from&#160;our acquisition of ITL Healthcare Pty Ltd (&#8220;ITL&#8221;).</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk125621676"></a><a id="_bb451836_25b8_4f38_a27f_6ca0b876fd0a"></a><a id="Tc_6kPOU-rm0kC0s-A8vEh08w_1_2"></a><a id="Tc_gnThce1DSUqKDaH30S51Zg_1_5"></a><a id="Tc_NCPuaPd6KkqnN_NdpzV4NQ_1_8"></a><a id="Tc_YbzuKumEC06rORQYp2fFmg_2_0"></a><a id="Tc_ANsBIPPH1kayA2DQWFaPqA_2_2"></a><a id="Tc_6y_p9sPQbkCm2KtHjZf1OQ_2_5"></a><a id="Tc_jeTbi9wvNkm16d0we24Feg_2_8"></a><a id="Tc_8CtWOY5gU02Pz318PqPz5w_3_0"></a><a id="Tc_SvPA26FR5Uqt_7GhpPrTYQ_4_0"></a><a id="Tc_aPJ4bEm34kib-nBlT85gyw_4_2"></a><a id="Tc_e_nvLV0g9kK3mmuBolzbjw_4_5"></a><a id="Tc_13of4LfHaUmtg7lY1GXEig_4_8"></a><a id="_6c5d4633_08d9_4a14_b519_05edb2b806f3"></a><a id="Tc_hUK3rB8d_E-jNUWVUzHVRg_1_2"></a><a id="Tc_Czze1ahGvkG-lCF0CkIAHg_1_5"></a><a id="Tc_3ykKfpnCh0K6N99CPa3dxw_1_8"></a><a id="Tc_MkCMRRc8lUOLFMKPQM4sfg_2_0"></a><a id="Tc_4Pf8IIcvOEuofdpSkGsX1A_3_0"></a><a id="Tc_9RRctvXj6UqzPZ2UZiwk7g_3_2"></a><a id="Tc__873gcFs10yoY9Lgi8em5g_3_5"></a><a id="Tc_19thsJKi0k2sCVDUsywVcA_3_8"></a><a id="Tc_V-mv1m9Ot0SYmP05zEdmqw_4_0"></a><a id="Tc_v91KgoQnq0yZ6sqnjcoeng_5_0"></a><a id="Tc_9UGBocTyJEyHmSPD1WdBZQ_6_0"></a><a id="Tc_lZBJ7VcKLES9xuYGI2d9_Q_8_0"></a><a id="Tc_OTTAw7HwS0uu07ETrnxUOw_9_0"></a><a id="Tc_6yIrSB4AnkS8RXHaaGs57w_10_0"></a><a id="Tc_XNpIAzoBckmiuJZnNjhrcw_11_0"></a><a id="Tc_mpPyvBoRfUOoZ3z5OptTlg_12_0"></a><a id="Tc_T3tss6Pnt0uqec4oxzhoTg_14_0"></a><a id="Tc_bqSM1IF9dki9rgc7F3G2IQ_14_2"></a><a id="Tc_bEdfgSSI5UuWET_i4KPWuQ_14_5"></a><a id="Tc_vP-Ngh3QgkmyuH0wieNjQg_14_8"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:IncomeTaxDisclosureTextBlock" id="Tb_e-qXvss9YkCwUpj-MMYW3w" continuedAt="Tb_e-qXvss9YkCwUpj-MMYW3w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span>INCOME TAXES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was signed into law. The $2.2 trillion economic stimulus bill contains numerous tax law changes. We evaluated the tax changes to determine what provisions would apply to us. As permitted by the CARES Act, we have deferred payment of the employer&#8217;s portion of social security payroll tax payments and made a payment equal to one half of the deferred amount during the year ended December 31, 2021. The remaining half was paid during the year ended December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law. We currently do not anticipate the recently enacted law, including the corporate alternative minimum tax, one percent excise tax on stock repurchases, or tax incentives to promote clean energy, to have a material impact on our consolidated financial statements.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="Tb_05Zz-XjrcEy7PKkiADHP2Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, income (loss) before income taxes is broken out between U.S. and foreign-sourced operations and consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Domestic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="Tc_W-S5AmEgG0KbyNF3l7wtfw_2_3">77,562</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="Tc_cVCHfBTavEq5UzNef8OGFQ_2_6">21,328</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" sign="-" scale="3" id="Tc_E2IvyGwcNESKFTYX4PBBeg_2_9">32,216</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="Tc_-URY4lbG0UONA1Q9Z92nrA_3_3">5,067</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="Tc_L0zlGgxDo06R3x2S2EvedA_3_6">32,589</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="Tc_XS0IajaglE6N9e72fH6ZRw_3_9">18,985</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_dRwdnUxv2EqDVp5DH07S8w_4_3">82,629</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="Tc_FscV2F5D_kS182qhMwJlsw_4_6">53,917</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" sign="-" scale="3" id="Tc_INe0TCLUWky2r5D2kGi31A_4_9">13,231</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Tb_C2SfUc9fUE6B0bx9Ue6onQ" continuedAt="Tb_C2SfUc9fUE6B0bx9Ue6onQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The components of the provision for income taxes for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current expense (benefit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="Tc_C38d_Qosq0qDsReBSj6zPw_3_3">9,584</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="Tc_4sqPJ1YFyU-NnX4IKDuaGQ_3_6">808</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" sign="-" scale="3" id="Tc_iPtnFs3100WvqfG6ine1ew_3_9">937</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="Tc_en5c1SnU2UWm6vUF-XGqiw_4_3">3,162</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="Tc_LKdwGqMKvEKc2FJ_oudUxQ_4_6">806</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="Tc_OoQZJekx40-C7AYGLefdvQ_4_9">437</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="Tc_8ErmDQsEyk-VeBYnWDCmZg_5_3">10,291</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="Tc_XRvAZTpBG0emrlF1gBtPQw_5_6">8,480</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="Tc_-f8paenKpUqgEcZ8MI5Pvw_5_9">8,407</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total current expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="Tc_z0g5z0Ep1Uuqa2GJSemywg_6_3">23,037</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="Tc_auoKmKH8s0GyL1rXGmSyLg_6_6">10,094</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="Tc_1QbYzP9F9kKAhIMkEkABsg_6_9">7,907</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred expense (benefit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_relg5wY45UqxR92SJZUcyg_9_3">10,438</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_VToSL9KthE-ON2OXrcvukA_9_6">468</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_NBuNArVqY0KZWBDuu1GKHQ_9_9">2,688</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_-86zWzAeAUK13dEAXlt5zg_10_3">3,615</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_YqCZ1oOzy0Oga6UPXcl6GQ_10_6">1,845</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_5h1g9aMkMUmIPI5Cubs7AQ_10_9">4,524</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_4-o5_YXssEG0UganzDRnBg_11_3">871</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_DqlSuMREPEidnFuZhI0Knw_11_6">2,318</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_XhOBuRN4Vk6l4QB96Kzwpg_11_9">4,083</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total deferred benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_cOWbYY5bEUKlKGh7bttoWQ_12_3">14,924</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_UXBtciIzPU-87eJQq5muXA_12_6">4,631</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_C3944l7cb0mIRuvD5tbpoQ_12_9">11,295</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_gYD2CXMIFEeo8O7V2rFkzA_14_3">8,113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_C6DJLYZcMkipmAYXL95Wig_14_6">5,463</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_YCbTBSAuPE20NpF-g_x2ug_14_9">3,388</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">69</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_478fd335_84e1_48a6_97b8_c92fdb9766f6"></a><a id="Tc_g4jx7eLMyk2pgiqmPeOi7Q_1_2"></a><a id="Tc_Xm8Y3R6HiU6iSO2zFIH9ig_1_5"></a><a id="Tc_9ljdazDybkWKRVzl-On4CQ_1_8"></a><a id="Tc_wrCb92Uc3EGMc4g-UMxrJQ_2_0"></a><a id="Tc_RkDmPNgE4ESeaDe6-N9wQg_2_2"></a><a id="Tc_bTWllUWSUUysrf3cA5IRnQ_2_5"></a><a id="Tc_o3MvnplUzkeP6FbG7ds16Q_2_8"></a><a id="Tc_0lqp5vSIRE2v6naKktjTKw_3_0"></a><a id="Tc_Qj-MYOfrsEuPugSQM-Ievg_4_0"></a><a id="Tc_0F91ssw-mEWl1fK39Lug5w_5_0"></a><a id="Tc_xbhmXXPpQ0iNWdr32XIEvQ_6_0"></a><a id="Tc_nqvkPRxuLEOOXadh3Qg_Dw_7_0"></a><a id="Tc_GTlpRhQhSUCpi9FnNm1QCA_8_0"></a><a id="Tc_TwUQOVoZwEurccO1vvf_4A_9_0"></a><a id="Tc_2Hx2MJeHl0eQ4m4d3OaKBQ_9_6"></a><a id="Tc_ETvNT-wQRkK6uuoubSOv6A_10_0"></a><a id="Tc_xpVOcLQcK0GLZGgjJ6hyBQ_10_3"></a><a id="Tc_2ohgzIgcNUezUgbdZf5reA_10_6"></a><a id="Tc_-GJdlViMYU-4m5SDYwOnyQ_11_0"></a><a id="Tc_Ki4kOn_bgU-opMGr_vcnrw_12_0"></a><a id="Tc_Y98AZ3H_cEqgVN-rxq_Ttw_13_0"></a><a id="Tc_1LW7O1I6qEG7wGb4kKASIw_14_0"></a><a id="Tc_PpfAy0Ywnk6htR0WV9UV0w_15_0"></a><a id="Tc_QOHQ7uj5k0i-eroqoKhcvA_15_2"></a><a id="Tc_YXPGCz890EigvXW0x1HFBw_15_5"></a><a id="Tc_lp-r0Cxo_kaX57GX5iX9jg_15_8"></a><a id="_e5cc854c_6df0_41af_857f_346b5cf880a5"></a><a id="Tc_58JUF7UvZ0yYtDj2eywg3Q_1_2"></a><a id="Tc_1-dGY-mLHUyQYiCzZFEaoA_1_5"></a><a id="Tc_Ms7tH9YfjUactZM0tm2Ldw_2_0"></a><a id="Tc_8xR6oOaWy0GnzKZxWa3b8A_3_0"></a><a id="Tc_coCkDdefO0SJZGn02sEy0g_3_2"></a><a id="Tc_tWabYXyz-0mFF9o5p-5Tcw_3_5"></a><a id="Tc_lo_ICEyc0EmZWm6p_GaZ4A_4_0"></a><a id="Tc_hlj3rfFsCkCNZWnqZSpU_A_5_0"></a><a id="Tc_7reEvlvunUSdwkhyFrRzYA_6_0"></a><a id="Tc_U96oH407RUCabd4FQDntKg_7_0"></a><a id="Tc_gL05y9JJTESCz0QSecCGSQ_8_0"></a><a id="Tc_4PCSb49GiEG2cjyfJCQZCA_9_0"></a><a id="Tc_15ZfA3Vo_0Gd4KA6GDCmvQ_10_0"></a><a id="Tc_pk4aqfDCLUuDBqEzEzoVjQ_11_0"></a><a id="Tc_lX1Cz_ORAky7wsehy8kkJQ_11_6"></a><a id="Tc_Flp3my81nk2du0qRMNNtXQ_12_0"></a><a id="Tc_N2btxMrB7UKeRoDSTyeHwA_13_0"></a><a id="Tc__FIzdrmztkyU1oypm3ti3w_15_0"></a><a id="Tc_BUbb7t69jEm0nkoMVBcgjA_16_0"></a><a id="Tc_lVtDxsX9akOe49qfSu4QCg_17_0"></a><a id="Tc_Izx0z5YpTkacL3CShKRq2Q_18_0"></a><a id="Tc_v9DkTl-tZkew26j2pvyS7A_19_0"></a><a id="Tc_L0i3KI8Oek2y0kwkKcOx6g_20_0"></a><a id="Tc_xvw1POtlX0y8eHp6216nBg_21_0"></a><a id="Tc_hk1oRnaEIkOCu2alVSTUXQ_22_0"></a><a id="Tc_6uR4FhhatEadAY8hnYowqQ_23_0"></a><a id="Tc_5Rmcfu0V9Uu0M8df20RiSw_24_0"></a><a id="Tc_xouvQVu8p0i_W_PrlpBhvw_24_2"></a><a id="Tc_Tu89MC0SiUGpyYCkrL2MCg_24_5"></a><a id="Tc_cUGuBsXqLkK9GZqtHjTF4w_26_0"></a><a id="Tc_8PlEvMtJDUCPy5po-ZKEYQ_27_0"></a><a id="Tc_PWwjknB6Jk2gLyk8wT1CRw_27_2"></a><a id="Tc_Q9rPsDdEhECDwoALGhh_jQ_27_5"></a><a id="Tc_91Qzkwc1O0-MOqWfNFGKew_28_0"></a><a id="Tc_vbA15Pi8ZEy4l4Haqr1rgw_29_0"></a><a id="Tc_mBe4xJctF0u3g6FfOEUHdw_29_2"></a><a id="Tc_RKqmiZVMf0G-fJgW53YezA_29_5"></a><ix:continuation id="Tb_e-qXvss9YkCwUpj-MMYW3w_cont1" continuedAt="Tb_e-qXvss9YkCwUpj-MMYW3w_cont2"><ix:continuation id="Tb_C2SfUc9fUE6B0bx9Ue6onQ_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Tb_Udu2fqdbLE6-S7u3pdRvqA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The difference between the income tax expense (benefit) reported and amounts computed by applying the statutory federal rate of <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr_ij1BWtIsnUyWd0Ybjde-WQ"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr__yJCP2ZE9kO6oogZCqzMgQ"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr_6usHWWLxgUGar5cB7SmXfQ">21.0</ix:nonFraction></ix:nonFraction></ix:nonFraction>% to pretax income (loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Computed federal income tax expense (benefit) at applicable statutory rate of <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr_72y66aBgY0yy_p2ieYklew"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr_cFrcJGrMCUiKFXs_ym32_Q"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="Narr_8mEkR9fQv0eV5QpMKhZVbw">21</ix:nonFraction></ix:nonFraction></ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="Tc_PyPevA5zSEamhBjU8sV3yA_2_3">17,352</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="Tc_dKuP0AGOWEK-_PQ2vEO5pw_2_6">11,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" sign="-" scale="3" id="Tc_0giBqivj9UOLTc7IW0ZpaQ_2_9">2,778</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="Tc_XXbJ2GKEj0aig2NmAZrf1A_3_3">35</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" sign="-" scale="3" id="Tc_I8ZcAY98e0G5ULdnbF6-Jw_3_6">283</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" sign="-" scale="3" id="Tc_kKK7AsgaO0Cu70tFs0B8eQ_3_9">1,448</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="Tc_SJmLAvh6Gki2KmY-ZiEDdw_4_3">1,978</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="Tc_2Y0-bDQfzUSs8ihLcvJWBQ_4_6">2,507</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="Tc_JlN3Y0uQbUqL0rovYpuBEw_4_9">2,391</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax effect of international items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" sign="-" scale="3" id="Tc_EitBJxiMtU2NCEFtwkybAA_5_3">10,698</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" sign="-" scale="3" id="Tc_wD2TA0vJG0KJf5VGMmb_8g_5_6">281</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="Tc_t6x7Fjqnhkuai1Ucc5XuHg_5_9">4,705</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Uncertain tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingencies" sign="-" scale="3" id="Tc_YixKfBUIBUGSSMS__P5BbQ_6_3">47</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="Tc_L8d58EXweky6-dpVXX2JlQ_6_6">401</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingencies" sign="-" scale="3" id="Tc_vWMjCsk8QEeUWvFnEJ63-w_6_9">455</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred compensation insurance assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" sign="-" scale="3" id="Tc_gTKsg2iVLkasYlb4oGPuiw_7_3">706</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="Tc_YbELEqaBmEa9EHutejq9vw_7_6">413</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="Tc_3Keq8yFiL0CKAFT9txBzKg_7_9">290</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" sign="-" scale="3" id="Tc_cDK0-0eJMkWVkrzGtOBuWA_8_3">3,423</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" sign="-" scale="3" id="Tc_5j3WO5sYE0qA_64FcnfdDQ_8_6">5,571</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" sign="-" scale="3" id="Tc_ruR2QnZtaE2Ce9p68r8nBg_8_9">1,822</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="Tc_Sd9sW5O81UO1p-eU68ZBFw_9_3">3,523</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="Tc_tfuyE5b4fEKA5eR1Ao2PKA_9_9">1,257</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">DOJ settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxSettlements" scale="3" id="Tc__o7HQ2ZVl0y1zG0-0HiWzQ_10_9">1,890</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Remeasurement of state deferred taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" scale="3" id="Tc_Gspns6KDIUGZKQacM6iNvQ_11_3">375</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" scale="3" id="Tc_GCxGpij-tE-XnlN0B5-nMw_11_6">526</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" scale="3" id="Tc_2E5p_z-uR0-pKltCLfAKQQ_11_9">1,765</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Non-deductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="Tc_UU6AT6fXpUK9UxesOMMEuQ_12_3">2,027</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="Tc_U33BxOzYy0OPmddcLoVtsQ_12_6">2,455</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="Tc_5X2OAdGkbke5adzIMP3GbQ_12_9">1,077</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Remeasurement of contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" scale="3" id="Tc_MgYRxpQ2OEirKmjuyMs6JA_13_3">1,061</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" scale="3" id="Tc_p1b-XAvbMEKWjRlqW5RQkQ_13_6">733</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" sign="-" scale="3" id="Tc_RB9l17t-B0qSSmtR9Dl4kw_13_9">1,185</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other &#8212; including the effect of graduated rates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" sign="-" scale="3" id="Tc_abOOkaUi5kyhGZtk74DfkQ_14_3">70</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="Tc_S_faOvaXW0iGyrqmOcLq3Q_14_6">132</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" sign="-" scale="3" id="Tc_-xugn6Nop06vSTuCkqiKng_14_9">183</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_YJE3-3j1WUSqt96TaAQjwA_15_3">8,113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_UiW7K4ThuEqnqPezw75xVA_15_6">5,463</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_XOOhKs827kG0timh7-34uw_15_9">3,388</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Tb_Ut0At0rTnESdlewnkfvQeA" continuedAt="Tb_Ut0At0rTnESdlewnkfvQeA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets and liabilities at December&#160;31,&#160;2022 and 2021, consisted of the following temporary differences and carry-forward items (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Allowance for credit losses on trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="3" id="Tc_v9AQ_FaGKk-KQgIDKGZWGQ_3_3">1,925</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="3" id="Tc_3LAQFxdJh0e7z9pOMOIMiA_3_6">1,494</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="Tc_0mLIWl8AYk2PPmO3DLzHxg_4_3">9,968</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="Tc_ITR_RMmUfUymOdS6WAhyHA_4_6">11,063</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Inventory differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="Tc_T_8NneC3l02SPfiGOBHHRQ_5_3">5,712</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="Tc_CKJrz7Hc9Ui7Pvgb0bWu4A_5_6">4,887</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="Tc_YEJwSCAxc0WBpibxTnoGCA_6_3">11,117</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="Tc_YkojpCzVnkGSTvW-hS2dRQ_6_6">14,833</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="Tc_h13BiMtvNUm7tqeLq4tAPw_7_3">7,167</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="Tc_s8ETu-xx8kGuhSabj_OSgw_7_6">6,388</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" scale="3" id="Tc_HGB_J4QRyEiO6tPve7LUCA_8_3">12,801</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" scale="3" id="Tc_p8Rc6C5ZM0i-mD3vmLt51g_8_6">13,431</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal R&amp;D tax credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" scale="3" id="Tc_ucXBwWZcjEGl46Fr7LWGJA_9_3">634</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" scale="3" id="Tc_RD6UG9tbPUyaXrh0BBWCVQ_9_6">5,003</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">UT R&amp;D Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" scale="3" id="Tc_HiUTCskDskqHMQnC5X1dPA_10_3">4,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" scale="3" id="Tc_vhyVtiyU7E2L09kwAkw2VA_10_6">4,126</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">IRC section 174 capitalized R&amp;D </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" scale="3" id="Tc_8x5nmLB8kkuAZcTCKeZJTw_11_3">15,012</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="Tc_MjRCScQclUWp63faNJNKcg_12_3">8,827</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="Tc_OtvKOHFlT0SpQ2DhkhlgQA_12_6">9,939</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="Tc_ZHSsbb1CCESpOz9b0VZEcQ_13_3">77,842</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="Tc_hzgLgQA93E----P-FOxaQg_13_6">71,164</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpense" scale="3" id="Tc_6HNy8i9CRkuvigCOVVDSQQ_16_3">1,568</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpense" scale="3" id="Tc_PG8HX-OZekuFmVES8Bp3sQ_16_6">1,047</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="Tc_2_eK-48DhU-y7hIwT3j05g_17_3">20,925</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="Tc_mO23A8am1Eaq-jy2FRnq6w_17_6">20,797</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="Tc_M-IJGshoF0iU5NP-vVuWMQ_18_3">38,547</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="Tc_UiJnmtSMKEK-xX4IrDpfqA_18_6">42,888</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Foreign withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxLiabilitiesForeignWithholdingTax" scale="3" id="Tc_PNNxOvu1p0ixqNyqGZClBA_19_3">1,571</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:DeferredTaxLiabilitiesForeignWithholdingTax" scale="3" id="Tc_7ao47mx-dkGe5fuch_Mlbg_19_6">5,575</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="Tc_Ipx_BuPUR0qhJWBLg3gBsA_20_3">11,527</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="Tc_W_pgPZ-mMUK8yClZM5GMjg_20_6">11,938</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="Tc_aW3VORQiKkepSMyCBpcpNg_21_3">2,040</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="Tc_4XpFCuqDZkKJwYVfrcGyDQ_21_6">3,556</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="Tc_FOoajWaO-kO-_Fa5cwoFMQ_22_3">76,178</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="Tc_z9FkZ9KaNUmFZvtR2TlL7A_22_6">85,801</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="Tc_D7T_zt6nfEaGXXrLNn-Ggg_23_3">13,527</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="Tc_8rgLyJgGPEaewV51qo7HbQ_23_6">10,786</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred income tax liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="Tc_JcZMyPYmdkqCgWvw_-mGrQ_24_3">11,863</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="Tc_QAag_S-UTE6Orm2isxoJ8A_24_6">25,423</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reported as:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="Tc_4wcbSrVdhU6lbVG2VPCuJA_27_3">6,599</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="Tc_HDWP0dP1pkuYYvU4PrhvAw_27_6">6,080</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="Tc_h332iVg0n0eZUOgsJlRLpw_28_3">18,462</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="Tc__07NQ8L8mUme8pSm9dfI0Q_28_6">31,503</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="Tc_Z4wUjR5HgkmNe5imxveGSw_29_3">11,863</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="Tc_R9pArpbGFUabVoz28MTAYA_29_6">25,423</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 64.8pt;"><span style="font-size:8pt;margin-bottom:6pt;margin-left:0pt;visibility:hidden;background:#ffff00;">&#8203;</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">70</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_e-qXvss9YkCwUpj-MMYW3w_cont2" continuedAt="Tb_e-qXvss9YkCwUpj-MMYW3w_cont3"><ix:continuation id="Tb_Ut0At0rTnESdlewnkfvQeA_cont1"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. Deferred income tax balances reflect the temporary differences between the carrying amounts of assets and liabilities and their tax basis and are stated at enacted tax rates expected to be in effect when taxes are actually paid or recovered. The valuation allowance is primarily related to state credit carryforwards, non-US net operating loss carryforwards, and capital loss carryforwards for which we believe it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="Narr_hJI0cLvufkK1-n1Sn7nDfw">2.7</ix:nonFraction> million during the year ended December 31, 2022, increased by $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="Narr_cHn-HwDCXkC_s6Com3EB1A">573,000</ix:nonFraction> during the year ended December 31, 2021, and increased by $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="Narr_tAPPMlczJkeFHBM8cW98XA">5.6</ix:nonFraction> million during the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, we had U.S federal net operating loss carryforwards of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="Narr_33HOSRatJU2cYuKctqj7dA">29.7</ix:nonFraction> million, which were generated by Cianna Medical, Vascular Access Technologies, Inc., DFINE Inc., and Biosphere Medical, Inc., prior to our acquisition of these companies. These net operating loss carryforwards are subject to annual limitations under Internal Revenue Code Section 382. If unused $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_fGTXof4L9kC2AsOYsnC7lA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="Narr_gSXa08Fc6EO378IautdNpg">29.6</ix:nonFraction> million of the NOLs will expire between 2025 and 2037. Of the NOLs incurred post-2017, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_fGTXof4L9kC2AsOYsnC7lA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="0" id="Narr_AGLCtR4NrU67x4Fwaa6OuQ">97,000</ix:nonFraction> can be carried forward indefinitely. We anticipate that we will utilize all current net operating loss carryforwards prior to their expiration dates over the next <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_umbZmmf59kKHmVjonTjMXg" format="ixt-sec:durwordsen" name="mmsi:NetOperatingLossCarryforwardsUtilization" id="Narr_We7WCKDrNUmasMalmu9RVQ">13 years</ix:nonNumeric>. We utilized a total of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_umbZmmf59kKHmVjonTjMXg" decimals="-5" format="ixt:numdotdecimal" name="mmsi:NetOperatingLossCarryforwardsUsedInCurrentPeriod" scale="6" id="Narr_D9-ooMWW6k6n1c0Obw-Y-Q">15.9</ix:nonFraction> million in U.S. federal net operating loss carryforwards during the year ended December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, we had $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="Narr_qgaROuljG0evqJUPbPgt_Q">22.2</ix:nonFraction> million of non-U.S. net operating loss carryforwards, of which $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_EqJKyjSWGE2cWtmKmguTYg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="Narr_iTpxdPL00Ui03pCbs_2-Vg">21.1</ix:nonFraction> million have no expiration date and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_EqJKyjSWGE2cWtmKmguTYg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="Narr_EpUQJWa4t02O3u5UvIYv7A">1.1</ix:nonFraction> million expire at various dates through 2034. Non-U.S. net operating loss carryforwards utilized during the year ended December 31, 2022 were not material.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We do not consider our foreign earnings to be permanently reinvested. Consequently, we have recorded tax expense of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" scale="0" id="Narr_VbIdi-NYW0qWol-V6fADZg">320,000</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" scale="0" id="Narr_Zd62ZCf90Ue80ILnpOp9qg">288,000</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" scale="0" id="Narr_yKt99fNDAkeUTarY8H8GvA">228,000</ix:nonFraction> for foreign withholding taxes on unremitted foreign earnings during the years ended December 31, 2022, 2021 and 2020, respectively. Additionally, for the year ended December 31, 2022, a tax benefit of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="mmsi:IncomeTaxExpenseBenefitRestructuringOfForeignEntities" sign="-" scale="6" id="Narr_rYLzXpesF0urHM1_AGsMtg">4.3</ix:nonFraction> million was recorded with respect to the restructuring of our foreign entities and the associated change in foreign withholding taxes on the unremitted foreign earnings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining our worldwide provision for income taxes and recording the related assets and liabilities. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. In our opinion, we have made adequate provisions for income taxes for all&#160;years subject to audit. We are no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019. In foreign jurisdictions, we are no longer subject to income tax examinations for&#160;years before 2016.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Although we believe our estimates are reasonable, the final outcomes of these matters may be different from those which we have reflected in our historical income tax provisions and accruals. Such differences could have a material effect on our income tax provision and operating results in the period in which we make such determination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The total liability for unrecognized tax benefits at December&#160;31,&#160;2022, including interest and penalties, was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="mmsi:UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" scale="6" id="Narr_PudkBow6vUm4ZwPvSBvhyA">1.9</ix:nonFraction> million, of which $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="Narr_L4SDePm1u02GFP28-ClSNg">1.9</ix:nonFraction> million would favorably impact our effective tax rate if recognized. At December 31, 2022, <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt-sec:numwordsen" name="mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" scale="6" id="Narr_cKeDn1tu7k2QXmrpCRIuTA">none</ix:nonFraction> of the total liability was presented as a reduction to non-current deferred income tax assets on our consolidated balance sheet. The total liability for unrecognized tax benefits at December&#160;31,&#160;2021, including interest and penalties, was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-5" format="ixt:numdotdecimal" name="mmsi:UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" scale="6" id="Narr_qXAr1Vat9kOLpLgu2fpmpw">2.0</ix:nonFraction> million, of which $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="Narr_dSjLTzMR9ECp4wb5h71rgA">2.0</ix:nonFraction> million would favorably impact our effective tax rate if recognized. At December 31, 2021, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" scale="6" id="Narr_JJ7s_SDgKkOB8F2jemSPAQ">1.0</ix:nonFraction> million of the total liability was presented as a reduction to non-current deferred income tax assets on our consolidated balance sheet. As of December&#160;31,&#160;2022 and 2021, we had accrued $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_pMfrzSZzwEatJia7kaBq3g">336,000</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" id="Narr_sBoHRR1c0kKcJ_UKLPxlCQ">322,000</ix:nonFraction> respectively, in total interest and penalties related to unrecognized tax benefits. We account for interest and penalties for unrecognized tax benefits as part of our income tax provision. During the&#160;years ended December&#160;31, 2022, 2021 and 2020, our liability for unrecognized tax benefit was increased (decreased) for interest and penalties by $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" scale="0" id="Narr_za4dv7QvBEebWy1acKiDHg">14,000</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" scale="0" id="Narr_Bf3tDxUSbUqV6KyYJAbxJQ">46,000</ix:nonFraction>, and $(<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" sign="-" scale="0" id="Narr_wFAfra-qlkOejUBMgFn8bA">90,000</ix:nonFraction>), respectively. We estimate it is reasonably possible that within the next 12&#160;months the total liability for unrecognized tax benefits may decrease, including expirations related to statutes of limitation, up to $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_4HjX7W_AtkazUBHgOvHHrw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="0" id="Narr_1P305i-35E6heXM5ZI_qZQ">109,000</ix:nonFraction>.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">71</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f878b2a6_b51a_4211_b193_b92a343702b0"></a><a id="Tc_Yy11ak79Kk6DTQ-Ovmm0-w_1_2"></a><a id="Tc_0ndg77r6B0qOQ-_Fg7XcIA_1_5"></a><a id="Tc_hbPgebkBuEyTLF8Qof--yg_1_8"></a><a id="Tc_W-BKSxbet0edl-3IqxEoFg_2_0"></a><a id="Tc_Q8esUpJLYESC16zoqvJjmw_2_2"></a><a id="Tc_BCJ6N51UEU2TG5RaaeOCKg_2_5"></a><a id="Tc_hljBN8Tcgk-RC8fckYEsfQ_2_8"></a><a id="Tc_XhyjRNRDiky2BQBZWdJ9iQ_3_0"></a><a id="Tc_7qx8j9SzDkqKETYmFpmCVw_4_0"></a><a id="Tc_ez-DdVHYE0GtohkfkzcZqw_5_0"></a><a id="Tc_zj7YMu_eKkqC15aCFhRKog_6_0"></a><a id="Tc_w4L4w4AWmUy7UeFnF-oQsg_6_2"></a><a id="Tc_yXlU4Qp9pkScBCHkdy0cpA_6_5"></a><a id="Tc_JIBySNYJ6k6UJf-AXvlGAA_6_8"></a><ix:continuation id="Tb_e-qXvss9YkCwUpj-MMYW3w_cont3"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="Tb_8d35pxwjHEq_0Qo5yhinng" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax benefits for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrecognized tax benefits, opening balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_4hwmsmT1s0S0XG3mq0FH5A_2_3">1,635</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_-Ftz8z9IKkitMHpmkXWWiw_2_6">1,674</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_5885hXVwi0a1SXb6-ZZo8g_2_9">2,161</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross increases (decreases) in tax positions taken in a prior year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_aKNIR3f2g0ywOr_QmvbOnA_3_3">10</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_9f2tBQeTwU23PTCWP24MzQ_3_6">82</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="Tc_e6itYSqZREexbmov4F5RGA_3_9">115</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross increases in tax positions taken in the current year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="Tc_47nAIZTCE0ynx2ufGIhKEg_4_3">294</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="Tc_eDJ3Lfd4KUWzzsaebLwYXw_4_6">316</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="Tc_jWJwqETC40eJkydgwJ1MGQ_4_9">283</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lapse of applicable statute of limitations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="Tc_td6AKW2y_EeEog7GrQKZPg_5_3">343</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="Tc_nMkmlVwIDkeNN8v3Ls5qrQ_5_6">437</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="Tc_Xq3zh0G_LEqxp4x0dIYUhQ_5_9">885</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrecognized tax benefits, ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_lBXF8AolfUGOptHjXueoRg_6_3">1,576</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_-xo60j_MhUel_4RnXtYLyA_6_6">1,635</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="Tc_sb6z7Bosmk6VdOCAr34hRw_6_9">1,674</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The tabular roll-forward ending balance does not include interest and penalties related to unrecognized tax benefits.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_688d70f1_9c0f_4c34_a9db_5c1a11b9b441"></a><a id="Tc__GhdxWOyIU-PR29XD9epkQ_1_2"></a><a id="Tc_-Q3y8vXqCkyqX6OpVkFYuw_1_5"></a><a id="Tc_W0FkKPV5nU-YLZ-ayC1w0Q_2_0"></a><a id="Tc_bocixekNKU2gRfSFhTjQIw_2_2"></a><a id="Tc_uFvPQfRCSEyUkqdWozp-6Q_2_5"></a><a id="Tc_bdo50Nk-Kk6qE1cfuWssvg_3_0"></a><a id="Tc_pFK1A87JrUCFTiFFTnQaLQ_4_0"></a><a id="Tc_P0ty-W2W7keQszs2m2kCkg_5_0"></a><a id="Tc_Q8U9Rj1fJkyoevqTqMax7A_6_0"></a><a id="Tc_bw9EwEeZBUyGieHKq3XnxQ_7_0"></a><a id="Tc_K5ESp5ksYkyBByCWBQwqow_9_0"></a><a id="Tc_Fq4FSVNT0Em2Pz-hrxb0cQ_9_2"></a><a id="Tc_LL_MDALTf0uiXsE2xB4J8A_9_5"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Tb_cgyV9e6580yGe26S_DdbyA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span>ACCRUED EXPENSES</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Tb_X7WihVOWVE-H7TEEGEBhzg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Payroll and related liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" scale="3" id="Tc_dJcXbsnpnUyx6Qeg7gIW5Q_2_3">58,620</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" scale="3" id="Tc_DyywB3dG_USkPlMTRGf4vw_2_6">59,435</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of contingent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="Tc_P6AazUYcEESqq2PqIIjf1Q_3_3">15,813</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="Tc_VUN3lyFf-UCslzqxWeWwEw_3_6">34,735</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Advances from employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AdvancesFromEmployeesCurrent" scale="3" id="Tc_2ItlGmlJl0ioE0y7wWhU1g_4_3">165</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AdvancesFromEmployeesCurrent" scale="3" id="Tc_lE0LqjFCt06PcZUCvFCizw_4_6">201</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued rebates payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AccruedRebatesPayableCurrent" scale="3" id="Tc_qD1_4afl0E2YPi9o-jJ_Aw_5_3">10,925</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AccruedRebatesPayableCurrent" scale="3" id="Tc_Ih29jXWsLEydBjQswBZaNw_5_6">11,271</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AccruedLegalSettlementCurrent" scale="3" id="Tc_e_S5cBZ0_06tSmNG6cZZMw_6_3">1,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:AccruedLegalSettlementCurrent" scale="3" id="Tc_s46DIy-5ikulutUkqfChJg_6_6">18,250</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="Tc_s7WYWFonC02p2yMO-7JaBA_7_3">36,666</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="Tc_-j03v6YiXUamf9b1R8qPHA_7_6">35,122</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_Gnp44WXPqUWJzWbiCOlQPg_9_3">123,189</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="Tc_jZYLgT5G7k-z9wcJZIVtzw_9_6">159,014</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_0e10047b_2c77_4b1a_b0c2_aa1441578d86"></a><a id="Tc_du9IC40uMU-paeJbBFbpgA_1_2"></a><a id="Tc_EGjabkhmSEKc7AfI9GauIg_1_5"></a><a id="Tc_dPDJNG8MT0qCKhDdmqAUFg_2_0"></a><a id="Tc_DcQ-8vuBck60M5c5olB8aQ_2_2"></a><a id="Tc_MxTBVqpvH0a6ppmWX6ejRg_2_5"></a><a id="Tc_HaGHdndNUkeBig8scIrDGg_3_0"></a><a id="Tc_oK4bVXxJ4E216kTktTzs5A_4_0"></a><a id="Tc_WOeHbL2A6Ue4R1j003HtOQ_5_0"></a><a id="Tc_AxVOr0JIfUyXGqX5b84VKw_6_0"></a><a id="Tc_MeGlsnFgEUaOzf0_if57fQ_7_0"></a><a id="Tc_HXDMeoQSmkydrL5YibnKKg_7_2"></a><a id="Tc_jkCiviiRdE2rkWUlWMOSUA_7_5"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:DebtDisclosureTextBlock" id="Tb_UW5w6epvcEy0nRToTJ3VfQ" continuedAt="Tb_UW5w6epvcEy0nRToTJ3VfQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span>REVOLVING CREDIT FACILITY AND LONG-TERM DEBT</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="Tb_EBbzSiNIb0C9EMz8If8lAg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Principal balances outstanding under our long-term debt obligations as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Term loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_nxzNJ9zo90yLi_8Qv5ROqg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="Tc_RdgBR7owz0SX7u0Xe3flmA_2_3">124,688</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_cNga-H3nA0mvS1ecmQSc8w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="Tc_RJStGAd9kEqo4apHU4q24A_2_6">133,125</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revolving credit loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_mnlw2YbJNke1XUMLVydA-Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="Tc_lgOG5lRBhUeTPA0fHYCOTA_3_3">73,500</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_9Ang2hn4Y0KLAWIwdCgBog" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="Tc_OaId6HaBGEmKNRdh4TKORg_3_6">110,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less unamortized debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="Tc_8Uq7NYhyAEaY15QeAnXbCQ_4_3">179</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="Tc_bPFlqCpSGE6H6M1DQ6KPVA_4_6">290</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="Tc_GPsZ0VEFlE-UQi9jkxLmSg_5_3">198,009</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="Tc_849Ad3nb50OkxLftwrV_vw_5_6">242,835</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current portion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="Tc_uHRh8B8dJE6JenMGztXq4A_6_3">11,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="Tc_yULZk33iGU2qKceH-_i_nQ_6_6">8,438</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term portion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="Tc_8oigAJxBkUSaGqxnQGyKfA_7_3">186,759</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="Tc_afJeRRKjf0KZBWcQBY4YUA_7_6">234,397</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:17.4pt;text-align:justify;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Third Amended and Restated Credit Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-family:'Segoe UI';visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">On July 31, 2019, we entered into a Third Amended and Restated Credit Agreement (the &quot;Third Amended Credit Agreement&quot;). The Third Amended Credit Agreement is a syndicated loan agreement with Wells Fargo Bank, National Association and other parties. The Third Amended Credit Agreement amends and restates in its entirety our previously outstanding Second Amended and Restated Credit Agreement and all amendments thereto. The Third Amended Credit Agreement provides for a term loan of&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_KKxUChovJUKc65GGLrR6Tg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="Narr_cj9006Jt-0qry8okBBJNBw">150</ix:nonFraction>&#160;million&#160;and a revolving credit commitment up to an aggregate amount of&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_LgZE-P7vHUGygqnbkaU4QA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="Narr_37UmAdM0k02fqSkRA7q_OA">600</ix:nonFraction>&#160;million, inclusive of sub-facilities for multicurrency borrowings,&#160;standby letters of credit and&#160;swingline loans. On July 31, 2024, all principal, interest and other amounts outstanding under the Third Amended Credit Agreement are payable in full. At any time prior to the maturity date, we may repay any amounts owing under all term loans and revolving credit loans in whole or in part, without premium or penalty, other than breakage fees (as defined in the Third Amended Credit Agreement).</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">72</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_f3c5f5f8_6ae3_47cb_ab00_ab07f9a0c101"></a><a id="Tc_cFPRrMsoREKTl3lkfDLgZQ_1_0"></a><a id="Tc_TwNL4P_wZUOKnQEElXR60g_1_2"></a><a id="Tc_a4_1Yz8QPUGkXs-_8x7UeQ_2_0"></a><a id="Tc_gIgNyqbrdUKqfIXalaGAfg_2_2"></a><a id="Tc_xhZE6nx2Z0aJ_90kDMA90Q_3_0"></a><a id="Tc_JYt_H4LrbkmVsvYXQOaNpw_3_2"></a><a id="Tc_o-3WdEOXQk2lKUqx2pbLpA_4_0"></a><a id="Tc_I5tyi2XaZ06Dksn5lECUfw_5_0"></a><a id="Tc_a0BvuLVV_Uem7vEhGruU2w_5_2"></a><ix:continuation id="Tb_UW5w6epvcEy0nRToTJ3VfQ_cont1" continuedAt="Tb_UW5w6epvcEy0nRToTJ3VfQ_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">Revolving credit loans denominated in dollars and term loans made under the Third Amended Credit Agreement bear interest, at our election, at either the Base Rate or the Eurocurrency Rate (as such terms are defined in the Third Amended Credit Agreement) plus the Applicable Margin (as defined in the Third Amended Credit Agreement).&#160;Revolving credit loans denominated in an Alternative Currency (as defined in the Third Amended Credit Agreement) bear interest at the Eurocurrency Rate plus the Applicable Margin. Swingline loans bear interest at the Base Rate plus the Applicable Margin (as defined in the Third Amended Credit Agreement). Interest on each loan featuring the Base Rate is due and payable on the last business day of each calendar quarter; interest on each loan featuring the Eurocurrency Rate is due and payable on the last day of each interest period applicable thereto, and if such interest period extends over three months, at the end of each three-month interval during such interest period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:ScheduleOfLongTermDebtCovenantsTableTableTextBlock" id="Group_elx6ptl-okmoBypzGmGyWw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">The Third Amended Credit Agreement is collateralized by substantially all of our assets. The Third Amended Credit Agreement contains affirmative and negative covenants, representations and warranties, events of default and other terms customary for loans of this nature.&#160;In particular, the Third Amended Credit Agreement requires that we maintain certain financial covenants, as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Covenant Requirement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidated Total Leverage Ratio <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA" decimals="INF" format="ixt:numdotdecimal" name="mmsi:LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" scale="0" id="Narr_mATOnn4tFEa1Yj8O1vQ4yA">4.0</ix:nonFraction> to 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidated Interest Coverage Ratio <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA" decimals="INF" format="ixt:numdotdecimal" name="mmsi:LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" scale="0" id="Narr_6za50JDvmEGVgZtHkiGuTA">3.0</ix:nonFraction> to 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility Capital Expenditures <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA" decimals="-6" format="ixt:numdotdecimal" name="mmsi:LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" scale="6" id="Narr_ugVMWvH1Dk6N7y1DSGF45A">50</ix:nonFraction> million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Maximum Consolidated Total Net Leverage Ratio (as defined in the Third Amended Credit Agreement) as of any fiscal quarter end.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Minimum ratio of Consolidated EBITDA (as defined in the Third Amended Credit Agreement and adjusted for certain expenditures) to Consolidated interest expense (as defined in the Third Amended Credit Agreement) for any period of four consecutive fiscal quarters.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Maximum level of the aggregate amount of all Facility Capital Expenditures (as defined in the Third Amended Credit Agreement) in any fiscal year.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;">As of December&#160;31,&#160;2022, we believe we were in compliance with all covenants set forth in the Third Amended Credit Agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;">As of December&#160;31,&#160;2022, we had outstanding borrowings of </span><span style="font-style:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="Narr_rxRG9p2HMk-8OeKJfbE6Rw">198.2</ix:nonFraction></span><span style="font-style:normal;"> million </span><span style="font-style:normal;">and issued letter of credit guarantees of </span><span style="font-style:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="Narr_8sk6PuMHGUCvVGbNuzsIOQ">3.2</ix:nonFraction></span><span style="font-style:normal;"> million</span><span style="font-style:normal;"> under the Third Amended Credit Agreement, with additional available borrowings of approximately </span><span style="font-style:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="6" id="Narr_CzeHx9mR40ejhwAu31oqRg">523</ix:nonFraction></span><span style="font-style:normal;"> million, based on the leverage ratio required pursuant to the Third Amended Credit Agreement. Our interest rate as of December&#160;31,&#160;2022 was a fixed rate of </span><span style="font-style:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="4" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="Narr_UxgOTFys6E-lJvP9DS0lEg">2.71</ix:nonFraction>%</span><span style="font-style:normal;"> on </span><span style="font-style:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongtermDebtPercentageBearingFixedInterestAmount" scale="6" id="Narr_VfJVMe6sLke10KlnJk7Aqw">75</ix:nonFraction></span><span style="font-style:normal;"> million as a result of an interest rate swap (see Note 9) and a variable floating rate of </span><span style="font-style:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="4" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" scale="-2" id="Narr_L2dYmr9tgUiDIsAYKophyw">5.38</ix:nonFraction>%</span><span style="font-style:normal;"> on </span><span style="font-style:normal;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongtermDebtPercentageBearingVariableInterestAmount" scale="6" id="Narr_1E1AQCWUqEWUJ7wNbjLTRA">123.2</ix:nonFraction></span><span style="font-style:normal;"> million. </span><span style="font-style:normal;background:#ffffff;">Our interest rate as of December&#160;31,&#160;2021 was a fixed rate of&#160;</span><span style="font-style:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="Narr_9MwXLI_QfkCfPwqmgnClGg">2.71</ix:nonFraction>%</span><span style="font-style:normal;background:#ffffff;"> on </span><span style="font-style:normal;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongtermDebtPercentageBearingFixedInterestAmount" scale="6" id="Narr_Cgjim5HAiUuv1nsCLB1MTQ">75</ix:nonFraction></span><span style="font-style:normal;background:#ffffff;">&#160;million as a result of an interest rate swap and a variable floating rate of&#160;</span><span style="font-style:normal;background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" scale="-2" id="Narr_SgRE0Xdrxk-YEsn-T3WPJg">1.10</ix:nonFraction>%</span><span style="font-style:normal;background:#ffffff;"> on </span><span style="font-style:normal;background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongtermDebtPercentageBearingVariableInterestAmount" scale="6" id="Narr_GATf1H_QRkWcBjt2Db9Qwg">168.1</ix:nonFraction></span><span style="font-style:normal;background:#ffffff;">&#160;million.</span><span style="font-style:normal;"> The foregoing fixed rates are exclusive of potential future changes in the applicable margin.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Certain of the interest rates applicable to our Third Amended Credit Agreement, and applicable to hedging instruments we have purchased to offset interest rate risk under our Third Amended Credit Agreement, are LIBOR-based. We anticipate replacement rates will be identified, as provided for in our Third Amended Credit Agreement, as LIBOR-based rates become unavailable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Future Payments</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="Tb_x7zoSwi2Jk-pL09HAaqozQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Future minimum principal payments on our long-term debt as of December&#160;31,&#160;2022, are as follows (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years&#160;Ending</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;Minimum </b></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal&#160;Payments</b></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="Tc_RApkqJrhUkuxZBxDRZ84nQ_3_3">11,250</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="Tc_0qSAgwtHkUuwJP8GBN8vKQ_4_3">186,938</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total future minimum principal payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="Tc_b-wC2pS1NUunWMwcwAQsWQ_5_3">198,188</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">73</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_UW5w6epvcEy0nRToTJ3VfQ_cont2"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="Tb_-3iAR70PqUGQWoySEDQ42Q" continuedAt="Tb_-3iAR70PqUGQWoySEDQ42Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span>DERIVATIVES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">General.</b>&#160;Our earnings and cash flows are subject to fluctuations due to changes in interest rates and foreign currency exchange rates, and we seek to mitigate a portion of these risks by entering into derivative contracts.&#160;The derivatives we use are interest rate swaps and foreign currency forward contracts.&#160;We recognize derivatives as either assets or liabilities at fair value in the accompanying consolidated balance sheets, regardless of whether or not hedge accounting is applied.&#160;We report cash flows arising from our hedging instruments consistent with the classification of cash flows from the underlying hedged items.&#160;Accordingly, cash flows associated with our derivative programs are classified as operating activities in the accompanying consolidated statements of cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We formally document, designate and assess the effectiveness of transactions that receive hedge accounting initially and on an ongoing basis.&#160;For qualifying hedges, the change in fair value is deferred in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;), a component of stockholders&#8217; equity in the accompanying consolidated balance sheets, and recognized in earnings at the same time the hedged item affects earnings. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings throughout the term of the derivative. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Interest Rate Risk</b>.&#160;Our debt bears interest at variable interest rates and, therefore, we are subject to variability in the cash paid for interest expense. In order to mitigate a portion of this risk, we use a hedging strategy to reduce the variability of cash flows in the interest payments associated with a portion of the variable-rate debt outstanding under our Third Amended Credit Agreement that is solely due to changes in the benchmark interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On August&#160;5, 2016, we entered into a pay-fixed, receive-variable interest rate swap with a current notional amount of&#160;$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_QrfXxo7G-0CQLXG-eerz5A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="Narr_45pfeuQikEOGFsZSecFbsw">175</ix:nonFraction> million&#160;with Wells Fargo Bank to fix the one-month LIBOR rate at&#160;<ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_mTy83y8sAEyrrLjPi86-Aw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="Narr_Sw_l_Xe5Ckyp1PIgLlO8HQ">1.12</ix:nonFraction>%. The variable portion of the interest rate swap was tied to the one-month LIBOR rate (the benchmark interest rate). The interest rate swap expired on July&#160;6, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On December 23, 2019, we entered into a pay-fixed, receive-variable interest rate swap with a notional amount of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_RnYw5KwjtEiUa6kDr0cJuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="Narr_IBLEx0wAXUCO6npYKJMvcw">75</ix:nonFraction> million with Wells Fargo Bank to fix the one-month LIBOR rate at <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_0hUma_OATUuPqA-Tunbzmw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="Narr__-5rtHEuxU-VbNN77XfVcQ">1.71</ix:nonFraction>% for the period from July 6, 2021 to July 31, 2024. The variable portion of the interest rate swap is tied to the one-month LIBOR rate (the benchmark interest rate). On a monthly basis, the interest rates under both the interest rate swap and the underlying debt reset, the swap is settled with the counterparty, and interest is paid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31,&#160;2022 and 2021, our interest rate swaps qualified as cash flow hedges.&#160;The fair value of our interest rate swap at December&#160;31,&#160;2022 was an asset of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JDBrXX4eGkm0WfKXgEw4_A" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="Narr_cArMqUn4qUOR5Xj3z4xWvA">3.4</ix:nonFraction> million, partially offset by $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JDBrXX4eGkm0WfKXgEw4_A" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsDerivativeInstruments" scale="6" id="Narr_h3ohrjAy7UeBZr3Ob9ugAQ">0.8</ix:nonFraction> million in deferred taxes. The fair value of our interest rate swaps at December&#160;31,&#160;2021 was a liability of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JOxaSybhBEmm93r7VwCklA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="Narr_bpyaQWMU_UGLfI-oY49n5A">1.4</ix:nonFraction> million, partially offset by $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JOxaSybhBEmm93r7VwCklA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsDerivativeInstruments" scale="6" id="Narr_bAXcn1WQ0EyXWmzda0vRgA">0.4</ix:nonFraction> million in deferred taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Foreign Currency Risk</b>.&#160;We operate on a global basis and are exposed to the risk that our financial condition, results of operations, and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. Our policy is to enter into foreign currency derivative contracts with maturities of up to <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_8_8yxPQPFUu5XLbijWH-yA" format="ixt-sec:durwordsen" name="us-gaap:DerivativeTermOfContract" id="Narr_Hyyab3uEaEW1EFbXBgfdtA">two years</ix:nonNumeric>. We are exposed to foreign currency exchange rate risk with respect to transactions and balances denominated in various currencies, with our most significant exposure related to transactions and balances denominated in Chinese Renminbi and Euros, among others. We do not use derivative financial instruments for trading or speculative purposes. We are not subject to any credit risk contingent features related to our derivative contracts, and counterparty risk is managed by allocating derivative contracts among several major financial institutions.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">74</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_skPA4ezGtEqynfRLBJYYUw_1_0"></a><a id="Tc_2j8N5zr1DUWD9CMFhOsdbQ_1_2"></a><a id="Tc_fEhg9IQZGEmLCrQoYw2KXw_1_4"></a><a id="Tc_OyMrPjUdIEmEK3lmc55DtQ_1_7"></a><a id="Tc_wl1mGQ9UIEmxfajJQkFNTA_2_0"></a><a id="Tc_dN0Rzj_KYkC1qHmOKOrCbw_3_0"></a><a id="Tc_FXuhuvvYiEq_kGZE9Y1beQ_3_2"></a><a id="Tc_cnGPjJ9ImkWpzsXk2FcLlA_3_4"></a><a id="Tc_evYgdDiqLEWV_p9Fr5Nyhg_3_7"></a><a id="Tc_Sq0sfJ6eRkymiEyepqSQ1A_3_8"></a><a id="Tc_QyzK-puP7kySxCvZohD6NQ_4_0"></a><a id="Tc_KzNJdN5lYEue92KzGwv94A_4_2"></a><a id="Tc_qNSDwYDdWkm2fQIaBUZcLQ_5_0"></a><a id="Tc_X2MH5KoS60WMJ2RKvvFKBw_5_2"></a><a id="Tc_mzr3v7J2QEepq4DJq8ukNQ_7_0"></a><a id="Tc_LRtWIHc0IUuvcXsy657MBA_8_0"></a><a id="Tc_vjBEvNH7uUqn2q9CcmjrtA_8_2"></a><a id="Tc_LwfMJDfTA0GlUl7RX60p8w_8_5"></a><a id="Tc_s_jNehqQ6U2H2D0A8nlV7A_9_0"></a><a id="Tc_yzRN23WfsEWkk_7_NAlvog_9_2"></a><a id="Tc_DHWsJAA3XUejZKzDQi8Itw_10_0"></a><a id="Tc_V6XcPDBf-kqWHq-WLGXSpg_10_2"></a><a id="Tc_c60XLiSd9UOWe4KK537onQ_12_0"></a><a id="Tc_mxGT7eAy9EOHWvjzXVzqhg_12_2"></a><a id="Tc_U3tDCzK-iUOvtWza7cmLhA_12_4"></a><a id="Tc_1O3JoRNFEU2TSB6RdL6poQ_12_7"></a><a id="Tc_R9vCSMc-okumpr6H55liHA_13_0"></a><a id="Tc_EwQErbdSoUuSrkVO9gJ1Xw_14_0"></a><a id="Tc_mr3vxY-f2EKz99ABG5hJ3Q_14_2"></a><a id="Tc_uKWaPpbIhEeroid0sYL76Q_14_4"></a><a id="Tc_-TxL60b89EGVmAg15Q_RUw_14_7"></a><a id="Tc_LHS2IZBudUuY0cnwWE84SQ_16_0"></a><a id="Tc_ldjz-AqHpU2-60htXqNz-w_17_0"></a><a id="Tc_0UpIn9CTLEGUQFiHQ2KzSQ_17_2"></a><ix:continuation id="Tb_-3iAR70PqUGQWoySEDQ42Q_cont1" continuedAt="Tb_-3iAR70PqUGQWoySEDQ42Q_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is temporarily reported as a component of other comprehensive income (loss) and then reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. We entered into forward contracts on various foreign currencies to manage the risk associated with forecasted exchange rates which impact revenues, cost of sales, and operating expenses in various international markets. The objective of the hedges is to reduce the variability of cash flows associated with the forecasted purchase or sale of foreign currencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We enter into approximately <ix:nonFraction unitRef="Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ" contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA" decimals="0" format="ixt:numdotdecimal" name="mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth" scale="0" id="Narr_vXl4I1WZBE-2ypbtic2UEg">100</ix:nonFraction> cash flow foreign currency hedges every&#160;month. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts, which qualified as cash flow hedges, with aggregate notional amounts of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="Narr_DI6Yu7KbD0eWGmT4FTam3w">87.8</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_H7J11ScbqEi4fWoBfmyKZw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="Narr_M_P1xWjuV0Kjo9BPUKMdjg">123.0</ix:nonFraction> million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Not Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We forecast our net exposure in various receivables and payables to fluctuations in the value of various currencies, and we enter into foreign currency forward contracts to mitigate that exposure. We enter into approximately <ix:nonFraction unitRef="Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ" contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_YBlNOyPkLU23Z6ZjVlbEKA" decimals="0" format="ixt:numdotdecimal" name="mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth" scale="0" id="Narr_7ZcPT9-noUWJlxscg22Gjg">50</ix:nonFraction> foreign currency fair value hedges every&#160;month. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts related to those balance sheet accounts with aggregate notional amounts of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_YBlNOyPkLU23Z6ZjVlbEKA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="Narr_G_AonGyHgUeUIe1njCwk2w">92.4</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_qFOq_wW62kSSMs1OwxY3-g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="Narr_5VAR6vd93kyz_ZwUQ0h2Bg">86.0</ix:nonFraction> million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Balance Sheet Presentation of Derivatives. </b>As of December&#160;31,&#160;2022 and 2021, all derivatives, both those designated as hedging instruments and those that were not designated as hedging instruments, were recorded gross at fair value on our consolidated balance sheets. We are not subject to any master netting agreements. <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="Group_hUiYn0Kyyk6TQTk3WvgQhQ" continuedAt="Group_hUiYn0Kyyk6TQTk3WvgQhQ_2" escape="true">The fair value of derivative instruments on a gross basis is as follows (in thousands):</ix:nonNumeric></p><ix:continuation id="Group_hUiYn0Kyyk6TQTk3WvgQhQ_2" continuedAt="Group_hUiYn0Kyyk6TQTk3WvgQhQ_2_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments Designated as Hedging Instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance&#160;Sheet&#160;Location</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets (long-term)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_IUTMOoGSYUSlf5FDP00RrQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_0nJdVvSvykaPiwdi1vlk6Q_3_5">3,444</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_vMDqDRimQUGVsJqDaXM38A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_f87-zobg9kaB9FnGc-ZwXQ_4_5">3,215</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_L0K7XndHi0OEyV8MrOqpmA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_0_8tx5kTGEeoVS4vXHZd3Q_4_8">1,326</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets (long-term)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_uNomnuKXAECdAPu7QMed0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_1B3TC93dCECnF_vBQSKleA_5_5">56</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_d3jAs283gEicHG2ZvBV4CQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_uqXl5e2xVEarWtvonTTcNw_5_8">179</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Liabilities)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_BBWY2l8nB0G5rPJksNt47A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc_gm9_lsrfF0WHVLaCti6PjA_8_8">1,447</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V3-frjJY_UmM_jR_g6jVHg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc_hCzTGUCS6Eae3NNf1oaR1w_9_5">1,509</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_jOoxPiQ8oEKYkVGlwyYgBg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc__YT7VBsiyE-XXiv-Qf-7bw_9_8">2,288</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V96Xu0PnRkq7CZcqhwZ9wg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc_rzoyOR0FAEmpXAfXUztaqg_10_5">531</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_6HKnbEJ3LkOuSxP6-rmASg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc_0Eyua-f7IUeePm3ZBJITag_10_8">502</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments Not Designated as Hedging Instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance&#160;Sheet&#160;Location</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_sDnLdoNkA0G_KKlMx5qh6g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_0T0FTdHlAEG8an2HsGVOfA_14_5">1,512</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OD_1uS3fckadl_NP9-khyA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="Tc_LIYwpu38ZkKhO-0-V6Dhtg_14_8">736</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Liabilities)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_7Bk5S5y3pUqsM1mFsZA5qw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc_xlhspwzor0Wrmm0vaSqq3Q_17_5">1,946</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_ubGIOi0F8UCMr2ybX-8S_g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="Tc_zDP96jKTXkeih8xwvdEWIg_17_8">856</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">75</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6e39d3a8_3a89_4be0_b037_5b828c1721e0"></a><a id="Tc_LparL8sBMEmrhDozde3a1Q_1_2"></a><a id="Tc_J6rsrUOWrEy9dSylzCi9dw_2_2"></a><a id="Tc_qBflk9p01kqC-3IGRljP1A_3_2"></a><a id="Tc_icalxA-KWk-0lT__qy5zFw_4_0"></a><a id="Tc_Er0Arx_jCEahxdrMJNcfSw_4_2"></a><a id="Tc_XvY9gLU4OU64vwf66VChaQ_4_5"></a><a id="Tc__aEkFAFtqESXcXVwM3wXYw_4_8"></a><a id="Tc_PS6KS-eWNEub66MVAxLovw_5_0"></a><a id="Tc_i4oiWXyV_0WfAhb7lMfr4w_5_2"></a><a id="Tc_97cdLfrDaUKPi7nAD3Bisw_5_5"></a><a id="Tc_lgu-7G3XC06QgB33oTjFhg_5_8"></a><a id="Tc_z1WiZz1Xl0KWyHBhSKFFlg_6_0"></a><a id="_4f3923aa_e6f0_4631_85cb_a839f9f5ac19"></a><a id="Tc_E2ICsjCS4EubZ971CypRaw_1_2"></a><a id="Tc_o07JPnr6UkCbSPPKCVXcfg_1_11"></a><a id="Tc_Krbb9FhtIUumA8y3ESxQ0w_2_2"></a><a id="Tc_gX1XrO_V6kKRJg7HYjXwpA_2_11"></a><a id="Tc_IyOyuJfSZkyoH-_MbO7tRg_3_2"></a><a id="Tc_3MlqYujvnkyUw6U3nv3HAg_3_11"></a><a id="Tc_hyDVre6u7Ea9BwZLdx8YGw_4_0"></a><a id="Tc_azukt-djsU25tHjCMeFOBg_4_2"></a><a id="Tc_TfOhqdlF1EWnuSxBCcD4BQ_4_6"></a><a id="Tc_vGclPJxtN0-xbCn2ytFYvg_4_8"></a><a id="Tc_cZpbkM576UWFWT2iOAWXxQ_4_11"></a><a id="Tc_VMJJuSSi80CvoCvsYgvwIw_4_14"></a><a id="Tc_vbUzvD3pTE2hGRx39vevLQ_4_17"></a><a id="Tc_R0JRZOt2TkGt3RXTiwv_Pw_5_0"></a><a id="Tc_LPy9viUcPkmoZNtmMtughA_5_2"></a><a id="Tc_a9NRFr-1kkmKDS9HM-7kOg_5_5"></a><a id="Tc_jnD5QqfoQkmOAwGyTVl50w_5_8"></a><a id="Tc_caa-pouYG0SyLAZiRx4LPw_5_11"></a><a id="Tc_WZbXOmILg0aAt1gS6JHQpA_5_14"></a><a id="Tc_7u495mYpOU2-u5CJBx8PHA_5_17"></a><a id="Tc_v2vGMfTFRkq5CLHYv7BHEg_6_0"></a><a id="Tc_27MeGprKWECjJrSKyNKC-w_7_0"></a><a id="_318f4503_af05_4f97_b4cb_462ca80cbb6c"></a><a id="Tc_d53-4-3ytEa7FdMFPSql9w_1_4"></a><a id="Tc_g1vNLtgUdE-6RUKrG4xtRw_2_0"></a><a id="Tc_VDxo9NMFG0K62I9tgaggIQ_2_2"></a><a id="Tc_UnRQJiZs40-6JCgr45aRZg_2_4"></a><a id="Tc_qotZWnMC4Uetpq6DhByPdw_2_7"></a><a id="Tc_4KeHNlt8i0q-R4MNlX123Q_2_10"></a><a id="Tc_-E06QEp3AE2QoWYBknj5ZQ_3_0"></a><a id="Tc_5dK_kWlHzUap4wtNmxDp7Q_3_4"></a><a id="Tc_InhUZYqw2Uq9CNOxZ68O1w_3_7"></a><a id="Tc_8FqKxdwWvkKYhhSrl1ux1A_3_10"></a><ix:continuation id="Tb_-3iAR70PqUGQWoySEDQ42Q_cont2"><ix:continuation id="Group_hUiYn0Kyyk6TQTk3WvgQhQ_2_cont1"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Statement Presentation of Derivatives</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Designated as Cash Flow Hedges</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="Tb_F4K6nRzWlUCPjhk6VyCnMw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income (&quot;OCI&quot;) in our consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount&#160;of&#160;Gain/(Loss)</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Recognized&#160;in&#160;OCI</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Derivative instrument</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Interest rate swaps</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_zc2ERyYBRUKEX1L10n6VZA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="Tc_2meS2_j_BUK3BqwNtINkrQ_5_3">4,879</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_GVmvdOejHUemtyQusSrLBA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="Tc_AlQqsXUUm0yskxYRWqddrg_5_6">1,402</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_cNz_-CadmU-KLZHsUgTE7w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" sign="-" scale="3" id="Tc_r-FRqHTYKEuStzjKL-QvIQ_5_9">6,131</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Foreign currency forward contracts</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_Ywl3JgUM702U95RFgQlRaw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="Tc_Hn8A3jqNg0aP5FHblCtw8Q_6_3">6,263</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_vnyL3I4nU0O1maZQbdeu6w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" sign="-" scale="3" id="Tc_x561jUM5s0OOqWLndrMkbw_6_6">1,521</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_bN8XBH6sl0Oi6_jiK3FrEA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" sign="-" scale="3" id="Tc_Nb4bhdL2TUaS45mkcXG_JA_6_9">5,516</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on AOCI and net earnings in our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Consolidated Statements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount&#160;of&#160;Gain/(Loss)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reclassified&#160;from&#160;AOCI</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;width:39.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Location in statements of income</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Interest expense</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="Tc_Rx96Z_8-zE6itOqWIaKFPA_5_3">6,339</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="Tc__8Z9M4ZiTUiLau65WdNstw_5_6">5,261</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="Tc_1OvL4VgvNkGZIyyI_eu53w_5_9">9,994</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_J_jEZHS6W0CE4zFDg0hOEA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" sign="-" scale="3" id="Tc_xucNMKAkPk6ALyOtRIu06w_5_12">12</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_DSBEv7Elwk6u3sZ3evR8Mg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" sign="-" scale="3" id="Tc_tfOmWzf1gkeX0OchSBmdCA_5_15">1,509</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_EjcLYIKKkkCUoWHgDM1Mxg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" sign="-" scale="3" id="Tc_BVM-m_8t50CtsHS7KNWi8g_5_18">872</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Revenue</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_eXQMW6twHUWCyEBb_h_xFg_6_3">1,150,981</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_O1kHlzFbkUenvUZ5AbIFDg_6_6">1,074,751</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_fOarFw9HCUW0MPjl-s-hjQ_6_9">963,875</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_YtPykTJnRkKC0CuJpKTvOA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="Tc_9meOa9E1WU6_bqIZ7HK1vA_6_12">3,583</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_651_ONWx0E-kOfcPokz1LQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" sign="-" scale="3" id="Tc_hk-plfKsiUaw_y4tdj2Hmg_6_15">5,592</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_z9Y6hxatL0aNPYGB24x1vQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="Tc_ABvmD8nu4Eid4eeHvMDm8A_6_18">36</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Cost of sales</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_hYDE8iKhpkSPQw7qMRMQWA_7_3">631,882</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_WmmwdUi2gka3EGwiedRGgw_7_6">589,418</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_ezxDZPUE9kKbwNNBJbpe2g_7_9">562,698</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9e9qLIpZ9kKq6G-HazuXuA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" sign="-" scale="3" id="Tc_NcRqtMcFq0mYDXlqlQLPEg_7_12">1,436</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9f2ZOgRsCESUeU-GyCvi5Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="Tc_57o7cFLuyky_KE-6ZbRShQ_7_15">1,017</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Mb6B1L4bMUW6eZXS3Daluw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" sign="-" scale="3" id="Tc_VJJhlW4boE-612zoYFx0Mw_7_18">1,288</ix:nonFraction>)</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew" decimals="-5" format="ixt:numdotdecimal" name="mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" scale="6" id="Narr_qJZpBAwB3E6On3PSgRMxcA">2.7</ix:nonFraction> million or $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="Narr_v9r9LM0ppUmphd9mk589XQ">2.1</ix:nonFraction> million after taxes, was expected to be reclassified from AOCI to earnings in revenue and cost of sales over the succeeding twelve&#160;months. As of December&#160;31,&#160;2022, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_HwhbRLWUDECOhM6E1bMPeg" decimals="-5" format="ixt:numdotdecimal" name="mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" scale="6" id="Narr_0Arn_8sSb0GPnSQiVhLTSQ">2.3</ix:nonFraction> million, or $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_HwhbRLWUDECOhM6E1bMPeg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="Narr_4hq3HTfi6UWImThm5Rz3fw">1.8</ix:nonFraction> million after taxes, was expected to be reclassified from AOCI to earnings in interest expense over the succeeding twelve&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;">Derivatives Not Designated as Hedging Instruments</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="Tb_trzGW2jPD0W-gocTFL0oMw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income (loss) for the&#160;years presented (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:30.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Derivative Instrument</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Location in statements of income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Foreign currency forward contracts</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_EbHCmjYljUGB_8dKno-fsQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Other income (expense) &#8212; net</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="Tc_YnRHOjQUeUGbv6A8WQwwng_3_5">1,420</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_a6q6MSDqW02kPa4lJGG3MQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" sign="-" scale="3" id="Tc_WiWkjsIKTk2nNwllCovt5w_3_8">1,598</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_w_w-NqxInkmFUqMf_XcMMQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" sign="-" scale="3" id="Tc_g8FjfTlj7EiD_CjHTjrEWA_3_11">2,190</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">See Note&#160;15 for additional information about our derivatives.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk34029420"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Tb_xxOyhcTdP0CrQVizlR8KEw" continuedAt="Tb_xxOyhcTdP0CrQVizlR8KEw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">10.</b></span>COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We are obligated under non-terminable operating leases for manufacturing facilities, finished good distribution centers, office space, equipment, vehicles, and land. See Note 17 for disclosures regarding these operating leases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Royalties</b>. As of December&#160;31,&#160;2022, we had entered into a number of agreements to license or acquire rights to certain intellectual property which require us to make royalty payments during the term of the agreements generally based on a&#160;percentage of sales. During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, total royalty expense approximated $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_bbrBKCNcLUOQmTf4LjLfbA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RoyaltyExpense" scale="6" id="Narr_joVNrkpUikG-9f7gaD3CbA">7.3</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W7ZIFyCygUuKNAAvOSvoSA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RoyaltyExpense" scale="6" id="Narr_oddmQ5fd_068kcAyp6_C2w">7.6</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Nn7nL1keE0GsDMUUEXCHfw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RoyaltyExpense" scale="6" id="Narr_3qdC40YLlESKaHtcsukYbA">7.1</ix:nonFraction> million, respectively, and is recorded in cost of sales on the consolidated statement of income (loss). Minimum contractual commitments under royalty agreements to be paid within twelve&#160;months of December&#160;31,&#160;2022 were not significant. See Note&#160;15 for discussion of future royalty commitments related to acquisitions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Litigation</b>.&#160;In the ordinary course of business, we are involved in various claims and litigation matters. T<span style="background:#ffffff;">hese proceedings, actions and claims may involve product liability, intellectual property, contract disputes, employment, governmental </span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">76</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_DV_C46"></a><a id="_DV_M744"></a><a id="_DV_C48"></a><a id="_DV_M745"></a><a id="_DV_C50"></a><a id="_DV_M746"></a><a id="_DV_M747"></a><a id="_DV_C53"></a><a id="_DV_M748"></a><a id="_DV_C55"></a><a id="_DV_X62"></a><a id="_DV_C56"></a><a id="_DV_X64"></a><a id="_DV_C57"></a><a id="_DV_C58"></a><a id="_DV_M749"></a><a id="_DV_M750"></a><a id="_DV_M751"></a><a id="_DV_C68"></a><a id="_DV_C69"></a><a id="_DV_X66"></a><a id="_DV_C70"></a><ix:continuation id="Tb_xxOyhcTdP0CrQVizlR8KEw_cont1" continuedAt="Tb_xxOyhcTdP0CrQVizlR8KEw_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">inquiries or other matters, including those more fully described below.&#160;The outcomes of these matters will generally not be known for prolonged periods of time. In certain proceedings, the claimants may seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief.&#160;For legal matters for which our management had sufficient information to reasonably estimate our future obligations, a liability representing management&#8217;s best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded.&#160;The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect our financial position, results of operations and cash flows. The ultimate cost to us with respect to</span> actions and claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Shareholder Derivative Action</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On June 3, 2021, Steffen Maute filed a complaint, derivatively on behalf of Merit, against Merit (as a nominal defendant), our Chief Executive Officer, our Chief Financial Officer, our former President of EMEA and certain of our directors in the United States District Court for the District of Utah (Case No. 2:21-cv-00346-DBP). The derivative complaint alleged that the individual defendants violated their fiduciary duties owed to Merit and were unjustly enriched at the expense of and to the detriment of Merit between February 2019 and October 2019, and sought unspecified damages, costs, and professional fees. Following mediation, the parties negotiated an agreement to settle the dispute, which, among other provisions, provides for the release of all claims against Merit and the other defendants in exchange for Merit&#8217;s undertaking to implement certain corporate governance revisions and pay attorneys fees and expenses in the amount of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_LitigationCaseAxis_mmsi_MeritShareholderDerivativeSuitMember_ewzR_Ik4L0K4K-iU6Qne5Q" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="Narr_W2Vjskr8qEK3T13F26hEuQ">1.0</ix:nonFraction> million. On February 16, 2023, the court held a hearing and announced approval of the settlement, which has the effect of resolving all claims arising from the litigation. The expense associated with the settlement has been reflected in our financial results reported for the year ended December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">SEC Inquiry </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We have received requests from the Division of Enforcement of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) seeking the voluntary production of information relating to the business activities of Merit&#8217;s subsidiary in China, including interactions with hospitals and health care officials in China. We are cooperating with the requests and investigating the matter and, at this time, are unable to predict the scope, timing, significance or outcome of this matter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">It is possible that the ultimate resolution of the foregoing matter, or similar matters, if resolved in a manner unfavorable to us, may be materially adverse to our business, financial condition, results of operations or liquidity. Legal costs for these matters, such as outside counsel fees and expenses, are charged to expense in the period incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">77</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><ix:continuation id="Tb_xxOyhcTdP0CrQVizlR8KEw_cont2"></ix:continuation><a id="_1d0970a1_8ff1_4a74_b76c_83f18644e018"></a><a id="Tc_vhi4NBv1PkC5s_rysRuMEQ_1_2"></a><a id="Tc_as2w_Ayl-ES2F8yh2XU7fA_1_5"></a><a id="Tc_hYvwgUNka0eY1YUyFvfyAw_1_8"></a><a id="Tc_TOvynZllQEGz8kQggi-tQA_2_0"></a><a id="Tc_qz3kz-62cEecQzyE6T8w7A_2_2"></a><a id="Tc_hfFf1IiDZUuDLOYg4Q6F1g_2_5"></a><a id="Tc_YIYOXYL5P0a-Q0iNAOlExw_2_8"></a><a id="Tc_8XqI5CmC9kqqFr3cXui8Qg_3_0"></a><a id="Tc_MXncjqPEgkqmeId6fWbqpg_4_0"></a><a id="Tc_3HhIV9Xahk6Ahotl-BZe1g_4_2"></a><a id="Tc_hcr_jZxXlUCqiNgMQoZwcQ_4_5"></a><a id="Tc_HAxRnIOIqEa9BgJam1Cajg_4_8"></a><a id="Tc_ZVf6ckVqh0KwP5YIQITuCg_6_0"></a><a id="Tc_xPVpCMDPZEK_lVxTT4kWOQ_7_0"></a><a id="Tc_q2K4p94HCk-DV55BsEMJVw_7_9"></a><a id="Tc_OW8bKvL0_Uy2X6Onrd9wTQ_8_0"></a><a id="Tc_jEp9CskqTEOncKCZAMhu8Q_9_0"></a><a id="Tc_eTlkeGs-wU2tmfuVf7qpKQ_9_2"></a><a id="Tc_5OdR3V3MD0a-rJkK_W9PDw_9_5"></a><a id="Tc_SaqVO4oNQkCNIeWbfpRU9A_9_8"></a><a id="Tc_TF1_b9ALq0uNXsC3P2QO6w_11_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:EarningsPerShareTextBlock" id="Tb_7PksVFuKNUKP3wz0iTHBUw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">11.</b></span>EARNINGS PER COMMON SHARE (EPS)</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Tb_3TNvpmKHy06NIM4WZHrKmg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The computation of weighted average shares outstanding and the basic and diluted earnings (loss) per common share for the following periods consisted of the following (in thousands, except per share amounts):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_-MUeoRD_4EWihOEIttfGMA_2_3">74,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_5a3PsTSuMUac5HUf20DqtA_2_6">48,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_aIYM5sWrMUCgfWhwwZI3eA_2_9">9,843</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Average common shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_A6FlFgvhjk6-h22WXANm0g_3_3">56,806</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_cOpguE4HpUiG2JPKQ4836g_3_6">56,145</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_3vg0cZ0WsUmEewMAZ0FS1w_3_9">55,434</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic EPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_iiFxIZFiWEOzkhqsP-kpaA_4_3">1.31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_qmQMCPzTRk6OEgWOS52v3A_4_6">0.86</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" scale="0" id="Tc_-bNZfG7Aakm0aPiC9sSycg_4_9">0.18</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Average common shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_bab-8ONdLEuDQ7DxW91tEg_6_3">56,806</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_txz5ONn0LkShmXQCgpGmJg_6_6">56,145</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_6-401uZsPU2rxJ4N0U3jiA_6_9">55,434</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of dilutive stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="Tc_QYCgI7Mwp0qxmfuAt8ZBHA_7_3">865</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="Tc_uQRUk4CKS0ezYU0qKc0R6A_7_6">1,214</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total potential shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_VmsawPbrbEepCs98ZflP0g_8_3">57,671</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_KSeHSKILn0GbqMp7gYgsTA_8_6">57,359</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_ScVT95KTN0eCuYNVKPDp3g_8_9">55,434</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted EPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_RGj-CXhj5EiHp8gwX4W8Ug_9_3">1.29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_5FevTUFoJkOCVoFfNJn1Zw_9_6">0.84</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" sign="-" scale="0" id="Tc_hkS4t9DNUUmPykkxXLpcBA_9_9">0.18</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity awards excluded as the impact was anti-dilutive <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_N3bwm3QOEEWF74cPy4zzeQ_11_3">1,438</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_k0xTrW2-c0yobjLn_Bz-qw_11_6">799</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_mcMkMQynxUKzRNs-HjITvQ_11_9">4,216</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Does </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">not</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> reflect the impact of incremental repurchases under the treasury stock method. </span></td></tr></table></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Tb_gXS9-BRpeEe291cNUxFecA" continuedAt="Tb_gXS9-BRpeEe291cNUxFecA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>EMPLOYEE STOCK PURCHASE PLAN, STOCK OPTIONS AND WARRANTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our stock-based compensation primarily consists of the following plans:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">2018 Long-Term Incentive Plan</b>.&#160;In June&#160;2018, our Board of Directors adopted and our shareholders approved, the Merit Medical Systems,&#160;Inc. 2018 Long-Term Incentive Plan, which was subsequently amended effective December&#160;14, 2018 (the &#8220;2018 Incentive Plan&#8221;) to supplement the Merit Medical Systems,&#160;Inc. 2006 Long-Term Incentive plan (the &quot;2006 Incentive Plan&quot;).&#160;The 2018 Incentive Plan provides for the granting of stock options, stock appreciation rights, restricted stock, stock units (including restricted stock units) and performance awards (including performance stock units).&#160;Options may be granted to directors, officers, outside consultants and key employees and may be granted upon such terms and such conditions as the Compensation Committee of our Board of Directors determines.&#160;Options typically vest on an annual basis over a <span style="-sec-ix-hidden:Hidden_hlnL4vN8SUG8ae4Eqn09kg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> to <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_R06ETi2TMkqS-odoJkwA1A" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_e29xbjSHCUqDcRRIOzi8dg">five-year</ix:nonNumeric> life with a contractual life of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_i-4hy_JVkUqCTXWyIeMrmQ" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Narr_nz1CPL5QQ0y6SWwGVj7T9g">seven years</ix:nonNumeric>. As of December&#160;31,&#160;2022, a total of <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_AIeZ1LxyUU-U04p2bkns4A" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_erVgO7OUGEmwurPNn6MVsw">2,817,861</ix:nonFraction> shares remained available to be issued under the 2018 Incentive Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">2006 Long-Term Incentive Plan</b>. In May&#160;2006, our Board of Directors adopted, and our shareholders approved, the 2006 Incentive Plan. As of December&#160;31,&#160;2022, the 2006 Incentive Plan was no longer being used for new equity award grants. However, as of December&#160;31,&#160;2022, options granted under this plan were still outstanding, vesting, and being exercised and will continue to be outstanding until the vesting periods end and the terms of the equity awards expire.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Employee Stock Purchase Plan</b>. We have a non-qualified Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which has an expiration date of June&#160;30, 2026. As of December&#160;31,&#160;2022, the total number of shares of common stock that remained available to be issued under our non-qualified plan was <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_7hQKDlFBGE-A_JKU8z88Kg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="Narr_yq_zfVuqDUizNJBBXpzoGw">102,739</ix:nonFraction> shares. ESPP participants purchase shares on a quarterly basis at a price equal to <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_73syZyrdCEaiuRTfMsiD0g" decimals="INF" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" scale="-2" id="Narr_m2nAyE86RUybU9BjEH-dRQ">95</ix:nonFraction>% of the market price of the common stock at the end of the applicable offering period.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">78</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_UnbOhHFH5EaxodRfupPwqw_1_2"></a><a id="Tc_VLs9YoKk4UixbYFcnVkVfw_1_5"></a><a id="Tc_Jp7MC2rQ7kSjDwfIQ7DbBQ_1_8"></a><a id="Tc_0Gd7gA1FS028yW0w-yMs_Q_2_0"></a><a id="Tc_F4G6vg9TfEqvq7LWmxuiLQ_3_0"></a><a id="Tc_bmW-wEpUNUiesSwAdEV1Fg_3_2"></a><a id="Tc_TWwGdqj1vEiQ5pvREvEaPw_3_5"></a><a id="Tc_i-4ViszBGUOPRFzH2M46IA_3_8"></a><a id="Tc_6OAAqS_OAkKtlSG8kqTUkQ_4_0"></a><a id="Tc_Rh-7F31yg0-GJR9umq2EiQ_5_0"></a><a id="Tc_IOFWH6FVK0GrlgJT7qyNGA_6_0"></a><a id="Tc_SAzIG-bs7kGBoxTax_C3bw_7_0"></a><a id="Tc_S1yDOjt0OUi3m9x8to2DNw_8_0"></a><a id="Tc_tvxZn4T_AUy77TCxOmvYnw_9_0"></a><a id="Tc_QTZ_kB6TbUWtT94tKWa9VA_10_0"></a><a id="Tc_FJkjw9XgVkSysXVvxdymrw_11_0"></a><a id="Tc_Hsm5v-YpLEyK4rPMvRBjwQ_13_0"></a><a id="Tc_Px3Xa_X_D0mwTyxa4jOEdg_13_2"></a><a id="Tc_QDLql-ykxEiYKR75cIrLXA_13_5"></a><a id="Tc_EcRXPgUAnkWcotUjWNlXyw_13_8"></a><a id="_92db4349_56b2_4186_9667_7a283228dacd"></a><a id="Tc_UTG9gXF8lkKVyzuvDv_E9A_1_2"></a><a id="Tc_xMsku_kHQkWcwFEwp7Urww_1_4"></a><a id="Tc_ORtEcqJDBkeSgtHcQ-uCHw_1_6"></a><a id="Tc_mHUXA123uEmWktx2rdlILQ_2_0"></a><a id="Tc_dXDGqO8CDEOQnPflF5TH6g_2_2"></a><a id="Tc_ygbsQIzDlEa47qIMwEvIKg_2_4"></a><a id="Tc_-FP4yuIoZ0m9_yOU8xWZJg_2_6"></a><a id="Tc_4eak1soBrkiwHTnh8mNhXw_3_0"></a><a id="Tc_pIyjsuAVPk-O86hTPgVzow_3_2"></a><a id="Tc_RgaKz0jFWkmNm2U2kzcq9A_3_4"></a><a id="Tc_bWzGusWniEyEo4hqjagLcw_3_6"></a><a id="Tc_QNmZPW2D90qT0fY5dLl3Aw_4_0"></a><a id="Tc_rKCl3dk1HEqMnsOoNfuONw_4_2"></a><a id="Tc_QEjxm4tIkUm4Eh7DxRaNcg_4_4"></a><a id="Tc_byg1YNJP20GRiKGETHK8dQ_4_6"></a><a id="Tc_f_ona5vVV0mMw2Cb3HO5ow_5_0"></a><a id="Tc_NatR6TN1Lkeh4L9_OlTlNw_5_2"></a><a id="Tc_4VyGBWJTcUiEpi3WHAscCQ_5_4"></a><a id="Tc_aHJfzZkHS0uRdrgNpMypfg_5_6"></a><a id="_207ab0ce_4fc5_482f_819a_310122e13016"></a><a id="Tc_VqSpnCq7OUWjaM1CGSKUxg_1_2"></a><a id="Tc_2RyrRLgIMEODEWRZYH5e0g_1_5"></a><a id="Tc_aLiPWhmiuEO2xjvwT8QoTg_1_8"></a><a id="Tc_FU-XfDdFgUuvIl93-ySPXg_2_0"></a><a id="Tc_mgBMWLK7gkeMjfy1Ev7jxg_2_2"></a><a id="Tc_rTnxxbrRXkC5uZuH6wNFxA_2_5"></a><a id="Tc_yO1dgd4c1Um_f5wv074ulA_2_8"></a><a id="Tc_8YpQcU00u0GQMHenWFQNTw_3_0"></a><a id="Tc_Ix_tyXJqsEWi6lLuWHlOdA_4_0"></a><ix:continuation id="Tb_gXS9-BRpeEe291cNUxFecA_cont1" continuedAt="Tb_gXS9-BRpeEe291cNUxFecA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b>.&#160;<ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="Group_W3bihTLNYUyOtKACNJqpVw" continuedAt="Group_W3bihTLNYUyOtKACNJqpVw_2" escape="true">The stock-based compensation expense before income tax expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</ix:nonNumeric></p><ix:continuation id="Group_W3bihTLNYUyOtKACNJqpVw_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_ZZfj3R7V5Eaf4KlhxZX0NA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_qi6Ue6DM10aoWRY0LJfScQ_3_3">1,606</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W2-lwaQajUmjU-r2zs34Yg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_vsgfYHyfn0GKhRhvX-6-lQ_3_6">1,476</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_4h-sVt6F-068ZNWfSqnEFQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_JpYkx7vUeEmX_zRn5-f9VA_3_9">1,357</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_IvGlF5Zb_0aI82EUdrzxpw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_ZQjjDo5NtkGJB1YKG97Ehg_5_3">1,789</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_QL5MDDksJk6BV7x5RToVoQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_JkMrynlF8ECLM8OMXWbfKw_5_6">1,343</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_z8YzjacK6k6Eh7TEMhdvDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_gxNxvqa6SU-gOXe6kc5AmA_5_9">1,157</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Imq-yl3UN0SxC6ocv52NnQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_JsddZVnxJkGpYACnSEw5jw_7_3">7,305</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_T7UpOFHUfUKuQYJJK2urrA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_YpOEpEnmDECqbZI3MQi1MQ_7_6">6,678</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N8U8BNsA1kKxcg9Cty-FoA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_QVOQh4RZB0CQm6sclUtx4g_7_9">7,332</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Performance-based restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_iDtT3Y7T4ES-G4M9NJ5iwA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_ByodiCBeckSB1v8uZc5E8A_8_3">3,509</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Kq8CJRyvgEqTiCMrffL5Dg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_j4Lha0TDbke2VKumX-S8gQ_8_6">3,525</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_wNH7WZpHE0KRoLTZeAliog" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_D_QJena8eEaHMmMfxXq17Q_8_9">2,829</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Cw05VY0_I0-Am1JQU64fgw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_iXbZaAM4v0qlUVFEDMoexQ_9_3">1,836</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N0bSnffBZEK-_wgFvh8Ohg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_ceeSGixGAUmSS6Y4tTAj-Q_9_6">1,557</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62E2hM7g4EGHRbMuBjMCIA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_5c0uygMxwEKClQUODpCp_Q_9_9">758</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash-settled performance-based share-based awards (&quot;Liability Awards&quot;)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_MSYHJr3mNU2lIv5avLZ04Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_s6qo6GPIHEC5_hyDky_i-w_10_3">1,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BOpfzPG26ECbr8ZPTKepRw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_a3kbJ7mF3kqWu-jR6LFZHg_10_6">1,511</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_yy2rfbwVDkuhigmz2rclqQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_5cVMcOMdO0CEXwkg-TrFHA_10_9">906</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Pn_ji6z-9EujtMdTc7Xe2g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_3D8vQZ8DWUuW63ooC-fa5w_11_3">14,647</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8PfvIfnmqUCeZXIMgXoYkQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_gZfFlzMVc0-DW8c4F1S0dw_11_6">13,271</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_NHhcrvVH_U2r85qDDyQQ3g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_NsxTPfhjZkSA8yxgP6ZLFA_11_9">11,825</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation expense before taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_8J2fEM7qY0Ov9kSZe0ZJ9A_13_3">18,042</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_4otzar4Pv0yEfPWIva-uOA_13_6">16,090</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="Tc_YD8HRhMGpkqnGhvP6dC01Q_13_9">14,339</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We recognize stock-based compensation expense (net of a forfeiture rate) for those awards which are expected to vest on a straight-line basis over the requisite service period.&#160;We estimate the forfeiture rate based on our historical experience and expectations about future forfeitures.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Nonqualified Stock Options</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, the total remaining unrecognized compensation cost related to non-vested stock options, net of expected forfeitures, was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_ATNZbLCh8keW60__JyknWA" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="Narr_YKfODDFTEE2HMPurY70zoA">20.4</ix:nonFraction> million and is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Narr_WOyN-iBcsUCfaCyIp07atA">2.1 </ix:nonNumeric>years.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Tb_0rLZ3frsEEiZwRl8EIH1Lw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">In applying the Black-Scholes methodology to the option grants, the fair value of our stock-based awards granted was estimated using the following assumptions for the years ended December&#160;31,&#160;2022, 2021 and 2020:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.57%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_zK8oljuS2kq2sQwiQDfDWQ">1.4</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_UMzvJl61nkWRB4lGhYnNYQ">4.3</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_iQS2LYLJq0KDPNJJT5eWXA">0.5</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_a8WmrXLEKUiLuLldROIYpw">1.1</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_eRr8SnK9206izPo6cvi7Tw">0.3</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_lfEIa6Gda0ai5AEkjXvcJQ">1.7</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected option term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_JZZebwMoYUKOugBTGVfvvg">4.0</ix:nonNumeric> years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr__i3BtPuJckqSaFF2VA5Mxw">4.0</ix:nonNumeric> years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yq6tnYStUk6a7MAFzkSQcg" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_YVnlSDa2GUOhTqHhAgx90Q">4.0</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_4i2h-0r8ekOAQM9CYwMASw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_hyHkxq5Xb0eKAgagbFdFYg">5.0</ix:nonNumeric> years</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected price volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_yoSRngNMrE-bE0kf7URBRA">46.2</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_BjQlFapHX06IH-N-tIRDIw">47.5</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_QRnmZzGd-U6fT6iATPBrnQ">46.1</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_SN6vOklD2U2y6PPDhHB11A">46.7</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_5o3kUtXFxk-fCuKSRHc-8A">38.7</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_naa1JcYcMk6AFfmOhWrQIQ">45.1</ix:nonFraction>%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The average risk-free interest rate is determined using the U.S.&#160;Treasury rate in effect as of the date of grant, based on the expected term of the stock option.&#160;We determine the expected term of the stock options using the historical exercise behavior of employees.&#160;The expected price volatility was determined based upon the historical volatility for our stock. We recognize compensation expense for options on a straight-line basis over the service period, which corresponds to the vesting period.&#160;During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, approximately <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" id="Narr_zAhHtxeInE6v9PEI06WxSQ">251,000</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" id="Narr_DXzoPd_L70ariKqpU6sRvQ">716,000</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" id="Narr_vr5p0JZjcEGxtJptail39Q">329,000</ix:nonFraction> nonqualified stock option grants were made, respectively, for a total fair value of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="-5" format="ixt:numdotdecimal" name="mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures" scale="6" id="Narr_g9GTLYZDDkiJZzOgvbgzWQ">6.3</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="-5" format="ixt:numdotdecimal" name="mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures" scale="6" id="Narr_Fj8pD0dJeUOvQku5w8xnMQ">17.5</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="-5" format="ixt:numdotdecimal" name="mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures" scale="6" id="Narr_YF2zXXYHrkWpARFHwjasYA">4.5</ix:nonFraction> million.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" id="Tb_OxiYpKs1Jkm1j1rD8jgdMw" continuedAt="Tb_OxiYpKs1Jkm1j1rD8jgdMw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The table below presents information related to stock option activity for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total intrinsic value of stock options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="Tc_apcWPZWEJEuu2kaJjFg0bQ_2_3">27,110</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="Tc_3JUNkQxzk0WogCmzkMbw8g_2_6">36,086</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="Tc_nFjT9zz_C0q1ciAn_KxFhQ_2_9">11,733</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash received from stock option exercises</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="Tc_hl6Dvo3utEmNiXWoypBkFA_3_3">18,952</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="Tc_nTitUUtd50-EOdNojLQteg_3_6">20,194</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="Tc_boWDuOdz5kma7wN8vZ86aA_3_9">5,481</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Excess tax benefit from the exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="3" id="Tc_1K3QBlgyZ0uqc5qay_ewWw_4_3">3,423</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="3" id="Tc_Y_UHtPiDm0GkltBqp03mpg_4_6">5,571</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="3" id="Tc_FGitXKliskurLJBX0cZd0Q_4_9">1,815</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">79</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a72791cd_063a_4f2b_b338_d94eecc2751e"></a><a id="Tc_hmyo6bFvx0aLiSIw7iw64w_1_2"></a><a id="Tc_2hw2njQB9UOWTMC2ahYaLQ_1_4"></a><a id="Tc_Hdw-7n1RHEC6Nw85ZQea0g_1_7"></a><a id="Tc_S3UiURPO6EiUT_LL1EX_uQ_1_9"></a><a id="Tc_x0SZaMtS0US9sydI-0E4Ow_2_2"></a><a id="Tc_x9KhgcBnWk6W1sxrct9DTA_2_4"></a><a id="Tc_DkU2HiutQU6gufHI4FpDgQ_2_7"></a><a id="Tc_rbnxr-6L-kKGF__SJLo-LQ_2_9"></a><a id="Tc_0D3YOzYr30eT3VEycq9n7Q_3_0"></a><a id="Tc_x47P9ygUsUGcg0JFxQSw-g_3_4"></a><a id="Tc_F-nsnSW8qUqF07EwF4FEeA_4_0"></a><a id="Tc_gWFyFjnavUajOY6ISfGqcg_5_0"></a><a id="Tc_tS3yG7-Od0aZJYYRHHZ7UA_6_0"></a><a id="Tc_qyCLrdSw_0mZoxbCW3Ie4Q_7_0"></a><a id="Tc_X5yYn2Mmn0CQzEPnVjZt1g_7_9"></a><a id="Tc_VU0fNrDFiUSAvNLzmAuwQg_8_0"></a><a id="Tc_9DW9Deqpr0SChpY7HDTnwA_9_0"></a><ix:continuation id="Tb_gXS9-BRpeEe291cNUxFecA_cont2" continuedAt="Tb_gXS9-BRpeEe291cNUxFecA_cont3"><ix:continuation id="Tb_OxiYpKs1Jkm1j1rD8jgdMw_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="Tb_pCe5k9gw0EKxkbSAp2bPkA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Changes in stock options for the&#160;year ended December&#160;31,&#160;2022, consisted of the following (shares and intrinsic value in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining&#160;Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of&#160;Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise&#160;Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;(in&#160;years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="Tc_s_F4U-J2OEe45Z5Y9UD32A_3_2">3,640</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_zPDUfldpAEON0P0c4XFJug_3_5">44.70</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="Tc_45ez61jwqkGmJCksCxAVOQ_4_2">251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_kHZJbqquo0yzya8oNpr4_Q_4_5">63.69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="Tc_KxMBFsDGukuXyzCF8Scbpw_5_2">703</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_ccUkhWggbkuiIpA_T-F_kw_5_5">28.58</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited/expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="Tc__ok5hnQj7k6GFgW6EcYPoA_6_2">111</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="Tc_tx6w9bugkkWTnO4InCn_qQ_6_5">53.16</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="Tc_3ZUlWJovCEWgC8s-9RBjqA_7_2">3,077</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_zKjtLqvBkUW1V0mQZMJDAQ_7_5">49.62</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Tc_CQRBrrdhwk-PRKk5nOgo2w_7_7"> 3.51</ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="Tc_n0L1CsnwMUuu83RjYPtovQ_7_10">64,634</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="Tc_8_3TnS7cMU6LIooY_O5EIQ_8_2">1,792</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="Tc_VqO_lEx_OU2n7MyKv_S11Q_8_5">43.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Tc_CJZxh3ML_kOu4tThg5BXbg_8_7"> 2.61</ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="Tc_-tuv8tyRnkaImPmg0GdA7Q_8_10">48,595</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending vested and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="Tc_UOgoAU91bkinVx_PPhOmmw_9_2">3,013</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_Nb3A7oVev0GZh1X4R40zwA_9_5">49.37</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="Tc_N05HVWn7pE2vF9hjbAkBuA_9_7"> 3.47</ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="Tc_sYiD6C1nCUGTu8EHJNBKUg_9_10">64,026</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The weighted average grant-date fair value of options granted during the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_XiEsk9_nDEG74ZwRIGQg-Q">24.98</ix:nonFraction>, $<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_mVLIroKvBUGu6UzM89FjTQ">24.38</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Narr_8YUYjrjM2UeXMyCjJDWQYg">13.70</ix:nonFraction>, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Stock-Settled Performance-Based Restricted Stock Units (&#8220;PSUs&#8221;) and Time-Vested Restricted Stock Units (&#8220;RSUs&#8221;)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Since 2020, we have granted PSUs to certain of our executive officers. Conversion of PSUs occurs at the end of <span style="-sec-ix-hidden:Hidden_xGgJ2uRJGkuzkcphmVUYXA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>, <span style="-sec-ix-hidden:Hidden_z1_aUA5vikuLxGHYLl_gBQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span> and <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_n09B1uG-xESAohYo-rybSQ" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_H4sJdpLvHEu195rQYf-Zqg">three-year</ix:nonNumeric> performance periods, or <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_K1XgukxuNkWcyYcKwon8kQ">one year</ix:nonNumeric> after the agreement date, whichever is later. The conversion ratio is based upon attaining targeted levels of free cash flow (&#8220;FCF&#8221;) and relative shareholder return as compared to the Russell 2000 Index (&#8220;rTSR&#8221;), as defined in the award agreements. In 2020, our Board of Directors amended PSUs granted in 2020 with a one-year performance period to adjust the performance targets and reduce the maximum FCF multiplier to <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_63ieaO-AO0SYaBWn-TK6JQ" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_oMiH4tNLjUG0m5vvYn0aQw">100</ix:nonFraction>% for the one-year awards, which lowered the potential shares of our common stock to be granted pursuant to the one-year awards by <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_4_1_2020_To_6_30_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_r8j-LAr880aFYWGRQw_EMw" decimals="INF" format="ixt:numdotdecimal" name="mmsi:PotentialSharesGrantedDuringPeriodIncreaseDecrease" scale="0" id="Narr_tzSB2Y9N80KQM4SF587VQw">25,415</ix:nonFraction> shares. We accounted for this amendment in accordance with ASC 718 as a &#8220;Type I&#8221; modification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The payout for each PSU is equal to <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="INF" format="ixt-sec:numwordsen" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" scale="0" id="Narr_j5dkdvzgFUeEtXq_sXWvcQ">one</ix:nonFraction> share of common stock multiplied by a FCF multiplier (between <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_WBGzb7-2s0OMpcaC1kZThA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_TcZ84gYTak2tAg0xXLisew">50</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_OtYJx8DRZUWhCfnnj12CUw" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_wMT6dHabsUiQ3fvMMg5khQ">100</ix:nonFraction>% in the case of the 2020 one-year awards, as amended, or <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_HTBgdVUkNka5_SS_wCZMfA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_Fms6WOlng0-uxaJM4Dt9WA"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_CR57zo9ehUqUx1y_296vpA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_G_0ZfaJghUuECb81zbnocg">50</ix:nonFraction></ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_TTFS404ILUWejinxzomjcA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_IyXrXPH5VUCWjUMDCDa6ZA"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_eA79SptKRUq01tLxfpAtTA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_xzbgPtLKM0i6wjiEDZVwQg">200</ix:nonFraction></ix:nonFraction>% in the case of all other PSU awards) and a rTSR multiplier (between <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_2cbkT8Rpj0C4W9Vnfbtf7w" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_CO2qLsOeEkG8IsKCTNwZYw">75</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_D2MaLgzSP0S3mTr5jl_ELQ">125</ix:nonFraction>%). PSUs convey no shareholder rights unless and until shares are issued in settlement of the award. We use Monte-Carlo simulations to estimate the grant-date fair value of the PSUs linked to total shareholder return. Compensation expense is recognized using the grant-date fair value for the number of shares that are probable of being awarded based on the performance conditions. Each reporting period, this probability assessment is updated, and cumulative catchups are recorded based on the level of FCF that is expected to be achieved. At the end of the performance period, cumulative expense is calculated based on the actual level of FCF achieved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We grant RSUs to our non-employee directors, which are subject to continued service through the vesting date, which is <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_C9DMsMWYo0K3qGpQk3tDDg">one year</ix:nonNumeric> from the date of grant. The expense recognized for RSUs is equal to the closing stock price on the date of grant, which is recognized over the vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">80</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_4a868109_7d35_4b88_951c_7c749902171d"></a><a id="Tc_VPpaVpuiHEKGnRUUyER29A_1_2"></a><a id="Tc_DFlrHmFFn0OxGV8M3zlTPA_1_7"></a><a id="Tc_OWVv5cgqr0ysBRo2IoG4qg_2_4"></a><a id="Tc_8l_x0w0qekCN8odGXyfbIA_2_9"></a><a id="Tc_e6yL0aj_ZE6bvEJbatcaew_3_2"></a><a id="Tc_4OVFsByeTEidMgHDMBk5Sw_3_4"></a><a id="Tc_rcwIMhEtW0ip6l-QRhsh2w_3_7"></a><a id="Tc_LHZjQlesO0ujqyNqKqBnKQ_3_9"></a><a id="Tc_Z4EcchwZfE615ZVyVRoHrA_4_2"></a><a id="Tc_YmdZsm46vkeMj36iCGrQuw_4_3"></a><a id="Tc_8zyJ-jK7j0up4Ba0DVcztg_4_4"></a><a id="Tc_rX7DOvjZbUu_fQSOrQ8Rpw_4_7"></a><a id="Tc_QO-vvsvvKU6rS0RxBEl6xw_4_9"></a><a id="Tc_w_wKA2hkUkaeqV-dNvTapA_5_0"></a><a id="Tc_Nbd_1q7ZWESomW4qOEthvw_5_4"></a><a id="Tc_btYLjDyvZkC8mICT6V2AuQ_5_9"></a><a id="Tc_OKpt6LXa6k21nPZZ3pjc2g_6_0"></a><a id="Tc_Ydpns8DNb0OO9PD9t0ZIzg_7_0"></a><a id="Tc_Q2uttEaAb0e4hkbox6gO3A_7_3"></a><a id="Tc_yk3dzz4HRUe0N1sQT3u6sg_7_7"></a><a id="Tc_kEsZP9AOCku1HaH2mj4WZA_7_10"></a><a id="Tc_fb4i1PEg-U-DMVkV4CJ3sA_8_0"></a><a id="Tc_wV1sTo-WXkW7tHxqAVGnbQ_9_0"></a><a id="Tc_oHJmwUR8uUut8x795H-IKg_9_7"></a><a id="Tc_tP3NUY87QE-4-Xun-Jferw_9_10"></a><a id="Tc_GUF6MABpAUeBIz9-SJxHaw_10_0"></a><a id="_1010022b_6d53_40a8_b500_22834564ae8f"></a><a id="Tc_JeK5zvRM9Eq4y02DisjHIw_1_2"></a><a id="Tc_yACUw8JIUUW-YOsSrkh9cg_1_5"></a><a id="Tc_EQomFGmcYkO2wF5PaNLvUA_1_8"></a><a id="Tc_zHsR6oDrf0evT6bkFfBqdw_2_0"></a><a id="Tc_zXor6of0zUugdvHnQqhHPA_3_0"></a><a id="Tc_8c_msL0ZSUuQpmeJ99RFbw_4_0"></a><a id="Tc_DKbjxvlfgEm7y-vAGQruBw_4_10"></a><a id="Tc_kEg0uu9J6kiy1V_tXS1w-w_5_0"></a><a id="Tc_Wa1sOl8cu0iYzdY-mXUZBQ_5_10"></a><a id="Tc_QkqZoNZBmE2H-96iLS6y8A_6_0"></a><a id="Tc_IBVny_m110a1j06H8Q5bbA_6_2"></a><a id="Tc_S_-mulzx9ECpEl1fGBCCKA_6_5"></a><a id="Tc_lZ-_r9v9RE6Jf8kM3Y_yMQ_6_8"></a><a id="Tc_w9XXyrSbSkiBdoF_0E9NSw_7_0"></a><a id="Tc_a6joGkS4lE6fjlVGM2hQ7w_8_0"></a><a id="Tc_e9QNcOYQYkmvnEpTc2ujiw_9_0"></a><a id="Tc_U90PxT_lO0aUD6emjCFgzQ_9_2"></a><a id="Tc_Za15spHQoEKMMOenGnmdBA_9_5"></a><a id="Tc_e5U-IIvr7UibA32pKuaZQA_9_8"></a><a id="_4b53f035_301c_4244_a542_6e09d54c2cde"></a><a id="Tc_vi3kfz1DA06dA43FWFPnfw_1_2"></a><a id="Tc_8usG4gV9V0SmiWJl0dc3QQ_1_4"></a><a id="Tc_szSChXnaPUO1wNFOitxRaA_2_0"></a><a id="Tc_xCzgWOepBEe80C4FcoWWmw_2_2"></a><a id="Tc_69UwkVOK0ke_jR0tJGiEHg_2_4"></a><a id="Tc_ayslrwHXW06Fm4Vx1-pYug_3_0"></a><a id="Tc_Qc8hiSIg70SkBA6Pgh_PJg_3_2"></a><a id="Tc_lk6IXZaAUUy_9EiqJgopzg_3_4"></a><a id="Tc_6l0qccSFrEictUuT2b3hJg_4_0"></a><a id="Tc_6LtUuBvKBUeA3f6OjXZd_g_4_2"></a><a id="Tc_dN454wnjvU6MT3aSjIJPgw_4_4"></a><a id="Tc_PtuF_CUigUGIrC3YvNA-uQ_5_0"></a><a id="Tc_t7YhTiPs8EmTlOXw_6ewXg_5_2"></a><a id="Tc_zSJMs1Ro702wBKONWFMb-Q_5_4"></a><ix:continuation id="Tb_gXS9-BRpeEe291cNUxFecA_cont3" continuedAt="Tb_gXS9-BRpeEe291cNUxFecA_cont4"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" id="Tb_vkuBjwevlESPxeznhg24Rg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Changes in PSUs and RSUs for the&#160;year ended December&#160;31,&#160;2022, consisted of the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PSUs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In Thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In Thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning nonvested balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="Tc_Cd088L1h8Ee2UpHicvYXeQ_5_2">163</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="Tc_JJ7FfK4DqEy-OpPtDoFU0w_5_5">53.71</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_30JNZGvr7EC6MKrc7WWXwA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="Tc_7K_kE_K-bEeE1Jo5lmGP2w_5_7">26</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_30JNZGvr7EC6MKrc7WWXwA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="Tc_Hqr6lqQRA0GspIYOu8jHNw_5_10">61.77</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_K-tQwWOq5EWBrf9ZZWW3Ag_6_2">97</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_vid-htiOT0elCyPB4P7pvQ_6_5">64.54</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_1BtavHAOnUWVUwfKF-YIaw_6_7">31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_70c6rzMNh0G3caLU0n7lNg_6_10">59.02</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">rTSR adjustment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="-3" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" scale="3" id="Tc_-tf15w0SHUK_E4XRljLSiA_7_2">8</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc__xNPmoqj2k6_b5cu7kuwWA_7_5">65.03</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="Tc_5uZcesp0_06icZwetpL4mQ_8_2">44</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_5_tlSwCJz06gMHg34KiBlw_8_5">65.03</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="Tc_BTodsaZWh029xKWTzUE-Gg_8_7">26</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_ba3z4B2oaU2GSTqR28l10g_8_10">61.77</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="Tc_iZxXD7IU0UOOPuGHrQ70Wg_9_2">45</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="Tc_ck9WFdP3d0izNdcQHCd00Q_9_5">60.81</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nonvested balance at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="Tc_H6GqtbNaXkK0-zdCfrmr3g_10_2">179</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="Tc_-tPjVocC3U6w0Pik1P7FMQ_10_5">65.20</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="Tc_1m_XN1vFDkqmLRH-1zEXFA_10_7">31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="Tc_Uq3sN2R-5UOheKdGVQf-SA_10_10">59.02</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Based on the maximum payout, excluding the impact of the rTSR multiplier. The actual number of shares which vest is determined based on the satisfaction of performance conditions and the application of an rTSR multiplier between </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_2cbkT8Rpj0C4W9Vnfbtf7w" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_FkBakKZSJEOCavryt2TQgw">75</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_bQFJd7WWCEuI0DSlmtrusA">125</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Represents the application of an rTSR multiplier of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_6xqiAKy5wky58rfPLPedWw" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_imoQxYNWZEqLyVc0mnG9Zg">125</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> to awards vested in 2022 based on the performance of our common stock and the terms of the awards.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" id="Tb_lgups91GCkKLzkKQ8mMP3Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes PSUs and RSUs granted during the years ended December 31, 2022, 2021, and 2020 (units and shares in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">PSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Target units granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_4HZjeHhca0CJ9R9TG0L3fA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_Atzh_AdKmk2ZRtmVKw3zoQ_3_3">48</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_94jGRzIuckyUf5V563Shhg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_WLQAGN1AMUO5Mk0bA5uHLw_3_6">52</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_kGEvFzHWaUq1-E8uQ61arA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_CIo1dK5mekaT0EFoc5PcAA_3_9">61</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Maximum units granted <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_b4qnuJ-OWEiHrjQRnWlLXw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_6_g4MpQQFUy0FLD2kFgzPg_4_3">97</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_RYZsnkxzTkaTfXLFz_Zj2g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_dvurOXLLlkGTV4QIfxo2uQ_4_6">103</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_OSPO592R7EqioAf9pi9vfA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_RMse3gGDJk2a_EW91X6Nqg_4_9">102</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Maximum potential shares<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> (1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_gLbiasFwxkmKONzOlnKAwg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_vrULHOMXEkuD9OSJOY1vDA_5_3">121</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s46DzGkVO0Sh6osOFwanZg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_shLb_5m-KU2b-d0syQAzXw_5_6">129</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_U_TUWGHmYk20d863KAh-8w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_kIn-q8JyW0iqEoG9OqgSPg_5_9">127</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Weighted average grant date fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_9JGwaufhYUazQDh5p7Gp7g_6_3">64.54</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_sDixEELpMUmofoHd91zfMg_6_6">61.39</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_fxzT2CfP7UGLlti0xqKeog" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_D_zuX698AEW_JK6X7wiIow_6_9">43.63</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Units granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_t1SbnwEYkEOiDofu87NARQ_8_3">31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_AqKghE_SbkmC6NDRAC8hUg_8_6">26</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="Tc_Qu5FPNeE_EOkWBQfTrjG0g_8_9">34</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Weighted average grant date fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_Ac6rLftJV0eqGFigOfnW9w_9_3">59.02</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_KsYSLjleeEaSHMrpNIYaNQ_9_6">61.77</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="Tc_2Pv4DFeyUk2xTlYYWHtyig_9_9">42.98</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Based on the maximum payout, excluding the impact of the rTSR multiplier. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Includes the impact of the maximum potential rTSR multiplier of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_FjBaJfLm20iTwgiblMYy_w">125</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Includes the impact of the 2020 amendment which reduced the maximum FCF multiplier for one-year awards from </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Xa71dYPKVEyT6sWRUfs7wg" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr__PRP_9rkC0yqcTaTZBvpXw">200</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Q9sli6HR8kmLtGS6z2LKLA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_FTYI3eDh5kaWJMO5OXAafg">100</ix:nonFraction>%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the years ended December 31, 2022 and 2021, there were approximately <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_Ud7J8BNd3UiBag5fKNRpeg">44,000</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_hrYBkN47ZkiAdEDs9Bcrlg">26,000</ix:nonFraction> shares, respectively, that vested under PSUs, prior to the reduction of shares withheld to satisfy tax withholding obligations. Vested shares were calculated based upon achievement of the maximum performance multiplier, as amended, of <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_MZN3RxPRPkq5v4w2teFQGQ" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_DZz4DDdmWUm13qGRXCqGXg">200</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Q9sli6HR8kmLtGS6z2LKLA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_DqtB3xdzkUasRiTz78jgrg">100</ix:nonFraction>% for 2022 and 2021, respectively, and an rTSR multiplier of <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_knYNKXRuQ0q39xpstvjvjw">125</ix:nonFraction>%. There were <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_fxzT2CfP7UGLlti0xqKeog" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_FXFl7_WVkEqGVpWlZ3UwjQ">no</ix:nonFraction> shares that vested under PSUs during the year ended December 31, 2020. During the years ended December 31, 2022 and 2021, there were approximately <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_Bl5C5r9cnUa6pGkDp5jmkg">26,000</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_ybZAl9FACkCom2vNmMkd2g">34,000</ix:nonFraction> shares, respectively, that vested under RSUs. There were <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_pNUV90vkgkOkPhYm-AGv7w">no</ix:nonFraction> shares that vested under RSUs during the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" id="Tb_WTU4nIdrQUCYwt1e9dqd3w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The fair value of each PSU was estimated as of the grant date using the following assumptions for awards granted in the years ended December 31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_7jAE4bFkVEajGUW-u0eYMg">1.6</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_TOgTthd4k0a2lTskA2kaqg">2.7</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="Narr_3-Tg1zh7e0mgahMGF13KJQ">0.1</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="Narr_SI9f-AnIRUmTRjDpEciXkA">0.3</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Performance period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_WBFuNp9-sEOaCJ0Ax7YM3A" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_3S7RR6_oY0yiIxd2pmQA7w">2.6</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_3fb8WLlr80-4_6v213qfgw" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_IcNT-VvBCEKNrG_-TLFsew">2.8</ix:nonNumeric> years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_GxO2voBvw0KcdDmVJ8OK8g" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_LCitmD4BPU2prwTfg0LRpg">1.8</ix:nonNumeric> - <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_a0RjGlBUeUa4iriFWOGd0A" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Narr_rUgg1SdCGUCYOJTQRauI1w">2.8</ix:nonNumeric> years</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected price volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_0wPeLFWNzUKIBKlGlBClpw">38.5</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_7w94u94WWEmq20AKN_zWvw">42.6</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="Narr_0iTHV0YzH0KRHkA6udVEQQ">43.7</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="Narr_hvsLBTjQsUmX0MAPmj0XQw">49.3</ix:nonFraction>%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The risk-free interest rate of return was determined using the U.S. Treasury rate at the time of grant with a remaining term equal to the expected term of the award. The expected volatility was based on a weighted average volatility of our stock </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">81</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk126848681"></a><ix:continuation id="Tb_gXS9-BRpeEe291cNUxFecA_cont4"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">price and the average volatility of our compensation peer group&#39;s volatilities. The expected dividend yield was assumed to be <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="3" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="Narr_LDJDVhcXgUC50nqqZmahlg"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="3" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="Narr_J_lGAx9qG02Vnu3VtsvzVA">zero</ix:nonFraction></ix:nonFraction> because, at the time of the grant, we had no plans to declare a dividend.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, the total remaining unrecognized compensation cost related to stock-settled performance stock units and restricted stock units, net of expected forfeitures, was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="Narr_D_-1QmQvBUmTDt5fcZFUIg">4.7</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="Narr_cP5cbRQOnkera5bLcpmvKw">0.7</ix:nonFraction> million, respectively, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Narr_y4656VnWZkCYsAYgtjRKJw">1.6</ix:nonNumeric> years and <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Narr_JOmr4E-qGEmZD8-t94JXaQ">0.4</ix:nonNumeric> years, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Cash-Settled Performance-Based Share-Based Awards (&#8220;Liability Awards&#8221;)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the years ended December&#160;31,&#160;2022, 2021 and 2020, we granted liability awards to certain executive officers. These awards entitle them to cash payments equal to a total target cash incentive of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog" decimals="-5" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" scale="6" id="Narr_8xx3L0DBfEeeppnZ9JfKug">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_qRyUmYl8O0y6oUbd1lTTIw" decimals="-5" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" scale="6" id="Narr_KhZmXKHs80-eSOrZx-niMg">1.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw" decimals="-5" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" scale="6" id="Narr_j4W8TlfVhE-KJSY4W2gosA">1.0</ix:nonFraction> million, respectively, multiplied by rTSR and FCF multipliers, as defined in the award agreements. In 2020, our Board of Directors amended the liability awards with a one-year performance period. The potential maximum payout of these liability awards is <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_mVSC0isQAkKGdsXQLJIZuA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_G7y9oLd-nEKWmL8HYjzr-g">125</ix:nonFraction>% of the target cash incentive for the 2020 one-year award, as amended, and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_w8-ho-GtDECtGQ1su5JiUA" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_3NP9fWxi5EmKXM7wNYOdTw"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_ps-20gTg802P7I1jBP-j0Q" decimals="2" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" scale="-2" id="Narr_eSjrGq7ZvEiW6AJU6zcUQA">250</ix:nonFraction></ix:nonFraction>% of the target cash incentive for all other liability awards, resulting in a total potential maximum payout of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_ps-20gTg802P7I1jBP-j0Q" decimals="-5" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" scale="6" id="Narr_zv4wWIIljkOc9DFsF4qFYg">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_w8-ho-GtDECtGQ1su5JiUA" decimals="-5" format="ixt:numdotdecimal" name="mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" scale="6" id="Narr_fBPfx1hwykuubGFXIz-YuQ">2.5</ix:nonFraction> million for liability awards granted during the years ended December 31, 2022 and 2021, respectively. Settlement generally occurs at the end of <span style="-sec-ix-hidden:Hidden_d8w-m4ewDEurtEdt4iLbkQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>, <span style="-sec-ix-hidden:Hidden_t8cBNSblNE-IWNGe1sg12Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span> and <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_WIq3iXtF5EuvyViG_OJs8g" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Narr_OBCRqRGiS0i0UCY9zOR3hw">three-year</ix:nonNumeric> performance periods based upon the same performance metrics and vesting period as our performance stock units. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">These awards are classified as liabilities and reported in accrued expenses and other long-term liabilities within our consolidated balance sheet. The fair value of these awards is remeasured at each reporting period until the awards are settled. As of December 31,&#160;2022, our recorded liabilities associated with these awards was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_IouJ1SF8gkaMhJelEUky_g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" scale="6" id="Narr_0rbwUdx2rk-Z9RDRyMRsjA">3.2</ix:nonFraction> million, and we had remaining unrecognized compensation cost related to cash-settled performance-based share-based awards of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_IouJ1SF8gkaMhJelEUky_g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="Narr_hp8oMfeWyUqJQl18ALID6Q">1.9</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Narr_MY2fy2nCrUSwejpl2X0p6w">1.7</ix:nonNumeric> years. During 2022 and 2021, we paid $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" scale="0" id="Narr_B9OWLyRqkUOiMH2OkV6Vnw">833,000</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_qRyUmYl8O0y6oUbd1lTTIw" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" scale="0" id="Narr_AWBnnRye-U6tiwr2GxIl3g">417,000</ix:nonFraction>, respectively, in connection with liability awards, and <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="Narr_yVI7svCiy0yOFIFOohGF8A">no</ix:nonFraction> awards were forfeited. There were <ix:nonFraction unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="Narr_3bSjdZq080C_g43ogd57-A">no</ix:nonFraction> liability awards vested or <span style="-sec-ix-hidden:Hidden_eEnAFWZ5UEGI9LcVSBtx5g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">forfeited</span></span> in the year ended December 31, 2020. </p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:SegmentReportingDisclosureTextBlock" id="Tb_CQxO6D6HJEmfAU4ukQ2JHA" continuedAt="Tb_CQxO6D6HJEmfAU4ukQ2JHA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.</b></span>SEGMENT REPORTING AND FOREIGN OPERATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-weight:normal;">We report our operations in </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="Narr_4vFBog2bKEqKRsRMAXeBaw">two</ix:nonFraction></span><span style="font-weight:normal;"> operating segments: cardiovascular and endoscopy.&#160;</span><span style="font-weight:normal;">Our cardiovascular segment consists of </span><span style="font-weight:normal;"><ix:nonFraction unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="INF" format="ixt-sec:numwordsen" name="mmsi:NumberOfProductCategories" scale="0" id="Narr_geqFhDFmqU2keUcCek7xYg">four</ix:nonFraction></span><span style="font-weight:normal;"> product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.</span><span style="font-weight:normal;"> We evaluate the performance of our operating segments based on net sales and operating income (loss). </span><span style="font-weight:normal;">See Note&#160;2 to our consolidated financial statements set forth in Item 8 of this report for a detailed breakout of our sales by operating segment and product category, disaggregated between domestic and international sales.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, we had international sales of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_dSg8kh6DlkyLKSVn2mRmPQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Narr_kviIY8wnZ0qaGBn48mHPgA">500.4</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_2Zks2ScobUOdPYr6gUlL_A" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Narr_9qRFQxzCrEGlwq86NLY2Yw">465.9</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_mCRjJpSbEE2JseTs6klpUw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Narr_PszM8Wsw1kGZOYziVxWh_A">413.8</ix:nonFraction> million, respectively, or <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_BT1_boCV1EyK74esn0nh_w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_PExAJq8vmUKya3JVIoe5Og">43</ix:nonFraction>%, <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_v_3MlJjEwkOhh_n4KP2NWg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_pGG4CxpOK0a1p1ft5Dp1Vw">43</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_qVc5qszmDkqekOg1yJuHmg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="Narr_cmYHtA1fQkqw2WY-S8C8rQ">43</ix:nonFraction>%, respectively, of net sales. Our largest international markets include China, Japan, Germany, France and the United Kingdom, with&#160;China representing our most significant international sales market with sales of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_CN_qZO_CIcm8EKmg0YTRChTXg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Narr_xtxwBtzWT0aZh0vdN2j1Dg">149.3</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_CN_P4z8MxOErEe5ei5ipgHNOQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Narr_FVqI8RXob0G9kxuvmtjHpg">138.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_CN_DoIlPAu9x0ysbFQn9Of8Yw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Narr_iZ-WXcPrfkai2XB8ZlTLuw">113.2</ix:nonFraction> million for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. International sales are attributed based on location of the customer receiving the product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">82</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b568ee79_3d70_4ad1_b320_cb13608b1ab8"></a><a id="Tc_FXCuyTh2w0u1fZ9Y-YB5ZQ_1_2"></a><a id="Tc_v_Fl2SztnE-Kjn3xX96q5w_1_5"></a><a id="Tc_0tBwCOjMzUa-OtE1EDjVgw_1_8"></a><a id="Tc_SQUbmFlOxkyeSg23kQOmEg_2_0"></a><a id="Tc_NiMiji0CmUWIGBXdDOSmAg_2_2"></a><a id="Tc_eeGSzYuPk0qXLcwpVhzZIw_2_5"></a><a id="Tc_gPBBew9INEO4XmLACmI3Rg_2_8"></a><a id="Tc_X18GpErkFUmHrUoRPrgWAg_3_0"></a><a id="Tc_TKkBBa_KjEiubS5_8K0ddQ_4_0"></a><a id="Tc_w-5uY65bJ0S5waoMhcRolQ_5_0"></a><a id="Tc_O5Ly-JnQBUSGOCUBpbOioA_5_2"></a><a id="Tc_vb0hUJqhY0S8NLk64vm_2A_5_5"></a><a id="Tc_BRmR2-pr4EWoGoXDob637A_5_8"></a><a id="_18bdcacc_649a_4fbc_ad77_b24ae964ef73"></a><a id="Tc_XwwaRNvz4k660svuEooGqQ_3_2"></a><a id="Tc_2pfN1v45I0Gz_m-EHvH7pw_3_5"></a><a id="Tc_rI4fwdAF10aDq7JoX1eLvA_3_8"></a><a id="Tc_ul66cJcXukq-RixAajk35w_4_0"></a><a id="Tc_54kT65usvkSxS7ZyynXbzw_5_0"></a><a id="Tc_KSMW_eRKe0WTlRMAO7SZEg_5_2"></a><a id="Tc_V4wp0P_wdUq4vtO_Adehpw_5_5"></a><a id="Tc_3ckiLiZMEUyxghC0ulm31g_5_8"></a><a id="Tc_DuOkBNGeH06jiVH1KI0NjQ_6_0"></a><a id="Tc_xwqRRE6UoE2YgkazbtKQIQ_7_0"></a><a id="Tc_ppQMdHz_uUCSoYZGuBpgCQ_9_0"></a><a id="Tc_gRLrzujZyE2nshJcvJfF8A_10_0"></a><a id="Tc_J5jHEdjANEaicNGHHcoj8Q_11_0"></a><a id="Tc_tWSBJ-2Oxkuh2DBdK_1AXQ_12_0"></a><a id="Tc_H97dwS3OT0KIDBPQGF6hiQ_14_0"></a><a id="Tc_6JmBnlCtWkOtezKq8qqPjw_15_0"></a><a id="Tc_I1zYmcnG0Ee5Fty6_lrqSQ_17_0"></a><a id="Tc_LV4O0NETwkWj_PPztLMvvA_17_2"></a><a id="Tc_K3q9deC-Hk2_eKKBTUCdfA_17_5"></a><a id="Tc_xTxbV0Yos0Si2yfUaH71Zw_17_8"></a><a id="_e00353bd_b409_4028_9f2a_ffb89474b3f2"></a><a id="Tc_L0a_vAEOc0KHZ7vuTdcsjQ_1_2"></a><a id="Tc_qb14WEB7kk-iVndQcTnh5Q_1_5"></a><a id="Tc_eqidhvWPGEyEMp8Wb4yp3Q_1_8"></a><a id="Tc_gRF9xiET5U2guvbQox1nvA_2_0"></a><a id="Tc_hGvEmqnOWkaousDRJ6QueA_2_2"></a><a id="Tc_VNjKV3pQTketzT5GayNcHQ_2_5"></a><a id="Tc_4MYWpkeWHkWaz3kpQ5WfFg_2_8"></a><a id="Tc_r60bS-HXFE6-cu6WVhJGGA_3_0"></a><a id="Tc_W9hcwPva0Um1xkrtth7SFQ_4_0"></a><a id="Tc_oG6_bdf7b02UWvnyZORZ2w_4_2"></a><a id="Tc_tSv9is5TnUGfv3bCbkdorQ_4_5"></a><a id="Tc__jYfmLRfTECrP8WB_MBORQ_4_8"></a><a id="_68c490c4_64fd_4af1_9064_df7fd66c6f03"></a><a id="Tc_2lv1IQM48Em9rEoF8UpKoA_1_2"></a><a id="Tc_joQzVX-SWk-inDzcz3tU0Q_1_5"></a><a id="Tc_5wCyckabw06Eq1fQ9_-7OA_1_8"></a><a id="Tc_B3Dr4yk9fU2lhGPeXcKzDA_2_0"></a><a id="Tc_kqa9_j4_U0aDFIgzr8nrsQ_2_2"></a><a id="Tc_7tGfxV2u606y32rp-abXwg_2_5"></a><a id="Tc_Kc35BN42e0GClZnjkO8Ztg_2_8"></a><a id="Tc_stdIEh4WOE2CDOVV80-4hw_3_0"></a><a id="Tc_Ovvzry_RD0iaLp5bPI8sdw_4_0"></a><a id="Tc_Hlf8F7RtJkG1O-3WreTJLQ_4_2"></a><a id="Tc_6oUZeskSok-FCmfDW5_-7w_4_5"></a><a id="Tc_F_Hr-7yFV0CZP4E1GnbiPg_4_8"></a><a id="_975035de_d7f7_407b_b00a_6fbddc67f88a"></a><a id="Tc_cUxMYdIzJEm_Ew1nnpwAfA_1_2"></a><a id="Tc_GCGT3CIOtESQo9gQ8xE4ag_1_5"></a><a id="Tc_qa33Fx0jKUGDOx5z9zJ_cw_1_8"></a><a id="Tc_UMY53dx8ckaMObzzilkyLA_2_0"></a><a id="Tc_gR5WASoVUkCvgyPHJ60LMQ_2_2"></a><a id="Tc_MzXJro1Qrk-cJ5cJwFxMoA_2_5"></a><a id="Tc_t9HQQ1g6A0CjmB6515dm0w_2_8"></a><a id="Tc_tbXBLpJge0uoVY1KENFUqw_3_0"></a><a id="Tc_hkT9lOxHkU-NeKHkecImPQ_4_0"></a><a id="Tc_dNBQkonfDUWNWb6jphvrfg_4_2"></a><a id="Tc_TZcPjfSZSkaPcvns05RVhQ_4_5"></a><a id="Tc_fust-wz4CkupX9R8YWc5Uw_4_8"></a><ix:continuation id="Tb_CQxO6D6HJEmfAU4ukQ2JHA_cont1"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="Tb_fbAFziddJEa5snZFyfypcA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United States</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_US_snTmzJ5T0E656AhhDMpMQg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_Sm70_bHhlEGfqdgFuUkDHg_2_3">281,290</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_US_GwhTWC6jokaibH93vL9asg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_QcqDbxYRM0OpbE7cZxX90A_2_6">275,311</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_US_8HeXqvsEIk-auaw5myy4uA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_sdUUgMKUf0CsvjZAiprGlg_2_9">277,643</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ireland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_IE_GfG6bD0w406OQ3evGEIt8A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_Oc65wrAdkU6Qt8wVkhmYlg_3_3">40,749</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_IE_VUWTuDtMwkqMhwjAVcktqA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_VQ81VrVVgk6OldKGJR1S-A_3_6">39,863</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_IE_eGJe27sczEalkw_qMPNw1Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_2aikQtzGBkGZtxynTAQdTA_3_9">42,951</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other foreign countries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_eeu5akz68Uus_Sjj54jzQw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_YviRdHlx8Uu8DlFUsOuhng_4_3">60,937</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_VeCyfvZPU0KduGRAlFl2sw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_78Hq37I2mkWQalj5Ly72yA_4_6">56,484</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember__hoYCGHvzUiBpV80UeFJuQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_HHbziwjbEUabq-M1JTvxFQ_4_9">62,134</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_AAYkgHX5p0iVUAdmzBfe2Q_5_3">382,976</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_qlQme6EU2EKM8sOngT372Q_5_6">371,658</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="Tc_sukFSVBQo0Ohe21jBoD4xw_5_9">382,728</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="Group_MIzkpKAj80eXfs3a_kePsg" continuedAt="Group_MIzkpKAj80eXfs3a_kePsg_2" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, are as follows (in thousands):</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="Tb_HnM_VFCiR0mlzQn36R51Yg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net sales</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_JqQbbJVH8EiGKBGeW47Y_A_5_3">1,118,224</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_kcjxZXPmnES2HAgd6vXb-g_5_6">1,043,227</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_AK6FLFE8Y0u3JUShRa37Tw_5_9">934,202</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_L3QUtDvbmky0XBvSf1htGw_6_3">32,757</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_OZq24RCElUS9khGQa5fFiw_6_6">31,524</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_iv0U1NlNrUK3Hh7XQtzIkg_6_9">29,673</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total net sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_abXWLcCy4E6DY_nVTDOBLA_7_3">1,150,981</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_so7lrtmHsUi5BhS84VQx_A_7_6">1,074,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="Tc_5jIEyN2L1UGXzfWR2K7yvw_7_9">963,875</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (loss) from operations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_rT40BbQJDkmKWLQKFVeaeg_10_3">80,946</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_kOJDVQb7N0CpQ10sX_U8sw_10_6">53,415</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="3" id="Tc_UbwyenjHlkOb4G_14f3gww_10_9">7,042</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_tso6nHL1x0KcJDnlF3H0hQ_11_3">6,617</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_7ZhwMpFI60uLO2qYTRnkaw_11_6">7,501</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_aojUelH3_0eI03NuVowRNQ_11_9">5,480</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total income (loss) from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_ghcLx7ct50KxcWRPZy1mnA_12_3">87,563</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="Tc_CDsB0LZfKUKshqVlUSYTIQ_12_6">60,916</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" scale="3" id="Tc_FbPmzr2wbEGl68RCOgQ28w_12_9">1,562</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total other expense &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="3" id="Tc_a1PKkXwif0aLGdh3h9SSVA_14_3">4,934</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="3" id="Tc_1G-gxCQGxkeLCkmRBqbaNQ_14_6">6,999</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" scale="3" id="Tc_4L7XJQEFjkGrO91SoaZyGA_14_9">11,669</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_gIjPOLQCUEaRgqIHtYqCTw_15_3">8,113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="Tc_3V58KczORkuEUvBl8Wod1w_15_6">5,463</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" sign="-" scale="3" id="Tc_AGqjRK0EakK3PV38APE6nQ_15_9">3,388</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_41ds51zZi02aweOVxJo_oQ_17_3">74,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="Tc_j2VAD0nhlEqSOJTRTmmrfw_17_6">48,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" scale="3" id="Tc_VwmLjtJTxUSLKayo30zx8w_17_9">9,843</ix:nonFraction>)</p></td></tr></table></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 6pt 0pt;">Total assets by operating segment at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_DL7l9lCsn0yCicMiO9Paag" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_lIvrDdzKRk2vIt6RLt2g9A_2_3">1,652,145</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_mhPvROMdBUy9ISn8bUcQsA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_OZ9Ygr_E-U-EnV0fO0XVGw_2_6">1,635,676</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_jPM7z4e9ckWasY0kB4A02w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_pl3fEVlw8EOH8ESL1M04zw_2_9">1,654,866</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_tITBjrk_HkGRwTnHLPq2Og" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_K0NxpWIF70qN5ZQCoJEiKw_3_3">11,821</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_lmH4hrr3Yk2ZNTHoyQXrRQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_rysQIDkSMk6wJ_1TjusXfQ_3_6">12,618</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_kZ1T208TZkm_Zha3uivU5w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_wbeVSHJU6ESNf0iim4G0IQ_3_9">9,530</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_faTKRDmemE2wgloi5zP6Tg_4_3">1,663,966</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_tmOY3lBKOkyNkKkyUYWubg_4_6">1,648,294</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="Tc_JoH4iVnY2USkA2EuzIzW6A_4_9">1,664,396</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><ix:continuation id="Group_MIzkpKAj80eXfs3a_kePsg_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Total depreciation and amortization by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_GAgz17SfLkGiYulcLRpGJw_2_3">80,777</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_WZixaQ9JmUeUAix7f7SXFg_2_6">83,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_8Y81wWz7a0qcFBWYoYYjhg_2_9">93,160</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_m9JgvODA10y4RqLdw6rzng_3_3">1,027</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_zMHpOsub5k68PKsTQW31vQ_3_6">1,066</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_rDkD3ViiIkWL90Dxk3pg5w_3_9">910</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_dPCzfQBcF0ehsEuQE8O9KA_4_3">81,804</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_5_scR70Xi0moxOAOOs-CBQ_4_6">84,066</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="Tc_mIu19RR7PU2knSC17jenOg_4_9">94,070</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Total capital expenditures for property and equipment by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_mZj04vt0w0WDnIMQerHd_g_2_3">44,925</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_ii-SuLjNOkS_CTfierTIIw_2_6">27,557</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_mlgV9JylpEW-y51QPQ1Daw_2_9">45,803</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_ctHrmlTgjUmkSs2uGwmK5g_3_3">104</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_oBpyMGo0l0Svs8VLYwOVSg_3_6">382</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_Bt6Se5JOOE2aoaaxwMvAUQ_3_9">185</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_Ud6zbvsdO06K2MSRRoQQxw_4_3">45,029</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_A55LsV7NG0ynNRz69bzjXw_4_6">27,939</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="Tc_c4jsJP4ANEGQndyEagyitQ_4_9">45,988</ix:nonFraction></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">83</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="Tb_ielJvofZzE-9aRTcE_zn9w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.</b></span>EMPLOYEE BENEFIT PLANS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We have defined contribution plans covering all U.S. full-time adult employees and certain of our foreign employees. Our contributions to these plans are discretionary in certain countries, including the U.S. In September 2019, we ceased discretionary contributions to certain of our defined contribution plans and subsequently reinstated those contributions in May 2021. Total expense for contributions made to these plans for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="Narr_4RS3hzIna0acErFtcqWilg">7.7</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="Narr_pDb8Da97oUCrSGie_0r57w">6.5</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="Narr_ICOgM2nIrUam7ii9AZkKcQ">3.9</ix:nonFraction> million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_71db4cb8_4df6_4532_b0be_f6259a3a825a"></a><a id="Tc_VU7JRVbQfEyr9_Tsfxfz9g_1_5"></a><a id="Tc_4GwLPe-HXUqqYq7khonctQ_2_2"></a><a id="Tc_1I-Tbp_DE02hezwejCFr1A_2_5"></a><a id="Tc_qnijwyDpL0-7ugSlE9EWrA_2_8"></a><a id="Tc_vXmVyBoV9E2r7bMlEiXVHg_2_11"></a><a id="Tc_3Eb2IJWSJEyjve4t3rQnPQ_3_2"></a><a id="Tc_1BAOhgNfkEWtV-GLOnEpQQ_3_5"></a><a id="Tc_R2HXoyXlh0WJGpCNhUP1-Q_3_8"></a><a id="Tc_HJ3u48vg00OciI1DBY__ww_3_11"></a><a id="Tc_Aic5M-QoOk61EhP0Q70ajQ_4_2"></a><a id="Tc_loBFbH7TsEOhA_R6JCVqsg_4_5"></a><a id="Tc_vwmE70YKBkiNMIX7tOD2yQ_4_8"></a><a id="Tc_EMF0fgKCqE2nVHFjChcOhw_4_11"></a><a id="Tc_B9GGDd-0g0OKKX1JWqVJFg_5_0"></a><a id="Tc_b5Rj2V2l8E-Ag98KgiYtTg_5_2"></a><a id="Tc_wOKXBK5kuEa2vy9dYRLHMA_5_5"></a><a id="Tc_ZELuhxMSA0KDlbbE0jckLw_5_8"></a><a id="Tc_JR4z6-9xi0Gr0_xzUoDiqA_5_9"></a><a id="Tc_BOW4Js_ChEyH_vSc5yG4YA_5_11"></a><a id="Tc_21Bl-WapKEKkoCfWxMTOXg_5_12"></a><a id="Tc_A7bykdQfQUWZbb7pYIeckw_6_0"></a><a id="Tc_DbwiMPn1S0moQ_dN-wSRog_6_2"></a><a id="Tc_DgZgudTqZEOpcOiJg0qAOA_6_5"></a><a id="Tc_OzjMV3OGikSgmL6HlJcncw_6_6"></a><a id="Tc_octcCcUhSkGHgD5CSzl9aQ_6_8"></a><a id="Tc_py_jJ3N1h02UxvZWd95Jug_6_11"></a><a id="Tc_1TYH6i3U6UW37HOpO4FnLg_6_12"></a><a id="Tc_vK9_ZkujFUWm5NXfkSh8qQ_7_0"></a><a id="Tc_hnEluwS4JEez1sZPGNRqZg_7_2"></a><a id="Tc_JtpVPzPjLkylWVAguzprSg_7_5"></a><a id="Tc_alSl9rS2XEuDD_2AqRAp8Q_7_6"></a><a id="Tc_Wlk_pIiAeE2rnzNrnD2i1w_7_8"></a><a id="Tc_Tx3iZYMNBE6PSs8ztqZ-sA_7_11"></a><a id="Tc_TtTbZ3lvdUyWfSdMulnMfw_7_12"></a><a id="Tc_zTwJNAd9P0ShlsYKZ8R4bQ_8_0"></a><a id="Tc_a6VMrEm1BkyPoEMco5xyRQ_8_2"></a><a id="Tc_q5x_AnxxXk2LRdButYTByA_8_5"></a><a id="Tc_d3zabjfB7UCDGoPDCghwRQ_8_6"></a><a id="Tc_DxNnPIRi-kiQEdztbfDO9g_8_8"></a><a id="Tc_U9S3y8OeaEGxQnpG8S1LHQ_8_11"></a><a id="Tc_wvWeU_JjKkmH8vLaOqE2tw_8_12"></a><a id="Tc_OxywZKz75kGuWXCWJ2_s0A_9_0"></a><a id="Tc_iNJfSwIPck2hMxGYB4gsfQ_9_2"></a><a id="Tc_fsYYzvkzZE6gTL5rS9mWBQ_9_5"></a><a id="Tc_wQK17F91cUm8t21uw63soA_9_6"></a><a id="Tc_D1d3DmFR1U2w6NxDOGZvPA_9_8"></a><a id="Tc_hsiqYxw6t0OEOAa32L_uRA_9_9"></a><a id="Tc_YGRRgZYmxUW1Dldujsu6uw_9_11"></a><a id="_37aa477c_4551_4bea_9287_2e1f6fc4cb3c"></a><a id="Tc_jwz3CHljyka_CdwRBtGLrQ_1_5"></a><a id="Tc_aXhp1UMhsUe64hb_gy1U0g_2_2"></a><a id="Tc_34_IUDLAvEyBgJs7C4jDPA_2_5"></a><a id="Tc_SU7KA7kuvkqHmSV5cdDITA_2_8"></a><a id="Tc_UTNOZ2krzEmbDg5jQNbgQA_2_11"></a><a id="Tc_Pd7r8TYjFEipQ3PVDU-2Xw_3_2"></a><a id="Tc_PAa15_Qjhkab3l_sT4uCqQ_3_5"></a><a id="Tc_YSNawOoahUe5gWMzrkSx7Q_3_8"></a><a id="Tc_J-lyRax96ECxIjr-MaygEg_3_11"></a><a id="Tc_ru0Xw2fA7ESbi-rDYnRWXw_4_2"></a><a id="Tc_cYJRUiVc3UG6Ne6WCMN00A_4_5"></a><a id="Tc_TcbglpndrUK4GQDirWOhBA_4_8"></a><a id="Tc_Inr7J48lNEa5yKxt3_gwVg_4_11"></a><a id="Tc_kcJtA_lhbkqw3LH2MY-olQ_5_0"></a><a id="Tc_peCeSRLHM0SPs9tBhukQww_5_2"></a><a id="Tc_rSEp-ittgUu7RBbKVdUDUw_5_5"></a><a id="Tc_p96ITOpTHkS0-GrDZ5ngAA_5_6"></a><a id="Tc_VdHDQtL1QkqUT2UeRcEtjA_5_8"></a><a id="Tc_51gKTLoC1EOWGP2vyXGr7A_5_11"></a><a id="Tc_zIq-wqBOuU-14XkgGIcaHw_5_12"></a><a id="Tc_QW2iSAztYU2bJyr0JU1iVg_6_0"></a><a id="Tc_BUc2HkoawkqCax4yTulBtw_6_2"></a><a id="Tc_XqjaFg2fY0OKuqd23YckHg_6_5"></a><a id="Tc_ubl4zyomeUSQ7rItV1zTLw_6_6"></a><a id="Tc_KbztEKkjxUysKlQ-RP9vJg_6_8"></a><a id="Tc_-g91zgC0TkCGBd_I0bvQmw_6_11"></a><a id="Tc_LOCZFBa7P0ijeH6HwjJiFA_6_12"></a><a id="Tc_N4ftcFE9yEyFzDwnDBQwlA_7_0"></a><a id="Tc_4ScfpO0QJEynCPRSdQHn2g_7_2"></a><a id="Tc_VNnUFQMMdEGe3azVXCwyqA_7_5"></a><a id="Tc_JLUN_CYIJES5hv_2Z3X3kQ_7_6"></a><a id="Tc_CBl7ol5qm0uE_8v9eBi1zA_7_8"></a><a id="Tc_c9NgUcbwOkWCxz-n_zz3DA_7_11"></a><a id="Tc_nIXn8bjf_0GZbClxgdQGHw_7_12"></a><a id="Tc_mwCaUMHd2USZKFFFKQGGXw_8_0"></a><a id="Tc_5QCqr54ykEu17snFO5-7Wg_8_2"></a><a id="Tc_6Hxbd1C5nUmsAQioiw872Q_8_5"></a><a id="Tc__gVPA2OWOE6VoorRIylsig_8_6"></a><a id="Tc_n1a_0UqhiEKkKHH59mCg9g_8_8"></a><a id="Tc_Va-LDbvBXUeSLvsxSs9Ulw_8_9"></a><a id="Tc_aAlslSGp40K29ZiQyQhRTw_8_11"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:FairValueDisclosuresTextBlock" id="Tb_-SOyXWaJ-Uejkz59f4N9cA" continuedAt="Tb_-SOyXWaJ-Uejkz59f4N9cA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">15.</b></span>FAIR VALUE MEASUREMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assets (Liabilities) Measured at Fair Value on a Recurring Basis</b></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="Tb_hbFEFruZjUW6jFv8-jbpFA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">active&#160;markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">observable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">unobservable&#160;inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Marketable securities <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="Tc_WE0MsOtS5UuHO0HEDpL4SA_5_3">138</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_T8JXswSBYku-qE6hvnoCVw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="Tc_3W4AMeQgJki1GJGAk7KlXg_5_6">138</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate contract asset, long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="3" id="Tc_QSiGWjq6e0ayiLD20AYsIg_6_3">3,444</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="3" id="Tc_SXqjW8vTfkqe60-EoNJQDg_6_9">3,444</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency contract assets, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="Tc_8UvEk4xZkkmIIabULXm1pw_7_3">4,783</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="Tc_5-7ISvGUQUK0dh3uFbMraw_7_9">4,783</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency contract liabilities, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="Tc_KChixvmvTkqgdX53UgdB3w_8_3">3,986</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="Tc_hG9ed9AVGE2c25Cf5odcMg_8_9">3,986</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_QszMVwVdIUG9-k0diBctwg_9_3">18,073</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__v2v-UROZ0yrwpSXvqOD4Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_CvqOhf8Se0eRXTLvUhzpzg_9_12">18,073</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted&#160;prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant&#160;other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">active&#160;markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">observable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">unobservable&#160;inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest rate contract liability, long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue" scale="3" id="Tc_hkcemHJGo0e7DJYyzIO1Dg_5_3">1,447</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue" scale="3" id="Tc_gUXuvebBr0SUFRYaMSVHMw_5_9">1,447</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency contract assets, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="Tc_7fg75aOSz0a8ej5pQmmblQ_6_3">2,241</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="Tc_ABMeS6yoEkmyAHwKmTmZMQ_6_9">2,241</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency contract liabilities, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="Tc_hrHTXD5_tEyqXCJML2dD6g_7_3">3,646</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="Tc_nq6Wkd8_hUSZ7ph50nt-WQ_7_9">3,646</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_ew9IBOf_0kC_Mpfx_026Tg_8_3">48,234</ix:nonFraction>)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_jvGr01_VCUqWKwQSHCGhuw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_j63kFgUXJ0yh3Z9ROCle3w_8_12">48,234</ix:nonFraction>)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the interest rate contracts is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as prepaid and other assets or other long-term assets in the consolidated balance sheets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.</span></td></tr></table><div style="margin-top:12pt;"></div></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Certain of our business combinations involve the potential for the payment of future contingent consideration, generally based on a&#160;percentage of future product sales or upon attaining specified future revenue or other milestones. Contingent consideration liabilities are re-measured to fair value at each reporting period, with the change in fair value recognized </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">84</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="Tc_b0C91Gw0DUeS_4ZYhZJwug_1_2"></a><a id="Tc_8hQbVFWEyUWB2YIZ1CZ-0Q_1_5"></a><a id="Tc_2gdoGLRL5Em1hqj7eQBcBw_2_0"></a><a id="Tc_ZU19USV-7Uu0oBgRRtgP1Q_2_2"></a><a id="Tc_VOQQibb4qUaac9pScB3jjw_2_5"></a><a id="Tc_Aj-oLahKtESavbtSPqOPdg_4_0"></a><a id="Tc_CQHQIq-8hUK90hQ8ldcd9w_5_0"></a><a id="Tc_IYDntx_x6UGzHznvzJwnbg_6_0"></a><a id="Tc_OHFmEB81BkKlQ1YOh0N16w_6_2"></a><a id="Tc_CuknkgSqfk6mAAbbaoISPA_6_5"></a><a id="_f8329757_e767_47af_b4d7_06fd25bf6f8f"></a><a id="Tc_IgKdOKXSFkOjz31YC2kDlg_1_2"></a><a id="Tc_UY8roAXCkU-gQkyqmwMHpA_2_2"></a><a id="Tc_x6xRXuK_KUGiTvpNPuq58g_2_5"></a><a id="Tc_I60z_v_eLECoIY8hjkMtNg_2_11"></a><a id="Tc_bVy04mYsXUiwr0gBQxNTwg_3_0"></a><a id="Tc_AX4cndw5iUqtTGL2BEB46w_3_2"></a><a id="Tc_UQAVQXhN3ECOB7wfKDYTKg_3_5"></a><a id="Tc_7PLb_K3tVUieJy-lgmCFkw_3_7"></a><a id="Tc_nHGHN296Tk2BwE7ZR49IYQ_3_9"></a><a id="Tc_pa2vNpnDV0qm22SM9wonNw_3_11"></a><a id="Tc_zhE692dOCUmZ23xIAuXQOQ_4_0"></a><a id="Tc_TrAKj5iPxEKnfb4RJQI01g_4_2"></a><a id="Tc_C4uKztohOk6csFwl5zodVw_4_5"></a><a id="Tc_UU_V95hYPUOKhTKQhfM-gA_4_7"></a><a id="Tc_xstCxQH2fUmZLfrra_20TA_4_9"></a><a id="Tc_-vi_-OFSGUuFK_8NAblv8A_5_7"></a><a id="Tc_Jqxf3eHasEG4RPPNsXc3uQ_5_9"></a><a id="Tc_a7sYPPu-HU6GFaXPw1RTXQ_5_11"></a><a id="Tc_EIhEAWr9qkW65A-R9Ze_rQ_7_0"></a><a id="Tc_IPND2dKI70me48elJyAU_g_7_2"></a><a id="Tc_UjCZZ7aQ6UerLWysyZlazQ_7_5"></a><a id="Tc_rK6RXo9Gw0eEYoFlP6Jmaw_7_7"></a><a id="Tc_N9fYV_n-EEGeorI92BJN5g_7_9"></a><a id="Tc_BtdyKeylaEibycWUql65lA_8_7"></a><a id="Tc_EsAnTyOm2USH6t56BAw5Hw_8_9"></a><a id="Tc_WoxHT8CfHkKF9M83wsRPRQ_8_11"></a><a id="Tc_tuxMLzgHfUyZQiZGBj2BYQ_10_0"></a><a id="Tc_E9N_jHq8_0qQmfZakrIPbg_10_2"></a><a id="Tc_bVFE8xzQ_0WzrsUNmFO6YA_10_5"></a><a id="Tc_QfXrf5AQeUeVbOh6lmBbLQ_10_7"></a><a id="Tc_fINyyRxj1EGUa46Nh2JBtw_11_7"></a><a id="Tc_DbhDN0_n9UGNm9KN0EFyEg_12_7"></a><a id="Tc_0YbBMZmYBUq5HahNTJ5UEQ_12_9"></a><a id="Tc_akWpLaeNYE-YFobw-jE9cg_12_11"></a><ix:continuation id="Tb_-SOyXWaJ-Uejkz59f4N9cA_cont1" continuedAt="Tb_-SOyXWaJ-Uejkz59f4N9cA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">within operating expenses in the accompanying consolidated statements of income (loss). We measure the initial liability and re-measure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements. <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="Group_O7lMSBid00iLFagufBoe9g" continuedAt="Group_O7lMSBid00iLFagufBoe9g_2" escape="true">Changes in the fair value of our contingent consideration liabilities during the&#160;years ended December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</ix:nonNumeric></p><ix:continuation id="Group_O7lMSBid00iLFagufBoe9g_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="Tc_w8a6FswB1UKD-uoIbmQxNA_2_3">48,234</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_-dsubK6ei02Er5tXNOop6g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="Tc_38b-r6eSnUqjGzKnOqcD9A_2_6">55,750</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_TpnXjRgdGkC2N239gRk-Nw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contingent consideration expense</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="Tc_hEDt61HS30yiS_1jWZPtcQ_3_3">4,610</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="Tc_CKks9D7wXEe3EOGVrxvFjA_3_6">3,161</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent payments made</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="Tc_NjAon663_EacKox2c4UOyQ_4_3">34,762</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="Tc_sTaIdg05kE-893x8H950UA_4_6">10,665</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of foreign exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ" decimals="-3" format="ixt:numdotdecimal" name="mmsi:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" sign="-" scale="3" id="Tc_AyCYrAYHz0iKzfA2dhezaA_5_3">9</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA" decimals="-3" format="ixt:numdotdecimal" name="mmsi:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" sign="-" scale="3" id="Tc_z-pmKHNus0q0wi-YAFHWYg_5_6">12</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_4qQbrD0xJ02K_LJUhv6gQw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="Tc_X4HySmDLPUWrIAULr2Jhcw_6_3">18,073</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="Tc_N8hHifW7FUaiocbx89YCTQ_6_6">48,234</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_9jqh0ZIn_keRlp7QGXHQFA" decimals="-5" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" scale="6" id="Narr_jwR5Fo93Xk6JC939G1X3aA">2.3</ix:nonFraction> million in contingent consideration liability was included in other long-term obligations and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_-o3_7GcrH0SXneGGIP-6AA" decimals="-5" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" scale="6" id="Narr_XS0wBlrrg0GWBibE83NibA">15.8</ix:nonFraction> million in contingent consideration liability was included in accrued expenses in our consolidated balance sheet related to contingent liabilities. As of December&#160;31,&#160;2021, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_Ra4A3LDTXUq1U3wrhOYTzA" decimals="-5" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" scale="6" id="Narr_vrGY0bUFV0KhAc2Wa7LiSg">13.5</ix:nonFraction> million in contingent consideration liability was included in other long-term obligations and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_wkB4WLQ3Z0eP8rqn-djVrA" decimals="-5" format="ixt:numdotdecimal" name="mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" scale="6" id="Narr_hPP-Cyz4RUG69bdU6eQb_g">34.7</ix:nonFraction> in contingent consideration liability was included in accrued expenses in our consolidated balance sheet related to contingent liabilities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Cash payments related to the settlement of the contingent consideration liability recognized at fair value as of the applicable acquisition date been reflected as a cash outflow from financing activities in the accompanying consolidated statements of cash flows. Payments related to increases in the contingent consideration liability subsequent to the date of acquisition of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="Narr_gQEGydZNMk6xXWMYUbr9tg">1.8</ix:nonFraction>&#160;million for the year ended December&#160;31,&#160;2022 are reflected as operating cash flows. </p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="Tb_-tk_5QHqQE2BlcipRsqnqg" continuedAt="Tb_-tk_5QHqQE2BlcipRsqnqg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The recurring Level 3 measurement of our contingent consideration liabilities includes the following significant unobservable inputs at December&#160;31,&#160;2022 and 2021 (amounts in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Valuation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingent consideration liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">technique</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue-based royalty payments contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member__0z7AfckH0-izPRxsHj-CA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_gBFjYbeWhkGu70fMfIs0Zg_4_3">2,097</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discounted cash flow</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_XG-RKCkLlk22Ae6PugLZbw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Narr_v_029kCfz0mHOFT-8WMp_Q">14</ix:nonFraction>%&#160;-&#160;<ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_9kdasnow90OyrWKURUS9Eg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Narr_DhBs1ApzgkSpqk6aLQ5zTA">17</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wS-nk3dwt0SoycQ0IxdNoA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_klqxeqFnLEip5gakLfFUqw_4_11">15.7</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2034</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue milestones contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_WLKoC-9vCUuynE48y7ekMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_avOfRVNymkajomJqI-bDZg_7_3">13,064</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Monte Carlo simulation</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_8hQxF1RJzU--ikXVveEKCQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Narr_rv2l3XCC-EibKJb6sZv6Qw">5.1</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_E2OX24rrYEG3vsZbSdeyig" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Narr_t2svBoZ-30KfXjSMrohZMg">14.0</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wFq40ECBeEqsCzPUL8162A" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_OKrdliAWNEq2895oumZUlA_7_11">5.2</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2033</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Regulatory approval contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_ShfGhn6sDEqCKCrlJf3LYg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_9iBpY1S_nUqHlP25hiTpzA_10_3">2,912</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Scenario-based method</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_DfuOLsD7TkeHPFVz0G_RxA" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_Cao9gvnHAEOHAbFaP3HUKw_10_9">5.7</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of milestone payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_sNZB_NpM8EKYkfbbamr2_g" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_bRrJWQwHwkacO0xnFJ6hAg_11_9">90</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2030</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.</span></td></tr></table><div style="margin-top:6pt;"></div></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">85</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6e1d9988_22b8_42d0_bb8d_3b99e18724f7"></a><a id="Tc_VUMReq1dYkW6YX3Pi-uDRA_1_2"></a><a id="Tc_2Z3Aoekfp0aHZia097UXPA_2_2"></a><a id="Tc_Vbh657U_zEicHDbdrK3JVw_2_5"></a><a id="Tc_WHItR2cSL0O3Lyp4v6nusg_2_11"></a><a id="Tc_Vyceia1xE0KR0WQ0z32e9w_3_0"></a><a id="Tc_Gttl_VrsdU6_wfgqv-4JsQ_3_2"></a><a id="Tc_LzbawA0KI0u0dj3fhYuiYw_3_5"></a><a id="Tc_eIFPInhT0EW_aedfpRabKA_3_7"></a><a id="Tc_c4rlUoAufkWwC3FRX7DYgg_3_9"></a><a id="Tc_3KY3kwhhu0u5HmXf7lRe3w_3_11"></a><a id="Tc_9A5xaMcx3kCoQBvgUi_PDw_4_0"></a><a id="Tc_QWfFf6PtZ0eoN62BR3Kptg_4_2"></a><a id="Tc_7WFmDapA0E-9N7qFE1wlSA_4_5"></a><a id="Tc_NuMxtr43EUu7bEYKfBxB4A_4_7"></a><a id="Tc_vRygRpoS3kCdNBAeUx2GWQ_4_9"></a><a id="Tc_kA8ixS70v0KGTguQfhEmRw_5_7"></a><a id="Tc_ETf5-YjmB06DmiN-P6rZFw_5_9"></a><a id="Tc_uE8KK35xM0GQjK3Kz8OrhA_5_11"></a><a id="Tc_Us6HMlgcrkGC1L5aEqMbxg_7_0"></a><a id="Tc_zz5_Wp1I1kmh1r-0DPV4nQ_7_2"></a><a id="Tc_5xmcjuPRbkSNkZwpl9r7Kw_7_5"></a><a id="Tc_8vv75aE6HEa8xf2j6WihQg_7_7"></a><a id="Tc_iLX6-Ec760yuMoyTiDxvAw_7_9"></a><a id="Tc_yA2TZ--YtUGI373D0_wu6w_8_7"></a><a id="Tc_395Zr4KcJU-wfAmS4hHhgA_8_9"></a><a id="Tc_djvFsSqOh0iefkqvVr9fUw_8_11"></a><a id="Tc_TKyq3f_WuE22r8ZfWPzTEA_10_0"></a><a id="Tc_F4RL_YqYukejyyN3wzN13g_10_2"></a><a id="Tc_JxF1MEu_tkyGCBx2AmXyIA_10_5"></a><a id="Tc_a8j6dkvRKkO4_hQgUt1r6g_10_7"></a><a id="Tc_ULuQgMfOG0eKPQ0E_Tgv5A_11_7"></a><a id="Tc_VS4MsVZsLkSCnKYcc406fA_12_7"></a><a id="Tc_Rse8AGl2XkeV6t3lvWELDw_12_9"></a><a id="Tc_0rlQXV6PbUKXhnbc0XICrA_12_11"></a><a id="_Hlk127277045"></a><a id="_0a4e146f_284f_4c54_9f18_08a1d632efd0"></a><a id="_0a4e146f_284f_4c54_9f18_08a1d632efd0_2"></a><a id="_0a4e146f_284f_4c54_9f18_08a1d632efd0_3"></a><a id="_0a4e146f_284f_4c54_9f18_08a1d632efd0_4"></a><ix:continuation id="Tb_-SOyXWaJ-Uejkz59f4N9cA_cont2" continuedAt="Tb_-SOyXWaJ-Uejkz59f4N9cA_cont3"><ix:continuation id="Tb_-tk_5QHqQE2BlcipRsqnqg_cont1"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Valuation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingent consideration liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">technique</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue-based royalty payments contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_FDcVr11fvEi_blj5LZlxhQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_3uY9YX602k2Ps4zt6aUK8g_4_3">2,870</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discounted cash flow</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_CDuUTCWXo02V70P4F5nz2w" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Narr_K1q6ssfxs0KM5MulD9pYWA">13</ix:nonFraction>%&#160;-&#160;<ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_SkTzv3hCxUmDhTZzadO0Pg" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="Narr_xsW8Dc72Uk2I47oPRt9gTA">16</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_xbdo5FZuEUGtMQe0eFs_lQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_IgLVlKJPHEq2N4FUdjia6g_4_11">14.7</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022-2034</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue milestones contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_UyL0y39Dlki1ZpAdwy5TMw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_53_27aaPb0az0c2WdJTNBQ_7_3">41,671</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Monte Carlo simulation</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_qnG1d3UiJEG-s9zu8DRZxQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Narr_KmAtGjZFVUaCmF69z2IYNg">7.5</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_5Yv24v4EpUO9_ajmgjSijg" decimals="1" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="Narr_48BfqNpwBUCgJvG99XQpxQ">12.5</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_NTaqduRlGUyMLasvGWVtVQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_OVcTosKnGEe9kR3B0n1Bng_7_11">8.2</ix:nonFraction>%</p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022-2031</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Regulatory approval contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_kDxdTejFnEar4hcZNMbfOg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="Tc_wH57UKQ8ZkWvwSBY9IGreg_10_3">3,693</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Scenario-based method</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_3l2pT_uLsEe6KfiO2ucLyg" decimals="1" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="Tc_f5U5usPjDky8We8cXanJUg_10_9">2.6</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of milestone payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_yo_aT89odUGvgS5r4beT1A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="Tc_JMuwu7KTvUKSfRwZ5osnPg_11_9">80</ix:nonFraction>%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024-2025</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2025</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The contingent consideration liabilities are re-measured to fair value each reporting period using projected revenues, discount rates, probabilities of payment, and projected payment dates. Projected contingent payment amounts are discounted back to the current period using a discounted cash flow model. Projected revenues are based on our most recent internal operational budgets and long-range strategic plans. An increase (decrease) in either the discount rate or the time to payment, in isolation, may result in a significantly lower (higher) fair value measurement. A decrease (increase) in the probability of any milestone payment may result in lower (higher) fair value measurements. Our determination of the fair value of contingent consideration liabilities could change in future periods based upon our ongoing evaluation of these significant unobservable inputs. We intend to record any such change in fair value to operating expenses in our consolidated statements of income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'TimesNewRomanPSMT';font-style:italic;">Contingent Payments to Related Parties. </i><span style="background:#ffffff;">During the years ended December 31, 2022 and 2020, we made contingent payments of approximately&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_3u3FWHkJQ0qDFakJiBI-Qg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForMergerRelatedCosts" scale="6" id="Narr_TuU5rkUkU0ygy2JgKGLxaw">1.6</ix:nonFraction></span><span style="background:#ffffff;">&#160;million and&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_sxaYw4aSrkameQjBWdLV-Q" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsForMergerRelatedCosts" scale="0" id="Narr_I-T0mJjtDUKUO2DP_-FUyw">800,000</ix:nonFraction></span><span style="background:#ffffff;"> to a former director of Merit and former shareholder of Cianna Medical which we acquired in 2018. We made no such payments in 2021.</span> <span style="background:#ffffff;">In 2023, the Company expects to make additional payments consistent with prior years. The terms of the acquisition, including contingent consideration payments, were determined prior to the appointment of the former Cianna Medical shareholder as a director of Merit. As a former shareholder of Cianna Medical, the former Merit director may be eligible for additional&#160;</span>payments for the achievement of sales milestones specified in our merger agreement with Cianna Medical.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair Value of Other Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of cash and cash equivalents, receivables, and trade payables approximate fair value because of the immediate, short-term maturity of these financial instruments.&#160;Our long-term debt re-prices frequently due to variable rates and entails no significant changes in credit risk and, as a result, we believe the fair value of long-term debt approximates carrying value. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs, with the exception of cash and cash equivalents, which are Level 1 inputs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Impairment Charges</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily property and equipment, intangible assets and goodwill in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Intangible Assets. </i>During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, we had losses of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_TyDRSgQHZkK8nHlLFMhXYA">1.7</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_XOtVZd4jKEuuRm7xZRQWXQ">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="Narr_gpiAqDjmukGL1Av2_1VDiA">28.7</ix:nonFraction> million, respectively, related to certain acquired intangible assets (see Note 5). </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">86</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_3r41PTiC1USvu9vx6by9UQ_1_2"></a><a id="Tc_DljKCjTtiU-VeST2Z-RJ6g_1_5"></a><a id="Tc_GkM_lfKgrUG0fmS_ziFFCg_2_0"></a><a id="Tc__Sb4GNoN-EiVxCcV00t7Qw_2_2"></a><a id="Tc_Nv7Ea_Lkt0-Ekg_tXsnQ7Q_2_5"></a><a id="Tc_WXTFc9R7v0afcSZNk5TJuw_3_0"></a><a id="Tc__CsFGV-S2EiINwcDT_zuTw_4_0"></a><a id="Tc_IquM-x_XZkeL3TYmjD9CQg_4_2"></a><a id="Tc_uXJ-WO6IkUOnjbGR37DdUg_4_5"></a><ix:continuation id="Tb_-SOyXWaJ-Uejkz59f4N9cA_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Right of Use Operating Lease Assets.</i> W<span style="background:#ffffff;">e identified changes in events and circumstances relating to certain right-of-use (&#8220;ROU&#8221;) operating lease assets. We compared the anticipated undiscounted cash flows generated by a sublease to the carrying value of the ROU operating lease and related long-lived assets and determined that the carrying values were not recoverable. Consequently, we recorded impairment losses during the years ended December 31, 2021 and 2020 of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="Narr_Z0hU6wb-ekeAKeMqog1HLw">1.4</ix:nonFraction></span><span style="background:#ffffff;"> million and </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="Narr_dM9ZDhjF3ke5H93qdpo3Cw">1.5</ix:nonFraction></span><span style="background:#ffffff;"> million, respectively, which is equal to the excess of the carrying value of the assets over their estimated fair value. The impairment losses were driven primarily by site consolidation decisions and changes in our projected cash flows for the ROU operating lease asset and related long-lived assets, due to changes in the real estate market as a result of the COVID-19 pandemic. These changes include an increase in the anticipated time to identify a lessee, an increase in anticipated lease concessions, and a decrease in the expected lease rates for the property. The ROU operating lease asset impairment losses pertained to our cardiovascular segment. We had </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="Narr_Um4ov2L6BkWZOjkLdxT1wg">no</ix:nonFraction></span><span style="background:#ffffff;"> such losses during the year ended December 31, 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Property and Equipment.</i> D<span style="background:#ffffff;">uring the year ended </span><span style="-sec-ix-hidden:Hidden_PXZ4MOWrBUiFixPo1YrNdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">December 31, 2021</span></span><span style="background:#ffffff;">, we had losses of </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="Narr_eqYHzDZZ6km_vCkX-IVM1A">1.3</ix:nonFraction></span><span style="background:#ffffff;">&#160;million related to the measurement of property and equipment at fair value based on the planned&#160;discontinuance of the Advocate&#8482; Peripheral Angioplasty Balloon product line, sold under our license agreements with ArraVasc, which pertained to our cardiovascular segment.&#160;</span>During the year ended <span style="-sec-ix-hidden:Hidden_5ha5obNG7EukzOsmSgU-lg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2020</span></span>, we had losses of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_CounterpartyNameAxis_mmsi_NinePointMedicalInc.Member_DqLbR1-f_USM3HqTH1_MPQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="0" id="Narr_84C632WsskKYtN2ZOG7k0Q">359,000</ix:nonFraction>&#160;related to the measurement of certain property and equipment measured at fair value based on restructuring activities associated with the suspension of our distribution agreement with NinePoint, which pertained to our endoscopy segment. We had <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" scale="6" id="Narr_tOgJc8EA3UqI-JFHwMAAWw">no</ix:nonFraction> such losses during the year ended December 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;background:#ffffff;">Equity Investments, Purchase Options and Notes Receivable.</i><span style="background:#ffffff;">&#160;During the year ended December 31, 2022, we recognized </span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_XableCathMember_olpSi2DLokilw5cmv-tukQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="Narr_nMDSagvF7ESuyz2EYafQZA">0.5</ix:nonFraction></span><span style="background:#ffffff;"> million of impairment expense related to our equity method investment in XableCath, as business ceased operations. During the year ended December 31, 2020, we recognized&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_rCYZXv1CfE2ubKNZDLYiJw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="Narr_t-M-7SqIx0OLoNIdUu2mbA">2.5</ix:nonFraction></span><span style="background:#ffffff;">&#160;million of impairment expense related to our equity method investment in the&#160;</span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_DUaZCPw_8kabeorUeHmx0g" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="Narr_ESF1iALY6k6FyA3XAte-1g">19.5</ix:nonFraction></span><span style="background:#ffffff;">&#160;percent ownership in preferred shares of Fusion Medical, Inc. (&#8220;Fusion&#8221;) due to&#160;uncertainty about future product development and commercialization associated with the technologies and a charge of&#160;</span><span style="background:#ffffff;">$<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_BluegrassVascularTechnologiesIncMember_F_LmcolU_0qcGjS4sv6hNg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="Narr_kDB4yu6RrEGZvOVghXIPiA">3.5</ix:nonFraction></span><span style="background:#ffffff;">&#160;million related to Bluegrass Vascular due to our decision not to exercise our option to purchase the company. We had </span><span style="background:#ffffff;"><ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="Narr_H_QkXW08vkWhO-sTppnZTw">no</ix:nonFraction></span><span style="background:#ffffff;"> such losses during the year ended December 31, 2021. </span>Our equity investments in privately held companies were $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="Narr_N3O5pXoHb0-n99SrUdNeRA">15.6</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="Narr_9H-JPWxScU-zSc0MRxFrPA">14.7</ix:nonFraction> million at December 21, 2022 and 2021, respectively, <span style="background:#ffffff;">which are included within other long-term assets in our consolidated balance sheets. We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Current Expected Credit Losses</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Our outstanding long-term notes receivable, including accrued interest and our allowance for current expected credit losses, were $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_ounleXUwDkGNqZctsTtL_g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" scale="6" id="Narr_-N-neBv10UC8rcT_slU9ug">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_FjbGmVYKb0ij4cN6X0KS1g" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent" scale="6" id="Narr_sQ4f8nCfLkqx1esJ21hhig">2.3</ix:nonFraction> million, as of December&#160;31,&#160;2022 and 2021, respectively. As of December&#160;31,&#160;2022 and 2021, we had an allowance for current expected credit losses of $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_ounleXUwDkGNqZctsTtL_g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="0" id="Narr_wpCd1j7TBkOz5dzlCFyoIw">281,000</ix:nonFraction> and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_FjbGmVYKb0ij4cN6X0KS1g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="0" id="Narr_Y33_lp56k0eQmgDQc2GmbA">199,000</ix:nonFraction>, respectively, associated with these notes receivable. We assess the allowance for current expected credit losses on an individual security basis, due to the limited number of securities, using a probability of default model, which is based on relevant information about past events, including historical experience, current conditions and reasonable and supportable forecasts that affect the expected collectability of securities. During the year ended December 31, 2021, we collected $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_mmsi_BluegrassVascularTechnologiesIncMember_SYBvPqScc0WI8eIanV1mkQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="Narr_cuTZ1coPEkCvgag1nUMdXg">2.8</ix:nonFraction> million from Bluegrass Vascular Technologies, Inc. pursuant to the terms of a note receivable, which represents the entire principal balance and all accrued interest payable pursuant to that note. </p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="Group_AU1yaXplNESIvzcOj1uRAA" continuedAt="Group_AU1yaXplNESIvzcOj1uRAA_2" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">The table below presents a rollforward of the allowance for current expected credit losses on our notes receivable for the years ended December&#160;31,&#160;2022 and 2021 (in thousands):</p></ix:nonNumeric><ix:continuation id="Group_AU1yaXplNESIvzcOj1uRAA_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="Tc_SEErURv2IUizMHOGbGCoow_2_3">199</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="Tc_-_LcMxXlzEyUE2vHmTaV5w_2_6">730</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for credit loss expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="Tc_IOBX1fofy0OzHMA633Jwxg_3_3">82</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForLoanLossesExpensed" sign="-" scale="3" id="Tc_BBesqeRTmUiuWxppxCO7Ew_3_6">531</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="Tc_3aio9eiv4EOWAKGOrA0fPg_4_3">281</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="Tc_tYIyPgTjmEeoJoN6biE7mw_4_6">199</ix:nonFraction></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">87</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_WjkGJnA16UWTEfnrYwophA_1_1"></a><a id="Tc_9CTL_VuBZkCYlhzwZ-z9kw_1_4"></a><a id="Tc_2frNkgV1qUeBJTyc8lAEDg_1_7"></a><a id="Tc_wMQgBq5GtU-Jd_XIDRdvMw_2_0"></a><a id="Tc_KmI5ViP_NE6ly3hgb5qh5A_2_1"></a><a id="Tc_MW-P9vgboE-zXewSsivaZQ_4_0"></a><a id="Tc_1VoP5lbEvkmQ4wMlCMUdsQ_5_0"></a><a id="Tc_q4AHEfbqp0KBImpM0sYYGA_6_0"></a><a id="Tc_UnB0RkdY80CqMCoJQURrlw_7_0"></a><a id="Tc_4Kxc6Mdp9EiS-5o08FhRhw_8_0"></a><a id="Tc_XWzXwojlwkuCr036o4SpzA_9_0"></a><a id="Tc_qSEdTwpeLU6gu2UzQW5Khg_10_0"></a><a id="Tc_qZPVBrYHG0ivXGu4TJ-G1A_12_0"></a><a id="Tc_5EJJZd54tUuQYRtmp7xy8w_14_0"></a><a id="Tc_K_bSpDyjfUGG4ftB18yNwg_15_0"></a><a id="Tc_EuDNOSouAk6xmAizcLB6MA_16_0"></a><a id="Tc_bJw_JGbGyUWslKwYtvzuIg_17_0"></a><a id="Tc_c385xACzAkOhdzMCB_bsVg_18_0"></a><a id="Tc_TmO1pbzShEmeGbZDXFKzhA_19_0"></a><a id="Tc_AlQ2-O3_006ra77cMKCXYw_20_0"></a><a id="Tc_cVCL-57TuEqBnswByLK17g_22_0"></a><a id="Tc_zwr1YBeY5EGwiOFQ_Knfqg_24_0"></a><a id="Tc_25zdM592KUeau9roI8ddBQ_25_0"></a><a id="Tc_jMx3w32rgUqWIxYTD_ogdQ_26_0"></a><a id="Tc_OWhnpKEeS0uoXompe1kjzQ_27_0"></a><a id="Tc_jMZjJBdqAEefZBW1xN7whQ_28_0"></a><a id="Tc_zuALEgdEsE6rH9lJG1rrCg_29_0"></a><a id="Tc_q4JAniNHGE6TdfB_CHXFrQ_30_0"></a><a id="Tc_1wM6xfAUOUqGDIEBjeXQBw_32_0"></a><a id="Tc_UmD42zmJt0iK8lvDZCRw2w_32_1"></a><a id="Tc_BYydHQUzykypMqVF04suhA_32_4"></a><a id="Tc_-gHpoyEj_0uashO4pQThfw_32_7"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="Tb_JClmpquhVE2u-i4QkssH-w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">16.</b></span>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="Group_yOqNJToByESMPqi6iLjsnQ" continuedAt="Group_yOqNJToByESMPqi6iLjsnQ_2" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="background:#ffffff;">The changes in each component of Accumulated Other Comprehensive Income (Loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows (in thousands):</span></p></ix:nonNumeric><ix:continuation id="Group_yOqNJToByESMPqi6iLjsnQ_2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash Flow Hedges</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Foreign Currency Translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_DsDJDza1hEOKOCEENBEccw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_G1fuCv1MREqRd81igq8VbA_2_2">218</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2ZYBTZI1iUGbF66gUMJ3jA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_BsZdI1_7kUihz3mIZLevhw_2_5">5,512</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_N2nptxswq06E37WY0fAdLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_Lr_x-7Ble0WSk_ogZdN33A_2_8">5,294</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" sign="-" scale="3" id="Tc_tU4sD_8xI0-Pz10M8PdcLw_4_2">11,647</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="Tc_uavXqGE6mkmMvCezkcTueQ_4_5">7,786</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" sign="-" scale="3" id="Tc_Rayq4TR8Y0yBqSy2w0IYIQ_4_8">3,861</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" sign="-" scale="3" id="Tc_xH8Fm79mN0-sRe-HxCLqOg_5_2">2,365</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="Tc_ucrs4LZGW0GGV24HtZ8Pvg_5_5">786</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" sign="-" scale="3" id="Tc_fiD9NdLNAUiC89ctVjh-AQ_5_8">1,579</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" sign="-" scale="3" id="Tc_TstlxVkPP0ul5VeO4oHacQ_7_2">36</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" sign="-" scale="3" id="Tc_KACwm-TIFU2jFF2pD9zqrg_7_8">36</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" sign="-" scale="3" id="Tc_DWMpMiI7cE2C034DeOsPSw_8_2">1,288</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" sign="-" scale="3" id="Tc_YtMKtk0tVEWG9w4elKxhOw_8_8">1,288</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" sign="-" scale="3" id="Tc_DOSnWtXjK0uXT5l3H_8tYg_9_2">872</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" sign="-" scale="3" id="Tc_CwvOKRa2nEeCCAlA1S988Q_9_8">872</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="3" id="Tc__m_iHLnCQkm33KlpOEHCSg_10_2">7,158</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="Tc_fg0yS4yGPEahIhGbwz3b6g_10_5">7,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="3" id="Tc_QXYJJWS6vU6jFMmylpULQA_10_8">158</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_m354GPzJSkesgFQaFE_wMA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_w_iutYfl10WvvHQbi8ZU1A_12_2">6,940</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_Xv_jjMZ61Uuj4krxMBlGGg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc_JMq_68qAj02FLketkHhLVw_12_5">1,488</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3aRiaMEyxkWBqtSJEkrr9g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_A-kfK2AypEici58_WRu3FQ_12_8">5,452</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" sign="-" scale="3" id="Tc_arTd4HK3NUKlwem3LCTmDA_14_2">119</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" sign="-" scale="3" id="Tc__v70p2WILEWh-2I40rDY-Q_14_5">7,704</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" sign="-" scale="3" id="Tc_hVqEQ21QV0mhii7hs_05Dw_14_8">7,823</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="Tc_Qlbe0_JRTEux0Jnr3X4OVQ_15_2">1,489</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" sign="-" scale="3" id="Tc_334ukiE660GHuUWP-FISsw_15_5">689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="Tc_-00vKZBvw0OJ4kNohO2i_A_15_8">800</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="Tc_ahgU0aKH20iyqluZXTkqAg_17_2">5,592</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="Tc_ZCI1I94_RUWC5jUwDgp0DA_17_8">5,592</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_q00Q-4S8P0-JF4UBonme1w_18_2">1,017</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="Tc_auls4viHD0-xmryPywfGgQ_18_8">1,017</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" sign="-" scale="3" id="Tc_gFWM690gEU-Kf3q1IJBrwQ_19_2">1,509</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" sign="-" scale="3" id="Tc_x9IRz3n1Akqcp0iLekh4Ww_19_8">1,509</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="Tc_1UeLtHZv1kayUhR9FWs4Lw_20_2">4,476</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="3" id="Tc_Tfhjcm3TWUqCCy628D1BSg_20_5">7,015</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="3" id="Tc_4BJfNuJzPk6ChUWSFWTvfw_20_8">2,539</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_NNFXt7P21UW4Paq_45LQzg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_tKxEwH1pqk-ZIaodTJRXsw_22_2">2,464</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_689J25SRoUeFQ-mb_xQzMQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_zjuD7LGgxU-V-og1Sz8wPg_22_5">5,527</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_aN4IaMh0wkmaWTjP49uYEQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_9X5WKzY8CU6kVSb1oFe0RA_22_8">7,991</ix:nonFraction>)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="Tc_I1hVVzUjKku4wppqlDSG5A_24_2">11,142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" sign="-" scale="3" id="Tc_FzMZl8OvBEuZs4K44k9UHw_24_5">10,491</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="Tc_LlxpIjfsWkSW02JV5SoaMA_24_8">651</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="Tc_WX9OjrVMIkujSby1YWBr0w_25_2">2,177</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" sign="-" scale="3" id="Tc_QjnvbcOnIEOl_uRI0xWIQg_25_5">102</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="Tc_a3NRfkjwzU6rQTarNimrDg_25_8">2,075</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" sign="-" scale="3" id="Tc_ejWotX67gUmiZ4ylcaoN9w_27_2">3,583</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" sign="-" scale="3" id="Tc_wOTxjsiGQEa69_ZEN0Mmjg_27_8">3,583</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" sign="-" scale="3" id="Tc_xDNQr3lKDEaPkGF5VWtVGA_28_2">1,436</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" sign="-" scale="3" id="Tc_JW6w5pIq80qT1l7RCyNUqA_28_8">1,436</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" sign="-" scale="3" id="Tc_eQoK-Ej8l02Fqv0gsF0_TA_29_2">12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" sign="-" scale="3" id="Tc_8gKQuJY5EUOZ8MDBQq6b_g_29_8">12</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="Tc_PImiw_xRN0uAOXJxz3bXgg_30_2">6,830</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="3" id="Tc_AGLpnWTrqUeHAJkWmJ2cBw_30_5">10,389</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="3" id="Tc_as6ePzBZakSs5HWuMVfPpQ_30_8">3,559</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-size:11pt;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0dOxMvz3KkeA-_6PU6WRIw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="Tc__eOomohCUk66xZhD_dd-Rw_32_2">4,366</ix:nonFraction></b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bQN0IS6wDU6ClnshU71aSg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_uJpSDLhSZUSXlDIU6mcRJQ_32_5">15,916</ix:nonFraction>)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_KA5J2PovC0-VQ20gGn884Q" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="3" id="Tc_Lsidd4wd50mKogzQe_U0Hg_32_8">11,550</ix:nonFraction>)</b></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:9pt;margin-bottom:6pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">88</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_72fdb0bb_dabe_4e8b_bfb7_78197be323b3"></a><a id="Tc_aBy5IhwMNECI6n9Y1XXAvA_1_2"></a><a id="Tc_KhlOpB-xNkKNQNmwBlBRng_1_5"></a><a id="Tc_Qq4kf9WPQUOUZ2Ncu68Mfg_2_0"></a><a id="Tc_CTroeEls5Eag1Aunps_aDw_3_0"></a><a id="Tc_rx6pQIXy10CERKZZZibOSQ_3_2"></a><a id="Tc_KJ5CJX4SDUe_r0L1L4R5kw_3_5"></a><a id="Tc_hocKP8ZfqUG8dyEt9SdVaQ_5_0"></a><a id="Tc_Yd1NPz8ZHU-QJO-UgKGwuw_6_0"></a><a id="Tc_qtqPhRCXpkmE6NJWq-sthw_6_2"></a><a id="Tc_RInDQjZUKEiMXLsrl2Q17A_6_5"></a><a id="Tc_v7NQZv05aUi7M-DPyavIdA_7_0"></a><a id="Tc_C5PbzAP3ukiAyNG_q7RFIg_8_0"></a><a id="Tc_fLut_q6bp0Oh4RCOP2OA7w_8_2"></a><a id="Tc_wTSSY7hwP0Kn1oCWowvmeQ_8_5"></a><a id="_734f9ee2_99e1_4d58_823e_1bad97212e14"></a><a id="Tc_bZJXRbNh1U2XlNMZxhIL5g_2_0"></a><a id="Tc_MOKLlvQsh0WjUhpm3NutGw_2_2"></a><a id="Tc_jyzKS_KgC0O4hdNJ4nAFlQ_2_4"></a><a id="Tc_ARRrMx3TJUKOZ-eByPi44g_2_7"></a><a id="Tc_-raV2SyqQkeeVAT47dTAfw_2_10"></a><a id="Tc__heVyL0c0kKLbbrs4otTkQ_3_0"></a><a id="Tc_eNkKoYIPkUO5x7_IgO7BAw_3_2"></a><a id="Tc_nUI_dac2zEClRWbak5k5qw_3_4"></a><a id="Tc_3Be3FSbkMU-TqfsmWA3mLg_3_7"></a><a id="Tc_uglIDg5VoEGmwUcfGYwHpw_3_10"></a><a id="Tc_mL5DoK_Ub0a1A_b3Q9asiA_4_0"></a><a id="Tc_ejjYoHGVmEmXiHS0DqEQKg_4_2"></a><a id="Tc_N1ufi-sc8UyIg0srs2tIdw_5_0"></a><a id="Tc_WEwgSDD2iEqK7bPJAHEKYw_5_4"></a><a id="Tc_NobKGAAIdESF9vW_zBS2hw_5_7"></a><a id="Tc_G4YGnLnE60KGUggU0q7AJg_5_10"></a><a id="_1730ca8a_23bb_43e4_94fa_0b55a346e8c4"></a><a id="Tc_5rzBDW7TbkyuVQmpWiYTiA_1_2"></a><a id="Tc_h7QEb3Fj9EKEtnAnJ_3_Ew_1_5"></a><a id="Tc_4fS14OLdM0KD_qbM1KlaGQ_1_8"></a><a id="Tc_kuxdBAi8ZEeFb0sWwje-Yg_2_0"></a><a id="Tc_EWI67AWwKkaKFPNxsNjfUg_2_2"></a><a id="Tc_-YvV-NYNFkKlJDmNS5yD1A_2_5"></a><a id="Tc_4N4uz3KulEihImUzqQuuIQ_2_8"></a><a id="Tc_YsItVl6r8k6CTgbJ3REeMg_3_0"></a><a id="Tc_IJlA1OQqZ0-_N20ZFEdq-A_3_2"></a><a id="Tc_hgQ9IcD-sEue0tmF5kPHFA_3_5"></a><a id="Tc_VtIuxZ1k6U-s8jM1c55E_A_3_8"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:LesseeOperatingLeasesTextBlock" id="Tb_rZFY9W1jZkmRRDkAaPSGKA" continuedAt="Tb_rZFY9W1jZkmRRDkAaPSGKA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">17.</b></span>LEASES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">We have operating leases for facilities used for manufacturing, research and development, sales and distribution, and office space, as well as leases for manufacturing and office equipment, vehicles, and land. Our leases have remaining terms ranging from less than </span><ix:nonNumeric contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_QnCxU02fNUm64FC2KL9WNA" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Narr_WuEQQMxzHk-k6mmrD2lugQ"><span style="font-weight:normal;">one year</span></ix:nonNumeric><span style="font-weight:normal;"> to approximately </span><ix:nonNumeric contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_4HjX7W_AtkazUBHgOvHHrw" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Narr_dLzjvF9hGU24K7XcFD6YqQ"><span style="font-weight:normal;">27 years</span></ix:nonNumeric><span style="font-weight:normal;">. A number of our lease agreements contain options to renew at our discretion for periods of up to </span><ix:nonNumeric contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Narr_mhkgwPcF7kKy0_-4YLMPYA"><span style="font-weight:normal;">15 years</span></ix:nonNumeric><span style="font-weight:normal;"> and options to terminate the leases within </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" format="ixt-sec:durwordsen" name="mmsi:LesseeOperatingLeaseTerminationPeriod" id="Narr_9neytra5BEu-nTTV7jMVZA"><span style="font-weight:normal;">one year</span></ix:nonNumeric><span style="font-weight:normal;">. The lease term used to calculate ROU assets and lease liabilities includes renewal and termination options that are deemed reasonably certain to be exercised. Lease agreements with lease and non-lease components are generally accounted for as a single lease component. We do not have any bargain purchase options in our leases. For leases with an initial term of one year or less, we do not record a ROU asset or lease liability on our consolidated balance sheet. Substantially all of the ROU assets and lease liabilities as of December&#160;31,&#160;2022 recorded on our consolidated balance sheet are related to our cardiovascular segment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">From time to time, we enter into agreements to sublease a portion of our facilities to third parties. Such sublease income is not material. We also lease certain hardware consoles to customers and record rental revenue as a component of net sales. Rental revenue under such console leasing arrangements for the years ended December&#160;31,&#160;2022, 2021 and 2020 was not significant.</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="mmsi:AssetsAndLiabilitiesLesseeTableTextBlock" id="Tb_RBq-gmc8YUKHiz7IhUli5Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following was included in our consolidated balance sheet as of December&#160;31,&#160;2022 and 2021 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">ROU operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Tc_GT2BB9CNAEa6RwqfYuI8SA_3_3">65,262</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="Tc_Vp4MZpRM4UyrPdab40G3PA_3_6">65,913</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Liabilities</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="Tc_XCLm2VY2r02ZmdmhzPC2Qw_6_3">11,005</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="Tc_OWsdatu2yUaIO5awWCjT0Q_6_6">10,668</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="Tc_ID6rI53YN0enUTrX9CG_iQ_7_3">59,736</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="Tc_3l9OP06Uq0e1dLpRZ2r2bg_7_6">61,526</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="Tc_wf6N0Q204kaqOZYgRhYsaQ_8_3">70,741</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="Tc_hf3bnob4w02hiFhDCuU-Bw_8_6">72,194</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:LeaseCostTableTextBlock" id="Tb_sfIz04_djEyhKszvRoepyQ" continuedAt="Tb_sfIz04_djEyhKszvRoepyQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">We recognize lease expense for operating leases on a straight-line basis over the term of the lease. Net lease cost for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="Narr_8bdBi2Xgj0u6h_EYRP__dw">13.8</ix:nonFraction> million, $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="Narr_A_fd2AjcE0aOKEVjIH8cyg">15.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="Narr_mOhV_sVYOUyiACdcb6mOEw">16.7</ix:nonFraction> million, respectively. The components of lease costs for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows, in thousands:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Lease Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Classification</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease cost (a)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="Tc_yr503gsip0WDdsOFH32QhQ_3_5">14,219</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="Tc_Yl7gz2yLxUWo_H_pZhPEbg_3_8">16,013</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="Tc_urQ1m_EGX0uGKgjFKMrkFA_3_11">16,735</ix:nonFraction></p></td></tr><tr><td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sublease (income) (b)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="Tc_YCXZtBO7zEqF5LA4hBTHuA_4_5">409</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="Tc_nAP3dQccDUq3VKlAAerYtA_4_8">75</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="Tc_90fEHcBA6kySE57IeFhf-g_4_11">15</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net lease cost</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="Tc_eKqbWqQurU6rp4yoTRtzfQ_5_5">13,810</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="Tc_evHUGlOjf0q_5t5f8p1enA_5_8">15,938</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="Tc_kOBaHxVd9EymxL6NXEgFEA_5_11">16,720</ix:nonFraction></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;padding:0.75pt;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(a)</p></td><td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Includes expense related to short-term leases and variable payments, which were not significant.</p></td></tr><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(b)</p></td><td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Does not include rental revenue from leases of hardware consoles to customers, which was not significant.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Supplemental cash flow information for the years ended December&#160;31,&#160;2022, 2021 and 2020 was as follows, in thousands:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="Tc_9Hbalf1_ck6LdeqtvxL7UA_2_3">13,710</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="Tc_U5jsmofagU-XMa1UsM9hXg_2_6">14,970</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="Tc_YArUl7lvSU633g00n6Fk_w_2_9">15,059</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets obtained in exchange for lease obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="Tc_f-lo6o0KokKGYFEL9XgEIw_3_3">11,130</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="Tc_o1vfeM9780yVnPIHgxZfJA_3_6">1,524</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="Tc_1THjO-LOZEKS5Fyj4b7CeA_3_9">10,938</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="background:#ffffff;">Generally, our lease agreements do not specify an implicit rate. Therefore, we estimate our incremental borrowing rate, which is defined as the interest rate we would pay to borrow on a collateralized basis, considering such factors as length </span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">89</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ed8d74e9_3c1e_453c_a57e_b9b603016996"></a><a id="Tc_kePU2PR9NkmigougP15XSA_1_3"></a><a id="Tc_6z1cGnLMKkeDZgs2WYMkoQ_1_6"></a><a id="Tc_Jz1TE5lnF0yNkvKiZ7aSzA_1_9"></a><a id="Tc_fqsLcplrREGnxww2rKfyow_2_0"></a><a id="Tc_75dcKJYoC0e4PEw6PReYvA_2_3"></a><a id="Tc_xJPGG0w340SlwLOJ-RQ8nA_2_6"></a><a id="Tc_srbKcJeCM0GBFOMs5gnR8A_2_9"></a><a id="Tc_CYaCmkiZD0yDnWKNF8gJYA_3_0"></a><a id="_b13b481e_dbd9_4438_896e_b0bc26ef698f"></a><a id="Tc_LK7A4Mj2_kaw9ItZ3MSFow_1_0"></a><a id="Tc_-fnS3L1hokGvbuxoX-270w_1_2"></a><a id="Tc_BxL46srFHkmvPRdfPwJPFw_2_0"></a><a id="Tc_ZeFt4oGnFUSmTU-lgE1A_g_2_2"></a><a id="Tc_Har7qToeJUyAiXVboJ-DbA_3_0"></a><a id="Tc_KrUv7RP1yUyOfB8cOxPHhg_4_0"></a><a id="Tc_mYrqdGD5QES-bULr5XptEw_5_0"></a><a id="Tc_u_bQT-EgE0GrJNGMqjD8dg_6_0"></a><a id="Tc_qPy2qUG4PUKq39WoccIb-w_7_0"></a><a id="Tc_BSdmaQPUtkCVhW15vSDqpg_8_0"></a><a id="Tc_zI8UAuJL80SSEHmNNXW43g_9_0"></a><a id="Tc_ajNklwYWe0aVvGVlJK9N-w_10_0"></a><a id="Tc_f7PIR5r1L0GIzXVTnA8hig_10_2"></a><ix:continuation id="Tb_rZFY9W1jZkmRRDkAaPSGKA_cont1"><ix:continuation id="Tb_sfIz04_djEyhKszvRoepyQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">of lease term and the risks of the economic environment in which the leased asset operates. As of December&#160;31,&#160;2022, 2021 and 2020, our lease agreements had the following remaining lease term and discount rates:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.28%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining lease term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Narr_iGH5k5I6BkqalVdPJQ5Z1w">10.4</ix:nonNumeric> years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Narr_nbp_L-ULvUK2RScfcTaAjQ">11.4</ix:nonNumeric> years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Narr_xG4FJ_4EjkiXBViy6RzOew">11.5</ix:nonNumeric> years</p></td></tr><tr><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="Tc_zHLLL0YL5U6S8EY9QH3I9g_3_3">3.4</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="Tc_pm7f9CTsQUiL-GShPqD1Lw_3_6">3.4</ix:nonFraction>%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ" contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ" decimals="3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="Tc_p-dY4Gvlm0iB-_BD9_b30g_3_9">3.3</ix:nonFraction>%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Tb_bQfyUGqzKE-tK23BjO6DUQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">As of December&#160;31,&#160;2022, maturities of operating lease liabilities were as follows, in thousands:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts&#160;due&#160;under&#160;operating&#160;leases</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="Tc_0_qZtO3fj0CZVR-WFxTLLg_2_3">12,638</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="Tc_GsW2pmlnN0uNhWm1pCxRNw_3_3">11,554</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="Tc_CXzshJVodEiAw170YMpeAQ_4_3">8,941</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="Tc_YefJRa4o2USgZUorL7R3uA_5_3">7,523</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="Tc_onRU3Mvwo0ePIQ4hIMkIxg_6_3">5,944</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="Tc_-qrtC9FHz02hSeeD9ADABw_7_3">37,983</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="Tc_duAfTIpVqECP4d9Jhq1x-Q_8_3">84,583</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Imputed interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="Tc_yYS8vZaIjEKDlt7Yo0unSg_9_3">13,842</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="Tc_9sCjtDfFPEGEhQG-PdPPFg_10_3">70,741</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">As of December&#160;31,&#160;2022, we had additional operating leases for office space that had not yet commenced. These leases will commence during 2023 and are not deemed material.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_64f30739_f465_49c0_b468_d691b6199f71"></a><a id="Item9ChangesinandDisagreementswithAccoun"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;9.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_eef93b49_5f01_4223_bd6c_604214de9bd8"></a><a id="Item9AControlsandProcedures_867997"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;9A.</b><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">&#160;</b></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Controls and Procedures.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the design and operation of our disclosure controls and procedures, as such term is defined under Rule&#160;13a-15(e)&#160;promulgated under the Securities Exchange Act of 1934 (&quot;Exchange Act&quot;), as of December&#160;31,&#160;2022. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of December&#160;31,&#160;2022, our disclosure controls and procedures were effective, at a reasonable assurance level, to ensure that information we are required to disclose in the reports we file or submit under the Exchange Act is (a)&#160;recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules&#160;and forms and is (b)&#160;accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">MANAGEMENT&#8217;S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules&#160;13a-15(f)&#160;and 15d-15(f)&#160;under the Securities Exchange Act of 1934, as amended. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the U.S. of America.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our management assessed the effectiveness of our internal control over financial reporting as of December&#160;31,&#160;2022.&#160;In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&quot;COSO&quot;) in <i style="font-style:italic;">Internal Control-Integrated Framework (2013)</i>.&#160;Based on the criteria discussed </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">90</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">above and our management&#8217;s assessment, our management concluded that, as of December&#160;31,&#160;2022, our internal control over financial reporting was effective.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the quarter ended December&#160;31,&#160;2022, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)&#160;under the Securities Exchange Act of 1934).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Our independent registered public accountants have also issued an audit report on our internal control over financial reporting.&#160;Their report appears below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">91</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6a20c9be_c222_4f69_8464_fc32fac9f350"></a><a id="_REPORT_OF_INDEPENDENT"></a><a id="INDEPENDENTREGISTEREDPUBLICACCOUNTINGFIR"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">To the stockholders and the Board of Directors of Merit Medical Systems, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Opinion on Internal Control over Financial Reporting</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We have audited the internal control over financial reporting of Merit Medical Systems, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022, based on criteria established in <i style="font-style:italic;">Internal Control &#8212; Integrated Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in <i style="font-style:italic;">Internal Control &#8212; Integrated Framework (2013)</i> issued by COSO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2022, of the Company and our report dated February 24, 2023, expressed an unqualified opinion on those financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Basis for Opinion</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Definition and Limitations of Internal Control over Financial Reporting</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">/s/ DELOITTE&#160;&amp; TOUCHE LLP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Salt Lake City, Utah</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">February 24, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">92</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_10a9b537_38d0_4328_8fcf_d1768345a873"></a><a id="Item9BOtherInformation_688057"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;9B.</b></span><span style="display:inline-block;width:18pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Information.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;9C.</b></span><span style="display:inline-block;width:18pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_ee3b4476_9f19_4795_bc3a_11807b61b103"></a><a id="PARTIII_31510"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">PART&#160;III</p><a id="Items10111213and14_536293"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Items 10, 11, 12, 13 and 14.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The information required by these items is incorporated by reference to our definitive proxy statement relating to our 2023 Annual Meeting of Shareholders.&#160;We currently anticipate that our definitive proxy statement will be filed with the SEC not later than 120&#160;days after December&#160;31,&#160;2022, pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_626ddb7f_9458_4048_b8f3_7fadde690bb3"></a><a id="PARTIV_707140"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;IV</p><a id="Item15ExhibitsandFinancialStatementSched"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 6pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:54pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;15.</b></span><span style="display:inline-block;width:18pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibits and Financial Statement Schedules.</b></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Documents filed as part of this Report:</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:14.4pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Statements</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.&#160;The following consolidated financial statements and the notes thereto, and the Reports of Independent Registered Public Accounting Firm are incorporated by reference as provided in Item&#160;8 and Item&#160;9A of this report:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a href="#Item8FinancialStatementsandSupplementary"><span style="font-style:normal;font-weight:normal;">Report of Independent Registered Public Accounting Firm</span></a> (PCAOB ID <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="dei:AuditorFirmId" id="Narr_Sa_SE0-ou0m09CRpQhnBrw">34</ix:nonNumeric>) <a href="#Item8FinancialStatementsandSupplementary"><span style="font-style:normal;font-weight:normal;">&#8212; Internal Control</span></a></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a href="#REGISTEREDPUBLICACCOUNTINGFIRM_44170"><span style="font-style:normal;font-weight:normal;">Report of Independent Registered Public Accounting Firm &#8212; Financial Statements</span></a></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a href="#CONSOLIDATEDBALANCESHEETS_917441"><span style="font-style:normal;font-weight:normal;">Consolidated Balance Sheets as of December&#160;31, 2022 and 2021</span></a></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a href="#CONSOLIDATEDSTATEMENTSOFINCOME_61101"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Income (Loss) for the&#160;Years Ended December&#160;31, 2022, 2021 and 2020</span></a></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINC"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Comprehensive Income (Loss) for the&#160;Years Ended December&#160;31, 2022, 2021 and 2020</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUI"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Stockholders&#8217; Equity for the&#160;Years Ended December&#160;31, 2022, 2021 and 2020</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#CONSOLIDATEDSTATEMENTSOFCASHFLOWS_863485"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Cash Flows for the Years Ended December 31, 2022, 2021 and 2020</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><a href="#NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS_7"><span style="font-style:normal;font-weight:normal;">Notes&#160;to Consolidated Financial Statements</span></a></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_74249a40_b0ee_45c5_9ed3_b5f7e7ef3644"></a><a id="Tc_W1cOUDdJKUS0wSTh9zkUrw_1_3"></a><a id="Tc_XUnNXugJbE6iQFLwpdGa0Q_1_6"></a><a id="Tc_O0BVizZPHkWFw8QC5JR8sg_1_12"></a><a id="Tc_N4Sk02IeF0-W5DfrJHPovA_2_0"></a><a id="Tc_ajoSonxwv0G9XD5rgtXTyg_2_3"></a><a id="Tc_kd8ptDQZu022HNBc3hfouw_2_6"></a><a id="Tc_lvE19QM980C5_0s6MSb3Sw_2_9"></a><a id="Tc_XXYYWcjIeE6Iz7_p71Q3SQ_2_12"></a><a id="Tc_u_uu2U-JpUmEtlB8I-59Ig_3_0"></a><a id="Tc_1UUKi-IGCE2p9wSvigFAxw_3_2"></a><a id="Tc_npgFSWcNDEuYHljvwom3ng_3_5"></a><a id="Tc_uAC6UiKPrU2M1cc_XiXIqw_3_8"></a><a id="Tc_MaQMgVTzckisVG4gA8GY7Q_3_11"></a><a id="Tc_C4zCEWES5UCOO0K_Ox27lA_4_0"></a><a id="Tc_tj3WswoBdEuYNDWt0Hw-Cw_4_2"></a><a id="Tc_T76Jruen70KS2VztEQIirg_4_5"></a><a id="Tc_R7PPcN7lYUCVZ6MxZ5z3Mg_4_8"></a><a id="Tc_0NTpp4sMpEm-D6gclECMqw_4_11"></a><a id="Tc_EjheVQ3ewk-2s0sVRommnA_5_0"></a><a id="Tc_KvwGvwnsZ0GSmYrtpL_ObA_5_2"></a><a id="Tc_QGKJKyy03kScxpmRdkfqYg_5_5"></a><a id="Tc_kNMttN6DOEy73Y8bWWfG8Q_5_8"></a><a id="Tc_dfplSyCE-E2mhMAXTd04bQ_5_11"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="Tb_npm2sw3zN0m8e7IXPHnjzA" continuedAt="Tb_npm2sw3zN0m8e7IXPHnjzA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 14.4pt;"><span style="font-weight:normal;">(2)&#160;</span><span style="font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Statement Schedules.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:28.8pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8212;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Schedule II&#160;- Valuation and qualifying accounts</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Years Ended December&#160;31,&#160;2022, 2021 and 2020</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">(In thousands)</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions&#160;Charged&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Allowance for Credit Losses: </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Beginning&#160;of&#160;Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Costs&#160;and&#160;Expenses&#160;(a)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduction&#160;(b)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">End&#160;of&#160;Year</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_85rQK-4M5ECcEsi9kKnxVA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_RTE-nn2fDU-97uPm0rTHxA_3_3">3,108</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_j64W9w2JFkaNZCAs8PllJQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="Tc_6ubN_SK8a0OBdo6n6mFWtw_3_6">3,115</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_j64W9w2JFkaNZCAs8PllJQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="Tc_eX1KqliORkWCyZ32CzLNAw_3_9">910</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Ksk8oPM3pkWXnmJp3aVfjA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_cWB8vCFC-0qSrkDXrHLuXQ_3_12">5,313</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Ksk8oPM3pkWXnmJp3aVfjA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_UwSQwTIzE0y4z4yyxLTnqw_4_3">5,313</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_ymPQ_EUUskWNwXusRc-oFg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="Tc_FQazj3-DT0qCONFsiDng8Q_4_6">2,678</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_ymPQ_EUUskWNwXusRc-oFg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="Tc_SgGHUj0E3UapzphPXPOsMQ_4_9">1,224</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_wOWt0khv_U6hpVmJA8ajHg_4_12">6,767</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_BA2tenkCWEavdkgL_Npwlg_5_3">6,767</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Tcw0rwvwnUCNggwvx-hToA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="Tc_o0lzALOZc0iyyP3-LKotCQ_5_6">1,858</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Tcw0rwvwnUCNggwvx-hToA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="Tc_n_SIX0fIiEOHrN3Psd6VjA_5_9">202</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_XT-DImLBW0CLqTtA5KznqQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_I-yOoGOeE0GzPTSwuLhYcA_5_12">8,423</ix:nonFraction>)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We record a bad debt provision based upon historical bad debt experience, current economic conditions, expectations of future economic conditions, and management&#8217;s evaluation of our ability to collect individual outstanding balances.</span></td></tr></table></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">93</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_f4cfaac3_9374_484b_ac6c_e776055f862c"></a><a id="Tc_qJ19YBpWx0O5cVJG6zhoyQ_1_3"></a><a id="Tc_-vTG3CzYXUmzsvpE-GFzng_1_6"></a><a id="Tc_e_e-xcDeD0Cmjhbhbkzh5g_1_12"></a><a id="Tc_VgWUknetJEKZLD9_TM7a4Q_2_0"></a><a id="Tc_n6xfxvCMfkuJEci6MdNYFw_2_3"></a><a id="Tc_cmfH3Gm-jUuU-URlT_oD7A_2_6"></a><a id="Tc_8Ld6DyEhKUi8LtElXVwiRA_2_9"></a><a id="Tc_yi6jJZEtTkOLvHYpxBy5yQ_2_12"></a><a id="Tc_g1pq-lm8sUeQAqTet9K3KQ_3_0"></a><a id="Tc_ZT9GlMUtVEKDEX9Fd6NS5Q_3_2"></a><a id="Tc_Iad3o7xYgkKA34Hjw1C0gg_3_5"></a><a id="Tc_QhNOb2_mcUuBwdqTw2WQpA_3_8"></a><a id="Tc_MyrmrXAYYUa3PMusaraE8A_3_9"></a><a id="Tc_HH7yu0-oREazSpM5bw1TuQ_3_11"></a><a id="Tc_weyZmyfApEuHfGgnbdE0CA_4_0"></a><a id="Tc_DENqo5k8CECQXG_1WgsKwQ_4_2"></a><a id="Tc_QHlx-MZ_MUSQkYNto7aXFQ_4_5"></a><a id="Tc_PgscaRZi2Uyrpn_vQG6_7w_4_8"></a><a id="Tc_iJBE9MZCG0CJU-S73JJazA_4_9"></a><a id="Tc_CWxtFkHtGEq4x6J4knjKIQ_4_11"></a><a id="Tc_ZqnA6UmiTU2mY3qeSgBaFg_5_0"></a><a id="Tc_xSEnLjehv0KEAwsRDZMTGQ_5_2"></a><a id="Tc_SeCb1tXRokG9fdfnIvQQPA_5_5"></a><a id="Tc_M6n3uyEV-U6fmxQiDYkLnQ_5_8"></a><a id="Tc_9qOm5uB29U2j1RfOKI2iRA_5_9"></a><a id="Tc_mWXbeW_tYkC10D0pdsF6Ow_5_11"></a><ix:continuation id="Tb_npm2sw3zN0m8e7IXPHnjzA_cont1"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">When an individual customer balance becomes impaired and is deemed uncollectible, a deduction is made against the allowance for uncollectible accounts.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Years Ended December&#160;31,&#160;2022, 2021 and 2020</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">(In thousands)</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions&#160;Charged&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax Valuation Allowance:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Beginning&#160;of&#160;Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Costs&#160;and&#160;Expenses&#160;(a)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">End&#160;of&#160;Year</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dwnvij5qh0aeUakBIbwM3A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_k38WYQXCXkaf0gRPBAgNrQ_3_3">4,644</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vb9_o2qO3UyDJVFE_VYJKA" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="Tc_4URn19xso0CuZ_VOHqH3vA_3_6">5,569</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_B7su2MaR6Ue9mzoD3SVZSw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_oyZS4otonEuOEGsuPIcgDA_3_12">10,213</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_B7su2MaR6Ue9mzoD3SVZSw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_3DSPGpnO9E2h-n5I2nvp9Q_4_3">10,213</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vuB28aRB70m7DQkE04axrQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="Tc_M3SosmTl70Ocv9ETPPmgEg_4_6">573</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_fERnc1ZCQkW-tUKySpgZRg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_Sc6CvSBLSESoIvxOhCALfg_4_12">10,786</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_fERnc1ZCQkW-tUKySpgZRg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_5tYNsOfKhUanPUSo5PVtiQ_5_3">10,786</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_eIOjLCC_ckKJd7j-tagx0A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="Tc_60YzdCI9mk2nIrzEuB_Fcg_5_6">2,741</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA" contextRef="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_DS1rt81n2UuuEQSAYL8cwQ" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="Tc_2gk40jXh4EmdG2BaP5tTwg_5_12">13,527</ix:nonFraction>)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We record a valuation allowance against a deferred tax asset when it is determined that it is more likely than not that the deferred tax asset will not be realized.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Exhibits:</span></td></tr></table><div style="margin-top:12pt;"></div></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The following exhibits required by Item&#160;601 of Regulation S-K are filed herewith or have been filed previously with the SEC as indicated below:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:7.2pt;"><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><div style="height:7.2pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><div style="height:7.2pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><div style="height:7.2pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:22.3pt;"><td style="vertical-align:bottom;width:8.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><div style="height:22.3pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit</b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">No.</b></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><div style="height:22.3pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></div></div></td><td style="vertical-align:bottom;width:91.25%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><div style="height:22.3pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Index&#160;to&#160;Exhibits</b></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">2.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:91.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000016/agreementandplanofmerg.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Agreement and Plan of Merger, dated October&#160;1, 2018, by and among Merit Medical Systems,&#160;Inc., CMI Transaction Co., Cianna Medical,&#160;Inc. and Fortis Advisors LLC, as the Securityholder&#8217;s Representative *</span></a> </p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">2.2</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000049/vascularinsight-ex103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Asset Purchase Agreement, dated December&#160;14, 2018, by and among Merit Medical Systems,&#160;Inc., Vascular Insights, LLC and VI Management,&#160;Inc.*</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">3.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000027/secondamendedandrestatedar.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amended and Restated Articles of Incorporation dated May&#160;31, 2018*</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">3.2</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000027/thirdamendedandrestatedbyl.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Third Amended and Restated Bylaws dated May&#160;31, 2018*</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">4.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000007/mmsi12312017ex4x1doc.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Specimen Certificate of the Common Stock*</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">4.2</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex4d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Description of the Registrant&#39;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000110465906045611/a06-14806_1ex4d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Systems,&#160;Inc. 2006 Long Term Incentive Plan, dated*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.2</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000110465909064902/a09-33317_1ex99d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to the Merit Medical Systems 2006 Long-Term Incentive Plan, dated May 31, 2007*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.3</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000007/mmsi-12312017x10kxex102lea.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Lease Agreement dated as of June&#160;8, 1993 for office and manufacturing facility*</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.4</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000093173104000064/ex10no12.txt"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">A</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">mended and Restated Deferred Compensation Plan, dated January 1, 2004*&#8224;</span></a> </p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.5</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000110465908077270/a08-30672_1ex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Systems,&#160;Inc. Amended and Restated Deferred Compensation Plan, effective January&#160;1, 2008*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.6</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000110465909035092/a09-14325_1ex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amendment to the Merit Medical Systems,&#160;Inc. 2006 Long-Term Incentive Plan made and adopted effective May 31, 2009*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.7</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000110465910000716/a10-1177_1ex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan made and adopted effective May 31, 2009*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">94</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.8</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/firstamendmenttothesecondr.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, effective September 19, 2010*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.9</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/secondamendmenttothesecond.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan,</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;"> dated November 29, 2010 </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.10</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/thirdamendmenttothesecondr.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Third Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, effective October 1, 2010*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.11</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/fourthamendmenttothesecond.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Fourth Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, dated December 31, 2011*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.12</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/fifthamendmenttothesecondr.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Fifth Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, dated December 28, 2012*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.13</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/sixthamendmenttothesecondr.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Sixth Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, dated December 31, 2013.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.14</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698214000040/seventhamendment-ex101.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Seventh Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, dated June 10, 2014*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.15</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698215000043/eighthamendmenttothesecond.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Eighth Amendment to the </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Restatement of the Merit Medical Systems,&#160;Inc. 401(k)&#160;Profit Sharing Plan, dated December 29, 2014*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.16</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698216000103/a2ndamendedrestatedcredita.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amended and Restated Credit Agreement dated as of July&#160;6, 2016 by and among Merit Medical Systems,&#160;Inc., Wells Fargo Bank, National Association, Well Fargo Securities, LLC and the lenders named therein*</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.17</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698216000103/employmentagreement-ex103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of Employment Agreement, dated May&#160;26, 2016 between the Company and each of the following individuals: Joseph C. Wright, and Brian G. Lloyd*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.18</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698216000103/employmentagreement-ex104.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement, dated May&#160;26, 2016 between the Company and Fred P. Lampropoulos*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.19</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000011/thirdamendmenttolongterm-e.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Third Amendment to the Merit Medical Systems,&#160;Inc. 2006 Long-Term Incentive Plan dated February&#160;13, 2015*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.20</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000011/restatementofthe1996plan-e.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Systems,&#160;Inc., Restatement of the 1996 Employee Stock Purchase Plan dated July&#160;1, 2000*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.21</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000011/firstamendmentto1996plan-e.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to the Merit Medical Systems,&#160;Inc., 1996 Employee Stock Purchase Plan dated April&#160;1, 2001*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.22</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000011/secondamendementto1996plan.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amendment to the Merit Medical Systems,&#160;Inc., 1996 Employee Stock Purchase Plan dated January&#160;1, 2006*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.23</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000011/thirdamendmentto1996plan-e.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Third Amendment to the Merit Medical Systems,&#160;Inc., 1996 Employee Stock Purchase Plan dated April&#160;7, 2006*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.24</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000011/fourthamendmentto1996espp-.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Fourth Amendment to the Merit Medical Systems,&#160;Inc., 1996 Employee Stock Purchase Plan dated February&#160;13, 2015*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.25</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000022/mmsi-20210630ex103741ed4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Fifth Amendment to the Merit Medical Systems, Inc., 1996 Employee Stock Purchase Plan dated April 15, 2021*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">95</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.26</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000045/amendmentfredplampropoulos.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to Employment Agreement made and entered into by and between Merit Medical Systems,&#160;Inc. and Fred P. Lampropoulos as of the 11th day of December, 2017*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.27</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698217000045/amendmentform103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of First Amendment to Employment Agreement for each of Joseph C. Wright, and Brian G. Lloyd*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.28</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000007/mmsi-12312017x10kxex1029am.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to Lease Agreement dated May&#160;22, 2017 for office and manufacturing facility*</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.29</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000032/meritmedicalsystemsinc2018.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Systems,&#160;Inc. 2018 Long-Term Incentive Plan effective May&#160;24, 2018*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.30</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000016/amendmenttolongterminc.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to the Merit Medical Systems,&#160;Inc. 2018 Long-Term Incentive Plan effective December&#160;14, 2018*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.31</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000022/mmsi-20210630ex102531102.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Second Amendment to the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan effective April 15, 2021*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.32</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698218000066/mmsi-6302018x10qxex103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement made and entered into by and between Merit Medical Systems,&#160;Inc. and Raul Parra as of the 1st day of August, 2018.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:8.65pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.33</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000049/a2019executivebonuspla.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Systems, Inc. 2019 Executive Bonus Plan, dated January 1, 2019*&#8224;</span></a></p></td></tr><tr style="height:8.65pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:8.65pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.34</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000109/ninthamendment-ex101.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Ninth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated August 1, 2016*&#8224;</span></a></p></td></tr><tr style="height:8.65pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:8.65pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.35</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000109/tenthamendment-ex102.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Tenth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated January 1, 2017*&#8224;</span></a></p></td></tr><tr style="height:8.65pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.36</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000109/eleventhamendment-ex103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Eleventh Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated January 1, 2019*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:4pt;"><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.37</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000085698219000109/twelfthamendment-ex104.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Twelfth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated June 1, 2018*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.38</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="http://www.sec.gov/Archives/edgar/data/856982/000155837019010598/ex-10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Third Amended and Restated Credit Agreement entered into by and among Merit Medical Systems,&#160;Inc., Wells Fargo Bank National Association and the lenders and subsidiary guarantors named therein, dated July&#160;9, 2019*</span></a></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/856982/000155837019010598/ex-10d2.htm"></a> <span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.39</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698220000011/mmsi-20191231ex1048fbbb1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Thirteenth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, effective January 1, 2019*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.40</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698220000019/mmsi-20191231ex103eaa878.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 26, 2020, by and between Merit Medical Systems, Inc. and Fred Lampropoulos.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.41</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698220000019/mmsi-20191231ex1062fbe42.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Form of Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 26, 2020, by and between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra, Joseph C. Wright, and Brian G. Lloyd.&#160;*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.42</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698220000031/mmsi-20200622ex10353ef9d.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to the Merit Medical Systems, Inc. 2019 Executive Bonus Plan, effective June 22, 2020 *&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.43</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698220000041/mmsi-20201013ex1017cba2a.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Settlement Agreement, dated October 13, 2020, by and among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (&#8220;OIG-HHS&#8221;) of the Department of Health and Human Services (&#8220;HHS&#8221;), and the Defense Health Agency (&#8220;DHA&#8221;), acting on behalf of the TRICARE Program (collectively, the &#8220;United States&#8221;); the Company; and Charles J. Wolf, M.D. (&#8220;Relator&#8221;), through their authorized representatives.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">96</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.44</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698220000041/mmsi-20201013ex102809a99.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Corporate Integrity Agreement, dated October 13, 2020, by and between the OIG-HHS and the Company.*</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.45</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000003/mmsi-20201231ex10497686b.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of Indemnification Agreement, dated October 24, 2020, between the Company and each of the following individuals: A. Scott Anderson, F. Ann Millner, Ed. D., Lynne N. Ward, and Thomas J. Gunderson *&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.46</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000003/mmsi-20201231ex1050b45b4.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of Indemnification Agreement, dated October 24, 2020, between the Company and each of the following individuals: Lonny J. Carpenter, David K. Floyd, and James T. Hogan *&#8224;</span></a> </p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.47</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000003/mmsi-20201231ex10519bde5.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of Indemnification Agreement between the Company and each executive officer. *&#8224;</span></a><span style="white-space:pre-wrap;">  </span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.48</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000056/mmsi-20220930xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Indemnification Agreement, dated as of June 17, 2021, between the Company and Stephen C. Evans.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.49</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000056/mmsi-20220930xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Indemnification Agreement, dated as of May 19, 2022, between the Company and each of Laura Kaiser and Michael McDonnell.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.50</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000003/mmsi-20201231ex10538e54a.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement between the Company and Michel J. Voigt, dated December 11, 2020*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.51</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex10d51.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement between the Company and Neil Peterson, dated May 19, 2022&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.52</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000012/mmsi-20210331ex10263fbb3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Performance Stock Unit Award Agreement (Two Year Performance Period), dated March 19, 2021, by and between Merit Medical Systems, Inc. and Fred Lampropoulos.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.53</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000012/mmsi-20210331ex1033446aa.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Performance Stock Unit Award Agreement (Three Year Performance Period), dated March 19, 2021, by and between Merit Medical Systems, Inc. and Fred Lampropoulos.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.54</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000012/mmsi-20210331ex1040840b8.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Form of Performance Stock Unit Award Agreement (Two Year Performance Period), dated March 19, 2021, by and between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra, Brian G. Lloyd, Michel J. Voigt, and Joseph C. Wright.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.55</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698221000012/mmsi-20210331ex10573f085.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;white-space:pre-wrap;background:#ffffff;">Form of Performance Stock Unit Award Agreement (Three Year Performance Period), dated March 19, 2021, by and between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra,  Brian G. Lloyd, Michel J. Voigt, and Joseph C. Wright.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.56</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000030/mmsi-20220331xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 26, 2022, by and between Merit Medical Systems, Inc. and Fred Lampropoulos.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.57</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000030/mmsi-20220331xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 26, 2022, by and between Merit Medical Systems, Inc. and Raul Parra.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.58</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000030/mmsi-20220331xex10d3.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;background:#ffffff;">Form of Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 26, 2022, by and between Merit Medical Systems, Inc. and each of the following individuals: Brian G. Lloyd, Michel J. Voigt, and Joseph C. Wright.*&#8224;</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.59</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000045/mmsi-20220630xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Performance Stock Unit Award Agreement (Three Year Performance Period), dated May 19, 2022, by and between Merit Medical Systems, Inc. and Neil Peterson.*&#8224;</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.60</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex10d60.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Restricted Stock Unit Award Agreement, dated May 24, 2022, by and between Merit Medical Systems, Inc. and each of the following individuals: A. Scott Anderson, Lonny J. Carpenter, Stephen C. Evans, David K. Floyd, James T. Hogan, Thomas J. Gunderson, Laura s. Kaiser, Michael R. McDonnell, F. Ann Millner, and Lynne N. Ward.&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">10.61</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex10d61.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amendment to Lease Agreement dated March 10, 2022 for office and manufacturing facility.</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">97</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.0978775%;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">10.62</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/856982/000085698222000045/mmsi-20220630xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Deferred Compensation Plan for Non-Employee Directors.*&#8224;</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">21</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex21.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Subsidiaries of Merit Medical Systems,&#160;Inc.</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">23.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex23d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of Independent Registered Public Accounting Firm</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">31.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex31d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Chief Executive Officer</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">31.2</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex31d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Chief Financial Officer</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">32.1</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex32d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Chief Executive Officer</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">32.2</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20221231xex32d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Chief Financial Officer</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">101</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following materials from the Merit Medical Systems,&#160;Inc. Annual Report on Form&#160;10-K for the fiscal&#160;year ended December&#160;31, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Statements of Income (Loss), (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Equity, and (vi) Notes to Consolidated Financial Statements</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;white-space:normal;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:normal;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:91.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">These exhibits are incorporated herein by reference.</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">&#8224;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">Indicates management contract or compensatory plan or arrangement.</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(c)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Schedules:</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 36pt;">None</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_c82d489d_3cfa_445c_89e6_6d05fd4937e4"></a><a id="Item16Form10KSummary_508739"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;16.</b></span><span style="display:inline-block;width:36pt;"></span><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Form&#160;10-K Summary.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">98</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_613a7e94_1608_4134_b838_947a8680893a"></a><a id="SIGNATURES_119406"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Pursuant to the requirements of Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form&#160;10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on February 24, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:top;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">MERIT MEDICAL SYSTEMS,&#160;INC.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:49.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ FRED P. LAMPROPOULOS</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fred P. Lampropoulos, President and</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">99</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">ADDITIONAL SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on form 10-K has been signed below by the following persons in the capacities indicated on February 24, 2023.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:middle;width:49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Signature</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Capacity&#160;in&#160;Which&#160;Signed</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: FRED P. LAMPROPOULOS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President, Chief Executive Officer and Director</p></td></tr><tr><td style="vertical-align:top;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Fred P. Lampropoulos</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal executive officer)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: RAUL PARRA</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer and Treasurer</p></td></tr><tr><td style="vertical-align:top;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Raul Parra</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(Principal financial and accounting officer)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: A. SCOTT ANDERSON</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">A. Scott Anderson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: LONNY J. CARPENTER</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Lonny J. Carpenter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: STEPHEN C. EVANS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Stephen C. Evans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: DAVID K. FLOYD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">David K. Floyd</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: THOMAS J. GUNDERSON</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Thomas J. Gunderson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: JAMES T. HOGAN</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">James T. Hogan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:13.95pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/: LAURA S. KAISER</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr style="height:13.95pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Laura S. Kaiser</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:13.95pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:13.95pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/: MICHAEL R. MCDONNELL</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr style="height:13.95pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Michael R. McDonnell</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:13.95pt;"><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: F. ANN MILLNER</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;width:49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">F. Ann Millner</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">/s/: LYNNE N. WARD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:top;width:49%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Lynne N. Ward</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">100</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>mmsi-20221231xex21.htm
<DESCRIPTION>EX-21
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:23 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit 21</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">SUBSIDIARIES OF MERIT MEDICAL SYSTEMS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Subsidiary Name</b></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Jurisdiction&#160;of</b><b style="font-weight:bold;"><br></b><b style="font-weight:bold;">Incorporation/Organization</b></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Australia Pty Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Australia</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">ITL Healthcare Pty Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Australia</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Austria GmbH</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Austria</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Belgium Sprl</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Belgium</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Comercializa&#231;&#227;o, Distribui&#231;&#227;o, Importa&#231;&#227;o e Exporta&#231;&#227;o de Produtos Hospitalares LTDA.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Brazil</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Canada Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Canada</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Colombia S.A.S.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Colombia</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Beijing Co. Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">China</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BioSphere Medical Japan, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BioSphere Medical, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Brightwater Medical, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BSMD Ventures, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Cianna Medical, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">DFINE, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Restore Endosystems, LLC</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Vascular Access Technologies, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Delaware</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Denmark A/S</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Denmark</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Egypt LLC</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Egypt</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Finland Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Finland</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">BioSphere Medical SA</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">France</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical France SAS</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">France</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Dfine Europe GmbH</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Germany</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical GmbH</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Germany</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Asia Company Limited</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Hong Kong</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Systems India Private Limited</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">India</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical (NRI) Ireland Limited</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Ireland</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Ireland, Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Ireland</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Italy S.R.L.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Italy</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Japan KK</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Japan</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Malaysia Sdn. Bhd</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Malaysia</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Maquiladora M&#233;xico, S. DE R.L. DE C.V.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Mexico</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Mexico Sales, S. de R.L. de C.V.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Mexico</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">KA Medical, LLC</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Minnesota</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Coatings B.V.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Netherlands</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Nederland B.V.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Netherlands</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Argon Medical Devices Netherlands BV</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Netherlands</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical New Zealand Limited</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">New Zealand</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Norway AS</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Norway</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Thomas Medical Products, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Pennsylvania</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Poland sp.z.o.o.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Poland</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Portugal, S.A.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Portugal</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">LLC Merit Technologies</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Russia</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Singapore Holdings Pte. Ltd</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Singapore</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Singapore Pte. Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Singapore</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Korea Co., Ltd.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">South Korea</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical South Africa (Pty) LTD</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">South Africa</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Africa (Pty) LTD</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">South Africa</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Spain S.L.Unipersonal</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Spain</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Systems AB</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Sweden</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Switzerland AG</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Switzerland</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical (Thailand) Limited</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Thailand</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical Turkey T&#305;bbi &#220;r&#252;nler Ticaret Anonim &#350;irketi</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Turkey</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical ME FZ-LLC</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">United Arab Emirates</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Medical UK Limited</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">United Kingdom</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Holdings,&#160;Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Utah</font></p></td></tr><tr><td style="vertical-align:top;width:64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Merit Sensor Systems, Inc.</font></p></td><td style="vertical-align:bottom;width:2.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:33.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">Utah</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>mmsi-20221231xex23d1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:22 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 23.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We consent to the incorporation by reference in Registration Statement No. 333-226320 on Form S-3ASR and Registration Statement Nos. 333-262158, 333-262157, 333-225426, 333-206297, 333-206296, 333-163104, 333-135614, 333-129267, 333-58112 and 333-58162 on Form S-8 of our reports dated February 24, 2023, relating to the financial statements of Merit Medical Systems, Inc. and the effectiveness of Merit Medical Systems, Inc.&#8217;s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ DELOITTE&#160;&amp; TOUCHE LLP</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Salt Lake City, Utah</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">February 24, 2023</p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>mmsi-20221231xex31d1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:23 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;31.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">I, Fred P. Lampropoulos, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">1.&#160;&#160;&#160;&#160;&#160; I have reviewed this Annual Report on Form&#160;10-K (the &#8220;Report&#8221;) of Merit Medical Systems,&#160;Inc. (the &#8220;Registrant&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">2.&#160;&#160;&#160;&#160;&#160; Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">3.&#160;&#160;&#160;&#160;&#160; Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">4.&#160;&#160;&#160;&#160;&#160; The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">c) evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">d) disclosed in this Report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">5.&#160;&#160;&#160;&#160;&#160; The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Date: February 24, 2023</p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Fred P. Lampropoulos</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fred P. Lampropoulos</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President and Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(principal executive officer)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>mmsi-20221231xex31d2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:23 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;31.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">I, Raul Parra, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">1.&#160;&#160;&#160;&#160;&#160; I have reviewed this Annual Report on Form&#160;10-K (the &#8220;Report&#8221;) of Merit Medical Systems,&#160;Inc. (the &#8220;Registrant&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">2.&#160;&#160;&#160;&#160;&#160; Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">3.&#160;&#160;&#160;&#160;&#160; Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">4.&#160;&#160;&#160;&#160;&#160; The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the Registrant and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">c) evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">d) disclosed in this Report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">5.&#160;&#160;&#160;&#160;&#160; The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:13.5pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 24, 2023</p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Raul Parra</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Raul Parra</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(principal financial officer)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>mmsi-20221231xex32d1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:43 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;32.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Certification of Principal Executive Officer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to 18 U.S.C. Section&#160;1350, as Adopted</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In connection with the Annual Report on Form&#160;10-K of Merit Medical Systems,&#160;Inc. (the &#8220;Company&#8221;) for the year ended&#160;December&#160;31, 2022, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;),&#160;I, Fred P. Lampropoulos, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">(1)&#160;&#160; The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15 (d)&#160;of the Securities Exchange Act of 1934; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:54pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">(2)&#160;&#160; The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 24, 2023</p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Fred P. Lampropoulos</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fred P. Lampropoulos</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President and Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(principal executive officer)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">This certification accompanies the foregoing Report pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Registrant for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended.&#160; A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>mmsi-20221231xex32d2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:44 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;32.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Certification of Chief Financial Officer</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to 18 U.S.C. Section&#160;1350, as Adopted</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In connection with the Annual Report on Form&#160;10-K of Merit Medical Systems,&#160;Inc. (the &#8220;Company&#8221;) for the year ended&#160;December&#160;31, 2022, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;),&#160;I, Raul Parra, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">(1)&#160;&#160; The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:54pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">(2)&#160;&#160; The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: February 24, 2023</p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Raul Parra</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Raul Parra</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(principal financial officer)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">This certification accompanies the foregoing Report pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Registrant for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended.&#160;A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>8
<FILENAME>mmsi-20221231xex4d2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:45 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT 4.2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXCHANGE ACT OF 1934</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.43;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Merit Medical Systems, Inc. (&#8220;Merit&#8221; &#8220;we&#8221; &#8220;us&#8221; or &#8220;our&#8221;) has one class of securities, our common stock, registered under Section 12 of the Securities Exchange Act of 1934, as amended.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">The general terms and provisions of our common stock are summarized below.  The below summary does not purport to be complete, and is subject to and qualified in its entirety by reference to our Amended and Restated Articles of Incorporation, as amended, referred to herein as our &#8220;Articles,&#8221; and our Second Amended and Restated Bylaws, referred to herein as our &#8220;Bylaws,&#8221; each of which have been filed as exhibits to our most recent Annual Report on Form 10-K, of which this exhibit is a part, and the applicable provisions of the Utah Code.  We encourage you to review complete copies of our Articles and Bylaws and the applicable provisions of the Utah Code for additional information.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Authorized Capital Stock</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We are authorized to issue 100,000,000 shares of common stock, no par value per share. We are also authorized to issue 5,000,000 shares of preferred stock, no par value per share. As of February 24, 2022, approximately 56,572,579 shares of common stock, and no shares of preferred stock, were issued and outstanding. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Description of Common Stock</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voting Rights.</u><font style="font-family:'Times New Roman','Times','serif';"> &#160;&#160;&#160;&#160;Holders of outstanding shares of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of our shareholders. Our common stock does not have cumulative voting rights. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Dividend Rights.</u><font style="font-family:'Times New Roman','Times','serif';"> &#160;&#160;&#160;&#160;Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available for dividend payments. We have never issued a cash dividend on our common stock and do not anticipate doing so in the foreseeable future. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Liquidation Rights.</u><font style="font-family:'Times New Roman','Times','serif';"> &#160;&#160;&#160;&#160;In the event of any liquidation, dissolution or winding-up of our affairs, holders of outstanding common stock at such time will be entitled to share ratably in our assets that are legally available for such purpose after payment or provision for payment of all of our debts and obligations, and after liquidation payments to holders of outstanding shares of preferred stock, if any.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Rights and Preferences.</u><font style="font-family:'Times New Roman','Times','serif';"> &#160;&#160;&#160;&#160;The holders of common stock have no preferences or rights of conversion, exchange, pre-emption or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;padding-left:10pt;text-indent:-10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Listing </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;padding-left:10pt;text-indent:-10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our common stock is listed on the NASDAQ Global Select Market under the symbol &quot;MMSI.&quot; </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;padding-left:10.1pt;text-indent:-10.1pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Transfer Agent and Registrar </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The transfer agent and registrar for our common stock is ZB, National Association, dba Zions Bank. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Description of Preferred Stock</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We are authorized to issue 5,000,000 shares of preferred stock, in one or more series, from time to time, with such rights and preferences as determined by our Board of Directors with respect to such series.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font><font style="font-family:'Times New Roman','Times','serif';"> </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT 4.2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;padding-left:10.1pt;text-indent:-10.1pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Anti-Takeover Effects of Provisions of Utah Law and Our Charter Documents</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-left:10.1pt;text-indent:-10.1pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Director Liability</u><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">.</i><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;Our Articles limit the personal liability of our directors to our company and our shareholders to the fullest extent permitted by applicable law. The inclusion of this provision in our Articles may reduce the likelihood of derivative litigation against our directors and may discourage or deter shareholders or management from bringing a lawsuit against our directors for breach of their duty of care.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shareholder Action and Meetings of Shareholders</u><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">.</i><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;Our Bylaws provide that shareholders wishing to propose business to be brought before a meeting of shareholders will be required to comply with various advance notice requirements. The inclusion of this provision in our Bylaws may deter our shareholders from submitting proposals for consideration at a meeting of shareholders.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><u style="font-family:'Times New Roman','Times','serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Classified Board of Directors</u><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">.</i><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;Our Articles provide for our Board of Directors to be divided into three classes of directors, with each class as nearly equal in number as possible, serving staggered three-year terms. As a result, approximately one-third of the Board of Directors will be elected each year. We believe the classified board provision will help to assure the continuity and stability of our Board of Directors and the business strategies and policies of our company as determined by the Board of Directors. The classified board provision could also have the effect of discouraging a third party from making a tender offer or attempting to obtain control of our company. In addition, the classified board provision could delay shareholders who do not agree with the policies of the Board of Directors from removing a majority of the directors for two years. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Authorized but Unissued Shares.</i><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;Our authorized capital stock consists of 100,000,000 shares of common stock and 5,000,000 shares of preferred stock. As of February 24, 2022, we had approximately 56,572,579 shares of common stock outstanding and no shares of preferred stock outstanding. Accordingly, our Articles would permit us to issue up to 36,232,402 additional shares of common stock (after taking into account 7,195,019 shares reserved for issuance under existing employee benefit plans or existing equity awards), and up to 5,000,000 shares of preferred stock. However, such issuances would be subject to the rules of the NASDAQ Global Select Market, which in some cases may require shareholder approval or impose other limitations. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions, and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could make it more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Utah Control Shares Acquisitions Act.</i><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;We are subject to the Control Shares Acquisitions Act, or Control Shares Act, as set forth in Section&#160;61-6-1 to 61-6-12 of the Utah Code. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Control Shares Act provides that any person or entity that acquires control shares of an issuing public corporation in a control share acquisition is denied voting rights with respect to the acquired shares, unless a majority of the disinterested shareholders of the issuing public corporation elects to restore such voting rights. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">For purposes of the Control Shares Act:</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8226; person or entity acquires &quot;control shares&quot; whenever it acquires shares that, not considering application of the Control Shares Act, would bring its voting power after the acquisition within any of the following ranges of voting power of the issuing public corporation: (i)&#160;1/5 to (but less than) 1/3 of all voting power, (ii)&#160;1/3 to (but less than) a majority of all voting power; or (iii)&#160;a majority or more of all voting power;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8226;an &quot;issuing public corporation&quot; is any Utah corporation, other than a depository institution, that has (a)&#160;100 or more shareholders, (b)&#160;a principal place of business, principal office or substantial assets within Utah, and (c)&#160;more than 10% of its shareholders resident in Utah, more than 10% of its shares owned by Utah residents or 10,000 shareholders resident in Utah; and </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8226;&quot;control share acquisition&quot; is generally defined as the direct or indirect acquisition (including through a series of acquisitions) of either ownership or voting power associated with issued and outstanding control shares (excluding voting power pursuant to a revocable proxy solicited by the issuing public corporation or its board of directors in connection with meetings of its shareholders). </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT 4.2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under the Control Shares Act, any person or entity that acquires control shares pursuant to a control share acquisition acquires voting rights with respect to those shares only to the extent consent is granted by a majority of the disinterested shareholders of each class of capital stock outstanding prior to the acquisition. To obtain such consent, the acquiring person may file an &quot;acquiring person statement&quot; with the issuing public corporation setting forth the number of shares acquired and certain other specified information. Upon delivering the statement, an acquiring person or entity may request a special meeting of shareholders if it undertakes to pay the issuing public corporation&#39;s expenses of a special shareholders&#39; meeting. Following receipt of such a request and undertaking, the directors of an issuing public corporation must call a special meeting (generally within 50&#160;days) to consider the voting rights to be given to the shares acquired or to be acquired in the control shares acquisition. If no request for a special meeting is made, the voting rights to be accorded the control shares are to be presented at the issuing public corporation&#39;s next special or annual meeting of shareholders. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">If either (i)&#160;the acquiring person does not file an acquiring person statement with the issuing public corporation or (ii)&#160;the shareholders do not vote to restore voting rights to the control shares, the issuing public corporation may, if its articles of incorporation or bylaws so provide, redeem the control shares from the acquiring person at fair market value. Our Articles and Bylaws do not currently provide for such a redemption right. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise provided in the articles of incorporation or bylaws of an issuing public corporation, all shareholders are entitled to dissenters&#39; rights if the control shares are accorded full voting rights and the acquiring person has obtained control shares with at least a majority of voting power. Notice of such dissenter&#39;s rights must be sent to shareholders as soon as practicable thereafter. Our Articles and Bylaws do not currently deny such dissenters&#39; rights. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The directors or shareholders of a corporation may elect to exempt the stock of the corporation from the provisions of the Control Shares Act through adoption of a provision to that effect in the corporation&#39;s articles of incorporation or bylaws. To be effective, such an exemption must be adopted prior to the control shares acquisition. Neither our directors nor our shareholders have taken any such action. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We expect the Control Shares Act to have an anti-takeover effect with respect to transactions not approved in advance by our Board of Directors. The Control Shares Act may also discourage takeover attempts that might result in a premium over the market price for the shares of common stock held by our shareholders. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Business Combinations.</i><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;Under Sections&#160;16-10a-1801 to 16-10a-1804 of the Utah Code and certain amendments to Section&#160;16-10a-840 of the Utah Code, all of which took effect on May&#160;9, 2017, we are prohibited from entering into a business combination, such as a merger, consolidation, recapitalization, asset sale, or disposition of stock, with any person that meets the definition of &quot;interested shareholder&quot; (discussed further below), including any entity that is, or after the business combination would be, an affiliate or associate of an interested shareholder, for a period of five years after the date such person became an interested shareholder, unless one of the of the following conditions is met:</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8226; the business combination, or the acquisition of stock that resulted in the person becoming an interested shareholder, was approved by our Board of Directors prior to the person becoming an interested shareholder; </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8226; the business combination is approved by a majority of our non-interested shareholders at a meeting called no earlier than five years after the date the person first became an interested shareholder; or </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8226; the cash and other consideration to be delivered to the holder of each share of our common stock meets certain minimum value criteria. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">For purposes of the business combination provisions, an &quot;interested shareholder&quot; includes any person who owns (or, in the case of affiliates and associates, did own within the last five years) 20% or more of that corporation&#39;s voting stock. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">These amendments may have an anti-takeover effect with respect to such business combinations. </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.51
<SEQUENCE>9
<FILENAME>mmsi-20221231xex10d51.htm
<DESCRIPTION>EX-10.51
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 08:59:45 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 10.51</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">EMPLOYMENT AGREEMENT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">THIS EMPLOYMENT AGREEMENT (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agreement</u>&#8221;) is made and entered into by and between Merit Medical Systems,&#160;Inc., a Utah corporation (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221;) and Neil Peterson (the &#8220;Executive&#8221;), effective May 19, 2022.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">RECITALS:</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">WHEREAS, the Executive currently serves as an executive employee of the Company; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">WHEREAS, the Board of Directors of the Company (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Board</u>&#8221;) has determined that it is in the best interests of the Company and its shareholders to assure that the Company will have the continued dedication of the Executive, notwithstanding the possibility, threat or occurrence of a Change in Control (as defined below) of the Company; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">WHEREAS, the Company and the Executive desire to enter into this Employment Agreement as follows:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">AGREEMENT:</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;NOW, THEREFORE, the above recitals are incorporated herein and the parties agree as follows:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Definitions</u>.&#160; For purposes of this Agreement, the following terms shall have the following meanings:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Affiliated Companies</u>&#8221; shall mean any corporation, partnership, limited liability company or other business entity controlled by, controlling or under common control with the Company.&#160; One entity shall be presumed to control another if it owns directly, or indirectly through other Affiliated Companies, a majority of the outstanding voting equity interests of the other entity.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change in Control</u>&#8221; shall mean:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The acquisition during any 12-month period in one or more integrated transactions by any individual, entity or &#8220;group&#8221; (within the meaning of Section&#160;13(d)&#160;or 14(d)(2)&#160;of the Securities Exchange Act of 1934, as amended (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</u>&#8221;))(a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Person</u>&#8221;) of beneficial ownership (within the meaning of Rule&#160;13d-3 promulgated under the Exchange Act) of more than 30% of the combined voting power of the then outstanding common stock and other voting securities of the Company entitled to vote generally in the election of directors of the Company (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Outstanding Company Voting Securities</u>&#8221;);provided, however, that for purposes of this subsection (i), the following acquisitions shall not constitute a Change in Control: (A)&#160;any acquisition by the Company, an employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or any corporation or other entity pursuant to a transaction which complies with clauses (A)&#160;and (B)&#160;of subsection (iii)&#160;of this Section&#160;1(b); and (B)&#160;any acquisition which does also not constitute a &#8220;change in effective control&#8221; of the Company within the meaning of Treasury Regulation Section&#160;1.409A-3(i)(5)(vi)(A)(1);</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The replacement during any 12-month period of a majority of the directors serving on the Board by directors whose appointment or election is not endorsed by at least a majority of the Board immediately before the date of any such appointment or election; provided that </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">1</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">this subsection (ii)&#160;shall only apply to a change in the Board that constitutes a &#8220;change in effective control&#8221; of the Company within the meaning of Treasury Regulation Section&#160;1.409A-3(i)(5)(vi)(A)(2); and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The sale or other disposition of all or substantially all of the assets of the Company (an &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Asset Sale</u>&#8221;), including a disposition by merger or consolidation, in a transaction that also constitutes a &#8220;change in ownership of a substantial portion&#8221; of the Company&#8217;s assets within the meaning of Treasury Regulation Section&#160;1.409A-3(i)(5)(vii); provided, however, that a transaction will not constitute a Change in Control under this subsection (iii)&#160;if: (A)&#160;the beneficial owners of the Outstanding Company Voting Securities immediately prior to such Asset Sale beneficially own, directly or indirectly, 50% or more of the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities of the acquiror or resulting corporation in such Asset Sale in substantially the same proportions as their ownership, immediately prior to such Asset Sale of the Outstanding Company Voting Securities; and (B)&#160;no Person beneficially owns, directly or indirectly, more than 30% of the combined voting power of the then outstanding voting securities of the acquiror or resulting corporation except to the extent that such ownership existed prior to the Asset Sale. For avoidance of doubt, no transaction or event will constitute a &#8220;Change in Control&#8221; under this Agreement unless it also constitutes a &#8220;change in effective control&#8221; of the Company within the meaning of Treasury Regulation Section&#160;1.409A-3(i)(5)(vi)&#160;or a &#8220;change in ownership of a substantial portion&#8221; of the Company&#8217;s assets within the meaning of Treasury Regulation Section&#160;1.409A-3(i)(5)(vii).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Code</u>&#8221; means the Internal Revenue Code of 1986, as amended.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221; shall mean Merit Medical Systems,&#160;Inc.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employment Period</u>&#8221; shall mean the period commencing on the date hereof and continuing through the effective date of termination of Executive&#8217;s employment as provided below.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Executive</u>&#8221; shall mean the executive employee of the Company named in the first introductory paragraph of this Agreement.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt 0pt 0pt 36pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Separation from Service</u>&#8221; means &#8220;separation from service&#8221; (as defined in Treasury Regulation Section&#160;1.409A-1(h)&#160;from the Company.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Treasury Regulation</u>&#8221; means the regulations promulgated under the Code.&#160; Any reference in this Agreement to a Treasury Regulation shall include such regulation as amended from time to time and shall be deemed to incorporate herein the full text of such regulation.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employment</u>.&#160; Subject to termination as provided below, the Company hereby agrees to continue the Executive in its employ &#8220;at will&#8221;, and the Executive hereby agrees to remain in the employ of the Company &#8220;at will&#8221;, subject to the terms and conditions of this Agreement.&#160; As an &#8220;at will&#8221; employee, the Company may terminate the Executive&#8217;s employment, and the Executive may resign his/her employment with the Company, at any time and for any or no reason.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">&#160;</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">2</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Terms of Employment.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Position and Duties</u>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the Employment Period, the Executive&#8217;s position and title shall be Chief Operating Officer.&#160; Notwithstanding the foregoing, upon a Change in Control: (A)&#160;the Executive&#8217;s position (including offices, titles and reporting requirements), authority, duties and responsibilities shall be at least commensurate in all material respects with the most significant of those held, exercised and assigned at any time during the 120-day period immediately preceding the effective date of a Change in Control; and (B)&#160;the Executive&#8217;s services shall be performed at the location where the Executive was employed immediately preceding the Effective Date or any office or location less than 35 miles from such location.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the Employment Period, and excluding any periods of vacation and sick leave to which the Executive is entitled, the Executive agrees to devote reasonable attention and time during normal business hours to the business and affairs of the Company and, to the extent necessary to discharge the responsibilities assigned to the Executive hereunder, to use the Executive&#8217;s reasonable best efforts to perform faithfully and efficiently such responsibilities.&#160; During the Employment Period it shall not be a violation of this Agreement for the Executive to: (A)&#160;serve on corporate, civic or charitable boards or committees, provided that the Executive obtains the Company&#8217;s prior, written consent, which will not be unreasonably withheld; (B)&#160;deliver lectures, fulfill speaking engagements or teach at educational institutions; and (C)&#160;manage personal investments, so long as such activities do not significantly interfere with the performance of the Executive&#8217;s responsibilities as an employee of the Company in accordance with this Agreement.&#160; It is expressly understood and agreed that to the extent that any such activities have been conducted by the Executive prior to the effective date of a Change in Control, the continued conduct of such activities (or the conduct of activities similar in nature and scope thereto) subsequent to the effective date shall not thereafter be deemed to interfere with the performance of the Executive&#8217;s responsibilities to the Company.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation</u>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Base Salary</u>.&#160; During the Employment Period the Executive shall receive an annual base salary (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annual Base Salary</u>&#8221;), which shall be paid in equal monthly installments, at least equal to the Executive&#8217;s then current salary or such other amount as is authorized by the Compensation Committee of the Board; provided, however that following a Change in Control, the Executive&#8217;s rate of Annual Base Salary for any fiscal year of the Company following the Change in Control shall not be less than 12 times the highest monthly base salary paid or payable (including any base salary which has been earned but deferred) to the Executive by the Company and its Affiliated Companies in respect of the 12-month period immediately preceding the month in which the Change in Control occurs.&#160; During the Employment Period, the Annual Base Salary shall be reviewed no more than 12 months after the last salary increase or decrease applicable to the Executive and thereafter at least annually.&#160; Any increase or decrease in Annual Base Salary shall not serve to limit or reduce any other obligation to the Executive under this Agreement.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annual Bonus</u>.&#160; In addition to Annual Base Salary, for each fiscal year of the Company that ends during the Employment Period (a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Bonus Award Year</u>&#8221;) the Executive shall be awarded an annual bonus (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annual Bonus</u>&#8221;) in cash in such amount as the Board determines in its sole discretion; provided that (A)&#160;no Annual Bonus shall be payable for a particular Bonus Award Year </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">3</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">unless the Executive is still employed by the Company on the last day of the Bonus Award Year in question (or such earlier dater as the Annual Bonus is paid); and (B)&#160;for any Company fiscal year ending on or after the effective date of a Change in Control, the Annual Bonus shall be at least equal to the Executive&#8217;s average annual cash bonus for the last three full 12-month fiscal years ending prior to the Change in Control (or such lesser number of full fiscal years as the Executive has completed with the Company, and annualized in the event that the Executive was not employed by the Company for the whole of any such full 12-month Company fiscal year) (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Average Annual Bonus</u>&#8221;).&#160; Each such Annual Bonus shall be paid to the Executive not later than the 15th&#160;day of the third month following the calendar year in which the Annual Bonus is earned, unless the Executive shall elect to defer the receipt of such Annual Bonus pursuant to a non-qualified deferred compensation plan maintained by the Company that complies with the requirements of Code Section&#160;409A.&#160; The Executive shall not be entitled to any Annual Bonus for a Bonus Award Year unless the Executive remains employed by the Company through the earlier of the date the Annual Bonus is paid or the last day of the Bonus Award Year in question.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Commissions</u><font style="white-space:pre-wrap;">.  In addition to the Annual Base Salary and Annual Bonus, the Executive may, at the Board&#8217;s discretion, be awarded monthly or quarterly commissions (the &#8220;</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Commissions</u>&#8221;), at least equal to the Executive&#8217;s then current commissions or such other amount as is authorized by the Board; provided, however that for any company fiscal year ending on or after the effective date of a Change in Control, the Executive&#8217;s Commissions shall not be less than the Executive&#8217;s average annual commissions for the last three full 12-month fiscal years ending prior to the Change of Control (or such lesser number of full fiscal years as the Executive has completed with the company, and annualized in the event the Executive was not employed by the Company for the whole of any such full 12-month Company fiscal year (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Average Annual Commissions</u><font style="white-space:pre-wrap;">&#8221;).  During the Employment Period, the Commissions shall be reviewed no more than 12 months after the last commission increase or decrease applicable to the Executive and thereafter at least annually.  Any increase or decrease in Commissions shall not serve to limit or reduce any other obligation to the Executive under this Agreement.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iv)<font style="display:inline-block;width:21.84pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Incentive and Retirement Plans</u>.&#160; During the Employment Period, the Executive shall be entitled to participate in all incentive, savings and retirement plans, practices, policies and programs applicable generally to other peer executives of the Company and its Affiliated Companies.&#160; In no event shall such plans, practices, policies and programs provide the Executive with incentive opportunities (measured with respect to both regular and special incentive opportunities, to the extent, if any, that such distinction is applicable), savings opportunities and retirement benefit opportunities, in each case, materially less favorable, in the aggregate following the effective date of a Change in Control, than the those provided by the Company and its Affiliated Companies for the Executive under such plans, practices, policies and programs as in effect at any time during the 120-day period immediately preceding the Change in Control or if more favorable to the Executive, those provided generally at any time after the Change in Control to other peer executives of the Company and its Affiliated Companies.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Welfare Benefit Plans</u>.&#160; During the Employment Period, the Executive shall be eligible for participation in and shall receive all benefits under welfare benefit plans, practices, policies and programs provided by the Company and its Affiliated Companies (including, without limitation, medical, prescription, dental, disability, employee life, group life, accidental death and travel accident insurance plans and programs for the Executive, the Executive&#8217;s spouse and the Executive&#8217;s qualifying dependent children ) to the extent applicable generally to other peer executives of the </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">4</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Company and its Affiliated Companies, but in no event shall such plans, practices, policies and programs provide the Executive with benefits following a Change in Control which are materially less favorable, in the aggregate, than the plans, practices, policies and programs in effect for the Executive at any time during the 120-day period immediately preceding the Change in Control or, if more favorable to the Executive, those provided generally at any time after the Change in Control to other peer executives of the Company and its Affiliated Companies.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses</u>.&#160; During the Employment Period, the Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by the Executive in accordance with the most favorable policies, practices and procedures of the Company and its Affiliated Companies.&#160;<font style="white-space:pre-wrap;"> In no event shall such policies, practices and procedures be materially less favorable, in the aggregate, following a Change in Control than the policies, practices and procedures in effect for the Executive at any time during the 120-day period immediately preceding the Change in Control or, if more favorable to the Executive, as in effect generally at any time thereafter with respect to other peer executives of the Company and its Affiliated Companies.  All such expense reimbursements shall be paid promptly following submission for the applicable expense reimbursement requests and appropriate substitution but in no event later than the end of the calendar year following the calendar year in which the expense in question is incurred by the Executive.  No reimbursement shall be exchanged or liquidated for another benefit and the amount of expenses eligible for reimbursement in a particular calendar year shall not affect the expense eligible for reimbursement in another taxable year.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fringe Benefits</u>.&#160; During the Employment Period, the Executive shall be entitled to fringe benefits, including, without limitation, tax and financial planning services, payment of club dues, and, if applicable, use of an automobile and payment of related expenses, in accordance with the generally applicable plans, practices and programs of the Company for its executive employees.&#160; In no event shall such policies and programs be materially less favorable following a Change in control than the most favorable plans, practices, programs and policies of the Company and its Affiliated Companies in effect for the Executive at any time during the 120-day period immediately preceding the Change in Control or, if more favorable to the Executive, as in effect generally at any time thereafter with respect to other peer executives of the Company and its Affiliated Companies.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(viii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Office and Support Staff</u>.&#160; During the Employment Period, the Executive shall be entitled to an office or offices of a size and with furnishings and other appointments, and to exclusive personal secretarial and other assistance, generally provided to other executive officers of the Company and its Affiliated Companies.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vacation</u>.&#160; During the Employment Period, the Executive shall be entitled to paid vacation in accordance with the generally applicable plans, practices and programs of the Company for its executive employees.&#160; In no event shall such policies and programs be materially less favorable following a Change in Control than the most favorable plans, policies, programs and practices of the Company and its Affiliated Companies as in effect for the Executive at any time during the 120-day period immediately preceding the Change in Control or, if more favorable to the Executive, as in effect generally at any time thereafter with respect to other peer executives of the Company and its Affiliated Companies.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination of Employment</u>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">5</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Death or Disability</u>.&#160; The Executive&#8217;s employment shall terminate automatically upon the Executive&#8217;s death during the Employment Period.&#160; If the Company determines in good faith that the Disability of the Executive has occurred during the Employment Period (pursuant to the definition of Disability set forth below), it may give to the Executive written notice in accordance with Section&#160;10(b)&#160;of this Agreement of its intention to terminate the Executive&#8217;s employment.&#160; In such event, the Executive&#8217;s employment with the Company shall terminate effective on the 30th day after receipt of such notice by the Executive (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disability Effective Date</u>&#8221;), provided that, within the 30 days after such receipt, the Executive shall not have returned to full-time performance of the Executive&#8217;s duties.&#160; For purposes of this Agreement, &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disability</u>&#8221; shall mean the absence of the Executive from the Executive&#8217;s duties with the Company on a full-time basis for 180 consecutive business days as a result of incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to the Executive or the Executive&#8217;s legal representative.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">By the Company for Cause</u>.&#160; The Company may terminate the Executive&#8217;s employment at any time during the Employment Period for Cause to be effective on the applicable Date of Terminations set forth in Section 4(g).&#160; For purposes of this Agreement, &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cause</u>&#8221; shall mean:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the willful and continued failure of the Executive to perform substantially all of the Executive&#8217;s duties with the Company or one of its Affiliates (other than any such failure results from incapacity due to physical mental illness), after a written demand for substantial performance is delivered to the Executive by the Board or the Chief Executive Officer of the Company which specifically identifies the manner in which the Board or Chief Executive Officer believes that the Executive has not substantially performed the Executive&#8217;s duties,</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Executive willfully engaging in illegal conduct, intentional misconduct or gross negligence which is materially and demonstrably injurious to the Company, or</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Executive&#8217;s&#160;violation of written Company policies prohibiting workplace discrimination, sexual harassment and alcohol or substance abuse.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">For purposes of this provision, no act or failure to act, on the part of the Executive, shall be considered &#8220;willful&#8221; unless it is done, or omitted to be done, by the Executive in bad faith or without reasonable belief that the Executive&#8217;s action or omission was in the best interests of the Company.&#160; Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the instructions of the Chief Executive Officer or a senior officer of the Company or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith and in the best interests of the Company.&#160; Following a Change in Control, the cessation of employment of the Executive shall not be deemed to be for Cause unless and until there shall have been delivered to the Executive a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board at a meeting of the Board called and held for such purpose (after reasonable notice is provided to the Executive and the Executive is given an opportunity, together with counsel, to be heard before the Board), finding that, in the good faith opinion of the Board, the Executive is guilty of the conduct described in subparagraph (i)&#160;or (ii)&#160;above, and specifying the particulars thereof in detail.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">By the Company without Cause</u>.&#160; The Company, acting through the Board, may terminate the Executive&#8217;s employment with the Company at any time &#8220;at will&#8221; without Cause for any or </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">6</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">no reason upon notice to the Executive to be effective on the applicable Date of Termination set forth in Section 4(g).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">By the Executive&#160;for Good Reason</u>.&#160; The Executive may terminate and resign the Executive&#8217;s employment for Good Reason effective on or after the date of a Change in Control upon the Executive&#8217;s delivery to the Company of a Notice of Termination (as defined below) not less than thirty (30) days prior to the termination date set forth in such notice; provided the Executive delivers such Notice of Termination to the Company within ninety (90) days after the occurrence of the event constituting Good Reason.&#160; For purposes of this Agreement, &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Good Reason</u>&#8221; shall mean:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company&#8217;s assignment to the Executive upon or within two (2)&#160;years after a Change in Control of any duties inconsistent in any respect with the Executive&#8217;s position (including offices, titles and reporting requirements), authority, duties or responsibilities as contemplated by Section&#160;3(a)&#160;of this Agreement, or any other action by the Company upon or within two (2)&#160;years after a Change in Control which results in a diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company&#8217;s failure upon or within two (2)&#160;years following a Change in Control to comply with any of the provisions of Section&#160;3(b)&#160;of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;upon or within two (2)&#160;years following a Change in Control, the Company&#8217;s requiring the Executive to be based at any office or location other than as provided in Section&#160;3(a)(i)(B)&#160;hereof or the Company&#8217;s requiring the Executive to travel on Company business to a substantially greater extent than required immediately prior to the Effective Date; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any failure by the Company to comply with and satisfy Section&#160;9(c)&#160;<font style="white-space:pre-wrap;">of this Agreement.  </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">By Executive without Good Reason</u>.&#160; The Executive may resign and terminate the Executive&#8217;s employment with the Company without Good Reason at any time &#8220;at will&#8221; upon notice to the Company to be effective on the applicable Date of Termination set forth in Section 4(g).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice of Termination</u>.&#160; Any termination by the Company for Cause or by the Executive for Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section&#160;10(b)&#160;of this Agreement.&#160; For purposes of this Agreement, a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice of Termination</u>&#8221; means a written notice which</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;indicates the specific termination provision in this Agreement relied upon,</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&#8217;s employment under the provision so indicated, and</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">7</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date (which date shall be as set forth Section 4(g)).&#160; The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company, respectively, hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstance in enforcing the Executive&#8217;s or the Company&#8217;s rights hereunder.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Date of Termination</u>.&#160; For purposes of this Agreement the term &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Date of Termination</u>&#8221; means:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="white-space:pre-wrap;">if the Executive&#8217;s employment is terminated by the Company for Cause, or upon or following a Change in Control by the Executive for Good Reason: (A) the date of the receipt of the Notice of Termination in the case of termination by the Company for Cause, or (B) the date set forth in the Notice of Termination in the case of termination by the Executive for Good Reason, which  shall be not less than thirty (30) days after the delivery of the Notice of Termination.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Executive&#8217;s employment is terminated by the Company other than for Cause, death or Disability; the Date of Termination shall be the tenth (10th) day after the Company notifies the Executive of such termination, provided that the Executive and the Company may mutually agree to a later effective Date of Termination;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Executive voluntarily resigns his/her employment (other than for Good Reason upon or following a Change in Control), the Date of Termination shall be the tenth (10th) day after the Executive notifies the Company of such resignation, provided that Executive and the Company may mutually agree to a later Date of Termination; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Executive&#8217;s employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of the Executive or the Disability Effective Date, as the case may be.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Obligations of the Company upon Termination of Executive&#8217;s Employment</u>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General</u>.&#160; Upon termination of the Executive&#8217;s employment with the Company the Company shall provide the Executive with the payments and benefits set forth in the applicable subsection of this Section&#160;5.&#160; The amounts payable under this Section&#160;5 are in addition to the Company&#8217;s obligations to the Executive under the Company&#8217;s various retirement, deferred compensation, stock option and long-term incentive, employee stock purchase and welfare benefit plans.&#160; The Company&#8217;s obligations under this Section&#160;5 vary depending upon whether or not the Executive&#8217;s termination of employment is in &#8220;Connection with a Change in Control.&#8221;&#160; For purposes of this Agreement, termination of the Executive&#8217;s employment shall be deemed to be in &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Connection with a Change in Control</u>&#8221; if and only if:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Executive&#8217;s Date of Termination is on or within two (2)&#160;years after the effective date of a Change in Control; or</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">8</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company terminates the Executive&#8217;s employment without Cause within six (6)&#160;months prior to the date on which a Change in Control occurs and the Executive reasonably demonstrates that such termination of employment (A)&#160;was at the request of a third party who has taken steps reasonably calculated to effect a Change in Control; or (B)&#160;otherwise arose in connection with or anticipation of a Change in Control.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Other Than in Connection with a Change in Control.</u>&#160; If the Executive&#8217;s employment shall terminate for any reason, voluntarily or involuntarily with or without Cause, other than in Connection with a Change in Control, the Company shall pay to the Executive (or if deceased to the Executive&#8217;s estate) the following amounts:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a lump sum cash payment equal to the Executive&#8217;s Annual Base Salary earned through the Date of Termination to the extent not theretofore paid and any accrued vacation pay through the Date of Termination, which lump sum shall be paid ten (10)&#160;days after the Date of Termination;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a lump sum cash payment equal to the Executive&#8217;s accrued Annual Bonus earned for the last Company fiscal year ending immediately prior to the Date of Termination to the extent not theretofore paid, which lump sum shall be paid within the time period set forth in Section&#160;3(b)(ii); </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)<font style="display:inline-block;width:21.76pt;"></font>if applicable to Executive, a lump sum Commissions payment earned through the Date of Termination to the extent not theretofore paid, which lump sum shall be paid ten (10) days after the date the applicable Commissions would have been calculated by the Company had the Executive&#8217;s employment not been terminated; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;such additional severance benefits, if any, as the Board approves in its sole and absolute discretion without reference to the amount of severance benefits, if any, paid to any other executive officer or employee of the Company; provided, however, that no such discretionary severance benefits shall be paid in a manner or amount that renders such payments non-qualified deferred compensation subject to additional tax or interest under Section&#160;409A(a)(1)(B)&#160;of the Code.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Resignation for Good Reason or Termination without Cause in Connection with a Change in Control</u>.&#160; If the Executive resigns for Good Reason in Connection with a Change in Control (i.e., on or within two (2)&#160;years after the date of a Change in Control) or the Company terminates the Executive without Cause in Connection with a Change in Control, the Company shall:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pay to the Executive the following amounts:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a lump sum cash payment equal to the Executive&#8217;s Annual Base Salary through the Date of Termination to the extent not theretofore paid and any accrued unpaid vacation pay through the Date of Termination, which lump sum shall be paid ten (10)&#160;days after the Date of Termination (on a date within that 10 day period designated by the Company); </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a lump sum cash payment equal to the Executive&#8217;s accrued Annual Bonus, if any, for the last Company fiscal year ending immediately prior to the Date of Termination to the extent not theretofore paid, which lump sum shall be paid within the time period set </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">9</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">forth in Section&#160;3(b)(ii).&#160; The sum of the amounts described in clauses (A)&#160;and (B)&#160;shall be hereinafter referred to as the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Accrued Obligations</u>;&#8221; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">(C)<font style="display:inline-block;width:23.46pt;"></font>if applicable to Executive, a lump sum Commissions payment earned through the Date of Termination to the extent not theretofore paid, which lump sum shall be paid ten (10) days after the date the applicable Commissions would have been calculated by the Company had the Executive&#8217;s employment not been terminated; and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pay to the Executive a cash severance benefit (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severance Benefit</u>&#8221;) in an amount equal to two (2)&#160;times the sum of: (A)&#160;the Executive&#8217;s Annual Base Salary (computed at the highest rate in effect at any time during the 12-month period immediately preceding the Change in Control); (B)&#160;the Executive&#8217;s Average Annual Bonus as defined in Section&#160;3(b)(ii); and (C) if applicable to Executive, the Executive&#8217;s Average Annual Commissions as defined in Section 3(b)(iii)<b style="font-weight:bold;">.&#160;&#160;</b>The Severance Benefit payable under this Section&#160;5(c)(ii)&#160;shall be paid:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In a cash lump sum within 30 days after the later of the date of the Executive&#8217;s Separation from Service with the Company or the date of the Change in Control to the limited extent the amount so paid constitutes &#8220;separation pay&#8221; due to an &#8220;involuntary separation from service&#8221; within the meaning and dollar limitations of Treasury Regulation Section&#160;1.409A-1(b)(9)(iii), or is otherwise exempt from Code Section&#160;409A under Treasury Regulation Section&#160;1.409A-1(b); and</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the balance, in a separate cash lump sum on the date that is six months and one day after the date of the Executive&#8217;s Separation from Service with the Company.&#160; The balance of the Severance Benefit payable under this clause (B)&#160;shall bear interest from the Executive&#8217;s Date of Termination at an annual rate equal to the &#8220;prime rate&#8221; of Wells Fargo Bank, NA in effect on the Date of Termination plus four (4)&#160;percentage points, which interest the Company shall pay to the Executive contemporaneously with payment of the Severance Benefit under this clause (B).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">This Section&#160;5(c)(ii)&#160;shall be interpreted and applied to permit the payment of the Change in Control Severance Benefit prior to the date that is six months and one day after Executive&#8217;s Separation from Service with the Company only to the extent such payments would not thereby constitute a deferral of compensation subject to Code Section&#160;409A.&#160; Neither the Company nor the Executive shall have the right to accelerate or defer such payments except as permitted or required by Code Section&#160;409A.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent permitted by law and the Company&#8217;s applicable insurance policies, for two (2) years after the Executive&#8217;s Date of Termination, continue benefits to the Executive and/or the Executive&#8217;s eligible spouse and dependent children at least equal to those which would have been provided to them in accordance with the welfare plans, programs, practices and policies described in Section&#160;3 of this Agreement if the Executive&#8217;s employment had not been terminated or, if more favorable to the Executive, as in effect generally at any time thereafter with respect to other peer executives of the Company and its Affiliated Companies and their families, provided, however, that if the Executive becomes reemployed with another employer and is eligible to receive medical and other welfare benefits described herein shall be secondary to those provided under such other plan during such applicable period of eligibility.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Provide at the Company&#8217;s sole expense for a period not to exceed twelve (12) months the Executive with reasonable outplacement services the scope and provider of which shall be selected by the Executive in his/her reasonable discretion; and</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">10</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the extent not theretofore paid or provided, the Company shall timely pay or provide to the Executive any other amounts or benefits required to be paid or provided or which the Executive is eligible to receive under any plan, program, policy or practice or contract or agreement of the Company and its Affiliated Companies (such other amounts and benefits shall be hereinafter referred to as the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Benefits</u>&#8221;) in accordance with the terms of such other plans, programs, policies or practices.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Death on or after Change in Control</u>.&#160; If the Executive&#8217;s employment is terminated by reason of the Executive&#8217;s death on or after the date of a Change in Control, this Agreement shall terminate without further obligations to the Executive&#8217;s legal representatives under this Agreement, other than for payment of Accrued Obligations and the timely payment or provision of Other Benefits.&#160; Accrued Obligations shall be paid to the Executive&#8217;s estate or beneficiary, as applicable, in cash in the manner and within the time frames set forth in Section&#160;5(b)(i)&#160;and (ii), as applicable.&#160; With respect to the provision of Other Benefits, the term Other Benefits as utilized in this Section&#160;5(d)&#160;shall include, without limitation, and the Executive&#8217;s estate and/or beneficiaries shall be entitled to receive, benefits at least equal to the most favorable benefits provided by the Company and Affiliated Companies to the estates and beneficiaries of peer executives of the Company and such Affiliated Companies under such plans, programs, practices and policies relating to death benefits, if any, as in effect with respect to other peer executives and their beneficiaries at any time during the 120-day period immediately preceding the Effective Date of a Change in Control, or, if more favorable to the Executive&#8217;s estate and/or the Executive&#8217;s beneficiaries, as in effect on the date of the Executive&#8217;s death with respect to other peer executives of the Company and its Affiliated Companies and their beneficiaries.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disability on or after Change in Control</u>.&#160; If the Executive&#8217;s employment is terminated by reason of the Executive&#8217;s Disability on or after the date of a Change in Control, this Agreement shall terminate without further obligations to the Executive, other than for payment of Accrued Obligations and the timely payment or provision of Other Benefits.&#160; Accrued Obligations shall be paid to the Executive in cash in the manner and within the time frames set forth in Section&#160;5(b)(i)&#160;and (ii), as applicable.&#160; With respect to the provision of Other Benefits, the term Other Benefits as utilized in this Section&#160;5(e)&#160;shall include, and the Executive shall be entitled after the Disability Effective Date to receive, disability and other benefits at least equal to the most favorable of those generally provided by the Company and its Affiliated Companies to disabled executives and/or their families in accordance with such plans, programs, practices and policies relating to disability, if any, as in effect generally with respect to other peer executives and their families at any time during the 120-day period immediately preceding the Effective Date of a Change in Control, or, if more favorable to the Executive and/or the Executive&#8217;s family, as in effect at any time thereafter generally with respect to other peer executives of the Company and its Affiliated Companies and their families.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination for Cause or Resignation Other than for Good Reason on or after a Change in Control</u>.&#160; If the Company terminates the Executive&#8217;s employment for Cause on or after the date of a Change in Control, this Agreement shall terminate without further obligations to the Executive hereunder other than the obligation to pay to the Executive (i)&#160;his/her Annual Base Salary, Commissions, if applicable, and accrued vacation through the Date of Termination, and (ii)&#160;Other Benefits, in each case to the extent theretofore unpaid. &#160;If the Executive voluntarily terminates employment upon or following a Change in Control (excluding a resignation for Good Reason in Connection with a Change in Control) this Agreement shall terminate without further obligations to the Executive under, other than for </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">11</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Accrued Obligations and timely payment or provision of Other Benefits.&#160; In such case, all Accrued Obligations shall be paid to the Executive in cash in the manner and within the time frames set forth in Section&#160;5(b)(i)&#160;and (ii), as applicable.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><font style="white-space:pre-wrap;"> (g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Limits on Timing of Post-employment Payments</u>.&#160; Notwithstanding any provision in this Agreement to the contrary, payments under Sections 5(b)&#160;and 5(c)&#160;shall be bifurcated into two portions, the first consisting of the portion that does not constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code and the second consisting of the portion of such payments that does constitute such &#8220;nonqualified deferred compensation.&#8221;&#160; Such payments shall first be made from the portion that does not constitute &#8220;nonqualified deferred compensation&#8221; until it is exhausted and then from the portion that constitutes &#8220;nonqualified deferred compensation.&#8221;&#160; Because Executive is a &#8220;specified employee&#8221; within the meaning of Code Section&#160;409A, the commencement and delivery of any such payments that constitute &#8220;nonqualified deferred compensation&#8221; shall be delayed to the date that is six months and one day after the date of Executive&#8217;s Separation from Service with the Company.&#160; The determination of whether, and the extent to which, payments under Section&#160;5(b)&#160;or Section&#160;5(c)&#160;are &#8220;nonqualified deferred compensation&#8221; shall be made after the application of all applicable exclusions under Treasury Regulation Section&#160;1.409A-1(b).&#160; Similarly, continuation coverage under each employee benefit plan pursuant to Section&#160;5.2(c)(iii)&#160;and outplacement assistance under Section&#160;5.2(c)(iv)&#160;shall be treated as separate plans from each other and from the cash payments under Section&#160;5.2(c)(i)&#160;and (ii).&#160; Each type of employee benefit plan continuation coverage specified in Section&#160;5.2(c)(iii)&#160;and the outplacement assistance described in Section&#160;5.2(c)(iv)&#160;shall also be bifurcated into two portions, one consisting of the maximum portion of such employee benefit plan continuation coverage or outplacement assistance, as applicable, that does not constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code, and the second portion consisting of the element that does constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Code Section&#160;409A.&#8221; Provision of the portion of any benefit under Section&#160;5(c)(iii)&#160;and 5(c)(iv)&#160;that constitutes &#8220;nonqualified deferred compensation&#8221; shall be deferred until six months and one day after the date of Executive&#8217;s Separation from Service with the Company.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">With respect to items eligible for reimbursement under the terms of this Agreement or any other plan of the Company, (i) the amount of such expenses eligible for reimbursement in any taxable year shall not affect the expenses eligible for reimbursement in another taxable year, (ii) no such reimbursement may be exchanged or liquidated for another payment or benefit, and (iii) any reimbursements of such expenses shall be made as soon as practicable under the circumstances but in any event no later than the end of the calendar year following the calendar year in which the related expenses were incurred. All payments under Section 5(c) on account of the Executive&#8217;s termination for Good Reason shall be treated for purposes of Code Section 409A, to the fullest extent permitted by the Treasury Regulations under Code Section 409A, as payments on account of the Executive&#8217;s involuntary termination.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-exclusivity of Rights</u>.&#160; Nothing in this Agreement shall prevent or limit the Executive&#8217;s continuing or future participation in any plan, program, policy or practice provided by the Company or any of its Affiliated Companies and for which the Executive may qualify, nor shall anything herein limit or otherwise affect such rights as the Executive may have under any contract or agreement with the Company or any of its Affiliated Companies.&#160; Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any plan, policy, practice or program of or any contract or agreement with the Company or any of its Affiliated Companies at or subsequent to the Date of </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">12</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Termination shall be payable in accordance with such plan, policy, practice or program or contract or agreement except as explicitly modified by this Agreement.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Full Settlement</u>.&#160; In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced whether or not the Executive obtains other employment.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</u>.&#160; Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its Affiliated Companies, and their respective businesses, which shall have been obtained by the Executive during the Executive&#8217;s employment by the Company or any of its Affiliated Companies and which shall not be or become public knowledge (other than by acts by the Executive or representatives of the Executive in violation of this Agreement).&#160; After termination of the Executive&#8217;s employment with the Company, the Executive shall not, without the prior written consent of the Company or as may otherwise be required by law or legal process, communicate or divulge any such information, knowledge or data to anyone other than the Company and those designated by it, or use such confidential information.&#160; In no event shall an asserted violation of the provisions of this Section&#160;8 constitute a basis for deferring or withholding any amounts otherwise payable to the Executive under this Agreement.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Successors</u>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution.&#160; This Agreement shall inure to the benefit of and be enforceable by the Executive&#8217;s legal representatives.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such success had taken place.&#160; As used in this Agreement, &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221; shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumed and agrees to perform this Agreement by operation of law, or otherwise.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous</u>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the State of Utah, without reference to principles of conflict of laws.&#160; The captions of this Agreement are not part of the provisions hereof and shall have no force or effect.&#160; This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.&#160; No waiver of any party&#8217;s rights or benefits under this Agreement shall be effective unless such party signs a written waiver of its rights or benefits.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">13</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All notices and other communications hereunder shall be writing and shall be given by hand delivery to the other party by registered or certified mail, return receipt requested, postage prepaid, or in the case of notices to the Executive by electronic mail (email) addressed as follows:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">If to the Executive</u>:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 144pt;">To the Executive&#8217;s most current home address (or email address, as applicable) on file with the Company&#8217;s Human Resources Department</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:108pt;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">If to the Company</u>:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#160;</font></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>Merit Medical Systems,&#160;Inc.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">1600 West Merit Parkway</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">South Jordan, Utah 84095</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:144pt;margin:0pt;">Attention:&#160; Chief Legal Officer</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">or to such other address as either party shall have furnished to the other in writing in accordance herewith.&#160; Notice and communications shall be effective when actually received by the addressee.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">(d)</font></font><font style="font-family:'Times New Roman','Times','serif';"> </font>The Company may withhold from any amounts payable under this Agreement such Federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. The Company makes no representation or warranty to the Executive regarding the tax consequences of any payment or benefit under this Agreement, including any representation as to the application of Code Section 409A to such payments. Neither the Company, any Affiliated Companies of the Company, nor any director, officer, employee or agent of the Company or of any of its Affiliated Companies shall have any obligation or liability to gross-up, reimburse or indemnify the Executive for any taxes (including tax-related interest and penalties) imposed on the Executive.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Executive&#8217;s or the Company&#8217;s failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right the Executive or the Company may have hereunder, including, without limitation, the right of the Executive to terminate employment for Good Reason, shall not be deemed to be a waiver of such provision or right of this Agreement.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement constitutes the entire agreement between the parties with respect to the Executive&#8217;s employment by the Company and supersedes and replaces all other agreements, oral or written, between the parties with respect to the subject matter hereof.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and the Executive irrevocably: (i)&#160;agree that any claim, law suit, cause of action or dispute arising under or with respect to this Agreement or the Executive&#8217;s employment hereunder (a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Claim</u>&#8221;) shall be adjudicated solely in the United States Federal District Court or Utah State Courts situated in Salt Lake City, Utah (collectively the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Utah Courts</u>&#8221;); (ii)&#160;consent and submit to the personal jurisdiction of the Utah Courts with respect to any Claim; (iii)&#160;agree that the Utah Courts shall have exclusive subject matter jurisdiction over any such Claims and that venue with respect to any such Claims is proper and most convenient in the Utah Courts; and (iv)&#160;agree and covenant not to assert any objection to personal jurisdiction, subject matter jurisdiction or venue in the Utah Courts with respect to any Claim. TO THE FULLEST EXTENT PERMITTED BY LAW, THE COMPANY AND THE EXECUTIVE </p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">14</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">IRREVOCABLY WAIVE AND RELEASE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM ARISING UNDER OR WITH RESPECT TO THIS AGREEMENT OR THE EXECUTIVE&#8217;S EMPLOYMENT BY THE COMPANY.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Executive or the Company retains legal counsel and/or incurs other costs and expenses in connection with the enforcement of any or all of the provisions of this Agreement, the prevailing party shall be entitled to recover from the other party reasonable attorneys&#8217; fees, costs, and expenses incurred by the prevailing party in connection with the enforcement of this Agreement.&#160; Notwithstanding the foregoing, in the event that following a Change in Control the Executive engages legal counsel to enforce the Executive&#8217;s rights or seek a determination under this Agreement, the Company shall pay the expenses of such legal counsel regardless of the outcome of any legal proceeding resulting therefrom; provided that such claim is not determined by a trier of fact to be frivolous or in bad faith.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">[<i style="font-style:italic;">Remainder of Page&#160;Intentionally Left Blank-Signature Page&#160;Follows</i>]</p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">15</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;">IN WITNESS WHEREOF, the Executive and Company have caused this Agreement to be executed as of the date first set forth above.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><font style="line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 211.5pt;">&#160;</p><div style="padding-left:5.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:106.73%;"><tr><td style="vertical-align:top;width:37.83%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>EXECUTIVE: </p></td><td style="vertical-align:top;width:62.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Name: Neil Peterson</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Title: Chief Operating Officer </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:37.83%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>COMPANY:</p></td><td style="vertical-align:top;width:62.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS, INC.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:none;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></font>Name: Fred Lampropoulos<br>Title: Chairman and Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:25.5pt;min-height:46.5pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Employment Agreement</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">Page </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font><font style="font-family:'Calibri','Helvetica','sans-serif';"> of </font><font style="font-family:'Calibri','Helvetica','sans-serif';">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.60
<SEQUENCE>10
<FILENAME>mmsi-20221231xex10d60.htm
<DESCRIPTION>EX-10.60
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 2/24/2023 09:00:02 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:9pt 0pt 0pt 0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:right;margin:9pt 0pt 0pt 0pt;"><b style="font-weight:bold;">Exhibit 10.60</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:9pt 0pt 0pt 0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:9pt 0pt 0pt 0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS, INC 2018 LONG-TERM INCENTIVE PLAN </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:9pt 0pt 0pt 0pt;"><b style="font-weight:bold;">RESTRICTED STOCK UNIT AWARD AGREEMENT </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:36pt;margin:9pt 0pt 0pt 0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:9pt 0pt 0pt 0pt;">This Restricted Stock Unit Award Agreement (this &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Award Agreement</u>&#8221;), dated effective as of May 24, 2022&#160;(the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Grant Date</u>&#8221;), is made by and between Merit Medical Systems, Inc. (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221;), and [_____________________], a director of the Company (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">you</u>&#8221;). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">1.</b></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Award of Restricted Stock Units </b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:4.5pt 0pt 0pt 0pt;">The Company hereby grants to you an award of restricted stock units (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">RSUs</u>&#8221;) with respect to its common stock, no par value (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shares</u>&#8221;), pursuant to the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan (as amended from time to time, the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Plan</u>&#8221;), subject to the terms and conditions set forth in this Award Agreement and the Plan. The RSUs constitute Restricted Stock Units and this Award Agreement constitutes an &#8220;Award Agreement&#8221; under the Plan. Capitalized terms used but not otherwise defined in this Award Agreement and the <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Appendix A</u> attached hereto have the applicable meanings set forth in the Plan. With respect to your RSUs granted hereunder, the applicable Total Number of Shares are as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:92.29%;"><tr><td style="vertical-align:top;width:53.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:12pt;text-indent:-12pt;margin:0pt;"><b style="font-weight:bold;">Total Number of Shares </b></p></td><td style="vertical-align:bottom;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt;"><b style="font-size:7.5pt;font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:43.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">3,050</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.24%;margin:0pt;padding:0pt;"></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">2.</b></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Vesting Conditions to Award </b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:4.5pt 0pt 0pt 0pt;">Subject to the other terms and conditions of this Award Agreement and the Plan, you will be entitled to a payment in Shares with respect to your RSUs based on your Total Number of Shares set forth above and the vesting provisions contained herein. Except as otherwise provided in Section 3 below, you shall become vested in the RSUs on the one (1) year anniversary of the Grant Date (the &#8220;Vesting Date&#8221;) and in accordance with the Plan, subject to your Continuous Service with the Company through the Vesting Date. Failure to satisfy the foregoing service-based vesting condition will result in total forfeiture of your RSUs and all rights to payment hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">3.</b></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Effect of a Change in Control </b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:4.5pt 0pt 0pt 0pt;">If a Change in Control occurs prior to the Vesting Date, then you will be entitled to receive, no later than thirty (30)&#160;days following the effective date of the Change in Control, the Total Number of Shares covered by this Award Agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">4.</b></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Payment </b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:4pt;margin:0pt;"><font style="font-size:4.5pt;">&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a)</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Timing of Settlement</u>. Subject to Section 2 of this Award Agreement, promptly following the Vesting Date the Company will issue to you the Total Number of Shares. Such issuance and payment will be made in accordance with Section&#160;4(c) below within the thirty (30) day period following the Vesting Date; provided, however, that in the event of a Change in Control, your RSUs will be settled and paid within the thirty (30) day period specified in Section 3 above. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:14pt 0pt 0pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Dividend Equivalents</u>.&#160;No Dividend Equivalents will be paid on or with respect to the RSUs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:14pt 0pt 0pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Form of Payment</u>.&#160;All amounts payable with respect to your RSUs will be paid in the form of Shares. RSUs will not be settled or paid in cash.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Taxes</u>. Taxes may be assessed and/or withheld as required by law at applicable United States federal, state and/or other tax rates (under the laws of the jurisdictions in which you reside or that may otherwise be applicable to </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">you) with respect to your RSUs and the issuance of Shares in payment of your RSUs. Notwithstanding anything in this Award Agreement to the contrary, the issuance of Shares in payment of your RSUs described in this Award Agreement will be reduced by a number of Shares having a then Fair Market Value equal to the amount necessary to satisfy the minimum tax withholding obligations applicable to such RSUs and Share issuance.  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:3.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">5.</b></p></td><td style="vertical-align:top;width:96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other Provisions </b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(a) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Future Adjustments</u>. In the event of any merger, acquisition, disposition or other corporate event affecting the Company prior to the Vesting Date, the Committee may make such adjustments to the Total Number of Shares subject to this Award Agreement pursuant to Section 12.2 of the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(b) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Guaranty of Future Awards</u>.<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#160;</u>This Award Agreement in no way guarantees you the right to or expectation that you may receive similar awards with respect to any other period which the Committee may, in its discretion, establish and as to which the Committee may elect to grant Awards under the Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Rights as Shareholder</u>.&#160;You will not be considered a shareholder of the Company with respect to the Shares covered by this Award Agreement unless and until such underlying Shares are issued to you in settlement of your RSUs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Rights to Continued Service</u>. This Award Agreement will not be deemed to create a contract or other promise of continued service as a director or otherwise with the Company and will not in any way prohibit or restrict the ability of the Company to terminate your service at any time for any reason, with or without cause, at will with or without notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Section&#160;409A of the Code</u><font style="white-space:pre-wrap;">. This Award Agreement and your RSUs are intended to constitute and result in a &#8220;short-term deferral&#8221; that is exempt from the definition of a &#8220;nonqualified deferred compensation plan&#8221; under Section 409A of the Code.  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Plan</u>. All terms and conditions of the Plan are incorporated herein by reference and constitute an integral part hereof. In the event of any conflict between the provisions of this Award Agreement and the Plan, the provisions of the Plan, including without limitation Sections 4.2, 13.5, 13.6 and 13.15 of the Plan, will govern and be controlling.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfers</u><font style="white-space:pre-wrap;">.  Neither the RSUs nor the right to receive Shares hereunder may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by you. Any attempt to assign, alienate, pledge, attach, sell or otherwise transfer or encumber the RSUs or the rights relating thereto will be wholly ineffective.  Notwithstanding the foregoing, in the event of your death, Shares deliverable with respect to the vested RSUs will be delivered to your designated beneficiary under the Plan (or if none, to your estate).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities Law Restrictions</u><font style="white-space:pre-wrap;">.  The issuance of Shares hereunder is conditioned upon compliance by the Company and you with all applicable requirements of federal and state securities laws and with all applicable requirements of any stock exchange on which the Company&#39;s Shares may be listed. No Shares will be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel.</font><font style="font-size:12pt;"> </font>In addition, the Company may require that prior to the issuance of Shares hereunder you enter into a written agreement to comply with any restrictions on subsequent disposition that the Company deems necessary or advisable under any applicable federal and state securities laws. The Shares issued hereunder may be legended to reflect such restrictions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</u>. This Award Agreement will be construed and interpreted in accordance with the laws of the State of Utah without regard to conflict of law principles.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effect on Other Benefits</u>. Participation in the Plan is voluntary. The value of the RSUs is an extraordinary item of compensation outside the scope of your normal service and compensation rights, if any. As such, the RSUs are not part of normal or expected compensation for purposes of calculating any severance, bonuses, awards, or retirement benefits or similar payments unless specifically and otherwise provided in the plans or agreements governing such compensation.</p></div><div style="clear:both;display:table;margin-bottom:28.8pt;min-height:43.2pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;">2</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(k) </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</u>. This Award Agreement supersedes in its entirety all prior undertakings and agreements of the Company and you, whether oral or written, with respect to the RSUs granted hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">By executing and accepting this Award Agreement, you agree to be bound as a Participant by the terms and conditions herein, the Plan and all conditions established by the Committee and the Company in connection with Awards issued under the Plan. </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:44.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS, INC.</b></p></td><td style="vertical-align:bottom;width:55.75%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:44.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:6pt 0pt 0pt 0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;">______________________________________</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fred P. Lampropoulos</p></td><td style="vertical-align:bottom;width:55.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">_________________________________________________</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">A. Scott Anderson</p></td></tr><tr><td style="vertical-align:top;width:44.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President and Chief Executive Officer</p></td><td style="vertical-align:bottom;width:55.75%;margin:0pt;padding:0pt;"></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 8pt 0pt;"><font style="font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:28.8pt;min-height:43.2pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;">3</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">APPENDIX A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Definitions) </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">For purposes of this Award Agreement, the following terms have the following meanings:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="font-size:10pt;">&#8220;</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change in Control</u><font style="font-size:10pt;">&#8221; has the meaning set forth in the Plan; </font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:10pt;">, that no event will constitute a Change of Control unless it is described in Code Section 409A(a)(2)(A)(v) and the Treasury Regulations thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="font-size:10pt;">&#8220;</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Continuous Service</u><font style="font-size:10pt;">&#8221; has the meaning set forth in the Plan and includes service with the Company as an employee or Director of the Company. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Total Number of Shares</u>&#8221; means the number of Shares specified in Section 1 of this Award Agreement. </p></div><div style="clear:both;display:table;margin-bottom:28.8pt;min-height:43.2pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;">4</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.61
<SEQUENCE>11
<FILENAME>mmsi-20221231xex10d61.htm
<DESCRIPTION>EX-10.61
<TEXT>
<html><head></head><body link=blue lang="EN-US"><div><div align="center"><div align="center"><div style="position:absolute; top:17px; right:64px; font-family:'Times New Roman'; font-size:10pt; font-weight:bold;">Exhibit 10.61</div><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="mmsi-20221231xex10d61g001.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">SECOND AMENDMENT TO LEASE AGREEMENT
THIS SECOND AMENDMENT TO LEASE AGREEMENT (this "Amendment") dated as
of l\'ltlCR JO_, 2022 (the "Effective Date") by and between MM (UT) QRS 11-59, INC., a
Delaware corporation ("Landlord"), as lessor, and MERIT MEDICAL SYSTEMS, INC., a Utah
corporation ("Tenant"), as lessee.
-W I TN E S S E T H: ---------
WHEREAS, QRS 11-20 (UT), INC., a Utah corporation ("Original Landlord") and Tenant
entered into that certain Lease Agreement dated as of June 8, 1993 (the "Original Lease"), as such
Original Lease was assigned pursuant to that certain Assignment and Assumption of Lease dated
August 29, 2002 (the "Assignment") from Original Landlord to Landlord, and amended by that
certain Addendum to Lease Agreement dated April 24, 2003 (the "Addendum"), and as further
amended by that certain First Amendment to Lease Agreement dated May 22, 2017 (the "First
Amendment", and collectively with the Original Lease, the Addendum and First Amendment, the
"Existing Lease"), with respect to certain real property located at 1600 West Merit Parkway, South
Jordan, UT (the "Leased Premises"); and
WHEREAS, Landlord and Tenant hereby desire to further amend the Existing Lease to (i)
revise the Tenant Improvement Allowance and (ii) to adopt the Green Lease Rider attached hereto
as Exhibit F.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, Landlord and Tenant hereby covenant and agree as follows:
1. Definitions. All capitalized terms contained in this Amendment shall, for the purposes
hereof, have the same meanings ascribed to them in the Existing Lease unless otherwise defined
herein. As used herein, the term "Lease" shall mean the Existing Lease as amended by this
Amendment and as hereafter amended.
2. Lease Amendments. Effective as of the Effective Date, the Existing Lease is hereby
amended as follows:
a. Paragraph 5 of the First Amendment, entitled Tenant Improvement Allowance, is
hereby amended by deleting subsection (a) in its entirety and replacing it with the following:
"(a) Landlord shall provide to Tenant an improvement allowance ("TI
Allowance") equal to $967,245.00 for Approved Work (hereinafter defined) to be completed
by Tenant that Tenant deems necessary or desirable for its continued use and occupancy of
the Leased Premises. Landlord shall reimburse Tenant after completion of the Approved
Work. As used herein, "Approved Work" shall be performed in accordance with Paragraph
13 of the Lease and shall mean (i) sustainability related physical improvements to the
building(s) located on or comprising a part of the Leased Premises, including the installation
of solar panels to the Building(s), the upgrade or replacement of building equipment and
systems with high efficiency alternatives (HV AC, plumbing, electrical, and building
automation systems), improvements to the building envelope, shell or facade, and other
projects subject to Landlord's review and prior written approval and (ii) certain soft costs
(which soft costs shall not, in any event, exceed thirty percent (30%) of the TI allowance),
including, but not limited to, space planning, space programming, interior design, design
development drawings, construction drawings, electrical / mechanical / plumbing / </font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="mmsi-20221231xex10d61g002.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">engineering drawings, commissioning fees, energy audit fees, approval fees, and other
construction design costs. Notwithstanding the foregoing, "Approved Work" shall
specifically exclude the purchase of moveable furniture, fixtures or other equipment which
have no permanent connection to the Leased Premises."
b. The Outside TI Completion Date is extended to November 1, 2022.
c. The Outside TI Submission Date is extended to January 1, 2023.
d. By the insertion of Exhibit "F" ("Green Lease Rider")_attached hereto.
3. Modification. Except as modified and amended by this Amendment, all of the
conditions, covenants and terms of the Lease hereby are confirmed and ratified and shall continue to
be and remain in full force and effect.
4. Entire Agreement. This Amendment and the Lease together contain the entire
understanding between the parties hereto and supersedes all prior agreements and understandings, if
any, relating to the subject matter hereof or thereof. Any guarantees, promises, representations or
warranties not herein or therein contained and hereinafter made shall have no force and effect unless
in writing and executed by the party or parties making such guarantees, promises, representations or
warranties.
5. Counterparts. This Amendment may be executed in any number of counterparts and
by different parties hereto on separate counterparts that may be electronically exchanged by email in
"PDF" format, all of which, when so executed, shall be deemed an original, but all such counterparts
shall constitute one (1) and the same instrument.
6. Enforceability. If any provision of this Amendment or its application to any person
or circumstances is invalid or unenforceable to any extent, the remainder of this Amendment, or the
applicability of such provision to other persons or circumstances, shall be valid and enforceable to
the fullest extent permitted by law and shall be deemed to be separate from such invalid or
unenforceable provisions and shall continue in full force and effect.
7. Brokers. Each of Landlord and Tenant represents and warrants to the other that it has
paid any realtors, brokers, finders or agents it worked with in connection with this Amendment, and
each releases and agrees to indemnify the other from and against any claims based on the failure or
alleged failure to pay any realtors, brokers, finders or agents and from any cost, expense or liability
for any compensation, commission or changes claimed by any realtors, brokers, finders or agents
claiming by, through or on behalf of it with respect to this Amendment or the negotiation of this
Amendment.
8. Governing Law. Paragraph 38(i) of the Lease is incorporated herein by this reference
to the same extent as if fully set forth herein.
9. Ratified. The Lease and all covenants agreements, terms and conditions thereof shall
remam m full force and effect, and are hereby ratified and confirmed, as modified by this
Amendment.
10. Binding Agreement. This Amendment shall be binding on the parties hereto and their
respective successors and assigns. </font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="mmsi-20221231xex10d61g003.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">11. Estoppel. Each of Landlord and Tenant hereby certifies to the other party that to the
knowledge of such party, no default by either Landlord or Tenant exists under the Lease as modified
and amended by this Agreement.
[SIGNATURE PAGE FOLLOWS] </font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="mmsi-20221231xex10d61g004.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">IN WITNESS WHER&#xCF;".;OF, l.,andlord and f'enant have caussd this Amendmcnt to be cluly
executed as of the date first above written.
[,4oNnr;Qlrn:
MM (UT) QRS 1l-59,INC.'
a Delaware corporation
By
Name:
rf)il&#xF9;,&#xBF;.Nll:
Merit Med Inc.
a t.ltah
By
Name: fr&#xA1;t*l f C-a&#xE7;f
Title: AAA
Ti
Signature Page to Seconcl Amendmenl to l.,ease Agreement</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="mmsi-20221231xex10d61g005.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">EXHIBIT "F"
GREEN LEASE RIDER
1. Definitions.
"Building Certifications" shall mean those Green Building Standards
under which the Improvements (i) are in the process of becoming certified, or (ii) may in the
future become certified.
"Green Building Laws" shall mean any present or future federal, state, or
local laws, regulations, ordinances or other governmental requirements applicable to the
Improvements expressly intended to require energy, waste, water, or carbon reduction, or other
sustainable practices.
"Green Building Standards" shall mean standards for the certification of
environmentally sustainable, high performance buildings or aspects of their performance,
including without limitation the US EPA Energy Star&#xAE; rating, Green Building Initiative's Green
GlobesTM for Continual Improvement of Existing Buildings (Green GlobesTM-CIEB), the US
Green Building Council's Leadership in Energy and Environmental Design (LEED&#xAE;) rating, and
other similar certification standards.
2. Reporting.
(a) Tenant shall enroll in Landlord's utility data sharing program
and provide Landlord with electricity consumption, recycling and water consumption data
for the Leased Premises.
(b) The Landlord will use commercially reasonable efforts to co-operate with the Tenant to evaluate whether the certification of the Leased Premises pursuant to
any rating scheme, such as ASHRAE standard 189.11, LEED-CI standard (as specified by the
U.S. Green Building Council) is feasible. Tenant agrees to provide all reasonable information
reasonably required by the Landlord consistent with the accreditation or certifications required to
comply with Green Building Laws or Landlord's Sustainability Practices, in a form acceptable to
the Landlord, acting reasonably, within 30 Days of request.
3. Compliance with Green Building Laws and Landlord's Sustainability
Practices.
(a) Landlord and Tenant shall cooperate to maintain the Building
Certifications and to consider adoption of sustainable management practices proposed by either
Party. Subject to the limitations in Section 3(b), Tenant shall not use or operate the Leased
Premises in any way that would cause the Improvements to lose its Building Certifications.
(b) Landlord and Tenant shall discuss and cooperate with one another to
obtain potential Building Certifications for the Building and the Leased Premises and establish
appropriate goals with respect thereto. Any failure for any reason by Landlord or Tenant to
obtain or maintain any Building Certifications shall be without liability to Landlord or Tenant
and shall not constitute a default by Landlord or Tenant hereunder, nor in the case of Tenant, </font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img src="mmsi-20221231xex10d61g006.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">entitle Tenant to any abatement or reduction in Fixed Rent or Additional Rent, relieve Tenant of
any obligation under this Lease or impose any liability upon Landlord.
(c) Landlord and Tenant shall consider and take into account the guidelines
promulgated by the Green Building Standards for the construction of alterations when
performing any work in the Improvements or the Leased Premises; it being understood,
however, that notwithstanding anything to the contrary contained in this Lease, compliance
with such guidelines shall be in Landlord's or Tenant's sole discretion and failure to so comply
shall not be a default under this Lease unless such compliance is required by Law and the party
required to so comply fails to do so in accordance with the terms of this Lease.
(d) Tenant shall endeavor in good faith to use proven and feasible energy,
water, carbon reduction, and other sustainable measures.
( e) Tenant shall, at its own cost and expense:
(i) comply with any present or future Green Building Laws
regarding collecting, sorting, separating, recycling, and composting of garbage, trash, and other
refuse (collectively, "Waste");
(ii)
or future Green Building Laws;
sort and separate Tenant's Waste according to any present
(iii) arrange for collection of any of Tenant's Waste that is not
sorted and separated as required by any present or future Green Building Laws; and
(iv) pay on demand any and all costs, expenses, fines, penalties
or damages that may be imposed on Landlord or Tenant due to Tenant's failure to comply with
the provisions of this Exhibit F.
4. On-Site Renewable Energy.
(a) To the extent provided by Landlord, Tenant shall purchase energy
from on-site renewables from Landlord via a Power Purchase Agreement (PP A). Landlord shall
install, own, and maintain the on-site generation, including without limitation solar panels and
arrays, and sell power directly to Tenant at a fixed rate that is at or below the electricity rate
offered by local utilities. Tenant hereby grants Landlord the right to install solar panels on the
roof of the Improvements or on the Leased Premises, provided Tenant shall not bear the expense
of such installation and such installation does not materially interfere with Tenant's quiet
enjoyment of the Leased Premises or business operations. Notwithstanding any other provisions
of this Section 4(a), Tenant shall not be obligated to purchase electricity directly from Landlord
to the extent its contractual obligations to Rocky Mountain Power prohibit Tenant's purchase of
electricity from a source other than Rocky Mountain Power. </font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:avoid;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>mmsi-20221231x10k001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231x10k001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  J /,# 2(  A$! Q$!_\0
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MYZV^[IYV/)(WDMI4="T4J$,IZ$'UILC-*7DD+.7)9G;^(GJ<UZ;\;/!>HO\
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MM#@H58XMX["8/EC74I*_=/K??35>6FALQMG]J)R!@?\ "2MQ_P #%>\?\%(
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>mmsi-20221231x10k002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231x10k002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (O \L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL?QAXIL
M? _A/6?$6ILR:=I-G-?7+(,L(XT+M@=SA3@4 ;%%>"^#/%?QI\;>"-+\;VD/
MA6&#5HX[N#PE/;SK<6]N[ J6O?-VO+Y?.SR47<<;\#)ZY_VB_ EOXN7PY<ZK
M-;7C73Z>M[-93II\EVBEI+=+PIY+2KA@8PY8%&&,J0 #TRBO$-*_;.^$VNK8
MOIOB&YOXM0-Q'8RVVEW3I>SPN5DMH&$>)9^ 1"F7965@I!!-JX_:[^%T+Z#!
M%KMQ?ZAKFFR:M8:9I^FW-S>RV\<GER-Y$<9D!5@^5*A@(I21B-L 'LM%>27_
M .U1\-["WT>Z.L7-SI^J6MM>Q:A9Z;<SVL,-PYCA>>9(RD 9U9?WA7E6]#6;
MK_[5?PTFTGQ>J>*K^PM= DELM2URPTV:2&QN%V@HLS0O"TN6 5/FW'( )!%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXX^"'QI\87FJW>H^"+'4IKOPIK/AM;*/4+*#3[=KIH3!+!%]X!#'N8L<E@"
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M'VCR YDE&>J[G ![X->N,H92K $$8(/>FQ1)!&L<2+'&HPJ(, #V% #Z***
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M\)?] "R_[XH_X59X2_Z %E_WQ7544 <K_P *L\)?] "R_P"^*/\ A5GA+_H
M67_?%=510!RO_"K/"7_0 LO^^*/^%6>$O^@!9?\ ?%=510!RO_"K/"7_ $ +
M+_OBC_A5GA+_ * %E_WQ7544 <K_ ,*L\)?] "R_[XH_X59X2_Z %E_WQ754
M4 <K_P *L\)?] "R_P"^*/\ A5GA+_H 67_?%=510!RO_"K/"7_0 LO^^*/^
M%6>$O^@!9?\ ?%=510!RO_"K/"7_ $ ++_OBC_A5GA+_ * %E_WQ7544 <K_
M ,*L\)?] "R_[XH_X59X2_Z %E_WQ7544 <K_P *L\)?] "R_P"^*/\ A5GA
M+_H 67_?%=510!RO_"K/"7_0 LO^^*/^%6>$O^@!9?\ ?%=510!RO_"K/"7_
M $ ++_OBC_A5GA+_ * %E_WQ7544 <K_ ,*L\)?] "R_[XH_X59X2_Z %E_W
MQ7544 <K_P *L\)?] "R_P"^*/\ A5GA+_H 67_?%=510!RO_"K/"7_0 LO^
M^*/^%6>$O^@!9?\ ?%=510!RO_"K/"7_ $ ++_OBC_A5GA+_ * %E_WQ7544
M <K_ ,*L\)?] "R_[XH_X59X2_Z %E_WQ7544 <K_P *L\)?] "R_P"^*/\
MA5GA+_H 67_?%=510!RO_"K/"7_0 LO^^*/^%6>$O^@!9?\ ?%=510!RO_"K
M/"7_ $ ++_OBC_A5GA+_ * %E_WQ7544 <K_ ,*L\)?] "R_[XH_X59X2_Z
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M] "R_P"^*/\ A5GA+_H 67_?%=510!RO_"K/"7_0 LO^^*/^%6>$O^@!9?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHI.E (/0Y^E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 <JG_)49O\ L#1_^CWKJJY5/^2HS?\ 8&C_ /1[UU5 !1110 4444 %
M%%% !1110 4444 %%%% !7E?[3/_ "2G_N8- _\ 3Q9UZI7E?[3/_)*?^Y@T
M#_T\6= 'JE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5^)-H$)M-+TRVDCN;A@VUAL9-X [G:>.QKPWX8_M ?M;_%CQSHDI^">D^ _
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"%+;?_ !- 'JE%>5_\+"^)W_1)%_\ "EMO_B:/^%A?$[_HDB_^%+;?_$T
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M)%_\*6V_^)H_X6%\3O\ HDB_^%+;?_$T >J45Y7_ ,+"^)W_ $21?_"EMO\
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M)%_\*6V_^)H ]4HKRO\ X6%\3O\ HDB_^%+;?_$T?\+"^)W_ $21?_"EMO\
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M: "BBB@ HHHH **** "LK6O"FB>(WB;5M'L-4:($1M>VJ3% >N-P.,X%:M%
M&0?"&A&WLX#HNG&"S;=;1?9(]L!]4&,*?I5G4-"TW5YK>6^T^UO9;=M\+W$"
MR-$WJI(.#[BKU% %5]*LI1=![.W<70Q<!HE/G#&/GX^;CCFJW_"+Z-_9']E?
MV38_V7_SX_9D\CU^YC;^E:=% $5M;0V=O'!;Q)!!&H5(XU"JH'0 #@"O,/VF
M?^24_P#<P:!_Z>+.O5*\K_:9_P"24_\ <P:!_P"GBSH ]4HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@/\ M(^ /VDO#]UJW@36AJ<5FZQW<$D;1S6S,"5#J?4 X()'!]*]/H ****
M"BBB@ HHHH *RK[PY9W-MJ8MHTT^\U"%H9+ZUC59\E2 V[&21G(S6K10!^?%
MCX=_:G_9 \8VUMI$TGQO^'%]>@&"=L7MH';GDG*XSUR1GM7W;/XQT6QU6QTB
M^U6QL=:O(A+#IT]RBSR#I\J$Y;G(X'8UM5\Z?M6?L4>%OVH)=.UJ;4;[PSXU
MTF+R=.U[3I"KQH&+A&7HR[B3ZC)P>: /HNBOG+X%I\2/V=O@UXJO?CKXOM?$
M]AX>\RYM=7M(F>X^PQIDM+QEFX)[X[G'3TCX,?M!^ /V@- 75O _B2TUB,+N
MFM5<+<V_3B2(_,O)QG&">A- 'HM%%% !1110 4444 <JG_)49O\ L#1_^CWK
MJJY5/^2HS?\ 8&C_ /1[UU5 !1110 4444 %%%% !1110 4444 %%%% !7E?
M[3/_ "2G_N8- _\ 3Q9UZI7E?[3/_)*?^Y@T#_T\6= 'JE%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD) (!/)Z4 +117P_\
M%#Q7^V/\4OB#KGAGP%X9T;X:>%+6X:&#Q)J4R2RW$8.-Z_?/(Y&$&/7- 'V1
MXI\8Z#X(TM]2\0ZS8:'8)]ZYU"Y2!/IEB.?:ODOXE_\ !5#X3>%[\Z1X+MM6
M^)NOL0L5IH5NPB=LXV^8RY)_W4(KFO#/_!+:U\6ZE'K?QN^)?B+XF:L<,UL;
MEX+8<YV_>+D?1A]*^LOAE\!/A[\'-/6S\'>$=*T*,  O;6Z^8^.[.?F8^Y-
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MEE8ZB[20N[,IE +D_,5&%R< XZ"@#W>BOCK]FO\ ;SOO''Q!L_A/\5_!&I>
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MM581MXB\-*9+8\XSU>)B>N!*OTK[X\/:Y;^)M"T_5K195M;V!+B)9XS'(%8
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MZ?NT!(!]3@5\T77[?WQA^.<[V/P$^"NI75LYV+X@\1J8[=.<9V@A<=^7'TH
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M ,10!#\/M+^&GPI\.PZ%X1;P]H&EQ 8@LIXDW$#&YCG+-QU))KI?^$W\._\
M0?TO_P #(_\ XJL#_A0_PT_Z)WX4_P#!);?_ !%'_"A_AI_T3OPI_P""2V_^
M(H W_P#A-_#O_0?TO_P,C_\ BJ/^$W\._P#0?TO_ ,#(_P#XJL#_ (4/\-/^
MB=^%/_!);?\ Q%'_  H?X:?]$[\*?^"2V_\ B* -_P#X3?P[_P!!_2__  ,C
M_P#BJ/\ A-_#O_0?TO\ \#(__BJP/^%#_#3_ *)WX4_\$EM_\11_PH?X:?\
M1._"G_@DMO\ XB@#?_X3?P[_ -!_2_\ P,C_ /BJ/^$W\._]!_2__ R/_P"*
MK _X4/\ #3_HG?A3_P $EM_\11_PH?X:?]$[\*?^"2V_^(H W_\ A-_#O_0?
MTO\ \#(__BJ/^$W\._\ 0?TO_P #(_\ XJL#_A0_PT_Z)WX4_P#!);?_ !%'
M_"A_AI_T3OPI_P""2V_^(H W_P#A-_#O_0?TO_P,C_\ BJ/^$W\._P#0?TO_
M ,#(_P#XJN'\0_#KX*^$K9Y]:\*>!=*B0;F:[TRSCP/Q2OG7XA?M9?L<?#]W
MA.F>$=?NQP+?1?#T%R2WIE8\"@#["_X3?P[_ -!_2_\ P,C_ /BJ/^$W\._]
M!_2__ R/_P"*KY,_9F^+OPG_ &G/&6KZ5H_P M]$TBRM1<1ZUJGAVUC@F.X#
M8/DSDYR/8&OH'Q/^SKX UCPUJUAIW@OPOI.H75I-!;:A'H-JS6TK(524 I@E
M20V#Z4 =DWCCPXH)/B#2P!R3]MC_ /BJ\=^(_P"W?\#/A<LJZQ\0=,GN8CAK
M33G^U3 _[B9-?,'A'_@C+X2EU)]1\=>.-1UR>5RTEOI=M'9QGZ$#C\%%?3/P
MZ_8&^!/PR6%M-\ :??748_X^M5!NG;ZA_E_\=H ^=9/^"I6N?%3Q&FD_!GX7
MW6O0+*JS:GK5TMM$B[P"V!G ([L1C/2ONZV\<Z"]O$TVN:5%,4!=!?1D*V.1
MG//-8G_"A_AI_P!$[\*?^"2V_P#B*/\ A0_PT_Z)WX4_\$EM_P#$4 <9JWP4
M^ VO_$6Y\=ZIHOA;4_%5RJK-?WMPDV_: %.QG*9  YVYKTZW\7>%[."."#6M
M(@AC&U(X[J)54>@ /%8G_"A_AI_T3OPI_P""2V_^(H_X4/\ #3_HG?A3_P $
MEM_\10!O_P#";^'?^@_I?_@9'_\ %4?\)OX=_P"@_I?_ (&1_P#Q58'_  H?
MX:?]$[\*?^"2V_\ B*/^%#_#3_HG?A3_ ,$EM_\ $4 ;_P#PF_AW_H/Z7_X&
M1_\ Q5'_  F_AW_H/Z7_ .!D?_Q58'_"A_AI_P!$[\*?^"2V_P#B*/\ A0_P
MT_Z)WX4_\$EM_P#$4 ;_ /PF_AW_ *#^E_\ @9'_ /%4?\)OX=_Z#^E_^!D?
M_P 56!_PH?X:?]$[\*?^"2V_^(H_X4/\-/\ HG?A3_P26W_Q% &__P )OX=_
MZ#^E_P#@9'_\51_PF_AW_H/Z7_X&1_\ Q58'_"A_AI_T3OPI_P""2V_^(H_X
M4/\ #3_HG?A3_P $EM_\10!O_P#";^'?^@_I?_@9'_\ %4?\)OX=_P"@_I?_
M (&1_P#Q58'_  H?X:?]$[\*?^"2V_\ B*/^%#_#3_HG?A3_ ,$EM_\ $4 ;
M_P#PF_AW_H/Z7_X&1_\ Q5'_  F_AW_H/Z7_ .!D?_Q58'_"A_AI_P!$[\*?
M^"2V_P#B*/\ A0_PT_Z)WX4_\$EM_P#$4 ;_ /PF_AW_ *#^E_\ @9'_ /%4
M?\)OX=_Z#^E_^!D?_P 56!_PH?X:?]$[\*?^"2V_^(H_X4/\-/\ HG?A3_P2
M6W_Q% &__P )OX=_Z#^E_P#@9'_\51_PF_AW_H/Z7_X&1_\ Q58'_"A_AI_T
M3OPI_P""2V_^(H_X4/\ #3_HG?A3_P $EM_\10!O_P#";^'?^@_I?_@9'_\
M%4?\)OX=_P"@_I?_ (&1_P#Q5<O>_!KX4::FZ[\#>#;5?[TVD6B#]4K@/&&L
M_LQ> 49M?A^&NF!1D^;961/Z(: /9_\ A-_#O_0?TO\ \#(__BJ/^$W\._\
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M^H7 //7- 'UCXT^,O@7X=6\D_B7Q;I&C)']X75VBL/\ @.<_I7SEXW_X*F_
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M.)1NS?W:1$CV!.3^%8/PU_:#^''Q@GN8/!OC+2M?N+=BLL%M-^\&/]EL$CW
MQ7R_X1_X).?#:*Y6^\>>(O$GQ!U MOD.HWS)$6_W5P<>Q)J]\5?^"7?P^U<0
M:O\ #"]O/A;XKLU'V:]TF5O*9ATWIG]00: /M2BOSJLOVH/VAOV-[J/3/CCX
M2E\?^"XCL3Q?HB[I43^])@<\?WP#_M5]B?!+]ICX<_M"Z0M]X)\2VNI2!=TM
M@[>7=0_[\1Y_$9'O0!ZC1110 4444 %%%>9^._VF?A3\,VE3Q+X_T'3)HB5D
MMVO%DF0CJ#&F6!_"@#TRBO%OC3^U#HGPI^#]A\0M*T?4O'FEZBT8LH]!B:0S
M!_NL3@E5]R/PKROX!?M9_&3XW?$?3[>Y^!E]X0\"2AOM&JZM*R3Q<94A6VYS
M_N_C0!]>U5U/4[31=/N+Z_NHK*RMT,DUQ.X1(U'4L3P!7RA^T!^S=\>OC'\1
M[UM$^-3^"? ,B(L6G:;;LL_3Y@S*PSSW->G?!?\ 9BT_X8_"#4O &N^(-4\>
MV&IF0WDNN2;RX<?,BXZ+0!ROB/\ X**_ 7P[KUIHZ^-8]7O[FX6V5-+@><*[
M' R< 8R>V:T/VH?C[\1OA5%H%M\-OA==_$*]U=&87"2;8+<C&%<9!R0<\D"N
MI^'W[)?P@^%[12>'/ &BV%S$0RW/V57ER.AW-DYKUL  8' H ^</V5_%7[1'
MBW6=;O?C'X;T?PSHK0I_9]E9L#<))D[MV"<KC'4UY=XM_P"":EY\4?'>KZWX
MX^,GBS5M.NKJ2>#3;>7RDCC9B5C/L <<>E?<-% 'GVA? ?P9H_PETKX;W&DI
MK?A33H4ABM-7)N2P5MP+%N2<\YKIO#?@CP]X.MDM]"T2PTB)%V*MG;)'QZ9
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M@ KRO]IG_DE/_<P:!_Z>+.O5*\K_ &F?^24_]S!H'_IXLZ /5**** "BBB@
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M\$FO 4]X-1^(OC#Q1\1-1<[IA>WK0PN?HGS?FQKZ3^''[+'PF^$R1_\ "+^
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MGYF7IU&>/4OVIM*_:/UW6-$T_P"">J^'-"T>:!_[1U#51NN(Y,\!04<;<=,
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M@ HHHH **** "BBB@ HHHH **** "BBB@#E4_P"2HS?]@:/_ -'O755RJ?\
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MQ-*QRS>6LH7D\XQCVH ],O/V@OAY:?"2]^)R>*;*^\"V<32RZQ8$W,> _ED
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MMEWS7E].L,48]2S$ 4 :M9GB3Q/I'@[1;G5]=U2ST;2K9=\U[?3K#%&/4LQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'_>D.0VSKA2>U'Q8W^ [[5=.U^5H+[7/A_::-I@>/<;F]1T5X8_[SY^;:.<
MGM7VM10!\[_'$[_@%::?'<K>7_AF;2)M:MX,220)&8V<NHY' +?0$UY2-;L_
M^$Y3XGF_0_#T^/3<#5MO^BK%]D,7GE^@C\P$;^GS=:^WJ* /'/V3[2X@^#]O
M<S+(L.H:A>W]J)$V'[/+.[Q<=AM(KC/VXO#?Q$USX0:O'X4\6:/HUM/>:3;V
MUO<:1(]RETVI6RQ2BZ$^U LA1O\ 4/PI'.>/I:O*_P!IG_DE/_<P:!_Z>+.@
M#\S?B/\ \$S_ -JKXA7#2^)_B!8>,L-N$5]KUS)']%210%'T KS7Q%_P2?\
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M3<?_ "TI?^$5^,W_ $4CP?\ ^$3<?_+.L+]ES]G#5_V==(URQU;XF>(/B/\
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M(FX_^6='_"*_&;_HI'@__P (FX_^6=>J44 >5_\ "*_&;_HI'@__ ,(FX_\
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MFX_^6=>J44 >5_\ "*_&;_HI'@__ ,(FX_\ EG1_PBOQF_Z*1X/_ /")N/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#E4_Y*C-_V!H__ $>]=57*I_R5&;_L#1_^
MCWKJJ "BBB@ HHHH **** "BBB@ HHHH **** "O*_VF?^24_P#<P:!_Z>+.
MO5*\K_:9_P"24_\ <P:!_P"GBSH ]4HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@:/_ -'O755RJ?\ )49O^P-'_P"CWKJJ "BBB@ HHHH **** "BBB@ HHHH
M**** "O*_P!IG_DE/_<P:!_Z>+.O5*\K_:9_Y)3_ -S!H'_IXLZ /5**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#E4_Y*C-_P!@:/\ ]'O755RJ
M?\E1F_[ T?\ Z/>NJH **** "BBB@ HHHH **** "BOG3]I2_P!9_P"%@^$;
M5-&\?ZIX6M[*\O\ 4QX(OI+ DJ J"6=;F#IDL$#EFVG"FO,O&GQ3NO$J>*O%
MGA3Q-X@M](\%Z-I%[HT']H7*)=&>3]Y]KC+_ +\X!7][NP<]^: /MBBO+?V@
MO&VH^$O@3KNO:6\EKJ+6\"12Q_>A,TD<98'L5#D@]B!7@.K>*_$'A/6]5^%]
MOXC\0W.FW/B/1K)-6N-3GEOX8+JU:>9%NF<RJ2R8!#9 8@8H ^T*\K_:9_Y)
M3_W,&@?^GBSJK^S7KNHZAX<\3:-J-]>:H?#GB*_T:WO;^9YIYH(92L9DD<EG
M8+@%F))QS7/?M:_%GP/X8\#C0]9\9>'])UO^V=#N?[-OM4@AN?*75;1VD\MG
M#;0BLQ;& %)Z T >_P!%>7_\-3?!?_HKW@/_ ,*:R_\ CM'_  U-\%_^BO>
M_P#PIK+_ ..T >H45Y?_ ,-3?!?_ **]X#_\*:R_^.T?\-3?!?\ Z*]X#_\
M"FLO_CM 'J%%>7_\-3?!?_HKW@/_ ,*:R_\ CM'_  U-\%_^BO> _P#PIK+_
M ..T >H45Y?_ ,-3?!?_ **]X#_\*:R_^.T?\-3?!?\ Z*]X#_\ "FLO_CM
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M*:R_^.T?\-3?!?\ Z*]X#_\ "FLO_CM 'J%%>7_\-3?!?_HKW@/_ ,*:R_\
MCM'_  U-\%_^BO> _P#PIK+_ ..T >H45Y?_ ,-3?!?_ **]X#_\*:R_^.T?
M\-3?!?\ Z*]X#_\ "FLO_CM 'J%%>7_\-3?!?_HKW@/_ ,*:R_\ CM'_  U-
M\%_^BO> _P#PIK+_ ..T >H45Y?_ ,-3?!?_ **]X#_\*:R_^.T?\-3?!?\
MZ*]X#_\ "FLO_CM 'J%%>7_\-3?!?_HKW@/_ ,*:R_\ CM'_  U-\%_^BO>
M_P#PIK+_ ..T >H45Y?_ ,-3?!?_ **]X#_\*:R_^.T?\-3?!?\ Z*]X#_\
M"FLO_CM 'J%%>7_\-3?!?_HKW@/_ ,*:R_\ CM'_  U-\%_^BO> _P#PIK+_
M ..T >H45Y?_ ,-3?!?_ **]X#_\*:R_^.T?\-3?!?\ Z*]X#_\ "FLO_CM
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M8WD)#<YC="<G)->UT4 <MXN^']GXXT;6]&U>]O)]&U2V6W-BGE(EN1R)(F5
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M2B@"/[/%_P \D_[Y%'V>+_GDG_?(J2B@"/[/%_SR3_OD4?9XO^>2?]\BI**
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MG_?(J2B@"/[/%_SR3_OD4?9XO^>2?]\BI** (_L\7_/)/^^11]GB_P">2?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!RJ?\E1F_[ T?_H]ZZJN53_DJ
M,W_8&C_]'O754 %%%% !1110 4444 %%%% !1110 4444 %>5_M,_P#)*?\
MN8- _P#3Q9UZI7E?[3/_ "2G_N8- _\ 3Q9T >J4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '*I_P E1F_[ T?_ */>NJKE4_Y*C-_V!H__ $>]
M=50 4444 %%%% !1110 4444 %%%% !1110 5Y7^TS_R2G_N8- _]/%G7JE>
M5_M,_P#)*?\ N8- _P#3Q9T >J4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\*L\>_\ 1:/$'_@FTK_Y%H_X59X]_P"BT>(/_!-I7_R+0!ZI17E?_"K/'O\
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MKRO_ (59X]_Z+1X@_P#!-I7_ ,BT?\*L\>_]%H\0?^";2O\ Y%H ]4HKRO\
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M\MO-'$% 4/%,JR(P&,JZA@>H!H WJ*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "FO*D0!=U0'^\<4ZOE7]L#PWI'B[XU_LXZ1KNEV6M:5<^)+
MQ9['4;=)X)0+*0@,C@JPR >1VH ^J$=9%RK!AZ@YIU?#<?Q"D_9N\;_'K1/!
M[Z;I'ARPGT0Z+I=S9W$UC8ZA>Y22&"WMP6._"R>2FT%CRR EASOBC]IOXO\
MC/P-]E^VVG@SQ!I'Q L?#U_)%IF#/!+L90\:7<@C(+88+,VX<;E.: /T&HKX
MWM_VN/B)??%#5-,TSPV=;T;1O$,/A^[LK#PU?O+,NU?.NQ?*S6\(!;(A8,VT
M<OR*^R* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KBOB/\&O"7Q9DT:7Q/IT]W<:-.USI]Q:ZA<V4UM(RE
M69)()$8$J2.O>NUHH \SF_9N^'%SX(OO"4_AM;C1KZ[6_NA/>7$ES-<*P99F
MN6D,Q<%5PV_(  !QQ5&#]E/X76V@:MHT?AEQ8ZK?P:I>9U*[,TEW$08Y_.,O
MF*X(!+*P+=\UZU10!YD_[-GPXD\81>*)/#:R:S')#.99+RX:*2:)=L<TD)D\
MN251QYCJ7]Z]-HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M - [5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\
MT#M5_P#"BU'_ .2*/^&8_A[_ - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0
M.U7_ ,*+4?\ Y(H_X9C^'O\ T#M5_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [
M5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\ T#M5
M_P#"BU'_ .2*/^&8_A[_ - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0.U7_
M ,*+4?\ Y(H_X9C^'O\ T#M5_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [5?\
MPHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\ T#M5_P#"
MBU'_ .2*/^&8_A[_ - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0.U7_ ,*+
M4?\ Y(H_X9C^'O\ T#M5_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [5?\ PHM1
M_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\ T#M5_P#"BU'_
M .2*/^&8_A[_ - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0.U7_ ,*+4?\
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M - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0.U7_ ,*+4?\ Y(H_X9C^'O\
MT#M5_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [5?\ PHM1_P#DBC_AF/X>_P#0
M.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\ T#M5_P#"BU'_ .2*/^&8_A[_ - [
M5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0.U7_ ,*+4?\ Y(H_X9C^'O\ T#M5
M_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [5?\ PHM1_P#DBC_AF/X>_P#0.U7_
M ,*+4?\ Y(KU2B@#RO\ X9C^'O\ T#M5_P#"BU'_ .2*/^&8_A[_ - [5?\
MPHM1_P#DBO5** /*_P#AF/X>_P#0.U7_ ,*+4?\ Y(H_X9C^'O\ T#M5_P#"
MBU'_ .2*]4HH \K_ .&8_A[_ - [5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+
M4?\ Y(KU2B@#RO\ X9C^'O\ T#M5_P#"BU'_ .2*/^&8_A[_ - [5?\ PHM1
M_P#DBO5** /*_P#AF/X>_P#0.U7_ ,*+4?\ Y(H_X9C^'O\ T#M5_P#"BU'_
M .2*]4HH \K_ .&8_A[_ - [5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\
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M .&8_A[_ - [5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\
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M - [5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\
MT#M5_P#"BU'_ .2*/^&8_A[_ - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0
M.U7_ ,*+4?\ Y(H_X9C^'O\ T#M5_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [
M5?\ PHM1_P#DBC_AF/X>_P#0.U7_ ,*+4?\ Y(KU2B@#RO\ X9C^'O\ T#M5
M_P#"BU'_ .2*/^&8_A[_ - [5?\ PHM1_P#DBO5** /*_P#AF/X>_P#0.U7_
M ,*+4?\ Y(H_X9C^'O\ T#M5_P#"BU'_ .2*]4HH \K_ .&8_A[_ - [5?\
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MX16^M[^_EU?7=2@NX;P7VK:C)<3,T6[RT9FZQJ6+!>F>:TO&WPF\%>(M8O\
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MK7_8FV'_ *77E>J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 >*_M366FWWA30AJ&M'PW)%JT,]IJUU;)<:=;SIED-ZKD+Y)
M(P2<8)'(ZUX7X:^)'_",>*;;58M2TG1] ?QE##K.O^'[F2+0M11K8A=@=V1,
M-M5L.5+;>_%?;-S:PWD+0W$23Q-]Z.10RGZ@U!_8]A]C%I]AMOLH.[R/)79G
MUVXQ0!\7> OB!XL\>Z]X4>'Q5K-Y"VG:[J,-O:WCHM[+#<.+8/C!=0 H"]"*
MXR/XIZL?&O@"#3?B+JVNMJ4=E<:S83Z@;A+6[:Z=9(]ISY9 &W9Q@#I7Z"'2
M;3R#%' EN"C1JT \MD!Z[2,%?PKBO WP+\*> -;O=8L8;Z_U6[01O>ZQ?S7T
MJH&+;4:5F*C))P,<T ?/(^+$>F>&O$_B#6_B#KEMXT0:A%=>%[*YWBVB60)&
MPA*L+7:"")2!D,3\VWC@O#/Q"U+7[J6SU'6I;[2-/\9Z'/:-<Z^=96)'M7,C
M+=LB;E+!B0!M4Y /%??)TFQ:6:4V=N99AMD<Q+N<>C''/XU&="T_[,]NEG!%
M$PVXBC"8X(R,=",G![4 >3?M9&RU[]F[Q-M:&_T^[%D,HP>.6-KR 'D<$$&O
ME]+J_P#$7BSX::#?F=H_A;XCL/#IDFS_ *1<RSN%E.?O'[+;VSAL_P#+RP]:
M^^-+T*QT?1K72K6W1;"VC6**%OF 5>@YZ]*L_8;;>S?9XMS.)"VP9+ 8#?4#
MO0!\-?"SXL_%'4]:U"^BU.*]\3/HNO3WWAN?6WO95O(<FU5;'R MELD"Q@,P
M$BOD;SS7+>&/%T3?'_X7WOA_QUJ/BV74].T1-6N+N\-TZSO]LDF@9CS&=VUC
M!QY9(^5=U?H;#IUI;W,MQ%:PQ7$O^LE2,!W^IZFHH-%T^V??#86T3;M^Y(54
M[O7@=?>@#XUB^+T.F?"K5/$6J?$;76\<7EC<C6/#EK?8739#=I$I^9&73_+W
M*F\@95F?#%<C#\ ^/[_7/$6C1:SK#76FZ1\18!9RW>MG5%AMVTTL=MXZJ98R
M^\AL8&6 )Q7W.='L";@FQMB;CB8^4O[S_>XY_&HKGP[IMU8RV;6<,<$BE2(D
M"$#!'!'0X)Y% 'GO[1GC>+PC\&=5UF&_NK:*40QQWFFW:VY D<*&^T%6$2<\
MRX.T<BOESP7X]\5^,KC2/#;>,-9LM-N/'3:<9;#7Y+V9K)K0/Y:WI57D0L"0
MX QS@\5]TVVC65II%OI:6T9L((5@2!UW*$4 *,'KP!3X=+L[?9Y5I!'L.5V1
MJ,'U'% 'YU:Y\0]6\3>!O$NE>-?'6JV,6GZ=)#H<;WK(=8D6^9&$B_\ +RZJ
MJKM.3CG'>OI/XYZCH>E1_!&Z\1W6GV>CQZK$9YM4D1+=1]F.-S/\HY]:^@)=
M&L)_+\RQMI/+)9-T*G:3U(XXI]WIUIJ$2Q75K#<Q+R$FC#J/P- 'QCXW\77F
M@+\2]>^&<T2>#K[5M*MY-2TR[%M9@E,74L-PBNL8R%5I5! ))SWJ+PQXB\8>
M,KWX>>';KQO?QZ+J7B#5;;[7H.NRW4LUK'"K1QM?>7&92C?\M%SD#[QR:^TX
M]-M(K0VJ6L"6I&# L8"'_@.,40Z=:6Z1+%:PQ+#GRU2, )GKC'3\* /S[^$/
MC^XT;2_B3XOUSQ1K4_B"7PAIQ\Q=0Q<2#S9(3,H?(7!V[I=IV99NM:?P*\<Z
MMXH_:?T+3KW59M2T[3[N^;3Q-KC:R$CDTZS9]EVR*9$+ASP, E@"<5]W_P!D
M6//^A6_*>6?W2\K_ '>G3VHM])L;1D:"SMX6084QQ*I ]L"@#Y&^.OB#6/"V
MK?M$:EH.J7&BZM%8^%D@O[0XEA+W#(2N>/NL1@]<UR/Q"\7:YX'\:^,_"\GQ
M$U(:#H.JNUK:ZMXHETR\G232K*?Y-097WF.260K;OR_G$CB(U]UR65O-YGF0
M1/YF-^Y =V.F?7':HKK1["^+&YL;:X+,'/FQ*V6 P#R.N.* /A;Q=K=[X?N/
MC+K.D^*->TKQ)J6G^$[A#=79AO$BF<)))Y/1",[3M&%+,O&<5N_$_P"*6J_#
M&[^(WA9?&VHP:G;ZSX?30[>]U!I+U[21D6=D+'>Z,1(&;D=<FOL^73K2>5Y9
M+6&21U"L[1@D@'(!/H#S39])L;JX$\UG;S3@!1+)$K, .0,D9H ^ -#U_P :
M:EH.@W4_Q%\5F?4O!.H>(+AEU-U'VJWN42$J!PBA6PRCAL<YR:Z$?%[X@ZS\
M3M/:378M+O/.TC[%97&N/!'=VTT*-*5T]8&^T;V9QY@;Y-HY6ON$:=:*% M8
M0%0H (QPIZCZ>U-.F6;7$4YM(#/$-L<IC7<@] <9% 'Q3X9USQ3?WNDWUYXQ
M\07XU_6]?T>YLI+]S MO%&YB$<8X1E(X8<US'PE\8OX9@\ 65GXZO=1M(TMH
M%TBS\1M'=V\K3.)%^R,K+>J>K $&,9Z&OT 6QMDV[;>(;6++A!P3U(]S4":'
MIT4T<J:?:I+&24=85#*3U(..* /F7]L_XD7?A>XL]*T[5]2TS43HU[?VZVVO
MG1XWD52$(98V>XD##(A& 1UZUYSJ?C[QCK,7B/Q)_P )IK=O-H6D^&[RUM+2
M\:.U>6XDA6<R1CB0.&((;C.2.:^Y;K3;2^9&N;6&X:/[AEC#%?ID<4HTZT"L
MHM8=K !AY8P0.@/TH ^)O&OBF3Q%\5K"/Q!XJO8/$=I\0K2WLO#!NB(?[/$+
M&.=;;IAMP8S8ZMMSVKU7]H,:7:?%GPQJDOBC1_"VKVFF3)&WC.T270[VWD?]
MY$'9T*7"ND3_ "L"5_O#./H)]+LY+H7+VD#7(&!,8E+@?7&:6]TVTU)%2[M8
M;I%.0L\8< _B* /@FP^,%S\/?AM<M'J4_@72;CX6ZO<:'82WLHB?4XKF<++9
M^;\[$JT3QKRRQL@Z#-7OA#\5M=UCQ-87 ^(&K:QXL_X6#-HDOAF6],D8T?R7
M=Y&M_P"ZFXN)R.&18]W\-?<UQI%C>+$L]E;SK""(Q)$K! >"!D<=!TK"\)?#
M7PYX'EU>71].2VFU6_GU*ZE8EW::8YD(8Y*J2/NC '84 ?"?A?XE:MXG^$4,
ML?CO4_&&H:SX1\1-XGT^[O#<)8>2I6V<Q_\ +NV0JC@>:'9OFQFIM'^)GB^W
M^''A"R_MF2PT.XU36(KC4)=?.BJCPJGV:$W0C? P78)QO* <]#]S^!?AMX=^
M&_AFVT#0=-CM--MXS$J/F1V4L6(9VRS<L>I-;DND6,UOY$EE;R0;M_E-$I7=
MZXQC- 'QAJ7Q*\36M]\/[O7?&LES?2Z58,^G:/K$EA<22M,5\^.UDA U#S%"
MY3"E<'@!Q7T/\-"]C\7?B=IEH@71UDL+U=I^474L<@G 'KB.(GZUZ3)I=E--
M#-):0/+#CRI&B4M'_NG''X51\-^$]-\*)?C3H61[^[>]NI9)&D>69L LS,23
MPJ@#L  * -BBBB@ HHHH \K_ &5_^3=/A[_V!X/Y5ZI7E?[*_P#R;I\/?^P/
M!_*O5* "BBB@ HHHH **** "BBB@ HHHH \KL?\ DZ36O^Q-L/\ TNO*]4K@
MO&GP3\,^//$D>OZA)KMEJZ6BV/VK0_$6H:67@5V=4<6L\8<!G8C<"1DUD?\
M#-WA;_H.>/\ _P .#KO_ ,F4 >J45Y7_ ,,W>%O^@YX__P##@Z[_ /)E'_#-
MWA;_ *#GC_\ \.#KO_R90!ZI17E?_#-WA;_H.>/_ /PX.N__ "91_P ,W>%O
M^@YX_P#_  X.N_\ R90!ZI17E?\ PS=X6_Z#GC__ ,.#KO\ \F4?\,W>%O\
MH.>/_P#PX.N__)E 'JE%>5_\,W>%O^@YX_\ _#@Z[_\ )E'_  S=X6_Z#GC_
M /\ #@Z[_P#)E 'JE%>5_P##-WA;_H.>/_\ PX.N_P#R91_PS=X6_P"@YX__
M /#@Z[_\F4 >J45Y7_PS=X6_Z#GC_P#\.#KO_P F4?\ #-WA;_H.>/\ _P .
M#KO_ ,F4 >J45Y7_ ,,W>%O^@YX__P##@Z[_ /)E'_#-WA;_ *#GC_\ \.#K
MO_R90!ZI17E?_#-WA;_H.>/_ /PX.N__ "91_P ,W>%O^@YX_P#_  X.N_\
MR90!ZI17E?\ PS=X6_Z#GC__ ,.#KO\ \F4?\,W>%O\ H.>/_P#PX.N__)E
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M "91_P ,W>%O^@YX_P#_  X.N_\ R90!ZI17E?\ PS=X6_Z#GC__ ,.#KO\
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M_P#PX.N__)E 'JE%>5_\,W>%O^@YX_\ _#@Z[_\ )E'_  S=X6_Z#GC_ /\
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MGC__ ,.#KO\ \F4?\,W>%O\ H.>/_P#PX.N__)E 'JE%>5_\,W>%O^@YX_\
M_#@Z[_\ )E'_  S=X6_Z#GC_ /\ #@Z[_P#)E 'JE%>5_P##-WA;_H.>/_\
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M '[*_P#R;I\/?^P/!_*O5*QO!WA'2O 7A;2_#NB6[VND:9;I:VL,DSS,D:C
2!=RS,?=B2>YK9H **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>mmsi-20221231xex10d61g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231xex10d61g001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1/ U8# 2(  A$! Q$!_\0
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MM% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4
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M #FC/^<T9]Q1GW% !G_.:,_YS1GW%&?<4 &?\YHS_G-&?<49]Q0 9_SFC/\
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MOA/\1K7QU>0^(?$6MI9ZA>S6MHT?DR"XR=AAVJ$^SJ01C[S9)XQ[!<?L=_\
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M+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M%
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M[BNXO/@1KUCXV^#NHZ9<Z?>6/@R:]N=2N;^X>.ZU">\@>*XG"K$R[BTCRG)
M9F*_*.:N_#GX8>,/A[<_$1?LWA_6;/Q7XCNM>5)[V:/R!-%%'Y3KY#!\"$'.
M1]XCMF@#BOB9XT\=_!#XE66N0:A>^+/!NG:);S>*M,*;Y%1Y'B>_MD +*4*!
MWC!*E"V ,;AW5E++\1_'VOKH7BZ_AT6YT/0]5LI[*??&$FNKLS&,'@>;%:HF
M?X=S$ &NB\,>"_$EGXP@U37+S3]4CDT&'3;V9 R/)<+(\CNL>W:(R9" "V<
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M=>$_'GC/P]XNTY+?P_ID6JZ'<Z9#!'>2RB:>=0GGS2?9U91$@;:JAMV\@E<
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M&?@7\>?$?B;P:?"/Q"N?[,\=S>'X]=TK4[;$:ZO920B198^,>=$3MD0 <C<
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MRZO!9II+^9>61W9N(@2 %!4@^84.2  20*T=4_:2\'V&AZ5J=E--JZ:EI/\
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M&ULKMR-IR!@UY1\%+^P\/>)_C=KFH*G]EV/C:XATUPF^7SI+6T^T1PCJ6DF
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M\5K\.M>\0W,_B_PEK%[+K]X(8$%_IX4-8DJL6U!,MS 1MP?]'F&<T ?2=(6
M->4?&[Q+J%EJW@G0=+U:[L[S6;Z</I^F!%O;Z**W=F6.63Y(41C&[N>=J[5R
MS 'PWP'\5OB#X^T_X#07'BZZL)O%=WXAT_5[BVM;8NZV9N?*D7,>%DVP@9 V
MY.=AQB@#[)8[1DUS7@/XBZ'\2;+4[O09YIX=-U&XTFZ\^WD@:.YA;;*A5P#P
M3C.*^</ 'Q?\2:MJO@CX?:WXDN3+?>)?%&D3:^$2*ZO8=*G:.&#(7:LD@8,6
M4!BL# '+;J[S]D6UGL-$^)=I=:E+K$UOX\U:(WT^WS)L&/!?: N[& < #(/
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M)E/_ !]V+S2J]N\?\0((#  LAQCY"U?:?QLM8;GX-^.%EACG']AWI"R*&&1
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MO=6]O)+*0L[EF>5FWY>1F=R78EB68YR35/\ X9R^'+Z"FC_\(O;#35O/[0$
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M1[6TUW5PHOKZ),23[0 ,_@JYQUVKG.!1;?#CPQ9V.C64.@V,=IHUR;S3H4A
M2UF(<&1!V;$LG/\ M&N T#QCXVU.W\4ZG#K>@ZSX<@L;G^S-3M=+EA,=];3S
M0W$4J&X;S$#1<,I7//;!/SI;_MO?$*R_9/T7XVWL/ANY$NL&PN?#ZVDT#3Q"
M5H_W,IG;$F%W<HPP"<<<@'UOKGP2\">)?&5KXLU3PKIE_P"(K8((]0FA!D^4
MY3=V;:0"-P."!C&!1+\$O MQX^'C:3PKII\5#:?[4,(\TLHPK'L6 X#$9  Y
MX%>0?%O]H/QCX3^._P '_!NAQZ6FE^.5:2X_M"TD:>U5 &?:RR@$E2< KP1W
MK*_:$^.GQ3^"!\)2R3>&Y1XH\7/HEM;-IDS&ULWF86\C.+D;Y#&%9N%&6Q@8
MY /<K;X'>!K6P-D/#EI):G4_[9\N<O*!?=?M(W,2)<\[QSGGK71>)_!^C>-+
M&.SUS3XM1MHY4GCCESA)$.4<8/#*<$$<@@$8-9W@;_A+(UUR+Q7-IUT8]0(T
MRYTV!H!+:&&(@R(TCX<2F93S@A5.!FO /!7[47BB+]JN;X8>+K?2QH&JB]3P
M_J=I;R0RRS6\C!XI=TC*3B.7IC.$_O8 !]$Z[X!\/^([#6K._P!,AF@UJ-8=
M2"9C:[C4;0DC*0S+MRN"<8)'0D5S&E_L\_#_ $30M.T73_#R66E:;??VE9VD
M%S.D=O<_\]4 ?AO\3ZG/BG@S]J#QCXY_:ZN?AW:QZ-9^"WTR?4["Y-M)+>7$
M44A@W%_-"!7D1W4A3^[*=R<4/A3^T;\2/B7XG^)^A2:WX4T:\\+^)9/#.F--
MHEQ(M_<!IU4MBZ!3/D$G .!D]J /IC6?ACX9\06'B"SOM(@EM_$)5M65"T9O
M=L:Q 2LI!8>6BI@G&!C')JQX&\!Z%\-?#EOH'AJP72M'MV9H;.-W9(MQR0H8
MG:"23@<9)/<U\\_&K]HCXB?"S4?@-I4FGZ+:ZGX^O+/2=8CN+>24Z==NT"S&
M/;, R@S. "3C8/F;=QM> /VC=>OOCYXJ^"OBRVTZR\5V%BNH:3K=C$_V34(6
M16),#.61UW9*^80=K\C:"P!WGPQ^#\?PPU;QAIVGB"X\'^(+^765LYOOVMS,
M +B$+C:T+8WCG*EF7!&"-'P;\!_ _@"ZCE\/Z&NFQ12M/#:)<S-:V\C9W/%;
MLYBC8Y/**#R?6OG;X0?MOW][^ROXD^,GCV"PV6-^]A9:9I,#PM-( @1"SR/D
MLTG) &U5)P:]5\/>(_C-K7PDMO&+1>&_[;O;)=2A\+I83[HXW4.L!G,_S3!3
M_<"EOEX'ST >A_$3X1^$?BQ;6=OXMT6'7+>SD\Z"*X=PD<G9PJL!N'KU&3ZU
MB_&'X0K\6?!-MX(GN#;^%KF:#^ULRN]Q<6T+I((%8\_O&10[EL[=W!+9'._M
M5_M#C]G'X=6GB%+ ZI=S:A;PFV"LVRW\U/M$K;>@5#M#'C?)&#G."?M0_&K5
M/A/^SKJWQ)\(3Z?>O:1VEQ +R%IH+F*>:*)2-KH1Q,&!R>F,<Y ![1';QPPI
M#&BQQ(H5$1<*H'  '85\Z_$K]D.SUSQEHOB+PCJ%KH$=G>?;;SPS?61N]#OY
M?F_?/:!T59OF_P!8.> >O->R?"K6M3\2_#/POK.M26\NJZEIMO>W)LXC%"'E
MC#E44LQ"C=@9))QFO,/VK?V@9/@)8^#':0:9I^NZPMA?:Y+:M<QZ= %+.XC4
MC<YQ@=0 &.UL;2 =_P"(O@_X6^(3Z->>,- T[6]7TR,?9[EX6"V\F59FARQ*
M'<H((.[@<U8U;X->"==\2+XAU#PQI=YKPM6LO[4EMU:Y,#(R-&9/O$%'93D]
M&(KSB'QC\1O$7@?Q5JW@G7/#7BWRK.&Z\-ZC';[[?46'G&:"4),-LN51=P(4
M$J2H^8#F/@U^TWKGQL^!OAC5-'DTZ#XAZGJITF[L9+)V@LY(VWW#O'YH942#
M#@E^6>-/O.!0![5H_P %?!'A_4+"[T_PW96C:?(TME!&I%O:2,,-)##GRXW(
M)RRJ#R>>371>)/#.G^+M%O-)U6 W6G7D9AN(/,9!*A&&5BI!*D<$=""0:^:I
M?VI;FY^/WC'X:WGB;1O!6K:(MM'H]OK=FPBUN22%7=FE+@(I9E540[L$GY\8
M&W\1OB-\8O!'PEUSQO>1>&](_L7PQ:ZC-ITUE)<O-J'E[[N/<MPH2-3A5X8G
MKD@<@'KWA[X2>%O"?@N3PEH^EC3?#CAQ_9]O<2JBAR6<+\^5#$DD*0"6.>IJ
MQX!^&?AOX7:-_9'A?3$T?2O,:5;.&1VC1CRQ568A<GDXQD\UXKX)^*_Q0\1?
M!JU^(5Q)X=?3+[P?<ZX@ATZ5&M+U!&\4+*;DF6-T,W(VD%!GJ <;X)_'KXF?
M&'X1^#_%UE<>&FUK6VFNV\.KI4ZL;*WU#[+<,LYN2 P1E9=R\G@ \D 'N/C'
MX(^#/'GBK2_$NLZ/Y^OZ9&8;34K>ZFMIXHSNRF^)U)4[F^4Y'S'CDUHZC\+_
M  MK&G:;IU[HEI<Z7IP MM.D3-HF,;3Y.=C$8&"5)'.,9-?/WQ1_:G\4?![]
MI'PSX3UJQTN;X?ZW?1V!U=(I([BSFE0>6DC%RF-SH=Q RH?@;<TSXW_M1^+/
M"/[0_@#P#X8MM)71=>U+^R+S4[^"2>1+I1!)*D:K(@PL5S <G.6<CC8: /9_
MBC\%M(^*FN>"=0U.W@$GA?58]6M;CRLSH\;*ZI&^?D5GCC+\'<$ XZC<\?\
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M#Y$^)'P+^(/Q/O?B3X^ETZ'2]?O;'2]-\.^'9KX"1K.QU!;UUN)8B522=D(
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M\O'W=10!\5_M!>"OB?\ %;QK^SGXH;P5>^9X;UMM8UVQM)8MMC$;JU>-/FD
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M'RY3>@52OF  MM)-3]E?X'76F_!CX9VWC&;66N_#$9E@T'5HXDCL[L"2/?\
M*NYU59'\L,Q"AP<95=O<>&OV:?#OA>WTC2[?4-1G\*:+J7]K:7X=N'C:UL[@
M,70JVSS"D;LSHA8A6(Z[5P <?HWQK^)FJ:3X\U@Z+X3M],\+W^HZ41-J4D!>
M:!HMDS22 (L01Y"VX@G:,8S7'^._VB?&6I_#[XOV.F:C866L>%WTK[/JD6F7
M-HT]K>%5)$$S[XSD2!90Q!'*X/(]?O?V:-"U'P-XS\+7&N:[-8^*-6.MW$SS
M0B:VN_/2</"RQ# $D49VMN&% Z9SG:A^ROI.K1>,1J/BKQ)J$OBNPMK34I9K
MB'+2P,&BN$"Q (ZX   "8S\ISP 9?C7XLGX6_$_Q)=>(M*T:[71/ ;Z[)K%A
M:-%?3K'<$-; LS;8BW*KN8;CDFK,7QB\9:+XX\!>']=MM%NAX[TNZETR:Q26
M-;*_A@^T&&;<[&2(QYQ(H4Y0_*-PQUC? /2;[Q*VM:QK.L:_+/X?D\-7MKJ+
MP-!>VDC%I/-"Q*VYF).590 <  <4>'/@'I7AP:$?[<UK4IO#UA+IVA3W[V\C
MZ5'(BQEHB(1O<(BJ'E\PX!'\3;@#S#X2_M(^-_%>H?!N?Q'I6A6^D_$:RO)(
M8M-,QGM)8+<SJ[,[;2CHK#:!E21\S<UV_P 4M;_X2#XV_#CX>S!9-(OH+[7=
M2@<96X6U$2P1,.Z^;,)"/6%<\$@S^'/V9]"\,)\-TM==UV1/ (F32%F>V.4E
MC,3I+B %AY;%!C!QSG/-;/Q,\%7MYXK\'>-M'C-SJWAF2Y1[$,%-[9W$82>)
M22 '#)#(NX@$Q;25W;E .>N/@1K_ -NN9K7QY-#!_P )4OB6UAETR"4PH5D$
MUJS'F16\T[7;YHPD87[@KE_'_A+1M"_:3^ 6E6>DPQ6(M/$2D!-R<6\!P^0=
MS,23N8YX;KDFOHW>2@8*>1G!X->&^*?#WB3Q=\2O"GC"?PKK]G<>&C<+96UK
MJ]@()%F0+*9496+%E 7AQM'*D'.0#.U_XC:UX/UGQ#X'^%GA2WO9O"UK!=2:
M<828IY;DR3+;HWF*(%VJY#D,H+JH4!><?Q?^T=X_TN[^*?\ 9OAG0[:'P)HM
MEKUU#J5U*9VBEMY)Y(,(-N\+#(-P; *CAMV5N>-/A?XD\6?$&#QE8Z#XE\(Z
MQ+:KI^I/H/B&TB74+922JRJRL"R[W"NNU@#PPXVFK?!>YU"Y^( M_#GB73K+
MQEHL&B7T,&H::0D$,1BC6(-DIB-Y5)+-GS"< A2 ";XM?M(:]X#^T:A9V.F2
M:?;VVG7<5DZ2W-U=1W$BK*SF)L6BH& 5Y5(D8$#I5;QO^T1X\\.7WQ5GL] T
M.XT?P#?V:3N\TS3WEO-!!.ZHHP%=8YPVXY7(V[3RPQ?$_P"SKJ.O1ZZL=EXU
MACUZQLK74K9-7TR*.>6UC6.&X+ $AE"+E%"HQ&2M:NN_!'4=?LOB!I]SI/BY
M[+QU#;QZQ+_:FFK,C01+"KQ #;\\<<:N#V'% &FFE:K\8?B/\;O GBB[TW4/
M#,-OIMM:V36;D0B6(S*Y!DPS*V23_$50_*%VUU5S^SGX?EN_$UW&JQ7NM:;:
M6!O%4_:$DMD*P7+2$DM,A"%7&-NP=\DP> O!>I6/Q9U+Q;-I_B739-;LH(-1
MM[RYT][1Y8(RD<S+$S2!RI(PAV9.2.!CT7QM?:Q9>'+O^P+476M3(8;,2$"*
M.5AA9)2>D:GYFQDD# !) (!R7[-GQ+NOC!\"/!/B^_C$.HZIIT<EVJC"F=<I
M(P'8%U8@>A%8/Q^^+OB/X:FX_L:'2RL&AWFJQK=P2WD]Y/#@B!((762--N2T
MY#(N5!&34GPX^"5]\+]1\ Z;H>N:C'X9\-Z"=+N[)YD%I?2<GSO)"DB8R?.7
M+  ?* =S$:7Q'^ &F_$?Q;-KT^NZYI$EWHKZ!?VVEW"1QWEFS,^QMR,R$,['
M<A5N<$XH X/QO^TGJVA'PO(#I/ABRU[0+35+&_UVUFDL;J\E+%[(W2NB6[J@
MC(:0$/YHZ;3GH_VT;:&Y_96^)OGQI.$T2>51(H8!U&Y6 /<$ @]B*EG_ &9-
M,U'PA'X5O_%7B'4/#TFE6VCWNGW$L#1W<$#,4)_<YC<AMA:,J2JK_$ U=Y\4
M/AS9?%CP)J_A+5+R\L],U6'[/<R6#HLK1DC<H+JP .,'C./2@#R[QS\:O&4W
MC'QEH'@#P_#K>H>%$M%N+6>+/VR>:,3>6)?-00CRF3#E7RS'@;>8=1^/>N6?
MQAMO"5\NG>&?M-[9QV5EK-K(&U.WDBC:9K>[#^49DD:1/)P2?+R"=P%='XB_
M9NTGQ!XP3Q/'XE\3:-K$]G%8ZK/I%^MJ-8BC&%-RJQXWX)&^,(P#$*1@8O7G
MP$TJ_P!6M9I]6U672+;5+?68-#=XC:P74&SR6C/E^:BJ8PVP/@G.>"00#R^Q
M_:RO=*'B^Y\2PV.FW?AW3-1O[KPG-;2VNI1^3*JV[)+(Q2XAD3>QEC4!3MX/
M2MG6_CGX_P#A_INO:MXD\+17>AQZ=:S6&HP1K:C[?/=1VR6;1F>4NN9D?S05
M& P('!KJ3^S5X?U)8(?$6H:IXKL;6PN],M+;5WB;R+>Y39,GF1QI(^4^4%F)
M4=.>:K:/^RKX6M/!.H>%-6U;Q#XJT6ZL#ID4.NZCYQL[?<KA(=JKM(:.,ACE
MAY:8. !0!N_#/Q5XZU+Q)KNG^*]$CM]*@B@ET[5XHA;&Y+ ^;$T'G2E2A PV
M[!#= 1SZ4#D=:\KT;]GVTT?PKJ&C'QIXROKBZABMTUJ[U8-?VL4;A@D,@0!
M2/F.TEAPQ.!CU0<"@ _&C\:.:.: #\:/QHYHYH /QH_&CFCF@ _&C\:.:.:
M#\:/QHYHYH /QH_&CFCF@ _&C\:.:.: #\:/QHYHYH /QH_&CFCF@ _&C\:.
M:.: #\:/QHYHYH /QH_&CFCF@ _&C\:.:.: #\:/QHYHYH /QH_&CFCF@ _&
MC\:.:.: #\:/QHYHYH /QH_&CFCF@ _&C\:.:.: #\:/QHYHYH /QH_&CFCF
M@ _&C\:.:.: #\:/QHYHYH /QH_&CFCF@ _&C\:.:.: #\:/QHYHYH /QH_&
MCFCF@ _&C\:.:.: #\:/QHYHYH /QH_&CFCF@ _&C\:.:.: #\:/QHYHYH /
MQH_&CFCF@ _&BCFB@ S_ )S1G_.:,^XHS[B@ S_G-&?\YHS[BC/N* #/^<T9
M_P YHS[BC/N* #/^<T9_SFC/N*,^XH ,_P"<T9_SFC/N*,^XH ,_YS1G_.:,
M^XHS[B@ S_G-&?\ .:,^XHS[B@ S_G-&?\YHS[BC/N* #/\ G-&?\YHS[BC/
MN* #/^<T9_SFC/N*,^XH ,_YS1G_ #FC/N*,^XH ,_YS1G_.:,^XHS[B@ S_
M )S1G_.:,^XHS[B@ S_G-&?\YHS[BC/N* #/^<T9_P YHS[BC/N* #/^<T9_
MSFC/N*,^XH ,_P"<T9_SFC/N*,^XH ,_YS1G_.:,^XHS[B@ S_G-&?\ .:,^
MXHS[B@ S_G-&?\YHS[BC/N* #/\ G-&?\YHS[BC/N* #/^<T9_SFC/N*HZMK
MVFZ#"LVIZA:Z?$S;5DNIEB4GT!8CF@"]G_.:,_YS67!XITBYU4Z9%JEE)J04
MN;-+A#-M !)V9SCYEYQW'K5JPU:RU7S_ +%>6]WY$ABE\B57\MQU5L'@CT-
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MA#31?=S"VR,2;#M&8\@*"%/LFH>%+JZ^"A\*1>'E47&E'2)=)753$8H&C,1
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M*H YSDL30!YSK7VRU_;FU?\ LO1K35YI?AW9RRV]Q.(<M_:-RH?)1LG"JOT
M]*]Q^&.GFR\%:>\VE1:'J-[$M_J&G0,2EO>3 2SJ.3C]X[=.YSWKR3Q!\/\
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M5KW5X-3M],?3)--GU%9[9QYJL)W5%56FP@ < ':Q&.: .U_.C\Z,^XHS[B@
M_.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\
MZ,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^X
MHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B
M@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.
MC\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.C\Z,^XHS[B@ _.BC/N
M** %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3
MCUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUJGJFM:?H=N)]2OK>P@+!!+=3+&
MI;D@98@9X/'M0!=HK*@\4Z/<ZFFG1ZK927[J'6U6Y0RLI7<"%SG&WGZ<U!=^
M./#UBTZW&NZ9 8)/)E$EY&OER<_(V6X;Y6X//!]* -RBL>]\7:+ILELEWJUC
M:O= - L]RB&8'H4!/S=1T]:KO\0/#$,LD4OB/28I8V*/&]]$&5AU!!;@T =!
M16'?^./#NF-$EWKVFVKRQK+&L]Y&A=#T89/(/8]*MR>(=+@TM=2FU"UBTY@K
M+=O.HA(/W2')QSGCF@#1HK&T[QAH>K7:6MEK.GW=PX)6&"Z1W; R< ')XK3E
MNX()H8I)D268D1HS@%R!D@#O@ F@":BL[7/$&F>&K'[;JVHVFF6FX)]HO9UA
MCW'H-S$#)]*FT[5+/5[87%E=0W<!QB2"0.IR PY!QR"#]"* +=%(S*@R3@?6
MLK3?%6CZU/-#IVJV5_+#_K([6Y21D_W@I./QH UJ*Q#XV\."\^R'7]+%WYGE
M>0;V/S-^<;=N[.<\8J]JVLZ?H-C+>ZG>V^GV<0S)<W4RQ1H/=F( H NT51TK
M6K#7+<7&GWMO?6YQ^]MI5D3D CE21T(/T(I;O5[*QO;.SN+N"&ZO69+:&24*
M\Q52S!%)RQ"@DXZ $T 7:*IWVL6&F3V<-W>06TUY+Y-O'-*J-,^"=J GYC@$
MX'8&K?&>M "T5A:=XY\.:OKESHUCK^FWNKVI(GL+>\C>>$CJ&0-N&/<58'BK
M1?\ A(/["_M:R_MK9YO]G?:$^T;,9W>7G=C'?% &K136(522< <]:YV#XC>%
MKK5;;3(?$>DRZE<KO@LTOHC-*N"<H@;+# )R!V- '245SU[\0/#6FW]Y8W?B
M#2K6]LH3<W5M/>QI)!$ "9'4ME5P0=QP,$51C^+O@>6=84\8Z \S,J"-=4@+
M%F^Z,;^IR,#OF@#KZ*J:=J=KJ]JMS9W$5U;L2%EAD#J2"00"..""/J*??ZA:
M:5:27=[=0V=K&,O/<2!$09QRQ.!R10!8HKG])\?>&->N8;?3?$>E:C/.NZ**
MUO8Y&D'/*A6.1\K=/0^E7;WQ+I6G:I;:;<ZE9V^HW2EH+26X5990" 2B$Y;D
M@<#O0!IT5@ZEXZ\.Z-JJ:9?:]IMKJ3@%;.>[C24@]"$+9Y[<5LVUQ%=V\<\,
MJ30RJ'22-@RLI&001U!'>@"6BDX]:.* %HK*/BK1!K0T<ZQ8#5V.T:>;I/M!
M.S?CR\[ON?-TZ<]*=%XGT:?7)M%CU:QDUF%!)+IRW*&XC4@$,T>=P&"#DCN*
M -.BDX]:S;;Q+I%YX@O-#@U2TFUBSB2>YL(YU:>&-\[&= <J&P<$CF@#3HI.
M/6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6FRRQP1/+*ZQQHI9G=L!0.I)["@
M!]%4=$US3O$NCV>JZ3?6^IZ9>1+/;7EI*)(IHV&596!P01W%7>/6@!:*3BJL
M^KV-K=?9IKR"*X\OS?)>50^S<%W8)SC) SZG% %NBJXO()&E2.="\) E4,"4
M) (!';@@\]C6;HOC3P_XCGE@TK7-.U2>(9DCL[N.5D&<<A22* -JBJNJ:I9Z
M)IEWJ.H74-C86D+W%Q=7$@2.&-%+.[,> H ))/0"GV=Y;ZC9P7=K/'<VL\:R
MQ31.&21&&592.""""#0!/16;<^)=(LM>LM$N-3M(=8OHI)[6PDF43SQQX\QD
M3.6"[ER0.,BM'CUH 6BHYIHK:&26618HHU+.[MA5 Y))/053T'Q!I?BG2;?5
M-&U&VU73+@$PWEG,LL4@!*DJZD@C((X]* -"BL70O&WAWQ3<3P:-KNFZM-
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M6G89RVP9(5<EFV@X!++0;X/>&KCX.)\,9K623PHND)HGD"4K(;=8A&/G'.[
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M3M_$,.I>&X-*L1]ENK>-819-'>+$3%Y"Q[6W2*J@-URPJ7X=V&EZUXNB\/\
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MV.  .I)KSOX>_%N/QAXC^(5C<Q6-E9>%M0AM4U""\$L-Q#):Q7"REBJA?EE
M(Y ((R<9/-?M/ZG>V'@_PCJ2Z9=ZOX:MO$=E<>(K*VMFFD;3@)"6,0!9U2;[
M.[(!DA#D8S7A=]K.D6.H_%:ZT_PS>MH&I^-?#]]:W,^C7D=G;H;6V)OGB"HT
MT:SPN2@.&+*3\K D ^O=;^(?ASP]#I$M]K%G%%J]TMG8/YRE;B5LD*AS@\*3
MQZ5LG5;(7R61O(!>.GFK;^8/,*?W@N<X]Z^"8[:!O#VGB_TK4[RRT?XPIJ=X
MU[H$T 6PN()<2B'R@-C.02B@D;EW 9&>T\-6FF:Y\5;[1_%]OXLA\9Z?X\DU
MK2([73%2&XM&FS;2_:Q!GR5MB%DC:4'$93&=HH ^A/BE\6#X"UGP=I]G#8:C
M)K.O6ND7<4EYLGM4F#E95C );E.Y'X]O0-0U*TTJTDNKVZAL[6, O/<2!$7G
M'+$X')%?#.EZE#<>$_A99ZYX8U9?B7H?Q @N/$,D>C7,TJRM+-YUSYRQD/%(
MOEE2"1M" <)Q[_\ M1ZY#HFE^")KK2)KVW_X2*%VU);.>\ATIEAFVW$EO#\T
MO)"JK?*&=6/*J" >N2^)M(ATI-3DU6RCTV3&R\:X00MG@8?.#^=7K>ZBNX5F
M@E2:)AE9(V#*?H17POX(TJZE\!7.G/J&M^$-3T+Q]K-_HU]JGAQS81QR>:46
M[@,:H(Y8YY<%=NQG !4E0??_  !#XJUK]DZ:VTO18?!OB^?0;VWTVQMMT<-M
M<;94MY(Q)\R(Q\N15;E58 ]* /7[+7],U&ZNK:TU&TNKBU.)X89E=X3S]\ Y
M7H>OI7F'@;XOZK\1_%]X/#UMH]WX9T_5[O2+YVO_ /38_(#+]I5 ""C2J4"G
M!(PX)!P/'? >F'Q'J?[/DWAW1[SP]KWAFTFM_%4,UI);M:VPM#'-;W!*@.7N
M5C9 V2V#(O&6KT']D:Q:PL/B0LVG7.G27'C?5[VW6ZLGMFDM);@M ZAU4E"N
M<?C0!VGCCXJWWA/XJ>!O!T.D6MY'XG2\D%_+J'DFU%JBR29B\MBX*NH!!'/7
M'!/>QZU92) PO+<B<E8B)5/F$=0O//X5X3K>I)\2_P!IKP))INE:BG_"%OK=
MOJTM[9O"B)+;P)&R.1ATD9EVX/S!'./D./$] <:-X2\ ^$+CPWK/]K^&OBE<
M7,\<>BS;+"TDOKN5)%D5"K(R3*04)X)XVKF@#[B_MS3OM,-O_:%KY\S,D47G
M+N=E&6"C.20.H'2E_MFP_M+^SOMUM_:&S?\ 9/-7S=OKLSG'OBOA32/!FDV/
MAF\UBR\-R)JUC\:4N;.ZL=,E>XATP:BDC%-B%E@^S>:2!\A&>]=5X!TFWU?Q
M\^B>,K'QA_PL#2O&<^K6RP6BK931&Z=XKQ;I8<>1]F<(T;R=%V!0=@ !]%?&
M#XMI\+X_"MM'9I>:GXEUF'1+$7$Q@MTED5VW2R!6VC:C8 !+-@#N1:^$/Q*;
MXFZ%JES-8#3;[2M6N]%O(HIQ/"T]O)L=HI, LA/JH(.01D5Y[^USH'_"8>$O
M"OA_4M*EN_".I:[ FO:C;QEY]-MU5W2:,@$QDRK$IDP=JLV<9R,/]GCQO+\'
MOA9IFA>,6NSIB^*)O#7AG518.IOK(OBUN9PJXC#MO7S&P&PKY.[<0#W;XA>*
M9O!'@?7/$%OIS:M)IEI)=_8DF6(RJBEF&]N!@ GOTX!/%<-??'Z"S^%/PZ\4
MKIF[5/'+:;:Z7ICS[8UN;R'SE224*=J(@D)8*2=F ,D"NJ^,B22_"3QI%%%+
M/-)HUY''%#&9'=V@<*JJH)))(  &3FO)](^'FC>,/V4/A=:^)[C4_#5YX>TS
M2+ZVO;>,QWVFZC;0(@*QNC9<$R1E&1MP8C!S0!K7O[34/AZ;Q!HNN:0MOXPT
MO6M-T2+3+:Y+0WTFH,!92QS,@VHW[S<2N5,,@PV!NVM.^,NJ7VI^,/#(\."?
MQQX?6T?^S+:\S;7<5R#Y,Z3NBE8P4D#DIE3&<!LKN\F\,_L_2^,M(^(OB_XE
MZGJVF7&OZE87FDW<YB@U#2XM/+_8;C"($CF+RNWE[3@,%;+$UN?"G2[KP1XB
M\?\ Q:\>7^K1VVN-9:3IW]I6>V[CL824266&WC7RS++*[[2@*+MW8.Z@#UGX
M2_$;4/B!!XBM]8T%O#NM:!JC:7>6JW(N86;R8IEDBF"J'5DF0X(!!R"/6[JW
MQ"M;;QHOANV\N6ZM;/\ M/5)I91'%86A+JCL<'+.T;A5X&(Y&)& &X/]G/P]
M>^'_ !!\23::EJFI^"KO5X[K1)=6E>60R/"&NS')(-[Q&5L*Q)!(;!/4U/AI
M9O;?M,?':UU0(XU.'0[NT@E /F6?V22$X!'*^=%.".<$\_>H W)?CY8W_B'X
M<+H1L=6\,^++N]M7U=;K!MS!:3W (0+@@^0026!&1QSQZ8^OZ9'I:ZDVHVBZ
M<P#"\,RB$@G ._..3QUKXA^'.C:+J?@C]FKPUK/A^6 :=K%U:>(-.O-+DB'V
MM-/GBS*"F)%:=X%+'*MNP3PP%;2);CPO'H%R]MKEA\/-'\:>*;2X;1=-$W]G
M+/="33IE@DADS!Y;2KN1?E\[&><$ ^Y-2UVVT[P_=ZP"UW:6]L]U_HH\QI$5
M2WR8^\2!QZUYCX6_::\*^);OPW$NHV,4.LZ--K$=R)W,;+"S+,D9* -Y?ER;
MV;;C"X!SQN_ ?0M)\.?#;3[+0;+5+#1!)-)90:QN6X$3RLP8HP#1JQ)94(!5
M2!@=!L?$;P-!XW^'?B7PU&4LFU72KO38[A5 ,'G0M'N7'3&[/'I0!PFE?'37
M_$_P[D^(6A>$%O?"'DO>6T,M\8M3O+5-VZ:.'RR@W!=R(TF67&2I(%>@^%_B
M1X;\8>$])\2Z;K%K)H^J6:W]K<22"/="0/F(;!&"P!!Z'@X->*_"'XF3?#[]
MGC1?#.MZ#?Q>.O#>CQZ+_P (W]BDDEO9[>+RHO*P"LD<@13YH;8 Q+,H!QYC
MX&_9XTGPSJG[/_@7QOH=OKDMEX3U>SUB1K-Y+=999+>6&&24#;A6-T$W$?,"
MP +"@#ZY\-:[JM[<^(O[9MM.L+2QOVALY+6]\YGMQ&C>9,"H$3Y9CLR<#;SW
M)XD\0W/_  AFIZKX76PUR_BMWDLXI;P16\\@'"M,H8*#C&<'%?)/B\Q>'/AY
M\=U$%SI49^)-AJD%LVFS"VU"&3^S5*NJIEX)I89T=DW'[W#9"M!JS^"_%_PT
M_:2UB%]/;Q#XBT,S1:%:V-RLEN4M?)MV0RPQ-(TERJ,=B;0PCSDG) /M"+5X
M(;**2^N+:VG$2R2KYH*IGK@G&1GC.!3[S6[#3FMUNKVWMFN&V0B:54,C>BY/
M)^E?(6N^&?!OBSXMK<ZQI-GJEK_PK!09+FT9HFN YV@Y7:91'G&?G QC'%>8
MZGJEQX@^"]EHE[H^I+K:_"F.RBNVTF>]ENYX_/C%M"FPI RO&K2RD;SA,;=@
M8@'VQ;?$6^/QTN/ DVF0)9+X?76H=12X+.Y\_P EHVC*C;@\YW'/\JWQ"^+-
M_P"#/B;\/_!]KHMM?GQ=-<PQ7LU\T/V8V\+3RYC$3;LQJ=OS#+<' YKS;X9^
M([?7?VB?#6H(+Q8KOX;PQJ]W:2PDR?:PQ5BZC#X!;:>2.>G-6OCWJEKI_P"T
MC\!+VX=TM--N]7EO)A$[);I-820Q,[ $*&D(4$X[^AH ^A9[B.UA>::5(HD!
M9G<X50.I)/052/B/2UTW^T3J5I_9_P#S]^>OE=<??SCKQUKYU_:-^(-QXP\'
M";P[::S?^'O#VN:;=Z[/I5H6FGM<RF58(Y8R)C"1;RL-K*0<=CCB]1N?"VDZ
M=H>K:%IGB&\T+5O&":G-XAUC2;EX[.[%C(AG2PABC9MQ(C!9-GFON(;8!0!]
M?7'B/2K2PAOIM3LXK*8J(KEYU$<F>1M8G!SVQ27/B/2[..T>?4;2!+LA;9I)
ME43$XP$)/S9R.GK7PQX&TZ=/AUH%A]OO/#/B'1M?\126 \2Z [Z5/&TIS;74
M91?+$D<PVM'@#]XHY^4VX'MYKB'2?B?X2\2Z)X9\2>$=*L=&TW1]/>]BMS%"
MZS6!)B>6"7S&C=<E22$)8% : /H/XA?'#Q;X0U#QU!I_@6#6(?#]O8WEI*-:
MCA-]%,<3!E*GRI%(<(AR9-HQU />^'_'JZAXSUGPKJ%LMAK-C&E[ BRB1;NR
MD9ECG0X!!#(R.N/E8#DAE)VO#M@EIX=TRW>&5#';1*R74@EE!55'SOSN88&6
M[D9KQ'XB:K_87[4^AZZ%N9+#0/ NJWFJ)91/-*T37-OY2"- 2[,T4A5>_EMZ
M4 ?0#,%')JG#KEA<P230WMO-#&-SR1R*RH,9R2#@<5Y]\1?&]EXE_9R\1^*-
M(T[4-=L+[P[<74%A:E[>[G1X&_=@CYXWYQP-RD' )&*^6=-MM+NM>\?6S7.L
MZ=H>N>%=$5=2T?PU/;VT,T-Z\:M'$Z_O8H0\(?>2602CD#  /NNPU2TU2V%Q
M97,-W >DL#AU/T(.*JMXHTA9[F%M4LUFME+SQ&=-T2C&2PSE0-PY/J/6O+?V
M:+G5Y?#_ (I35],TR&:/6I%35=%ADM[36!Y$.;I(G)V9.48*2I>-R"<FO$-%
MT?5;_5-=T71+5/%^CZUHGB!+9M0TY[75=!FF.]K:YD/R3))-\J%L-QD%E!)
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MVHS1Z7+ C7GGVCHL[[ /-PET?G.[[W]X9^IZ $S[BC/N*6B@!,^XHS[BEHH
M3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BBEHH 3CUHX]
M:6B@!./6CCUI:* $X]:./6EHH 3CUHX]:6B@!./6CCUI:* $X]:,CUI17@=Q
MX@O?B1^U5JG@J[NKJT\,^$M#MM2>Q@E>$:C=W+N%:1E(+Q1HA 3.TNQ+9V@
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M4=*./6O!)_VJEL[/Q'/-X5NIUTOP[+XDBDL+M)X98(\&2&20A5BF4'<4^8$
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M=&;Q'?Z';P76H65O<^7=,LN2L=M%L8S2;%+[24&"H#$D@ 'JFF:9%I&G6]E
MTSPP*$1KFX>>0@?WG<EF/N236=9^#--LYM9N LK7FKG_ $N[,K"9U (1%=2"
MBH&(4+C;DG[S,3Y7XO\ VGH?!NN64=[X?DM]$NM1T[3XKR]N?LUU<?:U0B:"
MV:/,D<9D57.Y6#+(-OR\W;#]HZRU+Q5X@T^*PB_L[0+J[M=4E^V9O;(6\;.9
MY;79E87V,(Y Q#93@;@* /7-.T^UTFPMK&R@CM;.VC6&&"(;4C11A5 [   5
M8) SSTKR+X=?M"0^/_&%GH0T.>S6_P!+&JVM[#,+B)5RH,%P0H$4X# [06!
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M\T%OX>86X2WG>5#L,YRKB64.#UW<8XQ;T;]FN\T#1-=L;&/PVFE:[JT=]?\
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M$GP5XOTG6;?3+CP_!?6DL%S9FX%S#<FW+A2)%V,#;* 3N&&/'2O0L^]&?<4
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MDWGA#0KG2K.;[1;6,NG0M!#)G.]$V[5.>X'- 'S7]DU;Q+XYCT:]^)'B#5+
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MC#9L_&;PCXFU?XX?![Q1H^@3ZQI7A:XU2?4#!<P1N/M%F;>-4621=QRQ8]
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MQ9^U!X$UWPGXQMM-\1ZWH\VEV5_]LU>ST&YD?3'MB$F)5X2OF(6#;&&=H+$
M<U;TSQ=K+?M(^$M"BUZ[OO#6H> [S4VM)XHE$ES%=V,:7!(0.&9+AP5SMY&
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M02 8Y5G(SM;'FOA3X,?$70_!GP@\.7>@6$@\$^,IM6N+N#55*W%J4O8PZJR
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M\ _%%AJ_C711\0=:CN+]D3QDHM4U0DM;R!5G\O9&RPA25R$B7C(H ^G/'GQ
MTOPLJ:=/<7ZZI>6L\\,6E63W=S'%& 'GV*K?*I=.6!!) P2<5YK\'OC0VH_
M/P!?^(K^_P!4\5Z]H?VYAI=B;BZ<*%\V<11H0%4R)U&,LH )(%>;Z;\3-4TK
MX@>&?'=WK_@G5=4O/#$7AW7M('BJUA6WN(IGE6]ADYW1N9) R ;@-GWMN*Y/
MX1ZG>?![_A66I0^(? >L3:;X6/A35=,'BVVB, 6<2PW22G(8<$.@!(S\N[I0
M![3^SY\=UO\ X#^"=8\2:E>^(_$.K6=Y>_Z)9^9<W$$-PR-,8XU 555H@>!R
MP R2!74S?M4?#X2:9%::AJ&JS:GI1UJRBTW2KJX:YM@X1B@6,Y96/S+U7!W
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M*A&1Q?(0I.?W;Y"_+D ]OT7X\^$?$/ARWUC3[F\N!/J$VE)8"QE%[]KBW^;
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MYHS_ )S0 <T<T9_SFC/^<T '-'-&?\YHS_G- !S1S1G_ #FC/^<T '-%&?\
M.:* #/N*,^XH_.C\Z #/N*,^XH_.C\Z #/N*,^XH_.C\Z #/N*,^XH_.C\Z
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M(^)GB+6_"7P>\&KK[PZEXC\,S^()]7N(XWG$4)@06\08$,Y>?>68$A4;J3D
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M)$2B1>-S,23MY[+X#2ZY>_$3XPRZIK%UJ-K:>(UL[:*=8@$46=LX VJ&  D
M'8YSRQ8D ]NS[BC/N*/SH_.@ S[BC/N*/SH_.@ S[BC/N*/SH_.@ S[BC/N*
M/SH_.@ S[BC/N*/SH_.@ S[BC/N*/SH_.@ S[BC/N*/SH_.@ S[BC/N*/SH_
M.@ S[BBC\Z* #\:/QHYHYH /QH_&CFCF@ _&C\:.:.: #\:/QHYHYH /QH_&
MCFCF@ _&O*OB#^S/X'^)FM:WJ>M0:@9-;L%T_4;>TU&:"WNE0,(I)(D8*\B!
MCM9@<<<<#'JO-<S\2_&G_"OO NL:\MI)J%S:PXM;&$$R7=RQ"00(!R6DD9$
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MO@'!_>9V\'CKUH X36OV:/ _B'PKI^B7UOJ$SV%]_:D&KG49_P"TEO,;3/\
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MS7=O;^:#C+2?OP<8 X[XY .PUO\ 9T\*^(5\;K>SZHX\9K FLA;PKYZQ((T
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M_=P: -#POX1TSP;H2:3I4)M[56DD)+L[R22.7DD=V)9G9V9F8DDEB37&Z?\
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MY/ KC/A9\7)/B+\1/B%HT,^DWVBZ!)8BPOM*F\[SEFB9W\Q@Q7<K+C"]._L
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M<D$C'>@"I\/OAUH_PUT1M-T@73K))YL]U?W<EU<W$FT+ODED8LQVJH'.
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M 2'8$X.*Z7X=_#;5?#WQ%\0^*;_2-)TRXUN%3>/I>L7<Z33*$4.;>2-(U)1
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MFWFDZE9OJ'B :Q9W<VFRQVT]L]E:1@I<$;&.^-OW><C!/KCKS\!?!YZIK/\
MX46H_P#Q^MCPI\+] \%ZE)?Z6FH+<O$86-WJUW=)M)!.$FE90<J.0,]1G!-
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M4 >&_LN++:P?$F&70=4T**X\7WVHVJ:AI\EHLT$P1DDC# 9!PV1U!Z@9KCO
M:SVGC77_  KXO^'^LZGKL/CRYU[2-86TD-DUK+*6@NC=@;%:&!O+,;')V*@!
MS\OU(!CTH(SZ4 ?%WA?P=XFU'X:?#/PC<:/J]A\2O#'C2.\U#5C8RI"8TNY)
M+N[^U%1')'/!(?E#Y=I-I'!P>-+#6+WX%_&;3K/0M>_M.Z^(B7EE$FE7(DN(
M1?V<WG1 )ED"PR'>./D]US]H[1[4F![4 ?'GBCPV^J_$OXB>'/%WA7QGK=OK
MNKV>MZ#<:1"QL;E$A@6*.2XV_P"C-%+"Y.]E 4G Y^;6^'$-S8>)]5\(^-?
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M))-:97<,&@#YC^!7PC\0_#7Q9J7A'6H9=3\ ^%O.U/1-0FC#&[EO4'FJ(E&
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MN$0!AC-?;VT>U<!XT^".@>-_%4/B2:ZUK2=;CM%T]KS1=6N+)IK<.SK%((W
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M\:7.EZ%_:]IX0TFTU?4VEO1;RF.X1Y%$2;'W$1QLQ+%1G"@D[L=[XCD3Q/\
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M;OQ[\0+.\\(::\NA>'=,U*+PY;ZL6F2:87;&(3" K([F$KV5=B8SN8UOZO\
M SQ%KC>$KN_\?27VKZ)KZ:_+=3Z8OESND#P+#'$LBK#'Y<LF<;F+-NR.E6O$
MOA&;X>?$3Q'\5HM4U*XTZZTJUMM4\/:=IGVN>Z^S&?R6B*G>,?:7)4 YP#D
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MO=75M#JR7@\^!83(HGFA*@+'(\1"X<L-RD@$D#%\)_LSKX;T7PYX6F\0M?\
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M="WB+18?[7TX*S R/ PE>'C[PE1&CVG@EAGIFO%M ^+OARU_:J\-^,K))8/
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M)^ _BQ?&;]GG0_!NBVFC^$?$FA7%V-/N;YWFA2WMX_W'F&-BRH)5(;JY49V
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M*-7^%?[-HT#PM/>Z#XEEA-Q%*D45_<6TSLOEPD2MY;^5$(X 6.T+$#G H ]
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M>M''K0 M%)QZT<>M "T4G'K1QZT +12<>M''K0 M%)QZT<>M "T4G'K1QZT
M+12<>M''K0 M%)QZT<>M "T4G'K1QZT +12<>M''K0 M%)QZT4 +12?G1^=
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MAR23LX^7DD\=S5?P-X)T[X?Z$FDZ6FVW$DD[L412\DCEF;:BJHY/ 50
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M!/LG!(R"?0GOS7JWYT?G0!Y?)\$;B:2[D;QKJJO=$F8KI>DGS/F#88M9$MR
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MJPJ"7?#LH(4 D\] 3VKK:JZGIMKK6FW>GWT"75E=Q-!/!(,K)&P*LI'H02*
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MP-=M^U!XFT;1X_ 6FZU<I:P:GKNU7U*Z6VTHF.VF?;>L0=\?1EB!7?(L?S
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M?L-(M+M[34OM=Q;7%X=+:%([N&&!S'*TB.ZA<.-H7)9C]T'!P >E<>M+C/\
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M*14$_P"U;X'LK7Q-+?#6=-?0+!=5GM[S2IHYKBR9MJW,*$9>/=@%N-N1NP*
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M9]Q0 9_SFC/^<T9]Q1GW% !G_.:,_P"<T9]Q1GW% !G_ #FC/^<T9]Q1GW%
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M_%O1;-M$@NO%/BRS\0:9,=0F'EQ0M9%ED_<?*^+$8V[AF7J-N3]+Y]Q1GW%
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M+T'X?W'A+5/^$,>*QTFXTNSU6P65+K4P86A@^T@Q8A !#N4+EF48P,[H]4^
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M5U)%;/>V^G;H('FV3S,J1*^P'8"70;FP/F7GD9 .GYHYH_.B@ YHYHHS_G-
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M RL"""".U;6?\YH .:.:,_YS1G_.: #FCFC/^<T9_P YH .:.:,_YS1G_.:
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MN5L58;2+=9798<K\O[L+\O'3BI=/^%?AG2O&U_XOM=/DB\1WZ".ZOOM<Q,Z
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MJ"Q &3@ #)ZU%:_"WPQ9^(-;UN/2P=3UM!%J<TLTD@O$"E52168JRJK%0I&
M#@8% 'D@\0>)O#WQ0^'VAV?C2XU_1/'&AZA))=21P-+:W$,44D=[;8CV[&\W
M!1@4&8\#D@ZW[(][XK\6?"+P_P",?%7BNY\17GB'2;2X^S2VL,$5HP#[BGEJ
M"2X9-Q8GYD)&T-M'?>'?A%X1\)VTMOI6CI:PO:&P5?.D?R;8DGR(MS'RH\G.
MQ-JY XX%;7A/PEH_@;0K71= T^+2])M05@L[<8CB!))"CL,DG ]: /$/C?XZ
M\5:=\1=<T+2;[5[$0^#9-4T5=$L/M;S:IYTJ 3*(WPHVP;5?:C[Y<YV_*SP_
MXF\8>,/B5#\.]9\0ZEX?U/3?!EEK%Q=VL=NL]W?S2/'+)_JRC1PL@4*JA29#
MN!PM2?%O]G_5O'OQ:E\2S:%X6\4Z9+ID&GPQZI>W>G7=AY;RLVV6!'\Y&:7<
M4;9]T#(ZUW.A? 7P]%X=\/VFN6W]J:GH\,T$&HQSSQ2Q12L2]NDGF&4P8(38
M[L"J+NR1F@#QCX*_&SQ=\==5\*>'-=U*X\+7DWA&?69KK242-K^Z34);+S$\
MQ6 15A6;:O!^TIN^4 &?X1_&'Q/\7K_P;X3U[7VT/4GT34[Z]OM(6..35)K7
M47L$>/>A"H1$9RJKR73G8"&]_P!9^$WA+78]&2YT6&+^Q8S!IKV3-:/9Q%0A
MBB:(JR1E54% =I"C(X%5O$OP2\"^+[+0;/5O"^GW5KH(VZ9%Y6Q;12H0I'MQ
MA"H"E/NL  0<4 <-^Q>LB?LS>"UEF^T2JEV&F*A?,/VN;+8' SUX]:\^\<_%
M7Q)IGQ)LKK1_$=Y?:7_PL"P\,W*F**'3[:&1(TELPA!DFF#,[F;Y5!95!PIQ
M])>"_ ?A[X=:#'HOAG1[70])C=Y%M+*,1QAF8LQP.Y)_SBN6U7]G+X::YK6H
MZM?^#M-N]1U"Y2\N9Y4)+S(5(DQG"L=JY(QN PV10!X,/&WC_3FFUJ3QUJ%[
M%8?%6V\+)82V=JD4UA-=P0.LNR(%F"S$JRE<%1P3DU6\8>+-1^*7@_PQXMN=
M=NX7@^+6G:3)X?18Q!;1VVN) D3@KN\PB-)R^0?GV_=XKZ0D^!_@66PN+)O#
M=I]DN+]=5EARVU[Q3D7!&?\ 6 X._KD#G@50UK]F_P"&7B/6[_5]3\%:5?:A
M?3)<W$TT.?,F0C$FW. _ !8#)&02030!VOB73[W5_#VH6FFZE+H]_-"R6]_"
MB.]O(1\KA7!4X.#@@@U\W_##XQZYXF\ RZCJ_B&?1-2\ Z%J$'BV6ZB$T8U1
M"T:M*JJ"ZHMO+-L3!(FBYY(/U'MXQSBL1_!&@2:=KE@VD69LM<:1]3M_)79>
M-)&(I#*.C%D55.>H'- 'RU9^-/$MQ#\3?#6M:GJ5U:3?#)=:MK?6)(6N?-<7
M<4DN(AB,.$C;RMS[<CD9VCK/A;XFU6U\;_"WPR=6N(-"U+X7->RVF]55+F%[
M"-)$)&X,$FESSCC..*]+TW]F_P"&6D*HL_!>EPL+)].,@B)DDMWX:-W)W.",
MK\Q)VDCH2*TM0^"/@/5K#P_8WGA73;FT\/C;I<,D(*VBX *)_L$  H?E.!D<
M"@#YI\+_ !?\5^-OA7X-6U\8:GJ'B.?PSJ^JR0:<MO!)/Y5SY,%[<73*46)
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M>N:KX*TF^U2\DCEN)YH ?-D0@K(R_=+\8+8R1E22"10!Y7X7\?>-_B'XFO\
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MJH&!7US\._ ]E\./!.D^&M/):ST^+RT.,#DECM&3M7).%R<# R<9K%U'X#>
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M#&0>"^2&/5AP<BK+?!SP:]KX@MI-!MY(/$#;M6C=F9;YN.9<GYSQC)[<=.*
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M'&1F1#GG( /5?"/Q(L-,^&WAC5/$/BG3M=N=0@'E:EI-LP346VEMT$*%V;Y
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MH(EMRS*H1&W\#(&6H ]PL_C]\.]0U&[L+;Q?I4]W:1W,MQ&DX/E) RK,S'H
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MY\)[3XE_$3QIXF\1:.VA>'-<\*Q>%Y;;4!''<7;M-(S2L%8A=F^-$)^8MG'
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M[AZY\.;SQ):6OA[1]?\ #4%A<0^';26]U.P>);2.]P%FM(HP=P52-RD?+M(
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M6]L;Q+&[A+L3;3-M"B0@$(N9$!=L*"P!(/%6_#?QCTGQ/\5?%/@6UM-06_\
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M]6##X;^$@PQ@C0K7(QT_@KM=*TJRT+3;;3].LX+"PMD$4%K:QK'%$@& JJN
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M,LL<33-(P<^6220$7<F.<C';_"KXK_$CXEOH.K1^';6U\):_I37T>I31(O\
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M*O$DQ\::-;Z'JDC36Q;[/$CH/+)@.UF6:8,3D?O6( (4K[%YB;<[ACUS09%
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M!Y'S2#9'@C _=C(.6W=]X;U"^U#P_IEUJ]E'I6J3VL<MW8QW G6VE*@R1B0
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M;3];T[QO#=R1ZI;:OF&T-LNZ=#B(ER!E1C&65@=H&X^TLZQQEW(10,EB< 4
M>0^)_P!E[PKXJT2.WN+[6;/78]6.N+XHL+I8-46]*"-I1(J;!F-5CV!-FQ5
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M5@^'_P!G[3O"6D06&A>)O$.DF#4+O4EN();=G,MR2TP97A9&4LQ8*RG!.1C
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M49F52521\'RP3C)(XJU;:Y'#:6(U*>TM+ZXC#>2LX*LP4%PA."P&>N.F#@4
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M+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M%
M"9]Q12T4 )^-'XT<T<T 'XT?C1S1S0 ?C1^-'-'- !^-'XT<T<T 'XT?C1S1
MS0 ?C7'_ !5\2W7ASP?<+I;J->U%TT[2PXR!=3':CD9Y5.9&_P!F-J[#FN \
M8_#N;QMX^T6[UBTTK5O">GVL^-.O8S(_VQR@6?:04;:BN@!P1YKG)X% '#?
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MJO"7PXU'5H;HO?6^BW,%KJKVMQ#YUO)+L*A(&<23!1)&7* [0W&XJX7$\<?
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M\:.:.: #\:/QHYHYH 0C/<?C3(/-\O\ ?; ^3]PG&.U2<T<T 'XT?C1S1S0
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M]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH
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M?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0
MM%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^
M='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT
M +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^=% !GW%&
M?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2
MT4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10
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M=;K@UQGP/^,9O_A/9:GXIU.;4]9DUS5-)#061::X>&]N4C5884YQ#$K':,
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M!\W7@<U-)\!KZ5-:0ZSH>S6N=37_ (16U_TXY)S/S^\Y)/S9ZFN[\9?$G0?
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M"/C1;6TCMM9LM6MGM2AF/FVNHPE_W\:*2PV(_P!\A3QS].'GKBDP/:@#Q?\
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M2:U/V9/&.K^//@UI>LZ[J3:OJ<E[J5O)>M''&9EAO[B%&VQ (/DC7[O'N>I
M/4Z*./6O*?%W[3WPZ\#ZOJ^F:MK4\%]I!C.H0QZ=<RFU1QD2.4C($?K)]T9
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MB0G*Y 0EL8./5_ WCS0_B/H"ZQH%[]LLO-DMWW1O%)%+&Q62.2-P&1U8$%6
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M1@05?;M(Z$UT&H?%#P[I%Q<07U]):R0:>FIR>;;2@) [E(\G;]]G!58_ODC
M4T =;17EU_\ M*_#_2-/U6[U+6)M+&DWEM8ZA!?6-Q#/:2W S 98V0,B..1(
M1L.#SQ6?>?M8_#>PMM8FGU/48SHY!U"$Z)>^=:Q% XN)(_)WK"5(/FD;>>M
M'L-%<+XO^-7A+P-!<3ZKJ$@M[:UCOKJ>TM9KE+6W=BJ32M&K!$)#8)ZA6/12
M1AZ]^U!\./#>H:I9WNO2>=I<<$]Z8+"YF2WAEYCF9DC*^401^\SM^8<\T >K
M45YYH'QDT_Q!\7M?\"06%_YNE6%G>_VA]ED-M+Y_FM@2 ;0H6-<,2 Q+@9*&
MO0N/6@!:*P/%GCC1_!2Z?_:EPZ3ZC<BTLK6WB>:>YEVLQ6.- 6;"JS$@8 4D
MX KR?QK\99-4\1_!;4/!VN,WAWQ-KMSI][";91]H1+>8LK>8N^-XY82I P<A
M@>E 'N]%>&_";XO3QV?Q1O/&6N&ZM-%\;W&AZ>YME63R_*M?)MTCB7,CF29E
M& 68D5T^J?M%^!-%\/:]K-]J5U;6^@W,=IJMO)I]P+FRDDQY7FP;/,57W+M?
M;M;(P30!Z717&7GQ<\,:?K?B/2+F]FBU#P_IW]K:A"UK*/+M<,1*IVX<'8X^
M0GE6'45G-\?O!,>M6NEOJ%U%<7%_!I0DDL+A88KV:(2Q6TDA3;'*49/D8@@N
MH."<4 >B45Y=;?M,?#J[UR/28];F^UOK)\/EFT^Y6*._SM6"20QA49FX4,1N
M/3-;+_&CPA'XIM_#YU)_MUQ?/ID,HMI3;/>*A=K<3A?+\T*&RF[(*D=010!W
M%%<7I7QA\)ZUXEL="M=28W^H)-)8&6WECAOUB_UIMY64)+MZG83QSTYKL^/6
M@!:0G':N'^+_ ,0F^'?AFSFM(H[C6M7U*UT;2X)3\CW5Q($0OR#L0;I&P<[8
MVQS7&>)_%WQ"\/W?BK3;'0=6US[!I5O<Z=J<$=N%NW+J)PN<#[0 SLL979B-
M<YW<@'MF*0L :^>OCGXM\;^!?!-IXJM_$EWI+ZCK>DV,.D"SM6%K!<2PPR*Y
M>)BTH+N<AMH.  0.9?C!?^/OA^?!4%GXSNIXM=\:6NCR73V5F98K&>')!_<A
M3(LL3!6"XVS?,&(! !] T4G'K1QZT +12<>M''K0 M%)QZT<>M "T4G'K1QZ
MT +12<>M''K0 M%)QZT<4 +12<>M% "T4F?\YHS_ )S0 M%)G_.:,_YS0 M%
M)G_.:,_YS0 M%)G_ #FC/^<T +129_SFC/\ G- "T4F?\YHS_G- "T4F?\YH
MS_G- "T4F?\ .:,_YS0 M%)G_.:,_P"<T +15=;ZV>]ELUN(FNXHTFDMQ(#(
MB,6"L5SD E' /0E6]#61>>//#MAJVH:7<:W80ZAI]F=0O+:2Y4/;6XZRR#/R
M)[G H WZ*SM U_3O%&CV>K:1?P:GIEY&)K>[M9 \4J'HRL."#ZBM#/\ G- "
MT4F?\YHS_G- ',_%#PI)X\^&GBSPU%-]GEUG2;O3DFW%=AFA>,-D9QC=G->#
M65OXR\5_!GX,'1=&:^32%CLO$^EVMW'97\$T-H]M(D,[L#$%G#JY1E=D. <,
MV?I\\BJ5IHUC87MY=V]K%#=7C*UQ+&@#3%5VJ6(ZD  9/8"@#Y#U/X?^*](_
M8XU_X6ZKHEMI7B37=7N]'TJVCO5O5NDO=1><S(>#MBBFD<E\,! S$#I7V0H*
MCFL?Q#=:!X?"^(-:FT_3EM$\D:G?ND0A61E&WS&(VAFV#&>3M]J5/&&B27[V
M*:O8O>QSK:O;+<H9%F9#(L97.0Q12P7J0">E &S1244 >"Z%IWC/PO\ M'?$
MGQ3)X)O]0\.:UIFE6%C<VEY9^8[VGVDLQ1YU*JQNFQGGY!D#-<W\1?#OQ2\=
MZMI\]_X,2ZTR]T/4K.2PL=7ALI;.XEG40)=7"OYDD/DJI982REQDHV$Q]/'!
MI,#TH ^4O@Q\./'?@[QO\-]5UKP;<1VN@_#-/"MSY-_:2E;R*2)E _>C(<0$
M C(!D3) W%<SX-?#?XG_  B3X9ZLW@R356T[PDWA75](CU6V$UM(EQYT=S$S
M2^6Z/]UAN##"\' KZK\4^*=&\$Z'<ZSKVIV>C:5; &:]OYUAACR0!EF( R2
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M:=MBE*7=M*SH!*K[%QN&5D;J,@]_J'B72M*U&RT^[U*UMM0O6*VMK+,JRS$
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MD<L;!E=2,A@1U!'>IJCABC@B6.-!'&@PJ*,!1Z 4_/\ G- "T4F?\YHS_G-
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MUIOQ^GM/V3-!^*%];K-J5UH]A,\+E41[N<QPC)R $,T@YR,+Z=LK5_C!\1_
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MAAADVA%4,Y2!%WL-VWCNQ;J/#OP^TS0-:OM;)GU'7KV-8)]4O7#S&%6++$N
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M>W"%^5#-(68MZ8 W$CWCQAX)T_QKX+U3PM>&:VTG4K5K&X2T<1MY##:Z*<'
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M@;=ZYXH^*<OB^RU>QT37O$RZG!I;WT#6>H6Z06Z(9$C9F!+P$LI*AE*!@?F
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MXQ@>"OV9/"'P\L[RST>?68[*6WGM;2UN=3EGBTV.7(<6J.2(N#C."<#&>3D
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M\4_%;XQ>%K3PS875IHECJ>K^,AX>MIM0B$K36<MO++!<R1P3E8W7RF#("0^
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M\,<!MK>5VC5?W3;OFW8!?[W(H ^R[+7=-U*[N;6TU"UNKFV.V>&&97>(\\,
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M<T >TR>(-,A@AGDU"V2&9#)'(TRA70#)8'/( YR.U)+XCTF#2EU.34[2/36
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M?<4 'YT?G1GW%&?<4 'YT?G1GW%&?<4 'YT?G1GW%&?<4 'YT?G1GW%&?<4
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M!%[\2/AAXI\)V5_!IDNNZ;<:8UY/ TRQ)-&T;L$#+E@K$CG&<9S78_C1GW%
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M#==_9DUGQ+XGO=?N]:T2TUJ32]1THZEI^E/#+?172A$^V 2XE\E,XZ9;!^4
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MT#XQVWB7Q/#IVGZ#K%UI$]S>647B*&*-[ SVS,DRLRN70;T=%9E"LR$ G@D
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M6!)K33VO58,T>Z5\/OR6@$;,<,M?0Q^&?A!K2^M#X7T9K6_6);N V$12Y$8
MC$B[<.$ &W.<8XQ5B?P'X9NO#B>'I_#VE3: F FE26436JX.X8B*[1@\CCKS
M0!\\:-KJ7GQ.\ _#R[\7ZKXC\$W>CZS+;:XU_)%)JNH17<6RW,\14R""!Y0"
M&^<KDDE:X31-=\4^,KGX9^'M2\:^(;#3[KQMXD\.V^L6>I-%/JVE6]O=FWE=
M^1(Q,2H)<;NC [B&K[%O_ _AO5=&MM(O= TN\TFU*F"PN+*-X(BHPI2,KM7
M)Q@<5'?^ /"VJ2:8][X<TB\?2P!8-/8Q.;0#&/*)7Y,;1]W'0>E 'Q?\;]<M
M?$/P4_:"TC7?%>KV_B#P?LTC3]/NM6>-Y+-;6!H)9(U95N&NF:4L[J22VT ;
M172_'#XJWEEXF\3:OX=\7W48T7Q)X?LW\W57M((%FEMQ+;P6RDI=ATE>1Y)
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M4%G9P1VMI!&L4,$*A$C11A551P    !TQ4_'K0 M%)QZT<>M "T4G'K1QZT
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M,>,/&'CSX=^+?$?A9M"N_!VCWZ7,27=O,]]=W$<49BM]C[1%^Z9MTFSGRQM
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MIZE=:F++Q5J&GVLE[:K;3101E D3QA5PRY(.1G.<UP=]\-O'MAJW@CQ[X?\
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MIZ(VL:9=3Z?)$)+5BJ)=1&5-CJ&DC."#]Y<@@T?LU^*M5\<? 3P'K^N79O\
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MJ'1U^8 DJVT'!QHVGQ@\*:AXET+0K34S=WVNV3:CISP6\CP7-NJ[FD68+Y9
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MJ25)P<8.&^&OVBM!U/P#X9U_48+^UO-8T8:S_9]O8S32K L4;S2A54DQ*94
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MBMJGBOQY\,_(NO#.L6_B+0=8NH-8L+5WVO;RVZ@Q.7RL;B6/?$?F5HR"Q(X
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MKX>NK^+RH6M8]*NX;(WBM+,7;= T:L&? PQR,# )IWQ^\<)>>+=/:6TNGM/
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M>$OVB/&/C72O!VB6UK;1^+=2M]9DO+BRMXY(V.GWYLLQ133Q??;]X1N)4 @
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M7* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH
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MM_$.H_%O17TZXTO0I_M=W:P7:2*LIGMYMT,*(AD(<A O&TC-?HH??%)@>H%
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M7T^Z),,*P;K<GR6A,9VM!O:8#RB24& *^["@(ZUY1;?LZ:18R:K;0^(_$O\
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MS$1IOV*"2=JKDYK=\=^#--^(G@S6_#&KIYNFZO9RV5PHZ[)%*DCT(SD'L0*
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M<UO%'%:RHT$R0.&,:NDQ1F7(9FXPOL&M_L^^)?$]O\8GF\36&GGXD:5;Z<T
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M32_ S7'B70X=/NM26'5&9M6C%JS(8E*$(RQ*RA<#>0 <<&J<W[+>M26VL/\
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M?LI:UKGA#XCZ5?\ C6VFO/&>K6&L372:.52VEMC Q54\_)5FMTZMD+D9).:
M-7QW^TWJ'A#7/B)8VG@6]U>W\"VMMJ.J7@U"&%#:21/*[H#EF=4C8A,<[6RR
M_+NO>-OVE[/PO%XNN]/T8ZUIWA+3+75=9F-T()4AN%9XUAC*GS&\M"YW%!R
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M?C+XP_#WPWXNUN&Q7P_IVJZ->C5)S/I.IR_:%$ N2_F&-Q;Q2,C,0!(<8!H
M^G\@]:,@=*^/KCXUZOX@^!&K?%"PN=4T&&RL=+T*=)VN)4M)/M42ZK<F(O\
M.8A(T8E^_F!SNP>(_&MWJ?A_P+XKU+1/C#/K44VJ^'IK./1;J:4:8LU]';S#
M[1-/.765)&?RF. 4SC:<4 ?8N[WHW>]?%'Q%EU3PRG[1=M9^/O&,?_"%Z;8:
MSI,0U:61K>YFM7DR9&.YXV>'!B9C& [D)DKC4\5>/M6\<>-?'6DWWQ-M_AM?
M:5::9>Z26:9&%O):PS23QQ"=$N09C-$0ZR8VA>">0#[#W>]5H=5M9]1N+".X
MC>\MT266%6!9%<L$)';.QL?0U\6?%G7-?T_1OVA/$5IX[\16EWX0OM,N]'M8
MM0FC@A>2SM)F5H0<F.21Y$\I\H,G@')KI]3CL++XH?M!V=AXJB\+>(+NVTHV
M=Y>:A.4#30@%B@DR$+[4WJ/W8<[2M 'UL&ST.:K7&IVUK>6MI+,B7-UN\F(G
MYGVC+8'L*\B_9N\175]%XQT75=*O=&UW2=407UG+J3:A9HTEM$R?9)FY\IE
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M6"9 Z2(1@JRG@@@X(-2_G69XF\1V/A'P_J.M:D9EL-/MWN;AH(7F<1J,L0B
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MC:2V7&-L;$90>PQ7F7C+XV^&=;\'27MCXJU+PU]@\0VFDWKQZ6[W,%SY\?\
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M*P((!XKEF^-WAG[=+;QM?S*CWL*7$5A,T,TMIO\ M$:/MPSJ8Y!C^(HVW.*
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M4(-%U;7(6N1)K-II:VTD\<LKOALL[=&"G+'.!67X<\<ZRWQQM;#4-;=]"N/
MT.LR6DR1)%#<?: CRA@H."O7)('.,=NIT?XZ^%-:U73=/BGO()M5M9;W2VN;
M&:-=2AC4,[VY*_O,*0VT?,5(8 @YH Z73_ WAW2='N=)L="TRRTJY+-/8V]G
M''!*6 #%D VMD  Y'( JUX>\+Z/X4L#9:+I=EI%F9&E-O8VZ0QESU;:H R?6
MO.] _::\!^*M)DU+2[^^N+(-#%#.VEW,:W<LLK0I%!NC'FR>8I4JN2ISNP <
M<+X8\9^-_B-;_'*R\.^(M3L-4TG68(-$DOM)A,]H/LUO*\ @D"*RLQD17<_=
M8/N/4@'T'_8FG_89[+[';_8YS(9;?RE\N3S&+2;EQ@[BS$YZEB3UK!MOA/X*
ML_#PT&#PEH46AB8W']FIIT(MO-/5_+V[=W/7&:QM7^+NG^!K2WLO$;7%SK=I
MIL%]JHTFREGCME<E/-;:#MC:2.7&>T;$\ FNN\3^)[#PCX=U#6]2DDBT^P@:
MXN)(HGE9(U&6.Q 6.!SP#0!4F^'?A:Y;46F\.:1*VI!5O2]C$3=!2"HEROS@
M$ C=G&!4-[\,?"&HW>D7-WX6T6ZN-' 739IK")FL@.@A)7]V!@8"XQBN:T#]
MHCP7XITY;S2;F_ODEECAMHHM-N/,NB\ G!A4H/,41G)9<J,<GD9=I/[0_@?7
MM2\*6%AJ=Q-<^)S=)I@^PSA9)+8,;B)V*8CD38^5?!^4T =1=?#KPK>M?M<>
M&]'N#J#*]X9;")OM+ Y4R97YR#R"<U-/X%\-W3R//H&ES/):K8NTEG&Q:W4Y
M6$Y',8(!"]!Z5Q.K?$G2M9\;^";&S\1ZII$MQK6HV"V46G,T&JO:PS">%YF0
MJBHT;,"&!8QD#."1>?X\>%H_$%AI327F=2GGM=.O/LS&VOIX0QDBB?\ B8;'
M Z!B/E)H [71-!TWPW9"RTFPM=-LPQ806D*Q(">IVJ ,FIKS2['49;:6[M(+
MF6UD\V!YHE<PO@C<A/W3@D9'/)KSK2/VB?!^N:;X/U"TEOFLO%=]-INF326<
MD8:XB9U>-]P'ED&*3 ;!.PX!Q7;^&?$UMXJM+NXM(IXXK:\GL6,R@;Y(9#'(
M5P3D!U9<^JF@"6U\-Z39:O/JMOIMG#J=PNR:]CMT6:1?1G R1P.":TL^XKS@
M?'GPX?%]GH)AU%5O-4GT2WU-K?%K+?0QL\D ;.[(".,E0I*, 3BL?0/VH_!G
MB/4-)@MH=:CMM3U631(;ZXTN6.W6]5I%$+.1PS>4V.N.-VTG% 'H,?P_\+0[
M-GAS24V7!NTVV,0VSE@QE'R\/D [NN0#FHE^&WA)+&^L4\,:,EE?.);JV73X
MA'<.#D-(NW#$'N<UX]\;/C9+'-X0A\*WFL6\1\<Z5HEYJ5I:H;&YW7L<-S:O
M(P+8 +J60!=ZE-^X%:]M\5^*+'P9X:U'7-3,ZV&GP/<W#6\#SNL:C+$(@+'
MYX% %S3-)LM%L8++3[6"QLX%"16]M&(XXU[!5& !["J'B3P7X?\ & @&NZ%I
MNM"W):'^T+6.?RR1@E=P.,CKBO/M!_:C\ ^([U;6VO=1AEETV35[4W6DW40O
M;6,9D>WS'^_VCDB/<<<@$<U@:C^T?X-\=^']&O=$\5Z[H-G/J^E11ZG;Z+*(
MKHW,A6. O-"4$;LK1NX^X1@L"<$ ]BUCP=H/B"WLX-4T?3]2@LI5FM8KNU25
M8)%&%9 P(4@$@$=*@;P!X8:6SD/A[2C)9SM=6SFRBS!,S!FD0[?E<LJDL.20
M#VKGO$GQT\(^$I]574KRXCMM(GBMM3U".TEDM;"20(RK-*JE4XDC)/10X+$"
MH7^/?A0?$2;P3$VIW6OP2V\<\=OIEQ)% )D9HW>0)M"':!OSC+KSUP =1%X"
M\-06NI6L>@:7';:FQ:^A6RC"79.<F4;<.>3][/6H&^&?A%M/EL#X7T4V,WEB
M2V.GP^4_EC$>5VX.T<#/3M47C_XE:)\,[32+K7I9[>WU/4(-+AEB@:11/,VV
M,.5'R MQN; R1S62GQQ\,27_ (QL1)>_;?"<MO#JEO\ 9)/,1I^8=BXS)O&"
M-N<@CUH W9/AMX2F>Y:3PSHSM=0BWG9K"(F6(%2(W^7YE!12 >/E'H*\N\1?
MLV27WCW4=;TZX\*OI%Y9VUDFDZ[X6COA81P@@+:NLL>Q#N9MC!AN8GIQ6CK7
M[27A"[F\3Z%;W.OV=]I4=[!?7UMHERXT]X8/-9B3&5+;2608(?8<9!!-'0/C
M];0ZO\.?#EK;ZSXB@USPP-:&M3VH$]R@CAV.40 ;WWEG "A2RXZX !ZMX(\*
M6W@7PEI'AZRD>2STRUCM(6E(+%47 S@ #@=  !T  IUQX-T"[\01:[-H>FS:
MW$NV/4Y+2,W*#!&!(1N P2.O<UY_\/?V@M-\9>!]&UZZTW4;"ZU>XN(K/2UM
M)))Y1'(X)55!R%51N?A0W&>5!:G[4WP[N$\.FTU.^U"3Q!%<2:9#9:5=327+
M0/LFB"K&3YB-PR'E>IP"#0!V)^%7@I[66V?P?H!MIIOM,D)TR$H\N"/,*[<%
ML,PW'GD^M=*UG;M=QW1AB:YB1HHYB@+HC%2RANH!*(2.^U?05@_#WQ_HOQ/\
M(V'B30+E[K2KT/Y4DD;1.&1VC=61@&5E=&4@C(*FL"\^._A*R\4'0I+J[^T+
MJ\>@/<K92FV2_>(2I;F7;M#%&0YZ98#.3B@#K)?".A3:]'KKZ-I\FMQIY::D
MUJAN57!&T28W 8)&,]S5>W\!>&K6'5(8/#VE00ZIG[?''91*MYG.?- 7]Y]Y
MOO9^\?6O.6_:R^'Z:BULUQJT<,6K_P!AW5_-I%S%:VEYNVK'-*Z!4); &?49
MP"#3+_\ :U^'^GWM]#/<ZK'!IVJMHVHWS:1<BUL+@%0//E*!8U8L &/!^G-
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M\#'-9D7Q]\*2>*K?0Q)>%[G4;K1[>^%LQMIKVV4M/;JPYWKM<<@ LC*I)!%
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M ,*>)]1US4M"UZX1K#4[);=(I(8(G;3US$K&(A@5E&3EP=S $-Z%X \9Z?\
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M+%L"GR? /PW/.S3S:S=6\SVLEU:76KW$T5X]N$$+S!W)=AY49))R^T!]PXH
MV/B[K/B/1/AWJM]X1L6U+7HA$8;:/9YC(94$IC#D*T@C,A16X+!0<YQ7R_\
M$'XA7'Q.T+X:/IWB+[7JMI\5;*TC.KZ8;>[TUQ97!$-W;#R_WB,7)VD*PP01
MD@?6_B_PAI_C;09-(U(7!M'EAG#6MS);2I)%*DT;K)&RLI5XT;@]L'()%<?-
M^SOX,OY[2ZO;2^O+^VUA=?%[+J=PLTE^L2Q).[*XW%8U"*I^55R H!- 'FFC
M?%WQ@FEZ_H^I^(K*35-(\>'PR-0@T_\ TR^M?L45V%M[=0Z-<?O@I) 141W;
M&TUSE_X_UGXA^!?AO>>(8]FJ:?\ %A-'D+Q)'(1;W-S""ZHS('VJ VQBN<X.
M*]CUG]F/P+J]U>WC6FI6VH7>M+X@DO;76+N.=;T1&$RQN),Q9B.PA-H*JHQ\
MJX99?LQ>!M.MH[>UM=4@MHM<7Q'#"FLW8CBO@Q;S%7S< $EB5Z$L2><8 ,_X
M*A8OC;\?8D 6-=?TW:J\=='LF/YDD_C4/C3Q'X]U3X\77@CP[XET_0].?PK_
M &O%)+I@N)HK@7/E#DO@J>^1P.@R=P](\+_#70O!WB/Q'KNEP7$6I>(;A+K4
MI);V:99I40(K!'<JF$"K\@'"J.BC%?4?A/X>U3QM<>+IHKU=?GTQ]':ZAU*Y
MB M6.2BHL@13N^8, &!P0<C- 'B?PD^._B/XW77@W1DU2+PU?7O@6U\5WES9
M0)(]Q--.\ 5%E5E6)3$[,/O?O(P& !SSGA/XF^*?BK\0?@-?ZC?W6E-='Q%;
M:C;V,:?8WO+!OL_G)O1CB4>;@$G"Y"X(8GV_3OV:_ 6C6GAZ#3M-O-.?0+>2
MRTV[M-5NXKF"V<Y:#SEE\QHLX(1F*J0"H! -:-]\#O!]Q#X11-+>T3PHQ;1Q
M9WD]O]GW*%8'RW'F!@,,'W!N<YR: .^!!Z&OEWXH?&3QMX0T[]HF?3M5T^"7
MP;;6&H:7(VG!]D<EMYDB.-WSL=I 8Y X^7M7M7PE^&R?#+2=7M(;B62'4-3F
MU%;9[F6X2UWA!Y:/*S.1\F\Y(&YWP%&%&;XA_9Z\%>)W\:'4+"^G7QE'#%KB
M#5;M%NTB 6-0%E C 4;<)MR,@Y!- &3X \7>,+;XZ^*/!/B75K#6;2/0K'7K
M.6TL3:FW\Z>YA>'[[;U!MPP).?FYK*_:"^(WBOPE?ZA#X9U*(367AN\U:/3;
M.U6>Z>>/)1[AI<1QVORL/O+([9"9VG'HND_"S0=(\<GQ?#'>MX@;38M(>[GU
M&XE#VL9+(C(\A4D,S-N(W$LQ)RQSD^/_ (!^$?B3XE_MS6K6\>]?37TBY^RW
M\]M'>6C,S>3.D;@2H&=V"MD98]: /']2^+_Q(\0ZQJR:3KNDZ)90?#VQ\8HG
M]E&>1)Y1<9A!:3!4M <DC(4A0,_/5B/]HGQ%X;N/A[XI\2RPGP;XV\)+>VMM
M:P*K0:S]G2X6V#GEO.0R"->273'.:]1TC]G/P3H;2R06NI233:"/#,DT^L7<
MKMIX+$0Y:4XP68AAAEW'! XK#'PQOYO$/A3P<GAS3[7X9^$7L[_3+Z;4'NKI
MY8$=88!&ZED\MO+;S"Y^5 HSN.P ](T=]3T#P1;SZ]=?VGJUI9>;>S01J@EE
M5=S[%& !G('MC->'_"SQW\3?B5:^$/$D&KV%IX9\5:;-),9'MF-C<-$9(/L:
M*FZ0J5=9$F8G",>""*^D=ORX[5YWX$_9\\!_#36[K5?#6AC3;BXDDF\H74SV
M\+R??:*%W,<1;H2BKQQTXH \D\#?M ^)-1\#W5QJ<LEQXF\$6&KW'C"QBMTP
M]Q:M(D,2X7*B4HTD97JB'DDU3U;XA?%;2OAAX@\<+XCTU='?P7<ZS:>>;>6=
M;Z.$W >V2.(!X"@VXE9F7 )W<Y^C],\$:'H^IZ_J-GIL$-[KTJ3:G+C)NF2)
M85W9XP$11@<=3U))X?P_^R]\-?"^D:UI6F>'3;Z;J]M+97-J;ZY:-;>5MTL$
M0:0^3&YQN2/:K  $$ 4 >4Z]XT\>6:>)-%U;QG)=/J7PWN?$L$EA:PVSZ?=P
MLJL("%+>6PE3_6%VRI(([>W? >"6U^"_@9;B^N-0E?1;.3S;D1A@&@0A?D51
M@9P.,X'))YIZ_!/P?'J5KJ']D&2[MM&/AZ-Y;J:0'3SUMV5G(=3@$[@22 <Y
M QSVD?LZ>&/#'BSP+J>AVS:9!X3CNH[1/M5Q-(Z3Q>48F9Y"&0#:1N#$>7&%
M*A<$ F^-OQ!U7PMK/@7P]HS_ &:\\3:C/:_:Q)&CJ(K66<11M*CH'D9%4%E(
MQO &XJ1YOXN\;_%[X8?#6'Q/K&IV&NWN@:T(M1T;38HY+K5M-D*;%^6,".]5
M9 2L8$;!21@$$>Y?$KX6^&/B]X;_ +"\6:5'JVFB=+F-&=XWBE3.V2.1"'1A
MDC<I!P2.A-4=%^"OA/P]+X?DL+":&30I+B>S=KZ=R99T*2RR[G/GR%21OEW,
M,G!&30!YA8_%W6;ZV^$NEKXLLY[GXA3W=V-9LXXG2W@B@,XMK<%=K-]U-\BD
M_+(=H) 6'4?B9X[TKQ?X:^',VL:=J?B>ZMM4N[G4M*$,;NL$D0MXMDV467RK
MA)9%VGA?E 4[AV4O[*OPUD\)'PVV@S-I*ZFVL0Q'4[KS+6[8DM+!)YN^'))R
M(V4'<W')J]K_ .S=\/\ Q3X?T/1]1T)I+?1+A[K3[B*^N(KNWE<Y>07"2"4L
MQ.6)8[C@G) H \NMOBA\5-6U'P]X%NY-/L_&_P#PCUSJM_<:)/;R)+/'=FV0
M+YR%0@V@R*J[@S[05VG=+8_$'QK\0!XC\(ZKKFG^'==T#PE%?:F^B>3=1WEY
M,UU&P7S$;]U']EPRKM8-+MW#:"?3_$?[./P_\4V7AVWO=#=#X?W_ -FW-G?7
M%K<P!_\ 6#SHI%D8.>6W,=QY.3S2:]^SGX \0:EH]]<^'UANM)L3IEK+8W4U
MH?LAZV[^4Z^;%U^1]R\MQ\QR 1?LQR+<?LR?"EHG*;O"6E8(.2O^AQ?J*^8]
M.N_$-]\'/"5U_;1U/69OB^L*76JQ1.J,-0G0RLL?E[CCYMH8#*A5VC K[-\#
M>!-&^&WA73O#?AZT-AHNGQ^3;6QF>7RTSG&YV+'J>IKA[K]F'X>7#7.-+O+=
M9]97Q 4M]6O(E2_#O()HPLH$9#R,VU,+DYQD# !Y5XD^+GCOPEX6^(]E=^(H
M-0U'P?XPT73AJTEA$KW5E?/8L49% 171;PC>%Z(.,_-6]J&O_$;Q#\3_ (J:
M/8>,[?1-!\+PV5Q EOI44ETXFM99&3S')5<%4(8JV>>!W]#UO]G/P-XB7Q(N
MH6%_.GB*^@U+5$&L7B+<7$)4POA90%V;(\!< >6G'RKC;T/X2^'/#OC#7O%%
MG;W7]LZ[#'!J,MQJ%Q/'<)&,1@Q.YC&T9 (4$!F'\1R ?/OA'XA>)?A=\(OV
M>_%&K>*7G\"ZIIVGVFORWT,(>T:YLU-K(TVT$1"4I&S-\WS!BQY-?1'PQOM6
MU?P99ZGK,SR76I;[V**2)8WMX)&+PPN%X+I&45CW8&O,=:^!TMAHNF?#'PYX
M=L3\+KKRY=4N-6U6>\FMTBDC9;:&&;>=K+&J*0ZK'RP *@-[N@*J : /D;QG
M\7_BSHV@?&/Q;8>(]%DTWX>^(9($T=]((:_MDM[6X>!I?,)0B.? =026SG P
M!T^G_%;XC>./$NM:AX:.GV^BZ!XOET.^M=1GAB@^Q0/Y<[LV#*)F),B$$+MV
M J>2;?PT^!<][XZ^*&K>+])U*SM-9\4KJ]E:-J@>RO8$@@CB,L$<A&Y9(&<J
MP (>,'=MPO>2_L[> Y?B#<>-?[%,6OW,L=Q<M%=S);W,T8_=RRVX<1.Z]0S(
M2#SUP: /#I?C5\2?#_A+Q?XNUGQ+I?\ 9FF^*;CPC:VXTH)%'NU"*VCU":7S
M"0(E:3,>,-A03SFN]^(WCOQG\*4CL)_$-GK?]O:_I^E:5<R111WEE'.DA<S8
M58B6>%TB8J%W, P8C![[3?@#X(TSPMXH\.#1VO-$\37,UYJMEJ%Y/=)<32G,
MDG[UV*,S8;*X^8 ]0#5&W_9G^'=OX$U'P>V@F[T'4!&MQ#>WMQ<2L(_]5B:2
M1I%V=4VL-IR5QDT >9:]XW^+WA5_"FDWVN:-97FK>,%T6&ZNH([J9[*6TGEB
M>=(C&BRAH& "!0^5Z $'FO%OC;QAXAM--T?5/%%Q!=:)\6;3PW)>Z;!#']NM
MS'#=1-*C(5W+YJC  7* D' KW.R_9P\"V>G:+9)87CQZ1JB:U:R2:K=M,;U5
MVK-)(9=TK!?E <D!?E QQ27W[-/@'4;+6K6?3;UH]7UF/Q!<LNL7BR#4$QMN
M8G$H:%QA1F,KD*H/ & "I^U1XRU#P#^SIXVUC2[[[%J,6G^1#J#D+]G:5UA\
M[(P 4\S?Z96NGU7P=%HO@B*R\-Z-I-YJ.F::VGZ7#JPQ"J;57RW=5+!&V)N
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MJJD$#%=EX(\!Z7\/]%_LW2_M+J\AFFNKVY>YN;B0@ R2RN2SMA5&2> J@8
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MZM^UKX,U>_\ #,FJ:3;>%]1M7U%]+>XA@N6FA>)3(%*AC&EP!G^\5ZN,^4_
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M;21);3DL#Z'.'4G=^*'AKQ?X@^(GQGTW0M"U3S/&O@;3[?0]7\AHK59X5O\
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M1S6L::C$3.DA B9,-\P<GY<?>YQG!KY6N?#5K?>#? FD6&@ZQK5W8_$Q-?\
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M5^(?P2\9:A81:?;^']"\4V6F1S2AS>M<6VIV\4L\3 @1[9MT87!)4,VX9"D
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M;WB;[=$,*90KY<NXD$M\H7Y2: /;?"G@S2O!EG+;:9#*JS2&::>YN)+F>=\
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M!FH_"T6MI=>/-<\5Z-ID9@T?3]4\I19Q8V@.Z*&G8+\JE^%&<*.H]9_.C\Z
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M'Y3(D8"(%*F-"&R"6JG]FNPBOO#=[:ZY>6]WIGB2X\67DGEHPU*_F1HW:1<
M*HC=HU"X(7;R2"3[)^='YT >0Z/\"=3\.#6FT[QA,6U76[O6[BWO+".6UE-S
M&$D@DB#+OB& RY;<".6(XJCX6_9FA\!ZIX%O?#7B6ZTK_A&M-O=*EA-K%*E[
M!<SQW#IAO]4HFC4@)R$^4$=:]L_.C\Z /$X?V:5B^".G?#P>*;SS-)U&'5-,
MUQ;:-;B">*Z%U$SH/D?$@.>%RIQP1FL75OV0HO$/_"2WFJ^-]5N]?U;4].UV
MWU=;6WCDT_4;.%8HIXE5-I& 5V'C82"2<L?H;\Z/SH \:UO]GN^\3^&='M]8
M\<:G?>)]-URVUV/Q";:!66:%6142W"^4J>6[C&#\S%CN-5]?_9:TGQ4?B"=5
MUW49Y/%\]C>/<0B.&:QN;-$6VFA90/F7RT/(()!XP2*]M_.C\Z /%_%O[-5O
MX]TCQ:NO>(KFZU[Q)I<>A7.LQ6D4;PZ>DCN((TP5&YI'9F.22V1M 4#JM'^%
MLVF_%2?QS/KUQ>7MSHEMHD]JUO&D3I#))(L@(&0Q>:4XSC#8QP*[[\Z/SH "
M"17S_P"+/V0--\31^+M.M_&7B+1/#'BC4EUF_P!#LC;-"+[SXYFFC>6%W3<\
M08J#MW$G&/EKZ _.C\Z /+7^ .GW-Y\19KSQ!K5]'XZTY=-U.&5K=1$BVYMP
M\)2%2C;&;J6&3G K-^'_ .SM/X'\9Z'XEF\=:YK5WIFB_P!@M!=0VB0W%JK;
MHE8)""NPX.5(9B!N)&5/LGYT?G0!XE/^R'X"G\(W_APVDO\ 9]YXD'B5PQ5B
MDOG^88$XPL)5I(]@Z++)CEB:ZK7/A/<ZK\5;/QU;>([G3KRTT2YT2&TCMHGB
M"3.DC2$L,EA)#"P&<?N\8PQKT/\ .C\Z /#M!_9GC\(V/PO6T\17U\?AU'<K
MIL4D$*&Z66$Q;)"!QB,E01CKDY->0_ #P)XU\,7>AW%I'XCT_P 0S72-XA@U
MOPW80V[(TP>\S?(HEFR3(8V5W9F"%E"YQ]GXSZT;1Z4 >+S?L_W%L!K$OBK6
MM6\2Z9H-YHVF:I$ENE^L<VULM*P EE4QH$:0@ EB<EBU>E^ M.UK2/!>B67B
M*_75-<M[2..]O5  FE"@,W  Y/? SUP.E;OYT?G0!R_Q/^'6E_%GP)JOA366
MGCL-0109K20QS0R(ZR12QMV9)$1QVRHR"*\^UC]G*^\2_#O6/#.N?$/7=9NM
M3%M%)JUU#;^9'!!()$C2-4$>2PRTA4NV>3PN/:?SH_.@#QJ__9VN&\?ZIX@T
MGQUK6@:=K_EOXBT.Q2/R-2E2-8_,1V!>V9D558Q$,0!AE(S46@_LUOX8\<:S
MJ&E>-]:LO"&KZF=;O/"2+$;=[UG#NZS%?,2)W4,T2D!B2"=IVU[5^='YT >"
MZC^RO)=66LZ?;^.=4M=+O?%B^+[:U6U@8V=V+DW3*KE=S*9\-ST  '.2>M\6
M? NP\:?$.;Q+JM_+<6MUX:N?"UYI/E@0W%I.^^7YL[E8D+R#T&.^:]-_.C\Z
M /!;7]E"-OAQ>>#-5\?^)=<TP:=_9>EM=_9PVFP!D9=NV(>:P\J-=TNX[05&
MT,V8=9_9+/B"V\<KJ/Q!U^^F\::5!I6L236]F%E6(N$=%6%=A"2.H"G'S$D,
M<$?0'YT?G0!7TRWGL]-M8+JZ:^N8HE26Z=%0S.!@N57 !)YP!@9XK-\0>%H/
M$6HZ#=7,L@32+TWT<"XV2R>4\:[_ %"^86 _O*I[5M?G1^= "UPGQB^%B?%W
MPU9:-+JDVDQ6VHVVI>;!$KL[P2"2-3NXV[U4GN<8R*[K\Z/SH \8\6?LVIXP
M/Q/6Z\47D4'CVUMK.]ACM8L6J0Q^6/*)&<LA8'<6Y.1BHKC]FEX_&D_B;2?'
M?B#0;[5+*VLM?CL##Y6K"!%C21A(CF*78NTO&0<=,')/MGYT?G0!XO:_LR6.
MC^.=;UC1?%OB#1M"UZ>.[U?PS:S1FSNYD4(6W,ADCWJJA]CC>!@G& *VK_LP
MKJOA;Q?H7_"7ZC#;^)/$D?B::1;>(M!.DL4JQQY& F^WA/.3\I_O&O<?SH_.
M@#P2^_912>]OYK3QUK^F07'B4>+(K>WCM76"_)!D<&2)F920<(Q*J#C!XQ=N
M_P!F<W7A^^TW_A+KZ.2Z\7Q^,OM0M(2T=U'*DR1@8QY8DC0\@D@8SR:]N_.C
M\Z /#_$?[+&E>*M-^(%E?Z[J"KXLU2#6EGM52*;3;N';Y,D#@=A''][.<'IF
MC4OV<=8UW2M$EU;XBZKJ?BK2M5M]4BUJXLX/*S"DL:1BT $0&)I#NQNW$')
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MK1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0
M<>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U
M !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NH
MW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&
MZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZ
MT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M'
M'K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZ
MT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 '
M'K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0
M <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K11NHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>mmsi-20221231xex10d61g002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231xex10d61g002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1/ U8# 2(  A$! Q$!_\0
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M+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M%
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M*,^XH ,_YS1G_.:,^XHS[B@ S_G-&?\ .:,^XHS[B@ S_G-&?\YHS[BC/N*
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MG0 M%)10 M%)^='YT +1244 +12?G10 M%)^='YT +12?G1^= "T4GYT?G0
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M!L/"6NV=_/XEL+&R_LR>?6/#3Q)(GGW06%$D+?Q,@5QC[D@_O@TOC3]IW0?
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M-3^,OVJ_#G@C5/%]G>>'_$URGA-[<ZQ=VNGJT%M!,H9;C<7&Z, Y.W+<,0I
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M!J^&)8+*VN$5)%>X990[,?ES<LQ&W/11]W>P!K>%/BY?+X\^''@_2M'U+4=
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MHR>*\P\6?%N#XCR_!/Q'X;NM4TNVN_'DNB7UF;@QB14L[_S8I5C<QRKYENC
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MR2+&I(7H-S#)/ JQXY\<Z5\._"E_XCUMYX]+LE5IWMK>2XD 9E4$(@+'EAG
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M\4?%_B/PM\6&N]2N]2?P2=7TJV@U30+X,NE2%H0UG?6F1N6=I0?-&6598QC
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MMKMUN&>5FDMV#0$LS%L1E1M7. .,8)KM0,#%<(_QT\!Q^,QX2?Q3IH\1^?\
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MN**6&.YA@ ECCD&UT5_O*I!(P#@ D#&36O>?%3PMI_B&VT.ZUJU@U2XG%I%
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M((-,O/VB_AWIFCZ;J=[XJLK.RU%KE+1[G=&TK6Y<3*%8!LJT;K@C)88&20"
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MKOBJ?4],\3H4-NMM+>I<BYD;=N26(;EV;<DJ@7(R5]6\ Z-J]C^TG\3M9N=
MN[+1=7T[2+:SU!C&8[B2U%UYK$!MP_U\:C(Y"'IQ7K!UK3EUE-)-[;_VF\#7
M*V?FKYQB#!2^S.=H+*,XQD@=ZO;5H \=^*7AO4M4^./PEU:'0;G4M)T9M2:\
MO8UC*6IFMQ'&<,P;.X'[H. :\@\+?#/Q3I?P_P#"5G+X/U!-0L_B8^OW$:K#
MNCLC<2N)B=^#\DBC );@C'%?7MS<0VD$DUQ*D,,8+/)(P55 [DGH*@T_5;'5
MHFDL+VWO(U.UFMI5D /H2": /DP?"CQAJ/PCO?A;?Z/>1>((?&"ZO9^*U"&!
M[8ZL+TWGF@_+,(R\7EX#YVX&W)'H.H?!_7K7]H:[U'35B'@#Q+%:ZMKL;'#+
MJ-D=L(09X\W,#-\I!%JP)RPKWX_-UYI-HH ^4?#?PSUZP\=:]H7B'X<W/B&W
MD\7S>(=(\2MJQ.FPPRW+7"O) 9@RSPAV10L9#,%Y ):L3PIX,^(*?$;X;:YJ
M?P^UB"30_$>KRZBEG=V<.G6\-S'=1QO:VZS ,I\Y9))''F$E\%]P%?9( '2E
MS[T ?(?@'X*^*&^&G@3P'JOAF73=1\->-!X@GUB9X'MC#%J,MXK0LCEV:2-U
MAP54C<^[ 7#4M5^%WCZ33]3US3_"E]<W6E_$6^\2IH,]^MF^J6,T+0[H98Y/
MEE4,74,5[CO@_6NG>)-,U?4;^PL]1M;N\L&5+N""97>W9AE5D Y4D<X.*9>>
M+]"TRY>VN];TZUN$^]%/=QHZ_4$Y% ')?!#1O[+\/:I=?\(G)X-.J:@]\VGW
M5R+B[=V1%::X<.ZF1BG0,?E"Y.20.#U'P=XGUKXG?&E6T.XM=+\3>&K/2=+U
M*:6/R7EACO5<L Q= 6N4 RO.TFO?EVD J01U!%+M!H ^6?!NA>/[SQ5\)+[5
M?A[>Z?8>%O"FHZ-?I+?VC.]R\5H,*!+@QN;;:C9!)8E@JC)K>&OA/XQTSX#?
M _P[+X0G;6O"^M:9-JT'VFT_=Q6S/YDH;S=K@EMR@$L3V%?5^!6;X@\0Z9X5
MTR34=7U"VTNPC9%>ZO)EBB4NX1 68@ EF51ZD@=Z /F'Q9\+?&UUX?\ BO9V
MO@Z[N)]=\=Z7K>GR+?VH\VTMY+)Y'"M, G_'DX .&/G)D8!VZWCGX9^,/$&O
M_'[2;7PZTVG>./#<<&F:I+<PB!+E+&2 1,NXN&\QE(.W: "=PP,_36!W.:,#
ML<4 ?(?B#P?\1?'@\13GX>7VF1:A\,;KPO;QW6HV9E^W-G:&42X5"2<-N/ R
M0N<5K>,OA]XPTK2/@QKUGX!'B<^&](FTG6_#1NX8KI3-#:J)HGW^6Q1K7!^8
MY5^.Y'U-@=N/I6-J/C'0=(:^6^UW3[(V*QO=BXNHT^SJYPADR?E#'@9QGM0!
MYMX(UV]^'%[X&\&CP#;:!8:\U_*4TJYB\G274/<+'(@.9&<;MSH-H<XY!!J7
M]I7P[XC\3^&?"]OX:T&;7KNR\4:1J\\45S!!M@M;N.>3F5U!)6,J ,\GM7JY
ML[=KH7?E1FYV>6)]HW[,YV[NN,\XJ?- '@J^'O%NA_'KQ[XQMO"=WJNG7WAJ
MQL["-;RUC%Q<PO(S1'=+E ?. W$8^1NOR[N5^#OP8\7?"#5?$WA>UT..Y\(>
M*--;4%U&)H(1H^I2(XELA%YA?[,#AH]FX(7(^;+/7U'@?2C'N: /D_PGX/\
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M",9H 6BDX]:* %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH
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M<(<'(;GA<9-WQC^TAXBTGP-XY^(>E6&FWWA7P;KMSI-_I95_MT\-K*(;N99
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M?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0
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M>:N^$OV</"?@KQ9<ZSIC:I':RWCZBFB-J$C:9!=.<M-';$[%;)9AV!8D $#
M ?&;Q7?^%_%OPGAM[?3+FQUKQ-_95Q]MMFDGB+6=S,DD#[@(V'D.I)!R'XQS
MGFO!OQIUV_\ C?-X+UZXBT.]:^ODM]'OM-DA%[8Q>8;>XL[K>4G8H(GD3@KN
M8!1L)/IGCSX8Z;\0K[PS=W]U>VT_A[4EU6R^R3! )U1XP6!!W#9)(N/1S65H
MOP4T?0_$&EZL;S4M0;2;FZN].M[RY\R*SEN ZR,G ;[LCJ S$ ,<#H0 <S\4
MOBCXHM?B+#X'\(6#S:F-#?6I)ECA<M^]\J),2S1+LW [R"S8*@;<YKBOB/\
M'WXB?">P\&:KXCL-%M[3Q%9?V9<6L; MI.M-M"2RRB4J]GNW!R!E/E^8Y /K
MOQ+^!GAWXH:QI6LWTNIZ5KNF*\5MJNBW\EE<K$^-\1=""R$@'!Z$<8YJ.^^
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MC/N* #/^<T9_SFC/N*,^XH ,_P"<T9_SFC/N*,^XH ,_YS1G_.:,^XHS[B@
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M?\YHS_G-&?<49]Q0 9_SFC/^<T9]Q1GW% !G_.:*,^XHH /SH_.C/N*,^XH
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M*=3\6Q?#K0(=5G\./91?9+IK<0W+S6\5Q(LDK7*/%A)=JE48!D;.[HO>Z_\
ML^>'/$DOCM[V]U5E\:Q0P:M&MRH5HXDV(L8V_(-F5..N2>O-9^H?LN^#=1\1
MC7'N-:M[V>Q@T[4A9ZE);1:M#"-L:W<<>U9?E^0G RO'2@#FOVW/$-YHW[.>
MI3V]Q/IMG?7FGV6I7<!^>"RGNHHY\,#QE&*$YZ,>>0:@_;2T^U\+_LOZWJ>C
M(FCZCX8^QWFASV:K$UC.D\21B' ^7*L8]HZJY7O7N^N>&-*\3:!=Z'JMC!?Z
M/=P&VGLIT#121D8*D>F*XRW^!'A[;HT&H7FK:YINC2K/I^FZI>F:W@D3_5L1
M@&4IQM,I?:0".0#0!YCXH^/'C;P_H'QJN-FE1WW@W3M/O[!);1\ S6WG2Q3#
MS?GP59005QD<'')H7C+QW<_%+XK75A?0:S+I_A+2M2TSP^UMLC>XFCOFBB5_
M,^7,D6&8_>#*/E"BN^\<_LT>#?B#J^OW^IOJT+:_91V6J6]CJ4L$%XL881/(
MBG#,@8XSQP,@U)=?L[^&9=9NM2@O-<LY[O0UT"Y%MJLJK<6Z)(D;29)+2()I
M-KD\%L]0#0!Y!K7[1&M:G\)?&>OV5YH>JWFA2Z8+C1=9T6>SNK%I9U26*YMG
MD)#='C<':<'KC-+^TMXWUCX@?"?X[V&EWUG9Z-X3M'TNZMI+;S9KZ1K6.>4Y
MW#RU F5%('+(Q.0,5ZKJO[-?ASQ#I&O66K:EK.HW&N"U2_U*6Y1+J6*V;?!#
MN1% 16);@;F)^8FH_&/[,'A#QCJ6NW][-K$,VOV4=EK"6.I26\>HB--B23(F
M%9PN!G &!@@C((!Q-]\8_B#K5WX@TKP#H4%U=^%8M,C:VD-NMM=/-;0W+K(\
MDZO&GE2A5*J<,I)+?='T*]A;:NFGW-U;1R2V["XBW8?RI"A7<I]<.PS[UYCJ
M7[+/@?4?$D&N!=6L;XV4.GWILM5GB74[>(!8X[L!OWP"C;EN2#@DC%>N+$J1
M+&H"HHP HQ@4 ?/'[+&G6OB#2/BDNH01W0MOB?KLD0E&=C1W89&'H00*U_V2
M;6&S\)^/1#%'#GQ_XD7;&H4874ID7IZ*JCZ 5WWP\^$VC?#)-=CT6>_,>LZA
M+JETMW<F;_29>99%)Y!<\D=,] *=\-?A1HGPIL]4M=$>\:/4]0GU2Z-Y<M.T
MES,VZ23+<Y8XSVXSU)) /FCXKV/BGX1ZG\4M=?2K;XD?![Q//)=>(;"W<+JN
MCN($AF="^1(BK&C!?X H(V@$GT_4?C;K*>(_&EII$]E<Z/8^ ;7Q;H\\UL_F
M;Y3=J%ERXWJ?LRMC"GYR,\9KM-9^".B:PVO*;O5K:SU^1I-6L+?4)%@O-RA6
M!4DF,,JA3Y93<.#FJOBW]GCPAXMUVVU:>"]L9HM)_L&2'3+Q[6&XL Q9;>1$
M(#1JQ)"\#YB#D$B@#Q'1=;\<_$KXD>#-?\.:GI'A[Q)K?PKM-3NKNZLGN(4E
MEG239''O&%+L1EBQ5>@8UI?#OXZ_$SXOZMX-TRPO- \-/K/AO4K^]E?3Y+HV
M]U97\=G(\/[X*Z2,^5!QA3DEB #ZQI_[.WAK18O#O]DW>M:1/HFEMHMO<VNI
MR&5[(L&\EV<MD C*D8*=$*@ #0L_@;X9TKQ'HNM:9%=:3=:/IDFD645E<M'#
M':ORZ>7T.6"/N/S;HT.>#D \>^$OQT^('BV?X,:UK%UI"Z1XZ^V6%SI5M9LK
MVTUO;7$WGK,7.=[6S IM 4, "Q&ZK=M\7/&NG^#/%6H6^DIJ4ND^.KS2=1?P
MWIP,\>GIDFYCMV8^9+N:/=RQPS-@[:]%T']G/PSX<T[P996=SJH@\(W,EUI(
M>]),;R9W[CCYP5>1,-GY96'7!$]I\ ]$TV*<6&JZU82RZTWB SPWQ,@O7C>.
M1\L""KJ[9C(*=, 4 >3ZY^TAKUIX+\,^(K?5K6X\,WUK?F?Q=IVD37%E!<Q3
M[+=;N'=YEO&5W>9P2KJ0& &39\8_M%:A\,/$GQ+U74;+2]6TO0O!^F:[93:?
M$8Y+PS/-&%,Y9M\1E5BK!0%#'@G)/H\G[.GAO^SC8VU[JVGV\UO=VUZ+>[Q]
MN%U(9+AYLJ=SNY8[A@C<0N!Q5M?@#X4.M:M?303W=MJFAQ>'+C2YY=]H;",$
M)"$(R -TASG.9&_  X/QW\7O&GPO\56VA7][I>MKK/AO5-9TV_CLG18+JR1)
M)8I$63YH625=K9# \$M4GPJ^,GC?7_$_PQB\1?V'-IOCGPO-KL$>FV\L4MG)
M$EHY5G>1@ZLMT.,+M((RP&3VUA\!- LM.>UDO-5OW72'T*VNKV[\V>TLWQOC
MB8KP6VIECECL3)^44_0?@5HGAS4?!-Y:7VJ%_"&G2:5I<<EPI1;9PJLCC;\_
MRQQ#)_YY)WR2 <?\:8$_X:6_9WW*K9O]<&2,D?\ $KD/\P#^ KD?B;>+\,OV
MN/"M[X5:TM+SQ!X9UB?Q%:RR^3;2):QH]I<SXX7]X63S#R%##/8^V>-OA+I_
MCKQ5X<\176I:G8ZIX>,S:=)8S(BPO*ACD8JR,&+(2O.0!T .351?@'X4N;7Q
M.-0@NM8OO$>G2:1J6I:A=/)=36CJP:%7R/*3YV.V,*,G.,\T > >*_CYXXU'
MPI\2=..H0V_V7X;OXLLM7MM->V(F17$R0K(Y+Q-L^21@"-V1N !KMKGXE^/)
M;RT\%>&=M]KUEX3M-;-ZL%OB::=YHX5>.:="(A]G.]DW'+CE>C=/:_LF>#8G
MNI+NZUW5I;S09?#5U)J&L3RF>P<%?*8;L?*K,!@#!8MRWS4NH_LH^#M0'AV9
MK_Q#;:OH=J;&WUJUUJXBOY;8G)@EF5MSIGD ].V,F@#L+C6M?O?@_<:I=6MC
MIWB4Z.UQ-:R_Z5:17/D[F0[6'F1[LCAAD5X=JOQY\4Z'\'?ACXG>,:#HFL>$
M;?4;K6[32C=65E?R00O&EQ&AWPVWS/\ ,H..!D8Y^C9/!^G)X0?PU:(]AI36
M9L42U<HT4139A&Z@@=^M<)!^SIX?M?#FGZ%!JNN0:;9Z,/#_ )*7Y FL03MB
MDXYVJQ16&&"\9H N_%SXK-\//A7;>([46VHWEY+96=HT4B_9WEN9HXE<.S*N
MP>9N!+*" ,L,Y' ZKXP^,VA> _'>IF#2;:ZT:&/4M+;7?*#7,"K(;B"<03%(
MV'EY24':=X!'#8]?\4_#/PUXQ\ S>"]6TN"[\-36R6C6#9""--OEA2#E2I52
MK Y!4$'(KF?#_P"S[X:\/:(-,6YU?4@;JUNY+O4M2EN+B4V[;H(W=CDQ(>1'
M]W))QDDD \9\??%C7_B)^R[XQ\>Z3KTVBVMS=V\-CIR0(+JQC2YC@G@N3R=[
ML7)48*J5&3DUT_B;XE_$76/%_C7PQX(:VNM4\'+I\;O>B!(KN6:%9W:?+AD0
MQL%!C488.<G@#OM2_9P\%ZC:>-;:2VO$MO&$JW&K0QW\JQR3 J1*BAL1OE%R
MR@$[1G.*HZO^R[X'UOQ#9:W=1:H=3ALETZYN8M6N8WU*W7I'=L'!G'KO)R.#
MD   'DOQ%^-WQ+T;_A=.I:?JND067P\6ROXK!K$R&\BEM8KAX6EW\  R+O5<
MDE3\H&*9^TCXRUGXB_![]H""TU6'3-)\)Q/I+V @666\;[)#/,[D\HI\_8FW
M',;$YS@>WZK^SUX/UQ/&4=W;7K1>+Q&NLQIJ$R+<+&H1% #?(H0!<+@;>.E9
M_B7]ESP#XIN]6N-0M-0,FL6<5EJ@@U:ZA744C7;&UPJ2!97 'WV!/O0!R'C3
MXG?$36O%_CS1_ -K;/?>$KBQMQ#>20"VN#+!%<R&=F<2(ICE**4'!0DEN@X+
MX^>-=>^*GP3^)NIV6JV]AI'A_P 0PZ(VF&W#_:%@N+43.TIY#%W8IM &U5SG
M=D>Y:I^S+X"UKQ';ZW<Z=>"_CLXK"=XM4N46^MX_N1W0$F+E0.#YN[(X.14/
MBO\ 9:^'_C#4?$%U?V-_&-?,;ZG:V6K75M;74D>W9(T4<BIO&Q?FQGC/6@"C
M^V'J.KZ+^S=XRU#0[Z:POX;5 K0(K-*K2(C1X(/#!B..?2JTOC'Q9XM^(?C#
MP)X>\0+I&H^%-'L;G[?=6:2_;[FZ$Y0NF !&@@7.S!)D/(QSZGXN\!Z+XZ\$
MWWA/6[9[_1+VW^RSPR3/O=!C!\S._<" =V<Y&<YKE[SX >%[N^MKY)-7M=2B
MT\Z5-?P:K.+B\M"6;RIY"Y:0;G9@Q.Y23M84 6/@-\29OC'\'?"7C*YL#IEQ
MK%BEQ+:\X1^0VW/.TD$J3V(KP;0/%5]X,UK]HC4+#4;+3+UO&>GVT-S?1O*
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MB:1V"HHR23P!6-X1\;Z'X[\-Q:_H6HQ:EH\K3(EY%D(QBD:.3&0.CHXS[>E
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M7>'?!ESHOAG0]=\"#Q#!:WT$E[):PQRV:QH9=R;V,5PBGY0%)<Y?"FM7P/\
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MW%%+10 G'K1QZTM% "<>M''K2T4 )QZT<>M+10 G'K1QZTM% "<>M''K2T4
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M&3GO_ /@72/AKX5L?#N@PRVVDV*>7;PRW$DYC7K@-(S''H,X':@#R_X^>/\
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M^*/@?XF\>> _A=\*+R'7+"X\+Z_K<NA/HZ6 2:U66>YV3I,68NZLF64KM(P
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MM':QD@,BM:SM=CY(FMHUV%&.<1@!6+8H ^E1XRT$ZZVB#6M/;65&XZ<+I#<
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M$)SDCH,<UY-\"VN[SXU_%K6V\,ZQH.EZV=*N+.?5+%K871CMC'(P!Y# X!!
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MM8CUW]G7[;X9\0:;_P ([X(OM,U*2\TR54@N#%9(JLP!"EC9S$ X)&SCYUR
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MQZT<>M "T4G'K1QZT +2;0>M''K1QZT +2;0>M''K1QZT +2;0>M''K1QZT
M&Q: ,=!1QZT<>M !L6@#'04<>M''K0 ;0.E!53U7-''K1QZT &Q:-BT<>M''
MK0 $ ]1FC8OIBCCUHX]: $:-2.F?K0L:@?<%+QZT<>M !M Z4M)QZT<>M  0
M#U&:  .@Q1QZT<>M !L7TS1L7^X/RHX]:./6@ (SU%&Q:./6CCUH 6BDX]:.
M/6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BD
MX]:./6@!:*3CUHH .:.:,_YS1G_.: #FCFC/^<T9_P YH .:.:,_YS1G_.:
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M*\M\"?%'Q'JWQ.U+P?XHT"RT6X_LF'6[ V5Z]P3 \C1/'-NC4"1&52=N5(D
M!.TFN[\7ZC>Z3X6U>]TX0&_MK26: 7()B,BH2N\*0=N1SCF@#0>_@CN(H'F1
M)I<^7&S ,^!DX'? JQ^(KXRTKQ)XM\5:A^S'XN&FZ1J_C+5=&OB;N2Y,4<B/
M81.7F=4+ AB2453AB0,<D>B^'OVHK_Q/HGA2UAT5+7Q7K$6JR7$,4-S?6UJ+
M"[-I*V(4,C!Y<!3@!022<@!@#Z'S[BC/N*Y+X5^+]4\=>!]-UG6M NO#&IW"
MN)]*NP1)"R2,F?F"G:VW>N0#M9<@5B_%3XK2^!]<\.^'M.L7O-;UQ+F:!FMI
M[B*&&W$?F.R0(SDYFB4  #YB21C! /1\^XHW>XKYW@_:(\=ZAKOP^T&/P!;Z
M1K/BFWU,M#K=[+ +:2SVY;:(BQC<.K+D!CG&!C<<VR^.?C/QS>_!.ZTZWT[1
MX_$&N:QI>L6+R/*&FLH;U&5' &8]UM(XR <K&,@;J /I.UO[>]:=;>>.8P2&
M*41N&V. "5.#P<$<'U%3Y]Q7S#>_'"?X:>#OBQXDTKP/I<%WHOCJ+2=1MX+U
ME^W-.MBHNMWE\RM]JA!4X "D[B1@]!J_QW\:Z7=ZMX?_ .$8LKCQCI&F_P!I
MW-GIPN[^WE$DLRVL"/'""CR) Q+. JDKP<G: >_9]Q1GW%9WAO4Y];\.:5J5
MUI\^E75Y:Q7$MA<D>;;.Z!FB?'&Y22I]Q6C^= !GW%&?<4?G1^= !GW%&?<4
M?G1^= !GW%&?<4?G1^= !GW%&?<4?G1^= !GW%&?<4?G1^= !GW%%'YT4 'X
MT?C1S1S0 ?C1^-'-'- !^-'XT<T<T 'XT?C1S1S0 ?C1^-'-'- !^-'XT<T<
MT 'XT?C1FC- !^-'XUR'@KXC0>,_$7C#1DTZ\T^Z\-7Z6%P;O9B8O"DR2)M9
MOE*2*1G!YY /%=?F@ _&JNHZ9::M;-;7MO#=VSXWPSH'1L$$9!X/(!_"K+,0
M..M4M,URQUB>^AL[E+A[*<VUP$.?+E"JQ0^X#K^= 'GFG_ C3?#GB#Q]KOAN
MYC\/ZSXHM(;:*[M;*'.GM'"8U=%QAN2'*MP2HKT;2;:XLM+L[>[NVOKJ&%(Y
M;IU"&9PH!<J. 2<G X&:MYI&;"YH 7\:/QKRW2?C9=^(K/Q.^E^$=3NKS0/$
MR>'+BR\V$2-D6[/<@[ROEJEP'QG.%[=O4(V+(">M #OQJKJ<DL&GW4L,;3RI
M&S)$@!9V .  64$GIR1]1UJUFN*^,GQ*C^$/PXUOQ=/I=UJ]KI4!N)K:S*"0
MH",G+L!@=3U.!P#0!XEX0TSQC\/=%\0:1H[>(D35]2O-7>ZF\*Q2SQ3W<K3S
M%"MV$QO=BH93MS@YQ5+4/!&IWS?$*$6OBS[)XO\ #=MX9D6YT!99;>&&*6(2
M>8;D&1RMQ.23CYF4_P )#?5J\J#T/M5/6-:L_#^EW>HZA<K:V5M&999G/"*!
MR30!\V^'/#NJ^%?&NB^(["U\7I/9>%K7PQ<VO]@0F&\2V:9H)3F8LF&G8E5;
MYL 9%9W@WP+J7@]/A1##:>)I;7P!;W%I C>'$!NXID$9#'[3\A"  $=^2#TK
MZQW'UI#SUH ^6M#\*ZKX7\=ZWJ.CR_$'3_"6M:HVLWWAE-'@93=.V^4QW!DW
MQI(XW,B]<L 1NX]O3XD74ENSQ^"/$Y1!SN@MU;H#PIG!/![#KQU!%=M@>U&!
M[4 >,>&-0U6T\7>*=>N_#'B35&UC[,(89;"U@-G%&KA8@S7/S+\[-C (9W/\
M0 \#\7^"?$'A?X;_ !(T'3]'\87VC>+=>&J3V<7AJ.1=*62Z22Z,2"X<S1F-
M&'EJ.6.05W&ON/ ]!7(>._B9I?@;P_XJU%@^I7'AS3#JU[I]FR&=8-LC X9E
M R(9,9(SL.,T ?)>E6WB7QK\//%O@D:3XG?PWXCM'BN=5?P(=/NXI\HIRDER
M#-OBR-[?=\L#)R /0/'>EZYXH\5^&?&.BQ^./#'C/2;!M-NK^WT"&:UU"!B&
M=)+=Y\ >8-RX;*YZG (^CO"VOQ>*_#.D:U!&\4&I6D5Y''(!N59$#@'!QD!N
MU:N!Z4 ?*&K>$=:7Q;8>)_#-U\1/#^M_V<-,U6XN-&M[T:I&'>17=7D"I(K2
M2%6484,%"[1@VKGPEJ-SJWCJ:*U\8QV?BOPW;>&Y(Y=%5[B!(4E1)_/:XR\F
M+B?)( )92?N\_4N![48'M0!\MZE\(KK5Y-+76=!\0ZOIUCX/F\'W&GPV-G";
MJVEV%W60WGR29@@(_N[#_>!&5:?#7QG+\/=9\(ZX/B/XAL;O2Y=%M)+B/2(V
MM+.3:&#;+P>=*515\R0G R !N;/UP=HZUS#^-#?KX;NM!TY]?TG5KAHY=0M9
MHUCM(@CD3-N(+J64+A<GYL]J /!M8\$ZKXBU6^NM2\'^-);>^\'R^#;BVBBT
MJ/=;R [I0WVTD29)]1CC'>O3O@]X0\0Z3H'A5=0UG6;>'2+&33Y=+U2ULXVN
M0"@AD;R&<*45,#:YR&.[FO4\#VHX[4 *.#UKSR^^%=S>?&S3/B&NO-"UCI4^
MC+I?V56C>":2*60E\[MQ>&,@C@!<8.3G2\._$9-?^)/B[PA_9UQ:S^'K:PN6
MNY70I<K=>?M*!22 I@8'=@Y[8P3V.: /*=>^",^L^*?'^L1^('M1XPT6'1+F
MW%JK"".)9E2123RX%Q+UXY'''.=I'[/$VD:]I6KQ>*)UO-.\(-X/ADBMEC?R
M"583A@W$H:-#P-O!XYR/9\U#=7D5E!)//(L4,:EG=R J@#))/84 >>?#WX0/
MX0\;:YXMU#4[;4M<U>TMK*XEL[!;))5@,A6610S;YCYI!?(&%4!0!SVWB?3+
MK6M!U"QL=1?2;NY@>&.^B4,]N6&-Z@\;AU&>,XZU9TK5+;6M+M-0LYA/9W<2
M3PR@$!T8!E;GGD$&K6: /*?B!\!;3X@? N/X9W&HFRLEL[2T%_;P 21B!HV1
MT7.%;]V,'/%-D^">I7/BR3Q%=^+'O-2E\,GPU*TMA&%D4N7-P0I'[PN02!A<
M# 4=:]8W>XHS[T >(:3^S%::?IWPZTV?77O-,\&:?=:7':R6B 7MO/#Y#+*0
M<@B,  KCG).<TWP?^SEK/A'PW=^&_P#A96LZCX=BL9M/T:QGMXD.G1.AC&Z1
M,-.R(<)O(5>#M) QWFN_$R/0?B5X5\(RZ9<R-X@CNGAU!'3R8V@0.R,-V_)!
M&#C'O7:DX- 'A;_LL65[I7@O2-0U^6\T?PYX7O/"1M?LRH;NRN88X)"S@Y5]
MD$/([JQQ\V WPO\ LX>(-!\1^$-8O?B7?ZU+X6L+S3-/2ZTRW&;>=8E E8#<
M[#R(B6R"VP?=RV[W;-(7 ZT >(^%/V9D\*0_"B*+Q++<K\.XKF&Q,MHN;E9H
M6A/F8;C;&V 5QSR<]*RD_9,?3M)T=M&\;WVB^)]%UB^U?3M=M[.-S']L?=<V
M\D+$K)$YQP<$;5YXY^@_,7UI0V>E 'E"?!"];Q1X*U^Z\87NI:EX<:\E>:\M
MT;[=)<ILD+!<"-0  B( %P.M<]I?[+C:)IWAR/3_ !A=66H:'XDO/$5M?1V4
M3-F[29+B$HV5P1/(%8@E<C@U[ON [TTS ;O84 +C" 9R?6O -?\ V5KS5]:U
MVZM?'VH:=8ZCXDM?%45FEA;R-#>PO$PW2,"TB9A7:AP%XSN Q7I7@KXIVWC+
MQOXX\,KIUS8W?A6XMK>>6=D*3^?")D9-I/&TCK@\]!7;>:G=@/J: /#;W]F-
M[[PEXL\/OXNNQ;>(?$D7B:2<VL;/!/'-#,$0$XV>9;Q'I_?_ +W&?XG_ &1X
M=?TOQ=HMOXWUC3/#GB;54UV[TJ*"WDCCOO.CFDDC9T+*KR1ARF<;CGH2#]!Y
MK*\3ZXWAWP[JFIQ6DFHRV5M)<+9P,JO,44ML4L0H)QC)(% &E;HT,,:/(965
M0"[8!8^IQ@<^PKROQC\!8O$WCGQ!XEM/$-[H\NO: ?#^HVD,,,L4\8$PCDRZ
MEE9?/8_*0#L3/&X,GA[]H"VU_5_A79#1+J >/]$DUJTG,J,EN$@BF:)AU)"S
M)R!C]<>KEPIP30!XFO[+^GSV7@W3M1UZYU+1_#GAJZ\+"QDMT075I/$D4F]A
MRK%(81E?[A/\5;OPE^"U[\-%MX]0\=:[XPM["W-IIL.K>2%M(21P3&BF5\*J
MAW)( (&-QSZ<\RJ,YK&TS6]2O/$FM6-SHLEEI=G';M9ZHUQ&ZWS.',BB,'<G
MEE5!+?>W\=#0!IZA#/<V%S%;7'V2YDC98KC8'\IB,!MIX.#S@]<5XYX&_9VO
M_ OPSTKP!:>-[QO#5B?+*I9Q1W,L!D+M"9!T#;BI(4-@]<\U[2TJ@=<4(X<9
M!!% 'C6D?LW#P]XZUO5]*\:Z[8>'=:U,ZQ?^%XVC-K)=,V^1ED*^9&KN SHK
M -R#\IQ61H/[)R^'+_PS-9^/-;2V\.:S=:MIUJ;>U*J+GS?/C=C%ND+":1=[
M$D!CCG!'OOFI_>%-,R9^^* /#=4_90T?Q?;S+XOUR]\17+Z%)X?^WB-+:Z>!
MG1_,ED3F616BC92W ()VDL37;?#/X8ZCX'!DUKQIK'C6\2(6T%SJPB0PPC!(
MQ&JAW8@%I&RQVCTY[WS4/1@32^8O=L4 9/C#PO9>-_"6M^'=2W_V?J]E/87/
ME-M?RI8V1]I['#'!KRW0_P!G!_#>K>&==L/&%^/$^BZ0V@-J4UI 4O+#=OCA
MEB55'[ML%&!!^]DMN->R^>O]\?E3EE4CKF@#Y'^+_P 'CX:O_AWX?TRS\2-X
M4T:WU*>35K#1X-<:6_N949GN+=T8AFS<MYBQX!F*C:#BNQTOX%ZYX_\ #OA[
M5]1\3:MX7\5^'KJ8:#K=KI]K:W:V,B(K07-J%:':VTX3 P%C.%.Y:^A&>-CR
MP/X4+*@& PP* /+Y_@2[ZYX'UJ+QCJZ:QX96]1[V9()GU%;MHVG64,F%!:)"
M/+"[0-JX&,<_9_LNBV\-^$-%?Q==3VWAOQ/+XIMW:RB5I;B2665D;'&W?<7!
MXY_>#^Z*]CTOQ)INLWNIVMG>17,^FSBVNTC.3#*4638WOM=#^-:08-T.10!X
MQX"_9O\ ^%;7T\&B^-=:C\*1SRW>F^&)!$UK82R%F^5]OF/&KNS",MMR1G.*
M[/X/?#@_"7P!I?A0:Q<:Y;Z:AB@NKM%27R\Y"G;P<9(SZ5V33*/X@*%E0C[P
M- ''?%[X6:7\8_!<_AW4Y[BR!ECNK74+)]EQ97,3AXIXF[,K 'W&1T-<9J/[
M."Z_HEA_;?C'5]7\5Z?J-OJMEXEE2%)K::'<(PL*J(O+VO(K(5^;S&)YQCK_
M !'\2G\._$OPAX3?2Y)D\1)=F/4%E4+$T$8<J4ZG(/7I7;>8!U/- 'CGB?\
M9ML_%&GZB\WB*\@U_4-=T_7[G6(H(]QELC&;:-4QA8T\I2!G.2Q))8TSQ?\
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M.\::'XNU;P;XDALO[-O+O3$AD6_MMQ94ECE1DW*Q8JV,C<>O&/6R2!7GNO\
MQ8?P5X&\0>)O%.B3Z+#IEX]M!;B>.9[Q#.(K:1"IPOG%X\*V"I;!Z9H [;1=
M+BT/1['3H9)9(K2%(%>>0O(P4  LQY9CC))ZFKGXUS?@S7M=UI=137O#W]@W
M%K<F*)H[Q+J&ZCP"LL; *P'."'12"#U&#72<T 'XT?C1S1S0 ?C1^-'-'- !
M^-'XT<T<T 'XT?C1S1S0 ?C1^-'-'- !^-%'-% !QZT<>M+10 G'K1QZTM%
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M#:#*^GW'G)-'NY8.MN,,/E+@8&_G[8M_#NF6=Z]Y;V%M;W;KL:>*%5=EXX+
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ML0>1G(('A_Q%_9S\<>,_%_C_ %JRN="L);[4]&U?0VNI)+B-YK&-HS%=1>6
M(Y%=ONLQ'O7M?PKT+Q!I6FW4OB.RT+2+RX9<:=X>4M;1!1@L9&1&=F)SRH"@
M*!GEB 0>(?C5HF@>);_1!9ZEJ=SIOV3^T9-/B21++[2Q6'S 7#G.,DJK!1RQ
M%4)_VA/#,6@:UJSV^I+:Z+X@C\-:@#"NZ"[>2&-<C?\ ,A:XA&Y2?O\ 3 ..
M.^+WP1\2_$#QL=9TBWTK1-6LIK3^R?%MIJ,]O?V\"NC3P3PI'MN(SB7",^T[
M^0.M<UXT_9]^(MU9?$70_#[^&O['\1^+++Q7;75_=W"3*\3V3R6[QK$P4%[0
ML) S9SC:-V5 ':7\?[;X0_$?XQVGBRZ\2ZSH.E:[9R+?16#W-MH]M/8VTN)'
M4 )&KRN !N8 9(YR?0M/^*7A?0O&OQ.O;WQ%K'D:/8Z;>WMM?J#86L,B3")[
M/"Y<RF-MV"VY@H7GBN8\5?!SQ9=W7QHM3)HT'AWXAQ0K/J,E[()]-C_LZ*RN
M/W7E;9"%B+J=Z@[N<8YXJ'X;6_Q=U[XRZ!X4UR%-)OO"OABRTO7+=EN8!-;F
M]EC^93M<#,!8 _=D![B@#V:#]I?P:UWK-A<M?6&L:7]D\S2YHE>XG^U.([?R
M1&S+)OD.S"M\I^]MZUD>-OVDXM%TZV?2O#FJ7&I+XGL/#=]9W<4<;6DEQ+$,
MDF0*^Y)1L*,R[F7<0 :XS7O@?\3O&W@B)YT\%^#?%VD7EEJ>E+H"2R6EQ=V\
M@<O<.T:.(V&Y!&H;&22S9 '2^//A_P#$[XB^ [5M43PU:>)-/\0:3K-GI5M=
MS-9;;*[CG97N##OW2;".(\* HP3N) /:-5UZ'1O#]SJ]U;W*PVUL]U+!&GF3
M!54L5"J3EN,8!.3TKRC3?VLO".L2Z"EEI/B:Y/B"P:^T7;I3#^TMJHTD4.2,
MN@<;BVU,9.X@9KTO5;+5-3\$WEJT5K_;4^GR1&(2L(//:,C;OVDA-QQNVDXY
MQVKPOP+\#O''A7_A1D<T6B2Q>!M/O;/4BFHR@RM+"(8S$/(^884,=VW!.!G&
M2 >@Z?\ M$:!KGACP[K&CZ5K>K2Z[]K%KID%JB72&U9DN5D$CJB-&Z%""^2W
M S6*O[1C:[XP^'5GX=\/WVJ:)XNTBYU:&^!A1@D?D@KM>52"GGJ7R#U&W=SC
M@M!^!'Q.TGP[X5TFY3PM?Z38:EK5UJ.C7=[</:7/VRZ>Y@F8"$>:83-*ODL
MIP&W XV7OAQ\"_B#X*?X,3W$OAZ=_!ECJ&BWZI<3XEM+@VNV6+]WS(!;'*M@
M98?-Q0!U/PV_:7MO$WPXTWQ+K6E7.GW.JZI>V&G:<DD >Z6&:5=RLTP4!$CP
M[.R#>K;00R;A_P!L+P8UCHTUGIOB+5+K56O8;?3].T[[1<?:+12TUN0C$&0
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M8N#/N  DW[^%R,;>^<@&-\9O$6KZ+X*FL_#+1)XLUB0:7H[7&?+CN9 Q\UL
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M/N* #\Z/SHS[BC/N* #\Z*,^XHH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH
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M\2?"5Q\*;#Q!XHL+R_N?&DV@:HFF+',MU:O97-Q )W:)"LR"&//EJ@.[./0
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M/0 =Z^8?%WQ#\7>))OCU+IOB.?PQ>?#R)&TFU2.,QR;;(77G7(=6+I*VY.,
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M .00>*\P\?\ QZ72_BI\./#7AW5=)OH=9UFYTW5;<HTLRB.!V_=N'"J4==K
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M[0CG5K?RE!+/Y@.W: "2<XXK$M_B[X1N%C/]N6T/F7T.F!9]T3?:I<>5"58
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MQR:O>#/@?X#^'>O7VL^&?">E:'J5Z&$]S8VRQLP8@L!CA02 2!@$BIKKXO\
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M9F21!C"MSEAP,Y)SWK U/X$^!-<FFEU'PU97LLVF#1I&G4N7LAC; <GE 0&
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M$-WR,O."/NY.,9-6(_B]X4FTPWR:FYB%X^G^2;6;[0;A5W/$(=GF%E7+$!>
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M ,+^&;V07%KX8U"PAE)LXM2?3KF6:>U\U6#(Y26,*>.4(!& :^P=H]*, =J
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MB5IGBK^QDGMU>RL[<0+-)('E"&641.VQ2<;QD@CCZ[//44A4$8Q0 D8"Q@#
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MK*4%D;I"$@9U7S%:0D$.HQD&MM_V3-)M_#7A/3],\6>)-*U;PM-=R:7KUM-
MMVD=RQ::!QY7EO&21P4S\J\]<[?B/]GFV\1>';S09O$^MMI&I:>VG:G;7,D5
MP+M&DDDDF^=#Y<[-,_[Q, #: HV)M /6XV+)ECS[4O'K7.>&O!Y\-:OJEU'J
M^I75G>);QP:9=2J]M8+%'LQ -H8;^&;<S9(R,5TE "<>M''K2T4 )QZT<>M+
M10 G'K1QZTM% "<>M''K2T4 )QZT<>M+10 G'K1QZTM% "<>M''K2T4 )QZT
M<>M+10 G'K1QZTM% "<>M''K2T4 )QZT<>M+10 G'K1QZTM% "<>M''K2T4
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M'%7?QH ,_P"<T9_SFEHH 3/^<T9_SFEHH 3/^<T9_P YHS[T?C0 9_SFC/\
MG-!XK.TWQ-I&LZCJ&GV&J6=[?:>RI>6UO.DDELS#*K(H.4) ) .,T :.?\YH
MS_G-'XTM "9_SFC/^<T?C69XA\2Z5X4TU]0UG4K32K%&"M<WDRQ1@G@#<QQD
MT :>?\YHS_G-5-*U:SUO3[:_TZ\@O[&Y02PW-O()(Y$/1E8$@@^HJY0 F?\
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MUL:3^S[I^B^(?!NLP^(M:DO?"NAR:!9&0VQ62!U +2?N.7&R,@C:,QC(.6W
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M\KC@$@@'GGP)^.VM?$7QK<:)KLNGZ3JEK:337WAFXL9K34;*19E6,J7D9;F
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M'R;\6/#?@KP3XY\.Z7J2WNC?"76]#O&M[VQLEU*S.IS2J\C2>;%/M>6')63
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M;P\UOJVE?%F&XTMXM/DWV]DMS#)FW4K\MOL\XGRP(R"_O0!]WOK-BM\+%KR
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MF8M,6,>P+M(92V[S% !SP >N:;826=C;P3W+WDT<:H]Q*JJ\K 8+D* H)/.
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M?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M% "9]Q12T4 )QZT<>M+10
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M'8\&*&WM[=((AZ )AOK(3WJ3]G20GQ5\<58DX\>RX^G]EZ;7;:7X"D\/^/\
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MU)N5GD+&-9%<*T>!SDKMVD#ZDMOAGX1LM1@U"W\+Z-;WT%H-/BN8M/B62.V
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M6EHH 3CUHX]:6B@!./6CCUI:* $X]:./6EHH 3CUHI:* $_.C\Z,^XHS[B@
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M>2?IF@#J?SH_.L/QGXMA\%:$VJ3V&HZF@GA@%MI5HUS.S22+&"$7G:"V6/8
MFLB/XL:/-XD\8:%%!J$NH^%K*WO[Z-+1CYD<ZS-&(>\K'R'&%'7 !)S@ [/\
MZ/SK#T;QA8ZSIFC7>V;3Y=5M4NX+'48_(NE5D5RKQ-\RNH8!EZJ>#6V&R.HH
M 7\Z/SI&.!GK7%:%\7-&\1?$'7O!EI;Z@-9T-(I+[S+5EBB64$Q'?T.\*Q&.
MNT^E ';?G1^=<)X%^+^F_$'5([?3=+U9=.NK-M0T_6I;=38W\ =4+12H[8.6
M!"2!&*G<%(YKN\^XH /SH_.C/N*,^XH /SH_.C/N*,^XH /SH_.C/N*,^XH
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MS*4D4@\9S6C8^*EOO%NJZ$--U.!M/AAF-_/:,EG/YF[Y893P[+M^8#[N1ZT
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MKMMRSKV8Y([4 ?(&FS>)[?P3JGBS2_B'XFU7Q1H'Q0G\/V>F7>KM);W-M_;
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M>:)%6-V*E 0JECQS7AVC_"7QQ8>"?AII\OAT"^T#XAWOB.^475N0]E++?,K
M[\&0+>QC;V,3<CY<RW'P>U[4-+\6Z=K?A/4+VTO?'MSK]A=:1JT-K?V<+P8B
MN[:3S5"RI(""KG[LA^]]V@#U:/\ :$T'4?&WA'0-+M]1OH_$=M=W4%\+"X2)
M!;NL;JV8^"';#9QLXW8W+F]I7[0?@36YVBM-9D8_89M2B>6QN(DN;6)MLLT#
M.@$RJ<9,9;@@]"#7DWA[P-\5=(U7X/:UJ]BGB35])L]=T[5;N>Z@A:!;JXMV
MM9I@IQ(PB@ D\K<2^<$YW5R'@[X7?$U/$'@W6M7\$O!J%GH&L:/JTW]N0.C3
M3+"8FM[=6$4-N3$51(P#E_G5=OF, ?0_@W]H3P#X_P!2M++0M>%Y+>6!U.VD
M:UFBAN+==N]HY714<H74.H8LAR& (.)M+^//@;5K^6TAUQ89$TY]862\MY;:
M*:R1L-<Q22*J2Q#KO0D8*MT8$^!#X%^,M4\)?!W0KC19-*_L7P/JOA+5KN&Z
MMV:RGN;6VMTN8QO^<9MW?Y?F D7@G<M7[3X<_%'XC? ^]^'WB/PMI'AC4[3P
MU-H,>O&^2Y%ZX1$B,0C^>*)S&K/OYR% 4]@#VR+X]^"'EU*&35I;.YT^SCU"
M>UO;&XMYS;NP5)8XY$5I59R$!0-EB%^\<5TGA3QMI7C2/4&TQ[DMI]T;*ZCN
M[.6VDBF"))M*2JK?<D1@<8(88-?/NC> ==\3^$=3'B/X+:!IE\VF?V7>V\5[
M!)<ZJ'GC:007"D&*(!7D42,&\SRR,;,MZ#^SQX,\3>";/Q'9:U=ZM/HSWRR:
M+!X@N(;G4H(/)0.LTT3,L@WA@F69@H )Z4 6/#?Q2TFPO_'-YJ/C%M7L[#6X
MM/6Q&EO%)ILKQPHEFH5=]PSR-N# $DR[1PM=]X4\7:9XUTV2^TJ6:2"*>2UD
M%Q;26\B2QMM=62158$'CD5\\W?PFUNXG^+T.L>"&\1:5XC\1V>I6D":C#!)+
M D<4;21.) T<R&'S%W%,Y4;OO >I? 7P]XH\*^$KZQ\3W][?@:G.VFMJLL<M
M]'9';Y27,L9*R29#G<"3M*Y.0: ,?P[\;_"_A?P[>:MXC\>QZG87/B2XTFWO
M9M.:U2UF,I5+(@+TBQM,KXS@DFM1_P!I?X>1>&-3\02:S<1:9IE\--OFETRZ
M26UN#C:DD)C$B[MR[25PQ90"217D%Y\*_':>&IK>'0)BW_"UD\6_9(KVW)?3
M1>"Y."T@4.2-Q3(^8GG'-=G9?!J\\8>(_CSIGBC2W@\+>-Y+865T)HG<HNGQ
M6KL%!)1@\6]2?53P010!Z?XA^*WAGPK-J$6JW[VCV%M;W5QFVE8*D\IA@ PI
MW/)(K(J#+$C %>7_ !O^/,5O\(=9\3>"M8N(+[P]KVFV&I026&R=!)>6T<T#
MPW" J6BGW!L#.5(.*Y^W^'?Q4TC]GMA=6]KKOQ+O;RP;54M9HD:2VMY(HR+>
M6;,:2F&(R!CPLLKLH!Q7%:C\#_'][X-^+FBVW@QK0^)=<T?6-/$^N)=%TA>T
M>9))9)"_F 6\FXDD;F 4LOS4 ?1.F>.]/_X6?XXAG\:)+9Z%IMI->:'/9"!-
M*#"9C<&X('F"14.1DA/*[;JX[PO\9[WQ;^U.GAC3[^]_X1:3P;)K L;_ $B2
MR<7 NX(DE5IHUD=2COR#MR3W''+_ !5^#WC3XA>(OC(FEV46G6GBOPYI5GIM
M_>S1M&+NSEGD,<J(Q8(_GA2<'[K<8QG;\$Z=\0O$'[0FC>.M=\%OX8TP^$IM
M$O8)-4MK@PW7VF.8,!&QWH=K*IX/)+!>A /8/%WQ*T'P3<16VIW,[7DD$MTM
MI8V<UY.88\;Y/+A5F"#(&XC&2!U(%<MX@_::^&WAFTTBZO\ Q)&+;5[%M1T^
M:VMIKA;J!2H9HS&K;BNX$J/F R2  2,CQ9X8\4^&OV@8_'^CZ._B?1K[PTN@
MWFG6LT,5U;2Q7$D\4R&9T5D;SG1@&!!"'!QQQ'PU^"7B?X>>)_A$KZ5%<Z?H
M5EKXU*>UN(Q':S:E=QW*QQ*Q#,D6QDR!]TKC/( ![[XK\?:+X(_LDZS<R6BZ
MKJ$.EVC"WDD5[F5ML2$J"$W-P"V!GO7.ZY^T#X%\,KJS:KK+V"Z3JD&C7S3V
M<ZBWNID5XE8[,!&5T82?<PP^:J'[1OA+7_%7@336\,Z?'JNK:1K^EZVFG/<+
M;FZ6UNXYWB61OE5F5" 6P*\2\5_"7XD>*KKX@7DWA6"V;7?%F@Z]:Q0ZI#(P
MAM(;=)4;=M 8"V X)!=R!E1O(!] :/\ 'CP7KNG:Q>6FISXTFZCL;RVGL+B&
MZCGD"F*,6[H)6:0.NP*IWY^7-4[K]H_X?V-J+B[UJ6S3^UAH;K<V%Q&\5Z0&
M6&1&0,A8$%2P 8'@FO&/B=\%O'/BKQ;\0=<TOP]83F36-#UG2K+5IXC!JHLH
M6CGMY<%O+WAV"E@1P-VWMHZI\-O%.M:?X6U"S^&.B^$I[?Q9IVL7>CZ3<6PE
M$-N&\R6:9=B22'?A$4' 7E_FPH!U/Q7_ &F-+T_X)>(O%?A"6\O+VRODT=EE
MTRXCEL;IIHHW$T,D8:)D64.!(H#97@[@#JZ;\4-.^&YUI/%/C'5?$$05=6"S
M:#(+C2;)UVJ+D6\(V+NCE8-(J' ;J$)KS/Q?\*/']]X0^-VE6'A_[1)XM\46
MNJ:6DEY;HOE*EJDKNV_*\6?"]<NG'W]O7W?@_P 8Z'\1_B#K=EX=;Q#H_CC2
M;6-;.6[@C?3+R"!X3','?:8'5D),1<A@_P ASF@#M]:_:,\ :!KNG:/=ZXS:
MAJ-M;WMG';64\ZW$$TBQQ2H\:,K(691N!P,\D5>T_P".'@W4_$=CHEOJKM>W
M[W,=D[VDR6]VUN"9UAG91%(4 ;(5C]UO[IQY1\'?@MXC^%7Q%\&P36#ZCH.C
M> H/#4NLK<1_->),)6(C+!_+." <9!VC!&6K.^$WPQ^)>C?#RW^%&OZ!ID.C
MZ1;7>GVWC,7B2O<6KQRQPM%;@!XY]LBJY8@8W$$EL  ]BL/C[X%U"_\ L8UP
M6LAT^35HY+^VEM8IK./_ %D\4DJJDB*/F+*2-I#=.:X[XG_'NPU'X0_$*^\$
MZW<V'B71?"LOB2T-SIDD+F$1220RK'<1@.CF%DR <<]#BN#\!_#'X@V'@FXT
MM_AAX+\.^+=$T2XTVR\3CR+G^U)OLYBB>-0@:))&VL_FD\978=Q*\X?@5\1O
M$E[XTFF\-/I$OB;X:77A87&I:XEY+'?MYI#S;20JLT@ 6+**J_P_= ![+X=_
M:)\._$7PGJ.E^'O$KQ^,(?#S:FKRV$D18"/'VF$2QJD\8D(Y3<O('>K?PQ^-
MEJOP+^'7B'Q;?W%UK6K^%;+6KQK.PDGE?-K%)/.8H$.U=S\D*%!8 =0*Y.;X
M;^)?&&K^%?$%_P"%Y="NO"GA;4-,AL9;NW>:]N[F&*,JK1R,@A40G!<J29!\
MJX.>)TCX)^//!MO\+M5;P#I'CA-+\%6?A#6/#NHW<"O;2VWW+J"20-&5;+;A
M]XKLZD8 !],W?Q*T1/AU+XVLYWU70!8'48YK",RM-"$W911WQZXQWQ@XP?"/
MQPT77? OA/7;N*\M;OQ!8)?0Z9;V4]S<8,2O(51(R[1KO \W;M.Y,'YESH:;
MX3O+?X52>'VL=,TR\?3Y;9;+2HC%96[.C )&!CY5W8S@9P3A<X'A/PR^&?Q&
M\ WWPK\3W'AL74VA>#%\%ZMH4%_ UP%C\ADNXG9EB8L\)!0N,*5.2WR@ ^E/
M"'C/1O'WAJQU_0+^+4](O4\R"YBSA@"000<%6!!!4@$$$$ @BN2TO]H;P-K4
MBK9:M/,LEA/JD$G]GW*QW5K"P666!S'MF"EE_P!66."" 1S4'P,^'&I_#CX?
MWUG=_98]6U'4]1UAK:(EH+5[JYDG6 'JP0.JDCK@X[5X+X.^%'Q0B\0>#]:U
MCP<G]I66A:OI&K7']M1-YDTPB,;P0KB**#,1"1IMQYGSA<%B >Z>'_VGOAYX
MJG@BTG69[Y[C39=6MMFFW0%U;QJ&D\DF/$KIN :-,N#D%0016_X:^,GA;QAI
M'AG4](O+F\LO$GF?V9*MA.OG! Q9F#(#&N%.&<*#Q@G(SXGX-^&GB?PP?V?+
MS5]$33K;P+X>O;#7KEM0A\NW=K6&'S!\^&0F%I"W558=RP&Y^S=\/K;1?&'C
M:]TS4HM2\&6.I3V_AA+?!BMH[GRKF]2-P2KQBX.Q=N-OE.ISC@ ]H\2^-])\
M)2VL.H2SM=70=H+6SM9;J>4( 798HE9R%W+DXP-R^HKF-+_:#\!:U/X:BLM=
M$X\26TUWI4HMIEBNDAW><!(5"ATVG=&Q#KW R*X3]H;X=^*=1^('@[QKX>\*
MZ9X_M],M;S2]0\-:G)%&9(9VA<3P/,/+61&@&<\E3@=36)\0O@;JWQ/^'.D>
M")O#.G^#[&VANM6C?01 (K&^)D^S6\:$+G/FNTSA55SE1Q(Q4 [ZX_:*T:X\
M2?#[3=+T_5+ZT\8QW%S:Z@--N41(8D)W%3'NRQVGD !#O) *[M[_ (7GX-36
M+?2VU*<7=U]I%J?L%P8[MH!F98)-FV5E /RH23M. <&O-)M%^)NM:S\&O$^I
M^$;<:UH4E[::[96NHQ)%&)X%C^TQ')#1@KG9]\9P >IP?@;\(O%WP\.E^'-9
M^''AF[7PW-*UIXYB-NUW?VX#^7LC(#QW+956=F5>6.3TH ]2\-?M/?#WQI>:
M3:Z)J]QJ$NKQ3RZ<\>G72QW9A0O+''(T85Y%4$F,'<,<BM;X(_%FW^,_@A?$
M=M97-C#)=W<$<=S"Z$I%<21(<D $E8P6"DA6)7.17B'PO^#WCGP?X9_9\TZ]
MT#,_@O4+U]79+R':(YK6Y@5D^?Y@#<AL=<1MQDC._P##>[\:_ ;X?^'_  S>
M^$[.\1O%-Q9EX=419)+2ZO9YA<0Q!#N*+*A,>0<)(3M"YH ].^+WQ93X66WA
MUGTV]U"36=9MM*0VENTHB\QOF=@N6.%#85026P,=2/,M"_:'@\$?$WXG:1XQ
MUO4;W3K#7+"&P==+9TTVWNK.WD43O#$!''YTK(K2G<?4D,:[K]H3P=K_ (JT
M+PK<^&K"'5-1T'Q+8:RUC-<BW^T11,P=1(00#A\\]=N*\E^(7P>\>>,/#WQ]
ML;70TM+SQI>:=+I<WV^+:!#;6L$A8Y#* ;=G&1DAAP#D4 >Y>)OC?X2\(:E-
M:ZG?2PQ6UY!I]W>I;.]M:7$^WRHI9 "$9MZ'GA0Z%BH89T/B+\4_#WPHTNUU
M'Q->26%C<W45FDZVTLRB61MJ!BBG:"3U; ]Z\-TOX3>,=#^)?BF4^!_#/B#1
M?$U^NL6^MZP\1NM$EDC030RQ[&-P$*938X'(7< <KZ+^T9X2U_QCX4T"#P[I
M2ZO>V'B32M7DMWN$@#PVMU'/(NYSC+"/:/=J )IOVE?!D'AH:\[ZDNFQP&ZN
MV.EW >PA$C1;[B,INB&Z-\ C)",P!4$U!XA_:G^'OAJ]UBTN=2O+B;1A!)J/
MV+2[JX2TAF7?'.[I&5\HJ<[P2.P)/%<'XT^$GBNW^.&N^)[#P-X9\>Z!XITV
MUMKBW\02QPRZ5/"K1Y!,<GF0NC_,JC.0<?[6=XD^$'CF:Q^/6GV>@VMQ'XM\
M-V6CZ/-#-#;HTR6<EK*Y3=^Z13*'5<=$89R0* /8-*_:%\$:O?:_;QZG+;KH
MNG'6)[F\M)8();$;LW4,CJ!-""C?.F5.,@D$&L?7OCQX:UOPCXRCBU75O"UW
MINAG4YKN32Y?M-I:RQR>5>QQ,AWA2CG&"08R' KS[Q!\,_B7=^.H]=T'38M)
MNE^',OAV&>\N89(X=2:6.52R MN4>65W8/+=,9K(TCX.?$.WUGQ9?_\ ")6=
MJOB/P4N@N+CQ"UW<QWBM<?O)9'0[@QN!]TD*D8P,X0 'K,O[0OA/PI:Z!I-[
M?ZMK>K7FB)JUL;?2+B6:_@"IF55CCVECNW,B_=&20 *V9_C1X=U/P]H]YI-S
M?:C_ &]8/J%@NCV;W%R;8*I:?R]IVA2Z###EF"X).*\^\&> /&F@?$'P!K%Y
MX<5K'0_ <GAZ[\J_B+&[9[>3"@D97_1 H;CF89 "DUQ_PD^#WQ0^$S^ -:@T
M.PU:]L/"J^$M4T>?51 L/EW#317D4H5PP8,5==H;A<9QR =M\!OCR+WX#^"]
M:\1WU]XBU[5;.\O!]ELO,NKB&&9U>8Q1* JJIC!. -SJHRS 'HKS]JGX>PS:
M/'!J-YJ+:O8+J=E]@TNZG$UNTBQ[P5C/1F^8=4P=P'?Q#PY^SS\0_!]A\/\
M5Y_"'AOQ=?:-9WVC:GX=OKU7B>"6\^TQ75O+)%M216R"I'((YST]8\(_#WQ7
MIOQI\-^(M0T;3+#2+'PO=Z5-#I4JI!!//=PW 6*/ 9E1850N=NYCN"J": /5
M?&/CC3/!-M9R:@\CS7MP+2SM+>(RS7,Q5FV1H.2=J,Q[ *22 ":\I^+7[15G
MIWP/\7>)_";3SZOI4PTR2V:S<7%A=LZ1D31,N5*;PXW#:WRX)# G8^.'P_\
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M+\'_ -I73[?X4_#N'Q;>ZIJWC/6O#8UKRK+2I[F:]"D"3RQ#&59\G)1>0.2
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MMM8;CUXXZ]UXR^.5_P##+Q/\7YKNRT:2'0;70&L)HHFAD=KZ:6W3[7)DY5)
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MGXHTS1-4U+1M5&O^'-3U:RU"*RD$5G=V422R*RK)F2W99!MP0XVG);<,=O\
ML\^)O&GC;P!I'BCQ;=Z3+#KNEV&I64&F6SQ-;B6!7D60LQW$EE((QC)'8&@#
MU-FV#)K)T+Q;H_B>?4X=*U&WOY=,NFL;U8) YMYU56:-\'A@&4X/J*\@T7XE
M>,/B!>Z_JOAN_P!%MM(\/^+GT"[T[4(V!>UMW$=W*TP.5ER7= !MVJN<[CCD
MM<^,GC?P[X'^)^KZ:OA\ZQH/CVTT*,_87CBNK><:?&N\B0D2_P"F*#(=PPF
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M&'C3Q5\0O#W@-+Z6WM-=T?XO#2;:XU&&,/LBMKDQO-'%($:0!QE8V )' '-
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M]L@YXUKSXP^%-&\13>']6UNPT_6+733JEY%)<*$MX00"69L8[D9 )4$X%7]
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M,5 !;:V/3/@/*;_XW_%S6X- UC2=)UTZ5=6=WJ&ESV:7>RU*2,OF*IR&P""
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MH!&!@^M 'Q=X>L?$_A:QL]2A\':U<^'M)^*>K:M?Z3!IDJ3SZ?<&X%I=10%
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M #FC/^<T9]Q1GW% !G_.:,_YS1GW%&?<4 &?\YHS_G-&?<49]Q0 9_SFC/\
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M,K*R \?*&S2W?[3\_AR[\6V_B+P7JFD2:-X</BBUA6:*>6ZM S(RLB']U(&
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M_P!EOQ7J&LZC>6?CZTMXI/%\7BZT-SHHFG612,6\TGFCS(D3*1@!2  -V!P
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MH?UH 6BDX]:"0HR3@>YH 6BDXI: "BDH!!)&>1[T +12<>M''K0 M%)Q1Q0
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M2XTZQL_$&E6D"QW<V](9+Q$D3S"^\@J[+@GH<#H*]VU[4!X1\)W]U8Z=/?\
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MLGX<>-M.\.Z);:E!;>$EU343J5UY)@^U6SRPQ(H1P\@12Y)*J,QX)R=O0S?
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M_LT^('UCPOXCMI[#4-+U#2]=GL+RQO=1^WQP3+#"Y6WF)RT&)%*@X*DL,#%
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M%7CO4_%6A^'?&L'Q+67Q];07ZZIX%6&=KB\O1#(6M9K9KEO)$;QY5DB3  Z
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MXJ?3OCIX/UC0='U:QO[B]@U::>"RM[>QG>ZEDA+K,OD!/,!C,;ALJ-I'/49
M-?5?A?X0UV^%[J?AC1M0O!#]G%Q=V$4L@B_N;F4G;[=*TM1\+:/K&AOHNH:9
M9WVCNBQM87,"20,JXVJ8R"I P,#'&!7AGB+]H2SB^*WPPU;2O$%W?>!/$^A:
MO,-/L],>>2YGMY+4(R1K$9RX$T@* 8 0D@8)KVWP?XUT?QYX7L/$6AW8O](O
MHO.MYT1EW+D@_*0&!!!!!&0010!EW'P@\#7<;QS>$-"EC<1!DDTV%E81KMCR
M"O.Q>%]!P,5G^,?AO<RP7%YX)N-*\(>)+J6$76L_V1%<2SP)@&-^5+?* %))
MQ@"LC0?VG_A_XD6Y:QU&]=+<,&>72[J)6D%P+;R5+1@-*9611$/G.]>/3D?C
M'\<4O_AYJ5]X1UF^T77M \1:-8ZG83VRI/&MS?6\)CE216^1XYBRLG7 PW#"
M@#VWPKX:M/"'AO3M%LB[6UE D"/*V7?:,%F/=B<DGN234MKX:TJQU:?5+?3K
M2'4[A=DUY'"JS2+QPS@9(X'4]AZ5R?B?XY>$O"&I26NI7<\4,%W!875^EL[V
MMI<3;?*BED PK-O3V&]-Q&X9CC^.WA67Q;;: L]T)KK49M(@O#:O]EEOHD+R
M6ZRXQO4*_ME& .010!T%C\.O"^F1ZFEGX>TJT35,F_6"RB07><Y\T!?WF<G[
MV>IJ&+X7>#X(HXH_#&C1QQVPLT1=/B 6 -N$0&WA QW;>F><5A:?\??"&H+=
M3?:[BUTZ"RN]1&IW-LZ6DMM;2B*XD27&TA'8#!P2"" 1S36_:!\'VMQK-KJ%
MS=:1?Z5#;W-Q8ZA:/#.T4\@C@=%(^</(0@ Y#':P4\4 =?'X.T*+4+&_31[!
M+ZPA:WM+D6R>9;Q-]Y(VQE%/<# J'3O /AG1S?&PT#2[$WX879MK../[0#G(
MDV@;\Y.<YZFE\'^,K+QI:7D]I#=VKV=RUI<VU];M!+#*%5BI5NHVNI##*D,"
M":YB'X]>%+CQ1;:&LUX)+K4KC1K>]-HXMI;Z ,9K=9,??78_/W248 D@B@#I
M7^'_ (9ETHZ7)H&F2:67\TV36<9A+]-VS&W/OBLS4OA3X>OM9\+WPL+6V3PV
MSOIUO!;Q(L+,A3Y2%RJA2?E4@$X)!VC',:%^U%X#\17^E6UG<:ILU+49-(@N
MI](N8H!>(S+]G>1T 61BCX4\\<XR*Y+XZ_&EX)_!UMX8U+5+,2^.-*T.ZN[>
MR#6EUNO4BNK5I60XPOF E2OS*5W$Y6@#W37_  UI'BFV2UUG2[+5K5'$JPWU
MNDR*XZ,%8$9'8U!=^"_#]_!8PW6BZ?<0V( M(Y;6-EMP,8\L$?+]U>F.@]*C
M\:>-M+\ Z,FI:M+(D,ES#9PQPQF22>>:01Q1(HZLSLJCMSR0,FN;M?CIX7O=
M&>_BENS*NK-H)T]K5Q=&_49-N$/5@H+9!V[06S@9H Z;4O!'AW6=6MM4U#0]
M-OM3M@%AO;FTCDFB .X!7()49 /!ZC-)=^!_#U[?75[/HFGSW=W'Y-Q<26R&
M29, ;'8C+#"J,'CY1Z5Q%W^TUX"T[0WU6]O[ZSM8M571)S-I=S^XO2VTPN0A
M *D')!(]^1F6;]HOPA#X9.O,=5^P16C:A=C^RYUELK59)(S-/&4#1KNADP",
MD(Q (!( .GN_ACX1U"/3([KPQH]Q'IDAEL5FL8G%HY;<6B!7Y#GG*X.>:T8_
M"6B1ZI/J2Z59#4IT,4MX+=!-(AQE6?&2.!P3V%<?XE_:"\%>%].DU*ZU.2?2
M;>&WN;O4;&W>XM[2&<9ADE= =H<%2.I 96("G-7HOC+X9N/$']D6]Q<WDJWJ
MZ:]S;6LDMM%=-$LRQ/*H*JQC=6R3CY@,Y(% $]S\(_":>']5TC3/#^D:1;:F
M@CNA:Z9;A91DD;T*%'P22-ZD9.<5J:;X)T;3/!UCX62QAFT*SLX[".RN5$L9
MAC0(J,&SN&U1UKE_C#\8(_A2OAA&TN^U*77-8M]+1K2W:580[?,S;03G:&VJ
M.6/0<&E\1?'KP?X5EOCJ5]/!9:=/':ZCJ2VLC6FGS2!"D<\H&V-CYJ$YX7<-
MQ7(R =''\/?"\"6JQ^'=*5;64SP*ME%B&0E270;?E8E5.1S\H]!2?\*[\*F!
MH3X;TCR3+YYC-A%M,G(WXV_>^9N>O)]:H?&#7[;PS\+O$^JW6KWF@VMM82N^
MJZ=:FYFLQM(\Y8PK;MF=QXP "20 2.5U?]HGPIX'FAT34)=;U35X](CU;9:Z
M1-/+/;'@S?NTV'')8C"KWQTH [R]^'OA74=3FU&[\.:3<:A,$$MY-91/*X0A
MDW.5R=I (R>"!BK9\*Z*=:_MC^R[,ZOL$7]H?9T\_8,X7S,;L?,W&>Y]:\_\
M9_&C1IO!8GT*ZU"_N=4T)]8LIM(M/.EBM6CS'=%64@#+*0&!+$'"MM;'*_"?
M]H"TT[X$>!]4\3W-[K.N3^'(]6OVL[?S95A5<//(!@#)!P/O,0VT':V #V.+
MP1X=@TV?3H]#TV/3[A@\UHEI&(I&!!!9,8)! ZCL*T-)T>PT&PCL=,L[?3[*
M+/EV]K$L4:9.3A5  YKRK5/VK/ .GS3107&J:J\>C1>( --TR>;S+"0$B=2%
MP4 !W-G /RD[OEK3\/\ [1/@_P 3:M'8V$FI2?:-,EU>RG;39UCU"VCV^8UM
ME<S$>8G"@D[AC- '<0>%M&M-6EU6'2[.+4Y1MDO4@03...&?&3T'4]A1I/AK
M1_#[3R:7IMGIS3L&F-I D7F$9P6V@9/)Z^IKS[P?^TMX,\>7^BV>EOJ:_P!M
MV4U]IMQ<:;-'%>)$JM*L3%?G=0P)4>X&2"*\ZU;XO7&E?!GX>W/AS6->\50^
M)?$46EMKDUHBWIA:Z?S5*80(^$:)20"H&3\PH ]]U+P+X;UN^N;V_P!"TR^O
M+F 6T]Q<6D<CRQ AA&S$9900#M/&1FO%-:_95N=8\5^(KFXO_#&HZ'K5PURR
MZOX8BN]0LMT:1>7;W!D"A52) NY&VX'!Q72_#[XGZ'X7TKQEI6H^(]<UN\\)
MDWVIG5]/=+NSMY5:6*/Y4'GX16 9-Q;'<XKLOB?\1T^''PM\0^,VTZ[OHM)T
M^6_:TBCQ*51"QW XV@ 98GH 3VQ0!<M?ASX:BET6:?1K&_O]&@6WL+^]MTFN
MK=%&!LE8%@>.2#S5J7P'X:F%T)- TQQ=.))PUG&1,P)(9^/F.23D^IKP74/C
MIJ.@?&KPW?W[:W/X:U?P1<ZBOAZSTUYIQ>1W=L"ZQ+'YG$<C\L=N!GCC/I\W
MQ^\*'PWI.MV,EWJ]KJFFG5[>.PMFDE^R  F5DX*@9 P>2<@ D' !U;^!?#<M
MPT\F@Z9),UNMFTC6<98P*05B)Q]P$#"]!@<5;T'PWI'A>S%GHVF6>DV88O\
M9[&!(8]QZG:H R?6J6D^.M#USP;!XLM-3@?P[-9_;UU MMC\C;O+DG& %R3G
M&,'/2N7T_P"/'AS4K^WT^*#4TU*^L)-3TRSN+-H9-3MT +-;[\!CAE.TD, P
M) '- '6'P=X?\G4;<Z+IWDZCQ>Q_9(]MUU_U@QA_O-][/4^M:MK;PV=O'!!&
MD,,:A$CC 544#   X  [5\L3?M%WVOK\#/&X&KZ1H7B&^O+>]T2*U\S[9G3Y
MY;?8%4N_[Q8U4J0I+'/3->Q:9\?_  OK'AO3M7L/M]U)J%W/90:8EJPO//@+
M">-HVQL\LHVXL0!P,Y900#OFTBS,<<8MH=D<OG(OEC"ODDL!V.23GKDFJFJ>
M$-"UK4;/4-0T73M0O[,YMKNZM4DE@.<_(S E>0#P>HKS*]_:Q\ V>F:+>BXU
M.\&KQ7DEI!9Z7/+-(UJ2+B/:%XDCP<J>0!GIS6U\=_B;>_#;X)^*?%^DV<ES
M>6.F2W-JKQ?<?8=CNIP=JD@D'GC% ';?\(GH:ZC<:A_8]@+^Y0Q377V=/-E0
M@ JS8R1@ 8)["JL?P_\ "T*VJQ^'-)1;60S6X6RB AD.W+I\ORL=J\CGY1Z"
MO'=,^,6C_"GQ+/I'B#7_ !=K.I:K:PZC;:-?:0\\]J@D$$KHT2<JSD.5W$(
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M%K-8N71[AE6W12@97:0NH4*Q)S0!Z-;Z?:65DEI;VT4-HB^6D$486-5] HX
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MQ5J'[0F@^.[S3[>VT=/"4^BW=J;W?+!=27,4Y9$"E67]R%SN!.X<?+7 :3\
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M $^:ZDU#Q!*NHR6UM,)4C@N9#B,HPRH.%Y8_>(-3^#?@1)XNT#7]$\:V6O\
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MH\J/]XH# H""#G._X0^&FB^#+^YU"U-Y>ZK<PQVTNHZG=O=7#0QEC'%O<DA
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M:A'&&>VEL+M4;YDC"^8DIW9?(VX%>P?LR2NO[/'PUDN+^:_DN?#NGSK).$#
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M2)YGF_<M*&=7=D=750-N0<,6]+^/OQ,O?AYI?@RSL'^S7?BGQ/8^'%ORJO\
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M/^<T +7#?&CXIZ=\&?AOK?BW4MKQ:? TD=L9 C7$F/DB4GN3[' R<<5W&?\
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M&^?Y5.Y<,>#N'K7S9J?@RQL?%MM+IO@O5TTNX^%UYI5W%:Z'.(I;EI(98H&
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MF"L0..H!KY(T[XD>)?$]_P#LU^+[K2DUCQ)K=KJ?EVMM=B*.X+60<.^Y56/
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M*IW/[5\ZV/A=1X3?2-;UVRO;B#2O$UX=-:6:WE$9MH7:(B21\[E!VY4J>Y
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M']JU_$GAO0KSP]X6N=0U;4?#</B1]./VB39'*SI%"KP02?,SQ2 ,P5?E![X
M!]!%5(Z U4TK2+/1DF2S@CMUFE>>38N"\C'+,?4GU-4O#FOS>(_"FG:PNFW.
MGW%Y:1W/]G:@OE30,R!O*E'.UE)VGK@@]:\0\!?M4ZIXK3P)J.I>#8M&\/\
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MCF@ _&C\:.:.: #\:/QHYHYH /QHHYHH ,_YS1G_ #FEHH 3/^<T9_SFEHH
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M<Z1MC&5#@@''<5GR_"GP;.-1$GA31)!J(1;T/IT)^U!,%!)\OS[<#&[.,#%
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M &EH7B#3/%&E0ZGI%_;ZGI\^?*NK2598GP2IVLI(.""/J#5_/^<U2T;0M/\
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MYHS_ )S2T4 )G_.:,_YS2T4 )G_.:,_YS2T4 )G_ #FC/^<TM% "9_SFC/\
MG-+10 F?\YHS_G-+10 F?\YHS_G-+10 F?\ .:,_YS2T4 )G_.:,_P"<TM%
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MC\ZP_"_B&]UQ=4-_HMUHC6E_-:0K=21O]IB1L)<)L)PCCD X8=P*W P(R#0
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M^='YUPOQ$^)K^#-5TC1M/TJ37=>U6&ZN;6PCF6+?%;HK2MO;C.9(D [M(O0
MD=5X=U:37=!T[49;*XTR2[MXYVLKQ0LT!90QCD ) 9<X(!/(/- &A^='YT9]
MQ1GW% !^='YT9]Q1GW% !^='YT9]Q1GW% !^='YT9]Q1GW% !^='YT9]Q1GW
M% !^='YT9]Q1GW% !^='YT9]Q1GW% !^='YT9]Q1GW% !^=%&?<44 +12<>M
M''K0 M%)QZT<>M "T4G'K1QZT +12<>M''K0 M%)QZT<>M "T4G'K2T %%)Q
MZT<4 +12<>M''K0 M13'"-[U)QZTA4$\T ? G[/<$V@_%7X<^*+>R2Z\&^+]
M0UU-)\-2.SW/A"Z+2O,R@G&'2$K)D QF5U7@G?\ =?A_Q#IGBG3$U#1[^WU.
MP=WC6YM)5DC9D=D<!@<95U93Z%2.U067@[0=-UBZU>TT:PM=5N@1<7T-LB3S
M9QG>X&YN@ZGL*OZ=IEGI%M]GL;:&SM][R>5;H$3<S%G; XRS,S$]R2>] %JB
MDX]:./6@!:*3CUHX]: /F+X!WJ^!_P!H7XT^%_$2+9>(/$&NKKVDW-RQ']I6
M#0HBK$3PWDE""HY&_I@5Q6M_%WQ-:W'CR6Z\17USX3TKX@Z7H=]?V<,,0@TY
MQ"9Y&FA16&&=(G?.548&#S7T-XF^#U_XNDE74?&VI75FTQFCLKC2],FBBYR
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MU19Y>,?-(!N/'J: /AG]I[3SJ7Q3^*OB;3$@LG\(V&B?VSX=OBPM_&%L6-P
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M"\6,[M[D*%X;+#(&16SX2\/W^B?#I=/DTK1M.OO*G*:9IL6VQA+L[)$  NX
M,%9L+N(9L#.!\]V?P,^(GA;0/$,?@2#_ (0^VN].M0GAN76FGMH[O[4KW7V2
M3#&V5H0Z*W]YP0J[<T >S7O[1O@_2-+U"]U1M1TMM.U:VT6^M;BQD:6UN9PC
M0[PFX!&65&#@E?F SN.*S+G]J[P-96FLSW*:[;?V+<I!JL<^C7"/IZ.$*3SJ
M5'EQ,KJP)Y(R0/E;'DDWP0^(J:9XZL;7PSH5A9>)-<T/6H(K;5WD-O\ 9&MG
MFC=GB&]F^R??[M+D\9(Z3Q]\&O&_C&'X^V=K8V=NOC:RL[/29[J^ 1?*MS"[
M2!$+*.2P&&)Z9'8 ]6\=?'KPI\.WOFU>6Z%CIKP)J>H06YDM].,Q41^>P.1G
M>I. =H8%L @GJ_%'B[3O!^E_;]2DD2)I$@BCAB:26:5V"I&B+DLS$@ #ZG !
M-> W?PF\<:/\2_$VIZ?X8\*^(M*\6/%?&[UN0&XT.[$"0R 9A)N(L1HRJ"G(
M(^7.:[[]HWX<:Y\1? >G0^'?[-N-:TC5+;5K>SUE-UG>F(L'@EP#A71V&<'!
MQTZ@ E?]I?P1;67VF\N;[3UBUN/P]>+<V3@V%ZY0(EP1D1JWF+B0GRSG[U5O
M''[0EEH&A6>IZ/I.H:U!-XEM_#C2I;E(_,:Z2"1D+$>8 2RJ4R"XQG@XYB3X
M9Z_XF^']WX:OO!/ASPOIWB6[6#6-/T22-OLUGLQ))O\ *023.1M!"_(-K EA
M7.1?"3XEVOP8L?!W]G:=?W'@WQ-IM]X?FEOQ$=3TZSO4FBCF*H1%)Y<80M@@
M\'&<Y /7?%7[0GA'P7).VK37=M96D\%K?W_V?=!833!#'',0<@_O(\X!"^8N
MXC(K*U']J?P/I>H:Q:S_ -L*NC:I'I.I7/\ 94P@LY9&14>20@!4+2* W?J!
MM()X.#X2?$71/B-XHN+?0?!^MZ1XFNEU./5=3.^ZT*Y>"..=%!B_TB,&,,@^
M3/1L9R*?B?X&^/-4\-?&W3[2PTS[3XQUNUU'36EU JBQ1F%&$A$9*MMM]V "
M/W@&>#0!Z[X$^+[>,_BEXY\(_P!B7MBOAE[>)KR8+MF:1-^>&. 59"HZD9)Q
MTJSXQ^.GACP/K%]I^HO>.=-CMI=2N;:V,D-@EQ(8X&E8<_,RM]T,0!DX'-<]
M\//!'BCPS\<?B%XBNK.S_P"$?\6)IUVLHNR9[6:"U6!H#&$PV2I;?N P0,'G
M'G'[0WP;^)'Q)UCQO:6-CI.K:/?6=DVAS7^I20K82PL'E0P+&1))(XXE)&U6
MQGJ" >Y2_&'08O$LNC!;Z:2&^CTN:[@M6DMXKMXUD6%W7.UMDB')&T;@"V>*
MI?%OQ-:Z!=^"DN-=U/0VOO$%K;1#3K(SK>LVX?9I6V,(XVSDME3\G!ZUYI>_
M"GQAJ_Q.L/%=EI4'A#6_[4LY-2U'2=49[34M.14,T%S"5'FR??C238IX1LJ!
MMKN_CWX/\0>++;P*?#]E%>RZ1XIL=6NUFG$6+:(MYFW/5B&X'3/4T <;-XPU
MSXG_ !R\:>#+#6-8\++X7BTR:TN;2T#1R22&=YC.'4AD=8U102!C++SR-KXT
M^/KVQ^(GP\\$VZZQ:6?B":\-Y?:3$?-"Q6[,B(X!V_.59B.0$&>&-6/A]X)\
M1Z)^T/\ $WQ1?:<D>@^([;2X;*X6Y1G!M(YE8LG4;C-D=?N\XJ3XJ>"?$.N_
M&CX4^)=+TU+O2?#%Q?SW[M<I&^+BU:W4(I^]MW;CTX'&30!-X9^,7A[PMX$$
MFJZ]JFM+I&K+X9O]6N]/*RF^\Q8@)5C0 9>2-=X&TEASS7D?Q#^(OBW3=+_:
MGM[;Q#>VY\++9W.DW*&/?:K+I\4S1K\F H<MSC=ANN>:G\8?!SXFRZ7X^\-Z
M'I^A7>D:UXPM?%-KJ-WJ$D,C1BZM)WMVC$;;65X&^?)!7HI8\:OBWX%^,_$<
M/[02QQ:5$?B#;V<6F[[U\1-%:);-YO[K@':6&W/IQ0!ZCX8^,VE77B&#PE>+
M>QZ[!H,.M3SSPJD$D!"JTBOG!^<D'C (/3BNGL_'NF7'@7_A+KD7&EZ.MBVH
MR-?1>7)% $+EG4$D?*,XZUX%\5?"NE^.O$?PT\-0ZW;:;\0],46.KV&GSB9S
MI$]L1?12< B-@B;)"HPYCP 6S7T'XNL[NY\%:Q::7:65U?26,T5K:WX_T620
MQD(DH'_+,G ;'8F@#E;;X[^'I-/N[NZMM2TT0K:-%#=VX$ET+DL+?R0K-OWE
M&'MM.<8..3\2_M1Z3;66GR:'I.IZK=R>(H?#U]:"!5ELIFPY#*6^8M'DH5)5
MB1S7F=]^S1XQ?0]47P];66CZ;:7NFZGI/@W7;UM2L!<P^=]JC5R"8H)5E"JN
M#\REL(" .P\0?#?QUK7@S0[RS\)^&M$U?2/$MCK$/AS3[SRH###D,&N%A WM
MO)^Y@*H')H ]$_:'^(M_\,?@IXK\3:5:27&IV5A));#RMZQ2;<+(XS]U203]
M*Y[0?&D/PT?4$O+[Q;XCEN+7^U/[&NK5;B[TVWC!CDE8C!VR.I94R22&V+@$
M#=_:%\%:]\2_@9XJ\*:(EF-;UG37LHS=3M'#&SC#,6"D\#./EYXZ=:YEO!WC
M?1?B_<?$+3M'M;Z+7/#\&EZCH<U\L<EG=022/%(DNTJ\3>:RM_$.& /*T ;>
ML_M/^!M+FT>*"?4]8;6-*&LV!TG2Y[H7%L9$3<FQ3EAY@)7JH!W8. ?,/'7[
M06J:]X"MO$<$.K^#[31_B)8:/>92-C=6J:BMO<QL%\QCP'W*F#G !89SO?"+
MX":_\*O&GP\V-97^AZ%X3OM$O+J.4PM]IN+N"YS%#M/[L-$R@%@0"/3G!N?@
M7\0H=*U[1K6TT>YM/^%D1^,[*ZN-2D0S6_V];UXF01-Y;#;Y?!());C^( ]T
M^'7Q8T7XFW.O6FFQ7]CJ.A726FH6&J6K6UQ"SQK+&Q0\[61@0?KZ5X\OQY7X
M5_%OXPP>,=0UC4?#FF7&F7%L]O9-/%I5M-;CS'D9$ 1!(3U); S@X8CT#X<^
M"O$N@_&7XF^(]5BL4T;Q$^GMIPMYV::,06_E.LJE !EMS ACP<=J\W^(7P)\
M;^*H_P!H6WLTTMD^(%M9VVDO<7\B^0(K5;=_- B.T9#. N[.<'&<T >J^./V
M@?"/P]N;Q-8N+F.UT^6"'4;Z*'?!8/-M\L3'.1D.A. =H=2V 1G/F_:>\$6W
MBK6=!EEU.&XT6::'4KF73)DMK/R[<W!:24KM560$J?X\?+D$$^>R?"GXBZ/\
M2?$UYIWA_P ):QH/BZ:*_FN-88R7&AW0@2*4*/+_ -)C/EJRKE.<@[>6-N3X
M&>)O$-C\=M&U![?3H/'#^;IFII<&9XB+9;=?,CVC;CRD; )^5L<$4 =%XR_:
M$\*W_A7QIITNHZYX5U'3=";5998[ M>6]H^4%W%& ^0C?>R,H1\P7!QIZK^T
M/X7\'7UMX?N1KVKZRNB+K(CM=+DFEGMA@-+E%"%N[ 8 /'!(%>?+\,/B#KOP
M@\;Z%JG@WPAX>UG4O#EYHD;:#(H_M"XGB$9N&;RU\F,?>V98G/.-HSN^&/ G
MCG2?B;HWB>XT>P-M9^!$T.>V%X TFH+(LH"\'$>592QY^93C@T >S^#_ !9I
MOCOPMI7B'1I_M.E:G;1W=M,5*EHW4$$@\@\\@\@UL5X_\!O"?C3X:>!/A_X.
MU2RTI]/TG1FM-1O;:[=W^T1E!%Y8,:Y1EWDYP00!]?8#^- !12?G1^= "T4G
MYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G
M0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%
M)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='
MYT +12?G1^= "T4GYT?G0 M%)^='YT +12?G1^= "T4GYT?G0 M%)^='YT +
M12?G1^= "T4GYT4 &?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4
M )GW%&?<4M% "9]Q1GW%+10 F?<49]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?
M<49]Q2YHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BC<*7- "9]Q1GW%+FDS0
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M''K2T4 )QZT<>M+10 G'K1QZTM% "<>M''K2T4 )QZT<>M+10 G'K1QZTM%
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M_@U?:SK7P\^U^&+&_P!'N?[,\5QW$MY+<1P1K+;PJF?F\@80DGYV'& 6^J?
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MB?X \;>*-%L9=%N?!&L^(+KQ!%K4TK"]LEN9S-/:B#85=MS/M<D !LG<1MH
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M"H=0.2 %/ ZG(&T^N_LZ^.M9\=^"-5D\03V]WJNC^(-5T*6[MX?)6X^R7DD
MDV9(4L$!('&: .W\5>,M'\$Z=#?ZW>BPM)KF&S25E9@9II%CB3Y03\SLH].>
M<5LA@:\K_:4\6:UX#^'EGKFA7D-I-#KFE6]P)K<2^;!/>PV[H,_=/[X'=SC:
M<<G(\E^)GQ8^(_AE/CCK.G^(-/CTSX>WEK<6M@^FJS7<+65O<RP22$G"[96
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M;>[F-O#Y#JH<R0MLWABP.),!0!BM;_'#X@Z#X.\1^+M;\3Z9-IEIXJN_!EM
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M]+NU+PW" @, 2IX."""""" 000:^68] U C]EE4\4:A'/?9VSBWM2ZA=#NI
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MX[T/Q];:C<:#?"_AT^^FTVY81NGEW$1 D3Y@,X)'(X]#7AECX^\?Z;XN\*>
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M0.?.0%L##8O[.?B[6M-\'_LM:5::I+!HFO>'[P7NGF&,B1H;421MO*[Q@L>
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M^!W@[X:Z[>ZUH.G3PZO?6\=K=7US?W%S+<1Q_<#M+(Q8CLQYQQG%=[^-'XT
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M@G/K7XT?C0!P6C? _P ):')XI,.G/<Q>*&9]8MKZYEN8+HE=AS'(S*!M^7
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MC?0&^QV2ZC<$:E$1%;-MVRL=W"'>G/\ M+ZC.E/\2O"EMX:L_$,GB'3O[#O
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M)X2OO"L?[-?VCPMJ6FSZ+IFI6^LSG29(ULGD@"#SGV@*'D4G)/HQX.:^B/\
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M1 )L?3?G'X4 >:_"S4]<^'EY\1[:]\%^(+LW/C*6[MIK:&(Q3VUU)$JRQDR
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MC9K_ (PE\%7\&E7_ ,/?[%BMYYK-I3=_:)IO(91,0"5D0$YV;LC=@9KZ2'
MQP*;Y:^E 'Q/X4^&WC7P6/"3^(OAG?>,-'O_  1I?AB_TRVU"%9].O+-)(V6
M1?.$4EO,)"=P8[?X@,X/;:OX#\06'CK5;FV\%-#IP^%O_"/P1::4>V^UK)(R
MVD9+!]JA@H8J!]*^H]H],4NT>E 'F_[.F@S>%_@AX$TJ^TQM(U>RT2SL[ZWD
MB5'$\4*I(3CKEU8@]P<]Z](S[B@ #M2T )GW%&?<4M% "9]Q1GW%+10 F?<4
M9]Q2T4 )GW%&?<4M% "9]Q1GW%+10 F?<44M% "<>M''K2T4 )QZT<>M+10
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M4+:Z6&Y-UO>1Y+C+H0D[&1OF4!1QA?E7: <EXR^/GQ!TO7_B7;:'X3T._L?
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M70/"=QX9L=(\>WVEW^KW>FW.H^;;VT%O.L$;"2-26\YY(F7@;5+[LLNTX/\
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M/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N*
M#\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/
MSHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[
MBC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N
M* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\
MZ/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SH
MS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC
M/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N*
M#\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/
MSHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[
MBC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N
M* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z/SHS[BC/N* #\Z*,^XHH 6BDX]:
M./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6B
MDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCU
MH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./
M6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %
MHI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX
M]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3
MCUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@
M!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6BDX]:
M./6@!:*3CUHX]: %HI./6CCUH 6BDX]:./6@!:*3CUHX]: %HI./6CCUH 6B
MDX]:./6@!:*3CUHX]: %HI./6B@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\
MZ/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH
M 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD
M_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\
MZ %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %H
MI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH
M_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!
M:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.C\Z %HI/SH_.@!:*3\
MZ/SH 6BD_.C\Z %HI/SH_.@!:*3\Z/SH 6BD_.B@!:*3\Z* #/N*,^XI:* $
MS[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*
M,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[B
MEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@
M!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[
MBC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^
MXI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEH
MH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,
M^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC
M/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI
M:* $S[BC/N*6B@!,^XHS[BEHH 3/N*,^XI:* $S[BAN5QD4M% "9]Q12T4 )
MQZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4
M ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC
M=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;
MJ-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K
M1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<
M>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K
M1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <
M>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U
M!QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW
M4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&Z
MC=0 <>M''K1NHW4 ''K1QZT;J-U !QZT<>M&ZC=0 <>M''K1NHW4 ''K11NH
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>mmsi-20221231xex10d61g003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231xex10d61g003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U,# 2(  A$! Q$!_\0
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MT@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4
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M!!0:!0: %I*6DH 4=*3O2CI2=Z %-(*4T@H .]+2=Z6@!!0:!0: %I!2T@H
M#2CI2&E'2@!.]*:3O2F@ '2D[THZ4G>@!32"E-(*  TM(:6@!!0:!0: %'2D
M%*.E(* %- Z4&@=* $[TII.]*: $%'>@4=Z %I!2T@H #2TAI: $I:2EH 04
M&@4&@!:3O2TG>@!3TH%!Z4"@!.]*>E)WI3TH !2&E%(: %I!2T@H #2TAI:
M$%!H%!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2
MB@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>E H 3O2GI2=Z4
M]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.]!H 44G>E%)WH 4]*!0>E H 0TIZ4
MAI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2
M"@ -+2&EH 04&@4&@!:2EI* %'2D[THZ4G>@!32"E-(* #O2TG>EH 04&@4&
M@!:04M(*  THZ4AI1TH 3O2FD[TIH !TI.]*.E)WH 4T@I32"@ -+2&EH 04
M&@4&@!1TI!2CI2"@!30.E!H'2@!.]*:3O2F@!!1WH%'>@!:04M(*  TM(:6@
M!*6DI: $%!H%!H 6D[TM)WH 4]*!0>E H 3O2GI2=Z4]*  4AI12&@!:04M(
M*  TM(:6@!!0:!0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+
M2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@ /2@4'I0*
M$[TIZ4G>E/2@!!0:!0: %I!2T@H #2TAI: $[T&CO0: %%)WI12=Z %/2@4'
MI0* $-*>E(:4]* $%!H%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH
M 4]*04IZ4@H #2TAI: $%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I32"@ [TM)W
MI: $%!H%!H 6D%+2"@ -*.E(:4=* $[TII.]*:  =*3O2CI2=Z %-(*4T@H
M#2TAI: $%!H%!H 4=*04HZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!1WH 6D%+2
M"@ -+2&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@ %(:4
M4AH 6D%+2"@ -+2&EH 04&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0
M:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2H)683Q*%)0DY([
M5.>E-V@F@!U%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T
M)WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0T'I0 "@T;@.31D$9% "T@I:04
M !I12&B@ [TIZ4G>@GB@!12=Z44F>: %/2D%!/% -  :6D)I: $%!H'6@T +
M24N:3- "CI2=Z!THSS0 II!030#0 =Z6D[TN: $%!H%!- "T@I<T@-  :4=*
M0THZ4 )WI32=Z": %'2D[T \4=Z %-(*": :  TM(32YH 04&@4$T *.E(*
M>*!0 IH'2@T@Z4 '>E-)WI30 @H[T"@GF@!:04M(.E  :6D-+F@!*6D%+F@!
M!0: :">* %I.]+2=Z %/2@4'I2"@ [TIZ4G>E/2@ %(:44AH 6D%+2#K0 &E
MI#2T (*#0*#TH 44G>E%)WH 4]*!0>E% "&E/2D-*>E ""@T"@T +2"EI!0
M&E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4
M]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH%
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MFR(S*Z@187EMA8LP'(&0P![8*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4
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MB:/XF>#OA/XWU?7[B34[SXDV]O<:3)=;;6U:.\N$B@$!X5X]D9#8WL<$D@J
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MBZ5\5?!EEXFT3[2=.NWFCC%U T,H:*9X7#(W*D/&PP>:Z<'CTKXC^%>L^(?
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M]EP0Z]>V.I:A>ZA<27V(YIH4;3KLL$WJ5RR@\L&(+D\]*V_#GQG\876H>'O
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M- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444
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M?P3\%7EEXBLY]!AEM?$,XN=6A:1]M[(/XI!NY[?@ .@%78OA=X9BUW2]9&F
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M-K<_)GO6Z*4T@H .]+2=Z6@!!0:!0: %I!2T@H #2CI2&E'2@!.]*:3O2F@
M'2D[THZ4G>@!32"E-(*  TM(:6@!!0:!0: %'2D%*.E(* %- Z4&@=* $[TI
MI.]*: $%'>@4=Z %I!2T@H #2TAI: $I:2EH 04&@4&@!:3O2TG>@!3TH%!Z
M4"@!.]*>E)WI3TH !2&E%(: %I!2T@H #2TAI: $%!H%!H 44G>E%)WH 4]*
M!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44
MG>@!3TI!2GI2"@!:***  ]*!0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+
M2&EH 3O0:.]!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*
M THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@ -+2&EH 04&@4&@!:2E
MI* %'2D[THZ4G>@!32"E-(* #O2TG>EH 04&@4&@!:04M(*  THZ4AI1TH 3
MO2FD[TIH !TI.]*.E)WH 4T@I32"@ -+2&EH 04&@4&@!1TI!2CI2"@!30.E
M!H'2@!.]*:3O2F@!!1WH%'>@!:04M(*  TM(:6@!*6DI: $%!H%!H 6D[TM)
MWH 4]*!0>E H 3O2GI2=Z4]*  4AI12&@!:04M(*  TM(:6@!!0:!0: %%)W
MI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+2"@ -**0THH 3O2GI2=Z4
M]*  4G>E%)WH 4]*04IZ4@/- "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0
M M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H-
MH- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0
M@H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !
MI1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"
ME'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#
M0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM "
M"@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI1
M0 G>E/2D[TIZ4  I.]**3O0 IZ5!);B297)8%,X <@'ZCH?QJ<]*04  &!12
MT4 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.
M]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2
MGI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TIKDA6(
MZX- "MP*0'V-?)&F?&_QII_[)?A#XD:EJ^J:I/JEU;'7+^QTZWDETRR,TBS3
MP1)$%. J_?60#).#7:P>-=8U?X:?$+Q7X9^(P\2^'(]!^WZ%J\$%HUQ;744=
MP\\<BB(*?NP<.@(!88!!- 'T&>*,^QKY?\-_&'Q9K_AWX'^$[76Y[CQ;X[T9
M=?U7Q!+9PDV%F+=)I3'&J+%O:25(DW*P7.6#'&?1M2U"X\,?$O1M&N_BC"8M
M2L9HSHNJRV$5\\Q*B":V58D9N1*""K*3CC@B@#UD-^%+G-?-'P3^-VO1^,=1
M^'WQ"U(M>:A>ZD/"OB39%'_:<-O=2P20,%C6,7,7EAMH7#*P...?2O!OB^Z\
M-?!5/$WB36+G7YH;:6[EN)HH8I)2&.V)%B1%R<!5&,DD<G- 'IV*;D"O%OV?
M?B?XF^(/AWQ9HGBD6FG_ !"\-:G<:?J$, W0H'_>VLBC +1F*1 #_%L)ZFL>
M&7QO:_M#:3X%NOB#JL^E3^#Y]8DE6ST]97NXKN"%C_QZX"%9@0HYR.OJ ?0.
M\'V^II0>*\$\%>)/&,'[2=UX(UGQ))J6G6/A"RU>1%MH8UDNWFD@D.50-L)B
MW@9&"Q[8 @^+7C#Q=X6T+XUZMIGB2>%O#.B+J6EP&WA9(I! \I#93+ F/')X
M#'O@@ ^@L\]#2%P.Q]:^8/!_Q7\7I\5/A?HEMXA7QUIOB719+SQ!"+>$2:(X
MA62.<R0JJJCN3&$D!)QP2:FTCXKW ^)7Q>T?Q/\ $M] T[PK>P?8EVV22^1)
M:).V5:$M)M+%5P,D#'+<T ?3(<8S2;P>:YZ*RU:#P+'!?ZD3KD5CMFU&U11F
M81\R*K*5^]R 01[5\H_#7]H3QO-I'P'U6Y\0P^*=0\=WILM8T)H81):IM<M<
MQ>4JE%BV L'W#![=0 ?:1I.@YKPGX_\ QUU+X5^+/"(M+>.7PU;7UNWBN\<<
M65I=,]O;MGM^^.\GJ!%Z-6O\9OBCJ>A^,? /@#PZ\5OXB\874X6_G4.MC9V\
M?FW$P0_?DP55 05W-ELA<$ ]?ST/:EKR.\U*[\*?$K1=(N_B/#>17UM(DFDZ
MK-8PWHD;:(9H52-"X+*ZE=I!+ _PXKR_X8?%?4_%?@SQ:=<^+,NC>)+?Q-J&
M@Z;"T6G,Z[+HV]H6@%OO;<2A/J"3\HY !]5YQ2%O8UR_Q NK^P^'&OWEI?2V
M.I6FG37$5U;HC,LB1E@0KJRD$KC!4\&O'_@9\1+WQ_X(\ :H_P 2UU7Q'=:3
M%K.MZ.\=FZ"'RU$ZD0PJT1225-N6R2A!S\V #Z)##'6DW 5X)\'O%?B_]H#X
M;/XZL?$LGA:TU::X.AV-M9V\R0P1RO'&USYBLTC.4W,$9  V 01NK@KG]HOQ
M3XS\ ?"_6;"X?PKK&J>.HO!FOV,,<<R+(&E2=HS(I*G,.5ST#D$-@&@#ZX+=
M,C'UIPZ5QOQ6N;_1OA=XHO=+U"2PU.PTRXNX+ORTDVR1QLZ[E88()7D<<$X(
MZU6^!^I:MKOPB\(:WK6I-JVJ:KI-MJ$]PT21 O-$LFU54 !1NP.IP.2: .Z)
MP>:-WXUX3\)?&OBC]H/2]?\ %5GK5QX2\/IJ=UINB06=K!))<1V\AB>XN#,C
MYW2(X")LVJN"S$Y'G7B7]H#QUK/[._B?Q9I5Y!H_BKP!X@FTGQ3!I]LD\-Q'
M;2JMT\ E#%?W3B5<DXP0<T ?7@%-8[>3TKYV\-?%Z]3]JJ[\&7WBV+4/#.K>
M$X?$>AP"&%-FZ4K(K2!0S_(GF+S]UFSG -<UXM^-_B#X>:#\/-4\1^(KVU\)
M>*M5NY;OQ3]@BW:99D%M.A<+'M0RH4WNR'!#_=&-H!]7;QC-*IR*\7&H^)XO
MA!XSUH>,(]3>S2YO]#UW3H[=ENK1+97CW@!T;YQ(K$!=VTE=@( ]"^%VLW7B
M/X:^%-6OG$E[?Z5:W4[@8#2/$K,<=N2: .F-+2&EH 2EI*6@!!0:!0: %I.]
M+2=Z %/2@4'I0* $[TIZ4G>E/2@ %(:44AH 6D%+2"@ -+2&EH 04&@4&@!1
M2=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G
M>E/2@ %)WI12=Z %/2D%*>E(* %HHHH #TH%!Z4"@!.]*>E)WI3TH 04&@4&
M@!:04M(*  TM(:6@!.]!H[T&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:
M!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(*  TM(:6@
M!!0:!0: %I*6DH 4=*9)]QOH:>.E)WH ^8OV8QXF/[*/PDG\+P64TT+&6\L[
MRX:&.6U+7 9%<*Y# LA7(ZJ,D#)I;7]GK4M-OOBOKOAKP_:>&8O%_AU=*B\,
MPW*)%+>%90]W*4!CB.)57";L[7;DL!7T1HWA31/#;7#:1H]AI;7!!F-E;)"9
M2,X+;0,XR>OJ?6M1>!0!\R6W[/7BS3/#/P6\0Z5]AL_B!\.]*CT>73[NY+6.
MIVI@C@GC,JH61B(P\;[3ACAE(.1U^J>!O$WC3XX^ /&UUH\6BZ=X7L-3@GMY
M[I)9[F6Y6)%$83*[5\ICN9@<.. <@>V=Z",^M 'A<WP+G^(_PDO_  UXHMCX
M?UF/6;_5])U6PN!)-I]Q+>37%O<1.NTAT$H5AQG##.#3;+X8^+[CP/\ #/P?
MXACAU&QL/+N/$E]8WIMVEN(ANB\K8%8+Y^R4E2I'EJ .2*]W%!H \#L_A%XB
M^'_[2<7B[PG9+=^%=:T=-.\0_P!HZM++<--'*3!<)YN]G*(2F"P&UN.16U?>
M#/%,G[4.E^-(K&W?PO;^&9]"D<S@3K++<13F14[K^Y13DYZD#U]BI : /'M=
M\#>(/#G[08^(VD:?_;^G:AX>70;[3X9HXKFW>*X::*:/S&5'4^8ZLI8$84C/
M(K+^(?P^\4^,OA7\6%71TB\0>+].DTZSTQ+I"88_LYAC,LA8)NR[NVTD $ %
MB.?=C0#Q0!\P^%?@[XN^%FM^$_&'@[P_!;3WFF6^D^,?"HN88EN3#'MBNX7'
MR>:AW#DC>CC.T@UJ^#?!/B?3/B#\7=3UCP(^H:-XRO;62""6]M6S#':);NLR
M[SC)3.!NX8]QS]$'D]:7H* .8L)=>?P*\FJV,3Z]);2/)86,@*J[;BL*NY4$
M@$+N. 2"> :\[_96^%ES\+/@WX=T?6_#=GI7BC3[8VEY<P"%WN<,2'\U.6!!
M'WL$$'M@GVL'BD)YH ^?KSX%/\3/ _C23QII6JVVO:_)="73[;7IA;M& 4M!
MY<<PA8K&L0^=?O*2>*P;?X+?$G4?#/PF\47S:5%\4O !DMW26Z9[35K22(13
M(9 I,;NBJ0^TX<'C!X^H": >* /%]2\)^)/&_P 9O 7B^[\.+H=CX9L=22=+
MRXAEGGEN4A55A\MF "^6_P S%>&QCFL#X1?#_P :> ?!7B?2=6\(:?K-S?>(
M[_7K5&U-!#^^N3/ K$H2K(0O(4XV@C-?0Y-% '(^)M*UK5OAAJ6F.EO<:]>:
M5);2"!O+A:=X2K%2V2J[B3SDX]:Y_P"!/P]N?!_PC\&Z)XCTRTBUW1=&31YI
M(7$P=55%<J^ =LGEHQ&!R!UQFO310>M 'A/P@\$^+_V?_ 4O@/2M#C\3:7I]
MS<'0+Y;V.!5MI9FE6.[#_,AC,C+NB63<J@X!.*X>]_9Q\3>$?A]\,-'TV$^*
MM7T?QO'XQUV[2>.!992TSSB(2,,_--A0<<+DD$U]7@\4@- 'D_CJ7QQXO\.^
M+["V\*/:V4^B7%G:6MU>0?:+RZF&Q3E9&2*-!NW$DD[N!\N#5^'0\=>'/AWX
M!\*KX2DTZZTZTL+#4;ZYO+>2WABAC193&$D+N6"%5RJX+ GI@^QDT \4 >"?
M"WP1XM^ %CXB\,Z;H4GBSPW-J5UJFAS07T43VPN)&E>VG$K*5"R,Q$B;\ASE
M01@[?P8^!,?@GX>^*-+\1M;:KJGC+4[[6/$*VZG[*\]WQ+%$&&?+5 J MR<$
MD#.!Z^>3S1C H ^-M)_8X\6+\./"=K=:X8O%VE:^8I]4CE7S#H1A&GM"C;3@
MM9QQOCJ').=W-?1/Q L]82YTFSL/#EOXE\+2P3VNKZ2[0J61A&(BBRX5\8<%
M"R@JQZD**] %(0": /FCP9\(I/A%\'OC0D=D?#^@:N-0O]+T!KD3_P!GPFR"
ML"RDJI=U=]BE@H*C<><>R_!,8^#?@08QC0;#_P!)TK?\1>%=&\7:>;#7-*LM
M8L2=QMK^W2>,G!&=K CH2/H35ZQLH-.LX;6UA2WMH$$<4,2A410,!5 X  X
M% $QI:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2
MBD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*
M#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%
M >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2B
MD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4
M  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2
MFD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T
M *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T
M"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.
M]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/
M2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]
M*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1W
MH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )W
MI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'
M2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .
ME)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32
M=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH
M% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"
M@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.
M] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D
M-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !
MI12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+2
M4 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>
ME-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#
M0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O
M0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2
MBD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ
M4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2
M"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0
M M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#
M0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=
M*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1T
MI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@
MT +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H-
M H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )
MWI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0
M@H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>
ME ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !
MI:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2
M"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@
MT *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2T
ME+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &
MEI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04
M!I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E
M/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0
M AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI
M2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0
M@H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D
M-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !
MI:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD-
M"T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#
M0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E
MH/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T
M*>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.
M]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD%
M!WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:0
M4II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0
M M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E
M  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*
M>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04
M+1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "
MBD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI
M.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T
M *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI
M1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T
M (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=
MZ4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!
M0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "G
MI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0
MG>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&
ME% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.
ME)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)W
MI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E
M"=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ
M4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T
M *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I
M.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!
M0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*
M6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0
M M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0TH
MZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0
MIH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2
M=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H-
M"BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3T
MI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H-
MH- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""
M@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0T
MM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!
M0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.
ME(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0
M@H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2
MT (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12
M&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[
MTIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3
MTI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/
M2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H-
MH- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0
M@H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0T
MM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I
M:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(
M*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@
M4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E
MH/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3
MO0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:
M3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!
M0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*
M6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0
MTHI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E "
M"@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +111
M0 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[T
MHI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>
ME  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:0
M4II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.
M] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.
M] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*
M3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI
M3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E
M/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T
M=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "
M=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI
M1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30
M#I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4
MTG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]
M*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E
M H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**
M3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &E
MI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%
M :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2
MTE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )
MWI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2
M@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D
M[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[
MTHI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*
M>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "
MT@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@
MT +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""
M@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E
M'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4
M=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H-
MH- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*
M#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E%
M"=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4
M (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2
MGI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%
M :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "
MT@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H-
MH- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4
MM)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04
M!I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%
M  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )W
MI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@
M4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 I
MZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T
M (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &E
MI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%
M :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#
M0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"
M@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I
M0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.]
M "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *
M3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!
M0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "F
MD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[
MT +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2G
MI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#
M2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%
M "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0
M HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]
M*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.
M] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=
MZ4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E
M- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0
MG>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2
M@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0
MIZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T
M )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44
MAI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "
MCI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32
M=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I
M0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *
M>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.
M] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E
M*3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:
M04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2
M"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@
MT +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-
M*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04
M *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "
MTG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#
M0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4
M]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#
M0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0
M@H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D
M-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:
M04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "
MCI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T
M (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0
MTM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :4
M4AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI
M.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:
M4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I
M3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#
M0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T
M (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D
M-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(
M*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +
M2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#T
MH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI
M0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2B
MD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z
M6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:
M04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2
M"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "
MD-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0
M @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T4
M44 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.
M]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2
MGI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "F
MD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*
M3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""
MCO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/
M2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (
M:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@
MI3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH
M-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10
M G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=
MZ4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T
M  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>
ME-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H
M/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "G
MI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2
MBD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !
MI:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!
M0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +2
M4M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E
M"=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!
MTH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>E
MI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI
M.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O
M2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0
M M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H-
MH- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0
M@H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !
MI1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"
ME'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#
M0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM "
M"@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI1
M0 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>
ME ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0
MTIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!
M0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0
M M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#
M0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0
ME+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%
M  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI
M!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "
M=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#T
MH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T
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MO0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0
M"D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:
M04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0
MII!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*
M.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[T
MIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*
M0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI
M!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@
MT **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E
M/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*
M3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4
MG>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)W
MI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4
M )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#
MTH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T
M *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0T
MM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E
M%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0
M HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4
MTG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH-
MZ4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.]
M"GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**
M3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0
M "D[THI.] "GI2"E/2D_B'TH 6BBB@ /2@4'I0* $[TIZ4G>E/2@!!0:!0:
M%I!2T@H #2TAI: $[T&CO0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%
M!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H #2TAI: $
M%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I32"@ [TM)WI: $%!H%!H 6D%+2"@ -
M*.E(:4=* $[TII.]*:  =*3O2CI2=Z %-(*4T@H #2TAI: $%!H%!H 4=*04
MHZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!1WH 6D%+2"@ -+2&EH 2EI*6@!!0:
M!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@ %(:44AH 6D%+2"@ -+2&EH 0
M4&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-**
M $[TIZ4G>E/2@ %)WI12=Z %/2D_BS[4IZ4@ZT +1110 'I0*#TH% "=Z4]*
M3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&
ME/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E)Z
MTIZ4@H 9'*)02O0'!J2F[0.@Q3J $%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I3
M2"@ [TM)WI: $%!H%!H 6D%+2"@ -*.E(:4=* $[TII.]*:  =*3O2CI2=Z
M%-(*4T@H #2TAI: $%!H%!H 4=*04HZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!
M1WH 6D%+2"@ -+2&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>
ME/2@ %(:44AH 6D%+2"@ -+2&EH 04&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI
M2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D_BS[
M4IZ4@H 6BBB@ /2@4'I0* $[TIZ4G>E/2@!!0:!0: %I!2T@H #2TAI: $[T
M&CO0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+2"@ -**0THH
M 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H #2TAI: $%!H%!H 6DI:2@!1TI.
M]*.E)WH 4T@I32"@ [TM)WI: $%!H%!H 6D%+2"@ -*.E(:4=* $[TII.]*:
M  =*3O2CI2=Z %-(*4T@H #2TAI: $%!H%!H 4=*04HZ4@H 4T#I0:!TH 3O
M2FD[TIH 04=Z!1WH 6D%+2"@ -+2&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4
M'I0* $[TIZ4G>E/2@ %(:44AH 6D%+2"@ -+2&EH 04&@4&@!12=Z44G>@!3
MTH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI
M12=Z %/2D%*>E(* %HHHH #TH%!Z4"@!.]*>E)WI3TH 04&@4&@!:04M(*
MTM(:6@!.]!H[T&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T@
MH #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(*  TM(:6@!!0:!0: %I
M*6DH 4=*3O2CI2=Z %-(*4T@H .]+2=Z6@!!0:!0: %I!2T@H #2CI2&E'2@
M!.]*:3O2F@ '2D[THZ4G>@!32"E-(*  TM(:6@!!0:!0: %'2D%*.E(* %-
MZ4&@=* $[TII.]*: $%'>@4=Z %I!2T@H #2TAI: $I:2EH 04&@4&@!:3O2
MTG>@!3TH%!Z4"@!.]*>E)WI3TH !2&E%(: %I!2T@H #2TAI: $%!H%!H 44
MG>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)W
MI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>E H 3O2GI2=Z4]* $%!H%!H
M 6D%+2"@ -+2&EH 3O0:.]!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@
M4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@ -+2&EH
M04&@4&@!:2EI* %'2D[THZ4G>@!32"E-(* #O2TG>EH 04&@4&@!:04M(*
MTHZ4AI1TH 3O2FD[TIH !TI.]*.E)WH 4T@I32"@ -+2&EH 04&@4&@!1TI!
M2CI2"@!30.E!H'2@!.]*:3O2F@!!1WH%'>@!:04M(*  TM(:6@!*6DI: $%!
MH%!H 6D[TM)WH 4]*!0>E H 3O2GI2=Z4]*  4AI12&@!:04M(*  TM(:6@!
M!0:!0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+2"@ -**0TH
MH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@ /2@4'I0* $[TIZ4G>E/
M2@!!0:!0: %I!2T@H #2TAI: $[T&CO0: %%)WI12=Z %/2@4'I0* $-*>E(
M:4]* $%!H%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@
MH #2TAI: $%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I32"@ [TM)WI: $%!H%!H
M 6D%+2"@ -*.E(:4=* $[TII.]*:  =*3O2CI2=Z %-(*4T@H #2TAI: $%!
MH%!H 4=*04HZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!1WH 6D%+2"@ -+2&EH
M2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@ %(:44AH 6D%+2"
M@ -+2&EH 04&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T
M@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(* %HHHH #TH%!Z4"@!
M.]*>E)WI3TH 04&@4&@!:04M(*  TM(:6@!.]!H[T&@!12=Z44G>@!3TH%!Z
M4"@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z
M%/2D%*>E(*  TM(:6@!!0:!0: %I*6DH 4=*3O2CI2=Z %-(*4T@H .]+2=Z
M6@!!0:!0: %I!2T@H #2CI2&E'2@!.]*:3O2F@ '2D[THZ4G>@!32"E-(*
MTM(:6@!!0:!0: %'2D%*.E(* %- Z4&@=* $[TII.]*: $%'>@4=Z %I!2T@
MH #2TAI: $I:2EH 04&@4&@!:3O2TG>@!3TH%!Z4"@!.]*>E)WI3TH !2&E%
M(: %I!2T@H #2TAI: $%!H%!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&
M@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***
M]*!0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.]!H 44G>E%)
MWH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH
M!2=Z44G>@!3TI!2GI2"@ -+2&EH 04&@4&@!:2EI* %'2D[THZ4G>@!32"E-
M(* #O2TG>EH 04&@4&@!:04M(*  THZ4AI1TH 3O2FD[TIH !TI.]*.E)WH
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M:04M(*  TM(:6@!*6DI: $%!H%!H 6D[TM)WH 4]*!0>E H 3O2GI2=Z4]*
M 4AI12&@!:04M(*  TM(:6@!!0:!0: %%)WI12=Z %/2@4'I0* $-*>E(:4]
M* $%!H%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6
MBBB@ /2@4'I0* $[TIZ4G>E/2@!!0:!0: %I!2T@H #2TAI: $[T&CO0: %%
M)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+2"@ -**0THH 3O2GI2=
MZ4]*  4G>E%)WH 4]*04IZ4@H #2TAI: $%!H%!H 6DI:2@!1TI.]*.E)WH
M4T@I32"@ [TM)WI: $%!H%!H 6D%+2"@ -*.E(:4=* $[TII.]*:  =*3O2C
MI2=Z %-(*4T@H #2TAI: $%!H%!H 4=*04HZ4@H 4T#I0:!TH 3O2FD[TIH
M04=Z!1WH 6D%+2"@ -+2&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[T
MIZ4G>E/2@ %(:44AH 6D%+2"@ -+2&EH 04&@4&@!12=Z44G>@!3TH%!Z4"@
M!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2
MD%*>E(* %HHHH #TH%!Z4"@!.]*>E)WI3TH 04&@4&@!:04M(*  TM(:6@!.
M]!H[T&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-*
M* $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(*  TM(:6@!!0:!0: %I*6DH 4=*
M3O2CI2=Z %-(*4T@H .]+2=Z6@!!0:!0: %I!2T@H #2CI2&E'2@!.]*:3O2
MF@ '2D[THZ4G>@!32"E-(*  TM(:6@!!0:!0: %'2D%*.E(* %- Z4&@=* $
M[TII.]*: $%'>@4=Z %I!2T@H #2TAI: $I:2EH 04&@4&@!:3O2TG>@!3TH
M%!Z4"@!.]*>E)WI3TH !2&E%(: %I!2T@H #2TAI: $%!H%!H 44G>E%)WH
M4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=
MZ44G>@!3TI!2GI2"@!:***  ]*!0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@
M -+2&EH 3O0:.]!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M
M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@ -+2&EH 04&@4&@!
M:2EI* %'2D[THZ4G>@!32"E-(* #O2TG>EH 04&@4&@!:04M(*  THZ4AI1T
MH 3O2FD[TIH !TI.]*.E)WH 4T@I32"@ -+2&EH 04&@4&@!1TI!2CI2"@!3
M0.E!H'2@!.]*:3O2F@!!1WH%'>@!:04M(*  TM(:6@!*6DI: $%!H%!H 6D[
MTM)WH 4]*!0>E H 3O2GI2=Z4]*  4AI12&@!:04M(*  TM(:6@!!0:!0: %
M%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+2"@ -**0THH 3O2GI2
M=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@ /2@4'I0* $[TIZ4G>E/2@!!0:!0
M: %I!2T@H #2TAI: $[T&CO0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!
MH%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H #2TAI:
M $%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I32"@ [TM)WI: $%!H%!H 6D%+2"@
M -*.E(:4=* $[TII.]*:  =*3O2CI2=Z %-(*4T@H #2TAI: $%!H%!H 4=*
M04HZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!1WH 6D%+2"@ -+2&EH 2EI*6@!!
M0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@ %(:44AH 6D%+2"@ -+2&EH
M 04&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-
M** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(* %HHHH #TH%!Z4"@!.]*>E)WI
M3TH 04&@4&@!:04M(*  TM(:6@!.]!H[T&@!12=Z44G>@!3TH%!Z4"@!#2GI
M2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E
M(*  TM(:6@!!0:!0: %I*6DH 4=*3O2CI2=Z %-(*4T@H .]+2=Z6@!!0:!0
M: %I!2T@H #2CI2&E'2@!.]*:3O2F@ '2D[THZ4G>@!32"E-(*  TM(:6@!!
M0:!0: %'2D%*.E(* %- Z4&@=* $[TII.]*: $%'>@4=Z %I!2T@H #2TAI:
M $I:2EH 04&@4&@!:3O2TG>@!3TH%!Z4"@!.]*>E)WI3TH !2&E%(: %I!2T
M@H #2TAI: $%!H%!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04
MM(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>E H
M 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.]!H 44G>E%)WH 4]*!0
M>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>
M@!3TI!2GI2"@ -+2&EH 04&@4&@!:2EI* %'2D[THZ4G>@!32"E-(* #O2TG
M>EH 04&@4&@!:04M(*  THZ4AI1TH 3O2FD[TIH !TI.]*.E)WH 4T@I32"@
M -+2&EH 04&@4&@!1TI!2CI2"@!30.E!H'2@!.]*:3O2F@!!1WH%'>@!:04M
M(*  TM(:6@!*6DI: $%!H%!H 6D[TM)WH 4]*!0>E H 3O2GI2=Z4]*  4AI
M12&@!:04M(*  TM(:6@!!0:!0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%
M!H%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mmsi-20221231xex10d61g004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231xex10d61g004.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ***:3S0 ZBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y/[._M15FB@#2T/_CU
MD_Z[2?\ H1K1K.T0?Z+)_P!=I/\ T(UHT %%%% !1110 4444 49+LPW,*;2
MZ2[LR#L15T#%)Y:^G'I2@8'K0 M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 UAD4*,"G44 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <WNHHVT4 :>B
MC;;R _\ /:3_ -"K1K/TKY5E7L)G_GFM"@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH QZ*K^<WM10!?TGA)!W$TG_H6:T:SM+_Y;?\ 79ZT: "BBB@!
M",C%58;!+>61TW L.A;Y?RJW10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &+O'O14
M&\T4 :.F?\MO^NSUH5GZ9_RV_P"NSUH4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MF<TM)C%+0 4444 8/E-[45)DT4 6=*.[S\=IGS6C6=I0V_:/>9ZT: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#&W44SSHO4T4 6]*.[[1[3/6C6=I
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M'U 1FOG&Y_8^L[_0?%>GSZQ+%+J/B*#5-*N;:21'TFRCG:7[+$0PV_\ 'S?
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M'/AJ?2?A!\/_  '>:K:Z5\5[34;:?0!IA^T.K)=>6\Z!T&Y%MY':3(P!NSD
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MC90RL,^H(-<_\4OB':?"GP%K'BR_L;W4;'2XA//!8*K3>7N 9@&91A0=QYZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH :8U,@<J"Z@J&QR <9&?P'Y"G444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 9-%,\Y/6B@";2?]?=>TSC]$K3K+T<YFO"?^>S'\U0UJ4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %,\U/,V;AOQG;WI],\I/,W[1OQC=WH R]AHIOV
M@_W1_P!]'_XFB@"31?\ 6WG_ %U_]D2M6LK1?]=>^TY'_CJ5JT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 45&DZR-@=:DH **** ,3=%Z'_OR_\ \3163YP_N+_W
MPG^-% &YHO\ K;S_ *Z_^R)6K69I*[9;K'>5OT""M.@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!G[V_OG\A14/VL_W_ -** ':-_K+S
MVF(_\=2M2LK1O];>?]=B?_'$K5H **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#LB5JUE:+_ *V\_P"NO_LB5JT %%%% !1110 4444 %%%% !1110 4444
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M3]GG2_!NE>!M-T_Q+XA^Q^#[J6YTZ.:6V;>LB-&893Y'S($DD48PP#GYN!@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *J:GJUCHMH;K4+R"PM@R(9KF58T#,P51N8@9+$
M#N2!5NO-?C[I^K:IX)M+?2-+EU2;^U["67[-#'-/:QQSI(9XHY&",Z% 0&R
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M'5)+Z);63@GY92VT_=;H>Q]*=J/COPWI-E!>WWB#2[*SGA>XBN+B]CCCDB0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#G?L+^H_P"^E_\ B**?]E]C_P!^A_\ &Z* +FD_
MZ^\_Z^)/_9:TZR])_P!?>?\ 7Q)_[+6I0 4444 %%%% !1110 4444 %%%%
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M.^/F91@9J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH S]EM_<'_?+45G[?^FZ?FG^%% %O1?\ 77W_ %\-
M_P"@K6K65HO^MO/^NQ/_ (ZE:M !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7FG[14VKVGPEUJ[T#6+C0M8@\IK:\MR/E=I50;@0
M=R_-R.]>EURGQ0\(7GCOP3?Z'8W<%A<731$7%Q$9439(K_=!4G.W'4=<]L4
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M5V"C ]^]+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% &;Y$7K^A_QHJA\O]]?^_8_PHH N:,,37OO</\ HJBM6LS2?]?>
M?]?$G_LM:= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B?8T_VOR'^%
M%1^4OH?^_)_^(HH MZ.<SWGM</\ J%-:E9>CC$]Y[W#_ *!16I0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 9F#_P _DG_?#45F_;F_Y[#_ +]44 :6
MD_Z^\_Z^)/\ V6M.LO2?]?>?]?$G_LM:E !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!D8M_^>;?]^3_ /$45@;/^G>W_(?X44 =#H[;I[S_ *^'_4*:
MU:R=%_UU[_U\-_Z"E:U !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44A.* <T +1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 <[\_\ =B_[\M_\313_ -U_SR'_ '[/_P 110!9T7_77O\ UW;_ -!2M:LK
M1UVSWG_7P_Z!16K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9&W_IE
M_P"/G_&BJ_V'_I@GY?\ V%% %O2?]?>?]?$G_LM:E9>D_P"OO/\ KXD_]EK4
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]:\0
M:7X;M!=ZMJ-II=J76(3WLZPH78X5=S$#)/0=ZT*Q_$GA'2?%\5C%K%E%?P6=
MW'>Q0SJ&03)G8Q4\'!.1GH0#VH I6GQ,\(:A?1V5KXIT6YO)'\M+>'4(7D9\
MXVA0V2<\8]:A7XK^"G$A7Q?H)$0)<C4X/D ZD_-Q7S;^S%X(T3Q7X^^.L&HZ
M?#(-/^(1O;1XT"/;S0REXV0@97D8..H9@>":XWX+>'[O7_BY\8= 'A>TU;PI
MK'C^[L=>G<!FCM?(NV5/+V?*OF"/]X&!4D #G( /MW_A)=)_M(:=_:=G_:!C
M246GGIYI1]P1MF<X;:V#CG:<=#1:>)-)O]2N]/MM2M+B_LRHN;6*=7E@+9*A
MU!RN<'&<9P:^2/CI\#%^,/BOP]<^ -;^R^)?#7AF&]\/:LDH F>&Y**KN!CD
M X;& ?8FND_9?^+<OQ \2?$?Q%XPT=?">OZ'INFV?B"*Y3RDAN(#>F24$G(3
MRRC9/0<9( ) /IZ.\@EGE@25'FB ,D:L"R9Z9';.#BH(]<T^;4I=/COK:2_B
M7?):I,IE1?4KG('OBOB_X8?%S6_"_P"U=%J/BI=2T_1/BA8(+:'4=.GLX[*[
MB=EM;<&1%#MY.P,5)!>;TQFS\8OA;XO_ .%N^-OBS\,_WOC;POK%M'/IG.W5
M+$Z99M)!M'WCDD[>IR=OS!: /K<^/?#2J&/B#2PID:($WL6"ZKN9?O=0O)'4
M#FI=/\9Z!JU\+*QUO3KV\*LPM[>[CDD(5MK':#G /!]#Q7AOP(M_"?QJ^&&G
M_$.3PU!;W+W&L3VEO<Q(QM7GF*S< 8+?N@H?&<9Z9(KG/V!?!^F:I^S7X!UM
M[6,:QIMQJ1MKH###?/.A5B.63#9V],@'J!0!]745F>&AK T"P'B V+:V(5%X
MVFAQ;&7'S&,/E@I/(!)(Z9/6M.@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S?,7_GJWYG_ !HK)_M:
M3T3_ +Y_^SHH U-)_P!?=^\\A_\ 0:U*R])_U]W[3R#_ -!K4H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ=!X;^/FAV'P]\,:OXK\4:,;W4]+_M%I].60P31J%,DT2X9O*7<,L>!P3C-
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MQ';OED65-\3X/574Y5AD'G!XKJJ "BBB@ HHHH **** "BBB@ HHHH ****
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MX^<(X# ?,O4?Q#U%+XJ\1V/@WPWJ>NZFTJ:?IUN]U<-#$TK+&BEF(502> :
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MM]&7QMX<M;&PMXM3CN'CN$LY(2C$!1P9.3TR#C<.:XCPG^S[XZ\%3_##69M
MM_$:Z5X1_P"$0UOP_<7L/RQ$EC*KN2C+G;D$=J^VR@88.?P.*88%('+C'3YS
M0!\+_M$?LY_$/XB?\)Q::'X9TRUTR^T?0XK*VL+F*-)[BUN [H<\D1K\J\(
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M-\!O&6HZ]^TGI4%A:VVE_$*RMI--UDW2JHE2U6!HY$SNR2"=W0 BOKIK=&4
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M %O1SA[M>_GO_3_&M.LO2?\ 7WG_ %\2?^RUJ4 %%%% !1110 4444 %%%%
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MXENQV^T2?^R_XUJ4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAL[.#3[6"VMHDM[:!%CBBC4*J*!@* .@ &,5-0!\=_'7P]J/P_\ VH_!&O\
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M$@8QN!AAU7.WF@#:^&_Q5Q\*/#&L^+[MVUJ^M9I9H[6S>25S$6\QA#$K,%4
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MBB@ HHHH **** "BBB@ HHHH YW=9?\ /-__  &;_P"(HK)^T?[2_P#?I/\
M&B@#I-%^8W9]+AZU*R]%^4W8];AZU* "BBB@ HHHH AGN!#C*LW/)49Q3XG6
M1=RG(/>A8PJ[<DCWI4C6,848'I0 ZBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **0G% .: %HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH \%NOV69=$U_5+_ , ^.]8^']EJ4@FG
MTK3HHY;59,DLT<;\+NR>QQP 0H"UUWPP^!.D_#>YO]3FU+5/$WB/485AO-9U
MJZ:>=D &8XR3E(\C(7)(XR3@5Z910!\RZ?\ L16%F^F:7/XWUV]\$Z9JHU2T
M\-SN3'$1N(B5]_"[FSD*#][D%B:]B^)WP;\+?%ZRM(/$FGFXDLRYM;N&0Q3P
M;P X1QR P !'0X&:[BB@#SCX>?L^^!OAHEH^EZ)#<7]L (]2OU6:Y7'0AR/E
MP,#Y0.@SD\UZ/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!S_DR?\ /9/^_7_UZ*L^8/[I_)O_ (FB@"71
M^MW_ -=VK2K,T0[A>$_\_#UIT )G-+28Q2T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% "$9H Q2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% &7Y<?]W]#_C16%N/_/&"B@#>T0Y2X']V=P?SK3K+T/[MY_U\
M/6I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 9>W_IE^A_QHK!^VR_W
M_P#QT?XT4 ;NBC=)>,.GVB3_ -E_PK5K,T(?N)V[M/(3^#8K3H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** $SFEI,8I: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Y#S'_N_^/'_ .-T53^T3>OZ?_6H
MH Z?0N8[INS3N1^!Q6I67H/_ ![2_P#7:7_T(UJ4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !12$XH!S0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!D^:G]UO\ OAJ*H_V9'_>_\AQ__$T4 :6A_P#'
MM)_UVE_]"K2K+T$YMI/^N\O_ *&:U* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#'HHHH DT _Z-+_UWE_]#-:#^9N^7&/>J&A+BVD_Z[2_^AFM.@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH Q**A\R7_ )Y_H:* +VA?\>TG
M_7>7_P!#-:=96@,3!./2>3_T(UJT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4W>-^WO3J;L&_=WH =1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!S7]GW'_/PO_?A**TJ* %T/_CVD_Z[2_\ H5:59FA?
M\>TG_7>7_P!#-:= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A&: ,4M% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8W
MVI/0T55HH T-!&+:3_KM+_Z$:TZS-"_X]I/^N\O_ *&:TZ "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#F?L\W]U**O[:* )=#_X]I/^N\O_ *$:TJS-
M"_X]I/\ KO+_ .AFM.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R:*
M=MHH - _X]I?^N\O_H9K4K+T#_CVE_Z[R_\ H9K4H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ
M*298V"DX9ONT 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 8/E-[45-10!+H7_'M)_UWE_\ 0S6G
M6;H?_'M)_P!=I?\ T*M*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
MO[+-_P \K7_OD?\ Q-%2_:']J* +NA?\>TG_ %VE_P#0S6E6;H7_ ![2?]=I
M?_0S6E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9-%5OM#^U% %S0O
M^/:3_KO+_P"AFM.LS03_ *-)_P!=I?\ T,UIT %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% &#Y3>U%-\YO:B@"WH3CR95[B:7_T,C^AK5K(T$<3_ /7:
M3_T8]:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_ )3>U%2T4 6-
M"_X]I/\ KO+_ .AFM.LW0O\ CVD_Z[2_^AFM*@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH QZ*** )=!'^C2?\ 7:7_ -#-:=8_AR1GMY<]II?_ $8P
M_H*V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** $)Q0#F@C- &* %HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'HHHH ET
M+_CVD_Z[R_\ H9K3K,T+_CVD_P"N\O\ Z&:TZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#'HHHH ET+_CVD_Z[R_\ H9K3K,T+_CVD_P"N\O\ Z&:T
MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$HHHH =X>82+,PZ>=*/R
ME>MFLCP]$$MY2,\SRG_Q\G^M:] !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 444TGF@!U%1"=#-Y6]?-V[M
MF1NQTSCTJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@P>(KV"9].&FMK<4<8N=NP(7 QM#E<C('!.1B@#Q3P'\<SJ7[0B3R^)+"_\
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M (\:U*RO#I_T*7_KXE_]#-:M !1110 4444 (3B@'-!&: ,4 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!CT444 .\-L&LI?^OB4?\ CYK6K'\,_P#'E-_U\S?^AFMB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH QZ*** '^'?^/*7_KXE_\ 0S6K
M67X=_P"/*7_KXE_]"-:E !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 A&: ,4M% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 8]%%% $GAW_CRE_Z^)?\ T(UJ5E^'?^/*7_KXE_\ 0C6I0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 8]%%% #M!0B.9NQFE_P#1C'^HK6K-T/\
MX]I/^N\O_H1K2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HWF
M"-@@_A4E)B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*CG\S8?*QO\ >I** "BBB@!JON[$<9YIU16\'V=-N]Y.2<N<FI: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R:*** )M)XCD4]1+)_P"A
M9K0K/TS_ );?]=GK0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,FBB
MB@"72#O25AT,S_SQ6C6=I(V)*HZ><_\ /-:- !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!E8-%&310!)I/"2#N)I/\ T+-:-9^E_P#+;_KL]:% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M- #J*;DT9- #J*K7=PT$6Y<$YQS1:7#3Q;FP#G'% %FBFY-&30 ZBF[C1DT
M.HIH/-!/- #J*;DT9- #J*;DT;C0 ZBFY-&30 ZBFY-&30 ZBFY-&30 ZBFY
M-&30 ZBFY-*#F@!:*:#S3J "BD)Q29- #J*;DT9- #J*;DT9- #J*;DT9- #
;J*;DT9- #J*;DT9- &5NHK)_M.;T3\J* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mmsi-20221231xex10d61g005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231xex10d61g005.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U,# 2(  A$! Q$!_\0
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M] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E
M*3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- %>WLD
M@N9I@!OE !..>.E6!2T@H #2TAI: $[T&CO0: %%)WI12=Z %/2@4'I0* $-
M*>E(:4]* $%!H%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04
MIZ4@H #2TAI: $%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I32"@ [TM)WI: $%!
MH%!H 6D%+2"@ -*.E(:4=* $[TII.]*:  =*3O2CI2=Z %-(*4T@H #2TAI:
M $%!H%!H 4=*04HZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!1WH 6D%+2"@ -+2
M&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@ %(:44AH 6D
M%+2"@ -+2&EH 04&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/2@!!0:!0: %
MI!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(* %HHHH #TH%!Z
M4=J $[TIZ55GOA!<PPF.1C*VT,BY"\9Y]*M'I0 @H- H- "T@I:04 !I:0TM
M "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%
M(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0
MHZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4T
MG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z
M4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "
MGI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3
MO0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0
M"D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6
MD%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T
M@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H
M- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#
M2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D%
M "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0
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MT=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E%
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MGI;Q6,"AC;"5Q)("AW,_E!2!@ $X ."/+=%^._PT\-_MJWGQ&LM;TVS\(SZ
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MX5SX4_Z%?1__  !B_P#B:Z0=*3O0!SA^&_A,C_D5M&_\ (O_ (FD'PV\)?\
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M@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0
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M?LPZIIWQU\4_$RV\2:8\_B"P32I]'O-&::V6V01!.1<*2^(5R>AR>*^@C2T
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M=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4
M(*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2G
MI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%
M:6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T
M@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H
M- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M
M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !
MI:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%
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MI!)&P!5UZ$>HIT<T<K.$=7*':VTYP>.#[T /-(*":!0 =Z6D[TM ""@T"@T
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MEI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T
M+2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H-
M "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"
M@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0
MIZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[
MTHI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WHSQ1WH 4T@I32"@
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MC2]7S)=+N=EK<0G'V=P0"-O.9&*AO+. -WR>XLH;@TR8I;Q/*58A%+$(I9L
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M'<X"2&>-]I0-OW2MN4 $U4E\#ZG%X/O)[+PCJ=OJK?%A=?3.CNLILEO/,$^
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M@6MY+=/]EO;,I;2$1NK'?<L)W5 /E+ #'7/JUQ\3O"%E>QV5QXHT>WO)+O[
MEO+?Q+(US@'R0I;)DPRG9U^8<<U\DZGH&L-H7C&YT_P;XAMI)OBOIWBBP$FB
M3%WMMEH\DZH$+#'V>8MD Y8*?F;;5CXK> +RZT3]HR[TWP9J%QK6I:QIEQHT
MT6B2N]TD45HKF(B/+ 317!.WU+]&!(!]:ZOX_P##6@:G%IVI:_IEA?R@&.UN
M;R..5P<XPA8$YVMV['TK&^,WQ3M_A%\*-?\ &[VCZI;:7:_:!;P/CS<L%7YL
M'"Y8$M@X&3@XKY6\=7\.L>-OBQH%WIFO7'A'6=7TG4+O4XO#MY?26C06UK+(
MB;$95)6.,8DVM%N8E#P*^JOB#XA$7PQNM4TK0SXNM)HH2NE01>9]LMI'19 J
M8PV8G8X(QQSQF@#!T#XH:Q'?6EUKLN@W/@VXT:;5O^$ITNY9;6-D>$>4VXE=
MI65F63?\VQOD7'.SX?\ C?X)UWP7I7B@^(].T_2-27=;S:A=Q0Y.TL4.6P'"
M\E<Y'>O _"'P>'@WXHWEK\+K77M(\":[H5__ &OHVK6=S;:=9W;!1;O;B=5(
M=F+AE0, JGIE17.^%/[=C^'GPLT&\\%>+-.EL/#%WI%WJ5KH4DEXEP$@5K11
M(ACBCE(/[^1=I\OY6 RU 'USJ7Q%\+:-$9=0\1:58Q"U^W%[F]BC7[/N5?.R
M6'[O+*-W3+ 9YJ/Q%X_T30] BU.77M(L+>[CS97E_>)';SL4+)ARV&!'/R]N
M:^3/@MX0N9O&7P>G\1^!]76+2?A_<:;>R:IH,Q$%TCQ[4W-&0K%8Y@H)!(;
M'SKN3X"1^(_AU-\/+[Q)X-\3W7A\^%)M#BMHM%GFFTJ]%Y(\@F@V[T2:(0J)
M,;?D4$@<@ ]_^%/QYTWQ)\&?"GC+QEJVB>'+G6H9),27:V\#%7<$1F5LMA5!
M//OQ7=W7Q!\,V)C%SX@TNV,D:2H);R-2R.P5&&6Y#,R@'H2P ZU\:>"-/\1Z
M;\,?ASX<N_ GBG26C\-:MI\E[9:.7O$D>9<61WJR6L<JA6,LB\[ %*X8UL?
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M.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E
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MB,FK)J-AXRURWTV_\/M#$L%G%<2R1H8'""7S(BJ[][,&VO@+Q@ ^I#@]5S0
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M73&5VX52<T ?5V[(/;ZUS&H?$SPQID]G!<:Q;K)>:G_8T&TEP][M9_(R,C>
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MQ\T"0:O;WMOJ&DZMIM[!ITNE7L*BXDGG3?"D6UF23>N3E6( 5BVT*< %NZ^
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M/#%<Y4-G(S7H Z4G>@#AOB9X D\63^'=9TXPP^(_#=]_:&FRS#",6C>*:!V
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M_ ;P7:76AW$>F3,VBZ8^C6,<U_<21QV3@!X&C:0K(A 4$.&X5?[JX]!-*.E
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MPY="&#$9)8$'))KJN]*>E 'GFD_ 7P;H<WA.:SL+J.?PK9RZ?H\AU&Y)M8)
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M&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***
M ]*!0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.]!H \F\:>
MO$.L?';X?>,;*ULI=(T*TU"SNTEN62<_:?*&]5V$$+Y70L"=W;'/FMO\"OB'
MILNA:396WAQ=!T3QY<>*89FNYEEGMYIKB7R]@BQ$R"X*XRP; ^Z!S]1A?<_G
M2;>>I_.@#YCN/@3XZC\&W.E0VNB3SZ-X]/C#16DO)%^V(VH2W31RGRCY#;92
M@*[^ASP:H:W\!/B9K#^)KJ>/P\;K4_&NE>*HA;ZA/'L2VC@1X"3">0(%4/\
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M+5B>,_@!XNUV?Q;XDL[;3E\0^(_$FA:M)I\MZXAM[;3'B9$\P1_-))Y1S\H
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M+<=J]OUGX.^!_$5WIUUJWA72-3N=.@^RVDMY9QRM!#_SS4L#A>.G2J=M\$?
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MXB_$+X?-I_BWQ[8OXFL)[2\T;4-*TOR8(+JVF66.XFC9F\QV*@,!M4 G"\T
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MC9X&3OZ7^U%HMSX<AN;^P?0M;?7+GPZVDZE=11"*[@5GE+3$[/+" -O&<[E
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MIOP'U.7XQZ5XZU)M'M[_ $V\OG.HZ9')%=ZC9RI)';VMT!A'$2R(=YW',*X
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M+D;<8XSG^&NX^#_@GXA^&%MHO''BW3_$,.GVOV.T;3[%[=[GD8GN2SL#)M4
M!0!\S$Y)& #.U[XS7_AGXUZMX>U6Q@LO">E>&#X@N=6-P"502,K.RXR OE,,
M#.=V:M>&?CW;:KXN\*:)JNB7NAMXML)=0T&>>2.1+I8T$CQ/M.8YA&PDV\C&
M?FRI%4OB7\";SX@?$:^U1M3M(O#>M^%I_"VLV3P.;DPN\CAX) P56S)@[E.
MO .>(_!GP3URSO\ X?2^*-7M-27P':2V^F36,3QR7DCP&V$TX8D*1"6&Q206
M<MD8 H U/&WQ)U?1_C=X0\$PZ6D^EZ[IM[=27:7.R96A>%6P.,!5EW9!R<C&
M,<^2?L[_ !UG\+^#?!F@ZOH_B#4+#5_$&IZ)#XGNYUG3[7]MNVBB;<YF<;(]
MOF$$9&,GM[#\0/AGK?B#XI^!O&FAZCIUK-H,%Y97-MJ-JTHE@N3"7,95EV2#
MR  3D8<Y]#PVF?LZ^)]/\%>"=".M:3(WACQ?)XECE^SR 3Q-+<2^3C/RMFYD
M&[Y@ J\'D4 ;>B_M3^'-=\5Z%IEC"][I^MWTVG6>H6EQ%,5FCW<S0JV^*-RC
MA7(YP,A003[=G/->&_"GX,^-_A=>)X=A\7V5W\-[*ZDN-.M7LF_M2.-F+BV>
M??L,89C\VTL5 &1GCW%1@#-  *#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2G
MI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "
MT444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0!Y
MGXN^*^H^&?C%X,\$0:+:W,/B2"[N%OWOS&\"6PC,H\KRSN)$J[?F SG)'&>\
MC\0Z;).D(U"U:=PY2(3*68(<.0,\[3P?0]:\.^*DL _:P^#5W+!.88--UNWG
MN1;NT,9F6W$2.X&U2Q1@,^G7D9\"T#X?^%5\+^!I4\/VT%S_ ,+1U".:1+%X
MY!I+7%YM1R%!%N8I+?Y6^0AP".30!]X0Z]IUU:1W4-];S6TK;8YHY59'.<8!
M!P3GBFVWB+2[RRCN[?4;6>TD?RTGCF5HV8MM"A@<$YXQZ\5\)>)- \.VGAC6
M;*YT^*WT+3_C/9RV]JELZI'83>0LGE* ,1LWG\+E>&X]%\=?#_08-3\0W.GZ
M24^'U[X]\/S65G%8,L*>6H&ISVZ!,B%E**S*-I,;XXH ^Z)?%&CQ06DSZI9I
M#>,%MI&G0+.3T"'/S$^U6SJ=IY[0?:(O. R8]XW ?2ODO4O"'A_P;\0OBAX:
M\2^&BG@C4_#%G;^%(K.Q::%85687-M!M!VS&>57"#!.4(^[Q6O\ X?\ COX?
MZ/\ !3QM:Z5_:WQ!BT&+PCX@4@.Y:X@017$C$=(;A$+M_=9^M 'UK=^)-)TZ
M&WFNM3L[:*Y?RX7FG5!(W]U23R?84M[XBTK3M_VO4K2UV; WG3JFW<2$SD\9
M(('K@U\A?$;P1HW@3XA1^$_$>G^(E^'=_P"$;;1-/N-&TP7L3RI).;F!PL,C
MQ22AX7W)M+,H.<J".9U_X9:5=:A\<H-4\+7$]POP_P!.723J]H;FX:\2SF3*
MR[<23JS6ZEUR=Q'/6@#[G@UG3[J\N+.*\@FNK?;YT$<@:2+<,KN4<KD=,U#;
M^)-(N6NU@U*TF-H<7 CF5O)/7#X/R_C7QEJ_A&>QU#0(_AU8RZ=XCU?X5ZI8
MF\AAD@:;4#]F>!9IF _?EENFW.=^0Q)[UDW6E>$_&?PJ\<:M9Z5XK?7X/ =W
MH=[IVN:0EI!9R[-UO 42VC$\PN -A7?MP3E<KD ^V-3\;Z!I>GZA>7.LZ?#;
M:?$)[R62Y0+;QE<AG.?E!'()ZU5T'Q_X?\0^&-&U^'4+:+3M7ABFLY+B18S(
M)$#JHR?O8/W>M?),G@;1]+\3>%[?PYX?%M_:OPJU2RO/(L7'VJ](M'MXYB5^
M>;Y+D@/E_E;/:J=XEKJ'P7^&]YH)&EZYI7@][271]<\/2-IVL,8H!=6CC:LB
M3F2%0LB<MDXW_-@ ^YB\:QB3(V$9W=L52A\0Z9<VHN(K^VDMV;8)5E4J3Z9S
MC->.?&F/Q+J?[)US_P (_HNH6>N'2["5]#LV#W4<(>%KFU7>/G?R1+'@@[NF
M#G%>07'ASX;^,?!GCC4+>U\4ZW%XE@LK$MJ6G"P1-2 *6ODQBWC$<L>07FVE
M54#)89% 'V2=3M%,H-S$#%CS 7'R9Z9]*1=4LW$K+=0E8O\ 6$./D^OI7PCX
MXE8?LP_&?0/&%@9OB+I=U%-K&M"W*C50DT(M[J!PHX6((FU>5(.>6),OQL^'
M/A^2P^*.J_#;3$?PY-X!EL[Z.TMG-O=ZN+A?L)4$'S+A )@S#YE+KN.6H ^X
M[OQ%I=C;2W%QJ%M!!&_EO+)*JJK_ -TDG /(X]Z+GQ%I=B]NESJ%M;O<_P"I
M6655,O?Y03S^%?(WCCPGX8^'OBKP5>VVEZEI?PPUC2;D37FAZ6MWY>I3"']]
M=0/#*V9(8MOF!-P(8' =L\[XV\'P>#_#MA%X4AU+5)+3PQ!9KX2\8V#RMK-A
M]LN#%'#.BA[>[&25& 5#0@J-A*@'VQ<Z_8+?'3TO+5]2V;ULVF42$8.#MY..
M.N*XOX)_%EOB9X L=;U:UM-#U.XOM0LFT^*Z\U0UM>S6QVL0I;/E YVC[W2O
M$?\ 2-)^/]IJ>BQ+X@M+KQ+*VI:3J^G2)?Z/,;5H9+VVNAPUMY2CY7RN& 4[
MB%7GK/P=/=?LO6_B[3[$-XN^'_BS6/$]G%=Q&%VB75;FXE@;>H($MI)D=.3&
M>". #[0AOK>X>18IDD:,[7",#M/H?0USWA?Q)J%U#JK:^FF:>8M5GL[/['>>
M:)8 ^V$R$@;96!&8^<$XR:J?";PW/H7A&&?4;2.UUK59)-4U*-<$I<3-O:,L
M!\WE@K$#W6-:^0M6T;1I?!.MV,VBE[-/C3%=)%]B=5ALC=Q--*!@$1&))_F7
M@CVH ^Q_$GQ/\+^%-'MM4U'6K.*QN;V'3H9A,I5YY)1&J YQD,>?0*Q/ -:[
M^(M+BN[:U?4;5+FZ&Z"%IE#S#KE!G+<>E?$WC'PII^AWGQ6LM.T.6W\,Z5\1
M/#6L+96&F,\45J([(7DL4(0JPWI/N"@@X.1BM#5+73/$?Q$\7:)XLTKQE!+J
MFK6&N>%QIVEE4NH$@MC;HDQ@+VKQ2)*'1VC"!G)QN;(!]E-XATQ+F.W:_MEN
M))#"D1F4,SA=Q4#.20"#CK@YK@OCE\8!\)O#UK?VD6GZC>RZCI]H]A<7?E2^
M3<W<5L944 E]K2@XX& >>,'Y;\1^ =.3PU\5-7M_"TL/B:W^*NGW.CSP:5+]
MI2W6XT]Y9(-J%MC(EVY*\$9/=:3XCWK3>$/B#I.N>&-7O?'$'Q M-=L9H-(G
MNWN]-74[=K>:"5$9=JV@,6W<,'*XRV" ?<<VOZ;;ZE#ITM];17\R[XK5Y5$K
MKSRJYR1P>GI7!?%WXP/\.)_"UO8V]CJ5QJNOZ=I%S;RW@CFMH;JX6'SUC )?
M!;H<#WXQ7SW'96>L?%7Q)HGC/3_%XU]?%T>MZ$EEI_\ HUW$&C-K,MT(2T0C
M0;'5I% 5",9)%<UJ^HFX\&^&+#Q-X9U>?XE:#\3[35M5N(-$N;AC"NJ;_M,<
ML<9#Q&U*(H!)PH4#Y10!]J^,/'NA> [6QN-<U*#3H[Z]@T^W\YP#+/,X1$4=
MSDY/H 2> :TY=;L()[>&6]@CGN/]3&\@#2_[HSSU'2O&OVNM,BG\!>&=1GTQ
MM1L]*\6Z)?7HCM#<M':)>Q&=MBJS$;,Y !XS7DGBN&T\0:;\>-%\1Z'>OJ^M
M01W?@ZX&G2K++:FPB6RBM<Q@QRPW*.2F R,Y9AU- 'V4TR11-([JB*,LS'
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M7PU%X,\-6'P,^.FO6=E_9&NVWB/5(;2]CL9=QL);Z)XH$4 '[/,$"G8,89R
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M\,^(KO1-$\7^%-1D^,>B:IJ0U5I;.9 Z3O,)+F:?:(Y;>2)EVHQ()V*HP 0
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M2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H-
MH- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0
M@H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0T
MM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I
M:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(
M*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@
M4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E
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M,\%V7Y@O4@@XYIA^*WA%->DT9_$.GQZB@F)ADG5<^4,S8)X)0<L ?EP<XP:
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MR%\K(/W\D#;U.1QS7%^._C?)!K7PMD\):CI>JZ#XF\0MH]W.H\XX$,S$(ZL
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MOXINM;T_5O!NI:O:ZE<6MN9[&\M A\P;(@C1N)5^5E."!@@<5Z3^SPGBJ_\
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MU.0#)^!,7BV\^'NG:OXK\2QZ[?ZS9VU\@@LDMDLP]O&6C4 G>-^YMS<_-C
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M,070*W)YYJ9O@1X%/P_@\$?V,1X5@E66+3!>3B-65]Z\[\X#_,%S@, <9 H
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M#( 8P&3=.V.0<(#CYB%YG6OV?_B3XBT31M(U"Y\)76FV_A5M -G>"XN(;&Z
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M&/$.DW'AJZO%\'V?A76K"\N)T@5[9I'BNK=UB+/S-)F)PF1@;P?FH R_@/\
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M7SGXZ70O%'P_TCPYX;\5OK/C32M<5/#/B":X1OM&HHWVA@[@GS8D1E6; ([
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M1-'92?\ "#ZAFTN6$4D.^XMV1&3/RL51CMZX0^E</\#-4T.7P?XYU6?XE_\
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M_P!H[QOX\?PI%X7\/:"AUWP9_P ),T^I7LNRUE$B(\95$RZ@N ,$$Y))&W#
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MM3>)?$^J>%]#TWPMI<>O7^M:SX;U*&\U)UAL[VP0LQ1Q$?-C90&X ;D#'4@
M^D+.SAL(5AMX8X8ESA(U"J.YP![U@6/@:TTKQCJ'B"Q=K674XU74;= /+NI$
M 6.9ACB15&S<#\R[0V=J[?%--_:4\8ZG;>$K.'PKI$NNZGXEU3PK?1_VC(D$
M5U9K.3+&?+),1\AF.?F X 8G(K:7^T[XT>UBO]2\):/;:?8>-(_!6K&+496E
M:XDNEMUFMU,0!C#2PM\Y!(+8Q@$@'T>VEVDEVET]M$UU&-J3-&"ZCG@-U'4_
MF:G\I0:\$7]H_7M9UE7\,>#KK7]#C\1/H4[0V\XD$<<K0S7:R[/)*)(K?)OR
M5&<@Y48FF?M/>,B=+U#5O">C6>B3>-9/!5RUIJDD]PLXN7MUEC4PJI0.BYW$
M$Y)VC R ?2$5C;)<S3QPQI-+CS)%4!GQP-Q[XJ"6WTW3E9Y4M[<7,JABP5/-
MD8@*#ZL3@#O7S]X/^,/C73_#?Q(UC5/[&U'^RO&,FC1-)<&S@L[</!&979R?
MDC1]Y4?,[;@.6&./\>?%)?C-X"TJ\O\ 2K>WO_"_Q<T+2(YU1PLA%]:$3QK(
MH>/=%<[<'GD\D&@#ZU.G6-L("((8A#_JCM V<$<>G!(X]34Q6&Y1E8I(K##+
MP01Z&O'_ -LFVAN/V8/B/)-#'.;?1YIXA(H.UT&Y6'N" 0:\K_:9\.Z?\)OV
M;;/XH>#X;7PKXL\,0:;>07.GI]G2\0RPQO:SK'@2QN'QM;/.,8YH ^K[72K2
MQA:*VMH;>)B2R11A5)P!D@?2DETBQ-G]F>T@:U!W>28UV9SG.,8Z\UXKJ?[0
MNN3ZWJ4?AKPE<^(+#2=<71KQ(8+CSF "">9'$9B'EE_N,V6"$Y7(I_@[X[7G
MQ&\6:]X9@M-'AU+3WU"WN?#^I7+P7T8B<I!*ZE&#P3#:Q>-6"B11\] 'LJQ6
M&N62OB"^M),,I^62-O0CJ#4USIUM=VY@G@CF@.,Q2(&4XY'!X["OG?X2_&$2
M^ _@]HOA3P]I?A\^*]#N=3MK5F;['91P)$S1*!AF9FG7GT5V.2,%/#W[3'C/
MQ5IWPQEL?!6EI<>.([YXDFU>3;:"W4G>Q$'S(1@Y7)((QG.: /H:XTFSN9XY
MIK:*66,@I(\8+*0<C![8ITT=L[.)?++%=K;@/NG/!]NM<5\&?B-??$GX?C6=
M5TQ='U6"]O=.O;.*3S8TGMKF2"38Y +*6B)!(!KY?^*5[_PG?_!/CQ3\1M6M
MX9M=\2VD.MM,RAC"C7:_9HD)^Z(H65 !WWDY+L2 ?:KVMM*ZSF.-G4<2%02.
MO0_B?SIVZ$C D7)]ZJVV@:;8:(FDV]A;0:8D1A6R2)1"(\8*[,8QCMBOC_\
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M!@9) ._<_&'P=9Z_;:+<>(;2#4[B:&WCMY&*GSI5WQ1,2,+(Z\JAPQ!&!R*
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MD-[)YMS;RQ'Y74R?,IX*X7J1D_09Z4"@#A/@]\+1\(O"]SHB:W?:[%-J%UJ
MGOTB616GF:9Q^[10<N[-DCJQQ@84=V>E(:4]* $%!H%!H 6D%+2"@ -**0TH
MH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@ /2@4'I0* $[TIZ4G>E/
M2@!!0:!0: %I!2T@H #2TAI: $[T&CO0: /$_&&D:_X;_:$L_&L>C7&O^&+K
MPR^B3Q6 5[BSN%N?.63RV8;DD4E25R047/'->;_#/X3^+/@WJ7PDGDT&XUB&
MSM-=L[Z#3VB*Z6+Z[ANH4.YE!2-8V0[<\KQG*@_694-R12E0>.U 'QSX1^&G
MBK3O"GP>M9/!^HV5]HOC+5=2U)U$&^&WN%OE24D2<_\ 'W"2 2?W;<?*,V?@
MI\.]>\/Z7X<T;Q5\,M0G\2^#K6YAB\3RZK]HM)E\IXUDLT:8D23 *"A10,DD
MC@5]>D#'04 #T% 'DG[*_A"Y\$? ?P5HVJ:%_86MZ=I<-E?6[JF\RH#N8LA(
M8,Q9\Y_C/?->>>&O!_B3P]\8DU;1M)URPT2YU;4[S7-"U4175D@99=EYI\V=
MT<DSE<Q*>DK[@H S].D<TI YXH ^/_A;\//%>BZ3^SA9ZKX+U!7\*S:B-6\P
M0.MF7@ECAD.)#D%I%(*9( )(%1)\/O$\'A"WCA\#WUO=)\61XG^R*L(9=/\
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M0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0
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MIJ7R^(7"BSEE9]OV=3U+@?,?;\,@'9&D%)O4\ TH(]10 =Z6DI: $%!H%!H
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M2TAI: $I:2EH 04&@4&@!:3O2TG>@!3TH%!Z4"@!.]*>E)WI3TH !2&E%(:
M%I!2T@H #2TAI: $%!H%!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&
M@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!
M0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.]!H 44G>E%)WH
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M&5A\S)Q\OT& "21R373^*O!.A^-;2UM];TZ+4(K6X6ZM_,)#0S*&42(P(*L
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MWF!026"H.!A0<EO3?$_P"^'7C75K[5-=\':3JFH7R(ES<7-N&:79PA/^TH&
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M  /UK0M$2VT[2K/2)K.U2]O/+@MT,94;YI6.U%SG)/ 'TH \*MOB9\4]%M_
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M  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T >!_M
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MQ%J7BE? FDV.LGPU=VMHUO+Y8COPT$,\I-PUPGE#RYAL(1AE#DD-A>&_:/\
M&/B#XJ? ?XG7MA)96F@Z'K<>E&QD@+W$WV6\@\Z4RB0!#OSM7:?E7N7&WUJ\
M_91\#R>*'UJPEUG0DN;2"QU#2])U"2WLM2@A0)$EQ&/O (H3@C*Y!R"<GB7]
ME#P?XIN?$I>_U_3M/\131W6I:3I^I-#9S7*,I$_EX.'.Q0<':< D9 ( -K]I
MFSCN_P!G/XGQS*'0>%]2;'NMM(P/X$ UY/H/P^\7:EXM\!_$2PTFQ\*VOASP
M=-:R>=,)9=4DD@0Q1R)"P!AC92XRV<MP!V^@O&'@6S\;^"K_ ,+7]U>)I=_;
M&RN6@GQ-+"1M=#(V3\RY4G[V">0>:=I/@FVT7P+!X5@OKUK.WL?[/BNI'1KA
M8@FQ>=NTE5P 2IS@9R<D@'SYX0^/OQ%OO#7P\OM9M-$-S\08K:;2(-(A=I;6
M,6CW%PT@FE1'9@(]BAAMWMG?L^:]J'QB^*VCS^"=*U31=&TC4]:\37.A-/>*
M76:W%N\MO=".*9O+)"G=$7.2O#*&R._U+]FCPGJOPPT+P--=:NNG:!+'-H]_
M!>>5?:>T8(C,4R@$;5++R#P<>F)&_9YT W'AJ=]6UR>[T/4_[82[N+M9IKNZ
MV>7OG=T);]V-@5=H"G  P, 'EEI\<_B;INB7VMZRWAM],\,^,8O#&KBUM)A)
M?1274,'VF/,I$)47$;;/WF2#R.E=#<_%'Q1HT_QM72] LM1U;P]K%C';IH^G
MDW-S#-;VLCR2)O!GFBAD8@ KN\H*,<8ZG4?V9_#^I^'M:T:;6M=^R:OKB>(;
MDBXBWF[5E8$$Q'"EXXVV],H,8&0;\_P&TJ75?%NHKKVO6]YXDN[2^NI8+F-/
M)EMB@A,6(_EPL:(0=VY5YR>: /-M)_:1U/Q -#TK0KRS\3ZCKNH7\5I>:;9"
M*2"WM8H6D2:VGGC*SJ\P#*7'R@L%/%,\2?'3XB>"?"^D3^,],L_!\\EO=K=:
MP+-[^QBNDE"VPG$4A-O'(A#%BS8)QD8Y[C6/V7_".M6;&6[U>WUHZPVO+X@L
M[H6]_'>-&L3NCHH50T:*A4+M('(SS5Z[_9ZT.YTQK&+6=?MH9[&;3[]DO1(V
MHQRDF1IS(C;I&+-\XVL Q"D#B@#TC2+LW^EV5RTL$S30I(9+5MT3$J#E#W4Y
MX/I5LUS/A7X?:?X.U*ZN=.N;\6\MG:V,>GS7;R6UM%;JR)Y4;$["0?F/5L#/
M2NF- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1
MTI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'
M2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*
M#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@
MT"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10
MG>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E
M""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TI
MZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0
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MI:0TM "=Z#1WH- "BD[T9Q1D9ZB@!3TH%(3@4 CU%  :4]*0D'O2GI0 @H-
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MQHM]IVHR/%%=6LCI*K+*J.4=)(P?ND,&(XX->):KX'F^$?QB^"^F:=?:1?\
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M@_C7R7??#%4\#?!'X=-X@L]'^*/AR.+2KJVTZZ2>=]+D@:&_)7JL;PIO5V4
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M?=+L <@$L #TW1OVC/!>O:C;VEM/J(-Y87.IV$CZ;.%OX+=@)C -FZ1ER/D
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M77P\M/$][\1M>T6WT&PN8EL=8B @#QLH4I-'O<B59,@D8#!EPHY O1_'_P
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MP9JB:EI?Q.G\17:M]G#)9M?W,ZSG]YS^ZN8TP#NRK#&!SA> -5N+.32+S6=
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MQ6(ES*SS@F$ ?[0!/MD9QD9M:7\9/!FNW\MA::_:-<I:M?8E)C62W4X::-F
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ME 'USJ/BBPE\&7&O6FL6-OIK6;746JRRJUJD93<LI;(!0#!SG&.]<?I7QO\
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MAI/H-YJ.H^*_$=QJ>BZ]'M-L8;F6.1'ED+9C>V\L@@C.$C";LB@#Z"U+X_\
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M0DKSM/'([>M<-^SW\1M2^,'P?\->-=4M+.QDUVU2^BMK0LRQ1, 54LW5NN>
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MC+ C]XOK5CX1?%FY\3Z#XTU#Q5+I>E+X>\1W^CM<0L8H/)@90KLTC'!(;DY
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MB-RSA58K\QRIP >]?"3Q;<^/OA7X.\47\,-O=ZUHMGJ4\, (C22:!)&5<DG
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M\'G7="7PO>VLUU=Z.US9+<&>-XEDD*&,':LN-QXSCJPR >\#Q?H;ZZ=$76;
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M23Z5G^'_ !'I?BG0K'6]+NDNM,OH4N;:X'"R1L 5(S@\@CK7!?#_ ,)Z:WP
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M#[&-*>E,C!$:Y))QR3UIYZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4
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MQG^%>NZ/8:';^"O!UM<VKZ/+))"^V92H\A40A/*^5T^9?F4 ;< U])TW )H
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M2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04
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M#\P(!'-=[X$^(">.A>/'I&HZ9'"L,D4MYY+174<BEEDADADD5UX(/(((Z=*
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M,2 !0!SK_L_>.O\ A45QX32X\/\ VU_&C>*8YVN9S$D?]IC45B.(LEO,RA/
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MB2_BC7M3;1;/Q/?^#KGPA8V]M=3/:1+<G-Q<.YB5LY"[4"'&S!8[LKE_ ?\
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M6_&>FW&A7EUXGTJVL]7TJZGFCMK:Z@,@AN(7$;%UV2;&0JF[:&W+]T='X8^
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M(=N=Z_,N:ZGP5^SEK_PG\8Z#J'A;4=,U#3-.\$VWA22+5#)'+(]N\DB2@H&
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M',-I C8!F/"@UU'P\^)FA?%'2+^^T.6=A87LNG7D%W;26\]M<QXWQ21N RL
MRGIT8'O0!XCX\_9N\:ZS'\2=*T#6M"L]$\7:Q9:Z)+^&:2XAGA-MYD1"D+L8
MVX8-G(R5QR&7=O/@-K^L_%G1O&5T=#TS4M-U5KA]<TAI8;R^T\QLHLKB(*%D
M&XJ-[.<*@PN<Y;X[\2>*/"7QM\"VJ?$/3_*U[5WMY?!US!;QH; 02MYL;D><
M9 T:\[MK,X4  <WM7\?:OX]B^*C>'M7ET73/"$5QI<5Y;Q1O)-J*VPFE<[U;
MY8O,C4# RV_)("X .4T3]G/QWH/AOPEX=CU#PQJ'A_0-4U"X&G7T$[6]U#/)
M))!)*@X:2%I.(_N\9W [2I\._P!G#QKX(U#X5O<ZAH.HP^"[O6)'> 2VYN(K
MXMC:FQ@K+O9L9 Z+VW'H?@G^T#H7Q(\(>$/"UQK.J6?C75/#5O>K=7.G26YO
M'$,?GS6[RQ^7,5=B3MW#O@C-=[\&O'\OCWP]JBZBB1:YH6JW.AZFD2E8S<0,
M/G0'G:\;1R 9.!(!DXH \HTO]GWQQ8^$_!FFSW&A2W6B>-I_%=Q(MU/MF262
MXD,2DQ$A@;IQDY^X/[QQ2\&?LW_$#1?&7@7Q#J>J^&KS4/#VH7TU]J/DSR7N
MJQW"/'YLDK'*NJ, (AE!C@X 6OH/Q3HNL:S-IXTW7I]"MHF=[DVD,+RS\810
M94=54').!DX'(&<^)?LX>-_%'B_X,>&/B5XJ\<3M9XOY]8M[NUM8[8P127$:
MLICA5D*^7&V=Q! ;(Y& "S\/?V?_ !)H7AKX>^&->GTJXTCP+>-J%E<V4TOG
M:C,J3) 9%9 (543L6 :3)5>@R#A:/^SS\1_"'A;P-<:'JGAX>*O"E[JI6TNV
MF?3]0L[Z?SGCD<1AT=6"8901\F>^!Z?JO[2/@;0;;69=5O;[2WTFPBU2YM[O
M3ITF%I(_EI.J;,LF_P"4D?=/WMM/@_:1\!R1^)7DU.YM$\/6L5_?&\L)X3]F
MEW"*:,,@,J,5(!0')QCJ,@'5>&]/U^S\)-%J\]C?:](DDCBW5H;42,25C4X+
M!%R%W$%CC=C)Q7BO@#X >,/"%I\$+:YGT69/ :WT=^\-U,3<B>%H5,0,0Y ?
M<0Q'(QGO7H%_^T;X(T?1=9U/5;V^TFWT6^@T[44O-/G62TEF"&+S%V'",)$(
M?[O/7/%87C#]JOPIH'@?Q;KEC'J-]<>')[:UO+">PFM9HVN"H@=ED16$;[@0
M^.0..: .&T[]GSXA6&D^'K"6?PSJ&FV?B'6=4O-'N[BY:SNHKV=KB%Y (QYL
MD$DC@(R[&R&RK 8F^#_[.OCCX<W'PLCO+O0+RT\&0:S:2203S(]S'>2(Z,J&
M(A64QC(+8PV.V3] :UXQT_PWX4F\0:HTMCI\$ FE\V)O,0'&%V $[B2!M'.3
MBO%?C/\ '%]/L_"^IZ-JFHZ#!8>-=.T77+2ZTTJ\\,RJS1;70L<K)&0T?7.!
MD] #F=._9S^)5EI^@V%S=^%]0TV"ZUNXO=,NYKF2R,M[=-<PW*Q"-?,>'S)$
M".<8.X,I/'F-UX8U[X5ZQX'\$7NO>#]*U_0_"$]A-/?:U<Z3'J%I-<\K'<>6
M?,*K S%0H,9D# GK7UAIW[1'@K4]$EU&WNKX&+5_[!;3YM/FBO?MY 80>0RA
M]Q0A^F-F6. "1P?Q)^)MGXQN_A+J?AN_:33+[QO_ &#J-G=6* EEM[HR12++
M'OCDCDMP/E*]3]X8- '/>%O 7C;5)O!_C[P!:^%=%,.B_P#"+W?A^]EGGTU[
M"WN7^S3VDR(K'@LR[D 9)!SWKLG^$WCJ+QYKNOC4-&OI+_P:GAY+B5G@<W:R
MSRB8Q+&RI%NN"NW<Q 0'))-;GP&\1ZWK7B'XLZ=K6K2:NFB>+7L+!Y88XS#;
M&RM)UB_=JH(4SL,G)/<FG:]^U!\/_#NMZUI5[J-]'<Z)>0V6ILNE7316+2[0
MCRR>7M2-BZXD)VG.02 2 #@=-_9Q\4II?PCTJ^N-(.G^%/"E[X7U1X+J4RSI
M<6\$!E@S" "!;J^&[N5_A#&7PK\)?BY9_#&\\#:YJ_A6YT^RT>?1].OK..:.
MXOT,!@A:ZW(1%M#;F\O<695Y SGT_P 5?'?PEX-N=3BU.]G6#27ACU2]@M)9
MK;3FE *?:)%4K'D,K'/W596; ()B\/?&:S\0_&'Q%X%@L+P'2=/LKW[>;9S#
M-]H\\_*X!4*!",,2-QW 9VT <!IWP&\41Z_\-+NYN-)$'ASPC<>&;XQ3R,S/
M+%&GFQ Q@,!Y*G#%3\Y_N_-W7[._@_Q'\-_@WX:\*^+&TIKW0;"#2XI-)DD>
M)X((DBC=FD53O8)N(  &<#.,UT%_\4?#VG^,9O"<US<?\)#%I;ZR;.*RFD+V
MB.J,Z%5(<[F5=BDL2>!7-77[1'@&7PG9ZXM[=:CHU]ICZN)+33+B?;8@[3/*
MBQED3.1\P!.&XPK8 /"?V</!.M_%?X%?#VSO%T:+PWHGB:;6X[RTNFEN;AK7
M49YH8S'Y06(F7;N8.V54\?/\O:6GP5^)&F? BX\'V5[HEMJR^(Y=6"QWUPL%
M[93:B]Y-:2RK$'CW"5XRR*<J.VXX]*U'XM> _AW//8R31Z7:074-M>7-O9.+
M2SN)@GE)/*B[(V8/']XC&],X#+GL/%/BW2_!FF+?ZM<_9[=Y8X$"QM+)+*[!
M4C1$!9V9B %4$GTH ^6H/V5_B%I&HZIKOA^_\+>']9M/%$7BG1+2S6<6.6LO
MLES9S($&Q&C)'F)EFZ[4S@>B^(_AS\2]>OO /B>6]\/2>)-!UR:_DTYC,+&"
MVFLI;1XXI F^1U$ADRRKN9B/E %=;??M&^ M(T#5]8U+6&TNTTB]AT[4UO+6
M:*6QGE*>6)HRFY%;>I#D;"#D,1S73^$?B'HGC;PNWB#3+B0:4CRH\MY;R6K(
M8G99-R2JK+M*MDD#I0!X)K?[/OC_ %.R\;W%A?:/I&NS^.(/&N@3>?+/"[Q6
M\,'V>Z7RE*JRP<E"Q_>'^[\VOXZ^%'Q/\;KX5\4S7'A9/&/A[4I9[?191-+I
M4MI+%Y4T+RE/,+GAP^S"E5&WJ3Z7I?QW\&ZMJ$=E#J%PEU/92:E:1SV,\37U
ML@!:6V#(//4!@?W>XX(.,$9R?"'[47PT\>ZQI.F:+XB^T76KP//I[36D\,5V
M$3?(D<KHJ,Z*060'<O.1P< ' _$#X&>+?'_AZTL]5T?PK<W0AN+BVELKF;3Y
M-"OFV^2]I/'"791C+E@I9N<;<(-W]IJQN="_8\\8:=J>IG4M0MO#@M9]1F^1
MKF8(J-(03P7;G'J:ZO\ X:*\!H]T)=7GB$.G/JRM)87"K/9H<//"?+_?(.I*
M;N/F^Z03F1_M$?#7QAIR+;SSZ_%<2M'!:1:5/.UR4A6=FC3R_G54=3N&1G@$
MD@$ X?QK\&?%'QI\/WNJWG]C:?J=SX*N_#>F+#=R2Q9OUB\^YDD$*G"B-=D8
M5ARQR-W'4ZU\+?%D'C/X?^.M(FTXZYHFD3:'JNC3W<B6MW;R^4Q,<XB+!DEA
M1ANCPPR/E/-:%A\?_#MWXS\#>'=!M+F^TGQ-H\NJV.IVUI(+;R$,*H%PO'$H
M+9P$&W=@L!71:'\:O"FO^*+#0+2^D^W:E!)=::\UO)'#J,49'F-;2,H64+E2
M=I/RL&&5.: /GSQ+X*U3X3>/_A (+O2[OQ)K7C/6]<NX+FX-M:^9=65P7BC<
M(S856"*Q7+-@D#=@=>O[._B2R\;V7Q(LK^P7QHOB"ZUB[TQIG6QFMY[.*S-K
MYHCW96.")Q(8^7!RO(([OQM\0M-M?C%X4\$W7AVYO;W5;*ZO8=4^QB1+;R6B
M7Y6(/(,JDGHORYZUP?[-W[1MCK/AGP]X=\6:]=ZIXROM3U73Q?RZ<\<%Q-!=
MW.R'S4C$(E\B-6\L'.T#CD9 )]5_9XO==T;Q*VMZ-X?\27'BSQ!_;&LZ1>SR
M1V\,:VBVT*6TZQ%UE011-YNQ229/NY%8OAWX _$OX<:QX<U_1=:T7Q/J8T?^
MP]8MO$TT[*88[F:>TDBG",[O")S&=RC>%!.T]/9++XW^%+WQ5I>@1WDRW6JO
M/'IT\EK(EM>O",RK#,5V.5 )X/(!*Y KF/C;XU\1>'/B5\)-%T?5GTZQ\2ZQ
M<6&H!;>*0F-+62<%2Z':V8P,],,>,X- '&>)?@;\1[74_'PT;5-"UJR\=Z#%
M8:I+JGF6DEI>QVS6YFA2*-P\;H1\A(*D Y/(/JMIX&U._P#@.W@G5);6WU.;
M0&T:6XM"TD*L8##O7< 2.AP0*[+Q#XBT[PGH\NIZK<BVLX=JF0J69F9@J(JJ
M"6=F9555!+$@ $G%<5#^T!X&FM[V1=7E$UIJ,6DS:?)97"7BW<HS'%]F,8E)
M9<L,+@J&;. 2 #A?#_P\U+PI8_#K6O'L^C:+I/PST65!=V=Z\XGD^R"V>:1G
MBC$<0B#MM^8DL.0$^:3]EOP-IFCOXO\ $6A:DVH^$]3U2;_A&X]JB&ULF<RR
MK!C_ )9M<RW!'JJ1]@*[;_A=O@?7/#Z7(NYM1L[V\GTD6*Z9<2W,EQ$K&:%K
M81F7*A&+ I@ <]13+OX[^!?#WABRUB2^GCTB;3AJ:M;:;<R&WLQTEEC2,M"G
M!Y<+]UO[IP <K\8OA/XMO_BEHWCSP=!X<U>X33&T;4='\3^8D$L'FF6.6*1$
MD*2*Q8<J00W:I-.^&'B^W^,'@+Q-<+HLNFZ-H&HZ9?&VE>W<374L$O[F 1%?
M+3[,JC<X8A\GD?,[X]?'S2/"WPF\5:AH&OW$&LP: ^KV5]INFR:@D 9&:WED
M*QNB)(5P#)@$;CG )'I_P_U.XUSP%X;U&\D\Z\N]-MKB:3:!N=XE9C@<#))Z
M4 ?/?@OX#?$'PWH/P8T:ZA\/3VW@/69[J:>+49PUS;M;7%NK*IM\!\73,4)P
M/+ W'=E:%S^SE\08+Y?$%@OAA]<T[Q=JVM6FG:C--/8WMA?D&6&9O)!25=JE
M656&5%?6=)WH \#LOAAXUD^)'PY\2WEEX<M;;15U,:A9:=*\20BZ6)42 >2/
M,V>2"7?86+M@*,5[XO04$ CI2B@!#2GI2&E/2@!!0:!0: %I!2T@H #2BD-*
M* $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(* %HHHH #TH%!Z4"@!.]*>E)WI3
MTH 04&@4&@!:04M(*  TM(:6@!.]*:3O0: /'?VBO OB+Q^_P_31-'LM5MM&
M\36VM7\=]<K&K0Q)(A15*G<Q\TD9P!L]ZN_&OPKXFOO"&BV?@BSMBMOJ\$VH
M:='<?86N+,;C)'%,HS$Q8H=RX) 8 C-,^.WC;Q'X,N? *:)J-K81Z[XDM]#N
M?M-E]H^65)'WK\Z[2/*(YR#N]N>8\#?M)PZ?XH^(/A[X@:II%@GA;5K+2X-?
MB!M[>^:YB,B1E&=]LJ8(?#8[X44 </X5^ WC_P -:CX8+>'-$M[#2?B#>>*3
M#8ZF71;6XMKB+8H:)/F0W (_O;#]WC/?MX;F\#?$[XJZ[XM&A0?#SQ='9&;4
M-1U$0"+9:K:-!(CJ%PYQ@[P,-CD\5VI_: ^'YT"UUL>)K=M)N8C.MZL;M%'&
M)3%YDK!?W2>8K+NDVC*D9X-9/C;XT_".Y34M"\3^(=$NDM;B*"^L;Y!-'$Y9
M63S5*E0 Q3YF^4$KD@D4 <Q^S-X1UCP9\&K^\L+J/Q/?2I-#X=>]D,*3:;;E
MX]-C:0*2%:,!]^#_ *XG%>N:[!XCU;X>7T=F;?2O%D^F-Y(27S(+>\,7 WE/
MF028&[9R!G':N8F^,_@O5=!\40Z%XPTVQN-$T]II[MTWQV,95@EQL.T21 J3
ME3M.TC-20_&7PSX;\'Z+>Z[XFCOFFTJWOYM3M;*41RQ.H NF1 _D1R-DKO..
MH!.TT <.?@SJ/B7XW>"?B!-X>L?"6L:-%<C6+[3[H2'5?,A,:V_RJIDC#$2!
MY0K#8 %^;(XSPQ\$_BCH-O\ #32/[.T%;#P9XMOM6:^.JR"2]M;AKSY@@@.P
MA+H@J2<D#E1DU] ZK\6O".B:_%HU]K45M?R74=B RMY:W,@S' TH&Q)6!!6-
MF#$,N!\PS)IOQ4\+:OXB70K/4_M&I/)/%&BP2>7(\)Q,J2[=C%#PP5B0<@\B
M@#P>T^#7B&U\')X0\0II^E:)I_C:;Q;)XB:Z1HVM_P"U)-0BC16VLDA+)&Y8
M!0I8AFX%<I)\*/$'Q T3QSJ?AVQT[5=5T+XK7NM6NE:T ;/5(EM8[>6%B00#
M\T@5B,!T[=1]!>/]3TG4O'^D^%=8U_0WTJ_TN\FO_"FI6:3R7\2E,3%F.$CC
MPX(92&W?[-1_#_XR?"K4+C1?#?A#Q%H[B\25=.L--PL3^5N,B(% 4$ %MO!Q
M\P!!S0!Y9KWPI^(>?"'CKPYX-\,>&-?\/:Q+>CP=97$:QW5K-;&WF62Z6)4\
M\Y+*=NU0%&3SG=\8>!?B'XA\0_#'QG_86DG5=!UJ[NKC0(K_ &1007%K)!DW
M!C^=E9@[E4YW$*&V@M[9XJ\9:+X,MK6;5[S[-]JF^SVT*1O+-<2;6;9'&@+N
MVU68A0<!2>@)KF+K]H+X<V.F:/?3^+M,CM=8BDGT]VF -RD>=Y5>I((*XQG=
M\O7B@#&_:+\'>(O&'ACPS+X:L8-2U/0_$>G:V+&:X%N+B."7<Z!R"%)!.,\<
M5YQJ?P=\>'PW\7O!O]GZ?J6E?$2::\@U W*^7I$MU;I#=)*"%>18RF^,HN6/
M#;.WL=K\>/ &H0^&I;;Q193Q^(Y'@TC8Q)O)%;:Z(,?>5L@CJ,'/2NJTCQ%I
MFO2:@FGW27+6$[6MTJ _NI0 2AXZ@,/SH X3XU?"N[\:?LX^+/A]HLRF]O?#
MTVDV<MTVT%_)V(6('&2!DX[UR6D^$_&]W\;-!\?ZGX;MK"*#P?<Z//I\.HI,
MT=R]RDR+OVJ"-L0!8# 9^X&ZN_F^//@*WTV[U"7Q+:I8VFH_V1<7#!MD5YG'
MD,<</D@;3SD@=ZTM8^*GA;P_>W-G?ZJD%W;O!&]N8G:1GFW>4B*%)=WV-A5R
M3M/'% 'ROX,_9Y\??#[3OA[?3^"O#GCJ;3?#2>&-6T/4KJ)?):*XEDBN[>=T
M92K"9PR%0<8QFOJ>QT.^TKX7MI8TZR74%TYXAI^C(L%LLA0_NX0Q4!03@$XX
M&3CI5*#XW>!;D:$8O$=HYUNYDL]/7D-/<(Q62$#&1(I!#(<,"#D"NETCQ1IN
MNSZC#87:W4FG3&VNE13F*4 $J>.N"#^- 'SYX2^&/C+3--_9QM[SPS&DO@>"
M6UU>;[7"Q@46#V:%/G^<.2LAQD@+CKQ6=;?#'Q[-X.\/P7'AE(KZS^)4_BRX
MBBO(-WV-[R:Y'S!MKR8GV8R/N=< 9WOB7^TZ)?AS\0M3\#3*NI^$M5M[":2_
MLI&293);"9E4[=N//903G_5L<8(:O4='^-G@/6]*UR_L?%.G7%EHCJFHS),-
MMN6^YNSV;^$C(;^'- 'AWC#X0^.M5\(_%C3+30H9+CQ)XXT[Q)IY-]&JM;V\
ME@65R?NL1IYXY_UZ<\-BYXU^&WQ)M_%'Q:U#POI5J\?BR71[Z"Y;4$@G*6\<
M$-Q:+\K>5*4CE*S9(4LI'S#(]*\6?M&^"_#.B6^HI?/?J^M6^@R0PP2>9;W,
MDB*R3(5W1%%?>0X!(  Y89[/Q1\0/#W@KPTFO:[J<&E:0Q0?;+C*Q@N0$!/;
M)( SW(% 'RG?_ 'X@2Z5\08K3PI8646H^(M$\2:?9IK9GDG-L+830M+(F0Y\
MEV,CG!9L#</FKJ/B9\"_&GQ/U'XO8M[;0F\4Z%H4.G77VSS8TO=/GFN#&X4!
MO*9Y0F[ )56.T9 KWM_BCX6CU76]-;68%O\ 0[9;S4K=LA[6!AN$CC'"D G/
M3 -5[SXO>#=/OX+2ZU^UMYYO(P9"5C1IO]2LCD;8V?C:KD%LC .: /%_B/\
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MUI'>03"> M+-)-&YP,E<R!64CD!NH(KV2?XQ^#;;4X]/DU^TCFDEBMUD9CY
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M?\ ^!O%7A_XU6%_HVEZQH'ABZOM2N->T?5)X+K3T=O,,5W8N&9XGF=@S1K@
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MU]5\5ZAKL=_XC&E+;37NGQK;/ CV?GG8D@58@S [E$DVWDY'U9@8Z4A0$]*
M/C*/X:ZW9? 'QXFIZ->^%O$?ASQ5?>,/#=YJ=VET\DZW+W$"AQ([2;U;R7+<
MMYK ;C7U'\,?#=YX;\%V$&JO'+K5P&O-3DB'R/=RL9)MO^R'8JH[*%':I/%'
MPQ\+^,]<T#6-=T6UU34M F:YTR>X4L;65MN749QGY%(R#@J",$9KIU  P.E
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MT8GUKZ[/6@CB@#Y-\7>"_%-_X+_:DLK3POJQNO%[.FB1+''FY+Z5!9[E._
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MKK_%'B'PAK.J:-HWB#6HO#GPVU;PC;0^&]2MM-62S6]5I?M?DMM(BN03$RL
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MJ$UR6:%Y D95W*H4#%<* <8!R *],_:'T:WUSX#_ !"M;FSCOU.@7SI!)&)
M9%@=D(!'W@P4CN" 1S7H.$C'857LM5M-2:Z6WN(I_L\I@E\MP=C@ E3CH1D<
M>] 'Q]X)\1>$M2\7^#=.U]])3X87G@1%TEY52'3GU,2'[=\_""<1[<-G< )<
M$'?7MW[*-OXA@^!/AR/Q)-<W%ZIN!;37Q8W#V?VB3[(92W)8P>4>>>F><UU?
MC/XDZ3X$\1^$-)U&TNW?Q-?MIMK=P*AAAG$3R@2DL&&X1L!M#<]<4[Q_\2K#
MX<'P^U]97MW%K6KVVBQ26:HRPS3MLC:3<RD)G@E<GVH [$4G>L+0/%$FMZMK
MMD^CZEIJZ7<+;K=7L2I#>@QJ_F0$,2R#=M)('S*PQQ69XG^)VE^$_&_A+PQ>
MPW9N_$\L\%E<1HI@5XH6E97.X$$JIQ@'GTH [$]*!29!'%** $-*>E(:4]*
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M!\2M$M[J/X\WVG^+=;MO&GAWQ##)X:MHM<N&9+F2TM)(X4MS)M99IRT84J0
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M+2->^'^J73QMK[R:A<7"20/#-.4(6.Z*/.0L0R@##)"C'V+\./ -E\.O#?\
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MA5]TACB)Q)N#A7;!4 8^T-%\/Z3X>M7M=)TZTTRV=S(T-G L2,Q !8A0!G
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M4E3]8ZSX6\):-IVI:K=Z%I_E0V3"YDBT]9)'MXU!V;54LX"HN$ /W0 .E4?
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MQ%+F08S(Z$8=A\OS$$]*M3>!_#DVGV=A)H.F26-FVZVM7M(S% ?5%QA3SV%
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M_P"*M"\=:9?-IE_%J%G!<SZ=<-&Q&V:-S'+&3P<A@1Q]1VH \3_8NUJQ\/\
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M_K7C0G;&SY.XH 6SSF@#K!R,T=Z 1CK2!P>00: ''I0*#TH% "&E/2D-*>E
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M33[?2KR*ST347U;3XUU6\_<73DEI0?-R22S<$D?._'S-D \?T7XP>+KOXG>
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MX:-25P2X)7C!]@?]FWP#-=7D[Z7=J;G5UUUHXM5NXXTO59G$J(DH5#O=WPH
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MRO*[<\8H \KO_'?BS6_$OQ-\-Z'XA_LV_P# FEV<L,MQ:PR'4KF:W></."@
MB.P)^Z"'/F<\ #<G\<-\4OV2[[Q;):_V?+K/@^>^>WSD1N]HS$ ]P"3@]QBM
MR^^ '@^_N8KAK2]CNO[/&E3W,.IW*37=J&+>5<2"3=,,EN7);YFYY.>LUKPC
MI>K^%9?#<T @T66V^QO:VKM OD8V^6I0@JNWY<*1QQ0!Q7[/6H6^G_LV_"R6
MZN$A#>&-(C\R5@H+O;0JHR>[,P '<D"O+_!/QJ\:ZI\2/!VG/JD.J:)XGL]7
M<7Z6<:V"RVY#0M9GY)I(PIVLT@PW!1B#FO3_  A\+/ LEK96.BZC<:KI_AB[
M6WAL!K<]U;V$\*C9$T?F$!HU9,(^=ORG .#6?H_[*7P_\/7FE7.FV&HV<VDM
M/_9[QZQ=C[(DPP\40\W"1]P@^4$ XH \P\#_ !V\?VNA_"/Q7XFU*RU72/%V
ME7UQ?:?86'E&W,-B]W%(C99G=A"ZL.%RX"KQDMBNM<\8?%+]FCQKJ6NQZC!K
ML>HW?V*"%$AMFGTJ255B(4.RA1M)<DDJ#\N2*]ETO]G;P=HZ>$8[:TO$@\)^
M?_8\+:A,R6ZR@K(A!8[U*DIALC:<=*I^'_V6OA[X8UO2=5TW2KN"XTBYFNM,
MB_M2Z,%BTHQ(L,7F;(T(R-@&W'&,4 >)? CQ[?Z1HG@?P98W_P#9!\5>*O$Z
MR:BB*\R+;3SR[(@ZL@9B1RP( 5L#)&-K5OB_\1Q-<>&[/7+&WU;3OB'!X5;5
MY;%)4NK*>U6Y1W0843(KA6"[067HN37LEO\ L[^!+70X-'CT2065OJ)U>WW7
M]RTMM=DDM-%*9/,C8DL3L89W-GJ:M:A\#/!^HZ9IMA<:;.\-AJ0UB%UU"Y24
MWH.1</(L@:20?WG)Q0!X9\3]9\4^-?AK\<?"UUXP3[1X-T V=U)'80PG4Y);
M W$DLJD-Y<;(XC41E<,KG)X ]-\9?$>3X)?LLCQ5%##J%SHV@6OEJ&+1/(4C
MC5B1C*!F!)&/E!Z5N^,_V>? _C_7;K5]9TB26]O+,Z?>M:WL]JM[;X($<ZQ.
MHE !.-^<?E72'P3X=L/ <GA:YLXI/#*6+64EI?2--&;;85*.TA)*[>,L>E '
MB7CCXH>./AIXPN= ?6H=>M]6\)ZEK>FZE/91K]BN[-4:166/:&@82IMW98'@
MLV:]#_9[U#QAXE^'FD^(O%^M6&K2Z[I]EJ-M%96'V;[*LENC,C'>V\DG=G"\
MLP  P!E^%?AM\,-2\,ZL=)U9-:TQ-/?0;B]_MR2Z-G: #?;+*9"85QMR 02
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MK368[^2;3WG,$UC+Y?FH!, =PQ\A. 23N88%>\>/_A)H?Q(O]#OM3DU"UO\
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M0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E
M""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +11
M10 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[
MTHI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*
M>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:
M04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI
M.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*
M.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]
M*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 A
MI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"
ME/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@
MT=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E%
M"=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)W
MI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30
M #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z
M4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@
M]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>
ME H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]*
M*3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &
MEI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%
M  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)
M2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4
M)WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'
M2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6
MD[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD
M[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]
M*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H-
M"T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"
M@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM "
M"@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &
ME'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*
M4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H-
M H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (
M*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E%
M "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ
M4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#
M2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%
M  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H-
M"T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H-
M H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "
M4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04
M !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D
M%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )
MWI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2
M@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0
MIZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2
MT (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &
MEI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%
M  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI
M#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T
M"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 '
MI0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.
M] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E
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)% "T444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>mmsi-20221231xex10d61g006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20221231xex10d61g006.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U,# 2(  A$! Q$!_\0
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M&EH 3O0:.]!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*
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ME%)WH 4]*04IZ4@H #2TAI: $%!H%!H 6DI:2@!1TI.]*.E)WH 4T@I32"@
M[TM)WI: $%!H%!H 6D%+2"@ -*.E(:4=* $[TII.]*:  =*3O2CI2=Z %-(*
M4T@H #2TAI: $%!H%!H 4=*04HZ4@H 4T#I0:!TH 3O2FD[TIH 04=Z!1WH
M6D%+2"@ -+2&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@
M %(:44AH 6D%+2"@ -+2&EH 04&@4&@!12=Z44G>@!3TH%!Z4"@!#2GI2&E/
M2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI12=Z %/2D%*>E(* %
MHHHH #TH%!Z4=J $[TIZ51N=5AM;B.%]S2OC"JI.,G )]!5T'*YH !0:!0:
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M:[9ZI#+:M#JLPE5#9V,A=5+\#<[+N X7Y 0H KL/%::/9?M#_%*2>_$%[<>
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MUHWC-<%\*/",OA[P8JW/B/6=?GU("]DN]6NA++&TD2!DC*JH1 06"@<%CCC
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M=@,4W+N +*,9'4<UY_X#\3:EX.T;X\7NI([?'JUL9[BY+!3'?6\,,IL)K*+
M'DA< J,MO!#DDB@#['W#UIKR+&I=F"J!DDGM7P]XH\6+_P *I\;>*/#OQ<EU
M<7?@Z:ZBTK1KBX$D$Z%##=R227$KV\FYO+>,; X)&,J<:GBS[79^)?&'AO\
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M==W,UR(##_HLL\<0D,<@1Y3&JC*$D' P6##BI_$/C;2FTKPIJ_C:/5->DO\
M5#';:%-&MQ);1)#)$+FZ>)%B, GC,C+'EPT?R-N84 >_P> ?#-MI=OIL/AS2
MHM.MV+PVB6<:PQ,>I5 N 3Z@5+<>"O#UY%?17&@Z;/'?D&[22TC9;@AMP,@(
M^?YN><\\U\CM\8/B!JWP6\"^,+B_U"[TQ_"9O-:NO#CPC4;"Z)&+Z2V8;9X
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M0XDXD!(.XX->%>#O$.L>+?#_ .SIJGB&_?5]6?QCJT,UY+&D;2^7;:K$I*H
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M</B>XUW2/'6BW<E[<O;V^[3YTLQ<I=P;4"["25V/N7E.>N>?^"?Q!\=:K??
M?6-8\6W.LVOC;3[_ /M*PEM((X4:* RQ21E%#*^5(;+$'=P%P* />=:\;>!?
M@[?:/I%RL>ASZY<_9[&VT_2Y66YGQ]P>3&1NP.AYP,]!77VNCZ;:7MQ?6UA:
MV]Y<_P"NN8X5627_ 'F R?QKQ+]I-0/B5\ R%!SXSPQ]OL-S75_'OQW!X7\(
M7=E::_+HFNSM:);FSMEN+DB6[CA"1J^$#REC&C.0 S;CPAP =Q%X*T&)[UTT
M73D>]1DNF6UC!N%;EA(<?,#W!SFDL?!^A:1;O;V6CZ?9P-$(&BM[5$4Q#HA
M&-O)XZ<FOCZ\^*_Q"MUUK18O$5[I,FG_ !+TC08',D5Y-'9W2QL\,DKH?,VE
MR?4?=+,!ST5S\3O$W@7Q-X@\#ZCXLO;VQ;QYI>@1>(-0\I;JTM;O3EO'7>J!
M,EP8E8K\OFC'10 #U&\^(7PC\*:=XH6;2;;3;/0K^VT+5(UT!T1))65X4*B/
MF(M*K!_N9<$'YAGT:3X?>&)Y[*>3P_I;S64#6MJ[649:"%EVM&AV_*A!(*C
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M**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0
M&EI#2T )WH-'>@T >:^(/V<_AWXJU74]1U3PM97=WJ4T=Q=2,7'F2IMVR8#
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MM4G'8U\^?LIQ1IXC^.[B-%9?B'?(&"@';]EM#C/IEF/XFJG[1'[0'B3X8?\
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M^"OVJO'D.EZ3/X(TY_!:WUGX3U0K';ZI>1S,7O(?(:2) L86-@IW$ON(^]@
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MCN8X[RQNYG9YFB=8P-LADDW*RLIWD8Z8JW?[(O@^^TC5[*XU+Q#/=:AK$7B
M:JVHXO+34$4+]H@D51L8@8/!'.    .L\1?%V/P=\$9OB'KND7>F&WTI-1N=
M&FXN(9&0$6[$@8;>P3)  /)P*Y?Q7\;O$_PQTS6]2\7^%;9=.@ALAIUYIE^'
MCN;RYF$(M&# .I5VC)EV[2K$@9&V@#5F_9UT>ZM_#@G\0^(KB\T75UUT7]Q=
MQRSW=VL7DJ\Q>,@A8R4"J%7!/&<&NH^*/PTT[XL^$)O#^IW5[81M/!=0WFG3
M"*XMYX95EBD1B",JZ*>01QTKROQG^T?K_P .=2\8Z#K7AVQN?$.C^%I?%M@;
M2[=+2^M86VSQEF0LDD9QQ@APRGY<X!9_M'^)K/4-4@U?P9"S#P<WB_3;72KY
MKB>=%(5K=P8P%D)9<;=XY/7'(!>N_P!DCP[>3:U+-XG\4&36-2L=7NW%W"S-
M=VI1HI06A)!W11M@8 V@*%7*UK>*/V8_"OC74_%>H:K?:Q-<>(I+&>1HYXXF
MLI[,YM9K9EC#QR(2<'<<[CG->:^*_P!HWQ1X@^'>FZ]X6NO#,]G<^)M$TU=0
ML+R2<-'<W4,<D3(45HI SA&#KD*Q(&[IV+_&SQ_>?$GQ=X4TSP=HTD7AB*SF
MO=2GU9PK1SV\DH9(Q%NR&CQM/;G)SP =KX ^">E?#[QAK7B>#6-;U?6M9M8+
M6^N-5NQ*)EAR(VVJJ@, Q'  Y/&22<WQU^SAX7^(&N^)=4U&[U>!O$6F1:7J
M-K97?E0RK$7,,V N?,C,C%3G;TRIQ7(Z+^U++?Z/\*-;N]'@L]'\9:1>ZC>N
M9F:2P:VM#<.$ 7]XIVL,\'@''.!)??&;XC7_ ( 'BG3O"FEVNC:CX6GU^TU%
M[[SOL$H19889X\*9"\;9S'PK(5.00Q +&J?LI^"]1OM<34?$/B2[O_$]C;VF
MI_:-6#27Z6T@=)""O#+N"Y0*%#<!2<G7NOV6_!E^OC&&Z;4+FP\71I_;-@TR
MK!<3JJ 7054'ESYC#ET*Y8Y(.!CA/!7CB:7Q!\#;KQ;HVE:CK.J>$+W4U\2[
MG:YMA'!:M*%4K_RT692QR>0P [G;T_\ :2U1K3X9^(;W1K)/"/Q#N8[/2Y(K
MAC<VDL\3S6?G<$,)43Y@H'E,<$N!F@#TOX;?"NR^&EG<1P:QK7B"[G6.-]0U
M^]-W<F.,'RX]Y PJ[G.,=78G)-<UXE_9OT+Q:_C]K[6M;">-[>&UU:&*6 )Y
M42E46/,)*?(64G))!Y.<$<%X,_:?\9:Y<>!;S5O!FEZ;H/B7Q+?>%C/;:LT\
M\5U ;L!PAB4&,FS=<D@]\8QGUGXC_$FX\)Z]X3\-Z5:07FO^)KF>"T6[E,4,
M20P--+*Y"DG 55"@9)<= "0 8/BG]G3P]XKU#5=0US6-9O6U+PW_ ,(Q>++/
M$J2VF2V\[8QB3>S/N!')QC;\M,T/X#Z )]-UO1?%6MQZU;:4=#FURVNH9)KZ
MU$F\)-F-D+(V[:RJK+N(!QQ7DOQD^-.N^-/@MXWTR33K;1-<\/\ BO3O#FM6
M[3.\,\,U[:*C1MM&^*>*X4,K 85W'/&?9[G38_@C\-O$.L>'O#6GC5)Y#J5U
MIUG/]FM9KI@D;R%GXC7:BLQP.%8XR3D U]8^%GA-?A%<> )+9=.\)OIQTKR8
M9/+,<++LX;^]SG)SD\G.:X4_L@^#=0_M(:WJGB#Q$-2T9-#O(]3U#S$F@C=F
MA8J% #QELJ5P WS8+$L?*_C;\5F^+?[/7Q;L]0T^Q,_A75M,AAO;,N\-QO>S
MG2:/S%5EP)BN1D$<@D-7<:I\=O$/@CXB?&6[UI;2[\->%(=*BL[*VWB9I;E3
MY8/!R7>1%8@<!5P&/4 ZD_LI^$[_ ,$7GAS6M4\0>(VG\CR]8U343)?VGD,6
MM_(E  C,;$L"!DDG=NK0F_9M\-7F@6=E>ZCKFHZK::A#JD'B*\OC)J4=S$"L
M;K*1@*%9UV;=F'?*Y8D\-XK_ &E?&W@KPGXRUF^\ &>WT,64EM=N;BR@O4GD
M$4B*)X5;S(W9>#A6#9W+C!L_$7X_^.OAMHMY<:UX:T.PO;33+O51#'?R78O?
M*=MMM"%17WF,!VE*E$R,C!R #MO$'[//A/7_  GKFD:G)>RSZQ?0ZI>ZV)DC
MOVNH61H9A(JA4,8BC50JA0JXQR<\_<_LL>$?$>G>)9AXA\1W2^+38W&I7@U-
M93=FVPT+@E"HSM4G: , *H"_+7*Z9\6_$_C?XE^+K9K;3+WPK'X(L=:CT:Z9
MXRRW,<[%9'VL"6*A20,!1P"<UH?";XW)K?AKX8^%/!N@:9I6J:MX47Q -/DD
M9++3[)#'$%7:NYBTDBJHQP Q). & .S\3?LW^'?&$WC635]3U>['BW3;;3-1
MB,L*H%MR3#)&%B&UU9G8')&7.1C ';'P3;7G@*Y\*:G>WNL6EW92V%U=WDH-
MQ.DBLKEF4 !B&/0 #L*\4TO]JG6?$R>#;/1?!]O)K6M:OJGAV^M+S4_*73M1
ML8I'E0L(V\R/]TQWC!VXPA)P(Q^UM+!X1T2^U;3=,\.:C>:QJFA74^IWSC3+
M:\LIGB*&X$9P)&0[695&%;/( (!W?AG]GG3?#&I^$-0C\3^(KZ\\+Z9/I-C+
M>3P2%H)0@8/^YY.(80,8_P!4.I+%L*+]C_PC9Z9X<@L=;\2Z;?\ AZ2[;3]8
ML;]8+Q([F0RS0LZQ@/&TA+89202<''%=]=^*_$4OPI7Q#INAP3^)6TM+U=&D
MNLQF<QAS )44YYRH8 @G!Z&O)/"_[7<&M:W\,TO8--LM&\9:#)J;7BW,C-87
M*1-(UM)E HSY5P%)8%C;R#'% 'O'AC2=-\+:=;:!I\I*VD(.R:<RSL"3F1V8
MEF9FW$L>2<G.:\&^//P]\0>)_C%HVL1Z'XGO]$L=):&VO?"6J6<%Q#<O+ND$
ML5TR@KB.':R'.0V>@KBF\1^-]*^-NN>-M%\,Z2-8O?AS:ZI=VEY.\,*!;JX9
M5=E0LTS1HB8. "I^8A>>[N?VHM3\1Z)%=>"_#4FK:BGAO3_$DMA):W,YG^UQ
MM)%:(\*,L;E4;]X_RY*\'YBH!T.A_!&]\5>'O"5YXMUS78/$V@SW;V=_;WT:
MWBV\Q*^1/)&@20F(1JS*,Y7*MD;C9T;]F#PWH%EX1L[#5]?@M?"VKW&M:?$]
MXDP^T3>8'WF2-B5VS3* "/\ 6L<ECN'%^(_VF/'%CJ7C*WT_P-IL8\.^%[3Q
M3,FIZLT4R121R/);RQK$VR=3#(H&2O );D"OH'PIKJ>*/#&D:S'&8H]1M(KM
M8V.2HD0. ?< T >3V_[)GA/3IM.33]6\1V&EZ9K/]NZ=HT&HXLK&YRY;RHRI
MPC&1SL)(&X[=N3G2\-?LT^&O"?BN\U?3+_6K?3[B^?5/^$=^WEM+BO&.XSI
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M\2WNA:I/HZZ)<I%!%,DD"RO*CKO7*R*TK\Y(.1E3CGFO%/[2"^%/&^GZ)>Z
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MEU7P[_PC6I16$< $]OOE?<C.C&)BTSY*GD8'! (S/$?[0&K^&M8G\/Z)\/\
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M"\%?$?7] T?7]8U+3_%]MI-[9:Y?1,MI-.MF@^S_ +PA8,7$6U 1\\C$X!)
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MGX]2?#GP1XRU+2M&N-6O]!TJ*_9P\0MD,Q<1[F,@)QL+,J@G;MQ]X4 9.O?
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M@DEJA; D9E97<[5^09/!- %M_@AKQ\57>N?\)+IYFN/"">%A&-(8B-E9G^T
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M%!&_E9=VPQ+E5'SXP=O/=>%=;U+PMX;TKQ-XC\5WNM:?JNG682SGLX3/]LD
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M3R3PH)!P >)^-?V:?&NM^(/$_B'1=8T;3-<'BVT\6^'WE>9XO-ALDLY(+H!
M?+DB0Y*9(WD<XS6]XO\ A5\5?$4OA?QE;ZUX;M_'^AW-PT>ER),VCM:SQ)'+
M;^8%$Q/[L2"3;]XXVXKN=:^/W@[1;$7IOKF_LETV+69Y]-LY;E;:QDR8[B78
MI*(0&8<9PK'&%)%+Q%^TOX%\.:G-ITMYJ%]>QZ6FM"+3=+N+KS;)^D\;1H0\
M8')920,<D'B@#MO!=GKUIH<7_"2W-G<ZQ(S23#3T*V\63Q''N&YE48&YN6.3
M@ A1N]Z\P\/_ +2'@;Q-JBV6G7U].9=-DU>UG.F7"Q7MM&5\QK=BG[XKN7*I
MD\]*H^%/VG? 'Q$U?2-$T;5K^.\UZT>?2[B;3IH(KK:FYUAEDC\MY$!RR@G!
M!!Y!% 'KN<@THKP/X%?'"S7P+X%TWQAKEW?>+/$EWJ5M9326,A^V-;W4X(+Q
M1^4A6.,'!*\#@5[/X<\3Z=XJMKJ?39)98;:ZFLY'D@DB'FQ.4D"[U&X!E(W+
ME20<$XH U#2GI2&E/2@!!0:!0: %I!2T@H #2BD-** $[TIZ4G>E/2@ %)WI
M12=Z %/2D%*>E(* %HHHH #TH%!Z4"@!.]*>E)WI3TH 04&@4&@!:04M(*
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M9,DK VZ,*A8G*,<+D"N2\2_!'QFNG?&7PA9VUMJOA_XA74MY9ZI+<JK:6]Q
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MGPPTOPSXF\(6>I);Z[J^J^=INL&"_L7N+J6YMY[6<!0'4SLC*2 < Y(^4O\
M"GPR^,OPT\6VVN6\&C>.I?$.@V6F>(%U;4VMVM;RVWJEP)!"?-C*2D,H0,S
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M/4M.M+I);S361+N$9W0LZAU#?52#]"* -,TIZ4AI3TH 04&@4&@!:04M(*
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MZ]H-SX=U32M,MM-FL[N2)W+P1+&S@QNRE6*DCG..H%9/[1'QMM_A%\/M8O\
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M2\.>(?AC?_ ?3M?\*WCZE:>)?$D[V22032B*>.XECE0K(RG:LJY&X,,, "0
M>@@^#GBG2_$?AK6X="O!!>_$JY\67-BLD1;3[62V,"[QOQN9L2,$+8W')R.?
MH?Q-X;\(:[=:/XUU8QR-H4;WECJGVMTBMD9/GD!5@FUDX)((*\'(KSZ[_:0M
M=1O?AEJVAW.DOX-\27UW::C>7LF)K58K.>X1@0VU/]1EM_0,.!G( .!NO!GQ
M"\.6'Q"FL/!MQ>?VI\1(]80QO9R73:<8XE:XM!(Y5)PT0VE]I4-D8(XP=(^%
MOCZ":TM)/ VJ):6/Q0@\5F6ZU6VNG>Q-L59C)),SO(C$9&#R<*3C(^L(_B!X
M8D\.0^(%U_2VT&?'E:FMY&;:3)P-LF=IY!'!ZBKEAXFTC5M#36K'4;2\TAXC
M.FH03*\#1CJX<':0,'G/:@#Y9U_X<?$71_%>O>+M%\(M>/IOQ!_X2:VTF:\M
MT_M:Q?3%L93$0[!)E(>0"0+G(P<Y%:7C[PSXPOK_ ,)^.['X71O9VE_J/]H>
M$K6Y@@U"6&[2 ?:G9)/*>?S(2S+N.5< G()'M?@_XW^"_&O@H>*[37["'1/M
M$ML;JYN(XU#+(R#<2WR[MH90<$AE.!G%:UW\3_!MCI]O>7/BK1H+*YA>Z@N)
M+^)8Y8D&7D5BV&50#DC@=Z ,[X2Z*OAKP%!%'X5M_"*R22W"Z':,C&#>Q;#L
MIV&1NK;3MRQ&3C)\"TWX4>(1\*M!T_6O"WB71==L=8UO4;;5/#6HVRWVEO<7
MDLT)55F*2QR1S;'0EAE<$8^8?0Z_%WP(US:VP\8Z";B[N?L5O$-2A+33X4^4
M@W?,^'0[1S\R^HJUIWQ*\(ZOI6HZI8>)=)O=-TZ1H;R[M[V*2&W<8)61PV%(
MR."1U% '$V.@^+9OV8QHFKZ?#-XSE\--8S66G>3%&;EK<IM7E8EP2,X(08.W
MC%>:^(/AUXLT3PE\%]<M?!<FM2>%M+?2];\+1W<,5R1+! GFQ,LGE.T;VXXW
M\JYZ'I](^'_$VC>++$WFBZG9ZM:*YC::RG65 XQE25)&1D<>]47\?>&4\1GP
M\=?TS^W.?^)9]KC^T<*&/[O.[@,IZ=&![T ?/FA>%?%WPV^*&A>*]$^&*KX>
MU31)M)FT#2KNV272)C=M<)+(7<(?-#?O3&Q *C[^T;N0^!^D^(;+X8_L]^+-
M,\-OXMCT:#6+.]73I+<7$?VF0JDD9E9$\O=%ABK#@J>1D5[+;_%W5/B)\2]>
M\,>$=2\.&S\/WUI:ZC:W<KFZNK>2-7N)H'B?*&,2*JY4@NC@LN016?XA>#_A
M5HGC'P#\/6TRUUKPCH[:E#I-S.SP*[K--Y07?O) C+LJ_=$J'O0!YW\.?ACX
M^L-6^#ESJ?A&XM%\-^(_$UUJICOK:1(X;Y[DPR*3(&=<W(Z+NQ&QV\J"\_!G
MQM-\ KVPL_":V/BK3O&<_B2WT>^OX FK0'4&NEA:6)V6/=&RKR1AXE/ YKV[
MPA\8-(\7>!DN+?7]"C\2Q:-#J%_:FY5DL))(0X,R!]R1AC_$0<#K5_3?B=HV
MC^!_#FI^+?$_AVUN[_3HKJ2\MKQ8[*Y;RT,DMNTC9:'+@J23\K+D\T >&ZEX
M%\5NOASQYX<^&$6@7>E:_%JE]X9DNX6OM5B^RW%M)(S!O+\R,3AHU9\G8W()
M45Z)\"-"\2:;XZ^*6KZWX:E\/V?B#5;;4;))Y[>1F064,3!A"S!7#1G/;)X9
MN2>O^,_CJ_\ AW\(?%?C#28K6ZFT+3)]4\JZ!:.2.&,R./E8'[JG!S70^#KV
M_P!4\)Z3>ZJUJ^HW-LD\WV*-DA!8;L*&9C@ @9)YQG S@ 'SIXI^$_B/7-&^
M-?@F7PR]POCO6FO+#6G>)K.""2UM8A))^\$@>%X'<+M.3MQD$UH:U\./,_:(
MT-?#NIV[Z1JVFQKXLLT(:24Z;)&UK(V#@.S2")@1S&".W'N.F_$7PMK&KW6E
M6?B'3;G4[57>:SAND:6-5;:Q*@Y !X/H>M<UX"O/AA9:EXGU;PC>^'S=74@U
M#6KO3;B)F8D,1+,RDX! <Y/'WCW- %[X\:7J6O?!CQOI&CV,FI:KJ6C7=C:V
ML6S+RRQ-&N=Y"@ L"23T!KG_  -XF\1:1X-\#^'XO!^J0WT5I9V=_-?")(+-
M(XE$K,RR$L?E*J%!^8C/%=S9_$7PKJ>C7.K6GB/2KK2[8[9[V&\C:&(^C.&P
MIY'4]ZT]#US2_$NFQ:CI%_:ZI82Y\NYLYEEC?!P<,I(.""* /DSX>^$/'D?Q
M+^%^OZSX!U+3YM*34[/4Q#<V<>GV1GP%%M;QR!5@&TG?CS&XSO.*9K'[-?CG
M2-#\0IX>> MX.UU]<^'MGYNQ&,LB7,\$HW ;/FFMU#$?*[D_PD?8FQ=V<4NT
M =* .-T;PO?>%/A8NC68M]2U>#3W4-=#$5W=E2S/(/1Y22W^\:^9/"'@?XAV
M?B#2]4N_ .LI//X%U#P[>H^H62Q6]XSPNJP0+/Y4-N3$4C";21@LH +'[.ZC
MFFE1GI0!\C3?!WQIJ>C_  ?TR+P[<:3<:+X%U+P_J.H/=V^VQNY[*&!#A)27
M&^(MN0,0"O?(&CX'T[Q_J/C7X+3:I\.-0T2'PAI][I&JW/VRT:W4O;Q1)+#B
M7<\9,0/W01NX!QS]4[: !S0!Y'\8]+UM_B+\*O$&DZ%=Z[:Z-J5W]MBM'A5X
MDGLY(5D/F.@*AF!."3CH">*\6T_X:>*K3P;:02^#]2:^3XL?\)2$'DDI9&[,
MQFSYF,^6Q7&<Y)&*^Q&4'M2[1Z4 ?*GPI^'OB#0?$EEX=\0?#RZO)M&UVXU&
MQ\53:N9M,\F2:603);F;='<;)2@41XRS,3C.>Q^/]X^F?&+X(72:5/K/EZKJ
M):VM51I%_P! E'F ,0#MSNZYP#C)P*]Y"CTKGO$'P]T'Q/K^BZUJ5DUQJ>BR
M--I\XGD3[.[##$!6 .1P<@Y!(/!(H ^9(?AUXR\,ZW]L@\%WMQHGB+Q'K&KW
M5MH\]M!J5@MPL$<"&9I%\F.41/)*87#@LHR<'<? CX;>+-!UOX.?V_X)O+&W
M\.>'-5TB]>::VF2WFFN(&B=<2%BI2"09 SAQD8-?7@C7KBC8N>@H ^6KCX=7
M-_\ "_XO>%_%5M/X91_$.HZ_H_B&XFA\L.9FNK:XB*ON!B**S!@O&1SSCV?X
M(:/J]G\/M.U'Q)'%'XHUD#5-66!2JK<2J#Y8!).(T"1CGI&*V_&/PW\,?$ :
M:/$>BVFLC3;E;RT%VF\13 $!@/QZ'C\JZ15"K@=*  TIZ4AI3TH 04&@4&@!
M:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>
ME H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.]!H \&^)/A"P\1?M
M,^ ;O4?"S:QI,&A:I:W%Y+I37%M'-*]N8%DDV%1\L=R/F.!OQQO&?-OAKX1O
MKC7E\-^*O!'BN\\4:'XGNM4L-9DN94T8B2XDD6]2=2%+".0J8F#%B=I&"Q7[
M!"+_ '12+&JG@8^E 'Q1X(U'4[9_V=O"NO\ A+6=$\1:#XAN+74=1U"T*PW,
MW]G7V]XIF_UPF;]Z2N1D<G.,V]/T_P 0Z39^&O#W_"$>(I+G0OBG=ZM<S1Z<
M1;"QFN;QXIHY,[739<)G9G;M(;;E<_4GB_X;:1XVUGPWJFH-=K=^'[PW]@;>
MY:)5F*,A9E!P_P C.N#D8=O6NI5% Z T ?&6K>";BZ\'3Z?/X.U6Z@3XN#53
M:C19F!T]KL2F55V<Q&,G)''4'GBM#QSX*CT#XJ^.- UKX=>(_$?@;Q1I]E'I
M4/A:-UL4\N,QO:3B-D$ \TF4.2%^=B3UKZ]*CT%*5![4 ?$?Q(TCQ/8^"/C1
MX/O? 6O:KJFN26U[HMUIUG)J%M+;1PVZQV_G8^5X3"^ V&8G<-Q;GWO]I33=
M3\=_LT^+X-(TN]N-5O-+\R#3EB/VDG*N4"9R7P"-H.2>!S7L&Q3VH9 01V-
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M[@3219DN[B)CFWC+1[,D#)VDC# U[84'I2[0>U !WI3TI.]*>E  *0THI#0
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M(!!!';-*/&$]KK6O0ZGIDNF:)I=O'<)K<\T?D7(*NTH !W+Y849+  [N.AH
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M9UF11=K+L!!#,< 8ZAO2?AQHEAXI_:!\66^I>*M<O-0T71=!U*VM;G4IX,7
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MN1FC6ZM) Z%E.&&?4$5N=ZQ?"7A:T\(Z=+:6>]A+,]S--*07FE<Y9VP ,GT
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M*U_5=5M-(U[0M8E>PN4$<^+&XMPRFUF@6,@2QC):%CN!)KWZ\^$/@?4M2O\
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M3.R:%@RG!((SZ@@@^A!% %T]*04IZ4GK0 &EKA;GXW^!+2_6RF\5Z5'>/+)
MD!N5W.\9(D51_$5(.0.F#FNJT#Q!IWBC2H-3TJ\AU"PGW>5<V[AT?!*G!'7!
M!'X4 7Q0: >:"1ZT +24M)GF@!1TI.] /%9'AWQ?HGBY]4&BZI;:I_9=Z^G7
MIM9 X@N45&>)B.-RAUR.V<=: -@T@I37%Q_&3P1-9PW<?BG39+:?51H<4J3@
MK)?E@OV=3_$^X@8'3G/0T =GWI:2ES0 @H- (]:R;?Q9H]YXDO\ P_!J,$NM
M6$$5S=62OF2&*4L(V8=@Q1\?2@#7I!2Y'K2 CUH #2CI2$T C'6@ [TII,\T
M&@!1TI.]*.E)0 II!06 [B@=*  TM(32YXH 04&L?PKXRT/QOITE_H&JVNKV
M4<\EL]Q:2B1!+&VUTR.X(P:V"1ZT *.E(* >* : %- Z4&D!&* #O2FDSS02
M/6@ %'>A3D4=Z %I!2T@H #2TAI: $I:2EH 04&@4&@!:3O2TG>@!3TH%!Z4
M"@!.]*>E)WI3TH !2&E%(: %I!2T@H #2TAI: $%!H%!H 44G>E%)WH 4]*!
M0>E H 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G
M>@!3TI!2GI2"@!:***  ]*!0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2
M&EH 3O0:.]!H 44G>E%)WH 4]*!0>E H 0TIZ4AI3TH 04&@4&@!:04M(*
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MUS.I?LB?#G4;6YM)+74TLKK2(=#NK6/5[E8[JVA0I!YP#_O6C5B%9\D<=<#
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M5XK-O_V<O!6JZ+XJTFZ@U":P\3ZDFKZI$=3N!YUTA0JX._*?ZJ(;5P,1H,8
MH \TU[XX^+=*^)&D0V=[:ZMHMSXVB\-74-I:[K2VMWA; :X;:S72R*"RIN1/
MNM@UYKXGP?A;XTW<?\7N0#/I_:%O7T#-^R=X GOIKIH]9#2:N->2)-;NTC@O
MBQ9YXE60!'<LVXCD[CC&:T;O]FOP3?:)J&E36^HR65_K8\13H=5N=S7X8.)0
MV_*_,JMM!"Y XH ]1!)4#&.*^9/BQ\<_%G@OQC=2:9>6M]I-EXHTK19+*VM2
M\,<%RL(E%S.VTK<[IB52(L%7RRZ_/7L/@?X>2^%?'/C'7GO;F2+7Y+=A9RWD
MD\<1B0J9%#\1EPP!51C]VO)[<[XF_9:\#>+=3UV]ODUA#K-]!J=Q;VNL7,$"
MW<7E[;B.-'"K(1%&"X&<+QCF@#._9WO];U+Q3\7CJNMSZK#9>,)K*WCGB1?+
M1;*S8 %0. 'P!@="3DDFN-^,WQ \4:5XC^.6EV-];Z>-'\!6^O:;>6%DOVM'
M)O5*2.Q;S/FMFQ@#:'XY^8^V>$?A%H'@CQ9KWB'21>PWNME'O(9+Z62W:141
M#*(F8J)&6.,,^,G8.>3F/5?@UX9UGQ+X@UR]M[BXO=?TD:)J*O=R>5-9C?B/
MR]VU<>9*05 .9&YYH \)\5?%7QA\,O G@FXGU"XLO#,_AB*>7Q0=-^VQVU^4
M3RUO50%HX-I_UBC[W4C'/KOQF^*[_#[X::?K=@UK<7>KW^GZ79W)S+:QR7<T
M<2SM@@M&H<O@$;L 9&<B%/V;/"RZ3'IBW^OFT_LS^QIU?5YI#<V>YCY,A<DD
M?.R@C!53A2!Q79>)_AQX=\9>![CP?J^F17/AZ:!+<V2DHJ(F#'L*D%2I52I!
M!!4$=* /#?&GQ%^*?AO7_B'X-T::PUC7M.\,1>)_#U_<60#7 $DD<MI-&C*&
M8M'\CKMQO&0<'/,VG[6][/XJLI[>\34/"FN^%A<Z/,EN(W;7?)CF^PEBW+-'
M*C!<##$KDD''TGX3^&VE>$+^[U&*2[U+5[N**WN-4U*<SW,D46?+C+'HJ[F.
M !DLS')8DX]O\ ? EII&@:7;:!;VVGZ%J[:[I]O'D"&\+2.9!W/S2O@=!P!P
MH  /"_B'\6?BMX9;XOK;:[H8;X?^'K#7 3I#,;QWMYY)8F)FP%8V[?,!D94#
MH2?:?C+\5)_AE\$=5\9QPPFZ@M[?RUG/[J.2:2.)6?D$HK2AFY!(4\BK6M_
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M0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*BDG2-PK.%)X /?C-
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MQPJC/4DD #O0!9I!5>TU&VOI9XX)XIGMW\N98W#&-\ [6 Z'# X/8CUJP*
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MJ2:3X_\ $FBSZOK&I^*+"QTF_L+"*W:5+6*8!Y(58#>1$\^8F)#[L<4 =_\
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M^SV=O=VB2)YC6YD;>95FE67YUW*5'!7<=#QE^S1>>,='\7R-XBM;3Q/XGO\
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M<$<$C<UKXVG2[J>UAT@75Q<:ZGA[2%6XVK?W/D^;,2=A\M(@LH9OF.87&,@
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MJ@RI$N^,JP+?> R#R'A3X8>*?B%X<ATRTUW3K.PT37;77;#6F\.7$,.J3@7
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M_LN>(]5UG5;JR\=V]I!<^*K?Q7 +C1?/G6:)U9()9?/'F0KL 10%*@ 9(XH
MM-^U5=&[N9!X&O(]#T_Q8/"6I:H]]%^XG:9(8Y$C4%G4M+'NSMQN&"W..=^/
M?Q&N?'/A;3;K2='$OA_3?'>DZ<-:74&CD^T1:G#%,RP*F&BW[X<L^=W(7 #5
MT4_[,^MR>%O$ND+XLLU;6?&$?B_SCI+$1R)-%-Y)7S_F7S((^00<;AW!%74/
MV6O$:Z;JFA:3X]M]/\)7/B"'Q+;:;/H@GEM+E;M;MXUE$R PM*I8*5W+D#<0
M"" >P?$3X@VO@"QTQY;>2\OM5U"'2M/M(R%,]S+G:I8\*H578L>@4X!. ?&O
MB=^TEKNB^&O&-A8Z+:Z5XQ\.7VF6][!<WN^'[/>RHD5Q;OY?[T$DKM94*E6R
M#@!O4OB]\*F^*GA[2X(M5DT76='U2VUG3-0CC\Q8;J$G;OCW#>C*SJR[AD,>
M17&^+/V;;CQCHGC>6^UZVA\5^*/[/$FJ6^GL+>W6RE66W00&4EAN#%LR G><
M8P* //[SXH:S\*/C3\9]33PW?^(;>RT32-8U&UMM07R[1$AN#,8_,.68A>%5
M "$))4X![KQC^UAI/A^ZU$:5I-SXB@TQ+1KM+,M]I/VA4D58(@C>8RQR([ E
M<!@!DY 35OV>_$NLZG\2]1N/%^GK=^-?#]MH<CQZ.RK;&.-XVE ,YW;O.E(7
MC'R\G!W5M)_9N\4^%O$%SJ'ASX@C1K?6+.UMM<M$TH2K/+!"L"W%LS2YMY#$
MBJ<^8,@'' H ZGPA\:M4\9_$;6_#5KX,OXM/T747T^_UF6ZA$41^S1SQ,(\[
MVWB11M RN5SU('K(Z5Y]\-_AIJ/@;Q9XZU6YU>VU&S\2:BFHQVR6;126S+!'
M!AI#*PDRD,?.U?FW'N /0ATH 0TIZ4AI3TH 04&@4&@!:04M(*  THI#2B@!
M.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>E H 3O2GI2=Z4]*
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M^K^)[SQ]XNLM4CM&\.6K6YTFX@MY8I"61O.CD9SMD*E5(9./GQU! [HC)/-
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MD%+2"@ -+2&EH 2EI*6@!!0:!0: %I.]+2=Z %/2@4'I0* $[TIZ4G>E/2@
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MI2"@!30.E!H'2@!.]*:3O2F@!!1WH%'>@!:049'K0#Q0 &EI#2YQ0 E+24M
M""@T"@T +2=Z6D[T *>E I"1@\THH 3O2GI2=Z4]*  4AI12&@!:04M(*  T
MM(:6@!!0:!0: %%)WI12=Z %/2@4'I0* $-*>E(:4]* $%!H%!H 6D%+2"@
M-**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@ /2@4'I0* $[TI
MZ4G>E/2@!!0:!0: %I!2T@H #2TAI: $[T&CO0: %%)WI12=Z %/2@4'I0*
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MB/\ A(/LQL_MWFON\@D'R\;MNW*AL8QG)ZDFNASF@T@H #2TAI: $%!H%!H
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M[0P_VU<^4LP7 VBW (#<!!G@5UGCC4I=<\/?'"/4[F2R^+.E:_(_A(JYCO!
M%B.FBTR<F.0A@P3Y6+2;J /MK))QC'O2\ 9)K\^OBU%;2:'^TKK,FJ2MXG\/
MS:5<V"V^K2NEA>-:VQD>%=_#>?YB#CC:4  R*^F?VGO$6M6G[.FK:SX8>XO6
MVV<]Q+I1+SM8-/$;IX2G)/D&0Y4\#)!R!0![+=7D5E;33RN$BB0N[G^$ 9)K
MSWX7?%+5?B0UEJ'_  BTUAX7U33(]5TO66NXY!-&Y^2.6+ :*0H5? W+@XW9
M!%>)@>'%^*'BT^&)=.N/A-=^!3?:Q%"R2:9%?B4&V<*/D21X=[,!R0D;$9P3
MZ!^RK/I6G?LE>!+S3XH5QX;M9[\:6BF1KH6R>=D+UEW @YYR,&@#W,-CKQ06
M R>WK7Y\?#;QSX8N_$NE74&OVT&A:[\.=56ZC@NY/MKW:R6\O^FW895FO1&\
MS.55#'E_X2#70_!RPT"75?V?;5;_ 'W'B_X?WT/B%'U)Y)+R58K+8KY<D.CB
MZ5<8*^6ZC&T@ 'W-Y@R!D#/J:-P!Q7S-^S-X?UI-8N/#7B&"XE'PTN+K1H-2
MG8'^TWG830W!(/+BT> MGJUPY/(S6U\6]4A3]H?P9I?C,6X^'-]H6H+#]O(%
MG)JXDA*K,6.TL+<3>6&[ERO(R #U;X@>/(O!%KI*BW^VZCJ^H1:7I]J7\M99
MW#-\SX.U52.1R<$X0X!. <^R\=^(I_#.F7EUX*O+/6KN[>UDTHW,4@M]ID_>
MM,OR^65CR&QD[T& 3BOE"46P\#_!I?%DUMJ5N/B3=0Z7<^(@))9]"S?+;,Q?
M+-&4-OM+9',1/!%?<V8XX<X5(U7Z  4 >6>!?C;>^-BTT'A.\BL(=;N]!NKF
M.XCE^SSV\CQ2,RCG9YD94,/7.!7JH=2,YKYC_9TUY]6^#OQ?/A:ZBOM;3Q;X
MIN+%;=U8L\M[<2VK#/!#AD(/0Y]C7EGA+6O!?BWX8:[XBTGQ9J\VN#P3>6FM
M:<L9LUMYQ$7$E\P"DSK,"J.6+L6;&5R0 ?=X9?[PH+CUKX1TWQ!X?^'5SHNH
MP:MJUR-8^#UY>ZD--U-YKV^NHC;E9$WLP\]5^U[6QA C\!4('-ZIXMT:/PU\
M7;*QUW34T_4?AM:WNFV_A^25(#>Q-=*H\W=^_E#"!))0%W%PC*""" ?H9?:A
M;:;93W=U/';VT"-++-*P5$0#)8D\  <YKA?$'Q:CTK4O XL]&OM6T;Q1*(UU
M:V"B.TWH'A,B,0^'!/13C:2V._S'K^E^'5U_QEH.ESQ:C;Z[\)FU&6QENFNQ
M?7Z-(T<Y5V;?-A@P;[V ".E?0G[.:^&M=^#/@:^T6'3[B.TTR",7%K$N(YS
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MZY?XF_#J'XD^#+G0?M]UHC2&)XKVP">9"\<J2I@.K*R[HUW*1AAD&ODC1/\
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M,2TA(/ QWW[:\-_;^&?AYKXBDN?#GASQGIFL:]%$A<K9QLP,K*.65&9&(YZ
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MPR ?9<.GVL 00V\<83)78@&W/)QZ9[UY1XK^,MEJUUX[\':7IOB:/6]$L?\
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M_;]>D2XN81#=B-9+4,([:..2*%8B,.<*?E+$5D:MXC\=^"-+U+2(KO7M0O\
MX3^)9-;U>\FU*Z;^U/#\DB311N22)I&ADDX.0OV)P1\^& /NZ.V@BFDF1(UE
M< ,X4!F Z9/>G.B2@@\\U\G>+9?$VI>'-!\2:1>W6I)JZZKX@N/"=QKMQIEW
M<V$AB$$EO*&Q&\$+19A;";IF/! ->N_"C7?#7B*7POJMGXEU"76=2\)V=Q%H
M>IZC^^:T/S+=26N?]868JTH'.,9( H ]26VAC"JJA%48"@8 %$MO!*VYU1V
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M%6%&T8I3TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E
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MEI@X'(Z=*[6;X>^&+B&>&3P]I4D4_E^;&UE&5D\M0D>X;>=J@*N>@  X%="
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MI:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T
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M@,8\-E^HP,@'NHI3TKY5^)?QI^(GPXUSPFNH:MHXL/&&F06GGVJ));Z!J3-
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MH%!H 6D%+2"@ -**0THH 3O2GI2=Z4]*  4G>E%)WH 4]*04IZ4@H 6BBB@
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MJ.O_ /".:9H-WI?B:^U^[OOLFHZ9:MB.VM8H'D$MM),C)/NG52C.NT9;'0$
M]3TGX.>$/"_PUU/P4EE)+X5O4N1<V=[=23J5GW&8;G8LH8L[<$8+$]363XK\
M-6'Q5^%]MX3\+W=D?!.J0G3;R^T^Y#JM@G[N6"$KD,SA6ASD! 7/)4*>6\+?
M%OQ[XGU;0O!.JZ1IGA;QO-IMYJ^I?:XS=6ZVL5PL$)CC28$F8NK$%_D"L#DE
M:3]B1)[+]E_PQ'=1K#<PW&J++&BD!&&HW(8 'D $'@T >\6UO':6T5O#&L4,
M2A$C0855 P !V %2U\X:/^T=XCOO"?PZ\>FQTR[\'^,]8MM,2QMT<7E@EU*8
MK:9I=Y20[M@D38NW?@$E><S1_P!H3XC/#INLZA8>'#H3>/)/!EQ#:I,+B1?M
MSV:W*,SX3$@7*$-N&3E>E 'T?J_B72O#R1OJFHVFG1R':CW<ZQ!CZ L1FO)/
MCGX U#XI^)OA;>Z3;R7FD:/K)U*\OK+4!;ND1@>-3$RL"QW.K'!^ZI'.<'*_
M;6MX)_AEX96:%)E;QCH:E9%# @WL:G@^H)'T)KV'QQKTWA3P9K6I6,-I+>V5
MC-<6T%Y<K;0R.D995>1N$7(Y8\ 9/:@#D]2_9R\#ZO;Z>MS8WGVJQOYM3BU"
M#4KF*\-Q*FR5VN$D$C;TPI!;&U5&,* .3UWX%-H>A/\ #KP9X<LH? /B6:XF
MUZYOM2EE>T$CJTBV\#AA^\&\#:RJC'=C/7C;G]J3Q;9:3\32D>C7]WX9\'V_
MBJPNGTZYM(;L$3^<HC>0M)'F#Y)%(!WCKU.IK'[1GB_X:ZCJ[>,]-T>[L4\'
M/XIM5T8RJ\<D<L436SLY.\$S1D2;4QSE3UH ]XF\7>'='N9=,N-7TZSN;2S:
M[DM'N$1X;9, RLN?EC&0-QX'%<IX8^"_@-);77-%MO.L)[PZY:P0WLDNG_:)
M!G[3%#N,0)W%@RC +;A@G->->*M.\0+\?M6_X2:72+XS_"W565M.M'A /VNW
MW1MOD?>!D8;Y<Y;*BMOX0?$37)_!WPM\ >&&T^RU-?AUIVO37NJ0//'L,<4,
M<:QI(A)+!RS9^4!>"6X /0I/V;?!4NCSZ8T6J-:S:V/$3 ZM<[OMX;=YP;?D
M?-\V <9 ..*V/B[X<\$^*O#UGI?C>:VMK.6^@-E+->&TE2\#9B,$JLKK+G(&
MPACDCN:\.TC]I;XB>.]3\!Z1X>T;0-,UC7[;5X;R/5C.R6E[ITZQ3 %""T;'
M(48!&023C!Q_C/XWUSXK> ?#/B6W;3D\+1?$+3K&*V2V>2Y(@U(6YG:;?M3=
M(APA3[K+DY.* /:G_99^'-SHOB+3+G2+J]MO$,\-WJ+7FI7,TLMQ$H$<ZR/(
M6248'SJ0Q[DU?@_9Z\&6\&@Q+;7SG1=0_M6UFEU*XDF:ZVA1++(SEI2%^4;R
M<+D=.*G^,/Q*G^'MKX9M;&.%]5\2:S!H=B]RI:&&217<R. 06"I&YV@C<=HR
M,Y'DOC+]HWQIX)3XA:+)9Z+J'B3PE<Z1,DYCEAMK^ROI1$IVAF,4BMN!Y8<
MXYH ])U?]G?P'/H'B*RU"*_&F:QJ2ZYJ/FZM<*K72$,)=WF?)@JAXP/W:?W1
MCG[_ .$/P5U+5KN_FO;0W=UJ::RRQ>(945+T$$SHBS!4=B!N90">]>EZ%H^L
M:_X,ET[Q[#H]]=W7G174&EK)]EDA9VV+B0[L[-H;MG/:O&_"/AO3-<_:L^,^
MD7]C;W6ES>'=#C>U=!M*L+L,/;(]* .^N/V;_!%SILEB]MJ7V636O^$A9/[6
MN<_;]V[SL^9D'=\V.F><9JK?_LL?#C4=3O;V31[J(WFI)K,EM;:G=06PO48,
M+A84D"+(2,EE )Y]:YGP]\8_'?BW5]/OO#7A^#4/"9U^XT6Y61$5H+:&:2!K
ML3F?YB'C!,?EY*G .>:YW0?VBO'TH\(:SJUKX='A_5?&EUX-G@LXY_M!=+BX
M@CG5F;:@#V^"A#9!SN&<  ]V\??"_P /?$S3]/M-=MII5T^[2^LY[:ZEMI[>
M= 0KI+&RLIPS#@\@UR4/[+_P^LI89+73[^U$.L+KZ1PZM=!!?*NT3;?,P6QG
M/KN.<YKB['X^>*6^*GACP[*VD3VVNZCJFG/':VLK1636\<CPXNRX2=R(QYB(
MN5)(X*UF>"OV@?B)K-A\./$&K6GAV+0O%&O77AV2VLHIC.DJ-="*X#L^ N;4
M@QX)P<[@3A0#NO%/PTU+P?;ZT/AQHUE/>>+M0>;6Y=8U*8PP&2(HURL9W!B,
M(/+7;D #( !'=Z-;^&_A#X/T+0OM5KH^DV44&EV0N95B#L $CC!.-SMCH.2:
MX/\ 9:UOQ+XB^'U]?^)-8AUFY.O:M;+*EL8F'DZA<1$<NPV_(-J@#:N%^;&:
M\H^/7BO6OBK\(]3U^R?2XO#.G>,[334M)(':[=;;58K=YO,\P!6,JMA"A_=X
M.<G@ ]DU?]ESX>:WJFIZA<Z9>I-J.I+K$J6^JW4,27H*DW$<:2!8Y"47+J 3
MSSR:MS_LX>";O1-8TF:VU&6QU;55UN[1M5N27O P82AM^5.Y5.!@?*O'%>;^
M+OVBO%WAWPU\9KR&WT>6Y\"ZK:VUKYEM+LN()4A<AP)<[P)2-P(' .WM6GK/
MQP\?:MJWB0>!_"R:];:!KB:/-;2*B&X"B-KE_/:X7RRHD^4&-L[<D_, H!U6
MN?LL_#GQ#?ZU=7NDWA&LS17.HVUOJMW;V]U/&RLD[Q1R*IERH^?&X]<YKL/'
MWPST#XF>&X]#U^UEN+**>&ZA>&YEAG@FB8-'+'*C!U=2/O YZ^M<'^U%XC\2
M>&O N@S^&M6AT>[NO$^BV$LTULTVZ.>_AB*\.A .X;AGYEW+E=VX8FO?&OQ?
M+8_$^[\.Q:/<'X>;8KJSNX'\S5)DM$NIA&5E_<*4D"H2)/F!SD"@#=O_ -FK
MX8Z3H>MK>VMW::;J-];ZI?R7&N7:JUU$ L<[.TO#Y"L6SEF52V2HQL^';?X=
M:5X]UGQ-IFOV,GB'7D@M[K&L"43",;856(N5!&2!M&?F/J:Z+2+C2/BOX#T7
M4+NP$^EZI;V>JQVMT,[3F.XBW <$JP0^F5[BO&O@[X1T[4_BW^T#IVK:;;SV
MW_"26$J1,H("G3K65"".ASAO4&@#T;QG^SOX#^('C"'Q3K6CO-K*VXM)98+R
M:!+J -N$5PD;JLR9)^5P01P<CBI]0^!'@O5-:U34Y]+D$FK2PS:E;174L=K?
M218\MYH%81R$;5ZKR% .0*\X\ ?&?XE?$BY\,ZMH_ARU/@_Q#:W<WVVZA5/[
M,(1FM69A<%IU<@*ZK&A!.0<5A_"S]H[QYXBE^$-]XCM?#D.E_$"SO9(X+$3)
M+:R0VYG1C([%2K*C KM^7(^9J /:'^"?A:7Q))K4EO>23R:BFK-;/?SM:F[1
M B3>07V!@%4CC&Y0W4 BA8?L\^#-&3&FV^IZ:%OY]2C^R:O=1B&:;?YOE@28
M16,CDHN%RQ.,UY;X5_:'\:Z[KITG9H=W/=>#KWQ#;W5O:3K:1W<$T*&!)C(5
MN8AYX4RQX!*$CAL"KX>^.OQ*UVP\(M>R>'+!?&W@F[\0Z;-9VDTCV$\,5M(?
M,#R 2*RW*D+\NTC&6 RP!Z7I/PI\+?#[XD>&-6L+F+0TMM'?0;*Q:^DW7@\P
MS;=C/M=E)D<MAG8ODL O.]\0?@;X.^)VMZ=K6N:=,=7L(V@@O["]FLY_*8Y:
M)I(75F0GG:21R?4UP?P=\'-\5/@G\'?$'BJYMM8U6UT[3=;@OFM?](5VMXY%
M'F.SL')V[W4C?@C !(IWA'XWZUJOQKN?!.KM8Z)<Q7UXD6D7EG+%/=V$:L8+
MNUN"YCG#?*711N3)! VDD Z;QK\*?AS:>&_$/_"210V6@:K86VEWT=U?/#;+
M;0Y$,2#>!$ 6; 3&2Q/4UYYX9^"EEXE^+Y\16?VNX\ GP=:>']-U.Q\12L]P
MD<\TCAV23?(C"55#,Q(,9Z9K8_:!;Q!)\8O@C9Z5JME9P76MWI$-Y9/<(98]
M,NW#L!*F0%#!1P0Q#9XP</3_ (R:OX6^(GA[PW8V>AQ^'[_Q3=^'7L-)LW\N
MS BN)DD-TK>5Y[-"S/ %ROFX.",D Z;Q3\-?@GXQO/#NLWLFEQ36#CP[IMUI
MVK-:>85?8+#,4B^9A@5$1S@D@#DUUM[\ _!U]J'B&\-G=02:]IL>D7RVU]-$
MC6B#:D2*K@1@#<!M P'?^\:\"U_Q%+XJ^%'ANYO=-TG3[ZP^,5EIDBZ1;>3#
M(\&OB%Y0I)(9]I9CG)+'UKKOB%^T1XK\%^$OC7J<46DW%SX#U2UM[57MY-D\
M$T%M,!)^\SO N<;@0/ESMYQ0!Z;;_L^>#+6**%;6_DM$%J'M)M3N)()OLP00
M&2,N5<J(T^\#G:,YQ3=*_9U\ Z+XXO/%MCHAMM7N[HWTRI=3"U>Y/6<V^_RO
M-ZG?MSDD]>:\]UWXX>.]#\;_ !/$D'A]_"'@""+4;UMLRWMU;O8RW'EI\Q4.
M&5/F(P03Q77?#+QM\0M=\7P0Z[HML?"M]I*WL6J0HENT%UN7,&SSY#(A1MP?
M"]"".10!:O\ ]GCPH-&OK.UL[FYEDTJXTBV6_P!4NG2WMYB#)%&V\M$K%4R4
MP<(H!  %=;X9\$1:!X T_P +3W=S?0VUBED]R9Y$ED4)M)\P-O!]#N+#U)YK
MR#Q_\2M>\ ?'?Q+>WVLI)X/T+P++X@DTI+0E\),XDPXDP7/E##%3@': ,EC;
MT?XU>*--\3_"N+Q$FEW.D?$&V?R3I\3QOIUT+8W*1EF=O-1D#+NPI#+GH<
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M>/\ 68_A;JVO6GANST?Q9K-YX=N+6U$WGQ7,"W6)DD9MH5GM'7RR"<,OS$G
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MGI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%
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M(7\36\GF6X?[8\CR/N(A *%Y925Q_&1G& /6S2T >&Z3^R3X:T2[\/S66O\
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MM4\/Z[IEC+IPU2QG1Y[JWE?S9$G,R2"7,I,FYAN#DD$9.?4Q2&@#R[2/V>M
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MFG3_ +%XGT./6+E/!WB/5CK&H:$8D(\UG62:..7@I%*Z!F7!/S.%*[N/:<T
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M  C>G?\ "3"P&O\ DK]M_LO?]E\W^+R]_P VWTSS6QWI:3O0 IZ4@I3TI!0
M-S7SQX _9_\ $?P'\?>/-4\!C2=3\-^+)QJ!TC4[J6U.GW@WY,;I'('C8OR"
M%( 4#IS]#FEH ^-K[]AK5C\#/B9X>BUNQO?'GQ#U.'4]9UFX62*V1DNA<".-
M &;:#YF">29"3@  =!X(_9(U2+XFZUJ_C(Z/J_A?5_"=AX=NM.AN)_.9[9(/
MWA;8GREHFZ$'!7W%?4X44O04 >,1_ ZX^&MYH4?PRM-+TWPU;)??VIX>OYYS
M%J#SBWV-O._:R^01N(; 8@#YB1XAXO\ V$-1UCP/\4;#P^-#\,WGCG5["]_L
MN"20V&G0VNXX1A&&9W=Y&("JJ[@!PO/VN1FF[10!\QP?LQ>*5^-GB#Q.^I:3
M%X=\3>$8O#NJ1()'NXF6$1MY)P$(RH(=O7&SO4_[*?[.OBSX(V-EI/B%?"%U
M9Z0)X[+5M*LF&IW:2.659Y'4;0NYN%))P@SA3N^ENH&:!Q0!\_\ QP^!GBGX
ME_&[X7^,+!]$;1?![79FL]0DE\R[%RJ)*N!&R@!$&,DY).1BN$\.?L8>(O!\
M?Q2\&:/K]E'\)_&MO<-;:9*9/M6CW4B</$-I1T!PI4L"55.<J=WUVW(YH7@8
MH ^-_#G[)?CZU^ 'B#P!J \#V^IS:.^AV>JZ;:21S7432H?-N9O+#Y5$P$4$
M,<%CQ6AX>_9 \4OXUTB^US4=)71;7X;Q_#^9=/GF-R0(BK7"[HP.69L+D8&.
M<C!^M]HS3AQ0!\L_LT_LO>)/A9X</A?Q?8^#-1T:UM[JRBU'3+(G4=0@F9LI
M<2.@VJ%=AM4L3\HSA3NXW0O^">,.E>$O 6FS:L)=0\/^);B_N[P2/FXTN0LI
MM%.,C=&D.Y>%R\W7=D_:_4<TA44 ?)W[37[+_P 0_C=XRU-K#6= 3PC+X>:P
ML]/U%9=T%[OW"7:BX;H KL6V;B53(YFTO]FCQUHOB_X,>+H9/#]YJG@'PN=#
MGL&N9H8[N0P-""LWE.0H5MV2F2<\#(Q]6GGK2#CB@#XSA_8B\2:5X0^&=AI^
MM:6^L:#XN?QAJ]Y*9(DGN&="8X0J-P%4+N;'W0<#.!M_"#]DSQ/\*?BKXFN8
M_P#A$M3\%ZIKAUZVO+VS,VKV3E]YAC+)M4?=&_<2,9 #&OK'&#Q2@\4 ?/\
M^UU\!/$OQ^T'PCIGA^\TO3SHFMPZT\VI22@.T2NJQA40\'>23D8QTYXT/$GP
MU\=Z_8^(-,L;?P]X=T74]/U,2V<%[-<F[O[F,HDDK- H6,;F8J%.6YYKW =:
M": /C7X7_L:>,_ /B#X,W<FKZ+-:>![+4+&]6*:7?=I=23DF,&+"E5F'4\D'
MD=:UO@#^R?XN^""ZGHRMX1U+1;:XNKK2-7DLV_M5Q)&46"639^[0$@EE+GJ
M,'CZT!XI,\T ?(EO\'M6_9T_8'\:^#M;71M?NM/T[4)4,2RR03K(S2*7!56#
M N0#T&U3D<X\\^"'CFT^#OBUI/'_ ('M-,L-1\-QVMUXEB\0+K1MK&W2***&
M2*,'9"Q>-00/F9AG=@D??S*&4@C(/!!K/MO#NE6D4L4&G6L$4HQ(D<2JKCW
M'/XT ?-_[,7P3U#X<?!OQA_PA^MI/>ZI=7X\+WFH,9;>VLUEE^Q\#(V,SO,2
MH^;S<X-?0/@"S\0Z?X+T>W\67MKJ7B6.V5=0N[%"D,LV/F9!@8'X#Z#I6\J!
M  HP!VIU ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"
MEI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D
M-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0
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MX+1Y)[@QF.Y6X1V1H]K$X'EL#N"G/:@#LA0:XOP]\3;;7OB;XJ\%C3;VSO-
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M3+E1(@<!^",C/([&I 1UR,4 !I::77^\/SI=P]10 "@T@=<_>'YT%U_O#\Z
M'"D[T@=?[P_.@NH/WA^= #CTH%(6&#R/SH!'J*  TIZ4AI3TH 04&@4&@!:0
M4M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>E
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M\*:A]J73]3>*7S1963/"\D3AE.2=R CH5^Z2#1\'_$R:3PY\,=$\2^,X]/\
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M*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H-
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MC\5O@9JM_P"#X=.\7PZQK6GQ6#WR^3<!;*0+(+C866!@/,^X7 S\I/![:?\
M9:\[X5> _"\?BFYL==\#21/H'B:SM42:V$:&(*\1+)(IB)1@>&&"1ZZO_"A=
M5N_$W@K7]2\8S:MJGAZ^N-1EGNK%!]KDFA\AE"HRK$@B^554'!^9BQ)R 8ND
M_M':QJG@NROY?#UAI&JIK5_H.JRZAJ.-.L+BT=T;$H3?)YC(%C4("2_/(P<B
MW_;%COO!7@+6O[(L=$F\5VU[+ -<U%K:S6XMY?*^R?:/*.))&W%2ZKPIX)^6
MM#3?V6M8TG5K#5;7Q]);:C::WJVM+)%I,10OJ)!G&QW<!E.?+?JH9@0P8Y=H
M7[+>IZ#\/4\%?\)JNM>'3#>VTMEKNC17,<J7$OFABJN@\Q&+D.<@ES\O   )
M_%O[3&HZ+<:U;Z-X%U/Q->Z$EF=1L=/2ZEF\R>))FBA,5M)&[)'(C?.\><XX
MZU[?/K%M9Z.^IW3&TM(X/M$K7 V>4@7<2V>F!U],5X7IW[*][X1UI;KPA\0]
M<\.V5UIECIFKVIBANGOUM85@CG620$PS>4H4NH[ XR*],^)W@.^\=^")/#EE
MJR:5!<-$EU+/;FZ\^W5@7A8>8IQ(!L8YR59P,$A@ ?//P-^,]S-^T=<6NH>(
M[75M+^).E?VWI-I!<HYTJ>W)46;(N=KM:&%V)QEXY*]'\9_M'WWAU_%D^E>'
M8-5T_P ,ZY8^'[TSWYMYWN+K[-L>-!$^8U-W"N2<M^\('R#?TGQJ^#5Q\6HO
M";V>MIX>U'PYJ\.M6E\EF)Y!+&K*$Y=0$8,P9>=PQTQFOG[7?"OB5OC)XXUQ
M8M8M_$+:G"VE6MSX$?4K*[,-M''!*MZA$:+O#L/,D0QYY/5B >GZK^U!K7A_
MQ'X_AU+P3''X<\#.3K.LVVKB1EC:Q%W$8H3$I=VW)&REE"EU.YAG"77[4^H^
M'4UR7Q'X%U33[&RT^VNK;4H+>\-K<7$URMLEH6FM8F67?+$?E5\JS$<KM.W9
M?L^-K#?% ^)]36^L?B''$-0TZUM_)^R%;1+7$<N]BWR1IR1]X9X!Q6>W[,=_
MK_P]U'PGXP^(6N>*+22S2TL;EDCMIK/9+'+',60?OIE>&(AWS]PX WMD R]?
M_:G\1^&]"\17]U\-[]AH]YI=M'--)/96^HK>3)!F![BW0^9'+(H,; #!!WTS
M7OVH/&/AJV^(WVWX>6+W'@6WBU'5/*\0?NGLI(6F!A8V^YI@J-E&55.TD2<@
M5KZ_^SKXE\6^!9M"U_XDWFMZC+<V,O\ :5SIL**D=K.MQ&JPQE5WM*B%Y"22
M%"X'6K'B7]F^Y\37WQ7NG\3BW/Q"TFVTB[2/3P1:Q11/$2A\SDLDLHYZ%E/\
M." 5?&/[3\^DWFMQ>&?"&I>+O[%BLWO+>PM[E[B1IXXYO+B$<$B%UAE1\.Z9
M)V\?>K'\4?M4>(=!NO&\R>!H)='\':K8V>IW3ZMLF>"ZCMY$>*(P@^:J7*%H
MW*@8P'8DXVA^S/J>G>+7UW0/'^I>'#JFGVECXAM;.UB:/43!$L23Q;]QMY?+
M7;N7=@!>XR8_$W[,=WXATSXF6 \6?98_&][:7DT@TX2/:?9HXHXPA:7YSLMX
M068')#''S< &S\,_&GBKQ!\<OB;H.JIIXT?0VL8[-;>Y<O&DL+2*S*8P"SY.
M[Y@%VJ!NY8PV7B$?$C]H[Q9X5O$$FB>"=,T^8V<@REQ>WOG.)7'1A'%" H/
M,C'!(4KT/A'X5WOAGXJ^)?&1U\S+XAMK1+[34LU2,SV\7EK(KEF8*5)^3/!_
MB-93>#+WP9\>-9\7V$#SZ?XNTVTT^_,,7F&UN[5I1;RNH^8QO'.R,1]TQIGA
MB5 /E/P3X2U[Q/\ #.PB\ Z'?6_CVS\>7AB\00H8+>VL8K^1766<G:\8A&SR
M?G] G2MOQ9X=75?'/[3.AZ#X6U#5O%"S:>GAR32(-C6%Y+IT<@D%QE5@'G.)
M6)9<@,>2<'ZE^"'PEN/@]X8O-%;61K%O<ZA<ZDKFT\AD>>5I9%^^V1O8XZ8'
M'-1_#SX077@CXF^/O%TNMI?MXPFMKBYLULO*6!X(5@CV-YC$CRU 8$<D C;R
M" <7\6+S6(O@EX6^'^O^*;71?&'B?34TS4=<:=(Q"4M@;RX0L5SEAL&.09E.
M.#C2^ 'C&#]H;]GRP77I%GU>%7TC6OL\WSQ7]LVQY$=#\K$JDR,IXWH1@UW]
MIX)O(OB5J/BBZU1+RVFL(["UL&M0IM%5B[%9-W.]CEAMYV1_W.>,T+X:W_PA
M\9?$+QK:ZG>:W8^);A+YO#-CIXW+<JB1(T3;^&<*N]FPO\1*@&@#4_9P\>ZC
M\0OA;:WFM.9-<TV^OM%U"4H$\V>TN9;9Y,#@;C%N(' +$"N!_:VTVUN?%'P-
M::UBE^U>.[6RGW*#YD#6UR[1MZJ6C0E3P=HKK?@S\'M<^'6@>&(I?$<L+QSZ
MCJ>O6$4:RQ:A>7LKSO\ O7^=5BDD;:5QN &[O6I\9/A#>?%+4_!MY!KR:-_P
MC&L1ZY;J;(7'FW"(Z*')=?DVR."!SSU&* .I\>^([CP5X+U+6++3&U>YLX@T
M5DDJPA\L%RSGA$7.YFP<*K$ XP?![[]K^?3?"GC?4H] L]=G\*ZSINF32:;J
M)%M>Q7OE>7-"[1\E3, 5/RG;D/@\=U\1/@;K7Q2TC5;76O&CPSW"6RV1T[3U
MC@M##<QW!8Q.[^;YC11JP=L;5( &XYY77/V3=1\0?\)>U]X_N[MO%%SIM[?+
M<:;"42:S:-D,80J57]TBA23A2V2S$, #03]I74M)U7Q9H?B/PK!IGB+2KS2;
M*QM+/5?M,-_)J+,EL#*84,9#HX?*$*%)&[C/C'Q*LKFZTW]L5=<T73K"Y'@^
MPN2EE.9XIG6TOG2?+1H0^Y1P1D%,Y/!KVKQI^R[+X[\2>*=:O/%DUA>ZQ_94
M]M-IMF(I-/N]/D:2VG0L[!QNDDW(PP0PP1C)AU/]F+5]=MOB,-3\?W%]=>.=
M%AT747;28$CC2-9$WQJA!!V32  L<%LG=@  &O>_&C4;6+7M)\*^&X_$E]X2
MT6UO-1BGU#[(7DEB,D<$.(I-SF-&8[MH!:,9.XE<+1_VHM3\9^+/#^G>$?!B
MZUH^K^'[+Q,NJ7&K+:FWLIYC')OC,3?O(\$[0Q#;2-R\9W5_9^U'3/$&H:]H
MOBU]+U?6]%M]'UV06"O'>- A2*[C3>/*G57=0273!7*';S/X-_9YM_ 7CK3-
M6T;4TM] L/#,/A:+0VM-W^C1,SH_G;\^9N8Y.W!!(QGY@ >9>)O'EW\4?B!^
MSSXK30K&U\/:AXCNI-+U,7S27<L#:9>F/="85"+*BB3 D;&U01D\>P_&7XQQ
M_".7PZMQ!8K%K%S):+?ZO?-8V-O((RR++.(I A<C:NX '#<\ 'B/#'[*5WX5
M/@BQM?'NH2^'O!>KOJ6B:9/8PNT,3131?9WF/S.JI.RJW! R"&.TKZ;\1O F
MH^-X[2&WU.RAL!#-;WVEZKIHOK.^239@21^8G*["0<_Q'MD$ ^?M:\:^(?#'
MQ\U7Q;H_@NWU#6;CX;6>JZGIL^KBW2'9<3LR><(WWOA=BD(%;;EF08KK_B+^
MUHO@GP99^+8_#D<F@W&@V>O1R:AJBVL]VLYRT%M$(Y/-DB3#/DH!O3G!)%_P
MW^R])X5\Z.P\4R-;GP<G@^);NS\UXXE9V$V[S!D[I'PN  -H'3)YG4_V,;_4
M/#NHZ*GQ!GMK/4?"MIX6N&CTJ)I/+M@RPLC,Y*(0?WD8/SG)#(2, &+\0K.R
MNIOVL'^SQM!+X-LKLH5QEQ87KJV/7*J<^HKZ5^&+^9\-O";>NDVA_P#(*5YQ
M<_L]:C?6_P 0TN_%<<TGC/0;?0[IUTP*(5BADA,JCS>2RS2<= =OH<^J>#]$
ME\,>%=)TB:Y%X]A:Q6GVA8_+$FQ N[;DXSCIDT :YI3TI#2GI0 @H- H- "T
M@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*
M!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z4T <??\ BJ[M/B+9
M:8=4T"'1O[+N+NYM+B=EU(R+)&$EC7.WR ID#L1D,4P>M7-+^)/A37-6BTS3
M?$FD:AJ,L'VJ.SM;Z*29X<X\P(K$E<_Q8Q7E?CZP:/\ :D\$ZN='OKG2H/"V
MLVE_>VVE33Q;I);-X8GD1"I)6*XPI/4XQEQGQ#X5^!K_ ,,>'?V;95\&ZG9:
MGI][JJZX1H,\4L"S6\T>9F\L% S21X9C@XSG"D@ ^I_%'Q[\!>%?"VNZ]<>*
M-+NK/1HFDNTL[R*612#M$84-]]F^4 ]6.*UI?BGX0M+/3KB\\3:18IJ$8EM?
MM-_$GG*2!\A+8;D@9&>3BOCN[\">+-0^%_COPIH^G:_KGAT^!)%T>3Q!HDUI
MJUA,'5DTK>R)]J&%)#*I*[0,X8;KGQU?7_B+X=\>:?I?@?Q5:/J?@B*'3Y[7
M0I#-JDJ"X/D7#3*1;B)SO$8"3-NRI)*(0#WG6_C#XFT_X@?%7P[!9:2R>&O#
M%IK^E22&7,IE^UADG(/0-:G&P=&ZD]/0?A9XJN/'?PP\(>);N.**ZUG1[/49
M8X 1&KS0)(P4$D@ L<9)..]?/,4^HZA\0/BGJY\.>(H;?4?AQIMA:B;1;D--
M<1_;F>)<(0T@^U0_(#G)(Q\K8] ^"/Q B\,^$/A%X"U/1->L-5NO#%K$+FYT
MN6&VBN+>V"RV\CN 4EQ%(P4CE5R#R,@'JWB7Q?H?@RS%YKVL6&BVA.T3ZA<I
M A."<;G('0$TV3QGH$5Y8VDFM:?'=W\9FM(&ND$EQ&%W%XUSEUP"<C(Q7D/C
M^WU?P]^TUX>\4ZAI6H:QX*F\+W>C!]/L9+TZ?>M<1RL[Q1JSA98T";@I&8P#
MC->6VOP>\8>#O@G\/_$'A_1)YO&7@_Q'=W^EZ+,^)?[)O+V5#8L3G9BUFC)!
M^YY0Z;: /J>+XD>%+C3$U*+Q+I$FG//]F6[2^B,32_\ /,/NQNY'RYSS1I?Q
M%\+:WJ5OI^G>(])O[^XA-S#:VU[%)+)$"09%56)*Y!&X<<5\[_"CX3>*/ GQ
M+UGP[K<!U3P#"[>,%OA$7674KF)HKBT6,+\R+)]HF5!DKOBZG%<'\(_!+^%O
M"O[,4B>!];TW5]-UR_?6I/[ N$FM4DM;N(M<-Y>41I9;?!8XV@'HAP ?<SG
MS7.V_P 1O"UWJEWIL'B+2IM1M%9[BTCO8VEA5?O%D#9 '<D<=ZI?#SXDZ?\
M$S0[Z^LK+4M,>SNY+&YL]8M&M;F&5 IPR-R 5=&![AA7R1X(CUJ?Q]\)-<U#
MP%XITVPL'UVWU718]#E6RTL3HV(QN0R7'F-AVF+LC'[H!.P 'V%I?Q(\*:WJ
MT.F:=XDTF_U*>#[5%9VU]%)+)#_ST5%8DI_M 8KS_P"(_P =HO#?Q&\!>'-#
MU+0M2DUC7?[(U2R-SOO+9?)E?>J*WRX,8!W#C<!CFOG7X8> KWPWX,_9F%MX
M/UG1_$6FW>H)J]RN@W,1M/-LKF(M<E8_E#3R6YW.,8!;.%)K1\)6_B!_"GP
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M@<J6 /HN7QUX<M[*\NYM>TR*TL[C[)<SO>1A()N!Y3MNPK\CY3SR*\]_:/\
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M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2GI2"@!:***  ]*!0>E H
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M\R",_P 08MT(Q6IH?Q#^*.J>$;'QJ-3TFW\/:OX;GU$?;/*D-M<^0T\1MDC
M9T"JP9)'9L#=G@B@#Z=V 'H*P_%'C;0O!UQI,.LW\5C+JUVEA8HZDF>=ONHN
M >3^5<'^SEJ?C+Q/\.])\5^+/$%IK \0:78ZC:VUI8"V%GYD"LZ%MQ,F2P.2
M!@YP " /#O&GC?5_BEX5^%GCV36RNC7GQ(LK6'0HX4$<4<=]);QEI5!D\T&/
M+_-L)8KM &Z@#ZQ\.>,-&\67.L0:5=K=RZ1>MIU\JJP\FX5$=HSD#)"R(>,C
MFMHJE?*/BKXP^/=!\#?%K4K+5M/?5?#WCZRT2R>33P(C;7']G(L;@$DD&].9
M,DD+QCC&C=^,?BO?>)?$_@;0]=M+_P 3^&M/@N_[1FM8+2*]EN9)WB\V%@Y\
MA(XXXB8F#%MYSG H ^G3M4<BL/Q?XPT7P)X=O]>UZ^BTW2+&/S;FZE!*QKG&
M3C)ZD< =Z\1TCXC^./BA>^,TT/7M(\-W_A"ZT^WDL;A!-9W.Z"&YN9992I;R
MF221(C&4/[O<V=V!Y[\2)-6D\)_M:K>Z[>:C:V,*VL5O<10A(XY=+MY@%VH"
M-HF9!ST^8Y8EJ /LBWN(KJWBG@99(I%#HZ'(8$9!![BGYYY _.OF#7OBEXE^
M%/C+1[75=3:;POXD\+!/#5LD$2;=9C2("T+E=S-*&#1[CC)D&#M!'J?Q/BUO
M1?@+XIE&N7,6O67A^YF.K6L<:2&>.!F+JI4JN67H!P#Q@X- 'I@*L.-OX4RX
MGBM+>2:5TBAC4N[N<*J@9))["OFGX:>,->U"Y^'WPWL_$=Y87+> X?$<^K/;
MV\EQ*6:*&.)%:+9L0EBQVEB#&"V22?2_V>_B!J/Q;^$MOJ?B.RMX]52XO-+O
MT@C(MKB2WGDMWDC5LG8_EDX/3)'.* ->/XV^ 9I%1/%6F&1H?M2IYXW&#=M,
MP'4Q@]9/NCUKKM+U&SUO3;34=/N8KNPNX4N+>XB(9)8V4,K*>X(((/O7A=Q;
M+!^W-HX5XA"_PVNT^SJ?F3;J=M@D=@0V!_NMZ5F^(O'?CW5?$_C70/ATEAIA
M\$7=E8PVET+>/39(C;6]PXN"?WL:^7*R)Y0 7R\DGH #Z0 7VKA/&GP9\/\
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MK6L7-]]G!!4^6LKL%;!(W ;L$C.#BM_QAXTT;P#H,NLZ_?1Z;IL<D437$H)
M:218T& ">691T[U\DS?$7Q?XYM_AC%J^NZGI.I+\2[[09Q##:(\L5N+K8TRJ
MKIY@"*#L)C)R<'"D>^_M'^+=:\"?#"36]$NH8;N#4],A;S[<3!XYKV"%P >
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MX&M;'['<Z;-J]H-,DT:.#5;N6Z2&RD*L\"!V.%)CC]QL7!  JC8?LN^ M/\
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MX2/X^6'CSPEI.K:@WB3P1$_C--%MGM;9&^VR)>20K"Y^<"-_+*R'C!R%;.*
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MQ!-J&M1:Q8V=K8PW"IILUM<&1YX?+4EI%*C8V_>, G@"O/OC=\/O$?C'QO\
M"[5]$M;2XM?#&M/JEZ+BY\IV0V\D(6,;2"W[TGD@?+C/.1ZE#J]C/JES81W,
M+7]O%'--;AP7C1RX1F'8,8WQZ[3Z5<+>AH ^?OC!\+?%TOQATCQ[X;\/:#XR
MMI-(.AZEH>OS"$(JS-+%<0R%'"D&1PPVG(QP3@AR?"GQA!X\GUG^S]&:W?P3
M)H.RPF^SQ+=M,90L<6SY81G:&)W<9*U[_@4F <T ?&NJ?LX?%36/A7I_@>\M
M?#]_I\'@*#PU!#<:I*D%E?Q1/$;LHL)\\LJQ,A;'EMG ZENS7X.>.[S4/&U]
M<:/I-M+KW@*W\.1QQ:FT@6\C2926)B&$Q.!N _Y9_=.<U]+K@=#^M+NYZT >
M!_"[X7^-?!?Q)\-ZS=Z?I3Z<W@G3?#FIF/4&,EK/9R3MNC'E?O5?SQC.W&TY
M[ ]/XB\$^(;C]H30/&5I865UHMAX?O-+E:6XVSB666*12B[<8_<A22>CGCBO
M52>^<XKAM6^+VEZ9XM\$:'%;W-_'XMFN8+'4K5HFMD>""2=@QWAN5B?!52/<
M4 ?-WAO]GKXA^ ;+P)JZ^&O#/BW4M,TRZT/5?#^HW8,#1/>/<Q7-O.\1PZ[R
MK IR#QG ->L>&?AWXLTWXS>'/$5QIFC6VBV?ABXTBXCTR0Q+#<37,4Y$46WF
M-1"%R2"22=HKW'*DYR#2.X1&8#=@=!C)]N: /FSX*_"/QI\.M3MO#.H^&/"L
M^B:7?2SV?C&(J;Z>V9W=(VA,65F^<(S[\!<XR<$U/"?P2\11^!OASX0\4V5G
MIVF^!M<_MZ?5H[P2177D/-) (AA67)E5G,@4*$(&[=D>S?"SXNZ?\6H];ETW
M2=4T^/1]1FTJX?44A4&ZA;;+&NR1R=IX)Z'L3S7;RQ)*C(ZAE88(/0T ?._P
M2\):1J_QI\:^+?"WB"WUKP+*Z7UI!9,LMK'J]Q&!>21R#.3Y4<)X. ;F4=<U
M9_:WU"6T7X:1Z>;1=<7Q,EW9/<Z@MBRF*UN&?RY71XPS*3'MD4AA(0 #AA[G
MH>@Z9X8TZ'3M(LK73+"+(BM+.%88DR<G:J@ <DGBH?$7A31?&&GMI^NZ58ZS
M8,0QM=0MTGB)'0E'!&1]* /ES0/#?B/QAX<BT+2_#,%EK&C^-['Q-K$UUKD5
MVETWGFXFVRPQA1-N0+Y6Q0JE#W%7?CU\'/B/\1=8\8Q6FGZ9JVG3KI]SH,MW
MJCVZ6;0,CRQF!4*O+(RL!*Q^56P".5/TYHN@:9X:L(K#2;&UTRQB&V.ULXEB
MB0>BJH 'X"N<N?B7:6_Q6L? C6%X+V[TN;58[["?9FCBDCC= =^[>#*G&W&#
MUH \0\??!CQ[XRT3XVVB:7I=M=>.+?3TL3_:3-%&\4"12AV\H,!E"00IR",A
M3TZ#5O 7C6X\<?$&[D\-:'K.@^*M%TZ.2QU"^/EB>%9$FMV41$L'63B3@#:#
M@GBO1?'/Q?LO _C+PSX8ET75M3U3Q"+@Z>+!8-CF!/,E4M)*FTA,-SP<\$GB
MKOPR^*>@_%G0[O4M#>=397LNG7UI>0F&XM+J,CS(9$/1ER.A(YX)H Y#]GOX
M>ZW\.+3Q':W9O+3PY/>1OH>BW^HF^FTZ$1*)$\TDX0R!BJ;FVC'3)%9_@_PK
MXY\(_%/XH^(VT33+RQ\37EK/8JFI%'18+98 )!Y6 6V!L@G&[';GVT%<#D4'
M'M0!\L?%?X1?%;XCP7=IJ=OH.L6>I^&)+0P2:C-;VVG:D[2%I!&L>;@!'C5&
M;&#&6^7<<NM/@U\0;O2?B']KTG1[6[\1>![/PQ:Q1:D75)HHIXR[MY(.,7&>
MC'Y,=,8^C_%VMS>&_#.HZK:Z5>:Y<6D+2QZ=IP4W%P1T1 S*N3[D5J02>9"K
M$%"0"5;&5]C0!\EW'P.^*&B^'_B!H.DV.AZA8>.?#T-K.UYJ#(=+OH[!;-\?
MNCYT;K&C+PN#G.!R>@U?X#>*_&-_'9ZO#8:=IEU\.9O"%U<VEZTKPW,A0[U4
MQKN0>6.<@DGI@9/TL2,CI2\9[9H ^<H_A/XS\33?#>Z\0Z;I]E>^!-/O(@]K
M>;UU*YDM/LR&,[08XB"7;>,@[0 <9K&T3X$^//"_P?\ @[%81Z9/XO\ AY=F
M=]-DO&%IJ,;1302*LNSY7,<Q*EEP#D'(YKZE(7'.*,J.A&/K0!X[\"?!OC'P
MWXI^(^J^)K#2["'Q-K$>L6\5C?/<O$?L<%NT3YB0<?9P=P/)8\8 )\]^(_P)
M\=ZWI_QUT'2[32+G3?',]O?V%W<7SQ,D@@MH7BD01G  @9MP;NH Y./J48'I
M2!E/<?G0!\Q_%SX#^,/BAXE\4W,<>F:3::EX5TW3+.668S^7>VE\;T"6/;AH
MF8A"0<X!.TYKTCX,>'?$NG2SWWB+PKX6\)3M;I#]E\.-YIG<'+2/(8HRJ] J
M?-CDECQ7=>+_ !%+X8T8WMMI%]KDOGPP_8].5&FP\BH7PS ;4#%CSG"GK65\
M5_B1:_"7X=:[XPOK"[U&RT>U:[GM[ (9C&OWBH=E' R3ST!QD\4 <IX.\'>)
M-#^.7Q+\3W6GVAT;7;?3UL)([O=,6MHG1E="@"AC)D$,>G.,U\Y_\(MXH^#6
MC_ KP@MOIJ^.-"@UF</!K<=F)+=V4,B2SPO&ZLT\9:-D+9A5EP%)K[BMIA/%
M')C;O4-@]LBO-/VA=?\ "?A+P'-KOC'PDGB_2;":$&U-C!=F(R2+&)-LQ  !
M902.<'IC. #R3X;>#]2UJ#X5)X<\-0Z1I/@/Q%?-J2W&L)=^?YUG*C2PS1IM
MG)>]9W^YAXW3''$6D_ KX@^'=<LM?M--TJ[O++XB:MXJCLIM2:-9+2^MIX,,
MXC;:\?G!B "#C@FOHS6]8M? >B62VFC7-XKRQVEKIND0)NRQX"@LB*J@%B20
M %-<AX8^/MEXKU#4;:U\*^(8X]-UH:!?W,D=JT=K=GR^'"3LQ4>;'EU4J-W7
M@X $^/?@OQ!XQT'PS/X;M[6[U70O$-AK2V=Y.84N4AD^>/S,':=K$@X/3H:\
MWU3X*^-G\._%GP6(-.O-$^(-Q-?)J+W'&DR74*1W4;*5#2A"A>(@#<3AMG4?
M389#_$#^- VD=J /)OV@?AEJ7CW]GW6_ 7AU(9+R\LH;&![Z;RT549#N9@I[
M)V'4URWB#X7^--6\4?%S48M-TM8/%WA*TTBR2:\+^7=Q17*D2#8!Y>;M@2"2
M1%T^; ^@L+GC%1W=Y!86LUS<31P00H9))9&"JB@9))/0 <YH ^5]6^ OC*[_
M .$:FTS3;?PYXJTFQTVQMO%6DZJT96&%8Q<0WD.T"XC(638,-]\ ^7@DV]6^
M%_Q4TNP\56&B6.FR:??>-O[?D":L]O/J.GR8,MN'$68'!5,L&R0& Z\_3MK<
MQ7MK%<0N)(94#HZ]&4C((_"N5^*/Q*L_A9X:BUJ^L+R_M6O[2P<600F)KB=(
M(W;>R_*'D0'&3STZX /GOPW\!O'>DV5OIXT+0+&SM?B+'XOCCL-1?RUM2"6C
M53"/F4D*.@8AC\HQGV7X8>#=<\.?$KXI:UJ=K;16'B75+:]LF@N3(^R*R@M<
M.NP;2?(W\$_?QVR?35((!R.1TKC_ (H_$JU^%?A^VUF\TZ\U"TEU&TT]S9>7
MF$W$R0I(^]E^7?(@.W)^8<8R0 >2>*?@KXDU_P"+L?B/3;"W\,WG]K1-=Z]I
M.I21?VGI:*H>WNK< ;Y6 9%?/R@*=PP%JCX2^ 7BR'P-\._A]K?V";2/!&N6
MNIPZ]%+F2[@M)&DMD$.W]W(?W:N2<8#X)R*]H\*_$VR\4_$+QCX2ALKJUOO#
M*6;W,L^SRYA<I(Z&/:Q. (SG=@\]*[$,N<Y'YT ?,1^$_P 2])T+7(;&TTUU
MU#QY/XAN=.CU:2#[;ILR-N@:98MT;B38Q X95*DD$@Y'A_X&_$+1I_#%O_8W
MA^"PT;X@7/B@1V=\RQ"TF@N(_*BC\H8*FYR,XR4/3(KZU)&.HJG)K%C#JD&F
MO<Q+?3PR7$=N6&]XT9%=@/0&1 3_ +0H \9_;5CCE_9;\>H^03:1;0#CYOM$
M6WL>^/\ ZW6N?^(GPS^(?CS4]7\7Z-%8^%?$J^'TT&QMVO=YE22\BGNRTR(?
M+RD.R)U!8%V8A3@#U'Q]XA\-7?C7POX#\1>'5UM/$4=U<6[WD$,]FIMD#L'5
MR3NPXQA2.>M=S:6=KIUI%:VL45M;0H(XH8@%1% P%4#@  8 % 'R#JW[/OQ!
MFTGXGV.G>'/#NG6_BR?1[NV@BUB60PO:O&91+(T&79A%DN<DLW.>2-KXJ_L]
M^,?B#XU^(.K6<6EV0U.WT2;1WOK@S1&YL)7E,=S"$P8W\QDR"3@9QS@?58=#
M_$I_&@E1Z4 ?+_B[X2^.?'GPDU;2AX/\*^$M7O;[3I1IVE7 \HK;72S/+).(
MER6"81 IVYR6.XA=;Q5\(/$VL_%V+Q7HVFIX6U<:I9/)K^F:B5CO],14\^VO
M[;I,_$J(P!P"AW+MP??]3UBST=;=KNYBMQ<3);Q>8V-\CG"J/4D]JYKX=_$J
MU^([^)TMK"]TV30-9ET6YCO1'N>6...0LNQV!0K*N"2#UR!0!S'QA^'^NZMX
MV^'?C;PZL=[J'A2[N?.TN6;R1>6MS#Y4P5CP)%PCJ&PIVD$C@UYU<_ CQ6=9
MM=?M[&Q2]U#XA0^,-0LOM6Q;2VBM!:K$K!"))64"1NB[BP!QAC].,0,9(S[T
MI8*.2 * /+/@IX.UWP5JWQ'?5[2"*WU[Q--K5D\%QYC&)X88]KC:-K PYX)'
MS#GBO*O%GP7\>ZGHGQ2\.6FFZ=)9:_XNM?$=A?R:CL+HKVCO&T?EG:5^RL,D
M\EQT&37U.'4\[A^=(67CD?G0!\N_%3X&^.?%WBGQUKVD6ND17-W<Z'J&D0ZE
M)YT-P]AYADAN$ ^02><P!4M]W)(S7L7P>T?6;/3;R\UKPOHO@ZYNF3_B5:,R
MR[=JX+R3*JAR>PV_* .22<>A9 ]*3>N<;A^= #CTH%(6'J*-P SD8H #2GI2
M9STI3TH 04&@4&@!:04M(*  THI#2B@!.]*>E)WI3TH !2=Z44G>@!3TI!2G
MI2"@!:***  ]*!0>E H 3O2GI2=Z4]* $%!H%!H 6D%+2"@ -+2&EH 3O0:.
M]!H ^</B=HTGC+]J'0_"T_B?6](TF[\)W5]/9Z7JDEMYLL5W (V"@_*1N))4
M D+@DC(/G5KXS\3:K\*=.\;V6HZC'\58O&RZ9?:(;N0QD'43 UBUOG8(UM&#
M [<C;YF<DFOL.7PSI<^K1:I)IMI)J<0VQWKP*9D'(P'QD<$]^YJ)_#.B6^LM
MK;:99)JH0J=0^SH)@I !'F8W8P .O8>E 'R)K'C3Q%K/PT\2>*[75K^S^*VD
M>./[,ATA;V18W07ZQ16?V?.UHGM7#[MASEI.U>A_!C2-.7]J[XZ2)+*T]N-&
M**UY(X)>UD+Y4L0<'@9'R]!CI7O+^&-$GU>/63IEB^JJI5-0,"&<*1@@28SC
M''6EL_"VCZ?J4VHVNF65MJ$V?-NX8$663)R=S 9.3SS0!X1XNU2/Q)\>?&?A
M'Q3KFH>'M,M/#%M?:$]I?R62L&:875R&1QODC98A@Y"CG'S'/F7A^\U'QOXT
M_90U7QE-<MXAU#3-5>]=IY;9Y2MHIBD**PVE^"< ;LX.1P/L76O#.C^(Q$-5
MTRRU(1'=']K@278?4;@<'@?E4.H>%]$OM1@O+S2[*YOHL>3<S6R/)'M.1M8C
M(P>>* /&?VN])TR;1?AM?:G<O:6]GXUTK?,+IH$6-Y"CEF##& <[L@C'!&3G
MPWQX[V1_:3\5Z5XCU33KS0-9TN^TR33]3>& 2?9+3+.J$+,'"JA$FY<= "23
M]RZKHMAKUF;34K*WU"U+*Q@NHEE0D'(.U@1D$ BLNZ\">&YS=^=H>F/]L</<
M[[.(^>V<@OE?F.><GO0!\I>(O%=SXR\?_$/2]5^*J_#S7-&UV#^RK<I.;F2S
M$<+PFWA%RD=PLQ\P%?*=B6QD_*!ZO^VX0W[)GQ(^;YCI9 SW^=:]=D\%Z!)J
M-GJ$FBZ<]]9QB*VNGM4,L"#HJ-C*@>@Q5O5M"TWQ!:&UU.PM=1M=P;R;J)94
MR.AVL",T ?-WB^TB\6_M :?HDOBS7+#0+CX?S:E)9:/K$ENDKK<Q*DJ;&&TA
M6)RI&[ SD9!XKX*:UJ=Q/^SOK=WXMUR_O/&&GZE;ZM'?:K(\=RL=H7CQ%NVH
MZ-&OSH Y);<6))KZX3P)X=AE26/1--65(#;*ZVD8*Q8(,8./NX)&WI@U!-X(
MT"VB@-KH>E17%H2;-C91@0.3G*X V\\G&* /CCP!%KDGP_\ A7XQTKQSXCU7
MQ9<>,FTFZL;K59;B&YLC>SQW$#PEL'RX$:7S&!<;<[L!=L&DZMK.A?!/Q=X_
M7Q;XFOI['Q5<Z%=,=5EN$M-'.K1K-(BD\2)#O(F)+*&/. ,?3?P*^"=I\+/"
M\5C>II&I:S#+<;M7L]/$$TD<LK2[')9F."Y'WL8 XKT+3?"NC:+:SVUAI=E9
M6\_^MBM[=(UDXQ\P4 'CCF@#YSO_  C<^*_BCXR\&>&_$^IQ>$=5\'P7RW-G
MJ4TATS4VF=()89@Y*AXU+F,'#>5DCYN>-@\?^,-9_9\UWQE!!JNFZ_X2TB'P
MW=PQ--(PNXIU35+E8]P$I2,%D?);(?G(KZ_T71M*T..2UTNRM=/BW;FAM85B
M7)[D*!SQ5V.U@A1DCC2-'8LRJ  2223]222?K0!\0>/M4M(_A[XKUWPI\7I=
M8L[R709(H-"NIXX=,+7T,+2>:]S*0\D3R;HF(!\O<5R,U:\<Z!_94W[15I:^
M,?$5O;>%=#M=:TB :[<%[>^>SFD,ID+EG#O&@\MB5RQ^7D8^OE\!^&TTU]/7
M0M,6P:3S6M1:1^47_O;,8S[XI\G@KP_-)<O)HNG.]R@CG9K6,F5000K''S ;
M5X/]T>E 'R+XL\>#QQXH\2:)XD^)4/P_N8]%TO4-!OW:5&>.2W#S7-J4N(D=
M_.,D94JY(50!@D5C?$N\OH] _:-UQ?%_B*/5_"LFF7FBHFI31"TN7L+:4OY&
M_ #RNZF-LHHW *.:^U)?!N@2FR\S1M/D^P8^R;[9#]GYR/+X^3D \8Z"FW/@
MKP[=-=O/HNFRFZ(>X:2UC;SB.07R/F(]30!\K:S#867Q9^.[VOC"#PIJNIZ7
MHW]EWUQ=R*FZ6.7=*,/RA8A2Z_ZL;B"M>K_LUZW>2IXRT+5='N-&UG2=0B%S
M"NIOJ%D=]M'L-I*_S+&RIO\ +;E6<YZUZD_@KP_)()'T?3W?[*+(,UK'G[.#
MD19Q]P$ [>GM5K1/#NE>&;+['I&G6FEVFXOY%G"L4>X]3M4 9- 'QWJ?C/7]
M4^%&L^,[;4M3M?BKI'CK^S#I!NW"%3J:Q1V!@W;7B:SD1N!DG+YZFO2_@-X?
M77OBS\3]8O/$FM7L_A_Q7<65CILNJRR6T,,ME;.V8BQ!&]W"@\*8SMQSGW9O
M"NC-K/\ :[:79'5<;?MQ@3S\8QC?C/08ZT[3O#VD:/=3W%CIUG97%TV9I;>%
M8WF;).6(&6/)//J: /!?%E]#XH^.WC?PIXPU6YT#2++PW:ZAX?F@OWM%Y>87
MEX'5E_>1.+=1DG8.>-YSYW\,V\1?$W7OAI9>/M;UW2[[4OAW=WVJVMKJT]D9
MIH[NU6&5E5QL<QL7)7:20<_+E:^P-5\.:7KI@.HZ=:WY@;?$;F%9/+;U7<#@
M_2HI_"^C7NH&_GTRQN+T(83<R0(T@0@@KN(SC#$8]"?6@#RC]EO6+SXC?LM>
M$)_$5U/J%U?:0;:[GDF<2RX+QDM(#NW$#ELYSSP:^<?A19Z)XB^'W[)^F6^N
MRPF[NKL:B]EJC&>*8Z1<B2(/N+0EC\A5"I7>=NUB#7W=IFCZ?HMH+33K.WL;
M4$D06T8C0$GDA5P*SO\ A!/#F^!QH>FAH)6N(C]DC_=RD@LZ\<,2JY(YX'I0
M!\;V'Q#O_#JZ?X9U'QG+9>#XO'>O:)+K6JW$\Z0I$ ]G;3W"SI(!EW +2C)1
M020"*^EOV>;,Z;\/1:#QI)\0+>"[G2#6G1MK1[\B-)&=S*L>2F_>WW2"<J:[
M&3P#X:FTV\TZ3P_I<FGWK;KJT:SC,4Y]73&&/U!K4M-/L=-LH[.VMX+:S1/*
M2WB4+&J@8VA1P!VP* /GK]E'Q%I6A^$/BK?WNHVMM:0?$#Q#/)-+,JJD?VDM
MN)STQS7 >/\ X@#Q_P"/_B#I5_\ $X_#1[6UT^]\/2S+/',UF]M',9X$%S$D
MKF8RHR,CGY0N.U?5 ^&/@[G_ (I31,GD_P#$OBY_\=J[JG@_0-7U*PU'4-%T
MZ]O[ _Z)=W-JDDMN?^F;L,K^!% 'Q=\3_B?-I_BV[U73_&-U]LT[QSI6F3G4
M-5DMG5!]G6XMXK!2$^SX=V:23))+#'RAJZR\\2>(- ^*RWJ7-QXHM=3U?58M
M"U72M6FV)<I:W&-/O;%R4V1F,[9(QUCC)&6.[ZCO/ WA[49[F>ZT73[B:Y"B
M>26U1VEVD,NXD?-@JI&>A ]*=9>"_#^G:M)JEKHNGV^IR@K)>PVJ),X)R07
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M2)$ H4L3D,QU?@GXPE\'>.53QAJHO;*;0KS5H/&%OJ[OINI6J30;IKF&5O\
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MW,KDPPR"*,2/D!%D8J/N@\Q=>-9-5^&7Q6T6]\0V=_'IGCWP^]I##J+74=M
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MB\FT* G<YQCGC=?\1^))_CI\./$NF>"I(_%FJ^#=46XT+4=06 6Y2XLV FE
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M_@[U4_9X^-%_X9^'OP#\-:EHD46E>(O#R6\&O27A54N;>WR(6C*'YG1-RDN
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MS\PR ?2.F^-_#^L:F-.L=<TV\U P+<BUM[N.27RFP5DV YVG(PV,'-1Q^/\
MPU*^H+'X@TN1M/4O>!;V,FV4'!:3YOD&0>3CI7Q3\)?A_'XT^$7P/O/A]H\V
MB>+=/T6[;4M:;3I+52)=-GARTQ4+-ON7@=1N;Y5+# K4L_#=GXE^%6N _#SQ
MI%XTTSP??Z)/_:UO,T5LY@*)!;JH*W*M,JLA16V@;R5XR ?7]W\1O"UC:RW5
MSXCTBWMH9?(DFEOXE1)-H?8S%L!MI#8/."#TJG??%CPM8>+=%\-2ZQ:_VMK%
MLUW:1"9,/$" &SGG<6PN,[L''0X^=-:T2W\,:'\*X-!\#ZEID5_HUPUWJNCZ
M!))=07+6MO$87@*;8Y)@NTRSH<"(CC<6'/\ P0TO5]#OOV>IM7\.>(;>/2M$
MU30[PRZ/<$P73/;B-9,KE(\!L2'Y?E//4@ ^J?"WBZX3PQ=ZKXHO]!M8XKRX
MC^U:=>;K185F9(MTCXP^T*''0/D#TK83QCHDMA9WR:O8/97CB.VN5ND,<[$X
M"HV<,2> !7R/X(TS6_#=E\/=0?P_J_\ PBNA>-O$$NJZ9'I4ZR1Q75Q<_8+I
M8-FYXX_-!^53MW@X&VJ7C#X>27']JW4WAR_O/"6K?$W3=5T_33I<LLB6@2(7
MTQAV;HHI)!(2& W#)P=PR ?8$/CSPY/HDVL1Z]ICZ3#(8I;];R,P1N"%*M)G
M:#D@8)ZG%:.E:Q9:W91WNGW4%]9R?ZNXMI!)&_.#AAP>0:^0]5\(01>+_B78
MZ?9^(_"-DWBS3+W1]4T;0YI8+6X33]K7!A\LI+"94=& !&75N.&'K?P#\4ZI
MI'A;P[HFO^%KNRU'5K[5"MYIFERP63+',\GVJ9'^:V\_=O5&'))P ,"@#V>]
M,PMI#;A&G"G8)"0I;'&2.0,UY!\&?V@4^)^L>)?"^IZ<OAWQCHES/&;!Y&DB
MN[=)GA%U;NRJ9(B\;*2!\K#!ZC/L<L@BC9R"0HR0!DU\U:E\-+SXD>!XO%'A
M-;SP[\1_#6M:K=Z-=ZG:2V[2K)>32&UG5PI>":-U!/(&X$<@B@#UWPE\1M_@
M6+Q#XOETOPTKSRPMOOAY";)6C7][($!+;,XP.N.U6O$?Q<\*>%;WPS::AK-I
M%-XCF:'3<3IMGVQF1G!)QL  &[U=!U85X+X>/B32M;^#'BCQ7X;U!-*73M5M
MM5L;2VEN?[(U&XDC>.5XD5F*[5GB#X( DY(#9/.:%X*U3X?R> M6N?#FKOX6
MM_B+J^HV.G06,MU/I^FW-I=);9@5"\2&5E;:5_=^8N[!!H ^KC\0/#*6S3MX
M@TM85G^S-(;V(*)?^>9.[[W^SUK*\9^,Y-.O-+L](U/0$O6U2VM[ZWU6]\MQ
M!)G*Q*N29F &Q3@-S7SG\2/V??$WB#QK\1/!F@0+IGA'Q:T'BZ/6 @Q9:M"F
MSRE)!PTDT-I,2.0BS#^(8=XATGQ#K/P]^'/C+Q!X5N8/%^I^-]*UC4;2#3I+
MN33[>,B(@[5+(HAC5CG&&=NIX(!ZA\0OVCK*T\+:WJ'@R?3M9N]!\06.BZC'
M<2DJ!//;Q.T80Y8J;E5R<#<CCG;@^JVWC/0+O3K^_M];TZ>RL':*[N8[N-H[
M=U ++(P.$(!&0<8S7R'\2?#LZ>!_CAX9G\*ZS-+J/CC3]3A-MI-Q*+ZRDFTZ
M64I(B%7P(KG(!RH3GDC.AXH\(:=!\2?BO96.E>)/#^CW\/AF:SOM T:;RX+V
MWFE;[2B"/RY%B+6AD4 Y"GCY20 ?1VJ?&KP5I5_X:M)/$>G2OXAN)+?3W@NH
MW20QQ-([;@V-H"A<_P!YT'\0K>C\:Z!/K<NC1:WITNKPJ7DL$NXS.B@ DF/.
MX !ESD?Q#UKY2T./Q38ZG\.=9\1>&9[N'2_'&I)-J>CZ).GV^"73IX8[U[3!
M:'?/(%;@+E=_1@3G:?<ZC<?$OP)JE]X-\26%EI'BW74U'3+?0)I;6WCN8;Q$
MG,I1I+@S%T=G1C$H;&U<+D ^NM.\<^'=7U&'3['7=,O+V: W$5O;WD<DDD0.
M#(J@Y*@\9'&:X#XB?&Y/"_Q+\ ^%M(GTG4WUO59-/U.'[4&NK)1;R2HPC4\9
M*8);\!SD?._PS\''PYHW[/\ >6/A.^TW6K77=8CO[D:'/%);^=;W<,3SGRP1
M%NGMOO$+M''"G$GA$:M=Q? &PU#P1XBL_%'A?798?$=S)HEPRB5K>9)+G[1L
M*R+-(1(75B.<G&!0!]7^%O&$ITR>X\1ZCH,$CZC<VUJVG7N^)XUE81*6?'[[
M:!O49PP.*V+?QIH%YH;ZU!K>G3:.A97U".[C:W4AMI!D!V@AN#SUXKXZB\+6
MNI>"-"TJ\\'ZA/9Q?%V\NA:3:!/Y::;)>3R+)L,>%@,<D63@+C@]"*I>(+>[
M\'W_ (PFL-'U6SM+?XHZ;JNF:=#I5PMO>1BV F*HL99DQ#,Q,2.0T:':1@T
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M2>U&K^*]$\-H[:KJ]AIB1PM.YO+E(0L:D!G.XC"@LH)Z D>M?.?P;^&NE_\
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M=X2LO WAC2] TUISI^FVZ6EL+B0R.L2#"*6/)PH !/. ,YJG>?#G0K[Q+?\
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M TOP1X0:;7+[Q+<ZEH2:O#="S+7=W:+%&SW<D4:C8#YB9&T?,X4 GBAOVC/
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MLL4H1XSAXV#8*2.I&>0QJ=M<'BSP%)JNC7EYIPO;#[5:7;6P2:(,FY&\N52
M>G#+7D?[,_QZU+Q5\+]>D^(5S;V_BSPDQ.LR1*$62W:(3P7*H  %>)N, 9*-
MP.E '=Z?\ ?".EZO)=V]K<):R:G_ &T=*^TN;(7V0?/$.<!MPWX^Z&^;&X U
MA?M1>!-:^(7@WP_IFAZ=<W\MOXAT_4;AK2YCMY(8()@\C([NF'P"%P>N.G6N
M<^ OQB\0ZCH7Q \1?$;5/LOV#Q,^DVNCPVZ$60*0O%;IY:>9-*3<*AR6)91M
M'<][?_M#>"M*T?7M0OKRZLQH5Q#;:I;3V,RW%FTQ B9XBN[8^X;7 *GL>#@
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M!/A=!I'B2R@L=5CU'4+F1;><S1N)[N6X5@Q).<2X.>X/;%>/ZKX?UCQ_XO\
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M !;:>"M5\.LESJOA;Q!;:U_9\D@B2^C5'CEBW'A7*2L5)XW 9P#D>M@48YH
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M>+OF7><GSXXMK-DY(P<U]7Z;X(\/Z)J=UJ6GZ+I]AJ-UGS[NVM4CEER<G<P
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M &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0
MM(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0
M*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E
M+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%
M :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!
M0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=
MZ4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH
M% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *
M>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM
M ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I
M:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0
M &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0
MT +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H-
MH- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z
M4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O
M0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "
MD[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:0
M4 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 I
MI!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.
M] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TI
MZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0
MTIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!
M0 M%%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T
M **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/
M2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3
MO0 II!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G
M>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI
M30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4
M)WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#T
MH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T
M*>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM
M "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%
M(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0
MHZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4T
MG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z
M4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "
MGI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3
MO0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0
M"D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6
MD%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T
M@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H
M- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#
M2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D%
M "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0
MM)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@
MT **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E
M/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H/2@4 )WI3TI.]*>E ""@
MT"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4
M(*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 &EI
M#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !WI:3O2T (*#0*#0 M(*6
MD%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0
MHZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M
M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D
M-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E
M%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*
M3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&
ME/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*
M4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@
MT"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM
M ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI
M#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2
M"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "
MT@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]
M*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ
M4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[TH
MI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>
MEI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2F
MD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T
M@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4
MI#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4
M (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%
M%%  >E H/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3
MO2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[T
MIZ4  I.]**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 I
MI!2FD% !WI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2
MD[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @
MH[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3
MTI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "
M&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(
M*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z
M#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44
M )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G
M>E'2D[T *:C296=T'5" >/49J0T@ - !WI:3O2T (*#0*#0 M(*6D%  :4=*
M0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04II!0 &EI#2T (*#0*#0 HZ4@I1TI
M!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0 M(*6D%  :6D-+0 E+24M ""@T"@T
M +2=Z6D[T *>E H/2@4 )WI3TI.]*>E  *0THI#0 M(*6D%  :6D-+0 @H-
MH- "BD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )W
MI3TI.]*>E  *3O2BD[T *>E(*4]*04 +1110 'I0*#TH% "=Z4]*3O2GI0 @
MH- H- "T@I:04 !I:0TM "=Z#1WH- "BD[THI.] "GI0*#TH% "&E/2D-*>E
M ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 !I
M:0TM ""@T"@T +24M)0 HZ4G>E'2D[T *:04II!0 =Z6D[TM ""@T"@T +2"
MEI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1TI.] "FD%*:04 !I:0TM ""@T"@T
M *.E(*4=*04 *:!TH- Z4 )WI32=Z4T (*.] H[T +2"EI!0 &EI#2T )2TE
M+0 @H- H- "TG>EI.] "GI0*#TH% "=Z4]*3O2GI0 "D-**0T +2"EI!0 &E
MI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !
MI12&E% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D% "T444 !Z4"@]*!0 G>E/
M2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G>@T=Z#0 HI.]**3O0 IZ4"@]*!0
MAI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI2
M"E/2D%  :6D-+0 @H- H- "TE+24 *.E)WI1TI.] "FD%*:04 '>EI.]+0 @
MH- H- "T@I:04 !I1TI#2CI0 G>E-)WI30 #I2=Z4=*3O0 II!2FD%  :6D-
M+0 @H- H- "CI2"E'2D% "F@=*#0.E "=Z4TG>E- ""CO0*.] "T@I:04 !I
M:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4"@]*!0 G>E/2D[TIZ4  I#2BD- "
MT@I:04 !I:0TM ""@T"@T **3O2BD[T *>E H/2@4 (:4]*0TIZ4 (*#0*#0
M M(*6D%  :44AI10 G>E/2D[TIZ4  I.]**3O0 IZ4@I3TI!0 M%%%  >E H
M/2@4 )WI3TI.]*>E ""@T"@T +2"EI!0 &EI#2T )WH-'>@T **3O2BD[T *
M>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.]
M**3O0 IZ4@I3TI!0 &EI#2T (*#0*#0 M)2TE "CI2=Z4=*3O0 II!2FD% !
MWI:3O2T (*#0*#0 M(*6D%  :4=*0THZ4 )WI32=Z4T  Z4G>E'2D[T *:04
MII!0 &EI#2T (*#0*#0 HZ4@I1TI!0 IH'2@T#I0 G>E-)WI30 @H[T"CO0
MM(*6D%  :6D-+0 E+24M ""@T"@T +2=Z6D[T *>E H/2@4 )WI3TI.]*>E
M *0THI#0 M(*6D%  :6D-+0 @H- H- "BD[THI.] "GI0*#TH% "&E/2D-*>
ME ""@T"@T +2"EI!0 &E%(:44 )WI3TI.]*>E  *3O2BD[T *>E(*4]*04 +
M1110 'I0*#TH% "=Z4]*3O2GI0 @H- H- "T@I:04 !I:0TM "=Z#1WH- "B
MD[THI.] "GI0*#TH% "&E/2D-*>E ""@T"@T +2"EI!0 &E%(:44 )WI3TI.
M]*>E  *3O2BD[T *>E(*4]*04 !I:0TM ""@T"@T +24M)0 HZ4G>E'2D[T
M*:04II!0 =Z6D[TM ""@T"@T +2"EI!0 &E'2D-*.E "=Z4TG>E-  .E)WI1
MTI.] "FD%*:04 !I:0TM ""@T"@T *.E(*4=*04 *:!TH- Z4 )WI32=Z4T
M(*.] H[T +2"EI!0 &EI#2T )2TE+0 @H- H- "TG>EI.] "GI0*#TH% "=Z
M4]*3O2GI0 "D-**0T +2"EI!0 &EI#2T (*#0*#0 HI.]**3O0 IZ4"@]*!0
M AI3TI#2GI0 @H- H- "T@I:04 !I12&E% "=Z4]*3O2GI0 "D[THI.] "GI
M2"E/2D% "T444 !Z4"@]*!0 G>E/2D[TIZ4 (*#0*#0 M(*6D%  :6D-+0 G
M>@T=Z#0 HI.]**3O0 IZ4"@]*!0 AI3TI#2GI0 @H- H- "T@I:04 !I12&E
M% "=Z4]*3O2GI0 "D[THI.] "GI2"E/2D%  :6D-+0 @H- H- "TE+24 *.E
M)WI1TI.] "FD%*:04 '>EI.]+0 @H- H- "T@I:04 !I1TI#2CI0 G>E-)WI
M30 #I2=Z4=*3O0 II!2FD%  :6D-+0 @H- H- "CI2"E'2D% "F@=*#0.E "
M=Z4TG>E- ""CO0*.] "T@I:04 !I:0TM "4M)2T (*#0*#0 M)WI:3O0 IZ4
M"@]*!0 G>E/2D[TIZ4  I#2BD- "T@I:04 !I:0TM ""@T"@T **3O2BD[T
M*>E H/2@4 (:4]*0TIZ4 (*#0*#0 M(*6D%  :44AI10 G>E/2D[TIZ4  I.
4]**3O0 IZ4@I3TI!0 M%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>20
<FILENAME>mmsi-20221231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/24/2023 8:59:49 PM-->
<!--Modified on: 2/24/2023 8:59:49 PM-->
<xsd:schema targetNamespace="http://www.merit.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:mmsi="http://www.merit.com/20221231" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:attributeFormDefault="unqualified" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>00100 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfIncome" id="StatementConsolidatedStatementsOfIncome">
        <link:definition>00200 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" id="StatementConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails">
        <link:definition>40105 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails">
        <link:definition>40106 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" id="DisclosureAcquisitionsPurchasePriceAllocationDetails">
        <link:definition>40303 - Disclosure - Acquisitions - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureInventoriesDetails" id="DisclosureInventoriesDetails">
        <link:definition>40401 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" id="DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails">
        <link:definition>40502 - Disclosure - Goodwill and Intangible Assets - Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails" id="DisclosureIncomeTaxesDomesticAndForeignDetails">
        <link:definition>40601 - Disclosure - Income Taxes - Domestic and Foreign (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" id="DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails">
        <link:definition>40602 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" id="DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>40603 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>40604 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAccruedExpensesDetails" id="DisclosureAccruedExpensesDetails">
        <link:definition>40701 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" id="DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails">
        <link:definition>40801 - Disclosure - Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" id="DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails">
        <link:definition>40804 - Disclosure - Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" id="DisclosureEarningsPerCommonShareEpsDilutedEpsDetails">
        <link:definition>41102 - Disclosure - Earnings Per Common Share (EPS) - Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" id="DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails">
        <link:definition>41303 - Disclosure - Segment Reporting and Foreign Operations - Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2" id="DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2">
        <link:definition>41409 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" id="DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails">
        <link:definition>41601 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" id="DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails">
        <link:definition>41702 - Disclosure - Leases - Schedule of Consolidated Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails" id="DisclosureLeasesComponentsOfLeaseCostDetails">
        <link:definition>41703 - Disclosure - Leases - Components of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" id="DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
        <link:definition>41706 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity" id="StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables" id="DisclosureAcquisitionsAndOtherStrategicTransactionsTables">
        <link:definition>30303 - Disclosure - Acquisitions and Other Strategic Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables">
        <link:definition>31203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails">
        <link:definition>40102 - Disclosure - Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <link:definition>40103 - Disclosure - Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails" id="DisclosureRevenuesDisaggregationOfRevenueDetails">
        <link:definition>40201 - Disclosure - Revenues - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" id="DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails">
        <link:definition>40301 - Disclosure - Acquisitions and Other Strategic Transactions - Asset Purchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" id="DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails">
        <link:definition>40302 - Disclosure - Acquisitions and Other Strategic Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" id="DisclosureGoodwillAndIntangibleAssetsNarrativeDetails">
        <link:definition>40503 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails" id="DisclosureIncomeTaxesNarrativeDetails">
        <link:definition>40605 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" id="DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails">
        <link:definition>40802 - Disclosure - Revolving Credit Facility and Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" id="DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails">
        <link:definition>40803 - Disclosure - Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivativesNarrativeDetails" id="DisclosureDerivativesNarrativeDetails">
        <link:definition>40901 - Disclosure - Derivatives - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails" id="DisclosureDerivativesForwardNotionalContractsDetails">
        <link:definition>40902 - Disclosure - Derivatives - Forward Notional Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" id="DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails">
        <link:definition>40903 - Disclosure - Derivatives - Fair Value of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" id="DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails">
        <link:definition>40904 - Disclosure - Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" id="DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails">
        <link:definition>40905 - Disclosure - Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" id="DisclosureCommitmentsAndContingenciesNarrativeDetails">
        <link:definition>41001 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails">
        <link:definition>41201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails">
        <link:definition>41202 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails">
        <link:definition>41203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails">
        <link:definition>41205 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails">
        <link:definition>41206 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" id="DisclosureSegmentReportingAndForeignOperationsNarrativeDetails">
        <link:definition>41301 - Disclosure - Segment Reporting and Foreign Operations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" id="DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails">
        <link:definition>41302 - Disclosure - Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" id="DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails">
        <link:definition>41304 - Disclosure - Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeBenefitPlansDetails" id="DisclosureEmployeeBenefitPlansDetails">
        <link:definition>41401 - Disclosure - Employee Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" id="DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails">
        <link:definition>41501 - Disclosure - Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" id="DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails">
        <link:definition>41502 - Disclosure - Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails" id="DisclosureFairValueMeasurementsNarrativeDetails">
        <link:definition>41503 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" id="DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails">
        <link:definition>41504 - Disclosure - Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails" id="DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails">
        <link:definition>41505 - Disclosure - Fair Value Measurements - Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesNarrativeDetails" id="DisclosureLeasesNarrativeDetails">
        <link:definition>41701 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails" id="ScheduleScheduleIiValuationAndQualifyingAccountsDetails">
        <link:definition>41801 - Schedule - Schedule II - Valuation and qualifying accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DocumentCoverPage" id="DocumentCoverPage">
        <link:definition>00090 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" id="StatementConsolidatedStatementsOfCashFlowsParenthetical">
        <link:definition>00505 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>10101 - Disclosure - Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevenues" id="DisclosureRevenues">
        <link:definition>10201 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions" id="DisclosureAcquisitionsAndOtherStrategicTransactions">
        <link:definition>10301 - Disclosure - Acquisitions and Other Strategic Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureInventories" id="DisclosureInventories">
        <link:definition>10401 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets" id="DisclosureGoodwillAndIntangibleAssets">
        <link:definition>10501 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>10601 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAccruedExpenses" id="DisclosureAccruedExpenses">
        <link:definition>10701 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt" id="DisclosureRevolvingCreditFacilityAndLongTermDebt">
        <link:definition>10801 - Disclosure - Revolving Credit Facility and Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivatives" id="DisclosureDerivatives">
        <link:definition>10901 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>11001 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEps" id="DisclosureEarningsPerCommonShareEps">
        <link:definition>11101 - Disclosure - Earnings Per Common Share (EPS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants">
        <link:definition>11201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations" id="DisclosureSegmentReportingAndForeignOperations">
        <link:definition>11301 - Disclosure - Segment Reporting and Foreign Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeBenefitPlans" id="DisclosureEmployeeBenefitPlans">
        <link:definition>11401 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>11501 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss" id="DisclosureAccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>11601 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeases" id="DisclosureLeases">
        <link:definition>11701 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts" id="DisclosureScheduleIiValuationAndQualifyingAccounts">
        <link:definition>11801 - Disclosure - Schedule II - Valuation and qualifying accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>20102 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>30103 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevenuesTables" id="DisclosureRevenuesTables">
        <link:definition>30203 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureInventoriesTables" id="DisclosureInventoriesTables">
        <link:definition>30403 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables" id="DisclosureGoodwillAndIntangibleAssetsTables">
        <link:definition>30503 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>30603 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAccruedExpensesTables" id="DisclosureAccruedExpensesTables">
        <link:definition>30703 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables" id="DisclosureRevolvingCreditFacilityAndLongTermDebtTables">
        <link:definition>30803 - Disclosure - Revolving Credit Facility and Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureDerivativesTables" id="DisclosureDerivativesTables">
        <link:definition>30903 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables" id="DisclosureEarningsPerCommonShareEpsTables">
        <link:definition>31103 - Disclosure - Earnings Per Common Share (EPS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables" id="DisclosureSegmentReportingAndForeignOperationsTables">
        <link:definition>31303 - Disclosure - Segment Reporting and Foreign Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>31503 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables" id="DisclosureAccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>31603 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>31703 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails">
        <link:definition>40101 - Disclosure - Organization and Summary of Significant Accounting Policies - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails">
        <link:definition>40104 - Disclosure - Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" id="DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails">
        <link:definition>40107 - Disclosure - Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails" id="DisclosureGoodwillAndIntangibleAssetsGoodwillDetails">
        <link:definition>40501 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails" id="DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails">
        <link:definition>40504 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails" id="DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails">
        <link:definition>40606 - Disclosure - Income Taxes - Summary of Income Tax Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails" id="DisclosureEarningsPerCommonShareEpsBasicEpsDetails">
        <link:definition>41101 - Disclosure - Earnings Per Common Share (EPS) - Basic EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails" id="DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails">
        <link:definition>41204 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails" id="DisclosureLeasesSupplementalCashFlowInformationDetails">
        <link:definition>41704 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails" id="DisclosureLeasesSupplementalDisclosureDetails">
        <link:definition>41705 - Disclosure - Leases - Supplemental Disclosure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.merit.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xsd:element name="AcquisitionOfDevelopedTechnologyInAccruedExpenses" id="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AssetsAndLiabilitiesLesseeTableTextBlock" id="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" id="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" id="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="CardiovascularSegmentMember" id="mmsi_CardiovascularSegmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" id="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CiannaMedicalMember" id="mmsi_CiannaMedicalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContingentConsiderationMember" id="mmsi_ContingentConsiderationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CreditAgreementMember" id="mmsi_CreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EndoscopyDevicesMember" id="mmsi_EndoscopyDevicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EndoscopySegmentMember" id="mmsi_EndoscopySegmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FluidxMedicalTechnologyLLCMember" id="mmsi_FluidxMedicalTechnologyLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" id="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" id="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LesseeOperatingLeaseTerminationPeriod" id="mmsi_LesseeOperatingLeaseTerminationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" id="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" id="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" id="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MilestonePaymentProbabilityMember" id="mmsi_MilestonePaymentProbabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RegulatoryApprovalMilestoneMember" id="mmsi_RegulatoryApprovalMilestoneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RevenueBasedPaymentsMember" id="mmsi_RevenueBasedPaymentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RevenueMilestonesMember" id="mmsi_RevenueMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" id="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockSurrenderedDuringPeriodSharesStockOptionsExercised" id="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" id="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="StockSurrenderedDuringPeriodValueStockOptionsExercised" id="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" id="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="STDPharmaceuticalProductsLimitedMember" id="mmsi_STDPharmaceuticalProductsLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseLiabilityForUncertainTaxPositions" id="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DeferredCompensationPolicyTextBlockPolicyTextBlock" id="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OtherAssetsPolicyTextBlockPolicyTextBlock" id="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConcentrationOfCreditRiskPolicyTextBlock" id="mmsi_ConcentrationOfCreditRiskPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LauraneMedicalS.A.S.Member" id="mmsi_LauraneMedicalS.A.S.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NinePointMedicalInc.Member" id="mmsi_NinePointMedicalInc.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FusionMedicalInc.Member" id="mmsi_FusionMedicalInc.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredTaxLiabilitiesForeignWithholdingTax" id="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="NetOperatingLossCarryforwardsUtilization" id="mmsi_NetOperatingLossCarryforwardsUtilization" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NetOperatingLossCarryforwardsUsedInCurrentPeriod" id="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" id="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AdvancesFromEmployeesCurrent" id="mmsi_AdvancesFromEmployeesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" id="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FairValueOfStockOptionOnGrantDateNetOfForfeitures" id="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="NonUSExcludingIrelandMember" id="mmsi_NonUSExcludingIrelandMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermIncentivePlan2018Member" id="mmsi_LongTermIncentivePlan2018Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeeStockPurchasePlanMember" id="mmsi_EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" id="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AccruedRebatesPayableCurrent" id="mmsi_AccruedRebatesPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="SelioMedicalLimitedSelioMember" id="mmsi_SelioMedicalLimitedSelioMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RevenueAndCostOfSalesMember" id="mmsi_RevenueAndCostOfSalesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfLongTermDebtCovenantsTableTableTextBlock" id="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" id="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" id="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="GoodwillPurchaseAccountingAdjustmentsAndAdditions" id="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" id="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DerivativeAverageNumberOfContractsEnteredIntoPerMonth" id="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" id="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" id="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" id="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PeripheralInterventionMember" id="mmsi_PeripheralInterventionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CardiacInterventionMember" id="mmsi_CardiacInterventionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CustomProceduralSolutionsMember" id="mmsi_CustomProceduralSolutionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OEMMember" id="mmsi_OEMMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" id="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" id="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" id="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" id="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="NumberOfProductCategories" id="mmsi_NumberOfProductCategories" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WellsFargoFixedRateDerivativeContractOneMember" id="mmsi_WellsFargoFixedRateDerivativeContractOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WellsFargoFixedRateDerivativeContractTwoMember" id="mmsi_WellsFargoFixedRateDerivativeContractTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BluegrassVascularTechnologiesIncMember" id="mmsi_BluegrassVascularTechnologiesIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashSettledPerformanceSharesMember" id="mmsi_CashSettledPerformanceSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PotentialSharesGrantedDuringPeriodIncreaseDecrease" id="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" id="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="LicenseAgreementArravascLimitedMember" id="mmsi_LicenseAgreementArravascLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="KaMedicalLLCMember" id="mmsi_KaMedicalLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BusinessCombinationConsiderationTransferredNotePayable" id="mmsi_BusinessCombinationConsiderationTransferredNotePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="OtherIntangibleAssetsAcquiredMember" id="mmsi_OtherIntangibleAssetsAcquiredMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" id="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" id="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" id="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" id="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" id="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" id="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccruedLegalSettlementCurrent" id="mmsi_AccruedLegalSettlementCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="TargetMember" id="mmsi_TargetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MaximumUnitsGrantedMember" id="mmsi_MaximumUnitsGrantedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MaximumPotentialSharesGrantedMember" id="mmsi_MaximumPotentialSharesGrantedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" id="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" id="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" id="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RestoreEndosystemsLLCMember" id="mmsi_RestoreEndosystemsLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContingentConsiderationPaymentOneMember" id="mmsi_ContingentConsiderationPaymentOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContingentConsiderationPaymentTwoMember" id="mmsi_ContingentConsiderationPaymentTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContingentConsiderationPaymentPeriod" id="mmsi_ContingentConsiderationPaymentPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BiotraceMedicalIncMember" id="mmsi_BiotraceMedicalIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" id="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" id="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="IncomeTaxExpenseBenefitRestructuringOfForeignEntities" id="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="XableCathMember" id="mmsi_XableCathMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MeritShareholderDerivativeSuitMember" id="mmsi_MeritShareholderDerivativeSuitMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" id="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>mmsi-20221231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/24/2023 8:59:49 PM-->
<!--Modified on: 2/24/2023 8:59:49 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfIncome" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsPurchasePriceAllocationDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureInventoriesDetails" roleURI="http://www.merit.com/role/DisclosureInventoriesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesDomesticAndForeignDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccruedExpensesDetails" roleURI="http://www.merit.com/role/DisclosureAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2" roleURI="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" roleURI="http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesComponentsOfLeaseCostDetails" roleURI="http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" roleURI="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <calculationLink xlink:role="http://www.merit.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="us-gaap_AssetsCurrent_638128691854669221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691854669221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_AccountsReceivableNetCurrent_638128691854669221" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_NontradeReceivablesCurrent_638128691854669221" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_InventoryNet_638128691854669221" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638128691854669221" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_PrepaidTaxes_638128691854669221" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638128691854669221" xlink:to="us-gaap_IncomeTaxesReceivable_638128691854669221" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638128691854669221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638128691854669221" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet_638128691854669221" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land" xlink:label="us-gaap_Land_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" xlink:to="us-gaap_Land_638128691854679219" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="us-gaap_BuildingsAndImprovementsGross_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" xlink:to="us-gaap_BuildingsAndImprovementsGross_638128691854679219" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="us-gaap_MachineryAndEquipmentGross_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" xlink:to="us-gaap_MachineryAndEquipmentGross_638128691854679219" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" xlink:to="us-gaap_FurnitureAndFixturesGross_638128691854679219" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" xlink:to="us-gaap_LeaseholdImprovementsGross_638128691854679219" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross_638128691854679219" xlink:to="us-gaap_ConstructionInProgressGross_638128691854679219" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638128691854679219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet_638128691854669221" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638128691854679219" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638128691854689224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" xlink:to="us-gaap_Goodwill_638128691854689224" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_638128691854689224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_638128691854689224" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_638128691854689224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" xlink:to="us-gaap_OtherAssetsNoncurrent_638128691854689224" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638128691854689224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638128691854689224" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638128691854689224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691854689224" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638128691854689224" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_638128691854699216" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_LiabilitiesCurrent_638128691854699216" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638128691854699216" xlink:to="us-gaap_AccountsPayableTradeCurrent_638128691854699216" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638128691854699216" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638128691854699216" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638128691854699216" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638128691854699216" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638128691854699216" xlink:to="us-gaap_LongTermDebtCurrent_638128691854699216" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638128691854699216" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638128691854699216" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638128691854699216" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_638128691854709222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_LongTermDebtNoncurrent_638128691854709222" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691854709222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691854709222" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_638128691854709222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_638128691854709222" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_638128691854709222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_638128691854709222" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_638128691854709222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_638128691854709222" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638128691854709222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638128691854709222" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_638128691854719221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent_638128691854719221" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691854719221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638128691854699216" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691854719221" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638128691854719221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies_638128691854719221" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638128691854719221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_638128691854719221" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638128691854719221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638128691854719221" xlink:to="us-gaap_CommonStockValue_638128691854719221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638128691854729221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638128691854719221" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638128691854729221" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_638128691854729221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638128691854719221" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_638128691854729221" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638128691854729221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638128691854719221" xlink:to="us-gaap_PreferredStockValue_638128691854729221" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfIncome" xlink:type="extended" xlink:title="00200 - Statement - CONSOLIDATED STATEMENTS OF INCOME" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691854729221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691854729221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638128691854729221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691854729221" xlink:to="us-gaap_OperatingIncomeLoss_638128691854729221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638128691854729221" xlink:to="us-gaap_GrossProfit_638128691854739221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit_638128691854739221" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691854739221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit_638128691854739221" xlink:to="us-gaap_CostOfGoodsAndServicesSold_638128691854739221" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638128691854729221" xlink:to="us-gaap_OperatingExpenses_638128691854739221" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638128691854739221" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_638128691854739221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638128691854739221" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_638128691854739221" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:label="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638128691854739221" xlink:to="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_638128691854739221" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638128691854739221" xlink:to="us-gaap_LitigationSettlementExpense_638128691854739221" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges_638128691854739221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638128691854739221" xlink:to="us-gaap_AssetImpairmentCharges_638128691854739221" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691854749219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638128691854739221" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691854749219" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638128691854749219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691854729221" xlink:to="us-gaap_NonoperatingIncomeExpense_638128691854749219" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet_638128691854749219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638128691854749219" xlink:to="us-gaap_InvestmentIncomeNet_638128691854749219" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_638128691854749219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638128691854749219" xlink:to="us-gaap_InterestExpense_638128691854749219" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638128691854749219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense_638128691854749219" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638128691854749219" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638128691854749219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638128691854749219" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" xlink:title="00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLoss_638128691854759218" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691854759218" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691854759218" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_638128691854759218" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691854759218" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_638128691854759218" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691854759218" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_638128691854759218" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691854759218" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_638128691854759218" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691854759218" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691854759218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691854759218" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638128691854769225" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_NetIncomeLoss_638128691854769225" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_DepreciationDepletionAndAmortization_638128691854769225" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="us-gaap_GainLossOnSaleOfBusiness_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_GainLossOnSaleOfBusiness_638128691854769225" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_GainLossOnDispositionOfAssets_638128691854769225" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment_638128691854769225" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_638128691854769225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_638128691854769225" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_638128691854779219" order="6" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638128691854779219" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_AmortizationOfFinancingCosts_638128691854779219" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854779219" order="9" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_ShareBasedCompensation_638128691854779219" order="10" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_638128691854779219" order="11" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_638128691854779219" order="12" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_638128691854779219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInInventories_638128691854779219" order="13" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638128691854789220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638128691854789220" order="14" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_638128691854789220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_638128691854789220" order="15" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_638128691854789220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_638128691854789220" order="16" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_638128691854789220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_638128691854789220" order="17" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_638128691854789220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_638128691854789220" order="18" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638128691854789220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638128691854789220" order="19" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638128691854799221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638128691854799221" order="20" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions" xlink:label="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_638128691854799221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_638128691854799221" order="21" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_638128691854799221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_638128691854799221" order="22" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638128691854799221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638128691854799221" order="23" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691854799221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691854799221" order="24" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_638128691854799221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691854769225" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_638128691854799221" order="25" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638128691854809222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638128691854809222" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_638128691854809222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_638128691854809222" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_638128691854809222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_638128691854809222" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_638128691854809222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_638128691854809222" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable_638128691854809222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable_638128691854809222" order="5" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_638128691854819225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_638128691854819225" order="6" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_638128691854819225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691854809222" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_638128691854819225" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638128691854819225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638128691854819225" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_638128691854819225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_638128691854819225" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt_638128691854819225" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" xlink:to="us-gaap_RepaymentsOfLongTermDebt_638128691854819225" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_638128691854829220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_638128691854829220" order="4" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" xlink:label="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_638128691854829220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691854819225" xlink:to="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_638128691854829220" order="5" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638128691854829220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638128691854829220" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="extended" xlink:title="40105 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_638128691854839218" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="us-gaap_DeferredCompensationPlanAssets_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_DeferredCompensationPlanAssets_638128691854839218" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_638128691854839218" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent_638128691854839218" order="4" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" xlink:type="extended" xlink:title="40106 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691854839218" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLongTermDebt_638128691854839218" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Acquisitions - Purchase Price Allocation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_638128691854839218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_638128691854839218" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_638128691854839218" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_638128691854849221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_638128691854839218" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_638128691854849221" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_638128691854849221" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_638128691854849221" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_638128691854849221" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_638128691854849221" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="us-gaap_Goodwill_638128691854849221" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_638128691854849221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_638128691854849221" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_638128691854859221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691854849221" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_638128691854859221" order="7" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureInventoriesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Inventories (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_638128691854859221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_638128691854859221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_638128691854859221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_638128691854859221" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_638128691854859221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_638128691854859221" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Goodwill and Intangible Assets - Other Intangible Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="FiniteLivedIntangibleAssetsNet" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_638128691854859221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_638128691854859221" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638128691854859221" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638128691854859221" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Income Taxes - Domestic and Foreign (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_638128691854869224" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_638128691854869224" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691854869224" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691854869224" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_638128691854869224" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691854869224" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638128691854869224" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691854869224" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_638128691854869224" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854869224" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854869224" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854869224" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638128691854879222" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854869224" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638128691854879222" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691854869224" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_638128691854879222" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended" xlink:title="40603 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_638128691854879222" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_638128691854879222" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_638128691854879222" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_638128691854879222" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies_638128691854879222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingencies_638128691854879222" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:label="us-gaap_IncomeTaxReconciliationTaxExemptIncome_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxExemptIncome_638128691854889218" order="6" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_638128691854889218" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_638128691854889218" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_638128691854889218" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_638128691854889218" order="10" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_638128691854889218" order="11" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_638128691854889218" order="12" use="optional" weight="-1" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements_638128691854889218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxSettlements_638128691854889218" order="13" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="40604 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_638128691854899223" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_638128691854899223" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInventory_638128691854899223" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638128691854899223" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638128691854899223" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_638128691854899223" order="6" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" xlink:label="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_638128691854899223" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" xlink:label="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_638128691854899223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_638128691854899223" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" xlink:label="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_638128691854909220" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther_638128691854909220" order="10" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpense_638128691854909220" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_638128691854909220" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_638128691854909220" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxLiabilitiesForeignWithholdingTax" xlink:label="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_638128691854909220" order="4" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_638128691854909220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_638128691854909220" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_638128691854919222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_638128691854919222" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_638128691854919222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_638128691854919222" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691854919222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691854919222" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureAccruedExpensesDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Accrued Expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_638128691854919222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_638128691854919222" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_638128691854919222" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_638128691854919222" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AdvancesFromEmployeesCurrent" xlink:label="mmsi_AdvancesFromEmployeesCurrent_638128691854929220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="mmsi_AdvancesFromEmployeesCurrent_638128691854929220" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AccruedLegalSettlementCurrent" xlink:label="mmsi_AccruedLegalSettlementCurrent_638128691854929220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="mmsi_AccruedLegalSettlementCurrent_638128691854929220" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AccruedRebatesPayableCurrent" xlink:label="mmsi_AccruedRebatesPayableCurrent_638128691854929220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="mmsi_AccruedRebatesPayableCurrent_638128691854929220" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_638128691854929220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_638128691854929220" order="6" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_638128691854929220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent_638128691854929220" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_638128691854929220" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent_638128691854929220" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" xlink:type="extended" xlink:title="40804 - Disclosure - Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="DebtInstrumentCarryingAmount" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_638128691854939218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_638128691854939218" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_638128691854939218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_638128691854939218" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Earnings Per Common Share (EPS) - Diluted EPS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691854939218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691854939218" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638128691854939218" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638128691854939218" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" xlink:type="extended" xlink:title="41303 - Disclosure - Segment Reporting and Foreign Operations - Operating Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638128691855119223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_638128691855119223" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638128691855119223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense_638128691855119223" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638128691855129219" order="3" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2" xlink:type="extended" xlink:title="41409 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Calc 2)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638128691855129219" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability_638128691855129219" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_638128691855129219" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_638128691855129219" order="2" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_Revenues_638128691855129219" order="3" use="optional" weight="1" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_638128691855129219" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_CostOfGoodsAndServicesSold_638128691855129219" order="4" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_638128691855139229" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_InterestExpense_638128691855139229" order="5" use="optional" weight="-1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Leases - Schedule of Consolidated Balance Sheet Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638128691855139229" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638128691855139229" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691855139229" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691855139229" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails" xlink:type="extended" xlink:title="41703 - Disclosure - Leases - Components of Lease Cost (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense_638128691855139229" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="us-gaap_OperatingLeaseExpense_638128691855139229" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome_638128691855139229" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="us-gaap_SubleaseIncome_638128691855139229" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="41706 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638128691855149223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638128691855149223" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_638128691855149223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_638128691855149223" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638128691855149223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638128691855149223" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_638128691855149223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_638128691855149223" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_638128691855149223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_638128691855149223" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_638128691855149223" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_638128691855149223" order="6" use="optional" weight="1" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>22
<FILENAME>mmsi-20221231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/24/2023 8:59:49 PM-->
<!--Modified on: 2/24/2023 8:59:49 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedBalanceSheetsParenthetical" roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactionsTables" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevenuesDisaggregationOfRevenueDetails" roleURI="http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsPurchasePriceAllocationDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesForwardNotionalContractsDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureCommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureLeasesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#ScheduleScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://www.merit.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureStandardAndCustomAxisDomainDefaults" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:label="BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:title="BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementAbstract" xlink:to="BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:title="definition: IncomeStatementAbstract to BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" use="optional" priority="0" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" xlink:title="us-gaap_AssetImpairmentCharges" />
    <link:definitionArc xlink:type="arc" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_AssetImpairmentCharges" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:IncomeStatementAbstract To us-gaap_AssetImpairmentCharges" order="2" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" xlink:title="us-gaap_LiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_LiabilitiesAbstract To us-gaap_OperatingLeaseLiabilityCurrent" order="1" priority="0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:title="definition:us-gaap_LiabilitiesAbstract To us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.merit.com/role/DisclosureStandardAndCustomAxisDomainDefaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="CumulativeEffectPeriodOfAdoptionAxis" xlink:title="CumulativeEffectPeriodOfAdoptionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="CumulativeEffectPeriodOfAdoptionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CumulativeEffectPeriodOfAdoptionAxis" xlink:to="CumulativeEffectPeriodOfAdoptionDomain" xlink:title="definition: CumulativeEffectPeriodOfAdoptionAxis to CumulativeEffectPeriodOfAdoptionDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain" xlink:title="definition: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="EquityInterestIssuedOrIssuableByTypeAxis" xlink:title="EquityInterestIssuedOrIssuableByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="EquityInterestIssuedOrIssuableTypeDomain" xlink:title="EquityInterestIssuedOrIssuableTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="EquityInterestIssuedOrIssuableTypeDomain" xlink:title="definition: EquityInterestIssuedOrIssuableByTypeAxis to EquityInterestIssuedOrIssuableTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="definition: VestingAxis to VestingDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="ValuationTechniqueAxis" xlink:title="ValuationTechniqueAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="ValuationTechniqueDomain" xlink:title="ValuationTechniqueDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ValuationTechniqueAxis" xlink:to="ValuationTechniqueDomain" xlink:title="definition: ValuationTechniqueAxis to ValuationTechniqueDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis" xlink:label="GranteeStatusAxis" xlink:title="GranteeStatusAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain" xlink:label="GranteeStatusDomain" xlink:title="GranteeStatusDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="GranteeStatusAxis" xlink:to="GranteeStatusDomain" xlink:title="definition: GranteeStatusAxis to GranteeStatusDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:label="UnusualRiskOrUncertaintyByNatureAxis" xlink:title="UnusualRiskOrUncertaintyByNatureAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:label="UnusualRiskOrUncertaintyNatureDomain" xlink:title="UnusualRiskOrUncertaintyNatureDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualRiskOrUncertaintyByNatureAxis" xlink:to="UnusualRiskOrUncertaintyNatureDomain" xlink:title="definition: UnusualRiskOrUncertaintyByNatureAxis to UnusualRiskOrUncertaintyNatureDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="RestatementAxis" xlink:title="RestatementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="RestatementDomain" xlink:title="RestatementDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RestatementAxis" xlink:to="RestatementDomain" xlink:title="definition: RestatementAxis to RestatementDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="StatementGeographicalAxis" xlink:title="StatementGeographicalAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="SegmentGeographicalDomain" xlink:title="SegmentGeographicalDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementGeographicalAxis" xlink:to="SegmentGeographicalDomain" xlink:title="definition: StatementGeographicalAxis to SegmentGeographicalDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain" xlink:title="definition: VariableRateAxis to VariableRateDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="DerivativeInstrumentRiskAxis" xlink:title="DerivativeInstrumentRiskAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="DerivativeContractTypeDomain" xlink:title="DerivativeContractTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DerivativeInstrumentRiskAxis" xlink:to="DerivativeContractTypeDomain" xlink:title="definition: DerivativeInstrumentRiskAxis to DerivativeContractTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="HedgingDesignationAxis" xlink:title="HedgingDesignationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="HedgingDesignationDomain" xlink:title="HedgingDesignationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="HedgingDesignationAxis" xlink:to="HedgingDesignationDomain" xlink:title="definition: HedgingDesignationAxis to HedgingDesignationDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:title="DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="HedgingRelationshipDomain" xlink:title="HedgingRelationshipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="HedgingRelationshipDomain" xlink:title="definition: DerivativeInstrumentsGainLossByHedgingRelationshipAxis to HedgingRelationshipDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain" xlink:title="definition: BalanceSheetLocationAxis to BalanceSheetLocationDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="LitigationCaseAxis" xlink:title="LitigationCaseAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="LitigationCaseTypeDomain" xlink:title="LitigationCaseTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LitigationCaseAxis" xlink:to="LitigationCaseTypeDomain" xlink:title="definition: LitigationCaseAxis to LitigationCaseTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="ConcentrationRiskByBenchmarkAxis" xlink:title="ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="ConcentrationRiskBenchmarkDomain" xlink:title="ConcentrationRiskBenchmarkDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConcentrationRiskByBenchmarkAxis" xlink:to="ConcentrationRiskBenchmarkDomain" xlink:title="definition: ConcentrationRiskByBenchmarkAxis to ConcentrationRiskBenchmarkDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="ConcentrationRiskByTypeAxis" xlink:title="ConcentrationRiskByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="ConcentrationRiskTypeDomain" xlink:title="ConcentrationRiskTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConcentrationRiskByTypeAxis" xlink:to="ConcentrationRiskTypeDomain" xlink:title="definition: ConcentrationRiskByTypeAxis to ConcentrationRiskTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis" xlink:label="RetirementPlanSponsorLocationAxis" xlink:title="RetirementPlanSponsorLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain" xlink:label="RetirementPlanSponsorLocationDomain" xlink:title="RetirementPlanSponsorLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RetirementPlanSponsorLocationAxis" xlink:to="RetirementPlanSponsorLocationDomain" xlink:title="definition: RetirementPlanSponsorLocationAxis to RetirementPlanSponsorLocationDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="FairValueByMeasurementBasisAxis" xlink:title="FairValueByMeasurementBasisAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="PortionAtFairValueFairValueDisclosureMember" xlink:title="PortionAtFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByMeasurementBasisAxis" xlink:to="PortionAtFairValueFairValueDisclosureMember" xlink:title="definition: FairValueByMeasurementBasisAxis to PortionAtFairValueFairValueDisclosureMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain" xlink:title="definition: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="FairValueByAssetClassAxis" xlink:title="FairValueByAssetClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:title="FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByAssetClassAxis" xlink:to="FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:title="definition: FairValueByAssetClassAxis to FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="DisposalGroupClassificationAxis" xlink:title="DisposalGroupClassificationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="DisposalGroupClassificationDomain" xlink:title="DisposalGroupClassificationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DisposalGroupClassificationAxis" xlink:to="DisposalGroupClassificationDomain" xlink:title="definition: DisposalGroupClassificationAxis to DisposalGroupClassificationDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:title="ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:title="ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:title="definition: ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis to ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain" xlink:title="definition: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="MajorCustomersAxis" xlink:title="MajorCustomersAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="NameOfMajorCustomerDomain" xlink:title="NameOfMajorCustomerDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MajorCustomersAxis" xlink:to="NameOfMajorCustomerDomain" xlink:title="definition: MajorCustomersAxis to NameOfMajorCustomerDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="definition: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentAxis" xlink:label="FinancingReceivablePortfolioSegmentAxis" xlink:title="FinancingReceivablePortfolioSegmentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablePortfolioSegmentDomain" xlink:label="FinancingReceivablePortfolioSegmentDomain" xlink:title="FinancingReceivablePortfolioSegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FinancingReceivablePortfolioSegmentAxis" xlink:to="FinancingReceivablePortfolioSegmentDomain" xlink:title="definition: FinancingReceivablePortfolioSegmentAxis to FinancingReceivablePortfolioSegmentDomain" use="optional" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_OtherIntangibleAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NontradeReceivablesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidTaxes" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land" xlink:label="us-gaap_Land" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_Land" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="us-gaap_BuildingsAndImprovementsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_BuildingsAndImprovementsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="us-gaap_MachineryAndEquipmentGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_MachineryAndEquipmentGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_FurnitureAndFixturesGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_LeaseholdImprovementsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_ConstructionInProgressGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsAbstract" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_Goodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_PreferredStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_OtherIntangibleAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_StatementTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables" xlink:type="extended" xlink:title="30303 - Disclosure - Acquisitions and Other Strategic Transactions (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_KaMedicalLLCMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" xlink:type="extended" xlink:title="40102 - Disclosure - Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="srt_StatementGeographicalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN" xlink:label="country_CN" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CN" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="extended" xlink:title="40103 - Disclosure - Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember" xlink:label="us-gaap_LandImprovementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandImprovementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits" xlink:label="us-gaap_NumberOfReportingUnits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_NumberOfReportingUnits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Revenues - Disaggregation of Revenue (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_CardiovascularSegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_EndoscopySegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PeripheralInterventionMember" xlink:label="mmsi_PeripheralInterventionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mmsi_PeripheralInterventionMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiacInterventionMember" xlink:label="mmsi_CardiacInterventionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mmsi_CardiacInterventionMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CustomProceduralSolutionsMember" xlink:label="mmsi_CustomProceduralSolutionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mmsi_CustomProceduralSolutionsMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OEMMember" xlink:label="mmsi_OEMMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mmsi_OEMMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopyDevicesMember" xlink:label="mmsi_EndoscopyDevicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mmsi_EndoscopyDevicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NumberOfProductCategories" xlink:label="mmsi_NumberOfProductCategories" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="mmsi_NumberOfProductCategories" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Acquisitions and Other Strategic Transactions - Asset Purchase (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BiotraceMedicalIncMember" xlink:label="mmsi_BiotraceMedicalIncMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mmsi_BiotraceMedicalIncMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RestoreEndosystemsLLCMember" xlink:label="mmsi_RestoreEndosystemsLLCMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mmsi_RestoreEndosystemsLLCMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentOneMember" xlink:label="mmsi_ContingentConsiderationPaymentOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="mmsi_ContingentConsiderationPaymentOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentTwoMember" xlink:label="mmsi_ContingentConsiderationPaymentTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="mmsi_ContingentConsiderationPaymentTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" xlink:label="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" xlink:label="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentPeriod" xlink:label="mmsi_ContingentConsiderationPaymentPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="mmsi_ContingentConsiderationPaymentPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" xlink:type="extended" xlink:title="40302 - Disclosure - Acquisitions and Other Strategic Transactions - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FluidxMedicalTechnologyLLCMember" xlink:label="mmsi_FluidxMedicalTechnologyLLCMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mmsi_FluidxMedicalTechnologyLLCMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_KaMedicalLLCMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationConsiderationTransferredNotePayable" xlink:label="mmsi_BusinessCombinationConsiderationTransferredNotePayable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mmsi_BusinessCombinationConsiderationTransferredNotePayable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetImpairmentCharges" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Acquisitions - Purchase Price Allocation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_KaMedicalLLCMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_Goodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Goodwill and Intangible Assets - Other Intangible Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_OtherIntangibleAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_PatentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionRightsMember" xlink:label="us-gaap_DistributionRightsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_DistributionRightsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_LicensingAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_TrademarksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember" xlink:label="us-gaap_CustomerListsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_CustomerListsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" xlink:type="extended" xlink:title="40503 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_STDPharmaceuticalProductsLimitedMember" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_STDPharmaceuticalProductsLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LauraneMedicalS.A.S.Member" xlink:label="mmsi_LauraneMedicalS.A.S.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_LauraneMedicalS.A.S.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OtherIntangibleAssetsAcquiredMember" xlink:label="mmsi_OtherIntangibleAssetsAcquiredMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_OtherIntangibleAssetsAcquiredMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LicenseAgreementArravascLimitedMember" xlink:label="mmsi_LicenseAgreementArravascLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mmsi_LicenseAgreementArravascLimitedMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails" xlink:type="extended" xlink:title="40605 - Disclosure - Income Taxes - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NetOperatingLossCarryforwardsUtilization" xlink:label="mmsi_NetOperatingLossCarryforwardsUtilization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="mmsi_NetOperatingLossCarryforwardsUtilization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" xlink:label="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" xlink:label="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" xlink:label="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Revolving Credit Facility and Long-Term Debt - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LoansPayableMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CreditAgreementMember" xlink:label="mmsi_CreditAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mmsi_CreditAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LettersOfCreditOutstandingAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" xlink:label="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" xlink:label="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" xlink:type="extended" xlink:title="40803 - Disclosure - Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CreditAgreementMember" xlink:label="mmsi_CreditAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mmsi_CreditAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" xlink:label="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureDerivativesNarrativeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Derivatives - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_InterestRateSwapMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeForwardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DerivativeTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_WellsFargoFixedRateDerivativeContractOneMember" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mmsi_WellsFargoFixedRateDerivativeContractOneMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_WellsFargoFixedRateDerivativeContractTwoMember" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mmsi_WellsFargoFixedRateDerivativeContractTwoMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_VariableRateAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" xlink:label="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_HedgingDesignationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_HedgingDesignationAxis" xlink:to="us-gaap_HedgingDesignationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueAndCostOfSalesMember" xlink:label="mmsi_RevenueAndCostOfSalesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mmsi_RevenueAndCostOfSalesMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember" xlink:label="us-gaap_InterestExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_InterestExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="us-gaap_DerivativeNotionalAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeNotionalAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="us-gaap_DerivativeFixedInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeFixedInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossLiability" xlink:label="us-gaap_DerivativeAssetFairValueGrossLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeAssetFairValueGrossLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:label="us-gaap_DeferredTaxAssetsDerivativeInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DeferredTaxAssetsDerivativeInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract" xlink:label="us-gaap_DerivativeTermOfContract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeTermOfContract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" xlink:label="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_DerivativeLineItems" xlink:to="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Derivatives - Forward Notional Contracts (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_HedgingDesignationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_HedgingDesignationAxis" xlink:to="us-gaap_HedgingDesignationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_NondesignatedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeForwardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="us-gaap_HedgingRelationshipDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember" xlink:label="us-gaap_CashFlowHedgingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_HedgingRelationshipDomain" xlink:to="us-gaap_CashFlowHedgingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" xlink:label="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeLineItems" xlink:to="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="us-gaap_DerivativeNotionalAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeNotionalAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Derivatives - Fair Value of Derivative Instruments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_HedgingDesignationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_HedgingDesignationAxis" xlink:to="us-gaap_HedgingDesignationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_NondesignatedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_InterestRateSwapMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeForwardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_BalanceSheetLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="us-gaap_OtherNoncurrentAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="us-gaap_AccruedLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_AccruedLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="us-gaap_DerivativesFairValueLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" xlink:type="extended" xlink:title="40904 - Disclosure - Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="us-gaap_HedgingRelationshipDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember" xlink:label="us-gaap_CashFlowHedgingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_HedgingRelationshipDomain" xlink:to="us-gaap_CashFlowHedgingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_InterestRateSwapMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeForwardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember" xlink:label="us-gaap_InterestExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_InterestExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_RevenueFromContractWithCustomerMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_InterestExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" xlink:type="extended" xlink:title="40905 - Disclosure - Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_HedgingDesignationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_HedgingDesignationAxis" xlink:to="us-gaap_HedgingDesignationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_NondesignatedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_ForeignExchangeForwardMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Commitments and Contingencies - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_LitigationCaseAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MeritShareholderDerivativeSuitMember" xlink:label="mmsi_MeritShareholderDerivativeSuitMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="mmsi_MeritShareholderDerivativeSuitMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForLegalSettlements" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LongTermIncentivePlan2018Member" xlink:label="mmsi_LongTermIncentivePlan2018Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PlanNameDomain" xlink:to="mmsi_LongTermIncentivePlan2018Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EmployeeStockPurchasePlanMember" xlink:label="mmsi_EmployeeStockPurchasePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PlanNameDomain" xlink:to="mmsi_EmployeeStockPurchasePlanMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashSettledPerformanceSharesMember" xlink:label="mmsi_CashSettledPerformanceSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mmsi_CashSettledPerformanceSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_TargetMember" xlink:label="mmsi_TargetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mmsi_TargetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MaximumUnitsGrantedMember" xlink:label="mmsi_MaximumUnitsGrantedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mmsi_MaximumUnitsGrantedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MaximumPotentialSharesGrantedMember" xlink:label="mmsi_MaximumPotentialSharesGrantedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mmsi_MaximumPotentialSharesGrantedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ValuationTechniqueAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="us-gaap_ValuationTechniqueDiscountedCashFlowMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDiscountedCashFlowMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_MarketApproachValuationTechniqueMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" xlink:label="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" xlink:label="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" xlink:label="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" xlink:type="extended" xlink:title="41202 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashSettledPerformanceSharesMember" xlink:label="mmsi_CashSettledPerformanceSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mmsi_CashSettledPerformanceSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" xlink:type="extended" xlink:title="41203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" xlink:type="extended" xlink:title="41205 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ValuationTechniqueAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_MarketApproachValuationTechniqueMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" xlink:type="extended" xlink:title="41206 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Segment Reporting and Foreign Operations - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_CardiovascularSegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="srt_StatementGeographicalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN" xlink:label="country_CN" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CN" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_GeographicConcentrationRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NumberOfProductCategories" xlink:label="mmsi_NumberOfProductCategories" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="mmsi_NumberOfProductCategories" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" xlink:type="extended" xlink:title="41302 - Disclosure - Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="srt_StatementGeographicalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE" xlink:label="country_IE" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IE" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NonUSExcludingIrelandMember" xlink:label="mmsi_NonUSExcludingIrelandMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_SegmentGeographicalDomain" xlink:to="mmsi_NonUSExcludingIrelandMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" xlink:type="extended" xlink:title="41303 - Disclosure - Segment Reporting and Foreign Operations - Operating Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_CardiovascularSegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_EndoscopySegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" xlink:type="extended" xlink:title="41304 - Disclosure - Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_CardiovascularSegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentDomain" xlink:to="mmsi_EndoscopySegmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:label="us-gaap_SegmentReportingAssetReconcilingItemLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="us-gaap_Assets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:label="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended" xlink:title="41502 - Disclosure - Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationMember" xlink:label="mmsi_ContingentConsiderationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="mmsi_ContingentConsiderationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" xlink:label="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails" xlink:type="extended" xlink:title="41503 - Disclosure - Fair Value Measurements - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BalanceSheetLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="us-gaap_AccruedLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_AccruedLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_DirectorMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LicenseAgreementArravascLimitedMember" xlink:label="mmsi_LicenseAgreementArravascLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mmsi_LicenseAgreementArravascLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CiannaMedicalMember" xlink:label="mmsi_CiannaMedicalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_CiannaMedicalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_STDPharmaceuticalProductsLimitedMember" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_STDPharmaceuticalProductsLimitedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_SelioMedicalLimitedSelioMember" xlink:label="mmsi_SelioMedicalLimitedSelioMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mmsi_SelioMedicalLimitedSelioMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_XableCathMember" xlink:label="mmsi_XableCathMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mmsi_XableCathMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FusionMedicalInc.Member" xlink:label="mmsi_FusionMedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mmsi_FusionMedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BluegrassVascularTechnologiesIncMember" xlink:label="mmsi_BluegrassVascularTechnologiesIncMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mmsi_BluegrassVascularTechnologiesIncMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="mmsi_BluegrassVascularTechnologiesIncMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_CounterpartyNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NinePointMedicalInc.Member" xlink:label="mmsi_NinePointMedicalInc.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mmsi_NinePointMedicalInc.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_PaymentsForMergerRelatedCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="us-gaap_GainLossOnSaleOfBusiness" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_GainLossOnSaleOfBusiness" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OperatingLeaseImpairmentLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentIncomeNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquityMethodInvestments" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" xlink:type="extended" xlink:title="41504 - Disclosure - Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputDiscountRateMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MilestonePaymentProbabilityMember" xlink:label="mmsi_MilestonePaymentProbabilityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="mmsi_MilestonePaymentProbabilityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueBasedPaymentsMember" xlink:label="mmsi_RevenueBasedPaymentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="mmsi_RevenueBasedPaymentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueMilestonesMember" xlink:label="mmsi_RevenueMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="mmsi_RevenueMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RegulatoryApprovalMilestoneMember" xlink:label="mmsi_RegulatoryApprovalMilestoneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="mmsi_RegulatoryApprovalMilestoneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_ValuationTechniqueAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_IncomeApproachValuationTechniqueMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:to="us-gaap_Revenues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:to="us-gaap_InterestExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/DisclosureLeasesNarrativeDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Leases - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LesseeOperatingLeaseTerminationPeriod" xlink:label="mmsi_LesseeOperatingLeaseTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="mmsi_LesseeOperatingLeaseTerminationPeriod" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended" xlink:title="41801 - Schedule - Schedule II - Valuation and qualifying accounts (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="us-gaap_AllowanceForCreditLossMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_AllowanceForCreditLossMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_MovementInValuationAllowancesAndReservesRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>23
<FILENAME>mmsi-20221231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/24/2023 8:59:49 PM-->
<!--Modified on: 2/24/2023 8:59:49 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cover page.</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Annual Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Well-known Seasoned Issuer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Voluntary Filers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Small Business</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ICFR Auditor Attestation Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Public Float</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Firm ID</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Location</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of Financial Position [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Developed technology</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ASSETS</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Receivable, after Allowance for Credit Loss, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables - net of allowance for credit losses - 2022 - $8,423 and 2021 - $6,767</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NontradeReceivablesCurrent" xlink:to="us-gaap_NontradeReceivablesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NontradeReceivablesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nontrade Receivables, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NontradeReceivablesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Inventories</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expense and Other Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and other current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes Receivable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax refund receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land" xlink:label="us-gaap_Land" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Land" xlink:to="us-gaap_Land_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Land_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Land_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Land and land improvements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="us-gaap_BuildingsAndImprovementsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingsAndImprovementsGross" xlink:to="us-gaap_BuildingsAndImprovementsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingsAndImprovementsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings and Improvements, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingsAndImprovementsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="us-gaap_MachineryAndEquipmentGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentGross" xlink:to="us-gaap_MachineryAndEquipmentGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Machinery and Equipment, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MachineryAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Manufacturing equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture and Fixtures, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture and fixtures</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold improvements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressGross" xlink:to="us-gaap_ConstructionInProgressGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction in Progress, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionInProgressGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction-in-progress</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less accumulated depreciation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment - net</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets Net Goodwill and Other Assets Noncurrent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Carrying Amount</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill balance at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill balance at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Income Tax Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income tax assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Right-of-Use Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use operating lease assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ROU operating lease assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Other Assets</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element represents sum of the carrying amounts of all intangible assets and goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Also includes aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets Net Goodwill and Other Assets Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LIABILITIES AND STOCKHOLDERS' EQUITY</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable, Trade, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Liabilities, Current, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Current Maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current portion of long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less current portion</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Liability, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Income Taxes, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Excluding Current Maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term portion</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Income Tax Liabilities, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income tax liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Income Taxes, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term income taxes payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liability for Uncertainty in Income Taxes, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities related to unrecognized tax benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Compensation Liability, Classified, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred compensation payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred compensation cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract with Customer, Liability, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred credits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Liability, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other long-term obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' equity:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock - 5,000 shares authorized as of December 31, 2022 and December 31, 2021; no shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, no par value; 100,000 shares authorized; issued and outstanding as of December 31, 2022 - 57,306 and December 31, 2021 - 56,570</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated other comprehensive loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total stockholders' equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities and stockholders' equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Receivable, Allowance for Credit Loss, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables, allowances</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangibles, accumulated amortization</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock shares authorized (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred stock shares issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock shares authorized (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock shares issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock shares outstanding (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contract with Customer, Excluding Assessed Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net sales</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of Goods and Services Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of sales</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross profit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expenses:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling, General and Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling, general and administrative</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Expense (Excluding Acquired in Process Cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Litigation Settlement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal settlement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Impairment Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment charges</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:label="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:to="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration expense (benefit)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Asset Acquired Other than Through Business Combination, Written-off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquired in-process research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquired in-process research and development</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total operating expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (loss) from operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (loss) from operations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonoperating Income (Expense) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income (expense):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment Income, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income (expense) - net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other expense - net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other expense - net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (loss) before income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total income tax expense (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense (benefit)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss) Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income (loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings (loss) per common share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic EPS (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted EPS (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average common shares outstanding (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total potential shares outstanding (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of Comprehensive Income [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income (loss):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flow hedges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Gain/(Loss) recognized in OCI</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax benefit (expense)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency translation adjustment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax benefit (expense)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other comprehensive loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total comprehensive income (loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of Stockholders' Equity [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Components [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cumulative Effect, Period of Adoption [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cumulative Effect, Period of Adoption [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassify upon adoption of ASU</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Standards Update [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Type of Adoption [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201613Member" xlink:to="us-gaap_AccountingStandardsUpdate201613Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ASU 2016-13</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options exercised</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options exercised (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Value, Employee Stock Purchase Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of common stock under Employee Stock Purchase Plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Employee Stock Purchase Plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of common stock under Employee Stock Purchase Plans (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued from time-vested restricted stock units (in shares)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" xlink:to="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares surrendered in exchange for payment of payroll tax liabilities</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Surrendered During Period Shares Payroll Tax Liabilities Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Surrendered During Period Shares Payroll Tax Liabilities Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares surrendered in exchange for payment of payroll tax liabilities (in shares)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" xlink:to="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element represents value of shares that have been surrendered during the period in exchange for stock options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Surrendered During Period Value Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares surrendered in exchange for exercise of stock options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Merit common stock surrendered (18, 3, and 39 shares, respectively) in exchange for exercise of stock options</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element represents number of shares that have been surrendered during the period in exchange for stock options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Surrendered During Period Shares Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares surrendered in exchange for exercise of stock options (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares surrendered in exchange for exercise of stock options (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of Cash Flows [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, Depletion and Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and amortization</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="us-gaap_GainLossOnSaleOfBusiness" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfBusiness" xlink:to="us-gaap_GainLossOnSaleOfBusiness_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (Loss) on Disposition of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfBusiness_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss (gain) on disposition of business</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss on sale or abandonment of property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Asset Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Write-off of certain intangible assets and other long-term assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Right-of-Use Asset, Amortization Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of right-of-use operating lease assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments related to contingent consideration liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract with Customer, Liability, Revenue Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of deferred credits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Debt Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of long-term debt issuance costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total deferred benefit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Noncash Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in operating assets and liabilities, net of acquisitions and divestitures:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and other current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Prepaid Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Income Taxes Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax refund receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Other Operating Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts Payable, Trade</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Income Taxes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes payable</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions" xlink:label="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions" xlink:to="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) Liability for Uncertain Tax Positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) Liability for Uncertain Tax Positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities related to unrecognized tax benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Deferred Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred compensation payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Operating Lease, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Other Operating Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other long-term obligations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total adjustments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash, cash equivalents, and restricted cash provided by operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:label="us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:to="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Productive Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital expenditures for:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital expenditures</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to acquire intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Sale of Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from the sale of property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Divestiture of Businesses, Net of Cash Divested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds (payments) from disposition of business</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Collection of Notes Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash received for settlement of note receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Notes Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of note receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Businesses, Net of Cash Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash paid in acquisitions, net of cash acquired</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash, cash equivalents, and restricted cash used in investing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of long-term debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayments of Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments on long-term debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment for Contingent Consideration Liability, Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent payments related to acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments related to the settlement of the contingent consideration liability, Financing activities</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" xlink:label="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" xlink:to="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash outflow for taxes related to an exchange of common stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments Related To Tax Withholding for Exchange of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment of taxes related to an exchange of common stock</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash, cash equivalents, and restricted cash used in financing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of exchange rates on cash, cash equivalents, and restricted cash</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net increase (decrease) in cash, cash equivalents and restricted cash</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, at Carrying Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CASH, CASH EQUIVALENTS AND RESTRICTED CASH:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">End of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total cash, cash equivalents and restricted cash</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEETS:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Cash and Cash Equivalents, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted cash reported in prepaid expenses and other current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Cash and Cash Equivalents, Current, Statement of Financial Position [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest (net of capitalized interest of $858, $480 and $813, respectively)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes Paid, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Expenditures Incurred but Not yet Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment purchases in accounts payable</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" xlink:label="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" xlink:to="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The fair value of equity investment acquired in exchange for settlement of note receivable in noncash investing or financing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value of Equity Investment in Exchange For Settlement of Note Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current note receivable converted to equity investment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of business in other receivables</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses" xlink:label="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses" xlink:to="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element represents future cash outflow to pay for acquisition of developed technology in a non cash investing and financing activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition of Developed Technology in Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition purchases in accrued expenses and other long-term obligations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use operating lease assets obtained in exchange for operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized" xlink:label="us-gaap_InterestPaidCapitalized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidCapitalized" xlink:to="us-gaap_InterestPaidCapitalized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidCapitalized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Paid, Capitalized, Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidCapitalized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net capitalized interest</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Organization and Summary of Significant Accounting Policies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contract with Customer [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contract with Customer [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combinations [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisitions and Other Strategic Transactions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Assets Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payables and Accruals [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revolving Credit Facility and Long-Term Debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments and Hedging Activities Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivatives</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings (Loss) Per Common Share (EPS)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Stock Purchase Plan, Stock Options and Warrants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting and Foreign Operations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Compensation and Employee Benefit Plans [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Benefit Plans</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Disclosures [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss) Note [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Leases [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule II - Valuation and qualifying accounts</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Use of Estimates in Preparing Financial Statements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidation, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principles of Consolidation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-Lived Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and Equipment</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock" xlink:label="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock" xlink:to="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy for deferred compensation plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred compensation policy text block [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Compensation</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock" xlink:label="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock" xlink:to="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy for other assets which are expected to be realized or consumed after on year (or the normal operating cycle, if longer).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets Policy Text Block [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-term Obligations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contract with Customer [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue Recognition/Shipping and Handling/Cost of Sales</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Expense, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per Common Share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ConcentrationOfCreditRiskPolicyTextBlock" xlink:label="mmsi_ConcentrationOfCreditRiskPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ConcentrationOfCreditRiskPolicyTextBlock" xlink:to="mmsi_ConcentrationOfCreditRiskPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ConcentrationOfCreditRiskPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy for concentration of credit risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ConcentrationOfCreditRiskPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration of Credit Risk [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ConcentrationOfCreditRiskPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration of Credit Risk</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivatives, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivatives</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Financial Accounting Standards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and Equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Other Assets, Noncurrent [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Noncurrent Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-term Obligations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disaggregation of Revenue [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Disaggregation of Revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Business Acquisitions, by Acquisition [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Business Acquisitions, by Acquisition [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Acquiree [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_KaMedicalLLCMember" xlink:to="mmsi_KaMedicalLLCMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_KaMedicalLLCMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to the unit purchase agreement to acquire KA Medical, LLC ("KA Medical").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_KaMedicalLLCMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">KA Medical</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Inventory, Current [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Inventory</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Goodwill [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in carrying amount of goodwill</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated amortization expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Income before Income Tax, Domestic and Foreign</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Components of Income Tax Expense (Benefit)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Effective Income Tax Rate Reconciliation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Deferred Tax Assets and Liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of Income Tax Contingencies [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of Income Tax Contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Accrued Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Accrued Liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock" xlink:label="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock" xlink:to="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule Of Long Term Debt Covenants Table [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule Of Long Term Debt Covenants Table [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Covenants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Maturities of Long-term Debt [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Maturities of Long-term Debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments, Gain (Loss) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments, Gain (Loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Earnings (Loss) Per Share, Basic and Diluted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation, Stock Option Activity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" xlink:label="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" xlink:to="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of the number and weighted-average grant date fair value for equity instruments other than options that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Equity Instruments Other than Options, Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation, PSUs and RSUs, Activity</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" xlink:label="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" xlink:to="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of the number and weighted-average grant date fair value for performance shares and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Performance Shares and Restricted Stock Unit, Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation, PSUs and RSUs Granted</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" xlink:label="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" xlink:to="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of performance shares, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, Performance Shares, Valuation Assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, PSUs, Valuation Assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-lived Assets by Geographic Areas [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-lived Assets by Geographic Area</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Segment Reporting Information, by Segment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Assets from Segment to Consolidated</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Inputs, Liabilities, Quantitative Information</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing Receivable, Allowance for Credit Loss [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Rollforward of Allowance for Credit Losses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Components of Accumulated Other Comprehensive Income (Loss)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:label="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets And Liabilities, Lessee [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets And Liabilities, Lessee [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Consolidated Balance Sheet Information and Supplemental Information</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease, Cost [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of Lease Costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturities of Operating Lease Liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Operating Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of operating segments</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NumberOfProductCategories" xlink:label="mmsi_NumberOfProductCategories" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_NumberOfProductCategories" xlink:to="mmsi_NumberOfProductCategories_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_NumberOfProductCategories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of product categories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_NumberOfProductCategories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Product Categories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_NumberOfProductCategories_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of product categories</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restrictions on Cash and Cash Equivalents [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN" xlink:label="country_CN" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CN_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHINA</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Cash and Cash Equivalents Items [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Property, Plant and Equipment [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-Lived Tangible Asset [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Manufacturing equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture and fixtures</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember" xlink:label="us-gaap_LandImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandImprovementsMember" xlink:to="us-gaap_LandImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Land improvements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold improvements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statistical Measurement [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statistical Measurement [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits" xlink:label="us-gaap_NumberOfReportingUnits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportingUnits" xlink:to="us-gaap_NumberOfReportingUnits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportingUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Reporting Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportingUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reporting units</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Useful life</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance" xlink:label="us-gaap_CashSurrenderValueOfLifeInsurance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="us-gaap_CashSurrenderValueOfLifeInsurance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashSurrenderValueOfLifeInsurance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Surrender Value of Life Insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashSurrenderValueOfLifeInsurance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash surrender value of life insurance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract" xlink:label="us-gaap_OtherAssetsNoncurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets, Noncurrent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investments in privately held companies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="us-gaap_DeferredCompensationPlanAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationPlanAssets" xlink:to="us-gaap_DeferredCompensationPlanAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationPlanAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Compensation Plan Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationPlanAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred compensation plan assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term notes receivable, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets, Miscellaneous, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebt" xlink:to="us-gaap_OtherLongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other long-term obligations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allocated share-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disaggregation of Revenue [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disaggregation of Revenue [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segments [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segments [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CardiovascularSegmentMember" xlink:to="mmsi_CardiovascularSegmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CardiovascularSegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cardiovascular Segment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CardiovascularSegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cardiovascular</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_EndoscopySegmentMember" xlink:to="mmsi_EndoscopySegmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_EndoscopySegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Endoscopy Segment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_EndoscopySegmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Endoscopy</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">United States</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonUsMember" xlink:to="us-gaap_NonUsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonUsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">International</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Product and Service [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Product and Service [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PeripheralInterventionMember" xlink:label="mmsi_PeripheralInterventionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_PeripheralInterventionMember" xlink:to="mmsi_PeripheralInterventionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_PeripheralInterventionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents Peripheral Intervention products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_PeripheralInterventionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Peripheral Intervention</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiacInterventionMember" xlink:label="mmsi_CardiacInterventionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CardiacInterventionMember" xlink:to="mmsi_CardiacInterventionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CardiacInterventionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents Cardiac Intervention products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CardiacInterventionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cardiac Intervention</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CustomProceduralSolutionsMember" xlink:label="mmsi_CustomProceduralSolutionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CustomProceduralSolutionsMember" xlink:to="mmsi_CustomProceduralSolutionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CustomProceduralSolutionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents Custom Procedural Solutions products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CustomProceduralSolutionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Custom Procedural Solutions</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OEMMember" xlink:label="mmsi_OEMMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_OEMMember" xlink:to="mmsi_OEMMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_OEMMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents OEM products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_OEMMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">OEM</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopyDevicesMember" xlink:label="mmsi_EndoscopyDevicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_EndoscopyDevicesMember" xlink:to="mmsi_EndoscopyDevicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_EndoscopyDevicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents Endoscopy Devices products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_EndoscopyDevicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Endoscopy Devices</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disaggregation of Revenue [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disaggregation of Revenue [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BiotraceMedicalIncMember" xlink:label="mmsi_BiotraceMedicalIncMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BiotraceMedicalIncMember" xlink:to="mmsi_BiotraceMedicalIncMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BiotraceMedicalIncMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to the asset acquisition of BioTrace Medical, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BiotraceMedicalIncMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">BioTrace</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RestoreEndosystemsLLCMember" xlink:label="mmsi_RestoreEndosystemsLLCMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_RestoreEndosystemsLLCMember" xlink:to="mmsi_RestoreEndosystemsLLCMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_RestoreEndosystemsLLCMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to the asset acquisition of Restore Endosystems, LLC.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_RestoreEndosystemsLLCMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restore Endosystems</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">In-process research and development</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Consideration by Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Consideration Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentOneMember" xlink:label="mmsi_ContingentConsiderationPaymentOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ContingentConsiderationPaymentOneMember" xlink:to="mmsi_ContingentConsiderationPaymentOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ContingentConsiderationPaymentOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the first contingent consideration payment under the asset purchase agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ContingentConsiderationPaymentOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Payment</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentTwoMember" xlink:label="mmsi_ContingentConsiderationPaymentTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ContingentConsiderationPaymentTwoMember" xlink:to="mmsi_ContingentConsiderationPaymentTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ContingentConsiderationPaymentTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the second contingent consideration payment under the asset purchase agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ContingentConsiderationPaymentTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second Payment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Productive Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase price</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" xlink:label="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" xlink:to="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of contingent annual payments under the asset acquisition agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition, Contingent Consideration, Number of Annual Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of annual payments</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" xlink:label="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" xlink:to="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of net sales revenue for contingent consideration from asset acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition, Contingent Consideration, Percent of Net Sales Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net sales revenue (as a percent)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Asset, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset Acquisition, Consideration Transferred, Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional payments upon the achievement of specified milestones</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentPeriod" xlink:label="mmsi_ContingentConsiderationPaymentPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ContingentConsiderationPaymentPeriod" xlink:to="mmsi_ContingentConsiderationPaymentPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ContingentConsiderationPaymentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the period for which an asset acquisition contingent consideration is to be paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ContingentConsiderationPaymentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Consideration, Payment Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ContingentConsiderationPaymentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-lived Intangible Assets Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquired intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment, Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FluidxMedicalTechnologyLLCMember" xlink:label="mmsi_FluidxMedicalTechnologyLLCMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_FluidxMedicalTechnologyLLCMember" xlink:to="mmsi_FluidxMedicalTechnologyLLCMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_FluidxMedicalTechnologyLLCMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fluidx Medical Technology, LLC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_FluidxMedicalTechnologyLLCMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fluidx</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Equity Method Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to acquire shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Ownership Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ownership percentage</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Businesses, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase consideration, upfront payment</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationConsiderationTransferredNotePayable" xlink:label="mmsi_BusinessCombinationConsiderationTransferredNotePayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationConsiderationTransferredNotePayable" xlink:to="mmsi_BusinessCombinationConsiderationTransferredNotePayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationConsiderationTransferredNotePayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of note payable issued by acquirer in consideration for the business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationConsiderationTransferredNotePayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Consideration Transferred, Note Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_BusinessCombinationConsiderationTransferredNotePayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase consideration, note payable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average useful life</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity method investment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets Acquired</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventories</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other long-term assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities Assumed</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade payables</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities assumed</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total net assets acquired</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Finished Goods, Net of Reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finished goods</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Work in Process, Net of Reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Work-in-process</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory, Raw Materials, Net of Reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Raw materials</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward" xlink:label="us-gaap_GoodwillRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill [Roll Forward]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="us-gaap_GoodwillForeignCurrencyTranslationGainLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillForeignCurrencyTranslationGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill, Foreign Currency Translation Gain (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GoodwillForeignCurrencyTranslationGainLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of foreign exchange</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions" xlink:label="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions" xlink:to="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill, Purchase Accounting Adjustments And Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill, Purchase Accounting Adjustments And Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions and adjustments as the result of acquisitions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Patents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionRightsMember" xlink:label="us-gaap_DistributionRightsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionRightsMember" xlink:to="us-gaap_DistributionRightsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DistributionRightsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Distribution agreements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">License agreements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trademarks</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember" xlink:label="us-gaap_CustomerListsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerListsMember" xlink:to="us-gaap_CustomerListsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerListsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Customer Lists</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Carrying Amount</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_STDPharmaceuticalProductsLimitedMember" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_STDPharmaceuticalProductsLimitedMember" xlink:to="mmsi_STDPharmaceuticalProductsLimitedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to STD Pharmaceutical Products Limited, a UK-based company engaged in the manufacture, distribution and sale of pharmaceutical sclerotherapy products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">STD Pharmaceutical Products Limited</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LauraneMedicalS.A.S.Member" xlink:label="mmsi_LauraneMedicalS.A.S.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LauraneMedicalS.A.S.Member" xlink:to="mmsi_LauraneMedicalS.A.S.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LauraneMedicalS.A.S.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Laurane Medical S.A.S. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LauraneMedicalS.A.S.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Laurane Medical S.A.S.</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OtherIntangibleAssetsAcquiredMember" xlink:label="mmsi_OtherIntangibleAssetsAcquiredMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_OtherIntangibleAssetsAcquiredMember" xlink:to="mmsi_OtherIntangibleAssetsAcquiredMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_OtherIntangibleAssetsAcquiredMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the aggregation and reporting of combined amounts of other intangible assets acquired during business acquisition transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_OtherIntangibleAssetsAcquiredMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Acquisitions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LicenseAgreementArravascLimitedMember" xlink:label="mmsi_LicenseAgreementArravascLimitedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LicenseAgreementArravascLimitedMember" xlink:to="mmsi_LicenseAgreementArravascLimitedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LicenseAgreementArravascLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the license agreement with ArraVasc Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LicenseAgreementArravascLimitedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ArraVasc Limited</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill, Impaired, Accumulated Impairment Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated goodwill impairment losses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill, Impairment Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill impairment loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate amortization expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of Intangible Assets, Finite-lived</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2023</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Amortization Expense, Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2024</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Amortization Expense, Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2025</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Amortization Expense, Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2026</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Amortization Expense, Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2027</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current expense (benefit):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Federal Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Federal</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current State and Local Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">State</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Foreign Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred expense (benefit):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Federal Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Federal</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred State and Local Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">State</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Foreign Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statutory federal rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Computed federal income tax expense (benefit) at applicable statutory rate of 21%</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">State income tax benefit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax credits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of international items</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Uncertain tax positions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:label="us-gaap_IncomeTaxReconciliationTaxExemptIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:to="us-gaap_IncomeTaxReconciliationTaxExemptIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxExemptIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxExemptIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred compensation insurance assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation allowance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="us-gaap_IncomeTaxReconciliationTaxSettlements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Tax Settlement, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">DOJ Settlement</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" xlink:to="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to remeasurement of state deferred taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Remeasurement of State Deferred Taxes, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement of state deferred taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-deductible expenses</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" xlink:to="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to remeasurement of contingent consideration liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Remeasurement of Contingent Consideration Liabilities, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement of contingent consideration liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other - including the effect of graduated rates</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Gross [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income tax assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allowance for credit losses on trade receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Inventory differences</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net operating loss carryforwards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating lease assets</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" xlink:label="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" xlink:to="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible federal research tax credit carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Federal Tax Credit Carryforwards, Research</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Federal R&amp;D tax credit</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" xlink:label="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" xlink:to="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state research tax credit carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, State Tax Credit Carryforwards, Research</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">UT R&amp;D Credit</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" xlink:label="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" xlink:to="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from IRC section 174 capitalized research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Capitalized Research and Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IRC section 174 capitalized R&amp;D</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total deferred income tax assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Gross [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income tax liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Deferred Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Property, Plant and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxLiabilitiesForeignWithholdingTax" xlink:label="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax" xlink:to="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Foreign Withholding Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Foreign Withholding Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign withholding tax</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Leasing Arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total deferred income tax liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation allowance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net deferred income tax liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of Deferred Tax Assets and Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reported as:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Authority [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Authority [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Domestic</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in valuation allowance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U.S. federal net operating loss carryforwards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss carryforward, expiring</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss carryforward, no expiration</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NetOperatingLossCarryforwardsUtilization" xlink:label="mmsi_NetOperatingLossCarryforwardsUtilization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_NetOperatingLossCarryforwardsUtilization" xlink:to="mmsi_NetOperatingLossCarryforwardsUtilization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_NetOperatingLossCarryforwardsUtilization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The Number Of Years That Net Operating Loss Carryforwards Are Expected To Be Utilized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_NetOperatingLossCarryforwardsUtilization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Operating Loss Carryforwards Utilization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_NetOperatingLossCarryforwardsUtilization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period to utilize the net operating loss carryforwards</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" xlink:label="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" xlink:to="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">US Federal Net Operating Loss Carryforwards Used In The Current Period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Operating Loss Carryforwards Used In The Current Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">NOL carryforward used in period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign operating loss carryforwards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign withholding tax</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" xlink:label="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" xlink:to="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of income tax expense (benefit) pertaining to restructuring of foreign entities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Expense (Benefit), Restructuring of Foreign Entities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax benefit from restructuring of foreign entities</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" xlink:label="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" xlink:to="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns) pertaining to uncertain tax positions taken in tax returns as of the balance sheet date including Interest and Penalties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits Gross Including Interest and Penalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits including interest and penalties</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits that would impact effective rate</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" xlink:to="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Uncertain tax positions, Reduction resulting from liabilities for reduction to non-current deferred income tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Uncertain Tax Positions Reduction Resulting from Liabilities For Non Current Deferred Income Tax Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits reduction to non-current deferred income tax assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued interest and penalties</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" xlink:to="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) of uncertain tax benefits related to certain liabilities for unrecognized tax benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in Unrecognized Tax Benefits is Reasonably Possible</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated decrease in unrecognized tax benefit in next twelve months</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized tax benefits, opening balance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross increases in tax positions taken in a prior year</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross decreases in tax positions taken in a prior year</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross increases in tax positions taken in the current year</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lapse of applicable statute of limitations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee-related Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payroll and related liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration, Liability, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current portion of contingent liabilities</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AdvancesFromEmployeesCurrent" xlink:label="mmsi_AdvancesFromEmployeesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AdvancesFromEmployeesCurrent" xlink:to="mmsi_AdvancesFromEmployeesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AdvancesFromEmployeesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advances From Employees, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AdvancesFromEmployeesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advances From Employees, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AdvancesFromEmployeesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advances from employees</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AccruedRebatesPayableCurrent" xlink:label="mmsi_AccruedRebatesPayableCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AccruedRebatesPayableCurrent" xlink:to="mmsi_AccruedRebatesPayableCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AccruedRebatesPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying value as of the balance sheet date of the obligations incurred through that date and payable for current portion of accrued rebates payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AccruedRebatesPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Rebates Payable Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AccruedRebatesPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued rebates payable</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AccruedLegalSettlementCurrent" xlink:label="mmsi_AccruedLegalSettlementCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_AccruedLegalSettlementCurrent" xlink:to="mmsi_AccruedLegalSettlementCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_AccruedLegalSettlementCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of legal settlement expenses incurred but not yet paid, due within one year or the normal operating cycle, if longer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_AccruedLegalSettlementCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Legal Settlement, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_AccruedLegalSettlementCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued legal settlement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Long-term Debt Instruments [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableMember" xlink:to="us-gaap_LoansPayableMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Term Loan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revolving Credit Facility</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total future minimum principal payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Issuance Costs, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less unamortized debt issuance costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total long-term debt</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CreditAgreementMember" xlink:label="mmsi_CreditAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CreditAgreementMember" xlink:to="mmsi_CreditAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CreditAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CreditAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit Agreement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Face Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt instrument, face amount</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Maximum Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum borrowing capacity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LettersOfCreditOutstandingAmount" xlink:to="us-gaap_LettersOfCreditOutstandingAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Letters of Credit Outstanding, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Letter of credit guarantees</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt Instrument, Unused Borrowing Capacity, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available borrowing capacity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fixed interest rate percent</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" xlink:label="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" xlink:to="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Percentage Bearing Fixed Interest, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt subject to fixed interest rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Variable interest rate percent</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" xlink:label="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" xlink:to="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Percentage Bearing Variable Interest, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Debt subject to variable interest rate</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" xlink:to="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Covenant Terms, Consolidated Total Leverage Ratio, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Covenant Terms, Consolidated Total Leverage Ratio, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Total Leverage Ratio</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" xlink:to="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Covenant Terms, Consolidated Ebitda To Fixed Charges Ratio, Minimum2</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Covenant Terms, Consolidated Ebitda To Fixed Charges Ratio, Minimum2</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Interest Coverage Ratio</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" xlink:label="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" xlink:to="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Covenant Terms, Facility Capital Expenditures, Next Twelve Months, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line of Credit Facility, Covenant Terms, Facility Capital Expenditures, Next Twelve Months, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Facility Capital Expenditures</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2023</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Debt, Maturities, Repayments of Principal in Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2024</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instrument [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Contract [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateSwapMember" xlink:to="us-gaap_InterestRateSwapMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateSwapMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate swap</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignExchangeForwardMember" xlink:to="us-gaap_ForeignExchangeForwardMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignExchangeForwardMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency forward contracts</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparty Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparty Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_WellsFargoFixedRateDerivativeContractOneMember" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_WellsFargoFixedRateDerivativeContractOneMember" xlink:to="mmsi_WellsFargoFixedRateDerivativeContractOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the Wells Fargo pay-fixed, receive-variable rate swap to fix the one-month LIBOR rate at 1.12%.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Wells Fargo 1.12% one-month LIBOR</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_WellsFargoFixedRateDerivativeContractTwoMember" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_WellsFargoFixedRateDerivativeContractTwoMember" xlink:to="mmsi_WellsFargoFixedRateDerivativeContractTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the Wells Fargo pay-fixed, receive-variable rate swap to fix the one-month LIBOR rate at 1.71%.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Wells Fargo 1.71% one-month LIBOR</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Variable Rate [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Variable Rate [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" xlink:label="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" xlink:to="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LIBOR Swap Rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HedgingDesignationAxis" xlink:to="us-gaap_HedgingDesignationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HedgingDesignationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Hedging Designation [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HedgingDesignationDomain" xlink:to="us-gaap_HedgingDesignationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HedgingDesignationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Hedging Designation [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Designated as hedging instrument</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueAndCostOfSalesMember" xlink:label="mmsi_RevenueAndCostOfSalesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_RevenueAndCostOfSalesMember" xlink:to="mmsi_RevenueAndCostOfSalesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_RevenueAndCostOfSalesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue And Cost Of Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_RevenueAndCostOfSalesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue and cost of sales</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember" xlink:label="us-gaap_InterestExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseMember" xlink:to="us-gaap_InterestExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="us-gaap_DerivativeNotionalAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeNotionalAmount" xlink:to="us-gaap_DerivativeNotionalAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeNotionalAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative, Notional Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeNotionalAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Notional amount of derivative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeNotionalAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate notional amount of derivative</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="us-gaap_DerivativeFixedInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFixedInterestRate" xlink:to="us-gaap_DerivativeFixedInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative, Fixed Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fixed rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Asset, Fair Value, Gross Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of derivative asset</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Liability, Fair Value, Gross Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of derivative liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Liability Derivatives</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossLiability" xlink:label="us-gaap_DerivativeAssetFairValueGrossLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssetFairValueGrossLiability" xlink:to="us-gaap_DerivativeAssetFairValueGrossLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeAssetFairValueGrossLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Asset, Fair Value, Gross Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeAssetFairValueGrossLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of derivative liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:label="us-gaap_DeferredTaxAssetsDerivativeInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:to="us-gaap_DeferredTaxAssetsDerivativeInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDerivativeInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Assets, Derivative Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsDerivativeInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax asset used to offset fair value of interest rate swap</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract" xlink:label="us-gaap_DerivativeTermOfContract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTermOfContract" xlink:to="us-gaap_DerivativeTermOfContract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative, Term of Contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity of derivative contract (up to)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" xlink:label="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" xlink:to="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow Hedge Gain (Loss) To Be Reclassified Within Twelve Months, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow Hedge Gain (Loss) To Be Reclassified Within Twelve Months, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount expected to be reclassified from accumulated other comprehensive income (loss) to earnings in next twelve months, gross</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount expected to be reclassified from accumulated other comprehensive income to earnings (loss) in next twelve months, net of tax</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NondesignatedMember" xlink:to="us-gaap_NondesignatedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NondesignatedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Not designated as hedging instrument</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Hedging Relationship [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HedgingRelationshipDomain" xlink:to="us-gaap_HedgingRelationshipDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HedgingRelationshipDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Hedging Relationship [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember" xlink:label="us-gaap_CashFlowHedgingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgingMember" xlink:to="us-gaap_CashFlowHedgingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivatives designated as cash flow hedges</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" xlink:label="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" xlink:to="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Average Number Of Contracts Entered Into Per Month</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Average Number Of Contracts Entered Into Per Month</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average number of contracts entered into per month</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance Sheet Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance Sheet Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="us-gaap_OtherNoncurrentAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentAssetsMember" xlink:to="us-gaap_OtherNoncurrentAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncurrentAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assets (long-term)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and other assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="us-gaap_AccruedLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesMember" xlink:to="us-gaap_AccruedLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other long-term obligations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="us-gaap_DerivativesFairValueLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativesFairValueLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesFairValueLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivatives, Fair Value [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesFairValueLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivatives, Fair Value [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments, Gain (Loss) [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments, Gain (Loss) [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of sales</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments, Gain (Loss) [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative Instruments, Gain (Loss) [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of Gain/(Loss) reclassified from AOCI</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative, Gain (Loss) on Derivative, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (loss) on derivative</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Commitments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Commitments [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LitigationCaseAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Litigation Case [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="srt_LitigationCaseTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LitigationCaseTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Litigation Case [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MeritShareholderDerivativeSuitMember" xlink:label="mmsi_MeritShareholderDerivativeSuitMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_MeritShareholderDerivativeSuitMember" xlink:to="mmsi_MeritShareholderDerivativeSuitMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_MeritShareholderDerivativeSuitMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to derivative suit filed by shareholders of Merit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_MeritShareholderDerivativeSuitMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Merit Shareholder Derivative Suit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Commitments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Commitments [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Royalty Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Royalty expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for Legal Settlements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Attorneys fees and expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of dilutive stock awards (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity awards excluded as the impact was anti-dilutive (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LongTermIncentivePlan2018Member" xlink:label="mmsi_LongTermIncentivePlan2018Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LongTermIncentivePlan2018Member" xlink:to="mmsi_LongTermIncentivePlan2018Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LongTermIncentivePlan2018Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information for the 2018 long-term incentive plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LongTermIncentivePlan2018Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 Incentive Plan</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EmployeeStockPurchasePlanMember" xlink:label="mmsi_EmployeeStockPurchasePlanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_EmployeeStockPurchasePlanMember" xlink:to="mmsi_EmployeeStockPurchasePlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_EmployeeStockPurchasePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Information for the non-qualified Employee Stock Purchase Plan ("ESPP").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_EmployeeStockPurchasePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ESPP</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Settled Performance-Based Restricted Stock Units</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashSettledPerformanceSharesMember" xlink:label="mmsi_CashSettledPerformanceSharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CashSettledPerformanceSharesMember" xlink:to="mmsi_CashSettledPerformanceSharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CashSettledPerformanceSharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash-Settled share-based payment arrangement awarded for meeting performance target.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CashSettledPerformanceSharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash-Settled Performance-Based Share-Based Awards (Liability Awards)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_TargetMember" xlink:label="mmsi_TargetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_TargetMember" xlink:to="mmsi_TargetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_TargetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the target for units granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_TargetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Target units granted</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MaximumUnitsGrantedMember" xlink:label="mmsi_MaximumUnitsGrantedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_MaximumUnitsGrantedMember" xlink:to="mmsi_MaximumUnitsGrantedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_MaximumUnitsGrantedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the maximum of units granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_MaximumUnitsGrantedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum units granted</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MaximumPotentialSharesGrantedMember" xlink:label="mmsi_MaximumPotentialSharesGrantedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_MaximumPotentialSharesGrantedMember" xlink:to="mmsi_MaximumPotentialSharesGrantedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_MaximumPotentialSharesGrantedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the maximum potential shares granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_MaximumPotentialSharesGrantedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum potential shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance period 1</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance period 2</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance period 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation Approach and Technique [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation Approach and Technique [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="us-gaap_ValuationTechniqueDiscountedCashFlowMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="us-gaap_ValuationTechniqueDiscountedCashFlowMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueDiscountedCashFlowMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">FCF</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketApproachValuationTechniqueMember" xlink:to="us-gaap_MarketApproachValuationTechniqueMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketApproachValuationTechniqueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">rTSR</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options granted in period (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award vesting period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expiration period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares available for grant (in shares)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" xlink:label="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" xlink:to="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangement Employee Stock Purchase Plan, Percentage of Market Price. Purchase Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangement Employee Stock Purchase Plan Percentage of Market Price Purchase Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase price for ESPP, percent of market price</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The annual target cash incentive amount for non-option equity instruments granted to participants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Annual Target Cash Incentive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Target cash incentive</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Compensation Arrangement with Individual, Recorded Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities associated with awards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Compensation cost not yet recognized</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Compensation cost not yet recognized, period of recognition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount paid in connection with liability awards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted stock units vested (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited (in shares)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" xlink:label="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" xlink:to="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Of Stock Option On Grant Date Net Of Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Of Stock Option On Grant Date Net Of Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of options, net of forfeitures</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options granted in period, weighted average grant date fair value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant-date fair value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted stock units granted (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation arrangement by share-based payment award, equity instruments other than options, conversion multiplying factor.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based payment Award, Equity Instruments Other than Options, Conversion Multiplying Factor</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Multiplying factor</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" xlink:label="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" xlink:to="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) during the period in the number of potential shares granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential Shares Granted During Period, Increase (Decrease)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in the potential shares of common stock to be granted</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of shares of common stock that each unit is equal to.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangement by Share Based Payment Award, Number of Shares of Common Stock For Each Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares of common stock for each unit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling, general and administrative</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate, minimum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate, maximum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected option term / Performance Period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected dividend yield</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected price volatility, minimum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected price volatility, maximum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total intrinsic value of stock options exercised</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash received from stock option exercises</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Excess tax benefit from the exercise of stock options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at December 31 (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited/expired (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending vested and expected to vest (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at December 31 (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited/expired (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending vested and expected to vest (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding, remaining contractual term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable, remaining contractual term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending vested and expected to vest, remaining contractual term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding, intrinsic value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable, intrinsic value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending vested and expected to vest, intrinsic value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Units</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at December 31 (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance (in shares)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in the number of equity-based payment instruments, excluding stock (or unit) options, from the application of the rTSR multiplier as originally specified in the agreements during the reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">rTSR adjustment (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Grant Date Fair Value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at December 31 (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for adjustments made based on the impact of the application of the rTSR multiplier as originally specified in the agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">rTSR adjustment (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Benchmark [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Benchmark [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sales Revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicConcentrationRiskMember" xlink:to="us-gaap_GeographicConcentrationRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographic Concentration</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting Information [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration Risk, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Concentration for geographic sales</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE" xlink:label="country_IE" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IE" xlink:to="country_IE_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IE_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ireland</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NonUSExcludingIrelandMember" xlink:label="mmsi_NonUSExcludingIrelandMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_NonUSExcludingIrelandMember" xlink:to="mmsi_NonUSExcludingIrelandMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_NonUSExcludingIrelandMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-US Countries Excluding Ireland</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_NonUSExcludingIrelandMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other foreign countries</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Segment Reporting Information, by Segment [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Assets from Segment to Consolidated [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of Assets from Segment to Consolidated [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:label="us-gaap_SegmentReportingAssetReconcilingItemLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="us-gaap_SegmentReportingAssetReconcilingItemLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAssetReconcilingItemLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting, Asset Reconciling Item [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingAssetReconcilingItemLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment Reporting, Asset Reconciling Item [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan Disclosure [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Contribution Plan, Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total expense for contributions made</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Recurring and Nonrecurring [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Recurring and Nonrecurring [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Basis [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Portion at Fair Value Measurement [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimate of Fair Value, Fair Value Disclosure</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Frequency [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Frequency [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurements, Recurring</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Hierarchy and NAV [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurements, Fair Value Hierarchy [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Inputs, Level 1</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Inputs, Level 2</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Inputs, Level 3</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable securities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:to="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Rate Cash Flow Hedge Asset at Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate contract asset, long-term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:label="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:to="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Rate Cash Flow Hedge Liability at Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate contract liabilities, long-term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Contract, Asset, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency contract assets, current and long-term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Contracts, Liability, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency contract liabilities, current and long-term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liability Class [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value by Liability Class [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationMember" xlink:label="mmsi_ContingentConsiderationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_ContingentConsiderationMember" xlink:to="mmsi_ContingentConsiderationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_ContingentConsiderationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Consideration [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_ContingentConsiderationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Consideration</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Income [Extensible List]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent payments made</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" xlink:label="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" xlink:to="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of foreign exchange</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related Party [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Director</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CiannaMedicalMember" xlink:label="mmsi_CiannaMedicalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_CiannaMedicalMember" xlink:to="mmsi_CiannaMedicalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_CiannaMedicalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cianna Medical [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_CiannaMedicalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cianna Medical</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_SelioMedicalLimitedSelioMember" xlink:label="mmsi_SelioMedicalLimitedSelioMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_SelioMedicalLimitedSelioMember" xlink:to="mmsi_SelioMedicalLimitedSelioMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_SelioMedicalLimitedSelioMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to Selio Medical Limited ("Selio").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_SelioMedicalLimitedSelioMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selio</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_XableCathMember" xlink:label="mmsi_XableCathMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_XableCathMember" xlink:to="mmsi_XableCathMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_XableCathMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the equity method investment in XableCath.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_XableCathMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">XableCath</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FusionMedicalInc.Member" xlink:label="mmsi_FusionMedicalInc.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_FusionMedicalInc.Member" xlink:to="mmsi_FusionMedicalInc.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_FusionMedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fusion Medical, Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_FusionMedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fusion Medical, Inc.</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BluegrassVascularTechnologiesIncMember" xlink:label="mmsi_BluegrassVascularTechnologiesIncMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BluegrassVascularTechnologiesIncMember" xlink:to="mmsi_BluegrassVascularTechnologiesIncMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BluegrassVascularTechnologiesIncMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represent information related to Bluegrass Vascular Technologies, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BluegrassVascularTechnologiesIncMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bluegrass Vascular Technologies, Inc</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposal Group Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposal Group Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NinePointMedicalInc.Member" xlink:label="mmsi_NinePointMedicalInc.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_NinePointMedicalInc.Member" xlink:to="mmsi_NinePointMedicalInc.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_NinePointMedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">NinePoint Medical, Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_NinePointMedicalInc.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">NinePoint Medical, Inc.</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration liability, noncurrent</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration liability, current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment for Contingent Consideration Liability, Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments related to the settlement of the contingent consideration liability, Operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForMergerRelatedCosts" xlink:to="us-gaap_PaymentsForMergerRelatedCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for Merger Related Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent payments related to acquisition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Impairment Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment loss on operating lease asset</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Method Investment, Other than Temporary Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of equity method investment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of Long-Lived Assets Held-for-use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment of property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing Receivable, Allowance for Credit Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allowance for expected credit losses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment received on entire principal balance and all accrued interest</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Input Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MilestonePaymentProbabilityMember" xlink:label="mmsi_MilestonePaymentProbabilityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_MilestonePaymentProbabilityMember" xlink:to="mmsi_MilestonePaymentProbabilityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_MilestonePaymentProbabilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone Payment Probability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_MilestonePaymentProbabilityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Probability of milestone payment</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueBasedPaymentsMember" xlink:label="mmsi_RevenueBasedPaymentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_RevenueBasedPaymentsMember" xlink:to="mmsi_RevenueBasedPaymentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_RevenueBasedPaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue-based Payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_RevenueBasedPaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue-based royalty</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueMilestonesMember" xlink:label="mmsi_RevenueMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_RevenueMilestonesMember" xlink:to="mmsi_RevenueMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_RevenueMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue Milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_RevenueMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue milestones</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RegulatoryApprovalMilestoneMember" xlink:label="mmsi_RegulatoryApprovalMilestoneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_RegulatoryApprovalMilestoneMember" xlink:to="mmsi_RegulatoryApprovalMilestoneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_RegulatoryApprovalMilestoneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory Approval Milestone [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_RegulatoryApprovalMilestoneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory approval</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeApproachValuationTechniqueMember" xlink:to="us-gaap_IncomeApproachValuationTechniqueMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discounted Cash Flow</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration, Liability, Measurement Input</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unobservable inputs, contingent liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:label="us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:to="us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing Receivable, Allowance for Credit Loss [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing Receivable, Allowance for Credit Loss [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing Receivable, Allowance for Credit Loss [Roll Forward]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed" xlink:label="us-gaap_ProvisionForLoanLossesExpensed" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForLoanLossesExpensed" xlink:to="us-gaap_ProvisionForLoanLossesExpensed_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForLoanLossesExpensed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing Receivable, Credit Loss, Expense (Reversal)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProvisionForLoanLossesExpensed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provision for credit loss expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss) [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow Hedges</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Translation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassification out of Accumulated Other Comprehensive Income [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassification out of Accumulated Other Comprehensive Income [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassification out of Accumulated Other Comprehensive Income [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss) [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated other comprehensive income (loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">OCI, before Reclassifications, before Tax, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income (loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss) before Reclassifications, Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassification from AOCI, Current Period, Tax [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassifications to:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net other comprehensive income (loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Lease, Description [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Lease, Description [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Lease, Description [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Lease, Description [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Term of Contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remaining lease term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Renewal Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Renewal term (up to)</label>
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LesseeOperatingLeaseTerminationPeriod" xlink:label="mmsi_LesseeOperatingLeaseTerminationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mmsi_LesseeOperatingLeaseTerminationPeriod" xlink:to="mmsi_LesseeOperatingLeaseTerminationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mmsi_LesseeOperatingLeaseTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Termination Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mmsi_LesseeOperatingLeaseTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Termination Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mmsi_LesseeOperatingLeaseTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Termination option (within)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating lease cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sublease Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sublease (income)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lease, Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net lease cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash paid for amounts included in the measurement of lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Weighted Average Remaining Lease Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining lease term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average discount rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2023</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2024</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2025</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2026</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2027</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due after Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Thereafter</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Payments, Due</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total minimum lease payments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less: Imputed interest</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="us-gaap_AllowanceForCreditLossMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossMember" xlink:to="us-gaap_AllowanceForCreditLossMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allowance for Doubtful Accounts</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Valuation Allowance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at End of Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at Beginning of Year</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions Charged to Costs and Expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deduction</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>24
<FILENAME>mmsi-20221231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/24/2023 8:59:49 PM-->
<!--Modified on: 2/24/2023 8:59:49 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DocumentCoverPage" roleURI="http://www.merit.com/role/DocumentCoverPage" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedBalanceSheetsParenthetical" roleURI="http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfIncome" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#StatementConsolidatedStatementsOfCashFlowsParenthetical" roleURI="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevenues" roleURI="http://www.merit.com/role/DisclosureRevenues" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactions" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureInventories" roleURI="http://www.merit.com/role/DisclosureInventories" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssets" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxes" roleURI="http://www.merit.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccruedExpenses" roleURI="http://www.merit.com/role/DisclosureAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebt" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivatives" roleURI="http://www.merit.com/role/DisclosureDerivatives" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://www.merit.com/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEarningsPerCommonShareEps" roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEps" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperations" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeBenefitPlans" roleURI="http://www.merit.com/role/DisclosureEmployeeBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurements" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurements" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeases" roleURI="http://www.merit.com/role/DisclosureLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureScheduleIiValuationAndQualifyingAccounts" roleURI="http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevenuesTables" roleURI="http://www.merit.com/role/DisclosureRevenuesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactionsTables" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureInventoriesTables" roleURI="http://www.merit.com/role/DisclosureInventoriesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsTables" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesTables" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccruedExpensesTables" roleURI="http://www.merit.com/role/DisclosureAccruedExpensesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtTables" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesTables" roleURI="http://www.merit.com/role/DisclosureDerivativesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEarningsPerCommonShareEpsTables" roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsTables" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsTables" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesTables" roleURI="http://www.merit.com/role/DisclosureLeasesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" roleURI="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevenuesDisaggregationOfRevenueDetails" roleURI="http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAcquisitionsPurchasePriceAllocationDetails" roleURI="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureInventoriesDetails" roleURI="http://www.merit.com/role/DisclosureInventoriesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsGoodwillDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails" roleURI="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesDomesticAndForeignDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails" roleURI="http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccruedExpensesDetails" roleURI="http://www.merit.com/role/DisclosureAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" roleURI="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesForwardNotionalContractsDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" roleURI="http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureCommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEarningsPerCommonShareEpsBasicEpsDetails" roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" roleURI="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" roleURI="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureEmployeeBenefitPlansDetails" roleURI="http://www.merit.com/role/DisclosureEmployeeBenefitPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails" roleURI="http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" roleURI="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesNarrativeDetails" roleURI="http://www.merit.com/role/DisclosureLeasesNarrativeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" roleURI="http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesComponentsOfLeaseCostDetails" roleURI="http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesSupplementalCashFlowInformationDetails" roleURI="http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesSupplementalDisclosureDetails" roleURI="http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" roleURI="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="mmsi-20221231.xsd#ScheduleScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <presentationLink xlink:role="http://www.merit.com/role/DocumentCoverPage" xlink:type="extended" xlink:title="00090 - Document - Cover Page" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638128691856409225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638128691856409225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentAnnualReport_638128691856419226" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentTransitionReport_638128691856419226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638128691856419226" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638128691856419226" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638128691856419226" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638128691856419226" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638128691856419226" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638128691856419226" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638128691856419226" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638128691856419226" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638128691856419226" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638128691856419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638128691856419226" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638128691856429227" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638128691856429227" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638128691856429227" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638128691856429227" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638128691856429227" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer_638128691856429227" order="19" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityVoluntaryFilers_638128691856429227" order="20" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus_638128691856429227" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent_638128691856429227" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638128691856429227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFilerCategory_638128691856429227" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntitySmallBusiness_638128691856439223" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638128691856439223" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag_638128691856439223" order="26" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityShellCompany_638128691856439223" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_638128691856439223" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityPublicFloat_638128691856439223" order="29" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AuditorName_638128691856439223" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_638128691856439223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AuditorFirmId_638128691856439223" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_638128691856449224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AuditorLocation_638128691856449224" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638128691856449224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_638128691856449224" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_638128691856449224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus_638128691856449224" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_638128691856449224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_638128691856449224" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638128691856449224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638128691856449224" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_638128691856459226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856459226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856459226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856459226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856459226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856459226" xlink:to="us-gaap_DevelopedTechnologyRightsMember_638128691856459226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856459226" xlink:to="us-gaap_OtherIntangibleAssetsMember_638128691856459226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856459226" xlink:to="us-gaap_StatementLineItems_638128691856459226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638128691856459226" xlink:to="us-gaap_AssetsAbstract_638128691856459226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638128691856459226" xlink:to="us-gaap_AssetsCurrentAbstract_638128691856459226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691856459226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_AccountsReceivableNetCurrent_638128691856459226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_NontradeReceivablesCurrent_638128691856459226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_InventoryNet_638128691856459226" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638128691856459226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638128691856459226" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_PrepaidTaxes_638128691856469222" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_IncomeTaxesReceivable_638128691856469222" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856459226" xlink:to="us-gaap_AssetsCurrent_638128691856469222" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638128691856459226" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land" xlink:label="us-gaap_Land_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_Land_638128691856469222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="us-gaap_BuildingsAndImprovementsGross_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_BuildingsAndImprovementsGross_638128691856469222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="us-gaap_MachineryAndEquipmentGross_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_MachineryAndEquipmentGross_638128691856469222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_FurnitureAndFixturesGross_638128691856469222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_LeaseholdImprovementsGross_638128691856469222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross_638128691856469222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_ConstructionInProgressGross_638128691856469222" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_638128691856479226" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638128691856479226" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_638128691856469222" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638128691856479226" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638128691856459226" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638128691856479226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" xlink:to="us-gaap_Goodwill_638128691856479226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_638128691856479226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638128691856479226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638128691856479226" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" xlink:to="us-gaap_OtherAssetsNoncurrent_638128691856489220" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856479226" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent_638128691856489220" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_638128691856459226" xlink:to="us-gaap_Assets_638128691856489220" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638128691856459226" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" xlink:to="us-gaap_AccountsPayableTradeCurrent_638128691856489220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638128691856489220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_638128691856489220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" xlink:to="us-gaap_LongTermDebtCurrent_638128691856489220" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638128691856499227" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_638128691856499227" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638128691856489220" xlink:to="us-gaap_LiabilitiesCurrent_638128691856499227" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_LongTermDebtNoncurrent_638128691856499227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691856499227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent_638128691856499227" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_638128691856499227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_638128691856499227" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_638128691856509221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_638128691856509221" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_638128691856509221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_638128691856509221" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691856509221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691856509221" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638128691856509221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638128691856509221" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638128691856509221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_Liabilities_638128691856509221" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638128691856509221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_CommitmentsAndContingencies_638128691856509221" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638128691856519224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" xlink:to="us-gaap_PreferredStockValue_638128691856519224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638128691856519224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" xlink:to="us-gaap_CommonStockValue_638128691856519224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638128691856519224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638128691856519224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_638128691856519224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_638128691856519224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638128691856519224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856519224" xlink:to="us-gaap_StockholdersEquity_638128691856519224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_638128691856529230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_638128691856489220" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_638128691856529230" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638128691856529230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_638128691856529230" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856529230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856529230" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856529230" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856529230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856529230" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856529230" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember_638128691856529230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856529230" xlink:to="us-gaap_DevelopedTechnologyRightsMember_638128691856529230" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember_638128691856529230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856529230" xlink:to="us-gaap_OtherIntangibleAssetsMember_638128691856529230" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856529230" xlink:to="us-gaap_StatementLineItems_638128691856539220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638128691856539220" xlink:to="us-gaap_AssetsCurrentAbstract_638128691856539220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638128691856539220" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_638128691856539220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract" xlink:label="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638128691856539220" xlink:to="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856539220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract_638128691856539220" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638128691856539220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638128691856539220" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" xlink:to="us-gaap_PreferredStockSharesAuthorized_638128691856539220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638128691856539220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" xlink:to="us-gaap_PreferredStockSharesIssued_638128691856539220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638128691856589224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" xlink:to="us-gaap_CommonStockSharesAuthorized_638128691856589224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" xlink:to="us-gaap_CommonStockSharesIssued_638128691856589224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_638128691856539220" xlink:to="us-gaap_CommonStockSharesOutstanding_638128691856589224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfIncome" xlink:type="extended" xlink:title="00200 - Statement - CONSOLIDATED STATEMENTS OF INCOME" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691856589224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold_638128691856589224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit_638128691856589224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit_638128691856589224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_638128691856599218" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_638128691856599218" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_638128691856599218" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="us-gaap_LitigationSettlementExpense_638128691856599218" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="us-gaap_AssetImpairmentCharges_638128691856599218" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit" xlink:label="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit_638128691856599218" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691856599218" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638128691856599218" xlink:to="us-gaap_OperatingExpenses_638128691856599218" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_638128691856599218" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_638128691856599218" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638128691856599218" xlink:to="us-gaap_InvestmentIncomeNet_638128691856599218" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_638128691856599218" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638128691856599218" xlink:to="us-gaap_InterestExpense_638128691856599218" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638128691856599218" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638128691856609223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract_638128691856599218" xlink:to="us-gaap_NonoperatingIncomeExpense_638128691856609223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691856609223" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638128691856609223" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_638128691856609223" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_638128691856609223" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_638128691856609223" xlink:to="us-gaap_EarningsPerShareBasic_638128691856609223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_638128691856609223" xlink:to="us-gaap_EarningsPerShareDiluted_638128691856609223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638128691856609223" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691856609223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638128691856609223" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691856609223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_638128691856609223" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638128691856619222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" xlink:title="00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss_638128691856619222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_638128691856619222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_638128691856619222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_638128691856619222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_638128691856619222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_638128691856619222" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691856619222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_638128691856619222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_638128691856619222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_638128691856629223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856629223" xlink:to="us-gaap_StatementEquityComponentsAxis_638128691856629223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638128691856629223" xlink:to="us-gaap_CommonStockMember_638128691856629223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638128691856629223" xlink:to="us-gaap_RetainedEarningsMember_638128691856629223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638128691856629223" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_638128691856629223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638128691856629223" xlink:to="us-gaap_EquityComponentDomain_638128691856629223" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856629223" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_638128691856629223" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis_638128691856629223" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_638128691856629223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis_638128691856629223" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_638128691856629223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856629223" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638128691856629223" order="3" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638128691856629223" xlink:to="us-gaap_AccountingStandardsUpdate201613Member_638128691856629223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_638128691856629223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638128691856629223" xlink:to="us-gaap_TypeOfAdoptionMember_638128691856629223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638128691856629223" xlink:to="us-gaap_StatementLineItems_638128691856639222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638128691856639222" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockholdersEquity_638128691856639222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_CommonStockSharesOutstanding_638128691856639222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_NetIncomeLoss_638128691856639222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_638128691856639222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_638128691856639222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638128691856639222" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638128691856639222" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_638128691856639222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_638128691856639222" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_638128691856649221" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_638128691856649221" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised_638128691856649221" order="11" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised_638128691856649221" order="12" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_638128691856649221" order="13" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_638128691856649221" order="14" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_StockholdersEquity_638128691856649221" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638128691856649221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_638128691856639222" xlink:to="us-gaap_CommonStockSharesOutstanding_638128691856649221" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_NetIncomeLoss_638128691856659221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_DepreciationDepletionAndAmortization_638128691856659221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="us-gaap_GainLossOnSaleOfBusiness_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_GainLossOnSaleOfBusiness_638128691856659221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_GainLossOnDispositionOfAssets_638128691856659221" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="us-gaap_GoodwillAndIntangibleAssetImpairment_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_GoodwillAndIntangibleAssetImpairment_638128691856659221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_638128691856659221" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_638128691856659221" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_638128691856659221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_638128691856659221" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638128691856669224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_AmortizationOfFinancingCosts_638128691856669224" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691856669224" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_ShareBasedCompensation_638128691856669224" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_638128691856669224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_638128691856669224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInInventories_638128691856669224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638128691856669224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="us-gaap_IncreaseDecreaseInPrepaidTaxes_638128691856669224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInPrepaidTaxes_638128691856669224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_638128691856679224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_638128691856679224" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_638128691856679224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_638128691856679224" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_638128691856679224" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions" xlink:label="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions_638128691856679224" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_638128691856679224" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_638128691856679224" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638128691856679224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_638128691856679224" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638128691856669224" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_638128691856689293" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638128691856659221" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638128691856689293" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:label="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_638128691856689293" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_638128691856689293" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638128691856689293" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PaymentsToAcquireProductiveAssetsAbstract_638128691856689293" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_638128691856689293" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_638128691856689293" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_638128691856689293" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_638128691856689293" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable_638128691856699228" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_638128691856699228" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_638128691856699228" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_638128691856689293" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638128691856699228" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638128691856699228" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_638128691856699228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_638128691856699228" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt_638128691856709228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" xlink:to="us-gaap_RepaymentsOfLongTermDebt_638128691856709228" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_638128691856709228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_638128691856709228" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock" xlink:label="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_638128691856709228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" xlink:to="mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock_638128691856709228" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691856709228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638128691856699228" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638128691856709228" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638128691856709228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_638128691856709228" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638128691856709228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_638128691856709228" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_638128691856719224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_638128691856719224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638128691856719224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_638128691856719224" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638128691856719224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6381286918567192241" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_638128691856719224" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6381286918567192241" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856719224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856719224" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691856719224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856719224" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638128691856719224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691856719224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856719224" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691856719224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList_638128691856729223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691856719224" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList_638128691856729223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638128691856729223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856719224" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638128691856729223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_638128691856729223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_638128691856729223" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet_638128691856729223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_638128691856729223" xlink:to="us-gaap_InterestPaidNet_638128691856729223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet_638128691856729223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_638128691856729223" xlink:to="us-gaap_IncomeTaxesPaidNet_638128691856729223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_638128691856739239" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_638128691856739239" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable" xlink:label="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable_638128691856739239" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" xlink:to="mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable_638128691856739239" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_638128691856739239" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_638128691856739239" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses" xlink:label="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses_638128691856739239" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" xlink:to="mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses_638128691856739239" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_638128691856749226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" xlink:to="mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised_638128691856749226" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_638128691856749226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_638128691856739239" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_638128691856749226" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="extended" xlink:title="00505 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidCapitalized" xlink:label="us-gaap_InterestPaidCapitalized_638128691856749226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_InterestPaidCapitalized_638128691856749226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised" xlink:label="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_638128691856749226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised_638128691856749226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" xlink:title="10101 - Disclosure - Organization and Summary of Significant Accounting Policies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_638128691856759229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_638128691856759229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevenues" xlink:type="extended" xlink:title="10201 - Disclosure - Revenues" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_638128691856759229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_638128691856759229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions" xlink:type="extended" xlink:title="10301 - Disclosure - Acquisitions and Other Strategic Transactions" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_638128691856759229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_638128691856759229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureInventories" xlink:type="extended" xlink:title="10401 - Disclosure - Inventories" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock_638128691856769224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock_638128691856769224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets" xlink:type="extended" xlink:title="10501 - Disclosure - Goodwill and Intangible Assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_638128691856769224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_638128691856769224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="10601 - Disclosure - Income Taxes" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_638128691856769224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_638128691856769224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAccruedExpenses" xlink:type="extended" xlink:title="10701 - Disclosure - Accrued Expenses" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_638128691856769224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_638128691856769224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt" xlink:type="extended" xlink:title="10801 - Disclosure - Revolving Credit Facility and Long-Term Debt" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock_638128691856779228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock_638128691856779228" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivatives" xlink:type="extended" xlink:title="10901 - Disclosure - Derivatives" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_638128691856779228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_638128691856779228" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="11001 - Disclosure - Commitments and Contingencies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638128691856779228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_638128691856779228" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEarningsPerCommonShareEps" xlink:type="extended" xlink:title="11101 - Disclosure - Earnings Per Common Share (EPS)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock_638128691856789221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock_638128691856789221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants" xlink:type="extended" xlink:title="11201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_638128691856789221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_638128691856789221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations" xlink:type="extended" xlink:title="11301 - Disclosure - Segment Reporting and Foreign Operations" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_638128691856789221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_638128691856789221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeBenefitPlans" xlink:type="extended" xlink:title="11401 - Disclosure - Employee Benefit Plans" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_638128691856799232" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_638128691856799232" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurements" xlink:type="extended" xlink:title="11501 - Disclosure - Fair Value Measurements" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_638128691856799232" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_638128691856799232" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" xlink:title="11601 - Disclosure - Accumulated Other Comprehensive Income (Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_638128691856799232" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_638128691856799232" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeases" xlink:type="extended" xlink:title="11701 - Disclosure - Leases" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_638128691856809227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_638128691856809227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" xlink:title="11801 - Disclosure - Schedule II - Valuation and qualifying accounts" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_638128691856809227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_638128691856809227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20102 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_638128691856809227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_UseOfEstimates_638128691856809227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock_638128691856809227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock_638128691856809227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638128691856809227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638128691856809227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock_638128691856809227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock_638128691856809227" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock_638128691856819225" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_638128691856819225" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_638128691856819225" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638128691856819225" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock" xlink:label="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock_638128691856819225" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock" xlink:label="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock_638128691856819225" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_638128691856819225" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_638128691856819225" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_638128691856819225" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_638128691856819225" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_638128691856819225" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_638128691856819225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_638128691856819225" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638128691856829222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638128691856829222" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ConcentrationOfCreditRiskPolicyTextBlock" xlink:label="mmsi_ConcentrationOfCreditRiskPolicyTextBlock_638128691856829222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mmsi_ConcentrationOfCreditRiskPolicyTextBlock_638128691856829222" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_638128691856829222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_638128691856829222" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock_638128691856829222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock_638128691856829222" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638128691856829222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_638128691856829222" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" xlink:title="30103 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_638128691856829222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_638128691856829222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_638128691856839227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_638128691856839227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevenuesTables" xlink:type="extended" xlink:title="30203 - Disclosure - Revenues (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_638128691856839227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables" xlink:type="extended" xlink:title="30303 - Disclosure - Acquisitions and Other Strategic Transactions (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856839227" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856839227" xlink:to="us-gaap_BusinessAcquisitionAxis_638128691856839227" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_638128691856839227" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_638128691856839227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691856839227" xlink:to="mmsi_KaMedicalLLCMember_638128691856839227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856839227" xlink:to="us-gaap_BusinessAcquisitionLineItems_638128691856839227" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_638128691856839227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856839227" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_638128691856839227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureInventoriesTables" xlink:type="extended" xlink:title="30403 - Disclosure - Inventories (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_638128691856849219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_638128691856849219" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables" xlink:type="extended" xlink:title="30503 - Disclosure - Goodwill and Intangible Assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_638128691856849219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_638128691856849219" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_638128691856849219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_638128691856849219" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_638128691856849219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_638128691856849219" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="30603 - Disclosure - Income Taxes (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_638128691856859227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_638128691856859227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_638128691856859227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_638128691856859227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638128691856859227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_638128691856859227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638128691856859227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_638128691856859227" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_638128691856859227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_638128691856859227" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAccruedExpensesTables" xlink:type="extended" xlink:title="30703 - Disclosure - Accrued Expenses (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_638128691856859227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_638128691856859227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables" xlink:type="extended" xlink:title="30803 - Disclosure - Revolving Credit Facility and Long-Term Debt (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_638128691856869225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_638128691856869225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock" xlink:label="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock_638128691856869225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock_638128691856869225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_638128691856869225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_638128691856869225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivativesTables" xlink:type="extended" xlink:title="30903 - Disclosure - Derivatives (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_638128691856869225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_638128691856869225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_638128691856869225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_638128691856869225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_638128691856869225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_638128691856869225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables" xlink:type="extended" xlink:title="31103 - Disclosure - Earnings Per Common Share (EPS) (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638128691856879223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables" xlink:type="extended" xlink:title="31203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_638128691856879223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_638128691856879223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_638128691856879223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_638128691856879223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock" xlink:label="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock_638128691856879223" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock" xlink:label="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock_638128691856879223" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock" xlink:label="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock_638128691856879223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock_638128691856879223" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables" xlink:type="extended" xlink:title="31303 - Disclosure - Segment Reporting and Foreign Operations (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_638128691856889223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_638128691856889223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_638128691856889223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsTables" xlink:type="extended" xlink:title="31503 - Disclosure - Fair Value Measurements (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_638128691856889223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_638128691856889223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_638128691856889223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_638128691856889223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_638128691856889223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" xlink:title="31603 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_638128691856899219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_638128691856899219" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesTables" xlink:type="extended" xlink:title="31703 - Disclosure - Leases (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:label="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock_638128691856899219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="mmsi_AssetsAndLiabilitiesLesseeTableTextBlock_638128691856899219" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock_638128691856899219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock_638128691856899219" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_638128691856899219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_638128691856899219" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - Organization and Summary of Significant Accounting Policies - Organization (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NumberOfOperatingSegments_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NumberOfProductCategories" xlink:label="mmsi_NumberOfProductCategories_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mmsi_NumberOfProductCategories_638128691856909220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" xlink:type="extended" xlink:title="40102 - Disclosure - Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_638128691856909220" xlink:to="srt_StatementGeographicalAxis_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638128691856909220" xlink:to="srt_SegmentGeographicalDomain_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN" xlink:label="country_CN_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691856909220" xlink:to="country_CN_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_638128691856909220" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_638128691856909220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_638128691856909220" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_638128691856909220" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList_638128691856909220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_638128691856909220" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList_638128691856909220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="extended" xlink:title="40103 - Disclosure - Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638128691856919223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638128691856919223" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638128691856919223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638128691856919223" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" xlink:to="us-gaap_BuildingMember_638128691856919223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" xlink:to="us-gaap_EquipmentMember_638128691856919223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" xlink:to="us-gaap_FurnitureAndFixturesMember_638128691856919223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandImprovementsMember" xlink:label="us-gaap_LandImprovementsMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" xlink:to="us-gaap_LandImprovementsMember_638128691856919223" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638128691856919223" xlink:to="us-gaap_LeaseholdImprovementsMember_638128691856919223" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638128691856919223" xlink:to="srt_RangeAxis_638128691856919223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691856919223" xlink:to="srt_RangeMember_638128691856919223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691856919223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691856919223" xlink:to="srt_MinimumMember_638128691856919223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691856919223" xlink:to="srt_MaximumMember_638128691856929227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638128691856919223" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_638128691856929227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits" xlink:label="us-gaap_NumberOfReportingUnits_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638128691856929227" xlink:to="us-gaap_NumberOfReportingUnits_638128691856929227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638128691856929227" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_638128691856929227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638128691856929227" xlink:to="us-gaap_Depreciation_638128691856929227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails" xlink:type="extended" xlink:title="40104 - Disclosure - Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance" xlink:label="us-gaap_CashSurrenderValueOfLifeInsurance_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashSurrenderValueOfLifeInsurance_638128691856929227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_638128691856929227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_638128691856929227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="extended" xlink:title="40105 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract" xlink:label="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_638128691856939223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="us-gaap_DeferredCompensationPlanAssets_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" xlink:to="us-gaap_DeferredCompensationPlanAssets_638128691856939223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_638128691856939223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent_638128691856939223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsNoncurrentAbstract_638128691856939223" xlink:to="us-gaap_OtherAssetsNoncurrent_638128691856939223" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails" xlink:type="extended" xlink:title="40106 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691856939223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OtherLongTermDebt_638128691856939223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638128691856939223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638128691856939223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="extended" xlink:title="40107 - Disclosure - Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638128691856949223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Revenues - Disaggregation of Revenue (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable_638128691856949223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638128691856949223" xlink:to="us-gaap_StatementBusinessSegmentsAxis_638128691856949223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis_638128691856949223" xlink:to="us-gaap_SegmentDomain_638128691856949223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691856949223" xlink:to="mmsi_CardiovascularSegmentMember_638128691856949223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691856949223" xlink:to="mmsi_EndoscopySegmentMember_638128691856949223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638128691856949223" xlink:to="srt_StatementGeographicalAxis_638128691856949223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638128691856949223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638128691856949223" xlink:to="srt_SegmentGeographicalDomain_638128691856949223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691856949223" xlink:to="country_US_638128691856959227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691856949223" xlink:to="us-gaap_NonUsMember_638128691856959227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638128691856949223" xlink:to="srt_ProductOrServiceAxis_638128691856959227" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis_638128691856959227" xlink:to="srt_ProductsAndServicesDomain_638128691856959227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PeripheralInterventionMember" xlink:label="mmsi_PeripheralInterventionMember_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain_638128691856959227" xlink:to="mmsi_PeripheralInterventionMember_638128691856959227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiacInterventionMember" xlink:label="mmsi_CardiacInterventionMember_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain_638128691856959227" xlink:to="mmsi_CardiacInterventionMember_638128691856959227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CustomProceduralSolutionsMember" xlink:label="mmsi_CustomProceduralSolutionsMember_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain_638128691856959227" xlink:to="mmsi_CustomProceduralSolutionsMember_638128691856959227" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OEMMember" xlink:label="mmsi_OEMMember_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain_638128691856959227" xlink:to="mmsi_OEMMember_638128691856959227" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopyDevicesMember" xlink:label="mmsi_EndoscopyDevicesMember_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain_638128691856959227" xlink:to="mmsi_EndoscopyDevicesMember_638128691856959227" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable_638128691856949223" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_638128691856959227" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638128691856959227" xlink:to="us-gaap_NumberOfOperatingSegments_638128691856959227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NumberOfProductCategories" xlink:label="mmsi_NumberOfProductCategories_638128691856959227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638128691856959227" xlink:to="mmsi_NumberOfProductCategories_638128691856959227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems_638128691856959227" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691856969221" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Acquisitions and Other Strategic Transactions - Asset Purchase (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_AssetAcquisitionTable_638128691856969221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638128691856969221" xlink:to="us-gaap_AssetAcquisitionAxis_638128691856969221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis_638128691856969221" xlink:to="us-gaap_AssetAcquisitionDomain_638128691856969221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BiotraceMedicalIncMember" xlink:label="mmsi_BiotraceMedicalIncMember_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain_638128691856969221" xlink:to="mmsi_BiotraceMedicalIncMember_638128691856969221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RestoreEndosystemsLLCMember" xlink:label="mmsi_RestoreEndosystemsLLCMember_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain_638128691856969221" xlink:to="mmsi_RestoreEndosystemsLLCMember_638128691856969221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638128691856969221" xlink:to="srt_RangeAxis_638128691856969221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691856969221" xlink:to="srt_RangeMember_638128691856969221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691856969221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691856969221" xlink:to="srt_MinimumMember_638128691856969221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691856969221" xlink:to="srt_MaximumMember_638128691856979225" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638128691856969221" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856979225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856979225" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856979225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856979225" xlink:to="us-gaap_DevelopedTechnologyRightsMember_638128691856979225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856979225" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_638128691856979225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638128691856969221" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_638128691856979225" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis_638128691856979225" xlink:to="us-gaap_ContingentConsiderationTypeDomain_638128691856979225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentOneMember" xlink:label="mmsi_ContingentConsiderationPaymentOneMember_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain_638128691856979225" xlink:to="mmsi_ContingentConsiderationPaymentOneMember_638128691856979225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentTwoMember" xlink:label="mmsi_ContingentConsiderationPaymentTwoMember_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain_638128691856979225" xlink:to="mmsi_ContingentConsiderationPaymentTwoMember_638128691856979225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638128691856969221" xlink:to="us-gaap_AssetAcquisitionLineItems_638128691856979225" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_638128691856979225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments" xlink:label="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments_638128691856979225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments_638128691856979225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue" xlink:label="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue_638128691856989224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_638128691856989224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_638128691856989224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationPaymentPeriod" xlink:label="mmsi_ContingentConsiderationPaymentPeriod_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="mmsi_ContingentConsiderationPaymentPeriod_638128691856989224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638128691856979225" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1_638128691856989224" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails" xlink:type="extended" xlink:title="40302 - Disclosure - Acquisitions and Other Strategic Transactions - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856989224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_638128691856989224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856989224" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_638128691856989224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_638128691856989224" xlink:to="srt_EquityMethodInvesteeNameDomain_638128691856999227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FluidxMedicalTechnologyLLCMember" xlink:label="mmsi_FluidxMedicalTechnologyLLCMember_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain_638128691856999227" xlink:to="mmsi_FluidxMedicalTechnologyLLCMember_638128691856999227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856989224" xlink:to="us-gaap_BusinessAcquisitionAxis_638128691856999227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_638128691856999227" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_638128691856999227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691856999227" xlink:to="mmsi_KaMedicalLLCMember_638128691856999227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856989224" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856999227" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691856999227" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856999227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691856999227" xlink:to="us-gaap_DevelopedTechnologyRightsMember_638128691856999227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691856989224" xlink:to="us-gaap_BusinessAcquisitionLineItems_638128691856999227" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_638128691856999227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_638128691856999227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_638128691856999227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_638128691856999227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationConsiderationTransferredNotePayable" xlink:label="mmsi_BusinessCombinationConsiderationTransferredNotePayable_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="mmsi_BusinessCombinationConsiderationTransferredNotePayable_638128691857009231" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_638128691857009231" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_EquityMethodInvestments_638128691857009231" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691857009231" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_638128691857009231" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691856999227" xlink:to="us-gaap_AssetImpairmentCharges_638128691857009231" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Acquisitions - Purchase Price Allocation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691857009231" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_638128691857009231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691857009231" xlink:to="us-gaap_BusinessAcquisitionAxis_638128691857009231" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_638128691857009231" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857019229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_KaMedicalLLCMember" xlink:label="mmsi_KaMedicalLLCMember_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857019229" xlink:to="mmsi_KaMedicalLLCMember_638128691857019229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691857009231" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691857019229" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691857019229" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691857019229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691857019229" xlink:to="us-gaap_DevelopedTechnologyRightsMember_638128691857019229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638128691857009231" xlink:to="us-gaap_BusinessAcquisitionLineItems_638128691857019229" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables_638128691857019229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables_638128691857019229" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_638128691857019229" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_638128691857019229" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_638128691857019229" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_638128691857019229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_638128691857019229" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="us-gaap_Goodwill_638128691857029223" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_638128691857019229" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill_638128691857029223" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_638128691857029223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_638128691857029223" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_638128691857029223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_638128691857029223" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_638128691857029223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_638128691857029223" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_638128691857029223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_638128691857029223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638128691857019229" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_638128691857029223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureInventoriesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Inventories (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="InventoryDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_638128691857039223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_638128691857039223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_638128691857039223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet_638128691857039223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward" xlink:label="us-gaap_GoodwillRollForward_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillRollForward_638128691857039223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward_638128691857039223" xlink:to="us-gaap_Goodwill_638128691857039223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="us-gaap_GoodwillForeignCurrencyTranslationGainLoss_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward_638128691857039223" xlink:to="us-gaap_GoodwillForeignCurrencyTranslationGainLoss_638128691857039223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions" xlink:label="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions_638128691857039223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward_638128691857039223" xlink:to="mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions_638128691857039223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward_638128691857039223" xlink:to="us-gaap_Goodwill_638128691857049229" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Goodwill and Intangible Assets - Other Intangible Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857049229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857049229" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691857049229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638128691857049229" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691857049229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638128691857049229" xlink:to="us-gaap_OtherIntangibleAssetsMember_638128691857049229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIntangibleAssetsMember_638128691857049229" xlink:to="us-gaap_PatentsMember_638128691857049229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DistributionRightsMember" xlink:label="us-gaap_DistributionRightsMember_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIntangibleAssetsMember_638128691857049229" xlink:to="us-gaap_DistributionRightsMember_638128691857049229" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIntangibleAssetsMember_638128691857049229" xlink:to="us-gaap_LicensingAgreementsMember_638128691857049229" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIntangibleAssetsMember_638128691857049229" xlink:to="us-gaap_TrademarksMember_638128691857049229" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember" xlink:label="us-gaap_CustomerListsMember_638128691857049229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIntangibleAssetsMember_638128691857049229" xlink:to="us-gaap_CustomerListsMember_638128691857049229" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857049229" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857059226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857059226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_638128691857059226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857059226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638128691857059226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857059226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638128691857059226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails" xlink:type="extended" xlink:title="40503 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857059226" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857059226" xlink:to="us-gaap_BusinessAcquisitionAxis_638128691857059226" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_638128691857059226" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857059226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_STDPharmaceuticalProductsLimitedMember" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857059226" xlink:to="mmsi_STDPharmaceuticalProductsLimitedMember_638128691857059226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LauraneMedicalS.A.S.Member" xlink:label="mmsi_LauraneMedicalS.A.S.Member_638128691857059226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857059226" xlink:to="mmsi_LauraneMedicalS.A.S.Member_638128691857059226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_OtherIntangibleAssetsAcquiredMember" xlink:label="mmsi_OtherIntangibleAssetsAcquiredMember_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857059226" xlink:to="mmsi_OtherIntangibleAssetsAcquiredMember_638128691857069222" order="3" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857059226" xlink:to="us-gaap_TypeOfArrangementAxis_638128691857069222" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638128691857069222" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638128691857069222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LicenseAgreementArravascLimitedMember" xlink:label="mmsi_LicenseAgreementArravascLimitedMember_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638128691857069222" xlink:to="mmsi_LicenseAgreementArravascLimitedMember_638128691857069222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638128691857059226" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857069222" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857069222" xlink:to="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_638128691857069222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857069222" xlink:to="us-gaap_GoodwillImpairmentLoss_638128691857069222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857069222" xlink:to="us-gaap_AmortizationOfIntangibleAssets_638128691857069222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638128691857069222" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_638128691857069222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857069222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_638128691857069222" xlink:to="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857069222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended" xlink:title="40504 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638128691857079224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638128691857079224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638128691857079224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638128691857079224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_638128691857079224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_638128691857079224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_638128691857149221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_638128691857149221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_638128691857159215" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Income Taxes - Domestic and Foreign (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_638128691857159215" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_638128691857159215" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_638128691857159215" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857159215" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857159215" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_638128691857159215" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857159215" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_638128691857159215" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857159215" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_638128691857159215" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691857159215" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857159215" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_638128691857159215" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857169224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857169224" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_638128691857169224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857169224" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_638128691857169224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857169224" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_638128691857169224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_638128691857169224" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_638128691857169224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638128691857169224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended" xlink:title="40603 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_638128691857169224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_638128691857169224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_638128691857169224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_638128691857169224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_638128691857169224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_638128691857169224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingencies_638128691857179224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:label="us-gaap_IncomeTaxReconciliationTaxExemptIncome_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxExemptIncome_638128691857179224" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_638128691857179224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_638128691857179224" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:label="us-gaap_IncomeTaxReconciliationTaxSettlements_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxSettlements_638128691857179224" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount_638128691857179224" order="11" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_638128691857179224" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount" xlink:label="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount_638128691857179224" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_638128691857179224" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638128691857179224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638128691857179224" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="40604 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_638128691857189224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_638128691857189224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsInventory_638128691857189224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_638128691857189224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_638128691857189224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_638128691857189224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch" xlink:label="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch_638128691857189224" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch" xlink:label="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch_638128691857189224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense" xlink:label="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_638128691857189224" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsOther_638128691857189224" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_638128691857189224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract_638128691857189224" xlink:to="us-gaap_DeferredTaxAssetsGross_638128691857189224" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpense" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpense_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpense_638128691857199225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_638128691857199225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_638128691857199225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DeferredTaxLiabilitiesForeignWithholdingTax" xlink:label="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="mmsi_DeferredTaxLiabilitiesForeignWithholdingTax_638128691857199225" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_638128691857199225" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_638128691857199225" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract_638128691857199225" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_638128691857199225" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_638128691857199225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities_638128691857199225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities_638128691857199225" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_638128691857209219" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_638128691857209219" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_638128691857209219" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_638128691857209219" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_638128691857209219" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_638128691857209219" xlink:to="us-gaap_DeferredTaxLiabilities_638128691857209219" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails" xlink:type="extended" xlink:title="40605 - Disclosure - Income Taxes - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_638128691857209219" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_638128691857209219" xlink:to="us-gaap_IncomeTaxAuthorityAxis_638128691857209219" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_638128691857209219" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis_638128691857209219" xlink:to="us-gaap_IncomeTaxAuthorityDomain_638128691857209219" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638128691857209219" xlink:to="us-gaap_DomesticCountryMember_638128691857219229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain_638128691857209219" xlink:to="us-gaap_ForeignCountryMember_638128691857219229" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_638128691857209219" xlink:to="srt_RangeAxis_638128691857219229" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857219229" xlink:to="srt_RangeMember_638128691857219229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857219229" xlink:to="srt_MaximumMember_638128691857219229" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_638128691857209219" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_638128691857219229" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_638128691857219229" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_638128691857219229" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_638128691857219229" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NetOperatingLossCarryforwardsUtilization" xlink:label="mmsi_NetOperatingLossCarryforwardsUtilization_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="mmsi_NetOperatingLossCarryforwardsUtilization_638128691857219229" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod" xlink:label="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod_638128691857219229" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_638128691857219229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_638128691857219229" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_638128691857229224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities" xlink:label="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities_638128691857229224" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties" xlink:label="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties_638128691857229224" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_638128691857229224" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets_638128691857229224" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_638128691857229224" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits" xlink:label="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits_638128691857229224" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_638128691857229224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_638128691857219229" xlink:to="us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_638128691857229224" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails" xlink:type="extended" xlink:title="40606 - Disclosure - Income Taxes - Summary of Income Tax Contingencies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_638128691857239226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" xlink:to="us-gaap_UnrecognizedTaxBenefits_638128691857239226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_638128691857239226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_638128691857239226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_638128691857239226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_638128691857239226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_638128691857239226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_638128691857239226" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_638128691857239226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_638128691857239226" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_6381286918572392261" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_638128691857239226" xlink:to="us-gaap_UnrecognizedTaxBenefits_6381286918572392261" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAccruedExpensesDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Accrued Expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_638128691857249223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_638128691857249223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AdvancesFromEmployeesCurrent" xlink:label="mmsi_AdvancesFromEmployeesCurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="mmsi_AdvancesFromEmployeesCurrent_638128691857249223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AccruedRebatesPayableCurrent" xlink:label="mmsi_AccruedRebatesPayableCurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="mmsi_AccruedRebatesPayableCurrent_638128691857249223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_AccruedLegalSettlementCurrent" xlink:label="mmsi_AccruedLegalSettlementCurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="mmsi_AccruedLegalSettlementCurrent_638128691857249223" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_638128691857249223" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638128691857249223" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable_638128691857249223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857249223" xlink:to="us-gaap_LongtermDebtTypeAxis_638128691857249223" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis_638128691857249223" xlink:to="us-gaap_LongtermDebtTypeDomain_638128691857249223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember_638128691857249223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_638128691857249223" xlink:to="us-gaap_LoansPayableMember_638128691857249223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_638128691857249223" xlink:to="us-gaap_RevolvingCreditFacilityMember_638128691857259226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857249223" xlink:to="us-gaap_DebtInstrumentLineItems_638128691857259226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857259226" xlink:to="us-gaap_DebtInstrumentCarryingAmount_638128691857259226" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857259226" xlink:to="us-gaap_DeferredFinanceCostsNet_638128691857259226" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857259226" xlink:to="us-gaap_LongTermDebt_638128691857259226" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857259226" xlink:to="us-gaap_LongTermDebtCurrent_638128691857259226" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857259226" xlink:to="us-gaap_LongTermDebtNoncurrent_638128691857259226" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Revolving Credit Facility and Long-Term Debt - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable_638128691857259226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857259226" xlink:to="us-gaap_LongtermDebtTypeAxis_638128691857259226" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_638128691857259226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis_638128691857259226" xlink:to="us-gaap_LongtermDebtTypeDomain_638128691857259226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember" xlink:label="us-gaap_LoansPayableMember_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_638128691857259226" xlink:to="us-gaap_LoansPayableMember_638128691857269225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain_638128691857259226" xlink:to="us-gaap_RevolvingCreditFacilityMember_638128691857269225" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857259226" xlink:to="us-gaap_DebtInstrumentAxis_638128691857269225" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_638128691857269225" xlink:to="us-gaap_DebtInstrumentNameDomain_638128691857269225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CreditAgreementMember" xlink:label="mmsi_CreditAgreementMember_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_638128691857269225" xlink:to="mmsi_CreditAgreementMember_638128691857269225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857259226" xlink:to="us-gaap_DebtInstrumentLineItems_638128691857269225" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_DebtInstrumentFaceAmount_638128691857269225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_638128691857269225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_DebtInstrumentCarryingAmount_638128691857269225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_LettersOfCreditOutstandingAmount_638128691857269225" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_638128691857269225" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_638128691857269225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_638128691857269225" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtPercentageBearingFixedInterestAmount" xlink:label="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_LongtermDebtPercentageBearingFixedInterestAmount_638128691857279225" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_638128691857279225" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtPercentageBearingVariableInterestAmount" xlink:label="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857269225" xlink:to="us-gaap_LongtermDebtPercentageBearingVariableInterestAmount_638128691857279225" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails" xlink:type="extended" xlink:title="40803 - Disclosure - Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable_638128691857279225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857279225" xlink:to="us-gaap_DebtInstrumentAxis_638128691857279225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_638128691857279225" xlink:to="us-gaap_DebtInstrumentNameDomain_638128691857279225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CreditAgreementMember" xlink:label="mmsi_CreditAgreementMember_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_638128691857279225" xlink:to="mmsi_CreditAgreementMember_638128691857279225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable_638128691857279225" xlink:to="us-gaap_DebtInstrumentLineItems_638128691857279225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857279225" xlink:to="mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum_638128691857279225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2" xlink:label="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2_638128691857279225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857279225" xlink:to="mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2_638128691857279225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum" xlink:label="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems_638128691857279225" xlink:to="mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum_638128691857289224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails" xlink:type="extended" xlink:title="40804 - Disclosure - Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_638128691857289224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_638128691857289224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount_638128691857289224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivativesNarrativeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Derivatives - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeTable_638128691857289224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857289224" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_638128691857289224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis_638128691857289224" xlink:to="us-gaap_DerivativeContractTypeDomain_638128691857289224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember_638128691857289224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857289224" xlink:to="us-gaap_InterestRateSwapMember_638128691857289224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857289224" xlink:to="us-gaap_ForeignExchangeForwardMember_638128691857299223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857289224" xlink:to="srt_CounterpartyNameAxis_638128691857299223" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638128691857299223" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857299223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_WellsFargoFixedRateDerivativeContractOneMember" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractOneMember_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857299223" xlink:to="mmsi_WellsFargoFixedRateDerivativeContractOneMember_638128691857299223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_WellsFargoFixedRateDerivativeContractTwoMember" xlink:label="mmsi_WellsFargoFixedRateDerivativeContractTwoMember_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857299223" xlink:to="mmsi_WellsFargoFixedRateDerivativeContractTwoMember_638128691857299223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857289224" xlink:to="us-gaap_VariableRateAxis_638128691857299223" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis_638128691857299223" xlink:to="us-gaap_VariableRateDomain_638128691857299223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLiborSwapRateMember" xlink:label="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain_638128691857299223" xlink:to="us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_638128691857299223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857289224" xlink:to="us-gaap_HedgingDesignationAxis_638128691857299223" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationAxis_638128691857299223" xlink:to="us-gaap_HedgingDesignationDomain_638128691857299223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationDomain_638128691857299223" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember_638128691857299223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638128691857299223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857289224" xlink:to="us-gaap_IncomeStatementLocationAxis_638128691857299223" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638128691857299223" xlink:to="us-gaap_IncomeStatementLocationDomain_638128691857309222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueAndCostOfSalesMember" xlink:label="mmsi_RevenueAndCostOfSalesMember_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857309222" xlink:to="mmsi_RevenueAndCostOfSalesMember_638128691857309222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember" xlink:label="us-gaap_InterestExpenseMember_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857309222" xlink:to="us-gaap_InterestExpenseMember_638128691857309222" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857289224" xlink:to="us-gaap_DerivativeLineItems_638128691857309222" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="us-gaap_DerivativeNotionalAmount_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DerivativeNotionalAmount_638128691857309222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="us-gaap_DerivativeFixedInterestRate_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DerivativeFixedInterestRate_638128691857309222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset_638128691857309222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability_638128691857309222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossLiability" xlink:label="us-gaap_DerivativeAssetFairValueGrossLiability_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DerivativeAssetFairValueGrossLiability_638128691857309222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:label="us-gaap_DeferredTaxAssetsDerivativeInstruments_638128691857309222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DeferredTaxAssetsDerivativeInstruments_638128691857309222" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract" xlink:label="us-gaap_DerivativeTermOfContract_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_DerivativeTermOfContract_638128691857319228" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross" xlink:label="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross_638128691857319228" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857309222" xlink:to="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_638128691857319228" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails" xlink:type="extended" xlink:title="40902 - Disclosure - Derivatives - Forward Notional Contracts (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeTable_638128691857319228" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857319228" xlink:to="us-gaap_HedgingDesignationAxis_638128691857319228" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationAxis_638128691857319228" xlink:to="us-gaap_HedgingDesignationDomain_638128691857319228" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationDomain_638128691857319228" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember_638128691857319228" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember_638128691857319228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationDomain_638128691857319228" xlink:to="us-gaap_NondesignatedMember_638128691857319228" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857319228" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_638128691857329223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis_638128691857329223" xlink:to="us-gaap_DerivativeContractTypeDomain_638128691857329223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857329223" xlink:to="us-gaap_ForeignExchangeForwardMember_638128691857329223" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857319228" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_638128691857329223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_638128691857329223" xlink:to="us-gaap_HedgingRelationshipDomain_638128691857329223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember" xlink:label="us-gaap_CashFlowHedgingMember_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingRelationshipDomain_638128691857329223" xlink:to="us-gaap_CashFlowHedgingMember_638128691857329223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857319228" xlink:to="us-gaap_DerivativeLineItems_638128691857329223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth" xlink:label="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857329223" xlink:to="mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth_638128691857329223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount" xlink:label="us-gaap_DerivativeNotionalAmount_638128691857329223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857329223" xlink:to="us-gaap_DerivativeNotionalAmount_638128691857329223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails" xlink:type="extended" xlink:title="40903 - Disclosure - Derivatives - Fair Value of Derivative Instruments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_638128691857339223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_638128691857339223" xlink:to="us-gaap_HedgingDesignationAxis_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationAxis_638128691857339223" xlink:to="us-gaap_HedgingDesignationDomain_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="us-gaap_DesignatedAsHedgingInstrumentMember_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationDomain_638128691857339223" xlink:to="us-gaap_DesignatedAsHedgingInstrumentMember_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationDomain_638128691857339223" xlink:to="us-gaap_NondesignatedMember_638128691857339223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_638128691857339223" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_638128691857339223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis_638128691857339223" xlink:to="us-gaap_DerivativeContractTypeDomain_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857339223" xlink:to="us-gaap_InterestRateSwapMember_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857339223" xlink:to="us-gaap_ForeignExchangeForwardMember_638128691857339223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_638128691857339223" xlink:to="us-gaap_BalanceSheetLocationAxis_638128691857339223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis_638128691857339223" xlink:to="us-gaap_BalanceSheetLocationDomain_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="us-gaap_OtherNoncurrentAssetsMember_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_638128691857339223" xlink:to="us-gaap_OtherNoncurrentAssetsMember_638128691857339223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_638128691857339223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_638128691857339223" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_638128691857339223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="us-gaap_AccruedLiabilitiesMember_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_638128691857339223" xlink:to="us-gaap_AccruedLiabilitiesMember_638128691857349221" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_638128691857339223" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_638128691857349221" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="us-gaap_DerivativesFairValueLineItems_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_638128691857339223" xlink:to="us-gaap_DerivativesFairValueLineItems_638128691857349221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativesFairValueLineItems_638128691857349221" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset_638128691857349221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="us-gaap_DerivativeFairValueOfDerivativeLiability_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativesFairValueLineItems_638128691857349221" xlink:to="us-gaap_DerivativeFairValueOfDerivativeLiability_638128691857349221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails" xlink:type="extended" xlink:title="40904 - Disclosure - Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_638128691857349221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_638128691857349221" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_638128691857349221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="us-gaap_HedgingRelationshipDomain_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_638128691857349221" xlink:to="us-gaap_HedgingRelationshipDomain_638128691857349221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember" xlink:label="us-gaap_CashFlowHedgingMember_638128691857349221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingRelationshipDomain_638128691857349221" xlink:to="us-gaap_CashFlowHedgingMember_638128691857349221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_638128691857349221" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_638128691857359223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis_638128691857359223" xlink:to="us-gaap_DerivativeContractTypeDomain_638128691857359223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember" xlink:label="us-gaap_InterestRateSwapMember_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857359223" xlink:to="us-gaap_InterestRateSwapMember_638128691857359223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857359223" xlink:to="us-gaap_ForeignExchangeForwardMember_638128691857359223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_638128691857349221" xlink:to="us-gaap_IncomeStatementLocationAxis_638128691857359223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638128691857359223" xlink:to="us-gaap_IncomeStatementLocationDomain_638128691857359223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember" xlink:label="us-gaap_InterestExpenseMember_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857359223" xlink:to="us-gaap_InterestExpenseMember_638128691857359223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857359223" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_638128691857359223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857359223" xlink:to="us-gaap_CostOfSalesMember_638128691857359223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_638128691857349221" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_638128691857359223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_638128691857359223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" xlink:to="us-gaap_InterestExpense_638128691857359223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691857369222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" xlink:to="us-gaap_CostOfGoodsAndServicesSold_638128691857369222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems_638128691857359223" xlink:to="us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_638128691857369222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails" xlink:type="extended" xlink:title="40905 - Disclosure - Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeTable_638128691857369222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis" xlink:label="us-gaap_HedgingDesignationAxis_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857369222" xlink:to="us-gaap_HedgingDesignationAxis_638128691857369222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain" xlink:label="us-gaap_HedgingDesignationDomain_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationAxis_638128691857369222" xlink:to="us-gaap_HedgingDesignationDomain_638128691857369222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember" xlink:label="us-gaap_NondesignatedMember_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HedgingDesignationDomain_638128691857369222" xlink:to="us-gaap_NondesignatedMember_638128691857369222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857369222" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_638128691857369222" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis_638128691857369222" xlink:to="us-gaap_DerivativeContractTypeDomain_638128691857369222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="us-gaap_ForeignExchangeForwardMember_638128691857369222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain_638128691857369222" xlink:to="us-gaap_ForeignExchangeForwardMember_638128691857369222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeTable_638128691857369222" xlink:to="us-gaap_DerivativeLineItems_638128691857379224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeLineItems_638128691857379224" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_638128691857379224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet_638128691857379224" xlink:to="us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857379224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Commitments and Contingencies - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OtherCommitmentsTable_638128691857379224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable_638128691857379224" xlink:to="srt_LitigationCaseAxis_638128691857379224" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis_638128691857379224" xlink:to="srt_LitigationCaseTypeDomain_638128691857379224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MeritShareholderDerivativeSuitMember" xlink:label="mmsi_MeritShareholderDerivativeSuitMember_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain_638128691857379224" xlink:to="mmsi_MeritShareholderDerivativeSuitMember_638128691857379224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable_638128691857379224" xlink:to="us-gaap_IncomeStatementLocationAxis_638128691857379224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638128691857379224" xlink:to="us-gaap_IncomeStatementLocationDomain_638128691857379224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember_638128691857379224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857379224" xlink:to="us-gaap_CostOfSalesMember_638128691857379224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems_638128691857389223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable_638128691857379224" xlink:to="us-gaap_OtherCommitmentsLineItems_638128691857389223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense_638128691857389223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_638128691857389223" xlink:to="us-gaap_RoyaltyExpense_638128691857389223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements_638128691857389223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_638128691857389223" xlink:to="us-gaap_PaymentsForLegalSettlements_638128691857389223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Earnings Per Common Share (EPS) - Basic EPS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691857389223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss_638128691857389223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691857389223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691857389223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638128691857389223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic_638128691857389223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Earnings Per Common Share (EPS) - Diluted EPS (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638128691857399222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_638128691857399222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638128691857399222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted_638128691857399222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638128691857399222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="us-gaap_PlanNameAxis_638128691857399222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_638128691857399222" xlink:to="us-gaap_PlanNameDomain_638128691857399222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LongTermIncentivePlan2018Member" xlink:label="mmsi_LongTermIncentivePlan2018Member_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638128691857399222" xlink:to="mmsi_LongTermIncentivePlan2018Member_638128691857399222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EmployeeStockPurchasePlanMember" xlink:label="mmsi_EmployeeStockPurchasePlanMember_638128691857399222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638128691857399222" xlink:to="mmsi_EmployeeStockPurchasePlanMember_638128691857399222" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="us-gaap_AwardTypeAxis_638128691857409230" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638128691857409230" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857409230" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857409230" xlink:to="us-gaap_EmployeeStockOptionMember_638128691857409230" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857409230" xlink:to="us-gaap_PerformanceSharesMember_638128691857409230" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashSettledPerformanceSharesMember" xlink:label="mmsi_CashSettledPerformanceSharesMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857409230" xlink:to="mmsi_CashSettledPerformanceSharesMember_638128691857409230" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857409230" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_638128691857409230" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="srt_StatementScenarioAxis_638128691857409230" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638128691857409230" xlink:to="srt_ScenarioUnspecifiedDomain_638128691857409230" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_TargetMember" xlink:label="mmsi_TargetMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638128691857409230" xlink:to="mmsi_TargetMember_638128691857409230" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MaximumUnitsGrantedMember" xlink:label="mmsi_MaximumUnitsGrantedMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638128691857409230" xlink:to="mmsi_MaximumUnitsGrantedMember_638128691857409230" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MaximumPotentialSharesGrantedMember" xlink:label="mmsi_MaximumPotentialSharesGrantedMember_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638128691857409230" xlink:to="mmsi_MaximumPotentialSharesGrantedMember_638128691857409230" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis_638128691857409230" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="us-gaap_VestingAxis_638128691857409230" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis_638128691857409230" xlink:to="us-gaap_VestingDomain_638128691857419226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain_638128691857419226" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_638128691857419226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain_638128691857419226" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_638128691857419226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain_638128691857419226" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_638128691857419226" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="us-gaap_ValuationTechniqueAxis_638128691857419226" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis_638128691857419226" xlink:to="us-gaap_ValuationTechniqueDomain_638128691857419226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="us-gaap_ValuationTechniqueDiscountedCashFlowMember_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain_638128691857419226" xlink:to="us-gaap_ValuationTechniqueDiscountedCashFlowMember_638128691857419226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain_638128691857419226" xlink:to="us-gaap_MarketApproachValuationTechniqueMember_638128691857419226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="srt_RangeAxis_638128691857419226" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857419226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857419226" xlink:to="srt_RangeMember_638128691857419226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857419226" xlink:to="srt_MinimumMember_638128691857429233" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857419226" xlink:to="srt_MaximumMember_638128691857429233" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857399222" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_638128691857429233" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638128691857429233" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638128691857429233" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_638128691857429233" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate" xlink:label="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate_638128691857429233" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate_638128691857429233" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive_638128691857439228" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638128691857439228" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_638128691857439228" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_638128691857439228" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_638128691857439228" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid_638128691857439228" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638128691857439228" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638128691857439228" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_638128691857449225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_638128691857449225" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures" xlink:label="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures_638128691857449225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures_638128691857449225" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638128691857449225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638128691857449225" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638128691857449225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638128691857449225" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638128691857449225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638128691857449225" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638128691857449225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638128691857449225" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_638128691857459224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_638128691857459224" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease" xlink:label="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease_638128691857459224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease_638128691857459224" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit_638128691857459224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857429233" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit_638128691857459224" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails" xlink:type="extended" xlink:title="41202 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638128691857459224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638128691857459224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638128691857459224" xlink:to="us-gaap_IncomeStatementLocationAxis_638128691857469224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638128691857469224" xlink:to="us-gaap_IncomeStatementLocationDomain_638128691857469224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857469224" xlink:to="us-gaap_CostOfSalesMember_638128691857469224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857469224" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_638128691857469224" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638128691857469224" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_638128691857469224" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638128691857459224" xlink:to="us-gaap_AwardTypeAxis_638128691857469224" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638128691857469224" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857469224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857469224" xlink:to="us-gaap_EmployeeStockOptionMember_638128691857469224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857469224" xlink:to="us-gaap_PerformanceSharesMember_638128691857469224" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857469224" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_638128691857469224" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CashSettledPerformanceSharesMember" xlink:label="mmsi_CashSettledPerformanceSharesMember_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857469224" xlink:to="mmsi_CashSettledPerformanceSharesMember_638128691857469224" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638128691857459224" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638128691857469224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638128691857469224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638128691857469224" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638128691857469224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails" xlink:type="extended" xlink:title="41203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857479227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857479227" xlink:to="us-gaap_AwardTypeAxis_638128691857479227" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857479227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857479227" xlink:to="us-gaap_EmployeeStockOptionMember_638128691857479227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857479227" xlink:to="srt_RangeAxis_638128691857479227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857479227" xlink:to="srt_RangeMember_638128691857479227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857479227" xlink:to="srt_MinimumMember_638128691857479227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857479227" xlink:to="srt_MaximumMember_638128691857479227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_638128691857479227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_638128691857479227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_638128691857489224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_638128691857489224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638128691857489224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638128691857489224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638128691857489224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638128691857489224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_638128691857489224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_638128691857489224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_638128691857489224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857479227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_638128691857489224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails" xlink:type="extended" xlink:title="41204 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_638128691857489224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_638128691857489224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_638128691857499223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_638128691857499223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638128691857499223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638128691857499223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638128691857499223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_638128691857499223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6381286918574992231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6381286918574992231" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_638128691857499223" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_638128691857499223" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638128691857499223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638128691857499223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_638128691857509220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_638128691857509220" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_638128691857509220" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_638128691857499223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638128691857509220" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_638128691857509220" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_638128691857509220" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_638128691857509220" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_638128691857509220" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_638128691857509220" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638128691857509220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_638128691857509220" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_638128691857519220" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_638128691857519220" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails" xlink:type="extended" xlink:title="41205 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857519220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857519220" xlink:to="us-gaap_AwardTypeAxis_638128691857519220" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638128691857519220" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857519220" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857519220" xlink:to="us-gaap_PerformanceSharesMember_638128691857519220" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857519220" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_638128691857519220" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis_638128691857519220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857519220" xlink:to="us-gaap_ValuationTechniqueAxis_638128691857519220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis_638128691857519220" xlink:to="us-gaap_ValuationTechniqueDomain_638128691857529224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain_638128691857529224" xlink:to="us-gaap_MarketApproachValuationTechniqueMember_638128691857529224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857519220" xlink:to="srt_RangeAxis_638128691857529224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857529224" xlink:to="srt_RangeMember_638128691857529224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857529224" xlink:to="srt_MinimumMember_638128691857529224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857529224" xlink:to="srt_MaximumMember_638128691857529224" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857519220" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857529224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638128691857529224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638128691857529224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_638128691857529224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_638128691857529224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638128691857539221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_638128691857539221" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638128691857539221" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_638128691857529224" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor_638128691857539221" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857529224" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_638128691857539221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638128691857539221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:label="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" xlink:to="mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_638128691857539221" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_638128691857539221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_638128691857539221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_638128691857549227" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_638128691857539221" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_638128691857549227" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails" xlink:type="extended" xlink:title="41206 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857549227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857549227" xlink:to="us-gaap_AwardTypeAxis_638128691857549227" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638128691857549227" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857549227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638128691857549227" xlink:to="us-gaap_PerformanceSharesMember_638128691857549227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857549227" xlink:to="srt_RangeAxis_638128691857549227" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857549227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857549227" xlink:to="srt_RangeMember_638128691857549227" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857549227" xlink:to="srt_MinimumMember_638128691857559223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857549227" xlink:to="srt_MaximumMember_638128691857559223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638128691857549227" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_638128691857559223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_638128691857559223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_638128691857559223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_638128691857559223" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_638128691857559223" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_638128691857559223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638128691857559223" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_638128691857559223" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Segment Reporting and Foreign Operations - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" xlink:to="us-gaap_StatementBusinessSegmentsAxis_638128691857569223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis_638128691857569223" xlink:to="us-gaap_SegmentDomain_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691857569223" xlink:to="mmsi_CardiovascularSegmentMember_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" xlink:to="srt_StatementGeographicalAxis_638128691857569223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638128691857569223" xlink:to="srt_SegmentGeographicalDomain_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691857569223" xlink:to="us-gaap_NonUsMember_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN" xlink:label="country_CN_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691857569223" xlink:to="country_CN_638128691857569223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_638128691857569223" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis_638128691857569223" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain_638128691857569223" xlink:to="us-gaap_SalesRevenueNetMember_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_638128691857569223" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_638128691857569223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis_638128691857569223" xlink:to="us-gaap_ConcentrationRiskTypeDomain_638128691857569223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="us-gaap_GeographicConcentrationRiskMember_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain_638128691857569223" xlink:to="us-gaap_GeographicConcentrationRiskMember_638128691857579221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_638128691857569223" xlink:to="us-gaap_SegmentReportingInformationLineItems_638128691857579221" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857579221" xlink:to="us-gaap_NumberOfOperatingSegments_638128691857579221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NumberOfProductCategories" xlink:label="mmsi_NumberOfProductCategories_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857579221" xlink:to="mmsi_NumberOfProductCategories_638128691857579221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857579221" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691857579221" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857579221" xlink:to="us-gaap_ConcentrationRiskPercentage1_638128691857579221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails" xlink:type="extended" xlink:title="41302 - Disclosure - Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_638128691857579221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_638128691857579221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_638128691857579221" xlink:to="srt_StatementGeographicalAxis_638128691857589225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638128691857589225" xlink:to="srt_SegmentGeographicalDomain_638128691857589225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691857589225" xlink:to="country_US_638128691857589225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE" xlink:label="country_IE_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691857589225" xlink:to="country_IE_638128691857589225" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NonUSExcludingIrelandMember" xlink:label="mmsi_NonUSExcludingIrelandMember_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638128691857589225" xlink:to="mmsi_NonUSExcludingIrelandMember_638128691857589225" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_638128691857579221" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_638128691857589225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_638128691857589225" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638128691857589225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails" xlink:type="extended" xlink:title="41303 - Disclosure - Segment Reporting and Foreign Operations - Operating Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638128691857589225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638128691857589225" xlink:to="us-gaap_StatementBusinessSegmentsAxis_638128691857589225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis_638128691857589225" xlink:to="us-gaap_SegmentDomain_638128691857589225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember_638128691857589225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691857589225" xlink:to="mmsi_CardiovascularSegmentMember_638128691857589225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691857589225" xlink:to="mmsi_EndoscopySegmentMember_638128691857599221" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_638128691857589225" xlink:to="us-gaap_SegmentReportingInformationLineItems_638128691857599221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857599221" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_638128691857599221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857599221" xlink:to="us-gaap_OperatingIncomeLoss_638128691857599221" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857599221" xlink:to="us-gaap_NonoperatingIncomeExpense_638128691857599221" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857599221" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638128691857599221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems_638128691857599221" xlink:to="us-gaap_NetIncomeLoss_638128691857599221" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails" xlink:type="extended" xlink:title="41304 - Disclosure - Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_638128691857599221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_638128691857599221" xlink:to="us-gaap_StatementBusinessSegmentsAxis_638128691857599221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_638128691857599221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis_638128691857599221" xlink:to="us-gaap_SegmentDomain_638128691857599221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CardiovascularSegmentMember" xlink:label="mmsi_CardiovascularSegmentMember_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691857599221" xlink:to="mmsi_CardiovascularSegmentMember_638128691857609222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_EndoscopySegmentMember" xlink:label="mmsi_EndoscopySegmentMember_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain_638128691857599221" xlink:to="mmsi_EndoscopySegmentMember_638128691857609222" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:label="us-gaap_SegmentReportingAssetReconcilingItemLineItems_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_638128691857599221" xlink:to="us-gaap_SegmentReportingAssetReconcilingItemLineItems_638128691857609222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems_638128691857609222" xlink:to="us-gaap_Assets_638128691857609222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems_638128691857609222" xlink:to="us-gaap_DepreciationDepletionAndAmortization_638128691857609222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAssetReconcilingItemLineItems_638128691857609222" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638128691857609222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureEmployeeBenefitPlansDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Employee Benefit Plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_638128691857609222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_638128691857609222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857619223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857619223" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_638128691857619223" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis_638128691857619223" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_638128691857619223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember_638128691857619223" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_638128691857619223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857619223" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_638128691857619223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_638128691857619223" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_638128691857619223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_638128691857619223" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_638128691857619223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857619223" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638128691857619223" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857619223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638128691857619223" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857619223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857619223" xlink:to="us-gaap_FairValueInputsLevel1Member_638128691857679222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857619223" xlink:to="us-gaap_FairValueInputsLevel2Member_638128691857679222" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857619223" xlink:to="us-gaap_FairValueInputsLevel3Member_638128691857679222" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857619223" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" xlink:to="us-gaap_MarketableSecurities_638128691857679222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" xlink:to="us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_638128691857679222" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:label="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" xlink:to="us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_638128691857679222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" xlink:to="us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_638128691857679222" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" xlink:to="us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_638128691857679222" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691857679222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857679222" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691857679222" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended" xlink:title="41502 - Disclosure - Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638128691857689223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638128691857689223" xlink:to="us-gaap_FairValueByLiabilityClassAxis_638128691857689223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis_638128691857689223" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_638128691857689223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_ContingentConsiderationMember" xlink:label="mmsi_ContingentConsiderationMember_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_638128691857689223" xlink:to="mmsi_ContingentConsiderationMember_638128691857689223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_638128691857689223" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638128691857689223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_638128691857689223" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_638128691857689223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638128691857689223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638128691857689223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_638128691857689223" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_638128691857699221" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_638128691857699221" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange" xlink:label="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" xlink:to="mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange_638128691857699221" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_638128691857689223" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_638128691857699221" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails" xlink:type="extended" xlink:title="41503 - Disclosure - Fair Value Measurements - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="us-gaap_BalanceSheetLocationAxis_638128691857699221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis_638128691857699221" xlink:to="us-gaap_BalanceSheetLocationDomain_638128691857699221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_638128691857699221" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_638128691857699221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="us-gaap_AccruedLiabilitiesMember_638128691857699221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_638128691857699221" xlink:to="us-gaap_AccruedLiabilitiesMember_638128691857699221" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638128691857709225" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_638128691857709225" xlink:to="us-gaap_RelatedPartyDomain_638128691857709225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_638128691857709225" xlink:to="srt_DirectorMember_638128691857709225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="us-gaap_TypeOfArrangementAxis_638128691857709225" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_638128691857709225" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638128691857709225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LicenseAgreementArravascLimitedMember" xlink:label="mmsi_LicenseAgreementArravascLimitedMember_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_638128691857709225" xlink:to="mmsi_LicenseAgreementArravascLimitedMember_638128691857709225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="us-gaap_BusinessAcquisitionAxis_638128691857709225" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_638128691857709225" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857709225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_CiannaMedicalMember" xlink:label="mmsi_CiannaMedicalMember_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857709225" xlink:to="mmsi_CiannaMedicalMember_638128691857709225" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_STDPharmaceuticalProductsLimitedMember" xlink:label="mmsi_STDPharmaceuticalProductsLimitedMember_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857709225" xlink:to="mmsi_STDPharmaceuticalProductsLimitedMember_638128691857709225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_SelioMedicalLimitedSelioMember" xlink:label="mmsi_SelioMedicalLimitedSelioMember_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_638128691857709225" xlink:to="mmsi_SelioMedicalLimitedSelioMember_638128691857709225" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_638128691857709225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_638128691857709225" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_638128691857709225" xlink:to="srt_EquityMethodInvesteeNameDomain_638128691857719223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_XableCathMember" xlink:label="mmsi_XableCathMember_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain_638128691857719223" xlink:to="mmsi_XableCathMember_638128691857719223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_FusionMedicalInc.Member" xlink:label="mmsi_FusionMedicalInc.Member_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain_638128691857719223" xlink:to="mmsi_FusionMedicalInc.Member_638128691857719223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BluegrassVascularTechnologiesIncMember" xlink:label="mmsi_BluegrassVascularTechnologiesIncMember_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain_638128691857719223" xlink:to="mmsi_BluegrassVascularTechnologiesIncMember_638128691857719223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_638128691857719223" order="6" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_638128691857719223" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_638128691857719223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BluegrassVascularTechnologiesIncMember" xlink:label="mmsi_BluegrassVascularTechnologiesIncMember_6381286918577192231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_638128691857719223" xlink:to="mmsi_BluegrassVascularTechnologiesIncMember_6381286918577192231" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="srt_CounterpartyNameAxis_638128691857719223" order="7" use="optional" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_638128691857719223" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857719223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_NinePointMedicalInc.Member" xlink:label="mmsi_NinePointMedicalInc.Member_638128691857719223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_638128691857719223" xlink:to="mmsi_NinePointMedicalInc.Member_638128691857719223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_638128691857699221" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent_638128691857729224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent" xlink:label="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent_638128691857729224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_638128691857729224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_638128691857729224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_PaymentsForMergerRelatedCosts_638128691857729224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_638128691857729224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857729224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_638128691857729224" xlink:to="us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857729224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="us-gaap_GainLossOnSaleOfBusiness_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_GainLossOnSaleOfBusiness_638128691857739229" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_638128691857739229" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_638128691857739229" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_InvestmentIncomeNet_638128691857739229" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_638128691857739229" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_638128691857739229" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_638128691857739229" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_638128691857739229" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:label="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857749225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_638128691857739229" xlink:to="us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_638128691857749225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_638128691857749225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent_638128691857749225" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_638128691857749225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses_638128691857749225" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_638128691857749225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_638128691857749225" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments_638128691857749225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_638128691857729224" xlink:to="us-gaap_EquityMethodInvestments_638128691857749225" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails" xlink:type="extended" xlink:title="41504 - Disclosure - Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" xlink:to="us-gaap_MeasurementInputTypeAxis_638128691857759221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis_638128691857759221" xlink:to="us-gaap_MeasurementInputTypeDomain_638128691857759221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638128691857759221" xlink:to="us-gaap_MeasurementInputDiscountRateMember_638128691857759221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_MilestonePaymentProbabilityMember" xlink:label="mmsi_MilestonePaymentProbabilityMember_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_638128691857759221" xlink:to="mmsi_MilestonePaymentProbabilityMember_638128691857759221" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_638128691857759221" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis_638128691857759221" xlink:to="us-gaap_ContingentConsiderationTypeDomain_638128691857759221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueBasedPaymentsMember" xlink:label="mmsi_RevenueBasedPaymentsMember_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain_638128691857759221" xlink:to="mmsi_RevenueBasedPaymentsMember_638128691857759221" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RevenueMilestonesMember" xlink:label="mmsi_RevenueMilestonesMember_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain_638128691857759221" xlink:to="mmsi_RevenueMilestonesMember_638128691857759221" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_RegulatoryApprovalMilestoneMember" xlink:label="mmsi_RegulatoryApprovalMilestoneMember_638128691857759221" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain_638128691857759221" xlink:to="mmsi_RegulatoryApprovalMilestoneMember_638128691857759221" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" xlink:to="srt_RangeAxis_638128691857769226" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857769226" xlink:to="srt_RangeMember_638128691857769226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857769226" xlink:to="srt_MinimumMember_638128691857769226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857769226" xlink:to="srt_MaximumMember_638128691857769226" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857769226" xlink:to="srt_WeightedAverageMember_638128691857769226" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" xlink:to="us-gaap_ValuationTechniqueAxis_638128691857769226" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis_638128691857769226" xlink:to="us-gaap_ValuationTechniqueDomain_638128691857769226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain_638128691857769226" xlink:to="us-gaap_IncomeApproachValuationTechniqueMember_638128691857769226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_638128691857769226" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_638128691857769226" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857769226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_638128691857769226" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_638128691857769226" xlink:to="us-gaap_FairValueInputsLevel3Member_638128691857769226" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638128691857779227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_638128691857759221" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638128691857779227" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691857779227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638128691857779227" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_638128691857779227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_638128691857779227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_638128691857779227" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_638128691857779227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails" xlink:type="extended" xlink:title="41505 - Disclosure - Fair Value Measurements - Allowance for Credit Losses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_638128691857779227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_638128691857779227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_638128691857779227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_638128691857779227" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses_638128691857779227" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForLoanLossesExpensed" xlink:label="us-gaap_ProvisionForLoanLossesExpensed_638128691857779227" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_638128691857779227" xlink:to="us-gaap_ProvisionForLoanLossesExpensed_638128691857779227" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_6381286918577792271" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_638128691857779227" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses_6381286918577792271" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_638128691857789222" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_638128691857789222" xlink:to="us-gaap_StatementEquityComponentsAxis_638128691857789222" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638128691857789222" xlink:to="us-gaap_EquityComponentDomain_638128691857789222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_638128691857789222" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_638128691857789222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_638128691857789222" xlink:to="us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_638128691857789222" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_638128691857789222" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_638128691857789222" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_638128691857789222" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_638128691857789222" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_638128691857789222" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_638128691857789222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_638128691857789222" xlink:to="us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_638128691857789222" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_638128691857789222" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638128691857789222" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" xlink:to="us-gaap_StockholdersEquity_638128691857789222" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" xlink:to="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_638128691857799225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_638128691857799225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_638128691857799225" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_638128691857799225" xlink:to="us-gaap_Revenues_638128691857799225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_638128691857799225" xlink:to="us-gaap_CostOfGoodsAndServicesSold_638128691857799225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract_638128691857799225" xlink:to="us-gaap_InterestExpense_638128691857799225" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_638128691857799225" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638128691857799225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_638128691857789222" xlink:to="us-gaap_StockholdersEquity_638128691857799225" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesNarrativeDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Leases - Narrative (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable_638128691857809220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable_638128691857809220" xlink:to="srt_RangeAxis_638128691857809220" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638128691857809220" xlink:to="srt_RangeMember_638128691857809220" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857809220" xlink:to="srt_MinimumMember_638128691857809220" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638128691857809220" xlink:to="srt_MaximumMember_638128691857809220" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable_638128691857809220" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_638128691857809220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems_638128691857809220" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_638128691857809220" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems_638128691857809220" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_638128691857809220" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="mmsi-20221231.xsd#mmsi_LesseeOperatingLeaseTerminationPeriod" xlink:label="mmsi_LesseeOperatingLeaseTerminationPeriod_638128691857809220" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems_638128691857809220" xlink:to="mmsi_LesseeOperatingLeaseTerminationPeriod_638128691857809220" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Leases - Schedule of Consolidated Balance Sheet Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638128691857819224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638128691857819224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638128691857819224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability_638128691857819224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails" xlink:type="extended" xlink:title="41703 - Disclosure - Leases - Components of Lease Cost (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseExpense_638128691857819224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_SubleaseIncome_638128691857819224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost_638128691857819224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeaseCost_638128691857819224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails" xlink:type="extended" xlink:title="41704 - Disclosure - Leases - Supplemental Cash Flow Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments_638128691857829225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments_638128691857829225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_638128691857829225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_638128691857829225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails" xlink:type="extended" xlink:title="41705 - Disclosure - Leases - Supplemental Disclosure (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_638128691857829225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_638128691857829225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638128691857829225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_638128691857829225" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="41706 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638128691857829225" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638128691857829225" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_638128691857839224" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638128691857839224" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_638128691857839224" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_638128691857839224" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_638128691857839224" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_638128691857839224" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_638128691857839224" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability_638128691857839224" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended" xlink:title="41801 - Schedule - Schedule II - Valuation and qualifying accounts (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable_638128691857839224" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_638128691857839224" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable_638128691857839224" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_638128691857839224" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis_638128691857839224" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_638128691857849223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="us-gaap_AllowanceForCreditLossMember_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain_638128691857849223" xlink:to="us-gaap_AllowanceForCreditLossMember_638128691857849223" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain_638128691857849223" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_638128691857849223" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable_638128691857839224" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems_638128691857849223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems_638128691857849223" xlink:to="us-gaap_MovementInValuationAllowancesAndReservesRollForward_638128691857849223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward_638128691857849223" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_638128691857849223" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward_638128691857849223" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_638128691857849223" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_638128691857849223" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward_638128691857849223" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_638128691857849223" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_6381286918578492231" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MovementInValuationAllowancesAndReservesRollForward_638128691857849223" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_6381286918578492231" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521690624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 22, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-18592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MERIT MEDICAL SYSTEMS INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000856982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0447695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West Merit Parkway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Jordan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">253-1600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MMSI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,318,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Salt Lake City, Utah<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517943344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 58,408<span></span>
</td>
<td class="nump">$ 67,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables - net of allowance for credit losses - 2022 - $8,423 and 2021 - $6,767</a></td>
<td class="nump">164,677<span></span>
</td>
<td class="nump">152,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Other receivables</a></td>
<td class="nump">12,992<span></span>
</td>
<td class="nump">17,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">265,991<span></span>
</td>
<td class="nump">221,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">22,324<span></span>
</td>
<td class="nump">16,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">3,913<span></span>
</td>
<td class="nump">3,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax refund receivables</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">529,084<span></span>
</td>
<td class="nump">482,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land and land improvements</a></td>
<td class="nump">25,940<span></span>
</td>
<td class="nump">25,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">189,148<span></span>
</td>
<td class="nump">190,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Manufacturing equipment</a></td>
<td class="nump">299,089<span></span>
</td>
<td class="nump">277,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">61,128<span></span>
</td>
<td class="nump">61,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">49,673<span></span>
</td>
<td class="nump">46,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction-in-progress</a></td>
<td class="nump">61,269<span></span>
</td>
<td class="nump">51,182<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">686,247<span></span>
</td>
<td class="nump">652,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(303,271)<span></span>
</td>
<td class="num">(280,618)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">382,976<span></span>
</td>
<td class="nump">371,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">359,821<span></span>
</td>
<td class="nump">361,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">6,599<span></span>
</td>
<td class="nump">6,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets</a></td>
<td class="nump">65,262<span></span>
</td>
<td class="nump">65,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">44,352<span></span>
</td>
<td class="nump">41,421<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">751,906<span></span>
</td>
<td class="nump">794,424<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,663,966<span></span>
</td>
<td class="nump">1,648,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">68,504<span></span>
</td>
<td class="nump">55,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">123,189<span></span>
</td>
<td class="nump">159,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">11,250<span></span>
</td>
<td class="nump">8,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term operating lease liabilities</a></td>
<td class="nump">11,005<span></span>
</td>
<td class="nump">10,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">6,697<span></span>
</td>
<td class="nump">2,536<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">220,645<span></span>
</td>
<td class="nump">236,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">186,759<span></span>
</td>
<td class="nump">234,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">18,462<span></span>
</td>
<td class="nump">31,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term income taxes payable</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Liabilities related to unrecognized tax benefits</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation payable</a></td>
<td class="nump">15,264<span></span>
</td>
<td class="nump">18,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred credits</a></td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">59,736<span></span>
</td>
<td class="nump">61,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">14,736<span></span>
</td>
<td class="nump">23,584<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">519,569<span></span>
</td>
<td class="nump">608,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock - 5,000 shares authorized as of December 31, 2022 and December 31, 2021; no shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value; 100,000 shares authorized; issued and outstanding as of December 31, 2022 - 57,306 and December 31, 2021 - 56,570</a></td>
<td class="nump">675,174<span></span>
</td>
<td class="nump">641,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">480,773<span></span>
</td>
<td class="nump">406,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(11,550)<span></span>
</td>
<td class="num">(7,991)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">1,144,397<span></span>
</td>
<td class="nump">1,039,799<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">1,663,966<span></span>
</td>
<td class="nump">1,648,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets</a></td>
<td class="nump">237,522<span></span>
</td>
<td class="nump">276,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets</a></td>
<td class="nump">$ 38,350<span></span>
</td>
<td class="nump">$ 42,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents sum of the carrying amounts of all intangible assets and goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Also includes aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521644512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade receivables, allowances</a></td>
<td class="nump">$ 8,423<span></span>
</td>
<td class="nump">$ 6,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in shares)</a></td>
<td class="nump">57,306<span></span>
</td>
<td class="nump">56,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in shares)</a></td>
<td class="nump">57,306<span></span>
</td>
<td class="nump">56,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangibles, accumulated amortization</a></td>
<td class="nump">$ 274,570<span></span>
</td>
<td class="nump">$ 234,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangibles, accumulated amortization</a></td>
<td class="nump">$ 69,780<span></span>
</td>
<td class="nump">$ 65,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521958544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,150,981<span></span>
</td>
<td class="nump">$ 1,074,751<span></span>
</td>
<td class="nump">$ 963,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">631,882<span></span>
</td>
<td class="nump">589,418<span></span>
</td>
<td class="nump">562,698<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">519,099<span></span>
</td>
<td class="nump">485,333<span></span>
</td>
<td class="nump">401,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">342,525<span></span>
</td>
<td class="nump">335,690<span></span>
</td>
<td class="nump">297,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">75,510<span></span>
</td>
<td class="nump">71,247<span></span>
</td>
<td class="nump">57,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,036<span></span>
</td>
<td class="nump">18,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
<td class="nump">36,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit', window );">Contingent consideration expense (benefit)</a></td>
<td class="nump">4,611<span></span>
</td>
<td class="nump">3,161<span></span>
</td>
<td class="num">(7,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">431,536<span></span>
</td>
<td class="nump">424,417<span></span>
</td>
<td class="nump">402,739<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">87,563<span></span>
</td>
<td class="nump">60,916<span></span>
</td>
<td class="num">(1,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6,339)<span></span>
</td>
<td class="num">(5,261)<span></span>
</td>
<td class="num">(9,994)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense) - net</a></td>
<td class="nump">966<span></span>
</td>
<td class="num">(2,507)<span></span>
</td>
<td class="num">(2,279)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense - net</a></td>
<td class="num">(4,934)<span></span>
</td>
<td class="num">(6,999)<span></span>
</td>
<td class="num">(11,669)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">82,629<span></span>
</td>
<td class="nump">53,917<span></span>
</td>
<td class="num">(13,231)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">8,113<span></span>
</td>
<td class="nump">5,463<span></span>
</td>
<td class="num">(3,388)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 74,516<span></span>
</td>
<td class="nump">$ 48,454<span></span>
</td>
<td class="num">$ (9,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">56,806<span></span>
</td>
<td class="nump">56,145<span></span>
</td>
<td class="nump">55,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">57,671<span></span>
</td>
<td class="nump">57,359<span></span>
</td>
<td class="nump">55,434<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521670592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 74,516<span></span>
</td>
<td class="nump">$ 48,454<span></span>
</td>
<td class="num">$ (9,843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Cash flow hedges</a></td>
<td class="nump">9,007<span></span>
</td>
<td class="nump">5,965<span></span>
</td>
<td class="num">(9,523)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Income tax benefit (expense)</a></td>
<td class="num">(2,177)<span></span>
</td>
<td class="num">(1,489)<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(10,491)<span></span>
</td>
<td class="num">(7,704)<span></span>
</td>
<td class="nump">7,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="num">(786)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="num">(3,559)<span></span>
</td>
<td class="num">(2,539)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="nump">$ 70,957<span></span>
</td>
<td class="nump">$ 45,915<span></span>
</td>
<td class="num">$ (10,001)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723516134432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Reclassify upon adoption of ASU</div>
</th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Reclassify upon adoption of ASU</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance (ASU 2016-13) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 587,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368,221<span></span>
</td>
<td class="num">$ (5,294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 949,944<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">55,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,843)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 13,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 6,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plans (in shares)</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised', window );">Shares surrendered in exchange for payment of payroll tax liabilities</a></td>
<td class="num">$ (866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised', window );">Shares surrendered in exchange for payment of payroll tax liabilities (in shares)</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options</a></td>
<td class="num">$ (1,467)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,467)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options (in shares)</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 606,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,803<span></span>
</td>
<td class="num">(5,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 958,575<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">55,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,539)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 14,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 20,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 1,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plans (in shares)</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Shares issued from time-vested restricted stock units (in shares)</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised', window );">Shares surrendered in exchange for payment of payroll tax liabilities</a></td>
<td class="num">$ (576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(576)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised', window );">Shares surrendered in exchange for payment of payroll tax liabilities (in shares)</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options</a></td>
<td class="num">$ (180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (180)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options (in shares)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 641,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,257<span></span>
</td>
<td class="num">(7,991)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,039,799<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">56,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,559)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,559)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 16,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 20,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 1,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plans (in shares)</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Shares issued from time-vested restricted stock units (in shares)</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised', window );">Shares surrendered in exchange for payment of payroll tax liabilities</a></td>
<td class="num">$ (2,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,474)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised', window );">Shares surrendered in exchange for payment of payroll tax liabilities (in shares)</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options</a></td>
<td class="num">$ (1,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options (in shares)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 675,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,773<span></span>
</td>
<td class="num">$ (11,550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,144,397<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">57,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Surrendered During Period Shares Payroll Tax Liabilities Stock Options Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents number of shares that have been surrendered during the period in exchange for stock options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents value of shares that have been surrendered during the period in exchange for stock options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517864896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 74,516<span></span>
</td>
<td class="nump">$ 48,454<span></span>
</td>
<td class="num">$ (9,843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">81,804<span></span>
</td>
<td class="nump">84,066<span></span>
</td>
<td class="nump">94,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss (gain) on disposition of business</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(517)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale or abandonment of property and equipment</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Write-off of certain intangible assets and other long-term assets</a></td>
<td class="nump">2,281<span></span>
</td>
<td class="nump">4,412<span></span>
</td>
<td class="nump">36,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use operating lease assets</a></td>
<td class="nump">10,394<span></span>
</td>
<td class="nump">11,718<span></span>
</td>
<td class="nump">12,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Adjustments related to contingent consideration liabilities</a></td>
<td class="nump">4,611<span></span>
</td>
<td class="nump">3,161<span></span>
</td>
<td class="num">(7,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amortization of deferred credits</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of long-term debt issuance costs</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(14,924)<span></span>
</td>
<td class="num">(4,631)<span></span>
</td>
<td class="num">(11,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">18,042<span></span>
</td>
<td class="nump">16,090<span></span>
</td>
<td class="nump">14,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivables</a></td>
<td class="num">(15,116)<span></span>
</td>
<td class="num">(8,618)<span></span>
</td>
<td class="nump">10,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">4,154<span></span>
</td>
<td class="num">(10,418)<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(47,929)<span></span>
</td>
<td class="num">(25,183)<span></span>
</td>
<td class="nump">29,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,798)<span></span>
</td>
<td class="num">(3,555)<span></span>
</td>
<td class="num">(446)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(379)<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax refund receivables</a></td>
<td class="nump">1,952<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">657<span></span>
</td>
<td class="num">(1,670)<span></span>
</td>
<td class="num">(3,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade payables</a></td>
<td class="nump">12,661<span></span>
</td>
<td class="nump">6,050<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(16,379)<span></span>
</td>
<td class="nump">36,462<span></span>
</td>
<td class="nump">4,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">4,521<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions', window );">Liabilities related to unrecognized tax benefits</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="num">(576)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Deferred compensation payable</a></td>
<td class="num">(2,848)<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
<td class="nump">1,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(11,127)<span></span>
</td>
<td class="num">(12,410)<span></span>
</td>
<td class="num">(12,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other long-term obligations</a></td>
<td class="nump">278<span></span>
</td>
<td class="num">(858)<span></span>
</td>
<td class="nump">3,606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Total adjustments</a></td>
<td class="nump">39,775<span></span>
</td>
<td class="nump">98,777<span></span>
</td>
<td class="nump">175,113<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash, cash equivalents, and restricted cash provided by operating activities</a></td>
<td class="nump">114,291<span></span>
</td>
<td class="nump">147,231<span></span>
</td>
<td class="nump">165,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Capital expenditures for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(45,029)<span></span>
</td>
<td class="num">(27,939)<span></span>
</td>
<td class="num">(45,988)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(3,175)<span></span>
</td>
<td class="num">(2,834)<span></span>
</td>
<td class="num">(3,288)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of property and equipment</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds (payments) from disposition of business</a></td>
<td class="num">(971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Cash received for settlement of note receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Issuance of note receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid in acquisitions, net of cash acquired</a></td>
<td class="num">(8,287)<span></span>
</td>
<td class="num">(7,171)<span></span>
</td>
<td class="num">(10,953)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash, cash equivalents, and restricted cash used in investing activities</a></td>
<td class="num">(57,397)<span></span>
</td>
<td class="num">(37,161)<span></span>
</td>
<td class="num">(58,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">20,070<span></span>
</td>
<td class="nump">21,306<span></span>
</td>
<td class="nump">6,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">215,205<span></span>
</td>
<td class="nump">98,421<span></span>
</td>
<td class="nump">68,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(260,143)<span></span>
</td>
<td class="num">(206,921)<span></span>
</td>
<td class="num">(157,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Contingent payments related to acquisitions</a></td>
<td class="num">(32,918)<span></span>
</td>
<td class="num">(10,665)<span></span>
</td>
<td class="num">(13,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock', window );">Payment of taxes related to an exchange of common stock</a></td>
<td class="num">(2,474)<span></span>
</td>
<td class="num">(576)<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash, cash equivalents, and restricted cash used in financing activities</a></td>
<td class="num">(60,260)<span></span>
</td>
<td class="num">(98,435)<span></span>
</td>
<td class="num">(95,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rates on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(3,826)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">1,684<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(7,192)<span></span>
</td>
<td class="nump">10,834<span></span>
</td>
<td class="nump">12,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>CASH, CASH EQUIVALENTS AND RESTRICTED CASH:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">67,750<span></span>
</td>
<td class="nump">56,916<span></span>
</td>
<td class="nump">44,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">60,558<span></span>
</td>
<td class="nump">67,750<span></span>
</td>
<td class="nump">56,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">58,408<span></span>
</td>
<td class="nump">67,750<span></span>
</td>
<td class="nump">56,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash reported in prepaid expenses and other current assets</a></td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList', window );">Restricted Cash and Cash Equivalents, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid Expense and Other Assets, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 60,558<span></span>
</td>
<td class="nump">67,750<span></span>
</td>
<td class="nump">56,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest (net of capitalized interest of $858, $480 and $813, respectively)</a></td>
<td class="nump">6,258<span></span>
</td>
<td class="nump">5,261<span></span>
</td>
<td class="nump">10,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">17,092<span></span>
</td>
<td class="nump">8,828<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment purchases in accounts payable</a></td>
<td class="nump">3,702<span></span>
</td>
<td class="nump">2,558<span></span>
</td>
<td class="nump">2,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable', window );">Current note receivable converted to equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Proceeds from sale of business in other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses', window );">Acquisition purchases in accrued expenses and other long-term obligations</a></td>
<td class="nump">3,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised', window );">Merit common stock surrendered (18, 3, and 39 shares, respectively) in exchange for exercise of stock options</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use operating lease assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">$ 11,130<span></span>
</td>
<td class="nump">$ 1,524<span></span>
</td>
<td class="nump">$ 10,938<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents future cash outflow to pay for acquisition of developed technology in a non cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of equity investment acquired in exchange for settlement of note receivable in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Liability for Uncertain Tax Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for taxes related to an exchange of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents value of shares that have been surrendered during the period in exchange for stock options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524840448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Net capitalized interest</a></td>
<td class="nump">$ 858<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised', window );">Shares surrendered in exchange for exercise of stock options (in shares)</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents number of shares that have been surrendered during the period in exchange for stock options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602770224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization and Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Organization</b>.&#160;Merit Medical Systems,&#160;Inc. (&#8220;Merit,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;) designs, develops, manufactures and markets single-use medical products for interventional and diagnostic procedures.&#160;For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology medical device products which assist in diagnosing and treating coronary artery disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within those two operating segments, we offer products focused in five product categories: <span style="color:#212529;background:#ffffff;">peripheral intervention, cardiac intervention, custom procedural solutions,</span> original equipment manufacturer (&#8220;<span style="color:#212529;background:#ffffff;">OEM&#8221;)</span> and endoscopy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We manufacture our products in plants located in the U.S., Mexico, The Netherlands,&#160;Ireland, France, Brazil and Singapore. We export sales to dealers and have direct or modified direct sales forces in the U.S., Canada, Western Europe, Australia, Brazil, Japan, China, Malaysia, South Korea, UAE, India, New Zealand and South Africa (see Note&#160;13).&#160;Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.&#160;The following is a summary of the more significant of such policies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates in Preparing Financial Statements</b>.&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b>.&#160;The consolidated financial statements include our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated. Amounts presented in this report are rounded, while percentages and earnings per share amounts presented are calculated from the underlying amounts. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b>. We consider interest-bearing deposits with an original maturity date of three&#160;months or less to be cash equivalents. As of <span style="-sec-ix-hidden:Hidden_wEJKBHaF4ku_LLZF6o-vSQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2021</span></span>, approximately $1.9 million, respectively, of our cash and cash equivalents represents restricted cash for the payment of certain import and other taxes for our subsidiary in China.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Receivables</b>.<b style="font-weight:bold;">&#160;</b>Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. An allowance for credit losses on trade receivables is recorded based on our expectation of credit losses and is based upon our historical bad debt experience, current economic conditions, expectations of future economic conditions and management&#8217;s evaluation of our ability to collect individual outstanding balances. Once collection efforts have been exhausted and a receivable is deemed to be uncollectible, such balance is charged against the allowance for credit losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Inventories</b>. We value our inventories at the lower of cost, at approximate costs determined on a first-in, first-out method, or net realizable value.&#160;Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160;Inventory costs include material, labor and manufacturing overhead.&#160;We review inventories on hand and record provisions based on estimated excess, slow moving and obsolete inventory, as well as inventories with a carrying value in excess of net realizable value.&#160;The regular and systematic review of the valuation of inventories includes an assessment of future product demand based on historical sales and raw material usage and product expiration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Goodwill and Intangible Assets</b>.<b style="font-weight:bold;">&#160;</b>We test goodwill balances for impairment on an annual basis as of July&#160;1 or whenever impairment indicators arise.&#160;When impairment indicators are identified, we may elect to perform an optional qualitative assessment to determine whether it is more likely than not that the fair value of our reporting units has fallen below their carrying value. During our annual impairment test, we utilize four reporting units in evaluating goodwill for impairment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">using a quantitative assessment, which uses a combination of a guideline public company market-based approach and a discounted cash flow income-based approach. The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Finite-lived intangible assets including developed technology, customer lists, distribution agreements, license agreements, trademarks and patents are subject to amortization. Intangible assets are amortized over their estimated useful life on a straight-line basis, except for customer lists, which are generally amortized on an accelerated basis. Estimated useful lives are determined considering the period the assets are expected to contribute to future cash flows. We evaluate long-lived assets, including amortizing intangible assets, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform the impairment analysis at the asset group for which the lowest level of identifiable cash flows are largely independent of the cash flows of other assets and liabilities. We compare the carrying value of the asset group to the undiscounted cash flows expected to result from the asset group and determine whether the carrying amount is recoverable. We determine the fair value of each asset group based on estimated future cash flows discounted back to their present value using a discount rate that reflects the risk profiles of the underlying activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In-process technology intangible assets, which are not subject to amortization until projects reach commercialization, are assessed for impairment at least annually and more frequently if events occur that would indicate a potential reduction in the fair value of the assets below their carrying value. An impairment charge would be recognized to the extent the carrying amount of the in-process technology exceeded its fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Long-Lived Assets</b>.&#160;We periodically review the carrying amount of our depreciable long-lived assets for impairment.&#160;An asset is considered impaired when undiscounted estimated future cash flows are less than the carrying amount of the asset.&#160;In the event the carrying amount of such asset is not considered recoverable, the asset is adjusted to its fair value.&#160;Fair value is generally determined based on discounted future cash flow.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Property and Equipment</b>.&#160;Property and equipment is stated at the historical cost of construction or purchase. Construction costs include interest costs capitalized during construction.&#160;Maintenance and repairs of property and equipment are charged to operations as incurred.&#160;Leasehold improvements are amortized over the lesser of the base term of the lease or estimated life of the leasehold improvements.&#160;Construction-in-process consists of new buildings and various production equipment being constructed internally and externally.&#160;Assets in construction-in-process will commence depreciating once the asset has been placed in service.&#160;Depreciation is computed using the straight-line method over estimated useful lives as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">40 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manufacturing equipment</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Furniture and fixtures</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land improvements</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4 - 25 years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Depreciation expense related to property and equipment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $33.4 million, $34.5 million, and $35.4 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Deferred Compensation</b>.&#160;We have a deferred compensation plan that permits certain management employees to defer a portion of their salary until the future.&#160;We established a Rabbi trust to finance obligations under the plan with corporate-owned variable life insurance contracts.&#160;The cash surrender value totaled $15.8 million and $19.1 million at December&#160;31,&#160;2022 and 2021, respectively, which is included in other assets in our consolidated balance sheets.&#160;We have recorded a deferred compensation payable of $15.3 million and $18.1 million at December&#160;31,&#160;2022 and 2021, respectively, to reflect the liability to our employees under this plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Assets</b>.<b style="font-weight:bold;">&#160;</b>Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in privately held companies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,711</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred compensation plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,126</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term notes receivable, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,612</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,239</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,352</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,421</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Our share of earnings associated with equity method investments is reported within other income (expense) in our consolidated statements of income (loss). Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Long-term Obligations. </b>Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,260</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,500</p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,084</p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,584</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In connection with a business combination, any contingent consideration is recorded at fair value on the acquisition date based upon the consideration expected to be transferred in the future. We re-measure the estimated liability each quarter based upon changes in revenue estimates, changes in the probability of achieving relevant milestones and changes in the discount rate or expected period of payment. Changes in the estimated fair value are recorded through operating expense in our consolidated statements of income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Revenue Recognition</b>.<b style="font-weight:bold;">&#160;</b>We sell our medical products through a direct sales force in the U.S. and&#160;through OEM relationships, custom procedure tray manufacturers and a combination of direct sales force and independent&#160;distributors in international markets.&#160;Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods.&#160;This core principle is achieved through the following steps:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Identify the contract with the customer</i>. A contract with a customer exists when (i)&#160;we enter into an enforceable contract with a customer that defines each party&#8217;s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii)&#160;the contract has commercial substance and (iii)&#160;we determine that collection of substantially all consideration for services that are transferred is probable based on the customer&#8217;s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred if the amortization period would have been one&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Identify the performance obligations in the contract</i>. Generally, our contracts with customers do not include multiple performance obligations to be completed over a period of time. Our performance obligations generally relate to delivering single-use medical products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds. We do not have significant returns. We do not typically offer extended warranty or service plans, except in limited cases which are not material. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Determine the transaction price</i>. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. Our contracts do not typically contain a financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Allocate the transaction price to performance obligations in the contract</i>. We typically do not have multiple performance obligations in our contracts with customers. As such, we generally recognize revenue upon transfer of the product to the customer&#8217;s control at contractually stated pricing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Recognize revenue when or as we satisfy a performance obligation.&#160;</i>We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue. Contract assets are recognized for the future right to invoice customers, and contract liabilities are recognized for unearned revenue if payment is received prior to our fulfillment of performance obligations. We do not have material contract assets or contract liabilities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Reserves are recorded as a reduction in net sales and are not considered material to our consolidated statements of income (loss) for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020.&#160;In addition, we invoice our customers for taxes assessed by governmental authorities, such as sales tax and value-added taxes.&#160;We present these taxes on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Shipping and Handling</b>.&#160;When billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cost of Sales</b>.&#160;We include product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, product royalty expense, developed technology amortization expense, production-related depreciation expense and product license agreement expense in cost of sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Research and Development</b>.&#160;Research and development costs, including new product development, clinical trials, and regulatory compliance, are expensed as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes</b>.&#160;Under our accounting policies, we initially recognize a tax position in our financial statements when it becomes more likely than not that the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax positions that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authorities assuming full knowledge of the position and all relevant facts. Although we believe our provisions for unrecognized tax positions are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our income tax provisions and accruals. Such differences could have a material impact on our income tax provisions and operating results in the periods&#160;in which we make such determination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Earnings per Common Share</b>.&#160;Net income (loss) per common share is computed by both the basic method, which uses the weighted average number of our common shares outstanding, and the diluted method, which includes the dilutive common shares from stock options and restricted stock units as calculated using the treasury stock method. Performance stock units are considered contingently issuable awards and are excluded from the weighted average basic share calculation. These awards are included in the weighted average dilutive share calculation, to the extent they are dilutive, based on the number of shares, if any, that would be issuable as of the end of the reporting period assuming the end of the reporting period is also the end of the performance period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements</b>.<b style="font-weight:bold;">&#160;</b>The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Financial assets are marked to bid prices and financial liabilities are marked to offer prices.&#160;Fair value measurements do not include transaction costs.&#160;A fair value hierarchy is used to prioritize the quality and reliability of the information </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">used to determine fair values.&#160;Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.&#160;The fair value hierarchy is defined in the following three categories:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Level 1: Quoted market prices in active markets for identical assets or liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Level 2: Observable market-based inputs or inputs that are corroborated by market data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Level 3: Unobservable inputs that are not corroborated by market data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation</b>.<b style="font-weight:bold;">&#160;</b>We recognize the fair value compensation cost relating to stock-based payment transactions in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718, <i style="font-style:italic;">Compensation&#160;&#8212; Stock Compensation</i>.&#160;Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#8217;s requisite service period, which is generally the vesting period.&#160;The fair value of our stock options is estimated using a Black-Scholes option valuation model.&#160;The fair value of our performance stock units linked to total shareholder return is estimated using Monte-Carlo simulations. Compensation expense is adjusted each period based on the grant-date fair value and the number of shares that are probable of being awarded based on the performance conditions of the awards. Restricted stock units are valued based on the closing stock price on the date of grant. Cash-settled share-based awards, or liability awards, are remeasured at fair value each reporting period until the awards are settled. Total stock-based compensation expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $18.0 million, $16.1 million, and $14.3 million, respectively (see Note 12).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b>.&#160;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&#160;We provide credit, in the normal course of business, primarily to hospitals and independent third-party custom procedure tray manufacturers and distributors.&#160;We perform ongoing credit evaluations of our customers and maintain allowances for potential credit losses. Due to the diversified nature and number of our customers, concentrations of credit risk with respect to accounts receivable are limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Foreign Currency</b>.&#160;The financial statements of our foreign subsidiaries are measured using local currencies as the functional currency, with the exception of our manufacturing subsidiaries in Ireland and Mexico, which each use the U.S. Dollar as its functional currency.&#160;Assets and liabilities are translated into U.S. Dollars at&#160;year-end rates of exchange and results of operations are translated at average rates for the&#160;year.&#160;Gains and losses resulting from these translations are included in accumulated other comprehensive income (loss) as a separate component of stockholders&#8217; equity.&#160;Transactional exchange gains or losses are included in other income (expense) in determining net income (loss) for the period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivatives</b>.<b style="font-weight:bold;">&#160;</b>We use forward contracts to mitigate our exposure to volatility in foreign exchange rates, and we use interest rate swaps to hedge changes in the benchmark interest rate related to our Third Amended Credit Agreement described in Note&#160;8.&#160;All derivatives are recognized in the consolidated balance sheets at fair value.&#160;Classification of each hedging instrument is based upon whether the maturity of the instrument is less than or greater than 12&#160;months.&#160;We do not purchase or hold derivative financial instruments for speculative or trading purposes (see Note&#160;9).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">New Financial Accounting Standards. In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2020-04, <i style="font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i>, which provides temporary optional expedients and exceptions in accounting for modifications of contracts that reference the London interbank offered rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued as a result of reference rate reform. In January 2021, the FASB issued ASU 2021-01, <i style="font-style:italic;">Reference Rate Reform (Topic 848): Scope</i>, which amends the scope of ASU 2020-04. In December 2022, the FASB issued ASU 2022-06, <i style="font-style:italic;">Deferral of the Sunset Date of Topic 848</i>, which defers the sunset date of the guidance in ASC 848 to December 31, 2024. ASU 2020-04 and ASU 2021-01 were effective as of March 12, 2020; ASU 2022-06 was effective upon its issuance in December 2022. The provisions of these updates may be applied prospectively to transactions through December 31, 2024, when reference rate reform activity is expected to be completed. As of December 31, 2022, we had not modified any contracts as a result of reference rate reform. We are currently assessing the anticipated impact of these standards on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We currently believe that all other issued and not yet effective accounting standards are not materially relevant to our financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602762384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span>REVENUES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="color:#212529;font-weight:bold;background:#ffffff;">Disaggregation of Revenue.</b><span style="color:#212529;background:#ffffff;"> Our revenue is disaggregated based on reporting segment, product category and geographical region. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#212529;background:#ffffff;">We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in&#160;</span><span style="color:#212529;background:#ffffff;">two</span><span style="color:#212529;background:#ffffff;">&#160;operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of&#160;</span><span style="color:#212529;background:#ffffff;">four</span><span style="color:#212529;background:#ffffff;">&#160;product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following table presents sales by operating segment disaggregated based on product category and geographic region for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands).</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cardiovascular</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Peripheral Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 263,602</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 176,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 439,810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 244,459</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 160,657</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 405,116</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 211,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 129,569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 341,568</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiac Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 128,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 214,475</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 343,186</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 122,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 198,189</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 320,641</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 108,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 171,562</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 279,671</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Custom Procedural Solutions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 108,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 81,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 190,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 108,068</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 85,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 193,942</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 110,269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 92,927</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 203,196</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">OEM</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 118,869</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 145,034</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 104,436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,092</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 123,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 91,826</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 17,941</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 109,767</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 619,960</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 498,264</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,118,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 579,415</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 463,812</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,043,227</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 522,203</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 411,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 934,202</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Endoscopy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy Devices</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 30,599</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,158</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,757</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,524</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 27,858</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,673</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 650,559</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 500,422</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 608,878</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 465,873</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 550,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 413,814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 963,875</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><i style="font-style:italic;"> </i><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524606832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Strategic Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Other Strategic Transactions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span>ACQUISITIONS AND OTHER STRATEGIC TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2022 Acquisitions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">On October 3, 2022, we entered into an asset purchase agreement with BioTrace Medical, Inc.,<span style="background:#ffffff;"> developer of the Tempo&#174; Temporary Pacing Lead device,</span> for a purchase price of $2.5 million.<span style="background:#ffffff;"> W</span>e are also required to pay a total of six annual royalty payments between 5% and 10% of net sales, dependent on net sales goal achievement, u<span style="background:#ffffff;">pon achievement of the first device sold in the United States</span>. We accounted for this transaction as an asset purchase. We recorded the amount paid upon closing as a developed technology intangible asset, which we are amortizing over 10 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">On April 30, 2022, we acquired the Restore Endosystems Bifurcated Stent System pursuant to the terms of a unit purchase agreement we executed with all of the members of Restore Endosystems. Subject to the terms and conditions of the unit purchase agreement, we paid $3 million in cash at closing. We also accrued $3.5 million of other long-term obligations, which represents the fair value of two separate $2 million payments which are payable no later than <span style="-sec-ix-hidden:Hidden_omYxHiM9FUeLz86EaJiDGg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span> and four years following the closing of the acquisition, respectively, or earlier upon the achievement of specified milestones. We will impute interest on these liabilities with the passage of time. We have accounted for this transaction as an asset purchase and recorded $6.5 million of acquired in-process research and development expense because the technological feasibility of the underlying research and development project has not yet been reached and such technology has no identified future alternative use as of the date of acquisition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During April 2022, we paid $1.4 million to acquire shares of series A preferred stock of Fluidx Medical Technology, Inc.("Fluidx"), owner of certain technology proposed to be used in the development of embolic and adhesive agents for use in arterial, venous, vascular graft and cardiovascular applications inside and outside the heart and related appendages. We had previously purchased, and continue to hold, $4.7 million of participating preferred shares of Fluidx. Our investments have been recorded as equity investments accounted for at cost and reflected within other assets in the accompanying consolidated balance sheets because we are not able to exercise significant influence over the operations of Fluidx. Our total current investment in Fluidx represents an ownership of approximately 17% of its outstanding capital stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2021 Acquisitions </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-weight:normal;">During September 2021, we paid </span><span style="font-weight:normal;">$2.7</span><span style="font-weight:normal;"> million to acquire series A preferred shares of Fluidx. We had previously purchased </span><span style="font-weight:normal;">$2</span><span style="font-weight:normal;"> million of participating preferred shares during 2019. Our investment has been recorded as an equity investment accounted for at cost and reflected within other assets in the accompanying consolidated balance sheets because we are not able to exercise significant influence over the operations of Fluidx. Our total current investment in Fluidx represents an ownership of </span><span style="font-weight:normal;">15.0%</span><span style="font-weight:normal;"> of the outstanding stock. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">2020 Acquisitions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On November 6, 2020, we entered into a unit purchase agreement to acquire KA Medical, LLC (&#8220;KA Medical&#8221;). Subject to the terms and conditions of the unit purchase agreement, we paid $14.6 million in cash, net of cash acquired, including adjustments for working capital and deferred payments of $4 million. KA Medical developed the Micro Plug Set, a self-expanding nitinol vascular occlusion device, which is FDA-cleared and CE marked. We accounted for this acquisition as a business combination. The sales and results of operations related to the acquisition have been included in our cardiovascular segment since the acquisition date and were not material for the years ended December 31, 2022, 2021 and 2020. <span style="background:#ffffff;">Acquisition-related costs associated with the KA Medical acquisition, which were included in selling, general and </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><span style="background:#ffffff;">administrative expenses, were not material. </span><span style="background:#ffffff;">During the fourth quarter of 2021, certain immaterial measurement period adjustments were recorded to our purchase price allocation. </span>The purchase price was allocated as follows (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:92.71%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets Acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 24</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 211</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 298</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other long-term assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Developed technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,000</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,570</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,126</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Liabilities Assumed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (507)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total liabilities assumed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (538)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total net assets acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,588</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We are amortizing the developed technology intangible asset acquired from KA Medical over 17 years. The goodwill consists largely of the synergies expected from combining operations and is expected to be deductible for income tax purposes. We do not deem the pro forma effects to our consolidated results of operations of the KA Medical acquisition to be material.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602768512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span>INVENTORIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Inventories at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finished goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 147,051</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 132,403</p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Work-in-process</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 29,534</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 22,160</p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Raw materials</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 89,406</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 67,359</p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 265,991</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 221,922</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521968784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span>GOODWILL AND INTANGIBLE ASSETS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The changes in the carrying amount of goodwill for the&#160;years ended December&#160;31,&#160;2022 and 2021, are as follows (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill balance at January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 361,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 363,533</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of foreign exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,920)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,078)</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions and adjustments as the result of acquisitions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 286</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill balance at December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 359,821</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 361,741</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total accumulated goodwill impairment losses aggregated to $8.3 million as of December&#160;31,&#160;2022 and 2021. We did not have any goodwill impairments for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020. The total goodwill balance as of December&#160;31,&#160;2022 and 2021 is related to our cardiovascular segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Other intangible assets at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross&#160;Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 29,445</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,203)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 19,242</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Distribution agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,715)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 535</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,859</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 30,221</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (17,863)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,358</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 34,105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (31,749)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,356</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 108,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (69,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 38,350</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross&#160;Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 26,349</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,315)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,034</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Distribution agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,519)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 731</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,768)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,895</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 30,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,256)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,986</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 34,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (31,195)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,790</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 107,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (65,053)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42,436</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Aggregate amortization expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $48.4 million, $49.6 million, and $58.6 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Estimated amortization expense for the developed technology and other intangible assets for the next five&#160;years consists of the following as of December&#160;31,&#160;2022 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.45%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:28.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Amortization Expense</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 47,496</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 44,434</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 42,610</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,040</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 28,966</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the years ended December&#160;31,&#160;2022, 2021 and 2020, we identified indicators of impairment associated with certain acquired intangible assets based on our qualitative assessment that carrying amounts may not be recoverable, which required us to then complete a quantitative impairment assessment. The primary indicators of impairment <span style="background:#ffffff;">were planned closure and restructuring activities and uncertainty about future product development and commercialization associated with certain acquired technologies, due in part to the economic impacts of the COVID-19 pandemic in 2021 and 2020.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the year ended <span style="-sec-ix-hidden:Hidden_C8dJmPtioUimQru8e7qEng;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2022</span></span>, we recorded total impairment charges related to our intangible assets of $1.7 million for our divestiture on April 30, 2022 of the STD Pharmaceutical Products Limited (&#8220;STD Pharmaceutical&#8221;) business acquired in our August 2019 acquisition of Fibrovein Holdings Limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the year ended <span style="-sec-ix-hidden:Hidden_VqI937vS7Uyy85OFwQu_0A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2021</span></span>, we recorded total impairment charges related to our intangible assets of $1.6 million for the remaining carrying value of ArraVasc license agreements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">During the year ended <span style="-sec-ix-hidden:Hidden_jrl_1y8mUE2lw5OKuH_56w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2020</span></span>, we recorded total impairment charges related to our intangible assets of $28.7 million which included <span style="background:#ffffff;">a partial impairment charge of </span><span style="background:#ffffff;">$8.2</span><span style="background:#ffffff;"> million of intangible assets from our acquisition of </span><span style="-sec-ix-hidden:Hidden_ys3ojRh7S0GRuIZh-sLDXg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">STD Pharmaceutical</span></span><span style="background:#ffffff;">, </span>a partial impairment charge of $8.0 million<span style="background:#ffffff;"> of intangible assets from our acquisition of certain assets from </span><span style="-sec-ix-hidden:Hidden_gcPAqbzfw0OI2MXDaQHSdA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Laurane Medical S.A.S</span></span><span style="background:#ffffff;">, a partial impairment charge of </span><span style="background:#ffffff;">$4.8</span><span style="background:#ffffff;"> million related to our license agreements with </span><span style="-sec-ix-hidden:Hidden_H5Y08u8ZsUaN3kikLiRRBA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ArraVasc Limited</span></span><span style="background:#ffffff;">, and </span><span style="-sec-ix-hidden:Hidden_Xf0THVuuXkWITmOMBoHiHQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">other intangible asset</span></span><span style="background:#ffffff;"> impairments charges of </span><span style="background:#ffffff;">$7.7</span><span style="background:#ffffff;"> million related to intangible assets from our acquisition of certain assets from DirectACCESS Medical, LLC, in-process technology intangible assets of Sontina Medical LLC </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">acquired in connection with our acquisition of certain divested assets from Becton, Dickinson and Company, and a customer list intangible asset&#160;from&#160;our acquisition of ITL Healthcare Pty Ltd (&#8220;ITL&#8221;).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602756688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span>INCOME TAXES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was signed into law. The $2.2 trillion economic stimulus bill contains numerous tax law changes. We evaluated the tax changes to determine what provisions would apply to us. As permitted by the CARES Act, we have deferred payment of the employer&#8217;s portion of social security payroll tax payments and made a payment equal to one half of the deferred amount during the year ended December 31, 2021. The remaining half was paid during the year ended December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law. We currently do not anticipate the recently enacted law, including the corporate alternative minimum tax, one percent excise tax on stock repurchases, or tax incentives to promote clean energy, to have a material impact on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, income (loss) before income taxes is broken out between U.S. and foreign-sourced operations and consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Domestic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 77,562</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 21,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (32,216)</p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 32,589</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,985</p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 82,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 53,917</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,231)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The components of the provision for income taxes for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current expense (benefit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 9,584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 808</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (937)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,162</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 437</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 10,291</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,480</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,407</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total current expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 23,037</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 10,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,907</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred expense (benefit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,438)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (468)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,688)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,615)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,845)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,524)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (871)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,318)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,083)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total deferred benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,924)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,631)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,295)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,388)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The difference between the income tax expense (benefit) reported and amounts computed by applying the statutory federal rate of 21.0% to pretax income (loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Computed federal income tax expense (benefit) at applicable statutory rate of 21%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 17,352</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,778)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (283)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,448)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,978)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,507)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,391)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax effect of international items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,698)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (281)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,705</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Uncertain tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (455)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred compensation insurance assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 706</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (413)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (290)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,423)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,571)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,822)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,523</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,257</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">DOJ settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,890</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Remeasurement of state deferred taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (375)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (526)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,765)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Non-deductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,077</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Remeasurement of contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 733</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,185)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other &#8212; including the effect of graduated rates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (70)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (183)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,388)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets and liabilities at December&#160;31,&#160;2022 and 2021, consisted of the following temporary differences and carry-forward items (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Allowance for credit losses on trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,494</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 11,063</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Inventory differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,887</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 11,117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 14,833</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 7,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,388</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 12,801</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 13,431</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal R&amp;D tax credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 634</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,003</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">UT R&amp;D Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,126</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">IRC section 174 capitalized R&amp;D </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 15,012</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,827</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,939</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 77,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 71,164</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,047)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,925)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,797)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (38,547)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42,888)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Foreign withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,571)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,575)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,527)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,938)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,040)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,556)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (76,178)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (85,801)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,527)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,786)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred income tax liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,863)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25,423)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reported as:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,599</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,080</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,462)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,503)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,863)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25,423)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 64.8pt;"><span style="font-size:8pt;margin-bottom:6pt;margin-left:0pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. Deferred income tax balances reflect the temporary differences between the carrying amounts of assets and liabilities and their tax basis and are stated at enacted tax rates expected to be in effect when taxes are actually paid or recovered. The valuation allowance is primarily related to state credit carryforwards, non-US net operating loss carryforwards, and capital loss carryforwards for which we believe it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $2.7 million during the year ended December 31, 2022, increased by $573,000 during the year ended December 31, 2021, and increased by $5.6 million during the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, we had U.S federal net operating loss carryforwards of $29.7 million, which were generated by Cianna Medical, Vascular Access Technologies, Inc., DFINE Inc., and Biosphere Medical, Inc., prior to our acquisition of these companies. These net operating loss carryforwards are subject to annual limitations under Internal Revenue Code Section 382. If unused $29.6 million of the NOLs will expire between 2025 and 2037. Of the NOLs incurred post-2017, $97,000 can be carried forward indefinitely. We anticipate that we will utilize all current net operating loss carryforwards prior to their expiration dates over the next 13 years. We utilized a total of $15.9 million in U.S. federal net operating loss carryforwards during the year ended December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, we had $22.2 million of non-U.S. net operating loss carryforwards, of which $21.1 million have no expiration date and $1.1 million expire at various dates through 2034. Non-U.S. net operating loss carryforwards utilized during the year ended December 31, 2022 were not material.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We do not consider our foreign earnings to be permanently reinvested. Consequently, we have recorded tax expense of $320,000, $288,000 and $228,000 for foreign withholding taxes on unremitted foreign earnings during the years ended December 31, 2022, 2021 and 2020, respectively. Additionally, for the year ended December 31, 2022, a tax benefit of $4.3 million was recorded with respect to the restructuring of our foreign entities and the associated change in foreign withholding taxes on the unremitted foreign earnings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining our worldwide provision for income taxes and recording the related assets and liabilities. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. In our opinion, we have made adequate provisions for income taxes for all&#160;years subject to audit. We are no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019. In foreign jurisdictions, we are no longer subject to income tax examinations for&#160;years before 2016.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Although we believe our estimates are reasonable, the final outcomes of these matters may be different from those which we have reflected in our historical income tax provisions and accruals. Such differences could have a material effect on our income tax provision and operating results in the period in which we make such determination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The total liability for unrecognized tax benefits at December&#160;31,&#160;2022, including interest and penalties, was $1.9 million, of which $1.9 million would favorably impact our effective tax rate if recognized. At December 31, 2022, none of the total liability was presented as a reduction to non-current deferred income tax assets on our consolidated balance sheet. The total liability for unrecognized tax benefits at December&#160;31,&#160;2021, including interest and penalties, was $2.0 million, of which $2.0 million would favorably impact our effective tax rate if recognized. At December 31, 2021, $1.0 million of the total liability was presented as a reduction to non-current deferred income tax assets on our consolidated balance sheet. As of December&#160;31,&#160;2022 and 2021, we had accrued $336,000 and $322,000 respectively, in total interest and penalties related to unrecognized tax benefits. We account for interest and penalties for unrecognized tax benefits as part of our income tax provision. During the&#160;years ended December&#160;31, 2022, 2021 and 2020, our liability for unrecognized tax benefit was increased (decreased) for interest and penalties by $14,000, $46,000, and $(90,000), respectively. We estimate it is reasonably possible that within the next 12&#160;months the total liability for unrecognized tax benefits may decrease, including expirations related to statutes of limitation, up to $109,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax benefits for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrecognized tax benefits, opening balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,635</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,674</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,161</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross increases (decreases) in tax positions taken in a prior year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 115</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross increases in tax positions taken in the current year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 283</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lapse of applicable statute of limitations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (343)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (437)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (885)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrecognized tax benefits, ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,635</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,674</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The tabular roll-forward ending balance does not include interest and penalties related to unrecognized tax benefits.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519818608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span>ACCRUED EXPENSES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Payroll and related liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 58,620</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 59,435</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of contingent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,813</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,735</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Advances from employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 201</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued rebates payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,271</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,250</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 36,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,122</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 123,189</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 159,014</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723603057968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revolving Credit Facility and Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Revolving Credit Facility and Long-Term Debt</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span>REVOLVING CREDIT FACILITY AND LONG-TERM DEBT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Principal balances outstanding under our long-term debt obligations as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Term loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 124,688</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 133,125</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revolving credit loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 73,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 110,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less unamortized debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (179)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (290)</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 198,009</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 242,835</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current portion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,438</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term portion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 186,759</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 234,397</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:17.4pt;text-align:justify;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Third Amended and Restated Credit Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-family:'Segoe UI';visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">On July 31, 2019, we entered into a Third Amended and Restated Credit Agreement (the "Third Amended Credit Agreement"). The Third Amended Credit Agreement is a syndicated loan agreement with Wells Fargo Bank, National Association and other parties. The Third Amended Credit Agreement amends and restates in its entirety our previously outstanding Second Amended and Restated Credit Agreement and all amendments thereto. The Third Amended Credit Agreement provides for a term loan of&#160;$150&#160;million&#160;and a revolving credit commitment up to an aggregate amount of&#160;$600&#160;million, inclusive of sub-facilities for multicurrency borrowings,&#160;standby letters of credit and&#160;swingline loans. On July 31, 2024, all principal, interest and other amounts outstanding under the Third Amended Credit Agreement are payable in full. At any time prior to the maturity date, we may repay any amounts owing under all term loans and revolving credit loans in whole or in part, without premium or penalty, other than breakage fees (as defined in the Third Amended Credit Agreement).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">Revolving credit loans denominated in dollars and term loans made under the Third Amended Credit Agreement bear interest, at our election, at either the Base Rate or the Eurocurrency Rate (as such terms are defined in the Third Amended Credit Agreement) plus the Applicable Margin (as defined in the Third Amended Credit Agreement).&#160;Revolving credit loans denominated in an Alternative Currency (as defined in the Third Amended Credit Agreement) bear interest at the Eurocurrency Rate plus the Applicable Margin. Swingline loans bear interest at the Base Rate plus the Applicable Margin (as defined in the Third Amended Credit Agreement). Interest on each loan featuring the Base Rate is due and payable on the last business day of each calendar quarter; interest on each loan featuring the Eurocurrency Rate is due and payable on the last day of each interest period applicable thereto, and if such interest period extends over three months, at the end of each three-month interval during such interest period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">The Third Amended Credit Agreement is collateralized by substantially all of our assets. The Third Amended Credit Agreement contains affirmative and negative covenants, representations and warranties, events of default and other terms customary for loans of this nature.&#160;In particular, the Third Amended Credit Agreement requires that we maintain certain financial covenants, as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Covenant Requirement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidated Total Leverage Ratio <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 to 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidated Interest Coverage Ratio <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.0 to 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility Capital Expenditures <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$50 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Maximum Consolidated Total Net Leverage Ratio (as defined in the Third Amended Credit Agreement) as of any fiscal quarter end.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Minimum ratio of Consolidated EBITDA (as defined in the Third Amended Credit Agreement and adjusted for certain expenditures) to Consolidated interest expense (as defined in the Third Amended Credit Agreement) for any period of four consecutive fiscal quarters.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Maximum level of the aggregate amount of all Facility Capital Expenditures (as defined in the Third Amended Credit Agreement) in any fiscal year.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;">As of December&#160;31,&#160;2022, we believe we were in compliance with all covenants set forth in the Third Amended Credit Agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;">As of December&#160;31,&#160;2022, we had outstanding borrowings of </span><span style="font-style:normal;">$198.2</span><span style="font-style:normal;"> million </span><span style="font-style:normal;">and issued letter of credit guarantees of </span><span style="font-style:normal;">$3.2</span><span style="font-style:normal;"> million</span><span style="font-style:normal;"> under the Third Amended Credit Agreement, with additional available borrowings of approximately </span><span style="font-style:normal;">$523</span><span style="font-style:normal;"> million, based on the leverage ratio required pursuant to the Third Amended Credit Agreement. Our interest rate as of December&#160;31,&#160;2022 was a fixed rate of </span><span style="font-style:normal;">2.71%</span><span style="font-style:normal;"> on </span><span style="font-style:normal;">$75</span><span style="font-style:normal;"> million as a result of an interest rate swap (see Note 9) and a variable floating rate of </span><span style="font-style:normal;">5.38%</span><span style="font-style:normal;"> on </span><span style="font-style:normal;">$123.2</span><span style="font-style:normal;"> million. </span><span style="font-style:normal;background:#ffffff;">Our interest rate as of December&#160;31,&#160;2021 was a fixed rate of&#160;</span><span style="font-style:normal;background:#ffffff;">2.71%</span><span style="font-style:normal;background:#ffffff;"> on </span><span style="font-style:normal;background:#ffffff;">$75</span><span style="font-style:normal;background:#ffffff;">&#160;million as a result of an interest rate swap and a variable floating rate of&#160;</span><span style="font-style:normal;background:#ffffff;">1.10%</span><span style="font-style:normal;background:#ffffff;"> on </span><span style="font-style:normal;background:#ffffff;">$168.1</span><span style="font-style:normal;background:#ffffff;">&#160;million.</span><span style="font-style:normal;"> The foregoing fixed rates are exclusive of potential future changes in the applicable margin.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Certain of the interest rates applicable to our Third Amended Credit Agreement, and applicable to hedging instruments we have purchased to offset interest rate risk under our Third Amended Credit Agreement, are LIBOR-based. We anticipate replacement rates will be identified, as provided for in our Third Amended Credit Agreement, as LIBOR-based rates become unavailable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Future Payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Future minimum principal payments on our long-term debt as of December&#160;31,&#160;2022, are as follows (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years&#160;Ending</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;Minimum </b></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal&#160;Payments</b></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,250</p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 186,938</p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total future minimum principal payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 198,188</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723603125328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span>DERIVATIVES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">General.</b>&#160;Our earnings and cash flows are subject to fluctuations due to changes in interest rates and foreign currency exchange rates, and we seek to mitigate a portion of these risks by entering into derivative contracts.&#160;The derivatives we use are interest rate swaps and foreign currency forward contracts.&#160;We recognize derivatives as either assets or liabilities at fair value in the accompanying consolidated balance sheets, regardless of whether or not hedge accounting is applied.&#160;We report cash flows arising from our hedging instruments consistent with the classification of cash flows from the underlying hedged items.&#160;Accordingly, cash flows associated with our derivative programs are classified as operating activities in the accompanying consolidated statements of cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We formally document, designate and assess the effectiveness of transactions that receive hedge accounting initially and on an ongoing basis.&#160;For qualifying hedges, the change in fair value is deferred in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;), a component of stockholders&#8217; equity in the accompanying consolidated balance sheets, and recognized in earnings at the same time the hedged item affects earnings. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings throughout the term of the derivative. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Interest Rate Risk</b>.&#160;Our debt bears interest at variable interest rates and, therefore, we are subject to variability in the cash paid for interest expense. In order to mitigate a portion of this risk, we use a hedging strategy to reduce the variability of cash flows in the interest payments associated with a portion of the variable-rate debt outstanding under our Third Amended Credit Agreement that is solely due to changes in the benchmark interest rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On August&#160;5, 2016, we entered into a pay-fixed, receive-variable interest rate swap with a current notional amount of&#160;$175 million&#160;with Wells Fargo Bank to fix the one-month LIBOR rate at&#160;1.12%. The variable portion of the interest rate swap was tied to the one-month LIBOR rate (the benchmark interest rate). The interest rate swap expired on July&#160;6, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On December 23, 2019, we entered into a pay-fixed, receive-variable interest rate swap with a notional amount of $75 million with Wells Fargo Bank to fix the one-month LIBOR rate at 1.71% for the period from July 6, 2021 to July 31, 2024. The variable portion of the interest rate swap is tied to the one-month LIBOR rate (the benchmark interest rate). On a monthly basis, the interest rates under both the interest rate swap and the underlying debt reset, the swap is settled with the counterparty, and interest is paid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">At December&#160;31,&#160;2022 and 2021, our interest rate swaps qualified as cash flow hedges.&#160;The fair value of our interest rate swap at December&#160;31,&#160;2022 was an asset of $3.4 million, partially offset by $0.8 million in deferred taxes. The fair value of our interest rate swaps at December&#160;31,&#160;2021 was a liability of $1.4 million, partially offset by $0.4 million in deferred taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Foreign Currency Risk</b>.&#160;We operate on a global basis and are exposed to the risk that our financial condition, results of operations, and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. Our policy is to enter into foreign currency derivative contracts with maturities of up to two years. We are exposed to foreign currency exchange rate risk with respect to transactions and balances denominated in various currencies, with our most significant exposure related to transactions and balances denominated in Chinese Renminbi and Euros, among others. We do not use derivative financial instruments for trading or speculative purposes. We are not subject to any credit risk contingent features related to our derivative contracts, and counterparty risk is managed by allocating derivative contracts among several major financial institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is temporarily reported as a component of other comprehensive income (loss) and then reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. We entered into forward contracts on various foreign currencies to manage the risk associated with forecasted exchange rates which impact revenues, cost of sales, and operating expenses in various international markets. The objective of the hedges is to reduce the variability of cash flows associated with the forecasted purchase or sale of foreign currencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We enter into approximately 100 cash flow foreign currency hedges every&#160;month. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts, which qualified as cash flow hedges, with aggregate notional amounts of $87.8 million and $123.0 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Not Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We forecast our net exposure in various receivables and payables to fluctuations in the value of various currencies, and we enter into foreign currency forward contracts to mitigate that exposure. We enter into approximately 50 foreign currency fair value hedges every&#160;month. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts related to those balance sheet accounts with aggregate notional amounts of $92.4 million and $86.0 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Balance Sheet Presentation of Derivatives. </b>As of December&#160;31,&#160;2022 and 2021, all derivatives, both those designated as hedging instruments and those that were not designated as hedging instruments, were recorded gross at fair value on our consolidated balance sheets. We are not subject to any master netting agreements. The fair value of derivative instruments on a gross basis is as follows (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments Designated as Hedging Instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance&#160;Sheet&#160;Location</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets (long-term)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,215</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,326</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets (long-term)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 179</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Liabilities)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,447)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,288)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (531)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (502)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments Not Designated as Hedging Instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance&#160;Sheet&#160;Location</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 736</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Liabilities)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,946)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (856)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Statement Presentation of Derivatives</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives Designated as Cash Flow Hedges</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income ("OCI") in our consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount&#160;of&#160;Gain/(Loss)</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Recognized&#160;in&#160;OCI</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Derivative instrument</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Interest rate swaps</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> 4,879</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> 1,402</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (6,131)</p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Foreign currency forward contracts</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> 6,263</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (1,521)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (5,516)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on AOCI and net earnings in our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Consolidated Statements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount&#160;of&#160;Gain/(Loss)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reclassified&#160;from&#160;AOCI</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;width:39.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Location in statements of income</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Interest expense</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,339)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,261)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,994)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,509)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (872)</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Revenue</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 963,875</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 3,583</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,592)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 36</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Cost of sales</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (631,882)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (589,418)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (562,698)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,436)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 1,017</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,288)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, $2.7 million or $2.1 million after taxes, was expected to be reclassified from AOCI to earnings in revenue and cost of sales over the succeeding twelve&#160;months. As of December&#160;31,&#160;2022, $2.3 million, or $1.8 million after taxes, was expected to be reclassified from AOCI to earnings in interest expense over the succeeding twelve&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;">Derivatives Not Designated as Hedging Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income (loss) for the&#160;years presented (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:30.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Derivative Instrument</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Location in statements of income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Foreign currency forward contracts</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_EbHCmjYljUGB_8dKno-fsQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Other income (expense) &#8212; net</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,598)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,190)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">See Note&#160;15 for additional information about our derivatives.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723603068848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">10.</b></span>COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We are obligated under non-terminable operating leases for manufacturing facilities, finished good distribution centers, office space, equipment, vehicles, and land. See Note 17 for disclosures regarding these operating leases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Royalties</b>. As of December&#160;31,&#160;2022, we had entered into a number of agreements to license or acquire rights to certain intellectual property which require us to make royalty payments during the term of the agreements generally based on a&#160;percentage of sales. During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, total royalty expense approximated $7.3 million, $7.6 million and $7.1 million, respectively, and is recorded in cost of sales on the consolidated statement of income (loss). Minimum contractual commitments under royalty agreements to be paid within twelve&#160;months of December&#160;31,&#160;2022 were not significant. See Note&#160;15 for discussion of future royalty commitments related to acquisitions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Litigation</b>.&#160;In the ordinary course of business, we are involved in various claims and litigation matters. T<span style="background:#ffffff;">hese proceedings, actions and claims may involve product liability, intellectual property, contract disputes, employment, governmental </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">inquiries or other matters, including those more fully described below.&#160;The outcomes of these matters will generally not be known for prolonged periods of time. In certain proceedings, the claimants may seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief.&#160;For legal matters for which our management had sufficient information to reasonably estimate our future obligations, a liability representing management&#8217;s best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded.&#160;The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect our financial position, results of operations and cash flows. The ultimate cost to us with respect to</span> actions and claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Shareholder Derivative Action</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On June 3, 2021, Steffen Maute filed a complaint, derivatively on behalf of Merit, against Merit (as a nominal defendant), our Chief Executive Officer, our Chief Financial Officer, our former President of EMEA and certain of our directors in the United States District Court for the District of Utah (Case No. 2:21-cv-00346-DBP). The derivative complaint alleged that the individual defendants violated their fiduciary duties owed to Merit and were unjustly enriched at the expense of and to the detriment of Merit between February 2019 and October 2019, and sought unspecified damages, costs, and professional fees. Following mediation, the parties negotiated an agreement to settle the dispute, which, among other provisions, provides for the release of all claims against Merit and the other defendants in exchange for Merit&#8217;s undertaking to implement certain corporate governance revisions and pay attorneys fees and expenses in the amount of $1.0 million. On February 16, 2023, the court held a hearing and announced approval of the settlement, which has the effect of resolving all claims arising from the litigation. The expense associated with the settlement has been reflected in our financial results reported for the year ended December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">SEC Inquiry </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We have received requests from the Division of Enforcement of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) seeking the voluntary production of information relating to the business activities of Merit&#8217;s subsidiary in China, including interactions with hospitals and health care officials in China. We are cooperating with the requests and investigating the matter and, at this time, are unable to predict the scope, timing, significance or outcome of this matter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">It is possible that the ultimate resolution of the foregoing matter, or similar matters, if resolved in a manner unfavorable to us, may be materially adverse to our business, financial condition, results of operations or liquidity. Legal costs for these matters, such as outside counsel fees and expenses, are charged to expense in the period incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723516468464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (EPS)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share (EPS)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">11.</b></span>EARNINGS PER COMMON SHARE (EPS)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The computation of weighted average shares outstanding and the basic and diluted earnings (loss) per common share for the following periods consisted of the following (in thousands, except per share amounts):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 74,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 48,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9,843)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Average common shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55,434</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic EPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.18)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Average common shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55,434</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of dilutive stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,214</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total potential shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 57,671</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 57,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55,434</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted EPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.18)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity awards excluded as the impact was anti-dilutive <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 799</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,216</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Does </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">not</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> reflect the impact of incremental repurchases under the treasury stock method. </span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517923232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Employee Stock Purchase Plan, Stock Options and Warrants</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>EMPLOYEE STOCK PURCHASE PLAN, STOCK OPTIONS AND WARRANTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our stock-based compensation primarily consists of the following plans:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">2018 Long-Term Incentive Plan</b>.&#160;In June&#160;2018, our Board of Directors adopted and our shareholders approved, the Merit Medical Systems,&#160;Inc. 2018 Long-Term Incentive Plan, which was subsequently amended effective December&#160;14, 2018 (the &#8220;2018 Incentive Plan&#8221;) to supplement the Merit Medical Systems,&#160;Inc. 2006 Long-Term Incentive plan (the "2006 Incentive Plan").&#160;The 2018 Incentive Plan provides for the granting of stock options, stock appreciation rights, restricted stock, stock units (including restricted stock units) and performance awards (including performance stock units).&#160;Options may be granted to directors, officers, outside consultants and key employees and may be granted upon such terms and such conditions as the Compensation Committee of our Board of Directors determines.&#160;Options typically vest on an annual basis over a <span style="-sec-ix-hidden:Hidden_hlnL4vN8SUG8ae4Eqn09kg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> to five-year life with a contractual life of seven years. As of December&#160;31,&#160;2022, a total of 2,817,861 shares remained available to be issued under the 2018 Incentive Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">2006 Long-Term Incentive Plan</b>. In May&#160;2006, our Board of Directors adopted, and our shareholders approved, the 2006 Incentive Plan. As of December&#160;31,&#160;2022, the 2006 Incentive Plan was no longer being used for new equity award grants. However, as of December&#160;31,&#160;2022, options granted under this plan were still outstanding, vesting, and being exercised and will continue to be outstanding until the vesting periods end and the terms of the equity awards expire.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Employee Stock Purchase Plan</b>. We have a non-qualified Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which has an expiration date of June&#160;30, 2026. As of December&#160;31,&#160;2022, the total number of shares of common stock that remained available to be issued under our non-qualified plan was 102,739 shares. ESPP participants purchase shares on a quarterly basis at a price equal to 95% of the market price of the common stock at the end of the applicable offering period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation Expense</b>.&#160;The stock-based compensation expense before income tax expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,357</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,789</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,343</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,157</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,678</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,332</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Performance-based restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,509</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,829</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,836</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 758</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash-settled performance-based share-based awards ("Liability Awards")</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,511</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 906</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,647</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 13,271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,825</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation expense before taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,042</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,090</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,339</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We recognize stock-based compensation expense (net of a forfeiture rate) for those awards which are expected to vest on a straight-line basis over the requisite service period.&#160;We estimate the forfeiture rate based on our historical experience and expectations about future forfeitures.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Nonqualified Stock Options</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, the total remaining unrecognized compensation cost related to non-vested stock options, net of expected forfeitures, was $20.4 million and is expected to be recognized over a weighted average period of 2.1 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">In applying the Black-Scholes methodology to the option grants, the fair value of our stock-based awards granted was estimated using the following assumptions for the years ended December&#160;31,&#160;2022, 2021 and 2020:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.57%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1.4% - 4.3%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.5% - 1.1%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.3% - 1.7%</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected option term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 - 5.0 years</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected price volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">46.2% - 47.5%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">46.1% - 46.7%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">38.7% - 45.1%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The average risk-free interest rate is determined using the U.S.&#160;Treasury rate in effect as of the date of grant, based on the expected term of the stock option.&#160;We determine the expected term of the stock options using the historical exercise behavior of employees.&#160;The expected price volatility was determined based upon the historical volatility for our stock. We recognize compensation expense for options on a straight-line basis over the service period, which corresponds to the vesting period.&#160;During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, approximately 251,000, 716,000 and 329,000 nonqualified stock option grants were made, respectively, for a total fair value of $6.3 million, $17.5 million and $4.5 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The table below presents information related to stock option activity for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total intrinsic value of stock options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 27,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 36,086</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,733</p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash received from stock option exercises</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 20,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,481</p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Excess tax benefit from the exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,815</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Changes in stock options for the&#160;year ended December&#160;31,&#160;2022, consisted of the following (shares and intrinsic value in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining&#160;Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of&#160;Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise&#160;Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;(in&#160;years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 44.70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 63.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (703)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 28.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited/expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (111)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 53.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,077</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 49.62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 64,634</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 43.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2.61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 48,595</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending vested and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,013</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 49.37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 64,026</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The weighted average grant-date fair value of options granted during the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $24.98, $24.38 and $13.70, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Stock-Settled Performance-Based Restricted Stock Units (&#8220;PSUs&#8221;) and Time-Vested Restricted Stock Units (&#8220;RSUs&#8221;)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Since 2020, we have granted PSUs to certain of our executive officers. Conversion of PSUs occurs at the end of <span style="-sec-ix-hidden:Hidden_xGgJ2uRJGkuzkcphmVUYXA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>, <span style="-sec-ix-hidden:Hidden_z1_aUA5vikuLxGHYLl_gBQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span> and three-year performance periods, or one year after the agreement date, whichever is later. The conversion ratio is based upon attaining targeted levels of free cash flow (&#8220;FCF&#8221;) and relative shareholder return as compared to the Russell 2000 Index (&#8220;rTSR&#8221;), as defined in the award agreements. In 2020, our Board of Directors amended PSUs granted in 2020 with a one-year performance period to adjust the performance targets and reduce the maximum FCF multiplier to 100% for the one-year awards, which lowered the potential shares of our common stock to be granted pursuant to the one-year awards by 25,415 shares. We accounted for this amendment in accordance with ASC 718 as a &#8220;Type I&#8221; modification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The payout for each PSU is equal to one share of common stock multiplied by a FCF multiplier (between 50% and 100% in the case of the 2020 one-year awards, as amended, or 50% and 200% in the case of all other PSU awards) and a rTSR multiplier (between 75% and 125%). PSUs convey no shareholder rights unless and until shares are issued in settlement of the award. We use Monte-Carlo simulations to estimate the grant-date fair value of the PSUs linked to total shareholder return. Compensation expense is recognized using the grant-date fair value for the number of shares that are probable of being awarded based on the performance conditions. Each reporting period, this probability assessment is updated, and cumulative catchups are recorded based on the level of FCF that is expected to be achieved. At the end of the performance period, cumulative expense is calculated based on the actual level of FCF achieved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We grant RSUs to our non-employee directors, which are subject to continued service through the vesting date, which is one year from the date of grant. The expense recognized for RSUs is equal to the closing stock price on the date of grant, which is recognized over the vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Changes in PSUs and RSUs for the&#160;year ended December&#160;31,&#160;2022, consisted of the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PSUs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In Thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In Thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning nonvested balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 53.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 61.77</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 64.54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 59.02</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">rTSR adjustment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 65.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (44)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 65.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (26)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 61.77</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (45)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 60.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nonvested balance at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 65.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 59.02</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Based on the maximum payout, excluding the impact of the rTSR multiplier. The actual number of shares which vest is determined based on the satisfaction of performance conditions and the application of an rTSR multiplier between </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">75%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">125%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Represents the application of an rTSR multiplier of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">125%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> to awards vested in 2022 based on the performance of our common stock and the terms of the awards.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes PSUs and RSUs granted during the years ended December 31, 2022, 2021, and 2020 (units and shares in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">PSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Target units granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Maximum units granted <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">103</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Maximum potential shares<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> (1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Weighted average grant date fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">64.54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">61.39</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 43.63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Units granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Weighted average grant date fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">59.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">61.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42.98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Based on the maximum payout, excluding the impact of the rTSR multiplier. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Includes the impact of the maximum potential rTSR multiplier of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">125%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Includes the impact of the 2020 amendment which reduced the maximum FCF multiplier for one-year awards from </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">200%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the years ended December 31, 2022 and 2021, there were approximately 44,000 and 26,000 shares, respectively, that vested under PSUs, prior to the reduction of shares withheld to satisfy tax withholding obligations. Vested shares were calculated based upon achievement of the maximum performance multiplier, as amended, of 200% and 100% for 2022 and 2021, respectively, and an rTSR multiplier of 125%. There were no shares that vested under PSUs during the year ended December 31, 2020. During the years ended December 31, 2022 and 2021, there were approximately 26,000 and 34,000 shares, respectively, that vested under RSUs. There were no shares that vested under RSUs during the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The fair value of each PSU was estimated as of the grant date using the following assumptions for awards granted in the years ended December 31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1.6% - 2.7%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.1% - 0.3%</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Performance period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2.6 - 2.8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1.8 - 2.8 years</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected price volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">38.5% - 42.6%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">43.7% - 49.3%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The risk-free interest rate of return was determined using the U.S. Treasury rate at the time of grant with a remaining term equal to the expected term of the award. The expected volatility was based on a weighted average volatility of our stock </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">price and the average volatility of our compensation peer group's volatilities. The expected dividend yield was assumed to be zero because, at the time of the grant, we had no plans to declare a dividend.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, the total remaining unrecognized compensation cost related to stock-settled performance stock units and restricted stock units, net of expected forfeitures, was $4.7 million and $0.7 million, respectively, which is expected to be recognized over a weighted average period of 1.6 years and 0.4 years, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Cash-Settled Performance-Based Share-Based Awards (&#8220;Liability Awards&#8221;)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the years ended December&#160;31,&#160;2022, 2021 and 2020, we granted liability awards to certain executive officers. These awards entitle them to cash payments equal to a total target cash incentive of $1.0 million, $1.0 million, and $1.0 million, respectively, multiplied by rTSR and FCF multipliers, as defined in the award agreements. In 2020, our Board of Directors amended the liability awards with a one-year performance period. The potential maximum payout of these liability awards is 125% of the target cash incentive for the 2020 one-year award, as amended, and 250% of the target cash incentive for all other liability awards, resulting in a total potential maximum payout of $2.5 million and $2.5 million for liability awards granted during the years ended December 31, 2022 and 2021, respectively. Settlement generally occurs at the end of <span style="-sec-ix-hidden:Hidden_d8w-m4ewDEurtEdt4iLbkQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>, <span style="-sec-ix-hidden:Hidden_t8cBNSblNE-IWNGe1sg12Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span> and three-year performance periods based upon the same performance metrics and vesting period as our performance stock units. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">These awards are classified as liabilities and reported in accrued expenses and other long-term liabilities within our consolidated balance sheet. The fair value of these awards is remeasured at each reporting period until the awards are settled. As of December 31,&#160;2022, our recorded liabilities associated with these awards was $3.2 million, and we had remaining unrecognized compensation cost related to cash-settled performance-based share-based awards of $1.9 million, which is expected to be recognized over a weighted average period of 1.7 years. During 2022 and 2021, we paid $833,000 and $417,000, respectively, in connection with liability awards, and no awards were forfeited. There were no liability awards vested or <span style="-sec-ix-hidden:Hidden_eEnAFWZ5UEGI9LcVSBtx5g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">forfeited</span></span> in the year ended December 31, 2020. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519511776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting and Foreign Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting and Foreign Operations</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.</b></span>SEGMENT REPORTING AND FOREIGN OPERATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt;"><span style="font-weight:normal;">We report our operations in </span><span style="font-weight:normal;">two</span><span style="font-weight:normal;"> operating segments: cardiovascular and endoscopy.&#160;</span><span style="font-weight:normal;">Our cardiovascular segment consists of </span><span style="font-weight:normal;">four</span><span style="font-weight:normal;"> product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.</span><span style="font-weight:normal;"> We evaluate the performance of our operating segments based on net sales and operating income (loss). </span><span style="font-weight:normal;">See Note&#160;2 to our consolidated financial statements set forth in Item 8 of this report for a detailed breakout of our sales by operating segment and product category, disaggregated between domestic and international sales.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, we had international sales of $500.4 million, $465.9 million and $413.8 million, respectively, or 43%, 43% and 43%, respectively, of net sales. Our largest international markets include China, Japan, Germany, France and the United Kingdom, with&#160;China representing our most significant international sales market with sales of $149.3 million, $138.2 million, and $113.2 million for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. International sales are attributed based on location of the customer receiving the product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United States</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 281,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 275,311</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 277,643</p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ireland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 40,749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 39,863</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42,951</p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other foreign countries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 60,937</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 62,134</p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 382,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 371,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 382,728</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, are as follows (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net sales</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,118,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,043,227</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 934,202</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,757</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,524</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,673</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total net sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 963,875</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (loss) from operations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 53,415</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,042)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,617</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,501</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,480</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total income (loss) from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 60,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,562)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total other expense &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,934)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,999)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,669)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,388)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,843)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 6pt 0pt;">Total assets by operating segment at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,652,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,635,676</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,654,866</p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,821</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,618</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 9,530</p></td></tr><tr><td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,663,966</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,648,294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,664,396</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Total depreciation and amortization by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 80,777</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 83,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 93,160</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 910</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 81,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 94,070</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Total capital expenditures for property and equipment by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 44,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 27,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 45,803</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 104</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 382</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 185</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 45,029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 27,939</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 45,988</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524616048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.</b></span>EMPLOYEE BENEFIT PLANS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We have defined contribution plans covering all U.S. full-time adult employees and certain of our foreign employees. Our contributions to these plans are discretionary in certain countries, including the U.S. In September 2019, we ceased discretionary contributions to certain of our defined contribution plans and subsequently reinstated those contributions in May 2021. Total expense for contributions made to these plans for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $7.7 million, $6.5 million and $3.9 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519791936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">15.</b></span>FAIR VALUE MEASUREMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Assets (Liabilities) Measured at Fair Value on a Recurring Basis</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">active&#160;markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">observable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">unobservable&#160;inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Marketable securities <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 138</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 138</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate contract asset, long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency contract assets, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,783</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,783</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency contract liabilities, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,986)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,986)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,073)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,073)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted&#160;prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant&#160;other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">active&#160;markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">observable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">unobservable&#160;inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest rate contract liability, long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,447)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,447)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency contract assets, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,241</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,241</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency contract liabilities, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,646)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,646)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48,234)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48,234)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the interest rate contracts is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as prepaid and other assets or other long-term assets in the consolidated balance sheets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Certain of our business combinations involve the potential for the payment of future contingent consideration, generally based on a&#160;percentage of future product sales or upon attaining specified future revenue or other milestones. Contingent consideration liabilities are re-measured to fair value at each reporting period, with the change in fair value recognized </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">within operating expenses in the accompanying consolidated statements of income (loss). We measure the initial liability and re-measure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements. Changes in the fair value of our contingent consideration liabilities during the&#160;years ended December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 48,234</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 55,750</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_TpnXjRgdGkC2N239gRk-Nw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contingent consideration expense</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,161</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent payments made</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (34,762)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,665)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of foreign exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 18,073</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 48,234</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31,&#160;2022, $2.3 million in contingent consideration liability was included in other long-term obligations and $15.8 million in contingent consideration liability was included in accrued expenses in our consolidated balance sheet related to contingent liabilities. As of December&#160;31,&#160;2021, $13.5 million in contingent consideration liability was included in other long-term obligations and $34.7 in contingent consideration liability was included in accrued expenses in our consolidated balance sheet related to contingent liabilities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Cash payments related to the settlement of the contingent consideration liability recognized at fair value as of the applicable acquisition date been reflected as a cash outflow from financing activities in the accompanying consolidated statements of cash flows. Payments related to increases in the contingent consideration liability subsequent to the date of acquisition of $1.8&#160;million for the year ended December&#160;31,&#160;2022 are reflected as operating cash flows. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The recurring Level 3 measurement of our contingent consideration liabilities includes the following significant unobservable inputs at December&#160;31,&#160;2022 and 2021 (amounts in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Valuation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingent consideration liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">technique</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue-based royalty payments contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,097</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discounted cash flow</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14%&#160;-&#160;17%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15.7%</p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2034</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue milestones contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 13,064</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Monte Carlo simulation</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5.1% - 14.0%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5.2%</p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2033</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Regulatory approval contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,912</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Scenario-based method</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5.7%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of milestone payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">90%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2030</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.</span></td></tr></table><div style="margin-top:6pt;"/><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Valuation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingent consideration liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">technique</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue-based royalty payments contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,870</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discounted cash flow</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13%&#160;-&#160;16%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14.7%</p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022-2034</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue milestones contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 41,671</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Monte Carlo simulation</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">7.5% - 12.5%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8.2%</p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022-2031</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Regulatory approval contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,693</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Scenario-based method</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2.6%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of milestone payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">80%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024-2025</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2025</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.</span></td></tr></table><div style="margin-top:6pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The contingent consideration liabilities are re-measured to fair value each reporting period using projected revenues, discount rates, probabilities of payment, and projected payment dates. Projected contingent payment amounts are discounted back to the current period using a discounted cash flow model. Projected revenues are based on our most recent internal operational budgets and long-range strategic plans. An increase (decrease) in either the discount rate or the time to payment, in isolation, may result in a significantly lower (higher) fair value measurement. A decrease (increase) in the probability of any milestone payment may result in lower (higher) fair value measurements. Our determination of the fair value of contingent consideration liabilities could change in future periods based upon our ongoing evaluation of these significant unobservable inputs. We intend to record any such change in fair value to operating expenses in our consolidated statements of income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'TimesNewRomanPSMT';font-style:italic;">Contingent Payments to Related Parties. </i><span style="background:#ffffff;">During the years ended December 31, 2022 and 2020, we made contingent payments of approximately&#160;</span><span style="background:#ffffff;">$1.6</span><span style="background:#ffffff;">&#160;million and&#160;</span><span style="background:#ffffff;">$800,000</span><span style="background:#ffffff;"> to a former director of Merit and former shareholder of Cianna Medical which we acquired in 2018. We made no such payments in 2021.</span> <span style="background:#ffffff;">In 2023, the Company expects to make additional payments consistent with prior years. The terms of the acquisition, including contingent consideration payments, were determined prior to the appointment of the former Cianna Medical shareholder as a director of Merit. As a former shareholder of Cianna Medical, the former Merit director may be eligible for additional&#160;</span>payments for the achievement of sales milestones specified in our merger agreement with Cianna Medical.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Fair Value of Other Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The carrying amount of cash and cash equivalents, receivables, and trade payables approximate fair value because of the immediate, short-term maturity of these financial instruments.&#160;Our long-term debt re-prices frequently due to variable rates and entails no significant changes in credit risk and, as a result, we believe the fair value of long-term debt approximates carrying value. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs, with the exception of cash and cash equivalents, which are Level 1 inputs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Impairment Charges</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily property and equipment, intangible assets and goodwill in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Intangible Assets. </i>During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, we had losses of $1.7 million, $1.6 million and $28.7 million, respectively, related to certain acquired intangible assets (see Note 5). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Right of Use Operating Lease Assets.</i> W<span style="background:#ffffff;">e identified changes in events and circumstances relating to certain right-of-use (&#8220;ROU&#8221;) operating lease assets. We compared the anticipated undiscounted cash flows generated by a sublease to the carrying value of the ROU operating lease and related long-lived assets and determined that the carrying values were not recoverable. Consequently, we recorded impairment losses during the years ended December 31, 2021 and 2020 of </span><span style="background:#ffffff;">$1.4</span><span style="background:#ffffff;"> million and </span><span style="background:#ffffff;">$1.5</span><span style="background:#ffffff;"> million, respectively, which is equal to the excess of the carrying value of the assets over their estimated fair value. The impairment losses were driven primarily by site consolidation decisions and changes in our projected cash flows for the ROU operating lease asset and related long-lived assets, due to changes in the real estate market as a result of the COVID-19 pandemic. These changes include an increase in the anticipated time to identify a lessee, an increase in anticipated lease concessions, and a decrease in the expected lease rates for the property. The ROU operating lease asset impairment losses pertained to our cardiovascular segment. We had </span><span style="background:#ffffff;">no</span><span style="background:#ffffff;"> such losses during the year ended December 31, 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Property and Equipment.</i> D<span style="background:#ffffff;">uring the year ended </span><span style="-sec-ix-hidden:Hidden_PXZ4MOWrBUiFixPo1YrNdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">December 31, 2021</span></span><span style="background:#ffffff;">, we had losses of </span><span style="background:#ffffff;">$1.3</span><span style="background:#ffffff;">&#160;million related to the measurement of property and equipment at fair value based on the planned&#160;discontinuance of the Advocate&#8482; Peripheral Angioplasty Balloon product line, sold under our license agreements with ArraVasc, which pertained to our cardiovascular segment.&#160;</span>During the year ended <span style="-sec-ix-hidden:Hidden_5ha5obNG7EukzOsmSgU-lg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2020</span></span>, we had losses of $359,000&#160;related to the measurement of certain property and equipment measured at fair value based on restructuring activities associated with the suspension of our distribution agreement with NinePoint, which pertained to our endoscopy segment. We had no such losses during the year ended December 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;background:#ffffff;">Equity Investments, Purchase Options and Notes Receivable.</i><span style="background:#ffffff;">&#160;During the year ended December 31, 2022, we recognized </span><span style="background:#ffffff;">$0.5</span><span style="background:#ffffff;"> million of impairment expense related to our equity method investment in XableCath, as business ceased operations. During the year ended December 31, 2020, we recognized&#160;</span><span style="background:#ffffff;">$2.5</span><span style="background:#ffffff;">&#160;million of impairment expense related to our equity method investment in the&#160;</span><span style="background:#ffffff;">19.5</span><span style="background:#ffffff;">&#160;percent ownership in preferred shares of Fusion Medical, Inc. (&#8220;Fusion&#8221;) due to&#160;uncertainty about future product development and commercialization associated with the technologies and a charge of&#160;</span><span style="background:#ffffff;">$3.5</span><span style="background:#ffffff;">&#160;million related to Bluegrass Vascular due to our decision not to exercise our option to purchase the company. We had </span><span style="background:#ffffff;">no</span><span style="background:#ffffff;"> such losses during the year ended December 31, 2021. </span>Our equity investments in privately held companies were $15.6 million and $14.7 million at December 21, 2022 and 2021, respectively, <span style="background:#ffffff;">which are included within other long-term assets in our consolidated balance sheets. We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Current Expected Credit Losses</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Our outstanding long-term notes receivable, including accrued interest and our allowance for current expected credit losses, were $2.4 million and $2.3 million, as of December&#160;31,&#160;2022 and 2021, respectively. As of December&#160;31,&#160;2022 and 2021, we had an allowance for current expected credit losses of $281,000 and $199,000, respectively, associated with these notes receivable. We assess the allowance for current expected credit losses on an individual security basis, due to the limited number of securities, using a probability of default model, which is based on relevant information about past events, including historical experience, current conditions and reasonable and supportable forecasts that affect the expected collectability of securities. During the year ended December 31, 2021, we collected $2.8 million from Bluegrass Vascular Technologies, Inc. pursuant to the terms of a note receivable, which represents the entire principal balance and all accrued interest payable pursuant to that note. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">The table below presents a rollforward of the allowance for current expected credit losses on our notes receivable for the years ended December&#160;31,&#160;2022 and 2021 (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 199</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 730</p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for credit loss expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (531)</p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 199</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517788480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">16.</b></span>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="background:#ffffff;">The changes in each component of Accumulated Other Comprehensive Income (Loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows (in thousands):</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash Flow Hedges</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Foreign Currency Translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 218</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,512)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,294)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,647)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,861)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,365</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (786)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,579</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,288</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,288</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 872</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 872</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,158)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (158)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (6,940)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,488</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,452)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (119)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,704)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,823)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,489)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (800)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,592</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,592</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,017)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,509</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,509</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,015)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,539)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,464)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,527)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,991)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,491)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 651</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,177)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,075)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,583)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,583)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,436</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,830</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,559)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-size:11pt;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,366</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (15,916)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (11,550)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602983872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">17.</b></span>LEASES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">We have operating leases for facilities used for manufacturing, research and development, sales and distribution, and office space, as well as leases for manufacturing and office equipment, vehicles, and land. Our leases have remaining terms ranging from less than </span><span style="font-weight:normal;">one year</span><span style="font-weight:normal;"> to approximately </span><span style="font-weight:normal;">27 years</span><span style="font-weight:normal;">. A number of our lease agreements contain options to renew at our discretion for periods of up to </span><span style="font-weight:normal;">15 years</span><span style="font-weight:normal;"> and options to terminate the leases within </span><span style="font-weight:normal;">one year</span><span style="font-weight:normal;">. The lease term used to calculate ROU assets and lease liabilities includes renewal and termination options that are deemed reasonably certain to be exercised. Lease agreements with lease and non-lease components are generally accounted for as a single lease component. We do not have any bargain purchase options in our leases. For leases with an initial term of one year or less, we do not record a ROU asset or lease liability on our consolidated balance sheet. Substantially all of the ROU assets and lease liabilities as of December&#160;31,&#160;2022 recorded on our consolidated balance sheet are related to our cardiovascular segment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">From time to time, we enter into agreements to sublease a portion of our facilities to third parties. Such sublease income is not material. We also lease certain hardware consoles to customers and record rental revenue as a component of net sales. Rental revenue under such console leasing arrangements for the years ended December&#160;31,&#160;2022, 2021 and 2020 was not significant.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following was included in our consolidated balance sheet as of December&#160;31,&#160;2022 and 2021 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">ROU operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65,262</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65,913</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Liabilities</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,005</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,668</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 59,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 61,526</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 72,194</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">We recognize lease expense for operating leases on a straight-line basis over the term of the lease. Net lease cost for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $13.8 million, $15.9 million, and $16.7 million, respectively. The components of lease costs for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows, in thousands:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Lease Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Classification</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease cost (a)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,219</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,013</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,735</p></td></tr><tr><td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sublease (income) (b)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (409)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (75)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15)</p></td></tr><tr><td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net lease cost</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 13,810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 15,938</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,720</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;padding:0.75pt;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"/></div></td><td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(a)</p></td><td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Includes expense related to short-term leases and variable payments, which were not significant.</p></td></tr><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"/></div></td><td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/></div></td></tr><tr><td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(b)</p></td><td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Does not include rental revenue from leases of hardware consoles to customers, which was not significant.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Supplemental cash flow information for the years ended December&#160;31,&#160;2022, 2021 and 2020 was as follows, in thousands:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,710</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,970</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,059</p></td></tr><tr><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets obtained in exchange for lease obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,130</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,524</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,938</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="background:#ffffff;">Generally, our lease agreements do not specify an implicit rate. Therefore, we estimate our incremental borrowing rate, which is defined as the interest rate we would pay to borrow on a collateralized basis, considering such factors as length </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">of lease term and the risks of the economic environment in which the leased asset operates. As of December&#160;31,&#160;2022, 2021 and 2020, our lease agreements had the following remaining lease term and discount rates:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.28%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining lease term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">10.4 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11.4 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11.5 years</p></td></tr><tr><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.4%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.4%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.3%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">As of December&#160;31,&#160;2022, maturities of operating lease liabilities were as follows, in thousands:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts&#160;due&#160;under&#160;operating&#160;leases</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,638</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,554</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,941</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,523</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,944</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 37,983</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 84,583</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Imputed interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,842)</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70,741</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">As of December&#160;31,&#160;2022, we had additional operating leases for office space that had not yet commenced. These leases will commence during 2023 and are not deemed material.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602954416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and qualifying accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and qualifying accounts</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 14.4pt;"><span style="font-weight:normal;">(2)&#160;</span><span style="font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Statement Schedules.</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="width:28.8pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">&#8212;</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Schedule II&#160;- Valuation and qualifying accounts</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Years Ended December&#160;31,&#160;2022, 2021 and 2020</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">(In thousands)</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions&#160;Charged&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Allowance for Credit Losses: </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Beginning&#160;of&#160;Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Costs&#160;and&#160;Expenses&#160;(a)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduction&#160;(b)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">End&#160;of&#160;Year</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,108)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,115)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,313)</p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,313)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,678)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,767)</p></td></tr><tr><td style="vertical-align:bottom;width:39.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,767)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,858)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,423)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We record a bad debt provision based upon historical bad debt experience, current economic conditions, expectations of future economic conditions, and management&#8217;s evaluation of our ability to collect individual outstanding balances.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">When an individual customer balance becomes impaired and is deemed uncollectible, a deduction is made against the allowance for uncollectible accounts.</span></td></tr></table><div style="margin-top:6pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Years Ended December&#160;31,&#160;2022, 2021 and 2020</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">(In thousands)</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Additions&#160;Charged&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&#160;at</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax Valuation Allowance:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Beginning&#160;of&#160;Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Costs&#160;and&#160;Expenses&#160;(a)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Deduction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">End&#160;of&#160;Year</b></p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,644)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,569)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,213)</p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (573)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,786)</p></td></tr><tr><td style="vertical-align:bottom;width:26.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,786)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,741)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> -</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,527)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We record a valuation allowance against a deferred tax asset when it is determined that it is more likely than not that the deferred tax asset will not be realized.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Exhibits:</span></td></tr></table><div style="margin-top:12pt;"/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518135168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in Preparing Financial Statements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates in Preparing Financial Statements</b>.&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Principles of Consolidation</b>.&#160;The consolidated financial statements include our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated. Amounts presented in this report are rounded, while percentages and earnings per share amounts presented are calculated from the underlying amounts. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Cash Equivalents</b>. We consider interest-bearing deposits with an original maturity date of three&#160;months or less to be cash equivalents. As of <span style="-sec-ix-hidden:Hidden_wEJKBHaF4ku_LLZF6o-vSQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">December 31, 2021</span></span>, approximately $1.9 million, respectively, of our cash and cash equivalents represents restricted cash for the payment of certain import and other taxes for our subsidiary in China.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Receivables</b>.<b style="font-weight:bold;">&#160;</b>Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. An allowance for credit losses on trade receivables is recorded based on our expectation of credit losses and is based upon our historical bad debt experience, current economic conditions, expectations of future economic conditions and management&#8217;s evaluation of our ability to collect individual outstanding balances. Once collection efforts have been exhausted and a receivable is deemed to be uncollectible, such balance is charged against the allowance for credit losses.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Inventories</b>. We value our inventories at the lower of cost, at approximate costs determined on a first-in, first-out method, or net realizable value.&#160;Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160;Inventory costs include material, labor and manufacturing overhead.&#160;We review inventories on hand and record provisions based on estimated excess, slow moving and obsolete inventory, as well as inventories with a carrying value in excess of net realizable value.&#160;The regular and systematic review of the valuation of inventories includes an assessment of future product demand based on historical sales and raw material usage and product expiration.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Goodwill and Intangible Assets</b>.<b style="font-weight:bold;">&#160;</b>We test goodwill balances for impairment on an annual basis as of July&#160;1 or whenever impairment indicators arise.&#160;When impairment indicators are identified, we may elect to perform an optional qualitative assessment to determine whether it is more likely than not that the fair value of our reporting units has fallen below their carrying value. During our annual impairment test, we utilize four reporting units in evaluating goodwill for impairment </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">using a quantitative assessment, which uses a combination of a guideline public company market-based approach and a discounted cash flow income-based approach. The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Finite-lived intangible assets including developed technology, customer lists, distribution agreements, license agreements, trademarks and patents are subject to amortization. Intangible assets are amortized over their estimated useful life on a straight-line basis, except for customer lists, which are generally amortized on an accelerated basis. Estimated useful lives are determined considering the period the assets are expected to contribute to future cash flows. We evaluate long-lived assets, including amortizing intangible assets, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform the impairment analysis at the asset group for which the lowest level of identifiable cash flows are largely independent of the cash flows of other assets and liabilities. We compare the carrying value of the asset group to the undiscounted cash flows expected to result from the asset group and determine whether the carrying amount is recoverable. We determine the fair value of each asset group based on estimated future cash flows discounted back to their present value using a discount rate that reflects the risk profiles of the underlying activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In-process technology intangible assets, which are not subject to amortization until projects reach commercialization, are assessed for impairment at least annually and more frequently if events occur that would indicate a potential reduction in the fair value of the assets below their carrying value. An impairment charge would be recognized to the extent the carrying amount of the in-process technology exceeded its fair value.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Long-Lived Assets</b>.&#160;We periodically review the carrying amount of our depreciable long-lived assets for impairment.&#160;An asset is considered impaired when undiscounted estimated future cash flows are less than the carrying amount of the asset.&#160;In the event the carrying amount of such asset is not considered recoverable, the asset is adjusted to its fair value.&#160;Fair value is generally determined based on discounted future cash flow.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Property and Equipment</b>.&#160;Property and equipment is stated at the historical cost of construction or purchase. Construction costs include interest costs capitalized during construction.&#160;Maintenance and repairs of property and equipment are charged to operations as incurred.&#160;Leasehold improvements are amortized over the lesser of the base term of the lease or estimated life of the leasehold improvements.&#160;Construction-in-process consists of new buildings and various production equipment being constructed internally and externally.&#160;Assets in construction-in-process will commence depreciating once the asset has been placed in service.&#160;Depreciation is computed using the straight-line method over estimated useful lives as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">40 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manufacturing equipment</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Furniture and fixtures</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land improvements</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4 - 25 years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Depreciation expense related to property and equipment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $33.4 million, $34.5 million, and $35.4 million, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock', window );">Deferred Compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Deferred Compensation</b>.&#160;We have a deferred compensation plan that permits certain management employees to defer a portion of their salary until the future.&#160;We established a Rabbi trust to finance obligations under the plan with corporate-owned variable life insurance contracts.&#160;The cash surrender value totaled $15.8 million and $19.1 million at December&#160;31,&#160;2022 and 2021, respectively, which is included in other assets in our consolidated balance sheets.&#160;We have recorded a deferred compensation payable of $15.3 million and $18.1 million at December&#160;31,&#160;2022 and 2021, respectively, to reflect the liability to our employees under this plan.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock', window );">Other Assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Assets</b>.<b style="font-weight:bold;">&#160;</b>Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in privately held companies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,711</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred compensation plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,126</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term notes receivable, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,612</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,239</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,352</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,421</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Our share of earnings associated with equity method investments is reported within other income (expense) in our consolidated statements of income (loss). Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Other Long-term Obligations</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Other Long-term Obligations. </b>Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,260</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,500</p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,084</p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,584</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In connection with a business combination, any contingent consideration is recorded at fair value on the acquisition date based upon the consideration expected to be transferred in the future. We re-measure the estimated liability each quarter based upon changes in revenue estimates, changes in the probability of achieving relevant milestones and changes in the discount rate or expected period of payment. Changes in the estimated fair value are recorded through operating expense in our consolidated statements of income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition/Shipping and Handling/Cost of Sales</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Revenue Recognition</b>.<b style="font-weight:bold;">&#160;</b>We sell our medical products through a direct sales force in the U.S. and&#160;through OEM relationships, custom procedure tray manufacturers and a combination of direct sales force and independent&#160;distributors in international markets.&#160;Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods.&#160;This core principle is achieved through the following steps:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Identify the contract with the customer</i>. A contract with a customer exists when (i)&#160;we enter into an enforceable contract with a customer that defines each party&#8217;s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii)&#160;the contract has commercial substance and (iii)&#160;we determine that collection of substantially all consideration for services that are transferred is probable based on the customer&#8217;s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred if the amortization period would have been one&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Identify the performance obligations in the contract</i>. Generally, our contracts with customers do not include multiple performance obligations to be completed over a period of time. Our performance obligations generally relate to delivering single-use medical products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds. We do not have significant returns. We do not typically offer extended warranty or service plans, except in limited cases which are not material. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Determine the transaction price</i>. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. Our contracts do not typically contain a financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Allocate the transaction price to performance obligations in the contract</i>. We typically do not have multiple performance obligations in our contracts with customers. As such, we generally recognize revenue upon transfer of the product to the customer&#8217;s control at contractually stated pricing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Recognize revenue when or as we satisfy a performance obligation.&#160;</i>We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue. Contract assets are recognized for the future right to invoice customers, and contract liabilities are recognized for unearned revenue if payment is received prior to our fulfillment of performance obligations. We do not have material contract assets or contract liabilities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Reserves are recorded as a reduction in net sales and are not considered material to our consolidated statements of income (loss) for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020.&#160;In addition, we invoice our customers for taxes assessed by governmental authorities, such as sales tax and value-added taxes.&#160;We present these taxes on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Shipping and Handling</b>.&#160;When billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cost of Sales</b>.&#160;We include product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, product royalty expense, developed technology amortization expense, production-related depreciation expense and product license agreement expense in cost of sales.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Research and Development</b>.&#160;Research and development costs, including new product development, clinical trials, and regulatory compliance, are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Income Taxes</b>.&#160;Under our accounting policies, we initially recognize a tax position in our financial statements when it becomes more likely than not that the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax positions that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authorities assuming full knowledge of the position and all relevant facts. Although we believe our provisions for unrecognized tax positions are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our income tax provisions and accruals. Such differences could have a material impact on our income tax provisions and operating results in the periods&#160;in which we make such determination.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Common Share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Earnings per Common Share</b>.&#160;Net income (loss) per common share is computed by both the basic method, which uses the weighted average number of our common shares outstanding, and the diluted method, which includes the dilutive common shares from stock options and restricted stock units as calculated using the treasury stock method. Performance stock units are considered contingently issuable awards and are excluded from the weighted average basic share calculation. These awards are included in the weighted average dilutive share calculation, to the extent they are dilutive, based on the number of shares, if any, that would be issuable as of the end of the reporting period assuming the end of the reporting period is also the end of the performance period.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurements</b>.<b style="font-weight:bold;">&#160;</b>The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Financial assets are marked to bid prices and financial liabilities are marked to offer prices.&#160;Fair value measurements do not include transaction costs.&#160;A fair value hierarchy is used to prioritize the quality and reliability of the information </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">used to determine fair values.&#160;Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.&#160;The fair value hierarchy is defined in the following three categories:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Level 1: Quoted market prices in active markets for identical assets or liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Level 2: Observable market-based inputs or inputs that are corroborated by market data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Level 3: Unobservable inputs that are not corroborated by market data.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Stock-Based Compensation</b>.<b style="font-weight:bold;">&#160;</b>We recognize the fair value compensation cost relating to stock-based payment transactions in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718, <i style="font-style:italic;">Compensation&#160;&#8212; Stock Compensation</i>.&#160;Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#8217;s requisite service period, which is generally the vesting period.&#160;The fair value of our stock options is estimated using a Black-Scholes option valuation model.&#160;The fair value of our performance stock units linked to total shareholder return is estimated using Monte-Carlo simulations. Compensation expense is adjusted each period based on the grant-date fair value and the number of shares that are probable of being awarded based on the performance conditions of the awards. Restricted stock units are valued based on the closing stock price on the date of grant. Cash-settled share-based awards, or liability awards, are remeasured at fair value each reporting period until the awards are settled. Total stock-based compensation expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $18.0 million, $16.1 million, and $14.3 million, respectively (see Note 12).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ConcentrationOfCreditRiskPolicyTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b>.&#160;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&#160;We provide credit, in the normal course of business, primarily to hospitals and independent third-party custom procedure tray manufacturers and distributors.&#160;We perform ongoing credit evaluations of our customers and maintain allowances for potential credit losses. Due to the diversified nature and number of our customers, concentrations of credit risk with respect to accounts receivable are limited.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Foreign Currency</b>.&#160;The financial statements of our foreign subsidiaries are measured using local currencies as the functional currency, with the exception of our manufacturing subsidiaries in Ireland and Mexico, which each use the U.S. Dollar as its functional currency.&#160;Assets and liabilities are translated into U.S. Dollars at&#160;year-end rates of exchange and results of operations are translated at average rates for the&#160;year.&#160;Gains and losses resulting from these translations are included in accumulated other comprehensive income (loss) as a separate component of stockholders&#8217; equity.&#160;Transactional exchange gains or losses are included in other income (expense) in determining net income (loss) for the period.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Derivatives</b>.<b style="font-weight:bold;">&#160;</b>We use forward contracts to mitigate our exposure to volatility in foreign exchange rates, and we use interest rate swaps to hedge changes in the benchmark interest rate related to our Third Amended Credit Agreement described in Note&#160;8.&#160;All derivatives are recognized in the consolidated balance sheets at fair value.&#160;Classification of each hedging instrument is based upon whether the maturity of the instrument is less than or greater than 12&#160;months.&#160;We do not purchase or hold derivative financial instruments for speculative or trading purposes (see Note&#160;9).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Financial Accounting Standards</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">New Financial Accounting Standards. In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2020-04, <i style="font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i>, which provides temporary optional expedients and exceptions in accounting for modifications of contracts that reference the London interbank offered rate (&#8220;LIBOR&#8221;) or another reference rate expected to be discontinued as a result of reference rate reform. In January 2021, the FASB issued ASU 2021-01, <i style="font-style:italic;">Reference Rate Reform (Topic 848): Scope</i>, which amends the scope of ASU 2020-04. In December 2022, the FASB issued ASU 2022-06, <i style="font-style:italic;">Deferral of the Sunset Date of Topic 848</i>, which defers the sunset date of the guidance in ASC 848 to December 31, 2024. ASU 2020-04 and ASU 2021-01 were effective as of March 12, 2020; ASU 2022-06 was effective upon its issuance in December 2022. The provisions of these updates may be applied prospectively to transactions through December 31, 2024, when reference rate reform activity is expected to be completed. As of December 31, 2022, we had not modified any contracts as a result of reference rate reform. We are currently assessing the anticipated impact of these standards on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">We currently believe that all other issued and not yet effective accounting standards are not materially relevant to our financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ConcentrationOfCreditRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for concentration of credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ConcentrationOfCreditRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred compensation plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for other assets which are expected to be realized or consumed after on year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524775936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text">Depreciation is computed using the straight-line method over estimated useful lives as follows:<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">40 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manufacturing equipment</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Furniture and fixtures</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land improvements</p></td><td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10 - 20 years</p></td></tr><tr><td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4 - 25 years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Other assets</a></td>
<td class="text">Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investments in privately held companies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,711</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred compensation plan assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,126</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term notes receivable, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,612</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,239</p></td></tr><tr><td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,352</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,421</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Long-term Obligations</a></td>
<td class="text">Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,260</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,500</p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,084</p></td></tr><tr><td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,584</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519818608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following table presents sales by operating segment disaggregated based on product category and geographic region for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands).</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">United States</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">International</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cardiovascular</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Peripheral Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 263,602</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 176,208</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 439,810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 244,459</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 160,657</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 405,116</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 211,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 129,569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 341,568</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiac Intervention</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 128,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 214,475</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 343,186</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 122,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 198,189</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 320,641</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 108,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 171,562</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 279,671</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Custom Procedural Solutions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 108,778</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 81,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 190,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 108,068</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 85,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 193,942</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 110,269</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 92,927</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 203,196</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">OEM</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 118,869</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 145,034</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 104,436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,092</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 123,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 91,826</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 17,941</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 109,767</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 619,960</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 498,264</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,118,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 579,415</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 463,812</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,043,227</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 522,203</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 411,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 934,202</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Endoscopy</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy Devices</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 30,599</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,158</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,757</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,524</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 27,858</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,673</p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 650,559</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 500,422</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 608,878</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 465,873</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 550,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 413,814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 963,875</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519572880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Strategic Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember', window );">KA Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><span style="background:#ffffff;">During the fourth quarter of 2021, certain immaterial measurement period adjustments were recorded to our purchase price allocation. </span>The purchase price was allocated as follows (in thousands):<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:92.71%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets Acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 24</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 211</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 298</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other long-term assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Developed technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,000</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,570</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total assets acquired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,126</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Liabilities Assumed</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trade payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (507)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total liabilities assumed</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (538)</p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total net assets acquired</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 14,588</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519573584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Inventories at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Finished goods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 147,051</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 132,403</p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Work-in-process</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 29,534</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 22,160</p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Raw materials</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 89,406</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 67,359</p></td></tr><tr><td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 265,991</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 221,922</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517927696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in carrying amount of goodwill</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The changes in the carrying amount of goodwill for the&#160;years ended December&#160;31,&#160;2022 and 2021, are as follows (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill balance at January&#160;1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 361,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 363,533</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of foreign exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,920)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,078)</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions and adjustments as the result of acquisitions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 286</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Goodwill balance at December&#160;31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 359,821</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 361,741</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Other intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Other intangible assets at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross&#160;Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 29,445</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,203)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 19,242</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Distribution agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,715)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 535</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,859</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 30,221</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (17,863)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,358</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 34,105</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (31,749)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,356</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 108,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (69,780)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 38,350</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Gross&#160;Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Net&#160;Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 26,349</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,315)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,034</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Distribution agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,519)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 731</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,768)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,895</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 30,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,256)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,986</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 34,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (31,195)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,790</p></td></tr><tr><td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 107,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (65,053)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42,436</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated amortization expense</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Estimated amortization expense for the developed technology and other intangible assets for the next five&#160;years consists of the following as of December&#160;31,&#160;2022 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.45%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:28.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Estimated Amortization Expense</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 47,496</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 44,434</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 42,610</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,040</p></td></tr><tr><td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 28,966</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521586160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, income (loss) before income taxes is broken out between U.S. and foreign-sourced operations and consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Domestic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 77,562</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 21,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (32,216)</p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,067</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 32,589</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,985</p></td></tr><tr><td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 82,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 53,917</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (13,231)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The components of the provision for income taxes for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Current expense (benefit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 9,584</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 808</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (937)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,162</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 437</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 10,291</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,480</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,407</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total current expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 23,037</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 10,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,907</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred expense (benefit):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,438)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (468)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,688)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">State</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,615)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,845)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,524)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (871)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,318)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,083)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total deferred benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (14,924)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,631)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (11,295)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,388)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The difference between the income tax expense (benefit) reported and amounts computed by applying the statutory federal rate of 21.0% to pretax income (loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Computed federal income tax expense (benefit) at applicable statutory rate of 21%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 17,352</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,778)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">State income tax benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (283)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,448)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,978)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,507)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,391)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax effect of international items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,698)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (281)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,705</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Uncertain tax positions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (47)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 401</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (455)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Deferred compensation insurance assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 706</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (413)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (290)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,423)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,571)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,822)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,523</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,257</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">DOJ settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,890</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Remeasurement of state deferred taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (375)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (526)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,765)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Non-deductible expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,077</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Remeasurement of contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 733</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,185)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other &#8212; including the effect of graduated rates</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (70)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (183)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,388)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets and liabilities at December&#160;31,&#160;2022 and 2021, consisted of the following temporary differences and carry-forward items (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Allowance for credit losses on trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,494</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,968</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 11,063</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Inventory differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,887</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 11,117</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 14,833</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 7,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,388</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 12,801</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 13,431</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal R&amp;D tax credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 634</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,003</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">UT R&amp;D Credit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,126</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">IRC section 174 capitalized R&amp;D </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 15,012</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,827</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,939</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 77,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 71,164</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,047)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,925)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,797)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (38,547)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42,888)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Foreign withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,571)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,575)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,527)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,938)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,040)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,556)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (76,178)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (85,801)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,527)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,786)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred income tax liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,863)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25,423)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reported as:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,599</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,080</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,462)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31,503)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net deferred income tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,863)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25,423)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 64.8pt;"><span style="font-size:8pt;margin-bottom:6pt;margin-left:0pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Summary of Income Tax Contingencies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax benefits for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrecognized tax benefits, opening balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,635</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,674</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,161</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross increases (decreases) in tax positions taken in a prior year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 115</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross increases in tax positions taken in the current year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 283</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Lapse of applicable statute of limitations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (343)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (437)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (885)</p></td></tr><tr><td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrecognized tax benefits, ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,635</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,674</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519581872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Accrued expenses at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Payroll and related liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 58,620</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 59,435</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of contingent liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,813</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,735</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Advances from employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 201</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued rebates payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,271</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,250</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 36,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,122</p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 123,189</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 159,014</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519744112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revolving Credit Facility and Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Principal balances outstanding under our long-term debt obligations as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Term loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 124,688</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 133,125</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revolving credit loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 73,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 110,000</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less unamortized debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (179)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (290)</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 198,009</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 242,835</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current portion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,438</p></td></tr><tr><td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Long-term portion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 186,759</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 234,397</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock', window );">Schedule of Long-term Debt Covenants</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;">The Third Amended Credit Agreement is collateralized by substantially all of our assets. The Third Amended Credit Agreement contains affirmative and negative covenants, representations and warranties, events of default and other terms customary for loans of this nature.&#160;In particular, the Third Amended Credit Agreement requires that we maintain certain financial covenants, as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Covenant Requirement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidated Total Leverage Ratio <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 to 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidated Interest Coverage Ratio <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.0 to 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Facility Capital Expenditures <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$50 million</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Maximum Consolidated Total Net Leverage Ratio (as defined in the Third Amended Credit Agreement) as of any fiscal quarter end.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Minimum ratio of Consolidated EBITDA (as defined in the Third Amended Credit Agreement and adjusted for certain expenditures) to Consolidated interest expense (as defined in the Third Amended Credit Agreement) for any period of four consecutive fiscal quarters.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Maximum level of the aggregate amount of all Facility Capital Expenditures (as defined in the Third Amended Credit Agreement) in any fiscal year.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Future minimum principal payments on our long-term debt as of December&#160;31,&#160;2022, are as follows (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years&#160;Ending</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;Minimum </b></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal&#160;Payments</b></p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,250</p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 186,938</p></td></tr><tr><td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total future minimum principal payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 198,188</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Long Term Debt Covenants Table [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519500832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text">The fair value of derivative instruments on a gross basis is as follows (in thousands):<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments Designated as Hedging Instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance&#160;Sheet&#160;Location</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets (long-term)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,215</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,326</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other assets (long-term)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 179</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Liabilities)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,447)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,509)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,288)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other long-term obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (531)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (502)</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Derivative Instruments Not Designated as Hedging Instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance&#160;Sheet&#160;Location</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Prepaid expenses and other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,512</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 736</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(Liabilities)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency forward contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,946)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (856)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income ("OCI") in our consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amount&#160;of&#160;Gain/(Loss)</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Recognized&#160;in&#160;OCI</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Derivative instrument</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:47.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Interest rate swaps</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> 4,879</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> 1,402</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (6,131)</p></td></tr><tr><td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Foreign currency forward contracts</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"> 6,263</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (1,521)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> (5,516)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on AOCI and net earnings in our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Consolidated Statements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount&#160;of&#160;Gain/(Loss)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">reclassified&#160;from&#160;AOCI</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;width:39.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Location in statements of income</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Interest expense</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,339)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,261)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,994)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,509)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (872)</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Revenue</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 963,875</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 3,583</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,592)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 36</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Cost of sales</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (631,882)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (589,418)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (562,698)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,436)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"> 1,017</p></td><td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,288)</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income (loss) for the&#160;years presented (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:30.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Derivative Instrument</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Location in statements of income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:37.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">Foreign currency forward contracts</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_EbHCmjYljUGB_8dKno-fsQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Other income (expense) &#8212; net</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,598)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,190)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519662080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) Per Share, Basic and Diluted</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The computation of weighted average shares outstanding and the basic and diluted earnings (loss) per common share for the following periods consisted of the following (in thousands, except per share amounts):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 74,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 48,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9,843)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Average common shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55,434</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic EPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.18)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Average common shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,806</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55,434</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of dilutive stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 865</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,214</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total potential shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 57,671</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 57,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 55,434</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted EPS</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.18)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equity awards excluded as the impact was anti-dilutive <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 799</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,216</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Does </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">not</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> reflect the impact of incremental repurchases under the treasury stock method. </span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517733568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</a></td>
<td class="text">The stock-based compensation expense before income tax expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,357</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,789</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,343</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,157</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nonqualified stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,678</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,332</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Performance-based restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,509</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,829</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,836</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 758</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash-settled performance-based share-based awards ("Liability Awards")</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,511</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 906</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,647</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 13,271</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,825</p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock-based compensation expense before taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,042</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,090</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,339</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">In applying the Black-Scholes methodology to the option grants, the fair value of our stock-based awards granted was estimated using the following assumptions for the years ended December&#160;31,&#160;2022, 2021 and 2020:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.57%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1.4% - 4.3%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.5% - 1.1%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.3% - 1.7%</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected option term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4.0 - 5.0 years</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected price volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">46.2% - 47.5%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">46.1% - 46.7%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">38.7% - 45.1%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Schedule of Share-based Compensation, Stock Option Activity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The table below presents information related to stock option activity for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total intrinsic value of stock options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 27,110</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 36,086</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,733</p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cash received from stock option exercises</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 18,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 20,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,481</p></td></tr><tr><td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Excess tax benefit from the exercise of stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,815</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Changes in stock options for the&#160;year ended December&#160;31,&#160;2022, consisted of the following (shares and intrinsic value in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining&#160;Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of&#160;Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise&#160;Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term&#160;(in&#160;years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 44.70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 63.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (703)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 28.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited/expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (111)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 53.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,077</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 49.62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 64,634</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,792</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 43.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2.61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 48,595</p></td></tr><tr><td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending vested and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,013</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 49.37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 64,026</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, PSUs and RSUs, Activity</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Changes in PSUs and RSUs for the&#160;year ended December&#160;31,&#160;2022, consisted of the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PSUs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In Thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(In Thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning nonvested balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 163</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 53.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 61.77</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 64.54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 59.02</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">rTSR adjustment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 65.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (44)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 65.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (26)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 61.77</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (45)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 60.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Nonvested balance at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 179</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 65.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 59.02</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Based on the maximum payout, excluding the impact of the rTSR multiplier. The actual number of shares which vest is determined based on the satisfaction of performance conditions and the application of an rTSR multiplier between </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">75%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">125%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Represents the application of an rTSR multiplier of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">125%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> to awards vested in 2022 based on the performance of our common stock and the terms of the awards.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock', window );">Schedule of Share-based Compensation, PSUs and RSUs Granted</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes PSUs and RSUs granted during the years ended December 31, 2022, 2021, and 2020 (units and shares in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">PSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Target units granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Maximum units granted <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">103</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Maximum potential shares<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> (1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 127</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Weighted average grant date fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">64.54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">61.39</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 43.63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Units granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Weighted average grant date fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">59.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;">61.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42.98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Based on the maximum payout, excluding the impact of the rTSR multiplier. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Includes the impact of the maximum potential rTSR multiplier of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">125%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:2.9pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Includes the impact of the 2020 amendment which reduced the maximum FCF multiplier for one-year awards from </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">200%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, PSUs, Valuation Assumptions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The fair value of each PSU was estimated as of the grant date using the following assumptions for awards granted in the years ended December 31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1.6% - 2.7%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0.1% - 0.3%</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Performance period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2.6 - 2.8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1.8 - 2.8 years</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected price volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">38.5% - 42.6%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">43.7% - 49.3%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of performance shares, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for equity instruments other than options that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for performance shares and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519741696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting and Foreign Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Area</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United States</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 281,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 275,311</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 277,643</p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ireland</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 40,749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 39,863</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42,951</p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other foreign countries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 60,937</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 56,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 62,134</p></td></tr><tr><td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 382,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 371,658</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 382,728</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, are as follows (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net sales</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,118,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,043,227</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 934,202</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,757</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,524</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,673</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total net sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 963,875</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (loss) from operations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 53,415</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,042)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,617</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,501</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,480</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total income (loss) from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 60,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,562)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total other expense &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,934)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,999)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,669)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,388)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,843)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Total depreciation and amortization by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 80,777</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 83,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 93,160</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 910</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 81,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 84,066</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 94,070</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">Total capital expenditures for property and equipment by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 44,925</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 27,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 45,803</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 104</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 382</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 185</p></td></tr><tr><td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 45,029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 27,939</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 45,988</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Reconciliation of Assets from Segment to Consolidated</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net sales</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,118,224</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,043,227</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 934,202</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,757</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,524</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,673</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total net sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,150,981</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,074,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 963,875</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (loss) from operations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cardiovascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80,946</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 53,415</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,042)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Endoscopy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,617</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,501</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,480</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total income (loss) from operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87,563</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 60,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,562)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total other expense &#8212; net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,934)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,999)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,669)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income tax expense (benefit)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,388)</p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,843)</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521628016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total&#160;Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted&#160;prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant&#160;other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">active&#160;markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">observable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">unobservable&#160;inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Marketable securities <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 138</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 138</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate contract asset, long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,444</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency contract assets, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,783</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,783</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency contract liabilities, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,986)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,986)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,073)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (18,073)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;Value&#160;Measurements&#160;Using</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;Fair</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted&#160;prices&#160;in</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant&#160;other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">active&#160;markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">observable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">unobservable&#160;inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Level&#160;3)</b></p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest rate contract liability, long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,447)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,447)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency contract assets, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,241</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,241</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency contract liabilities, current and long-term <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,646)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,646)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Contingent consideration liabilities</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48,234)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48,234)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the interest rate contracts is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as prepaid and other assets or other long-term assets in the consolidated balance sheets.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.</span></td></tr></table><div style="margin-top:12pt;"/><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">Changes in the fair value of our contingent consideration liabilities during the&#160;years ended December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 48,234</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 55,750</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_TpnXjRgdGkC2N239gRk-Nw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Contingent consideration expense</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,161</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent payments made</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (34,762)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,665)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Effect of foreign exchange</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (9)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12)</p></td></tr><tr><td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 18,073</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 48,234</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Inputs, Liabilities, Quantitative Information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The recurring Level 3 measurement of our contingent consideration liabilities includes the following significant unobservable inputs at December&#160;31,&#160;2022 and 2021 (amounts in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Valuation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingent consideration liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">technique</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue-based royalty payments contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,097</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discounted cash flow</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14%&#160;-&#160;17%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15.7%</p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2034</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue milestones contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 13,064</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Monte Carlo simulation</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5.1% - 14.0%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5.2%</p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2033</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Regulatory approval contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,912</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Scenario-based method</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5.7%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of milestone payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">90%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023-2030</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.</span></td></tr></table><div style="margin-top:6pt;"/><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&#160;value&#160;at</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Valuation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contingent consideration liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">technique</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable&#160;inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b><sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue-based royalty payments contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,870</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discounted cash flow</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13%&#160;-&#160;16%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14.7%</p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022-2034</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2026</p></td></tr><tr><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenue milestones contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 41,671</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Monte Carlo simulation</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">7.5% - 12.5%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8.2%</p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payments</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022-2031</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Regulatory approval contingent liability</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,693</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Scenario-based method</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Discount rate</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2.6%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Probability of milestone payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">80%</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Projected year of payment</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024-2025</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2025</p></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.</span></td></tr></table><div style="margin-top:6pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Rollforward of Allowance for Credit Losses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">The table below presents a rollforward of the allowance for current expected credit losses on our notes receivable for the years ended December&#160;31,&#160;2022 and 2021 (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 199</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 730</p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for credit loss expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (531)</p></td></tr><tr><td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ending balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 199</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519573584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Components of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><span style="background:#ffffff;">The changes in each component of Accumulated Other Comprehensive Income (Loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows (in thousands):</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash Flow Hedges</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Foreign Currency Translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 218</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,512)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,294)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,647)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,786</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,861)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,365</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (786)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,579</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,288</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,288</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 872</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 872</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,158)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (158)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (6,940)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 1,488</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,452)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (119)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,704)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,823)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,489)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (800)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,592</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,592</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,017)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,509</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,509</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,015)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,539)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (2,464)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (5,527)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (7,991)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,491)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 651</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,177)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,075)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reclassifications to: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,583)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,583)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of sales</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,436</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,436</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,830</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,559)</p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-size:11pt;font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><b style="font-weight:bold;"> 4,366</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (15,916)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (11,550)</b></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521689376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Consolidated Balance Sheet Information and Supplemental Information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The following was included in our consolidated balance sheet as of December&#160;31,&#160;2022 and 2021 (in thousands):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Assets</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">ROU operating lease assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65,262</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65,913</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Liabilities</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,005</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,668</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 59,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 61,526</p></td></tr><tr><td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 72,194</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Costs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">We recognize lease expense for operating leases on a straight-line basis over the term of the lease. Net lease cost for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $13.8 million, $15.9 million, and $16.7 million, respectively. The components of lease costs for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows, in thousands:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Lease Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:31.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Classification</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Operating lease cost (a)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 14,219</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,013</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,735</p></td></tr><tr><td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sublease (income) (b)</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (409)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (75)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15)</p></td></tr><tr><td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net lease cost</p></td><td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 13,810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 15,938</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 16,720</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;padding:0.75pt;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"/></div></td><td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(a)</p></td><td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Includes expense related to short-term leases and variable payments, which were not significant.</p></td></tr><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"/></div></td><td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/></div></td></tr><tr><td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(b)</p></td><td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Does not include rental revenue from leases of hardware consoles to customers, which was not significant.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Supplemental cash flow information for the years ended December&#160;31,&#160;2022, 2021 and 2020 was as follows, in thousands:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,710</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,970</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,059</p></td></tr><tr><td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets obtained in exchange for lease obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,130</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,524</p></td><td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,938</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="background:#ffffff;">Generally, our lease agreements do not specify an implicit rate. Therefore, we estimate our incremental borrowing rate, which is defined as the interest rate we would pay to borrow on a collateralized basis, considering such factors as length </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">of lease term and the risks of the economic environment in which the leased asset operates. As of December&#160;31,&#160;2022, 2021 and 2020, our lease agreements had the following remaining lease term and discount rates:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.28%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining lease term</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">10.4 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11.4 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11.5 years</p></td></tr><tr><td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.4%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.4%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.3%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">As of December&#160;31,&#160;2022, maturities of operating lease liabilities were as follows, in thousands:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year ended December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amounts&#160;due&#160;under&#160;operating&#160;leases</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,638</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,554</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,941</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,523</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,944</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 37,983</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 84,583</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Imputed interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;">&#160;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,842)</p></td></tr><tr><td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 70,741</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602835184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Organization (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment </div>
<div>item</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NumberOfProductCategories', window );">Number of product categories | item</a></td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_NumberOfProductCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of product categories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_NumberOfProductCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521699712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList', window );">Restricted Cash and Cash Equivalents, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid Expense and Other Assets, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList', window );">Restricted Cash and Cash Equivalents, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prepaid Expense and Other Assets, Current<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723522651184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Reporting units | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation | $</a></td>
<td class="nump">$ 33.4<span></span>
</td>
<td class="nump">$ 34.5<span></span>
</td>
<td class="nump">$ 35.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Manufacturing equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Manufacturing equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723516117296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of life insurance</a></td>
<td class="nump">$ 15,800<span></span>
</td>
<td class="nump">$ 19,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation cost</a></td>
<td class="nump">$ 15,264<span></span>
</td>
<td class="nump">$ 18,111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723522651632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in privately held companies</a></td>
<td class="nump">$ 15,576<span></span>
</td>
<td class="nump">$ 14,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">15,767<span></span>
</td>
<td class="nump">19,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent', window );">Long-term notes receivable, net</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">10,612<span></span>
</td>
<td class="nump">5,239<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total Other Assets</a></td>
<td class="nump">$ 44,352<span></span>
</td>
<td class="nump">$ 41,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517797824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other long-term obligations</a></td>
<td class="nump">12,476<span></span>
</td>
<td class="nump">10,084<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total</a></td>
<td class="nump">$ 14,736<span></span>
</td>
<td class="nump">$ 23,584<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521745680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">$ 18,042<span></span>
</td>
<td class="nump">$ 16,090<span></span>
</td>
<td class="nump">$ 14,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513501200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Disaggregation of Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NumberOfProductCategories', window );">Number of product categories | item</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,150,981<span></span>
</td>
<td class="nump">$ 1,074,751<span></span>
</td>
<td class="nump">$ 963,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">650,559<span></span>
</td>
<td class="nump">608,878<span></span>
</td>
<td class="nump">550,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 500,422<span></span>
</td>
<td class="nump">465,873<span></span>
</td>
<td class="nump">413,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NumberOfProductCategories', window );">Number of product categories | item</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,118,224<span></span>
</td>
<td class="nump">1,043,227<span></span>
</td>
<td class="nump">934,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | Peripheral Intervention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">439,810<span></span>
</td>
<td class="nump">405,116<span></span>
</td>
<td class="nump">341,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | Cardiac Intervention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">343,186<span></span>
</td>
<td class="nump">320,641<span></span>
</td>
<td class="nump">279,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | Custom Procedural Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">190,194<span></span>
</td>
<td class="nump">193,942<span></span>
</td>
<td class="nump">203,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | OEM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">145,034<span></span>
</td>
<td class="nump">123,528<span></span>
</td>
<td class="nump">109,767<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">619,960<span></span>
</td>
<td class="nump">579,415<span></span>
</td>
<td class="nump">522,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | United States | Peripheral Intervention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">263,602<span></span>
</td>
<td class="nump">244,459<span></span>
</td>
<td class="nump">211,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | United States | Cardiac Intervention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">128,711<span></span>
</td>
<td class="nump">122,452<span></span>
</td>
<td class="nump">108,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | United States | Custom Procedural Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">108,778<span></span>
</td>
<td class="nump">108,068<span></span>
</td>
<td class="nump">110,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | United States | OEM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">118,869<span></span>
</td>
<td class="nump">104,436<span></span>
</td>
<td class="nump">91,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">498,264<span></span>
</td>
<td class="nump">463,812<span></span>
</td>
<td class="nump">411,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | International | Peripheral Intervention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">176,208<span></span>
</td>
<td class="nump">160,657<span></span>
</td>
<td class="nump">129,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | International | Cardiac Intervention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">214,475<span></span>
</td>
<td class="nump">198,189<span></span>
</td>
<td class="nump">171,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | International | Custom Procedural Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">81,416<span></span>
</td>
<td class="nump">85,874<span></span>
</td>
<td class="nump">92,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | International | OEM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">26,165<span></span>
</td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">17,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember', window );">Endoscopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">32,757<span></span>
</td>
<td class="nump">31,524<span></span>
</td>
<td class="nump">29,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember', window );">Endoscopy | Endoscopy Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">32,757<span></span>
</td>
<td class="nump">31,524<span></span>
</td>
<td class="nump">29,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember', window );">Endoscopy | United States | Endoscopy Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">30,599<span></span>
</td>
<td class="nump">29,463<span></span>
</td>
<td class="nump">27,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember', window );">Endoscopy | International | Endoscopy Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,158<span></span>
</td>
<td class="nump">$ 2,061<span></span>
</td>
<td class="nump">$ 1,815<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_NumberOfProductCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of product categories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_NumberOfProductCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mmsi_PeripheralInterventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mmsi_PeripheralInterventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mmsi_CardiacInterventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mmsi_CardiacInterventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mmsi_CustomProceduralSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mmsi_CustomProceduralSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mmsi_OEMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mmsi_OEMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mmsi_EndoscopyDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mmsi_EndoscopyDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518079984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Other Strategic Transactions - Asset Purchase (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 04, 2022 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_BiotraceMedicalIncMember', window );">BioTrace</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase price</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments', window );">Number of annual payments | item</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_BiotraceMedicalIncMember', window );">BioTrace | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_BiotraceMedicalIncMember', window );">BioTrace | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue', window );">Net sales revenue (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_BiotraceMedicalIncMember', window );">BioTrace | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue', window );">Net sales revenue (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_RestoreEndosystemsLLCMember', window );">Restore Endosystems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Additional payments upon the achievement of specified milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_RestoreEndosystemsLLCMember', window );">Restore Endosystems | First Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Additional payments upon the achievement of specified milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ContingentConsiderationPaymentPeriod', window );">Payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_RestoreEndosystemsLLCMember', window );">Restore Endosystems | Second Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Additional payments upon the achievement of specified milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ContingentConsiderationPaymentPeriod', window );">Payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mmsi_RestoreEndosystemsLLCMember', window );">Restore Endosystems | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of contingent annual payments under the asset acquisition agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of net sales revenue for contingent consideration from asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ContingentConsiderationPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the period for which an asset acquisition contingent consideration is to be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ContingentConsiderationPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mmsi_BiotraceMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mmsi_BiotraceMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mmsi_RestoreEndosystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mmsi_RestoreEndosystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_ContingentConsiderationPaymentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mmsi_ContingentConsiderationPaymentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_ContingentConsiderationPaymentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mmsi_ContingentConsiderationPaymentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513780880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Strategic Transactions - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 06, 2020</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to acquire intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,175<span></span>
</td>
<td class="nump">2,834<span></span>
</td>
<td class="nump">$ 3,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,219<span></span>
</td>
<td class="nump">$ 4,283<span></span>
</td>
<td class="nump">$ 36,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember', window );">KA Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase consideration, upfront payment</a></td>
<td class="nump">$ 14,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationConsiderationTransferredNotePayable', window );">Purchase consideration, note payable</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember', window );">KA Medical | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_FluidxMedicalTechnologyLLCMember', window );">Fluidx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationConsiderationTransferredNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of note payable issued by acquirer in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationConsiderationTransferredNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_FluidxMedicalTechnologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_FluidxMedicalTechnologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518083184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets Acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 359,821<span></span>
</td>
<td class="nump">$ 361,741<span></span>
</td>
<td class="nump">$ 363,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember', window );">KA Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets Acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables', window );">Trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,570<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities Assumed</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Trade payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(507)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(538)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember', window );">KA Medical | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets Acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Trade Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_KaMedicalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524452640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 147,051<span></span>
</td>
<td class="nump">$ 132,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">29,534<span></span>
</td>
<td class="nump">22,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">89,406<span></span>
</td>
<td class="nump">67,359<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total Inventories</a></td>
<td class="nump">$ 265,991<span></span>
</td>
<td class="nump">$ 221,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524782576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill balance at beginning of period</a></td>
<td class="nump">$ 361,741<span></span>
</td>
<td class="nump">$ 363,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effect of foreign exchange</a></td>
<td class="num">(1,920)<span></span>
</td>
<td class="num">(2,078)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions', window );">Additions and adjustments as the result of acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill balance at end of period</a></td>
<td class="nump">$ 359,821<span></span>
</td>
<td class="nump">$ 361,741<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Purchase Accounting Adjustments And Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723522631504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Other Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 108,130<span></span>
</td>
<td class="nump">$ 107,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(69,780)<span></span>
</td>
<td class="num">(65,053)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">38,350<span></span>
</td>
<td class="nump">42,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">29,445<span></span>
</td>
<td class="nump">26,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(10,203)<span></span>
</td>
<td class="num">(8,315)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">19,242<span></span>
</td>
<td class="nump">18,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">3,250<span></span>
</td>
<td class="nump">3,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,715)<span></span>
</td>
<td class="num">(2,519)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">License agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">11,109<span></span>
</td>
<td class="nump">12,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,250)<span></span>
</td>
<td class="num">(7,768)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,859<span></span>
</td>
<td class="nump">4,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">30,221<span></span>
</td>
<td class="nump">30,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(17,863)<span></span>
</td>
<td class="num">(15,256)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">12,358<span></span>
</td>
<td class="nump">14,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember', window );">Customer Lists</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">34,105<span></span>
</td>
<td class="nump">34,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31,749)<span></span>
</td>
<td class="num">(31,195)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 2,356<span></span>
</td>
<td class="nump">$ 3,790<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518019680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment losses</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Aggregate amortization expense</a></td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
<td class="nump">58.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 28.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mmsi_LicenseAgreementArravascLimitedMember', window );">ArraVasc Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_STDPharmaceuticalProductsLimitedMember', window );">STD Pharmaceutical Products Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_LauraneMedicalS.A.S.Member', window );">Laurane Medical S.A.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_OtherIntangibleAssetsAcquiredMember', window );">Other Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mmsi_LicenseAgreementArravascLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mmsi_LicenseAgreementArravascLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_STDPharmaceuticalProductsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_STDPharmaceuticalProductsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_LauraneMedicalS.A.S.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_LauraneMedicalS.A.S.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_OtherIntangibleAssetsAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_OtherIntangibleAssetsAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521696448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Future Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 47,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">44,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">42,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">32,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">$ 28,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521622032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Domestic and Foreign (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 77,562<span></span>
</td>
<td class="nump">$ 21,328<span></span>
</td>
<td class="num">$ (32,216)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">5,067<span></span>
</td>
<td class="nump">32,589<span></span>
</td>
<td class="nump">18,985<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 82,629<span></span>
</td>
<td class="nump">$ 53,917<span></span>
</td>
<td class="num">$ (13,231)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723522605696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 9,584<span></span>
</td>
<td class="nump">$ 808<span></span>
</td>
<td class="num">$ (937)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3,162<span></span>
</td>
<td class="nump">806<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">10,291<span></span>
</td>
<td class="nump">8,480<span></span>
</td>
<td class="nump">8,407<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current expense</a></td>
<td class="nump">23,037<span></span>
</td>
<td class="nump">10,094<span></span>
</td>
<td class="nump">7,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(10,438)<span></span>
</td>
<td class="num">(468)<span></span>
</td>
<td class="num">(2,688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(3,615)<span></span>
</td>
<td class="num">(1,845)<span></span>
</td>
<td class="num">(4,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(871)<span></span>
</td>
<td class="num">(2,318)<span></span>
</td>
<td class="num">(4,083)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred benefit</a></td>
<td class="num">(14,924)<span></span>
</td>
<td class="num">(4,631)<span></span>
</td>
<td class="num">(11,295)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense (benefit)</a></td>
<td class="nump">$ 8,113<span></span>
</td>
<td class="nump">$ 5,463<span></span>
</td>
<td class="num">$ (3,388)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518025120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Computed federal income tax expense (benefit) at applicable statutory rate of 21%</a></td>
<td class="nump">$ 17,352<span></span>
</td>
<td class="nump">$ 11,323<span></span>
</td>
<td class="num">$ (2,778)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax benefit</a></td>
<td class="nump">35<span></span>
</td>
<td class="num">(283)<span></span>
</td>
<td class="num">(1,448)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Tax credits</a></td>
<td class="num">(1,978)<span></span>
</td>
<td class="num">(2,507)<span></span>
</td>
<td class="num">(2,391)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax effect of international items</a></td>
<td class="num">(10,698)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="nump">4,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax positions</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="num">(455)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome', window );">Deferred compensation insurance assets</a></td>
<td class="nump">706<span></span>
</td>
<td class="num">(413)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(3,423)<span></span>
</td>
<td class="num">(5,571)<span></span>
</td>
<td class="num">(1,822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">3,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">DOJ Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount', window );">Remeasurement of state deferred taxes</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="num">(1,765)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="nump">2,027<span></span>
</td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">1,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount', window );">Remeasurement of contingent consideration liabilities</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">733<span></span>
</td>
<td class="num">(1,185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other - including the effect of graduated rates</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="num">(183)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense (benefit)</a></td>
<td class="nump">$ 8,113<span></span>
</td>
<td class="nump">$ 5,463<span></span>
</td>
<td class="num">$ (3,388)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to remeasurement of contingent consideration liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to remeasurement of state deferred taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513790528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances', window );">Allowance for credit losses on trade receivables</a></td>
<td class="nump">$ 1,925<span></span>
</td>
<td class="nump">$ 1,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Accrued compensation expense</a></td>
<td class="nump">9,968<span></span>
</td>
<td class="nump">11,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory differences</a></td>
<td class="nump">5,712<span></span>
</td>
<td class="nump">4,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">11,117<span></span>
</td>
<td class="nump">14,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation expense</a></td>
<td class="nump">7,167<span></span>
</td>
<td class="nump">6,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent', window );">Operating lease assets</a></td>
<td class="nump">12,801<span></span>
</td>
<td class="nump">13,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch', window );">Federal R&amp;D tax credit</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">5,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch', window );">UT R&amp;D Credit</a></td>
<td class="nump">4,679<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense', window );">IRC section 174 capitalized R&amp;D</a></td>
<td class="nump">15,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">8,827<span></span>
</td>
<td class="nump">9,939<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">77,842<span></span>
</td>
<td class="nump">71,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpense', window );">Prepaid expenses</a></td>
<td class="num">(1,568)<span></span>
</td>
<td class="num">(1,047)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(20,925)<span></span>
</td>
<td class="num">(20,797)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(38,547)<span></span>
</td>
<td class="num">(42,888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DeferredTaxLiabilitiesForeignWithholdingTax', window );">Foreign withholding tax</a></td>
<td class="num">(1,571)<span></span>
</td>
<td class="num">(5,575)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease liabilities</a></td>
<td class="num">(11,527)<span></span>
</td>
<td class="num">(11,938)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(2,040)<span></span>
</td>
<td class="num">(3,556)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(76,178)<span></span>
</td>
<td class="num">(85,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(13,527)<span></span>
</td>
<td class="num">(10,786)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">(11,863)<span></span>
</td>
<td class="num">(25,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Reported as:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">6,599<span></span>
</td>
<td class="nump">6,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="num">(18,462)<span></span>
</td>
<td class="num">(31,503)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">$ (11,863)<span></span>
</td>
<td class="num">$ (25,423)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from IRC section 174 capitalized research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible federal research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_DeferredTaxLiabilitiesForeignWithholdingTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Foreign Withholding Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_DeferredTaxLiabilitiesForeignWithholdingTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518049088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (Decrease) in valuation allowance</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="nump">$ 573<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. federal net operating loss carryforwards</a></td>
<td class="nump">29,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign operating loss carryforwards</a></td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount', window );">Foreign withholding tax</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities', window );">Tax benefit from restructuring of foreign entities</a></td>
<td class="nump">4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties', window );">Unrecognized tax benefits including interest and penalties</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective rate</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets', window );">Unrecognized tax benefits reduction to non-current deferred income tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits', window );">Increase (decrease) of uncertain tax benefits related to certain liabilities for unrecognized tax benefits</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="num">$ (90)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated decrease in unrecognized tax benefit in next twelve months</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforward, expiring</a></td>
<td class="nump">29,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforward, no expiration</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NetOperatingLossCarryforwardsUtilization', window );">Period to utilize the net operating loss carryforwards</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod', window );">NOL carryforward used in period</a></td>
<td class="nump">$ 15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforward, expiring</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforward, no expiration</a></td>
<td class="nump">$ 21,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) pertaining to restructuring of foreign entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>US Federal Net Operating Loss Carryforwards Used In The Current Period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_NetOperatingLossCarryforwardsUtilization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Number Of Years That Net Operating Loss Carryforwards Are Expected To Be Utilized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_NetOperatingLossCarryforwardsUtilization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uncertain tax positions, Reduction resulting from liabilities for reduction to non-current deferred income tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns) pertaining to uncertain tax positions taken in tax returns as of the balance sheet date including Interest and Penalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723516442352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, opening balance</a></td>
<td class="nump">$ 1,635<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
<td class="nump">$ 2,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases in tax positions taken in a prior year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases in tax positions taken in a prior year</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases in tax positions taken in the current year</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of applicable statute of limitations</a></td>
<td class="num">(343)<span></span>
</td>
<td class="num">(437)<span></span>
</td>
<td class="num">(885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, ending balance</a></td>
<td class="nump">$ 1,576<span></span>
</td>
<td class="nump">$ 1,635<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521750736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">$ 58,620<span></span>
</td>
<td class="nump">$ 59,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of contingent liabilities</a></td>
<td class="nump">15,813<span></span>
</td>
<td class="nump">34,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AdvancesFromEmployeesCurrent', window );">Advances from employees</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AccruedRebatesPayableCurrent', window );">Accrued rebates payable</a></td>
<td class="nump">10,925<span></span>
</td>
<td class="nump">11,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_AccruedLegalSettlementCurrent', window );">Accrued legal settlement</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">18,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">36,666<span></span>
</td>
<td class="nump">35,122<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current, Total</a></td>
<td class="nump">$ 123,189<span></span>
</td>
<td class="nump">$ 159,014<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AccruedLegalSettlementCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of legal settlement expenses incurred but not yet paid, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AccruedLegalSettlementCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AccruedRebatesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for current portion of accrued rebates payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AccruedRebatesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_AdvancesFromEmployeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advances From Employees, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_AdvancesFromEmployeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524468912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 198,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less unamortized debt issuance costs</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">$ (290)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">198,009<span></span>
</td>
<td class="nump">242,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">11,250<span></span>
</td>
<td class="nump">8,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term portion</a></td>
<td class="nump">186,759<span></span>
</td>
<td class="nump">234,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">124,688<span></span>
</td>
<td class="nump">133,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 73,500<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518054688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revolving Credit Facility and Long-Term Debt - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="nump">$ 198,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mmsi_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="nump">198,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit guarantees</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Available borrowing capacity</a></td>
<td class="nump">$ 523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Fixed interest rate percent</a></td>
<td class="nump">2.71%<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtPercentageBearingFixedInterestAmount', window );">Debt subject to fixed interest rate</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate', window );">Variable interest rate percent</a></td>
<td class="nump">5.38%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtPercentageBearingVariableInterestAmount', window );">Debt subject to variable interest rate</a></td>
<td class="nump">$ 123,200<span></span>
</td>
<td class="nump">$ 168,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="nump">124,688<span></span>
</td>
<td class="nump">133,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="nump">$ 73,500<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtPercentageBearingFixedInterestAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtPercentageBearingFixedInterestAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtPercentageBearingVariableInterestAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtPercentageBearingVariableInterestAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mmsi_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mmsi_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519566624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details) - Credit Agreement<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum', window );">Consolidated Total Leverage Ratio</a></td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2', window );">Consolidated Interest Coverage Ratio</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum', window );">Facility Capital Expenditures</a></td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Facility Capital Expenditures, Next Twelve Months, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Consolidated Ebitda To Fixed Charges Ratio, Minimum2</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Consolidated Total Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mmsi_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mmsi_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723512807520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 11,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">186,938<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total future minimum principal payments</a></td>
<td class="nump">$ 198,188<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521164000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 23, 2019</div></th>
<th class="th"><div>Aug. 05, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mmsi_RevenueAndCostOfSalesMember', window );">Revenue and cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross', window );">Amount expected to be reclassified from accumulated other comprehensive income (loss) to earnings in next twelve months, gross</a></td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Amount expected to be reclassified from accumulated other comprehensive income to earnings (loss) in next twelve months, net of tax</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross', window );">Amount expected to be reclassified from accumulated other comprehensive income (loss) to earnings in next twelve months, gross</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Amount expected to be reclassified from accumulated other comprehensive income to earnings (loss) in next twelve months, net of tax</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Fair value of derivative liability</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDerivativeInstruments', window );">Deferred tax asset used to offset fair value of interest rate swap</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Wells Fargo 1.12% one-month LIBOR | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Wells Fargo 1.12% one-month LIBOR | LIBOR Swap Rate | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.12%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Wells Fargo 1.71% one-month LIBOR | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Wells Fargo 1.71% one-month LIBOR | LIBOR Swap Rate | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Maturity of derivative contract (up to)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Hedge Gain (Loss) To Be Reclassified Within Twelve Months, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mmsi_RevenueAndCostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mmsi_RevenueAndCostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mmsi_WellsFargoFixedRateDerivativeContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mmsi_WellsFargoFixedRateDerivativeContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLiborSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLiborSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mmsi_WellsFargoFixedRateDerivativeContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mmsi_WellsFargoFixedRateDerivativeContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517820432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Forward Notional Contracts (Details) - Foreign currency forward contracts<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>DerivativeInstrument</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Derivatives designated as cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth', window );">Average number of contracts entered into per month | DerivativeInstrument</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate notional amount of derivative | $</a></td>
<td class="nump">$ 87.8<span></span>
</td>
<td class="nump">$ 123.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth', window );">Average number of contracts entered into per month | DerivativeInstrument</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate notional amount of derivative | $</a></td>
<td class="nump">$ 92.4<span></span>
</td>
<td class="nump">$ 86.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Average Number Of Contracts Entered Into Per Month</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513386752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Fair Value of Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Interest rate swap | Other assets (long-term)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset</a></td>
<td class="nump">$ 3,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Interest rate swap | Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Liability Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,447)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Foreign currency forward contracts | Other assets (long-term)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Foreign currency forward contracts | Prepaid expenses and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset</a></td>
<td class="nump">3,215<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Foreign currency forward contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Liability Derivatives</a></td>
<td class="num">(1,509)<span></span>
</td>
<td class="num">(2,288)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Foreign currency forward contracts | Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Liability Derivatives</a></td>
<td class="num">(531)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument | Foreign currency forward contracts | Prepaid expenses and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument | Foreign currency forward contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Liability Derivatives</a></td>
<td class="num">$ (1,946)<span></span>
</td>
<td class="num">$ (856)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518022320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Amount of Gain/(Loss) recognized in OCI</a></td>
<td class="nump">$ 9,007<span></span>
</td>
<td class="nump">$ 5,965<span></span>
</td>
<td class="num">$ (9,523)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6,339)<span></span>
</td>
<td class="num">(5,261)<span></span>
</td>
<td class="num">(9,994)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,150,981<span></span>
</td>
<td class="nump">1,074,751<span></span>
</td>
<td class="nump">963,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(631,882)<span></span>
</td>
<td class="num">(589,418)<span></span>
</td>
<td class="num">(562,698)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Derivatives designated as cash flow hedges | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain/(Loss) reclassified from AOCI</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(1,509)<span></span>
</td>
<td class="num">(872)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Derivatives designated as cash flow hedges | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain/(Loss) reclassified from AOCI</a></td>
<td class="nump">3,583<span></span>
</td>
<td class="num">(5,592)<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Derivatives designated as cash flow hedges | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain/(Loss) reclassified from AOCI</a></td>
<td class="num">(1,436)<span></span>
</td>
<td class="nump">1,017<span></span>
</td>
<td class="num">(1,288)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Derivatives designated as cash flow hedges | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Amount of Gain/(Loss) recognized in OCI</a></td>
<td class="nump">4,879<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="num">(6,131)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Derivatives designated as cash flow hedges | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Amount of Gain/(Loss) recognized in OCI</a></td>
<td class="nump">$ 6,263<span></span>
</td>
<td class="num">$ (1,521)<span></span>
</td>
<td class="num">$ (5,516)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517848016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details) - Not designated as hedging instrument - Foreign currency forward contracts - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) on derivative</a></td>
<td class="nump">$ 1,420<span></span>
</td>
<td class="num">$ (1,598)<span></span>
</td>
<td class="num">$ (2,190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
<td class="text">Other Nonoperating Income (Expense)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524418048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mmsi_MeritShareholderDerivativeSuitMember', window );">Merit Shareholder Derivative Suit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Attorneys fees and expenses</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mmsi_MeritShareholderDerivativeSuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mmsi_MeritShareholderDerivativeSuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518137744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (EPS) - Basic EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 74,516<span></span>
</td>
<td class="nump">$ 48,454<span></span>
</td>
<td class="num">$ (9,843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average common shares outstanding (in shares)</a></td>
<td class="nump">56,806<span></span>
</td>
<td class="nump">56,145<span></span>
</td>
<td class="nump">55,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic EPS (in dollars per share)</a></td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517784560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (EPS) - Diluted EPS (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average common shares outstanding (in shares)</a></td>
<td class="nump">56,806<span></span>
</td>
<td class="nump">56,145<span></span>
</td>
<td class="nump">55,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive stock awards (in shares)</a></td>
<td class="nump">865<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total potential shares outstanding (in shares)</a></td>
<td class="nump">57,671<span></span>
</td>
<td class="nump">57,359<span></span>
</td>
<td class="nump">55,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted EPS (in dollars per share)</a></td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Equity awards excluded as the impact was anti-dilutive (in shares)</a></td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">4,216<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723511884464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,042,000<span></span>
</td>
<td class="nump">$ 16,090,000<span></span>
</td>
<td class="nump">$ 14,339,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,000<span></span>
</td>
<td class="nump">716,000<span></span>
</td>
<td class="nump">329,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures', window );">Fair value of options, net of forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted in period, weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.98<span></span>
</td>
<td class="nump">$ 24.38<span></span>
</td>
<td class="nump">$ 13.70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64.54<span></span>
</td>
<td class="nump">$ 61.39<span></span>
</td>
<td class="nump">$ 43.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock units vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit', window );">Number of shares of common stock for each unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | FCF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | rTSR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | rTSR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | rTSR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease', window );">Decrease in the potential shares of common stock to be granted</a></td>
<td class="nump">25,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 1 | FCF | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 1 | FCF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 2 | FCF | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 2 | FCF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Performance period 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Target units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Maximum units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Maximum potential shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,000<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember', window );">Cash-Settled Performance-Based Share-Based Awards (Liability Awards)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive', window );">Target cash incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">Liabilities associated with awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid', window );">Amount paid in connection with liability awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 833,000<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock units vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember', window );">Cash-Settled Performance-Based Share-Based Awards (Liability Awards) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive', window );">Target cash incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.00%<span></span>
</td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember', window );">Cash-Settled Performance-Based Share-Based Awards (Liability Awards) | Performance period 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember', window );">Cash-Settled Performance-Based Share-Based Awards (Liability Awards) | Performance period 1 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember', window );">Cash-Settled Performance-Based Share-Based Awards (Liability Awards) | Performance period 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember', window );">Cash-Settled Performance-Based Share-Based Awards (Liability Awards) | Performance period 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59.02<span></span>
</td>
<td class="nump">$ 61.77<span></span>
</td>
<td class="nump">$ 42.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock units vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mmsi_LongTermIncentivePlan2018Member', window );">2018 Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,817,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mmsi_LongTermIncentivePlan2018Member', window );">2018 Incentive Plan | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mmsi_LongTermIncentivePlan2018Member', window );">2018 Incentive Plan | Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mmsi_LongTermIncentivePlan2018Member', window );">2018 Incentive Plan | Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mmsi_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate', window );">Purchase price for ESPP, percent of market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Stock Option On Grant Date Net Of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of potential shares granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, equity instruments other than options, conversion multiplying factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The annual target cash incentive amount for non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares of common stock that each unit is equal to.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement Employee Stock Purchase Plan, Percentage of Market Price. Purchase Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20015-108363<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid to settle liability for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=mmsi_TargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=mmsi_TargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=mmsi_MaximumUnitsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=mmsi_MaximumUnitsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=mmsi_MaximumPotentialSharesGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=mmsi_MaximumPotentialSharesGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mmsi_LongTermIncentivePlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mmsi_LongTermIncentivePlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mmsi_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mmsi_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518114384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">$ 18,042<span></span>
</td>
<td class="nump">$ 16,090<span></span>
</td>
<td class="nump">$ 14,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">14,647<span></span>
</td>
<td class="nump">13,271<span></span>
</td>
<td class="nump">11,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">7,305<span></span>
</td>
<td class="nump">6,678<span></span>
</td>
<td class="nump">7,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative | Stock-Settled Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">3,509<span></span>
</td>
<td class="nump">3,525<span></span>
</td>
<td class="nump">2,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">1,836<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
<td class="nump">758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative | Cash-Settled Performance-Based Share-Based Awards (Liability Awards)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated share-based compensation</a></td>
<td class="nump">$ 1,997<span></span>
</td>
<td class="nump">$ 1,511<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mmsi_CashSettledPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723518126096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term / Performance Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected price volatility, minimum</a></td>
<td class="nump">46.20%<span></span>
</td>
<td class="nump">46.10%<span></span>
</td>
<td class="nump">38.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected price volatility, maximum</a></td>
<td class="nump">47.50%<span></span>
</td>
<td class="nump">46.70%<span></span>
</td>
<td class="nump">45.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term / Performance Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term / Performance Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521864400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised</a></td>
<td class="nump">$ 27,110<span></span>
</td>
<td class="nump">$ 36,086<span></span>
</td>
<td class="nump">$ 11,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock option exercises</a></td>
<td class="nump">18,952<span></span>
</td>
<td class="nump">20,194<span></span>
</td>
<td class="nump">5,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Excess tax benefit from the exercise of stock options</a></td>
<td class="nump">$ 3,423<span></span>
</td>
<td class="nump">$ 5,571<span></span>
</td>
<td class="nump">$ 1,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">3,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited/expired (in shares)</a></td>
<td class="num">(111)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December 31 (in shares)</a></td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">3,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">1,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Ending vested and expected to vest (in shares)</a></td>
<td class="nump">3,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 44.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">63.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">28.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited/expired (in dollars per share)</a></td>
<td class="nump">53.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">49.62<span></span>
</td>
<td class="nump">$ 44.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">43.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Ending vested and expected to vest (in dollars per share)</a></td>
<td class="nump">$ 49.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, remaining contractual term</a></td>
<td class="text">3 years 6 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, remaining contractual term</a></td>
<td class="text">2 years 7 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Ending vested and expected to vest, remaining contractual term</a></td>
<td class="text">3 years 5 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, intrinsic value</a></td>
<td class="nump">$ 64,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, intrinsic value</a></td>
<td class="nump">48,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Ending vested and expected to vest, intrinsic value</a></td>
<td class="nump">$ 64,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723512642672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">97,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod', window );">rTSR adjustment (in shares)</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(44,000)<span></span>
</td>
<td class="num">(26,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(45,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at December 31 (in shares)</a></td>
<td class="nump">179,000<span></span>
</td>
<td class="nump">163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 53.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">64.54<span></span>
</td>
<td class="nump">$ 61.39<span></span>
</td>
<td class="nump">$ 43.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue', window );">rTSR adjustment (in dollars per share)</a></td>
<td class="nump">65.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">65.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">60.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at December 31 (in dollars per share)</a></td>
<td class="nump">$ 65.20<span></span>
</td>
<td class="nump">$ 53.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | rTSR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | rTSR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | rTSR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor', window );">Multiplying factor</a></td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(26,000)<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at December 31 (in shares)</a></td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 61.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">59.02<span></span>
</td>
<td class="nump">$ 61.77<span></span>
</td>
<td class="nump">$ 42.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">61.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at December 31 (in dollars per share)</a></td>
<td class="nump">$ 59.02<span></span>
</td>
<td class="nump">$ 61.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of equity-based payment instruments, excluding stock (or unit) options, from the application of the rTSR multiplier as originally specified in the agreements during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for adjustments made based on the impact of the application of the rTSR multiplier as originally specified in the agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, equity instruments other than options, conversion multiplying factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521103840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected price volatility, minimum</a></td>
<td class="nump">38.50%<span></span>
</td>
<td class="nump">43.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected price volatility, maximum</a></td>
<td class="nump">42.60%<span></span>
</td>
<td class="nump">49.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term / Performance Period</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Stock-Settled Performance-Based Restricted Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term / Performance Period</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513787248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting and Foreign Operations - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NumberOfProductCategories', window );">Number of Product Categories | item</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,150,981<span></span>
</td>
<td class="nump">$ 1,074,751<span></span>
</td>
<td class="nump">$ 963,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 500,422<span></span>
</td>
<td class="nump">$ 465,873<span></span>
</td>
<td class="nump">$ 413,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Sales Revenue | Geographic Concentration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration for geographic sales</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 149,300<span></span>
</td>
<td class="nump">$ 138,200<span></span>
</td>
<td class="nump">$ 113,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_NumberOfProductCategories', window );">Number of Product Categories | item</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,118,224<span></span>
</td>
<td class="nump">1,043,227<span></span>
</td>
<td class="nump">934,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 498,264<span></span>
</td>
<td class="nump">$ 463,812<span></span>
</td>
<td class="nump">$ 411,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_NumberOfProductCategories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of product categories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_NumberOfProductCategories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513406192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">$ 382,976<span></span>
</td>
<td class="nump">$ 371,658<span></span>
</td>
<td class="nump">$ 382,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">281,290<span></span>
</td>
<td class="nump">275,311<span></span>
</td>
<td class="nump">277,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">40,749<span></span>
</td>
<td class="nump">39,863<span></span>
</td>
<td class="nump">42,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mmsi_NonUSExcludingIrelandMember', window );">Other foreign countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Long-lived assets</a></td>
<td class="nump">$ 60,937<span></span>
</td>
<td class="nump">$ 56,484<span></span>
</td>
<td class="nump">$ 62,134<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mmsi_NonUSExcludingIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mmsi_NonUSExcludingIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521941120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting and Foreign Operations - Operating Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,150,981<span></span>
</td>
<td class="nump">$ 1,074,751<span></span>
</td>
<td class="nump">$ 963,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">87,563<span></span>
</td>
<td class="nump">60,916<span></span>
</td>
<td class="num">(1,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense - net</a></td>
<td class="num">(4,934)<span></span>
</td>
<td class="num">(6,999)<span></span>
</td>
<td class="num">(11,669)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">8,113<span></span>
</td>
<td class="nump">5,463<span></span>
</td>
<td class="num">(3,388)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">74,516<span></span>
</td>
<td class="nump">48,454<span></span>
</td>
<td class="num">(9,843)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,118,224<span></span>
</td>
<td class="nump">1,043,227<span></span>
</td>
<td class="nump">934,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">80,946<span></span>
</td>
<td class="nump">53,415<span></span>
</td>
<td class="num">(7,042)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember', window );">Endoscopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">32,757<span></span>
</td>
<td class="nump">31,524<span></span>
</td>
<td class="nump">29,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">$ 6,617<span></span>
</td>
<td class="nump">$ 7,501<span></span>
</td>
<td class="nump">$ 5,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521200400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 1,663,966<span></span>
</td>
<td class="nump">$ 1,648,294<span></span>
</td>
<td class="nump">$ 1,664,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">81,804<span></span>
</td>
<td class="nump">84,066<span></span>
</td>
<td class="nump">94,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">45,029<span></span>
</td>
<td class="nump">27,939<span></span>
</td>
<td class="nump">45,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,652,145<span></span>
</td>
<td class="nump">1,635,676<span></span>
</td>
<td class="nump">1,654,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">80,777<span></span>
</td>
<td class="nump">83,000<span></span>
</td>
<td class="nump">93,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">44,925<span></span>
</td>
<td class="nump">27,557<span></span>
</td>
<td class="nump">45,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember', window );">Endoscopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">11,821<span></span>
</td>
<td class="nump">12,618<span></span>
</td>
<td class="nump">9,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,027<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 382<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAssetReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723603104832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total expense for contributions made</a></td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513788752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="num">$ (2,260)<span></span>
</td>
<td class="num">$ (13,500)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate contract asset, long-term</a></td>
<td class="nump">3,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue', window );">Interest rate contract liabilities, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contract assets, current and long-term</a></td>
<td class="nump">4,783<span></span>
</td>
<td class="nump">2,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contract liabilities, current and long-term</a></td>
<td class="num">(3,986)<span></span>
</td>
<td class="num">(3,646)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="num">(18,073)<span></span>
</td>
<td class="num">(48,234)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value, Fair Value Disclosure | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate contract asset, long-term</a></td>
<td class="nump">3,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue', window );">Interest rate contract liabilities, long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contract assets, current and long-term</a></td>
<td class="nump">4,783<span></span>
</td>
<td class="nump">2,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contract liabilities, current and long-term</a></td>
<td class="num">(3,986)<span></span>
</td>
<td class="num">(3,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="num">$ (18,073)<span></span>
</td>
<td class="num">$ (48,234)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521907696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Contingent Consideration - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 48,234<span></span>
</td>
<td class="nump">$ 55,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Contingent consideration expense</a></td>
<td class="nump">$ 4,610<span></span>
</td>
<td class="nump">$ 3,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Income [Extensible List]</a></td>
<td class="text">Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit<span></span>
</td>
<td class="text">Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Contingent payments made</a></td>
<td class="num">$ (34,762)<span></span>
</td>
<td class="num">$ (10,665)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange', window );">Effect of foreign exchange</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 18,073<span></span>
</td>
<td class="nump">$ 48,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=mmsi_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=mmsi_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723513236432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payments related to the settlement of the contingent consideration liability, Financing activities</a></td>
<td class="nump">$ 32,918,000<span></span>
</td>
<td class="nump">$ 10,665,000<span></span>
</td>
<td class="nump">$ 13,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payments related to the settlement of the contingent consideration liability, Operating activities</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 28,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss (gain) on disposition of business</a></td>
<td class="nump">$ 1,417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (517,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment loss on operating lease asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="nump">439,000<span></span>
</td>
<td class="nump">769,000<span></span>
</td>
<td class="nump">604,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in privately held companies</a></td>
<td class="nump">15,576,000<span></span>
</td>
<td class="nump">14,711,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent', window );">Long-term notes receivable, net</a></td>
<td class="nump">2,397,000<span></span>
</td>
<td class="nump">2,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="nump">281,000<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
<td class="nump">730,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mmsi_NinePointMedicalInc.Member', window );">NinePoint Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 359,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mmsi_BluegrassVascularTechnologiesIncMember', window );">Bluegrass Vascular Technologies, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payment received on entire principal balance and all accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_XableCathMember', window );">XableCath</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_FusionMedicalInc.Member', window );">Fusion Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_BluegrassVascularTechnologiesIncMember', window );">Bluegrass Vascular Technologies, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_STDPharmaceuticalProductsLimitedMember', window );">STD Pharmaceutical Products Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mmsi_SelioMedicalLimitedSelioMember', window );">Selio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent', window );">Long-term notes receivable, net</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="nump">281,000<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mmsi_LicenseAgreementArravascLimitedMember', window );">ArraVasc Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Asset Impairment Charges<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Director | Cianna Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForMergerRelatedCosts', window );">Contingent payments related to acquisition</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent', window );">Contingent consideration liability, noncurrent</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">13,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent', window );">Contingent consideration liability, current</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="nump">$ 34,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (c)<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the reporting period for charges associated with the mergers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mmsi_NinePointMedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mmsi_NinePointMedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mmsi_BluegrassVascularTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mmsi_BluegrassVascularTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_XableCathMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_XableCathMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_FusionMedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_FusionMedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_BluegrassVascularTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mmsi_BluegrassVascularTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_STDPharmaceuticalProductsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_STDPharmaceuticalProductsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_SelioMedicalLimitedSelioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_SelioMedicalLimitedSelioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mmsi_LicenseAgreementArravascLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mmsi_LicenseAgreementArravascLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mmsi_CiannaMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mmsi_CiannaMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723512765360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_RevenueBasedPaymentsMember', window );">Revenue-based royalty | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">2,097<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_RevenueMilestonesMember', window );">Revenue milestones | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">13,064<span></span>
</td>
<td class="nump">41,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_RegulatoryApprovalMilestoneMember', window );">Regulatory approval | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">$ 2,912<span></span>
</td>
<td class="nump">$ 3,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue-based royalty | Minimum | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue-based royalty | Maximum | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.17<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue-based royalty | Weighted Average | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.157<span></span>
</td>
<td class="nump">0.147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue milestones | Minimum | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.051<span></span>
</td>
<td class="nump">0.075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue milestones | Maximum | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.140<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Revenue milestones | Weighted Average | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.052<span></span>
</td>
<td class="nump">0.082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Regulatory approval | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.057<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=mmsi_MilestonePaymentProbabilityMember', window );">Probability of milestone payment | Regulatory approval | Discounted Cash Flow | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Unobservable inputs, contingent liability</a></td>
<td class="nump">0.90<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mmsi_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_RevenueMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mmsi_RevenueMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mmsi_RegulatoryApprovalMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mmsi_RegulatoryApprovalMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=mmsi_MilestonePaymentProbabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=mmsi_MilestonePaymentProbabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723519554352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Allowance for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Beginning balance</a></td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Provision for credit loss expense</a></td>
<td class="nump">82<span></span>
</td>
<td class="num">(531)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Ending balance</a></td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (c)<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLossesExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of credit loss expense (reversal of expense) for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLossesExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517616608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 1,039,799<span></span>
</td>
<td class="nump">$ 958,575<span></span>
</td>
<td class="nump">$ 949,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract', window );"><strong>Reclassifications to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(631,882)<span></span>
</td>
<td class="num">(589,418)<span></span>
</td>
<td class="num">(562,698)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6,339)<span></span>
</td>
<td class="num">(5,261)<span></span>
</td>
<td class="num">(9,994)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">1,144,397<span></span>
</td>
<td class="nump">1,039,799<span></span>
</td>
<td class="nump">958,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(7,991)<span></span>
</td>
<td class="num">(5,452)<span></span>
</td>
<td class="num">(5,294)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">651<span></span>
</td>
<td class="num">(7,823)<span></span>
</td>
<td class="num">(3,861)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(2,075)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract', window );"><strong>Reclassifications to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(3,559)<span></span>
</td>
<td class="num">(2,539)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(11,550)<span></span>
</td>
<td class="num">(7,991)<span></span>
</td>
<td class="num">(5,452)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss) | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract', window );"><strong>Reclassifications to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">(3,583)<span></span>
</td>
<td class="nump">5,592<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="num">(1,017)<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(2,464)<span></span>
</td>
<td class="num">(6,940)<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">11,142<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="num">(11,647)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(2,177)<span></span>
</td>
<td class="num">(1,489)<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract', window );"><strong>Reclassifications to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">6,830<span></span>
</td>
<td class="nump">4,476<span></span>
</td>
<td class="num">(7,158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">4,366<span></span>
</td>
<td class="num">(2,464)<span></span>
</td>
<td class="num">(6,940)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract', window );"><strong>Reclassifications to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">(3,583)<span></span>
</td>
<td class="nump">5,592<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="num">(1,017)<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(5,527)<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
<td class="num">(5,512)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(10,491)<span></span>
</td>
<td class="num">(7,704)<span></span>
</td>
<td class="nump">7,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="num">(786)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract', window );"><strong>Reclassifications to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(10,389)<span></span>
</td>
<td class="num">(7,015)<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (15,916)<span></span>
</td>
<td class="num">$ (5,527)<span></span>
</td>
<td class="nump">$ 1,488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723522637808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term (up to)</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mmsi_LesseeOperatingLeaseTerminationPeriod', window );">Termination option (within)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease term</a></td>
<td class="text">27 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mmsi_LesseeOperatingLeaseTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Termination Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mmsi_LesseeOperatingLeaseTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mmsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517848960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Consolidated Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU operating lease assets</a></td>
<td class="nump">$ 65,262<span></span>
</td>
<td class="nump">$ 65,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term operating lease liabilities</a></td>
<td class="nump">11,005<span></span>
</td>
<td class="nump">10,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">59,736<span></span>
</td>
<td class="nump">61,526<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 70,741<span></span>
</td>
<td class="nump">$ 72,194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521701056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease cost</a></td>
<td class="nump">$ 14,219<span></span>
</td>
<td class="nump">$ 16,013<span></span>
</td>
<td class="nump">$ 16,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease (income)</a></td>
<td class="num">(409)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">$ 13,810<span></span>
</td>
<td class="nump">$ 15,938<span></span>
</td>
<td class="nump">$ 16,720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723602749232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of lease liabilities</a></td>
<td class="nump">$ 13,710<span></span>
</td>
<td class="nump">$ 14,970<span></span>
</td>
<td class="nump">$ 15,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use operating lease assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">$ 11,130<span></span>
</td>
<td class="nump">$ 1,524<span></span>
</td>
<td class="nump">$ 10,938<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723517985392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Disclosure (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">10 years 4 months 24 days<span></span>
</td>
<td class="text">11 years 4 months 24 days<span></span>
</td>
<td class="text">11 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723524464960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 12,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">11,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">8,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">7,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">5,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">37,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">84,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(13,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 70,741<span></span>
</td>
<td class="nump">$ 72,194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139723521711312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and qualifying accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="num">$ (6,767)<span></span>
</td>
<td class="num">$ (5,313)<span></span>
</td>
<td class="num">$ (3,108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions Charged to Costs and Expenses</a></td>
<td class="num">(1,858)<span></span>
</td>
<td class="num">(2,678)<span></span>
</td>
<td class="num">(3,115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deduction</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="num">(8,423)<span></span>
</td>
<td class="num">(6,767)<span></span>
</td>
<td class="num">(5,313)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Tax Valuation Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="num">(10,786)<span></span>
</td>
<td class="num">(10,213)<span></span>
</td>
<td class="num">(4,644)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions Charged to Costs and Expenses</a></td>
<td class="num">(2,741)<span></span>
</td>
<td class="num">(573)<span></span>
</td>
<td class="num">(5,569)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="num">$ (13,527)<span></span>
</td>
<td class="num">$ (10,786)<span></span>
</td>
<td class="num">$ (10,213)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>mmsi-20221231x10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mmsi="http://www.merit.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mmsi-20221231.xsd" xlink:type="simple"/>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_eIOjLCC_ckKJd7j-tagx0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Tcw0rwvwnUCNggwvx-hToA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vuB28aRB70m7DQkE04axrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_ymPQ_EUUskWNwXusRc-oFg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vb9_o2qO3UyDJVFE_VYJKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_j64W9w2JFkaNZCAs8PllJQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_DS1rt81n2UuuEQSAYL8cwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_XT-DImLBW0CLqTtA5KznqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_fERnc1ZCQkW-tUKySpgZRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_B7su2MaR6Ue9mzoD3SVZSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Ksk8oPM3pkWXnmJp3aVfjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dwnvij5qh0aeUakBIbwM3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_85rQK-4M5ECcEsi9kKnxVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gSVl3EPpKEKYTN8MPw6Tkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bQN0IS6wDU6ClnshU71aSg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_KA5J2PovC0-VQ20gGn884Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0dOxMvz3KkeA-_6PU6WRIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_4hpPQW9-gkirQ7OHsm1waA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_689J25SRoUeFQ-mb_xQzMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_aN4IaMh0wkmaWTjP49uYEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_NNFXt7P21UW4Paq_45LQzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGIvY-Wghke_ETbCqrVrlA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_Xv_jjMZ61Uuj4krxMBlGGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3aRiaMEyxkWBqtSJEkrr9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_m354GPzJSkesgFQaFE_wMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gK8hNbA-mU2xGdCtF3REPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_0Wxh9uRER0u6z2OziPvL-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_G-kv3r9YKUyaVq6iMWD8VQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2ZYBTZI1iUGbF66gUMJ3jA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_N2nptxswq06E37WY0fAdLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_DsDJDza1hEOKOCEENBEccw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_AIeZ1LxyUU-U04p2bkns4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_7hQKDlFBGE-A_JKU8z88Kg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_WBFuNp9-sEOaCJ0Ax7YM3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_3fb8WLlr80-4_6v213qfgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_GxO2voBvw0KcdDmVJ8OK8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_a0RjGlBUeUa4iriFWOGd0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yq6tnYStUk6a7MAFzkSQcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_4i2h-0r8ekOAQM9CYwMASw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_i-4hy_JVkUqCTXWyIeMrmQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_30JNZGvr7EC6MKrc7WWXwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_fxzT2CfP7UGLlti0xqKeog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_4HZjeHhca0CJ9R9TG0L3fA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:TargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_b4qnuJ-OWEiHrjQRnWlLXw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumUnitsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_gLbiasFwxkmKONzOlnKAwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumPotentialSharesGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_94jGRzIuckyUf5V563Shhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:TargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_RYZsnkxzTkaTfXLFz_Zj2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumUnitsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s46DzGkVO0Sh6osOFwanZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumPotentialSharesGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_kGEvFzHWaUq1-E8uQ61arA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:TargetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_OSPO592R7EqioAf9pi9vfA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumUnitsGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_U_TUWGHmYk20d863KAh-8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mmsi:MaximumPotentialSharesGrantedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_zAFzt7xtHEazGu7si-1YKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_R06ETi2TMkqS-odoJkwA1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:LongTermIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember__4rStAvy_02iitxQUT2v7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_n09B1uG-xESAohYo-rybSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_iyd5XGEpw0C-bvBjxzoeAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cPPJwMeQPUeIYf6LbWUGag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_WIq3iXtF5EuvyViG_OJs8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_NDXPu66jak-ZMyYsakdLbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_OvQHRNSqw06QppxX6EnjNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_bbrBKCNcLUOQmTf4LjLfbA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W7ZIFyCygUuKNAAvOSvoSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Nn7nL1keE0GsDMUUEXCHfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XDLejGk_vku62keNdhz1pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_W4Nbl4v2vEWmCyXaR8_MbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_JN31JqK8TUSZFC4jUhNaUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_GzZqc0UGTEKLB-X3K1JMdg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_PGWSswwuFk6OV2hMBsWqtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_5mDvHL5jDk-TEtW54Ne1dw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_fMTs59rneUqo5v_BpAVSDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o4zAyiweSU6Li2EVnzgs_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_va_cfvyIrkys5qSCajkJtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dh9NAeeWGEOTyKx9dRNgQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_80TSk5DGpEiuyohE3PdYuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_EZu2oq9JWkySFQgXZx80hQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pL5Mknj4JEmgIcuiUR69sg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_gXuoUnaox02wGzKWXWNqtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_1Z_4de4ygUqLS5DxUcunbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qOiOMhYAGEOB7wKJJI87ZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_-UggGEQK5U2pkGO6tH6iag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_dSg8kh6DlkyLKSVn2mRmPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_q-ArAJXhsESzPPSHFsKcWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_CN_qZO_CIcm8EKmg0YTRChTXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_67-Tqlponk6UZvQATQw19w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vqVnEcbqgk2jvODZ8WKvRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_lluU2dZDfkKiBp-RaJI-hQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vZc6fJE-3EKIbRcC9xqtKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_rbVoGsHPjU-z7VMqPG5eTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_TuXIR_4O_0SCoIN9zotxUg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_6oiLFHWLjEaJLXpc4zEA1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_aoV-srO-v0C_CmlJQCQsxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_cOSP19REXkC1_oAwXrzLgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_g8ILwIqCCkGF8WrNEHY3EA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_b4I5jqtYA0uVHc7AxRDbqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_Hz0JZzm31kalsEp3ZcM9cA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_129nQ-x5H0i8Qfcm3bT7Ew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_NKU1bXBovEOvuplur33cjg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_49WaWthqHUyKFHaIaWPRbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_UdQi9w9_x0afDHEY0-2BYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hYBaR7_UwkCAZ6qoxFrGIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_2Zks2ScobUOdPYr6gUlL_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_lPoQtyNyi0OGB2OF5XQXnw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_CN_P4z8MxOErEe5ei5ipgHNOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hLXkkEVnQ0euQQ6ojlb_1g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XRuhIx6aiEeybATIhaSCew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_RROgTsYenkCF6Vl9lsgjUQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_m-3FCbMdj0GAx8FAxAcY0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_ezMW-IvdrEydHhCgww1eQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_-HWMY93UmE2VbbgFMJMnIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pPXbTXxRSEOTXXv96LRH3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o6wsE8xC70etjMC36EOexw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_nB-ZtSzHwEaoYetvplSrzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_SZX6ag4YY02YUh000gdDGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_9SbQy8Y_7E6dXc-zGjv5Ng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_rIqmoSek306nJEUyZctJvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:PeripheralInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vOi-T_pyI0GCZHYU5lqDhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:OEMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_oykmNEiVm0ie0Ya6Hql15Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:EndoscopyDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_2faHD7Y0VE2-7TwAJ3e-Vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CustomProceduralSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dQ1w9qgJwkKMRf4Eg6YHWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mmsi:CardiacInterventionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_bAPCtJ49gEqQWOqwDxwUJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_mCRjJpSbEE2JseTs6klpUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_UKcyzBm0EE25HgNKqiye4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_CN_DoIlPAu9x0ysbFQn9Of8Yw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_YvMztLBIikevootYF9Q_Vw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_r2Dw8i5qFkieuyppXBpYLA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_YTeZcpsajkOtbBGdZAUyYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_s1acsZS6iEKC098oWQyTug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_5XhIeqfIC0aQ7HSWBJyoYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_c5bBLUi-vkiFEa6Kh9D6GQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_4_A4JH-cIkyKmiFBjtHFug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_bHmUCFOtj06ZlP-Hj9nRQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember_zjDdU-1CK0yQn-YgCOPErQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_eeu5akz68Uus_Sjj54jzQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mmsi:NonUSExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_US_snTmzJ5T0E656AhhDMpMQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_IE_GfG6bD0w406OQ3evGEIt8A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_VeCyfvZPU0KduGRAlFl2sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mmsi:NonUSExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_US_GwhTWC6jokaibH93vL9asg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_IE_VUWTuDtMwkqMhwjAVcktqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember__hoYCGHvzUiBpV80UeFJuQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mmsi:NonUSExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_US_8HeXqvsEIk-auaw5myy4uA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_IE_eGJe27sczEalkw_qMPNw1Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_SNuT8N5JSkC1oU513hKP5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-04</startDate>
            <endDate>2022-10-04</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_4_30_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_kSDG572XaUOLA_xcDYEc0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="Duration_9_1_2021_To_9_30_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_2Xu6PUGyB0KxT8eU3R1ceA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_12_31_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_nvOWf0YPFkKnDI6lHS5MgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_3u3FWHkJQ0qDFakJiBI-Qg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:CiannaMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_sxaYw4aSrkameQjBWdLV-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:CiannaMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_LitigationCaseAxis_mmsi_MeritShareholderDerivativeSuitMember_ewzR_Ik4L0K4K-iU6Qne5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mmsi:MeritShareholderDerivativeSuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_YtPykTJnRkKC0CuJpKTvOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_J_jEZHS6W0CE4zFDg0hOEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9e9qLIpZ9kKq6G-HazuXuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_651_ONWx0E-kOfcPokz1LQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_DSBEv7Elwk6u3sZ3evR8Mg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9f2ZOgRsCESUeU-GyCvi5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_z9Y6hxatL0aNPYGB24x1vQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_EjcLYIKKkkCUoWHgDM1Mxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Mb6B1L4bMUW6eZXS3Daluw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_zc2ERyYBRUKEX1L10n6VZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_Ywl3JgUM702U95RFgQlRaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_GVmvdOejHUemtyQusSrLBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_vnyL3I4nU0O1maZQbdeu6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_cNz_-CadmU-KLZHsUgTE7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_bN8XBH6sl0Oi6_jiK3FrEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_smMsnEfusEi6-EuzPWs_CQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_e0_SslW0xEmjVG9Y4QH58Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QnNOgXob5EeqCbUSSdW6NQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_T8JXswSBYku-qE6hvnoCVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_LgZE-P7vHUGygqnbkaU4QA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_QnCxU02fNUm64FC2KL9WNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_Yg3eGli2zEW7bA8OSCslYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:STDPharmaceuticalProductsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_ccOqommAIUOJx6oYxeTW7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:STDPharmaceuticalProductsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_OtherIntangibleAssetsAcquiredMember_kqfrwoAXJEelfiTvRFAw3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:OtherIntangibleAssetsAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_GZdF6FbMRk6IMRPpvp4agg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mmsi:LicenseAgreementArravascLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_LauraneMedicalS.A.S.Member_1wpeXbI0cEecSrjzJb-LeQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:LauraneMedicalS.A.S.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mmsi:LicenseAgreementArravascLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_CounterpartyNameAxis_mmsi_NinePointMedicalInc.Member_DqLbR1-f_USM3HqTH1_MPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:NinePointMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_MDSV0pNPBkaFq-morkVg5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-04</startDate>
            <endDate>2022-10-04</endDate>
        </period>
    </context>
    <context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_Q-sH4tc8t0y8Us3FOrczrg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_M_cqHBv4VEmQzw8E4TMvlQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_ivrHt2y9VEu_1nKzuAKxTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_ounleXUwDkGNqZctsTtL_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:SelioMedicalLimitedSelioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_FjbGmVYKb0ij4cN6X0KS1g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:SelioMedicalLimitedSelioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_4qQbrD0xJ02K_LJUhv6gQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_-dsubK6ei02Er5tXNOop6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_mmsi_BluegrassVascularTechnologiesIncMember_SYBvPqScc0WI8eIanV1mkQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mmsi:BluegrassVascularTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_bvBD3HDjRUa2xKKy5B1nrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_WFeSl2nEiUeMnJom75DnaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FluidxMedicalTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_DUaZCPw_8kabeorUeHmx0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FusionMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_XableCathMember_olpSi2DLokilw5cmv-tukQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:XableCathMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_rCYZXv1CfE2ubKNZDLYiJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:FusionMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_BluegrassVascularTechnologiesIncMember_F_LmcolU_0qcGjS4sv6hNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mmsi:BluegrassVascularTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_ATNZbLCh8keW60__JyknWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_8_8yxPQPFUu5XLbijWH-yA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_H7J11ScbqEi4fWoBfmyKZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_qFOq_wW62kSSMs1OwxY3-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_RnYw5KwjtEiUa6kDr0cJuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-23</instant>
        </period>
    </context>
    <context id="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_QrfXxo7G-0CQLXG-eerz5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-08-05</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_a6q6MSDqW02kPa4lJGG3MQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_w_w-NqxInkmFUqMf_XcMMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_0hUma_OATUuPqA-Tunbzmw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLiborSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-23</instant>
        </period>
    </context>
    <context id="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_mTy83y8sAEyrrLjPi86-Aw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mmsi:WellsFargoFixedRateDerivativeContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLiborSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-08-05</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V96Xu0PnRkq7CZcqhwZ9wg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_7Bk5S5y3pUqsM1mFsZA5qw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V3-frjJY_UmM_jR_g6jVHg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_BBWY2l8nB0G5rPJksNt47A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_6HKnbEJ3LkOuSxP6-rmASg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_ubGIOi0F8UCMr2ybX-8S_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_jOoxPiQ8oEKYkVGlwyYgBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_sDnLdoNkA0G_KKlMx5qh6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_vMDqDRimQUGVsJqDaXM38A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_IUTMOoGSYUSlf5FDP00RrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_uNomnuKXAECdAPu7QMed0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OD_1uS3fckadl_NP9-khyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_L0K7XndHi0OEyV8MrOqpmA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_d3jAs283gEicHG2ZvBV4CQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_EqJKyjSWGE2cWtmKmguTYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_fGTXof4L9kC2AsOYsnC7lA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JDBrXX4eGkm0WfKXgEw4_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JOxaSybhBEmm93r7VwCklA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_IouJ1SF8gkaMhJelEUky_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_4HjX7W_AtkazUBHgOvHHrw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_KKxUChovJUKc65GGLrR6Tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_mnlw2YbJNke1XUMLVydA-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_nxzNJ9zo90yLi_8Qv5ROqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_9Ang2hn4Y0KLAWIwdCgBog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_cNga-H3nA0mvS1ecmQSc8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_BT1_boCV1EyK74esn0nh_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_v_3MlJjEwkOhh_n4KP2NWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_qVc5qszmDkqekOg1yJuHmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_jemfLXarqUS_VyGv8WDThA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e1glezOlAEmHZyfzYLhmhA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_iWQuWEDGp0W1mLQsaz5M_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e03sqdjmAUSi1TluISkF4w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_hsK8EQLFzEaatbWI6fI09A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-06</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wFq40ECBeEqsCzPUL8162A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wS-nk3dwt0SoycQ0IxdNoA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_8hQxF1RJzU--ikXVveEKCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_XG-RKCkLlk22Ae6PugLZbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_E2OX24rrYEG3vsZbSdeyig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_9kdasnow90OyrWKURUS9Eg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_DfuOLsD7TkeHPFVz0G_RxA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_sNZB_NpM8EKYkfbbamr2_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mmsi:MilestonePaymentProbabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_NTaqduRlGUyMLasvGWVtVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_xbdo5FZuEUGtMQe0eFs_lQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_qnG1d3UiJEG-s9zu8DRZxQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_CDuUTCWXo02V70P4F5nz2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_5Yv24v4EpUO9_ajmgjSijg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_SkTzv3hCxUmDhTZzadO0Pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_3l2pT_uLsEe6KfiO2ucLyg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_yo_aT89odUGvgS5r4beT1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mmsi:MilestonePaymentProbabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__v2v-UROZ0yrwpSXvqOD4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_WLKoC-9vCUuynE48y7ekMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member__0z7AfckH0-izPRxsHj-CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_ShfGhn6sDEqCKCrlJf3LYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_jvGr01_VCUqWKwQSHCGhuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_UyL0y39Dlki1ZpAdwy5TMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_FDcVr11fvEi_blj5LZlxhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_kDxdTejFnEar4hcZNMbfOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:RegulatoryApprovalMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_tITBjrk_HkGRwTnHLPq2Og">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_DL7l9lCsn0yCicMiO9Paag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_lmH4hrr3Yk2ZNTHoyQXrRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_mhPvROMdBUy9ISn8bUcQsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_kZ1T208TZkm_Zha3uivU5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:EndoscopySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_jPM7z4e9ckWasY0kB4A02w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_K77TjlnLw02weRu3pGVeuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Cw05VY0_I0-Am1JQU64fgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_iDtT3Y7T4ES-G4M9NJ5iwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Imq-yl3UN0SxC6ocv52NnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_IvGlF5Zb_0aI82EUdrzxpw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_ZZfj3R7V5Eaf4KlhxZX0NA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_MSYHJr3mNU2lIv5avLZ04Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Pn_ji6z-9EujtMdTc7Xe2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N0bSnffBZEK-_wgFvh8Ohg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Kq8CJRyvgEqTiCMrffL5Dg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_T7UpOFHUfUKuQYJJK2urrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_QL5MDDksJk6BV7x5RToVoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W2-lwaQajUmjU-r2zs34Yg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BOpfzPG26ECbr8ZPTKepRw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8PfvIfnmqUCeZXIMgXoYkQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62E2hM7g4EGHRbMuBjMCIA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_wNH7WZpHE0KRoLTZeAliog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N8U8BNsA1kKxcg9Cty-FoA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_z8YzjacK6k6Eh7TEMhdvDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_4h-sVt6F-068ZNWfSqnEFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_yy2rfbwVDkuhigmz2rclqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_NHhcrvVH_U2r85qDDyQQ3g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_oIKpm7mrOkCqi-F2r9hloA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-06</startDate>
            <endDate>2020-11-06</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_73syZyrdCEaiuRTfMsiD0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mmsi:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_qRyUmYl8O0y6oUbd1lTTIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_63ieaO-AO0SYaBWn-TK6JQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_2cbkT8Rpj0C4W9Vnfbtf7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_MZN3RxPRPkq5v4w2teFQGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_6xqiAKy5wky58rfPLPedWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_ps-20gTg802P7I1jBP-j0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_CR57zo9ehUqUx1y_296vpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_eA79SptKRUq01tLxfpAtTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Q9sli6HR8kmLtGS6z2LKLA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_w8-ho-GtDECtGQ1su5JiUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_HTBgdVUkNka5_SS_wCZMfA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_WBGzb7-2s0OMpcaC1kZThA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_TTFS404ILUWejinxzomjcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_OtYJx8DRZUWhCfnnj12CUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Xa71dYPKVEyT6sWRUfs7wg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_mVSC0isQAkKGdsXQLJIZuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mmsi:CashSettledPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2020_To_6_30_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_r8j-LAr880aFYWGRQw_EMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mmsi:CardiovascularSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_umbZmmf59kKHmVjonTjMXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mmsi:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">mmsi:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_YBlNOyPkLU23Z6ZjVlbEKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentTwoMember_ezEJWgK2Dki4vj-ItKKXBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:ContingentConsiderationPaymentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentOneMember_p32be_SWykGz2teKntXcOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:RestoreEndosystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mmsi:ContingentConsiderationPaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_HwhbRLWUDECOhM6E1bMPeg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mmsi:RevenueAndCostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_9jqh0ZIn_keRlp7QGXHQFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_Ra4A3LDTXUq1U3wrhOYTzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_-o3_7GcrH0SXneGGIP-6AA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_wkB4WLQ3Z0eP8rqn-djVrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-06</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mmsi:KaMedicalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-06</startDate>
            <endDate>2020-11-06</endDate>
        </period>
    </context>
    <context id="As_Of_10_4_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_nXJmF9kinUC64uCJFUF8Uw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-04</instant>
        </period>
    </context>
    <context id="As_Of_10_4_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_gvKcRF6bkEqNTgBLgoiS5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-04</instant>
        </period>
    </context>
    <context id="As_Of_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_-2X5MrVXTE-f1Bx7exs50Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mmsi:BiotraceMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-04</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2022_B0at-ZgNSUal6WBDs0yTtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="As_Of_2_22_2023_L_MER9-GsU2ij8SaU2daZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <instant>2023-02-22</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg">
        <measure>mmsi:item</measure>
    </unit>
    <unit id="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ">
        <measure>mmsi:DerivativeInstrument</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg">
        <measure>mmsi:segment</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      id="Hidden_jZK6Ff6E6E29e0MCB7PA_w"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      id="Hidden_Q5mMTZ3-9Ei4SLdnz3sSZA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_a6q6MSDqW02kPa4lJGG3MQ"
      id="Hidden_-F6JAansME-6ivQLmCJpgQ">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg"
      id="Hidden_ojRaZ6fkA069121R4Kpt7A">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_zeVN8Ij9d0uMa9UYvBsSEw_2_1">0000856982</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_dQfE1MA3vUmOHWgK1H53og_3_1">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_ftZzsjtvp0Sz2HdeH0pGEA_4_1">false</dei:AmendmentFlag>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ"
      id="Hidden_frXeFarGiUC9Xa6_8PBv_w">http://www.merit.com/20221231#BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      id="Hidden_RRFbuM6IW0WMiChfS3Tzdg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      id="Hidden_UWAof0yarU6NTEHaMNw7SA">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Hidden_pJvOPl2RREyfdTsXzdBBYg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Hidden_POn8fFDjMkenU0zOUvoI0g">MERIT MEDICAL SYSTEMS INC</dei:EntityRegistrantName>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Hidden_ExF1dirmUkOPTq79RIy2qw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56570000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Hidden_p8UrIZ0jDUysfw2uR9n5Qw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57306000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      id="Hidden_3TY6OSQeDUqQF8jraSti9w">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
      contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg"
      id="Hidden_wEJKBHaF4ku_LLZF6o-vSQ">http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList>
    <mmsi:ContingentConsiderationPaymentPeriod
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentOneMember_p32be_SWykGz2teKntXcOw"
      id="Hidden_omYxHiM9FUeLz86EaJiDGg">P2Y</mmsi:ContingentConsiderationPaymentPeriod>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_Yg3eGli2zEW7bA8OSCslYA"
      id="Hidden_C8dJmPtioUimQru8e7qEng">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw"
      id="Hidden_VqI937vS7Uyy85OFwQu_0A">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      id="Hidden_jrl_1y8mUE2lw5OKuH_56w">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_ccOqommAIUOJx6oYxeTW7g"
      id="Hidden_ys3ojRh7S0GRuIZh-sLDXg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_LauraneMedicalS.A.S.Member_1wpeXbI0cEecSrjzJb-LeQ"
      id="Hidden_gcPAqbzfw0OI2MXDaQHSdA">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_GZdF6FbMRk6IMRPpvp4agg"
      id="Hidden_H5Y08u8ZsUaN3kikLiRRBA">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_OtherIntangibleAssetsAcquiredMember_kqfrwoAXJEelfiTvRFAw3A"
      id="Hidden_Xf0THVuuXkWITmOMBoHiHQ">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_w_w-NqxInkmFUqMf_XcMMQ"
      id="Hidden_EbHCmjYljUGB_8dKno-fsQ">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_zAFzt7xtHEazGu7si-1YKg"
      id="Hidden_hlnL4vN8SUG8ae4Eqn09kg">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_iyd5XGEpw0C-bvBjxzoeAw"
      id="Hidden_xGgJ2uRJGkuzkcphmVUYXA">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember__4rStAvy_02iitxQUT2v7w"
      id="Hidden_z1_aUA5vikuLxGHYLl_gBQ">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_NDXPu66jak-ZMyYsakdLbQ"
      id="Hidden_d8w-m4ewDEurtEdt4iLbkQ">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cPPJwMeQPUeIYf6LbWUGag"
      id="Hidden_t8cBNSblNE-IWNGe1sg12Q">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw"
      decimals="-3"
      id="Hidden_eEnAFWZ5UEGI9LcVSBtx5g"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA"
      id="Hidden_TpnXjRgdGkC2N239gRk-Nw">http://www.merit.com/20221231#BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw"
      id="Hidden_PXZ4MOWrBUiFixPo1YrNdQ">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_CounterpartyNameAxis_mmsi_NinePointMedicalInc.Member_DqLbR1-f_USM3HqTH1_MPQ"
      id="Hidden_5ha5obNG7EukzOsmSgU-lg">http://fasb.org/us-gaap/2022#AssetImpairmentCharges</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dei:DocumentType
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_ltB52QqM1Um0ZvQBbrSy4Q">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_APBXb6jPxUKsp8pnl1DP4A">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_v2Ie5_ggEkCZ3Ai13vaT-Q">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_VSl2nKyTQkO71ZciqKAk-g">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_yMNiiz3-sEC5gsi90CUvww">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_h1ryGjXd4kKt2UUBOyFzSA">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_wfZxCj4cgUyAEJxS4vts3g">0-18592</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_y-yhUIgOR0KMOw6ylu9dIw_0_0">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_PRmJ0GyGYUO4cVa-3pHidA_0_2">87-0447695</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_whzlD0vO_kCi_trIqTDeEA">1600 West Merit Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_MPqdKQCQFUumJfvdcSw0Tw">South Jordan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_PcylK2Jgo0Go1bt7uVzyXw">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_s44rlI8ZckGRch7qQwS8Dg">84095</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_XY65n8I-2kW_IhYCwkpF5g">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_SGQsIA_-4kuzcmnyT8KUWQ">253-1600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_mbwhihsbzkmI8wMDxz-3eg_1_0">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_c_7vdpZam0eB9GBgoAgLUg_1_1">MMSI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_UIyCKukdzUaJT-5-HzLuVw">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_pPkalVO0TkWbK2x_23TjDw">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_YojeUEbHzEuKRcL3PzgXLg">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_Y5j8wTvvq0mXQabibwaw1Q">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_puJEPQ3Skke8_4eNymw0ng">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_M7HysM7ZlkGjhxwyA3keFw">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_7JhUistK1UyRx6wV5v7hDw">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_QQN1_g6geUySCzxa6WqJPg">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_eAShb5VNq0eVYpfuJqaSyQ">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_TkrDoxSoj0GStp4qlrWuPg">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="As_Of_6_30_2022_B0at-ZgNSUal6WBDs0yTtQ"
      decimals="-8"
      id="Narr_m9YeDKAblk-Na6s34MPXjg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3000000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_2_22_2023_L_MER9-GsU2ij8SaU2daZQ"
      decimals="INF"
      id="Narr_vrPCJwp2WEGEDIsleXMufA"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57318032</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_DKPpif7EFka5LylY4MJIBw">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_cgTBfJhI2EK7vq7g47asng_2_0">Salt Lake City, Utah</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_jTT5Wo9mu0aokoJ02YtCfQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">58408000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_YbyaXmc1E0CWqxt3aRsySA_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">67750000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Narr_KG5IWsyp00KbioJQxOEZvQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8423000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Narr_bL7N3gNy_EWN5427qWCgfg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6767000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_UM6FsSiR9E677f2WEZ0FqQ_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">164677000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_JZyVs8kkl02_3O0T-9fz1w_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">152301000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_v2wGX7WBUUqi5phloyBAnA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12992000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_NMx31AOrf0mL0ktr4KSyuA_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">17763000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_JGYjCTfIFkuHU0l7JjRglA_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">265991000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_4gGTmtqSb0Ky8GSopWxewA_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">221922000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_3s0X5Zse8kmrzge3zBYckw_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">22324000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_mPYnwoQrw0aVnnhQvQ8Xtw_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16149000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_nTfaDENs20y63VvEQQtl8A_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3913000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_HEaJoEjr80aC1T58rdlv7g_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3550000</us-gaap:PrepaidTaxes>
    <us-gaap:IncomeTaxesReceivable
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_gm5iDZlan0CoLK58Kg7ykQ_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">779000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc__v9YVVEgg0KrHw0VKAdyDQ_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2777000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_kGfYQ7mwRkGtZXIeRdjERg_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">529084000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_w1BPDjuaC0WZQmQns43oMg_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">482212000</us-gaap:AssetsCurrent>
    <us-gaap:Land
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_kge-qe-BCkK6GOe3NqCwRA_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">25940000</us-gaap:Land>
    <us-gaap:Land
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_ulTNQcleW0aySj9s95mTCQ_15_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">25287000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_tJCK1a4do0W8uhJpoSZHgw_16_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">189148000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_8KxzU7DHCUG8h5BTBStCwg_16_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">190044000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_HDQDuejSZ0qAIq81UOLKnw_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">299089000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_nUCp8JQJV06k62qi7qmWmA_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">277976000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_VxIbM2iRFkeaOZ1IsVyAlQ_18_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">61128000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_Klxz_rlpJUKOEZAT1cbZoA_18_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">61446000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_dZuQoSmIb0-3oXYAld1ekw_19_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">49673000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_ekCjluBXnkGz1Twc8AMG0w_19_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">46341000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_tE_HZZUPw02qqLS5Hk_FQQ_20_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">61269000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_FrFgBcp5EUK1PknAKiLFNw_20_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">51182000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_RvBbZesXu0WKPI94FdmrLA_21_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">686247000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_fZ59AiMFtEqAYFaqBZbl1g_21_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">652276000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_2heARNmNmUumAi06blY0tg_22_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">303271000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_pSqyXcLo9UOX6tSXurfiow_22_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">280618000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_KyviPuWB2EqQAp4X9LyjMg_23_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">382976000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_webbUFgKL0-cVct9HT-gzg_23_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">371658000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_M_cqHBv4VEmQzw8E4TMvlQ"
      decimals="-3"
      id="Narr_jAgH3HdXNUigqf4IHpcMqQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">274570000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_ivrHt2y9VEu_1nKzuAKxTw"
      decimals="-3"
      id="Narr_lANE1gCUV0CuTFyk7O0cNA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">234016000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_M_cqHBv4VEmQzw8E4TMvlQ"
      decimals="-3"
      id="Tc_OdedzssmGE2RbavUtQAFDw_27_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">237522000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_ivrHt2y9VEu_1nKzuAKxTw"
      decimals="-3"
      id="Tc_BAGDlYsnSki_QVpgpHzCQw_27_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">276833000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA"
      decimals="-3"
      id="Narr__eXyE55LIUSmuYicenWVyA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">69780000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg"
      decimals="-3"
      id="Narr_keCaFPMGT0a-riOJH9ycgw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65053000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA"
      decimals="-3"
      id="Tc_suzSzTmJ1kGoLZxS5LpFgw_28_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">38350000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg"
      decimals="-3"
      id="Tc_RyV65ond606xOHCFc6SrEw_28_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">42436000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_iTmr11orCEWn3ZlqSlMZbg_29_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">359821000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_5QKfiTl-rkGIIZ9qs50UDA_29_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">361741000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_CqPAhu8u7U6_mvPfqpEKMg_30_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6599000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_CsRBTChXdkOcf6wONo2Vsw_30_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6080000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_Xbvsozxoz0qeBtmGllr4aQ_31_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65262000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_R019c1kwNkmXskxIwCWEaQ_31_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65913000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_vKXwrYPEkUa1AGtrey53uA_32_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">44352000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_ug_fDNOUCEGM5iFLoC8dyQ_32_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">41421000</us-gaap:OtherAssetsNoncurrent>
    <mmsi:IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_NqZp56Ef5ke4Og2W0BdyDQ_33_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">751906000</mmsi:IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent>
    <mmsi:IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_05CTI6DHP0mYyroj4IcuAA_33_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">794424000</mmsi:IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_d_Yn6WIW1UabnkApbX2qSQ_35_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1663966000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_NjhFn_vhl0-LRDTKnpTDAg_35_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1648294000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_eI6Yt6YXokeJ0dlnQZwCCA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">68504000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_1Mq61tDkdEqShJUv2i47mA_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">55624000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_1-J51LmCHkmD38bVTey7_w_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">123189000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc__-NM-Wd17E63othx4V8FXA_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">159014000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_m6xqvbN9RkywqoPrp5OrMw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11250000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_aH-b0E6Puky5T407gWYQjQ_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8438000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_hog9UqcNqU2K90SP5WnbFA_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11005000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_hESGnyOvmkyJ-BvBSoru-w_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10668000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_NWfjdeF9akW-bASw7dO5Sg_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6697000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_9qEijmhshUmIwF-_0qvVTw_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2536000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_MVVMmlDkLke1tqkqzrXECA_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">220645000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_Bg242Cx4HE6oNuAwCmld_g_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">236280000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_JnYtgVyde0Sfd_yeZdbjwA_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">186759000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_9cpfV9_XaE6WbIiQYiwOkw_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">234397000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_ebkuE2AIDE2roPCr53h4ww_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18462000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_wmOq53S-UkiZe0z9CR7HKA_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31503000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_JXSVMMG9VUee-1jabecWcQ_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">347000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_QwXZ4siIE0uvyhl_dZ639Q_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">347000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_ZWB_z76U3Eq9LadKGvHxqg_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1912000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_mgOF5PHVH0KilT-nKxYS9g_15_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">932000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_8FpXxiK4J0KXOPgaUgqvcw_16_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15264000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_fFG7KzSUmkSHYH1hgrL9jQ_16_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18111000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_vu5t3MGQ-EGqMFiP25A4uA_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1708000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_uucDyVjSak2ekRJnmaJdzQ_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1815000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_oH8kLyr48kagBklGEigsdQ_18_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">59736000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_UvczEFWNDEmJg0-BiKhAZQ_18_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">61526000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_jrpqAzaY2kq_lVRtGBuG_A_19_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14736000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_jli6Q8ma0Ey2QcPWzEo5-w_19_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">23584000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_I_IbDjQk8U2zJ6AjXOZm5Q_20_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">519569000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_RDae6OG4O0aAe2Esp8TTaQ_20_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">608495000</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Narr_uufwkqpvhUWkqyxDTtC-oQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Narr_cSLD-tvE0Uuqidu8pODwLw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Narr_xDd-e30PEk2gC6J2QQkhDg"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Narr_TpHUzaExNUKCwB6BLNlYvg"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_vIWXQSe4qE-cxZwoGWqpNw_25_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_z4HsySwZAUSXxlRwAuHOyA_25_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="INF"
      id="Narr_5kjQc0J-c0uGuosYIIWjLA"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="INF"
      id="Narr_untn8JEAT0a5NUAbxYVj0Q"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Narr_uc4X4npzz0enk6jNMplG8g"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Narr_JUbAw3p9QkO68q1mvojuDQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Narr_IMXwK_gU0U6sCDKOBZtYbQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57306000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Narr_Qqsbt7KnWUGPKPlZeKoeiw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56570000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_C_WyWwLLRUWhocjYes7TuQ_26_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">675174000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_IRIXaAwlmUmu3fwiWm3Vjw_26_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">641533000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_wXUmioLw_U6Zmh6R3Rt7yQ_27_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">480773000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_ObpgLA97BU2v-fdpsRQuQw_27_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">406257000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_5SfvPjY3qkK6YKDy4gP1Bw_28_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11550000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_HPBGGGzjFkG-X7CRtZwxTg_28_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7991000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_khLkvvaiTUSLSW6vI6bbVg_29_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1144397000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc__3JKjofwtUaBq7oPIU00iA_29_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1039799000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_I_k5GMzoBESzkLvW5GplVQ_31_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1663966000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_w3EP7tveX0iFC3z8Boe4zA_31_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1648294000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_FZvdbXZHuUqP6l0kb9ePog_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1150981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_M2Rh_HN56kWC3s8AIOj0AQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1074751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_2jJQ3dZHfEi766GFxeu_4w_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">963875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_BiahxntyeUCvk54r_NJyHg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">631882000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_xm1B1UKPbUOUT7FdPgJpEw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">589418000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_Scp1YrrfOUyrCneU1edkbw_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">562698000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_HTzKuuPPAEWR_9i_lmbCTw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">519099000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_JnXD3krIg06si-InpwJJQw_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">485333000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_CnnakW_k8kibQ4hJrj_DjA_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">401177000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_TQDbJlmO30GA3KOHowRDNQ_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">342525000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_MoU9ciSpJ0m8vvRz6WXNJw_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">335690000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_tZnW6Y5Dp0GWsWHtOyrrSQ_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">297724000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_I3gbnmcrvUSaqGub3OXw7Q_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">75510000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_fEE9YOxuy0mK4wVl0UVP4g_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">71247000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_3QQRaPYsH06ddTC9fWxxjg_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">57537000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:LitigationSettlementExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_yCaczoWaMk-CmZD87ISUiw_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10036000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_rqxwEn7Fy0CkLtF2HkF6dQ_11_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18684000</us-gaap:LitigationSettlementExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_83sB3DBV40uwaXk4KayNIg_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2219000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Sz3W0dAByECwonK1Ksfu_g_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4283000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_3WmaHzuBFk2BgWfKJ9WCHQ_12_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">36504000</us-gaap:AssetImpairmentCharges>
    <mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_G8r5ZocvmU2tYfywJad8LQ_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4611000</mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit>
    <mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_N99DBDH-JkedPtxyp9CMLg_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3161000</mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit>
    <mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_5klC-jvg9kaNcfeaiqnEUA_13_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7960000</mmsi:BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_UUxI1k1DIUGEBALZQUdLtA_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6671000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_mEru_xsTwkqMhIZvh6md-g_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">250000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_D3bQ0mdAF0qRjQIxo2ZZlg_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">431536000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_TkRezI-xrESXorXFC-Ummg_15_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">424417000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_DSvN8EZIu0Kt-L2v7BshSg_15_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">402739000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc__XXHLZMwWUeIdmKz2xWpKQ_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">87563000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_-vghc-0dX0S7bTI1ukhT_A_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">60916000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_3xj2SnfrzUyUnFqZHpx8eQ_17_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1562000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_K-Ojl_Jo50KtkKI1gtQHaQ_20_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">439000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_RJUswgAn7EOf88Eb3p5CDg_20_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">769000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_aaWFmWlmxEO_b7T1bkkvPg_20_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">604000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_72RTZhaGT02p3bSkAk70fg_21_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6339000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_CTJLuhTD4UGHBIeH7U6qHQ_21_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5261000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_8vu63HS7OkCKECvswwPKSQ_21_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9994000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_39_YmBycv0qkDC84wVRRLw_22_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">966000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_miFyDMwjUkaNdzvPymBUOw_22_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2507000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_S6wyhpxz8UeTSnQcYUWyUA_22_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2279000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_ZFCBK3WPLE-Uav-DsPKlIQ_23_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4934000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_NjCfz1tgg0mIS8I5qUbN5g_23_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-6999000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_blaPruGRtE2JypZEoh1c3A_23_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11669000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_4qPR4H2fL0Kgl9EMThJkzg_25_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">82629000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_CzYwS70h2E6p1f53gNz1jw_25_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">53917000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_BdN-B5dxMEmQXS0hIBje_Q_25_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-13231000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_frnWLcnMEkmZkYPktwFv3Q_27_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8113000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_mLGehLkCCUmG0RKq071xlQ_27_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5463000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_dBQOsD9r50SYzLmzB0unCQ_27_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3388000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Wpkx9GxQmk2NEos4ObeINg_29_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_6UP8pTWYb06mFxu_FVFCFg_29_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_IJlVJlDklUuzg0B1LV04ng_29_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_WSrC1q883Euw9EyuPhbX_Q_32_3"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">1.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="2"
      id="Tc_NVcx_AeNUUyZT3Jv4jCy4w_32_6"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="2"
      id="Tc_SqUDLopadkqRgei1V4n7nw_32_9"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_U0Pe8C5Z5kGH6vqd9mpQ8A_33_3"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="2"
      id="Tc_MG7CQ_3rMUWn1PGvlsS1XQ_33_6"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="2"
      id="Tc_YiDqHLRJoUCYLa5Mv0fxvQ_33_9"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_A60ulvhEnkKbFPqJXIEkAg_36_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56806000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_8F_Gzy2XhE65UOqUiODjDg_36_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56145000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_nEd9kvwjG0W1ipELQWr3Zw_36_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55434000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_WWOISGrY50Sb06_vjT9Hcw_37_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57671000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ViH2rahetk2P5TiARqzoGw_37_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57359000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_K-jLFtPiBE-aL3DJIw54jw_37_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55434000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_N1Pb9CGzEEGeGL_XFdQ3hQ_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_6Lp2-t8O4kea7zR2_B6L2w_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ixXqY3RBPUGXVmviRi_IXg_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Jb-aiDoAgk6tole7yaa2dw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9007000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_-cehm6SfdkKIWOwDtOZ2OQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5965000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_m_y3NCzeukKZeOlqDr9PMQ_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9523000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_hCx0B304PkSp2xmtqWkEFQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2177000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Z7uwmI_vgkmiO_1jsNvCvg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1489000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_qsEmkQRQAEmkf97TUVCHdw_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2365000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_b9UUnGXrC0qqMF6njQtIQQ_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10491000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_94Ug_59-bkOa-JB_FkoPHg_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7704000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_BU_u2PwDyke5OhtpSFvxDg_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7786000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_urKWVbKXikyGEZ6CzY76Xg_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-102000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ia3FMMzwOE2zG73ED4LwOw_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-689000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_pZIh0oQ7mkyiVICWSFaHVA_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">786000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_f_Oxv1lNwkSo_8q9gWDMDA_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3559000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_gpK3esns3UW9jncAIspYIg_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2539000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_CpGuuWtAXEW_EvLDJeA_fw_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-158000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_9EaOgnLdYk-kkQnlr2FIqQ_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">70957000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_v-KEwO6_OE25-HzDgu3XWg_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">45915000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_MPWuElGl2kCvYRxR3KSGZQ_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10001000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e03sqdjmAUSi1TluISkF4w"
      decimals="-3"
      id="Tc_vNHkK7HwW061U8a4LV7M0Q_3_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55213000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e03sqdjmAUSi1TluISkF4w"
      decimals="-3"
      id="Tc_pFPKv3BoOky_VdOto2cP2Q_3_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">587017000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_G-kv3r9YKUyaVq6iMWD8VQ"
      decimals="-3"
      id="Tc_D-D6UNWs_Uup7ZCB2iTO6g_3_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">368221000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_N2nptxswq06E37WY0fAdLQ"
      decimals="-3"
      id="Tc_fy-n7ciTlEOlqTfPW4VntA_3_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5294000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ"
      decimals="-3"
      id="Tc_UylojrW3ZkerU7tjWM92pA_3_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">949944000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_QnNOgXob5EeqCbUSSdW6NQ"
      decimals="-3"
      id="Tc_qyzDAsLN6EiWvhRBNYumDA_4_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_dkYlehu9dkO_8RSzREqUqw_4_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gK8hNbA-mU2xGdCtF3REPw"
      decimals="-3"
      id="Tc_vj9wX0DDtkugfT492Qy7WA_5_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-575000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_0Wxh9uRER0u6z2OziPvL-g"
      decimals="-3"
      id="Tc_qisdpHKvEkCl1024OXBI8g_5_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-575000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg"
      decimals="-3"
      id="Tc_iuS578-mekKkip4_rtcKYA_6_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-158000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_8dAhohrgJ0uxJR9z5eOYIQ_6_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-158000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_zSX_yid3u0SsiB6aSV5mpw_7_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13433000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_IMUPRlFLmkmpzKU6pRJwcA_7_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13433000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_hMwA5pGVDkSozuo2KaXLPg_8_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">442000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_rnl7enQ4fU6Fg1BH3FQt5Q_8_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6948000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_udQsimzY7k-s52CrE0cKRA_8_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6948000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_AgAMnAyQz0uiq8_OXlAZfQ_9_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">30000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_hqUQGc_acUy4OQon0Qooog_9_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1159000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_7LrvZYn1dkmvDSDyaKNxVA_9_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1159000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_A_qnxQTGq0yc3mE24SqK3A_10_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">23000</mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_MWkUA_CAMk-AquJADLrY2A_10_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">866000</mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ZlnlgphBIUaWunO5gi4ZDg_10_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">866000</mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_jEqJu0FpD0CF_yHJD7VTQg_11_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">39000</mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_H98-5a1ThUmmxVo_m_FMHg"
      decimals="-3"
      id="Tc_XVpP3jzJ20agklcTV2zFww_11_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1467000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_7fy6PIJcZUabB-vXIi5MNQ_11_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1467000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_iWQuWEDGp0W1mLQsaz5M_g"
      decimals="-3"
      id="Tc_0-FmeCeI20C-fcOTrv9ZHg_12_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55623000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_iWQuWEDGp0W1mLQsaz5M_g"
      decimals="-3"
      id="Tc_lnkQy3KOd028RA1SOcJdgA_12_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">606224000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_tGIvY-Wghke_ETbCqrVrlA"
      decimals="-3"
      id="Tc_PaUCMl54TEqydN4pzfaTgA_12_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">357803000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3aRiaMEyxkWBqtSJEkrr9g"
      decimals="-3"
      id="Tc_dbRlCMtkpEet8ZChqyM6Vg_12_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5452000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_c9gulu64a0azS_GANUwenw_12_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">958575000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_e0_SslW0xEmjVG9Y4QH58Q"
      decimals="-3"
      id="Tc_Yrgd5jkbNEqtkyvDHbcgeg_13_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_2nnboQ9xM0KaPdu-ST-X4w_13_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A"
      decimals="-3"
      id="Tc_2XAOzBu4eEmmTUaRgA-j8w_14_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2539000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_OcyMMjSAuk-366kCeOLsug_14_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2539000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_2sUwdqjaQUa7U3k1cQ1RxQ_15_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14579000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_uPqBAzxOnkK6a5jwb0h7wA_15_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14579000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_2jBsS5verUmwBat9Vbmszw_16_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">883000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_X7BXxb7pbECfsxfRfFQeqw_16_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20374000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Ful7iBJhD0O56PNFaItdhQ_16_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20374000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_c3sObtSguEmWNIQxPrWeAA_17_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">18000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_RH8h0F5BLUiXhgFPqEepLg_17_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1112000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_6TwjWi1CbECEoyCrVNgbcw_17_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1112000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_Zyfp7YSCuECBzZVrZ--smQ_18_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">59000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_qEdkJ8qYTEWjFWnNb4uaWw_19_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">10000</mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_Op6Ikt6y0EaxXlIHVN67NA_19_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">576000</mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_xWoJO-Glb0W4awsK3izDrg_19_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">576000</mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_npa0lIkFqUiVpAor6dFm-A_20_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">3000</mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HnHkjX7b8EyX7sugkLo9wg"
      decimals="-3"
      id="Tc_h4Many8CIUmhpkPwtTKdEQ_20_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">180000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_V-W8_1bXqEmJ_7_yvYo2eA_20_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">180000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e1glezOlAEmHZyfzYLhmhA"
      decimals="-3"
      id="Tc_WJh-91popE2rwVeEteyftw_21_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56570000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_e1glezOlAEmHZyfzYLhmhA"
      decimals="-3"
      id="Tc_OlEIwlmhskWEsHLYcZnarQ_21_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">641533000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_4hpPQW9-gkirQ7OHsm1waA"
      decimals="-3"
      id="Tc_wEh_7OyUe0WwbkMY6OI0sA_21_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">406257000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_aN4IaMh0wkmaWTjP49uYEQ"
      decimals="-3"
      id="Tc_gsHQ5QbO7EqEzln2P_9WVw_21_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7991000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_Sf5u0Gai8EaplEIUqPFEeQ_21_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1039799000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_smMsnEfusEi6-EuzPWs_CQ"
      decimals="-3"
      id="Tc_PW1RXP6UFUmKm5Wy0TuznQ_22_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_kHTodCTbQkuVsk-GNuMmyQ_22_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ"
      decimals="-3"
      id="Tc_dJu5OjPbw0OyCJMVQo9WWA_23_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3559000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_pfne92Rsz0-iGsXs72wXVQ_23_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3559000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_7Tb0kF4BwEiEaIWZ3aQeSw_24_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16045000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc___CMTeUPJ0e9ZgYC3swC7A_24_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16045000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_9w3-TU5G0U2Lki3paV_LMg_25_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">703000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_aHf05jGdt0eKv9H0vQ228A_25_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20092000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Xb4SptV-C06tiuy85ZC1ig_25_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20092000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_4OMvYcd1SUuTwCs3BPF2lQ_26_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">19000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_8zlEpp5F2EG8SUi61_Ojkw_26_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1118000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_4qIVzhxPn0uV3MvXcuXKYQ_26_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1118000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_rAJi-dgeEUW69k0tEB3Wwg_27_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">70000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_cnS4WmNln06UnpH7aomhug_28_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">38000</mmsi:StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_lZvyh3W8tEqCdbJTiigu8A_28_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2474000</mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Qd9JGaaVWUOr5e3uuNyxwg_28_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2474000</mmsi:StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_7-ZIlLUP10m61k6TXefrsQ_29_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">18000</mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bzmojhmp6UG8MNBp98sRMA"
      decimals="-3"
      id="Tc_0hD8Dk1hIk6KF9aMmHk6Fw_29_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1140000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_tN2mee0kyUuWnk_csHHNuQ_29_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1140000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_jemfLXarqUS_VyGv8WDThA"
      decimals="-3"
      id="Tc_axei0-OOnEWwFtgdH2_RBQ_30_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57306000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_jemfLXarqUS_VyGv8WDThA"
      decimals="-3"
      id="Tc_lIE5HWFxaUitFYqkE2N1Yg_30_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">675174000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gSVl3EPpKEKYTN8MPw6Tkg"
      decimals="-3"
      id="Tc_GdUy2ykPcUqrZtN2rAvBPw_30_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">480773000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_KA5J2PovC0-VQ20gGn884Q"
      decimals="-3"
      id="Tc_aeeVWlDNUkK51UDVcPCc7g_30_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11550000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_GutcmxRru0uQu2B1YJM5Yw_30_14"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1144397000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_R4UHMkl5PUOOrxMLfbkvxg_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_RGg3WRVOiU-dpFZ0KKIXmQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_5J13lb5pykK1600nEHXYtg_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_JLT0ZipBHUKEF70f6oNC8A_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">81804000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ejjoHShP0Umz5vg7412SVA_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">84066000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_6JNyMNxOP02o_IRS6MBTXA_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">94070000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_wVv-095c_0e0piUrkjRkqA_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1417000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_pVA7W69WBUGBnnwuqNuvGQ_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">517000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_g3BhD185gUSvpBgKZTSiJA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-380000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_wS17lgwgskmLtdnms13ttw_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1303000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_JTwjw11i-0u2LwfHim_VnA_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2159000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_urlGgg5QkkiZC1vqGrLFCg_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2281000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_sa3fpkox5k6DeMhNkDotqg_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4412000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_xShyTKL_DkW7hWNiX05h9A_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">36609000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_mdZQK5Z7k0aR_dy9TsgivQ_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6671000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_n7rv4l1atk2GB-kdU_146Q_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">250000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_4opHVMn5xkOFga0uS5gvcg_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10394000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Q5CQ9hAaZ0e_Cu7aL4HM1Q_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11718000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_r00kNT5Cv0COPSoIFx0wmw_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12746000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_lyD7-6p7vE2Ga78vCtGXAA_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4611000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_FeTJ4PwLuEaji4kSAIS4hQ_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3161000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_02Q_TI04RUaueYgyK5TJ9w_11_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7960000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_ni0Ub9JMTEm5ILXZ49nw0A_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">107000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_BM3a_RvNWki39OSdMoUpuA_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">108000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_cfqAsE7jR06JQOYaruralA_12_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">130000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_jMnXKqEZ60uU7s1g0zMcPQ_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">604000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_l0-cDawcQ02XSL1s_ovrZg_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">604000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_SahanZ8ya0yirQZM3eknBg_13_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">604000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_9qAaT9ZAy0KEFZqgweBtGA_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-14924000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_M0ejBN6d9UCt91JkgIfaqw_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4631000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_95PuESD3N0OmQoeofrE7fg_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11295000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_4fCpY5n4QUCUz4_qpRPIFA_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18042000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_fNeLlTDqCE6lsILlTc3ziA_15_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16090000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_RzZvWotfkEiPRBUNhzxjuA_15_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14339000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_z0_SZ_W_1Um1ER5wVMF8OA_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15116000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ukJpH-ToqEiG4FjUwpQHsg_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8618000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_PJ5ddURe00u8SInigDD8Mg_17_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10425000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_rfFbLBjgtECAoVnLNATDsg_18_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4154000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_6X52VFvAXUyptLwV8zskRw_18_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10418000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_qaZbW7wBFUmQlaswlAgrig_18_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1668000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_o78Ca6SLeUWNk-Jv4qFHWg_19_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">47929000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_nqou5RJv-EmoNZdWLlf9yA_19_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">25183000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_vARBtHbpGEiq_jOR_xM--g_19_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-29429000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_hwT5u2zloUiT0nmEp9tAZQ_20_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1798000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_lo9kVrcb10SXPglqrWDOMQ_20_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3555000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_TYyjIb-ID02Yl0UDy-l9EA_20_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">446000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_fKGLqFTiDUyZEyxgSyKYlQ_21_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">379000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_UO9330NbV0G7PhnnXpFrRQ_21_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-125000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_Rb1prcRaiEK-imQZCiFq8A_21_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">162000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_9-de5bbwKUWmxyvyZlmvwg_22_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1952000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_M4aLAoT7eUy6EJAYQdiesA_22_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-739000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_tzeOwVgKV0edmTiw8Dtb6Q_22_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">339000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Wwi0Shg8V0KFanCjlP6lng_23_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-657000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_bQ201Ac91kSmIj28NFdA1w_23_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1670000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_Fg_8pHQOeEWp2tuoffSHVw_23_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3511000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_21asuyRuUUqu4_QuTAcgvw_24_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12661000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_wTLy9qYom0KSdVrzpvFCDw_24_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6050000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_duKnBcX1JU2CqN1HBQHSTg_24_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">333000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_ws6_jEej5E6F86ucFFpG5g_25_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-16379000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_I7xqhlZs8UKCUyTbdLYTmw_25_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">36462000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_S9kv6joIpUuPs2HOAsWB3w_25_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4603000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_lSHQgUiOLkGSvm95eSxoVA_26_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4521000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc__fiVGpqWr0mcxLuGG4ih-A_26_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-119000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ROr-yZtoRkuzpIt6Kvi5eg_26_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-86000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_86_z-kvvLUuWy8ka7d8dcw_27_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-45000</mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions>
    <mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ZvxP5qK77k6kGWW-VFF7wA_27_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">314000</mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions>
    <mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_kpWFXo8gJECmiJTfqvJjDw_27_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-576000</mmsi:IncreaseDecreaseLiabilityForUncertainTaxPositions>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_LYBJFL4QBUCq6w-eLaZ9KA_28_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2848000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_B7RQw1XLsEyuKqkapAoNkA_28_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1303000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_W0H0gznkUkWA9M2RaFDyvg_28_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1953000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_8BrCRkB7y0S7Dqqm9uEP0Q_29_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11127000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_6l-3sJGXmk6sWyyf1kmIyA_29_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-12410000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_AUkGJDl1g0C8mBs0x-4MBg_29_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-12659000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_MYWezI7tw0K-4GdHb-CWgA_30_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">278000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_KA9ysdU8HEuY34MHLqjq6Q_30_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-858000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_kU_OtQe0iU2mGy60PIAJCw_30_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3606000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_ROPXztxEBkOb7tYNuSaBtQ_31_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">39775000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_o6oIuw8S_U6cWY78eihU3Q_31_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">98777000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_L45MZ4QeTUORjzYeS5EE6w_31_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">175113000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_X593VyLeG0CuG6JNu0jbQA_32_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">114291000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Qhlk5yzaKUem9ydWsztzrw_32_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">147231000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_N6l71Az7PE6_6QXmjq0ViA_32_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">165270000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Slmpfet0-0CI8Zr0Ce9t1Q_36_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">45029000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ZbknVG-iLUykRmrr8Ron-A_36_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">27939000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_gXUaAXiGUU2XftSd3boDaQ_36_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">45988000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_5DyAc3Eae0alF6ujywF6KQ_37_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3175000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_YLOMVYQzyU-FgzLQfmQJJg_37_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2834000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_1UMfBkPHAE67I_645rqsLg_37_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3288000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Hs0ZBisuQE-Y2LSw-q3vUA_38_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_dnTzEzjGJkij1xD8OkgmNw_38_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1037000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_nQlwK12hNUi8lzfIiEvrRA_38_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">42000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Up3blAHGM0-yH6WHmlNf_w_39_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-971000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_sSQ0gv5PSkCDBFX7v49vIA_39_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1285000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_R5WGSSG3bkSYon_Kfp3HvQ_40_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_DtuIOrr2DUCPTivUMk74zw_40_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">250000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_JZ6AsWs3g06CPNFndkKdcg_41_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2254000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_CkF5y5hHDEOEKNSQnxk7Gw_42_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8287000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_WCipkP_1xkyOOISHg_VxMw_42_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7171000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_qgJZ02J8CU6EnVbt4oEJGQ_42_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10953000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_jdTjx5H3TESltphzYh14CA_43_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-57397000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_WVht8mi_A0qCYrEpD07ENg_43_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-37161000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_qIOxqu1Fa0CXjs2upJce9w_43_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-58652000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_r2ZUgstTA0-nqB-WejPZMw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20070000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_ASL6oRD-qUWzId8toHGOtg_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">21306000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ZFHE06Z8t0ujEs9zAJwbrg_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6635000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_nWU1gjS1LEOD_ypsWSnw2w_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">215205000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_wp9iNuNoVU2Ury0_7pTAEQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">98421000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_aRRYCF9mmUWe7zr4HSlZDw_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">68625000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_tb9Vrddi50W4NGFIDJ3e8g_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">260143000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_yVg__szaikicmyLGG5RL8Q_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">206921000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_pqexBZzq8k2A4zausm_r2Q_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">157000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Nf1Oh3AY902H39VgG8Ockw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">32918000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_mra1HgpE806mNZxJOZnV4A_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10665000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_xkJnFegcDEOmIdMkH9KZPA_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13100000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_iiR2XepMxEWchq1Xpws84Q_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2474000</mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock>
    <mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_0pbnSfffvkyPCvq32jabeA_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">576000</mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock>
    <mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_zHFH1mjoAkm8vj8k7IfCvw_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">866000</mmsi:PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_v6Q-Ye_u6USSaIotPs4X6A_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-60260000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_XHK018TmPkedsCxTMjQuqQ_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-98435000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_x1HyO4f8s0uPUPCH-DfY7g_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-95706000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_gfHmPypWC0aiM2i85im5Vw_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3826000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_DGhknU4y_ESXbx0DzfvkyQ_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-801000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_yzhlLgflsEuR4CQETiiU9A_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1684000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_ZCvKzHuuFEaz0sOVdLb5Jg_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7192000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_miCwUS8VDU2agIRsgZb5UQ_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_TeK7ds3pjk2cnVmtuJhuxg_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12596000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc__hjPQLZZ20aknkarpOTtRA_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">67750000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_xaw3k8CJI06nRXslEiEwVg_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">56916000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ"
      decimals="-3"
      id="Tc_V5PGPfXQoUuYg-GRdimjCw_13_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">44320000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_XYKXKw1S_0mwsBXnrGGNFg_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">60558000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_kgB5SZizCE28vOWncFLkWQ_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">67750000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_ADeQ-_AysUmlUo184-gb0w_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">56916000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_gfoyJbQ0L0iTpqoQ9t-uSA_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">58408000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_JhyHDOi45EyAcHFlMn2SIg_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">67750000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_jfkoBvHbbUebvP8iGJjw_g_17_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">56916000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_koGD3Lbc5EC5BG9UeVnadg_18_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2150000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_M-ZZNkQdkE6h6SXL-pQeAQ_19_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">60558000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_CaRBYbsGQ0O9Pv5cyQ2aIQ_19_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">67750000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_ci-vVgYxe0aVfHVL53zEqA_19_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">56916000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidCapitalized
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Narr_DwTKzUHbv0S1J1WV7GQnMg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">858000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Narr_1ZCOig7Jl06Q22LwDM81YA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">480000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Narr_PAOA8biz4k-na4WI82GORw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">813000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Yv5htOC8wUSdLexCVTDXDg_23_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6258000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_j45EZyj4xUuS2hx87gyH2g_23_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5261000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_mQizF46hdkGueLfz6cvkyQ_23_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10077000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_VQSkqlZ0pEG9NTTgZlK7Lw_24_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">17092000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_4afZ5ZFYTUKqvawPPqgkww_24_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8828000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_qU_Qzb0nYE6q9NRpMK-mng_24_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8918000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_oBrr6FMhL0-sgxFSKWw2og_27_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3702000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_951R3gne0k20YhxlR1MYPg_27_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2558000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_BTxPTRzwBkqb94BqW9qFLA_27_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2180000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <mmsi:FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_qna9rdHm_0aXUHMW5GMWcw_28_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">899000</mmsi:FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_NtcBVLhFzk6MmncXQHIAfw_29_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">321000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_TGhgb1b_JU2aamOq7XkrQQ_30_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3526000</mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses>
    <mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_V7voei2QX0aTbArIlzxoJQ_30_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4358000</mmsi:AcquisitionOfDevelopedTechnologyInAccruedExpenses>
    <mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Narr_5r5rzM5_fE-0W3NUZoKWTw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">18000</mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Narr_iPUwh6U3GkqBOrIdhcuc-w"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">3000</mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Narr_tqepRbi6_ke4Iex_b33LKg"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">39000</mmsi:StockSurrenderedDuringPeriodSharesStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_HLsV_svZd0--bfBC-Yhm4w_31_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1140000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_9YfK2FBZCEuCIyamsI83lw_31_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">180000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_P75CLuLvZUutbooAIJVV8g_31_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1467000</mmsi:StockSurrenderedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_IkNL9pzCqUuPcgOBmoVLrg_32_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11130000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_h95XqXocoEm2LJjk9YhZVw_32_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1524000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_w8BNJBFzTUuTgd1P-z2FWA_32_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10938000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_5jD4bbOy-UiONCdRKNNt3Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"&gt;MERIT MEDICAL SYSTEMS,&#160;INC. AND SUBSIDIARIES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;1.&lt;/b&gt;&lt;/span&gt;ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Organization&lt;/b&gt;.&#160;Merit Medical Systems,&#160;Inc. (&#x201c;Merit,&#x201d; &#x201c;we,&#x201d; or &#x201c;us&#x201d;) designs, develops, manufactures and markets single-use medical products for interventional and diagnostic procedures.&#160;For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology medical device products which assist in diagnosing and treating coronary artery disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within those two operating segments, we offer products focused in five product categories: &lt;span style="color:#212529;background:#ffffff;"&gt;peripheral intervention, cardiac intervention, custom procedural solutions,&lt;/span&gt; original equipment manufacturer (&#x201c;&lt;span style="color:#212529;background:#ffffff;"&gt;OEM&#x201d;)&lt;/span&gt; and endoscopy. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We manufacture our products in plants located in the U.S., Mexico, The Netherlands,&#160;Ireland, France, Brazil and Singapore. We export sales to dealers and have direct or modified direct sales forces in the U.S., Canada, Western Europe, Australia, Brazil, Japan, China, Malaysia, South Korea, UAE, India, New Zealand and South Africa (see Note&#160;13).&#160;Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.&#160;The following is a summary of the more significant of such policies.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Use of Estimates in Preparing Financial Statements&lt;/b&gt;.&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Principles of Consolidation&lt;/b&gt;.&#160;The consolidated financial statements include our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated. Amounts presented in this report are rounded, while percentages and earnings per share amounts presented are calculated from the underlying amounts. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/b&gt;. We consider interest-bearing deposits with an original maturity date of three&#160;months or less to be cash equivalents. As of &lt;span style="-sec-ix-hidden:Hidden_wEJKBHaF4ku_LLZF6o-vSQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;, approximately $1.9 million, respectively, of our cash and cash equivalents represents restricted cash for the payment of certain import and other taxes for our subsidiary in China.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Receivables&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. An allowance for credit losses on trade receivables is recorded based on our expectation of credit losses and is based upon our historical bad debt experience, current economic conditions, expectations of future economic conditions and management&#x2019;s evaluation of our ability to collect individual outstanding balances. Once collection efforts have been exhausted and a receivable is deemed to be uncollectible, such balance is charged against the allowance for credit losses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Inventories&lt;/b&gt;. We value our inventories at the lower of cost, at approximate costs determined on a first-in, first-out method, or net realizable value.&#160;Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160;Inventory costs include material, labor and manufacturing overhead.&#160;We review inventories on hand and record provisions based on estimated excess, slow moving and obsolete inventory, as well as inventories with a carrying value in excess of net realizable value.&#160;The regular and systematic review of the valuation of inventories includes an assessment of future product demand based on historical sales and raw material usage and product expiration.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Goodwill and Intangible Assets&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We test goodwill balances for impairment on an annual basis as of July&#160;1 or whenever impairment indicators arise.&#160;When impairment indicators are identified, we may elect to perform an optional qualitative assessment to determine whether it is more likely than not that the fair value of our reporting units has fallen below their carrying value. During our annual impairment test, we utilize four reporting units in evaluating goodwill for impairment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;using a quantitative assessment, which uses a combination of a guideline public company market-based approach and a discounted cash flow income-based approach. The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#x2019;s carrying value exceeds its fair value. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Finite-lived intangible assets including developed technology, customer lists, distribution agreements, license agreements, trademarks and patents are subject to amortization. Intangible assets are amortized over their estimated useful life on a straight-line basis, except for customer lists, which are generally amortized on an accelerated basis. Estimated useful lives are determined considering the period the assets are expected to contribute to future cash flows. We evaluate long-lived assets, including amortizing intangible assets, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform the impairment analysis at the asset group for which the lowest level of identifiable cash flows are largely independent of the cash flows of other assets and liabilities. We compare the carrying value of the asset group to the undiscounted cash flows expected to result from the asset group and determine whether the carrying amount is recoverable. We determine the fair value of each asset group based on estimated future cash flows discounted back to their present value using a discount rate that reflects the risk profiles of the underlying activities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;In-process technology intangible assets, which are not subject to amortization until projects reach commercialization, are assessed for impairment at least annually and more frequently if events occur that would indicate a potential reduction in the fair value of the assets below their carrying value. An impairment charge would be recognized to the extent the carrying amount of the in-process technology exceeded its fair value.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Long-Lived Assets&lt;/b&gt;.&#160;We periodically review the carrying amount of our depreciable long-lived assets for impairment.&#160;An asset is considered impaired when undiscounted estimated future cash flows are less than the carrying amount of the asset.&#160;In the event the carrying amount of such asset is not considered recoverable, the asset is adjusted to its fair value.&#160;Fair value is generally determined based on discounted future cash flow.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Property and Equipment&lt;/b&gt;.&#160;Property and equipment is stated at the historical cost of construction or purchase. Construction costs include interest costs capitalized during construction.&#160;Maintenance and repairs of property and equipment are charged to operations as incurred.&#160;Leasehold improvements are amortized over the lesser of the base term of the lease or estimated life of the leasehold improvements.&#160;Construction-in-process consists of new buildings and various production equipment being constructed internally and externally.&#160;Assets in construction-in-process will commence depreciating once the asset has been placed in service.&#160;Depreciation is computed using the straight-line method over estimated useful lives as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;40 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Manufacturing equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Land improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;10 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4 - 25 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Depreciation expense related to property and equipment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $33.4 million, $34.5 million, and $35.4 million, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred Compensation&lt;/b&gt;.&#160;We have a deferred compensation plan that permits certain management employees to defer a portion of their salary until the future.&#160;We established a Rabbi trust to finance obligations under the plan with corporate-owned variable life insurance contracts.&#160;The cash surrender value totaled $15.8 million and $19.1 million at December&#160;31,&#160;2022 and 2021, respectively, which is included in other assets in our consolidated balance sheets.&#160;We have recorded a deferred compensation payable of $15.3 million and $18.1 million at December&#160;31,&#160;2022 and 2021, respectively, to reflect the liability to our employees under this plan.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other Assets&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investments in privately held companies&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,711&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred compensation plan assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,767&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term notes receivable, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,612&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,239&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,352&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,421&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Our share of earnings associated with equity method investments is reported within other income (expense) in our consolidated statements of income (loss). Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other Long-term Obligations. &lt;/b&gt;Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,260&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,500&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,084&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,584&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;In connection with a business combination, any contingent consideration is recorded at fair value on the acquisition date based upon the consideration expected to be transferred in the future. We re-measure the estimated liability each quarter based upon changes in revenue estimates, changes in the probability of achieving relevant milestones and changes in the discount rate or expected period of payment. Changes in the estimated fair value are recorded through operating expense in our consolidated statements of income (loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenue Recognition&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We sell our medical products through a direct sales force in the U.S. and&#160;through OEM relationships, custom procedure tray manufacturers and a combination of direct sales force and independent&#160;distributors in international markets.&#160;Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods.&#160;This core principle is achieved through the following steps:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-style:italic;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Identify the contract with the customer&lt;/i&gt;. A contract with a customer exists when (i)&#160;we enter into an enforceable contract with a customer that defines each party&#x2019;s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii)&#160;the contract has commercial substance and (iii)&#160;we determine that collection of substantially all consideration for services that are transferred is probable based on the customer&#x2019;s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred if the amortization period would have been one&#160;year or less.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Identify the performance obligations in the contract&lt;/i&gt;. Generally, our contracts with customers do not include multiple performance obligations to be completed over a period of time. Our performance obligations generally relate to delivering single-use medical products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds. We do not have significant returns. We do not typically offer extended warranty or service plans, except in limited cases which are not material. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Determine the transaction price&lt;/i&gt;. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. Our contracts do not typically contain a financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Allocate the transaction price to performance obligations in the contract&lt;/i&gt;. We typically do not have multiple performance obligations in our contracts with customers. As such, we generally recognize revenue upon transfer of the product to the customer&#x2019;s control at contractually stated pricing.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Recognize revenue when or as we satisfy a performance obligation.&#160;&lt;/i&gt;We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue. Contract assets are recognized for the future right to invoice customers, and contract liabilities are recognized for unearned revenue if payment is received prior to our fulfillment of performance obligations. We do not have material contract assets or contract liabilities. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Reserves are recorded as a reduction in net sales and are not considered material to our consolidated statements of income (loss) for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020.&#160;In addition, we invoice our customers for taxes assessed by governmental authorities, such as sales tax and value-added taxes.&#160;We present these taxes on a net basis.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shipping and Handling&lt;/b&gt;.&#160;When billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost of Sales&lt;/b&gt;.&#160;We include product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, product royalty expense, developed technology amortization expense, production-related depreciation expense and product license agreement expense in cost of sales.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Research and Development&lt;/b&gt;.&#160;Research and development costs, including new product development, clinical trials, and regulatory compliance, are expensed as incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income Taxes&lt;/b&gt;.&#160;Under our accounting policies, we initially recognize a tax position in our financial statements when it becomes more likely than not that the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax positions that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authorities assuming full knowledge of the position and all relevant facts. Although we believe our provisions for unrecognized tax positions are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our income tax provisions and accruals. Such differences could have a material impact on our income tax provisions and operating results in the periods&#160;in which we make such determination.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Earnings per Common Share&lt;/b&gt;.&#160;Net income (loss) per common share is computed by both the basic method, which uses the weighted average number of our common shares outstanding, and the diluted method, which includes the dilutive common shares from stock options and restricted stock units as calculated using the treasury stock method. Performance stock units are considered contingently issuable awards and are excluded from the weighted average basic share calculation. These awards are included in the weighted average dilutive share calculation, to the extent they are dilutive, based on the number of shares, if any, that would be issuable as of the end of the reporting period assuming the end of the reporting period is also the end of the performance period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value Measurements&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Financial assets are marked to bid prices and financial liabilities are marked to offer prices.&#160;Fair value measurements do not include transaction costs.&#160;A fair value hierarchy is used to prioritize the quality and reliability of the information &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;used to determine fair values.&#160;Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.&#160;The fair value hierarchy is defined in the following three categories:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;Level 2: Observable market-based inputs or inputs that are corroborated by market data.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Level 3: Unobservable inputs that are not corroborated by market data.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock-Based Compensation&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We recognize the fair value compensation cost relating to stock-based payment transactions in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718, &lt;i style="font-style:italic;"&gt;Compensation&#160;&#x2014; Stock Compensation&lt;/i&gt;.&#160;Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#x2019;s requisite service period, which is generally the vesting period.&#160;The fair value of our stock options is estimated using a Black-Scholes option valuation model.&#160;The fair value of our performance stock units linked to total shareholder return is estimated using Monte-Carlo simulations. Compensation expense is adjusted each period based on the grant-date fair value and the number of shares that are probable of being awarded based on the performance conditions of the awards. Restricted stock units are valued based on the closing stock price on the date of grant. Cash-settled share-based awards, or liability awards, are remeasured at fair value each reporting period until the awards are settled. Total stock-based compensation expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $18.0 million, $16.1 million, and $14.3 million, respectively (see Note 12).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Concentration of Credit Risk&lt;/b&gt;.&#160;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&#160;We provide credit, in the normal course of business, primarily to hospitals and independent third-party custom procedure tray manufacturers and distributors.&#160;We perform ongoing credit evaluations of our customers and maintain allowances for potential credit losses. Due to the diversified nature and number of our customers, concentrations of credit risk with respect to accounts receivable are limited.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Foreign Currency&lt;/b&gt;.&#160;The financial statements of our foreign subsidiaries are measured using local currencies as the functional currency, with the exception of our manufacturing subsidiaries in Ireland and Mexico, which each use the U.S. Dollar as its functional currency.&#160;Assets and liabilities are translated into U.S. Dollars at&#160;year-end rates of exchange and results of operations are translated at average rates for the&#160;year.&#160;Gains and losses resulting from these translations are included in accumulated other comprehensive income (loss) as a separate component of stockholders&#x2019; equity.&#160;Transactional exchange gains or losses are included in other income (expense) in determining net income (loss) for the period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Derivatives&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We use forward contracts to mitigate our exposure to volatility in foreign exchange rates, and we use interest rate swaps to hedge changes in the benchmark interest rate related to our Third Amended Credit Agreement described in Note&#160;8.&#160;All derivatives are recognized in the consolidated balance sheets at fair value.&#160;Classification of each hedging instrument is based upon whether the maturity of the instrument is less than or greater than 12&#160;months.&#160;We do not purchase or hold derivative financial instruments for speculative or trading purposes (see Note&#160;9).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;New Financial Accounting Standards. In March 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) 2020-04, &lt;i style="font-style:italic;"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/i&gt;, which provides temporary optional expedients and exceptions in accounting for modifications of contracts that reference the London interbank offered rate (&#x201c;LIBOR&#x201d;) or another reference rate expected to be discontinued as a result of reference rate reform. In January 2021, the FASB issued ASU 2021-01, &lt;i style="font-style:italic;"&gt;Reference Rate Reform (Topic 848): Scope&lt;/i&gt;, which amends the scope of ASU 2020-04. In December 2022, the FASB issued ASU 2022-06, &lt;i style="font-style:italic;"&gt;Deferral of the Sunset Date of Topic 848&lt;/i&gt;, which defers the sunset date of the guidance in ASC 848 to December 31, 2024. ASU 2020-04 and ASU 2021-01 were effective as of March 12, 2020; ASU 2022-06 was effective upon its issuance in December 2022. The provisions of these updates may be applied prospectively to transactions through December 31, 2024, when reference rate reform activity is expected to be completed. As of December 31, 2022, we had not modified any contracts as a result of reference rate reform. We are currently assessing the anticipated impact of these standards on our consolidated financial statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;We currently believe that all other issued and not yet effective accounting standards are not materially relevant to our financial statements.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="INF"
      id="Narr_Jkg26a-uVUq-yhR433r-ng"
      unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="INF"
      id="Narr_rZrKUsV8g06llDvzjRODOQ"
      unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg">2</us-gaap:NumberOfOperatingSegments>
    <mmsi:NumberOfProductCategories
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="INF"
      id="Narr_ciDVumrR902dNgb2uAI6eQ"
      unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg">5</mmsi:NumberOfProductCategories>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_-HkjOEfWikGwXArI_357OA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Use of Estimates in Preparing Financial Statements&lt;/b&gt;.&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_J5xV1EFotUSFXtN7akIA1Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Principles of Consolidation&lt;/b&gt;.&#160;The consolidated financial statements include our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated. Amounts presented in this report are rounded, while percentages and earnings per share amounts presented are calculated from the underlying amounts. &lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_7WX--GWk6UCZQ_xCB-0PBw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/b&gt;. We consider interest-bearing deposits with an original maturity date of three&#160;months or less to be cash equivalents. As of &lt;span style="-sec-ix-hidden:Hidden_wEJKBHaF4ku_LLZF6o-vSQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;, approximately $1.9 million, respectively, of our cash and cash equivalents represents restricted cash for the payment of certain import and other taxes for our subsidiary in China.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg"
      decimals="-5"
      id="Narr_G-wg3zM74kG7y3BpcoWI5g"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1900000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_V-Wse2vZvEK7ki4uzUTmDA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Receivables&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. An allowance for credit losses on trade receivables is recorded based on our expectation of credit losses and is based upon our historical bad debt experience, current economic conditions, expectations of future economic conditions and management&#x2019;s evaluation of our ability to collect individual outstanding balances. Once collection efforts have been exhausted and a receivable is deemed to be uncollectible, such balance is charged against the allowance for credit losses.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_2a84z0xoH02oW-DVI4bInw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Inventories&lt;/b&gt;. We value our inventories at the lower of cost, at approximate costs determined on a first-in, first-out method, or net realizable value.&#160;Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160;Inventory costs include material, labor and manufacturing overhead.&#160;We review inventories on hand and record provisions based on estimated excess, slow moving and obsolete inventory, as well as inventories with a carrying value in excess of net realizable value.&#160;The regular and systematic review of the valuation of inventories includes an assessment of future product demand based on historical sales and raw material usage and product expiration.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_DneT-g_Vg0eLiXRNC1acvQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Goodwill and Intangible Assets&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We test goodwill balances for impairment on an annual basis as of July&#160;1 or whenever impairment indicators arise.&#160;When impairment indicators are identified, we may elect to perform an optional qualitative assessment to determine whether it is more likely than not that the fair value of our reporting units has fallen below their carrying value. During our annual impairment test, we utilize four reporting units in evaluating goodwill for impairment &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;using a quantitative assessment, which uses a combination of a guideline public company market-based approach and a discounted cash flow income-based approach. The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#x2019;s carrying value exceeds its fair value. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Finite-lived intangible assets including developed technology, customer lists, distribution agreements, license agreements, trademarks and patents are subject to amortization. Intangible assets are amortized over their estimated useful life on a straight-line basis, except for customer lists, which are generally amortized on an accelerated basis. Estimated useful lives are determined considering the period the assets are expected to contribute to future cash flows. We evaluate long-lived assets, including amortizing intangible assets, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform the impairment analysis at the asset group for which the lowest level of identifiable cash flows are largely independent of the cash flows of other assets and liabilities. We compare the carrying value of the asset group to the undiscounted cash flows expected to result from the asset group and determine whether the carrying amount is recoverable. We determine the fair value of each asset group based on estimated future cash flows discounted back to their present value using a discount rate that reflects the risk profiles of the underlying activities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;In-process technology intangible assets, which are not subject to amortization until projects reach commercialization, are assessed for impairment at least annually and more frequently if events occur that would indicate a potential reduction in the fair value of the assets below their carrying value. An impairment charge would be recognized to the extent the carrying amount of the in-process technology exceeded its fair value.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="INF"
      id="Narr_5vNPZ4wUSUyMe95FbRB2uA"
      unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg">4</us-gaap:NumberOfReportingUnits>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_zjeF_pCyL0mrgYCfH3NpXQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Long-Lived Assets&lt;/b&gt;.&#160;We periodically review the carrying amount of our depreciable long-lived assets for impairment.&#160;An asset is considered impaired when undiscounted estimated future cash flows are less than the carrying amount of the asset.&#160;In the event the carrying amount of such asset is not considered recoverable, the asset is adjusted to its fair value.&#160;Fair value is generally determined based on discounted future cash flow.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_rLKOhMhFj02yeGcziig4iw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Property and Equipment&lt;/b&gt;.&#160;Property and equipment is stated at the historical cost of construction or purchase. Construction costs include interest costs capitalized during construction.&#160;Maintenance and repairs of property and equipment are charged to operations as incurred.&#160;Leasehold improvements are amortized over the lesser of the base term of the lease or estimated life of the leasehold improvements.&#160;Construction-in-process consists of new buildings and various production equipment being constructed internally and externally.&#160;Assets in construction-in-process will commence depreciating once the asset has been placed in service.&#160;Depreciation is computed using the straight-line method over estimated useful lives as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;40 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Manufacturing equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Land improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;10 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4 - 25 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Depreciation expense related to property and equipment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $33.4 million, $34.5 million, and $35.4 million, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_bVWzP05CbE-fxt--meR8Hg">Depreciation is computed using the straight-line method over estimated useful lives as follows:&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;40 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Manufacturing equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Land improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;10 - 20 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:84.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:13.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4 - 25 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember_zjDdU-1CK0yQn-YgCOPErQ"
      id="Tc_PkYU-EXnT0muXaNJDYLY5A_1_2">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_s1acsZS6iEKC098oWQyTug"
      id="Narr_8E2IvHG5E0OhQBoDRQp7Sw">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_EquipmentMember_bHmUCFOtj06ZlP-Hj9nRQQ"
      id="Narr_oKovrGwt3EueuiYI9kUrTw">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_YTeZcpsajkOtbBGdZAUyYg"
      id="Narr_sYC0SpNEYEeQ8OOUD-F6GQ">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember_4_A4JH-cIkyKmiFBjtHFug"
      id="Narr_zDiGl_8BvkaEgJpF4gBXqQ">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_r2Dw8i5qFkieuyppXBpYLA"
      id="Narr_7Lh1J8y2o0iWSIOCSIK28g">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandImprovementsMember_c5bBLUi-vkiFEa6Kh9D6GQ"
      id="Narr_ZmVdg6-7vUioo2PtHKiu9A">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_YvMztLBIikevootYF9Q_Vw"
      id="Narr_y97TnOjN5kqcd-iydbiZCg">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember_5XhIeqfIC0aQ7HSWBJyoYA"
      id="Narr_qMTO3EXF2EKgSVWrPHGsLQ">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_a60GH25IzU-8XL6dF5Szgw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">33400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_F8vMuR2qV02ihVOZ7wUp_w"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">34500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_Aatt7sO_70-TrpgavRXLoA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">35400000</us-gaap:Depreciation>
    <mmsi:DeferredCompensationPolicyTextBlockPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_G67VY3QI3UmT8teA_LcKjQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deferred Compensation&lt;/b&gt;.&#160;We have a deferred compensation plan that permits certain management employees to defer a portion of their salary until the future.&#160;We established a Rabbi trust to finance obligations under the plan with corporate-owned variable life insurance contracts.&#160;The cash surrender value totaled $15.8 million and $19.1 million at December&#160;31,&#160;2022 and 2021, respectively, which is included in other assets in our consolidated balance sheets.&#160;We have recorded a deferred compensation payable of $15.3 million and $18.1 million at December&#160;31,&#160;2022 and 2021, respectively, to reflect the liability to our employees under this plan.&lt;/p&gt;</mmsi:DeferredCompensationPolicyTextBlockPolicyTextBlock>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_ffleO8pcA0eCvgkKDW-AtQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15800000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-5"
      id="Narr_LLebnAixWUmIsQCTLzMjTQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">19100000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_Ea96FG3z2E-mS03PnhIaoQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15300000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-5"
      id="Narr_cIoYenszHUGm3PKtUMOIKw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18100000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <mmsi:OtherAssetsPolicyTextBlockPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_PZ1iBMdfr0yeuUCCKNGTSw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other Assets&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investments in privately held companies&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,711&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred compensation plan assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,767&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term notes receivable, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,612&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,239&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,352&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,421&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Our share of earnings associated with equity method investments is reported within other income (expense) in our consolidated statements of income (loss). Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.&lt;/p&gt;</mmsi:OtherAssetsPolicyTextBlockPolicyTextBlock>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_gsMw028Kd0qo5CfnzvDHJQ">Other assets as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Investments in privately held companies&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,711&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred compensation plan assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,767&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term notes receivable, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,612&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,239&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.23%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,352&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,421&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_tcd5atVH10--efJhEgtmAA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15576000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_UzCJ61UIyEy1AUduwm1CkQ_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14711000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_lQph9SnuBkqG6_Zn_bctxQ_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15767000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_lUSHdaEYRE2noVxv8Wp-Qg_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">19126000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_t4I3ixkKPkCWCXfi_hIdZA_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2397000</us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_DPnEiPVwGkavlT6hMmcMMQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2345000</us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_7QsmYkAih0Kggfewk9pCUw_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10612000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_0DZLss3ViEmnK2oZyovihQ_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5239000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_9vPoCwLQZEecBldbJzojhA_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">44352000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_I658gWEAq0u-I9seHFw7HA_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">41421000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_k--irQcjbkaKp9D4gSJazg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Other Long-term Obligations. &lt;/b&gt;Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,260&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,500&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,084&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,584&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;In connection with a business combination, any contingent consideration is recorded at fair value on the acquisition date based upon the consideration expected to be transferred in the future. We re-measure the estimated liability each quarter based upon changes in revenue estimates, changes in the probability of achieving relevant milestones and changes in the discount rate or expected period of payment. Changes in the estimated fair value are recorded through operating expense in our consolidated statements of income (loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_DUlWstePNkSHq4IEmKGTtg">Other long-term obligations as of December&#160;31,&#160;2022 and 2021 consisted of the following (in thousands):&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,260&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,500&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,084&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.83%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,584&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_6SvKyC8Vu0q3RhUDyheuBQ_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2260000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_xhvdaw-QO0qxH88txVr3VA_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherLongTermDebt
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_WLsWXG5zeUiv69EFAWIQvw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12476000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_1RW-M5Bjm0K9Q-QiVXr8Aw_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10084000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_JXBLWE7DS0mcspSMic-g9A_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14736000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_heMQkGo-eU2JUiejGIy7cg_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">23584000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_nFR3Mtmzokywxdngxa4s7w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenue Recognition&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We sell our medical products through a direct sales force in the U.S. and&#160;through OEM relationships, custom procedure tray manufacturers and a combination of direct sales force and independent&#160;distributors in international markets.&#160;Revenue is recognized when a customer obtains control of promised goods based on the consideration we expect to receive in exchange for these goods.&#160;This core principle is achieved through the following steps:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-style:italic;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Identify the contract with the customer&lt;/i&gt;. A contract with a customer exists when (i)&#160;we enter into an enforceable contract with a customer that defines each party&#x2019;s rights regarding the goods to be transferred and identifies the payment terms related to these goods, (ii)&#160;the contract has commercial substance and (iii)&#160;we determine that collection of substantially all consideration for services that are transferred is probable based on the customer&#x2019;s intent and ability to pay the promised consideration. We do not have significant costs to obtain contracts with customers. For commissions on product sales, we have elected the practical expedient to expense the costs as incurred if the amortization period would have been one&#160;year or less.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Identify the performance obligations in the contract&lt;/i&gt;. Generally, our contracts with customers do not include multiple performance obligations to be completed over a period of time. Our performance obligations generally relate to delivering single-use medical products to a customer, subject to the shipping terms of the contract. Limited warranties are provided, under which we typically accept returns and provide either replacement parts or refunds. We do not have significant returns. We do not typically offer extended warranty or service plans, except in limited cases which are not material. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Determine the transaction price&lt;/i&gt;. Payment by the customer is due under customary fixed payment terms, and we evaluate if collectability is reasonably assured. Our contracts do not typically contain a financing component. Revenue is recorded at the net sales price, which includes estimates of variable consideration such as product returns, rebates, discounts, and other adjustments. The estimates of variable consideration are based on historical payment experience, historical and &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;projected sales data, and current contract terms. Variable consideration is included in revenue only to the extent that it is probable that a significant reversal of the revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Allocate the transaction price to performance obligations in the contract&lt;/i&gt;. We typically do not have multiple performance obligations in our contracts with customers. As such, we generally recognize revenue upon transfer of the product to the customer&#x2019;s control at contractually stated pricing.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Recognize revenue when or as we satisfy a performance obligation.&#160;&lt;/i&gt;We generally satisfy performance obligations at a point in time upon either shipment or delivery of goods, in accordance with the terms of each contract with the customer. We do not have significant service revenue. Contract assets are recognized for the future right to invoice customers, and contract liabilities are recognized for unearned revenue if payment is received prior to our fulfillment of performance obligations. We do not have material contract assets or contract liabilities. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Reserves are recorded as a reduction in net sales and are not considered material to our consolidated statements of income (loss) for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020.&#160;In addition, we invoice our customers for taxes assessed by governmental authorities, such as sales tax and value-added taxes.&#160;We present these taxes on a net basis.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Shipping and Handling&lt;/b&gt;.&#160;When billed to our customers, shipping and handling charges are included in net sales for the applicable period, and the corresponding shipping and handling expense is reported in cost of sales.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cost of Sales&lt;/b&gt;.&#160;We include product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, product royalty expense, developed technology amortization expense, production-related depreciation expense and product license agreement expense in cost of sales.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_vBbYWLZMA0qi92YHjJ6gqA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Research and Development&lt;/b&gt;.&#160;Research and development costs, including new product development, clinical trials, and regulatory compliance, are expensed as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_r5aVYQ6xkk69tprQBrUC6A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income Taxes&lt;/b&gt;.&#160;Under our accounting policies, we initially recognize a tax position in our financial statements when it becomes more likely than not that the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax positions that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authorities assuming full knowledge of the position and all relevant facts. Although we believe our provisions for unrecognized tax positions are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our income tax provisions and accruals. Such differences could have a material impact on our income tax provisions and operating results in the periods&#160;in which we make such determination.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_PMcg10o0A0mM-YVhKIWvWg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Earnings per Common Share&lt;/b&gt;.&#160;Net income (loss) per common share is computed by both the basic method, which uses the weighted average number of our common shares outstanding, and the diluted method, which includes the dilutive common shares from stock options and restricted stock units as calculated using the treasury stock method. Performance stock units are considered contingently issuable awards and are excluded from the weighted average basic share calculation. These awards are included in the weighted average dilutive share calculation, to the extent they are dilutive, based on the number of shares, if any, that would be issuable as of the end of the reporting period assuming the end of the reporting period is also the end of the performance period.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_gLO5n6DWfUemJ-7Os1RiVQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value Measurements&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Financial assets are marked to bid prices and financial liabilities are marked to offer prices.&#160;Fair value measurements do not include transaction costs.&#160;A fair value hierarchy is used to prioritize the quality and reliability of the information &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;used to determine fair values.&#160;Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.&#160;The fair value hierarchy is defined in the following three categories:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;Level 2: Observable market-based inputs or inputs that are corroborated by market data.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"&gt;Level 3: Unobservable inputs that are not corroborated by market data.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_HcuwySpH70yUkupANk5UyQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock-Based Compensation&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We recognize the fair value compensation cost relating to stock-based payment transactions in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718, &lt;i style="font-style:italic;"&gt;Compensation&#160;&#x2014; Stock Compensation&lt;/i&gt;.&#160;Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee&#x2019;s requisite service period, which is generally the vesting period.&#160;The fair value of our stock options is estimated using a Black-Scholes option valuation model.&#160;The fair value of our performance stock units linked to total shareholder return is estimated using Monte-Carlo simulations. Compensation expense is adjusted each period based on the grant-date fair value and the number of shares that are probable of being awarded based on the performance conditions of the awards. Restricted stock units are valued based on the closing stock price on the date of grant. Cash-settled share-based awards, or liability awards, are remeasured at fair value each reporting period until the awards are settled. Total stock-based compensation expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $18.0 million, $16.1 million, and $14.3 million, respectively (see Note 12).&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_vHx90eOFyUSHMKzJGxmhBg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_eFHFoAzVTkSM3JNAxkYfbQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_arQlSUvQ1k6GidmnZx4Osw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <mmsi:ConcentrationOfCreditRiskPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_eAPgoSUQbUC0Df5p01R4mg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Concentration of Credit Risk&lt;/b&gt;.&#160;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&#160;We provide credit, in the normal course of business, primarily to hospitals and independent third-party custom procedure tray manufacturers and distributors.&#160;We perform ongoing credit evaluations of our customers and maintain allowances for potential credit losses. Due to the diversified nature and number of our customers, concentrations of credit risk with respect to accounts receivable are limited.&lt;/p&gt;</mmsi:ConcentrationOfCreditRiskPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_-9g_3-F-ak21oKS3sLNDgg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Foreign Currency&lt;/b&gt;.&#160;The financial statements of our foreign subsidiaries are measured using local currencies as the functional currency, with the exception of our manufacturing subsidiaries in Ireland and Mexico, which each use the U.S. Dollar as its functional currency.&#160;Assets and liabilities are translated into U.S. Dollars at&#160;year-end rates of exchange and results of operations are translated at average rates for the&#160;year.&#160;Gains and losses resulting from these translations are included in accumulated other comprehensive income (loss) as a separate component of stockholders&#x2019; equity.&#160;Transactional exchange gains or losses are included in other income (expense) in determining net income (loss) for the period.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_NGFpM0gFgUiKUXOWyci1vw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Derivatives&lt;/b&gt;.&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;We use forward contracts to mitigate our exposure to volatility in foreign exchange rates, and we use interest rate swaps to hedge changes in the benchmark interest rate related to our Third Amended Credit Agreement described in Note&#160;8.&#160;All derivatives are recognized in the consolidated balance sheets at fair value.&#160;Classification of each hedging instrument is based upon whether the maturity of the instrument is less than or greater than 12&#160;months.&#160;We do not purchase or hold derivative financial instruments for speculative or trading purposes (see Note&#160;9).&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_g1O2ijbPoUSraWSOz3OcTg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;New Financial Accounting Standards. In March 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) 2020-04, &lt;i style="font-style:italic;"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/i&gt;, which provides temporary optional expedients and exceptions in accounting for modifications of contracts that reference the London interbank offered rate (&#x201c;LIBOR&#x201d;) or another reference rate expected to be discontinued as a result of reference rate reform. In January 2021, the FASB issued ASU 2021-01, &lt;i style="font-style:italic;"&gt;Reference Rate Reform (Topic 848): Scope&lt;/i&gt;, which amends the scope of ASU 2020-04. In December 2022, the FASB issued ASU 2022-06, &lt;i style="font-style:italic;"&gt;Deferral of the Sunset Date of Topic 848&lt;/i&gt;, which defers the sunset date of the guidance in ASC 848 to December 31, 2024. ASU 2020-04 and ASU 2021-01 were effective as of March 12, 2020; ASU 2022-06 was effective upon its issuance in December 2022. The provisions of these updates may be applied prospectively to transactions through December 31, 2024, when reference rate reform activity is expected to be completed. As of December 31, 2022, we had not modified any contracts as a result of reference rate reform. We are currently assessing the anticipated impact of these standards on our consolidated financial statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;We currently believe that all other issued and not yet effective accounting standards are not materially relevant to our financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_Jc_Nr_-jU0WgAZTGiitvcQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.&lt;/b&gt;&lt;/span&gt;REVENUES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="color:#212529;font-weight:bold;background:#ffffff;"&gt;Disaggregation of Revenue.&lt;/b&gt;&lt;span style="color:#212529;background:#ffffff;"&gt; Our revenue is disaggregated based on reporting segment, product category and geographical region. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in&#160;&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;two&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of&#160;&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;four&lt;/span&gt;&lt;span style="color:#212529;background:#ffffff;"&gt;&#160;product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The following table presents sales by operating segment disaggregated based on product category and geographic region for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands).&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;United States&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;International&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;United States&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;International&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;United States&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;International&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cardiovascular&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Peripheral Intervention&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 263,602&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 176,208&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 439,810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 244,459&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 160,657&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 405,116&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 211,999&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 129,569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 341,568&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiac Intervention&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 128,711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 214,475&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 343,186&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 122,452&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 198,189&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 320,641&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 108,109&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 171,562&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 279,671&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Custom Procedural Solutions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 108,778&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 81,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 190,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 108,068&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 85,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 193,942&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 110,269&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 92,927&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 203,196&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;OEM&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 118,869&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,165&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 145,034&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 104,436&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,092&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 123,528&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 91,826&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 17,941&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 109,767&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 619,960&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 498,264&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,118,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 579,415&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 463,812&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,043,227&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 522,203&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 411,999&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 934,202&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Endoscopy&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy Devices&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 30,599&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,158&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,757&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,061&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 27,858&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,815&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,673&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 650,559&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 500,422&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 608,878&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 465,873&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 550,061&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 413,814&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt; &lt;/i&gt;&lt;span style="font-style:italic;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="INF"
      id="Narr_cJxGVKgw0kGOFjZB18-n4A"
      unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg">2</us-gaap:NumberOfOperatingSegments>
    <mmsi:NumberOfProductCategories
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="INF"
      id="Narr_tJXgb_tuxUWjor2kpjzTUA"
      unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg">4</mmsi:NumberOfProductCategories>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_2sFaCj-1t0eF0bTYMpqgtw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The following table presents sales by operating segment disaggregated based on product category and geographic region for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands).&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:28.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:27.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;United States&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;International&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;United States&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;International&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;United States&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;International&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cardiovascular&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Peripheral Intervention&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 263,602&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 176,208&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 439,810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 244,459&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 160,657&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 405,116&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 211,999&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 129,569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 341,568&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiac Intervention&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 128,711&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 214,475&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 343,186&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 122,452&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 198,189&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 320,641&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 108,109&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 171,562&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 279,671&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Custom Procedural Solutions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 108,778&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 81,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 190,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 108,068&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 85,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 193,942&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 110,269&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 92,927&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 203,196&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;OEM&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 118,869&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,165&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 145,034&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 104,436&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,092&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 123,528&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 91,826&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 17,941&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 109,767&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 619,960&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 498,264&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,118,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 579,415&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 463,812&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,043,227&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 522,203&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 411,999&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 934,202&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Endoscopy&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy Devices&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 30,599&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,158&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,757&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,061&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 27,858&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,815&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,673&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:10.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 650,559&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 500,422&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 608,878&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 465,873&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.88%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 550,061&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 413,814&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_W4Nbl4v2vEWmCyXaR8_MbQ"
      decimals="-3"
      id="Tc_pk7UvnWaUkq4eGRI6PJYEA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">263602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XDLejGk_vku62keNdhz1pg"
      decimals="-3"
      id="Tc_STZdPEtxB0W8q679-7MQGg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">176208000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_EZu2oq9JWkySFQgXZx80hQ"
      decimals="-3"
      id="Tc_V5GWiAwnLEiUoJAyocRGgg_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">439810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vqVnEcbqgk2jvODZ8WKvRQ"
      decimals="-3"
      id="Tc_NEyj28zfUkaL36ga_w1uGg_5_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">244459000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_67-Tqlponk6UZvQATQw19w"
      decimals="-3"
      id="Tc_kPnuKoUXU0WsRJRdGVDbTA_5_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">160657000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_Hz0JZzm31kalsEp3ZcM9cA"
      decimals="-3"
      id="Tc_MZQIMeJoG0qRNFtZaNvSpg_5_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">405116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_XRuhIx6aiEeybATIhaSCew"
      decimals="-3"
      id="Tc_662v6U--_02M8xZDbUI_-g_5_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">211999000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hLXkkEVnQ0euQQ6ojlb_1g"
      decimals="-3"
      id="Tc_nyqfKxuvNES00jeTRsLhpw_5_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">129569000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_PeripheralInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_rIqmoSek306nJEUyZctJvw"
      decimals="-3"
      id="Tc_A65lj4VpZ0S-QIfa-5ynnw_5_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">341568000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dh9NAeeWGEOTyKx9dRNgQQ"
      decimals="-3"
      id="Tc_w1zLuQwFv0CseLLfHOozFQ_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">128711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_va_cfvyIrkys5qSCajkJtQ"
      decimals="-3"
      id="Tc_JEqwfPQ2IUKqKqpaOkF8_w_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">214475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qOiOMhYAGEOB7wKJJI87ZQ"
      decimals="-3"
      id="Tc_qX2K0QWhnEyY_qf9SZvFyw_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">343186000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_g8ILwIqCCkGF8WrNEHY3EA"
      decimals="-3"
      id="Tc_VlPwemcQRUOvItcZV5-zuw_6_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">122452000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_cOSP19REXkC1_oAwXrzLgw"
      decimals="-3"
      id="Tc_ZsLe1LkegUOPQHgF67clTg_6_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">198189000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_UdQi9w9_x0afDHEY0-2BYw"
      decimals="-3"
      id="Tc_0oIUEmI2VUi1ivEWWCw3Vg_6_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">320641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_SZX6ag4YY02YUh000gdDGQ"
      decimals="-3"
      id="Tc_3jmfOCmv5kG0mORgyWaVLA_6_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">108109000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_nB-ZtSzHwEaoYetvplSrzw"
      decimals="-3"
      id="Tc_JNVVXGPUA0yEzZrGLVDuOw_6_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">171562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CardiacInterventionMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_dQ1w9qgJwkKMRf4Eg6YHWw"
      decimals="-3"
      id="Tc_aJ_f1H6PmE-wu6RvGz_6Gg_6_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">279671000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o4zAyiweSU6Li2EVnzgs_A"
      decimals="-3"
      id="Tc_pCSP67KLgEKwwAmYzCkspA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">108778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_fMTs59rneUqo5v_BpAVSDw"
      decimals="-3"
      id="Tc_LCJSyEYexk6_DANiLhmQ9g_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">81416000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_1Z_4de4ygUqLS5DxUcunbQ"
      decimals="-3"
      id="Tc_wvFEMMHtsEW7xI6qHvFCog_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">190194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_aoV-srO-v0C_CmlJQCQsxw"
      decimals="-3"
      id="Tc_I-g_y6dAKEab1f_dU44mGA_7_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">108068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_6oiLFHWLjEaJLXpc4zEA1A"
      decimals="-3"
      id="Tc_MenCyNPhuEWCfD-5d3w8jw_7_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">85874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_49WaWthqHUyKFHaIaWPRbw"
      decimals="-3"
      id="Tc_T9Zx9OQvCUyRy_oGceRjFA_7_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">193942000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_o6wsE8xC70etjMC36EOexw"
      decimals="-3"
      id="Tc_Em9HVv_P_06KCEx_3z1sSg_7_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">110269000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pPXbTXxRSEOTXXv96LRH3g"
      decimals="-3"
      id="Tc_ZrSmwCHo_EC9DFPsgpFG9g_7_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">92927000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_CustomProceduralSolutionsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_2faHD7Y0VE2-7TwAJ3e-Vg"
      decimals="-3"
      id="Tc_fUSKfr04OEid1Xb1yMOCgA_7_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">203196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_GzZqc0UGTEKLB-X3K1JMdg"
      decimals="-3"
      id="Tc_is6QwpLm90OGwCt0eJj9UQ_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">118869000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_JN31JqK8TUSZFC4jUhNaUw"
      decimals="-3"
      id="Tc_NLvpp0kx70O1uZevB03iEw_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">26165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_pL5Mknj4JEmgIcuiUR69sg"
      decimals="-3"
      id="Tc_IWJHDrHAK02wTT7CcJJ94Q_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">145034000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vZc6fJE-3EKIbRcC9xqtKg"
      decimals="-3"
      id="Tc_q4x9_hBVJ0aqZEMxce1rNw_8_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">104436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_lluU2dZDfkKiBp-RaJI-hQ"
      decimals="-3"
      id="Tc_vgAHQJNBzkaZrodffV4iIQ_8_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">19092000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_129nQ-x5H0i8Qfcm3bT7Ew"
      decimals="-3"
      id="Tc_k-Ioqq34D0CW2F7VfGNx5g_8_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">123528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_m-3FCbMdj0GAx8FAxAcY0g"
      decimals="-3"
      id="Tc_byogR4u6bEeuRxRjLzXwYg_8_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">91826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_RROgTsYenkCF6Vl9lsgjUQ"
      decimals="-3"
      id="Tc_VYiPHuvjqkCzWDKFm9S97g_8_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">17941000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_OEMMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_vOi-T_pyI0GCZHYU5lqDhg"
      decimals="-3"
      id="Tc_mgjfcGuFQEKOblCJTZUNbQ_8_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">109767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_-UggGEQK5U2pkGO6tH6iag"
      decimals="-3"
      id="Tc_zl1iqTtDQEKy5oFWGacEXw_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">619960000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_80TSk5DGpEiuyohE3PdYuw"
      decimals="-3"
      id="Tc_NhojXB30wEa-ugVlSjmjwQ_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">498264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="-3"
      id="Tc_8y4Hm0sgnEGAXlmlo4a0yg_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1118224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_hYBaR7_UwkCAZ6qoxFrGIA"
      decimals="-3"
      id="Tc_jJoEF3OefEe5Y90Q6LFp5Q_9_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">579415000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_b4I5jqtYA0uVHc7AxRDbqQ"
      decimals="-3"
      id="Tc_CtIfdm1e7kCRiSXRXGdWsA_9_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">463812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ"
      decimals="-3"
      id="Tc_nx280WDxXkGurXYrzw3ztA_9_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1043227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_bAPCtJ49gEqQWOqwDxwUJA"
      decimals="-3"
      id="Tc_D5JwNqapzEyB6lvACiAd8Q_9_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">522203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_9SbQy8Y_7E6dXc-zGjv5Ng"
      decimals="-3"
      id="Tc_6btPRIUsfUadPBbOjMov3w_9_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">411999000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ"
      decimals="-3"
      id="Tc_0F1-6pBZx0mwPzH6OVl2rw_9_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">934202000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_5mDvHL5jDk-TEtW54Ne1dw"
      decimals="-3"
      id="Tc_z6uA0XrvXEazK_EVLMmbrw_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">30599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_PGWSswwuFk6OV2hMBsWqtQ"
      decimals="-3"
      id="Tc_OFIMuvBCZEy3kiPRfYW96g_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_gXuoUnaox02wGzKWXWNqtQ"
      decimals="-3"
      id="Tc_RuqPY8EqEUaw3EiukJYEJQ_12_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">32757000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_TuXIR_4O_0SCoIN9zotxUg"
      decimals="-3"
      id="Tc_uEoiIURrbkeaVY4-J32hwQ_12_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_rbVoGsHPjU-z7VMqPG5eTw"
      decimals="-3"
      id="Tc_7AfH6BsLVU-2e9UUf8TqNg_12_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_NKU1bXBovEOvuplur33cjg"
      decimals="-3"
      id="Tc_FA4OoJrnF0ycdVYcRYiDuw_12_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31524000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_-HWMY93UmE2VbbgFMJMnIA"
      decimals="-3"
      id="Tc_9JjCiFq7okSl58_wx28fKw_12_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">27858000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_ezMW-IvdrEydHhCgww1eQg"
      decimals="-3"
      id="Tc_nbl1cYm0IkCH3EiOIYKueQ_12_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1815000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ProductOrServiceAxis_mmsi_EndoscopyDevicesMember_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_oykmNEiVm0ie0Ya6Hql15Q"
      decimals="-3"
      id="Tc_dMS29-o7HU2_kRZXMyUadw_12_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29673000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_q-ArAJXhsESzPPSHFsKcWQ"
      decimals="-3"
      id="Tc_mT4A1y6fA0-FYsBRdmLkmA_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">650559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_dSg8kh6DlkyLKSVn2mRmPQ"
      decimals="-3"
      id="Tc_jTNLq9m0ck2m6SMav2copQ_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">500422000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_FKmwpeRzOEqOQFbRd18pAA_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1150981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_US_lPoQtyNyi0OGB2OF5XQXnw"
      decimals="-3"
      id="Tc_rZZ-X1aB7EqJ_De9taATxQ_14_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">608878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_2Zks2ScobUOdPYr6gUlL_A"
      decimals="-3"
      id="Tc_aSD_SwV_T0CnDzFWhkFu8w_14_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">465873000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_BO62jgBx-Ei-OQlHZnrH7Q_14_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1074751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_US_UKcyzBm0EE25HgNKqiye4g"
      decimals="-3"
      id="Tc_g5Eb8alzgUakVjCDIinvMg_14_21"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">550061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_mCRjJpSbEE2JseTs6klpUw"
      decimals="-3"
      id="Tc_4i-br6_q30KxZ4wK-PTFVQ_14_24"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">413814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_N4InPPMPoUmkyA1u4xBBLg_14_27"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">963875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_1GOOT9V20U6mvXpiWCzELQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;3.&lt;/b&gt;&lt;/span&gt;ACQUISITIONS AND OTHER STRATEGIC TRANSACTIONS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022 Acquisitions&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;On October 3, 2022, we entered into an asset purchase agreement with BioTrace Medical, Inc.,&lt;span style="background:#ffffff;"&gt; developer of the Tempo&#xae; Temporary Pacing Lead device,&lt;/span&gt; for a purchase price of $2.5 million.&lt;span style="background:#ffffff;"&gt; W&lt;/span&gt;e are also required to pay a total of six annual royalty payments between 5% and 10% of net sales, dependent on net sales goal achievement, u&lt;span style="background:#ffffff;"&gt;pon achievement of the first device sold in the United States&lt;/span&gt;. We accounted for this transaction as an asset purchase. We recorded the amount paid upon closing as a developed technology intangible asset, which we are amortizing over 10 years.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;On April 30, 2022, we acquired the Restore Endosystems Bifurcated Stent System pursuant to the terms of a unit purchase agreement we executed with all of the members of Restore Endosystems. Subject to the terms and conditions of the unit purchase agreement, we paid $3 million in cash at closing. We also accrued $3.5 million of other long-term obligations, which represents the fair value of two separate $2 million payments which are payable no later than &lt;span style="-sec-ix-hidden:Hidden_omYxHiM9FUeLz86EaJiDGg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;two&lt;/span&gt;&lt;/span&gt; and four years following the closing of the acquisition, respectively, or earlier upon the achievement of specified milestones. We will impute interest on these liabilities with the passage of time. We have accounted for this transaction as an asset purchase and recorded $6.5 million of acquired in-process research and development expense because the technological feasibility of the underlying research and development project has not yet been reached and such technology has no identified future alternative use as of the date of acquisition.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;During April 2022, we paid $1.4 million to acquire shares of series A preferred stock of Fluidx Medical Technology, Inc.("Fluidx"), owner of certain technology proposed to be used in the development of embolic and adhesive agents for use in arterial, venous, vascular graft and cardiovascular applications inside and outside the heart and related appendages. We had previously purchased, and continue to hold, $4.7 million of participating preferred shares of Fluidx. Our investments have been recorded as equity investments accounted for at cost and reflected within other assets in the accompanying consolidated balance sheets because we are not able to exercise significant influence over the operations of Fluidx. Our total current investment in Fluidx represents an ownership of approximately 17% of its outstanding capital stock.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021 Acquisitions &lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt;"&gt;&lt;span style="font-weight:normal;"&gt;During September 2021, we paid &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;$2.7&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; million to acquire series A preferred shares of Fluidx. We had previously purchased &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;$2&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; million of participating preferred shares during 2019. Our investment has been recorded as an equity investment accounted for at cost and reflected within other assets in the accompanying consolidated balance sheets because we are not able to exercise significant influence over the operations of Fluidx. Our total current investment in Fluidx represents an ownership of &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;15.0%&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; of the outstanding stock. &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020 Acquisitions&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;On November 6, 2020, we entered into a unit purchase agreement to acquire KA Medical, LLC (&#x201c;KA Medical&#x201d;). Subject to the terms and conditions of the unit purchase agreement, we paid $14.6 million in cash, net of cash acquired, including adjustments for working capital and deferred payments of $4 million. KA Medical developed the Micro Plug Set, a self-expanding nitinol vascular occlusion device, which is FDA-cleared and CE marked. We accounted for this acquisition as a business combination. The sales and results of operations related to the acquisition have been included in our cardiovascular segment since the acquisition date and were not material for the years ended December 31, 2022, 2021 and 2020. &lt;span style="background:#ffffff;"&gt;Acquisition-related costs associated with the KA Medical acquisition, which were included in selling, general and &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;administrative expenses, were not material. &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;During the fourth quarter of 2021, certain immaterial measurement period adjustments were recorded to our purchase price allocation. &lt;/span&gt;The purchase price was allocated as follows (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:92.71%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets Acquired&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Inventories&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 211&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 298&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other long-term assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;Developed technology&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,570&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total assets acquired&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Liabilities Assumed&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (507)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (538)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total net assets acquired&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We are amortizing the developed technology intangible asset acquired from KA Medical over 17 years. The goodwill consists largely of the synergies expected from combining operations and is expected to be deductible for income tax purposes. We do not deem the pro forma effects to our consolidated results of operations of the KA Medical acquisition to be material.&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_SNuT8N5JSkC1oU513hKP5A"
      decimals="-5"
      id="Narr_GuN6kta98UihFTM1yypjPg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <mmsi:AssetAcquisitionContingentConsiderationNumberOfAnnualPayments
      contextRef="As_Of_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_-2X5MrVXTE-f1Bx7exs50Q"
      decimals="INF"
      id="Narr_noGZDDiAU02ZVG0T8ARpHA"
      unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg">6</mmsi:AssetAcquisitionContingentConsiderationNumberOfAnnualPayments>
    <mmsi:AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue
      contextRef="As_Of_10_4_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_nXJmF9kinUC64uCJFUF8Uw"
      decimals="2"
      id="Narr_h4hgYHpIZkK3vgSvL5uU8g"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.05</mmsi:AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue>
    <mmsi:AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue
      contextRef="As_Of_10_4_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_gvKcRF6bkEqNTgBLgoiS5g"
      decimals="2"
      id="Narr_0BjsA_2stkKhysi1b5c3Dg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.10</mmsi:AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_MDSV0pNPBkaFq-morkVg5g"
      id="Narr_OmyzHAeDE0uP-eVdlT3crQ">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_K77TjlnLw02weRu3pGVeuw"
      decimals="-6"
      id="Narr_TWJlT75Yb0KF6uOxHSQVow"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_K77TjlnLw02weRu3pGVeuw"
      decimals="-5"
      id="Narr_mh9biEXdZEKuKEsqnQ4dVw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3500000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentTwoMember_ezEJWgK2Dki4vj-ItKKXBA"
      decimals="-6"
      id="Narr_noHOY_SugUig_RC7i_ZvHQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2000000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentOneMember_p32be_SWykGz2teKntXcOw"
      decimals="-6"
      id="Narr_4fmUhK3jVkylZe8C7nGKIw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2000000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <mmsi:ContingentConsiderationPaymentPeriod
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_ContingentConsiderationPaymentTwoMember_ezEJWgK2Dki4vj-ItKKXBA"
      id="Narr_Vz2FVtGh9EyK16gXL_-0wA">P4Y</mmsi:ContingentConsiderationPaymentPeriod>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="Duration_4_30_2022_To_4_30_2022_us-gaap_AssetAcquisitionAxis_mmsi_RestoreEndosystemsLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_Q-sH4tc8t0y8Us3FOrczrg"
      decimals="-5"
      id="Narr_S3ewgPSnRkabeemsixQfgw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6500000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="Duration_4_1_2022_To_4_30_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_kSDG572XaUOLA_xcDYEc0Q"
      decimals="-5"
      id="Narr_Vp8F-53iq0G4bgjzbcn7gw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1400000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="As_Of_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_bvBD3HDjRUa2xKKy5B1nrA"
      decimals="-5"
      id="Narr_9gtU36L_jUSFX2H7tYHPNQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4700000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_bvBD3HDjRUa2xKKy5B1nrA"
      decimals="2"
      id="Narr_OwqIbvPlmUWRhl5ir1Dg8Q"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.17</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="Duration_9_1_2021_To_9_30_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_2Xu6PUGyB0KxT8eU3R1ceA"
      decimals="-5"
      id="Narr_jdAbpISAx0-caLwcwEFK4Q"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2700000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="Duration_1_1_2019_To_12_31_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_nvOWf0YPFkKnDI6lHS5MgA"
      decimals="-6"
      id="Narr_Lxu5H1RpjkKcjuEKNSoQYg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_12_31_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FluidxMedicalTechnologyLLCMember_WFeSl2nEiUeMnJom75DnaA"
      decimals="3"
      id="Narr_QsVsNkzsHEyniS65X9CucQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.150</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw"
      decimals="-5"
      id="Narr_AgPk8eudak2kU_ZGN4ISrQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <mmsi:BusinessCombinationConsiderationTransferredNotePayable
      contextRef="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw"
      decimals="-6"
      id="Narr_6xAnbXDRakKLZfgeSBlVXw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4000000</mmsi:BusinessCombinationConsiderationTransferredNotePayable>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_OvQHRNSqw06QppxX6EnjNA"
      id="Group_pAXQ1k8-iEmKR4VKhUzuxw">&lt;span style="background:#ffffff;"&gt;During the fourth quarter of 2021, certain immaterial measurement period adjustments were recorded to our purchase price allocation. &lt;/span&gt;The purchase price was allocated as follows (in thousands):&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:92.71%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets Acquired&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Inventories&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 211&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 298&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other long-term assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;Developed technology&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,570&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total assets acquired&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Liabilities Assumed&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (507)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (538)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:79.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total net assets acquired&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.2%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 14,588&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_zbJhaE7ZQ06nKZbH37b8sA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">24000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_QLpUYvMuGk-nZnTdk0OUCw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_184B5PuPdEeGTi7Q1QAcBg_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">211000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_-vbKkaLreEWpOnk-J8Gd0g_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">298000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_8bqDW567vUKTd1UfqJjBlQ_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_hsK8EQLFzEaatbWI6fI09A"
      decimals="-3"
      id="Tc_QXnIqhOktk-rby6gKKF62w_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_C9SH1Rb8_0mmfimJvX8Mxg_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8570000</us-gaap:Goodwill>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_v0ZOzsPCPkOb_Qn1q_8HRA_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15126000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_b6q5U9gRoUqpYNaZurOH3Q_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_KmIV-Xs3Y0OSU5PiaZfVmQ_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">507000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_FFhVFAmWIE2DS5lBVzzkeA_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">538000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A"
      decimals="-3"
      id="Tc_76DPlFpWiE6HfRR1m9Cevg_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14588000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember_oIKpm7mrOkCqi-F2r9hloA"
      id="Narr_NtEv9Bz8S06T6y00ytnG-Q">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_f7UrCzRQR0-Q4Z3NDMxXSw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;4.&lt;/b&gt;&lt;/span&gt;INVENTORIES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Inventories at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 147,051&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 132,403&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Work-in-process&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 29,534&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 22,160&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 89,406&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 67,359&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 265,991&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 221,922&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_qwBgxZeoZ0iWA3AQXKlZmg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Inventories at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 147,051&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 132,403&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Work-in-process&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 29,534&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 22,160&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 89,406&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 67,359&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:62.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 265,991&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 221,922&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_NvzmD7BH4Uad6EvD0LLuHw_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">147051000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_r5-lYX2R80GmURNNQdZIQg_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">132403000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_oLyVmyq0I02Qfp6irmO1sg_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29534000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_nsMefU1m5EWhNnPB7xN2jw_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">22160000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_8cYnapMmOkqZ2QHAkyRrBw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">89406000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_QdW2WxZxD0CPvg39urQL9g_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">67359000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_fZws5wYpYEipWqt5ePBzRw_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">265991000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_egx4NobdKkWto99ABiTIVw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">221922000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_8Hrn1JPULUqm5yJKxFwmqw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt; &lt;/span&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;5.&lt;/b&gt;&lt;/span&gt;GOODWILL AND INTANGIBLE ASSETS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The changes in the carrying amount of goodwill for the&#160;years ended December&#160;31,&#160;2022 and 2021, are as follows (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Goodwill balance at January&#160;1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 361,741&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 363,533&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Effect of foreign exchange&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,920)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,078)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions and adjustments as the result of acquisitions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 286&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Goodwill balance at December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 359,821&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 361,741&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Total accumulated goodwill impairment losses aggregated to $8.3 million as of December&#160;31,&#160;2022 and 2021. We did not have any goodwill impairments for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020. The total goodwill balance as of December&#160;31,&#160;2022 and 2021 is related to our cardiovascular segment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Other intangible assets at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 29,445&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,203)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 19,242&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Distribution agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,715)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 535&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;License agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,109&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (7,250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,859&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trademarks&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 30,221&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (17,863)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12,358&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Customer lists&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 34,105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (31,749)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,356&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 108,130&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (69,780)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 38,350&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 26,349&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (8,315)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,034&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Distribution agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,519)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 731&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;License agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12,663&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (7,768)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,895&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trademarks&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 30,242&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (15,256)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,986&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Customer lists&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 34,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (31,195)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,790&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 107,489&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (65,053)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 42,436&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Aggregate amortization expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $48.4 million, $49.6 million, and $58.6 million, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Estimated amortization expense for the developed technology and other intangible assets for the next five&#160;years consists of the following as of December&#160;31,&#160;2022 (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.45%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ending December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:28.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Estimated Amortization Expense&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 47,496&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 44,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 42,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,040&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 28,966&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;During the years ended December&#160;31,&#160;2022, 2021 and 2020, we identified indicators of impairment associated with certain acquired intangible assets based on our qualitative assessment that carrying amounts may not be recoverable, which required us to then complete a quantitative impairment assessment. The primary indicators of impairment &lt;span style="background:#ffffff;"&gt;were planned closure and restructuring activities and uncertainty about future product development and commercialization associated with certain acquired technologies, due in part to the economic impacts of the COVID-19 pandemic in 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;During the year ended &lt;span style="-sec-ix-hidden:Hidden_C8dJmPtioUimQru8e7qEng;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;, we recorded total impairment charges related to our intangible assets of $1.7 million for our divestiture on April 30, 2022 of the STD Pharmaceutical Products Limited (&#x201c;STD Pharmaceutical&#x201d;) business acquired in our August 2019 acquisition of Fibrovein Holdings Limited.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;During the year ended &lt;span style="-sec-ix-hidden:Hidden_VqI937vS7Uyy85OFwQu_0A;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;, we recorded total impairment charges related to our intangible assets of $1.6 million for the remaining carrying value of ArraVasc license agreements. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;During the year ended &lt;span style="-sec-ix-hidden:Hidden_jrl_1y8mUE2lw5OKuH_56w;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;, we recorded total impairment charges related to our intangible assets of $28.7 million which included &lt;span style="background:#ffffff;"&gt;a partial impairment charge of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$8.2&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million of intangible assets from our acquisition of &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_ys3ojRh7S0GRuIZh-sLDXg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;STD Pharmaceutical&lt;/span&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, &lt;/span&gt;a partial impairment charge of $8.0 million&lt;span style="background:#ffffff;"&gt; of intangible assets from our acquisition of certain assets from &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_gcPAqbzfw0OI2MXDaQHSdA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;Laurane Medical S.A.S&lt;/span&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, a partial impairment charge of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$4.8&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million related to our license agreements with &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_H5Y08u8ZsUaN3kikLiRRBA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;ArraVasc Limited&lt;/span&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, and &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_Xf0THVuuXkWITmOMBoHiHQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;other intangible asset&lt;/span&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; impairments charges of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$7.7&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million related to intangible assets from our acquisition of certain assets from DirectACCESS Medical, LLC, in-process technology intangible assets of Sontina Medical LLC &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;acquired in connection with our acquisition of certain divested assets from Becton, Dickinson and Company, and a customer list intangible asset&#160;from&#160;our acquisition of ITL Healthcare Pty Ltd (&#x201c;ITL&#x201d;).&lt;/span&gt;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_DRVBgVwtoEepjc_d5g6j9A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The changes in the carrying amount of goodwill for the&#160;years ended December&#160;31,&#160;2022 and 2021, are as follows (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Goodwill balance at January&#160;1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 361,741&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 363,533&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Effect of foreign exchange&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,920)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,078)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Additions and adjustments as the result of acquisitions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 286&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Goodwill balance at December&#160;31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 359,821&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 361,741&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_Hj9h6KkCr0m0CCY97KA_sQ_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">361741000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_aXNGHgBA8UCFtPRXEWESqA_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">363533000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_5wa2Sd0E4E2tz4B3mnn8_A_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1920000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_7opA6UJTJU6JOWwkyMmdXQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2078000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <mmsi:GoodwillPurchaseAccountingAdjustmentsAndAdditions
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_FgjDJqJ3-kmJ37ZpohCY4A_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">286000</mmsi:GoodwillPurchaseAccountingAdjustmentsAndAdditions>
    <us-gaap:Goodwill
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_mnJzOKQBZ0mrZI1hMyjrFg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">359821000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_yTTgF74ZnkCT6WzgjDQecw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">361741000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-5"
      id="Narr_pxZ0_lw5sUee6t489bdtHg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8300000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_ZrSRhlhuI0ii-l0X1hlaGA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8300000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_frlmbo_VCE-U1cT6CScNMA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_Au8RTFP-Qk205T9LpVYkww"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_dl6FnW-1k0admSTCpNCjQQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_ZREdzo_pGUOylSt8DzLhDQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Other intangible assets at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 29,445&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,203)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 19,242&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Distribution agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,715)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 535&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;License agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,109&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (7,250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,859&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trademarks&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 30,221&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (17,863)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12,358&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Customer lists&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 34,105&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (31,749)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,356&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 108,130&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (69,780)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 38,350&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:37.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net&#160;Carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 26,349&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (8,315)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,034&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Distribution agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,519)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 731&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;License agreements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12,663&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (7,768)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,895&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Trademarks&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 30,242&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (15,256)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,986&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Customer lists&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 34,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (31,195)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,790&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:59.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 107,489&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (65,053)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 42,436&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw"
      decimals="-3"
      id="Tc_hZ7xsBk4VkCFW8qABlrN4Q_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29445000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw"
      decimals="-3"
      id="Tc_RxDU9X50I0GsFFG09fW-tA_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10203000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_j1svgQlE2UaXZRFZOiBjDw"
      decimals="-3"
      id="Tc_5VCTqgqObk-mEeuckK0Eaw_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">19242000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA"
      decimals="-3"
      id="Tc_MS2gF6dNIEeddao2swudJg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3250000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA"
      decimals="-3"
      id="Tc_GzE9cNT0I0OnyYUmXKClDg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2715000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_1_GjUPLoN0WMP3sFLne4DA"
      decimals="-3"
      id="Tc_N5zUfETsWUGxoMd-97rZYg_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">535000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg"
      decimals="-3"
      id="Tc_8RtE9qRyb0Sm1uBvQMQ0lw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11109000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg"
      decimals="-3"
      id="Tc_aR_dhzUFYk-0vOdwHXNWYQ_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7250000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_safEShfmxUCWicS568-lcg"
      decimals="-3"
      id="Tc_0duFq31MlEOz2rmwSVqAdQ_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3859000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg"
      decimals="-3"
      id="Tc_8O1NF3eC20G0u5TPJTSvnw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">30221000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg"
      decimals="-3"
      id="Tc_Kj3I4APIGUmC792rOKoAtg_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">17863000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_9y2RY-oSwE-lG0EyxK4MGg"
      decimals="-3"
      id="Tc_86ZfKc2HT0y5wfanphGrXg_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12358000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q"
      decimals="-3"
      id="Tc_z_oTR1djQUKt_Ing237DcQ_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">34105000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q"
      decimals="-3"
      id="Tc_kinCVc0zjE2j4ZRwkO8sPg_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31749000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_iyOM_HpF_kGfb5AVqSlx5Q"
      decimals="-3"
      id="Tc_xhL07lEfKUmHKJuetyDfWQ_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2356000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA"
      decimals="-3"
      id="Tc_dV8XhckSjk6nAh8Q1mR1Jw_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">108130000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA"
      decimals="-3"
      id="Tc_cF9s0-TxFkO5d6Eg_wbeYg_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">69780000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA"
      decimals="-3"
      id="Tc_0NlQz7igRkaJw1H_bsQUDQ_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">38350000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw"
      decimals="-3"
      id="Tc_Xk2u2wLl9EWBrzZzuXJ5fQ_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">26349000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw"
      decimals="-3"
      id="Tc_duPugOZHWEqbQK3PemmEHg_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8315000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_PatentsMember_Y5RRRcV1x0CFBNwl2s5nCw"
      decimals="-3"
      id="Tc_0IlM7KN_fEGZPkyP0YBnIg_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18034000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w"
      decimals="-3"
      id="Tc_9yCKCug48UWaONYpBzLhQQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3250000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w"
      decimals="-3"
      id="Tc_bI3PNLLtu0W-VvF0O-m4nA_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2519000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DistributionRightsMember_8OSt4OfDskaUU9gFNT5r4w"
      decimals="-3"
      id="Tc_pg5E41R3Tky-kby8IvUdAA_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">731000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw"
      decimals="-3"
      id="Tc_IMMgx_njikW6PcsaHTscnw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12663000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw"
      decimals="-3"
      id="Tc_Ykehq7tK9kaGlmpqVUIU4A_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7768000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicensingAgreementsMember_klRwDLa5akWO0HbpN-Hhfw"
      decimals="-3"
      id="Tc_wwUg5jWCQ0KIRC5I3rBvDA_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4895000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew"
      decimals="-3"
      id="Tc_37eJ12H2hE6jUhNGeshVQg_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">30242000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew"
      decimals="-3"
      id="Tc_0jGu9F0RwU66-xeB2AfcIA_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15256000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember_Zpm9RTOueE6fixQUNHZHew"
      decimals="-3"
      id="Tc_KJrbBAen6UaWRrX7rpywJw_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14986000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA"
      decimals="-3"
      id="Tc_bKDuCiCEZkGseRgoNhpJHw_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">34985000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA"
      decimals="-3"
      id="Tc_FdWVASwwS0-oXgYMstxVzg_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31195000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerListsMember_xcth5zzbikKpsrC76JWzOA"
      decimals="-3"
      id="Tc_XZXiavwgREmqYTbZ_41OeA_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3790000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg"
      decimals="-3"
      id="Tc_kI4JB3bcTUyXvQ5ZGKvOBQ_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">107489000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg"
      decimals="-3"
      id="Tc_2YGJMg_auUi1vGotNwRRYg_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65053000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_24JnROBJrU6n6uAzcYYcEg"
      decimals="-3"
      id="Tc_3DKvj08YckORes7rlDka3w_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">42436000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_lDwtVN4ZXESy84r0mRwIVg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_bO9UReIiBEaIfqRKf_CSjA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">49600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_qj5nTU2Xh0mFh2JKZgdlKQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">58600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_iuW-7iIiwEmwSuO7BLv0PQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Estimated amortization expense for the developed technology and other intangible assets for the next five&#160;years consists of the following as of December&#160;31,&#160;2022 (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.45%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ending December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:28.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Estimated Amortization Expense&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 47,496&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 44,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 42,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,040&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:25.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 28,966&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_VMxTniLuKk-Dtg8ez3xlVQ_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">47496000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_3ikcCUN8lUicmEuCdBxaig_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">44434000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_V4BU6RI0fkyl1Vbazpxwow_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">42610000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_dwzB4ieCXkiZPAJa3MTN5A_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">32040000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_oOCJ74B-dUKPheSLSkv0aA_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">28966000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_Yg3eGli2zEW7bA8OSCslYA"
      decimals="-5"
      id="Narr_t2UxUY3ii02bv-wEe6qlJg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw"
      decimals="-5"
      id="Narr_o1YqQ2tJrkqLSNJ4OlzAkw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1600000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_3NOUndhvvkuYZh9EXNFHpQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">28700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_STDPharmaceuticalProductsLimitedMember_ccOqommAIUOJx6oYxeTW7g"
      decimals="-5"
      id="Narr_Ge79CGGwE0mNFFzdgSmpaQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8200000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_LauraneMedicalS.A.S.Member_1wpeXbI0cEecSrjzJb-LeQ"
      decimals="-5"
      id="Narr_IV_m_eYL60mzyjaxB499oQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8000000.0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_GZdF6FbMRk6IMRPpvp4agg"
      decimals="-5"
      id="Narr_zdg7adgVHE2cuKj4nCm1Tg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4800000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_BusinessAcquisitionAxis_mmsi_OtherIntangibleAssetsAcquiredMember_kqfrwoAXJEelfiTvRFAw3A"
      decimals="-5"
      id="Narr_qq2gGSZj-EiE3KpLg0K5zQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_e-qXvss9YkCwUpj-MMYW3w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;6.&lt;/b&gt;&lt;/span&gt;INCOME TAXES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was signed into law. The $2.2 trillion economic stimulus bill contains numerous tax law changes. We evaluated the tax changes to determine what provisions would apply to us. As permitted by the CARES Act, we have deferred payment of the employer&#x2019;s portion of social security payroll tax payments and made a payment equal to one half of the deferred amount during the year ended December 31, 2021. The remaining half was paid during the year ended December 31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law. We currently do not anticipate the recently enacted law, including the corporate alternative minimum tax, one percent excise tax on stock repurchases, or tax incentives to promote clean energy, to have a material impact on our consolidated financial statements.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, income (loss) before income taxes is broken out between U.S. and foreign-sourced operations and consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Domestic&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 77,562&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 21,328&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (32,216)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,067&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 32,589&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,985&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 82,629&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 53,917&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (13,231)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The components of the provision for income taxes for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Current expense (benefit):&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Federal&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 9,584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 808&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (937)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;State&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,162&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 437&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 10,291&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,480&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,407&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Total current expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 23,037&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 10,094&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,907&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred expense (benefit):&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Federal&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,438)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (468)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,688)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;State&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,615)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,845)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,524)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (871)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,318)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,083)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Total deferred benefit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (14,924)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,631)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (11,295)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;The difference between the income tax expense (benefit) reported and amounts computed by applying the statutory federal rate of 21.0% to pretax income (loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Computed federal income tax expense (benefit) at applicable statutory rate of 21%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 17,352&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,323&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,778)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;State income tax benefit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 35&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (283)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,448)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,978)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,507)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,391)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Tax effect of international items&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,698)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (281)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,705&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Uncertain tax positions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (47)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (455)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred compensation insurance assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 706&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (413)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (290)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,423)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,571)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,822)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,523&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,257&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;DOJ settlement&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,890&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Remeasurement of state deferred taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (375)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (526)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,765)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Non-deductible expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,077&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Remeasurement of contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,061&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 733&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,185)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other &#x2014; including the effect of graduated rates&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (70)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (183)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred income tax assets and liabilities at December&#160;31,&#160;2022 and 2021, consisted of the following temporary differences and carry-forward items (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax assets:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Allowance for credit losses on trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 1,925&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 1,494&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Accrued compensation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 9,968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 11,063&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Inventory differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 5,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 4,887&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 11,117&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 14,833&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Stock-based compensation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 7,167&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 6,388&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Operating lease assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 12,801&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 13,431&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Federal R&amp;amp;D tax credit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 634&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 5,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;UT R&amp;amp;D Credit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 4,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 4,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;IRC section 174 capitalized R&amp;amp;D &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 15,012&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 8,827&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 9,939&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total deferred income tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 77,842&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 71,164&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax liabilities:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Prepaid expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,047)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (20,925)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (20,797)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (38,547)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42,888)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Foreign withholding tax&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,571)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,575)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,527)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,938)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,040)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,556)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total deferred income tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (76,178)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (85,801)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (13,527)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,786)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net deferred income tax liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,863)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25,423)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reported as:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 6,599&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 6,080&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,462)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31,503)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net deferred income tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,863)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25,423)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 64.8pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:6pt;margin-left:0pt;visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. Deferred income tax balances reflect the temporary differences between the carrying amounts of assets and liabilities and their tax basis and are stated at enacted tax rates expected to be in effect when taxes are actually paid or recovered. The valuation allowance is primarily related to state credit carryforwards, non-US net operating loss carryforwards, and capital loss carryforwards for which we believe it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $2.7 million during the year ended December 31, 2022, increased by $573,000 during the year ended December 31, 2021, and increased by $5.6 million during the year ended December 31, 2020.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2022, we had U.S federal net operating loss carryforwards of $29.7 million, which were generated by Cianna Medical, Vascular Access Technologies, Inc., DFINE Inc., and Biosphere Medical, Inc., prior to our acquisition of these companies. These net operating loss carryforwards are subject to annual limitations under Internal Revenue Code Section 382. If unused $29.6 million of the NOLs will expire between 2025 and 2037. Of the NOLs incurred post-2017, $97,000 can be carried forward indefinitely. We anticipate that we will utilize all current net operating loss carryforwards prior to their expiration dates over the next 13 years. We utilized a total of $15.9 million in U.S. federal net operating loss carryforwards during the year ended December 31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31,&#160;2022, we had $22.2 million of non-U.S. net operating loss carryforwards, of which $21.1 million have no expiration date and $1.1 million expire at various dates through 2034. Non-U.S. net operating loss carryforwards utilized during the year ended December 31, 2022 were not material.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We do not consider our foreign earnings to be permanently reinvested. Consequently, we have recorded tax expense of $320,000, $288,000 and $228,000 for foreign withholding taxes on unremitted foreign earnings during the years ended December 31, 2022, 2021 and 2020, respectively. Additionally, for the year ended December 31, 2022, a tax benefit of $4.3 million was recorded with respect to the restructuring of our foreign entities and the associated change in foreign withholding taxes on the unremitted foreign earnings.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining our worldwide provision for income taxes and recording the related assets and liabilities. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. In our opinion, we have made adequate provisions for income taxes for all&#160;years subject to audit. We are no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019. In foreign jurisdictions, we are no longer subject to income tax examinations for&#160;years before 2016.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Although we believe our estimates are reasonable, the final outcomes of these matters may be different from those which we have reflected in our historical income tax provisions and accruals. Such differences could have a material effect on our income tax provision and operating results in the period in which we make such determination.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The total liability for unrecognized tax benefits at December&#160;31,&#160;2022, including interest and penalties, was $1.9 million, of which $1.9 million would favorably impact our effective tax rate if recognized. At December 31, 2022, none of the total liability was presented as a reduction to non-current deferred income tax assets on our consolidated balance sheet. The total liability for unrecognized tax benefits at December&#160;31,&#160;2021, including interest and penalties, was $2.0 million, of which $2.0 million would favorably impact our effective tax rate if recognized. At December 31, 2021, $1.0 million of the total liability was presented as a reduction to non-current deferred income tax assets on our consolidated balance sheet. As of December&#160;31,&#160;2022 and 2021, we had accrued $336,000 and $322,000 respectively, in total interest and penalties related to unrecognized tax benefits. We account for interest and penalties for unrecognized tax benefits as part of our income tax provision. During the&#160;years ended December&#160;31, 2022, 2021 and 2020, our liability for unrecognized tax benefit was increased (decreased) for interest and penalties by $14,000, $46,000, and $(90,000), respectively. We estimate it is reasonably possible that within the next 12&#160;months the total liability for unrecognized tax benefits may decrease, including expirations related to statutes of limitation, up to $109,000.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax benefits for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unrecognized tax benefits, opening balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,635&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,674&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,161&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross increases (decreases) in tax positions taken in a prior year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 115&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross increases in tax positions taken in the current year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 294&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 316&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 283&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lapse of applicable statute of limitations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (343)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (437)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (885)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unrecognized tax benefits, ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,635&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,674&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;The tabular roll-forward ending balance does not include interest and penalties related to unrecognized tax benefits.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_05Zz-XjrcEy7PKkiADHP2Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, income (loss) before income taxes is broken out between U.S. and foreign-sourced operations and consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Domestic&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 77,562&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 21,328&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (32,216)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,067&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 32,589&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,985&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 82,629&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 53,917&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (13,231)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_W-S5AmEgG0KbyNF3l7wtfw_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">77562000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_cVCHfBTavEq5UzNef8OGFQ_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">21328000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_E2IvyGwcNESKFTYX4PBBeg_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-32216000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_-URY4lbG0UONA1Q9Z92nrA_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5067000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_L0zlGgxDo06R3x2S2EvedA_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">32589000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_XS0IajaglE6N9e72fH6ZRw_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18985000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_dRwdnUxv2EqDVp5DH07S8w_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">82629000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_FscV2F5D_kS182qhMwJlsw_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">53917000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_INe0TCLUWky2r5D2kGi31A_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-13231000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_C2SfUc9fUE6B0bx9Ue6onQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The components of the provision for income taxes for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Current expense (benefit):&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Federal&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 9,584&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 808&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (937)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;State&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,162&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 437&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 10,291&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,480&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,407&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Total current expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 23,037&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 10,094&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,907&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred expense (benefit):&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Federal&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,438)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (468)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,688)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;State&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,615)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,845)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,524)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (871)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,318)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,083)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Total deferred benefit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (14,924)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (4,631)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (11,295)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_C38d_Qosq0qDsReBSj6zPw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9584000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_4sqPJ1YFyU-NnX4IKDuaGQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">808000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_iPtnFs3100WvqfG6ine1ew_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-937000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_en5c1SnU2UWm6vUF-XGqiw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3162000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_LKdwGqMKvEKc2FJ_oudUxQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">806000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_OoQZJekx40-C7AYGLefdvQ_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">437000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_8ErmDQsEyk-VeBYnWDCmZg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10291000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_XRvAZTpBG0emrlF1gBtPQw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8480000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_-f8paenKpUqgEcZ8MI5Pvw_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8407000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_z0g5z0Ep1Uuqa2GJSemywg_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">23037000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_auoKmKH8s0GyL1rXGmSyLg_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10094000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_1QbYzP9F9kKAhIMkEkABsg_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7907000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_relg5wY45UqxR92SJZUcyg_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10438000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_VToSL9KthE-ON2OXrcvukA_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-468000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_NBuNArVqY0KZWBDuu1GKHQ_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2688000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_-86zWzAeAUK13dEAXlt5zg_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3615000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_YqCZ1oOzy0Oga6UPXcl6GQ_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1845000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_5h1g9aMkMUmIPI5Cubs7AQ_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4524000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_4-o5_YXssEG0UganzDRnBg_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-871000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_DqlSuMREPEidnFuZhI0Knw_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2318000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_XhOBuRN4Vk6l4QB96Kzwpg_11_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4083000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_cOWbYY5bEUKlKGh7bttoWQ_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-14924000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_UXBtciIzPU-87eJQq5muXA_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4631000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_C3944l7cb0mIRuvD5tbpoQ_12_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11295000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_gYD2CXMIFEeo8O7V2rFkzA_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8113000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_C6DJLYZcMkipmAYXL95Wig_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5463000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_YCbTBSAuPE20NpF-g_x2ug_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3388000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_Udu2fqdbLE6-S7u3pdRvqA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;The difference between the income tax expense (benefit) reported and amounts computed by applying the statutory federal rate of 21.0% to pretax income (loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Computed federal income tax expense (benefit) at applicable statutory rate of 21%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 17,352&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,323&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,778)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;State income tax benefit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 35&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (283)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,448)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,978)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,507)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,391)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Tax effect of international items&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,698)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (281)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,705&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Uncertain tax positions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (47)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 401&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (455)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Deferred compensation insurance assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 706&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (413)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (290)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,423)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (5,571)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,822)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,523&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,257&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;DOJ settlement&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,890&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Remeasurement of state deferred taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (375)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (526)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,765)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Non-deductible expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,077&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Remeasurement of contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,061&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 733&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,185)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other &#x2014; including the effect of graduated rates&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (70)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (183)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="3"
      id="Narr_ij1BWtIsnUyWd0Ybjde-WQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="3"
      id="Narr__yJCP2ZE9kO6oogZCqzMgQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="3"
      id="Narr_6usHWWLxgUGar5cB7SmXfQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="2"
      id="Narr_72y66aBgY0yy_p2ieYklew"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="2"
      id="Narr_cFrcJGrMCUiKFXs_ym32_Q"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Narr_8mEkR9fQv0eV5QpMKhZVbw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_PyPevA5zSEamhBjU8sV3yA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">17352000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_dKuP0AGOWEK-_PQ2vEO5pw_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11323000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_0giBqivj9UOLTc7IW0ZpaQ_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2778000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_XXbJ2GKEj0aig2NmAZrf1A_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">35000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_I8ZcAY98e0G5ULdnbF6-Jw_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-283000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_kKK7AsgaO0Cu70tFs0B8eQ_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1448000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_SJmLAvh6Gki2KmY-ZiEDdw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1978000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_2Y0-bDQfzUSs8ihLcvJWBQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2507000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_JlN3Y0uQbUqL0rovYpuBEw_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2391000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_EitBJxiMtU2NCEFtwkybAA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10698000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_wD2TA0vJG0KJf5VGMmb_8g_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-281000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_t6x7Fjqnhkuai1Ucc5XuHg_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4705000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_YixKfBUIBUGSSMS__P5BbQ_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-47000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_L8d58EXweky6-dpVXX2JlQ_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">401000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_vWMjCsk8QEeUWvFnEJ63-w_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-455000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_gTKsg2iVLkasYlb4oGPuiw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-706000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_YbELEqaBmEa9EHutejq9vw_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">413000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_3Keq8yFiL0CKAFT9txBzKg_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">290000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_cDK0-0eJMkWVkrzGtOBuWA_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3423000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_5j3WO5sYE0qA_64FcnfdDQ_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5571000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ruR2QnZtaE2Ce9p68r8nBg_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1822000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Sd9sW5O81UO1p-eU68ZBFw_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3523000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_tfuyE5b4fEKA5eR1Ao2PKA_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1257000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc__o7HQ2ZVl0y1zG0-0HiWzQ_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1890000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Gspns6KDIUGZKQacM6iNvQ_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">375000</mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount>
    <mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_GCxGpij-tE-XnlN0B5-nMw_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">526000</mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount>
    <mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_2E5p_z-uR0-pKltCLfAKQQ_11_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1765000</mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_UU6AT6fXpUK9UxesOMMEuQ_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2027000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_U33BxOzYy0OPmddcLoVtsQ_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2455000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_5X2OAdGkbke5adzIMP3GbQ_12_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1077000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_MgYRxpQ2OEirKmjuyMs6JA_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1061000</mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount>
    <mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_p1b-XAvbMEKWjRlqW5RQkQ_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">733000</mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount>
    <mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_RB9l17t-B0qSSmtR9Dl4kw_13_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1185000</mmsi:EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_abOOkaUi5kyhGZtk74DfkQ_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-70000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_S_faOvaXW0iGyrqmOcLq3Q_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">132000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_-xugn6Nop06vSTuCkqiKng_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-183000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_YJE3-3j1WUSqt96TaAQjwA_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8113000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_UiW7K4ThuEqnqPezw75xVA_15_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5463000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_XOOhKs827kG0timh7-34uw_15_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3388000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_Ut0At0rTnESdlewnkfvQeA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred income tax assets and liabilities at December&#160;31,&#160;2022 and 2021, consisted of the following temporary differences and carry-forward items (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax assets:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Allowance for credit losses on trade receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 1,925&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 1,494&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Accrued compensation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 9,968&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 11,063&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Inventory differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 5,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 4,887&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 11,117&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 14,833&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Stock-based compensation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 7,167&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 6,388&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Operating lease assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 12,801&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 13,431&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Federal R&amp;amp;D tax credit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 634&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 5,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;UT R&amp;amp;D Credit&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 4,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 4,126&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;IRC section 174 capitalized R&amp;amp;D &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 15,012&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 8,827&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 9,939&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total deferred income tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 77,842&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 71,164&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax liabilities:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Prepaid expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,047)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (20,925)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (20,797)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Intangible assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (38,547)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42,888)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Foreign withholding tax&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,571)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,575)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,527)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,938)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,040)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,556)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total deferred income tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (76,178)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (85,801)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (13,527)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,786)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net deferred income tax liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,863)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25,423)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reported as:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 6,599&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 6,080&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Deferred income tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,462)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31,503)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net deferred income tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,863)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (25,423)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 64.8pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:6pt;margin-left:0pt;visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_v9AQ_FaGKk-KQgIDKGZWGQ_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1925000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_3LAQFxdJh0e7z9pOMOIMiA_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1494000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_0mLIWl8AYk2PPmO3DLzHxg_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9968000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_ITR_RMmUfUymOdS6WAhyHA_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11063000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_T_8NneC3l02SPfiGOBHHRQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5712000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_CKJrz7Hc9Ui7Pvgb0bWu4A_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4887000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_YEJwSCAxc0WBpibxTnoGCA_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11117000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_YkojpCzVnkGSTvW-hS2dRQ_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14833000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_h13BiMtvNUm7tqeLq4tAPw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7167000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_s8ETu-xx8kGuhSabj_OSgw_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6388000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_HGB_J4QRyEiO6tPve7LUCA_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12801000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_p8Rc6C5ZM0i-mD3vmLt51g_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13431000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <mmsi:DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_ucXBwWZcjEGl46Fr7LWGJA_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">634000</mmsi:DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch>
    <mmsi:DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_RD6UG9tbPUyaXrh0BBWCVQ_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5003000</mmsi:DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch>
    <mmsi:DeferredTaxAssetsStateTaxCreditCarryforwardsResearch
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_HiUTCskDskqHMQnC5X1dPA_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4679000</mmsi:DeferredTaxAssetsStateTaxCreditCarryforwardsResearch>
    <mmsi:DeferredTaxAssetsStateTaxCreditCarryforwardsResearch
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_vhyVtiyU7E2L09kwAkw2VA_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4126000</mmsi:DeferredTaxAssetsStateTaxCreditCarryforwardsResearch>
    <mmsi:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_8x5nmLB8kkuAZcTCKeZJTw_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15012000</mmsi:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_MjRCScQclUWp63faNJNKcg_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8827000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_OtvKOHFlT0SpQ2DhkhlgQA_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9939000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_ZHSsbb1CCESpOz9b0VZEcQ_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">77842000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_hzgLgQA93E----P-FOxaQg_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">71164000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpense
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_6HNy8i9CRkuvigCOVVDSQQ_16_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1568000</us-gaap:DeferredTaxLiabilitiesDeferredExpense>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpense
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_PG8HX-OZekuFmVES8Bp3sQ_16_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1047000</us-gaap:DeferredTaxLiabilitiesDeferredExpense>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_2_eK-48DhU-y7hIwT3j05g_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20925000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_mO23A8am1Eaq-jy2FRnq6w_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20797000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_M-IJGshoF0iU5NP-vVuWMQ_18_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">38547000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_UiJnmtSMKEK-xX4IrDpfqA_18_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">42888000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <mmsi:DeferredTaxLiabilitiesForeignWithholdingTax
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_PNNxOvu1p0ixqNyqGZClBA_19_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1571000</mmsi:DeferredTaxLiabilitiesForeignWithholdingTax>
    <mmsi:DeferredTaxLiabilitiesForeignWithholdingTax
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_7ao47mx-dkGe5fuch_Mlbg_19_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5575000</mmsi:DeferredTaxLiabilitiesForeignWithholdingTax>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_Ipx_BuPUR0qhJWBLg3gBsA_20_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11527000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_W_pgPZ-mMUK8yClZM5GMjg_20_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11938000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_aW3VORQiKkepSMyCBpcpNg_21_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2040000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_4XpFCuqDZkKJwYVfrcGyDQ_21_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3556000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_FOoajWaO-kO-_Fa5cwoFMQ_22_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">76178000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_z9FkZ9KaNUmFZvtR2TlL7A_22_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">85801000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_D7T_zt6nfEaGXXrLNn-Ggg_23_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13527000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_8rgLyJgGPEaewV51qo7HbQ_23_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10786000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_JcZMyPYmdkqCgWvw_-mGrQ_24_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11863000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_QAag_S-UTE6Orm2isxoJ8A_24_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">25423000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_4wcbSrVdhU6lbVG2VPCuJA_27_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6599000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_HDWP0dP1pkuYYvU4PrhvAw_27_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6080000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_h332iVg0n0eZUOgsJlRLpw_28_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18462000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc__07NQ8L8mUme8pSm9dfI0Q_28_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31503000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_Z4wUjR5HgkmNe5imxveGSw_29_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11863000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_R9pArpbGFUabVoz28MTAYA_29_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">25423000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_hJI0cLvufkK1-n1Sn7nDfw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Narr_cHn-HwDCXkC_s6Com3EB1A"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">573000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_tAPPMlczJkeFHBM8cW98XA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_33HOSRatJU2cYuKctqj7dA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_fGTXof4L9kC2AsOYsnC7lA"
      decimals="-5"
      id="Narr_gSXa08Fc6EO378IautdNpg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_fGTXof4L9kC2AsOYsnC7lA"
      decimals="-3"
      id="Narr_AGLCtR4NrU67x4Fwaa6OuQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">97000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <mmsi:NetOperatingLossCarryforwardsUtilization
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_umbZmmf59kKHmVjonTjMXg"
      id="Narr_We7WCKDrNUmasMalmu9RVQ">P13Y</mmsi:NetOperatingLossCarryforwardsUtilization>
    <mmsi:NetOperatingLossCarryforwardsUsedInCurrentPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_umbZmmf59kKHmVjonTjMXg"
      decimals="-5"
      id="Narr_D9-ooMWW6k6n1c0Obw-Y-Q"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15900000</mmsi:NetOperatingLossCarryforwardsUsedInCurrentPeriod>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_qgaROuljG0evqJUPbPgt_Q"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">22200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_EqJKyjSWGE2cWtmKmguTYg"
      decimals="-5"
      id="Narr_iTpxdPL00Ui03pCbs_2-Vg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">21100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="As_Of_12_31_2022_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_EqJKyjSWGE2cWtmKmguTYg"
      decimals="-5"
      id="Narr_EpUQJWa4t02O3u5UvIYv7A"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Narr_VbIdi-NYW0qWol-V6fADZg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">320000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Narr_Zd62ZCf90Ue80ILnpOp9qg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">288000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Narr_yKt99fNDAkeUTarY8H8GvA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">228000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
    <mmsi:IncomeTaxExpenseBenefitRestructuringOfForeignEntities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_rYLzXpesF0urHM1_AGsMtg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4300000</mmsi:IncomeTaxExpenseBenefitRestructuringOfForeignEntities>
    <mmsi:UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_PudkBow6vUm4ZwPvSBvhyA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1900000</mmsi:UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_L4SDePm1u02GFP28-ClSNg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_cKeDn1tu7k2QXmrpCRIuTA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets>
    <mmsi:UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-5"
      id="Narr_qXAr1Vat9kOLpLgu2fpmpw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2000000.0</mmsi:UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-5"
      id="Narr_dSjLTzMR9ECp4wb5h71rgA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2000000.0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_JJ7s_SDgKkOB8F2jemSPAQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1000000.0</mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Narr_pMfrzSZzwEatJia7kaBq3g"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">336000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Narr_sBoHRR1c0kKcJ_UKLPxlCQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">322000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Narr_za4dv7QvBEebWy1acKiDHg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14000</mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits>
    <mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Narr_Bf3tDxUSbUqV6KyYJAbxJQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">46000</mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits>
    <mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Narr_wFAfra-qlkOejUBMgFn8bA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-90000</mmsi:UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_4HjX7W_AtkazUBHgOvHHrw"
      decimals="-3"
      id="Narr_1P305i-35E6heXM5ZI_qZQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">109000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_8d35pxwjHEq_0Qo5yhinng">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;A reconciliation of the beginning and ending amount of liabilities associated with uncertain tax benefits for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unrecognized tax benefits, opening balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,635&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,674&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,161&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross increases (decreases) in tax positions taken in a prior year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 115&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Gross increases in tax positions taken in the current year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 294&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 316&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 283&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Lapse of applicable statute of limitations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (343)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (437)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (885)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Unrecognized tax benefits, ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,635&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,674&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_4hwmsmT1s0S0XG3mq0FH5A_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1635000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_-Ftz8z9IKkitMHpmkXWWiw_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1674000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ"
      decimals="-3"
      id="Tc_5885hXVwi0a1SXb6-ZZo8g_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2161000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_aKNIR3f2g0ywOr_QmvbOnA_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_9f2tBQeTwU23PTCWP24MzQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">82000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_e6itYSqZREexbmov4F5RGA_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">115000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_47nAIZTCE0ynx2ufGIhKEg_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">294000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_eDJ3Lfd4KUWzzsaebLwYXw_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">316000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_jWJwqETC40eJkydgwJ1MGQ_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">283000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_td6AKW2y_EeEog7GrQKZPg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">343000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_nMkmlVwIDkeNN8v3Ls5qrQ_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">437000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_Xq3zh0G_LEqxp4x0dIYUhQ_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">885000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_lBXF8AolfUGOptHjXueoRg_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1576000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_-xo60j_MhUel_4RnXtYLyA_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1635000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_sb6z7Bosmk6VdOCAr34hRw_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1674000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_cgyV9e6580yGe26S_DdbyA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;7.&lt;/b&gt;&lt;/span&gt;ACCRUED EXPENSES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Accrued expenses at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll and related liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 58,620&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 59,435&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of contingent liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,813&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,735&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Advances from employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 165&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 201&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued rebates payable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,925&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,271&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued legal settlement&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 18,250&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 36,666&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 35,122&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 123,189&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 159,014&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;font-style:italic;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_X7WihVOWVE-H7TEEGEBhzg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Accrued expenses at December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll and related liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 58,620&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 59,435&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Current portion of contingent liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,813&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,735&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Advances from employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 165&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 201&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued rebates payable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,925&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,271&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued legal settlement&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 18,250&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 36,666&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 35,122&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 123,189&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 159,014&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_dJcXbsnpnUyx6Qeg7gIW5Q_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">58620000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_DyywB3dG_USkPlMTRGf4vw_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">59435000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_P6AazUYcEESqq2PqIIjf1Q_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15813000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_VUN3lyFf-UCslzqxWeWwEw_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">34735000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <mmsi:AdvancesFromEmployeesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_2ItlGmlJl0ioE0y7wWhU1g_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">165000</mmsi:AdvancesFromEmployeesCurrent>
    <mmsi:AdvancesFromEmployeesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_lE0LqjFCt06PcZUCvFCizw_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">201000</mmsi:AdvancesFromEmployeesCurrent>
    <mmsi:AccruedRebatesPayableCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_qD1_4afl0E2YPi9o-jJ_Aw_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10925000</mmsi:AccruedRebatesPayableCurrent>
    <mmsi:AccruedRebatesPayableCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_Ih29jXWsLEydBjQswBZaNw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11271000</mmsi:AccruedRebatesPayableCurrent>
    <mmsi:AccruedLegalSettlementCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_e_S5cBZ0_06tSmNG6cZZMw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1000000</mmsi:AccruedLegalSettlementCurrent>
    <mmsi:AccruedLegalSettlementCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_s46DIy-5ikulutUkqfChJg_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18250000</mmsi:AccruedLegalSettlementCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_s7WYWFonC02p2yMO-7JaBA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">36666000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_-j03v6YiXUamf9b1R8qPHA_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">35122000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_Gnp44WXPqUWJzWbiCOlQPg_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">123189000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_jZYLgT5G7k-z9wcJZIVtzw_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">159014000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_UW5w6epvcEy0nRToTJ3VfQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.&lt;/b&gt;&lt;/span&gt;REVOLVING CREDIT FACILITY AND LONG-TERM DEBT&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Principal balances outstanding under our long-term debt obligations as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Term loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 124,688&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 133,125&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Revolving credit loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 73,500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 110,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less unamortized debt issuance costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (179)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (290)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total long-term debt&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 198,009&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 242,835&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less current portion&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,438&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Long-term portion&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 186,759&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 234,397&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:17.4pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Third Amended and Restated Credit Agreement&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="font-family:'Segoe UI';visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;On July 31, 2019, we entered into a Third Amended and Restated Credit Agreement (the "Third Amended Credit Agreement"). The Third Amended Credit Agreement is a syndicated loan agreement with Wells Fargo Bank, National Association and other parties. The Third Amended Credit Agreement amends and restates in its entirety our previously outstanding Second Amended and Restated Credit Agreement and all amendments thereto. The Third Amended Credit Agreement provides for a term loan of&#160;$150&#160;million&#160;and a revolving credit commitment up to an aggregate amount of&#160;$600&#160;million, inclusive of sub-facilities for multicurrency borrowings,&#160;standby letters of credit and&#160;swingline loans. On July 31, 2024, all principal, interest and other amounts outstanding under the Third Amended Credit Agreement are payable in full. At any time prior to the maturity date, we may repay any amounts owing under all term loans and revolving credit loans in whole or in part, without premium or penalty, other than breakage fees (as defined in the Third Amended Credit Agreement).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;Revolving credit loans denominated in dollars and term loans made under the Third Amended Credit Agreement bear interest, at our election, at either the Base Rate or the Eurocurrency Rate (as such terms are defined in the Third Amended Credit Agreement) plus the Applicable Margin (as defined in the Third Amended Credit Agreement).&#160;Revolving credit loans denominated in an Alternative Currency (as defined in the Third Amended Credit Agreement) bear interest at the Eurocurrency Rate plus the Applicable Margin. Swingline loans bear interest at the Base Rate plus the Applicable Margin (as defined in the Third Amended Credit Agreement). Interest on each loan featuring the Base Rate is due and payable on the last business day of each calendar quarter; interest on each loan featuring the Eurocurrency Rate is due and payable on the last day of each interest period applicable thereto, and if such interest period extends over three months, at the end of each three-month interval during such interest period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;The Third Amended Credit Agreement is collateralized by substantially all of our assets. The Third Amended Credit Agreement contains affirmative and negative covenants, representations and warranties, events of default and other terms customary for loans of this nature.&#160;In particular, the Third Amended Credit Agreement requires that we maintain certain financial covenants, as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Covenant Requirement&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Consolidated Total Leverage Ratio &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 to 1.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Consolidated Interest Coverage Ratio &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3.0 to 1.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Facility Capital Expenditures &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;$50 million&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Maximum Consolidated Total Net Leverage Ratio (as defined in the Third Amended Credit Agreement) as of any fiscal quarter end.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Minimum ratio of Consolidated EBITDA (as defined in the Third Amended Credit Agreement and adjusted for certain expenditures) to Consolidated interest expense (as defined in the Third Amended Credit Agreement) for any period of four consecutive fiscal quarters.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Maximum level of the aggregate amount of all Facility Capital Expenditures (as defined in the Third Amended Credit Agreement) in any fiscal year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:normal;"&gt;As of December&#160;31,&#160;2022, we believe we were in compliance with all covenants set forth in the Third Amended Credit Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-style:normal;"&gt;As of December&#160;31,&#160;2022, we had outstanding borrowings of &lt;/span&gt;&lt;span style="font-style:normal;"&gt;$198.2&lt;/span&gt;&lt;span style="font-style:normal;"&gt; million &lt;/span&gt;&lt;span style="font-style:normal;"&gt;and issued letter of credit guarantees of &lt;/span&gt;&lt;span style="font-style:normal;"&gt;$3.2&lt;/span&gt;&lt;span style="font-style:normal;"&gt; million&lt;/span&gt;&lt;span style="font-style:normal;"&gt; under the Third Amended Credit Agreement, with additional available borrowings of approximately &lt;/span&gt;&lt;span style="font-style:normal;"&gt;$523&lt;/span&gt;&lt;span style="font-style:normal;"&gt; million, based on the leverage ratio required pursuant to the Third Amended Credit Agreement. Our interest rate as of December&#160;31,&#160;2022 was a fixed rate of &lt;/span&gt;&lt;span style="font-style:normal;"&gt;2.71%&lt;/span&gt;&lt;span style="font-style:normal;"&gt; on &lt;/span&gt;&lt;span style="font-style:normal;"&gt;$75&lt;/span&gt;&lt;span style="font-style:normal;"&gt; million as a result of an interest rate swap (see Note 9) and a variable floating rate of &lt;/span&gt;&lt;span style="font-style:normal;"&gt;5.38%&lt;/span&gt;&lt;span style="font-style:normal;"&gt; on &lt;/span&gt;&lt;span style="font-style:normal;"&gt;$123.2&lt;/span&gt;&lt;span style="font-style:normal;"&gt; million. &lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;Our interest rate as of December&#160;31,&#160;2021 was a fixed rate of&#160;&lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;2.71%&lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt; on &lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;$75&lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;&#160;million as a result of an interest rate swap and a variable floating rate of&#160;&lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;1.10%&lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt; on &lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;$168.1&lt;/span&gt;&lt;span style="font-style:normal;background:#ffffff;"&gt;&#160;million.&lt;/span&gt;&lt;span style="font-style:normal;"&gt; The foregoing fixed rates are exclusive of potential future changes in the applicable margin.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Certain of the interest rates applicable to our Third Amended Credit Agreement, and applicable to hedging instruments we have purchased to offset interest rate risk under our Third Amended Credit Agreement, are LIBOR-based. We anticipate replacement rates will be identified, as provided for in our Third Amended Credit Agreement, as LIBOR-based rates become unavailable.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;Future Payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Future minimum principal payments on our long-term debt as of December&#160;31,&#160;2022, are as follows (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Years&#160;Ending&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;Minimum &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Principal&#160;Payments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,250&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 186,938&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total future minimum principal payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 198,188&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_EBbzSiNIb0C9EMz8If8lAg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Principal balances outstanding under our long-term debt obligations as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Term loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 124,688&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 133,125&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Revolving credit loans&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 73,500&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 110,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less unamortized debt issuance costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (179)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (290)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total long-term debt&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 198,009&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 242,835&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Less current portion&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8,438&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:69.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Long-term portion&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 186,759&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 234,397&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_nxzNJ9zo90yLi_8Qv5ROqg"
      decimals="-3"
      id="Tc_RdgBR7owz0SX7u0Xe3flmA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">124688000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_cNga-H3nA0mvS1ecmQSc8w"
      decimals="-3"
      id="Tc_RJStGAd9kEqo4apHU4q24A_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">133125000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="As_Of_12_31_2022_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_mnlw2YbJNke1XUMLVydA-Q"
      decimals="-3"
      id="Tc_lgOG5lRBhUeTPA0fHYCOTA_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">73500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="As_Of_12_31_2021_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_9Ang2hn4Y0KLAWIwdCgBog"
      decimals="-3"
      id="Tc_OaId6HaBGEmKNRdh4TKORg_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">110000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_8Uq7NYhyAEaY15QeAnXbCQ_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">179000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_bPFlqCpSGE6H6M1DQ6KPVA_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">290000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_GPsZ0VEFlE-UQi9jkxLmSg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">198009000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_849Ad3nb50OkxLftwrV_vw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">242835000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_uHRh8B8dJE6JenMGztXq4A_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11250000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_yULZk33iGU2qKceH-_i_nQ_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8438000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_8oigAJxBkUSaGqxnQGyKfA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">186759000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_afJeRRKjf0KZBWcQBY4YUA_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">234397000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember_KKxUChovJUKc65GGLrR6Tg"
      decimals="-6"
      id="Narr_cj9006Jt-0qry8okBBJNBw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="As_Of_7_31_2019_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_LgZE-P7vHUGygqnbkaU4QA"
      decimals="-6"
      id="Narr_37UmAdM0k02fqSkRA7q_OA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mmsi:ScheduleOfLongTermDebtCovenantsTableTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_elx6ptl-okmoBypzGmGyWw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;The Third Amended Credit Agreement is collateralized by substantially all of our assets. The Third Amended Credit Agreement contains affirmative and negative covenants, representations and warranties, events of default and other terms customary for loans of this nature.&#160;In particular, the Third Amended Credit Agreement requires that we maintain certain financial covenants, as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Covenant Requirement&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Consolidated Total Leverage Ratio &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 to 1.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Consolidated Interest Coverage Ratio &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;3.0 to 1.0&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:77.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Facility Capital Expenditures &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;$50 million&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Maximum Consolidated Total Net Leverage Ratio (as defined in the Third Amended Credit Agreement) as of any fiscal quarter end.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Minimum ratio of Consolidated EBITDA (as defined in the Third Amended Credit Agreement and adjusted for certain expenditures) to Consolidated interest expense (as defined in the Third Amended Credit Agreement) for any period of four consecutive fiscal quarters.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Maximum level of the aggregate amount of all Facility Capital Expenditures (as defined in the Third Amended Credit Agreement) in any fiscal year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</mmsi:ScheduleOfLongTermDebtCovenantsTableTableTextBlock>
    <mmsi:LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA"
      decimals="INF"
      id="Narr_mATOnn4tFEa1Yj8O1vQ4yA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">4.0</mmsi:LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum>
    <mmsi:LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA"
      decimals="INF"
      id="Narr_6za50JDvmEGVgZtHkiGuTA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">3.0</mmsi:LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2>
    <mmsi:LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA"
      decimals="-6"
      id="Narr_ugVMWvH1Dk6N7y1DSGF45A"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">50000000</mmsi:LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="-5"
      id="Narr_rxRG9p2HMk-8OeKJfbE6Rw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">198200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="-5"
      id="Narr_8sk6PuMHGUCvVGbNuzsIOQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3200000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="-6"
      id="Narr_CzeHx9mR40ejhwAu31oqRg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">523000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="4"
      id="Narr_UxgOTFys6E-lJvP9DS0lEg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.0271</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongtermDebtPercentageBearingFixedInterestAmount
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="-6"
      id="Narr_VfJVMe6sLke10KlnJk7Aqw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">75000000</us-gaap:LongtermDebtPercentageBearingFixedInterestAmount>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="4"
      id="Narr_L2dYmr9tgUiDIsAYKophyw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.0538</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <us-gaap:LongtermDebtPercentageBearingVariableInterestAmount
      contextRef="As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg"
      decimals="-5"
      id="Narr_1E1AQCWUqEWUJ7wNbjLTRA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">123200000</us-gaap:LongtermDebtPercentageBearingVariableInterestAmount>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ"
      decimals="4"
      id="Narr_9MwXLI_QfkCfPwqmgnClGg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.0271</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongtermDebtPercentageBearingFixedInterestAmount
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ"
      decimals="-6"
      id="Narr_Cgjim5HAiUuv1nsCLB1MTQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">75000000</us-gaap:LongtermDebtPercentageBearingFixedInterestAmount>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ"
      decimals="4"
      id="Narr_SgRE0Xdrxk-YEsn-T3WPJg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.0110</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <us-gaap:LongtermDebtPercentageBearingVariableInterestAmount
      contextRef="As_Of_12_31_2021_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_0vfkHN9nf0aj-GX1RyOZiQ"
      decimals="-5"
      id="Narr_GATf1H_QRkWcBjt2Db9Qwg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">168100000</us-gaap:LongtermDebtPercentageBearingVariableInterestAmount>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_x7zoSwi2Jk-pL09HAaqozQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Future minimum principal payments on our long-term debt as of December&#160;31,&#160;2022, are as follows (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Years&#160;Ending&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;Minimum &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Principal&#160;Payments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,250&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 186,938&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:80.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total future minimum principal payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 198,188&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_RApkqJrhUkuxZBxDRZ84nQ_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_0qSAgwtHkUuwJP8GBN8vKQ_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">186938000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_b-wC2pS1NUunWMwcwAQsWQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">198188000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_-3iAR70PqUGQWoySEDQ42Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;9.&lt;/b&gt;&lt;/span&gt;DERIVATIVES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;General.&lt;/b&gt;&#160;Our earnings and cash flows are subject to fluctuations due to changes in interest rates and foreign currency exchange rates, and we seek to mitigate a portion of these risks by entering into derivative contracts.&#160;The derivatives we use are interest rate swaps and foreign currency forward contracts.&#160;We recognize derivatives as either assets or liabilities at fair value in the accompanying consolidated balance sheets, regardless of whether or not hedge accounting is applied.&#160;We report cash flows arising from our hedging instruments consistent with the classification of cash flows from the underlying hedged items.&#160;Accordingly, cash flows associated with our derivative programs are classified as operating activities in the accompanying consolidated statements of cash flows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We formally document, designate and assess the effectiveness of transactions that receive hedge accounting initially and on an ongoing basis.&#160;For qualifying hedges, the change in fair value is deferred in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;), a component of stockholders&#x2019; equity in the accompanying consolidated balance sheets, and recognized in earnings at the same time the hedged item affects earnings. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings throughout the term of the derivative. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest Rate Risk&lt;/b&gt;.&#160;Our debt bears interest at variable interest rates and, therefore, we are subject to variability in the cash paid for interest expense. In order to mitigate a portion of this risk, we use a hedging strategy to reduce the variability of cash flows in the interest payments associated with a portion of the variable-rate debt outstanding under our Third Amended Credit Agreement that is solely due to changes in the benchmark interest rate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;Derivatives Designated as Cash Flow Hedges&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;On August&#160;5, 2016, we entered into a pay-fixed, receive-variable interest rate swap with a current notional amount of&#160;$175 million&#160;with Wells Fargo Bank to fix the one-month LIBOR rate at&#160;1.12%. The variable portion of the interest rate swap was tied to the one-month LIBOR rate (the benchmark interest rate). The interest rate swap expired on July&#160;6, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 23, 2019, we entered into a pay-fixed, receive-variable interest rate swap with a notional amount of $75 million with Wells Fargo Bank to fix the one-month LIBOR rate at 1.71% for the period from July 6, 2021 to July 31, 2024. The variable portion of the interest rate swap is tied to the one-month LIBOR rate (the benchmark interest rate). On a monthly basis, the interest rates under both the interest rate swap and the underlying debt reset, the swap is settled with the counterparty, and interest is paid.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;At December&#160;31,&#160;2022 and 2021, our interest rate swaps qualified as cash flow hedges.&#160;The fair value of our interest rate swap at December&#160;31,&#160;2022 was an asset of $3.4 million, partially offset by $0.8 million in deferred taxes. The fair value of our interest rate swaps at December&#160;31,&#160;2021 was a liability of $1.4 million, partially offset by $0.4 million in deferred taxes.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Foreign Currency Risk&lt;/b&gt;.&#160;We operate on a global basis and are exposed to the risk that our financial condition, results of operations, and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. Our policy is to enter into foreign currency derivative contracts with maturities of up to two years. We are exposed to foreign currency exchange rate risk with respect to transactions and balances denominated in various currencies, with our most significant exposure related to transactions and balances denominated in Chinese Renminbi and Euros, among others. We do not use derivative financial instruments for trading or speculative purposes. We are not subject to any credit risk contingent features related to our derivative contracts, and counterparty risk is managed by allocating derivative contracts among several major financial institutions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;Derivatives Designated as Cash Flow Hedges&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is temporarily reported as a component of other comprehensive income (loss) and then reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. We entered into forward contracts on various foreign currencies to manage the risk associated with forecasted exchange rates which impact revenues, cost of sales, and operating expenses in various international markets. The objective of the hedges is to reduce the variability of cash flows associated with the forecasted purchase or sale of foreign currencies.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We enter into approximately 100 cash flow foreign currency hedges every&#160;month. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts, which qualified as cash flow hedges, with aggregate notional amounts of $87.8 million and $123.0 million, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;Derivatives Not Designated as Cash Flow Hedges&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We forecast our net exposure in various receivables and payables to fluctuations in the value of various currencies, and we enter into foreign currency forward contracts to mitigate that exposure. We enter into approximately 50 foreign currency fair value hedges every&#160;month. As of December&#160;31,&#160;2022 and 2021, we had entered into foreign currency forward contracts related to those balance sheet accounts with aggregate notional amounts of $92.4 million and $86.0 million, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance Sheet Presentation of Derivatives. &lt;/b&gt;As of December&#160;31,&#160;2022 and 2021, all derivatives, both those designated as hedging instruments and those that were not designated as hedging instruments, were recorded gross at fair value on our consolidated balance sheets. We are not subject to any master netting agreements. The fair value of derivative instruments on a gross basis is as follows (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Fair Value of Derivative Instruments Designated as Hedging Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Assets&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest rate swaps&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other assets (long-term)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 3,444&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Prepaid expenses and other assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 3,215&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 1,326&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other assets (long-term)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 56&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;(Liabilities)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest rate swaps&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,447)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,509)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,288)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (531)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (502)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Fair Value of Derivative Instruments Not Designated as Hedging Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Assets&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Prepaid expenses and other assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 1,512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;(Liabilities)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,946)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (856)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;Income Statement Presentation of Derivatives&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"&gt;Derivatives Designated as Cash Flow Hedges&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income ("OCI") in our consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&#160;of&#160;Gain/(Loss)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Recognized&#160;in&#160;OCI&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"&gt;Derivative instrument&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Interest rate swaps&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"&gt; 4,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"&gt; 1,402&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"&gt; (6,131)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Foreign currency forward contracts&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"&gt; 6,263&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"&gt; (1,521)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"&gt; (5,516)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on AOCI and net earnings in our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Consolidated Statements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&#160;of&#160;Gain/(Loss)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;reclassified&#160;from&#160;AOCI&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;width:39.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"&gt;Location in statements of income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Interest expense&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,339)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,261)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,994)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (12)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,509)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (872)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Revenue&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 3,583&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,592)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 36&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Cost of sales&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (631,882)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (589,418)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (562,698)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,436)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 1,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,288)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 12pt 0pt;"&gt;As of December&#160;31,&#160;2022, $2.7 million or $2.1 million after taxes, was expected to be reclassified from AOCI to earnings in revenue and cost of sales over the succeeding twelve&#160;months. As of December&#160;31,&#160;2022, $2.3 million, or $1.8 million after taxes, was expected to be reclassified from AOCI to earnings in interest expense over the succeeding twelve&#160;months.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;Derivatives Not Designated as Hedging Instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income (loss) for the&#160;years presented (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:30.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Derivative Instrument&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Location in statements of income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Foreign currency forward contracts&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_EbHCmjYljUGB_8dKno-fsQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"&gt;Other income (expense) &#x2014; net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,420&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,598)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,190)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;See Note&#160;15 for additional information about our derivatives.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_QrfXxo7G-0CQLXG-eerz5A"
      decimals="-6"
      id="Narr_45pfeuQikEOGFsZSecFbsw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">175000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="As_Of_8_5_2016_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractOneMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_mTy83y8sAEyrrLjPi86-Aw"
      decimals="INF"
      id="Narr_Sw_l_Xe5Ckyp1PIgLlO8HQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.0112</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_RnYw5KwjtEiUa6kDr0cJuw"
      decimals="-6"
      id="Narr_IBLEx0wAXUCO6npYKJMvcw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="As_Of_12_23_2019_srt_CounterpartyNameAxis_mmsi_WellsFargoFixedRateDerivativeContractTwoMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLiborSwapRateMember_0hUma_OATUuPqA-Tunbzmw"
      decimals="INF"
      id="Narr__-5rtHEuxU-VbNN77XfVcQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.0171</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JDBrXX4eGkm0WfKXgEw4_A"
      decimals="-5"
      id="Narr_cArMqUn4qUOR5Xj3z4xWvA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3400000</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DeferredTaxAssetsDerivativeInstruments
      contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JDBrXX4eGkm0WfKXgEw4_A"
      decimals="-5"
      id="Narr_h3ohrjAy7UeBZr3Ob9ugAQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">800000</us-gaap:DeferredTaxAssetsDerivativeInstruments>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JOxaSybhBEmm93r7VwCklA"
      decimals="-5"
      id="Narr_bpyaQWMU_UGLfI-oY49n5A"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1400000</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DeferredTaxAssetsDerivativeInstruments
      contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_JOxaSybhBEmm93r7VwCklA"
      decimals="-5"
      id="Narr_bAXcn1WQ0EyXWmzda0vRgA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">400000</us-gaap:DeferredTaxAssetsDerivativeInstruments>
    <us-gaap:DerivativeTermOfContract
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_8_8yxPQPFUu5XLbijWH-yA"
      id="Narr_Hyyab3uEaEW1EFbXBgfdtA">P2Y</us-gaap:DerivativeTermOfContract>
    <mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth
      contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA"
      decimals="0"
      id="Narr_vXl4I1WZBE-2ypbtic2UEg"
      unitRef="Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ">100</mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth>
    <us-gaap:DerivativeNotionalAmount
      contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA"
      decimals="-5"
      id="Narr_DI6Yu7KbD0eWGmT4FTam3w"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">87800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_H7J11ScbqEi4fWoBfmyKZw"
      decimals="-5"
      id="Narr_M_P1xWjuV0Kjo9BPUKMdjg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">123000000.0</us-gaap:DerivativeNotionalAmount>
    <mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth
      contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_YBlNOyPkLU23Z6ZjVlbEKA"
      decimals="0"
      id="Narr_7ZcPT9-noUWJlxscg22Gjg"
      unitRef="Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ">50</mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth>
    <us-gaap:DerivativeNotionalAmount
      contextRef="As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_YBlNOyPkLU23Z6ZjVlbEKA"
      decimals="-5"
      id="Narr_G_AonGyHgUeUIe1njCwk2w"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">92400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="As_Of_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_qFOq_wW62kSSMs1OwxY3-g"
      decimals="-5"
      id="Narr_5VAR6vd93kyz_ZwUQ0h2Bg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">86000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_hUiYn0Kyyk6TQTk3WvgQhQ">The fair value of derivative instruments on a gross basis is as follows (in thousands):&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Fair Value of Derivative Instruments Designated as Hedging Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Assets&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest rate swaps&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other assets (long-term)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 3,444&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Prepaid expenses and other assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 3,215&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 1,326&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other assets (long-term)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 56&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;(Liabilities)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest rate swaps&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,447)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,509)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,288)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other long-term obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (531)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (502)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-style:italic;font-weight:bold;"&gt;Fair Value of Derivative Instruments Not Designated as Hedging Instruments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;Sheet&#160;Location&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Assets&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Prepaid expenses and other assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 1,512&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;(Liabilities)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency forward contracts&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.81%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,946)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (856)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_IUTMOoGSYUSlf5FDP00RrQ"
      decimals="-3"
      id="Tc_0nJdVvSvykaPiwdi1vlk6Q_3_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3444000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_vMDqDRimQUGVsJqDaXM38A"
      decimals="-3"
      id="Tc_f87-zobg9kaB9FnGc-ZwXQ_4_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3215000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_L0K7XndHi0OEyV8MrOqpmA"
      decimals="-3"
      id="Tc_0_8tx5kTGEeoVS4vXHZd3Q_4_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1326000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_uNomnuKXAECdAPu7QMed0A"
      decimals="-3"
      id="Tc_1B3TC93dCECnF_vBQSKleA_5_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">56000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_d3jAs283gEicHG2ZvBV4CQ"
      decimals="-3"
      id="Tc_uqXl5e2xVEarWtvonTTcNw_5_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">179000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_BBWY2l8nB0G5rPJksNt47A"
      decimals="-3"
      id="Tc_gm9_lsrfF0WHVLaCti6PjA_8_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1447000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V3-frjJY_UmM_jR_g6jVHg"
      decimals="-3"
      id="Tc_hCzTGUCS6Eae3NNf1oaR1w_9_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1509000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_jOoxPiQ8oEKYkVGlwyYgBg"
      decimals="-3"
      id="Tc__YT7VBsiyE-XXiv-Qf-7bw_9_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2288000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_V96Xu0PnRkq7CZcqhwZ9wg"
      decimals="-3"
      id="Tc_rzoyOR0FAEmpXAfXUztaqg_10_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">531000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_6HKnbEJ3LkOuSxP6-rmASg"
      decimals="-3"
      id="Tc_0Eyua-f7IUeePm3ZBJITag_10_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">502000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_sDnLdoNkA0G_KKlMx5qh6g"
      decimals="-3"
      id="Tc_0T0FTdHlAEG8an2HsGVOfA_14_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1512000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OD_1uS3fckadl_NP9-khyA"
      decimals="-3"
      id="Tc_LIYwpu38ZkKhO-0-V6Dhtg_14_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">736000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_7Bk5S5y3pUqsM1mFsZA5qw"
      decimals="-3"
      id="Tc_xlhspwzor0Wrmm0vaSqq3Q_17_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1946000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_ubGIOi0F8UCMr2ybX-8S_g"
      decimals="-3"
      id="Tc_zDP96jKTXkeih8xwvdEWIg_17_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">856000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_F4K6nRzWlUCPjhk6VyCnMw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income ("OCI") in our consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&#160;of&#160;Gain/(Loss)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:49.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Recognized&#160;in&#160;OCI&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"&gt;Derivative instrument&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:47.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Interest rate swaps&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"&gt; 4,879&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"&gt; 1,402&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"&gt; (6,131)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:47.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Foreign currency forward contracts&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"&gt; 6,263&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"&gt; (1,521)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:13.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"&gt; (5,516)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on AOCI and net earnings in our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated balance sheets (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Consolidated Statements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amount&#160;of&#160;Gain/(Loss)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:39.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;reclassified&#160;from&#160;AOCI&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;width:39.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year Ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:top;white-space:nowrap;width:31.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"&gt;Location in statements of income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Interest expense&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,339)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,261)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,994)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (12)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,509)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (872)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Revenue&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 3,583&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,592)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 36&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:24.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Cost of sales&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (631,882)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (589,418)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (562,698)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,436)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0.05pt 0pt;"&gt; 1,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.88%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,288)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_zc2ERyYBRUKEX1L10n6VZA"
      decimals="-3"
      id="Tc_2meS2_j_BUK3BqwNtINkrQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4879000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_GVmvdOejHUemtyQusSrLBA"
      decimals="-3"
      id="Tc_AlQqsXUUm0yskxYRWqddrg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1402000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_cNz_-CadmU-KLZHsUgTE7w"
      decimals="-3"
      id="Tc_r-FRqHTYKEuStzjKL-QvIQ_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-6131000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_Ywl3JgUM702U95RFgQlRaw"
      decimals="-3"
      id="Tc_Hn8A3jqNg0aP5FHblCtw8Q_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6263000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_vnyL3I4nU0O1maZQbdeu6w"
      decimals="-3"
      id="Tc_x561jUM5s0OOqWLndrMkbw_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1521000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_bN8XBH6sl0Oi6_jiK3FrEA"
      decimals="-3"
      id="Tc_Nb4bhdL2TUaS45mkcXG_JA_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5516000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Rx96Z_8-zE6itOqWIaKFPA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6339000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc__8Z9M4ZiTUiLau65WdNstw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5261000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_1OvL4VgvNkGZIyyI_eu53w_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9994000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_J_jEZHS6W0CE4zFDg0hOEA"
      decimals="-3"
      id="Tc_xucNMKAkPk6ALyOtRIu06w_5_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-12000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_DSBEv7Elwk6u3sZ3evR8Mg"
      decimals="-3"
      id="Tc_tfOmWzf1gkeX0OchSBmdCA_5_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1509000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_EjcLYIKKkkCUoWHgDM1Mxg"
      decimals="-3"
      id="Tc_BVM-m_8t50CtsHS7KNWi8g_5_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-872000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_eXQMW6twHUWCyEBb_h_xFg_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1150981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_O1kHlzFbkUenvUZ5AbIFDg_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1074751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_fOarFw9HCUW0MPjl-s-hjQ_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">963875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_YtPykTJnRkKC0CuJpKTvOA"
      decimals="-3"
      id="Tc_9meOa9E1WU6_bqIZ7HK1vA_6_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3583000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_651_ONWx0E-kOfcPokz1LQ"
      decimals="-3"
      id="Tc_hk-plfKsiUaw_y4tdj2Hmg_6_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5592000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_RevenueFromContractWithCustomerMember_z9Y6hxatL0aNPYGB24x1vQ"
      decimals="-3"
      id="Tc_ABvmD8nu4Eid4eeHvMDm8A_6_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">36000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_hYDE8iKhpkSPQw7qMRMQWA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">631882000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_WmmwdUi2gka3EGwiedRGgw_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">589418000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ezxDZPUE9kKbwNNBJbpe2g_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">562698000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9e9qLIpZ9kKq6G-HazuXuA"
      decimals="-3"
      id="Tc_NcRqtMcFq0mYDXlqlQLPEg_7_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1436000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_9f2ZOgRsCESUeU-GyCvi5Q"
      decimals="-3"
      id="Tc_57o7cFLuyky_KE-6ZbRShQ_7_15"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1017000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Mb6B1L4bMUW6eZXS3Daluw"
      decimals="-3"
      id="Tc_VJJhlW4boE-612zoYFx0Mw_7_18"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1288000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew"
      decimals="-5"
      id="Narr_qJZpBAwB3E6On3PSgRMxcA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2700000</mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew"
      decimals="-5"
      id="Narr_v9r9LM0ppUmphd9mk589XQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2100000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_HwhbRLWUDECOhM6E1bMPeg"
      decimals="-5"
      id="Narr_0Arn_8sSb0GPnSQiVhLTSQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2300000</mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_HwhbRLWUDECOhM6E1bMPeg"
      decimals="-5"
      id="Narr_4hq3HTfi6UWImThm5Rz3fw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1800000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_trzGW2jPD0W-gocTFL0oMw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income (loss) for the&#160;years presented (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:30.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Derivative Instrument&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Location in statements of income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:37.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Foreign currency forward contracts&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_EbHCmjYljUGB_8dKno-fsQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"&gt;Other income (expense) &#x2014; net&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,420&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (1,598)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (2,190)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg"
      decimals="-3"
      id="Tc_YnRHOjQUeUGbv6A8WQwwng_3_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1420000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_a6q6MSDqW02kPa4lJGG3MQ"
      decimals="-3"
      id="Tc_WiWkjsIKTk2nNwllCovt5w_3_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1598000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_w_w-NqxInkmFUqMf_XcMMQ"
      decimals="-3"
      id="Tc_g8FjfTlj7EiD_CjHTjrEWA_3_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2190000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_xxOyhcTdP0CrQVizlR8KEw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;10.&lt;/b&gt;&lt;/span&gt;COMMITMENTS AND CONTINGENCIES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We are obligated under non-terminable operating leases for manufacturing facilities, finished good distribution centers, office space, equipment, vehicles, and land. See Note 17 for disclosures regarding these operating leases.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Royalties&lt;/b&gt;. As of December&#160;31,&#160;2022, we had entered into a number of agreements to license or acquire rights to certain intellectual property which require us to make royalty payments during the term of the agreements generally based on a&#160;percentage of sales. During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, total royalty expense approximated $7.3 million, $7.6 million and $7.1 million, respectively, and is recorded in cost of sales on the consolidated statement of income (loss). Minimum contractual commitments under royalty agreements to be paid within twelve&#160;months of December&#160;31,&#160;2022 were not significant. See Note&#160;15 for discussion of future royalty commitments related to acquisitions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Litigation&lt;/b&gt;.&#160;In the ordinary course of business, we are involved in various claims and litigation matters. T&lt;span style="background:#ffffff;"&gt;hese proceedings, actions and claims may involve product liability, intellectual property, contract disputes, employment, governmental &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;inquiries or other matters, including those more fully described below.&#160;The outcomes of these matters will generally not be known for prolonged periods of time. In certain proceedings, the claimants may seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief.&#160;For legal matters for which our management had sufficient information to reasonably estimate our future obligations, a liability representing management&#x2019;s best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded.&#160;The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect our financial position, results of operations and cash flows. The ultimate cost to us with respect to&lt;/span&gt; actions and claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Shareholder Derivative Action&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;On June 3, 2021, Steffen Maute filed a complaint, derivatively on behalf of Merit, against Merit (as a nominal defendant), our Chief Executive Officer, our Chief Financial Officer, our former President of EMEA and certain of our directors in the United States District Court for the District of Utah (Case No. 2:21-cv-00346-DBP). The derivative complaint alleged that the individual defendants violated their fiduciary duties owed to Merit and were unjustly enriched at the expense of and to the detriment of Merit between February 2019 and October 2019, and sought unspecified damages, costs, and professional fees. Following mediation, the parties negotiated an agreement to settle the dispute, which, among other provisions, provides for the release of all claims against Merit and the other defendants in exchange for Merit&#x2019;s undertaking to implement certain corporate governance revisions and pay attorneys fees and expenses in the amount of $1.0 million. On February 16, 2023, the court held a hearing and announced approval of the settlement, which has the effect of resolving all claims arising from the litigation. The expense associated with the settlement has been reflected in our financial results reported for the year ended December 31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;SEC Inquiry &lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;We have received requests from the Division of Enforcement of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) seeking the voluntary production of information relating to the business activities of Merit&#x2019;s subsidiary in China, including interactions with hospitals and health care officials in China. We are cooperating with the requests and investigating the matter and, at this time, are unable to predict the scope, timing, significance or outcome of this matter.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;It is possible that the ultimate resolution of the foregoing matter, or similar matters, if resolved in a manner unfavorable to us, may be materially adverse to our business, financial condition, results of operations or liquidity. Legal costs for these matters, such as outside counsel fees and expenses, are charged to expense in the period incurred.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RoyaltyExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_bbrBKCNcLUOQmTf4LjLfbA"
      decimals="-5"
      id="Narr_joVNrkpUikG-9f7gaD3CbA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7300000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W7ZIFyCygUuKNAAvOSvoSA"
      decimals="-5"
      id="Narr_oddmQ5fd_068kcAyp6_C2w"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7600000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_Nn7nL1keE0GsDMUUEXCHfw"
      decimals="-5"
      id="Narr_3qdC40YLlESKaHtcsukYbA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7100000</us-gaap:RoyaltyExpense>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_LitigationCaseAxis_mmsi_MeritShareholderDerivativeSuitMember_ewzR_Ik4L0K4K-iU6Qne5Q"
      decimals="-5"
      id="Narr_W2Vjskr8qEK3T13F26hEuQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1000000.0</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_7PksVFuKNUKP3wz0iTHBUw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;11.&lt;/b&gt;&lt;/span&gt;EARNINGS PER COMMON SHARE (EPS)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;The computation of weighted average shares outstanding and the basic and diluted earnings (loss) per common share for the following periods consisted of the following (in thousands, except per share amounts):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 74,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 48,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (9,843)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Average common shares outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,145&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 55,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Basic EPS&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 0.86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.18)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Average common shares outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,145&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 55,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Effect of dilutive stock awards&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,214&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total potential shares outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 57,671&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 57,359&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 55,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Diluted EPS&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 0.84&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.18)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Equity awards excluded as the impact was anti-dilutive &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 799&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Does &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;not&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; reflect the impact of incremental repurchases under the treasury stock method. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_3TNvpmKHy06NIM4WZHrKmg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;The computation of weighted average shares outstanding and the basic and diluted earnings (loss) per common share for the following periods consisted of the following (in thousands, except per share amounts):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 74,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 48,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (9,843)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Average common shares outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,145&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 55,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Basic EPS&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 0.86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.18)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Average common shares outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,806&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,145&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 55,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Effect of dilutive stock awards&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,214&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total potential shares outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 57,671&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 57,359&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 55,434&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Diluted EPS&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1.29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 0.84&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (0.18)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Equity awards excluded as the impact was anti-dilutive &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 799&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Does &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;not&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; reflect the impact of incremental repurchases under the treasury stock method. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_-MUeoRD_4EWihOEIttfGMA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_5a3PsTSuMUac5HUf20DqtA_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_aIYM5sWrMUCgfWhwwZI3eA_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_A6FlFgvhjk6-h22WXANm0g_3_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56806000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_cOpguE4HpUiG2JPKQ4836g_3_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56145000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_3vg0cZ0WsUmEewMAZ0FS1w_3_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55434000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_iiFxIZFiWEOzkhqsP-kpaA_4_3"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">1.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="2"
      id="Tc_qmQMCPzTRk6OEgWOS52v3A_4_6"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="2"
      id="Tc_-bNZfG7Aakm0aPiC9sSycg_4_9"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_bab-8ONdLEuDQ7DxW91tEg_6_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56806000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_txz5ONn0LkShmXQCgpGmJg_6_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">56145000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_6-401uZsPU2rxJ4N0U3jiA_6_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55434000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_QYCgI7Mwp0qxmfuAt8ZBHA_7_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">865000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_uQRUk4CKS0ezYU0qKc0R6A_7_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">1214000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_VmsawPbrbEepCs98ZflP0g_8_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57671000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_KSeHSKILn0GbqMp7gYgsTA_8_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">57359000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_ScVT95KTN0eCuYNVKPDp3g_8_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">55434000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_RGj-CXhj5EiHp8gwX4W8Ug_9_3"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="2"
      id="Tc_5FevTUFoJkOCVoFfNJn1Zw_9_6"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="2"
      id="Tc_hkS4t9DNUUmPykkxXLpcBA_9_9"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_N3bwm3QOEEWF74cPy4zzeQ_11_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">1438000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_k0xTrW2-c0yobjLn_Bz-qw_11_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">799000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_mcMkMQynxUKzRNs-HjITvQ_11_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">4216000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_gXS9-BRpeEe291cNUxFecA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;12.&lt;/b&gt;&lt;/span&gt;EMPLOYEE STOCK PURCHASE PLAN, STOCK OPTIONS AND WARRANTS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Our stock-based compensation primarily consists of the following plans:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2018 Long-Term Incentive Plan&lt;/b&gt;.&#160;In June&#160;2018, our Board of Directors adopted and our shareholders approved, the Merit Medical Systems,&#160;Inc. 2018 Long-Term Incentive Plan, which was subsequently amended effective December&#160;14, 2018 (the &#x201c;2018 Incentive Plan&#x201d;) to supplement the Merit Medical Systems,&#160;Inc. 2006 Long-Term Incentive plan (the "2006 Incentive Plan").&#160;The 2018 Incentive Plan provides for the granting of stock options, stock appreciation rights, restricted stock, stock units (including restricted stock units) and performance awards (including performance stock units).&#160;Options may be granted to directors, officers, outside consultants and key employees and may be granted upon such terms and such conditions as the Compensation Committee of our Board of Directors determines.&#160;Options typically vest on an annual basis over a &lt;span style="-sec-ix-hidden:Hidden_hlnL4vN8SUG8ae4Eqn09kg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;three&lt;/span&gt;&lt;/span&gt; to five-year life with a contractual life of seven years. As of December&#160;31,&#160;2022, a total of 2,817,861 shares remained available to be issued under the 2018 Incentive Plan. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2006 Long-Term Incentive Plan&lt;/b&gt;. In May&#160;2006, our Board of Directors adopted, and our shareholders approved, the 2006 Incentive Plan. As of December&#160;31,&#160;2022, the 2006 Incentive Plan was no longer being used for new equity award grants. However, as of December&#160;31,&#160;2022, options granted under this plan were still outstanding, vesting, and being exercised and will continue to be outstanding until the vesting periods end and the terms of the equity awards expire.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Employee Stock Purchase Plan&lt;/b&gt;. We have a non-qualified Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which has an expiration date of June&#160;30, 2026. As of December&#160;31,&#160;2022, the total number of shares of common stock that remained available to be issued under our non-qualified plan was 102,739 shares. ESPP participants purchase shares on a quarterly basis at a price equal to 95% of the market price of the common stock at the end of the applicable offering period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock-Based Compensation Expense&lt;/b&gt;.&#160;The stock-based compensation expense before income tax expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Nonqualified stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,357&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Nonqualified stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,789&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,343&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,157&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Nonqualified stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,305&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 6,678&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,332&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Performance-based restricted stock units&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,509&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,525&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,829&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Restricted stock units&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,836&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,557&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 758&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Cash-settled performance-based share-based awards ("Liability Awards")&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,511&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 906&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Total selling, general and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,647&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 13,271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,825&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock-based compensation expense before taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,042&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,090&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,339&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We recognize stock-based compensation expense (net of a forfeiture rate) for those awards which are expected to vest on a straight-line basis over the requisite service period.&#160;We estimate the forfeiture rate based on our historical experience and expectations about future forfeitures.&#160;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Nonqualified Stock Options&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31,&#160;2022, the total remaining unrecognized compensation cost related to non-vested stock options, net of expected forfeitures, was $20.4 million and is expected to be recognized over a weighted average period of 2.1 years.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;In applying the Black-Scholes methodology to the option grants, the fair value of our stock-based awards granted was estimated using the following assumptions for the years ended December&#160;31,&#160;2022, 2021 and 2020:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.57%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;1.4% - 4.3%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.5% - 1.1%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.3% - 1.7%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected option term&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 - 5.0 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected price volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;46.2% - 47.5%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;46.1% - 46.7%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;38.7% - 45.1%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The average risk-free interest rate is determined using the U.S.&#160;Treasury rate in effect as of the date of grant, based on the expected term of the stock option.&#160;We determine the expected term of the stock options using the historical exercise behavior of employees.&#160;The expected price volatility was determined based upon the historical volatility for our stock. We recognize compensation expense for options on a straight-line basis over the service period, which corresponds to the vesting period.&#160;During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, approximately 251,000, 716,000 and 329,000 nonqualified stock option grants were made, respectively, for a total fair value of $6.3 million, $17.5 million and $4.5 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The table below presents information related to stock option activity for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total intrinsic value of stock options exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 27,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 36,086&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,733&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cash received from stock option exercises&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,952&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 20,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,481&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Excess tax benefit from the exercise of stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,423&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,571&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,815&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Changes in stock options for the&#160;year ended December&#160;31,&#160;2022, consisted of the following (shares and intrinsic value in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&#160;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Remaining&#160;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of&#160;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercise&#160;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Term&#160;(in&#160;years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 44.70&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 63.69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (703)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 28.58&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Forfeited/expired&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (111)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 53.16&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Outstanding at December 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,077&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 49.62&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3.51&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 64,634&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,792&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 43.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2.61&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 48,595&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ending vested and expected to vest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,013&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 49.37&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3.47&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 64,026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted average grant-date fair value of options granted during the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 was $24.98, $24.38 and $13.70, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Stock-Settled Performance-Based Restricted Stock Units (&#x201c;PSUs&#x201d;) and Time-Vested Restricted Stock Units (&#x201c;RSUs&#x201d;)&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Since 2020, we have granted PSUs to certain of our executive officers. Conversion of PSUs occurs at the end of &lt;span style="-sec-ix-hidden:Hidden_xGgJ2uRJGkuzkcphmVUYXA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;one&lt;/span&gt;&lt;/span&gt;, &lt;span style="-sec-ix-hidden:Hidden_z1_aUA5vikuLxGHYLl_gBQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;two&lt;/span&gt;&lt;/span&gt; and three-year performance periods, or one year after the agreement date, whichever is later. The conversion ratio is based upon attaining targeted levels of free cash flow (&#x201c;FCF&#x201d;) and relative shareholder return as compared to the Russell 2000 Index (&#x201c;rTSR&#x201d;), as defined in the award agreements. In 2020, our Board of Directors amended PSUs granted in 2020 with a one-year performance period to adjust the performance targets and reduce the maximum FCF multiplier to 100% for the one-year awards, which lowered the potential shares of our common stock to be granted pursuant to the one-year awards by 25,415 shares. We accounted for this amendment in accordance with ASC 718 as a &#x201c;Type I&#x201d; modification.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;The payout for each PSU is equal to one share of common stock multiplied by a FCF multiplier (between 50% and 100% in the case of the 2020 one-year awards, as amended, or 50% and 200% in the case of all other PSU awards) and a rTSR multiplier (between 75% and 125%). PSUs convey no shareholder rights unless and until shares are issued in settlement of the award. We use Monte-Carlo simulations to estimate the grant-date fair value of the PSUs linked to total shareholder return. Compensation expense is recognized using the grant-date fair value for the number of shares that are probable of being awarded based on the performance conditions. Each reporting period, this probability assessment is updated, and cumulative catchups are recorded based on the level of FCF that is expected to be achieved. At the end of the performance period, cumulative expense is calculated based on the actual level of FCF achieved.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;We grant RSUs to our non-employee directors, which are subject to continued service through the vesting date, which is one year from the date of grant. The expense recognized for RSUs is equal to the closing stock price on the date of grant, which is recognized over the vesting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Changes in PSUs and RSUs for the&#160;year ended December&#160;31,&#160;2022, consisted of the following:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;PSUs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;RSUs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&#160;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&#160;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock Units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock Units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In Thousands)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In Thousands)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Beginning nonvested balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 163&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 53.71&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 61.77&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 64.54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 59.02&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;rTSR adjustment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 65.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Vested&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (44)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 65.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (26)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 61.77&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (45)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 60.81&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Nonvested balance at December 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 65.20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 59.02&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Based on the maximum payout, excluding the impact of the rTSR multiplier. The actual number of shares which vest is determined based on the satisfaction of performance conditions and the application of an rTSR multiplier between &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;75%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;125%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Represents the application of an rTSR multiplier of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;125%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; to awards vested in 2022 based on the performance of our common stock and the terms of the awards.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;The following table summarizes PSUs and RSUs granted during the years ended December 31, 2022, 2021, and 2020 (units and shares in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;PSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Target units granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;52&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 61&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Maximum units granted &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;103&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 102&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Maximum potential shares&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt; (1)(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;121&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;129&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 127&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Weighted average grant date fair value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;64.54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;61.39&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 43.63&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Units granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Weighted average grant date fair value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;59.02&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;61.77&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 42.98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Based on the maximum payout, excluding the impact of the rTSR multiplier. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Includes the impact of the maximum potential rTSR multiplier of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;125%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Includes the impact of the 2020 amendment which reduced the maximum FCF multiplier for one-year awards from &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;200%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;100%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;During the years ended December 31, 2022 and 2021, there were approximately 44,000 and 26,000 shares, respectively, that vested under PSUs, prior to the reduction of shares withheld to satisfy tax withholding obligations. Vested shares were calculated based upon achievement of the maximum performance multiplier, as amended, of 200% and 100% for 2022 and 2021, respectively, and an rTSR multiplier of 125%. There were no shares that vested under PSUs during the year ended December 31, 2020. During the years ended December 31, 2022 and 2021, there were approximately 26,000 and 34,000 shares, respectively, that vested under RSUs. There were no shares that vested under RSUs during the year ended December 31, 2020.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;The fair value of each PSU was estimated as of the grant date using the following assumptions for awards granted in the years ended December 31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;1.6% - 2.7%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.1% - 0.3%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Performance period&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;2.6 - 2.8 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;1.8 - 2.8 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected price volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;38.5% - 42.6%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;43.7% - 49.3%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;The risk-free interest rate of return was determined using the U.S. Treasury rate at the time of grant with a remaining term equal to the expected term of the award. The expected volatility was based on a weighted average volatility of our stock &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;price and the average volatility of our compensation peer group's volatilities. The expected dividend yield was assumed to be zero because, at the time of the grant, we had no plans to declare a dividend.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31,&#160;2022, the total remaining unrecognized compensation cost related to stock-settled performance stock units and restricted stock units, net of expected forfeitures, was $4.7 million and $0.7 million, respectively, which is expected to be recognized over a weighted average period of 1.6 years and 0.4 years, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;i style="font-style:italic;"&gt;Cash-Settled Performance-Based Share-Based Awards (&#x201c;Liability Awards&#x201d;)&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;During the years ended December&#160;31,&#160;2022, 2021 and 2020, we granted liability awards to certain executive officers. These awards entitle them to cash payments equal to a total target cash incentive of $1.0 million, $1.0 million, and $1.0 million, respectively, multiplied by rTSR and FCF multipliers, as defined in the award agreements. In 2020, our Board of Directors amended the liability awards with a one-year performance period. The potential maximum payout of these liability awards is 125% of the target cash incentive for the 2020 one-year award, as amended, and 250% of the target cash incentive for all other liability awards, resulting in a total potential maximum payout of $2.5 million and $2.5 million for liability awards granted during the years ended December 31, 2022 and 2021, respectively. Settlement generally occurs at the end of &lt;span style="-sec-ix-hidden:Hidden_d8w-m4ewDEurtEdt4iLbkQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;one&lt;/span&gt;&lt;/span&gt;, &lt;span style="-sec-ix-hidden:Hidden_t8cBNSblNE-IWNGe1sg12Q;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;two&lt;/span&gt;&lt;/span&gt; and three-year performance periods based upon the same performance metrics and vesting period as our performance stock units. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;These awards are classified as liabilities and reported in accrued expenses and other long-term liabilities within our consolidated balance sheet. The fair value of these awards is remeasured at each reporting period until the awards are settled. As of December 31,&#160;2022, our recorded liabilities associated with these awards was $3.2 million, and we had remaining unrecognized compensation cost related to cash-settled performance-based share-based awards of $1.9 million, which is expected to be recognized over a weighted average period of 1.7 years. During 2022 and 2021, we paid $833,000 and $417,000, respectively, in connection with liability awards, and no awards were forfeited. There were no liability awards vested or &lt;span style="-sec-ix-hidden:Hidden_eEnAFWZ5UEGI9LcVSBtx5g;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;forfeited&lt;/span&gt;&lt;/span&gt; in the year ended December 31, 2020. &lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_R06ETi2TMkqS-odoJkwA1A"
      id="Narr_e29xbjSHCUqDcRRIOzi8dg">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_i-4hy_JVkUqCTXWyIeMrmQ"
      id="Narr_nz1CPL5QQ0y6SWwGVj7T9g">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_LongTermIncentivePlan2018Member_AIeZ1LxyUU-U04p2bkns4A"
      decimals="INF"
      id="Narr_erVgO7OUGEmwurPNn6MVsw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">2817861</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="As_Of_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_7hQKDlFBGE-A_JKU8z88Kg"
      decimals="INF"
      id="Narr_yq_zfVuqDUizNJBBXpzoGw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">102739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <mmsi:ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_PlanNameAxis_mmsi_EmployeeStockPurchasePlanMember_73syZyrdCEaiuRTfMsiD0g"
      decimals="INF"
      id="Narr_m2nAyE86RUybU9BjEH-dRQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.95</mmsi:ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_W3bihTLNYUyOtKACNJqpVw">The stock-based compensation expense before income tax expense for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Nonqualified stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,357&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Nonqualified stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,789&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,343&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,157&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Nonqualified stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,305&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 6,678&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 7,332&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Performance-based restricted stock units&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,509&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,525&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2,829&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Restricted stock units&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,836&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,557&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 758&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Cash-settled performance-based share-based awards ("Liability Awards")&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,511&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 906&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"&gt;Total selling, general and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,647&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 13,271&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,825&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Stock-based compensation expense before taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,042&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,090&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,339&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_ZZfj3R7V5Eaf4KlhxZX0NA"
      decimals="-3"
      id="Tc_qi6Ue6DM10aoWRY0LJfScQ_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1606000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_W2-lwaQajUmjU-r2zs34Yg"
      decimals="-3"
      id="Tc_vsgfYHyfn0GKhRhvX-6-lQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1476000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_4h-sVt6F-068ZNWfSqnEFQ"
      decimals="-3"
      id="Tc_JpYkx7vUeEmX_zRn5-f9VA_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1357000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_IvGlF5Zb_0aI82EUdrzxpw"
      decimals="-3"
      id="Tc_ZQjjDo5NtkGJB1YKG97Ehg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1789000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_QL5MDDksJk6BV7x5RToVoQ"
      decimals="-3"
      id="Tc_JkMrynlF8ECLM8OMXWbfKw_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1343000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_z8YzjacK6k6Eh7TEMhdvDQ"
      decimals="-3"
      id="Tc_gxNxvqa6SU-gOXe6kc5AmA_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1157000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Imq-yl3UN0SxC6ocv52NnQ"
      decimals="-3"
      id="Tc_JsddZVnxJkGpYACnSEw5jw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7305000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_T7UpOFHUfUKuQYJJK2urrA"
      decimals="-3"
      id="Tc_YpOEpEnmDECqbZI3MQi1MQ_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6678000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N8U8BNsA1kKxcg9Cty-FoA"
      decimals="-3"
      id="Tc_QVOQh4RZB0CQm6sclUtx4g_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_iDtT3Y7T4ES-G4M9NJ5iwA"
      decimals="-3"
      id="Tc_ByodiCBeckSB1v8uZc5E8A_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3509000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Kq8CJRyvgEqTiCMrffL5Dg"
      decimals="-3"
      id="Tc_j4Lha0TDbke2VKumX-S8gQ_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3525000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_wNH7WZpHE0KRoLTZeAliog"
      decimals="-3"
      id="Tc_D_QJena8eEaHMmMfxXq17Q_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2829000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Cw05VY0_I0-Am1JQU64fgw"
      decimals="-3"
      id="Tc_iXbZaAM4v0qlUVFEDMoexQ_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1836000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_N0bSnffBZEK-_wgFvh8Ohg"
      decimals="-3"
      id="Tc_ceeSGixGAUmSS6Y4tTAj-Q_9_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1557000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62E2hM7g4EGHRbMuBjMCIA"
      decimals="-3"
      id="Tc_5c0uygMxwEKClQUODpCp_Q_9_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">758000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_MSYHJr3mNU2lIv5avLZ04Q"
      decimals="-3"
      id="Tc_s6qo6GPIHEC5_hyDky_i-w_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1997000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BOpfzPG26ECbr8ZPTKepRw"
      decimals="-3"
      id="Tc_a3kbJ7mF3kqWu-jR6LFZHg_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1511000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_yy2rfbwVDkuhigmz2rclqQ"
      decimals="-3"
      id="Tc_5cVMcOMdO0CEXwkg-TrFHA_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">906000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_Pn_ji6z-9EujtMdTc7Xe2g"
      decimals="-3"
      id="Tc_3D8vQZ8DWUuW63ooC-fa5w_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14647000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8PfvIfnmqUCeZXIMgXoYkQ"
      decimals="-3"
      id="Tc_gZfFlzMVc0-DW8c4F1S0dw_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13271000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_NHhcrvVH_U2r85qDDyQQ3g"
      decimals="-3"
      id="Tc_NsxTPfhjZkSA8yxgP6ZLFA_11_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11825000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_8J2fEM7qY0Ov9kSZe0ZJ9A_13_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18042000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_4otzar4Pv0yEfPWIva-uOA_13_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16090000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_YD8HRhMGpkqnGhvP6dC01Q_13_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14339000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_ATNZbLCh8keW60__JyknWA"
      decimals="-5"
      id="Narr_YKfODDFTEE2HMPurY70zoA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      id="Narr_WOyN-iBcsUCfaCyIp07atA">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_0rLZ3frsEEiZwRl8EIH1Lw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;In applying the Black-Scholes methodology to the option grants, the fair value of our stock-based awards granted was estimated using the following assumptions for the years ended December&#160;31,&#160;2022, 2021 and 2020:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.57%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;1.4% - 4.3%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.5% - 1.1%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.3% - 1.7%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected option term&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;4.0 - 5.0 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected price volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;46.2% - 47.5%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;46.1% - 46.7%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;38.7% - 45.1%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="3"
      id="Narr_zK8oljuS2kq2sQwiQDfDWQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="3"
      id="Narr_UMzvJl61nkWRB4lGhYnNYQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="3"
      id="Narr_iQS2LYLJq0KDPNJJT5eWXA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="3"
      id="Narr_a8WmrXLEKUiLuLldROIYpw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="3"
      id="Narr_eRr8SnK9206izPo6cvi7Tw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="3"
      id="Narr_lfEIa6Gda0ai5AEkjXvcJQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      id="Narr_JZZebwMoYUKOugBTGVfvvg">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      id="Narr__i3BtPuJckqSaFF2VA5Mxw">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_yq6tnYStUk6a7MAFzkSQcg"
      id="Narr_YVnlSDa2GUOhTqHhAgx90Q">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_4i2h-0r8ekOAQM9CYwMASw"
      id="Narr_hyHkxq5Xb0eKAgagbFdFYg">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="3"
      id="Narr_yoSRngNMrE-bE0kf7URBRA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.462</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="3"
      id="Narr_BjQlFapHX06IH-N-tIRDIw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="3"
      id="Narr_QRnmZzGd-U6fT6iATPBrnQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.461</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="3"
      id="Narr_SN6vOklD2U2y6PPDhHB11A"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.467</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="3"
      id="Narr_5o3kUtXFxk-fCuKSRHc-8A"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.387</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="3"
      id="Narr_naa1JcYcMk6AFfmOhWrQIQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="-3"
      id="Narr_zAhHtxeInE6v9PEI06WxSQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="-3"
      id="Narr_DXzoPd_L70ariKqpU6sRvQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">716000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="-3"
      id="Narr_vr5p0JZjcEGxtJptail39Q"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">329000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="-5"
      id="Narr_g9GTLYZDDkiJZzOgvbgzWQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6300000</mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures>
    <mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="-5"
      id="Narr_Fj8pD0dJeUOvQku5w8xnMQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">17500000</mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures>
    <mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="-5"
      id="Narr_YF2zXXYHrkWpARFHwjasYA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4500000</mmsi:FairValueOfStockOptionOnGrantDateNetOfForfeitures>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_OxiYpKs1Jkm1j1rD8jgdMw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The table below presents information related to stock option activity for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020 (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total intrinsic value of stock options exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 27,110&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 36,086&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,733&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cash received from stock option exercises&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 18,952&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 20,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,481&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Excess tax benefit from the exercise of stock options&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,423&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 5,571&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,815&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_apcWPZWEJEuu2kaJjFg0bQ_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">27110000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_3JUNkQxzk0WogCmzkMbw8g_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">36086000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_nFjT9zz_C0q1ciAn_KxFhQ_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11733000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_hl6Dvo3utEmNiXWoypBkFA_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18952000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_nTitUUtd50-EOdNojLQteg_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">20194000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_boWDuOdz5kma7wN8vZ86aA_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5481000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_1K3QBlgyZ0uqc5qay_ewWw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3423000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Y_UHtPiDm0GkltBqp03mpg_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5571000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_FGitXKliskurLJBX0cZd0Q_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1815000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_pCe5k9gw0EKxkbSAp2bPkA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Changes in stock options for the&#160;year ended December&#160;31,&#160;2022, consisted of the following (shares and intrinsic value in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&#160;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Remaining&#160;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of&#160;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercise&#160;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Term&#160;(in&#160;years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 44.70&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 63.69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (703)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 28.58&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Forfeited/expired&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (111)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 53.16&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Outstanding at December 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,077&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 49.62&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3.51&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 64,634&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,792&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 43.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 2.61&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 48,595&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ending vested and expected to vest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,013&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 49.37&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3.47&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 64,026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_s_F4U-J2OEe45Z5Y9UD32A_3_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">3640000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="2"
      id="Tc_zPDUfldpAEON0P0c4XFJug_3_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">44.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_45ez61jwqkGmJCksCxAVOQ_4_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_kHZJbqquo0yzya8oNpr4_Q_4_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">63.69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_KxMBFsDGukuXyzCF8Scbpw_5_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">703000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_ccUkhWggbkuiIpA_T-F_kw_5_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">28.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc__ok5hnQj7k6GFgW6EcYPoA_6_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">111000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="2"
      id="Tc_tx6w9bugkkWTnO4InCn_qQ_6_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">53.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_3ZUlWJovCEWgC8s-9RBjqA_7_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">3077000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="2"
      id="Tc_zKjtLqvBkUW1V0mQZMJDAQ_7_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">49.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_CQRBrrdhwk-PRKk5nOgo2w_7_7">P3Y6M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_n0L1CsnwMUuu83RjYPtovQ_7_10"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">64634000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_8_3TnS7cMU6LIooY_O5EIQ_8_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">1792000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="2"
      id="Tc_VqO_lEx_OU2n7MyKv_S11Q_8_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">43.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_CJZxh3ML_kOu4tThg5BXbg_8_7">P2Y7M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_-tuv8tyRnkaImPmg0GdA7Q_8_10"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48595000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_UOgoAU91bkinVx_PPhOmmw_9_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">3013000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="2"
      id="Tc_Nb3A7oVev0GZh1X4R40zwA_9_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">49.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tc_N05HVWn7pE2vF9hjbAkBuA_9_7">P3Y5M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_sYiD6C1nCUGTu8EHJNBKUg_9_10"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">64026000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ"
      decimals="2"
      id="Narr_XiEsk9_nDEG74ZwRIGQg-Q"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">24.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_xfvsWyzWOUiKufCxffLD2g"
      decimals="2"
      id="Narr_mVLIroKvBUGu6UzM89FjTQ"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">24.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_JF5aVXaiOkeufO8meHg2Xg"
      decimals="2"
      id="Narr_8YUYjrjM2UeXMyCjJDWQYg"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">13.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_n09B1uG-xESAohYo-rybSQ"
      id="Narr_H4sJdpLvHEu195rQYf-Zqg">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      id="Narr_K1XgukxuNkWcyYcKwon8kQ">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_63ieaO-AO0SYaBWn-TK6JQ"
      decimals="2"
      id="Narr_oMiH4tNLjUG0m5vvYn0aQw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:PotentialSharesGrantedDuringPeriodIncreaseDecrease
      contextRef="Duration_4_1_2020_To_6_30_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_r8j-LAr880aFYWGRQw_EMw"
      decimals="INF"
      id="Narr_tzSB2Y9N80KQM4SF587VQw"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">25415</mmsi:PotentialSharesGrantedDuringPeriodIncreaseDecrease>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="INF"
      id="Narr_j5dkdvzgFUeEtXq_sXWvcQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">1</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_WBGzb7-2s0OMpcaC1kZThA"
      decimals="2"
      id="Narr_TcZ84gYTak2tAg0xXLisew"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.50</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_OtYJx8DRZUWhCfnnj12CUw"
      decimals="2"
      id="Narr_wMT6dHabsUiQ3fvMMg5khQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_HTBgdVUkNka5_SS_wCZMfA"
      decimals="2"
      id="Narr_Fms6WOlng0-uxaJM4Dt9WA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.50</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_CR57zo9ehUqUx1y_296vpA"
      decimals="2"
      id="Narr_G_0ZfaJghUuECb81zbnocg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.50</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_TTFS404ILUWejinxzomjcA"
      decimals="2"
      id="Narr_IyXrXPH5VUCWjUMDCDa6ZA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_eA79SptKRUq01tLxfpAtTA"
      decimals="2"
      id="Narr_xzbgPtLKM0i6wjiEDZVwQg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_2cbkT8Rpj0C4W9Vnfbtf7w"
      decimals="2"
      id="Narr_CO2qLsOeEkG8IsKCTNwZYw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.75</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA"
      decimals="2"
      id="Narr_D2MaLgzSP0S3mTr5jl_ELQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1.25</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      id="Narr_C9DMsMWYo0K3qGpQk3tDDg">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mmsi:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_vkuBjwevlESPxeznhg24Rg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Changes in PSUs and RSUs for the&#160;year ended December&#160;31,&#160;2022, consisted of the following:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;PSUs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;RSUs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&#160;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&#160;Average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock Units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Stock Units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In Thousands)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In Thousands)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Beginning nonvested balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 163&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 53.71&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 61.77&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 64.54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 59.02&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;rTSR adjustment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 8&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 65.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Vested&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (44)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 65.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (26)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 61.77&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (45)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 60.81&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Nonvested balance at December 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 179&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 65.20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 59.02&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Based on the maximum payout, excluding the impact of the rTSR multiplier. The actual number of shares which vest is determined based on the satisfaction of performance conditions and the application of an rTSR multiplier between &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;75%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; and &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;125%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Represents the application of an rTSR multiplier of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;125%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; to awards vested in 2022 based on the performance of our common stock and the terms of the awards.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</mmsi:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA"
      decimals="-3"
      id="Tc_Cd088L1h8Ee2UpHicvYXeQ_5_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">163000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA"
      decimals="2"
      id="Tc_JJ7FfK4DqEy-OpPtDoFU0w_5_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">53.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_30JNZGvr7EC6MKrc7WWXwA"
      decimals="-3"
      id="Tc_7K_kE_K-bEeE1Jo5lmGP2w_5_7"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_30JNZGvr7EC6MKrc7WWXwA"
      decimals="2"
      id="Tc_Hqr6lqQRA0GspIYOu8jHNw_5_10"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">61.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="-3"
      id="Tc_K-tQwWOq5EWBrf9ZZWW3Ag_6_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">97000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="2"
      id="Tc_vid-htiOT0elCyPB4P7pvQ_6_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">64.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="-3"
      id="Tc_1BtavHAOnUWVUwfKF-YIaw_6_7"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">31000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="2"
      id="Tc_70c6rzMNh0G3caLU0n7lNg_6_10"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">59.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="-3"
      id="Tc_-tf15w0SHUK_E4XRljLSiA_7_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">8000</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="2"
      id="Tc__xNPmoqj2k6_b5cu7kuwWA_7_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">65.03</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="-3"
      id="Tc_5uZcesp0_06icZwetpL4mQ_8_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">44000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="2"
      id="Tc_5_tlSwCJz06gMHg34KiBlw_8_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">65.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="-3"
      id="Tc_BTodsaZWh029xKWTzUE-Gg_8_7"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="2"
      id="Tc_ba3z4B2oaU2GSTqR28l10g_8_10"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">61.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="-3"
      id="Tc_iZxXD7IU0UOOPuGHrQ70Wg_9_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="2"
      id="Tc_ck9WFdP3d0izNdcQHCd00Q_9_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">60.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q"
      decimals="-3"
      id="Tc_H6GqtbNaXkK0-zdCfrmr3g_10_2"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">179000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q"
      decimals="2"
      id="Tc_-tPjVocC3U6w0Pik1P7FMQ_10_5"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">65.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ"
      decimals="-3"
      id="Tc_1m_XN1vFDkqmLRH-1zEXFA_10_7"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">31000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ"
      decimals="2"
      id="Tc_Uq3sN2R-5UOheKdGVQf-SA_10_10"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">59.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_2cbkT8Rpj0C4W9Vnfbtf7w"
      decimals="2"
      id="Narr_FkBakKZSJEOCavryt2TQgw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.75</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA"
      decimals="2"
      id="Narr_bQFJd7WWCEuI0DSlmtrusA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1.25</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_6xqiAKy5wky58rfPLPedWw"
      decimals="2"
      id="Narr_imoQxYNWZEqLyVc0mnG9Zg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1.25</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_lgups91GCkKLzkKQ8mMP3Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;The following table summarizes PSUs and RSUs granted during the years ended December 31, 2022, 2021, and 2020 (units and shares in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;PSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Target units granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;52&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 61&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Maximum units granted &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;103&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 102&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Maximum potential shares&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt; (1)(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;121&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;129&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="vertical-align:top;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 127&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Weighted average grant date fair value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;64.54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;61.39&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 43.63&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;RSUs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Units granted&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"&gt;Weighted average grant date fair value&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;59.02&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt;61.77&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 42.98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Based on the maximum payout, excluding the impact of the rTSR multiplier. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Includes the impact of the maximum potential rTSR multiplier of &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;125%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:2.9pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;Includes the impact of the 2020 amendment which reduced the maximum FCF multiplier for one-year awards from &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;200%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt; to &lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;100%&lt;/span&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;"&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</mmsi:ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_4HZjeHhca0CJ9R9TG0L3fA"
      decimals="-3"
      id="Tc_Atzh_AdKmk2ZRtmVKw3zoQ_3_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">48000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_94jGRzIuckyUf5V563Shhg"
      decimals="-3"
      id="Tc_WLQAGN1AMUO5Mk0bA5uHLw_3_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">52000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_TargetMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_kGEvFzHWaUq1-E8uQ61arA"
      decimals="-3"
      id="Tc_CIo1dK5mekaT0EFoc5PcAA_3_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">61000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_b4qnuJ-OWEiHrjQRnWlLXw"
      decimals="-3"
      id="Tc_6_g4MpQQFUy0FLD2kFgzPg_4_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">97000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_RYZsnkxzTkaTfXLFz_Zj2g"
      decimals="-3"
      id="Tc_dvurOXLLlkGTV4QIfxo2uQ_4_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">103000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumUnitsGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_OSPO592R7EqioAf9pi9vfA"
      decimals="-3"
      id="Tc_RMse3gGDJk2a_EW91X6Nqg_4_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">102000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_gLbiasFwxkmKONzOlnKAwg"
      decimals="-3"
      id="Tc_vrULHOMXEkuD9OSJOY1vDA_5_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">121000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s46DzGkVO0Sh6osOFwanZg"
      decimals="-3"
      id="Tc_shLb_5m-KU2b-d0syQAzXw_5_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">129000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementScenarioAxis_mmsi_MaximumPotentialSharesGrantedMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_U_TUWGHmYk20d863KAh-8w"
      decimals="-3"
      id="Tc_kIn-q8JyW0iqEoG9OqgSPg_5_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="2"
      id="Tc_9JGwaufhYUazQDh5p7Gp7g_6_3"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">64.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"
      decimals="2"
      id="Tc_sDixEELpMUmofoHd91zfMg_6_6"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">61.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_fxzT2CfP7UGLlti0xqKeog"
      decimals="2"
      id="Tc_D_zuX698AEW_JK6X7wiIow_6_9"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">43.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="-3"
      id="Tc_t1SbnwEYkEOiDofu87NARQ_8_3"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">31000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw"
      decimals="-3"
      id="Tc_AqKghE_SbkmC6NDRAC8hUg_8_6"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw"
      decimals="-3"
      id="Tc_Qu5FPNeE_EOkWBQfTrjG0g_8_9"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">34000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="2"
      id="Tc_Ac6rLftJV0eqGFigOfnW9w_9_3"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">59.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw"
      decimals="2"
      id="Tc_KsYSLjleeEaSHMrpNIYaNQ_9_6"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">61.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw"
      decimals="2"
      id="Tc_2Pv4DFeyUk2xTlYYWHtyig_9_9"
      unitRef="Unit_Divide_USD_shares_PGWkHEOV-Umu6QWamvCi4w">42.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA"
      decimals="2"
      id="Narr_FjBaJfLm20iTwgiblMYy_w"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1.25</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Xa71dYPKVEyT6sWRUfs7wg"
      decimals="2"
      id="Narr__PRP_9rkC0yqcTaTZBvpXw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Q9sli6HR8kmLtGS6z2LKLA"
      decimals="2"
      id="Narr_FTYI3eDh5kaWJMO5OXAafg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="-3"
      id="Narr_Ud7J8BNd3UiBag5fKNRpeg"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">44000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"
      decimals="INF"
      id="Narr_hrYBkN47ZkiAdEDs9Bcrlg"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_MZN3RxPRPkq5v4w2teFQGQ"
      decimals="2"
      id="Narr_DZz4DDdmWUm13qGRXCqGXg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_ValuationTechniqueDiscountedCashFlowMember_Q9sli6HR8kmLtGS6z2LKLA"
      decimals="2"
      id="Narr_DqtB3xdzkUasRiTz78jgrg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember_mp0CZzFsikGjHxzekgM7eA"
      decimals="2"
      id="Narr_knYNKXRuQ0q39xpstvjvjw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1.25</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_fxzT2CfP7UGLlti0xqKeog"
      decimals="-3"
      id="Narr_FXFl7_WVkEqGVpWlZ3UwjQ"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      decimals="INF"
      id="Narr_Bl5C5r9cnUa6pGkDp5jmkg"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_XTcC98_wdEWJbHKCLzqwaw"
      decimals="INF"
      id="Narr_ybZAl9FACkCom2vNmMkd2g"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">34000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_0Xn6_jz-VEGxjafnO7loUw"
      decimals="-3"
      id="Narr_pNUV90vkgkOkPhYm-AGv7w"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <mmsi:ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_WTU4nIdrQUCYwt1e9dqd3w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;The fair value of each PSU was estimated as of the grant date using the following assumptions for awards granted in the years ended December 31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;1.6% - 2.7%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;0.1% - 0.3%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Performance period&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;2.6 - 2.8 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;1.8 - 2.8 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Expected price volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;38.5% - 42.6%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:15.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;43.7% - 49.3%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</mmsi:ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="3"
      id="Narr_7jAE4bFkVEajGUW-u0eYMg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="3"
      id="Narr_TOgTthd4k0a2lTskA2kaqg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"
      decimals="3"
      id="Narr_3-Tg1zh7e0mgahMGF13KJQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"
      decimals="3"
      id="Narr_SI9f-AnIRUmTRjDpEciXkA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_WBFuNp9-sEOaCJ0Ax7YM3A"
      id="Narr_3S7RR6_oY0yiIxd2pmQA7w">P2Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_3fb8WLlr80-4_6v213qfgw"
      id="Narr_IcNT-VvBCEKNrG_-TLFsew">P2Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_GxO2voBvw0KcdDmVJ8OK8g"
      id="Narr_LCitmD4BPU2prwTfg0LRpg">P1Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_a0RjGlBUeUa4iriFWOGd0A"
      id="Narr_rUgg1SdCGUCYOJTQRauI1w">P2Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="3"
      id="Narr_0wPeLFWNzUKIBKlGlBClpw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.385</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      decimals="3"
      id="Narr_7w94u94WWEmq20AKN_zWvw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"
      decimals="3"
      id="Narr_0iTHV0YzH0KRHkA6udVEQQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.437</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_wlNc1YeMRka-VL_zaiCBsQ"
      decimals="3"
      id="Narr_hvsLBTjQsUmX0MAPmj0XQw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.493</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="3"
      id="Narr_LDJDVhcXgUC50nqqZmahlg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="3"
      id="Narr_J_lGAx9qG02Vnu3VtsvzVA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_s4l64DV6NEy9vjZyW1Lb_Q"
      decimals="-5"
      id="Narr_D_-1QmQvBUmTDt5fcZFUIg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_MTNr-6jS40mMbEho_VgmZQ"
      decimals="-5"
      id="Narr_cP5cbRQOnkera5bLcpmvKw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g"
      id="Narr_y4656VnWZkCYsAYgtjRKJw">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_idItnOFohkm9rpYVXlLUxw"
      id="Narr_JOmr4E-qGEmZD8-t94JXaQ">P0Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog"
      decimals="-5"
      id="Narr_8xx3L0DBfEeeppnZ9JfKug"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1000000.0</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_qRyUmYl8O0y6oUbd1lTTIw"
      decimals="-5"
      id="Narr_KhZmXKHs80-eSOrZx-niMg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1000000.0</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw"
      decimals="-5"
      id="Narr_j4W8TlfVhE-KJSY4W2gosA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1000000.0</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheOneMember_mVSC0isQAkKGdsXQLJIZuA"
      decimals="2"
      id="Narr_G7y9oLd-nEKWmL8HYjzr-g"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">1.25</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_w8-ho-GtDECtGQ1su5JiUA"
      decimals="2"
      id="Narr_3NP9fWxi5EmKXM7wNYOdTw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2.50</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_ps-20gTg802P7I1jBP-j0Q"
      decimals="2"
      id="Narr_eSjrGq7ZvEiW6AJU6zcUQA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2.50</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_ps-20gTg802P7I1jBP-j0Q"
      decimals="-5"
      id="Narr_zv4wWIIljkOc9DFsF4qFYg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2500000</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive>
    <mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_w8-ho-GtDECtGQ1su5JiUA"
      decimals="-5"
      id="Narr_fBPfx1hwykuubGFXIz-YuQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2500000</mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_us-gaap_VestingAxis_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_WIq3iXtF5EuvyViG_OJs8g"
      id="Narr_OBCRqRGiS0i0UCY9zOR3hw">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_IouJ1SF8gkaMhJelEUky_g"
      decimals="-5"
      id="Narr_0rbwUdx2rk-Z9RDRyMRsjA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3200000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_IouJ1SF8gkaMhJelEUky_g"
      decimals="-5"
      id="Narr_hp8oMfeWyUqJQl18ALID6Q"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog"
      id="Narr_MY2fy2nCrUSwejpl2X0p6w">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog"
      decimals="0"
      id="Narr_B9OWLyRqkUOiMH2OkV6Vnw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">833000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_qRyUmYl8O0y6oUbd1lTTIw"
      decimals="0"
      id="Narr_AWBnnRye-U6tiwr2GxIl3g"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">417000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_Kjg5b2X_wkishAXCKGBZog"
      decimals="-3"
      id="Narr_yVI7svCiy0yOFIFOohGF8A"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_mmsi_CashSettledPerformanceSharesMember_zkFZlV8rgECjr9xdkSzJPw"
      decimals="-3"
      id="Narr_3bSjdZq080C_g43ogd57-A"
      unitRef="Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_CQxO6D6HJEmfAU4ukQ2JHA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;13.&lt;/b&gt;&lt;/span&gt;SEGMENT REPORTING AND FOREIGN OPERATIONS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt;"&gt;&lt;span style="font-weight:normal;"&gt;We report our operations in &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;two&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; operating segments: cardiovascular and endoscopy.&#160;&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;Our cardiovascular segment consists of &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;four&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; We evaluate the performance of our operating segments based on net sales and operating income (loss). &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;See Note&#160;2 to our consolidated financial statements set forth in Item 8 of this report for a detailed breakout of our sales by operating segment and product category, disaggregated between domestic and international sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, we had international sales of $500.4 million, $465.9 million and $413.8 million, respectively, or 43%, 43% and 43%, respectively, of net sales. Our largest international markets include China, Japan, Germany, France and the United Kingdom, with&#160;China representing our most significant international sales market with sales of $149.3 million, $138.2 million, and $113.2 million for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, respectively. International sales are attributed based on location of the customer receiving the product.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;United States&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 281,290&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 275,311&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 277,643&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ireland&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 40,749&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 39,863&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 42,951&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other foreign countries&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 60,937&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,484&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 62,134&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 382,976&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 371,658&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 382,728&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"&gt;Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, are as follows (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net sales&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,118,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,043,227&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 934,202&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,757&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,673&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total net sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income (loss) from operations&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80,946&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 53,415&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,042)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,617&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,501&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,480&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total income (loss) from operations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 87,563&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 60,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,562)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total other expense &#x2014; net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,934)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,999)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,669)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,843)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 6pt 0pt;"&gt;Total assets by operating segment at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,652,145&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,635,676&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,654,866&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 11,821&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 12,618&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 9,530&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,663,966&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,648,294&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,664,396&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Total depreciation and amortization by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 80,777&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 83,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 93,160&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 910&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 81,804&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 94,070&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Total capital expenditures for property and equipment by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 44,925&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 27,557&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 45,803&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 104&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 382&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 45,029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 27,939&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 45,988&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="INF"
      id="Narr_4vFBog2bKEqKRsRMAXeBaw"
      unitRef="Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg">2</us-gaap:NumberOfOperatingSegments>
    <mmsi:NumberOfProductCategories
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="INF"
      id="Narr_geqFhDFmqU2keUcCek7xYg"
      unitRef="Unit_Standard_item_m_h3yMt8Z0eAgzYRPfCfWg">4</mmsi:NumberOfProductCategories>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_dSg8kh6DlkyLKSVn2mRmPQ"
      decimals="-5"
      id="Narr_kviIY8wnZ0qaGBn48mHPgA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">500400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_2Zks2ScobUOdPYr6gUlL_A"
      decimals="-5"
      id="Narr_9qRFQxzCrEGlwq86NLY2Yw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">465900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_mCRjJpSbEE2JseTs6klpUw"
      decimals="-5"
      id="Narr_PszM8Wsw1kGZOYziVxWh_A"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">413800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_BT1_boCV1EyK74esn0nh_w"
      decimals="2"
      id="Narr_PExAJq8vmUKya3JVIoe5Og"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_v_3MlJjEwkOhh_n4KP2NWg"
      decimals="2"
      id="Narr_pGG4CxpOK0a1p1ft5Dp1Vw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_qVc5qszmDkqekOg1yJuHmg"
      decimals="2"
      id="Narr_cmYHtA1fQkqw2WY-S8C8rQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_CN_qZO_CIcm8EKmg0YTRChTXg"
      decimals="-5"
      id="Narr_xtxwBtzWT0aZh0vdN2j1Dg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">149300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_srt_StatementGeographicalAxis_country_CN_P4z8MxOErEe5ei5ipgHNOQ"
      decimals="-5"
      id="Narr_FVqI8RXob0G9kxuvmtjHpg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">138200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_StatementGeographicalAxis_country_CN_DoIlPAu9x0ysbFQn9Of8Yw"
      decimals="-5"
      id="Narr_iZ-WXcPrfkai2XB8ZlTLuw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">113200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_fbAFziddJEa5snZFyfypcA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;United States&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 281,290&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 275,311&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 277,643&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ireland&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 40,749&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 39,863&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 42,951&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Other foreign countries&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 60,937&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 56,484&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 62,134&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:55.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 382,976&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 371,658&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 382,728&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_US_snTmzJ5T0E656AhhDMpMQg"
      decimals="-3"
      id="Tc_Sm70_bHhlEGfqdgFuUkDHg_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">281290000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_US_GwhTWC6jokaibH93vL9asg"
      decimals="-3"
      id="Tc_QcqDbxYRM0OpbE7cZxX90A_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">275311000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_US_8HeXqvsEIk-auaw5myy4uA"
      decimals="-3"
      id="Tc_sdUUgMKUf0CsvjZAiprGlg_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">277643000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022_srt_StatementGeographicalAxis_country_IE_GfG6bD0w406OQ3evGEIt8A"
      decimals="-3"
      id="Tc_Oc65wrAdkU6Qt8wVkhmYlg_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">40749000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_country_IE_VUWTuDtMwkqMhwjAVcktqA"
      decimals="-3"
      id="Tc_VQ81VrVVgk6OldKGJR1S-A_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">39863000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020_srt_StatementGeographicalAxis_country_IE_eGJe27sczEalkw_qMPNw1Q"
      decimals="-3"
      id="Tc_2aikQtzGBkGZtxynTAQdTA_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">42951000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_eeu5akz68Uus_Sjj54jzQw"
      decimals="-3"
      id="Tc_YviRdHlx8Uu8DlFUsOuhng_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">60937000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember_VeCyfvZPU0KduGRAlFl2sw"
      decimals="-3"
      id="Tc_78Hq37I2mkWQalj5Ly72yA_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">56484000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020_srt_StatementGeographicalAxis_mmsi_NonUSExcludingIrelandMember__hoYCGHvzUiBpV80UeFJuQ"
      decimals="-3"
      id="Tc_HHbziwjbEUabq-M1JTvxFQ_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">62134000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_AAYkgHX5p0iVUAdmzBfe2Q_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">382976000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_qlQme6EU2EKM8sOngT372Q_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">371658000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_sukFSVBQo0Ohe21jBoD4xw_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">382728000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_MIzkpKAj80eXfs3a_kePsg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"&gt;Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, are as follows (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net sales&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,118,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,043,227&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 934,202&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,757&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,673&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total net sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income (loss) from operations&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80,946&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 53,415&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,042)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,617&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,501&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,480&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total income (loss) from operations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 87,563&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 60,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,562)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total other expense &#x2014; net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,934)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,999)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,669)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,843)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Total depreciation and amortization by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 80,777&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 83,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 93,160&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 1,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 910&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 81,804&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 84,066&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 94,070&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Total capital expenditures for property and equipment by operating segment for the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 44,925&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 27,557&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 45,803&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 104&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 382&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 185&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 45,029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 27,939&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 45,988&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_HnM_VFCiR0mlzQn36R51Yg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net sales&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,118,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,043,227&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 934,202&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,757&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,673&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total net sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,150,981&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,074,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 963,875&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Income (loss) from operations&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cardiovascular&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80,946&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 53,415&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,042)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Endoscopy&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,617&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,501&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,480&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total income (loss) from operations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 87,563&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 60,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,562)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total other expense &#x2014; net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,934)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,999)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,669)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income tax expense (benefit)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,463&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,388)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:63.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,843)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="-3"
      id="Tc_JqQbbJVH8EiGKBGeW47Y_A_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1118224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ"
      decimals="-3"
      id="Tc_kcjxZXPmnES2HAgd6vXb-g_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1043227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ"
      decimals="-3"
      id="Tc_AK6FLFE8Y0u3JUShRa37Tw_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">934202000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg"
      decimals="-3"
      id="Tc_L3QUtDvbmky0XBvSf1htGw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">32757000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ"
      decimals="-3"
      id="Tc_OZq24RCElUS9khGQa5fFiw_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">31524000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg"
      decimals="-3"
      id="Tc_iv0U1NlNrUK3Hh7XQtzIkg_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">29673000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_abXWLcCy4E6DY_nVTDOBLA_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1150981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_so7lrtmHsUi5BhS84VQx_A_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1074751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_5jIEyN2L1UGXzfWR2K7yvw_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">963875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="-3"
      id="Tc_rT40BbQJDkmKWLQKFVeaeg_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">80946000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ"
      decimals="-3"
      id="Tc_kOJDVQb7N0CpQ10sX_U8sw_10_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">53415000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ"
      decimals="-3"
      id="Tc_UbwyenjHlkOb4G_14f3gww_10_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7042000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg"
      decimals="-3"
      id="Tc_tso6nHL1x0KcJDnlF3H0hQ_11_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6617000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ"
      decimals="-3"
      id="Tc_7ZhwMpFI60uLO2qYTRnkaw_11_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7501000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg"
      decimals="-3"
      id="Tc_aojUelH3_0eI03NuVowRNQ_11_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5480000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_ghcLx7ct50KxcWRPZy1mnA_12_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">87563000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_CDsB0LZfKUKshqVlUSYTIQ_12_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">60916000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_FbPmzr2wbEGl68RCOgQ28w_12_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1562000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_a1PKkXwif0aLGdh3h9SSVA_14_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-4934000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_1G-gxCQGxkeLCkmRBqbaNQ_14_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-6999000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_4L7XJQEFjkGrO91SoaZyGA_14_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11669000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_gIjPOLQCUEaRgqIHtYqCTw_15_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8113000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_3V58KczORkuEUvBl8Wod1w_15_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5463000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_AGqjRK0EakK3PV38APE6nQ_15_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3388000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_41ds51zZi02aweOVxJo_oQ_17_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">74516000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_j2VAD0nhlEqSOJTRTmmrfw_17_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48454000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_VwmLjtJTxUSLKayo30zx8w_17_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9843000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_DL7l9lCsn0yCicMiO9Paag"
      decimals="-3"
      id="Tc_lIvrDdzKRk2vIt6RLt2g9A_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1652145000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_mhPvROMdBUy9ISn8bUcQsA"
      decimals="-3"
      id="Tc_OZ9Ygr_E-U-EnV0fO0XVGw_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1635676000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_jPM7z4e9ckWasY0kB4A02w"
      decimals="-3"
      id="Tc_pl3fEVlw8EOH8ESL1M04zw_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1654866000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_tITBjrk_HkGRwTnHLPq2Og"
      decimals="-3"
      id="Tc_K0NxpWIF70qN5ZQCoJEiKw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11821000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_lmH4hrr3Yk2ZNTHoyQXrRQ"
      decimals="-3"
      id="Tc_rysQIDkSMk6wJ_1TjusXfQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12618000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_kZ1T208TZkm_Zha3uivU5w"
      decimals="-3"
      id="Tc_wbeVSHJU6ESNf0iim4G0IQ_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">9530000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_faTKRDmemE2wgloi5zP6Tg_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1663966000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_tmOY3lBKOkyNkKkyUYWubg_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1648294000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_JoH4iVnY2USkA2EuzIzW6A_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1664396000</us-gaap:Assets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="-3"
      id="Tc_GAgz17SfLkGiYulcLRpGJw_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">80777000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ"
      decimals="-3"
      id="Tc_WZixaQ9JmUeUAix7f7SXFg_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">83000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ"
      decimals="-3"
      id="Tc_8Y81wWz7a0qcFBWYoYYjhg_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">93160000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg"
      decimals="-3"
      id="Tc_m9JgvODA10y4RqLdw6rzng_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1027000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ"
      decimals="-3"
      id="Tc_zMHpOsub5k68PKsTQW31vQ_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1066000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg"
      decimals="-3"
      id="Tc_rDkD3ViiIkWL90Dxk3pg5w_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">910000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_dPCzfQBcF0ehsEuQE8O9KA_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">81804000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_5_scR70Xi0moxOAOOs-CBQ_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">84066000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_mIu19RR7PU2knSC17jenOg_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">94070000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w"
      decimals="-3"
      id="Tc_mZj04vt0w0WDnIMQerHd_g_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">44925000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_z6Vu0iwmi0KNorbMZAV_oQ"
      decimals="-3"
      id="Tc_ii-SuLjNOkS_CTfierTIIw_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">27557000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_qZlljkR4oE6GJttgCka_kQ"
      decimals="-3"
      id="Tc_mlgV9JylpEW-y51QPQ1Daw_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">45803000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_8GLtiR9dHkaDW5Qgv9awCg"
      decimals="-3"
      id="Tc_ctHrmlTgjUmkSs2uGwmK5g_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">104000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_0ktx-0F8vEKllVftte-EKQ"
      decimals="-3"
      id="Tc_oBpyMGo0l0Svs8VLYwOVSg_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">382000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementBusinessSegmentsAxis_mmsi_EndoscopySegmentMember_EZecMRRRdEuc5KOfuwJxbg"
      decimals="-3"
      id="Tc_Bt6Se5JOOE2aoaaxwMvAUQ_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">185000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_Ud6zbvsdO06K2MSRRoQQxw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">45029000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_A55LsV7NG0ynNRz69bzjXw_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">27939000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_c4jsJP4ANEGQndyEagyitQ_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">45988000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_ielJvofZzE-9aRTcE_zn9w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;14.&lt;/b&gt;&lt;/span&gt;EMPLOYEE BENEFIT PLANS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;We have defined contribution plans covering all U.S. full-time adult employees and certain of our foreign employees. Our contributions to these plans are discretionary in certain countries, including the U.S. In September 2019, we ceased discretionary contributions to certain of our defined contribution plans and subsequently reinstated those contributions in May 2021. Total expense for contributions made to these plans for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $7.7 million, $6.5 million and $3.9 million, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_4RS3hzIna0acErFtcqWilg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_pDb8Da97oUCrSGie_0r57w"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_ICOgM2nIrUam7ii9AZkKcQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3900000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_-SOyXWaJ-Uejkz59f4N9cA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;15.&lt;/b&gt;&lt;/span&gt;FAIR VALUE MEASUREMENTS&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets (Liabilities) Measured at Fair Value on a Recurring Basis&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;Value&#160;Measurements&#160;Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;active&#160;markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;observable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Marketable securities &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 138&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 138&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest rate contract asset, long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,444&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,444&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency contract assets, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,783&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,783&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency contract liabilities, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,986)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,986)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (18,073)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (18,073)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;Value&#160;Measurements&#160;Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;active&#160;markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;observable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest rate contract liability, long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,447)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,447)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Foreign currency contract assets, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,241&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,241&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Foreign currency contract liabilities, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,646)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,646)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48,234)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48,234)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The fair value of the interest rate contracts is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as prepaid and other assets or other long-term assets in the consolidated balance sheets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(4)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;Certain of our business combinations involve the potential for the payment of future contingent consideration, generally based on a&#160;percentage of future product sales or upon attaining specified future revenue or other milestones. Contingent consideration liabilities are re-measured to fair value at each reporting period, with the change in fair value recognized &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;within operating expenses in the accompanying consolidated statements of income (loss). We measure the initial liability and re-measure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements. Changes in the fair value of our contingent consideration liabilities during the&#160;years ended December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 48,234&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 55,750&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_TpnXjRgdGkC2N239gRk-Nw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Contingent consideration expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 4,610&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 3,161&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Contingent payments made&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (34,762)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,665)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Effect of foreign exchange&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (9)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (12)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 18,073&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 48,234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31,&#160;2022, $2.3 million in contingent consideration liability was included in other long-term obligations and $15.8 million in contingent consideration liability was included in accrued expenses in our consolidated balance sheet related to contingent liabilities. As of December&#160;31,&#160;2021, $13.5 million in contingent consideration liability was included in other long-term obligations and $34.7 in contingent consideration liability was included in accrued expenses in our consolidated balance sheet related to contingent liabilities. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Cash payments related to the settlement of the contingent consideration liability recognized at fair value as of the applicable acquisition date been reflected as a cash outflow from financing activities in the accompanying consolidated statements of cash flows. Payments related to increases in the contingent consideration liability subsequent to the date of acquisition of $1.8&#160;million for the year ended December&#160;31,&#160;2022 are reflected as operating cash flows. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The recurring Level 3 measurement of our contingent consideration liabilities includes the following significant unobservable inputs at December&#160;31,&#160;2022 and 2021 (amounts in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Valuation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingent consideration liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;technique&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue-based royalty payments contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 2,097&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discounted cash flow&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;14%&#160;-&#160;17%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;15.7%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023-2034&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue milestones contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 13,064&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Monte Carlo simulation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;5.1% - 14.0%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;5.2%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023-2033&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Regulatory approval contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 2,912&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Scenario-based method&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;5.7%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Probability of milestone payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;90%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023-2030&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt;"/&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Valuation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingent consideration liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;technique&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue-based royalty payments contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,870&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discounted cash flow&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;13%&#160;-&#160;16%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;14.7%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2022-2034&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue milestones contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 41,671&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Monte Carlo simulation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;7.5% - 12.5%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;8.2%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2022-2031&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Regulatory approval contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,693&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Scenario-based method&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2.6%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Probability of milestone payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;80%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2024-2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The contingent consideration liabilities are re-measured to fair value each reporting period using projected revenues, discount rates, probabilities of payment, and projected payment dates. Projected contingent payment amounts are discounted back to the current period using a discounted cash flow model. Projected revenues are based on our most recent internal operational budgets and long-range strategic plans. An increase (decrease) in either the discount rate or the time to payment, in isolation, may result in a significantly lower (higher) fair value measurement. A decrease (increase) in the probability of any milestone payment may result in lower (higher) fair value measurements. Our determination of the fair value of contingent consideration liabilities could change in future periods based upon our ongoing evaluation of these significant unobservable inputs. We intend to record any such change in fair value to operating expenses in our consolidated statements of income (loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-family:'TimesNewRomanPSMT';font-style:italic;"&gt;Contingent Payments to Related Parties. &lt;/i&gt;&lt;span style="background:#ffffff;"&gt;During the years ended December 31, 2022 and 2020, we made contingent payments of approximately&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1.6&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;million and&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$800,000&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; to a former director of Merit and former shareholder of Cianna Medical which we acquired in 2018. We made no such payments in 2021.&lt;/span&gt; &lt;span style="background:#ffffff;"&gt;In 2023, the Company expects to make additional payments consistent with prior years. The terms of the acquisition, including contingent consideration payments, were determined prior to the appointment of the former Cianna Medical shareholder as a director of Merit. As a former shareholder of Cianna Medical, the former Merit director may be eligible for additional&#160;&lt;/span&gt;payments for the achievement of sales milestones specified in our merger agreement with Cianna Medical.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair Value of Other Financial Instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The carrying amount of cash and cash equivalents, receivables, and trade payables approximate fair value because of the immediate, short-term maturity of these financial instruments.&#160;Our long-term debt re-prices frequently due to variable rates and entails no significant changes in credit risk and, as a result, we believe the fair value of long-term debt approximates carrying value. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs, with the exception of cash and cash equivalents, which are Level 1 inputs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Impairment Charges&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily property and equipment, intangible assets and goodwill in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Intangible Assets. &lt;/i&gt;During the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, we had losses of $1.7 million, $1.6 million and $28.7 million, respectively, related to certain acquired intangible assets (see Note 5). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Right of Use Operating Lease Assets.&lt;/i&gt; W&lt;span style="background:#ffffff;"&gt;e identified changes in events and circumstances relating to certain right-of-use (&#x201c;ROU&#x201d;) operating lease assets. We compared the anticipated undiscounted cash flows generated by a sublease to the carrying value of the ROU operating lease and related long-lived assets and determined that the carrying values were not recoverable. Consequently, we recorded impairment losses during the years ended December 31, 2021 and 2020 of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1.4&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million and &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million, respectively, which is equal to the excess of the carrying value of the assets over their estimated fair value. The impairment losses were driven primarily by site consolidation decisions and changes in our projected cash flows for the ROU operating lease asset and related long-lived assets, due to changes in the real estate market as a result of the COVID-19 pandemic. These changes include an increase in the anticipated time to identify a lessee, an increase in anticipated lease concessions, and a decrease in the expected lease rates for the property. The ROU operating lease asset impairment losses pertained to our cardiovascular segment. We had &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;no&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; such losses during the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Property and Equipment.&lt;/i&gt; D&lt;span style="background:#ffffff;"&gt;uring the year ended &lt;/span&gt;&lt;span style="-sec-ix-hidden:Hidden_PXZ4MOWrBUiFixPo1YrNdQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;, we had losses of &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$1.3&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;million related to the measurement of property and equipment at fair value based on the planned&#160;discontinuance of the Advocate&#x2122; Peripheral Angioplasty Balloon product line, sold under our license agreements with ArraVasc, which pertained to our cardiovascular segment.&#160;&lt;/span&gt;During the year ended &lt;span style="-sec-ix-hidden:Hidden_5ha5obNG7EukzOsmSgU-lg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;, we had losses of $359,000&#160;related to the measurement of certain property and equipment measured at fair value based on restructuring activities associated with the suspension of our distribution agreement with NinePoint, which pertained to our endoscopy segment. We had no such losses during the year ended December 31, 2022. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;i style="font-style:italic;background:#ffffff;"&gt;Equity Investments, Purchase Options and Notes Receivable.&lt;/i&gt;&lt;span style="background:#ffffff;"&gt;&#160;During the year ended December 31, 2022, we recognized &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$0.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; million of impairment expense related to our equity method investment in XableCath, as business ceased operations. During the year ended December 31, 2020, we recognized&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$2.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;million of impairment expense related to our equity method investment in the&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;19.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;percent ownership in preferred shares of Fusion Medical, Inc. (&#x201c;Fusion&#x201d;) due to&#160;uncertainty about future product development and commercialization associated with the technologies and a charge of&#160;&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;$3.5&lt;/span&gt;&lt;span style="background:#ffffff;"&gt;&#160;million related to Bluegrass Vascular due to our decision not to exercise our option to purchase the company. We had &lt;/span&gt;&lt;span style="background:#ffffff;"&gt;no&lt;/span&gt;&lt;span style="background:#ffffff;"&gt; such losses during the year ended December 31, 2021. &lt;/span&gt;Our equity investments in privately held companies were $15.6 million and $14.7 million at December 21, 2022 and 2021, respectively, &lt;span style="background:#ffffff;"&gt;which are included within other long-term assets in our consolidated balance sheets. We analyze our investments in privately held companies to determine if they should be accounted for using the equity method based on our ability to exercise significant influence over operating and financial policies of the investment. Investments not accounted for under the equity method of accounting are accounted for at cost minus impairment, if applicable, plus or minus changes in valuation resulting from observable transactions for identical or similar investments.&lt;/span&gt; &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Current Expected Credit Losses&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;Our outstanding long-term notes receivable, including accrued interest and our allowance for current expected credit losses, were $2.4 million and $2.3 million, as of December&#160;31,&#160;2022 and 2021, respectively. As of December&#160;31,&#160;2022 and 2021, we had an allowance for current expected credit losses of $281,000 and $199,000, respectively, associated with these notes receivable. We assess the allowance for current expected credit losses on an individual security basis, due to the limited number of securities, using a probability of default model, which is based on relevant information about past events, including historical experience, current conditions and reasonable and supportable forecasts that affect the expected collectability of securities. During the year ended December 31, 2021, we collected $2.8 million from Bluegrass Vascular Technologies, Inc. pursuant to the terms of a note receivable, which represents the entire principal balance and all accrued interest payable pursuant to that note. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;The table below presents a rollforward of the allowance for current expected credit losses on our notes receivable for the years ended December&#160;31,&#160;2022 and 2021 (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 199&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 730&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Provision for credit loss expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 82&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (531)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 281&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 199&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_hbFEFruZjUW6jFv8-jbpFA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;Value&#160;Measurements&#160;Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;active&#160;markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;observable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Marketable securities &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 138&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 138&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Interest rate contract asset, long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,444&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 3,444&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency contract assets, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,783&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 4,783&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Foreign currency contract liabilities, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,986)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (3,986)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (18,073)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (18,073)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;Value&#160;Measurements&#160;Using&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;Fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Quoted&#160;prices&#160;in&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&#160;other&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Significant&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;active&#160;markets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;observable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;1)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;2)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(Level&#160;3)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest rate contract liability, long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,447)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,447)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Foreign currency contract assets, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,241&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,241&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Foreign currency contract liabilities, current and long-term &lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,646)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,646)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Contingent consideration liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48,234)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:12.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48,234)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(2)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The fair value of the interest rate contracts is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(3)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as prepaid and other assets or other long-term assets in the consolidated balance sheets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(4)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expenses or other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw"
      decimals="-3"
      id="Tc_WE0MsOtS5UuHO0HEDpL4SA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">138000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_T8JXswSBYku-qE6hvnoCVw"
      decimals="-3"
      id="Tc_3W4AMeQgJki1GJGAk7KlXg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">138000</us-gaap:MarketableSecurities>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw"
      decimals="-3"
      id="Tc_QSiGWjq6e0ayiLD20AYsIg_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3444000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A"
      decimals="-3"
      id="Tc_SXqjW8vTfkqe60-EoNJQDg_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3444000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw"
      decimals="-3"
      id="Tc_8UvEk4xZkkmIIabULXm1pw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4783000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A"
      decimals="-3"
      id="Tc_5-7ISvGUQUK0dh3uFbMraw_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4783000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw"
      decimals="-3"
      id="Tc_KChixvmvTkqgdX53UgdB3w_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3986000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_g4BnEV1vIkCCSz-Fm4hF6A"
      decimals="-3"
      id="Tc_hG9ed9AVGE2c25Cf5odcMg_8_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3986000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_dnExq0M-W0aDF5sqmiEkIw"
      decimals="-3"
      id="Tc_QszMVwVdIUG9-k0diBctwg_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18073000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__v2v-UROZ0yrwpSXvqOD4Q"
      decimals="-3"
      id="Tc_CvqOhf8Se0eRXTLvUhzpzg_9_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18073000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA"
      decimals="-3"
      id="Tc_hkcemHJGo0e7DJYyzIO1Dg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1447000</us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g"
      decimals="-3"
      id="Tc_gUXuvebBr0SUFRYaMSVHMw_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1447000</us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA"
      decimals="-3"
      id="Tc_7fg75aOSz0a8ej5pQmmblQ_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2241000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g"
      decimals="-3"
      id="Tc_ABMeS6yoEkmyAHwKmTmZMQ_6_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2241000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA"
      decimals="-3"
      id="Tc_hrHTXD5_tEyqXCJML2dD6g_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3646000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_pOmZkfjnkUCu9wpmnni1-g"
      decimals="-3"
      id="Tc_nq6Wkd8_hUSZ7ph50nt-WQ_7_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3646000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_f_rUPDmMDUOybhxdDlGJaA"
      decimals="-3"
      id="Tc_ew9IBOf_0kC_Mpfx_026Tg_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48234000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_jvGr01_VCUqWKwQSHCGhuw"
      decimals="-3"
      id="Tc_j63kFgUXJ0yh3Z9ROCle3w_8_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48234000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_O7lMSBid00iLFagufBoe9g">Changes in the fair value of our contingent consideration liabilities during the&#160;years ended December&#160;31,&#160;2022 and 2021, consisted of the following (in thousands):&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 48,234&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 55,750&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="-sec-ix-hidden:Hidden_TpnXjRgdGkC2N239gRk-Nw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Contingent consideration expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 4,610&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 3,161&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Contingent payments made&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (34,762)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (10,665)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Effect of foreign exchange&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (9)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (12)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:74.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 18,073&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"&gt; 48,234&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q"
      decimals="-3"
      id="Tc_w8a6FswB1UKD-uoIbmQxNA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48234000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_-dsubK6ei02Er5tXNOop6g"
      decimals="-3"
      id="Tc_38b-r6eSnUqjGzKnOqcD9A_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">55750000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ"
      decimals="-3"
      id="Tc_hEDt61HS30yiS_1jWZPtcQ_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4610000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA"
      decimals="-3"
      id="Tc_CKks9D7wXEe3EOGVrxvFjA_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3161000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ"
      decimals="-3"
      id="Tc_NjAon663_EacKox2c4UOyQ_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">34762000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA"
      decimals="-3"
      id="Tc_sTaIdg05kE-893x8H950UA_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10665000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <mmsi:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_LgNuGTDaRES5Q4Khxv-FvQ"
      decimals="-3"
      id="Tc_AyCYrAYHz0iKzfA2dhezaA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-9000</mmsi:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange>
    <mmsi:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_r3sZxXx-A0CI_BpU4UAdiA"
      decimals="-3"
      id="Tc_z-pmKHNus0q0wi-YAFHWYg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-12000</mmsi:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2022_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_4qQbrD0xJ02K_LJUhv6gQw"
      decimals="-3"
      id="Tc_X4HySmDLPUWrIAULr2Jhcw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">18073000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q"
      decimals="-3"
      id="Tc_N8hHifW7FUaiocbx89YCTQ_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">48234000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_9jqh0ZIn_keRlp7QGXHQFA"
      decimals="-5"
      id="Narr_jwR5Fo93Xk6JC939G1X3aA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2300000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent
      contextRef="As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_-o3_7GcrH0SXneGGIP-6AA"
      decimals="-5"
      id="Narr_XS0wBlrrg0GWBibE83NibA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15800000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_Ra4A3LDTXUq1U3wrhOYTzA"
      decimals="-5"
      id="Narr_vrGY0bUFV0KhAc2Wa7LiSg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13500000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent>
    <mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent
      contextRef="As_Of_12_31_2021_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_wkB4WLQ3Z0eP8rqn-djVrA"
      decimals="-5"
      id="Narr_hPP-Cyz4RUG69bdU6eQb_g"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">34700000</mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_gQEGydZNMk6xXWMYUbr9tg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1800000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_-tk_5QHqQE2BlcipRsqnqg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The recurring Level 3 measurement of our contingent consideration liabilities includes the following significant unobservable inputs at December&#160;31,&#160;2022 and 2021 (amounts in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Valuation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingent consideration liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;technique&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue-based royalty payments contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 2,097&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discounted cash flow&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;14%&#160;-&#160;17%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;15.7%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023-2034&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue milestones contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 13,064&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Monte Carlo simulation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;5.1% - 14.0%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;5.2%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023-2033&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Regulatory approval contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 2,912&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Scenario-based method&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;5.7%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Probability of milestone payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;90%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.47%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2023-2030&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt;"/&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair&#160;value&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Valuation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contingent consideration liability&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:19.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;technique&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:27.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unobservable&#160;inputs&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:7pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Average&lt;/b&gt;&lt;sup style="font-size:5.25pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue-based royalty payments contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,870&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discounted cash flow&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;13%&#160;-&#160;16%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;14.7%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2022-2034&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Revenue milestones contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 41,671&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Monte Carlo simulation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;7.5% - 12.5%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;8.2%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2022-2031&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Regulatory approval contingent liability&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,693&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Scenario-based method&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2.6%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Probability of milestone payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;80%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:7.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:19.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:27.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Projected year of payment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2024-2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:6.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member__0z7AfckH0-izPRxsHj-CA"
      decimals="-3"
      id="Tc_gBFjYbeWhkGu70fMfIs0Zg_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2097000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_XG-RKCkLlk22Ae6PugLZbw"
      decimals="2"
      id="Narr_v_029kCfz0mHOFT-8WMp_Q"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.14</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_9kdasnow90OyrWKURUS9Eg"
      decimals="2"
      id="Narr_DhBs1ApzgkSpqk6aLQ5zTA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.17</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wS-nk3dwt0SoycQ0IxdNoA"
      decimals="3"
      id="Tc_klqxeqFnLEip5gakLfFUqw_4_11"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.157</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_WLKoC-9vCUuynE48y7ekMA"
      decimals="-3"
      id="Tc_avOfRVNymkajomJqI-bDZg_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13064000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_8hQxF1RJzU--ikXVveEKCQ"
      decimals="3"
      id="Narr_rv2l3XCC-EibKJb6sZv6Qw"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.051</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_E2OX24rrYEG3vsZbSdeyig"
      decimals="3"
      id="Narr_t2svBoZ-30KfXjSMrohZMg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.140</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_wFq40ECBeEqsCzPUL8162A"
      decimals="3"
      id="Tc_OKrdliAWNEq2895oumZUlA_7_11"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.052</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_ShfGhn6sDEqCKCrlJf3LYg"
      decimals="-3"
      id="Tc_9iBpY1S_nUqHlP25hiTpzA_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2912000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_DfuOLsD7TkeHPFVz0G_RxA"
      decimals="3"
      id="Tc_Cao9gvnHAEOHAbFaP3HUKw_10_9"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.057</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_sNZB_NpM8EKYkfbbamr2_g"
      decimals="2"
      id="Tc_bRrJWQwHwkacO0xnFJ6hAg_11_9"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.90</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_FDcVr11fvEi_blj5LZlxhQ"
      decimals="-3"
      id="Tc_3uY9YX602k2Ps4zt6aUK8g_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2870000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_CDuUTCWXo02V70P4F5nz2w"
      decimals="2"
      id="Narr_K1q6ssfxs0KM5MulD9pYWA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.13</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_SkTzv3hCxUmDhTZzadO0Pg"
      decimals="0"
      id="Narr_xsW8Dc72Uk2I47oPRt9gTA"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">16</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_xbdo5FZuEUGtMQe0eFs_lQ"
      decimals="3"
      id="Tc_IgLVlKJPHEq2N4FUdjia6g_4_11"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.147</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_UyL0y39Dlki1ZpAdwy5TMw"
      decimals="-3"
      id="Tc_53_27aaPb0az0c2WdJTNBQ_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">41671000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_qnG1d3UiJEG-s9zu8DRZxQ"
      decimals="3"
      id="Narr_KmAtGjZFVUaCmF69z2IYNg"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.075</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_5Yv24v4EpUO9_ajmgjSijg"
      decimals="1"
      id="Narr_48BfqNpwBUCgJvG99XQpxQ"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">12.5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueMilestonesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_NTaqduRlGUyMLasvGWVtVQ"
      decimals="3"
      id="Tc_OVcTosKnGEe9kR3B0n1Bng_7_11"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.082</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_kDxdTejFnEar4hcZNMbfOg"
      decimals="-3"
      id="Tc_wH57UKQ8ZkWvwSBY9IGreg_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3693000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_3l2pT_uLsEe6KfiO2ucLyg"
      decimals="1"
      id="Tc_f5U5usPjDky8We8cXanJUg_10_9"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">2.6</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="As_Of_12_31_2021_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RegulatoryApprovalMilestoneMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_MeasurementInputTypeAxis_mmsi_MilestonePaymentProbabilityMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember_yo_aT89odUGvgS5r4beT1A"
      decimals="2"
      id="Tc_JMuwu7KTvUKSfRwZ5osnPg_11_9"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.80</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:PaymentsForMergerRelatedCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_3u3FWHkJQ0qDFakJiBI-Qg"
      decimals="-5"
      id="Narr_TuU5rkUkU0ygy2JgKGLxaw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1600000</us-gaap:PaymentsForMergerRelatedCosts>
    <us-gaap:PaymentsForMergerRelatedCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_CiannaMedicalMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_DirectorMember_sxaYw4aSrkameQjBWdLV-Q"
      decimals="0"
      id="Narr_I-T0mJjtDUKUO2DP_-FUyw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">800000</us-gaap:PaymentsForMergerRelatedCosts>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_TyDRSgQHZkK8nHlLFMhXYA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_XOtVZd4jKEuuRm7xZRQWXQ"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1600000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_gpiAqDjmukGL1Av2_1VDiA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">28700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_Z0hU6wb-ekeAKeMqog1HLw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1400000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_dM9ZDhjF3ke5H93qdpo3Cw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1500000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_Um4ov2L6BkWZOjkLdxT1wg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_TypeOfArrangementAxis_mmsi_LicenseAgreementArravascLimitedMember_Hq3kh_zQVkuVg6thBV46rw"
      decimals="-5"
      id="Narr_eqYHzDZZ6km_vCkX-IVM1A"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1300000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_CounterpartyNameAxis_mmsi_NinePointMedicalInc.Member_DqLbR1-f_USM3HqTH1_MPQ"
      decimals="-3"
      id="Narr_84C632WsskKYtN2ZOG7k0Q"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">359000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_tOgJc8EA3UqI-JFHwMAAWw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="Duration_1_1_2022_To_12_31_2022_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_XableCathMember_olpSi2DLokilw5cmv-tukQ"
      decimals="-5"
      id="Narr_nMDSagvF7ESuyz2EYafQZA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">500000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_rCYZXv1CfE2ubKNZDLYiJw"
      decimals="-5"
      id="Narr_t-M-7SqIx0OLoNIdUu2mbA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2500000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="As_Of_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_FusionMedicalInc.Member_DUaZCPw_8kabeorUeHmx0g"
      decimals="3"
      id="Narr_ESF1iALY6k6FyA3XAte-1g"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.195</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="Duration_1_1_2020_To_12_31_2020_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mmsi_BluegrassVascularTechnologiesIncMember_F_LmcolU_0qcGjS4sv6hNg"
      decimals="-5"
      id="Narr_kDB4yu6RrEGZvOVghXIPiA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3500000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_H_QkXW08vkWhO-sTppnZTw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-5"
      id="Narr_N3O5pXoHb0-n99SrUdNeRA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15600000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-5"
      id="Narr_9H-JPWxScU-zSc0MRxFrPA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="As_Of_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_ounleXUwDkGNqZctsTtL_g"
      decimals="-5"
      id="Narr_-N-neBv10UC8rcT_slU9ug"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2400000</us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent>
    <us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent
      contextRef="As_Of_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_FjbGmVYKb0ij4cN6X0KS1g"
      decimals="-5"
      id="Narr_sQ4f8nCfLkqx1esJ21hhig"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2300000</us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="As_Of_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_ounleXUwDkGNqZctsTtL_g"
      decimals="-3"
      id="Narr_wpCd1j7TBkOz5dzlCFyoIw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">281000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="As_Of_12_31_2021_us-gaap_BusinessAcquisitionAxis_mmsi_SelioMedicalLimitedSelioMember_FjbGmVYKb0ij4cN6X0KS1g"
      decimals="-3"
      id="Narr_Y33_lp56k0eQmgDQc2GmbA"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">199000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_mmsi_BluegrassVascularTechnologiesIncMember_SYBvPqScc0WI8eIanV1mkQ"
      decimals="-5"
      id="Narr_cuTZ1coPEkCvgag1nUMdXg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_AU1yaXplNESIvzcOj1uRAA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;The table below presents a rollforward of the allowance for current expected credit losses on our notes receivable for the years ended December&#160;31,&#160;2022 and 2021 (in thousands):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 199&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 730&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Provision for credit loss expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 82&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (531)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:75.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 281&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"&gt; 199&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_SEErURv2IUizMHOGbGCoow_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">199000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="-3"
      id="Tc_-_LcMxXlzEyUE2vHmTaV5w_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">730000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_IOBX1fofy0OzHMA633Jwxg_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">82000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_BBesqeRTmUiuWxppxCO7Ew_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-531000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_3aio9eiv4EOWAKGOrA0fPg_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">281000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_tYIyPgTjmEeoJoN6biE7mw_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">199000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_JClmpquhVE2u-i4QkssH-w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;16.&lt;/b&gt;&lt;/span&gt;ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The changes in each component of Accumulated Other Comprehensive Income (Loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash Flow Hedges&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Foreign Currency Translation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;January 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 218&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,512)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,294)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,647)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,786&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,861)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,365&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (786)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,579&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclassifications to: &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,288&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,288&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 872&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 872&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,158)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (158)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (6,940)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,488&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,452)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (119)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,704)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,823)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,489)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (800)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclassifications to: &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,592&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,592&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,017)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,509&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,509&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,015)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,539)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,464)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,527)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,991)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,491)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 651&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,177)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 102&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,075)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclassifications to: &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,583)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,583)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,436&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,436&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,830&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,559)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-size:11pt;font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,366&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (15,916)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (11,550)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Group_yOqNJToByESMPqi6iLjsnQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;The changes in each component of Accumulated Other Comprehensive Income (Loss) for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Cash Flow Hedges&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Foreign Currency Translation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;January 1, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 218&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,512)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,294)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,647)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,786&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,861)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,365&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (786)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,579&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclassifications to: &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (36)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,288&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,288&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 872&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 872&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,158)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (158)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (6,940)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 1,488&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,452)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (119)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,704)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,823)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,489)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (800)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclassifications to: &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,592&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,592&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,017)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,509&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,509&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,476&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,015)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,539)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (2,464)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (5,527)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (7,991)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,491)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 651&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Income taxes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,177)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 102&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,075)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Reclassifications to: &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,583)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,583)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Cost of sales&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,436&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,436&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Net other comprehensive income (loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,830&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,559)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:53.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December 31, 2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-size:11pt;font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; 4,366&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (15,916)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;$&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; (11,550)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_DsDJDza1hEOKOCEENBEccw"
      decimals="-3"
      id="Tc_G1fuCv1MREqRd81igq8VbA_2_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2ZYBTZI1iUGbF66gUMJ3jA"
      decimals="-3"
      id="Tc_BsZdI1_7kUihz3mIZLevhw_2_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5512000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_N2nptxswq06E37WY0fAdLQ"
      decimals="-3"
      id="Tc_Lr_x-7Ble0WSk_ogZdN33A_2_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5294000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw"
      decimals="-3"
      id="Tc_tU4sD_8xI0-Pz10M8PdcLw_4_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11647000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw"
      decimals="-3"
      id="Tc_uavXqGE6mkmMvCezkcTueQ_4_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7786000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg"
      decimals="-3"
      id="Tc_Rayq4TR8Y0yBqSy2w0IYIQ_4_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3861000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw"
      decimals="-3"
      id="Tc_xH8Fm79mN0-sRe-HxCLqOg_5_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2365000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw"
      decimals="-3"
      id="Tc_ucrs4LZGW0GGV24HtZ8Pvg_5_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">786000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg"
      decimals="-3"
      id="Tc_fiD9NdLNAUiC89ctVjh-AQ_5_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1579000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q"
      decimals="-3"
      id="Tc_TstlxVkPP0ul5VeO4oHacQ_7_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-36000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w"
      decimals="-3"
      id="Tc_KACwm-TIFU2jFF2pD9zqrg_7_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-36000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q"
      decimals="-3"
      id="Tc_DWMpMiI7cE2C034DeOsPSw_8_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1288000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w"
      decimals="-3"
      id="Tc_YtMKtk0tVEWG9w4elKxhOw_8_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1288000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Rnfh34X-_kWRnVOup34S2Q"
      decimals="-3"
      id="Tc_DOSnWtXjK0uXT5l3H_8tYg_9_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-872000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GPCwgMt7WkeKenGf_d7H0w"
      decimals="-3"
      id="Tc_CwvOKRa2nEeCCAlA1S988Q_9_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-872000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_3zCCH5uW2UuXBmiv7PXayw"
      decimals="-3"
      id="Tc__m_iHLnCQkm33KlpOEHCSg_10_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7158000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bTBVF6kedEO9wvChti15Sw"
      decimals="-3"
      id="Tc_fg0yS4yGPEahIhGbwz3b6g_10_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_AT1i4KwsWUyaNmhK_LThbg"
      decimals="-3"
      id="Tc_QXYJJWS6vU6jFMmylpULQA_10_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-158000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_m354GPzJSkesgFQaFE_wMA"
      decimals="-3"
      id="Tc_w_iutYfl10WvvHQbi8ZU1A_12_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-6940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_Xv_jjMZ61Uuj4krxMBlGGg"
      decimals="-3"
      id="Tc_JMq_68qAj02FLketkHhLVw_12_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1488000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3aRiaMEyxkWBqtSJEkrr9g"
      decimals="-3"
      id="Tc_A-kfK2AypEici58_WRu3FQ_12_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5452000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw"
      decimals="-3"
      id="Tc_arTd4HK3NUKlwem3LCTmDA_14_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-119000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ"
      decimals="-3"
      id="Tc__v70p2WILEWh-2I40rDY-Q_14_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7704000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A"
      decimals="-3"
      id="Tc_hVqEQ21QV0mhii7hs_05Dw_14_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7823000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw"
      decimals="-3"
      id="Tc_Qlbe0_JRTEux0Jnr3X4OVQ_15_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1489000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ"
      decimals="-3"
      id="Tc_334ukiE660GHuUWP-FISsw_15_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-689000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A"
      decimals="-3"
      id="Tc_-00vKZBvw0OJ4kNohO2i_A_15_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ"
      decimals="-3"
      id="Tc_ahgU0aKH20iyqluZXTkqAg_17_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5592000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g"
      decimals="-3"
      id="Tc_ZCI1I94_RUWC5jUwDgp0DA_17_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5592000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ"
      decimals="-3"
      id="Tc_q00Q-4S8P0-JF4UBonme1w_18_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1017000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g"
      decimals="-3"
      id="Tc_auls4viHD0-xmryPywfGgQ_18_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1017000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F182OpNMmEe26v6Prg4zkQ"
      decimals="-3"
      id="Tc_gFWM690gEU-Kf3q1IJBrwQ_19_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1509000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_WQYrmhueV0m3e5Uk910p8g"
      decimals="-3"
      id="Tc_x9IRz3n1Akqcp0iLekh4Ww_19_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1509000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_YuaLw0VDjUygKi4kMM6Itw"
      decimals="-3"
      id="Tc_1UeLtHZv1kayUhR9FWs4Lw_20_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4476000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_PuCiCITtHEKc9UMSpM09HQ"
      decimals="-3"
      id="Tc_Tfhjcm3TWUqCCy628D1BSg_20_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7015000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_sGDXxuOgMUe-oGenuX2Z0A"
      decimals="-3"
      id="Tc_4BJfNuJzPk6ChUWSFWTvfw_20_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2539000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_NNFXt7P21UW4Paq_45LQzg"
      decimals="-3"
      id="Tc_tKxEwH1pqk-ZIaodTJRXsw_22_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-2464000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_689J25SRoUeFQ-mb_xQzMQ"
      decimals="-3"
      id="Tc_zjuD7LGgxU-V-og1Sz8wPg_22_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-5527000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_aN4IaMh0wkmaWTjP49uYEQ"
      decimals="-3"
      id="Tc_9X5WKzY8CU6kVSb1oFe0RA_22_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-7991000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw"
      decimals="-3"
      id="Tc_I1hVVzUjKku4wppqlDSG5A_24_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11142000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA"
      decimals="-3"
      id="Tc_FzMZl8OvBEuZs4K44k9UHw_24_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10491000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ"
      decimals="-3"
      id="Tc_LlxpIjfsWkSW02JV5SoaMA_24_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">651000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw"
      decimals="-3"
      id="Tc_WX9OjrVMIkujSby1YWBr0w_25_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2177000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA"
      decimals="-3"
      id="Tc_QjnvbcOnIEOl_uRI0xWIQg_25_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-102000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ"
      decimals="-3"
      id="Tc_a3NRfkjwzU6rQTarNimrDg_25_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2075000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ"
      decimals="-3"
      id="Tc_ejWotX67gUmiZ4ylcaoN9w_27_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3583000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA"
      decimals="-3"
      id="Tc_wOTxjsiGQEa69_ZEN0Mmjg_27_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3583000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ"
      decimals="-3"
      id="Tc_xDNQr3lKDEaPkGF5VWtVGA_28_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1436000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA"
      decimals="-3"
      id="Tc_JW6w5pIq80qT1l7RCyNUqA_28_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-1436000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0NHx5sGpe0KjyDUDNol5OQ"
      decimals="-3"
      id="Tc_eQoK-Ej8l02Fqv0gsF0_TA_29_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-12000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_vGxT2XAn50KnsKU186FLCA"
      decimals="-3"
      id="Tc_8gKQuJY5EUOZ8MDBQq6b_g_29_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-12000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_oR21gABl4kCqG3w6NRz1Kw"
      decimals="-3"
      id="Tc_PImiw_xRN0uAOXJxz3bXgg_30_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6830000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_r_tqf3hRxkCrIn-1xp5fwA"
      decimals="-3"
      id="Tc_AGLpnWTrqUeHAJkWmJ2cBw_30_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-10389000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ"
      decimals="-3"
      id="Tc_as6ePzBZakSs5HWuMVfPpQ_30_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-3559000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0dOxMvz3KkeA-_6PU6WRIw"
      decimals="-3"
      id="Tc__eOomohCUk66xZhD_dd-Rw_32_2"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4366000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_bQN0IS6wDU6ClnshU71aSg"
      decimals="-3"
      id="Tc_uJpSDLhSZUSXlDIU6mcRJQ_32_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-15916000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_KA5J2PovC0-VQ20gGn884Q"
      decimals="-3"
      id="Tc_Lsidd4wd50mKogzQe_U0Hg_32_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">-11550000</us-gaap:StockholdersEquity>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_rZFY9W1jZkmRRDkAaPSGKA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:36pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;17.&lt;/b&gt;&lt;/span&gt;LEASES&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;We have operating leases for facilities used for manufacturing, research and development, sales and distribution, and office space, as well as leases for manufacturing and office equipment, vehicles, and land. Our leases have remaining terms ranging from less than &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;one year&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; to approximately &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;27 years&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;. A number of our lease agreements contain options to renew at our discretion for periods of up to &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;15 years&lt;/span&gt;&lt;span style="font-weight:normal;"&gt; and options to terminate the leases within &lt;/span&gt;&lt;span style="font-weight:normal;"&gt;one year&lt;/span&gt;&lt;span style="font-weight:normal;"&gt;. The lease term used to calculate ROU assets and lease liabilities includes renewal and termination options that are deemed reasonably certain to be exercised. Lease agreements with lease and non-lease components are generally accounted for as a single lease component. We do not have any bargain purchase options in our leases. For leases with an initial term of one year or less, we do not record a ROU asset or lease liability on our consolidated balance sheet. Substantially all of the ROU assets and lease liabilities as of December&#160;31,&#160;2022 recorded on our consolidated balance sheet are related to our cardiovascular segment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="font-weight:normal;"&gt;From time to time, we enter into agreements to sublease a portion of our facilities to third parties. Such sublease income is not material. We also lease certain hardware consoles to customers and record rental revenue as a component of net sales. Rental revenue under such console leasing arrangements for the years ended December&#160;31,&#160;2022, 2021 and 2020 was not significant.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The following was included in our consolidated balance sheet as of December&#160;31,&#160;2022 and 2021 (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Assets&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;ROU operating lease assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65,262&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65,913&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Liabilities&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,005&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 59,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 61,526&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70,741&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 72,194&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;We recognize lease expense for operating leases on a straight-line basis over the term of the lease. Net lease cost for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $13.8 million, $15.9 million, and $16.7 million, respectively. The components of lease costs for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows, in thousands:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:31.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Lease Cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:31.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Classification&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Operating lease cost (a)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling, general and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,219&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,013&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,735&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Sublease (income) (b)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling, general and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (409)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (75)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (15)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net lease cost&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 13,810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 15,938&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,720&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;padding:0.75pt;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;(a)&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Includes expense related to short-term leases and variable payments, which were not significant.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:1pt;"&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;(b)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Does not include rental revenue from leases of hardware consoles to customers, which was not significant.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Supplemental cash flow information for the years ended December&#160;31,&#160;2022, 2021 and 2020 was as follows, in thousands:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,710&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,970&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,059&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,130&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,938&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Generally, our lease agreements do not specify an implicit rate. Therefore, we estimate our incremental borrowing rate, which is defined as the interest rate we would pay to borrow on a collateralized basis, considering such factors as length &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;of lease term and the risks of the economic environment in which the leased asset operates. As of December&#160;31,&#160;2022, 2021 and 2020, our lease agreements had the following remaining lease term and discount rates:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.28%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average remaining lease term&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;10.4 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;11.4 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;11.5 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;3.4%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;3.4%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;3.3%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;As of December&#160;31,&#160;2022, maturities of operating lease liabilities were as follows, in thousands:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amounts&#160;due&#160;under&#160;operating&#160;leases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,554&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,941&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,523&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,944&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 37,983&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total lease payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 84,583&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less: Imputed interest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (13,842)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70,741&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;background:#ffffff;margin:0pt;"&gt;As of December&#160;31,&#160;2022, we had additional operating leases for office space that had not yet commenced. These leases will commence during 2023 and are not deemed material.&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MinimumMember_QnCxU02fNUm64FC2KL9WNA"
      id="Narr_WuEQQMxzHk-k6mmrD2lugQ">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="As_Of_12_31_2022_srt_RangeAxis_srt_MaximumMember_4HjX7W_AtkazUBHgOvHHrw"
      id="Narr_dLzjvF9hGU24K7XcFD6YqQ">P27Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      id="Narr_mhkgwPcF7kKy0_-4YLMPYA">P15Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <mmsi:LesseeOperatingLeaseTerminationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_9neytra5BEu-nTTV7jMVZA">P1Y</mmsi:LesseeOperatingLeaseTerminationPeriod>
    <mmsi:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_RBq-gmc8YUKHiz7IhUli5Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The following was included in our consolidated balance sheet as of December&#160;31,&#160;2022 and 2021 (in thousands):&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Assets&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;ROU operating lease assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65,262&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65,913&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Liabilities&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,005&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,668&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 59,736&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 61,526&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:70.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"&gt;Total operating lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70,741&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 72,194&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</mmsi:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_GT2BB9CNAEa6RwqfYuI8SA_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65262000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_Vp4MZpRM4UyrPdab40G3PA_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">65913000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_XCLm2VY2r02ZmdmhzPC2Qw_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11005000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_OWsdatu2yUaIO5awWCjT0Q_6_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10668000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_ID6rI53YN0enUTrX9CG_iQ_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">59736000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_3l9OP06Uq0e1dLpRZ2r2bg_7_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">61526000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_wf6N0Q204kaqOZYgRhYsaQ_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">70741000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="-3"
      id="Tc_hf3bnob4w02hiFhDCuU-Bw_8_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">72194000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_sfIz04_djEyhKszvRoepyQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;We recognize lease expense for operating leases on a straight-line basis over the term of the lease. Net lease cost for the years ended December&#160;31,&#160;2022, 2021 and 2020 was $13.8 million, $15.9 million, and $16.7 million, respectively. The components of lease costs for the years ended December&#160;31,&#160;2022, 2021 and 2020 were as follows, in thousands:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:31.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Lease Cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:31.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Classification&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Operating lease cost (a)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling, general and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 14,219&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,013&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,735&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Sublease (income) (b)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:31.59%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Selling, general and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (409)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (75)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt; (15)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;Net lease cost&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:31.59%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 13,810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 15,938&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.38%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"&gt; 16,720&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;padding:0.75pt;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:4.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;(a)&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;width:95.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Includes expense related to short-term leases and variable payments, which were not significant.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:1pt;"&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"/&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="vertical-align:top;white-space:nowrap;width:4.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;(b)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;width:95.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;Does not include rental revenue from leases of hardware consoles to customers, which was not significant.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Supplemental cash flow information for the years ended December&#160;31,&#160;2022, 2021 and 2020 was as follows, in thousands:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="position:absolute;top:0pt;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,710&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,970&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,059&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,130&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,524&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,938&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="background:#ffffff;"&gt;Generally, our lease agreements do not specify an implicit rate. Therefore, we estimate our incremental borrowing rate, which is defined as the interest rate we would pay to borrow on a collateralized basis, considering such factors as length &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;of lease term and the risks of the economic environment in which the leased asset operates. As of December&#160;31,&#160;2022, 2021 and 2020, our lease agreements had the following remaining lease term and discount rates:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.28%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average remaining lease term&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;10.4 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;11.4 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;11.5 years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average discount rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;3.4%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;3.4%&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;3.3%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:LeaseCost
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-5"
      id="Narr_8bdBi2Xgj0u6h_EYRP__dw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-5"
      id="Narr_A_fd2AjcE0aOKEVjIH8cyg"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-5"
      id="Narr_mOhV_sVYOUyiACdcb6mOEw"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16700000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_yr503gsip0WDdsOFH32QhQ_3_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14219000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_Yl7gz2yLxUWo_H_pZhPEbg_3_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16013000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_urQ1m_EGX0uGKgjFKMrkFA_3_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16735000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SubleaseIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_YCXZtBO7zEqF5LA4hBTHuA_4_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">409000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_nAP3dQccDUq3VKlAAerYtA_4_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">75000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_90fEHcBA6kySE57IeFhf-g_4_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_eKqbWqQurU6rp4yoTRtzfQ_5_5"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13810000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_evHUGlOjf0q_5t5f8p1enA_5_8"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15938000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_kOBaHxVd9EymxL6NXEgFEA_5_11"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">16720000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_9Hbalf1_ck6LdeqtvxL7UA_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13710000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_U5jsmofagU-XMa1UsM9hXg_2_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">14970000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_YArUl7lvSU633g00n6Fk_w_2_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">15059000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      decimals="-3"
      id="Tc_f-lo6o0KokKGYFEL9XgEIw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11130000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2021_To_12_31_2021_by10a9z4OU273-gmTs0ekg"
      decimals="-3"
      id="Tc_o1vfeM9780yVnPIHgxZfJA_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1524000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="Duration_1_1_2020_To_12_31_2020_YwS2XguONkyELI82jUNFVQ"
      decimals="-3"
      id="Tc_1THjO-LOZEKS5Fyj4b7CeA_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10938000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      id="Narr_iGH5k5I6BkqalVdPJQ5Z1w">P10Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      id="Narr_nbp_L-ULvUK2RScfcTaAjQ">P11Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      id="Narr_xG4FJ_4EjkiXBViy6RzOew">P11Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="3"
      id="Tc_zHLLL0YL5U6S8EY9QH3I9g_3_3"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.034</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ"
      decimals="3"
      id="Tc_pm7f9CTsQUiL-GShPqD1Lw_3_6"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.034</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ"
      decimals="3"
      id="Tc_p-dY4Gvlm0iB-_BD9_b30g_3_9"
      unitRef="Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ">0.033</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_bQfyUGqzKE-tK23BjO6DUQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="background:#ffffff;"&gt;As of December&#160;31,&#160;2022, maturities of operating lease liabilities were as follows, in thousands:&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Year ended December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Amounts&#160;due&#160;under&#160;operating&#160;leases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 11,554&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,941&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,523&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,944&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 37,983&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total lease payments&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 84,583&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Less: Imputed interest&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (13,842)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:11pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:28.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 70,741&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;background:#ffffff;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_0_qZtO3fj0CZVR-WFxTLLg_2_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">12638000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_GsW2pmlnN0uNhWm1pCxRNw_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">11554000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_CXzshJVodEiAw170YMpeAQ_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8941000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_YefJRa4o2USgZUorL7R3uA_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">7523000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_onRU3Mvwo0ePIQ4hIMkIxg_6_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5944000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_-qrtC9FHz02hSeeD9ADABw_7_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">37983000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_duAfTIpVqECP4d9Jhq1x-Q_8_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">84583000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_yYS8vZaIjEKDlt7Yo0unSg_9_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13842000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ"
      decimals="-3"
      id="Tc_9sCjtDfFPEGEhQG-PdPPFg_10_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">70741000</us-gaap:OperatingLeaseLiability>
    <dei:AuditorFirmId
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Narr_Sa_SE0-ou0m09CRpQhnBrw">34</dei:AuditorFirmId>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw"
      id="Tb_npm2sw3zN0m8e7IXPHnjzA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 14.4pt;"&gt;&lt;span style="font-weight:normal;"&gt;(2)&#160;&lt;/span&gt;&lt;span style="font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"&gt;Financial Statement Schedules.&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;border:0;"&gt;&lt;tr&gt;&lt;td style="width:28.8pt;padding:0pt;"/&gt;&lt;td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"&gt;Schedule II&#160;- Valuation and qualifying accounts&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Years Ended December&#160;31,&#160;2022, 2021 and 2020&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In thousands)&lt;/b&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Additions&#160;Charged&#160;to&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Allowance for Credit Losses: &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Beginning&#160;of&#160;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Costs&#160;and&#160;Expenses&#160;(a)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deduction&#160;(b)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;End&#160;of&#160;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,108)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,115)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 910&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,313)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,313)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,678)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.66%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,224&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.61%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,767)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,767)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,858)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.66%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 202&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.61%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,423)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(a)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;We record a bad debt provision based upon historical bad debt experience, current economic conditions, expectations of future economic conditions, and management&#x2019;s evaluation of our ability to collect individual outstanding balances.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(b)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;When an individual customer balance becomes impaired and is deemed uncollectible, a deduction is made against the allowance for uncollectible accounts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Years Ended December&#160;31,&#160;2022, 2021 and 2020&lt;/b&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(In thousands)&lt;/b&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Additions&#160;Charged&#160;to&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance&#160;at&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:26.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Tax Valuation Allowance:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Beginning&#160;of&#160;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Costs&#160;and&#160;Expenses&#160;(a)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Deduction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;End&#160;of&#160;Year&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:26.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,644)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,569)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:26.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (573)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,786)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:26.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,786)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,741)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; -&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (13,527)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:36pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(a)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;We record a valuation allowance against a deferred tax asset when it is determined that it is more likely than not that the deferred tax asset will not be realized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"&gt;&lt;span style="margin-left:0pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;"&gt;(b)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Exhibits:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_85rQK-4M5ECcEsi9kKnxVA"
      decimals="-3"
      id="Tc_RTE-nn2fDU-97uPm0rTHxA_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3108000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_j64W9w2JFkaNZCAs8PllJQ"
      decimals="-3"
      id="Tc_6ubN_SK8a0OBdo6n6mFWtw_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">3115000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_j64W9w2JFkaNZCAs8PllJQ"
      decimals="-3"
      id="Tc_eX1KqliORkWCyZ32CzLNAw_3_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">910000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Ksk8oPM3pkWXnmJp3aVfjA"
      decimals="-3"
      id="Tc_cWB8vCFC-0qSrkDXrHLuXQ_3_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5313000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Ksk8oPM3pkWXnmJp3aVfjA"
      decimals="-3"
      id="Tc_UwSQwTIzE0y4z4yyxLTnqw_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5313000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_ymPQ_EUUskWNwXusRc-oFg"
      decimals="-3"
      id="Tc_FQazj3-DT0qCONFsiDng8Q_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2678000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_ymPQ_EUUskWNwXusRc-oFg"
      decimals="-3"
      id="Tc_SgGHUj0E3UapzphPXPOsMQ_4_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1224000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg"
      decimals="-3"
      id="Tc_wOWt0khv_U6hpVmJA8ajHg_4_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6767000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg"
      decimals="-3"
      id="Tc_BA2tenkCWEavdkgL_Npwlg_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">6767000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Tcw0rwvwnUCNggwvx-hToA"
      decimals="-3"
      id="Tc_o0lzALOZc0iyyP3-LKotCQ_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">1858000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_Tcw0rwvwnUCNggwvx-hToA"
      decimals="-3"
      id="Tc_n_SIX0fIiEOHrN3Psd6VjA_5_9"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">202000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_XT-DImLBW0CLqTtA5KznqQ"
      decimals="-3"
      id="Tc_I-yOoGOeE0GzPTSwuLhYcA_5_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">8423000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_dwnvij5qh0aeUakBIbwM3A"
      decimals="-3"
      id="Tc_k38WYQXCXkaf0gRPBAgNrQ_3_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">4644000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vb9_o2qO3UyDJVFE_VYJKA"
      decimals="-3"
      id="Tc_4URn19xso0CuZ_VOHqH3vA_3_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">5569000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_B7su2MaR6Ue9mzoD3SVZSw"
      decimals="-3"
      id="Tc_oyZS4otonEuOEGsuPIcgDA_3_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10213000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2020_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_B7su2MaR6Ue9mzoD3SVZSw"
      decimals="-3"
      id="Tc_3DSPGpnO9E2h-n5I2nvp9Q_4_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10213000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_vuB28aRB70m7DQkE04axrQ"
      decimals="-3"
      id="Tc_M3SosmTl70Ocv9ETPPmgEg_4_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">573000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_fERnc1ZCQkW-tUKySpgZRg"
      decimals="-3"
      id="Tc_Sc6CvSBLSESoIvxOhCALfg_4_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10786000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_fERnc1ZCQkW-tUKySpgZRg"
      decimals="-3"
      id="Tc_5tYNsOfKhUanPUSo5PVtiQ_5_3"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">10786000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_eIOjLCC_ckKJd7j-tagx0A"
      decimals="-3"
      id="Tc_60YzdCI9mk2nIrzEuB_Fcg_5_6"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">2741000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="As_Of_12_31_2022_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_DS1rt81n2UuuEQSAYL8cwQ"
      decimals="-3"
      id="Tc_2gk40jXh4EmdG2BaP5tTwg_5_12"
      unitRef="Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA">13527000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>127
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *>%6%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "GA5A6.&JLO.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>NDT+AZC+98@32$A, G&+$F^+:/XH,6KW]K1EZX3@ 3C&_N7S
M9\F=CD*'A,\I1$QD,=^,KO=9Z+AA1Z(H +(^HE.YG!)^:NY#<HJF9SI 5/I#
M'1!X5=V!0U)&D8(96,25R&1GM- )%85TQAN]XN-GZA>8T8 ].O24H2YK8'*>
M&$]CW\$5,,,(D\O?!30K<:G^B5TZP,[),=LU-0Q#.31+;MJAAK>GQY=EW<+Z
M3,IKG'YE*^@4<<,NDU^;[?WN@4E>\::H>,';':]%VXK;]GUV_>%W%7;!V+W]
MQ\870=G!K[N07U!+ P04    " "GA5A6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *>%6%:'G%1P;0<  *8P   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9MM<YI*&(;_RHZGTVEG8H1%$],FSAC44]N\>()I)^?;"AME JQG66+R[\^"
M+TAF>829M1^B*,\-7.[+?</V<L7X2[R@5*"W,(CBJ\9"B.6W5BMV%S0D\2E;
MTDA^\\QX2(3<Y/-6O.24>%E1&+2P89RU0N)'C=YE]MF$]RY9(@(_HA..XB0,
M"7^_I@%;737,QO:#!W^^$.D'K=[EDLRI0\7C<L+E5FNGXODAC6*?18C3YZM&
MW_PVL"[2@FR/WSY=Q7OO47HI,\9>THVQ=]4PTC.B 75%*D'DRRNU:1"D2O(\
M_MN(-G;'3 OWWV_51]G%RXN9D9C:+/CC>V)QU>@VD$>?21*(![;Z03<7U$GU
M7!;$V5^T6N_;;C>0F\2"A9MB>0:A'ZU?R=L&Q%X!/B\IP)L"_*' +#N"M2FP
MJA:T-P7MC,SZ4C(. R)([Y*S%>+IWE(M?9/!S*KEY?M1^KL[@LMO?5DG>C9[
MI1Q-Y$^,FNC1&: OG[ZB3\B/T+4?!/*7B2];0AXGW;OE;C2OUYJX1-/$Z)9%
M8A&C8>11KRC0DB>X.TN\/<MK#"H.J'N*+/,$80-CQ0G9</F(SDX1QEFYI2@?
MP.4_DT@>W5 =O7 UUHZYE>E9(/.T6YVJX*Z+V^KB=!SX%B^)2Z\:LJ/'E+_2
M1N_S7^:9\5T%1J?80)-8 5I[!ZT-J?<&S$WD>"/0]'U)5=C@<M-H_E+Q :OJ
M\M$D5N#3V?'I5./3CZ*$!.B!+AD7*E"PCN")"J\-5M4%I4FL .IL!^JL8D/B
M1$Y?V>Q3#@O6>B9!K*0%EM6EI4FL0.M\1^N\&JT)Y3[STA$=R8E&V0,/*&W'
M\-)!'*RO"TV36 %:=P>M"U[J,!*^>$<C/Z#H+@EGE*MPP1I&T^QV+I2<P,*Z
MG#2)%3A=[#A=5.'T0.=^+&1O%.B.A,JF!>O<#A_&4W0['(SM_@URGISI\-9!
MXSM;10^4JDM/DUB!GFGDWLVHPF\<N8S+ 8RD8]D)<H3LGXAQ9+,D$OQ=OGI*
MJ ?4'Z<J?'!177ZZU(H ]\RO606@+0<X+N?,L;2K;^@7?5?2@J4,^:_;.;OH
M*KLL7%R;FB:U(C6<4\-5J$W)&QI[$IW_[+M9VP,&NP.2W?.FT6Z?GUUTE/3
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M)4=^G-Z(?:*$@PM>#L@UFR9N6LK;UG!E;6S',/=6;NZMBFN$]KF-Y(=*AW]
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M;[UK=FDF+A?JYFE$_2065W__&^+A>RB[$W4VR94<<B6^WJ]NTF8;J*L69/I
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MFLG_(, 40'Y?42K>!FJ!YE_-\!=02P,$%     @ IX585@B8+R-<"@  PV,
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M N+[QT(4C]T;>8/#[^!<_0]02P,$%     @ IX585K/L)8SB @  JP<  !@
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MD8?4Z(D[IVCUS!5Z362)US7+3$1W@L1U(RM.=I'F1+H5VY _G'TK]3U<2J>
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M3JWD;GA20>-D!TPR0Z;8JY.R)<&]\A(G"BB(IHH",L0469D<2D7%)/RQI2)
M&0;Q$8 3WLJ*GA8E%XDZKIT'<7(P>*-*9,O@7T\N:GDU*,'XLVW9B$W1"D>$
M?*;(ONJ>'46&6N&,!YU8V[A< T,SC_V)INH$-601'+*5)@X9NQ&9*0"T'. @
M36#"XL,(U/:S%5HBH(BD* 8P2=$82"RM*7.6UCN*WL 0" "14MA20L+"R.B%
M)@XM6[%M4THSN!1"*XP<M+-"X-9.K!A.^<HKB%G4K;E.=<%0#+$9BZSJHH+/
MP$"P+7%(YC+;!4^NXW(T9&CVQ<*:]1,R)$@=3R\"4T"2MJ&;@W2@@0:25S&
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M)5&0: />+PS (#P0@_IW+I__"U!+ P04    " "GA5A6EM8CHTH&   ^$P
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MI*BE<1NPOM5Z.+ZX TZ?S*[_#5!+ P04    " "GA5A6R@XB+QT(  #@%
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MD#0$^#X70F]>C(+VJO+R?U!+ P04    " "GA5A6%;N (<P/   H,@  &0
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M*Y (*)J [^NRU.T+;=#]<\B;_P-02P,$%     @ IX585E#@Y%7S @  &P<
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M==L5OEZ@K &>EU*:K6 #=._A] ]02P,$%     @ IX585GHL-#05"0  9!H
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M!KQ/%.*R>B &S8>ER_\!4$L#!!0    ( *>%6%88N@V;$ H  /0B   9
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MLU0R7RP!RXF/$2HEP\-]S:4-D05OA#;L#MWF+M8/S'%2N'<%N.%ZR3Y"+J
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M@X"".:-%( AAFK?+3;,<$B74$0!1AV1!J,!7-#,A:(G$#,%5"V-IEC+#@$E
M;-(O(25J7Z@55V9C0:=B --7/([:;&IJ3R@S+4U%57I,YFJ/5+K YM@&<8A!
M/,<@MCAM%=[$H?V$T*J[[#$B("5@MK'.TVOW2^_Q&&['9@\YG^.,V8:==-OC
MRK\ LZI<8/C3:^31^P3RK4 L ?^)$P1\0HP7R-0_)A.D."@2,W9#L!1N7@V5
MF"-KX&U@..5?!'(7[L&H14K=9S3K2PLHW!G0Q<2(L-$$=X<'!8F _*@@KF#?
M2F!<64FW,N?S";AP<JSKPP3,;CV+,*C*/D5VH\2(=4R1#;6684S[J]P> $+
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MV&L 9M# - A-QZN_F_?A22YY")6T3@OYC,,U7,S[?W'-M[K>N'NZK]7QNA"
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MZ=@!68\0M:!%::_M.Z%I"+"?*4U=*(T"_=\*.F2-8#9HY[CEOU!+ P04
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MS=2 QF3-[+W:ST"JZ7B8"U9P74IUQTW15EP[.J(NE2E4\S!G[X!SM*,_R@H
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MO(2YGUO!2Z%I ];72MG]@ 0,_X^X_@U02P,$%     @ IX585L)V-2[_ @
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MIQZH5C7;C9&54ZJ%-*1[;IG3CP:5=:#S3$JSW=@+NE_7Y"]02P,$%     @
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M&=B5*:&EK,6DY1192@.(]$XQM!6T%JH'S6/-I2=RS7H/$+.Z@H-F$G<9Q;[
M,USGL$E4 _!YS$J5*<;*N8I@K$J3U> 2F2K>:;VBP15A2Y2S*Y7"1Y-=<1-*
MD+(@OC=$66K,K RV,[B?F98,Y20D696)^0*7KR2L*P38E 2,\-8F@]75U<)1
MVIDKD#.:1QQ$./$[ -) HO6*5P>$P$G/*G#8+%>R6-/+#;[9"C].\$ C2*N!
M">TA^;;' _$I9(;>X&EF4(@"6)C:G?&@]F5G+AF+YSC()$GPS(EOD9'NUM
M. _)]GI> UD2+I*,W:R5L0<KF$AARYL:2S*X3WHV>)75I5-6)=9*EA;.CK3D
M.TM^&0,.XUXH&(3"T==I8)2*L'./'IR=]2_.AON%UHM-F#'IGR?#<#?N)^=)
M/-DKJ(4?S=I)O3%2H/,H)NPEP_[Y^=FQ>#6;J=3ILS>>P1-O;[!WM9LY]!(
M?55DW9MU^<;^W3_O+F+TQ:/18$PZG1,%P*\[Q60M;B6)&1EV,)T4[X"Q)#EY
ME)P-+K]RC1TC3>LZJ=YCA:%[.3^%O8D6C*1]L(<J^/LH&0_._FBRC">#B^^*
M'-?2+EJQCB:06B-HJ'+5N"3O >_".[+2FR4W5U1CX[Q:Y0@Y*>:6*6)GJQD&
M;4%,E>+B.E7)O;,6*2%IZFH&(^."7U_W@UYPA.LLV0--/T,ED"##NPX*@/B(
ML2.?<H_-VQH)Z6\U#?$TY$U1VA!M%+>/DD@_&O]/]G>_^66?&M&E=7[Q3BAV
M:UU0XW8BQ_$@Y^ %T&Y9>1NE]5U).!B_WW^(GER:NFCBT3^O4/IZ(R3Y5E W
M-A[7.AQU[POF$Q_?@--W!EQK1]Y*I8M"0_;$APZ.O-]P.L]O  3WE 2_=]'>
MB0LC2[.6.4 &D]!A.-8;987AU04?7Q!+ 2#(8GCHLL5F2C+Y09R(Y.*']LG9
M(+K;_GU7FO]V(L_: >$-J$6QP?@$5Y/XR?D?+CZ><%%T?!>QDG%_>#[A8RD%
MRUOF!IJTK'/'SVYZG0T2)MAD,/PA>CCZ)A0;;SSY%U!L3ILUY9I<0&F@>W?+
MUU4R:LN)R&XD4@4OK$L%\Y&UFK>'@ >DZZ&_H.TT1/NSEO4A=6L&7@V_Z:+=
M#-WAYS!^,F'U[C(&MPJ^Y+8Q,-,U6W?V?)1\=-5]0O(]$'\W[53I[0BGUY3,
M41)I[NE;*(>#4Z>4B8T3%NOP)8/_=PM?X1:2/\TM7%X,'^06QFSESB.W,/EZ
MMS#ZMW +DZ1_?I$\S"U<#,Z88"/Z;1Y>?KU;8(HE&T^^1[<P[I]?M?[JGW$+
MH\'YG^ 6+O_5;F$"?H[.XB=G_\O<PJ_WR<SN+DIV5B1]\6X5*.U+H[8OLEBJ
M<+\*(D!KM<SH<][30FAX1'DA)9[A1;I39A)-GD289ZTMG<KT<Y->-N=R&_C*
M>'1K>9<F4WF\9+,;7B"4D2DY7!HZY5%43':G/@5TTB><AJZG=39O^FVXWN&8
M18U+E9KK5*QR65"YI0AYM.AERET=4^:G-!=+.$?>T%"?#//1%G89Z(@Y&KF\
MKW\O)94:;)U77!R)4])\#90@S**W@$"J\GA/"178B08E/K=HD>-J_*92RV+=
MH=B;:-QK65"%#AZ;$PS9E 1V:[CW$FM0+L_B@KFO^K- 6,]6+OD38\$JP_7R
M<+;HEP8)[LCJN3I.PE"P[KCS%":+K>FLM*MDCW'=-?J=RM7!LGP4[(1*#4"_
M]\6:=[)TU:R7#ZQE#_LP6JZ8NZM^C @[I"]ZB74@5H^2P7FHVG!![W(X[ ^'
M0\)&DHU;8I5,@S:589/\,]C@3LW]2[N LBU,3D5_O+_6LB@DAF5\!NN.G6]]
M7:QTE;_1,+ET1Q.$:&$<O0.6/&*4#,0;OACW>?_7K@;&1$\=N9;R,P!GF?8Z
M' =S7,_'WOD$9@71*1T%74&))+6MWK65K+YH3_OV"FNS3-\YF.CDSJWC+1DH
M#<FLXFJC)]D6C6(*<GEPA]Y<Y97WHG@_7L@Q*X CW9[",^1ZKDD-R(5%Y(O[
M$V?B+5NSUZ$?\4UTP,DN2I8E5R2=40\%2!(-OJ F BB-HQ297LW*9YT#@5W-
MV.KPLU@L8W6;JE36MG70RR5VB3%]$ &.S16E,8G:%-:MXK==E!LNG:Q46\O.
MU)1<PHGO8)B5KLX)K<B<HM\@!&-SP1Z1L::S2)U;EMG(N*3MP15L+@@J2FT_
MTXR^XZBSJ*R<4Y!?^1/33>NXA5I$$MM2FT</.DZTHW[1C>B#SZ$WIV^"C@^8
M#YQ#.YL9'6FJ+ZE:-0;W .N="2"/W':$.//[!AJM2U:0:\@T4?!3="I*CC-S
M?<1=Y$K]^7335L1&1!)OBI/M-EH*9[#=4H.[V#HLN#_Z)$Q7C3NNP$56C(B6
M<V.R6QA(?\A1^%YWIH)N\6_=#\4(&.Z+TD"F+5Y'[2_UW>[)MQ' Q-!9&S8/
MJ.YLM2F"[_K8A8:1*M/%FHQGV,YSWPC#'P30K ]8_6UP8S]QO- ,4KZ#A@_0
M(\&FT,HCE>HRK9=P< 4IC@NHR4N9P).25CHQLQ/:9X\BV]'P\?NW'_@J>7P<
M.=&<5V]Z=3Z1XP)9.9XE(TJ]/'K%7A&;[X@"K>\<\"&^I",+![.)*#=EWQ,-
MR.PBP6?AS@6S,N;($[)8&B+MJ!:RZH#OLPYJ_"!!IL0!Z+#'MXV!83L0VC<B
M*:+HX/XGV$GP^OX 9K+IRI/V^(\,,+5%4.+#Z[-.0MV!$I3$4XHTV@:WV$VW
MIB?GQH6ZD#P$D&Q)LD@0G8':W9ESF"6P*"*-!-O@?N-V%#X]4ZFVX:0QDD32
MJS;_B 2A.7;JY"WA?9C#_<;PIYM]"-281KLDW^2[WB*CWA#F^NW'-R]/DBOX
M-'!KJ5.F@541-#YZ @YM!M&<\$52WJ0)7@M)HN$@K5+][9GQ++=)$) X2$1S
M7E:V^8!?RH5/889S;:%?QYM&Q[[]9-QE[,HIOLM".1:69:;-C;1IG2.9MVKN
M,A0H^$)F(>CKEOA]82[G>JWQ?M48[X&XU_Q$L.;1^GY=IS=M\\#6>?'6*6.W
MY]@Z%0YI)Q,422,1A0T7A9,UGV9[D7F>W9@4Z\$J3BY'C\4[A&NK!75!(<V<
M:X/9%JN]@.4W%'?ZOB?Z^ 3N#@&@]P=$[QQ!##5^R'FI?-K!/NIY6<J/X$*C
M\_=FU#;QADQNH/.FN($R^ CX70UO(]F=M%T!?^?VS?<AY-O)8_;Q-QA&?][^
M:!AU,% 6%3E<W^@2<8QVXSM7?<5,!U1)_/]!N%S+:L%!6=O/IAS'FF+ ;MJU
M!]WA#KJC;XDNK9Y< :)O@A/F%G[.+O2*WJX0%JB2W"2G RS*KVO^DB]D F\*
M&*'&^[J7P0%[4U<7WF635$^I3+759)=1K&&\H),=-HC!2PJM]._.3L,DF%3S
MKD)LR$5ZDYNY]H&S)#-8NNK7H[@O)2+("ZC/O 0X\;&11H^EX?*"<P?L6O%,
M?2$T*#>@*H +1*FZT@BD:W#@G/'KK X2T3:$#0TL3</>WL;4PZTL+M212+O6
MO[LMM,RWCK_0'<[1%RK/_$Z(FMACB$*$9D.RIFR(BB93URSB(B0RZBZ$9[N_
M(6D;M;&F)A03-8Y-=3$#9]AND==O70)7 4*DO<).4U\K=-749D.#V&8P_[:P
M9"NVBR5WF?! 7JW<WIVDS-Q6]-5F;2-MZQ-=VIX<!/]YS8VB;F#DWMNBD7/F
MM [WXT31^$8+.BW;=ICCQFI(LMQ@'X(]7\1\U3C;:Y<5_N3DCO)0J!H%T%QI
M:,6G8,O9)LMQ/:+IEPI-Z]PH3?RC+I;07=D44(.C]QFIDWE?LX"EV@H6HQ:Z
M_CT^%XS#R7T]:/%X[W81P3P$6[86H\N$*U(NIKVZHIOM>+;#!KGNZPUJ.ITC
MP*[_YV&H%"[^RO2-SBAH]E]'K%U;; @>70?M4A.$HF9Z8!?QIQ1-37NK'NN_
M='95[2A$#[H*4XDTTRDD?R_-S&.CO9+T4<>-\\FMR"RTK4S)HDJ[*C5I<?OM
M"\R3*_Y8'QA+:PK7Q89;6Z_H\$#Z2I%"H$UE-TI[I&L#W8@G4Y-3*U>TH7;/
M]_6H3E \).=0HZ8RTLL.'_%KY&N\SX,3L+5L>]9"N4^R3&PHF*-SJ?CS8J[#
MTJ[X^Q@RP@5%V'DPWNS+D(CO**.O9&TM#5K1@K[HR .F])F^"*LAC<!V0=];
MQ&$AR7J@8+I*PZ:P;S3AW=T$_8=_Y;MQ\GIGXS/T/+J[& \I\K]Q 0#3I"7!
M3L]S.)O</>GMG8V3 QW(,#7=.'1]:WX:_4\ A$1S_L\'?'Q15.[? X2GX9\K
M/'?_4Z =[OXSP\\(C32T,%<S3!T.+LZ.7 FEN:G,BO_#P-14E5GRY4))>$T:
M@/<S ^[[&UH@_,N)9_\#4$L#!!0    ( *>%6%:X1T-4300  *D/   9
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M[,\F/50W?F/V@](4_*Z[,"48 ?^[5A+PH07XOC2F; :DH'WHO_D=4$L#!!0
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M<8+)E$V]:M0UA1-XE^UB)?S/M5"JS[.;@";_VX(V@MJ)E'C_R=)8M@>.&,A
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M#'?7&^_7'CMA63*#5TK\R0M;S8+3  HL62OL-[7^C#V>L?.7*V'\$]:];A1
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M.CZAFT=WLU&WL:KQ\\A269IN_+*B<1*U4Z#OI:+3TV]<@&% G?\+4$L#!!0
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M$B>[(=E;8^#,8O)$&8>RL=B3@ET,C(V6" K#Z2B>0Y>GU%.'";0&\S(306O
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MS[<0#WK#T6@CV->UX=98*-!D]?"SP'6E7#,A.FDW7V?-6/G?O!G.-\QD@@:
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MUM&UNP-U&DZH-!/(Q&<Q>E]=#CW'L#K&Z"<?AWT!+B;\T&_%O,2? @'TNV%
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MJ'. @6FKCY)JX<TB? A,C,?\"(]S?,>190&\GQKCZP4;:+X,Q_\#4$L#!!0
M   ( *>%6%:,PB).M 4  +$4   9    >&PO=V]R:W-H965T<R]S:&5E=#,V
M+GAM;-U8;6_;-A#^*X06% Z@U7JQ93E-##C.L@9HUR#I.@S#/M#2V2(JB1Y)
MQ>E^_8Z4+5.UH[I8N@+[(HDO=[RWY^[$\S47'V4&H,ACD9?RPLF46IWU^S+)
MH*#R)5]!B2L++@JJ<"B6?;D20%-#5.3]P/.B?D%9Z4S.S=RMF)SS2N6LA%M!
M9%445'RZA)RO+QS?V4[<L66F]$1_<KZB2[@']>OJ5N"HWW!)60&E9+PD A87
MSM0_NXST?K/A X.UM+Z)UF3.^4<]N$DO'$\+!#DD2G.@^'J &>2Y9H1B_+7A
MZ31':D+[>\O]VNB.NLRIA!G/?V.IRBZ<V"$I+&B5JSN^?@T;?8::7\)S:9YD
MO=GK.22II.+%AA@E*%A9O^GCQ@['$ 0;@L#(71]DI+RBBD[.!5\3H7<C-_UA
M5#74*!PKM5/NE<!5AG1J<@6"/5!M&4EZ[^D\!WEZWE?(6:_WDPV7RYI+\ 07
M/R!O>:DR27XJ4TC;#/HH4B-7L)7K,NCD> 7)2Q+Z+@F\(.C@%S9ZAH9?^$4]
MR4TIE:@PL)0DM$S):TB7K%R2J0X0IAA:XHK)).>R$D#^F,YQ.P;/GX?,4A\Z
M.'RH!M297-$$+AQ$C 3Q ,[DQ0]^Y+WJ4&G0J#3HXCZY1X"F50Z$+\@3ZK&2
MW"NJ0(_TMFM6TC)A-">W7#(-"Y=<4R;(!YI7<$C!;A'>9T 6FOY!T^L3TIT@
MS!)$XX\L!9=28XBA9&A[218\QZR D8>"JHQ7$OTA3\_(BQ_BP M?/=M[IV.'
ML:Y LF6)UDJU:-NHL'=<TAS-!^3>I,LW/*$FLV"L0C$'T<3KWHQ/IE("<OA<
ML)M2 4:&(@+/)7)-5Y*\4QE2TIJ@E_-R^2-N*DX;HA,2NH/!P!KK+S] /;G
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MJ/K/HF^J+:LCI,0DB08MD4H>$7"M$'/_+Z'Y7.^9K=/]SAQ?!P%<WB2Q[8R
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MG"O%"_.9 <48TQMP?<&YV@[T <TMY>0?4$L#!!0    ( *>%6%8B'86[N ,
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M]BTN^\/0U8Y'5TD>O+G@ /SB+HC[99D]L2+FN.]=&O0FENN:>=&'1#GMX2*
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M:U'9UR6C!9/F .S/A=";A5'0WP!/_P)02P,$%     @ IX585M_7:4@%"
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M#FZ ]:4 K1<#1%!]1'3Y'U!+ P04    " "GA5A6JHJKTUP$  # #P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6R]5VUOVS80_BN$&A0V(,2BWBRG
MMH'$7=$4:Q<DV?9AV =:.EM")=(CJ3CY]SM*MN-&M)=T;;Z((G7O=\]1-UX+
M^57E )K<5R57$R?7>G4V&*@TAXJI4[$"CE\60E9,XU8N!VHE@64-4U4.?,^+
M!Q4KN#,=-V=7<CH6M2X+#E>2J+JJF'RX@%*L)PYUM@?7Q3+7YF P':_8$FY
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M$1ND(<#O"R'T=F,4[(;VZ;]02P,$%     @ IX585L6J+OE>!@   !,  !D
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MP3<!Z;ZWN($6E?W&L1 :.P#[F /%&S$+<'XIA-X,C('VH]?\;U!+ P04
M" "GA5A6<,P[\WL"  "=!0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6R-5-]OTS 0_E=.04(@C25-UPV--%*[,;&'0;4*>$ \N,XEL>;8P7;:@?;'
MXQ]IUD%7[26Y.]]]]]W9=]E&JCM=(QJX;[C0TZ@VICV/8TUK;(@^EBT*>U)*
MU1!C557%NE5("A_4\#A-DM.X(4Q$>>9M"Y5GLC.<"5PHT%W3$/5[CEQNIM$H
MVAIN654;9XCSK"45+M%\;1?*:O& 4K &A692@,)R&LU&Y_.)\_<.WQAN](X,
MKI*5E'=.N2ZF4>(((4=J' *QOS5>(.<.R-+XU6-&0TH7N"MOT:]\[;:6%=%X
M(?EW5IAZ&KV/H,"2=-S<RLTG[.OQ!*GDVG]AT_LF$=!.&]GTP99!PT3XD_N^
M#SL!Z=DS 6D?D'K>(9%G>4D,R3,E-Z"<MT5S@B_51UMR3+A+61IE3YF-,_D7
M51'!_I#0(E' ,MP.R!*6K!*L9)0( S-*92<,$Q4L)&>4H89W\"3ZS24:PKA^
MF\7&,G/X,>U9S .+]!D6HQ1NI#"UAH^BP.(I0&Q+&NI*MW7-TX.(ETB/83PZ
M@C1)4]!8V8=D@!EL#H"/AZ:-/?CX!4T[@@LIM&U)\=C#A4)MTP6#;>05$T10
M1C@LK1$=%0T_9BMME'V5/_?U*Q XV4_ 3>JY;@G%:=2Z7&J-4?[ZU>@T^7"@
MO).AO)-#Z/GGKEFA<L3M["OB+[WOH(:'K;B/=<"=>%RW#M9YFL7K/50F Y7)
M"ZFT2A8=-4!M RNIW/M[V'.?@<?D/QZ3?WC$.R/3H*K\8M#@'WF8GL$Z[)Y9
M&+E']["X;HBJF-# L;2AR?&9S:O",@B*D:T?P)4T=IR]6-O]B<HYV/-22K-5
M7()A(^=_ 5!+ P04    " "GA5A6!^+G8N4"  "A"@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6S-EEUOFS 4AO^*Q:JID[I"R.<Z@I0FJ=J+K5&S
M;A?3+APX"5:-36V39/OULPUEB490V^5B-\$&OR_G.>0<G6##Q8-, !3:II3)
MH9,HE5VXKHP22+$\YQDP_63)18J5WHJ5*S,!.+:BE+J^Y_7<%!/FA(&]-Q-A
MP'-%"8.90#)/4RQ^7@+EFZ'3<IYNW)%5HLP--PPRO((YJ/ML)O3.K5QBD@*3
MA#,D8#ET1JV+\<"<MP>^$MC(G34R) O.'\SF)AXZG@D(*$3*.&!]6<,8*#5&
M.HS'TM.I7FF$N^LG]RO+KED66,*8TV\D5LG0&3@HAB7.J;KCFVLH>;K&+^)4
MVE^T*<]Z#HIRJ7A:BG4$*6'%%6_+/.P(.OX!@5\*_.<*VJ6@;4&+R"S6!"L<
M!H)OD#"GM9M9V-Q8M:8AS'S%N1+Z*=$Z%=Z*%6;D%RYRRF(T+SXGXDLT)RM&
MEB3"3*%1%/&<*<)6:,8IB0A(]!Z-L4RLRBZFCSE98PI,270Z 84)E>_TJ?OY
M!)V>O$,GB##T)>&YU!(9N$K';Z)PHS+6RR)6_T"L$XC.4;MUAGS/]VODX^?+
M6_MR5V>M2IU?I<ZW?NT#?@?AZ\@*JTZ]E2G5"YGA"(:.KD4)8@U.^/9-J^=]
MK.,\DMD>=;NB;C>YAW<@E2"1@AA%FKN.M3#H60/31=:AW^IZ@;O>96A\RRL9
M.A5#Y[D,!S_B&1KG0NC5&9HKK$!W+F6*XHHPS"*"J:X#26S9?)]NE>EK"PIH
MRO(4A"VG'W6Y:0YL)B##)$;3K>[2$FQ@MRH!@492PDY0=?^*1NM79K1;9;3;
M&/CX^N;SJ(ZW4?;2__V1S/8(>Q5A[WC5WCLF]9',]JC[%77_7ZN]T>"EK/V_
M6D?K@_>G=>PQ#"J&P?]:[8V!O30WS92O;!U%1MV= <(,;Y^P6!$F$86E?IEW
MWM>5)XJ!J-@HGMF98L&5GE#L,M$S) AS0#]?<JZ>-F9,J:;2\#=02P,$%
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M8K=HAR7V<] N /=SI>S#Q+6,X0^1_@502P,$%     @ IX585E>?K,W2 @
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M,JX_X<#3=$Q.3SZ1$\($>2SD4F-N/70-(ML?NUF+=]/@^0?PQI!=D, [(_[
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MJN;B:#I&5O79.Y,&3_*Z6>!="\H&X'@N<>+;CCW.N]L[_0M02P,$%     @
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M%4;QGB9_I\G8!O^-JH+A/>>P0EQP>H8TJFF:S<3(VO6=I338Q=RPQ/\,*!N
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M#-#/YYRKEYNR@N;D[^P?4$L#!!0    ( *>%6%9S_WS;F@0  &$?   9
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;*V9_W.;-AC&_Q4=Z^W:NR4@,/Z2
MV;Y+"]UR6S=?DVX_*Z#8N@KD2K*=W.V/G\"$+PVH=OO^$H.MYP,\+WG1@^8'
M(3^K#:4:/68\5PMGH_7VRG55LJ$949=B2W/SRX.0&=%F5ZY=M964I*4HXZ[O
M>6,W(RQWEO/RNY5<SL5.<Y;3E41JEV5$/KVE7!P6#G:>O_C(UAM=?.$NYUNR
MIK=4?]JNI-ES:TK*,IHK)G(DZ</"N<97L>\5@G+$/XP>5&L;%9=R+\3G8N<F
M73A><4:4TT07"&(^]O0=Y;P@F?/X4D&=^IB%L+W]3']?7KRYF'NBZ#O!_V6I
MWBR<J8-2^D!V7'\4A]]I=4%AP4L$5^5?=#B.G8P=E.R4%EDE-F>0L?SX21XK
M(UH"/!H0^)7 /U405(+@5,&H$HQ.%825H+QT]WCMI7$1T60YE^* 9#':T(J-
MTOU2;?QB>7&CW&II?F5&IY?7R9<=4ZPHFD(7:+63R<;XCE:2)11=<RX24E;T
M=40U85R],:,^W4;H]:LWZ!5B.;K;B)TB>:KFKC8G5&#=I#KXV^/!_8&#1S2Y
M1 '^!?F>[_?(WYTNQSWRZ'2YUR./[?*_Q/X2>>,^N6N*4%?"KROAE[Q@J!)*
M4:U061!)TSXWCX!1/Z!H*5=J2Q*Z<$S/4%3NJ;/\^2<\]G[M\Q82%D'"8B!8
MIPI!787 1E_^)D1Z8)SWV7]4CDMET8#WRR"<38M;;]\VMF?8&$]&7PV+^H8%
M81!TA\76T_U.,T:U&2.K&7]<HP\T90GIM<.J/?=NA(1%D+ 8"-8I0%@7(/S1
MGA!"5@$2%D'"8B!8IPKCN@ICZ[_!G20I-;.BA+(]N>>T]TEG19Q;!TA8! F+
MQR^ZEC^J.U;'W4GM[L3J[M]Z0^6WW+4BSG47$A9!PN(C+&RYBX-^=Z>UNU.K
MNS?YGN9:2-;OJU5\KJ^0L @2%D]?^.ICW&_LK#9V9C5V)4U8D_H)F:DOHJ8_
M;TU\TGT>6SGG>@P)BR!A\>REQ[-IO\?8:]*)=T)SX")?7V@J,T3*!V)OTK""
MSK49E!:!TN**UND2WH#1K1B(OWO>:Y>>;2TD+0*EQ16M;>TTG R9VR0[;(TL
MRSNA":_N740LDSD[YVRG02,>*"VN:)V;.,3^>,#J)K[AP#IC_I.1>\:9-L\[
M9&;/NVS :*!851D-28M :3$4K5N/)D%B>X0\SIVWY&EP:F<'G%T*T" )2HLK
M6ON>OP@&IB&XB8C8FGV6UTDB=]3,01ZW-%<#'H.F1%!:!$J+*UK'X]";#)C<
M)$#\C0A8=G#>:B[$TEQ LR H+0*EQ16MZW8P-.MK$B&V1\*CVSG5)STS0;,A
M*"T"I<6X)QZ.PNF0W4U$Q/:,V+SF0_^AB.XI-]$F19HFFUQPL7[JM1TT.H+2
M(E!:#$7K5J?)F7CVH^\ ,6C$!*5%H+08BM9=H6GBJ&^/HS>Y)OF:F:F,)8G:
M&6<OTX F45!:7-':;P/'GO=U7');JY/%XO,'(M<L5XC3!R/S+B>FH<GC>NYQ
M1XMMN6!Y+[066;FYH68:*8L!YO<'(?3S3K$&6J^J+_\'4$L#!!0    ( *>%
M6%9N; *#B (  -(&   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;*U5
M76^;,!3]*Q:KIE9:"YB/-%F"U":JVH=)53_6AVD/#MP$J\9FMA/:?S\;*"(-
MS?JP%_"U[SD^Q^9>II60SRH'T.BE8%S-G%SK<N*Z*LVA(.I,E,#-RDK(@F@3
MRK6K2@DDJT$%<['GQ6Y!*'>2:3UW*Y.IV&A&.=Q*I#9%0>3K)3!1S1S?>9NX
MH^M<VPDWF99D#?>@'\M;:2*W8\EH 5Q1P9&$U<RY\"?SV.;7"3\I5*HW1M;)
M4HAG&]QD,\>S@H!!JBT#,:\MS($Q2V1D_&DYG6Y+"^R/W]BO:N_&RY(HF OV
M1#.=SYQS!V6P(ANF[T1U#:V?R/*E@JGZB:HF-QPY*-TH+8H6;!04E#=O\M*>
M0P_@AQ\ < O GP4$+2"HC3;*:EL+HDDRE:)"TF8;-CNHSZ9&&S>4VUN\U]*L
M4H/3R0W? M="4E#H> &:4*9.T"EZO%^@XZ,3=(0H1P^YV"C",S5UM=G3(MVT
MY;]L^/$'_ M(SU#@?T/8PW@ /O\\W-^%N\9I9Q=W=G'-%_S#[BM:4)4RH382
MT*^+I=+2?%"_A_PUA.$PH2VRB2I)"C/'5)$"N04G^?K%C[WO0V[_$]F.]Z#S
M'AQB3ZXHI^9#R=!:B.&K;/!QC;?EOTW\<.1%YN"W?1,#:0$.O:!+VY$7=O+"
M@_*>3+F?4GY:2I&"&M37$$2]C?$X"L)W\@:RL#G"8751IRXZJ.Z.5*;L-$A*
MV*"V:&_7\W'HQ>^T[6?%HR :#VN+.VWQ06T/0A.&>I4\I"_>NS0<1^/Q^[L=
M2,/^V);NCD*WUW%LM_]!Y)IRA1BL#- [&QF+LNF@3:!%63>AI="FI=7#W/QT
M0-H$L[X20K\%MJ]UO['D+U!+ P04    " "GA5A69Y^;Z.T"   0"   &0
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MV6YJ>=:^X0M=;V3:X,PF6[PF2R*_;N^X.G-*E(!&)!:4Q8"3U=2:>Q<(]M.
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MR/U?T 0:E7I+F>OJ%^T;+/;0<J>-+!JR=5!DHO[G;TTA3@@D'"#0AD"[A&"
MP!H"NY80-(2@JDP=I:I#P@V?393<(U6BK5IY4!6S8MOXF2CG_<DH>S>S/#/[
M)I:R /3,WT"C.[20Q58*$$8CN4+'F^C+FWW2-*";.0A89>86W21@>);K6TO[
M^92@FT^WZ!/*!'K>R)WF(M43WUB'Y3C^LG$SK]W0 3>$HN]2F(U&7T0*Z;F
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M;G)U+7;?6!-0J/UE(J_J7[1KL-X(99M*B:(Q!@8%+_?_]+%)Q($!#@8,2&-
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MF/>J%OI2:U*K@]Y@^#-D4X'/L/?:JUKH2ZW9 W48';CCZ'=2T32?IT]SVO3
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MSE6P.U<I/WQ9<7C]N.Y5+?2EUJ169S%X\#-LQMAK1N15+?2EUNR!.B/"[G.
MDS=CW#X "(+V'/>:N_A2:[*J<Q?LSEW^YUX\:I\'V8AYS5%\J17$NCN'RBF(
M97XXKT'PC*GB@+9Z6OT X&U^[+WW_"HX#XMC_%JF^%7!!R*6E$F4P$)+]L[&
MNLM%<5!?W"B^SH^NYUPIGN:7*R Q"%- OU]PKIYN3 75SR5F_P%02P,$%
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MJR8/MC9;R5>44Y%"EZ85=N*P;86^GP9)U!_[]_M:=1D-XD.CQ;%1&"1!8W3
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MC#K"Z#AA6_@"9GH/2%0U16$CC/8)O03O,EJB?-P_0-GO*/LG43)8$(8D*,5
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MU$E5V[WW87H?7+A)K('-LTVRO;_^V4!I$BCK-KXD-MQS..=R[6OF>R&_JBV
M1M_RC*N%L]6ZN'!=E6PAI^I<%,#-G;60.=5F*C>N*B30M +EF>MA/'%SRK@3
MSZMK-S*>BU)GC,.-1*K,<RJ_7T(F]@N'.(\7;MEFJ^T%-YX7= -WH#\7-]+,
MW)8E93EPQ01'$M8+YSVY6!+? JJ(OQCLU<$862L/0GRUDZMTX6"K"#)(M*6@
MYF\'2\@RRV1T_-N0.NTS+?!P_,C^H3)OS#Q0!4N1_<U2O5TXD8-26-,RT[=B
M_Q$:0Z'E2T2FJE^T;V*Q@Y)2:9$W8*,@9[S^I]^:1!P 2/ ,P&L WDL!?@.H
M,N?6RBI;*ZII/)=BCZ2--FQV4.6F0ALWC-O7>*>EN<L,3L>WL!/9CO$-6DI(
MF48?:,(RIK\CRE-T+?CF[!YDCE;PH-$9NI&,)ZR@&;JD&>4)*%3R%&0=J=O(
M-RO0E&7JK<%\OENA-Z_>HE>(<72_%:4RU&KN:B/?BG"31NIE+=5[1NH*DG/D
MDW?(PY[7 U^^'$Z.X:Y)6ILYK\V<5_'YS_(9GU=<:5F:LM;HR[4)0%<:<O5/
MG[F:+>AGLZOU0A4T@85CEJ,"N0,G?OT'F> _^ZR.1'9DW&^-^T/L\=.K3DT*
M^JS6^$F%M_O(+B:SB$31W-T=FAA\S"^:"%H3P; )4+9T:2ZD9O]!6GE!3*G2
M5C5*A-*])5JSA@?6SLAT=F(LZ/@_\V:X#3H2'+:"PT'!]T*;59?],/=A1Z#)
M/<:G$KMA7N!%?M@O<M**G/PXJTDII5T0A4VMX'TB)UV1Q OQB<9N5!3X4;_"
M::MP^L+B'9 W[<J+)M/P-(?=,,\/_-FT7V'4*HR&7[05=RUHK[)!Z,]N(B.1
M';F<M2YGH^Z>LS&-CT1V9)S@IXZ+?W/_; B."M +)IT-M"_.]\U*ZJ] <G H
M((,2GST5]*H=Y/K9=S,6V['SIZ9.QNWJ9-2V/A;;L?FGQDY^M[.3;FN?^B$^
MW;E[P@C!&)_V0/?@X&J_&CY1N6%<H0S6!HC/IZ:T97T0KR=:%-59]D%H<S*N
MAEOS\0+2!IC[:R'TX\0>C]O/H?A_4$L#!!0    ( *>%6%8;<27/Q 0  ,4>
M   9    >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;+6986_:.!C'OXJ5FTZ;
MM#6Q0X#V *DCJJZG;E>UV^[%Z5Z8\ "Y)3%G.]!)]^%GAS0A)%A0N6\@"7[^
MMG\\3_*W,]HR_EVL "1Z2I-,C)V5E.LKUQ71"E(J+M@:,O7+@O&42G7*EZY8
M<Z#S(BA-7.)Y?3>E<>9,1L6U>SX9L5PF<0;W'(D\32G_\1$2MAT[V'F^\! O
M5U)?<">C-5W"(\BOZWNNSMQ*91ZGD(F898C#8NQ<XZN0]'1 T>);#%NQ=XST
M5&:,?=<GM_.QX^D100*1U!)4?6U@"DFBE=0X_BM%G:I/';A__*Q^4TQ>369&
M!4Q9\E<\EZNQ,W30'!8T3^0#V_X.Y80"K1>Q1!2?:%NV]1P4Y4*RM Q6(TCC
M;/=-GTH0>P&X=R2 E 'DU "_#/!/#>B5 05J=S>5@D-()9V,.-LBKELK-7U0
MP"RBU?3C3/_OCY*K7V,5)R</L&'))LZ6:,IA'DMT0Z,XB>4/1+,YNF/9\L,7
MX"D*82;1!_29<D[U/X7>AB!IG(AWZNK7QQ"]??,.O4%QAKZL6"Y4L!BY4@U0
M=^-&Y6 ^[@9#C@PFA.@"^?@](AXA'>'3T\-Q1WAH#O\C3Y[#\64SW%54*[2D
M0DL*/?_H<!2RVTQ(GJM"D>CO.]4 W4I(Q3]=;'9JO6XU7?]78DTC&#NJP 7P
M#3B37W_!?>^W+E(VQ4)+8@V*?D71-ZE/_LRED"J==(K.&%?1ZJ@SMW8Z_4)'
MW^XV$WPYQ,/AR-WLDS%V=RX92V(-,KV*3,](IBS8ZR4'T G6Q<2H<&Y.V10+
M+8DUR 45N<!J908V*=H4"RV)-2CV*XI]2Y6YTPF:E:F<R4%E&KL[EXPEL0:9
M045F8"1S!U("1VR!HEV-+G/*:28!.O$,6GC\-AQCC^?"L236@#.LX R-<*XW
MRC;060)UTJ"(JNZ4Z>BB,VS=U@/B>RT^QD[/Y6-)K,'GLN)S:>1S$S_!7!DI
ME4$@)%)V"] :>'3D#K\3PWB/CW?AD0$^X'-BN] XN!=.'7NU&_6,DR_NS"*?
M_:N6!4@RM&C#Z+257BM)!D$[1TYK%IK'^%(&>XX<&QE\HSPNZN/D'"@%#__<
MP#_T/D<:XL,D,(_PI01JXXR-CK*5!9M.(ITD2-L$DHZ[:5>[_A"W4^$UK"^N
MO2\VF]]BZ77':-8Y5YM.=FI5+;2EUN16.V/<LVKPL%6?;%4MM*761%E;96ST
MD&>XO%*H8?-(K]]:@'6U\WU,@L/:>PUSBVMWB\WVMJH]]#\Z9:EEECL[AZR:
M85MJ392U'<8#N^5HT^Q.K:J%MM2:*&OSC,WNN4 95RC?HX7J"]&4Y4>RTJ8O
MGEI5"W';VF-MQ^J'<!-2[:"QV4(?W=3L)&3)\9:$;*J%MM2:^Y>U&R>>W1U,
M2\:YW,*TJ1;:4FNBK$T],9OZTQ^CI5!CD>('+0?;T0QCK[V8,8_KI?/>VP,W
M6_GC[Q=.>ZJ:Y<].*;O;XJ^Q."#UXH#X=JO3ZGK!JEIH2ZV)LEXO$/-6^B?Z
M%*=Y>N*.E%GL;)!65PNEVOYMH>]U/%/=O5>&^@7O)\J7RE:@!!8JT+L8*//-
M=^],=R>2K8NWB#,F)4N+PQ70.7#=0/V^8$P^G^@7D]6;Z\E/4$L#!!0    (
M *>%6%;I.MH3F@(  /T%   9    >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM
M;(V4;4_;,!#'OXJ5H0FD0=+T81-K(]$6M$H@H0+;BVDOW.2:6CAV9E]2^/8[
M.VG6;:7:F]8/=W___G;NQEMMGNT& -E+(96=!!O$\C(,;;J!@ML+78*BG;4V
M!4>:FCRTI0&>^:1"AG$4C<*""Q4D8[]V;Y*QKE *!?>&V:HHN'F=@M3;2= +
M=@M+D6_0+83)N.0Y/  ^E?>&9F&GDHD"E!5:,0/K27#5NYR.7+P/^"I@:_?&
MS#E9:?WL)HML$D0.""2DZ!0X_=4P RF=$&'\;#6#[DB7N#_>J=]X[^1EQ2W,
MM/PF,MQ,@D\!RV#-*XE+O?T"K9^ATTNUM/Z7;=O8*&!I95$7;3(1%$(U__RE
MO8>]A#A^(R%N$V+/W1SD*><<>3(V>LN,BR8U-_!6?3;!">4>Y0$-[0K*PV0)
MM9:U4#F;&<@$LAN>"BGPE7&5L5NM\O-', 6;PPK9.;L1BJM4<,EFN@8:HV6G
M<T NI#VC_5;D*C< ]'3(3IA0[$Y(24]@QR$2LCLX3%N\:8,7OX'7B]F=5KBQ
M[%IED/TI$)+7SG"\,SR-CRK.(;U@_=X'%D=QS)X>YNSTY.R(;K^[R+[7[;^I
M2Q>T4!9-Y8U_OZ4 MD H[(]#OANUP6$U5XJ7MN0I3 *J-0NFAB!Y_ZXWBCX?
M81UTK(-CZLF,WD)+D7&$C#UJI.>\A1H,52%;<JJ60\"-Y-!+NE*OD\$XK ]0
M##N*X?]3+!0"&47_71T'&?X#TC\,,NI 1D=!ND]^QDOA+N/ZA7H>?<<5$1TB
M:.1&>P3#Z"^$<*\D"S"Y;SR6I;I2V%1GM]KUMJNFI'^'-XWQCIM<*,LDK"DU
MNOA(UDW3;)H)ZM(7^$HCM0L_W%!_!N,":'^M->XF[H"NXR>_ %!+ P04
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M7E Y#V8!%+AFC: [M?N,71YO,%?"^"?LNMHH@+PQI*H.;!U47+9O]MQ]ASU
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M4F2[SP]+>]VA=@5V?ZT4O4Y<"_87:/8;4$L#!!0    ( *>%6%818XP'( 8
M ($P   9    >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;-6;;6_;-A#'OPKA
M=4,+-)9)/R6=8R")%"Q TQ4)NKX8]H*QS[8P2?1(RG: ??B1DF*9ML+&P75
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MWZ(T ;0?"J%7"S-"51/SZ!=02P,$%     @ IX585I;.NN-G!   /QL  !D
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M,6HE1J_NT+H)7?+J1(MTH77E;4M=.%COO=RD]I&Q;#>P^RX]CAJY;HCZ+E6
M>2<\VI:<<+CF/,NCWRP?AAL[>RKI1(MTH76%;BM@Z+Z^4P>K[+/EU8D6Z4+K
MRMO6YG"X.'^Q4X\+[A%T#OQ5:Z:JWZ'?=ZH*# 4GBE[85N]PN'S_OK*7R2#
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M9O*^=^:1#,9TQLV#7'R"*A[G8"JY=D^RJ&P#CZ0S;611@=&#@HGR39>5#AN
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MTCJ8[PLA]'YB U2]=O0/4$L#!!0    ( *>%6%:.M4OP^0(  'P(   9
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M!W];92D2@*0A^$8X)ZD4X!K<Q3$+2)X]-@>/-&"+-/J'AF!*><1"\,"$DKO
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MZ@3RO,&9#R1+LY;?,Y.2Q=GC"D@(7!NH]PO&Y-M ?Z!L,T__ U!+ P04
M" "GA5A6?2I'5R,&  #N(@  &0   'AL+W=O<FMS:&5E=',O<VAE970X,2YX
M;6RUFEUOVS84AO\*X15#"Z2V2'TZ2PPD<;KMHJO1M.O%L M&IFVADNB1M)/\
M^Y&2+)F20LL%>Y-8,OF2YQ%Y]!Y95T^4?><;0@1XSM*<7X\V0FPO)Q,>;TB&
M^9AN22Z_65&682$/V7K"MXS@9=$I2R?(<8))AI-\-+LJSBW8[(KN1)KD9,$
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M7CQTWN$4",*R7EQF91>\$,4\ %GY_-\%2_S2]XCKSJQT-M&?40&@I@) )RJ
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M<$W)@G(=H+Y?,B8/)WJ 9L-L]A]02P,$%     @ IX585B@QBJUY P  FA
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M!+P$I@+D\Q6EXG&@3IO#WQ'9_U!+ P04    " "GA5A6/-2WQB<$  !&$@
M&0   'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6RU6&V/HS80_BL6/56[4K-@
MWMDF2+>A55?J75>[=^V'JA^\,$G0 ::VD^S]^S,O(0EX:;;BOB08GGF89P:/
MQY[O*?O"-P "O>19P1?:1HCR5M=YO(&<\!M:0B&?K"C+B9!#MM9YR8 DM5&>
MZ:9AN'I.TD(+Y_6]!Q;.Z59D:0$/#/%MGA/V]0XRNE]H6#O<>$S7&U'=T,-Y
M2=;P!.)S^<#D2.]8DC2'@J>T0 Q6"^T]OHVP6QG4B#]3V/.3:U1)>:;T2S6X
M3Q::47D$&<2BHB#R;P=+R+**2?KQ;TNJ=>^L#$^O#^R_UN*EF&?"84FSO])$
M;!::KZ$$5F2;B4>Z_PU:04[%%].,U[]HWV(-#<5;+FC>&DL/\K1H_LE+&X@3
M RE4;6"V!F;?P'[%P&H-K$L-[-; KB/32*GC$!%!PCFC>\0JM&2K+NI@UM92
M?EI4>7\23#Y-I9T(GV MLRC0(Y24B;18(U(D2(94!JQ ?Y3 2)4?CF:'@83<
M%S'- 5U%($B:\6OY\/-3A*[>7:-W*"W0IPW=<LG#Y[J0/E9OTN/6G[O&'_,5
M?[")/M!";#CZI4@@.2?0I;A.H7E0>&>.,D80WR +_X1,PS05#BTO-\<*\^AR
M<V-$C=7ERZKYK(OS=5\TL[^:17__+N'H7D#._U'%ON&VU=Q5B;GE)8EAH<D:
MPH'M0 M__ &[QL^JN$U)%DU$=A93NXNI/<8>?I3EE9,,E)]K8^K6IE41W848
M.T;@RV]A=QH-!<[P;,_IX:(A+G MWW,ZV)D$IY/@C$HXS,B,<CD=5XSFB'9S
M5R6KH7-.W) ^N%9/U!#E&@%V>Y*&J!EV7%.MR.T4N:.*/E%!,D3%!AB"%[G,
M<9!EI@"A4N,./; #R^ZI4:#<( AZ:A0HC%TW4,OQ.CG>)0D2Y*53<_4,!:Q2
M<:U2Y WS@W$_/4.08_=S& U!,\OR?;4<OY/C_^>424^_.94&?_!FSW;Z7\]R
MB+)]V^GE+AJB9H%O6VH50:<B&%6Q)"Q)Z8[P>)L1II(P:O_6@CDE6301V5G<
ML''L&HSON RUY!.%=5*V:"JV\\">M&/X_Z]%K:USMAAAWS3[E4X%-&S+-+W>
MM%( 9=V4O8IZ8F'SJ,.<=D%J^<XJGA'8_6JA@#F6C9V^KB%LYAGV:[*.W1<>
M;41"V912'M/RJU+"I.W5I&S15&SG<3MV6-C^GO5BM'][<V"G9(NF8CL/[+'O
MP^.-WWB]&'9FENDY7G].*6#8Z1>52 $S ]=[90W&QT8/CW=Z;R\5[J"'=ET\
M4#5$>8[1;\<5*,?VC9XF_62#G0-;UP<5',5T6XAF)]K=[0Y#WM=' +W[=]4A
M2;UQ/](T)RP?"%NG<I^=P4I2&C>>C#-K#BV:@:!EO8U_ID+0O+[< $F 50#Y
M?$6I. RJ%W1'1^$W4$L#!!0    ( *>%6%:2@X=:$ 0  'T2   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@W+GAM;+U876_;-A3]*X16#"V01B3UG=D&$JO%
M"JQHD*S;P[ '1J)MH9*HD;2=[M>/E&19DFDO+82^V!)USQ'/N>+%)6=[QK^(
M#:42/!=Y*>;61LKJQK9%LJ$%$=>LHJ5ZLF*\(%+=\K4M*DY)6H.*W,80^G9!
MLM):S.JQ>[Z8L:W,LY+><R"V14'XUSN:L_W<0M9AX"%;;Z0>L!>SBJSI(Y6?
MJWNN[NR.)<T*6HJ,E8#3U=RZ13<Q\C6@CO@CHWO1NP9:RA-C7_3-AW1N03TC
MFM-$:@JB_G9T2?-<,ZEY_-.26MT[-;!_?6!_7XM78IZ(H$N6_YFE<C.W0@ND
M=$6VN7Q@^U]I*\C3? G+1?T+]FTLM$"R%9(5+5C-H,C*YI\\MT;T $JH&8!;
M !X#W#, IP4X+P6X+<"MG6FDU#[$1)+%C+,]X#I:L>F+VLP:K>1GI<[[H^3J
M::9P<O%(URJ+$CS0BG&9E6M RA0H2Y5A)?A444YT?@1X"VZ%H%)<@9BJ+RS)
MZO$K<%MHW+^DR:+"+DF529*#=\_JVTPSN>54@-<QE23+Q1O%\_DQ!J]?O0&O
M0%:"WS=L*Q1,S&RIY.A)V4D[];MFZOC,U!$&'UDI-P*\*U.:#@ELY4-G!CZ8
M<8<O,L8TN08.N@(88FR8T/+E<&2 QR^'PPMJG"ZU3LWGO#2U5TT*U4#"RB3+
M=;8_2%J OWY3T/I2_&W*0_,>U_P>79EN1$42.K?4AR$HWU%K\?-/R(>_F#R<
MDBR>B&S@K]OYZUYB7S3KP>17@_-KG"Z\NP7R?2?R_9F]ZUMABG-#'+G#N-C(
MYRK"+FX@P.L$>!<%]!=RO71);RV;=#5T7F\>(0KA:+9+0Y0+Q]KCTZC(A0$T
M*_([1?Y%18?:0WNUQR3$/WFYZT$<C82<1N$@<D91L8DK"D.SD* 3$OR/$)YF
M;$=$LLT)-TFXB/_6-3DE63P1V<"WL/,M_$$U+YS2WRG)XHG(!OY&G;_1=]:\
MZ&09(-_#R/5&B\H4YWA^,*X/1CXW],_4/ 2/#0^<MNJU?(."!H,@& DSA3D0
MPI$N0UCDJ.R<D=7KX] DI:^E&=0K-\+C-!G"<.!YP5B-@<T+H7-&#3ZJP1?5
MJ(Z.B8157XT2+F*_=6U.RA9/Q3;T[=CRH1_5\Z%)F[Y)V>*IV(8F'_L^]+V-
M7PL<5"T4ZLW <'$9PK"/PO'B.@V+/.=<I3AV?6CBM@^=]FH(XI/Z9XHZ:?L,
M41$Z)^G8]J%I^KZ69M!)G_2OAB GQ&,=!J;0&^FP>_OR@O)U?;XA0,*VI6QV
MI=UH=X9R6Y\<C,;O]-E*O=\_TC0',Q\)7V=J>Y[3E:*$UX%REC=G'<V-9%6]
M^W]B4K*BOMQ0DE*N ]3S%6/R<*-?T)TX+?X#4$L#!!0    ( *>%6%:(IH _
M@ (  )L&   9    >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;*U5RV[;,!#\
M%4(-BA1HK9<?:2H+B*T4[2& D33MH>B!EE86$8I42=I._KY+2E:=Q YRR$4B
M5SNSNT-PE&RENM,5@"'W-1=ZZE7&-.>^K_,*:JH'L@&!7TJI:FIPJU:^;A30
MPH%J[D=!,/9KRH27)BZV4&DBUX8S 0M%]+JNJ7J8 9?;J1=ZN\ U6U7&!OPT
M:>@*;L#<-@N%.[]G*5@-0C,IB()RZEV$Y]G0YKN$GPRV>F]-["1+*>_LYGLQ
M]0+;$'#(C66@^-K '#BW1-C&WX[3ZTM:X/YZQ_[5S8ZS+*F&N>2_6&&JJ7?F
MD0)*NN;F6FZ_03?/R/+EDFOW)-LV=S3Q2+[61M8=&#NHF6C?]+[380\0CH\
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M:\HX6S^2&PQ*VQ4<PZZR#?Z HQO_T([.T5JUK3.*.O:=$U;<)72O#5QH(\V
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M-6BEY>JF&XOFK47!=RSR W*/IQ2:W(H,LGT %]W3^2C8^F@>G$2\@?22A/Z
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MHISS!5+R-E'4T)GS$K4?IC4[H.*J1@N"[0NJ%\$H=I,3&N44OHUR\L.VKH4
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M!6=]3%C5H[K>&+ETTVXF#<Y.MRSQZP;*!N#]N93F>6,':/N]S/X 4$L#!!0
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M:]FM E,3Y/4EI>)EH/JANO^-_P%02P,$%     @ IX585O3***G; P  U@\
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MREQP\"XF J>4OY?H+R\Q>'?U'ER!- >?UZSDTHJ/;2']4NSVHO9A5OF SO@
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MF>*5B,T47VM _.L&C"3Q[S:6!QC8+F"U _G]>:"F_)PH@EW%O&%/,(XD"89
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M6;5Q4EE4U@&M-<6$9F%6R[1P8:N<Y/W((9?TF&7RR9CED\ZR-FI3EWH4ZX9
MC,K2>9]2(IGTF&TR+5*3*W$O?_B10^[H,<MCE*:V5DLQ^>$N4OI<2!<]9E^X
MMFFR1Y?-B;%52UV)*YFVJ6=[BZ\I)A)&C]D8E\KJ1]GDI%[DD!YZW'XP>:ZK
MYJ1=)S)VJ;B+HRK25PT6Z:''[(>)M(6#*L7<=7 -L=/$8B.M$F\F\\5;BHD$
MT6,VQ"3?9N:G4JX/-NDW,:]MNI&E$O-,%O\(+Y-&X@B8Q;%0Z^8,<:>VQC8W
MN[WQ5\8JO2X$35,#)(Z 61S/T?RH"K5R;;H)(_U*!G \PNR0*ZFM^"*S6HD;
M)<O:JK8-43PDCX!9'JZCKO/:5:A]7N":C1OD;URW[;H?BHE\$C#[Y-J%SNMF
M F21@-DB"W>-9>T2@>E4G+4W]R4C_5[306: +!(P6P1FRUY*'R"S!,QFP9A]
MBHG<$C"[99_6BS?WTKUS26T2()L$S#:!^;UWF_O()GUFFY#\_E (^T@A?6:%
MX$1?4$SDDCZS2VBF?S"&<$Z+WR1>RG\0$#FDS^P0F/O[[03)I<\L%Y+['PPA
M,DJ?V2@PO_9#B(S29S8*S*]]3&24/K-18'[M8R*_])G]\I<,=O_EI+/5R"\#
M]FDND,EZT1P@U0R85;/+9 ^U[ %2RX!9+3@)&U!,))D!LV0P9D@QX=()LVHP
M9D0QD6H&S*K!F#'%1-89G'0<DU!,9)W!2<<Q0XJ)K#,XX1K*UW:AXAD366=P
MI%44-\"^U*5<KZU:[Y@=YQV=F B1=<)3+JYX@]<062=DM@[&I-U[B"P4,EO(
MPSPCB9MU_R]&%!-9*&1?<2%#V4M529UY)@^1>T)F]\"QK)<'A7#AGMD]&--K
M.,@](;-[,*;7<)![0F;W8$R:%X7(/2&S>[P)#->QNX.RTNE^W$,QD7M"9O>\
MPFS&$:9HQSS./=."[BI![HG89]0\S,EJI=I];&)703&1>R+VA7W_IJN5LM8-
MTEQ!\_VDF,@]T3$GU\[$K;2VG87YW<-33.2>Z(BK_0Z3)&]M#<5$%HJ.O '@
MH"<C)*#HE%L!/ %%<.\8LX P)A50A 04,0L(8U(!14A $?\B#L"D _,("2AB
M%A"= _ZS*\KHCD$DH)A90#ZF$_B3M$MQ:YH394:736(DH)A90*\P7Z8S7:?I
MZB@F$E#,+" ?<Y2;NJ@:Q$]2%^(-W9L4(P'%S +R,7_#F;)\*]Q?U89B(@'%
MW-N7T7XE<48QD85B9@OA%15JH1A9*#[IP@^U4 SW,)]TX<>+)K)0S+U-#6)Z
MT406BD^Y3<US>H(LE#!;"&-2IR?(0LFQMJD=Q*23[0FR4,)L(8Q))]L39*&$
MV4)X[92V] 19*&&V$,:D+3U!%DJX-[1!3*^E(PLES!;"F%Y+1Q9*CF4A;T/J
M\PB88L)G:9@M]+=U?9<BZT+26:X$62@YT?:#,W&MY0.=EQDB"PV9+?1WS';X
M1C&1A8;,%@(WO:FAF,A"P]/LFF[&15EFGB@FLM#PE+NG/0L-D86&1]D]?6@F
MP9N.&R(%#9D5],SXO+G:#7W=H*TTF5[*BF(B!0V9%?2,Z2\*M,6NC&(B!0V9
M%?02S7J[S=K&(S,QEN5&7+UJ/TA!0V8%'<:\U&6:&=?H*29\H)-90<^8-[*J
MK:Z:&01WTV=;U;0F:LI>%S_IR?W$#GHPP5O[[77ALY[=W6\=M*>7']XO71I3
MJ.6M>Y/2E:<R2^=6-"_MM8)!V#Q/M:JS;.S*9L6UD<O][R7L?^OAPW]02P,$
M%     @ IX585F/$$4K= @  7#L  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<\W;O6[B0!A&X5M!OH#8\S^S"JFV2;O*#2!B( I@A+W:Y.X7D0+>
MT1;;1#X5&B,^CEP\0F;F\5>_7TUOPW'<O9W&Q<=A?QR7S6Z:3C_:=ESO^L-J
M?!A._?'RSF8X'U;397G>MJ?5^GVU[5O;=;$]W\]HGA[O9RY>/D_]_TP<-INW
M=?]S6/\^],?I'X/;/\/Y?=SU_=0L7E;G;3\MF_9C?[L\MM<7\W"9W"R>7Y?-
M^?G5-.W<05:"[/Q!3H+<_$%>@OS\04&"POQ!48+B_$%)@M+\05F"\OQ!18+*
M_$&F4QD[0%*%-4!KHUP;@-=&P38 L8V2;0!F&T7; -0VRK8!N&T4;@.0VRC=
M!F"W4;P-0&^K>EN WE;UM@"];?5C&Z"W5;TM0&^K>EN WE;UM@"]K>IM 7I;
MU=L"]+:JMP7H;55O"]#;J=X.H+=3O1U ;Z=Z.X#>KGI8 M#;J=X.H+=3O1U
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MJ\W> +VSZIT!>A?5NP#T+JIW >A=5.\"T+NHW@6@=U&]"T#OHGH7@-Y%]2X
MO8OJ70!Z%]6[ /0NU6$=@-ZFJX_K /PV775@I_M.P<?I<]^/MZ*O=17PG5Y/
ME\_VM^^_+K\NUK?A2G1[GS$^_0502P,$%     @ IX585G_@0\Q; @  33D
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "GA5A6.&JLO.X    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "G
MA5A6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( *>%6%:'G%1P;0<  *8P   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "G
MA5A6!W%TLBD)  "'+   &               @(&P#P  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ IX585F4):FW$ P  A0\  !@
M         ("!#QD  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( *>%6%:;-Z^]<P8  #0=   8              " @0D=  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "GA5A6-0@SQ+D#  #A#
M&               @(&R(P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ IX585@B8+R-<"@  PV,  !@              ("!H2<  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( *>%6%;(PU9WT0T
M !-'   8              " @3,R  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " "GA5A6L^PEC.("  "K!P  &               @($Z
M0   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ IX585I')
M?,Z4#0  \R(  !@              ("!4D,  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( *>%6%:6UB.C2@8  #X3   9
M  " @1Q1  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
MIX585LH.(B\="   X!0  !D              ("!G5<  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " "GA5A6>=9+H)<"  #Q!0  &0
M            @('Q7P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( *>%6%9C:G<(&0<  +84   9              " @;]B  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ IX585A6[@"',#P
M*#(  !D              ("!#VH  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " "GA5A64.#D5?,"   ;!P  &0              @($2
M>@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( *>%6%9Z
M+#0T%0D  &0:   9              " @3Q]  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ IX585ABZ#9L0"@  ]"(  !D
M     ("!B(8  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *>%6%;"=C4N_P(  ,8&   9              "
M@7^U  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ IX58
M5L"X&R"C$0  ?D(  !D              ("!M;@  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " "GA5A6N$=#5$T$  "I#P  &0
M        @(&/R@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( *>%6%:EU]$"7P@  /07   9              " @1//  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ IX585@4$AO56!   X@L
M !D              ("!J=<  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " "GA5A6 SIY4%L-   [*P  &0              @($VW
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( *>%6%::_4UD
M_0,  *P*   9              " @<CI  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ IX585H77:@"+!   YPX  !D
M ("!_.T  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "G
MA5A6&JS#C'H#  "!"   &0              @(&^\@  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *>%6%9H)(J)HP(  /D%   9
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M970S-2YX;6Q02P$"% ,4    " "GA5A6C,(B3K0%  "Q%   &0
M    @('I#P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M *>%6%8B'86[N ,  .H)   9              " @=05 0!X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ IX585LE!).=T"0  YR$  !D
M             ("!PQD! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " "GA5A6P&V__5<%   -%@  &0              @(%N(P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( *>%6%;?UVE(!0@
M % D   9              " @?PH 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ IX585JJ*J]-<!   P \  !D              ("!
M.#$! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " "GA5A6
MQ:HN^5X&    $P  &0              @('+-0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( *>%6%9PS#OS>P(  )T%   9
M      " @6 \ 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ IX585@?BYV+E @  H0H  !D              ("!$C\! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "GA5A6IUHP@C<%   .*@
M&0              @($N0@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( *>%6%;;:C+%CP(  "T&   9              " @9Q' 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ IX585E>?K,W2
M @  R0<  !D              ("!8DH! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " "GA5A6W7]P)+ "  #%!@  &0
M@(%K30$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( *>%
M6%9(LDJ4N (   L'   9              " @5)0 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ IX585HW#!W8@"0  (%(  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( *>%6%9GGYOH[0(  ! (   9
M  " @1AO 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
MIX585FZ2O%^=!   &1L  !D              ("!/'(! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " "GA5A6N!Q.(OD$   D(   &0
M            @($0=P$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( *>%6%805 !S8@(  /\%   9              " @4!\ 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ IX585A\2O072 @
M(@@  !D              ("!V7X! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " "GA5A6+IV?R:X#  #_#0  &0              @('B
M@0$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( *>%6%8@
M$8O;!04  .02   9              " @<>% 0!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ IX585G=]L/,X!0  ^!4  !D
M     ("! XL! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *>%6%8;<27/Q 0  ,4>   9              "
M@3:A 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ IX58
M5NDZVA.: @  _04  !D              ("!,:8! 'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    " "GA5A6"I8>H%\"  !,!0  &0
M        @($"J0$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( *>%6%818XP'( 8  ($P   9              " @9BK 0!X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ IX585ILA^DH6 P  /0L
M !D              ("![[$! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    " "GA5A6ELZZXV<$   _&P  &0              @($\M0$
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( *>%6%;7P@FG
MX@0  )(;   9              " @=JY 0!X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ IX585DC&7.8+ P  H @  !D
M ("!\[X! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " "G
MA5A6I7H-)OH"  !W"P  &0              @($UP@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( *>%6%:.M4OP^0(  'P(   9
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M970X,"YX;6Q02P$"% ,4    " "GA5A6?2I'5R,&  #N(@  &0
M    @($!Y@$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    (
M *>%6%8;;=SM.@8  (\L   9              " @5OL 0!X;"]W;W)K<VAE
M971S+W-H965T.#(N>&UL4$L! A0#%     @ IX585F1#7!K[ P  N!$  !D
M             ("!S/(! 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"
M% ,4    " "GA5A63;\B.[0$   \&P  &0              @('^]@$ >&PO
M=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( *>%6%8H,8JM>0,
M )H0   9              " @>G[ 0!X;"]W;W)K<VAE971S+W-H965T.#4N
M>&UL4$L! A0#%     @ IX585CS4M\8G!   1A(  !D              ("!
MF?\! 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " "GA5A6
MDH.'6A $  !]$@  &0              @('W P( >&PO=V]R:W-H965T<R]S
M:&5E=#@W+GAM;%!+ 0(4 Q0    ( *>%6%:(IH _@ (  )L&   9
M      " @3X( @!X;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%
M  @ IX585G6 Q4QF!   SA@  !D              ("!]0H" 'AL+W=O<FMS
M:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " "GA5A6_H,S&(H#  #6"@
M&0              @(&2#P( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+
M 0(4 Q0    ( *>%6%8E;E0",@D  .1'   9              " @5,3 @!X
M;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ IX585FTQU.UH
M!0  5"<  !D              ("!O!P" 'AL+W=O<FMS:&5E=',O<VAE970Y
M,BYX;6Q02P$"% ,4    " "GA5A6GKW2*[\"   F!P  &0
M@(%;(@( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( *>%
M6%8HF%/WZP8  (DL   9              " @5$E @!X;"]W;W)K<VAE971S
M+W-H965T.30N>&UL4$L! A0#%     @ IX585B\^4&J> @  !PD  !D
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M=#DY+GAM;%!+ 0(4 Q0    ( *>%6%:5?>.P @,   L+   :
M  " @<<Z @!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    (
M *>%6%;TRBBIVP,  -8/   :              " @0$^ @!X;"]W;W)K<VAE
M971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( *>%6%8D7C';0P,  *H4   -
M              "  11" @!X;"]S='EL97,N>&UL4$L! A0#%     @ IX58
M5I>*NQS     $P(   L              ( !@D4" %]R96QS+RYR96QS4$L!
M A0#%     @ IX585@IWE?PC!P  ;T(   \              ( !:T8" 'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *>%6%9CQ!%*W0(  %P[   :
M          "  ;M- @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( *>%6%9_X$/,6P(  $TY   3              "  =!0 @!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !M &T ]!T  %Q3 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>393</ContextCount>
  <ElementCount>515</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>108</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DocumentCoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00200 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00505 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10101 - Disclosure - Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Acquisitions and Other Strategic Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions</Role>
      <ShortName>Acquisitions and Other Strategic Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureInventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Revolving Credit Facility and Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt</Role>
      <ShortName>Revolving Credit Facility and Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11001 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Earnings Per Common Share (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEarningsPerCommonShareEps</Role>
      <ShortName>Earnings Per Common Share (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>11201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>11301 - Disclosure - Segment Reporting and Foreign Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations</Role>
      <ShortName>Segment Reporting and Foreign Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>11401 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>11501 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>11601 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>11701 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>11801 - Disclosure - Schedule II - Valuation and qualifying accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and qualifying accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>20102 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>30103 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>30203 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevenuesTables</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureRevenues</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>30303 - Disclosure - Acquisitions and Other Strategic Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables</Role>
      <ShortName>Acquisitions and Other Strategic Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureInventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureInventories</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>30703 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureAccruedExpenses</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>30803 - Disclosure - Revolving Credit Facility and Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables</Role>
      <ShortName>Revolving Credit Facility and Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>30903 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureDerivatives</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>31103 - Disclosure - Earnings Per Common Share (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables</Role>
      <ShortName>Earnings Per Common Share (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureEarningsPerCommonShareEps</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>31203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>31303 - Disclosure - Segment Reporting and Foreign Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables</Role>
      <ShortName>Segment Reporting and Foreign Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>31503 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>31603 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>31703 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureLeases</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>40101 - Disclosure - Organization and Summary of Significant Accounting Policies - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>40102 - Disclosure - Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>40103 - Disclosure - Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>40104 - Disclosure - Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>40105 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>40106 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>40107 - Disclosure - Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Revenues - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails</Role>
      <ShortName>Revenues - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Acquisitions and Other Strategic Transactions - Asset Purchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails</Role>
      <ShortName>Acquisitions and Other Strategic Transactions - Asset Purchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>40302 - Disclosure - Acquisitions and Other Strategic Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails</Role>
      <ShortName>Acquisitions and Other Strategic Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>40303 - Disclosure - Acquisitions - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails</Role>
      <ShortName>Acquisitions - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureInventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureInventoriesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>40502 - Disclosure - Goodwill and Intangible Assets - Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>40503 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>40504 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Income Taxes - Domestic and Foreign (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails</Role>
      <ShortName>Income Taxes - Domestic and Foreign (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>40602 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>40603 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>40604 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>40605 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>40606 - Disclosure - Income Taxes - Summary of Income Tax Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails</Role>
      <ShortName>Income Taxes - Summary of Income Tax Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureAccruedExpensesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails</Role>
      <ShortName>Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>40802 - Disclosure - Revolving Credit Facility and Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails</Role>
      <ShortName>Revolving Credit Facility and Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>40803 - Disclosure - Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails</Role>
      <ShortName>Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>40804 - Disclosure - Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails</Role>
      <ShortName>Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Derivatives - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivativesNarrativeDetails</Role>
      <ShortName>Derivatives - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>40902 - Disclosure - Derivatives - Forward Notional Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails</Role>
      <ShortName>Derivatives - Forward Notional Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>40903 - Disclosure - Derivatives - Fair Value of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails</Role>
      <ShortName>Derivatives - Fair Value of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>40904 - Disclosure - Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails</Role>
      <ShortName>Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>40905 - Disclosure - Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails</Role>
      <ShortName>Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Earnings Per Common Share (EPS) - Basic EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails</Role>
      <ShortName>Earnings Per Common Share (EPS) - Basic EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>41102 - Disclosure - Earnings Per Common Share (EPS) - Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails</Role>
      <ShortName>Earnings Per Common Share (EPS) - Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>41202 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>41203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>41204 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>41205 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>41206 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails</Role>
      <ShortName>Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>41301 - Disclosure - Segment Reporting and Foreign Operations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails</Role>
      <ShortName>Segment Reporting and Foreign Operations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>41302 - Disclosure - Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails</Role>
      <ShortName>Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>41303 - Disclosure - Segment Reporting and Foreign Operations - Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting and Foreign Operations - Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>41304 - Disclosure - Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails</Role>
      <ShortName>Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>41401 - Disclosure - Employee Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureEmployeeBenefitPlansDetails</Role>
      <ShortName>Employee Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureEmployeeBenefitPlans</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>41501 - Disclosure - Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>41502 - Disclosure - Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>41503 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>41504 - Disclosure - Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>41505 - Disclosure - Fair Value Measurements - Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails</Role>
      <ShortName>Fair Value Measurements - Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>41601 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>41701 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>41702 - Disclosure - Leases - Schedule of Consolidated Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Schedule of Consolidated Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>41703 - Disclosure - Leases - Components of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails</Role>
      <ShortName>Leases - Components of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>41704 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>41705 - Disclosure - Leases - Supplemental Disclosure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails</Role>
      <ShortName>Leases - Supplemental Disclosure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>41706 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="mmsi-20221231x10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>41801 - Schedule - Schedule II - Valuation and qualifying accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuation and qualifying accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts</ParentRole>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 10 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, mmsi:ContingentConsiderationPaymentPeriod, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod -  mmsi-20221231x10k.htm 9</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 8 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies, us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration, us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList, us-gaap:ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration -  mmsi-20221231x10k.htm 9</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="mmsi-20221231x10k.htm">mmsi-20221231x10k.htm</File>
    <File>mmsi-20221231.xsd</File>
    <File>mmsi-20221231_cal.xml</File>
    <File>mmsi-20221231_def.xml</File>
    <File>mmsi-20221231_lab.xml</File>
    <File>mmsi-20221231_pre.xml</File>
    <File>mmsi-20221231xex10d51.htm</File>
    <File>mmsi-20221231xex10d60.htm</File>
    <File>mmsi-20221231xex10d61.htm</File>
    <File>mmsi-20221231xex21.htm</File>
    <File>mmsi-20221231xex23d1.htm</File>
    <File>mmsi-20221231xex31d1.htm</File>
    <File>mmsi-20221231xex31d2.htm</File>
    <File>mmsi-20221231xex32d1.htm</File>
    <File>mmsi-20221231xex32d2.htm</File>
    <File>mmsi-20221231xex4d2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mmsi-20221231x10k001.jpg</File>
    <File>mmsi-20221231x10k002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1387">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>133
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mmsi-20221231x10k.htm": {
   "axisCustom": 0,
   "axisStandard": 41,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 1387,
    "http://xbrl.sec.gov/dei/2022": 36
   },
   "contextCount": 393,
   "dts": {
    "calculationLink": {
     "local": [
      "mmsi-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mmsi-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mmsi-20221231x10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mmsi-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mmsi-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mmsi-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 817,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 29,
    "http://www.merit.com/20221231": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 34
   },
   "keyCustom": 60,
   "keyStandard": 455,
   "memberCustom": 40,
   "memberStandard": 67,
   "nsprefix": "mmsi",
   "nsuri": "http://www.merit.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.merit.com/role/DocumentCoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10201 - Disclosure - Revenues",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.merit.com/role/DisclosureRevenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41706 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_TWQZ90UXcEKlQdHOiW6rJg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "41801 - Schedule - Schedule II - Valuation and qualifying accounts (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuation and qualifying accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2019_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember_85rQK-4M5ECcEsi9kKnxVA",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10301 - Disclosure - Acquisitions and Other Strategic Transactions",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions",
     "shortName": "Acquisitions and Other Strategic Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10401 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.merit.com/role/DisclosureInventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10501 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10601 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10701 - Disclosure - Accrued Expenses",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.merit.com/role/DisclosureAccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10801 - Disclosure - Revolving Credit Facility and Long-Term Debt",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt",
     "shortName": "Revolving Credit Facility and Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10901 - Disclosure - Derivatives",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.merit.com/role/DisclosureDerivatives",
     "shortName": "Derivatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11001 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.merit.com/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11101 - Disclosure - Earnings Per Common Share (EPS)",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.merit.com/role/DisclosureEarningsPerCommonShareEps",
     "shortName": "Earnings Per Common Share (EPS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00100 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11301 - Disclosure - Segment Reporting and Foreign Operations",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations",
     "shortName": "Segment Reporting and Foreign Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11401 - Disclosure - Employee Benefit Plans",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.merit.com/role/DisclosureEmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11501 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11601 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11701 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.merit.com/role/DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11801 - Disclosure - Schedule II - Valuation and qualifying accounts",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts",
     "shortName": "Schedule II - Valuation and qualifying accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20102 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30103 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Organization and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30203 - Disclosure - Revenues (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.merit.com/role/DisclosureRevenuesTables",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_OvQHRNSqw06QppxX6EnjNA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30303 - Disclosure - Acquisitions and Other Strategic Transactions (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables",
     "shortName": "Acquisitions and Other Strategic Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_OvQHRNSqw06QppxX6EnjNA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30403 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.merit.com/role/DisclosureInventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30503 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30603 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30703 - Disclosure - Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.merit.com/role/DisclosureAccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30803 - Disclosure - Revolving Credit Facility and Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables",
     "shortName": "Revolving Credit Facility and Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30903 - Disclosure - Derivatives (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.merit.com/role/DisclosureDerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31103 - Disclosure - Earnings Per Common Share (EPS) (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables",
     "shortName": "Earnings Per Common Share (EPS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31303 - Disclosure - Segment Reporting and Foreign Operations (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables",
     "shortName": "Segment Reporting and Foreign Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31503 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31603 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mmsi:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31703 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.merit.com/role/DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mmsi:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40101 - Disclosure - Organization and Summary of Significant Accounting Policies - Organization (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40102 - Disclosure - Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_srt_StatementGeographicalAxis_country_CN_5-btpkjfxUKLkQH_I3JAJg",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40103 - Disclosure - Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "mmsi:DeferredCompensationPolicyTextBlockPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashSurrenderValueOfLifeInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40104 - Disclosure - Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Deferred Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "mmsi:DeferredCompensationPolicyTextBlockPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashSurrenderValueOfLifeInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "mmsi:OtherAssetsPolicyTextBlockPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40105 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Assets (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "mmsi:OtherAssetsPolicyTextBlockPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40106 - Disclosure - Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Other Long-term Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40107 - Disclosure - Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Stock Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00300 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40201 - Disclosure - Revenues - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
     "shortName": "Revenues - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_country_US_q-ArAJXhsESzPPSHFsKcWQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_SNuT8N5JSkC1oU513hKP5A",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40301 - Disclosure - Acquisitions and Other Strategic Transactions - Asset Purchase (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
     "shortName": "Acquisitions and Other Strategic Transactions - Asset Purchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_10_4_2022_To_10_4_2022_us-gaap_AssetAcquisitionAxis_mmsi_BiotraceMedicalIncMember_SNuT8N5JSkC1oU513hKP5A",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40302 - Disclosure - Acquisitions and Other Strategic Transactions - Narrative (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
     "shortName": "Acquisitions and Other Strategic Transactions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_11_6_2020_To_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_sGJHmwQCQU6-FNqRSvZMLw",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40303 - Disclosure - Acquisitions - Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
     "shortName": "Acquisitions - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_11_6_2020_us-gaap_BusinessAcquisitionAxis_mmsi_KaMedicalLLCMember_WjSu27_dSUK6Ov68lnAs0A",
      "decimals": "-3",
      "lang": null,
      "name": "mmsi:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40401 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.merit.com/role/DisclosureInventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40501 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40502 - Disclosure - Goodwill and Intangible Assets - Other Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_PeYXaKQ4oEWbLqxh5bH7uA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40503 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40504 - Disclosure - Goodwill and Intangible Assets - Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40601 - Disclosure - Income Taxes - Domestic and Foreign (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails",
     "shortName": "Income Taxes - Domestic and Foreign (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gK8hNbA-mU2xGdCtF3REPw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2019_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201613Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_gK8hNbA-mU2xGdCtF3REPw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40602 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "p",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40603 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Effective Income Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "p",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40604 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40605 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40606 - Disclosure - Income Taxes - Summary of Income Tax Contingencies (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails",
     "shortName": "Income Taxes - Summary of Income Tax Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2019__tDI3JY27UmCxIKWgTsZRQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40701 - Disclosure - Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.merit.com/role/DisclosureAccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40801 - Disclosure - Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails",
     "shortName": "Revolving Credit Facility and Long-Term Debt - Principal Balances under Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40802 - Disclosure - Revolving Credit Facility and Long-Term Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
     "shortName": "Revolving Credit Facility and Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_FHUCTtwQ8EeTH227ESzOeg",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mmsi:ScheduleOfLongTermDebtCovenantsTableTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "mmsi:LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40803 - Disclosure - Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails",
     "shortName": "Revolving Credit Facility and Long-Term Debt - Financial Covenants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mmsi:ScheduleOfLongTermDebtCovenantsTableTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_DebtInstrumentAxis_mmsi_CreditAgreementMember_TDzhf-MKz0-lbZ2mK_4EtA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "mmsi:LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40804 - Disclosure - Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails",
     "shortName": "Revolving Credit Facility and Long-Term Debt - Future Minimum Payments on Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GainLossOnDispositionOfAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40901 - Disclosure - Derivatives - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails",
     "shortName": "Derivatives - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_mmsi_RevenueAndCostOfSalesMember_m7lyP_t3nEW1n1AwdiWVew",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "mmsi:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40902 - Disclosure - Derivatives - Forward Notional Contracts (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
     "shortName": "Derivatives - Forward Notional Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_GzBRxIVZLESnPCwc0TNnAA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "mmsi:DerivativeAverageNumberOfContractsEnteredIntoPerMonth",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_DerivativeInstrument_cjuB-byLZkaiJYEseIOaGQ",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_IUTMOoGSYUSlf5FDP00RrQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40903 - Disclosure - Derivatives - Fair Value of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
     "shortName": "Derivatives - Fair Value of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_IUTMOoGSYUSlf5FDP00RrQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40904 - Disclosure - Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
     "shortName": "Derivatives - Amount of Gain (Loss) Recognized in OCI and Income Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_J_jEZHS6W0CE4zFDg0hOEA",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40905 - Disclosure - Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
     "shortName": "Derivatives - Gain (Loss) in the Consolidated Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_fWqMlQmnjkueNxOdhAMdTg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_bbrBKCNcLUOQmTf4LjLfbA",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41001 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_bbrBKCNcLUOQmTf4LjLfbA",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41101 - Disclosure - Earnings Per Common Share (EPS) - Basic EPS (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails",
     "shortName": "Earnings Per Common Share (EPS) - Basic EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41102 - Disclosure - Earnings Per Common Share (EPS) - Diluted EPS (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails",
     "shortName": "Earnings Per Common Share (EPS) - Diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41201 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41202 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants - Allocation of Recognized Period Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_ZZfj3R7V5Eaf4KlhxZX0NA",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaidCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00505 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaidCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41203 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants - Option Granted Fair Value Calculation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_nSjblSLaqkOaV0K0r1mGzQ",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41204 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mmsi:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_A-y-jPtaQU2OTZZaL2OhkA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41205 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants - Changes in PSUs and RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mmsi:ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g",
      "decimals": "-3",
      "lang": null,
      "name": "mmsi:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_JUqcsoyYI0KyCl1tKx9QEA",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41206 - Disclosure - Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails",
     "shortName": "Employee Stock Purchase Plan, Stock Options and Warrants - PSUs Fair Value Calculation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mmsi:ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_bbHFkbAD8kmvxXQupu5p8g",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "Unit_Standard_segment_NQjW0DVFc0Smqsc-32cuwg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41301 - Disclosure - Segment Reporting and Foreign Operations - Narrative (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails",
     "shortName": "Segment Reporting and Foreign Operations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_BT1_boCV1EyK74esn0nh_w",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_rH-sclDBe06MPEofB-9IXQ",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41302 - Disclosure - Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails",
     "shortName": "Segment Reporting and Foreign Operations - Long-lived Assets by Geographic Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41303 - Disclosure - Segment Reporting and Foreign Operations - Operating Income (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails",
     "shortName": "Segment Reporting and Foreign Operations - Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_StatementBusinessSegmentsAxis_mmsi_CardiovascularSegmentMember_wD7Sn1iTxEKRZlJrkns27w",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41304 - Disclosure - Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
     "shortName": "Segment Reporting and Foreign Operations - Assets, Depreciation, Amortization and Capital Expenditures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2020_dBmBrWJVREGj_siGLwcIYQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41401 - Disclosure - Employee Benefit Plans (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.merit.com/role/DisclosureEmployeeBenefitPlansDetails",
     "shortName": "Employee Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41501 - Disclosure - Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Assets and (Liabilities) Carried at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_T8JXswSBYku-qE6hvnoCVw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10101 - Disclosure - Organization and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_3CoBZhHg7EasNbcNxb5N0Q",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41502 - Disclosure - Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails",
     "shortName": "Fair Value Measurements - Liability Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_mmsi_ContingentConsiderationMember_-dsubK6ei02Er5tXNOop6g",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41503 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:CommitmentsAndContingenciesPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41504 - Disclosure - Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
     "shortName": "Fair Value Measurements - Fair Value Inputs, Liabilities, Quantitative Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_ContingentConsiderationByTypeAxis_mmsi_RevenueBasedPaymentsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member__0z7AfckH0-izPRxsHj-CA",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41505 - Disclosure - Fair Value Measurements - Allowance for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails",
     "shortName": "Fair Value Measurements - Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ProvisionForLoanLossesExpensed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2021_nJW6T9eN_EW0iDpkiYTqLQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41601 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
     "shortName": "Accumulated Other Comprehensive Income (Loss) - Changes in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4q9528rWuUGvboqycnruTQ",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41701 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.merit.com/role/DisclosureLeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41702 - Disclosure - Leases - Schedule of Consolidated Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails",
     "shortName": "Leases - Schedule of Consolidated Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41703 - Disclosure - Leases - Components of Lease Cost (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails",
     "shortName": "Leases - Components of Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41704 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_Yh99K2RFqUCdJU2tE2HpAw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jP1BfFa6eUqtFiYS3pvUTA",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41705 - Disclosure - Leases - Supplemental Disclosure (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails",
     "shortName": "Leases - Supplemental Disclosure (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mmsi-20221231x10k.htm",
      "contextRef": "As_Of_12_31_2022_D8fp460dr0WJ1_jSQQYiDQ",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 108,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r821",
      "r822",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r821",
      "r822",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r821",
      "r822",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r821",
      "r822",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r821",
      "r822",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.merit.com/role/DocumentCoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mmsi_AccruedLegalSettlementCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of legal settlement expenses incurred but not yet paid, due within one year or the normal operating cycle, if longer.",
        "label": "Accrued Legal Settlement, Current",
        "terseLabel": "Accrued legal settlement"
       }
      }
     },
     "localname": "AccruedLegalSettlementCurrent",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_AccruedRebatesPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for current portion of accrued rebates payable.",
        "label": "Accrued Rebates Payable Current",
        "terseLabel": "Accrued rebates payable"
       }
      }
     },
     "localname": "AccruedRebatesPayableCurrent",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_AcquisitionOfDevelopedTechnologyInAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents future cash outflow to pay for acquisition of developed technology in a non cash investing and financing activity.",
        "label": "Acquisition of Developed Technology in Accrued Expenses",
        "terseLabel": "Acquisition purchases in accrued expenses and other long-term obligations"
       }
      }
     },
     "localname": "AcquisitionOfDevelopedTechnologyInAccruedExpenses",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_AdvancesFromEmployeesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advances From Employees, Current",
        "label": "Advances From Employees, Current",
        "terseLabel": "Advances from employees"
       }
      }
     },
     "localname": "AdvancesFromEmployeesCurrent",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_AssetAcquisitionContingentConsiderationNumberOfAnnualPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of contingent annual payments under the asset acquisition agreement.",
        "label": "Asset Acquisition, Contingent Consideration, Number of Annual Payments",
        "terseLabel": "Number of annual payments"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationNumberOfAnnualPayments",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mmsi_AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of net sales revenue for contingent consideration from asset acquisition.",
        "label": "Asset Acquisition, Contingent Consideration, Percent of Net Sales Revenue",
        "terseLabel": "Net sales revenue (as a percent)"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationPercentOfNetSalesRevenue",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mmsi_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Consolidated Balance Sheet Information and Supplemental Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_BiotraceMedicalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the asset acquisition of BioTrace Medical, Inc.",
        "label": "BioTrace"
       }
      }
     },
     "localname": "BiotraceMedicalIncMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_BluegrassVascularTechnologiesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information related to Bluegrass Vascular Technologies, Inc.",
        "label": "Bluegrass Vascular Technologies, Inc"
       }
      }
     },
     "localname": "BluegrassVascularTechnologiesIncMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_BusinessCombinationConsiderationTransferredNotePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of note payable issued by acquirer in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Note Payable",
        "terseLabel": "Purchase consideration, note payable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredNotePayable",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit",
        "label": "Business Combination, Contingent Consideration Arrangements, Contingent Consideration Benefit",
        "negatedTerseLabel": "Contingent consideration expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses",
        "negatedLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Current",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Current",
        "terseLabel": "Contingent consideration liability, current"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityCurrent",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Noncurrent",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Contingent Liability Noncurrent",
        "terseLabel": "Contingent consideration liability, noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiabilityNoncurrent",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other Receivables",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other Receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Trade Receivables",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Trade Receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsTradeReceivables",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_CardiacInterventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Cardiac Intervention products.",
        "label": "Cardiac Intervention"
       }
      }
     },
     "localname": "CardiacInterventionMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_CardiovascularSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular Segment [Member]",
        "label": "Cardiovascular"
       }
      }
     },
     "localname": "CardiovascularSegmentMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Hedge Gain (Loss) To Be Reclassified Within Twelve Months, Gross",
        "label": "Cash Flow Hedge Gain (Loss) To Be Reclassified Within Twelve Months, Gross",
        "terseLabel": "Amount expected to be reclassified from accumulated other comprehensive income (loss) to earnings in next twelve months, gross"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsGross",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_CashSettledPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash-Settled share-based payment arrangement awarded for meeting performance target.",
        "label": "Cash-Settled Performance-Based Share-Based Awards (Liability Awards)"
       }
      }
     },
     "localname": "CashSettledPerformanceSharesMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_CiannaMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cianna Medical [Member]",
        "label": "Cianna Medical"
       }
      }
     },
     "localname": "CiannaMedicalMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_ConcentrationOfCreditRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for concentration of credit risk.",
        "label": "Concentration of Credit Risk [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationOfCreditRiskPolicyTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_ContingentConsiderationPaymentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the first contingent consideration payment under the asset purchase agreement.",
        "label": "First Payment"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentOneMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_ContingentConsiderationPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the period for which an asset acquisition contingent consideration is to be paid.",
        "label": "Contingent Consideration, Payment Period",
        "terseLabel": "Payment period"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentPeriod",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mmsi_ContingentConsiderationPaymentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second contingent consideration payment under the asset purchase agreement.",
        "label": "Second Payment"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentTwoMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement",
        "label": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_CustomProceduralSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Custom Procedural Solutions products.",
        "label": "Custom Procedural Solutions"
       }
      }
     },
     "localname": "CustomProceduralSolutionsMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_DeferredCompensationPolicyTextBlockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred compensation plan.",
        "label": "Deferred compensation policy text block [Policy Text Block]",
        "terseLabel": "Deferred Compensation"
       }
      }
     },
     "localname": "DeferredCompensationPolicyTextBlockPolicyTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from IRC section 174 capitalized research and development.",
        "label": "Deferred Tax Assets, Capitalized Research and Development Expense",
        "terseLabel": "IRC section 174 capitalized R&amp;D"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible federal research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Federal Tax Credit Carryforwards, Research",
        "terseLabel": "Federal R&amp;D tax credit"
       }
      }
     },
     "localname": "DeferredTaxAssetsFederalTaxCreditCarryforwardsResearch",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_DeferredTaxAssetsStateTaxCreditCarryforwardsResearch": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state research tax credit carryforwards.",
        "label": "Deferred Tax Assets, State Tax Credit Carryforwards, Research",
        "terseLabel": "UT R&amp;D Credit"
       }
      }
     },
     "localname": "DeferredTaxAssetsStateTaxCreditCarryforwardsResearch",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_DeferredTaxLiabilitiesForeignWithholdingTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Foreign Withholding Tax",
        "label": "Deferred Tax Liabilities, Foreign Withholding Tax",
        "negatedTerseLabel": "Foreign withholding tax"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesForeignWithholdingTax",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_DerivativeAverageNumberOfContractsEnteredIntoPerMonth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Average Number Of Contracts Entered Into Per Month",
        "label": "Derivative Average Number Of Contracts Entered Into Per Month",
        "terseLabel": "Average number of contracts entered into per month"
       }
      }
     },
     "localname": "DerivativeAverageNumberOfContractsEnteredIntoPerMonth",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to remeasurement of contingent consideration liabilities.",
        "label": "Effective Income Tax Rate Reconciliation, Remeasurement of Contingent Consideration Liabilities, Amount",
        "terseLabel": "Remeasurement of contingent consideration liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRemeasurementOfContingentConsiderationLiabilitiesAmount",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to remeasurement of state deferred taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Remeasurement of State Deferred Taxes, Amount",
        "negatedLabel": "Remeasurement of state deferred taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRemeasurementOfStateDeferredTaxesAmount",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information for the non-qualified Employee Stock Purchase Plan (\"ESPP\").",
        "label": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_EndoscopyDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Endoscopy Devices products.",
        "label": "Endoscopy Devices"
       }
      }
     },
     "localname": "EndoscopyDevicesMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_EndoscopySegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Endoscopy Segment",
        "label": "Endoscopy"
       }
      }
     },
     "localname": "EndoscopySegmentMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange",
        "terseLabel": "Effect of foreign exchange"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchange",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of equity investment acquired in exchange for settlement of note receivable in noncash investing or financing activities.",
        "label": "Fair Value of Equity Investment in Exchange For Settlement of Note Receivable",
        "terseLabel": "Current note receivable converted to equity investment"
       }
      }
     },
     "localname": "FairValueOfEquityInvestmentInExchangeForSettlementOfNoteReceivable",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_FairValueOfStockOptionOnGrantDateNetOfForfeitures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Of Stock Option On Grant Date Net Of Forfeitures",
        "label": "Fair Value Of Stock Option On Grant Date Net Of Forfeitures",
        "terseLabel": "Fair value of options, net of forfeitures"
       }
      }
     },
     "localname": "FairValueOfStockOptionOnGrantDateNetOfForfeitures",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_FluidxMedicalTechnologyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fluidx Medical Technology, LLC [Member]",
        "label": "Fluidx"
       }
      }
     },
     "localname": "FluidxMedicalTechnologyLLCMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_FusionMedicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fusion Medical, Inc. [Member]",
        "label": "Fusion Medical, Inc."
       }
      }
     },
     "localname": "FusionMedicalInc.Member",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_GoodwillPurchaseAccountingAdjustmentsAndAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Purchase Accounting Adjustments And Additions",
        "label": "Goodwill, Purchase Accounting Adjustments And Additions",
        "terseLabel": "Additions and adjustments as the result of acquisitions"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustmentsAndAdditions",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_IncomeTaxExpenseBenefitRestructuringOfForeignEntities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) pertaining to restructuring of foreign entities.",
        "label": "Income Tax Expense (Benefit), Restructuring of Foreign Entities",
        "negatedLabel": "Tax benefit from restructuring of foreign entities"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitRestructuringOfForeignEntities",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_IncreaseDecreaseLiabilityForUncertainTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Liability for Uncertain Tax Positions",
        "label": "Increase (Decrease) Liability for Uncertain Tax Positions",
        "terseLabel": "Liabilities related to unrecognized tax benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseLiabilityForUncertainTaxPositions",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents sum of the carrying amounts of all intangible assets and goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Also includes aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations.",
        "label": "Intangible Assets Net Goodwill and Other Assets Noncurrent",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Net Goodwill and Other Assets Noncurrent [Abstract]",
        "terseLabel": "Other assets:"
       }
      }
     },
     "localname": "IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrentAbstract",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "mmsi_KaMedicalLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the unit purchase agreement to acquire KA Medical, LLC (\"KA Medical\").",
        "label": "KA Medical"
       }
      }
     },
     "localname": "KaMedicalLLCMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_LauraneMedicalS.A.S.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laurane Medical S.A.S. [Member]",
        "label": "Laurane Medical S.A.S."
       }
      }
     },
     "localname": "LauraneMedicalS.A.S.Member",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_LesseeOperatingLeaseTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Termination Period",
        "label": "Lessee, Operating Lease, Termination Period",
        "terseLabel": "Termination option (within)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTerminationPeriod",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mmsi_LicenseAgreementArravascLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the license agreement with ArraVasc Limited.",
        "label": "ArraVasc Limited"
       }
      }
     },
     "localname": "LicenseAgreementArravascLimitedMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Facility Capital Expenditures, Next Twelve Months, Maximum",
        "label": "Line of Credit Facility, Covenant Terms, Facility Capital Expenditures, Next Twelve Months, Maximum",
        "verboseLabel": "Facility Capital Expenditures"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTermsFacilityCapitalExpendituresNextTwelveMonthsMaximum",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Consolidated Ebitda To Fixed Charges Ratio, Minimum2",
        "label": "Line of Credit Facility, Covenant Terms, Consolidated Ebitda To Fixed Charges Ratio, Minimum2",
        "terseLabel": "Consolidated Interest Coverage Ratio"
       }
      }
     },
     "localname": "LineofCreditFacilityCovenantTermsConsolidatedEbitdaToFixedChargesRatioMinimum2",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mmsi_LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Consolidated Total Leverage Ratio, Maximum",
        "label": "Line of Credit Facility, Covenant Terms, Consolidated Total Leverage Ratio, Maximum",
        "terseLabel": "Consolidated Total Leverage Ratio"
       }
      }
     },
     "localname": "LineofCreditFacilityCovenantTermsConsolidatedTotalLeverageRatioMaximum",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mmsi_LongTermIncentivePlan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information for the 2018 long-term incentive plan.",
        "label": "2018 Incentive Plan"
       }
      }
     },
     "localname": "LongTermIncentivePlan2018Member",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_MaximumPotentialSharesGrantedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum potential shares granted.",
        "label": "Maximum potential shares"
       }
      }
     },
     "localname": "MaximumPotentialSharesGrantedMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_MaximumUnitsGrantedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum of units granted.",
        "label": "Maximum units granted"
       }
      }
     },
     "localname": "MaximumUnitsGrantedMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_MeritShareholderDerivativeSuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to derivative suit filed by shareholders of Merit.",
        "label": "Merit Shareholder Derivative Suit"
       }
      }
     },
     "localname": "MeritShareholderDerivativeSuitMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_MilestonePaymentProbabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment Probability [Member]",
        "label": "Probability of milestone payment"
       }
      }
     },
     "localname": "MilestonePaymentProbabilityMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_NetOperatingLossCarryforwardsUsedInCurrentPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Federal Net Operating Loss Carryforwards Used In The Current Period.",
        "label": "Net Operating Loss Carryforwards Used In The Current Period",
        "terseLabel": "NOL carryforward used in period"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsUsedInCurrentPeriod",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_NetOperatingLossCarryforwardsUtilization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Number Of Years That Net Operating Loss Carryforwards Are Expected To Be Utilized",
        "label": "Net Operating Loss Carryforwards Utilization",
        "terseLabel": "Period to utilize the net operating loss carryforwards"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsUtilization",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mmsi_NinePointMedicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NinePoint Medical, Inc. [Member]",
        "label": "NinePoint Medical, Inc."
       }
      }
     },
     "localname": "NinePointMedicalInc.Member",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_NonUSExcludingIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-US Countries Excluding Ireland",
        "label": "Other foreign countries"
       }
      }
     },
     "localname": "NonUSExcludingIrelandMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_NumberOfProductCategories": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of product categories.",
        "label": "Number of Product Categories",
        "terseLabel": "Number of product categories"
       }
      }
     },
     "localname": "NumberOfProductCategories",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails",
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mmsi_OEMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents OEM products.",
        "label": "OEM"
       }
      }
     },
     "localname": "OEMMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_OtherAssetsPolicyTextBlockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for other assets which are expected to be realized or consumed after on year (or the normal operating cycle, if longer).",
        "label": "Other Assets Policy Text Block [Policy Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsPolicyTextBlockPolicyTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_OtherIntangibleAssetsAcquiredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of other intangible assets acquired during business acquisition transactions.",
        "label": "Other Acquisitions"
       }
      }
     },
     "localname": "OtherIntangibleAssetsAcquiredMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for taxes related to an exchange of common stock.",
        "label": "Payments Related To Tax Withholding for Exchange of Common Stock",
        "negatedLabel": "Payment of taxes related to an exchange of common stock"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_PeripheralInterventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Peripheral Intervention products.",
        "label": "Peripheral Intervention"
       }
      }
     },
     "localname": "PeripheralInterventionMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_PotentialSharesGrantedDuringPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of potential shares granted.",
        "label": "Potential Shares Granted During Period, Increase (Decrease)",
        "terseLabel": "Decrease in the potential shares of common stock to be granted"
       }
      }
     },
     "localname": "PotentialSharesGrantedDuringPeriodIncreaseDecrease",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mmsi_RegulatoryApprovalMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Approval Milestone [Member]",
        "label": "Regulatory approval"
       }
      }
     },
     "localname": "RegulatoryApprovalMilestoneMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_RestoreEndosystemsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the asset acquisition of Restore Endosystems, LLC.",
        "label": "Restore Endosystems"
       }
      }
     },
     "localname": "RestoreEndosystemsLLCMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_RevenueAndCostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue And Cost Of Sales",
        "label": "Revenue and cost of sales"
       }
      }
     },
     "localname": "RevenueAndCostOfSalesMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue-based Payments [Member]",
        "label": "Revenue-based royalty"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_RevenueMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Milestones [Member]",
        "label": "Revenue milestones"
       }
      }
     },
     "localname": "RevenueMilestonesMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_STDPharmaceuticalProductsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to STD Pharmaceutical Products Limited, a UK-based company engaged in the manufacture, distribution and sale of pharmaceutical sclerotherapy products.",
        "label": "STD Pharmaceutical Products Limited"
       }
      }
     },
     "localname": "STDPharmaceuticalProductsLimitedMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_ScheduleOfLongTermDebtCovenantsTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Long Term Debt Covenants Table [Table Text Block]",
        "label": "Schedule Of Long Term Debt Covenants Table [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Covenants"
       }
      }
     },
     "localname": "ScheduleOfLongTermDebtCovenantsTableTableTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of performance shares, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Performance Shares, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, PSUs, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardPerformanceSharesValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_SelioMedicalLimitedSelioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Selio Medical Limited (\"Selio\").",
        "label": "Selio"
       }
      }
     },
     "localname": "SelioMedicalLimitedSelioMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in the number of equity-based payment instruments, excluding stock (or unit) options, from the application of the rTSR multiplier as originally specified in the agreements during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments in Period",
        "terseLabel": "rTSR adjustment (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for adjustments made based on the impact of the application of the rTSR multiplier as originally specified in the agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "rTSR adjustment (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, conversion multiplying factor.",
        "label": "Share-based Compensation Arrangement by Share-based payment Award, Equity Instruments Other than Options, Conversion Multiplying Factor",
        "terseLabel": "Multiplying factor"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionMultiplyingFactor",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The annual target cash incentive amount for non-option equity instruments granted to participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Annual Target Cash Incentive",
        "terseLabel": "Target cash incentive"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAnnualTargetCashIncentive",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares of common stock that each unit is equal to.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Number of Shares of Common Stock For Each Unit",
        "terseLabel": "Number of shares of common stock for each unit"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOfCommonStockForEachUnit",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mmsi_ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement Employee Stock Purchase Plan, Percentage of Market Price. Purchase Date",
        "label": "Share Based Compensation Arrangement Employee Stock Purchase Plan Percentage of Market Price Purchase Date",
        "terseLabel": "Purchase price for ESPP, percent of market price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementEmployeeStockPurchasePlanPercentageofMarketPricePurchaseDate",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mmsi_ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for equity instruments other than options that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Equity Instruments Other than Options, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, PSUs and RSUs, Activity"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEquityInstrumentsOtherThanOptionsActivityTableTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for performance shares and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Performance Shares and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, PSUs and RSUs Granted"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementPerformanceSharesAndRestrictedStockUnitActivityTableTextBlock",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mmsi_StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Surrendered During Period Shares Payroll Tax Liabilities Stock Options Exercised",
        "label": "Stock Surrendered During Period Shares Payroll Tax Liabilities Stock Options Exercised",
        "negatedTerseLabel": "Shares surrendered in exchange for payment of payroll tax liabilities (in shares)"
       }
      }
     },
     "localname": "StockSurrenderedDuringPeriodSharesPayrollTaxLiabilitiesStockOptionsExercised",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "mmsi_StockSurrenderedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents number of shares that have been surrendered during the period in exchange for stock options exercised.",
        "label": "Stock Surrendered During Period Shares Stock Options Exercised",
        "negatedTerseLabel": "Shares surrendered in exchange for exercise of stock options (in shares)",
        "terseLabel": "Shares surrendered in exchange for exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockSurrenderedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "mmsi_StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised",
        "label": "Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised",
        "negatedTerseLabel": "Shares surrendered in exchange for payment of payroll tax liabilities"
       }
      }
     },
     "localname": "StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_StockSurrenderedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents value of shares that have been surrendered during the period in exchange for stock options exercised.",
        "label": "Stock Surrendered During Period Value Stock Options Exercised",
        "negatedTerseLabel": "Shares surrendered in exchange for exercise of stock options",
        "terseLabel": "Merit common stock surrendered (18, 3, and 39 shares, respectively) in exchange for exercise of stock options"
       }
      }
     },
     "localname": "StockSurrenderedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_TargetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the target for units granted.",
        "label": "Target units granted"
       }
      }
     },
     "localname": "TargetMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncertain tax positions, Reduction resulting from liabilities for reduction to non-current deferred income tax assets.",
        "label": "Uncertain Tax Positions Reduction Resulting from Liabilities For Non Current Deferred Income Tax Assets",
        "terseLabel": "Unrecognized tax benefits reduction to non-current deferred income tax assets"
       }
      }
     },
     "localname": "UncertainTaxPositionsReductionResultingFromLiabilitiesForNonCurrentDeferredIncomeTaxAssets",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits",
        "label": "Uncertain Tax Positions Reduction Resulting From Liabilities For Unrecognized Tax Benefits",
        "terseLabel": "Increase (decrease) of uncertain tax benefits related to certain liabilities for unrecognized tax benefits"
       }
      }
     },
     "localname": "UncertainTaxPositionsReductionResultingFromLiabilitiesForUnrecognizedTaxBenefits",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns) pertaining to uncertain tax positions taken in tax returns as of the balance sheet date including Interest and Penalties.",
        "label": "Unrecognized Tax Benefits Gross Including Interest and Penalties",
        "terseLabel": "Unrecognized tax benefits including interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsGrossIncludingInterestAndPenalties",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mmsi_WellsFargoFixedRateDerivativeContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the Wells Fargo pay-fixed, receive-variable rate swap to fix the one-month LIBOR rate at 1.12%.",
        "label": "Wells Fargo 1.12% one-month LIBOR"
       }
      }
     },
     "localname": "WellsFargoFixedRateDerivativeContractOneMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_WellsFargoFixedRateDerivativeContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the Wells Fargo pay-fixed, receive-variable rate swap to fix the one-month LIBOR rate at 1.71%.",
        "label": "Wells Fargo 1.71% one-month LIBOR"
       }
      }
     },
     "localname": "WellsFargoFixedRateDerivativeContractTwoMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mmsi_XableCathMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the equity method investment in XableCath.",
        "label": "XableCath"
       }
      }
     },
     "localname": "XableCathMember",
     "nsuri": "http://www.merit.com/20221231",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r304",
      "r305",
      "r450",
      "r477",
      "r771",
      "r778",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r254",
      "r318",
      "r325",
      "r331",
      "r398",
      "r554",
      "r555",
      "r556",
      "r586",
      "r587",
      "r619",
      "r622",
      "r624",
      "r625",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Reclassify upon adoption of ASU"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r254",
      "r318",
      "r325",
      "r331",
      "r398",
      "r554",
      "r555",
      "r556",
      "r586",
      "r587",
      "r619",
      "r622",
      "r624",
      "r625",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r254",
      "r318",
      "r325",
      "r331",
      "r398",
      "r554",
      "r555",
      "r556",
      "r586",
      "r587",
      "r619",
      "r622",
      "r624",
      "r625",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r512",
      "r694",
      "r726",
      "r755",
      "r756",
      "r796",
      "r809",
      "r817",
      "r885",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails",
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r512",
      "r694",
      "r726",
      "r755",
      "r756",
      "r796",
      "r809",
      "r817",
      "r885",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r381",
      "r696",
      "r797",
      "r815",
      "r880",
      "r881",
      "r887",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r381",
      "r696",
      "r797",
      "r815",
      "r880",
      "r881",
      "r887",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r503",
      "r512",
      "r544",
      "r545",
      "r546",
      "r693",
      "r694",
      "r726",
      "r755",
      "r756",
      "r796",
      "r809",
      "r817",
      "r879",
      "r885",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails",
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r503",
      "r512",
      "r544",
      "r545",
      "r546",
      "r693",
      "r694",
      "r726",
      "r755",
      "r756",
      "r796",
      "r809",
      "r817",
      "r879",
      "r885",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails",
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r304",
      "r305",
      "r450",
      "r477",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r331",
      "r513",
      "r827",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r314",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II - Valuation and qualifying accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureScheduleIiValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r382",
      "r383",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r760",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r798",
      "r816",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r382",
      "r383",
      "r740",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r760",
      "r761",
      "r798",
      "r816",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r331",
      "r513",
      "r827",
      "r828",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r755",
      "r756",
      "r942",
      "r944",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance.",
        "label": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r1",
      "r18"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Trade receivables - net of allowance for credit losses - 2022 - $8,423 and 2021 - $6,767"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r4",
      "r226",
      "r241"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r6",
      "r226",
      "r241"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Long-term income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued Liabilities, Current, Total",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r120",
      "r264"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r278",
      "r287",
      "r288",
      "r609",
      "r781",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r40",
      "r41",
      "r270",
      "r721",
      "r734",
      "r738"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r37",
      "r41",
      "r179",
      "r687",
      "r729",
      "r730",
      "r835",
      "r836",
      "r837",
      "r850",
      "r851",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r36",
      "r41",
      "r179",
      "r287",
      "r288",
      "r653",
      "r654",
      "r655",
      "r656",
      "r659",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r319",
      "r320",
      "r321",
      "r322",
      "r331",
      "r390",
      "r391",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r554",
      "r555",
      "r556",
      "r584",
      "r585",
      "r586",
      "r587",
      "r601",
      "r602",
      "r603",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r661",
      "r662",
      "r666",
      "r667",
      "r668",
      "r669",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r698",
      "r699",
      "r700",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r147",
      "r148",
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Total adjustments"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Allocated share-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r845",
      "r846",
      "r847",
      "r848",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r99",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Rollforward of Allowance for Credit Losses"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r271",
      "r389",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables, allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r46",
      "r469",
      "r664",
      "r839"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of long-term debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r71",
      "r106",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Aggregate amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Equity awards excluded as the impact was anti-dilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "auth_ref": [
      "r921",
      "r922",
      "r923"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.",
        "label": "Asset Acquisition, Consideration Transferred, Contingent Consideration",
        "terseLabel": "Additional payments upon the achievement of specified milestones"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Asset Acquisition [Line Items]"
       }
      }
     },
     "localname": "AssetAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionTable": {
     "auth_ref": [
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset acquisition.",
        "label": "Asset Acquisition [Table]"
       }
      }
     },
     "localname": "AssetAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r71",
      "r117"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r224",
      "r240",
      "r268",
      "r300",
      "r365",
      "r371",
      "r377",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r607",
      "r611",
      "r639",
      "r814",
      "r883",
      "r884",
      "r940"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r259",
      "r274",
      "r300",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r607",
      "r611",
      "r639",
      "r814",
      "r883",
      "r884",
      "r940"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r599",
      "r807",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r162",
      "r163",
      "r599",
      "r807",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r606",
      "r838"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Adjustments related to contingent consideration liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r171",
      "r172",
      "r605"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "negatedLabel": "Contingent consideration liabilities",
        "terseLabel": "Contingent liability",
        "verboseLabel": "Contingent consideration liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r171",
      "r173"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Current portion of contingent liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Unobservable inputs, contingent liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r174",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Other Strategic Transactions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets Acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Trade payables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTotalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r76",
      "r77",
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment purchases in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r73",
      "r262",
      "r772"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r67",
      "r73",
      "r79"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash and Cash Equivalents",
        "verboseLabel": "RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEETS:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r67",
      "r216"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Amount expected to be reclassified from accumulated other comprehensive income to earnings (loss) in next twelve months, net of tax"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Derivatives designated as cash flow hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r831"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Cash surrender value of life insurance"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r29",
      "r232",
      "r247"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r432",
      "r433",
      "r742",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Other Long-term Obligations"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r850",
      "r851",
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r10",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r10",
      "r814"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, no par value; 100,000 shares authorized; issued and outstanding as of December 31, 2022 - 57,306 and December 31, 2021 - 56,570"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Reported as:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r175",
      "r180",
      "r282",
      "r284",
      "r292",
      "r717",
      "r723"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r55",
      "r291",
      "r716",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r84",
      "r85",
      "r214",
      "r215",
      "r385",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r84",
      "r85",
      "r214",
      "r215",
      "r385",
      "r739",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r84",
      "r85",
      "r214",
      "r215",
      "r385",
      "r741",
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r84",
      "r85",
      "r214",
      "r215",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Concentration for geographic sales"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r84",
      "r85",
      "r214",
      "r215",
      "r385",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r479",
      "r480",
      "r499"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred credits"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r500"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedTerseLabel": "Amortization of deferred credits"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r48",
      "r696"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails",
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r843",
      "r917",
      "r919"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r843",
      "r917"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r161",
      "r581",
      "r591",
      "r843"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current expense (benefit):"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r843",
      "r917",
      "r919"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerListsMember": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.",
        "label": "Customer Lists"
       }
      }
     },
     "localname": "CustomerListsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r299",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r463",
      "r470",
      "r471",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Revolving Credit Facility and Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r225",
      "r228",
      "r239",
      "r307",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r665",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r5",
      "r228",
      "r239",
      "r474"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding borrowings",
        "totalLabel": "Total future minimum principal payments",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r218",
      "r220",
      "r447",
      "r665",
      "r792",
      "r793"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r27",
      "r307",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r665",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r27",
      "r130",
      "r131",
      "r132",
      "r133",
      "r217",
      "r218",
      "r220",
      "r237",
      "r307",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r472",
      "r665",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFinancialCovenantsDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "terseLabel": "Available borrowing capacity"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "verboseLabel": "Estimated decrease in unrecognized tax benefit in next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.",
        "label": "Deferred Compensation Arrangement with Individual, Recorded Liability",
        "terseLabel": "Liabilities associated with awards"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRecordedLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation payable",
        "verboseLabel": "Deferred compensation cost"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesDeferredCompensationDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r831"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation plan assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r843",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r219",
      "r886"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r161",
      "r843",
      "r918"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r71",
      "r161",
      "r582",
      "r590",
      "r591",
      "r843"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred expense (benefit):"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r7",
      "r8",
      "r227",
      "r238",
      "r575"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Deferred income tax liabilities",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r843",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDerivativeInstruments": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from derivative instruments.",
        "label": "Deferred Tax Assets, Derivative Instruments",
        "terseLabel": "Deferred tax asset used to offset fair value of interest rate swap"
       }
      }
     },
     "localname": "DeferredTaxAssetsDerivativeInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "U.S. federal net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Foreign operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforward, no expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforward, expiring"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Accrued compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances",
        "terseLabel": "Allowance for credit losses on trade receivables"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r151",
      "r915"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpense": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r159",
      "r916"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "verboseLabel": "Total expense for contributions made"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r71",
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r71",
      "r360"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "auth_ref": [
      "r31",
      "r33",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Asset, Fair Value, Gross Liability",
        "negatedLabel": "Fair value of derivative liability"
       }
      }
     },
     "localname": "DerivativeAssetFairValueGrossLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r32",
      "r190",
      "r221",
      "r275",
      "r780"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "verboseLabel": "Fair value of derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r32",
      "r190",
      "r221",
      "r275",
      "r780"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedLabel": "Fair value of derivative liability",
        "negatedTerseLabel": "Total Liability Derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r927"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "verboseLabel": "Gain (loss) on derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r189",
      "r191",
      "r195",
      "r197",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r186",
      "r189",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r186",
      "r189",
      "r195",
      "r197",
      "r201",
      "r202",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r925",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of derivative",
        "verboseLabel": "Aggregate notional amount of derivative"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r193",
      "r195",
      "r198",
      "r200",
      "r202",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Maturity of derivative contract (up to)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r182",
      "r183",
      "r186",
      "r187",
      "r199",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as hedging instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r498",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r518",
      "r549",
      "r550",
      "r552",
      "r558",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Employee Stock Purchase Plan, Stock Options and Warrants"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r807",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution agreements"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r293",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r332",
      "r334",
      "r339",
      "r340",
      "r341",
      "r345",
      "r625",
      "r626",
      "r718",
      "r724",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic EPS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r293",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r334",
      "r339",
      "r340",
      "r341",
      "r345",
      "r625",
      "r626",
      "r718",
      "r724",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted EPS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r81",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings (Loss) Per Common Share (EPS)"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEps"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r932"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rates on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r302",
      "r565",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory federal rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount": {
     "auth_ref": [
      "r914"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount",
        "terseLabel": "Foreign withholding tax"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r231",
      "r248"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Employee-related Liabilities",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation cost not yet recognized, period of recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Excess tax benefit from the exercise of stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Manufacturing equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r129",
      "r254",
      "r286",
      "r287",
      "r288",
      "r315",
      "r316",
      "r317",
      "r320",
      "r328",
      "r330",
      "r348",
      "r398",
      "r478",
      "r554",
      "r555",
      "r556",
      "r586",
      "r587",
      "r624",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r659",
      "r687",
      "r729",
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r102",
      "r366",
      "r829"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r461",
      "r638",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value, Fair Value Disclosure"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r628",
      "r629",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Inputs, Liabilities, Quantitative Information"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r461",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r629",
      "r690",
      "r691",
      "r692",
      "r792",
      "r793",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r205",
      "r211",
      "r461",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r628",
      "r629",
      "r631",
      "r632",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r461",
      "r504",
      "r509",
      "r629",
      "r690",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r461",
      "r504",
      "r509",
      "r629",
      "r691",
      "r792",
      "r793",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r461",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r629",
      "r692",
      "r792",
      "r793",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r207",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r207",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "terseLabel": "Payment received on entire principal balance and all accrued interest"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Contingent consideration expense"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Contingent payments made"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r461",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r690",
      "r691",
      "r692",
      "r792",
      "r793",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r634",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Income [Extensible List]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r188",
      "r193",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLosses": {
     "auth_ref": [
      "r98",
      "r271",
      "r401",
      "r402",
      "r404",
      "r757",
      "r758",
      "r759",
      "r948"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Allowance for expected credit losses"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r266",
      "r423"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization",
        "terseLabel": "Intangibles, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r420",
      "r422",
      "r423",
      "r424",
      "r697",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r112",
      "r701"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r107",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r112",
      "r697"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Acquired intangible assets"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign currency contract assets, current and long-term"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "negatedTerseLabel": "Foreign currency contract liabilities, current and long-term"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r839",
      "r877",
      "r878"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedTerseLabel": "Loss on sale or abandonment of property and equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r610",
      "r839"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Loss (gain) on disposition of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r83",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r265",
      "r408",
      "r714",
      "r790",
      "r814",
      "r865",
      "r872"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "mmsi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill balance at end of period",
        "periodStartLabel": "Goodwill balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "verboseLabel": "Write-off of certain intangible assets and other long-term assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedLabel": "Effect of foreign exchange"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r410",
      "r417",
      "r790"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment losses"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r71",
      "r409",
      "r414",
      "r419",
      "r790"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r47",
      "r300",
      "r365",
      "r370",
      "r376",
      "r379",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r639",
      "r788",
      "r883"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r186",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.",
        "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset.",
        "label": "Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r839",
      "r876"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "verboseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r71",
      "r117",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment of Long-Lived Assets Held-for-use",
        "terseLabel": "Impairment of property and equipment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeApproachValuationTechniqueMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach converting future amounts to single current discounted amount.",
        "label": "Discounted Cash Flow"
       }
      }
     },
     "localname": "IncomeApproachValuationTechniqueMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r301",
      "r592"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r44",
      "r222",
      "r234",
      "r251",
      "r365",
      "r370",
      "r376",
      "r379",
      "r719",
      "r788"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r301",
      "r592"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesDomesticAndForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r807",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r427",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails",
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails",
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r302",
      "r566",
      "r573",
      "r580",
      "r588",
      "r594",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r303",
      "r329",
      "r330",
      "r363",
      "r564",
      "r589",
      "r595",
      "r725"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Total income tax expense (benefit)",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails",
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r285",
      "r560",
      "r561",
      "r573",
      "r574",
      "r579",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Tax effect of international items"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Computed federal income tax expense (benefit) at applicable statutory rate of 21%"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other - including the effect of graduated rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxExemptIncome": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount",
        "negatedTerseLabel": "Deferred compensation insurance assets"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxExemptIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "auth_ref": [
      "r914"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Amount",
        "terseLabel": "DOJ Settlement"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r230",
      "r249",
      "r833"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax refund receivables"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedLabel": "Income tax refund receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r838",
      "r936"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 25.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 23.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r341",
      "r517"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Effect of dilutive stock awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r219",
      "r236",
      "r289",
      "r359",
      "r663"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense.",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r782",
      "r840"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "terseLabel": "Net capitalized interest"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r295",
      "r297",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest (net of capitalized interest of $858, $480 and $813, respectively)"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.",
        "label": "Interest Rate Cash Flow Hedge Asset at Fair Value",
        "verboseLabel": "Interest rate contract asset, long-term"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.",
        "label": "Interest Rate Cash Flow Hedge Liability at Fair Value",
        "negatedLabel": "Interest rate contract liabilities, long-term"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureInventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r104",
      "r775"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r273",
      "r773",
      "r814"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureInventoriesDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r261",
      "r272",
      "r347",
      "r405",
      "r406",
      "r407",
      "r695",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r104",
      "r777"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r104",
      "r776"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r51",
      "r53"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r832"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in privately held companies"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r830"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land and land improvements"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to real estate held.",
        "label": "Land improvements"
       }
      }
     },
     "localname": "LandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r679",
      "r813"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term (up to)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letter of credit guarantees"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r22",
      "r300",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r608",
      "r611",
      "r612",
      "r639",
      "r787",
      "r883",
      "r940",
      "r941"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r14",
      "r229",
      "r245",
      "r814",
      "r842",
      "r862",
      "r931"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r24",
      "r260",
      "r300",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r608",
      "r611",
      "r612",
      "r639",
      "r814",
      "r883",
      "r940",
      "r941"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Liabilities related to unrecognized tax benefits"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "License agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Legal settlement"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Term Loan"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLiborSwapRateMember": {
     "auth_ref": [
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on single-currency, constant-notional interest rate swap that has its variable-rate leg referenced to London Interbank Offered Rate (LIBOR) with no additional spread on variable-rate leg.",
        "label": "LIBOR Swap Rate"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLiborSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived Assets by Geographic Area"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermAccountsNotesAndLoansReceivableNetNoncurrent": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as noncurrent. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Long-term notes receivable, net"
       }
      }
     },
     "localname": "LongTermAccountsNotesAndLoansReceivableNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r5",
      "r228",
      "r242",
      "r460",
      "r475",
      "r792",
      "r793"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-term Debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Less current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r126",
      "r307",
      "r465"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r126",
      "r307",
      "r465"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtFutureMinimumPaymentsOnLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r269"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Fixed interest rate percent"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.",
        "label": "Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate",
        "terseLabel": "Variable interest rate percent"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongtermDebtPercentageBearingFixedInterestAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-term Debt, Percentage Bearing Fixed Interest, Amount",
        "terseLabel": "Debt subject to fixed interest rate"
       }
      }
     },
     "localname": "LongtermDebtPercentageBearingFixedInterestAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtPercentageBearingVariableInterestAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.",
        "label": "Long-term Debt, Percentage Bearing Variable Interest, Amount",
        "terseLabel": "Debt subject to variable interest rate"
       }
      }
     },
     "localname": "LongtermDebtPercentageBearingVariableInterestAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r27",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Manufacturing equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketApproachValuationTechniqueMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities.",
        "label": "rTSR"
       }
      }
     },
     "localname": "MarketApproachValuationTechniqueMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash, cash equivalents, and restricted cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash, cash equivalents, and restricted cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r67",
      "r69",
      "r72"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash, cash equivalents, and restricted cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r45",
      "r72",
      "r235",
      "r250",
      "r258",
      "r280",
      "r283",
      "r288",
      "r300",
      "r319",
      "r323",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r338",
      "r365",
      "r370",
      "r376",
      "r379",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r626",
      "r639",
      "r788",
      "r883"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "New Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "auth_ref": [
      "r76",
      "r77",
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.",
        "label": "Proceeds from sale of business in other receivables"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not designated as hedging instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureDerivativesForwardNotionalContractsDetails",
      "http://www.merit.com/role/DisclosureDerivativesGainLossInConsolidatedStatementsOfIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Total other expense - net",
        "totalLabel": "Total other expense - net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Nontrade Receivables, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "NontradeReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOrganizationDetails",
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r365",
      "r370",
      "r376",
      "r379",
      "r788"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "netLabel": "Income (loss) from operations",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r934"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r933"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Impairment loss on operating lease asset"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesCalc2": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Short-term operating lease liabilities",
        "verboseLabel": "Short-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r672",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use operating lease assets",
        "verboseLabel": "ROU operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesScheduleOfConsolidatedBalanceSheetInformationDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r839"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-of-use operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r678",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r677",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesSupplementalDisclosureDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r0",
      "r80",
      "r89",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r267"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "mmsi_IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Total Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r35",
      "r38",
      "r648",
      "r649",
      "r651"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r35",
      "r39",
      "r648",
      "r650",
      "r658"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax",
        "negatedTerseLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r39",
      "r286"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r276"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "terseLabel": "Cash flow hedges",
        "verboseLabel": "Amount of Gain/(Loss) recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r276",
      "r279",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Amount of Gain/(Loss) reclassified from AOCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r42",
      "r129",
      "r281",
      "r284",
      "r291",
      "r652",
      "r657",
      "r659",
      "r716",
      "r722",
      "r835",
      "r836"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Total other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r175",
      "r176",
      "r178",
      "r281",
      "r284"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Net other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term obligations",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r5",
      "r228",
      "r242"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "verboseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesOtherLongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other assets (long-term)"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other Long-term Obligations"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense) - net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Contingent payments related to acquisitions",
        "terseLabel": "Payments related to the settlement of the contingent consideration liability, Financing activities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payments related to the settlement of the contingent consideration liability, Operating activities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Attorneys fees and expenses"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForMergerRelatedCosts": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the reporting period for charges associated with the mergers.",
        "label": "Payments for Merger Related Costs",
        "terseLabel": "Contingent payments related to acquisition"
       }
      }
     },
     "localname": "PaymentsForMergerRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r60",
      "r604"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Purchase consideration, upfront payment"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Cash paid in acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to acquire shares"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Intangible assets",
        "terseLabel": "Payments to acquire intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Payments to Acquire Notes Receivable",
        "negatedLabel": "Issuance of note receivable"
       }
      }
     },
     "localname": "PaymentsToAcquireNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r294",
      "r921",
      "r922",
      "r923"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsAssetPurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Productive Assets [Abstract]",
        "terseLabel": "Capital expenditures for:"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Property and equipment",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Stock-Settled Performance-Based Restricted Stock Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFinancialAssetsAndLiabilitiesCarriedAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r9",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r9",
      "r814"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock - 5,000 shares authorized as of December 31, 2022 and December 31, 2021; no shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r834"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesFairValueOfDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r774",
      "r789",
      "r864"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Cash received for settlement of note receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds (payments) from disposition of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from the sale of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r62",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received from stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r119",
      "r263"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r121",
      "r246",
      "r720",
      "r814"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Long-lived assets",
        "totalLabel": "Property and equipment - net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Property and equipment:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForLoanLossesExpensed": {
     "auth_ref": [
      "r403",
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.",
        "label": "Financing Receivable, Credit Loss, Expense (Reversal)",
        "terseLabel": "Provision for credit loss expense"
       }
      }
     },
     "localname": "ProvisionForLoanLossesExpensed",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsAllowanceForCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r858",
      "r859",
      "r860",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivables, Policy [Policy Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification from AOCI, Current Period, Tax [Abstract]",
        "terseLabel": "Reclassifications to:"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": {
     "auth_ref": [
      "r92",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r92",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r510",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r510",
      "r688",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 24.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.",
        "label": "Research and Development Asset Acquired Other than Through Business Combination, Written-off",
        "terseLabel": "Acquired in-process research and development",
        "verboseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r73",
      "r79",
      "r262"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash reported in prepaid expenses and other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage, classified as current.",
        "label": "Restricted Cash and Cash Equivalents, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r11",
      "r134",
      "r244",
      "r733",
      "r738",
      "r814"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r254",
      "r315",
      "r316",
      "r317",
      "r320",
      "r328",
      "r330",
      "r398",
      "r554",
      "r555",
      "r556",
      "r586",
      "r587",
      "r624",
      "r729",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r356",
      "r357",
      "r369",
      "r374",
      "r375",
      "r381",
      "r382",
      "r385",
      "r497",
      "r498",
      "r696"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails",
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r385",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesAmountOfGainLossRecognizedInOciAndIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r502",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Revenue Recognition/Shipping and Handling/Cost of Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r290",
      "r300",
      "r356",
      "r357",
      "r369",
      "r374",
      "r375",
      "r381",
      "r382",
      "r385",
      "r393",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r639",
      "r719",
      "r883"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtNarrativeDetails",
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtPrincipalBalancesUnderLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r676",
      "r813"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use operating lease assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesSupplementalCashFlowInformationDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r385",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Sales Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r162",
      "r163",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsNarrativeDetails",
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables",
      "http://www.merit.com/role/DisclosureAcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Components of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r27",
      "r130",
      "r131",
      "r132",
      "r133",
      "r217",
      "r218",
      "r220",
      "r237",
      "r792",
      "r794",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r189",
      "r195",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings (Loss) Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r143",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r107",
      "r111",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r107",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r790",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r2",
      "r15",
      "r16",
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureInventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevolvingCreditFacilityAndLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAcquisitionsAndOtherStrategicTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "auth_ref": [
      "r79",
      "r223",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r43",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsLongLivedAssetsByGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r90",
      "r91",
      "r93",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r90",
      "r91",
      "r93",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.",
        "label": "Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r514",
      "r516",
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated amortization expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r353",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r385",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r430",
      "r431",
      "r790",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAssetReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Asset Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Asset Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingAssetReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r365",
      "r368",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting and Foreign Operations"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)",
        "terseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock units granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Weighted average grant-date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance at December 31 (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Stock Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at December 31 (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid to settle liability for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid",
        "terseLabel": "Amount paid in connection with liability awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)",
        "terseLabel": "Vested (in shares)",
        "verboseLabel": "Restricted stock units vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected price volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected price volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited/expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited/expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted in period, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at December 31 (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at December 31 (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Ending vested and expected to vest, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Ending vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Ending vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsAllocationOfRecognizedPeriodCostsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Performance period 1"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Performance period 3"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Performance period 2"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r522",
      "r541",
      "r542",
      "r543",
      "r544",
      "r547",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "verboseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected option term / Performance Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsOptionGrantedFairValueCalculationAssumptionsDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsPsusFairValueCalculationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Ending vested and expected to vest, remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r257",
      "r353",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r385",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r428",
      "r430",
      "r431",
      "r790",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureRevenuesDisaggregationOfRevenueDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsAssetsDepreciationAmortizationAndCapitalExpendituresDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsNarrativeDetails",
      "http://www.merit.com/role/DisclosureSegmentReportingAndForeignOperationsOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r30",
      "r129",
      "r254",
      "r286",
      "r287",
      "r288",
      "r315",
      "r316",
      "r317",
      "r320",
      "r328",
      "r330",
      "r348",
      "r398",
      "r478",
      "r554",
      "r555",
      "r556",
      "r586",
      "r587",
      "r624",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r659",
      "r687",
      "r729",
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r348",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r9",
      "r10",
      "r129",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under Employee Stock Purchase Plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r9",
      "r10",
      "r129",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Shares issued from time-vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r9",
      "r10",
      "r129",
      "r134",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsStockOptionActivityDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r9",
      "r10",
      "r129",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r30",
      "r129",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r10",
      "r12",
      "r13",
      "r100",
      "r814",
      "r842",
      "r862",
      "r931"
     ],
     "calculation": {
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureAccumulatedOtherComprehensiveIncomeLossChangesInAociDetails",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedBalanceSheets",
      "http://www.merit.com/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r674",
      "r813"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease (income)"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureLeasesComponentsOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r153",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Income Tax Contingencies"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r319",
      "r320",
      "r321",
      "r322",
      "r331",
      "r390",
      "r391",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r554",
      "r555",
      "r556",
      "r584",
      "r585",
      "r586",
      "r587",
      "r601",
      "r602",
      "r603",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r661",
      "r662",
      "r666",
      "r667",
      "r668",
      "r669",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r698",
      "r699",
      "r700",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r924"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureFairValueMeasurementsNarrativeDetails",
      "http://www.merit.com/role/DisclosureGoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r559",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits, ending balance",
        "periodStartLabel": "Unrecognized tax benefits, opening balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Gross decreases in tax positions taken in a prior year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increases in tax positions taken in the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases in tax positions taken in a prior year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Lapse of applicable statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r86",
      "r87",
      "r88",
      "r349",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates in Preparing Financial Statements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase (Decrease) in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r845",
      "r846",
      "r847",
      "r848",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "Tax Valuation Allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r308",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "negatedPeriodEndLabel": "Balance at End of Year",
        "negatedPeriodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "negatedTerseLabel": "Additions Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Deduction"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/ScheduleScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "FCF"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsChangesInPsusAndRsusDetails",
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails",
      "http://www.merit.com/role/DisclosureFairValueMeasurementsFairValueInputsLiabilitiesQuantitativeInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureDerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEmployeeStockPurchasePlanStockOptionsAndWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r333",
      "r341"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Total potential shares outstanding (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r332",
      "r341"
     ],
     "calculation": {
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsBasicEpsDetails",
      "http://www.merit.com/role/DisclosureEarningsPerCommonShareEpsDilutedEpsDetails",
      "http://www.merit.com/role/StatementConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r818": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r819": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r821": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r822": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r823": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r824": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r825": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r826": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>134
<FILENAME>0000856982-23-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000856982-23-000011-xbrl.zip
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M&F7T('\L&\*"*I)D15I"66*>T+9X-L%3+*0#7]T6@<_7KQM869-+XD,%0S/
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M!.P%,Y=_":%1_TIZ;RNLM8M\^[U7?5W!KIWXXWACO+"_W+QH7RV#+S[+W"=
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MX:B\PH?AL28) &Z_55;CPK(?AM=[O3@G8QU'?!B#Z4\W()*,W45U/@[;M:D
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MY=C['1P$3O;F6)#Z"X8I2N.ES0L'9_LOSN^8+ (GBABP#?EOT3/GN%%/&ZI
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MQ5.^R3Q/XDU:-TOH*!0UJKG.CAO!P$KB&10W$V(&8"=0\ 1K8W?L!6P.>G
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M\9 !Q"+M'<CZUB-(5##4<>/9<Y3N(E%C8 :!N:TMP L0GXX\R15\#7SMS5[
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M3I"J"Q:VK=41O464()$?HSM$'GT794Z%6^3B=<8_616<_J>%D'/2@4#U3RA
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M2%YZ4J,?D)PRA32J>-1 JH^-]#^=+\ACE7&OKA;<;#!A*PC)#MH25.YW/$S
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M68L\@0;](>0/F/+4 #U 3#V2Q )M%'TF.-)>GD?=("0(G+PLC[#J/6!8S+C
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MSY>+TAVAQ*$[JT1 >.&^)B:\L@L$6U!!>"4.@,S!3 O2"20;0*,-')]/KSM
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M"%Z#:M"DL:LE6*#YB5791*%W>UR_>\!YIUKQ)Q#ON8OHKY@%DECEUX%-5 4
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M[;\XOV.R2*(84R9$9_L2]YP8D5YT_X21AU9^,97K='4D$5U=452 (XGS*_I
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M14G,)KLAV$O2FV**W4:W)PAW@S$#=+'KA2<H\''.^WRZ_"<A+Q0]( 1]6_!
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M_=$2:^4D ,1>?JY8>L?Z?N.$]VB[P\0A^P,* J:W&6A8W?[.DBRTH0P@"3F
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M?GI#3.P2*#Y#M,QU1;7.K0(C0%Q@[YPL5Y\Q]E@4]PZ11]]%T1TU*P1\D76
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MQX?OOO_ <8=]\M?CA'E4])_"T/M,?+_Z+N..^G-C8I\!R '%JZ$,Q;"L+RV
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MJF<!9(GS,E9.O3!Q?)NJ/C$!RA7(6I"U\R2(/4<Z/R[]H["+LC%PB&I6LO(
MJ+8E8$!J$7B(LA"UE:[R(%RK1]%C*<\>[4&K2'5:*;$XB,^J>+6\*NA$ +A#
M=S=&<WE156_ CF^@A'%&Z_JBF>6]5<;0>N#\A#81!Z2\THT4REY>?$O'DPL>
M 4^W+(XK"NKQM\"LD4=8CER1AM=.\/NIQ;+:S?$#=C%Y=M:^ZB)<L^OLD$1M
M@&8,.>TW*_1H$']@W,@YH9*5K4#:2<SP%#D>9H]D,H)V3B=JL)'%YI1ZJ@X<
MM3K.SLM5RK>L$XYZS<K#E<(/O2[@,5\/ZO%NS[L'-X'0%9YOWP3/=)L61J2#
M6U?[S,ZC:U1N=F:IPZS\N$[N@5U88@''>8?56ZF@)8^]C_#!(5Y^])B=JRP#
MCT-,XS,78V*S\_$N1FIV?AU*LT*%3@H-#!<9[^*F@NUMQ<RXK W'M(<ADU@I
M-T=V7"A'PKL\;UAB,TQ5:90G=N'2U9)YI[E"245I+<C@/>8(#57!1X* I^%O
M[3K&%8VL?ZYHTRVEM45_=EV)34[O5+UGY]F-9FC;$M1TG96O-VLP^#8A#U+
M,$_S1K-&YOITY[]) P_@ 0!?SY0Y@+IM'Q2=9X<$34;0..@[ZCDK'&A48)0#
M/RF5%K!%_RBV$$J#6L?G=Q?WSBN#(G[OT/GBXZCS['R^R0AZ%WARSUGY?*,"
M8UWB9<P6B+.#<N\_BBG$1=Y!D 3D]%%*$;&,-^ABI-.N<W1XA0%:W?VHW]R<
M727^\*[..,D%Y@"Y^=!&R+7-#^]@N;FTH<F@K:NM:BG,U>G5YM#R_=/N<X2
M!BW&W.]GO(!!P3C&*$[Z\ME_P()6QZH4;R"OP^A3D*77H0K=9RF]CN=W8R)
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MZ3)/&R6L6279X:S&.*BBXK)!+LNLS:O->59>#\=WF-7)<^*=^%Y9\\V0U(S
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M]X>*'Z@[%>#S@:%9J@]!.I$ C/&FFI@_&SE%[5-LOTBC"-O*H6O1)'7+S*F
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M$=^DP)!CO_(FR/K$-9$AI* #$5>PXG$%CPDKE[(E+GJ*G"!F\2FV @O894I
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M(8 A"<M X(4NS];/)1WF5^Z?UJ(,H*&+ABQ$A%U9'P02;.BRPLO$0J[\RO]
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M4I[J,Q>*1T_(MT:97&".C]^LA2UC:E%K["*[AN\&EJW=9X.">H:HA[?FOK/
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M=3\\*!\_=.T+U-&-3%#-Q:W1$?"*L)O\YI&]9P?!!D49'Q[9YI6<[)29J<]
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M=1H#VS%('XZZ+U =RD,WNSB+]R73.?,[ ,IO)FJM=8<'/H?7X/8V 5;7S ,
M;!NKMP>PVAI; =A%<:>Y4&,ME7+:&T_H)A?@&K!BM@ N.XLW5RQ$*]X)_6.J
MYVKS@&,</2M7HGH]@8->!_5E -/H!AB,NDC?]P7>JPC^8UPX6L0<$5@2[9R5
MG=NW*6Q0*+YEM.VZ]R]A]/>;X#X*70J)G=R[L>=<W+M=_5KW5G>;@WMK2#^
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MM6J$3F P5\_7=_/9^?1H#@S*50?7\M@7[>Q@]^Q0[3>^?EMMCD^A5%N:MD[
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M$&<!)A'HV)I+RV01CF@WUV>A+OTC_RP[A& ORJ)GNBH*O*7K1JGCQP\X2:.
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MU&]GY_1V SRZQTBOGZM3\4!!CC;EL&]>='&4KQ.F6_Q0$+&H##>4B3J24/<
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M73[<W?WI.\L^.[=5J%)NMDGHDH;F4RO6"(=M@'JK4J76]H/8 '#0UBVG]G8
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MWRI/AU:Y?-U%_"GL_@#2$'T?$-"D*8_@SP1QZ-AG5$>'P-?(-"?J/>/L*1V
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M/A47<OJ]/A\-<X/3]%U:$'VB(&:*YV5,\&F?U2\U7"=AAHD@GS#_?Y=AM:A
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M@GR6-:N^LU6*NGRE(M'#\X1 <["+BB 62_RAKTR0_^?H'.I]&=4*R-Z3"(<
MQN8L67["SSA.=U3H4N3VZ_4'7V-83^  .$)]$<X&= ,,3F.DGW 4RWBP0;]L
MN+B))'!,R*U_Q@G.@IBH?;;<1DF4%_2UQ&=<:IXKA_M8&L 'OI9)6C/Z& *
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MJ$#C@H96#]^&\+&ZRB'<-/=I"'=(;7P(NXP-?L;I.@MVFR@\4ET9)PSI!WQ
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M;^2'79H'\<]9NM^5>;]DT4#;L+R,/5[>[LI4756Q-6O,@2*3FX_0?F_ !F>
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M]$IYD&_059R^G%+BQ$V4X.L";WN3V.9C"]S';!G>0A)%S1.P7UM3W?;9/Y4
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M$[J; @XW^B36WOT_]-,;6;E(2]F#,^GY2,\0')U.S*D2 9CJ _)%3]S49 8
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M\\^-3#?D7^27U:_*CO_K_P-02P,$%     @ IX585CLF1C0>C@  :*H* !4
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M#_!EZ=#%.LGQC -4[K6X/E&9QQ_T^=.*8(![I( X9H4R: ,LT@B, 8DVO?]
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MU_3'6\!PJ21)%SF=%$=G-266-Z_E1Z20X7-,@CYRGG6U/].N4@J_-"F!:1%
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M;^^I%NZN3H+4+W(;2$]D62&A%H,&D\Z<H2U45*E)^ZI&YHF,$RWOO. '5C=
MZG&]9(9/L-$N+EDE'M)5>L40'SJ$8 G\:&L??@@BT=VOU-J&3V'UZAK2*5 M
M#%\<Z&-=4#H^".=!N$(?NHZ_XO4,G[XJ%67?HK 0;!D_/1'X),[I[5IHB7A:
M$YLJ+WB$2AZE18](V:._W$ZF?S5_V;@?AIJR)J0GTW?PO->D*R<BWATWT$MB
MX<M 0J65>\4GU"O.]0P?3>A1SIH[RVJ?R?AVM?:"#0#3&#]9E(3N$O4U'"V+
M?)$&.,8#[W<G#+?F%=Z!H29F2U[?B)0_RFL<X2K_*_LRJY68D_-ZS1\Q"M$
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MY^X8C6-,.7E95:=(59_MY8: B K"ILH)C>1$RSLO^($/(, 7!_H/:$A\#J[
M$W ])XK@'(+9=Q@OH5^\EDI&SCHK8Y?R!L --3I0$!:UY]&CI4HH@TO+T@;
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MD ^,^ TFO42[H-8W]%[0F\YR4MM^1B-G'BXKK(=EU%Z%98A.!T?K_I26\_J
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M?(:4DK8M>N#_ZH2_@_ARO0X#QUU6Y69.)7R9+: & ]TJ.3I(;1Y5I+_P;@+
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MW@/O [VK5H%3XA"ZPJ\!=C+PT)S6\^:"V8!CY]"D8Z5N?I9O,"C:[&^+P6S
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MX,AJ'-X]6OW;JD>!-T??EA'R2LEXGIT,[_1'LY/0TIM'G[:@UAA1A(16>H=
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MTK>:7FXY<_2N/PA.#SWY81/.L%FI9P^#J,0C_M>>0_R/_WYQL)YQ58T^O/X
M:,X8$.^YX;0)RFB[PG4OU^=!0!9;R>H(PQ4W/@N.L:&]+C\JC&T<?0ZVU/ P
MA<+<_Z7LI=BS,+%:P(F&G\2&>9D$V]6>$+AQ+.2%Z/PI0*EQN'WD<M4;Y]G!
MSHU^4H"K(#@R91!RL-G5'0@HCCX_H)Q<FQ8Z;4MAS4^#HWKPE3 !7!B[E/K<
M?9,!Z45ZB+TXUE8.G#1$J.(CNMU>Q0>]'-/SS&_(=BS391SOJC\V"G+:X3UP
MRKR&JF7E8?7E;F,&SZ:%XHBTY"[P[3A)1](RNO*5G"9W/6R7%#;K2HR >D"N
MXV="S S(_D3EGEEBHIR+VZPT VW+TL6#M4%V[.+O G*G+$ED$FU\^]K;H3 B
M<\#Z7Q&Z-9]1P[2J;W7@]##4O$L)<(Q8&<D3LQ:%T5K>.!-K+U U5N-E!$I8
MJXJB Q)JIP'_)FI>F-&&[O,/'@%%5P<\#[P[CW620DID#MU7>&0C!_F34>G:
ML_Y*YX_RZ,1X%+%2TBXCA9H+/+X\!688_FZ&) 8S6"%KX_FN_X0'&=PR.E-\
M)2=&7 ^C^QXPZ-,O)>0F)L>%BO-#Y7UV/.TXMVTGM:845'?QBO^Q]4/3_37P
MXVUV^ E/3,@S2:J/&$]?MEF6#U9VIV%>#D:INM;=-,+,R,BH;QE/R#3JE+)G
M;>!4J5$E=<G*!%7MU%7#.*LY%DLF-[)&8=4A>"W?H@L_)MGFMR30@;&*T?08
M.#\PY.H$-R 9N6>,<>3#($S?HVT<6!NSM)UY: 1U 8*[+!A-"'%4I;:?L6I]
M]JWCH3O?\2*N+U?ZTZ!XZ@?X@2,6M!G*/OVX[SH[>X_1/#T.[S\<FIDV/VD[
MB46;.-:3WI-SK$^>\R>RKVW,D[-V")(9,NF.D5U%"/\6/R-[GV&S..VZ/\'0
M./<<ZN63%#A;<(=S6JU0*[VZ[60<76&AK1\LYDZ@'6<%B<)Z](#>4YP[\Y5,
M[:[\H.V*E"L,M&<1]JS(V;%NR.Q5YU&+6QV"DG85H*1IX0<H6SN2*MN&.F?9
M*D%P8MF%,H#"*W(>*7A"07:D:>&'U)1RS#*S[#HA)"E#3[.L)*T<BNRZ/F\Q
M['G"QLCTGIQB[H,'""="KK/;I^DYW#;E*SU+K2=6?:^3:[Q[>"^[3Y!DEV)Q
M0["H)1-=XM'A&=N\(2E%=^@PP^BEAV?EZ7 A+E@Y[P4G]3ZR$Q*Q0OSDQIOI
M',7S-+E+[\$D097YURA%KK3'JRB=8)0^'Y]#%0*'L6TGXP;MX9543(-O,+IH
MWR\)(A0UL8K,BNH"D((5?9V3P>80[R0-T6IC>BOTO/4#,WC=(T-1FGA%L_[D
MP9:I\O-$5+E'(ITWW"*:[!J>G'4E@$L^SWH[D3432G]Z\7#[-L[V#@468;^6
ME%RX_*RRWFCEVE.S/SA\:.\>@?#:.U^ODYS0*'R('T/'=LP@W47RK>2O&/Y_
MDAB7W_'C))RUU;]UJ'/6J!($<]VJV=7[J'5EYL;'4V'R09\R]!6Y]I4?? ]I
M_I*K[*S#7DCE>E.S':=S ;J*PQX&E:N "MY99>U4_R'O[EICZ78HY*:S]D<0
M6Z'@^=RR2#1L>.NG8\R-;R8W12 GN4@"3\ZI$7-]J@*G2QU^5QIPN2S5;"\/
M[X:+8) ]".>NZ[^0DU=D4Q[;XR3K8-3)J4 -LQ0EX)4K4,U.]'BN3ZK>L9,0
M.-1E>X<OFW4]++1Y%^B[+Z[Q;I/F11.:;"E/S[H3Q"873N?M0*;O+';\A[UP
MJ_ACVKM*B/\6FU[D1,E-6=?>V@^>TVL+!"_F.N6_F*OT2]J:-T:I/6^,<HN,
M4I/F>[Q GT@CY1.>DM/0SH\8*;_:B_;*:K_^\/FH;OL2 F7\%X"5G$OB34B:
M;T8R%]KC8"2C30IU-0IA!>5P;5.CF9E1Z 7 :4*($#X^&99"931)X1%[T;T9
M(>:-!>T%1\$P@Z)VCCEM5IO)X)OCXBFW[Z$LI/XN\!^S$QOTA :MA:9#7@][
MH5P"1CF9<_':,AZWE@/',H"!N1MHP*72.E"WE@,GE6X\<?,]S/A-\>GW:(>\
M&&$YDZNSTI-2=&=.?WHLI(DY<T%[!Z&J&&#:>3I\=-(D<1FK-@WN/7J*7?+T
MZ_EV&_@[TRT:Q>*JI=!46>MBMLY;!N[)Q5249'O%;]56?\2M_GBT\YQV8+33
M2;WLLO0K&$K;\6S GF&#SB26WQS/>8Z?J?A7?H?' *-=50[:[=#*@OF3S4+Y
M]S&ST&J'TJ^J%A;^A9RG383L\QT>21D^J?&Y$;/";X_2<4+@F[<^$#+61)H?
M!L,7@ E"!Z2H*5^T*X&YZ$%[')P:!*C@X9%A)91]B31:.?D(,:U-W03FW@1?
MX1&PS""JSG,/JZ&P7GB]B]?B?[\Z>!P*K,WK#=HAE^'9^0J#8QV I^^!'#4K
M$X @UK!N#',X$*H#KH[$260HHC,4X%Q*%IQ'@#AACAZ,$G!)[\P3@WM.^\$Q
M+=>1W@R0#)[UVBKF9QCS,R": S!@#8FYI%QP&L/Y&E(PMR7]I(B^0TW'HF.V
MB.I:E@6EI&C3:JI"^ (]C N2)]C#FF<!2Q,P%[0*LK;K.!U".ULH>@CD _\A
MD.*5QMH/C/2E1OK6^9P'A).\][[KXC^]F $MP6^WRL"X*.&S&?+,U7E']IA/
M@T,8T.2IH)?$5.IJBP</GR3J#2( 9[_O G_GD/O*,0(D%4-J_^7/+?)":O)Q
M=J'C4E4'+)3>1J,A?8!FEZ4[8AVNSV)%YG5Q6I<>(_^RLDGUN67%SW%R.422
MD+4AJ1%!8+$A40XDN9QO.6)SZX]OWQW.K4LO-9*W&I77&NE[C5_(F_^"G\_>
M;CB><;Y<7(]@EMT XRV*ENN5^;.XS_G.#Y*>%$6!\QA'1'XKG^3GP9]WF"7<
MG*=K<KLH"B/*!%W96P9V<IPB9)W)%JFBVID_X<[\7H^74ZR2LJ_KC0]C@J8O
M&VF1E2W-DD&,\KUD68"^D<TL T8:TGBK2T$< )#<'[2>N??<^"PXKL6)J9/+
M;RF4C44.A3,WE+G+@^.;GZM._IQA-4#N\VM/\ "X,,/-%9Z'?T7V$[I+8.15
M $\M4]5!9]NAG*XMV;(*3"]T4Q+L_\5ITBM>$3 *3Y5[49.A!)?C+V_7#$-G
M[5A)XY<QGOYR^#;&_*Y/E>#DH6#Z)QT?QHJ;OMEA5RN9T\A^E8(3EW0ER!/;
M".:M74UCCF+]*IV,PH2&00680=$8I_N_:0FB%*T&G(X4#(-2,%%ZA_RIAN4T
MW_ICX[O8J#"=F%+7T X?'*MDV/PV+9YQ63[ =O;P\EA:S@5:^P$Z]+AA^N>5
M^;.Z3)U^>5(TU+&V*MR?]2>%5B0TF? HW1/7H$,&S!3,,%HT&7:J[&A4* ^=
MOF-ERU7%P\OPT/(K3 C9'E^D]ZO<);Z;=-/FS=NNU1R+]*3@0CTZ/T[/EZ7]
MHB]]I3^#DX@4+ILDPK!707YPG=0O_!!_UO[J^S8YBO" @IUCH?#!=VEQA/0"
MQR(/003ZSI):!B@-=UYF<2%9O"1%)P=/'8LX>,Q6/&497A&L\3F//&H,.&)_
MR?6K%9SB-,REN\)$31 A.,CYD>D"&.2D+4!-5T6<EDLZ3DT/359_&]0-,D,4
MWII!D-RG)!9U?%:/.D[KP_]35#F"0.*TT91/R,,?A[[Y%84A2FGZ@D(K<!*1
ML:)T&24J*O[T%JOXK9[^VXQXY;9502N WE0D/?6O3M:Z<K-GM]TNG5E+NV7N
MU<E(.YX-V#-L&&?F7A ,,-I5Y:#=CG%F[AT9"ZUV0(G8;/:V;>$(+:7 ,-=_
M3.ECL;($'0.K8[E-\I-X3XGYY);ZY9ID,&%LB;07'(E&V S3=")L^,26NIM0
MN$<>>C%= H: :$JECD@Q;59K]RR4JV1HZL_2'J4KO0?L\Q><F !Z&JX@<FV0
MY: ':X/LV$6)1PQ]U[') MN%Z9)#^P\;A*+.-X&?O7U/73+*7VOX:Z/\8B-[
MLY&\>F17?D->6SKP:.32A.7Z>Y@F8Z/M0[#*5'O!.]P+3J&N+XG;,87LA%6K
MBV1VV38?%^6'A4;+.9<ADH9QB*23_ 9=>-^7&S_U+;9(&L ALB_&^?B99O';
M.W*MM+,[R 1MG[5@N4[^0J)P1"=B)]2)V+YZ,A5+_FR0-\S3+8D]D1TPU/CL
M:'LAJ_U -^Y$ BKB1Y=8F<8;T((I*@^-B$F.ALL-ZEOI7$S-?"EU^2O[?43\
ML=LL:XEBZ!'P(=YNW22/C^GFB3AZ+$J<TA<E2B\RR)L,\JIY$4+1J)A?ALXU
M+.8/5Y7]7E]8FNBXR#1@_ /CP:K*\A%W$P_9U][E3RO)-GGE!V*?)SUJ')%(
M9%LYOFL(ZDY^_YNH;Z_=.M#LVTN/S Y=GD,_N(OW'I&D$^5ME'=<KKZ]FA'U
M;RFFC7]X8,) NJ,?>]$]_B2X0X'%NTS97LU4A,)KVEB]_S<SBH/D(J#ENGFT
M<T2OH#E[^Y$Z&.Q?1Q:]BA=FRU^E5\[#@_3 DV+ZDD^(O\3H%K.X>D'N#GWS
MO6C#CG,3KVY$7D"JB4<0QM2$S7^0&:Q>_)XBRFJI GL">_6GOV7:0YF&50E^
M)_MHC4 ]4U4*U39E(4\@M7+EQ[0D@Z+53%0I5-,4) V!+!1G)\.GD&JF*A2:
M:;).7\,7ROD:-U*26BIU35 R[?:-_ZYK7BQZ2F6"ZF )XDSZ5B<,07SW[&Q!
M"-F7/RW\Z/DS^5<7==#JFHI4A.S+=/-I]-$-"B(!04M Q(*,Y,_0%TGS,Q+Y
M?Z^=XOKS<\_^+39=9_U*+DJW$GD+KH]^2A)Z%.<P2O][?8W_5;S*,#W;^%&\
MS#"SM^E:&FTYT\R&B+),REMH@#/9+107R]E-64&$RX/IX&*LY>>Z^]LZ_HVU
M/0;Y3:LD-]\]9B[8H7"%W\RXVH6O,!B5R.&\/GCT@ '*Q09L$YB7L/ 4K=I^
MBFT_T7O6LP=EHOPS$(#"?O,MR^SKO1A%1L8V@Z ZU\)V0^&XCL%R_24;I$BV
M3A(]QJ9<H(8I*Z O#$ISQ4B:'=Y0,L9TJ@.,&&2/__+0&/^VZ3=_ET1'7GOL
MKG;ONRYVG2]F0,N3W:&F42J,K8BZWY&%R]2_6;(,$)UFJUE9,'J2S;WHW)6%
M1U\=5=<Z[VHW*X$2U6)C!D]X?/?)Z2C\=_:)S$YUS:+K@,]DCA.V3%"1'5OD
MUVXK,?OBL\CX(!E_;)*.0?+=<6J)"4C?X*6F87*?_YVQ<?3WOZ749GLG__@_
M4$L#!!0    ( *>%6%:@" WX1,0$ (H@-@ 5    ;6US:2TR,#(R,3(S,7@Q
M,&LN:'1M[+U9EZI(%C_Z?C_%N:?7O?URJ0)4U-/=]5^*.((HB-,+"R$49%(F
MQ4]_P533S-1,,],A-*G5795*&,3>^[?'F/[[?Y:F\2L CJO9UO_^C?V%_OL7
ML&1;T:S)__XM=,I([M__YY__ZU?TS_I?OW[]]_]&D%]:O\C1OQ1;]DU@>;]D
M!T@>4'XM-$_]\ZMCSV:2]8L!CJ,9QJ^BHRD3L/D)AOZ%_X7^E?Z%(/_L=UB4
MW.CWMO5GV^XO['43<O.2N!'^-Y[^&T?QU*_<GTS^#Y[^U6)>MW_JB-9&CN2$
M6Q+_1#VC?^72:.8O/)LG\H=_Q ,GT&3PJVZ/?M5*?WX!D,WD9&6,$-D<BJ1S
M:07)IS$4D?/9=#:'86.<2.WU%/WGOZH7\37BK>7^\5UD(DFS__U6/6_VY^^_
MQY([^LMV)G]O'L2$X+\WC0W-TG<M%XO%7\N18ZQ;XRB:^CM^/(IXM6TNV[[E
M.>'N%^O6+I#_FMC!WYN'+_HW35=[T;\)',W[2[;-=3,,3V';ILM7+1>I[3BP
MO_L,S<LJ,"5$LUQ/LN3=B.(1*-[+ 6U^EOG[Z>&VJ;;TD&BL+UZR';MF1:2"
M6!I_>XYDN6/;,24ODF#4$99!T!SR/%#7\=XR-_KR!>':\AA;L=3>V[;-'3 ^
M*@;B[^CI/KW:.Q)[S1\%:(>E%3UX.6#73N-8]KVNGUIL?G!(5E@^G_][&6-Q
M-]PW 'O1-'[Z+/\OB#^2Z>$1?R10',&)%QC2#F*(>,*0]ON?_ZI 4O[YKPD\
MZ9=L6UYDB/[WVP-+[^\G>N,?(V#N:\'_?F^>(UXXBT;Z]S__]33/ /_\]^_M
M?Y_Z&ME*^,]_%2WXY7JA ?[WVY2<B68AGCW[DT)GWG^BM_X=/7[11M'<F2&%
M?RS; G$#;?DG[@TX3W]JB@*L]9]1@[(CR3'-OWQ+\[@88D+TA\A'+%0D1Q$%
MOB1.6UAQ7)8((,R]LC;@4[- Z!0BUKA_+,V(2'3\B(8U1<NG/@JNR(Y%#!=3
MF!@C2"SEQK,T@2H.VJMCXI1OMP=:J?W[ER69T8 W9N</:9NFYL4&W"U8"AEU
M&!G]R/AKP/W]2U/^][NZ'KLX'3:(\IB@" K/ Y0AB]E605S$K'A)U%6)Q$2K
MWB,Z>= 4J1ZJE6:Z-NC,Z2\3V<Z83&>80O*4EN9IQ5JE7'Y8.$YDTX\-I_QB
MB"7?62-:Q,3-&#OV_H@W8Q)+T2^#J&4 :I'V.&L?RFFN7EAJ[JY1V7: -K&H
MI:Q*T8BCCXN(>0PP1\#9-:H")<+GI 3<J.GZW2_Z:-J6LGD$MC^5B#G!\*5Y
M#\7UEI0VZI5*BGG#MN<A5B3-HFW7C<3G@7BD[+@6!0@F8)V(MS,'J,!RUZ3$
M7U)++_XX,@!EQ1Q:C^D%HY$R42]$^L]0"*$%;=HDZ[-)^_<_[SG'?[&>"IR(
M&GNV[M*:;-\VB]X&MC+:R.0S(L)?B B'0T3CWIPQVJ8UU7W07+**6F"4SN1Z
M(K*GG#0DQGH!)?(8CG'IQLS+%F 1T4#-YQLX5YX+I%(7<(_"J[/"8LN=R(O^
MH2(E]T(R8H0C&;6(O\L&")\H[,CB"G2;N=HTKZ ^(^6%05!T>6HAXB+V^Q\T
M^B>7(?(Y_*H#+FT"Z;+FRI+1BMY@*^7H.W<W:*4]IC"FD H$DZWV)@VLFDG9
M$S$5#[H\N.I@"]%(E?5H#6FR&^#8&Z[<J1?,4'Z%5Q5016<5JB"FXP&.)>,B
M2EJ6-*<K&3XHAK0FC30CEKHAN>Y:P^)(5]P9?"_ZR]64#=PWBD9/FGZE4Y(X
MBL^TTPUU&2#EX(TMW+V& [(?Y336),I6-%>P[)$;)0I2I$DU:^9'8X^(D*-1
MK%^Q&]%1[7Q61%ISO1<:.';ZH"PY%4T@\WV)$'.M8A"[W'?C]G\5?3<*L5PW
M4OJ1]F1KCM!?<)S88JW=XI$F16"!L>9]0VSH"[&AXF#!X_V)SS;UD*)K.7PJ
M-,O=-]RNF;.(WUL^13'#).90P75!I!Y1'!$Q*P#*N4P=QY5'/D/4>FB/T4AU
MS*<Z*V7R@:E;#^9YG*0:18G _0:G7@<*HQ!#I?PJS0IX-H5,S(Z+ OV- [@N
MIX1>P1ZCH>0(1+-#526FN<CR'SF%LW/J<^;J-IR:U0.V9> <1X5CI>/V5TJQ
M.+@ZIK[J-CDPB:Q19!Z\9O3D!6$MULJ-RZ4IHP-+0%>L$-@U-"*,H;A:YQ=#
ME6ID@?[%#_@.Q?"_:DWRR/ _2A#<B'C@BG5A+KMV.*BAC<BL8UYCF6]3A2]F
M!0J0-3/R0__[C:0.Y0BVQ7NVK//K5]=<UP?*"]JI91E3(MD(.MOJS+-YKA;B
M\\@B9XA,-HX:OIH,?9W6XVG>IVAE?2_.X.."WTL4YP2G-D2G)2%TQPO<Y_)6
MIAT3G$VAQ#L$'\+F%Q-4#D1 U.0H,"8E5XW3M^@_5)S12\;:<T7>./KO6G7V
ME#=2:2GRPU$@9;M:/+1W'&VJ,R!8O@U*PKQ=SDT=B?>T_.(#76TY(-)391/:
M1N-:Q[[K86S'] G%?0-AUUGCXXF<"K GCC13M2@P7(<UFZ*>2#;%##+R9OIT
MO!0:M-ZNBK54O5!_XR:NP,4%56\4JU(YK?LB30_+A(T$_$<YW7FYN#-_:3&%
M[NS?\X=MS+CNOR!'Y#]1]1PJQGR*$CK*4FPW=",VN#1-ODKFCL5*82><@0^C
MSI84KGEK@4VWLQ0^ B+?"_7*"O= P_+Z,KNSR7%7?][OZBE5>)F\F8-E56/R
M90'0JQQ!276M5(F,= L_9YJP9<@VY#S(4;Y3:D4VQI1DX'LQ@%N.K?BRY]*:
MJ3VGNX-)"E0,#5]1O>RHD&-YTC4&A=OZ<#*GU,U6]+6@F6W'SX'LG+)N'A=N
MN1ZCC1WO!?'//*<U>:U.$P<\/8D:!9(KOV1Y=9[257'5[NI^=T)X:K&;)IP;
MATW=>2V?R@9\5@C#7(8M+]J^B%X]P+R'I&7J&"(6YDR!PHU%AFWX53%#?.2T
M+LZI<YH$66;G4:!2J EL?4G8@R7H]+(W3H!"-V5/.37+HQ7.KPU5Q*5+_:N;
MA"]QG9:B7F*OH\0LY_\J_,7_M>$TMIB!_JB&RA20>6>ZJH\0&MP8WQ.Y59B/
M5N,%RM9PIE^2VE5>N;DE.)OQK0R5,E$>,9Q.U!BN-0MF:6ER8W!7,P,TY^>&
MKB U4[JFTQK'%:%A^;O@7H>-KSCTU-+9L5R?CYV%7>C7*6",M4[ E0N+U(U#
MC/X8[52[OM_7>[6.R3)%NZI5/PJ:K\;RFTZ +,0%TIPO:Y9NEH4Y,Q;[,G/-
M.2IJ5"7-Z<"8"I6BF%,:EHV,76CFJ.+\D(OYO>9C_(F)T&GZYBO&%V)A[!*3
M[;>4.3/L$(!U"8"=[57#MRU:AF3%M9\]NV9;DPYPS(BBB+D1(^,F.(KE-K]<
M%<HK+[OTJI2TJOA95T.P0>.-15O7&]8+?6*A1$QY78HNAL]--@G.FH;UO[I1
M>A8Q]2GCP5Z(2S4L.ATT<[Q0R4D@3<TM-*_'*4_J$BG/8;9&XUJO:(@X]%17
M><74S?!?_.8(0];]1TR15?"<*FJADNE7J-D")9%14)PN5S9X6^B\&(N7E4D=
M][EZ1?=7NCQ3S:XPZ$?^H87=.XL["WO3CYAV>*\0A"**:YJW; L=/,A>C\4K
M3)2$0B;0=)]>5JH#VA GQ?:E$O>7+'ZJ6DBNR@//,Z)Q7QC-S5*_Y1/$5-*1
M(1,.7$E7Z-$; W\Q5BNY!6*FP:)$^8Y'*5Y:HT=Z^SIHO@ZKGU$MMUKU!0/:
M+0'4!F."'O6$BG0]V^SEY&*3'QE-"JGUFA6 N1,,?Q?59ZR8GQKL?$U"*[T\
M-+HY9T*14R>_5'1^56\MWB^_?YG/<<'6"Y]C,7<=;G2BN.O)A[M1\#4&<991
MLPY4!:-0IU#N#3,"5:GE:;G+%[UE)G*1GRKCGUJ>^O:\O)-RA\O^$BF@9$TL
MSH2T4%"T-^'Z#>;E.S.K/^4F2D4G\2:>RD\X'6G>V[P\-%7%.*Q<IU3KK*8*
M#"4"L>""<X7QK?XPS; ]IRAH96W9LK&!TU1NGF'% 3L93^( 9R8Y7O@RU&Y&
M2&G9FN5MBC41K=M236E.CS@,&8L"SZ2J\TX5$YG6.Z6:2[,WHTH9>]2L9"E?
M7[&NR4\$Q#A30>SOETMG'3 &#H@,L/O/?^,ERG_<]>KCB-^_UDN6_\0+>__W
MV]6BY"9>BKS^3EVOX8ZYBFQ5\:^EJ\1K.E_V\?2Z_7>L/[JV[ZP_K9=X_]G(
M>,V!4UU_;)Z>%-LP[$7L0>)5J!R([1-PWT2X;YNSXU(\+ <H'6GY5-K8H '4
MV"E-DJ*L-^I*=HIXTF09E\LWHP7KR?SMI\AZ1)_'&G!^K:D&!]?<D[7&RR5P
MKW^\[<X%DUAX3Q^5Z&7+F:')FO<TM%^*9L;0L:UG5)[&B-__'&]_E!/__?O@
M*/[9#G\WV+\/<6:V]I4[PKQ((TN1>OP3BQ%!L>A_NWYVSW8L5IZ;8CB2PIY?
M\?1D^WG[DK]?(.F*P-JUBBP &;%0\V+/MT%21UZ@SB)86 +9G$P6P1)1._;#
M(.D]TA\:.L?<_ 5M4N 7\9S$%;.HF2VU=0I-2TNG_2A(@L$F8:<#"X,<6._:
MI-!LM45*$%R]UUST?9>3$;L\>10DW<0FP0"=8PGX)6W2*"_:^)Q-"6&IWBU3
M8G=0;SR,=X/!)J&G PN%'%COVJ0ID>[E%WB]K$O-(5EP<RW#J#^,=[N)3;H%
M=-XL1KV"$2KQF./E, L7?)]J\X4!G9,7#P.=&QFAIZW'WH$@>OOD=N!XUY#T
M.TBI9M+%'DK2\XY7R#16UOQAT' M0W(%\5\E:1I3G"5C0[*M]Q!/:(3\;#+D
M'B;4O;UMP& #Q_O%F%Y[F$>%ODPUC+929;4>X=0?!@TWL V7$O]5DI=BUO5Q
M1N(( >3-E5U*\=TAOW@4--S>-J"P@>-=V]!P]9S=8E(SO=>WS/HL)77'TX=)
M96]@&RXD?BQ_#=N@+*Q FV;F*BH!0=*+M=&"23T,&FYN&[ \;.!XUS;D,DZ[
M@:29#$7*E*OE]8:U[#X,&JYO&RXE_KV4<C</_[2V)YZ#MZUXY<<+J7/ DS0+
M*)3D6)HUV<I[PG>-%-6:-:C&H-/,,:T%T=&AC1/?)?59S(=IO;.D\;,"+LBR
M;_I&O/P]7KSG&D^*H4Q]=WUNU4;@HW83K?'$HB00I&&YJI#%)/[>!7X:[3\'
M .M%?0<6XVP#P$*FCK?L@$21;AM')Q4KETM#6SCZ/ ;>)__GP&"[-+$)O'@=
M:CER?O$N&M"2G&>#@"KLD@E6J88."HA(M 2BQ]6@S0T_#X93F'!GD,#.X_O3
MZJS5[N61B:XY[2Q;=4UL(4$;Z\'H^R]?$SRK[R=R^3J>X3E; .4V8H[$97O%
M/)#=O[[OAQ  '_A^J9FN28R*+G13ZG6FK73>'U /A(&;^'X(87"2[V\VRWTO
MV\(QH9=N27,QG:';JP=*!F[H^R\_7_ MW^]5:L$ Z4U4'8A49T3.G:YC)+[_
M$P*^?,W_K+Z_'XC3*3,D,,&?IG5GR12-2N6!5/WZOA]" 'S@^U,2ITD,%2[U
M7G'N\75*=YS\ V'@)KX?0AB<Y/O-5"9=::WJO [<2;DME2EQP=R[!X##]U]N
M/G"]Z>^)P@C=U'@,Y,WA?>RXH-BSW;$H)S5\[2-V4-H]B+<#-\$B8FN\TS#>
MF^W85O2G_+2W]#4 -XVV>ZQ=8:9$HHA&3F"I5^_XWJQ%(Z<V1P7$%/!E12&]
M<HJC6M#5K"(9_#E%6+__.:GEJ5[M9)WZE)A?Z-C'<O[^Z"",^2XXEWO_BHWV
MEFK>YR@.]8D5SJZT5D CT 47B4[>D5*<Q5=4$#U(.?E!0PBE[IS0F%XIU[WW
M@M>#6+V+9+KX<%#L#&N8)E1&98*8"$P]!>_RMCO(=&$$P >9;A.W9M[27<Q1
M@DIE>P,T,MGTO2O]C3-=&&%P4J9;<DOUTDK"5(IML"1%-8N4+$.7+=QCIGN%
MU6V?/T6R4 -#C%Z&@H (:'J&CW3+34-K__?I^_W/^JS^#PB\L\4*[XGRQ2&B
M+=^15<E=4[L1959M-TI&N5BAD()8;PBY52[7@"ZG>$>4'Q (NR@O>X3LL0/Q
M>L6RWYSE$9=B);*.%I;9 80KTN/\<$?[4[KX@O@SY(+[7'NV_$?8=DXL07<(
MS0G DY;?!EYJ/,KU:,.)+^<6B0#'4O/Q!+I X1#P]HE/@'?!0VHN8_$J2Q8/
M[&*P0!NR4C*[]1S;R$'GYWZ,Q8/AB)L3@'<&BR>AW+1B% 4@2&G-T<H]MJ+
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M(_[15UM>',K/#$[ ?&$PL]86REJH9/H5:K9 2604%*?+E0T*B57^'I1W[$V
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M?WS!EN]'@R?P\SD>>(>A%[,J,-RT?!6P2M8AG#IX:9'3,O.RK@$_G,WZQ=F
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M@DGW!<J*!EM0!?.4!6%8"]<1FE,/ 01JG"N<XN23 *9&,3N"?<8HVUX%*0G
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MFV5)T,LSAD?8M")C*>4$>M3)#DDI$/Z>&+IAGPY+@CR<S%?L>$_TAD\\ 'P
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M=07NR!ALP0D00,".449==AEIK0S+081  KB>!.DE'V^.4A<2?Y1H&LX)*-Z
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M7I$MSB6*AQ8_K/TA;6.X9\6!6"R(V- &!X+V?^)[QH,BK:A2[9&O 1<'/C1
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M",Z/@V&+<YZ>_7YB[N#0.NU[3E2ZZ23)4#$?&@Q.H-L$&2G)9$$4C,@:&$0
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M8N1XH-QAA&6:][ X1J8,OF@YG#J8%-;CV.W2AJ(<8 "G=,?C$#T]I+M1^%D
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M+_5.RA.J&2M#M/ ::;' RB>P>T"L7AZ$"L H\.$:\0@^L_!E9UISV V5HR5
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M1G!,A,]$*5!JJQ$LI3- TD>3*H\SD-Y0?7B*WBC804+6RP'+$>TIXQ2%,V>
MU2W&,<G,<*Q]6$;D!=2O N3TB !1$D,</4W%B*K>.+(T'NSN"SIS,^&.9(V\
M8HHMUK>Y"OP<H91@ A="UV_!1$U#"GTP\>+T,10#R;J^HL,XHW7D"5)1U"^
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M0?ZGM;[36', #$-2._^GM;;=:)O/^.;_M%IKYCMM&;H?PD E[CD8&3BM!H:
MTI#(<D@GYV,H![%_9!:,KKB]UR+X@B7&<!Q*M2K D-3HN=@T\('(V6@VS20R
M40KG#^GBU>'&I/A(Y3E (0 WC6?-5*>H(1H"A47L%.&A)>5<)5=)$*/8Y]0Z
M)G=*B) 0HAIDP)+D2A@M*9VE*$3:M@IZEA9-4K26@ K;Y-;<(Q!^6#K0WC<E
M=\TR#]3'Z#$MJ:HRW%Y -<5&[B45Z,ZL33]%;]I6Y4VKO&G?ZTTKY?IM-3=6
MA]._!E4IBJ2NS,07>;WNIU=VG0#%2/*Q"B J:%%S;:.D5;$!B(Y8&QA)8RA<
MU]R,.%1AK#F5]<?7=-OF'&WN"(H!!:P^(GUR0_1'2*)&A>U 37>]PG*4L5SM
M19OTBF,!*P5I% 2<H2 RAU:)@#JZ&9L4>J+Z6,.##6$!2!I 7V</%8O@)P&3
M5R"10J]*IJV%<0^]CIRLJ.0EHX_J1BVVI5;)(RVZQ-2=*+\ W*T<D)D$:E5N
MPKD3;.)-I;HWHFGBI*PDL!'4QZU'!:NM,@=;O@X?8'^*$@SJMS0\F8&ET4*&
MNE-[!MLD/<[).D[>C[)=FGL] CQCRC$-9I1PV><)U5TW8[N>!2:68=C8:7$
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M1CN"P[#;3NG]VUPT'[_43=Q.8]=')?AFQZ@L,,IP6W.ZT\AS]O_6;;6PZ=H
MFZXY!Q@1!X >A_I'BFWRT![_^D_YY9SSWVZNK36W5^?\=Y5AUS@K;B%,4*@,
M3 G"-<5WG8EK%^26\\P%(>T0<38"H#Z@\%EY,@"7+J"(6!G!^L@. 'Y<X<BN
M7:W<P 45*$^MZ*=Q(G,A2_EE3 (P;RK@,F:4!!=@R8$OLN<%AU%BKV0R*V$
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M,;<D]=HYF8'L/JFC8<JM&N?LO.PWI>*GPSSSL>CWW +&Q2Q'-CAZ5OU5DW_
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MOR(0LS4HWC_3(6)'RDI%3]WB/$^TR$-BV,?T>FX7N>*GM2/\P>'%!SW#3%Z
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MPK,]B2<%=L>#>U0+ND](I@O95+9;"-[&.)Z\XI6AQHSQ8$")Z5;S9PDH3FI
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M"5!@OGG7J=KS>DIGOG*3T!=ZD^R6B$YU\:)EJ+:B+2G]V3KCJ\SE2@U(^M-
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M>FW9+3.IJT%RW]QJ9[-0B!K-KLL,\#1;H*#Q@1LLVI]K7GL8)8KN-'2AP;V
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M@8IE[/CNKJNS4 ,GQA .'#N3TP!UH!FCOQ#]#!B U$&6])M1/=@UHO_\/=^
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M"IB@+W>S<_AR>]"L]>+&V"LR![KQ)R?8DS(YF+J@X,%05LZC4^$]=%DX-,A
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M,$Z0J+[_=[QC4\Q>[OJ^*G'M9]')+1.F"$8<1RYWAUNWRZP\ZX+43@18Y%:
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MS1_.SYRR N'F!*/XP3T.1H=A76$P+KJP#E%SCD4?E<STAL, \V,<G.#@CE;
M]&T^VIXCV<;DD)XS?28OZ7J47']E6MW?T:'RXG3V4TE%^$V<V586PN/SLHI#
MH"'D[*]MW#3%[(7RCV)-Q.,KK&9/N2T]GA'/R2*$+IJ_[I0IBOV%Z0EIZ;O
MCRR3G6"T9,^K>85#^)Q?)YH2-%X)KXD<2'8.R#O&0WT5G-I2?'OZ/7W**'/M
M;YI\+AP&#@G/%O?P\$VVA=;[:S#$@TYESF[JW(DH)<T>G5=Y<X&E*6&O$D-
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M(YBN;.U[!WSK"2HF GA4,D:I<E%Y@Z0UZ;%M1MQO3X%M,$M"""&)*C+V7+S
MI@228G)Q9*#)5!*CLY]6<'2U8?WQTJU1],9C\=? W:0 !#$?!8OZU2U-"V5
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M@0E_D*,,$NPFL?[QV\E#&,NCJP&LJW[>80]2U+HCP&>Y#2.LES;O\:.@UW4
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M165>(CZ3W;!40K]5,,9V%2U"A4OHAQ)W+Y"?H3T5C\]]:8AAGLG%7!<HH:.
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M$-MWG"Y\QMY1N#FX!S J 0CJW\'Z?3,:(>M<:[0>4J+>((Q+W&"B?;?Y>^$
M_'"\"'T))X7*UQF# ,WGH.N0V//!)D4,'#6#S'!&^R00']9!\V"#!ZU&"P$-
M;Z&PY/4."3J>'=]K>+<9W2MAT*K0V&H$JSA*$N=+'$V#]/[1JV[&&&<TMSG-
MS0')Y1>PE("<I8R KSM=.#L7_].2UP0H";V2T]P8WTG#.[F$4H7H5I<BO&;9
M:V//W6"F.!M^ SR7)TEW \BUK R7X-<P<J)QW03"?"^F/O FB7X$U/)G8XF@
M)27M-"8Z@"DD".$+_]\IF6XY\-Y%9*'(:40K N%+X15^/*%A)2 7 8&"G/[E
M6MP,0@^QA$DHP'!I\&\)V/UK#I:J6#$A'#2,X"9U(FRO*)(Q@9+)'[HX' *3
M$0 7[@%8O0KPLG!G%LZM[)7JR+RR(VO>^LC,7BS9  V==A6DYXX__M<B8'4/
MI.#S3LO<?=I"MN<&EIFY8Q6,X O7/JS,T007\.<E0</3ETM(B/??S+WL#&Y(
M34IY. _F<X*)A1=DJ'/EF59%8*V4LI]A,^!X80UO>8L> "FP\FZZ$P&T.3MS
MG3_$3,02%?!H D9>D*0QV3/6=J'K B^%1/WJS/J5G_W5 ;I#6\U7)W_\IW\Q
M?W5$?WJO7B@"36S[H)>#4F\UFG!]W(."\;P]:#3SJ.V#6[VK3-U0BS6+7'-E
MHBW2&M(,VAZJU#A=,(^&]W%E5H76\S= <=?N>O*WPH?7EP-9\CR0/\O,-/1'
M47RHOI>",0.NW3.N9_-+7$XB4.\FZ,[<K8+V5KQ04A[/#JX8N-'#*%G$2MI+
M 0W<!4>I9VB3&0T32/!/#38.XGDB+H*Q@[B/P6S!RP)Y0,)A':3O1OBS8%O$
MT2_8O!2(#'9 KQ^7C:^-?;2@1 SR@>]7UG=@>]"DF>BK$R8&%HXXBU+<'6<L
MXM1'2$_X9:) @B6V\(F8I^P1)X>XUX>KBR#/%S%<KGC]G<6"+E+>8W0>P*0^
MB@G!HW\3X_,92-$SA#3]DH(V^2&=-+3,RCZM)!>Z(!QTHJ4D.Z:9G9$RN>6U
MNJTA;,IZ'SXPZQ4872B9)^1I,8()]UW=XP%NUVS&J*Z\&+(JU38!M8@T#7FM
M9%K23IS#I2?0=(N#2Q;(H7^5+$#%F@8A[SF9FYDPS9N 2<@YACU.M2FH/X;A
MOZ<^Z$%G<"Z@6WZ$T5.7#N3X/!!3N"K$>$%O^SR=!G" ]I?OX/AG0/BA^I((
M6YVR/%B.'U10M[@/H>7=06@UEPNM4BF5]^"@!FQ^#;^2$@9F=!$DB880'D6S
M16)3HX7V:V/\NI)2@=L3\I< ?\Y!Z8@)RAO_ Y3!0TX7<1@MSLY56 DNSC<L
M_-:%O6 9Z^61,))EJ6@":ELIF<SQ/IA06K\PVKSGWJ"16T>,^PQS@^7,DBDZ
MN6DM#-5LWRV%"POV )V/]$^8ZIE(W#*!@XM[AY.1[BVD]#_BZ J^@OT]B_V+
M>P .WT=U^JM(@'J!SW#OW\"-'T9S.N^B#AW;CTZL1]4E])4(\$U1;]Y I00M
M!#1*_%\:O@?J]#H@<J<,4COO<Y%S*M/A07%XWLD&&NBU: ;WNY:A? O=+NM8
M?MX'33EO=Q=]\86Y5D:I+)'/Q(D(D:YD0T[Q/!?^A%S%#><'R)$PB6SU23L"
M0,(&$P$:07P92)!XF\7I3=+UH<4]?D;J(JJ$I!W!90]OT"[IX&+.Z@6+%: T
M_/3CFZ_J-GB[B*.Y@!F#-A'-&GL9[FW5X=XZW%NY<._F%]X:R>RU+4<D.EC:
M& 8L"---4H]RPKC;+\KV5;\OB9HND]2K,Z!VJSH;"7K?"G(V&+=2_FL)GME)
MI;*J;0:5#6.:R0:F_8%1%5$'_!'[\R2:7#M'_W".QF.,=[Q%4\X?7X,)N9A<
MO[!]%7H2UO[>\"Y1:F5UXGB[T2L_B#-,(-.&/JF1*_T/RC1YMQ%'VXZ(G,WD
M9;P2F!NQPC,!\S$V#D4W@( ".'(\>_93T&P2 ;0+<A0.;ASZ0$8^#Z)\%/!3
M/4LPI(8W\#@0!:YR.MS$\W$LD%W#C ?D& X;OI\%OG. STAU_9C6<<3K^ !K
M.Z.#-,ZC;^>!+2:0K^#%:,ZUNO866^Z<G!S"S8<'G@\LB0U_P\8LV+,(!S<6
M8I*LI(RJ.5;62Z$-:+B)G@&YKN6+7^(NL'QP _N:7.F$\^V#RAGV)?0ET-.J
M?'1_PTT:FQA)V<Q+Y_KF\]\40=URM7P)DE,#A,LELZ,<UNN_PAOG$A-_S[2
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MT:78/9H4ZCMXSW2!;K*I<*VZ>KCJQ*6?M9>J@V,)9YFB!QCEC#IA(V8(1]H
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M_&?A#G?SHD9+?HI$L2?0^/LR?E+M%]='9,M.WD^V&E LCUCG1_(BF^R'T)<
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M,E"K4WYY_0!J.II,I ->.E?HB2U?97?ITZG=.K9SR6I>6D+KAJ2EK6WD/5(
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M<#8&(?4K$-YDY."%G9.(NS5IPX3O1$QUM8$SMJ,_&L;1A+YF:R/=AZ$$Z(9
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MSZ6#G,(I:%S@$"7.:F5 ^%\-'B#\[\>\^13\39VJ,Y:*""NL/JBUUX)#ID(
M__AF:))D[J%1Y*LBAS#( :NCP>IH%REN>$ !%91"/S.M&XR,K8L4-^V(/8NL
M1Q.)HQPHFR0I6!T"XA;B]I)5#0_@MI%1-4K,$2*B<AHF>#.FV51CW(* ",(D
M"?;DIR2/YR] -^FAZ+[Q.F]0S*&8/X"87[G7&SV3=RQ+]ZW(Y?<2D541FPW1
M&S5[ )U>>$;X!<;O,S$G(PF*'!2YWQ,YZ&I &PS:8'=F@T$QAV+^ &)^_:Z&
MY#L#8^*80\WU_M\_</;OA#8/ &W0YH,V'W0SH,@]BLC=GIOQIH]US=W=-/6
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M1B%(FE)8%&>4(:WU46V(C484_FWSUG.@M/_JF=M%Z$>F=_2/%:%1:"8J0J;
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M"G-I[RU/YZR=@:"VNHSOL\7EGM(Z5#RV+1:DG-LE$:F/4,IBVF3S@TA?Q7W
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MNT;*,.JVZ6+9PAQT#P1U2Y$D2YZQ< #4 E +W(46.+,G<WXML$B5A%"D%%'
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M>D (&OWE6C!8*2.G?#3M-MEB850-%>R $+AV6"HP$:!DJF6&5'/!KKUV-/2
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M.E Z_D@Z4.36(T)QL:77*_-[QO&E:\6EN3)7Y85$? 4.^SM15.U =5<)-)D
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M1V,!NK=3_] 5P_YG*EQVS?">CJ+ RGF3P#-LX'G(%8LL_;MUQ2;/W"B'<(7
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MQQ046F@ := R,[4UN2I5!B'_1&VMR5R:)4[S[)"3%"'W 9'[Z0;$V\BU5TY
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MY_L9;F6<G(7_+]T-\M3HEY>K@8LMU&TC*)=)8Y:)>  F9>'7]#7$3/X1#3Q
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MS9#-O YQSQX*WU!7J/0;&U/]I^*_EF/K&1^XBY0S"5\]6DI4X.OZ7IJ)XVK
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M=^XY.A8EZ;@PP]+?18F8,#-S"5-AD:\(V1W)L:COO>1B1]D=\],Y-42H"YY
MV[$4V^=LC7_"[;DVX]9B.04^EL$*56;L8@7 ^GA7SAY:\%)IC$#=-Q'^$?YC
MG-_X5_@?3TR[7\X8#6EG]A:NR_0<.\-!_-.PFE":S2+\(_PGVN]X[R48_PK_
M^E!2N*%1EB1B./4%+3MQBDJT_[/1_L\R;Y8"NB?O[-&DJ=KA>NK&Q (IQ?,
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MXULZI(+0O,J&]A6-#NX@*O@#HPE1P<U[R/\F%:RJ[>TJP$L*5AC./2)8UE3
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MEY5_A6-Y_O=#M!J-B41S_FK.\;^8\]]TX;PK\U<8M0! E#[II7P'[B319JE
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M /.!?QHBD$,S14J&<.1?MNI$SNKO>5OI@L>B"*0'-8K7*='QD@1]@G0,; '
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M)ZH/ Y*$QB(]328B\;<;]@F@'O5?P!J +C@;CJ"HB[8* Y:L.3-0_5*P,2;
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M-S^Y<_.3!)#KS0MW_%+;>_4,\/?E$?<E_,2^>763OR]WVI<P:=SI;\RC;0P
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MK>@R$)F.>Q*1]Y'#"O?(0)L!;+?73IV@:\;0U<,OR6M)_"L$K\-#"T>SYS!
M_ .:DD,<W7KT56BB$!J"D2(_T'GU5KBCX_@P<+U%^(\"?Y HB;U4Q#G@:(6>
MVR=4#AX](/CKF?UK#$CJDLUM7EWHR%X.&AS[\]D>'2K]]!@$M<L L"->V.LO
M<D./GJ:%Q&-H$,$F[_H8VY"UI]S!*7O)[U+0/7&I<_*?\A. KB./02<2I/!C
M/)14ZBB;B?R$/O^OU_;*)F'P:,!K>U[!6+;SQ0205=%6N/^B,%/!CI3VIX[0
M\S'@LY#C^9Z(("FH=WH>=/Q9Y'VP__0S21=%UXRW \I7=O+2:+]]E-4 P!)F
M:762H[3 :7)TEC3&ZH96-YGQRZ ZK*69M9QB7XKS<EQ:IQ\A6/I3[.@LF>R4
M9]$>SCQY9')\A/);T&9;9#$5%N3LMN?!8$  #B0>&A-YV#[Y=5&R@'4T?4^]
MOC)/_#G4+B DGW@]\_?ILUDBAQM80Z^%V/48WW]IQ7>+13QEKO161N]EXQ^/
M#^@ZJ=GGV?L>\7>2CK;'UJQ.5UK[5);MZ-/1GN#)N>JX(AS[Y-C6UJ,_$.T:
M3..QB.\W DL,^BKR KOT@HFL4A?HS/9CND,2.W@,BBI0 :Q>)_U&W %A[:"Y
M[<$E)_Q1 7@*=% !\,[/.;Z<=2!OGEC%=C(0X48<4B&'GHG0:%'%\G0X,MT9
M4;H ZA"XZ5)BS/_2I<DSC88TQB)-]X$M/3AK0&L/T1X4;]-4*% >-?K3U1#7
M\9*TL;6 ( M5V\+Q+8FN[>;0BVAY\(2;683I!F@9*MC?4R)!B3%,#(26[!6)
M01AN#UQ+]6CCE[1S?=DB80DP&^"\6J!.27W;1.%V-Q'Y0"&C:)9)N([.UB"*
MMXE*G>OF&&.6$X8JD K$24"&<0,I1%W7Q:GMI; YS=9(R42/"R$T$ 0=K%.'
M#9RQ!>+K<*-[_%']Q3;#@&;:]P8^9DG1UL+')"^B[1A4G. S=^J$0D0;=2*\
MU("\"\QQ=O_HIJAWL*?T:VC7K E2F-&8-+.LA5[ZLTIIL!E\O!["SG)Q=P+8
M2AGVEZS; WUUT3PS;?!A@3Y,&V^3))7ERC*IT8'^6++G:!4(=EMK)]9B&7;>
M )T)H@GH;3S(JFJA681"0 VMXPL,E!",[^/I>E28)[)"7GGZ C>8XSZ"N3:G
MPQ$) IU>6 ##FB[SPE=P,%.?*/D2$X1)6!S.;,&B^MVQ[[FI$T#<VP_3:3P%
MFA[K^F087?1:EL>43P4#889%C )^R^N3HS5ZZAB\2C9*9+H1SC1)QD&70(DS
MX)EE<G4HEUH7HP4O/+GBGHSI_"1XFC1QW$M*<=J;7-T';=QR6LH?U^U&DT5U
M<G3\HHE#CEH:_79A_GL/8I*48FCGSWD='_3)^\!,GI?U/IK:C6G>T09**C"?
M1;2!,Q5;JC9B:CPWF/;$93F4:!CAMMQO748FKC_W<;(7D2H!0I9 C:H:2QH%
M^O$,1@RL>G.DI\<@,1YB+HF10>ST%LL)3 @.4[H^-#>)&JTQ,IA*/6#H %OQ
M,DUS<OS$O"<O&AV1Z"T%44<%SN,4'XOF%I-F: HBR60 )7+%HQ)H*P;+X^))
M2K<-Q"ZG>!V.9!B:SBU3'[/MRSJN^MRA>/P)37Z@/W)><B2>9QH762S>%1'S
MQ_YYVDO]F0RP @83B?-;!GTG\4O"9 XT7K &+00)1N'W2$#WH@=:+8'O^4LC
MVA$_HNU'M/]<1#OZ4Q'MV.OO>/.TN4M$VX&88Z;H$8P<@,H"GDH 0+8CS[[P
MQ3P]-DZ ZT2O4;0M6KP*.G6HSQ^T7CNN;9R$BVQ]:7H53]WT[M=?2S-VCV4Y
M;G:W"4R)NAE=A_@G$[TC\?/SO$H($?X::%D:4<7M4XV>0R0<1Q1*.^'^["*9
M8S3)&T2Z_WK8KX'&\28<.O<0Y0.RX63*]K_<9&)TWVL K;QM!=FDP+2*^RWI
M7$3H^B)? SW5<]?/^5)H#.P[R_GS;FEBF69P&\!41<<H&;-!#+BT.BFI>-@"
MMS4Q8?-,ARX*UG;?6143S+ZWL%;I^B+6V[<>02O^N> 5VI,A0H. EP@_6>5S
M=%&>893@&9/&(KP9+L2:M07!S?7TWA-U)?Z>/OI+G0); Z8^(3A)7O-/3*%@
M07?L9,F_PO_Y5R 13@8#;V<H>)?O=+5-LF'V/P%"I#/RR*>>7#NAP_%< 9+#
MV^E;O8N\) <@\]$-2M5U"3.&B:)^9@2?&B+$W$!CG#HP3HN-2)(W,5:7*T7;
MB^*Q/$.D]9WB,1_9CAO:[@YONC=)<<+$4M<2OG[2V#Z64P^(;'BJ(:F7@P]D
M%- _0QUAIF$4DS[JN3]LJ4U$Y<UWK%[QABBR:ELA)FED0OP$\)8)2?7&E-IK
M$ZHAJ(2RO*YH> >9[9TPGDYVVQLEI6FW\'M:^4*] R>[1+8O1$IGO26@MH_I
MW)%Q!$DW@\WU7Y/=%<^&]ZY?P-BNZ7"<RQ &YBQ?]SSI(IW/V:""HAFTT@N?
MI7E6]E=D(9@1@\L"NO#&+$0]Z!.Z!)NUZ9N#WL-W[WY(G=E>1O>0AE#RPN."
M,JYXUD3&L%_\%*#-:EX5+6?#WB%I(K#EC< _WKG2_U?/+T_A?^PG"O^=C+K)
M]1//#L2Z30#B])2K\[H^VA1W*49LY/>]3K%6.90+N^4L(WWY%DX^739^Q+IJ
MA7CW;DVP\ G!PJ/Q/LSPJ4.TT6,3D9"T[!J,N)#N03 Q7\QKZ4._N^C4(N5Z
M>K=XF8Y;0+#XT^4%ID>"(;O=FFC,"=&8T<NVPSY+5J.^V'/54I*=]^KY?NL>
M1./UEM+I;5KA1;P@3Y;J<!=M&%ML0_,4>8-HF-XB$H, SJI_&F#&U,%J .7G
M7W_6#;M<&O)7,,E17Z3C-*99 #K8/=E8O!;S$=--2>OT6N->ELE-8RLFW(XN
M/U[,YV3=Q#=!5A[ I7O"/ODK7E/[]%MIZ,N@06*G0,PBI6."=VQRR ET<!T&
M=VY8Q/,*YBZ3ZBLLHJ(9%>0?J.S *4/>9<<I226-[9/%\]:;D48+Q.@[@HZI
M3+TOZ,[5#7HZVVTW@IXWPV1GFK%";=(XKR"'461]$B)ELC]<J>XM./=,D9[^
M<#A+&DD4H^0070W*<.-=;B8?CK;$%'92XX1F/T\"LW@XNJ1W1L*('$;S<Y;H
MN!PFF!5K8('N!/B=))_BD&?AM6-*V]N;1I1X6W!)=>#ECI"CWBZ*NU,\1=.!
MQ]4L*5P V?78)& 8DC]M3?$UX0ZEI%$DE _Q"S:L53H1HUK/21]/N&U"!!Q*
M> 2Z:Z<<7*2>V!PQM7^**1_R1.9U-U[@J(%4!<=#0[%K1 2:>V'G.:N"W5[!
M_G(?/"9LT.I)&W%(?PE7@H@BZWTIL'T)S4Z5UIO7Q)TL:(Z]0[1/RRY;)OTF
M<G@#*<E+1Y7YRC2<V(0=-5$G%R$1T^80XN !)O>,BU&9HSX:PF"B[E3MN=T;
M[. QR7? ]:U$1YK.1D?;P0ZVTE$N-%Y[L@72:X+,E4CX^4W-=A:NA[,O0KP@
MJ=;2#EK3&D34N<'(@F.=MI_P!O5)FHXA NBA >&64Q++!]5V:IH9MEUJ7UGM
ML-91WDB1N4T5B:P!#0RZA/,)OG[-MN/!I<ETY_D'3B[M/2.X.9%<H@YT?!52
MZH7\JL9(>:DG5WK/C<%>D,.;[8>#%,]*?]++9%&+#LU!3U$.B!><%%AS0%.L
M8-\UVF-*"VPT9&8G@NH@DLM0.JVOM>N*+9(Q"XR"'GG"M<:67Y$7S$CRUUF;
MJ#%@P0S=F&>_\K2LP/ET\? /I)?4\+25H[2;JSN![8-SGG(PJJ]TR4D'9!0%
M'G$I=E[!<:QX.E81C'F%>D=FHDB#P$=CVXE:*+QA'#UF3B4++A-%Y#2N[6G#
MM9V)1,9(5!E5@9/0JO='V+*!9N>!<)UDZX59.H<E[.#,H]K8$>&5I0.=#=)W
M"S'"L_JKD7<*>:A.6#2,A3\$UB")LS 8, .0S34.Z.M2?]A <*0<Y._HOVSJ
MFJIA@:$G1^,UV9?"#5:>CYM:KZ/S@T[C$&D(W8=0)T!(<>2C>G_-0?L4**F!
M&DEV1LLS2!CF[9\$,AK*N>/,S:<[&=>;BUD^P))7?A;HK8C#ZN@#[KF_PC>'
MF.CW_,"PW31U,=#&D>!/5+C_V=56P!+):/)?7P-Y7D!0<84'5\--IZ) C^OK
M(\"CQQ6W'7<7>I(=5<2V/T!N1#@M=>R#0!VDWDXK]!!WU1_71VX3 H5AZ?&&
M4_W[")9H;^GN_'#B54V=:'9#JS&O+F@6ATC5$I>0U5*FT79)22HD-+N-AC,8
M>?ZL(2!I76!'AYUR*=0[<%9GO]0)F0BGE$&7P]6C:\?F%=A^=]L[/?)-B F_
MPUYV!-"NO+O (U)3%=3 [Z@SO^>P#YF@XSX,4(?A*S-D0TS\>S/,X0SU8VUR
MQU(Q'RAG>UW=F7IG.,'?V#.DCSM.6N)_MF0:+@'&P" $_!@WPYUR)$P\G+ 0
MSZH(4WD("^<A9@L2GD9,I>ET5(+#U$7*_,>[3N(F/3Y/3@M4GTE"GCV;$ZK1
MIA6G,1.JA%I$A TX8/;(0J3"B10@:AYOCY,HY42*G,YE%\L,TE3XJ\Q&H\EV
MXY SSG4;YI R7YC<^<BLW1QI0ONT$)DC':WV'GG[,98?4)/7KI.GG4O@_'02
M$['S#:9T$7/"SIMVB&6X>*E=Z1YYS3Z[:SS\G;JRWN><&WBWR,GJI_$;;')(
MK0^* ,1! FRQ!^'T2-$1IX_[=M[IAW99HM4$3KGMJ]OX]Z6O1?WT-3]][<^E
MKV%"VIUZ/']L=/1G?W7V/.&Y44I,C)DQDQS%IHGP*)H:3T?CQ%08A1D^,0Y'
M8DF>27RA?,\['=?U3F:5R1VJ5:[!,_-V99C2UD4)S<WS)^>\$"YTBNT64^FV
M-S$^%4E'MOAD.'S^:+.8'W"5EV*MQ\=+L_V8GY;+63(H<_YH+%O>B.6\V%HT
M^%1LF0\_)]LIO-WSXOUJ(QY;-UN1*<,N7EAE,(G$BU-\\O+]J^[:%#FY(S&6
ME$SQUK3]W%/)H!?O#T^'195GB@+3*2\W!6M^:+=RTBAR^?Y1:Y](1%[B^T5<
MX"VS/E&2Z7@:GHR=/YGJYAOQT7.NSL4'NMR)2N-XG\$QD^=/]A:%QL[(6@J3
M36V8Y^U2DGHA?/)R35*B/IR9-:O%=-*P"3%NEH]9+7PT>OXHUS(/D7DA,6-X
M:;5:*Z-=953$F88OMK_<-5Y&7#)D,GRUO9@T>5W/;O$&HDM*]8OSWJ*;7W4Y
M?K< ?E)+PF!.'HV</QKJYI6*F>YUF$(ZM^AT%P>3R9-'X^>/SA2VWZN6-\8B
ME%TOG[,R5VVS>!_(Q?L7T?RX9O8:,6XYBI4:^1 [*&OI4>SRR>IF7Q.DZ>)Y
M$1I(7$)OMCM*6H(G+_9TG"M.4H-0VN385CV:;>>EK5EJP9,7>YJ?MEJ%S;2Q
M6RP+B930C&?*S1R^_6)/N]9HL"B&&FHOR^U63'8F1N-M?/OEGHX'$BAIJZ3
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M[Q&%4FCY1H+AY.TBAP\F?W[O@'<W"Q^O)<##)S$\CEDH)4O5;6F=S2X*^>1
MKW/%EPAW[U2'OM+<BDNAU>XU-B53&/9CH8.%>(5)FV&6#49CMRMY>S!)]>W"
M]\8KW]S[8WAU0W-/:'2:X52;>UYDPR,MO7W6#U7IWC&&H5$5P]6%*/4:S591
MRL<3@M*5$+@PWS.5!$WK=O'*!Q-9W][S[;T'!JYW@J'>I"6GMJG1CN&GN2+W
MPH38S,N]88C12CUN66+[/3DL;[C!(+N-] D,)<'@8YE@/.K[U7V#SS?X_EC6
MQ>,8?)WA<YR7HB\O#/O2FS$,(TURA7L[J"+SY;2176YBBP*S;+2E_8#O5],
M6)AE&F9 ;V)\O<DW^'R#[]'QZH8&GYH)#<W.H;CE>.U%-#<KI:,?[JUIE>O]
M_G.AV4LS>^XPU O5?LYJH*>*)*@F,*G,]U3Y!M^OY[+ZP/5>P/5>>52M\#:U
MELK;1:76GD8Y*?Y2'-P;AOCR:!HNQIM++K2UXNU-X3"*%]#@P]Q6-I$*QA-O
M&7P?K]<FI4\ ^$ 0)Q:VW.QHBH7+,OQ^FQ^S^NB=,U4_&4K^9!H$$9^C]+C"
M<R>C5(L>TGMY*W9Z\:K,<GWU(!FC>T<A5]E.,YZH5"6NLMVFER^'[,)8I4<)
MDIP*-FDBX;>^^TNPYUYIISY(W0RD;FB)3FM=(Y;255BZ%MN,,JMTOY.[MPI8
MS98[>^Y%W"WBHURZ+E=GRU9* K2*?_F6# >C?G.(OZ50\IU#BCX&_08&O1.B
MA(>CZ$2,[J7>NMJ)Y78]P5+OWG=\N\ESM5K1-+A!8E>*KXN;?%9#1$EA+@,3
M#*>B/J3\)?UFWCD\^,DPY2=S$A[,^.*U?LC0&Z$-DQUEETJYE6T9NWNK,Z60
M--K')^D*QX_#T]&D%XTN"VA\D110L+Z8-ZNU??3Y0-;7.\?Z?/#YB$957).K
M^>*@.N?X<O5Y)40/7#I\;Q=0352S^WIS9G&#[#07BDTBV^1\BR@4 ZLJ%DPF
M?!7(MZI\J^J=0>B=("6:&O #<[8N]O:5?)$O\8-F>WQOQ::;&NY2C=8FV]NW
M]R.M((CM>9XH-DDTJR+!5-2_SLDWJWRSZJ<C_P]F5FGQK<$E=]D$(YKS6C82
MYQKBW<TJ;IDJ]C>CYHB)5[+<;A0YA(T.^G1(HF68";)^0SW?K/+-JC\+/C<T
MJU;-YW'W>=?N<(WN\_,F%:^VBY%[M_4<ZIWE-EO41EPVE<LW#6F5+Y!8%69-
MIMA@BO5O1?#-*K^UYSN#T#M!"COEB[G$"]/GV%"BNTV7(V*H?V](F?8ZE:G.
M1!N</ D_C\/[6B,KH5E%,B"92#"<>BL _E=T]VQP-;^9YZV+8L::/A'U$/WY
MU_!J%S T19X$_H<A__=W@.VKS3[OO?H'P^>?2R8 ^;R3+5HX#-<"TRMTN4HU
M$WJ.5,+EVN3>D"T;\=9V55VFF$9AFS49L3Q/]5JC),FO#">#R1N:HCZ\?4!X
M>Z#FH/<FTZ? P1N:Q>5Z)%Q>5Y+=7F>8ST;GO5F=[]W;.5>O;E8K9K%+,(VP
M-10W&28B<UL 1&P6&@^&XWZOT#]>2GAO0;]O;YE[K_XO@;GW\N558[6%.H^6
MN:54$BRYUXZGC'MK<:5!N9C3B^D*PVZ[W416*)=34=3B,$LT&@LRD=NE2'QZ
MU'JUU<R]!?>^K6CNO?H'@ZV?2\ZXGY6Z&0KQ:9D+1;A*:=P6LJG=VJS<&]_6
MT5UJ-,OTRPR_'G*UG2"&]3HJ9301-1J,1OSFR;Z9^D=;U]Q[]9\"WVYH?2J*
MU6,GP]QT49$SJU";+Y="LWN7^VRD=+%5KF<."WX(Q)M.^U&YA(H<[5T:9%)^
M)QO?_/3-SX^'<^]5I,BFU%9H%RLR<K(U%9:1<3?!W=MGM@B5M/4Z$LTQV0&;
M3_2GA?HN)B%J83HM&PG&V-O5"7UZV/+MSX=<_8/AUL]EL=S/_ER&(OGLN#:9
M,X7T+IE/[]+""W-O^W.\UZ1VU(J/.=%J[]KSZN%Y^X( AQF[J7 PR?KFIV]^
M^N;GWP9O-S0_V^V&U#5>1'61S<?[2DHQI'GOWN9G_T5N%JW-?+W('@:Y2GZ9
MZJ02!.=()]5@RF]9[YN??[;1ZKU7_Y?@W'M%!QIRJ#M:[4M,(3LLOO1BRCHW
MN[=VMI3F4Z%@Y5M<I3%6LN7NL%<?H],,TX[#3"J8B+]5RO"1&J_25W0UDU?\
M%JM^19C?8O5/FZ>AGB05N%8EUF-7BT(C;A;C,G]O #PH87G=-7, @/N8EA\4
M>(%[WHY2F,0;#Z>"J3CCEW+]'>CA-TE]0)BYH9F89+J=12Q76'&RM==F7*0Y
M>;'N[>^OS[3Y<R;";#D^9$E]I3-?SK<MP)OXEV_15#+(QOV./'[IJ-^1YP)&
MW@D4MKE$1PW+W1U7:0^5LKY0#39Q;U!([J/%)6-(*E=(/RM+18ORS%X"4, <
MU"#6$K&L#PM^4QV_J<[U)((_:<7,7C)\.S'J;1?9]#"^UG9YO5"Z=Y^_>5GC
M\I&&..7$V$N*:<6K^54,M0I,\HPE4L%H^':U-Y\-/_XB)\CGLTY^#CYN:)V,
MHZ78?&V^I!FK7Q02Z5T[-U[?.XB5-4O3R3(L)A;9MMQY;C\7)@,CC3@2 _,D
M'@DFPWYS/]\\\<V3"QQY)U0XQ/L6(V^7,E.I:_JX-DSW1]J]44'=L4EFD-L]
M+PJ6_ORB'[:1@TE0 7,4@TPT O:)W_'*MT]\^^1ZE/E/VB?C=#-KEJ,IB5NW
M!HWU-K?;]LKWMD]RL?*VON97!VZ?B2N;=%9.3Y)HGV 28(QE@R!#/G[X]HEO
MG_P<?-S0/DEUQJU]\F64X.*39R%T*,PWL?J]H[7QL=ELEWK&M,=/FIEQ8U[3
M-A&,UF*2730<#J92?OM?WS[Q.V]>X,@[H<)ZJ"CS13NJ<?%"V32E[((?+>YM
MGS#Y<"B^R@QWS'+;/!3CC;["Z@05$E^^I2)1T"[>\EI\\-Z9=S14_#Z;KY=8
M_!70^6H?S7NBZ4-LNI]U_YBL_T ]%GT9\;GCU<J4ST6%5SLD^#+B<\?K5?B?
MBPROEN/[0N)SAZ]L^<J6+R.^LN4K6[Z,_'W*UNU;&OF\_W";[NM0O@[U2'3Q
M9<37H;[;4^7OD)&/U[?CO^.35VQ%) [,4IG EYPZT0Q!6^W_^^_Q^X4V/Q?'
MWSUO["X'X9U3;>]TR'VV)7]&SOX#J9./M>9/R-EWS]&[EW/K<ZWY$W+V_:M@
M[A7_^UQK_I2L[:LCGV#-GY"S?77D4ZSY$W*VKXY\CC5_2M;VU9%/L.9/R-F?
M4!WY,Z6.#Q22>IA 99R\P@U$!7(B7B=@^'5V?W/NQM]=9_< 35_?OJ+#E39;
MV&YX[9K[JM-RZ-@RMRE68_/<(M3ES$$L6A?#DWMWDSW$K33SK&^>.?Y0&7']
M:FTYUK>$K%^^19A@[(8]$AY,0'V8>F^8>KS,L;\3IGZSL\LK>-4L##K&=FOE
M%_%&GYW5,L9@;=Z[?4,C7ZI9FTQVR.TC"[G9GKX,4G$)Z1O_\HT-AF/^!;B?
M*MOO]O=R^W#U\W#U^^ C/5M:3^6U'<-N"X?*X'E0OS_XM*UU\R7)K;D>OXUP
MLK4HOW#E%E(K!<H2&TS$;M?8\L'DSJ]%>7=MZ?%J41Z@5>ZC&W5=Z[G4'D4;
M(Z:3U4KUU$$S=[U[=[ZS.$TN]=KZ>"'R_9=HJ!QA9UN"4]CBGTT%H_';==!\
M, GUK3K?JON8.'4;JTX?][6"46S.>Z%#HE];-PLQL7MO+U0B/2W&,T:UWPNQ
M8JK7FR:[ZSJQZO N 3;(Q/W[L'VSSC?K[HQ7OX\^]4HO/'[.:!NNL;%6BJ5'
M(L+\WNI2/AUM:&5=S3-[8=)_$=HO<LXB/G"\LR 2#L9N>*':@PF>;]?Y=MV?
M:E7^R'9=J#BHO:0BO27']L=C*5\KU]2[W]R6*L^S<GZ=T!8=)98<;7=L<EHA
M0(57([")8-)W?_MVG6_7/39.W<:N$P^U0:BTF>C<?E*<9:7M-BRV[JU9J6,E
M++PLF=(B6XQP<J/T4K%$XHC".QC"P>0-;YI\,$GU[;IWQ:N'[+GQ4?'J]]%'
MVR^6=4[N+QE99%[X>'&MA&/W#M=-:ATV%=(2Q1X[6K2'S[5]CY]0=2E!W.#Q
MQ%MN\ _8]^0>QMM'S2'^33U0TR>B'J+/?@VO=@%#4^1)X'\8\G^?C"1V2JI/
MD\]=1.%+QFMVE4^3SRT95!?WN> R,N/3Y'-+ANW^]]G@,FC@T^2SBX:O3OGJ
ME"\9OCKEJU.^9/CJE*].^:+AJU.^.N5+AJ]._:$['?Y&FGSPYCGT%5W-Y!6_
M8<ZM<]M.!2 " C#1K+$B/H0$_..6S73NOO('2S2Y5A?^0[FXZU!:3Y>?9P;7
M.32;G6+>J B#>Z>&++O1='@?GZ:94/[%R+0GR^IBF1Z%H]CV)AYC@K&8W_?&
M1YL;H,WU+-N[K_Q#H\VUC-I)1THN9O&<LMA7*YV^RB[;R^:]86?>K5?7J24C
M+-AEO%/C-ZR@K5H(._$OWV(,$XRRK \[?SHA]N["=WO8>:4(\NXK?W#8>9FE
M4A6VG5_WLI-RCS4YMKA*W[M8.E]9;E=B^]#@UHU6?MR>A).K--%=4IA3'P;M
M)97TZZ7_?,'BW:7I#Z@O#XJ@#X8CUZJM?\A84II:R]S7]S+3*&381C[VW'I6
M[PTX^G 8>@[SF02W+H]R8LKDT]T=T5JPG4R<20:3";_NT+>6?&OI0\#--6N)
M'2X,MB-HXUYCTGS1XU)/J8[N7>[, SDZV_ZHRV35W"$_F"WR5G)+<"?VY5LT
M'@/<\?M8^>:2;RX]".Z,]V&&3QVBC1Z;B(2D9==@Q,6]:Y SC3@[ES*[$">'
M&BVE.%3U8H)J+TFTEYA$-)B(^?:2;R_Y]M*]@.1:%?,/V4N]BK _9)8,Q[&Q
MHE2OK.6]&+TWXD@Q;ISDE8/4XQ?]>397DM5-34+$P38ML1CC][/S[27?7OHH
M<'/-7EIFV_/RJC,&W"D;8M>(+Y15[]Y^FJ@<&NOQT3K"5';#Z+82:G;S?:+I
M8+>5:#@23(;]1G:^O?3>N/-J+Y:[K_S!<>=EVV&?):M17^RY:BG)SGMU$-@[
MHT@]6E*;S5I3ZRT7^W38BNXRF2K57A)?OJ7B@"*)M[HVD?3"?YL\[/,WY[&Z
M!>^7A7=C:%D-S43<4!"Z4PX_E_SC+_'+'\2!=V>^.6R!/-W3CV057FQ^C<0O
M)BZ?SAK__54V80B!,.>_Y6MK\SY%AW/S5=D?7_+Y1OU[(F^^_1?^X[Q,4$1>
M1RB8G;TE@I-W4D69_[V)\ I ,%%WJ,5&'21S)3<>HZL@LR;__;__QSO[(SB%
M!$W1]*\. GF697,42\!($N$L%?E%B)_"F[_RRI;?&XZ>E3I6$GQU00SI$ @S
M3Y'8_P8\_T9Z7!!SR>]"'I+9V!=2Q*GYU?Z9\QG!+?=#S9!1W+[JH@+(LA%Q
M])-QR<Z8VNHK&WZ*GXI*-/R4B-UHK\Z.F,AQ9_[+!V8Z@N'_=!O9J\))&%A%
MD%/HL%LZ7_NC+]^ZB"4!;1I 5,-V5"[C\M\\V_X:LYZ2^AH%@?<1MF75(G!-
MD7 \*@,8ZJ/0O,<,I/2P6Y!E<R.T1OAH^ L5&>_/OOWW1(;>)='@%."=MEQ9
M;3F653)@3C8$13,L7>S"NS**)BR^./,/%QJ-;JK/,KWX<O.\D@?9 U=MT2,*
M)BU.TN8;S]GK#(AP0JQ@$J9NB>_&+]Y]'FO*Y)R!PLQU16XB&RN%WW^5504H
M$1KC>D]0]0A&$7K+ZG_'[S?A5UF5+.'+M\C3?_\]_F9S9SK;ZI4ZI6ZI4>\$
MTO5<H-$M<NU I]M.=[E"*1N ?]0[Z2QYX,\=.U>D-7ZD]2FQ3E>'C!I("VM+
MIB)DT,4^Q,0;:J AF!J89H%(,( S#0:V8H <&^(D(*NF%@ NXD'M,0,K2Q=F
MO"$&>$D7B<T7V(*>%,C(6A?T&3%0$R>H_@8#)55X"IXPH%?+G9+_PZ-Y IJ7
MHJW@[8!2YDP,=,7E2OO__B><B/Z'_EOG]7V@R0L Z8&JR$_P)[(@!FUF024O
MP!]GM@( (9#WCYNII,PH>D0B]P_'V$4=T?1L]K$#(% )54O1)A*0R+:).W6K
MFZS'RIU%-JSU8N'(K-*,G<808S^AS3;Y/>D]V-7(-'31;FL(F$TF9[BZ:YPB
M7IW7]5'!JL<7)I]*]N19OEL+[_>K>5,"YGVZU%D#P*<*_./I!W9X8&\4,(T.
M_Z\86D 7R;0F >"M%;^'[3.Q* 5W[0<W#>RIY6@YFD7V-3,Y9,2T='AI-Z?9
MZ4 ZW;6T,6I,WV>70NQSK*;WG[M<:!K.[!+BSH@Q)S9'J9X_V::0(0JX55M0
M> Q1=?8)7_/U? )9<K1(L&_P+T,&!8EP&QR)\.[&-*W"6:DX.^MN(./90%4K
M#',Y.=UCV&&_P'23Z?:JF/[RS9!WEQO(D_$"NK;G%7./NT &#HQ%<RN*ZH_N
M XB=.-*+(3A*<QF1B=>:G#;-A%*EY];;^X".HS8/ZR6$Q[]JLBHOK>598\U?
MV"?UN;S,IQ:RVLO&HU:VG._EDZ<>)O8'A.EG-JDIZJAG-Z9UT>S OABV/>EN
M4XCU[-,L.I->BJO2<%&);*3.IAJS>DD0M$LQ^U_8ILD]MH+?O<]62)N*T,['
MQPMN7>]*8 QK<B<F/<Y6,)FYD1ZQAKFHS/:&'!['A$@.MB+,7-D+0"<5SD #
M1PW"$E8B.5X#L"7NYP%) ZGBA9D,KT6)"@:L[V/D"H;P_,8Y"J>R;ICV<8?E
MDW@:DR]PXP$]B>/54>F? @- 5X%$>. [/!7-F6P$8&-4P^8<WK@\RLGO=%%
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MY0 :*]N-_!NSD)X?3'=/$02^#+;<-H$4 +$BRN!R@/0O:J$L!+D]A +XIN@
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M[7[ 9<TRPNVV=:)9_EH]IHVV2KA2P) RXI.#3FW0WUBP:!_TNB!WV*7ZA:3
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M4>R!.%E-<Q0-,.N,^(199Y3M*DQN H>; 10263AVBNBX&04\5LZ\7J,<N\M
MJLP JH8_()E =#/_=68,%'TGG*B "H?NC0/[:2_'R9QAZEBOM.8+<HW'/ ZK
MK-CG3EKR#TCWZ4765E]2[P/I4A'IMD3'$<QBX U;Q'3,]7<TX2#+7E =:H!P
MZ?O3BAL9</(F^.'NXAN%/MLH5)CM4$1D]D2;QW)X5EL.7$0QM*_<J%F;X7M*
M5<]S8E5=]^JJ4.@O6+!1@-6_L5&0O"Z]6<BSS4*$2=#'QIK?;AD[KE&EL07?
M*@V[7[E9ZP5I#7AL/$>6I3E6JT\UV:QW__J'I-_<+$=Q5XH$^X.8N_N0%3WC
M1&>!UO.U]:6Y(ONF8JMOL/V2[_F.\G0;N(CO#"#;'H 9Y4U;,@X7PDS0_5$V
MIU?U@%L&?;^=RS<V2 ?LOP)V:@5>[CF^<HDK_L_9*@>^L(0B\)ML%1 ..!%[
M!89YBC2W;-/6=B%EV_!:SN@/^Y41PPU[^*(%9I)1P9X^Y<S@%%UHU\S8:CA(
MM4W3#H#L [X-/WN#9V?^I5O@.[;O@K>[__Z5V#ZK-')/D&?HM$HQ]\@/;<P3
MB:;W"/E K4EJF(3]IH1]>B[7.A>&3L\E@>="WC,I8"YW,'_H83O<*U>N=_[F
M'KU5['P"!(D,9\$)/8@+&2 IG*W,_97[D_SA=KQ>)/_%=GR^4#Y&WS/7)YPS
M[MVC"/Q4P,\<)/Q/U=,_@NR:\3"GNP'D:/QL&$G8VK[>@!W)&PG;AG-8L \7
M=C(SO)\N]L)V:TPHTNJ*H!#9048U5%CTN]V)7NQ>Q"=U:F)H@6D- L7<*$TP
MQWF<&WO8W XLO>'7C6S1TVAECV_-85? H!N;R-T1S!DS+7ZKCWX)_R)NX8Y/
M++.ZYIK/%H/X6WTBY45GYT50ZAX$=IP+3#>D M^B35Z7EIQ?D/-;4=<$/&1!
MQ!UQSNK=B96JR%2J^M92U;EY5RI:)8"=S1U%B9.IB#Q/]:J(:NQ,=#@3]ZMM
M8 =1ER("NZ/0,T8[)T.FHE*9ZD9EJBNL.16^KL*M2K;OQ/50"O9Y0E<*8T.?
M=MB:B#<'+9(]M"7 [A#B_,PJ85<S.)Y<*GVETE<J?=T6/P-C8_B9W2[4<D0^
M*_/USESI-_K&!A'9J' Q1M\QU!<'5/Y1B,U+Q!Z"2(Z>$NP/?'S)"\,L^@YT
MN<&HG8]%6=YE @4<,WB3KNK@F^"M +J>[821/_IR)>H.+(4) XEL20_],H'N
MS3,2 +FH6QE16ONZ$W[S9=#13'3!YP GX);,K'VP1B_T!(=_=]WPL=Y<]#*2
MZ#B[,-XH[)GL9I;B+F/97F:F9!Q%@CYF2#Y@KG-=FH./#J_TW8QGP\5; %?+
ME:G <%3X)K":PZN>K^#PUOO, &S8R@&@<7:O+_D9V3QE3VKX#]C^0'' <TS1
MLL!L)--V?? [W%I'<3W'E[SH>" F-KJG [J ?_2MP^9YNXPXLWTOHX8!;6!&
MM@R^= SOBF9M02_A$I <V'WSZ W[[6D\Q(6!E]YE9!_LA)59B8YWV+$,V%;+
M7NI2N&#I,?BKT!Y6BUF4 8,!*84#K.<D<_\4$\G#P $"SPXOZRI25M]F(W3_
MJH3_$PJT7%MVP'[R^K+K^+226W.6%AL.\-&%1;_"!P'. =BV^?=3C^?A(["$
M)RYSN,?8PQ:'_PM!"H'@P)5Y,#'V*9U*<[ W8%IAI$4X($3<*2#!$7]U0/4Q
M7R#ON[H%X,=" HW"/<)\@N72U87^H-@!:U@"T< /)8=.! 2WH2_!#28?6R)J
MN%(V=6S/C7(SEF[W"ZXY83\<1EM]V,'3(-KHZC3AU1D;3^MA_):?X+J.8+--
M-N 4:FW6M+_^0>]SKX;3AD&8\&!D\%A Y"'DP<<L8$1F!D>BDS_B$.Q)YOFF
M9(Z[DCEL2^9?\)+"D+]/QX9_0/_^=V9VV/>G?#J<!.MK &G@E0#JXN.AP->7
M])D#>"X86+%-*'4]O/'^YC$_7%<9/+?IY_C=CB;;I:#K"PB;!,RC-XOYE[D!
M#R7P=BNEK;*. Z84UM-^1/RA"<Y#I6TX:".ZTG/ 5]:X,1?VW:'A#S7*F^>'
M!.5\/!OC,X"WT<FZBWDUQU@W^JT:T3;WK!% P+\>/_\0=>TH2W Y0X)]D'0V
MH@GN9' X<.5#L/*,>=(7Z#YS+;A]!F$+QQ30';WD.<P,R';=KP@D%20!8<C-
M(NS""26? 0;>:O.6/-]L#'\RG3/<N%6JK+I0+WSK*HP$>=V23/^$K&(E;3$4
M7O6X(X('<#S9WS[GJT_JG/*/)+770!-@JWR[MJ7LR589C'(?S[GZS*F7E1Q3
M*)<##EFV2J6]K/7!P\"IT_=QM;_?>38/U '5L-,4%L=>A@A\(:W$/3Z>,^U<
MW%[TYKD^4N[YU>D\ZS:*XRO(^[&+/Y7AGG.KWV_?W7$K?H.51$*@(8*G6$I3
M@;JXV;]G[_OW![)'@Y4RGE41B5.DOK/8UV;9AG(=9E<="DM!F30H9+G?+<1M
MGF 8.R3[4XO^D9K?0?=_1.\/JOZ38>_'@"9UV/5LKP9(NXHUQT6Q6^G+5Y!_
M8S?B0 29 Q5D0C+X<QC<^EWQ:;FY/)5+5&G6[!E4M=GKK#8K0M2N<U& JR$G
MRMJPPF&27U\05F&)#F Z\_UI-ZL_ORA>R&:G(G1D'7L_/"KD!*%]>NKR8@LW
M=*.A]WKYI,#C054XG/8'D&')?[ 98Q495(:^/S9&U<&RW<S;%;W23<AFQ&>Z
M_NF6/.$0[H/$?PL\XLW+-+8X!WLP !U[6JU5)[#9<8U33%4?;'HE-L"O8TQ;
MKS&MW)\NLIS.X?550T/JY![<JKD8#>)3/.)SEVP1[)[DL84"U^\?KZB[3*-1
MN ,/SJX<6X)VMB<)V;&J8A\<MFZ)#W<<^'[FI9-)"L?XXF'%85+9D]0YR00*
M.72KSO]^[LS"(:0ND3OW:GH/1CR6K#F8YF";PN<)<?_G/YXE_CV<%DP*MYU?
MQQ2E)\LZ)!QBH>-74[)17J&H@C?_$LU W+F'9>:8>_R8_/3K(<L)#ZV%R#U.
M_G?FR<]P/TXV$R:</]FR9PGEAZ\]SRD_?OB;_,;#R7CVZA>&WL,,]R7X]; P
M KW/D1<ZJQ=&4_SQ9/Y7S,P=R&3^<] NQ"8]_M:D$A98@&1<B'+TW0?2%9_F
M0;Y&K,^W.FX'7U#_L8(#77$LM-;A&_QZ2>YJ]6TI6*X# 0[%+EFYX74+]#M,
M%D\L[F"BEA)=$*%$\@;+B;P#L +$$]Z3!U^&!3F*NF3HE@L]@. J+]B ZUJ[
MZ%X7,]+3=A<GW"=R <.G13_%3*$Z:&0JBFAZ<TETE$S'VV4:WJ.; ?SYZ%>X
M?YME?8G)$J<NY.<70ZH3*J:!8B2%H52.^BNB\,-?9C."1&F<$C!R1@N$BM."
MB.54@9)$9$;G*%5&Q&??&$@"973:?-99(D8!<;,LO>'F"!W 2_[E2,T:S"4%
M+?;Y=;TH5G"D3Z)3#8PD7XYL%3J^V)&INK&V6D)+7NV'1*L+1M(O1TYF>[_N
M+[D"0CGM7G>RPM324A,P 7DYDFVY^6JG4T$-<<=BQ>ZH)';6+!AY,D]J)ZP8
MM].=&84E5O<JBZF*MF&:T\D\%\I@IC/!IF4L44I& @4C2@I\^\D\Z8(W:D](
MC4>PSAY'Z<ZZLR<# 3^=9W_383&JU".!,"7DRO-5QQE,N@)Q.E+LU(@9M\0)
M0Y]EK;PYH$EM!T.'3U:D"-:F,40TQJCCRZ6?M\W]; %'GJP(Q6V5:*@5D5]Z
M6LZ<H.4QIVM@Y/,5 8H@98+"P?QIF1$($26$&8DR D(J\@R;T0BEXB^?/>?K
MN).G98'++EK\:,CO*\.>%D<IA?U>0<5Y>6.4LV:AA!2,*EN)I11\9]35E568
M(W6JQ3"%CHC+VR".4II&H=GK2;3)MQNE9KW3;1*N&DLI1$>EJU5IT^9\6Y57
M?:/LCE$V[JP8\$!O,UY0_'K?F6+\5 ^,',Q&.5F10.=P32JY*+*S)TQ#TVEE
M2<*1IR? >'.W5M<1 W,+PR+O[H*A!-]^LJ)A=KE!ETS;0_J390<A]YP,[XX8
M2MDP:%VSN]8:V4TI=VTM)%NQ-(&,61%?SMO28%?C=I5EOU-$1W)^VA6HTY'F
M-%_+#:5Z@^LS6W]2KF* $+H"?3JR/1BP0:X2]!'?1W+<P+&V?!N6K3L92>VJ
M3C]/L);1IWOCBBB673('3A,Y'3INK:KLWLY+QE+W:U.KM9@[$AB*G@Y=KCJ[
M3=[NJ7S;GN)[LKWR!J8&E8^3H0/<<UVJ8WF(OU8DPM[NY_8 #(W9T]FZWT2K
M)48V=,;1I%P)+V/5+AQZ<O@S3E:U?K]*\OZ(&P@Z4>^,_'#HR>EO.MF6-L>[
MFK'<^14DT)76HAM.X'C\ERY45;4D<-<.Q&U1=P^1/Z>%IY3L>KQQ769B% )^
MM<@VFY,1'D0:'[@M%9GUWA@7BC?HA<I4G63>OU/4D75W98J[7[IE @4T.X/K
M/?$D1E)>>$&?9/M?QE1P*!Y W4<% L++O-HJM)M<9L".N7Y2 A?:5J8I.M(\
M@^7N#@%X8=25[=B6N-$=W\VPNGR7Z0%]65$CR8X[AFKU%<EW@/22827O02HK
ML#VN#S]YB/F A1-=,+TH*,_.F&(01;S]%W:/93SGH!@_1(#!@@N^"=X,9",S
MI$T@A[H9"V+'AC%VXA8^ ]I'+$UQ[S,C):- !W:D5X,'PQ&'OT(]6U: H@;4
M'243P/ ^H!I#R<L&SPQLWP2BZFIE[N! 'SR,=3,K.-J##YOMHNTXKBGTT<[%
M#2QYIBH.E*97XBXTZ![B9)3ERK1W,-21QM#<W^!A,+(UDF?#&#DSXQZW#7S5
ML<$2X70/CXDB\I:BK(1FX^C1"@Q6#(V*%GR[J1Y?]C")*% Q(\<ZR4\B.Z+=
M?XP""!\)3VDEZO(['X(E)O8&D/ A> BEHJE%-%RU5#-2VGH*]%["GR"A@KT+
M YMBR1*0$C@<![P54(1LAU&?,'Q3TE>PN&@4/2%%?U8L48)$ KYX=_ ='S=.
MLAUP[F$Y4A/0GA4%?P(2!)2]A.=]%YXE(#0I/."MI+L1V=J0LP$>!EZS\@$P
M11<&3,+ #?!'\!(8&;N)R!K0\=(&KX J+8"/I3@:T+W 'T("%3.P:HES=#O
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MDKY#T5,W5\H'4CYP+FOO#V<#%[;]OI\-%*ABK3&92DU#7RW9R;C!D"-=@VR
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MFZY G8ZTUANCT]OZ#:[='HOR' =;5 R$W.G(\L!<]>;=>9\OK'2F9+66:+?
M"O3IR$' =]M#>QIPOB-);72S404"5F$Y&8E5MEBSIE1,1.D22T+&VV(]WXWJ
MM3P?R0TVK4$VZ/:,.N7[0#CHMS<4"Q.[3A>_&K:E1E>J(^7&M*PM:M1\E^\>
MDK=?O-^>:_NJ)K5X9<]K,WFJDH["'G)!GP_-EFNR.=2;$SY++,E^<1*TK5T7
MAH">3*"N$T;;$F8:G[57S;(C;"3+">#]?C)TPM#L%*\($K?6AJVLLUT+ P\,
MC:$3M#'*M=$JM>;*N: \(XPZVZ\&\$8^&=I9J>P.F0260<V]'C(:,OP0 4-C
M**7;KG1S_H(T$#VK./;:KL^E#0N'GL!D,NZ4"WN:03A=VXQ'R!:ME/+A4T]P
M8JZR#E+8VH(ACLE<>4SJ8V:AP:'/@2(HI"31)"$)E*PB H&*JD"3.57 "6I&
M2BI-(^+)PTFZQI=R_&:*["9><8$INT##8QD0FI7+D^RR4>%WW8E>V$]+G&BS
M<0RHZ>:\"C-1%SP09J9-Q%MB#3F(8ROTMD?9;7&T0\K6OC[=CD1\1K-QP);L
M@E&4%;6-]&O3LH5@+K=#-##R9)[>2)Q-QKM]%EF62HQ-KK+D0(+,XG1C;:%:
MX'82PBVGHR6U$LKB%$ KA@;FY@)WU));, JMZ<A:3_LK7F#CF$7.4;B-N?$M
MOB\'QGQ7<GK["1O'+'B&LBL$DNOQ!7$F$Z5NT?+J6ARST!H(N6-JM0'7+^R1
M;E^1"N5^-XY9$)U"?T8P99TK8])BI]8*W6DAEEF@Y%1E\:$M(&69J+-4N5A8
M;KJQ+&!E$.):+18:O%_,K[D]M[>'BWBPFF.TL!?:/=;8Y0)7F>]HPZAU#XD;
MSX>6S!6^W-&H96"RCZQ[S5;+&W=C<=W"9MZVZ>1S?%WIV<7^8*=4 C86UT*I
MNI>=Y=XS=CQJ[U9+W-/Q>+#F^=DLYU',@ELBEF$WAWE)6X"GQAR5.?2*6W?,
MB$9;(9BUVO>);@$@,.:LJOLMLB<GJX$A2@V\T)_7>VL,+"OFL#9,T1B866]J
M* %&+;#59M?/@0G$G%8#T?%ZE6XK!K9#C,"H2^TM!:[?.(:]"=!.VS/'R(Y6
M*BL*0RF8%H?%G-;<0.V>)7)5HUWP,=$<]@<\. (LY@@HOT>4YG/1XT29G=!S
M:V(':S TY@C(WE)2?02P21]ITK**(3V]#] ? ZNM[6^Z0Y]>(;HP$CJ.N<K/
M-^'0$U0/?)II%I"^SI=7NTG!<!I8$QP!&'H":XDO^WEWO&X8=:8\77N5Q:!$
M@*?&'"S=,;E-TZL5^4)G1Z[L[+3.3<"R8@ZV,PH6AI6G:@:F-78&'0S00B^
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M\2NRI09@$WYKPSSL=/CBXU!QYMHFN(@N;+M\>?9/!K[_V)_8H#_I(,+24TC
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MB;" <DD_%%I8RPGNY%,Z*#OC&L6N$+$(JD;;46Y1Z"_BT# Z>1^>Q@E5DH4
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MTO[6I/T%JL<7=TQ[N03M4[2='%%6J@':2XZBZ^UTMTY%*FN4:0JMD<1Q]]*
MM /2_HHP^XW1]H5;\UV(MD%,LOJM^5.3!:N!JB\BV6@SA^1V$LT,/>4]_!;!
MD$,;Y66[!,_;\@K)SVJ;W!A$ H?+!=2<G^=TN0VKQI\[[G7Y?X4_1N(:4WAJ
MIUG"T5:4/<H5)B5VS$>074,E S]LP!8"MO!-#*+WL 60*=+ET3!2XKKKM2F
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MN4H+4)>#G_O>-1WG5&98(62"&LU;<I.)S_D:\^MOS"=S<^^N'R"C$!7;E!8
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MFQ;5<-T2&MAH#P#^'2RPQPON O(A 5K&.Q:J*RA$"!((6,/!QK/+\7#+:GA
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M/-((Y=E!O<4$HHW3Y/8)P RP_ZNPG[XU[/>8K@*YJ^(F-P*_&E"<L'G:\OP
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M<IR90_T@[M>7_IW* 28V^'Y408;]2P?T:BZ%6>@?$X!058>_)G^[OH'0 IX
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MS$+8N+WC$?D_WV#:4\5J&O JOI[KQ(X-*L0U\(,WBW;K[UH0( ?/\(RO#9+
MD^]]^QEY&--;^OPN[U$-8]1;Z?%<F$@WRKU<& !C'7U_'^1C,['JW=6)*K-(
M=#8"=D.2V5HN:SZU@)@=F*BCE$^%Z::JW+UPC!<8\"$,^5!*T+!2#G$+DS04
MLMX$;ESPXY60>_AYF?K.'X$NF[6;6D+TIKV'E'5MJ&MX(P-X)S6H6QCN*<O2
M0#?0KM OWN/4MI.@G83)L(YAE*=U*1$+(]_#>^<]'*/?&\O66TM>X7L@FI:=
M&5DOC,M*+9%OX/+5XPX(_W(':&\9UH',\N-?D&E;DEL\]R):_G-"!OUV7^GS
M:"C3<;,C^/ZBK3@N9L<0YZ7(F[$#H&#8)GY2-!8+R?.)A6-Q$+I8F2]%(^).
MGH.XVTO]-HF[J?67T=)R:K$2)\3DC$&(17OY-;*@D"JS*V+)]+AT+:;-^J5B
M92'Z=P_:=@7ZJ!1X:P#S_07^/P%+SBP"B FG"GR-:7-V?<Z$V[8V6*M?*0+X
M<-2P\JR]XL*=0;4:C_=&'1&+ +_.)=BP0KCE=7[&GB/$@$,>[T7XAW^G2?Q!
MY-U"0_J\S(!\5PCA+\&-8"_(@U_QN&M&H9C72WM!?H4#OQ@VQN R8+G/W.P9
M?F I&X,.&Z,[!.!Z*+8O@,N1E7HS<HJQ3C;[0WM'=_N 34X_?ZSK6?*<>EL+
MV/,R[;AX]UTI_D]#'.K5UH.:Z[*]J,P[;GIU$PRHF$D9O5X$Y&25Z(Y*O3&[
MC/#,)QKA;D[%((AFX0UUT 7E#-TTRQO/AJ_0$AFC,N>TR)RK-:.]*;V.K+H+
M//XK\J+4>@@A@G ]EEX_A8$3W.%G[]#UU+:%%;Y$TS=<Z7N'$UJ?&%/&B7,@
M]630M4'2'C.0_1./QVD^6\U#TIZ=PY:P@B0>>BMUFZ?)>]/&3-EUJ7UA\YK;
MP([:2F@Y@TF*5=4D;<0[R[2L7(7"!S-':'0K',_ERJ-"6.]'DAH:N43>&H5_
M_SO\,(4/F)ZHD=T&P3J]KKH>"L2B.680A;]\ASX4?BNZRNFR4R\FG-[$A \"
M$5W@A1P!#I6%QHH^@ 8T5A'=J!SNGS33S6<%%#?XP8YTQ-%&DB9H(NJG!+'1
M[;3]X'5LPZ$[+Z*I:UY4:B<< !5"98A:^0C#!3!,Y)!W8T\HH.7L>N5?B<5#
M;KL7@7CN\02\6!8>R'+J&5 [7H!M]Q<-TN@F*O7LGS@*VC^??3>\M8F2Z6[T
MZN7W'L7G75U9%::Z<?!LR;(Q#-WFU#-=D>"#D&&@[V[MZ%5^"0:;EVS*!- >
M[1EZTB>2AM[%;#RD9#TX9%TP>'PBP2><5;U1SW)VM%<>2--N/NPP>YPA; +Q
MS] V4#L%$V@OLW=4$U$;;2SH'1:0=QQA0-NLP'9)-COHI<:CH059@+74\4@4
M\S!5UVU+M4\+KR 4)A,,:T@-,R]&MQ?(1N3@!6Y1<%G354GS)A)A^U"WS<W#
M)12;WN82J#K4(!#+Q?D+FN7NRL9A53<D_9Y7I2>2AI)4FD"#GPXDO)BUH3!\
M0)XT:.+A +>)83#4<9 7!0)?)01L&AL"CM#!'Q$0;,5+@; -!$=S"U?TT)U8
M)AI1XPUQP'!T,\+&*.@S H([_&;GK <)%EM<]UC.CN'I/@Y2#N3+PMAE-% R
MZZ*;=>%+,"X03-Q=7CE-GKZ#9^XM$3H2)$('B= ?3806-G43IEQG(F"=L]BY
MHXV:Y52QW^>64'P0O]RW;5=2TT0UNC;(#-?-)-.5[*1F#@<-)&@.5X[8R3A9
M:#SE6+6<-AIZ?TF5>NB9D<.5-:=BU*?<L,"J;(E65#$:S5CHF?'#E4N%5'.-
M) =7KD;"M-B0L]4VPU/'^QQ6B>9ZRI?Z<IJ<Y]5:J6:D!TN>/EZ9[=D3>['H
M2^R<EW-/;+)/#@"J&3XZD:CEZM-BLJ#*W=G:[,E45BPK#%QY="*PZ(^'&6E>
M9KL=?I;,&M&J,QG#E4<G:LT)<U2,@:;LJ!+K@-F\U2#1,Q.'*QO.NA2>V?6X
M[+16Z<63/LG$JJCB[^A$I76U.*Q&E3YK@R156N>6BV2$@2N/3C2OMC++?F;8
ME55JU"@(*>Y)+*-ZF:-G]JA*/EK26S&B6RE2S=)BD2VEEBAL>KA271OT(EZD
M&BP\3"13G"=L&>XS?OS,<M/J%O(B4>#LA=@SG5@T7DDQ4*LX6KF8IMA%-1^W
MN;E&S9-I49T:%EIY]/;R<E0I9D9MAL@IG!)O]F+$++%$ =[#E28_K8+)O!'C
MJ#R5(9B$IG3B#)\\?KNS;E8INCLRV:XLPX-4&66AC^'*H[=G\EVSR#!TCP/3
MI](ZTY 2!0OB/''\T$ZL)]8SJ5%8GG?S\W"WG.NU9F.T]!CO8D2O++6&2:[6
M!9%2*4K'=:V!5+JCIZJK7#L.&"?)UO+=Q73=ZZSG$/%0>.-P*4=;F31$*8FK
M+:SN6HB+:GG"H*5'Z$S6Z*+>K&99CFJW4K'FL!R;Z7@#1_C<3"[2K8H8UF5;
MG1FQ?#2J2'GX5!_"8Y<-UA@,6SIGMPRY4TN.BR1B$#X8K4*46O7#(XHMK9-)
M)I6+3HIT RT].I9=Z@KUV: P88&A2T/"[)?C,;STZ%CA]JH<(P:)))OKJ,R8
MC#;X)H<W<'2L<KY%%9Y2]I"S^X2H+;ML(M*"3XT=[U493M=A9IZ?<50X1DRL
MWKRZ#L.G^A  P<T*6C+=+K,YKI&5\@U(K.BI\>VQ7BA5.9UD_XZ4?.J\2?C?
M-DL*9:#NZ)N[FC.VKI%:O)M,"359+V'5+ZC@!E_&N#,P:EUJFINQ2+[OP,8C
M4&>Z 0T-:'B[F=4NP [R4E]/;_6B0AH*UC^G,V.3=)O;Z5G%..T4E49XN:8'
MB7^>X0S@Z;!J_VS#> &CYX=L1JT:WD\HK1^GUB\GDCC9S6K=>\I1<FOW(/O@
MV"K7G\VQ YL/F<\H=1+;$L_.D<-3[9QHWW'A[5529_!%$'H+ $D,7J6(##R4
M$BPHFTJ#Y\QP+WO3W#43L5_9]<QA$\60@>4YH75L5'G=K[=0,3WOP9OR-E^Y
MI4U/:&SD":YZ>0RHFW&8=??<.0>SW][FE/5S<_#BU$Z%!T[Y21:D8I\U0:$F
MY-X^[N>SCI-33S)SD"^4(:VF',\_V\0J.S19)])L[QV(6R)FZ:T[OR,XMTXU
M5X7.4YEM:?7T4B3:58W9<P03;_ #H\2)74>^._D-FMSP%<\N'Y-U*;L ;[H.
M#-SC9^L3)G8<0HN>$BF0W:<4&Z:<V<"21(I#D\6@G7/L$WYFO4<N((^VD*O
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M)Y^:M$K9K#+F8P?[Y",C.DG1@L"#V(C@(S$H>A-1<< +"3HY2HZB@D@FCVZ
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MK/!/Q:Q39O3;2Q5$+'A"0=>8*$DGH0<,'_VO>/Y371ES,E$=O#>"#P8CDBK
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M]3;;R0$?D198:WRGHT^[NCZ^QQ/>*I[VV?[O_WG3;M_6LOR-/QKO,2D@/+"
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M9CH] ->ZYLP&RUD/RVNB90F]\K">S>8Z' P&JPW7ZL7)1S/UZR]-1J(',$Y
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M')5DOE/I];-932WU'^O*?* \HB-Y[)$"Z747Q]#9Z?V%^/;%],Z-$],L*9<
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M^?=I"<,D(['@1.TU'.2D(R_>PA#PX8OXD(BP+_8[#Q@1*,2/X@,5B;YX#4+
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M8EQX&Q=BS>B'\7U4$?!/>7VOKW9\\OU0O M:+R9@P_J8!6+1C^D>BWZLWT2
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M?I92^4&EWDPUAQE>GL*^Q]$1AC<TD[/[+'>*Q)\[B<+-:P ZV8H0Y9E>9V8
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M2.[[CSFJ#'Z>U]'H[=.R/92;F+D^RJRK:4)R#,28<?YG<ZQW7''TEI9DPP^
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MG$5WN%HV\_'VC96W')C%=)+NBJC8&?9J*WJZ76RA\H;A;]'>7+/X/VZ7AM#
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MQ[,DH10D>EA!-U-BG.DT<ZI(.$ !@W?FO:Z!G=R9)\BKS\O8XV&G[&KLW4_
MK[L(\B.6$>?_+'13AM/Y;8@J"UN;/;G![F@V!P\!O#Q/-W[O:O7W=]NMSSS.
M#5(_)L5=VR(\\8CNRO\A/<2][,=8V])C: R%[_T/>/'N_^^XON]SH+(C5?+P
MR2[&[LX!4=F-;EN_)_):%(XW\<P&QLED<TP[?X4^;)PZ*3XZ52\/X%UXE@Y
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MU;-<I4=I0R>'.85&I+:R6<Z=>FE!GN/ .KGN#.TJ4Z6+<F^U:+3L92(MG>-
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M-L99IK&HIZGJ2)EP'#LW<"94EU<  Y3K&)5!VRDY"LLWT;56J"2GI,1@&#1
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M$'2[33"#!5;&E/D4,Q TW^K'M388&2!H8CWG9W:KPRG=AC)V%FK&2%4=,#)
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M+.V>'"X4:;IW6.QQR!V!8SNE.O;Z;,ON-X@'%PIS^GP!3R!XM/ >OLY9!<P
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M82OIL'F;DP/I/,J!DU8&9JN\$H7S]M(FW^E*[=)8J::UDEHKU*?#$0GMI51
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M[C$:S)1B12.Q)#WH41/-&#GZ8DI"F_?I#3V97*_&].WL6,F-U.G6&2/;C.*
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MGBL#)>!Q]VD"+:B8=XGXH-U3JFE-Z[6?P^W7.J-2ST+4:G4%#MD]T<AN3[W
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MZ%*XG4MA5Y^HH./"X-K'6K\3BMWEZ@CV?^*4D97)[__ ?Q;?DU0@&HBS][:
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M\/+L4G$PY_.9*-EO%%,OE3/!95CJO0CF2ZO4F"NQA"RUV6&)1[C"AB,'X&(
M<P0DU,)"G;M]0==::D+B75'KG_?T X;3:]#M/V<^8>L]XD[;(N[3_=\673B^
MW #.TI>:$A>^9JN1W?XB:"C/[@E/K79N"_@S=WQQX/VQ,4(RP15<Y K<YOY$
MF+EF/ZH' ?AQ&_RJ:'_%)D<^NP@B3#UH&S"_703IC,(-;N+J-Q'P)I]<1,";
M_'(1 6_RR4T$O,DG%Q'P)K]<1,";3GL37TP0.>9#NMRAHU\X]%F9\-G;,VX5
M5)VX_.^HB^3&S^>'Z_--)U(J3),7K17<"XV/"7H'//=!X5>&2H XMXHX 6_Q
M"8I\2TWR<<OG8XCC#C9$,=R3]0>_;Q[[1\K7#2-*0A5-TQE\AVRAFT*6FQ._
M-XPF)YTT$"#'W2$'<5/(<0>J_&VC"_[5^1/;65!7382'SRQM%3,Y6:9_B3\_
M00*?2#"Z]ND^[;S9R=2Y]LYK0%7A&YX6 [J=I$!1'BJ:@E*(D4=XD6U\FJHS
M/US7-:I1J&M7H_QSHO(3-R#AS_*3L]6>G"#Y_/NE*+Q+?WL*4>8&@U-=4QGA
MS:1LEE+/%%GI501*8'[\)N@GDMA-O Z(."#B@(B_6RUQ#B)NJ9'N.SG/SQI-
M77@61F^],M_N0B*.HAJ!)_Q@Z_: B ,B?F@B_D9ISSF(V#8JQ%#@TZ^XG<YU
M^ZE<P1BDT/P%@G"H.$(=:JKW=7ONLD:"W7:MMK\43=*'X"?V5_M$EMN-F&GW
M;Y,]!MOW36>CKV#C9P6!?UL9(3GPUVV;9 L>F'$XX#XU+O'Z9L5+D7=^G&+R
M,;H7KS_;,8%&MAB-[QIBGV&@ >D&I/L I'MF0^PHZ6JQ,B57)"G9&%,O.346
M T;+0J0++;#(KMX64&Y N0'E7L+Z.DJY'-[AGZ5XC!W,:SP3R8!4KQ/J0LIU
MS*Z#I'M[,;3-'BV/&#D[EE;D*U?(5CIBX+,+?':!S^X2IMIN.YZ5P "Y<;LY
MKMA&@S5&]%RO5ZWW3D5@G(@9]10E\,#9'A!N0+A7,=0.$N[DN9%62_T./A88
MB^E$1P308I!P492,>>*H0T,M L(-"/>A"??,=MHAPAV4XN+S[$7F^/EPEF>+
MKWPWQ2/"743&R$,B=Z-;ZEI=\O=O)KQ"LX79OO;)HEW5$/Z\J*<.$QP8[JF4
MWBQ_7B^:7B(;ZI&G&[\6WH!EA?9LS^.<5X=9L*BI(9DPOG P(.B )0)AHFWI
M&([AZ+WK%<ZGZM*W=K(E:80CC$L=W^O(]Q%]TF&<NH&&9?LJ^H_G)@_A[M0%
MHG!,F&-]=U0&GL\R1,U$Q/[+^0E^&_R%/X7@GWX> \,GO2C?O?VS==_=D#/;
M><BGOMC+G"*C2:HMPT<NN@,[> !D#/(*<S7%T^L2C&+*$]%0'(XQ$N=#U%?T
M"8,W)?7<AJ":;F$F?)M3[*19X1W7V8=LX#C\CB#%P;I*'W.$SR'+X8%IM\X%
MSGOY%V((GTIO^=J]7F;G21T^#E&NXG(## W9$57XGPG0;(!U#'W) O0.UH-*
MY50TD$=9@^@ /X3,0H(/UH? 6+$#T3S&#4[;T/Z/K9]K=6U'[?/WC;Q8-S\Z
MSO^<M*K12 5#]X(DT>QAB*+AS;EZ-S(#3M"'_4!?YQ6\3J4X>EJTT]T9*:F+
M#]SNSLXGG^X '?UF ^B-PG26"+/75+JNV#_IR!26M>^-KM)A+!+<RQ7NY:#P
M=8?F^$PWV56]'NA&N##K/VWQH6\$,JY(<"/^NI& :_GK1KAPY!:<>@]T(P'7
M\M^-!%S+7S<"N=8M.!YO\D:^V$_NJ-E^-2!<K WO,0/Y_)U]O@03'S3ZP</<
M==/-CS7ZV0/0"_40.R;^ V3:G;*+^[MKU->1Z50]QP)D^@8R^;L]ZM>1Z<L=
MR?;)=Y^-YTZ@&,Q(A%>"XB[B$&[,,A>1--F-G@!L"$33-IRXS6H.I^J-BU9.
M4I+MRO[KYJQ=E^B^;5#Y#*4^D\+X"0>P/],7SSGM_:H=M\I>/LR^BK/GMJAV
M"$$:L'D9C*W)+!]IQ 2X,:> (/*] H)/^&Y\A@*'F4% [7_B./7955^!VB_:
MFNL M3>8OCG4.V*W$7HMB$3#+'"]URZD=M9IL,=%[HC: ^(^/W&3 7%?N&77
M >)NQ8R&&E$GM09+45T<U]C40)A"XN:<DB*<.=0]\_8<FE5T]2&]$[*AO2*:
M)H"VC=ZV1$5S;1LPDWJBU@6.\>-:-7H;GL2YN]-9-8$)\_V8T$TPN<,)*W?)
MT<YLG#B46^HT3!!#9%ORB#:C\1[)IG1CD^OE/7?$? _;ZX14G=7QG#[(I5LI
M/L^]=OG,5* <"X9X(JASZ32!N7+CE'TXJ>,N*?O,ALAI*5LG)AU0X")1?/ZB
ME3//W=E;)XN:D")KY8DAZ1LE[(".3V^&/!@=G]GF."T=$_7G?BF4+[WQN1J3
MFO?I=B0!$!TCPP0_TNO@#.4X7ZJ#V:;)S5)K5""S1Y'>6Q_CC[J>3Y7RI-U.
MO>K\"=/MA?4D=@W@A(E,3-;= JH11)_.'(-/4X8C59$4"X,X <)8O0<, -$-
M/&%3@ &X*8AXP'F8HDG&HDJHK1N&/D5C=-#7%O59"GP!Z#AVG&@Z,2H%&3[P
M*<XR],2I;JLRJO-$!5[N4S!(92+F%/=8:/,0/#+6%DW%?'+*P109 @^^R;3A
M*SH0SW3#J292@=:U>M@&0W6QL6@/X5>D/;\[B4!KN4X2A)"!#,;>5BD^A9\I
MW^E#LY"D5YT8/&84Y;:3F/[[OSY5W[]V+"]#C'3X:Q>$W$0PL0/?_$M4I^+<
M](X9X<+4LLQ_&01&<, (/$PQ_\;6?O[GQQY@H@*LW8I]M\#*^]IFC=7BPR,)
M:6LM$4@BC"J^UKHBT(3;$. "N6G4ZF;^(V(] _'W?]5+B;W6._H9XA[DV^J&
M!>]]].-WW2EUTSM8PJU9,Y>(+*[GKGV$K)N@W@=!T6'C I"C<H0&G$!)!!!H
MAI($D8D H<VU69S""9;CV!_N6\5EKPQ0;I#E*E<<#)6N;G?+!/-:BT$)1FVO
M9-\)*:WE"[D!2+YU3;+9*@ST"ERY\\SL.U'G&55+X?/B8))3WB)B[1T]D]M>
MV1F;>6FD&E4^K<VF4]+(=>8Z\H?AVRLCC"SELBT]@0.ZS$_9<A6T)EX0;'/E
M+%M.I_$I1>,U=9HO94/52E2+N0[TS96FT<Y)69 HX.EXJE0PF:Y6C<9<;]SF
MRD1+3 P'REL2GR>U9JZ8BG:S+20>-_<IM FJ34<A\.6VS DT346%*,?"&\#;
M$LF"#LM%.]O/SN<B,;K0)X6!..4RUAM5J*4@#(A=&(0Z6HW*$SU]D)ZT[9G^
M&B(C.%I);J^,S_(T:QJIY\%P4J[*G?(T6T[MA>L;2%FTGM92C=JPW@BI79Z(
M"2C<L//,9]&(C.LZR#;F,>7UI:UG0\GV+@S@RIS1F$2J96+>F)<Z\:A4FI6?
M>ZA%YL[*8<L8R^DD4^%KH78C;S"O(XN?"LSN2EMH5^HAOLOC:2-;3!?&_614
M[@KL[LIQ>4Z.&VFZW,B-*:ZI2U*F'9H*D=V5\9H\%"OEAC5(O/2:!#.I)<>C
MKA#=7?F>B39B=C8?Q6LU_GE8++XV::HK<+LKQ7YQH$Y;38"++Y/TBYK-<47X
M=@+?7=J)E#-5QB#R>#KS_OI2UV+1GM)%2Q>PAS(-:9B*9KNUN<X7VX+QEFIQ
M3:+_-AA6J\E!3"S7TKF8@)82/S[\EMG)O..T(/?Y>2]GOD^J.AC-*\MO7:!8
M_.OURLMD%Z>/!"HR1JJ&H9@#IY8<_0+@ ?2A(F% FRB&KCE),HKFZ2EHA?,$
MV?4_8[JC$@,SC,6<1WR^M/D#/:LGNIMR*YX=/0D,H2J^&CRXW+NLF!)*\'%4
MI%NHAG8LSU,41%/7K 1YV,+;XZWF\(,=P8-[N<Z]X->MP WNY>-T?X8.+L:'
M%Q.F#PZH"NXE8&3!O02,S/\7XPR.#^[%;_>"AP,#QH?7$O QOY50'S;TKP>$
MKT#AK#:UW^KJUN?%;,Z..4GAYC$-\ $PPF-2=U6*>;HB\<.&VT/DY_J#AFX<
M2/=(9:>KGC]L500(=%S%#P3539+0'_<,H/Q7&==T#HDBFG#O8A?L#3B>3)7U
MV>%/-MD0OU:5^TWP -_W@=A(]]O(PXV90JFS7AJ3C'9&-(O+!M[,$D*_5JFT
ME&1E(]4V9 +IEVP;J.GYX>*^!?'%7-JK+DC/^6,=$A[AYM061<,0E/0S,V R
M;'PP%M47N9RM,&_$%&74ANGMC$6WX?K)=&K_W^#)L^A]2_%^!\S]$3TA:-DF
M6^= 4>";N)(<#916?9R_"-%K[9&0#S7RDT:.K-:DCE078_T**G0[+]%?I]#;
M7YCL*/%^AD(@TT]!WK@@QX=QHYE]J?+IOF JZ?Q4RK0N0MZS-)W*"C3?'RBO
M\1=ESE;?2V#JD#=SC+QOSY^^8VMLY##>@K_\TA9%P&I\YVKZ7)W?R#: 8#R'
M3$E-Q@'.%LJ\WHF'N,QKY<?W#(Q59=_WFXEL\::D1WY52'UE8*#3+ZOY0N2R
MG._].9_/XZT\TV!K4;[%59ZI#-=U"^ZI\&Y1[K\?P9<?..LO;5'X# SGY0,?
MVQS7XP.C8:3#)>IFI:'D0^E:KSQ.$OFI6YY_1CYP@6B#O_ ]"!X\(L5_;(9<
MD>)#<HM.3]0AKL1#0CS)"6T*[[J%_%28.D3QER_CI]C1Q>KX_]XJBSMD;GZW
MV=+VB'K3!."#'@P%T;(-^%^G-K@.7QQ7=6GP8U&LUZYTYHWT^#W'AZP<2<7[
M)3;9@(@%X(V/X#LLPP;G+-H[Y=#13Q3:#5UH*.Z(6'T!LMU.U^Z<Z <?,,J$
MHT$ZJ@_34<DP'@P8]>&]4.%KCH8+KN4C<HF&(T']J7^RMUVQ<N7TGV\G^[2
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M'->)H.F+J\&0&0L,N80SP=M4- BVI&*NQ@U.%:L7DY "XWWI-$!R?T4/^J5
MD:](NTUX/UD!"M6KD2K.?RF:JF@@U$95K3N$ZLD_=K0G ?\$1]@SB]?+YT?
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M,5<&+42,KVV?.)!$>'9'4#HHA )\\&+4%>-^^@(U#\6Y4R?D784#4><",*0
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M[MN1Z,%LNCN:37?AP7,D&Z9I7_9?O>"8%>;!!\T0 03H,.?/X1J7) /FL2%
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MY+Q]@6W;W!VI(NSN#7F8O&S _LG2J+NCN@L3EJ,5^GY^!#_K062PS%]?G=A
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M\JJB.S=UL,+;E8I.E/;0NO^T#>SOWT>7%?7P*N![8J[VT05;AJC!+QDKB?B
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MK36,(3TH&YJNW+.586Z4;"$+E 7*%LBY%8>RS_@)$B-RF)B\_.3[  PUM0_
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ME/EQ ? 7Q?D-<[]D61"JV4JTHROOYO%Y%(%/!??P!O1Z[=XS>]9<D4/(!T5
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MF$;+6-L4YP]B7X1!<]M(5*<RI/;*:QDS7^K#I"X)/Q<8E"ZB/ UK."W43XT
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M.#C9 @O0_<#2?'"\S461XO+^91&4)C+UWO$LP'[CNM9[2L.>5K\I83SA*1.
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M#"3+7Y,LA>=D!7I][H<&VI3VEA7<FM)86E_8?0ES^9N!*$6QQ1<\' $VMYP
MU:D!9 LFT*HFHFE-N] PEWMF'.UV'SIY2+R>I QMQI(M<=%399KEWB3L6!3I
MT*^/HK4C2*F,[I]C3DR@Y%N5T;J^O3P3Z#X/C( L!LBI 1=#Q,(Y45WU_ /Z
M+'\NP8X=G.BWC*A@?/L*JVT5W\FRGY1F[2@::;Z3>3\5+8+J9P)[ES=.[OG5
M3)C@0A\= H)&NJJNK!\\CJ5VAE:2QXF6$0P(^$"5OQ$ETT\_G=V.^6[?)!S$
M0J*3#UC6&Z._,63%?8#<3X1&H 00P:J01I3T1_)R*I1>4O+HL/_.C$_1U-)Q
M^6'X?^Z%+7_Q]=EI"ISJ7@P63"O57JC7H> C[HN6F/-R1VK8+TZGG0R\O\9^
M[F?T"2W4CO+O;]=(@ ZT8R/(8Y3W8 8]=!JW[S:O^Z%GE\ "V\1EI4NC#K&<
M,3SRF6LI3ZFE9)<X4G<X0^'3X,D09]LULY*TM8LAK\X5>L->V)C)F@BP2PM^
M[A9=#+#B;H4);T@@#^LU#K[S\B.I18EMNSR1/(CJ?2"IVPC=?'=Z3VF12-H
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M[Y-L'4R@29F%:&)-(EB>%E/%!'Z^A9)CZ6Y,(#.)E77I!WU@6^YP9>AH!'6
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M[%0?^F:4);L7[NJ+'>_;A/F#2G)C5(.I_V4<64;A%I-WEG-K&[S)\V.[79N
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MBLP2K2>X8BA$=].$Q&5C7^I'+;](-9,1R.LJ.;+3&(W%W35YY]J2P_Y3P9T
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M$.(K307D4\W@K06Z;Y'W@ *-2C0I,L$!P9<MM2G4>L()]#QME2?-KV#+JD:
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MSH1RD8,4'DS@,6=QTK,R[9;R"Y#B^X+5L.'085J]^\6(]VHNE0?)D9K!F9*
M!GG>Q^,BGSLLR4J?F<_]2CZ-505!IJJJE&XB$"@'<!]KN5'-1")W9Z7<."_%
M#'ZR&;4]&W.\?,A]?4)I8Q"F@G,,K&EM19"SI6/?;V!<KT!H<%E+8#[9!8>V
M>04AC]7ZRSWLHO/A7\LA[Z_H2E[YR_SNIECM7>@<W35YFS+/P;Z< N*-<VL:
M"''BN]- DN4TD!4I'_>N>UR#RU@M)5HBQ- EM:O'%AR9W4%\(5H86NB_*7<3
M4[C,&W'G4C X_#EVZX/KK[E(J)^M!TLR+E.5TU"CK$B^:Z-_9WOSEU>\"2L4
M3L=4JNPP1]^0(=8CV E62J-OH-96R\;4VR+<7C9?.V7_M9IY2%YEWAY'E<!:
MT@87;*>!VC6!TQ#V0W#C&<P_,0ABD&FGI<#\2G<-705^>"E?B)G$G$8SO;D=
M[OH"IU[4!A@&<VA>'C'99>>GA6^;N2N*JYHC*&8(GVYRC7V:4N*UD1\F>HL]
M1HO:)$*7#'F";Y3(Y@W5PE;&V#6'Q) K80;D6<.O35UNMYWK[FC"Z;4.RM39
M;[T8D0EH2"; TV*+W(:S(6D_%F= G/"6V(A <0I,"7/66U;ATBJ'5A\8].TR
MBJ\0*>^B+)EG7NF\1>4*J=T87MX3;*?.1R2^[!YV>'W<W@5W,X(47BOPNN^Y
ME1OTS"/69S<*6*]$%OPILS$V!GRO+_$M,7_00I2)7SKNKPM6ND(0%GQ%/Z,9
M5/K.G>N)^5T\KL!NKW;Q'3PG)I9;-#4K6;K:ZY2KB,74D"PIU8P_QH/'3X&%
M"M.MU()Y,S6&>T@MB?2?19(H_@G\4@ C)RVQ!.LFL]\A?JLI"5Q**PX7UV%0
M\TRM:E8@Y+V3\6\?8-_6!1YM*F>2:#A*)BI+P>*,UELXX6O)V"$R/42FA\CT
M_)%>#9'I(3(]1*:?8V1Z&:4D)@RPNC/CT^I;"^'7.@:'FM@53#C/'%MVILYF
MZEIA=V%%Q8,9]6C,J$<#_#WX@=%A>;O>,V,D854_8(VE5--14U8N,90M*9O&
M*O4DT"?44-2ZD[G7FUFH<^C==3 7U;N]YL["Y6K*:[G3EG'USW6Y73ZAT17Y
MU&+FY[C8Y6]^F PL\$;ULR\O3M%V-]Z<=471OCD]39<A ;=A)4SDF9^A4S4C
M$X<Q.^O9H[VC$LB"&G53N&V&C2]*12F?V$1 YPAW!&P+OB+SU/:;"* I2\-6
MS.1\K)A:<#%AN[X4K:4XGJ";WQ*N(E/_;K 9C31%^'1_=NTM,8:_C@_#*BQ7
M"'PSX:NHJ8T'-@]7Y@)1@LG)7^$EH^KIU>(''1J.]Q!"3P]"N-U,NJU$KOV&
M+,LZ"6]7O(UY;*..>NV8^GUQ0$-<>U+E(+VH&0BHF#DW>.$2*C'F3W #T'$$
M@XV Z>*G5&P"(R"6?<14&8)BYPB?**8%F!CL-_.&,(V#S1V*YPE0C\$Z#M76
M@$.]MY.86'(9TTYU\4OC4;UJ]2)Y.$?X)6WAUU8+NAJ]C7W@J\T\KB F!N$Y
MZ/V]K/&ZO'$UG=2Y:!(>X7%#P<_HN ;9>*OL4>1><29=>4OW0X*=I9<3X8V;
M,E?5Q$;2-3[,-4.N= '@@JL)5612F'(H%8)/:D&UM;Q?@]:%%<42#&18\G>Y
M;(;&';/B"?:6^1G(?!Y>Y,>5B7PEY/U/75OJEJ$@H.3;JE5/68QV;,@Y8M2S
M+'TI:I=Y%3$J!DEZ#RSF834,>/48&P:<M#HLA?T#[N7TALCU$+D>(M>]([T>
M(M=#Y'J(7#^3R/53J7C^D3!WH!1_M' ]W[0),BW[.CNRD> :[I"_4)"8QIJ;
MLV)>^A*#_1;5ZK$V2:C2AH5E3K&>)]6BC6RJLEM*IQ8E92)1:2Z,-"RN%.3G
MON(CU'!.&6W,>PFVL\;ZN!/NU+0>8QU;[")TRC5IVT #71HV+]"6Z3/WPMYU
M6[989+<$+GR"ZCU6Y,QM@LO2W8\\JX^#46<$A[_L9YT4\@X5.'BZ/O^76WC8
ML"5LR[1SCO56=$*R*\_(\DXUK D>)BP&E8MBOY?VRRU<IDF;TI60:;']G@",
M'%%=V5+63:F+-F.JV@;9?TO55>42\N8PL:4ZD"YP0]G36"N^I^U<T#-4C"K9
MM[[(-FF<M^0N(5)!?[=](U$I!@AO_[+%M9A-K4!3AIM/"_N^<Z][NE)Y(F8B
M02I(&[K!4T8HX]9.+BIJGJRRC ;@P*:J'&.B,QSA[VKM.81CA#.DO) +C";2
M& K67U%"?D^]C5+?:\QX*77$-DGDK.Y/K6M[->Q&9?*4.@,@1AO70 '59]WL
M\M%4WGW?S6S]()I*MN7S]3K?S?-[=06A?;$FZPYS]_R1'W4VDN>ZJ#SYJ&Q?
MUNC5VNGZ0V19=HN[W&KWR3K,[K;T,=((%KX'ONRW&)>DN&58I[S#^KU& P1.
M 36,O<QX%I<(PAZI4 *I2J,L65\HUE-G!,:$:BV:1'$]*98'NL%'5R180:!E
M@Y8'6,Z TYNMHI?*J>D+Z2TFD.TD/JC<?U_;!K]P@6'UW/K&/:-;W[0=P+H\
M,B9$CK523BDU6,*%L_1A KEL073LF^:]!11=)<]HA$Y]H(E.T0\/SO5M671V
M\7,/>]W&K6OCFNGFP1%0MPCD\UB0,V/-0'<2B)T)@12M*MMAH,1L+5!S<GF:
MJ5-2U*S&XT5_D,"!SH'=UR4UM%#YOT"H%$V[RG\,0S[[0[[N*?=>'?XJ:)1B
M.(_A C9^!X;+1(T4]:0Z+\KOLTPDNBBK,@([!H'] ^M13$0IJHJ5!=0_LZ28
M<+*MOMH8YP=%^HX5RE4?7_"^7M6$S+^*MBHOL ,'[HD1&S5]$AOE")&#'8D5
MNS@P&B7 D9'O:S5'7UBC?^CJ5(K:F:0@QV*29U1+WE@:_'$?HGDDC'ND*"UR
M+&CODR&'[[)Q5V>&]35^)R-.SSERB<]3>R!J"$+(TE#Z^ 7#>4^ZVX15WU/=
MBLUT12/'2=XJ/@8O*#*&J*8-<IRTF'F6DQ59UN>$1?_+)O$Z3"^0FBBOP4!2
M%D_2D:3PC3=7TGO3,\5V:U(T8%IF-KH<^D7XE#6\A./'53-M'=X5SM3S>5%\
M]PHG\=OE706HSY1A))Z]T-'1@FI%KCO,2'H6@R9>G&8#TB7C@+;^J>NGLT#W
M$;!WLPL&]UQ" @(.KIR2B1M1MR[X$17@\RHI@4VQH:MBV3U"N8>I/!(K&E43
M-0LZ-)"A!%_*FMO\>=^@/J5[YV'O)JWA(5Z".4:T9MQ=]KX9IU\5((9:2^ZT
M)(?'^4H@\,E6E,"*%<6I)!66=%Y-AK$^AHG$28[DN-!]\6C6H*".E>F'*&J+
M__>HJIBIW+;<TC]KNZ]P2HW*G(_5: PI)8./N(P3" I@@.*T%+-)9$T*V":G
MZ8A106 (4[>#\Z\-ZV30=<5T0ZX9]+, #WE:,N<2GT7R2'T61N L\EO$)&'H
MR%U%14UR5W1I= P_W\>AI:NH22,VTC68H2W^5@PEY >XPP!W6#32FP'N,, =
M!KC#,X$[!'2>%UJC95-(J[0=-?9:T8(%P8)G';5*'YD&Z.EI^&I4K/Z!!L81
M$<Y<B$E+X]-=T8'A7J[\M5X1$EY0KW=!R;S%B!4R4B]:#DT>Z0M?@A8QKXF*
M82-HI!(VI&.0JA),J+676^L<B0ZJ\-;>4-R;U;\<'G(BZ*7D;Z>>LV[AVS_)
MUG(TF"&'2>/,WIJ9N?W3^!DO9L\) ^C*XC1BT.:]HWB(8;X6,0[!OML,]K5[
M8G-#<KJEW0*\,[Z>!D-S7D1K.WHVNIJT#J?U)%IP>6<=]E,Y^5*KVN977]A\
M"6L9=J^UD:-^.TJ=4A9'E*-CBGNBWP6_]9L58+C/N"UC,Q/*]NYVM<:X)S(L
MH7U6 <SKI<4,]MP,8Y9R AK+Q!9BY";[R $=$^^DA/<4PP&-R4?224"\44NN
M..:4.MI/]HNJRCK&!*;\%[03,:%<7%B479HB1?.70@^\7&I(+;[+//1J4ZJ?
MB4?AF:2JBZ:Q]1,ZZ#.CNVCO$CO9VC[7>[V:#X$YW%90LLT73"S@<MJ]))NL
MX.KR++PB+93)A6@B-21P6A=N+JPRC@)<P-*D:M:#M,I"4D=;!WI]'/%5_O<-
MR3&.^FB=A89%6;6L)(XL:7>E2VW."IT3ZM.C%SIP)I(3(B#+;0,M329A5&J9
M*>D"K(4+(5O ) 7C0FP'W!LJ$J,+H](TM9!L9TYZVFT(L*767\^=<&]6&YE0
M@IH%M;L5M3ED&F&0KQJWM)"W-M2P3$FJ#N/<C*('4,#FL?5.>&"N!OF(7 UA
M^48,Y"SM9=!^!0JVWB#$U//>)<)./8XS[ZH^,K?9?(_X_1/S^-8,VY60=*^'
MQJ=CA-+X;J&>]D<<RD2X2AL[TG*1!2BDZ;3)8?>U:;K04Z0K#PCT7*&& 1^S
M(GJ35*9EG42K[=\^]SS,14974>5A??6=)A7_R0J-N_4@(3@E(7@V$IN!+@=4
M;\TZ!J\$*7$E(MH8I36@B6_#<)_3] !AHE0H60L=#^3$"!WZV5@DNN!DHLJD
MF3)LM(J23"@-&#/EF(67KE6'I2\N%<NFC9=G\4=5$1E22F-K70R0C@'2,4 Z
M>D?Z>8!T#)". =+Q3" =CT%]N9G^HEAQZ#.7>P+SH'EX7E8?)]!?K2 VJJE6
M5#O!^C7V\W/@WAA:PD^']>WT==]3T?+B=?*\/5]!8/CC=_VF&_L&.5/%U\1T
M,(+*VZI10UHW.7@G[-^&87S/AC4O'?C_7#!F_2*BJ]W-$PCG')N8+.5"Q&1
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M#^_=B]&O*(\[!'!YDM!:LN[N1L"^5I!W\:!]+3?S!![FAC%8X:"]$2^WVO*
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MX3NL;4#M=4J*&7,H325D%3,+\F@J@]OE?*'N14!YIGR9WTK!0D&=838$_H?
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M]$P5F<=[?+YA0V_['",(@[F7[D3;%&Y5,G>K=>F^S,FPV.=YB4X_#@#UU)/
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M4I=CJG8D@ X.5E#CWZXU&^CCGYFBNW:+A"TTJ)T;]G>F0AV$O@D! F?/)B$
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M.->25<#'P]\.<1X(PF@'0/'8BTQ="O3 !%^P)N&SV1?OLX.P/7"*O!^B1!H
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M89IZE-=Z&0<"^>+QR?BD_G?@(W5ZH/%U^NQDGEQ3L?-83283?$RN<+B:,G3
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M>P^!';4D#E OH1*K#;-_QNC@YL(N!GQ<"!=@0R0,W/)M-J]Y4*Q(L"O"-FE
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MS8^^K>=0XG_8YGXI=_(_4$L#!!0    ( *>%6%8@Z_1E3P@  '<G   8
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MNSG:33PL\QQ6$G10$[98:<'J2A=:B6W=<$-D[9QK;!5FP6]N90'NPH^W&;>
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M'9U)Q3LYXQZ>(;J^_X30]>@Q@M32C_'XFZ#)4ZJ!Z?5)H+!>1V^("(5&"-^
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M+3(P,C(Q,C,Q+GAS9%!+ 0(4 Q0    ( *>%6%8A\_Q=G1\  '#U 0 5
M          "  :4;  !M;7-I+3(P,C(Q,C,Q7V-A;"YX;6Q02P$"% ,4
M" "GA5A66R%H9%M8  "@$P8 %0              @ %U.P  ;6US:2TR,#(R
M,3(S,5]D968N>&UL4$L! A0#%     @ IX585G7= >UQQ0  %FP- !4
M         ( ! Y0  &UM<VDM,C R,C$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M *>%6%8[)D8T'HX  &BJ"@ 5              "  :=9 0!M;7-I+3(P,C(Q
M,C,Q7W!R92YX;6Q02P$"% ,4    " "GA5A6H @-^$3$! "*(#8 %0
M        @ 'XYP$ ;6US:2TR,#(R,3(S,7@Q,&LN:'1M4$L! A0#%     @
MIX585C;LY_.6$@  *Q,  !@              ( !;ZP& &UM<VDM,C R,C$R
M,S%X,3!K,# Q+FIP9U!+ 0(4 Q0    ( *>%6%8N'/L9XL(  -D9 0 8
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M+FAT;5!+ 0(4 Q0    ( *>%6%:]1#E1D 0   L1   8              "
M =3R!P!M;7-I+3(P,C(Q,C,Q>&5X,C-D,2YH=&U02P$"% ,4    " "GA5A6
MKU("%G,(  #])P  &               @ &:]P< ;6US:2TR,#(R,3(S,7AE
M>#,Q9#$N:'1M4$L! A0#%     @ IX585B#K]&5/"   =R<  !@
M     ( !0P ( &UM<VDM,C R,C$R,S%X97@S,60R+FAT;5!+ 0(4 Q0    (
M *>%6%9M!80\U@4  ),7   8              "  <@(" !M;7-I+3(P,C(Q
M,C,Q>&5X,S)D,2YH=&U02P$"% ,4    " "GA5A6'.P,1K\%  !@%P  &
M            @ '4#@@ ;6US:2TR,#(R,3(S,7AE>#,R9#(N:'1M4$L! A0#
M%     @ IX585G)0\*V.%0  V8,  !<              ( !R10( &UM<VDM
H,C R,C$R,S%X97@T9#(N:'1M4$L%!@     2 !( U@0  (PJ"     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
